LF1|LF2|Synonym
lower oesophageal segment|lower esophageal segment|Y
postendoscopic retrograde cholangiopancreatography pancreatitis|post endoscopic retrograde cholangio-pancreatography pancreatitis|Y
postendoscopic retrograde cholangiopancreatography pancreatitis|postendoscopic retrograde cholangio-pancreatography pancreatitis|Y
postendoscopic retrograde cholangiopancreatography pancreatitis|post-endoscopic retrograde cholangio-pancreatography pancreatitis|Y
gastrooesophageal reflux disease-related|gastro-oesophageal reflux disease-related|Y
gastrooesophageal reflux disease-related|gastro-esophageal reflux disease-related|Y
gastrooesophageal reflux disease-related|gastroesophageal reflux disease-related|Y
nonaqueous reversed phase liquid chromatography|nonaqueous reversed-phase liquid chromatography|Y
nonaqueous reversed phase liquid chromatography|non-aqueous reversed phase liquid chromatography|Y
endo-ethenotetrahydrooripavine|endoethenotetrahydrooripavine|Y
anti-cluster of differentialion 8 monoclonal antibody|anti-cluster of differentialion 4 monoclonal antibody|Y
step-wise discriminant analysis|stepwise discriminant analysis|Y
phosphorylated cAMP-responsive element-binding protein|phosphorylated cAMP responsive element-binding protein|Y
phosphorylated cAMP-responsive element-binding protein|phosphorylated cAMP-responsive element binding protein|Y
phosphorylated cAMP-responsive element-binding protein|phosphorylated cAMP-response element-binding protein|Y
p-hydroxymercuriphenylsulphonate|p-hydroxymercuriphenyl sulphonate|Y
anti-human immunodeficiency virus type 1 antibody|anti-human immunodeficiency virus type-1 antibody|Y
herniated inter-vertebral disc|herniated intervertebral disc|Y
peroxisome proliferator activated receptor-gamma2|peroxisome proliferator activated receptor-gamma 2|Y
peroxisome proliferator activated receptor-gamma2|peroxisome proliferator activated receptor gamma2|Y
peroxisome proliferator activated receptor-gamma2|peroxisome proliferator-activated receptor-gamma2|Y
peroxisome proliferator activated receptor-gamma2|peroxisome proliferator activated receptor-gamma-2|Y
matrix assisted laser desorption/ionization|matrix-assisted laser desorption/ionization|Y
matrix assisted laser desorption/ionization|matrix assisted laser desorption ionization|Y
matrix assisted laser desorption/ionization|matrix assisted laser desorption/ionisation|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-8|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-9|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-10|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-6|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-13|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-19|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-8|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-3|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-15|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-18|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-14|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-13|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-3|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-4|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-2|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-2|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-9|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-19|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-20|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-15|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
a disintegrin and metalloprotease with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
inter-ventricular delay|interventricular delay|Y
fibromuscular hyperplasia|fibro-muscular hyperplasia|Y
anti-mitochondrial antibody-M2|anti-mitochondrial antibody-2|Y
anticanine immunoglobulin G|anti-canine immunoglobulin G|Y
cluster of differentiation 13|cluster of differentiation 103|Y
cluster of differentiation 13|cluster of differentiation 3|Y
cluster of differentiation 13|cluster of differentiation 163|Y
cluster of differentiation 13|cluster of differentiation 133|Y
linear mixed-effects modeling|linear mixed-effects modelling|Y
2'3'-dideoxycytidine|2',3'-dideoxycytidine|Y
myelo-ablative conditioning|myeloablative conditioning|Y
nonalcoholic liver disease|non-alcoholic liver disease|Y
A disintegrin and metalloprotease 28|A disintegrin and metalloprotease 8|Y
1-beta-D-arabiofuranosylcytosine|1-beta-D-arabinofuranosylcytosine|Y
F-18 fluoro-deoxy-glucose|F-18 fluoro-deoxyglucose|Y
eukaryotic translation elongation factor 1-α|eukaryotic translation elongation factor 1 α|Y
eukaryotic translation elongation factor 1-α|eukaryotic translation elongation factor 1α|Y
eukaryotic translation elongation factor 1-α|eukaryotic translation elongation factor 1α1|Y
estrogen-progestin therapy|oestrogen-progestin therapy|Y
cemento-ossifying fibroma|cementoossifying fibroma|Y
ultraperformance liquid chromatography/electrospray ionization tandem mass spectrometry|ultra-performance liquid chromatography/electrospray ionisation tandem mass spectrometry|Y
ultraperformance liquid chromatography/electrospray ionization tandem mass spectrometry|ultraperformance liquid chromatography-electrospray ionisation tandem mass spectrometry|Y
ultraperformance liquid chromatography/electrospray ionization tandem mass spectrometry|ultra performance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
ultraperformance liquid chromatography/electrospray ionization tandem mass spectrometry|ultra performance liquid chromatography/electrospray ionization tandem mass spectrometry|Y
ultraperformance liquid chromatography/electrospray ionization tandem mass spectrometry|ultraperformance liquid chromatography/electrospray ionisation tandem mass spectrometry|Y
ultraperformance liquid chromatography/electrospray ionization tandem mass spectrometry|ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry|Y
ultraperformance liquid chromatography/electrospray ionization tandem mass spectrometry|ultraperformance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
ultraperformance liquid chromatography/electrospray ionization tandem mass spectrometry|ultra performance liquid chromatography/electrospray ionisation tandem mass spectrometry|Y
ultraperformance liquid chromatography/electrospray ionization tandem mass spectrometry|ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
partial least square|partial least squares|Y
ammonia mono-oxygenase α-subunit|ammonia monooxygenase α-subunit|Y
interleukin-2 receptor α subunit|interleukine-2 receptor α subunit|Y
radio-contrast-induced nephropathy|radiocontrast-induced nephropathy|Y
intra-stromal corneal ring|intrastromal corneal ring|Y
BCL-2-associated X protein|BCL2-associated X protein|Y
non-lipodystrophic patient|nonlipodystrophic patient|Y
4,4'-diisothiocyanostilbene-2,2'-disulfonate|4,4'-diisothiocyanatostilbene-2,2'-disulfonate|Y
Special Supplemental Nutrition Program for Women, Infants, and Children|Special Supplemental Nutrition Program for Women, Infants and Children|Y
ultrasound-guided fine-needle aspiration|ultrasound-guided fine needle aspiration|Y
ultrasound-guided fine-needle aspiration|ultrasound guided fine-needle aspiration|Y
Durham Veterans Administration Medical Center|Durham Veterans' Administration Medical Center|Y
Durham Veterans Administration Medical Center|Durham Veteran's Administration Medical Center|Y
anti-interleukin-5 monoclonal antibody|anti-interleukin-15 monoclonal antibody|Y
oxygen-limited autotrophic nitrification-denitrification|oxygen-limited autotrophic nitrification/denitrification|Y
γ-amino-butyric acid type B receptor|γ-aminobutyric acid type B receptor|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell expressed developmentally downregulated 1|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell expressed, developmentally down-regulated 9|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell expressed, developmentally downregulated 8|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell expressed developmentally down-regulated 4|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell expressed developmentally downregulated 8|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell expressed, developmentally downregulated 1|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell expressed developmentally downregulated 9|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell-expressed, developmentally downregulated 4|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell expressed, developmentally down-regulated 2|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell expressed, developmentally down-regulated 8|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell-expressed developmentally downregulated 4|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell expressed, developmentally downregulated 5|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell expressed, developmentally downregulated 9|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell expressed developmentally downregulated 4|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell expressed developmentally downregulated 5|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell expressed developmentally downregulated 2|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell expressed, developmentally downregulated 2|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell expressed, developmentally down-regulated 4|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell expressed, developmentally down-regulated 1|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell expressed, developmentally downregulated 4|neural precursor cell expressed, developmentally down-regulated 5|Y
dual-colour chromogenic in situ hybridisation|dual-colour chromogenic in situ hybridization|Y
dual-colour chromogenic in situ hybridisation|dual-colour chromogenic in-situ hybridisation|Y
dual-colour chromogenic in situ hybridisation|dual-color chromogenic in situ hybridisation|Y
thyrotropin-stimulating hormone stimulation test|thyrotropin stimulating hormone stimulation test|Y
neuro-developmental impairment|neurodevelopmental impairment|Y
non-iron deficiency anemia|noniron deficiency anemia|Y
non-iron deficiency anemia|non-iron deficiency anaemia|Y
bcl-2 associated X protein|bcl2 associated X protein|Y
American Society of Anaesthesiologists Status III|American Society of Anesthesiologists Status II|Y
American Society of Anaesthesiologists Status III|American Society of Anesthesiologists Status III|Y
American Society of Anaesthesiologists Status III|American Society of Anaesthesiologists Status I|Y
American Society of Anaesthesiologists Status III|American Society of Anaesthesiologists status III|Y
American Society of Anaesthesiologists Status III|American Society of Anaesthesiologists Status II|Y
X-linked lymphoproliferative disease|X-linked lympho-proliferative disease|Y
non-high density lipoprotein cholesterol|non-high-density lipoprotein cholesterol|Y
ras-related GTP-binding protein 27B|ras-related GTP-binding protein 27|Y
ras-related GTP-binding protein 27B|ras-related GTP-binding protein 2B|Y
methyl malonyl-coenzyme A epimerase|methylmalonyl-coenzyme A epimerase|Y
tail-less complex polypeptide 1 ring complex|tail-less complex polypeptide-1 ring complex|Y
tail-less complex polypeptide 1 ring complex|tailless complex polypeptide 1 ring complex|Y
thallium 201 single photon emission computed tomography|thallium-201 single photon emission computed tomography|Y
thallium 201 single photon emission computed tomography|thallium 201 single-photon emission computed tomography|Y
ras-related GTP-binding protein 2|ras-related GTP-binding protein 24|Y
ras-related GTP-binding protein 2|ras-related GTP-binding protein 25|Y
ras-related GTP-binding protein 2|ras-related GTP-binding protein 21|Y
ras-related GTP-binding protein 2|ras-related GTP-binding protein 23|Y
ras-related GTP-binding protein 2|ras-related GTP-binding protein 32|Y
ras-related GTP-binding protein 2|ras-related GTP-binding protein 2A|Y
ras-related GTP-binding protein 2|ras-related GTP-binding protein 27|Y
ras-related GTP-binding protein 2|ras-related GTP-binding protein 2B|Y
ras-related GTP-binding protein 2|ras-related GTP-binding protein 22|Y
oro-caecal transit time|oro-cecal transit time|Y
dopamine beta mono-oxygenase|dopamine beta monooxygenase|Y
peroxisome proliferator-activated receptor gamma co-activator-1 alpha|peroxisome proliferator-activated receptor-gamma co-activator-1alpha|Y
peroxisome proliferator-activated receptor gamma co-activator-1 alpha|peroxisome proliferator-activated receptor gamma co-activator 1alpha|Y
peroxisome proliferator-activated receptor gamma co-activator-1 alpha|peroxisome proliferator-activated receptor-gamma coactivator-1 alpha|Y
peroxisome proliferator-activated receptor gamma co-activator-1 alpha|peroxisome proliferator-activated receptor gamma coactivator-1alpha|Y
peroxisome proliferator-activated receptor gamma co-activator-1 alpha|peroxisome proliferator-activated receptor gamma coactivator-1 alpha|Y
peroxisome proliferator-activated receptor gamma co-activator-1 alpha|peroxisome proliferator-activated receptor-gamma co-activator-1 alpha|Y
peroxisome proliferator-activated receptor gamma co-activator-1 alpha|peroxisome proliferator-activated receptor gamma coactivator 1 alpha|Y
peroxisome proliferator-activated receptor gamma co-activator-1 alpha|peroxisome proliferator-activated receptor gamma co-activator-1alpha|Y
peroxisome proliferator-activated receptor gamma co-activator-1 alpha|peroxisome proliferator-activated receptor gamma co-activator 1 alpha|Y
peroxisome proliferator-activated receptor gamma co-activator-1 alpha|peroxisome-proliferator-activated receptor gamma coactivator-1 alpha|Y
peptidyl-glycine alpha-amidating mono-oxygenase|peptidyl glycine alpha-amidating mono-oxygenase|Y
peptidyl-glycine alpha-amidating mono-oxygenase|peptidylglycine alpha-amidating monooxygenase|Y
peptidyl-glycine alpha-amidating mono-oxygenase|peptidylglycine alpha-amidating mono-oxygenase|Y
peptidyl-glycine alpha-amidating mono-oxygenase|peptidyl-glycine-alpha-amidating mono-oxygenase|Y
peptidyl-glycine alpha-amidating mono-oxygenase|peptidyl-glycine alpha-amidating monooxygenase|Y
hydroxyindole-O-methyl transferase|hydroxyindole-O-methyltransferase|Y
crossed radio immunoelectrophoresis|crossed radioimmunoelectrophoresis|Y
conductorlike polarisable continuum model|conductor-like polarisable continuum model|Y
local intraarterial thrombolysis|local intra-arterial thrombolysis|Y
antiIL-1 alpha monoclonal antibody|antiIL-1alpha monoclonal antibody|Y
antiIL-1 alpha monoclonal antibody|anti-IL-1 alpha monoclonal antibody|Y
immuno-peroxidase assay|immunoperoxidase assay|Y
light harvesting chlorophyll a/b-binding protein II|light harvesting chlorophyll a/b-binding protein-II|Y
light harvesting chlorophyll a/b-binding protein II|light harvesting chlorophyll a/b-binding protein I|Y
light harvesting chlorophyll a/b-binding protein II|light harvesting chlorophyll a/b binding protein II|Y
light harvesting chlorophyll a/b-binding protein II|light-harvesting chlorophyll a/b-binding protein II|Y
sedimentation co-efficient|sedimentation coefficient|Y
intra-mammary infection|intramammary infection|Y
anti-deoxyribonuclease B|antideoxyribonuclease B|Y
programed cell death|programmed cell death|Y
Durham Veterans' Administration Medical Center|Durham Veteran's Administration Medical Center|Y
Fcgamma receptor IIIb|Fcgamma receptor III|Y
multi-planar reformation image|multiplanar reformation image|Y
structural maintenance of chromosomes 1-like 2|structural maintenance of chromosomes 1-like 1|Y
maximal mid-expiratory flow rate|maximal midexpiratory flow rate|Y
ethoxylated bisphenol A dimethacrylate|ethoxylated bis-phenol A dimethacrylate|Y
granulocyte-colony stimulating factor|granulocytecolony stimulating factor|Y
allergic bronchopulmonary aspergillosis|allergic broncho-pulmonary aspergillosis|Y
infrared multiphoton dissociation spectroscopy|infrared multi-photon dissociation spectroscopy|Y
anti-insulin-like growth factor receptor type 1 monoclonal antibody|anti-insulin-like growth factor receptor type I monoclonal antibody|Y
stretch-activated ion channels|stretch-activated ion channel|Y
anti-mucin 1 antibody|anti-mucin1 antibody|Y
corticotropin-like intermediate lobe peptide|corticotrophin-like intermediate lobe peptide|Y
corticotropin-like intermediate lobe peptide|corticotropin-like intermediate-lobe peptide|Y
granulocyte macrophage-colony-stimulating factor receptor alpha chain|granulocyte-macrophage-colony-stimulating factor receptor alpha chain|Y
granulocyte macrophage-colony-stimulating factor receptor alpha chain|granulocyte macrophage-colony-stimulating factor receptor alpha-chain|Y
transthoracic echocardiogram|trans-thoracic echocardiogram|Y
transthoracic echocardiogram|trans thoracic echocardiogram|Y
prekallikrein activator|pre-kallikrein activator|Y
small interfering RNA|small interfering RNAs|Y
Enterococcus faecalis HH22|Enterococcus faecalis HH-22|Y
recombinant human platelet derived growth factor B chain|recombinant human platelet-derived growth factor B chain|Y
murine γ herpesvirus 68|murine γherpesvirus 68|Y
phospholipase C-gamma-1|phospholipase Cgamma-1|Y
alanine aminopeptidase|alanine amino-peptidase|Y
interaural level difference|inter-aural level difference|Y
Salmonella choleraesuis subspecies bongori|Salmonella cholerae-suis subspecies bongori|Y
molecular adsorbents recirculating system|molecular adsorbent recirculating system|Y
secondary anti-phospholipid syndrome|secondary anti-phospholipide syndrome|Y
secondary anti-phospholipid syndrome|secondary antiphospholipid syndrome|Y
para-nitrosophenetol|para-nitrosophenetole|Y
chicken luteinizing hormone-releasing hormone II|chicken luteinizing hormone-releasing hormone-II|Y
chicken luteinizing hormone-releasing hormone II|chicken luteinizing hormone-releasing hormone I|Y
chicken luteinizing hormone-releasing hormone II|chicken luteinising hormone-releasing hormone II|Y
chicken luteinizing hormone-releasing hormone II|chicken luteinizing hormone releasing hormone II|Y
pentylene tetrazole-kindled|pentylene tetrazol-kindled|Y
pentylene tetrazole-kindled|pentylenetetrazole-kindled|Y
p-nitrophenylphosphatase|p-nitrophenyl-phosphatase|Y
p-nitrophenylphosphatase|p-nitrophenyl phosphatase|Y
human cationic amino acid transporter 2|human cationic amino acid transporter 2A|Y
human cationic amino acid transporter 2|human cationic amino acid transporter 2B|Y
5,5-dimethylpyrroline-N-oxide|5,5-dimethyl-pyrroline-N-oxide|Y
trans-thoracic needle biopsy|transthoracic needle biopsy|Y
good laboratory practices|good laboratory practice|Y
latent transforming growth factor-beta binding protein-3|latent transforming growth factor-beta binding protein-4|Y
latent transforming growth factor-beta binding protein-3|latent transforming growth factor-beta binding protein|Y
latent transforming growth factor-beta binding protein-3|latent transforming growth factor-beta binding protein 3|Y
latent transforming growth factor-beta binding protein-3|latent transforming growth factor beta binding protein-3|Y
latent transforming growth factor-beta binding protein-3|latent transforming growth factor-beta binding protein-2|Y
latent transforming growth factor-beta binding protein-3|latent transforming growth factor-beta binding protein-1|Y
p21-activated kinase interacting exchange factor|p21-activated kinase-interacting exchange factor|Y
atrioventricular conduction|atrio-ventricular conduction|Y
anti-cytomegalovirus immunoglobulin M|anticytomegalovirus immunoglobulin M|Y
nonmelanoma skin carcinoma|non-melanoma skin carcinoma|Y
laryngo-tracheal reconstruction|laryngotracheal reconstruction|Y
bromo-palmitoyl coenzyme A|bromopalmitoyl coenzyme A|Y
endoplasmic reticulum-associated protein degradation|endoplasmic reticulum associated protein degradation|Y
endoplasmic reticulum-associated protein degradation|endoplasmic-reticulum-associated protein degradation|Y
[D-Ala2,D-Leu5]-enkephalin|[D-Ala2,D-Leu5]enkephalin|Y
spinocerebellar tract|spino-cerebellar tract|Y
mitogen-activated protein kinase-activated protein kinase 3|mitogen-activated protein kinase-activated protein kinase|Y
mitogen-activated protein kinase-activated protein kinase 3|mitogen-activated protein kinase-activated protein kinase-3|Y
mitogen-activated protein kinase-activated protein kinase 3|mitogen-activated protein kinase-activated protein kinase 2|Y
mitogen-activated protein kinase-activated protein kinase 3|mitogen-activated protein kinase activated protein kinase 3|Y
mitogen-activated protein kinase-activated protein kinase 3|mitogen-activated protein kinase-activated protein kinase 1|Y
mitogen-activated protein kinase-activated protein kinase 3|mitogen-activated protein kinase-activated protein kinase 5|Y
mitogen-activated protein kinase-activated protein kinase 3|mitogen activated protein kinase-activated protein kinase 3|Y
anti-interleukin-3 monoclonal antibody|anti-interleukin-13 monoclonal antibody|Y
antidouble stranded DNA|anti-double stranded DNA|Y
benzoyl-phenylalanyl-alanyl-proline|benzoylphenylalanyl-alanyl-proline|Y
pulmonary intra-vascular macrophage|pulmonary intravascular macrophage|Y
bi-directional reflectance distribution function|bidirectional reflectance distribution function|Y
free tri-iodothyronine|free triiodothyronine|Y
minichromosome maintenance 2|mini-chromosome maintenance 2|Y
mixed lymphocyte tumor cell culture|mixed lymphocyte tumor cell cultures|Y
chronic non-spherocytic hemolytic anemia|chronic nonspherocytic hemolytic anemia|Y
chronic non-spherocytic hemolytic anemia|chronic non-spherocytic haemolytic anaemia|Y
chronic non-spherocytic hemolytic anemia|chronic non spherocytic hemolytic anemia|Y
American Society of Anesthesiologists Grade 4|American Society of Anesthesiologists Grade|Y
American Society of Anesthesiologists Grade 4|American Society of Anesthesiologists Grade 5|Y
American Society of Anesthesiologists Grade 4|American Society of Anesthesiologists grade 4|Y
American Society of Anesthesiologists Grade 4|American Society of Anesthesiologists Grade 2|Y
American Society of Anesthesiologists Grade 4|American Society of Anesthesiologists Grade V|Y
American Society of Anesthesiologists Grade 4|American Society of Anaesthesiologists Grade 4|Y
American Society of Anesthesiologists Grade 4|American Society of Anesthesiologists Grade 3|Y
American Society of Anesthesiologists Grade 4|American Society of Anesthesiologists Grade I|Y
American Society of Anesthesiologists Grade 4|American Society of Anesthesiologists Grade 1|Y
metaphenylenediamine|meta-phenylenediamine|Y
cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 2|Y
spleno-gonadal fusion|splenogonadal fusion|Y
cerebello-pontine angle lesion|cerebellopontine angle lesion|Y
anti-prion protein monoclonal antibody|antiprion protein monoclonal antibody|Y
intermetatarsal angle|inter-metatarsal angle|Y
linearized multi-stage model|linearized multistage model|Y
pre-replicative complex|prereplicative complex|Y
BCL2 homology domain 3|BCL-2 homology domain 3|Y
anti-IL2R alpha monoclonal antibody|anti-IL 2R alpha monoclonal antibody|Y
anti-IL2R alpha monoclonal antibody|anti-IL-2R alpha monoclonal antibody|Y
total anti-oxidant status|total antioxidant status|Y
platelet micro-particle|platelet microparticle|Y
mucosa associated lymphoid tissue type lymphoma|mucosa-associated lymphoid tissue type lymphoma|Y
mucosa associated lymphoid tissue type lymphoma|mucosa associated lymphoid tissue-type lymphoma|Y
endothelial-monocyte-activating polypeptide 2|endothelial monocyte-activating polypeptide 2|Y
endothelial-monocyte-activating polypeptide 2|endothelial-monocyte-activating polypeptide|Y
endothelial-monocyte-activating polypeptide 2|endothelial-monocyte-activating polypeptide-2|Y
endothelial-monocyte-activating polypeptide 2|endothelial-monocyte-activating polypeptide I|Y
guanine adenine thymine adenine-binding protein|guanine adenine thymine adenine-binding protein 3|Y
guanine adenine thymine adenine-binding protein|guanine adenine thymine adenine-binding protein 4|Y
guanine adenine thymine adenine-binding protein|guanine adenine thymine adenine-binding protein 1|Y
inhibitor of apoptosis proteins|inhibitor of apoptosis protein|Y
chromatin accessibility complex-14|chromatin accessibility complex-1|Y
interleukine-6 receptor alpha-chain|interleukin-6 receptor alpha-chain|Y
systemic lupus erythematosus|systemic lupus erythmatosus|Y
systemic lupus erythematosus|systemic lupus erythematous|Y
poly (styrene sulfonate)|poly(styrene sulfonate)|Y
post-transplantation lympho-proliferative disease|posttransplantation lymphoproliferative disease|Y
post-transplantation lympho-proliferative disease|post-transplantation lymphoproliferative disease|Y
post-transplantation lympho-proliferative disease|posttransplantation lympho-proliferative disease|Y
polymorphonuclear leucocyte|polymorpho-nuclear leucocyte|Y
polymorphonuclear leucocyte|poly-morphonuclear leucocyte|Y
flavin containing mono-oxygenase 4|flavin containing monooxygenase 4|Y
anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody|anticytotoxic T-lymphocyte antigen-4 monoclonal antibody|Y
anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody|anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody|Y
macrophage inflammatory protein-3β|macrophage inflammatory protein-3 β|Y
heparin induced thrombocytopaenia|heparin induced thrombo-cytopaenia|Y
heparin induced thrombocytopaenia|heparin induced thrombocytopenia|Y
nuclear corepressor 2|nuclear co-repressor 2|Y
reaction center light-harvesting complex 1|reaction center light-harvesting complex I|Y
reaction center light-harvesting complex 1|reaction center-light-harvesting complex 1|Y
reaction center light-harvesting complex 1|reaction centre light-harvesting complex 1|Y
C. difficile associated disease|C difficile associated disease|Y
mitogen activated protein kinase activated protein kinase-5|mitogen activated protein kinase activated protein kinase 5|Y
mitogen activated protein kinase activated protein kinase-5|mitogen-activated protein kinase activated protein kinase-5|Y
mitogen activated protein kinase activated protein kinase-5|mitogen activated protein kinase activated protein kinase-1|Y
mitogen activated protein kinase activated protein kinase-5|mitogen activated protein kinase-activated protein kinase-5|Y
mitogen activated protein kinase activated protein kinase-5|mitogen activated protein kinase activated protein kinase-3|Y
mitogen activated protein kinase activated protein kinase-5|mitogen activated protein kinase activated protein kinase|Y
mitogen activated protein kinase activated protein kinase-5|mitogen activated protein kinase activated protein kinase-2|Y
granulocyte-macrophage-colony-stimulating factor receptor α-chain|granulocyte-macrophage colony-stimulating factor receptor α-chain|Y
granulocyte-macrophage-colony-stimulating factor receptor α-chain|granulocyte-macrophage-colony-stimulating factor receptor α chain|Y
granulocyte-macrophage-colony-stimulating factor receptor α-chain|granulocyte macrophage-colony-stimulating factor receptor α-chain|Y
nucleoside reverse-transcriptase inhibitor-sparing|nucleoside reverse transcriptase inhibitor-sparing|Y
malformations of cortical development|malformation of cortical development|Y
non-nucleoside inhibitors|non-nucleoside inhibitor|Y
gamma amino-butyric acidA|gamma aminobutyric acidA|Y
interleukin-15 receptor α subunit|interleukin-5 receptor α subunit|Y
interleukin-15 receptor α subunit|interleukine-15 receptor α subunit|Y
anti-β-2 glycoprotein-1 antibody|anti-β2 glycoprotein-1 antibody|Y
O-linked N-acetyl-glucosamine transferase|O-linked N-acetylglucosamine transferase|Y
granulocyte-macrophage colony-stimulating factors|granulocyte-macrophage colony-stimulating factor|Y
mass analyzed threshold ionization spectrum|mass-analyzed threshold ionization spectrum|Y
mass analyzed threshold ionization spectrum|mass analyzed threshold ionisation spectrum|Y
5'-untranslated region|5'-untranslated regions|Y
staphylococcal nuclease domain-containing 1|staphylococcal nuclease domain containing 1|Y
lactyl coenzyme A dehydratase|lactoyl coenzyme A dehydratase|Y
cyclin-dependent kinase inhibitor-1|cyclin-dependent kinase inhibitor-1A|Y
contrast echo-cardiography|contrast echocardiography|Y
vestibulo-sympathetic reflex|vestibulosympathetic reflex|Y
American Society of Anesthesiologists Class 5|American Society of Anesthesiologists Class V|Y
American Society of Anesthesiologists Class 5|American Society of Anesthesiologists Class 1|Y
American Society of Anesthesiologists Class 5|American Society of Anesthesiologists class 5|Y
American Society of Anesthesiologists Class 5|American Society of Anesthesiologists Class I|Y
American Society of Anesthesiologists Class 5|American Society of Anaesthesiologists Class 5|Y
American Society of Anesthesiologists Class 5|American Society of Anesthesiologists Class|Y
American Society of Anesthesiologists Class 5|American Society of Anesthesiologists Class 3|Y
American Society of Anesthesiologists Class 5|American Society of Anesthesiologists Class 2|Y
American Society of Anesthesiologists Class 5|American Society of Anesthesiologists Class 4|Y
monocyte-derived dendritic cells|monocyte-derived dendritic cell|Y
activated clotting times|activated clotting time|Y
hemodialysis patients|haemodialysis patients|Y
deoxynorlaudanosolinecarboxylic acid|deoxy-norlaudanosolinecarboxylic acid|Y
IL-2 receptor α-chain|IL2 receptor α-chain|Y
ribosomal protein L2|ribosomal protein L32|Y
ribosomal protein L2|ribosomal protein L28|Y
ribosomal protein L2|ribosomal protein L27|Y
ribosomal protein L2|ribosomal protein L29|Y
ribosomal protein L2|ribosomal protein L21|Y
ribosomal protein L2|ribosomal protein L24|Y
ribosomal protein L2|ribosomal protein L20|Y
ribosomal protein L2|ribosomal protein L12|Y
ribosomal protein L2|ribosomal protein L26|Y
ribosomal protein L2|ribosomal protein L23|Y
ribosomal protein L2|ribosomal protein L25|Y
ribosomal protein L2|ribosomal protein L22|Y
acute non-lymphoblastic leucaemia|acute non-lymphoblastic leucemia|Y
DNA interstrand cross-links|DNA interstrand crosslinks|Y
tumor necrosis factor receptor superfamily member 13B|tumor necrosis factor receptor superfamily member 13C|Y
tumor necrosis factor receptor superfamily member 13B|tumor necrosis factor receptor superfamily member 1B|Y
insulinlike growth factor binding protein 6|insulinlike growth factor binding protein 5|Y
insulinlike growth factor binding protein 6|insulinlike growth factor binding protein 1|Y
insulinlike growth factor binding protein 6|insulinlike growth factor binding protein 4|Y
insulinlike growth factor binding protein 6|insulinlike growth factor binding protein 3|Y
cob(I)alamin adenosyl transferase|cob(I)alamin adenosyltransferase|Y
intimal medial thickness|intima medial thickness|Y
succinic semi-aldehyde dehydrogenase deficiency|succinic semialdehyde dehydrogenase deficiency|Y
extended Huckel tight binding band calculation|extended Hückel tight binding band calculation|Y
international Classification of Diseases|International Classification of Diseases|Y
fibronectin leucine rich transmembrane protein 2|fibronectin leucine rich transmembrane protein 3|Y
Bandeiraea simplicifolia lectin II|Bandeiraea simplicifolia lectin I|Y
circulating endothelial cells|circulating endothelial cell|Y
American Society of Anesthesiologists Physical Status Classification|American Society of Anesthesiologists Physical Status classification|Y
antifilaggrin antibody|anti-filaggrin antibody|Y
5-aminoimidazole-4-carboxamide ribonucleotide|5-aminoimidazole-4-carboxamide ribonucleoside|Y
major histocompatibility complex-peptide complex|major histocompatibility complex/peptide complex|Y
FADD-like interleukin 1beta-converting enzyme|FADD-like interleukin-1beta-converting enzyme|Y
FADD-like interleukin 1beta-converting enzyme|FADD-like interleukin 1beta converting enzyme|Y
diethylenetriaminepentaacetic acid scan|diethylenetriamine penta-acetic acid scan|Y
American Academy of Orthopaedic Surgeons|American Academy of Orthopedic Surgeons|Y
retinoic acid-related orphan receptor beta 1|retinoic acid-related orphan receptor beta|Y
retinoic acid-related orphan receptor beta 1|retinoic acid-related orphan receptor beta 2|Y
ventrolateral prefrontal cortex|ventro-lateral prefrontal cortex|Y
heart rate-corrected QT interval|heart rate-corrected Q-T interval|Y
tert.-butyldimethylsilyl|tert-butyldimethylsilyl|Y
silver-stained nucleolar organizer region|silver-stained nucleolar organiser region|Y
silver-stained nucleolar organizer region|silver stained nucleolar organizer region|Y
extra-intracranial artery bypass|extraintracranial artery bypass|Y
intra-cellular mature virion|intracellular mature virion|Y
intrathoracic gas volume|intra-thoracic gas volume|Y
glycosyl phosphatidylinositol-linked protein|glycosylphosphatidyl-inositol-linked protein|Y
glycosyl phosphatidylinositol-linked protein|glycosyl-phosphatidylinositol-linked protein|Y
glycosyl phosphatidylinositol-linked protein|glycosylphosphatidylinositol-linked protein|Y
glycosyl phosphatidylinositol-linked protein|glycosyl phosphatidyl inositol-linked protein|Y
glycosyl phosphatidylinositol-linked protein|glycosylphosphatidyl inositol-linked protein|Y
mitogen-activated protein kinase-activated protein kinase|mitogen-activated protein kinase-activated protein kinase-3|Y
mitogen-activated protein kinase-activated protein kinase|mitogen-activated protein kinase-activated protein kinase-1|Y
mitogen-activated protein kinase-activated protein kinase|mitogen-activated protein kinase-activated protein kinase-2|Y
mitogen-activated protein kinase-activated protein kinase|mitogen-activated protein kinase-activated protein kinase 2|Y
mitogen-activated protein kinase-activated protein kinase|mitogen-activated protein kinase-activated protein kinase-5|Y
mitogen-activated protein kinase-activated protein kinase|mitogen-activated protein kinase-activated protein kinase 1|Y
mitogen-activated protein kinase-activated protein kinase|mitogen activated protein kinase-activated protein kinase|Y
mitogen-activated protein kinase-activated protein kinase|mitogen-activated protein kinase-activated protein kinase 5|Y
mitogen-activated protein kinase-activated protein kinase|mitogen-activated protein kinase activated protein kinase|Y
Legionnaire's disease|Legionnaires disease|Y
human insulin-like growth factor-I|human insulin-like growth factor-II|Y
simultaneous saccharification and fermentation|simultaneous saccharification and cofermentation|Y
anti-phenolic glycolipid 1|antiphenolic glycolipid 1|Y
Sepulveda Veteran's Administration Medical Center|Sepulveda Veterans Administration Medical Center|Y
Sepulveda Veteran's Administration Medical Center|Sepulveda Veterans' Administration Medical Center|Y
methyl-mercapto-imidazole|methyl-mercapto-imidazol|Y
β2-adrenergic receptor|β-2-adrenergic receptor|Y
β2-adrenergic receptor|β-adrenergic receptor|Y
β2-adrenergic receptor|β 2-adrenergic receptor|Y
Cu/Zn superoxide dismutase 2|CuZn superoxide dismutase 2|Y
State University of New York, Upstate Medical University|State University of New York Upstate Medical University|Y
RNAIII-inhibiting peptide|RNA III-inhibiting peptide|Y
technetium 99m-labelled red blood cell|technetium 99m-labeled red blood cell|Y
transforming growth factor β receptor type II|transforming growth factor-β receptor type II|Y
midwall fractional shortening|mid-wall fractional shortening|Y
anti-interleukin-4 receptor alpha antibody|anti-interleukin-2 receptor alpha antibody|Y
fluorine-18-labeled fluorodeoxyglucose|fluorine-18-labelled fluorodeoxyglucose|Y
fluorine-18-labeled fluorodeoxyglucose|fluorine-18-labeled fluoro-deoxyglucose|Y
glucocorticoid-induced tumor necrosis factor receptor|glucocorticoid induced tumor necrosis factor receptor|Y
takotsubo cardiomyopathy|tako-tsubo cardiomyopathy|Y
human tumor necrosis factor β|human tumour necrosis factor β|Y
entero-haemorrhagic E coli|entero-haemorrhagic E. coli|Y
entero-haemorrhagic E coli|entero-hemorrhagic E coli|Y
phenyl-tert-butylnitrone|phenyl-tert-butyl nitrone|Y
antigen-presenting cells|antigen-presenting cell|Y
continuous veno-venous hemodiafiltration|continuous veno-venous haemo-diafiltration|Y
continuous veno-venous hemodiafiltration|continuous veno-venous haemodiafiltration|Y
continuous veno-venous hemodiafiltration|continuous venovenous hemodiafiltration|Y
continuous veno-venous hemodiafiltration|continuous veno-venous hemo-diafiltration|Y
continuous veno-venous hemodiafiltration|continuous venovenous hemo-diafiltration|Y
multiwavelength anomalous dispersion|multi-wavelength anomalous dispersion|Y
multi-reference configuration interaction|multi-reference configuration-interaction|Y
multi-reference configuration interaction|multireference configuration interaction|Y
single-photon emission computed tomography/computed tomography|single photon emission computed tomography/computed tomography|Y
single-photon emission computed tomography/computed tomography|single-photon-emission computed tomography/computed tomography|Y
caspase 1/interleukin-1β converting enzyme|caspase 1/interleukin-1β-converting enzyme|Y
pseudo-vitamin D deficiency rickets|pseudovitamin D deficiency rickets|Y
killer immunoglobulinlike receptor|killer immunoglobulin-like receptor|Y
enterochromaffin-like|enterochromaffinlike|Y
capillary electrophoresis-single-strand conformation polymorphism|capillary electrophoresis single-strand conformation polymorphism|Y
capillary electrophoresis-single-strand conformation polymorphism|capillary electrophoresis-single strand conformation polymorphism|Y
1,1-diphenyl-2-picryl-hydrazyl|1,1-diphenyl-2-picrylhydrazyl|Y
mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes|mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes|Y
diethyldithio-carbamate|diethyldithiocarbamate|Y
diethyldithio-carbamate|diethyl-dithio-carbamate|Y
POU domain, class 3, transcription factor 2|POU domain, class 3, transcription factor 4|Y
POU domain, class 3, transcription factor 2|POU domain, class 3, transcription factor 1|Y
POU domain, class 3, transcription factor 2|POU domain, class 3, transcription factor 3|Y
5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino) tetralin|5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin|Y
5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino) tetralin|5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)-tetralin|Y
data monitoring committee|data monitoring committees|Y
multi-slice spiral computed tomography scan|multislice spiral computed tomography scan|Y
micro x-ray absorption near-edge structure|micro X-ray absorption near-edge structure|Y
micro x-ray absorption near-edge structure|micro x-ray absorption near edge structure|Y
micro x-ray absorption near-edge structure|micro-x-ray absorption near-edge structure|Y
psychogenic non-epileptic seizure|psychogenic nonepileptic seizure|Y
psychogenic non-epileptic seizure|psychogenic non-epileptic seizures|Y
ras-related GTP-binding protein 31|ras-related GTP-binding protein 1|Y
ras-related GTP-binding protein 31|ras-related GTP-binding protein 3|Y
iso-osmolar contrast medium|isoosmolar contrast medium|Y
homozygous alpha-1-protease inhibitor deficiency|homozygous alpha-1-proteinase inhibitor deficiency|Y
homozygous alpha-1-protease inhibitor deficiency|homozygous alpha-1 protease inhibitor deficiency|Y
homozygous alpha-1-protease inhibitor deficiency|homozygous alpha 1-protease inhibitor deficiency|Y
trifluoro-methylphenyl-piperazine|trifluoro-methyl-phenyl-piperazine|Y
trifluoro-methylphenyl-piperazine|trifluoro-methylphenylpiperazine|Y
pre-operative autologous donation|preoperative autologous donation|Y
anti-IL12 monoclonal antibody|anti-IL-12 monoclonal antibody|Y
anti-IL12 monoclonal antibody|anti-IL2 monoclonal antibody|Y
anti-IL12 monoclonal antibody|anti-IL 12 monoclonal antibody|Y
mitogen-activated protein kinase-dependent signalling pathway|mitogen activated protein kinase-dependent signaling pathway|Y
mitogen-activated protein kinase-dependent signalling pathway|mitogen-activated protein kinase-dependent signaling pathway|Y
mitogen-activated protein kinase-dependent signalling pathway|mitogen activated protein kinase-dependent signalling pathway|Y
anti-intercellular adhesion molecule 1 antibody|anti-intercellular adhesion molecule1 antibody|Y
anti-intercellular adhesion molecule 1 antibody|anti-intercellular adhesion molecule-1 antibody|Y
methylenedioxy-methamfetamine|methylenedioxymethamfetamine|Y
TATA-binding protein-associated factor-11|TATA-binding protein-associated factor-15|Y
TATA-binding protein-associated factor-11|TATA-binding protein-associated factor-17|Y
TATA-binding protein-associated factor-11|TATA-binding protein-associated factor 11|Y
TATA-binding protein-associated factor-11|TATA-binding protein-associated factor-12|Y
TATA-binding protein-associated factor-11|TATA-binding protein-associated factor-10|Y
TATA-binding protein-associated factor-11|TATA-binding protein associated factor-11|Y
TATA-binding protein-associated factor-11|TATA-binding protein-associated factor-1|Y
Bos taurus autosome 25|Bos taurus autosome 2|Y
catheter associated urinary tract infection|catheter-associated urinary tract infection|Y
delayed non-match-to-sample|delayed nonmatch-to-sample|Y
sub-acromial decompression|subacromial decompression|Y
nonprotein sulfhydryl|non-protein sulfhydryl|Y
spinocerebellar degeneration|spino-cerebellar degeneration|Y
human parathyroid-hormone-related protein|human parathyroid hormone-related protein|Y
inductively coupled plasma-mass spectrometry|inductively coupled plasma-mass spectrometer|Y
inductively coupled plasma-mass spectrometry|inductively coupled plasma/mass spectrometry|Y
inductively coupled plasma-mass spectrometry|inductively coupled plasma mass spectrometry|Y
surface enhanced laser desorption/ionization time of flight mass spectrometry|surface enhanced laser desorption ionization time of flight mass spectrometry|Y
surface enhanced laser desorption/ionization time of flight mass spectrometry|surface-enhanced laser desorption/ionization time of flight mass spectrometry|Y
surface enhanced laser desorption/ionization time of flight mass spectrometry|surface enhanced laser desorption/ionisation time of flight mass spectrometry|Y
recombinant murine interleukin 12|recombinant murine interleukin 2|Y
recombinant murine interleukin 12|recombinant murine interleukin 1|Y
tubuloreticular structure|tubulo-reticular structure|Y
intra-membranous particle|intramembranous particle|Y
anti-interleukin-1 receptor antibody|anti-interleukin-10 receptor antibody|Y
para-nitrophenyl-phosphate|para-nitrophenylphosphate|Y
hemoglobin Decines-Charpieu|haemoglobin Decines-Charpieu|Y
dihydroxyphenyl-acetaldehyde|dihydroxyphenylacetaldehyde|Y
total abdominal hysterectomy and bilateral salpingo-oophorectomy|total abdominal hysterectomy and bilateral salpingo oophorectomy|Y
American Society of Anaesthesiologists status V|American Society of Anesthesiologists status IV|Y
American Society of Anaesthesiologists status V|American Society of Anaesthesiologists status 3|Y
American Society of Anaesthesiologists status V|American Society of Anesthesiologists status V|Y
American Society of Anaesthesiologists status V|American Society of Anaesthesiologists status 2|Y
American Society of Anaesthesiologists status V|American Society of Anaesthesiologists status 4|Y
American Society of Anaesthesiologists status V|American Society of Anaesthesiologists status IV|Y
American Society of Anaesthesiologists status V|American Society of Anaesthesiologists status I|Y
American Society of Anaesthesiologists status V|American Society of Anaesthesiologists status 1|Y
American Society of Anaesthesiologists status V|American Society of Anaesthesiologists status 5|Y
Dromaius novae-hollandiae|Dromaius novaehollandiae|Y
non-commissioned officer|noncommissioned officer|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motifs-14|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-10|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motifs-13|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-16|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-6|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-20|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motifs-20|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-19|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motifs-1|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-15|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-1|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-9|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motifs-19|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motifs-17|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-8|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-14|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motifs-15|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
interleukine 5 receptor α|interleukin 5 receptor α|Y
STE-20-related proline alanine-rich kinase|STE-20-related proline-alanine-rich kinase|Y
STE-20-related proline alanine-rich kinase|STE20-related proline alanine-rich kinase|Y
STE-20-related proline alanine-rich kinase|STE-20-related proline alanine rich kinase|Y
para-aortic lymph node|para-aortic lymph nodes|Y
para-aortic lymph node|paraaortic lymph node|Y
intrauterine insemination|intra-uterine insemination|Y
International Classification of Disease|International Classification of Diseases|Y
insulin response sequence|insulin response sequences|Y
post-anaesthetic recovery unit|post-anesthetic recovery unit|Y
American Society of Anesthesiology physical status V|American Society of Anesthesiology physical status 5|Y
American Society of Anesthesiology physical status V|American Society of Anesthesiology physical status 1|Y
American Society of Anesthesiology physical status V|American Society of Anaesthesiology physical status V|Y
American Society of Anesthesiology physical status V|American Society of Anesthesiology physical status 4|Y
American Society of Anesthesiology physical status V|American Society of Anesthesiology physical status I|Y
American Society of Anesthesiology physical status V|American Society of Anesthesiology physical status IV|Y
American Society of Anesthesiology physical status V|American Society of Anesthesiology physical status 2|Y
American Society of Anesthesiology physical status V|American Society of Anesthesiology physical status|Y
American Society of Anesthesiology physical status V|American Society of Anaesthesiology physical status IV|Y
American Society of Anesthesiology physical status V|American Society of Anesthesiology physical status 3|Y
insecticide-treated bednets|insecticide-treated bednet|Y
athero-sclerotic occlusive disease|atherosclerotic occlusive disease|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labelling|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labelling|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labelling|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling|Y
cytokine induced neutrophil chemoattractant 2|cytokine-induced neutrophil chemoattractant 2|Y
cytokine induced neutrophil chemoattractant 2|cytokine induced neutrophil chemoattractant 1|Y
cytokine induced neutrophil chemoattractant 2|cytokine induced neutrophil chemoattractant-2|Y
cytokine induced neutrophil chemoattractant 2|cytokine induced neutrophil chemoattractant 3|Y
cytokine induced neutrophil chemoattractant 2|cytokine induced neutrophil chemoattractant|Y
anti-TCR-α β monoclonal antibody|anti-TCR-αβ monoclonal antibody|Y
endothelial monocyte-activating polypeptide|endothelial monocyte-activating polypeptide I|Y
endothelial monocyte-activating polypeptide|endothelial monocyte-activating polypeptide 2|Y
endothelial monocyte-activating polypeptide|endothelial monocyte-activating polypeptide-I|Y
endothelial monocyte-activating polypeptide|endothelial-monocyte-activating polypeptide|Y
endothelial monocyte-activating polypeptide|endothelial monocyte-activating polypeptide-2|Y
endothelial monocyte-activating polypeptide|endothelial monocyte activating polypeptide|Y
intra-atrial conduction defect|intraatrial conduction defect|Y
neuronal precursor cell-expressed developmentally downregulated 4-1|neuronal precursor cell-expressed developmentally down regulated 4|Y
neuronal precursor cell-expressed developmentally downregulated 4-1|neuronal precursor cell-expressed developmentally downregulated 4-2|Y
neuronal precursor cell-expressed developmentally downregulated 4-1|neuronal precursor cell-expressed developmentally downregulated 4|Y
neuronal precursor cell-expressed developmentally downregulated 4-1|neuronal precursor cell-expressed developmentally down-regulated 4|Y
intravenous drug abuser|intravenous drug abuse|Y
2-amino-6, 7-dihydroxy-1, 2,3,4-tetrahydronaphthalene|2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene|Y
modulatory calcineurin-interacting protein 1|modulatory calcineurin interacting protein 1|Y
modulatory calcineurin-interacting protein 1|modulatory calcineurin-interacting protein-1|Y
Clinical Evaluation of Language Fundamentals-3|Clinical Evaluation of Language Fundamentals|Y
technetium-99m-labelled red blood cell|technetium-99m-labeled red blood cell|Y
loco-regional recurrence|locoregional recurrence|Y
aortopulmonary collateral artery|aorto-pulmonary collateral artery|Y
Karolinska Scale of Personality|Karolinska Scales of Personality|Y
alpha subunit of eukaryotic initiation factor 2|alpha-subunit of eukaryotic initiation factor 2|Y
leukaemia/lymphoma-related factor|leukemia/lymphoma-related factor|Y
antiethinylestradiol antibody|anti-ethinylestradiol antibody|Y
methicillin resistant S. epidermidis|meticillin resistant S. epidermidis|Y
encephaloduroarterio-synangiosis|encephaloduroarteriosynangiosis|Y
encephaloduroarterio-synangiosis|encephaloduro-arterio-synangiosis|Y
phospho-glycogen synthase kinase-3β|phospho-glycogen synthase kinase-3 β|Y
International Classification of Diseases, 10th Revision|International Classification of Diseases 10th Revision|Y
gonadotropin-releasing hormone agonists|gonadotropin-releasing hormone agonist|Y
paired immunoglobulin-like type-2 receptor alpha|paired immunoglobulin-like type 2 receptor alpha|Y
third complementarity-determining region|third complementarity-determining regions|Y
third complementarity-determining region|third complementarity determining region|Y
intra-vaginal ejaculatory latency time|intravaginal ejaculatory latency time|Y
PGC-1 related coactivator|PGC-1 related co-activator|Y
cortico-basal syndrome|corticobasal syndrome|Y
ano-rectal malformation|anorectal malformation|Y
eukaryotic elongation factor 1 α|eukaryotic elongation factor 1α|Y
phospholipase Cgamma1|phospholipase Cgamma|Y
phospholipase Cgamma1|phospholipase Cgamma-1|Y
synchronized moving aperture radiation therapy|synchronised moving aperture radiation therapy|Y
TBP associated factor-17|TBP associated factor-1|Y
TBP associated factor-17|TBP associated factor-7|Y
never in mitosis, gene A-related kinase 2A|never in mitosis, gene A-related kinase 2B|Y
never in mitosis, gene A-related kinase 2A|never in mitosis, gene A-related kinase 2|Y
APOBEC-1 complementation factor|APOBEC1 complementation factor|Y
tripeptidyl peptidase II|tripeptidyl peptidase I|Y
super conducting quantum interference device|superconducting quantum interference device|Y
super conducting quantum interference device|super-conducting quantum interference device|Y
cross polarization magic-angle spinning nuclear magnetic resonance|cross polarization magic-angle-spinning nuclear magnetic resonance|Y
cross polarization magic-angle spinning nuclear magnetic resonance|cross polarization magic angle spinning nuclear magnetic resonance|Y
cross polarization magic-angle spinning nuclear magnetic resonance|cross polarization/magic-angle spinning nuclear magnetic resonance|Y
cross polarization magic-angle spinning nuclear magnetic resonance|cross-polarization magic-angle spinning nuclear magnetic resonance|Y
cross polarization magic-angle spinning nuclear magnetic resonance|cross polarisation magic-angle spinning nuclear magnetic resonance|Y
cellular inhibitor-of-apoptosis protein-2|cellular inhibitor-of-apoptosis protein|Y
cellular inhibitor-of-apoptosis protein-2|cellular inhibitor-of-apoptosis protein 2|Y
cellular inhibitor-of-apoptosis protein-2|cellular inhibitor-of-apoptosis protein-1|Y
alternatively activated macrophage|alternatively activated macrophages|Y
reduced nicotinamide-adenine dinucleotide dehydrogenase|reduced nicotinamide adenine dinucleotide dehydrogenase|Y
tumor necrosis factor receptor-associated factor-2|tumor necrosis factor receptor-associated factor-1|Y
tumor necrosis factor receptor-associated factor-2|tumor necrosis factor receptor-associated factor-5|Y
tumor necrosis factor receptor-associated factor-2|tumor necrosis factor receptor-associated factor|Y
tumor necrosis factor receptor-associated factor-2|tumour necrosis factor receptor-associated factor-2|Y
tumor necrosis factor receptor-associated factor-2|tumor necrosis factor receptor-associated factor 2|Y
tumor necrosis factor receptor-associated factor-2|tumor necrosis factor receptor-associated factor-6|Y
tumor necrosis factor receptor-associated factor-2|tumor necrosis factor receptor associated factor-2|Y
interleukin 10 receptor|interleukin 1 receptor|Y
receptor-like protein tyrosine phosphatase-ζ|receptor-like protein tyrosine phosphatase|Y
receptor-like protein tyrosine phosphatase-ζ|receptor-like protein tyrosine phosphatase-α|Y
receptor-like protein tyrosine phosphatase-ζ|receptor-like protein tyrosine phosphatase-η|Y
receptor-like protein tyrosine phosphatase-ζ|receptor-like protein tyrosine phosphatase-δ|Y
receptor-like protein tyrosine phosphatase-ζ|receptor-like protein tyrosine phosphatase-κ|Y
receptor-like protein tyrosine phosphatase-ζ|receptor-like protein tyrosine phosphatase ζ|Y
receptor-like protein tyrosine phosphatase-ζ|receptor-like protein tyrosine phosphatase-ψ|Y
receptor-like protein tyrosine phosphatase-ζ|receptor-like protein tyrosine phosphatase-μ|Y
receptor-like protein tyrosine phosphatase-ζ|receptor-like protein-tyrosine phosphatase-ζ|Y
intracoronary ultrasound|intra-coronary ultrasound|Y
laser Doppler flux-metry|laser Doppler fluxmetry|Y
tetramethyl-phenylenediamine oxidase|tetramethylphenylenediamine oxidase|Y
extra-corporeal circuit|extracorporeal circuit|Y
granulocyte-macrophage colony-stimulating factor receptor α subunit|granulocyte-macrophage-colony-stimulating factor receptor α subunit|Y
granulocyte-macrophage colony-stimulating factor receptor α subunit|granulocyte macrophage colony-stimulating factor receptor α subunit|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motif-9|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motifs-6|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motifs-19|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motif-8|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motifs-3|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motif-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motifs-18|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motifs|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motifs-13|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motif-3|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motifs-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motifs-4|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motifs-2|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motif-2|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motifs-9|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motifs-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motifs-20|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motif-8|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motifs-8|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
a disintegrin and metalloprotease with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
anti-granulocyte macrophage colony-stimulating factor auto-antibody|anti-granulocyte macrophage colony-stimulating factor autoantibody|Y
anti-granulocyte macrophage colony-stimulating factor auto-antibody|anti-granulocyte-macrophage colony-stimulating factor auto-antibody|Y
anti-granulocyte macrophage colony-stimulating factor auto-antibody|anti-granulocyte-macrophage colony-stimulating factor autoantibody|Y
POU domain, class 3, transcription factor 4|POU domain, class 3, transcription factor 1|Y
POU domain, class 3, transcription factor 4|POU domain, class 3, transcription factor 3|Y
2',3'-cyclic nucleotide-3'-phosphodiesterase|2',3'-cyclic nucleotide 3'-phosphodiesterase|Y
myocyte enhancer factor-2 interacting transcription repressor|myocyte enhancer factor-2 interacting transcriptional repressor|Y
interleukin 5 receptor α-chain|interleukine 5 receptor α-chain|Y
anti-IL17 monoclonal antibody|anti-IL7 monoclonal antibody|Y
anti-IL17 monoclonal antibody|anti-IL 17 monoclonal antibody|Y
anti-IL17 monoclonal antibody|anti-IL-17 monoclonal antibody|Y
tumour colony-forming unit|tumor colony-forming unit|Y
1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one|1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one|Y
1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one|1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one|Y
LESION SIMULATING DISEASE1|LESION SIMULATING DISEASE 1|Y
CXC chemokine receptor 3|CC chemokine receptor 3|Y
antimüllerian hormone|anti-müllerian hormone|Y
laser induced thermo-therapy|laser induced thermotherapy|Y
tyrosylprolylarginyl chloromethyl ketone|tyrosyl-prolyl-arginyl chloromethyl ketone|Y
pharyngo-upper esophageal sphincter|pharyngo-upper oesophageal sphincter|Y
nonselective cationic conductance|non-selective cationic conductance|Y
immuno-gold electron microscopy|immunogold electron microscopy|Y
relapsing-remitting experimental autoimmune encephalomyelitis|relapsing remitting experimental autoimmune encephalomyelitis|Y
uridine diphosphate glucuronosyltransferase 2B10|uridine diphosphate glucuronosyltransferase 2B15|Y
preproatrial natriuretic factor|prepro-atrial natriuretic factor|Y
provider-sponsored organization|provider-sponsored organizations|Y
West Los Angeles Veterans' Administration Medical Center|West Los Angeles Veteran's Administration Medical Center|Y
West Los Angeles Veterans' Administration Medical Center|West Los Angeles Veterans Administration Medical Center|Y
hereditary nonpolyposis colorectal cancer|hereditary non-polyposis colorectal cancer|Y
ubiquitin-like protein-specific protease 1|ubiquitin-like protein-specific protease 2|Y
receiver operating characteristic curve analysis|receiver-operating characteristic curve analysis|Y
highly polysialylated neural cell adhesion molecule|Highly polysialylated neural cell adhesion molecule|Y
plasma concentrations|plasma concentration|Y
time averaged velocity|time average velocity|Y
corticotropin-releasing factor receptor antagonist|corticotrophin-releasing factor receptor antagonist|Y
corticotropin-releasing factor receptor antagonist|corticotropin releasing factor receptor antagonist|Y
human chorionic gonadotropin β subunit|human chorionic gonadotrophin β subunit|Y
anterolateral rotatory instability|antero-lateral rotatory instability|Y
prematurely condensed chromosome|prematurely condensed chromosomes|Y
transforming growth factor-β-inducible gene-H3|transforming growth factor β-inducible gene-H3|Y
transforming growth factor-β-inducible gene-H3|transforming growth factor-β-inducible gene H3|Y
glycosylphosphatidyl-inositol-linked protein|glycosyl-phosphatidyl-inositol-linked protein|Y
glycosylphosphatidyl-inositol-linked protein|glycosyl-phosphatidylinositol-linked protein|Y
glycosylphosphatidyl-inositol-linked protein|glycosylphosphatidylinositol-linked protein|Y
glycosylphosphatidyl-inositol-linked protein|glycosylphosphatidyl inositol-linked protein|Y
anti-β2 glycoprotein-I antibody|anti-β 2 glycoprotein-I antibody|Y
anti-β2 glycoprotein-I antibody|anti-β-2 glycoprotein-I antibody|Y
ethanol-derived calories|ethanol-derived calorie|Y
intra-ductal hyperplasia|intraductal hyperplasia|Y
3 β-hydroxysteroid-dehydrogenase deficiency|3 β-hydroxysteroid dehydrogenase deficiency|Y
3 β-hydroxysteroid-dehydrogenase deficiency|3β-hydroxy steroid-dehydrogenase deficiency|Y
3 β-hydroxysteroid-dehydrogenase deficiency|3β-hydroxysteroid-dehydrogenase deficiency|Y
haemagglutinin-neuraminidase protein|hemagglutinin-neuraminidase protein|Y
γglutamyl carboxylase|γ-glutamyl carboxylase|Y
γglutamyl carboxylase|γ glutamyl carboxylase|Y
Balloon-occluded retrograde transvenous obliteration|balloon-occluded retrograde transvenous obliteration|Y
antiIL-4 receptor alpha antibody|anti-IL-4 receptor alpha antibody|Y
radioimmunoassay method|radio-immunoassay method|Y
scapho-lunate ligament|scapholunate ligament|Y
2,5-di-(tert-butyl)-1,4-benzohydroquinone|2,5-di(tert-butyl)-1,4-benzohydroquinone|Y
products of conception|product of conception|Y
transcriptional intermediary factor 1-γ|transcriptional intermediary factor 1γ|Y
phosphatidyl ethanolamine binding protein-2|phosphatidyl-ethanolamine binding protein-2|Y
phosphatidyl ethanolamine binding protein-2|phosphatidyl ethanolamine-binding protein-2|Y
anti-neutrophilic cytoplasmic antibody|antineutrophilic cytoplasmic antibody|Y
terminal restriction fragment length polymorphism fingerprinting|terminal-restriction fragment length polymorphism fingerprinting|Y
Schedule of Recent Experiences|Schedule of Recent Experience|Y
methoxyresorufin O-dealkylase|ethoxyresorufin O-dealkylase|Y
methoxyresorufin O-dealkylase|methoxy-resorufin O-dealkylase|Y
electron probe X-ray micro-analysis|electron probe X-ray microanalysis|Y
tumour initiating cell|tumor initiating cell|Y
macrophage inflammatory protein-3 α|macrophage inflammatory protein-3α|Y
contract research organizations|contract research organization|Y
semi-carbazide sensitive amine oxidase|semicarbazide sensitive amine oxidase|Y
decompressive hemicraniectomy|decompressive hemi-craniectomy|Y
Matrix-assisted laser desorption ionization|matrix-assisted laser desorption ionization|Y
polymerase chain reaction/sequence specific priming|polymerase chain reaction/sequence-specific priming|Y
polymerase chain reaction/sequence specific priming|polymerase chain reaction-sequence specific priming|Y
myelo-dysplastic syndrome|myelodysplastic syndrome|Y
methylthioadenosine phosphorylase|methyl-thioadenosine phosphorylase|Y
tetanus and diphtheria toxoids|tetanus and diphtheria toxoid|Y
Drosophila glutamate receptor IIA|Drosophila glutamate receptor IA|Y
Drosophila glutamate receptor IIA|Drosophila glutamate receptor II|Y
peri-tubular capillary|peritubular capillary|Y
ultrasound guided fine needle aspiration cytology|ultrasound-guided fine needle aspiration cytology|Y
ultrasound guided fine needle aspiration cytology|ultrasound guided fine-needle aspiration cytology|Y
toll-IL-1 receptor domain-containing adaptor-inducing IFN-β|toll/IL-1 receptor domain-containing adaptor-inducing IFN-β|Y
toll-IL-1 receptor domain-containing adaptor-inducing IFN-β|Toll-IL-1 receptor domain-containing adaptor-inducing IFN-β|Y
toll-IL-1 receptor domain-containing adaptor-inducing IFN-β|toll-IL-1 receptor domain-containing adaptor-inducing IFNβ|Y
non-inflammatory neurological diseases|non-inflammatory neurological disease|Y
tri-functional protein deficiency|trifunctional protein deficiency|Y
gastrointestinal transit test|gastro-intestinal transit test|Y
Helicoverpa armigera beta-thymosin gene transcript variant 1|Helicoverpa armigera beta-thymosin gene transcript variant 2|Y
recommended dietary allowance|recommended dietary allowances|Y
gamma-aminobutyric acid A/benzodiazepine receptor complex|gamma-aminobutyric acid A-benzodiazepine receptor complex|Y
gamma-aminobutyric acid A/benzodiazepine receptor complex|gamma-aminobutyric acid/benzodiazepine receptor complex|Y
gamma-aminobutyric acid A/benzodiazepine receptor complex|gamma-aminobutyric acidA/benzodiazepine receptor complex|Y
Behavior Assessment System for Children-2nd edition|Behavioral Assessment System for Children-2nd edition|Y
diethyl dimercapto-succinate|diethyl dimercaptosuccinate|Y
wingless-type MMTV integration site family member 2|Wingless-type MMTV integration site family member 2|Y
wingless-type MMTV integration site family member 2|wingless-type MMTV integration site family member|Y
topoisomerase IIα protein|topoisomerase II α protein|Y
topoisomerase IIα protein|topoisomerase II-α protein|Y
intra-thoracic pressure|intrathoracic pressure|Y
human T-cell leukaemia virus type 1-infected|human T-cell leukaemia virus type-1-infected|Y
human T-cell leukaemia virus type 1-infected|human T-cell leukemia virus type 1-infected|Y
human T-cell leukaemia virus type 1-infected|human T cell leukaemia virus type 1-infected|Y
human T-cell leukaemia virus type 1-infected|human T-cell leukaemia virus type I-infected|Y
immunosuppressive drug|immuno-suppressive drug|Y
antero-superior iliac spine|anterosuperior iliac spine|Y
impaired fasting glycemia|impaired fasting glycaemia|Y
calcium-calmodulin dependent protein kinase kinase beta|calcium/calmodulin dependent protein kinase kinase beta|Y
calcium-calmodulin dependent protein kinase kinase beta|calcium-calmodulin-dependent protein kinase kinase beta|Y
video assisted thoracoscopic sympathectomy|video-assisted thoracoscopic sympathectomy|Y
hypo-gamma-globulinaemia|hypo-gammaglobulinaemia|Y
hypo-gamma-globulinaemia|hypo-gamma-globulinemia|Y
hypo-gamma-globulinaemia|hypogamma-globulinaemia|Y
pre-hematopoietic stem-cell transplantation|pre-hematopoietic stem cell transplantation|Y
human hepatocellular carcinoma cell line|human hepatocellular carcinoma cell line 2|Y
human hepatocellular carcinoma cell line|human hepatocellular carcinoma cell line 3|Y
human hepatocellular carcinoma cell line|human hepatocellular carcinoma cell line 1|Y
macrophage inflammatory protein 3β|macrophage inflammatory protein 3 β|Y
excision repair cross-complementing group 2|excision repair cross-complementing group 8|Y
excision repair cross-complementing group 2|excision repair cross-complementing group 1|Y
excision repair cross-complementing group 2|excision repair cross-complementing group 4|Y
excision repair cross-complementing group 2|excision repair cross-complementing group 6|Y
excision repair cross-complementing group 2|excision repair cross-complementing-group 2|Y
excision repair cross-complementing group 2|excision repair cross-complementing group 3|Y
excision repair cross-complementing group 2|excision repair cross complementing group 2|Y
excision repair cross-complementing group 2|excision repair cross-complementing group 5|Y
atrio-ventricular re-entrant tachycardia|atrio-ventricular reentrant tachycardia|Y
atrio-ventricular re-entrant tachycardia|atrioventricular re-entrant tachycardia|Y
ribosomal protein L7B|ribosomal protein L7|Y
m-chlorophenylpiperazine|m-chlorophenyl piperazine|Y
m-chlorophenylpiperazine|m-chlorophenyl-piperazine|Y
acid sensing ion channel 2|acid sensing ion channel 2b|Y
acid sensing ion channel 2|acid sensing ion channel 2a|Y
hemoglobin Hopkins-2|haemoglobin Hopkins-2|Y
peri-infarct depolarisation|periinfarct depolarisation|Y
contact microradiography|contact micro-radiography|Y
temperature-programmed desorption mass spectrometry|temperature programmed desorption mass spectrometry|Y
temperature-programmed desorption mass spectrometry|temperature-programmed desorption-mass spectrometry|Y
temperature-programmed desorption mass spectrometry|temperature-programed desorption mass spectrometry|Y
temperature-programmed desorption mass spectrometry|temperature-programmed-desorption mass spectrometry|Y
inositol-1,4,5-trisphosphate|inositol-1,4,5-triphosphate|Y
transient evoked otoacoustic emission|transient evoked oto-acoustic emission|Y
transient evoked otoacoustic emission|transient evoked otoacoustic emissions|Y
penicillinase producing neisseria gonorrheae|penicillinase producing neisseria gonorrhoeae|Y
Kruppel-associated box|Krueppel-associated box|Y
colony-forming unit-granulocyte macrophage|colony-forming unit-granulocyte/macrophage|Y
colony-forming unit-granulocyte macrophage|colony-forming unit-granulocyte-macrophage|Y
colony-forming unit-granulocyte macrophage|colony-forming units-granulocyte macrophage|Y
colony-forming unit-granulocyte macrophage|colony-forming unit granulocyte macrophage|Y
colony-forming unit-granulocyte macrophage|colony forming unit-granulocyte macrophage|Y
fibreoptic trans-illumination|fibre-optic trans-illumination|Y
fibreoptic trans-illumination|fibre optic trans-illumination|Y
filtering face piece respirator|filtering facepiece respirator|Y
interleukine-3 receptor-α|interleukin-3 receptor-α|Y
cyclic adenosine monophosphate-dependent protein kinase|cyclic adenosine monophosphate-independent protein kinase|Y
Houston Veteran's Affairs Medical Center|Houston Veterans' Affairs Medical Center|Y
Houston Veteran's Affairs Medical Center|Houston Veterans Affairs Medical Center|Y
uretero-pelvic junction|ureteropelvic junction|Y
IL5 receptor α chain|IL-5 receptor α chain|Y
bidirectional best hit|bi-directional best hit|Y
gadolinium diethylenetriaminepenta-acetic acid|gadolinium diethylenetriamine pentaacetic acid|Y
magnetic-resonance-guided focused ultrasound surgery|magnetic resonance-guided focused ultrasound surgery|Y
parathyroid hormone-parathyroid hormone-related protein receptor|parathyroid hormone-parathyroid hormone related protein receptor|Y
parathyroid hormone-parathyroid hormone-related protein receptor|parathyroid hormone/parathyroid hormone-related protein receptor|Y
fiberoptic trans-illumination|fiber optic trans-illumination|Y
fiberoptic trans-illumination|fiber-optic trans-illumination|Y
fiberoptic trans-illumination|fiberoptic transillumination|Y
p38 mitogen-activated protein kinase|p-38 mitogen-activated protein kinase|Y
p38 mitogen-activated protein kinase|p38α mitogen-activated protein kinase|Y
American Society of Anesthesiologists status|American Society of Anesthesiologists status 1|Y
American Society of Anesthesiologists status|American Society of Anesthesiologists status 2|Y
American Society of Anesthesiologists status|American Society of Anesthesiologists status 3|Y
American Society of Anesthesiologists status|American Society of Anesthesiologists status 4|Y
American Society of Anesthesiologists status|American Society of Anesthesiologists status V|Y
American Society of Anesthesiologists status|American Society of Anesthesiologists status I|Y
American Society of Anesthesiologists status|American Society of Anesthesiologists status 5|Y
Toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta|Toll-IL-1 receptor domain-containing adaptor-inducing IFN-beta|Y
Toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta|Toll-IL-1 receptor domain-containing adaptor-inducing IFNbeta|Y
Toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta|Toll/IL-1 receptor domain-containing adaptor-inducing IFNbeta|Y
Toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta|toll/IL-1 receptor domain-containing adaptor-inducing IFNbeta|Y
Toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta|toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta|Y
Behavior Assessment System for Children, 2nd edition|Behavioral Assessment System for Children, 2nd edition|Y
gastrointestinal syndrome|gastro-intestinal syndrome|Y
recombinant human thyroid stimulating hormone|recombinant human thyroid-stimulating hormone|Y
self-nano-emulsifying drug delivery system|self nano-emulsifying drug delivery system|Y
nicotinamide-adenine dinucleotide phosphate-cytochrome P-450 reductase|nicotinamide adenine dinucleotide phosphate-cytochrome P450 reductase|Y
nicotinamide-adenine dinucleotide phosphate-cytochrome P-450 reductase|nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase|Y
nicotinamide-adenine dinucleotide phosphate-cytochrome P-450 reductase|nicotinamide-adenine dinucleotide phosphate-cytochrome P450 reductase|Y
nucleosidetriphosphatase|nucleoside-triphosphatase|Y
nucleosidetriphosphatase|nucleoside triphosphatase|Y
recombinant canine granulocyte-colony stimulating factor|recombinant canine granulocyte-colony-stimulating factor|Y
extra-cranial carotid arterial disease|extracranial carotid arterial disease|Y
retinoic acid receptor-related orphan receptor gamma|retinoic acid receptor-related orphan receptor gamma-t|Y
retinoic acid receptor-related orphan receptor gamma|retinoic acid receptor-related orphan receptor gamma t|Y
retinoic acid receptor-related orphan receptor gamma|retinoic acid receptor-related orphan receptor gammaT|Y
retinoic acid receptor-related orphan receptor gamma|retinoic acid receptor-related orphan receptor gamma-T|Y
retinoic acid receptor-related orphan receptor gamma|retinoic acid receptor-related orphan receptor-gamma|Y
retinoic acid receptor-related orphan receptor gamma|retinoic acid receptor-related orphan receptor gamma T|Y
retinoic acid receptor-related orphan receptor gamma|retinoic acid receptor-related orphan receptor gammat|Y
sino-atrial reentrant tachycardia|sinoatrial reentrant tachycardia|Y
oculoauricolovertebral dysplasia|oculo-auricolovertebral dysplasia|Y
electro-magnetic interference|electromagnetic interference|Y
modified semi-solid Rappaport-Vassiliadis medium|modified semisolid Rappaport-Vassiliadis medium|Y
subpopulation treatment effect pattern plot|sub-population treatment effect pattern plot|Y
Nurses' Observation Scale for In-patient Evaluation|Nurses Observation Scale for In-patient Evaluation|Y
Nurses' Observation Scale for In-patient Evaluation|Nurses Observation Scale for Inpatient Evaluation|Y
Nurses' Observation Scale for In-patient Evaluation|Nurses' Observation Scale for Inpatient Evaluation|Y
liquid chromatography-electrospray/mass spectrometry|liquid chromatography-electrospray-mass spectrometry|Y
liquid chromatography-electrospray/mass spectrometry|liquid chromatography/electrospray/mass spectrometry|Y
Toll/IL-1 receptor domain-containing adaptor-inducing IFN-β|toll/IL-1 receptor domain-containing adaptor-inducing IFN-β|Y
Toll/IL-1 receptor domain-containing adaptor-inducing IFN-β|Toll-IL-1 receptor domain-containing adaptor-inducing IFN-β|Y
Toll/IL-1 receptor domain-containing adaptor-inducing IFN-β|Toll/IL-1 receptor domain-containing adaptor-inducing IFNβ|Y
angiotensin II type 1A receptor|angiotensin II type 1 receptor|Y
electrocortical stimulation|electro-cortical stimulation|Y
thromboembolytic disease|thrombo-embolytic disease|Y
gamete intrafallopian transfer|gamete intra-fallopian transfer|Y
phosphatidylinositol mono-phosphate|phosphatidylinositol monophosphate|Y
Pediatric Risk of Mortality III|Pediatric Risk of Mortality II|Y
Pediatric Risk of Mortality III|Paediatric Risk of Mortality III|Y
electrospray ionization-quadrupole-time of flight-mass spectrometry|electrospray ionisation-quadrupole-time of flight-mass spectrometry|Y
intraepithelial leucocyte|intra-epithelial leucocyte|Y
melanocyte-stimulating hormone release inhibiting factor-1|melanocyte-stimulating hormone release-inhibiting factor-1|Y
melanocyte-stimulating hormone release inhibiting factor-1|melanocyte-stimulating hormone release inhibiting factor 1|Y
melanocyte-stimulating hormone release inhibiting factor-1|melanocyte-stimulating hormone release inhibiting factor|Y
sodium/calcium exchanger|sodium/calcium exchange|Y
thyrotrophin-releasing hormone test|thyrotropin-releasing hormone test|Y
γ-aminobutyric acid receptor|γ-amino-butyric acid receptor|Y
γ-aminobutyric acid receptor|γ-amino butyric acid receptor|Y
γ-aminobutyric acid receptor|γ-aminobutyric acidB receptor|Y
antiinsulin antibody|anti-insulin antibody|Y
Schonlein-Henoch syndrome|Schoenlein-Henoch syndrome|Y
2,2'-azobis(2-amidinopropane) dihydrochloride|2,2'-azobis(2-amidinopropane)dihydrochloride|Y
transient receptor potential vanilloid type 6|transient receptor potential vanilloid type 4|Y
transient receptor potential vanilloid type 6|transient receptor potential vanilloid type 5|Y
transient receptor potential vanilloid type 6|transient receptor potential vanilloid type 1|Y
transient receptor potential vanilloid type 6|transient receptor potential vanilloid type 2|Y
transient receptor potential vanilloid type 6|transient receptor potential vanilloid type 3|Y
recombinant human transforming growth factor-beta2|recombinant human transforming growth factor-beta3|Y
recombinant human transforming growth factor-beta2|recombinant human transforming growth factor-beta1|Y
recombinant human transforming growth factor-beta2|recombinant human transforming growth factor beta2|Y
recombinant human transforming growth factor-beta2|recombinant human transforming growth factor-beta 2|Y
recombinant human transforming growth factor-beta2|recombinant human transforming growth factor-beta|Y
organophosphorus-induced delayed neuropathy|organophosphorus induced delayed neuropathy|Y
anti-retroviral treatment|antiretroviral treatment|Y
laser desorption-ionisation time-of-flight mass spectrometry|laser desorption-ionization time-of-flight mass spectrometry|Y
laser desorption-ionisation time-of-flight mass spectrometry|laser desorption ionisation time-of-flight mass spectrometry|Y
laser desorption-ionisation time-of-flight mass spectrometry|laser desorption/ionisation time-of-flight mass spectrometry|Y
NON-EXPRESSOR OF PATHOGENESIS-RELATED GENES-1|NON-EXPRESSOR OF PATHOGENESIS-RELATED GENES 1|Y
NON-EXPRESSOR OF PATHOGENESIS-RELATED GENES-1|NONEXPRESSOR OF PATHOGENESIS-RELATED GENES1|Y
NON-EXPRESSOR OF PATHOGENESIS-RELATED GENES-1|NON-EXPRESSOR OF PATHOGENESIS-RELATED GENES1|Y
NON-EXPRESSOR OF PATHOGENESIS-RELATED GENES-1|NONEXPRESSOR OF PATHOGENESIS-RELATED GENES-1|Y
University of Washington Quality of Life questionnaire|University of Washington Quality of Life Questionnaire|Y
attenuated total reflection-Fourier transform infrared spectroscopy|attenuated total reflection Fourier transform infrared spectroscopy|Y
cotton-tail rabbit papilloma virus|cotton-tail rabbit papillomavirus|Y
multidrug resistance-associated protein-3|multidrug resistance associated protein-3|Y
multidrug resistance-associated protein-3|multidrug resistance-associated protein|Y
multidrug resistance-associated protein-3|multidrug resistance-associated protein 3|Y
Ca(2+)-activated K(+) channels|Ca(2+)-activated K(+) channel|Y
transforming growth factor beta inhibitory element|transforming growth factor-beta inhibitory element|Y
non-tuberculous mycobacterial|non-tuberculous mycobacteria|Y
non-tuberculous mycobacterial|nontuberculous mycobacterial|Y
trauma focused cognitive-behavioural therapy|trauma focused cognitive behavioural therapy|Y
trauma focused cognitive-behavioural therapy|trauma-focused cognitive-behavioural therapy|Y
trauma focused cognitive-behavioural therapy|trauma focused cognitive-behavioral therapy|Y
IL-12-receptor beta 1 chain|IL-12-receptor beta1 chain|Y
human immunodeficiency virus type 1 transactivator protein|human immunodeficiency virus type 1 trans-activator protein|Y
iso-volumic relaxation|isovolumic relaxation|Y
radio-chemical purity|radiochemical purity|Y
cross-polarisation magic angle spinning nuclear magnetic resonance|cross polarisation magic angle spinning nuclear magnetic resonance|Y
cross-polarisation magic angle spinning nuclear magnetic resonance|cross-polarisation magic-angle spinning nuclear magnetic resonance|Y
cross-polarisation magic angle spinning nuclear magnetic resonance|cross-polarization magic angle spinning nuclear magnetic resonance|Y
cross-polarisation magic angle spinning nuclear magnetic resonance|cross-polarisation/magic angle spinning nuclear magnetic resonance|Y
anodized aluminum oxide|anodized aluminium oxide|Y
trans-epithelial resistance|transepithelial resistance|Y
metallo-beta-lactamase|metallo-beta-lactamases|Y
anti-IL 4 receptor alpha antibody|anti-IL4 receptor alpha antibody|Y
dorso-lateral striatum|dorsolateral striatum|Y
myeloid DAP12 associating lectin 1|myeloid DAP 12 associating lectin 1|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase|mitogen-activated protein kinase/extracellular signal regulated kinase kinase|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase|mitogen-activated protein kinase-extracellular signal-regulated kinase kinase|Y
interleukin 5 receptor-α chain|interleukine 5 receptor-α chain|Y
intraarterial catheter|intra-arterial catheter|Y
oral hypoglycaemic agents|oral hypoglycaemic agent|Y
SECONDARY WALL ASSOCIATED NAC DOMAIN PROTEIN1|SECONDARY WALL ASSOCIATED NAC DOMAIN PROTEIN 1|Y
SECONDARY WALL ASSOCIATED NAC DOMAIN PROTEIN1|SECONDARY WALL-ASSOCIATED NAC DOMAIN PROTEIN1|Y
insertion/deletion polymorphism|insertion/deletion polymorphisms|Y
thermoluminescent detector|thermo-luminescent detector|Y
X-ray absorption near edge structure spectroscopy|x-ray absorption near edge structure spectroscopy|Y
X-ray absorption near edge structure spectroscopy|X-ray absorption near-edge structure spectroscopy|Y
miniplacental alkaline phosphatase|mini-placental alkaline phosphatase|Y
American Society of Anesthesiologists grade IV|American Society of Anaesthesiologists grade V|Y
American Society of Anesthesiologists grade IV|American Society of Anesthesiologists Grade IV|Y
American Society of Anesthesiologists grade IV|American Society of Anaesthesiologists grade IV|Y
American Society of Anesthesiologists grade IV|American Society of Anaesthesiologists grade I|Y
American Society of Anesthesiologists grade IV|American Society of Anesthesiologists grade V|Y
American Society of Anesthesiologists grade IV|American Society of Anesthesiologists grade I|Y
American Society of Anesthesiologists grade IV|American Society of Anesthesiologists grade II|Y
matrix metallopeptidase 3|matrix metallopeptidase 13|Y
pro-apolipoprotein AII|pro-apolipoprotein A-II|Y
pro-apolipoprotein AII|proapolipoprotein AII|Y
pro-apolipoprotein AII|pro-apolipoprotein A II|Y
pro-apolipoprotein AII|pro-apolipoprotein AI|Y
TBP-associated factor 12|TBP-associated factor 2|Y
TBP-associated factor 12|TBP-associated factor 1|Y
aminoacyl-tRNA synthetase-interacting multi-functional protein 1|aminoacyl tRNA synthetase-interacting multifunctional protein 1|Y
aminoacyl-tRNA synthetase-interacting multi-functional protein 1|aminoacyl-tRNA synthetase-interacting multifunctional protein 1|Y
aminoacyl-tRNA synthetase-interacting multi-functional protein 1|aminoacyl-tRNA synthetase-interacting multifunctional protein 2|Y
aminoacyl-tRNA synthetase-interacting multi-functional protein 1|aminoacyl-tRNA synthetase-interacting multifunctional protein 3|Y
aminoacyl-tRNA synthetase-interacting multi-functional protein 1|aminoacyl tRNA synthetase-interacting multi-functional protein 1|Y
antiimmunoglobulin G|anti-immunoglobulin G|Y
receptor-like protein tyrosine phosphatase ψ|receptor-like protein tyrosine phosphatase μ|Y
receptor-like protein tyrosine phosphatase ψ|receptor-like protein tyrosine phosphatase|Y
receptor-like protein tyrosine phosphatase ψ|receptor-like protein tyrosine phosphatase κ|Y
receptor-like protein tyrosine phosphatase ψ|receptor-like protein tyrosine phosphatase δ|Y
receptor-like protein tyrosine phosphatase ψ|receptor-like protein tyrosine phosphatase α|Y
receptor-like protein tyrosine phosphatase ψ|receptor-like protein-tyrosine phosphatase ψ|Y
receptor-like protein tyrosine phosphatase ψ|receptor-like protein tyrosine phosphatase ζ|Y
receptor-like protein tyrosine phosphatase ψ|receptor-like protein tyrosine phosphatase-ψ|Y
receptor-like protein tyrosine phosphatase ψ|receptor-like protein tyrosine phosphatase η|Y
anti-tumor necrosis factor antibody|anti-tumour necrosis factor antibody|Y
anti-tumor necrosis factor antibody|antitumor necrosis factor antibody|Y
anti-interleukin-12 monoclonal antibody|anti-interleukin-2 monoclonal antibody|Y
never in mitosis, gene A-related kinase 2B|never in mitosis, gene A-related kinase 2|Y
cGMP-dependent protein kinase Iβ|cGMP-dependent protein kinase I|Y
cGMP-dependent protein kinase Iβ|cGMP-dependent protein kinase I β|Y
non-transmural myocardial infarction|nontransmural myocardial infarction|Y
mitogen/extracellular signal-regulated kinase kinase-5|mitogen/extracellular-signal-regulated kinase kinase-5|Y
mitogen/extracellular signal-regulated kinase kinase-5|mitogen extracellular signal-regulated kinase kinase-5|Y
mitogen/extracellular signal-regulated kinase kinase-5|mitogen/extracellular signal-regulated kinase kinase 5|Y
sterol regulatory element binding protein 1a|sterol regulatory element binding protein 1-a|Y
sterol regulatory element binding protein 1a|sterol regulatory element binding protein 1|Y
sterol regulatory element binding protein 1a|sterol regulatory element binding protein 1c|Y
anti-liver specific protein antibody|antiliver specific protein antibody|Y
acid mucopolysaccharide|acid muco-polysaccharide|Y
poly (styrene sulphonate)|poly(styrene sulphonate)|Y
intra-renal hemorrhage|intrarenal hemorrhage|Y
interleukin-12 receptor β 1 chain|interleukin-12 receptor β1 chain|Y
ventral postero-medial thalamic nucleus|ventral posteromedial thalamic nucleus|Y
regional citrate anticoagulation|regional citrate anti-coagulation|Y
peroxisome proliferator activated receptor γ coactivator 1|peroxisome proliferator activated receptor γ co-activator 1|Y
peroxisome proliferator activated receptor γ coactivator 1|peroxisome proliferator activated receptor γ coactivator-1|Y
peroxisome proliferator activated receptor γ coactivator 1|peroxisome proliferator-activated receptor γ coactivator 1|Y
synchronized intermittent mandatory ventilation|synchronised intermittent mandatory ventilation|Y
gradient- and spin-echo|gradient and spin-echo|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor-cell-expressed developmentally downregulated 4|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally down-regulated 2|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor-cell-expressed developmentally downregulated 1|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor-cell-expressed developmentally downregulated 8|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally down-regulated 9|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor cell-expressed, developmentally down-regulated 2|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor-cell-expressed developmentally down-regulated 8|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor cell-expressed developmentally downregulated 2|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor-cell-expressed developmentally downregulated 2|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally down-regulated 1|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor-cell-expressed developmentally downregulated 9|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor-cell-expressed developmentally down-regulated 5|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally down-regulated 8|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally down-regulated 5|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor-cell-expressed developmentally down-regulated 9|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally down-regulated 4|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor-cell-expressed developmentally downregulated 5|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor-cell-expressed developmentally down-regulated 1|Y
neural-precursor-cell-expressed developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally downregulated 2|Y
conserved non-coding sequence 2|conserved noncoding sequence 2|Y
A disintegrin and metalloproteinase 29|A disintegrin and metalloproteinase 9|Y
interleukin-1beta converting enzyme|interleukin-1 beta converting enzyme|Y
β-amyloid precursor protein cleaving enzyme-1|β-amyloid precursor protein cleaving enzyme|Y
β-amyloid precursor protein cleaving enzyme-1|β-amyloid precursor protein cleaving enzyme-2|Y
β-amyloid precursor protein cleaving enzyme-1|β-amyloid precursor protein cleaving enzyme 1|Y
β-amyloid precursor protein cleaving enzyme-1|β-amyloid precursor protein-cleaving enzyme-1|Y
β-amyloid precursor protein cleaving enzyme-1|β amyloid precursor protein cleaving enzyme-1|Y
tissue non-specific alkaline phosphatase|tissue nonspecific alkaline phosphatase|Y
tissue non-specific alkaline phosphatase|tissue-non-specific alkaline phosphatase|Y
chronic rhino-sinusitis|chronic rhinosinusitis|Y
post-reperfusion syndrome|postreperfusion syndrome|Y
macrophage inflammatory protein 1 β|macrophage inflammatory protein 1β|Y
NFkappaB-repressing factor|NF-kappaB-repressing factor|Y
G protein-coupled oestrogen receptor 1|G protein-coupled estrogen receptor 1|Y
butylated hydroxyanisol|butylated hydroxyanisole|Y
cardio-vascular reactivity|cardiovascular reactivity|Y
recombinant human interleukin 1 α|recombinant human interleukin 1α|Y
delayed traumatic intracerebral haematoma|delayed traumatic intracerebral hematoma|Y
disinfection by-product|disinfection by-products|Y
anti-myelin associated glycoprotein antibody|anti-myelin-associated glycoprotein antibody|Y
ultraviolet nanoimprint lithography|ultra-violet nanoimprint lithography|Y
hydroxymethylglutaryl CoA reductase|hydroxymethyl-glutaryl CoA reductase|Y
plasmon-wave-guide resonance spectroscopy|plasmon-waveguide resonance spectroscopy|Y
plasmon-wave-guide resonance spectroscopy|plasmon-wave guide resonance spectroscopy|Y
Schimke immunoosseous dysplasia|Schimke immuno-osseous dysplasia|Y
polyphosphate accumulating organisms|polyphosphate accumulating organism|Y
crosspolarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
preintensive care unit|pre-intensive care unit|Y
p-nitro-phenylacetate|p-nitrophenylacetate|Y
athero-sclerotic heart disease|atherosclerotic heart disease|Y
Fas-associated death domain-like interleukin-1 beta-converting enzyme-inhibitory protein|Fas-associated death domain-like interleukin-1 beta converting enzyme inhibitory protein|Y
Fas-associated death domain-like interleukin-1 beta-converting enzyme-inhibitory protein|Fas-associated death domain-like interleukin-1 beta-converting enzyme inhibitory protein|Y
Fas-associated death domain-like interleukin-1 beta-converting enzyme-inhibitory protein|Fas-associated death domain-like interleukin-1beta converting enzyme-inhibitory protein|Y
Fas-associated death domain-like interleukin-1 beta-converting enzyme-inhibitory protein|Fas-associated death domain-like interleukin-1beta-converting enzyme inhibitory protein|Y
Fas-associated death domain-like interleukin-1 beta-converting enzyme-inhibitory protein|Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein|Y
choline mono-oxygenase|choline monooxygenase|Y
anti-4-1-BB monoclonal antibody|anti-4-1BB monoclonal antibody|Y
Insulin-like growth factor-binding protein|insulin-like growth factor-binding protein|Y
Insulin-like growth factor-binding protein|Insulin-like growth factor binding protein|Y
transforming growth factor-β activated kinase 1|transforming growth factor-β-activated kinase 1|Y
transforming growth factor-β activated kinase 1|transforming growth factor-β activated kinase-1|Y
intra-cavitary radium|intracavitary radium|Y
low density lipoprotein receptor related protein|low density lipoprotein receptor related protein 5|Y
low density lipoprotein receptor related protein|low density lipoprotein receptor related protein 1|Y
low density lipoprotein receptor related protein|low density lipoprotein receptor related protein 6|Y
hepato-iminodiacetic acid scan|hepatoiminodiacetic acid scan|Y
tetra-ethyl ammonium|tetra-methyl ammonium|Y
self nanoemulsifying drug delivery system|self nano-emulsifying drug delivery system|Y
self nanoemulsifying drug delivery system|self nano emulsifying drug delivery system|Y
reticuloomasal orifice|reticulo-omasal orifice|Y
intra-vascular blood coagulation|intravascular blood coagulation|Y
uncoordinated protein 73|uncoordinated protein 7|Y
uncoordinated protein 73|uncoordinated protein 3|Y
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride|1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|Y
granulocyte-macrophage colony forming units|granulocyte-macrophage colony-forming units|Y
mandibulofacial dysostosis|mandibulo-facial dysostosis|Y
dimercaptosuccinic acid scan|dimercapto-succinic acid scan|Y
aortoduodenal fistula|aorto-duodenal fistula|Y
peripheral primitive neuro-ectodermal tumor|peripheral primitive neuroectodermal tumor|Y
peripheral primitive neuro-ectodermal tumor|peripheral primitive neuro-ectodermal tumour|Y
American Spinal Injury Association grade|American Spinal Injury Association grade D|Y
American Spinal Injury Association grade|American Spinal Injury Association grade C|Y
American Spinal Injury Association grade|American Spinal Injury Association grade B|Y
American Spinal Injury Association grade|American Spinal Injury Association grade A|Y
3,3',5-tri-iodothyronine|3,3',5-triiodothyronine|Y
oxidised low-density lipoprotein receptor 1|oxidised low-density lipoprotein receptor-1|Y
oxidised low-density lipoprotein receptor 1|oxidized low-density lipoprotein receptor 1|Y
oxidised low-density lipoprotein receptor 1|oxidised low density lipoprotein receptor 1|Y
basic helix-loop-helix leucine-zipper transcription factor|basic helix-loop-helix leucine zipper transcription factor|Y
Schizosaccharomyces malidevorans|Schizo-saccharomyces malidevorans|Y
salmon gonadotrophin releasing hormone analogue|salmon gonadotropin releasing hormone analogue|Y
salmon gonadotrophin releasing hormone analogue|salmon gonadotrophin-releasing hormone analogue|Y
salmon gonadotrophin releasing hormone analogue|salmon gonadotrophin releasing hormone analog|Y
cardio-pulmonary bypass|cardiopulmonary bypass|Y
corrected count increments|corrected count increment|Y
Canadian Nurses' Association|Canadian Nurses Association|Y
non-anaemic iron deficiency|non-anemic iron deficiency|Y
Salmonella enterica serotype Paratyphi C|Salmonella enterica serotype Paratyphi B|Y
Salmonella enterica serotype Paratyphi C|Salmonella enterica serotype Paratyphi A|Y
enterically transmitted non-A, non-B hepatitis|enterically transmitted non-A non-B hepatitis|Y
enterically transmitted non-A, non-B hepatitis|enterically-transmitted non-A, non-B hepatitis|Y
striatonigral degeneration|striato-nigral degeneration|Y
human fetal osteoblastic cell line 1.19|human foetal osteoblastic cell line 1.19|Y
multi-planar reconstruction|multiplanar reconstruction|Y
sporulation protein IVA|sporulation protein IVFA|Y
auditory evoked response|auditory evoked responses|Y
neuro-axonal dystrophy|neuroaxonal dystrophy|Y
intra-uterine foetal death|intra-uterine fetal death|Y
Bos taurus autosome 26|Bos taurus autosome 2|Y
Bos taurus autosome 26|Bos taurus autosome 6|Y
pattern visual evoked potentials|pattern visual evoked potential|Y
capillary electrophoresis-electrospray ionization time-of-flight mass spectrometry|capillary electrophoresis-electrospray ionisation-time-of-flight mass spectrometry|Y
capillary electrophoresis-electrospray ionization time-of-flight mass spectrometry|capillary electrophoresis electrospray ionisation time-of-flight mass spectrometry|Y
capillary electrophoresis-electrospray ionization time-of-flight mass spectrometry|capillary electrophoresis-electrospray ionisation time-of-flight mass spectrometry|Y
capillary electrophoresis-electrospray ionization time-of-flight mass spectrometry|capillary electrophoresis electrospray ionization time-of-flight mass spectrometry|Y
capillary electrophoresis-electrospray ionization time-of-flight mass spectrometry|capillary electrophoresis-electrospray ionization-time-of-flight mass spectrometry|Y
capillary electrophoresis-electrospray ionization time-of-flight mass spectrometry|capillary electrophoresis-electrospray ionization time of flight mass spectrometry|Y
technetium-99m diethylene-triaminepenta-acetic acid-galactosyl human serum albumin|technetium-99m diethylene-triaminepentaacetic acid-galactosyl-human serum albumin|Y
technetium-99m diethylene-triaminepenta-acetic acid-galactosyl human serum albumin|technetium-99m-diethylene-triaminepentaacetic acid-galactosyl human serum albumin|Y
technetium-99m diethylene-triaminepenta-acetic acid-galactosyl human serum albumin|technetium 99m diethylenetriaminepentaacetic acid-galactosyl human serum albumin|Y
technetium-99m diethylene-triaminepenta-acetic acid-galactosyl human serum albumin|technetium-99m diethylene-triaminepentaacetic acid-galactosyl human serum albumin|Y
technetium-99m diethylene-triaminepenta-acetic acid-galactosyl human serum albumin|technetium-99m diethylene-triaminepentaacetic acid galactosyl human serum albumin|Y
technetium-99m diethylene-triaminepenta-acetic acid-galactosyl human serum albumin|technetium-99m diethylenetriaminepentaacetic acid-galactosyl human serum albumin|Y
technetium-99m diethylene-triaminepenta-acetic acid-galactosyl human serum albumin|technetium 99m diethylene-triaminepenta-acetic acid-galactosyl human serum albumin|Y
International Neuroblastoma Staging System Stage IV|International Neuroblastoma Staging System Stage II|Y
International Neuroblastoma Staging System Stage IV|International Neuroblastoma Staging System Stage I|Y
International Neuroblastoma Staging System Stage IV|International Neuroblastoma Staging System stage IV|Y
reference strand-mediated conformation analysis|reference strand-mediated conformational analysis|Y
reference strand-mediated conformation analysis|reference strand mediated conformation analysis|Y
gas chromatography-high-resolution mass spectrometry|gas chromatography-high resolution mass spectrometry|Y
gas chromatography-high-resolution mass spectrometry|gas chromatography/high-resolution mass spectrometry|Y
human immuno-deficiency virus infection|human immunodeficiency virus infection|Y
X-ray computed tomography|Xray computed tomography|Y
para-pharyngeal space|parapharyngeal space|Y
frequency tuning curves|frequency tuning curve|Y
trans-esophageal echocardiogram|trans-oesophageal echocardiogram|Y
trans-esophageal echocardiogram|transesophageal echocardiogram|Y
N-methyl-D-aspartate receptor subunit 2A|N-methyl-D-aspartate receptor subunit 2B|Y
immuno-cyto-chemistry|immunocyto-chemistry|Y
dual energy Xray absorptiometry scan|dual energy X-ray absorptiometry scan|Y
Bos taurus autosome 23|Bos taurus autosome 2|Y
Bos taurus autosome 23|Bos taurus autosome 3|Y
8-anilino-1-naphthalene sulfonic acid|8-anilino-1-naphthalenesulfonic acid|Y
dynamic multileaf collimator|dynamic multi-leaf collimator|Y
anti-IL-10 receptor mAb|anti-IL10 receptor mAb|Y
anti-IL-10 receptor mAb|antiIL-10 receptor mAb|Y
Yo-Yo Intermittent Recovery Test Level 1|Yo-Yo Intermittent Recovery Test level 1|Y
Yo-Yo Intermittent Recovery Test Level 1|Yo-Yo Intermittent Recovery Test Level 2|Y
Deutsches Institut fur medizinische Dokumentation und Information|Deutsches Institut für medizinische Dokumentation und Information|Y
cross polarisation magic angle spinning nuclear magnetic resonance|cross polarization magic angle spinning nuclear magnetic resonance|Y
cross polarisation magic angle spinning nuclear magnetic resonance|cross polarisation/magic angle spinning nuclear magnetic resonance|Y
cross polarisation magic angle spinning nuclear magnetic resonance|cross polarisation magic-angle spinning nuclear magnetic resonance|Y
acid-sensing ion channel-1|acid-sensing ion channel-1a|Y
acid-sensing ion channel-1|acid-sensing ion channel-1b|Y
Lectin-like oxidized low-density lipoprotein receptor-1|lectin-like oxidized low-density lipoprotein receptor-1|Y
immobilized metal-ion affinity chromatography|immobilized metal ion affinity chromatography|Y
immobilized metal-ion affinity chromatography|immobilised metal-ion affinity chromatography|Y
5'-N-methylcarboxamideadenosine|5'-N-ethylcarboxamideadenosine|Y
anti-T-cell receptor α β monoclonal antibody|anti-T cell receptor α β monoclonal antibody|Y
anti-T-cell receptor α β monoclonal antibody|anti-T-cell receptor α/β monoclonal antibody|Y
anti-T-cell receptor α β monoclonal antibody|anti-T-cell receptor-α β monoclonal antibody|Y
Charcot-Marie-Tooth type 1 disease|Charcot-Marie-Tooth type X1 disease|Y
Charcot-Marie-Tooth type 1 disease|Charcot-Marie-Tooth type 1A disease|Y
Charcot-Marie-Tooth type 1 disease|Charcot-Marie-Tooth type 1B disease|Y
cytokine-induced neutrophil chemoattractant-2α|cytokine-induced neutrophil chemoattractant 2α|Y
cytokine-induced neutrophil chemoattractant-2α|cytokine-induced neutrophil chemoattractant-2|Y
G protein gamma subunit|G protein βgamma subunit|Y
1-methyl-1-nitrosourea|1-ethyl-1-nitrosourea|Y
hairy-enhancer of split1|hairy-enhancer of split-1|Y
hairy-enhancer of split1|hairy-enhancer of split 1|Y
123I-meta-iodobenzylguanidine scintigraphy|(123)I-meta-iodobenzylguanidine scintigraphy|Y
123I-meta-iodobenzylguanidine scintigraphy|123I-metaiodobenzyl-guanidine scintigraphy|Y
123I-meta-iodobenzylguanidine scintigraphy|123I-metaiodobenzylguanidine scintigraphy|Y
123I-meta-iodobenzylguanidine scintigraphy|123I-meta-iodobenzyl-guanidine scintigraphy|Y
high resolution scanning electron microscopy|high-resolution scanning electron microscopy|Y
11beta-hydroxysteroid dehydrogenases|11beta-hydroxysteroid dehydrogenase|Y
pulsed electromagnetic fields|pulsed electromagnetic field|Y
histidine containing phosphotransfer domain|histidine-containing phosphotransfer domain|Y
heme-controlled repressor|haeme-controlled repressor|Y
cardio-pulmonary cerebral resuscitation|cardiopulmonary cerebral resuscitation|Y
circulating intercellular adhesion molecule 1|circulating intercellular adhesion molecule 3|Y
circulating intercellular adhesion molecule 1|circulating intercellular adhesion molecule 2|Y
circulating intercellular adhesion molecule 1|circulating intercellular adhesion molecule-1|Y
radio-iodinated serum albumin|radioiodinated serum albumin|Y
antiinterleukin 4 receptor monoclonal antibody|antiinterleukin 6 receptor monoclonal antibody|Y
antiinterleukin 4 receptor monoclonal antibody|antiinterleukin 2 receptor monoclonal antibody|Y
antiinterleukin 4 receptor monoclonal antibody|anti-interleukin 4 receptor monoclonal antibody|Y
human papillomavirus type 6b|human papillomavirus type 6|Y
Bcl2-associated X protein|Bcl-2-associated X protein|Y
meta-iodo-benzylguanidine scan|meta-iodobenzylguanidine scan|Y
meta-iodo-benzylguanidine scan|meta-iodo-benzyl-guanidine scan|Y
sputter-initiated resonance ionisation spectroscopy|sputter-initiated resonance ionization spectroscopy|Y
toll/interleukin-1 receptor domain-containing adaptor inducing IFN-beta|Toll/interleukin-1 receptor domain-containing adaptor inducing IFN-beta|Y
toll/interleukin-1 receptor domain-containing adaptor inducing IFN-beta|toll-interleukin-1 receptor domain-containing adaptor inducing IFN-beta|Y
Leucaena leucocephala trypsin inhibitor|Leucaena leucocephala trypsin inhibitor 1|Y
estrogen receptor status|oestrogen receptor status|Y
a disintegrin and metalloprotease|adisintegrin and metalloprotease|Y
retinoic acid receptor-related orphan receptor gamma-t|retinoic acid receptor-related orphan receptor gamma t|Y
retinoic acid receptor-related orphan receptor gamma-t|retinoic acid receptor-related orphan receptor gamma-T|Y
retinoic acid receptor-related orphan receptor gamma-t|retinoic acid receptor-related orphan receptor gammat|Y
sex-determining region Y box 3|sex-determining region Y, box 3|Y
gas-chromatography-negative ion chemical ionization-mass spectrometry|gas chromatography-negative ion chemical ionization-mass spectrometry|Y
gas-chromatography-negative ion chemical ionization-mass spectrometry|gas-chromatography-negative ion chemical ionisation-mass spectrometry|Y
auto-immune thrombocytopenic purpura|autoimmune thrombocytopenic purpura|Y
α-methyl acyl-coenzyme-A racemase|α-methylacyl-coenzyme-A racemase|Y
villitis of unknown aetiology|villitis of unknown etiology|Y
microtubule associated protein-2d|microtubule associated protein-2|Y
eicosapentaenoic acid|eicosapentanoic acid|Y
tumor necrosis factor receptor associated factor 2|tumor necrosis factor receptor associated factor|Y
tumor necrosis factor receptor associated factor 2|tumor necrosis factor receptor associated factor 6|Y
tumor necrosis factor receptor associated factor 2|tumor necrosis factor receptor associated factor 5|Y
tumor necrosis factor receptor associated factor 2|tumor necrosis factor receptor-associated factor 2|Y
tumor necrosis factor receptor associated factor 2|tumour necrosis factor receptor associated factor 2|Y
tumor necrosis factor receptor associated factor 2|tumor necrosis factor receptor associated factor 1|Y
tumor necrosis factor receptor associated factor 2|tumor necrosis factor receptor associated factor-2|Y
Kellgren-Lawrence grade IV|Kellgren-Lawrence grade I|Y
glycosylphosphatidyl inositol linked|glycosylphosphatidylinositol linked|Y
glycosylphosphatidyl inositol linked|glycosyl phosphatidyl inositol linked|Y
atrioventricular nodal conduction|atrio-ventricular nodal conduction|Y
periodic lateralised epileptiform discharge|periodic lateralised epileptiform discharges|Y
periodic lateralised epileptiform discharge|periodic lateralized epileptiform discharge|Y
latent transforming growth factor-beta binding protein-4|latent transforming growth factor-beta binding protein|Y
latent transforming growth factor-beta binding protein-4|latent transforming growth factor-beta binding protein 4|Y
latent transforming growth factor-beta binding protein-4|latent transforming growth factor-beta binding protein-2|Y
latent transforming growth factor-beta binding protein-4|latent transforming growth factor-beta binding protein-1|Y
latent transforming growth factor-beta binding protein-4|latent transforming growth factor beta binding protein-4|Y
transforming growth factor beta receptor I|transforming growth factor beta receptor|Y
transforming growth factor beta receptor I|transforming growth factor beta receptor II|Y
transforming growth factor beta receptor I|transforming growth factor beta receptor 1|Y
transforming growth factor beta receptor I|transforming growth factor-beta receptor I|Y
American Society of Anaesthesiologists class II|American Society of Anaesthesiologists class IV|Y
American Society of Anaesthesiologists class II|American Society of Anesthesiologists class III|Y
American Society of Anaesthesiologists class II|American Society of Anaesthesiologists class I|Y
American Society of Anaesthesiologists class II|American Society of Anaesthesiologists Class II|Y
American Society of Anaesthesiologists class II|American Society of Anesthesiologists class II|Y
American Society of Anaesthesiologists class II|American Society of Anaesthesiologists class III|Y
American Society of Anaesthesiologists class II|American Society of Anesthesiologists class I|Y
2-aminoethylisothiouronium bromide|2-aminoethylisothiuronium bromide|Y
anticytotoxic T-lymphocyte antigen-4 monoclonal antibody|anticytotoxic T-lymphocyte antigen 4 monoclonal antibody|Y
magic-angle spinning nuclear magnetic resonance spectroscopy|magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
magic-angle spinning nuclear magnetic resonance spectroscopy|magic angle spinning nuclear magnetic resonance spectroscopy|Y
hereditary angioneurotic edema|hereditary angio-neurotic edema|Y
corticotrophin-releasing factor receptor|corticotrophin releasing factor receptor|Y
corticotrophin-releasing factor receptor|corticotrophin-releasing factor receptor-1|Y
corticotrophin-releasing factor receptor|corticotropin-releasing factor receptor|Y
corticotrophin-releasing factor receptor|corticotrophin-releasing factor receptor 1|Y
corticotrophin-releasing factor receptor|corticotrophin-releasing-factor receptor|Y
metatarsophalangeal joint|metatarso-phalangeal joint|Y
insulinlike growth factor 1 deficient|insulin-like growth factor 1 deficient|Y
Charcot-Leyden crystals|Charcot-Leyden crystal|Y
sterol carrier protein|sterol carrier protein2|Y
eating attitude test|eating attitudes test|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon β|Toll/interleukin-1 receptor domain-containing adapter-inducing interferon β|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon β|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon β|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon β|toll/interleukin1 receptor domain-containing adapter-inducing interferon β|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon β|Toll-interleukin1 receptor domain-containing adapter-inducing interferon β|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon β|Toll/interleukin 1 receptor domain-containing adapter-inducing interferon-β|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon β|toll/interleukin 1 receptor domain-containing adapter-inducing interferon β|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon β|Y
non-relapse mortality|nonrelapse mortality|Y
corticotrophin releasing factor receptor|corticotropin releasing factor receptor|Y
corticotrophin releasing factor receptor|corticotrophin releasing factor receptor-1|Y
corticotrophin releasing factor receptor|corticotrophin releasing factor receptor 1|Y
catechol O-methyltransferase|catechol O-methyl transferase|Y
American Society of Anesthesiology status II|American Society of Anaesthesiology status II|Y
American Society of Anesthesiology status II|American Society of Anesthesiology status I|Y
American Society of Anesthesiology status II|American Society of Anesthesiology status IV|Y
American Society of Anesthesiology status II|American Society of Anesthesiology status III|Y
American Society of Anesthesiology status II|American Society of Anaesthesiology status III|Y
American Society of Anesthesiology status II|American Society of Anaesthesiology status I|Y
sperm-associated antigen 6|sperm-associated antigen 16|Y
persistent hyperinsulinaemic hypoglycemia of infancy|persistent hyperinsulinaemic hypoglycaemia of infancy|Y
persistent hyperinsulinaemic hypoglycemia of infancy|persistent hyperinsulinemic hypoglycemia of infancy|Y
glycoinositolphospholipid|glycoinositol phospholipid|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed, developmentally downregulated 8|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed developmentally downregulated 9|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor-cell-expressed, developmentally down-regulated 9|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor-cell-expressed, developmentally downregulated 9|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed developmentally down-regulated 9|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed, developmentally down-regulated 2|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed, developmentally downregulated 2|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed, developmentally downregulated 4|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed developmentally down-regulated 8|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed developmentally down-regulated 1|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed, developmentally downregulated 9|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed, developmentally down-regulated 8|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed, developmentally down-regulated 1|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed, developmentally downregulated 5|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural precursor cell-expressed, developmentally downregulated 9|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor-cell-expressed developmentally down-regulated 9|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural precursor cell-expressed developmentally down-regulated 9|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural-precursor cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed, developmentally downregulated 1|Y
nonclaret disjunctional protein|non-claret disjunctional protein|Y
tubero-infundibular dopaminergic neurone|tubero-infundibular dopaminergic neuron|Y
time tradeoff utility|time trade-off utility|Y
para-chloromercuriphenylsulphonic acid|para-chloromercuriphenyl sulphonic acid|Y
chronic megakaryocytic granulocytic myelosis|chronic megakaryocytic-granulocytic myelosis|Y
intra-vascular consumption coagulopathy|intravascular consumption coagulopathy|Y
preeclampsia-related|pre-eclampsia-related|Y
colony forming unit-granulocyte-macrophage|colony-forming unit-granulocyte-macrophage|Y
colony forming unit-granulocyte-macrophage|colony forming units-granulocyte-macrophage|Y
colony forming unit-granulocyte-macrophage|colony forming unit/granulocyte-macrophage|Y
colony forming unit-granulocyte-macrophage|colony forming unit-granulocyte macrophage|Y
colony forming unit-granulocyte-macrophage|colony forming unit-granulocyte/macrophage|Y
solute carrier family 7 member 13|solute carrier family 7 member 3|Y
solute carrier family 7 member 13|solute carrier family 7 member 1|Y
Women, Infants, and Children program|Women, Infants and Children program|Y
trans-endothelial migration|transendothelial migration|Y
anti-B-cell leukaemia/lymphoma-2|anti-B-cell leukemia/lymphoma-2|Y
basement-membrane-specific chondroitin sulphate proteoglycan|basement membrane-specific chondroitin sulphate proteoglycan|Y
chicken gonadotrophin releasing hormone|chicken gonadotropin releasing hormone|Y
trans-mural laser revascularisation|transmural laser revascularisation|Y
interleukine 3 receptor α chain|interleukin 3 receptor α chain|Y
insulinlike growth factor type 1 receptor|insulin-like growth factor type 1 receptor|Y
lateral premotor system|lateral pre-motor system|Y
thoracoabdominal irradiation|thoraco-abdominal irradiation|Y
intra-cerebroventricular|intracerebroventricular|Y
intra-cerebroventricular|intra-cerebro-ventricular|Y
thyrotrophin-releasing factor|thyrotropin-releasing factor|Y
midblastula transition|mid-blastula transition|Y
streptococcal superantigen|streptococcal super-antigen|Y
invariant T-cell receptor V α14|invariant T-cell receptor V α 14|Y
invariant T-cell receptor V α14|invariant T-cell receptor Vα14|Y
deoxyribonucleic acid methyltransferase 2|deoxyribonucleic acid methyltransferase|Y
deoxyribonucleic acid methyltransferase 2|deoxyribonucleic acid methyltransferase 1|Y
post-mitochondrial supernatant|postmitochondrial supernatant|Y
reversive post-optokinetic nystagmus|reversive postoptokinetic nystagmus|Y
anti-matrix metallopeptidase 3 antibody|anti-matrix metallopeptidase 13 antibody|Y
tumour infiltrating T lymphocyte|tumor infiltrating T lymphocyte|Y
phosphopantetheine adenylyltransferase|phosphopantetheine adenylyl-transferase|Y
phosphorylated glycogen synthase kinase 3 β|phosphorylated glycogen synthase kinase-3 β|Y
phosphorylated glycogen synthase kinase 3 β|phosphorylated glycogen synthase kinase 3β|Y
Brainstem auditory evoked potentials|Brain stem auditory evoked potentials|Y
dealcoholized red wine|de-alcoholized red wine|Y
SNF2-related CBP activator protein|SNF-2-related CBP activator protein|Y
5-hydroxytryptamine2A|5-hydroxytryptamine2|Y
cardio-facio-cutaneous syndrome|cardio-faciocutaneous syndrome|Y
slowly adapting pulmonary stretch receptors|slowly adapting pulmonary stretch receptor|Y
stress-activated protein kinase-2b|stress-activated protein kinase-2|Y
inter-α trypsin inhibitor|inter-αtrypsin inhibitor|Y
antitissue transglutaminase antibody|anti-tissue transglutaminase antibody|Y
inhibitory postsynaptic potential|inhibitory post-synaptic potential|Y
shrinking lung syndrome|shrinking lungs syndrome|Y
phenylmethylsulfonyl fluoride|phenylmethyl-sulfonyl fluoride|Y
phenylmethylsulfonyl fluoride|phenyl-methylsulfonyl fluoride|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling assay|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labelling assay|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling assay|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling assay|terminal-deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling assay|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling assay|terminal-deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling assay|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labelling assay|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling assay|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling assay|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling assay|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling assay|Y
anti-mitochondrial antibody M2|antimitochondrial antibody M2|Y
three-dimensional computed tomographic angiography|three dimensional computed tomographic angiography|Y
src homology-2 domain-containing protein tyrosine phosphatase-2|src homology 2 domain-containing protein tyrosine phosphatase-2|Y
src homology-2 domain-containing protein tyrosine phosphatase-2|src-homology-2 domain-containing protein tyrosine phosphatase-2|Y
src homology-2 domain-containing protein tyrosine phosphatase-2|src homology-2 domain-containing protein tyrosine phosphatase 2|Y
src homology-2 domain-containing protein tyrosine phosphatase-2|Src homology-2 domain-containing protein tyrosine phosphatase-2|Y
src homology-2 domain-containing protein tyrosine phosphatase-2|src homology-2 domain-containing protein tyrosine phosphatase|Y
three-colour fluorescence in-situ hybridisation|three-colour fluorescence in situ hybridisation|Y
three-colour fluorescence in-situ hybridisation|three colour fluorescence in-situ hybridisation|Y
three-colour fluorescence in-situ hybridisation|three-colour fluorescence in-situ hybridization|Y
three-colour fluorescence in-situ hybridisation|three-color fluorescence in-situ hybridisation|Y
tumour necrosis factor related apoptosis-inducing ligand receptor|tumor necrosis factor related apoptosis inducing ligand receptor|Y
tumour necrosis factor related apoptosis-inducing ligand receptor|tumor necrosis factor-related apoptosis-inducing ligand receptor|Y
tumour necrosis factor related apoptosis-inducing ligand receptor|tumour necrosis factor-related apoptosis-inducing ligand receptor|Y
tumour necrosis factor related apoptosis-inducing ligand receptor|tumor necrosis factor related apoptosis-inducing ligand receptor|Y
tumour necrosis factor related apoptosis-inducing ligand receptor|tumour necrosis factor related apoptosis inducing ligand receptor|Y
Matrix-assisted laser desorption ionization mass spectrometry|matrix-assisted laser desorption ionization mass spectrometry|Y
plasmin α 2 plasmin inhibitor complex|plasmin α2 plasmin inhibitor complex|Y
Rush Presbyterian Saint Luke's Medical Centre|Rush Presbyterian Saint Luke's Medical Center|Y
Rush Presbyterian Saint Luke's Medical Centre|Rush Presbyterian-Saint Luke's Medical Centre|Y
intra-duodenal stimulation|intraduodenal stimulation|Y
interleukine-18 receptor α subunit|interleukin-18 receptor α subunit|Y
trans-bronchial biopsy|transbronchial biopsy|Y
cartilage-derived morphogenetic protein 2|cartilage-derived morphogenetic protein 1|Y
cartilage-derived morphogenetic protein 2|cartilage-derived morphogenetic protein 3|Y
cartilage-derived morphogenetic protein 2|cartilage-derived morphogenetic protein-2|Y
cartilage-derived morphogenetic protein 2|cartilage-derived morphogenetic protein|Y
neonatal allo-immune neutropenia|neonatal alloimmune neutropenia|Y
neonatal allo-immune neutropenia|neonatal allo-immune neutropaenia|Y
α-foetoprotein level|α-foeto-protein level|Y
T-cell-receptor gammadelta-positive|T-cell-receptor gamma delta-positive|Y
eucaryotic translation initiation factor 5A|eucaryotic translation initiation factor 5|Y
promyelocytic leukaemia/retinoic acid receptor-alpha|promyelocytic leukaemia/retinoic acid receptor alpha|Y
promyelocytic leukaemia/retinoic acid receptor-alpha|promyelocytic leukaemia-retinoic acid receptor-alpha|Y
promyelocytic leukaemia/retinoic acid receptor-alpha|promyelocytic leukemia/retinoic acid receptor-alpha|Y
Penicillium brevi-compactum|Penicillium brevicompactum|Y
[3H]-N-methylscopolamine|[3H]N-methylscopolamine|Y
[3H]-N-methylscopolamine|[3H]-N-methyl scopolamine|Y
human adenovirus type 2|human adenovirus type 25|Y
human adenovirus type 2|human adenovirus type 24|Y
human adenovirus type 2|human adenovirus type 27|Y
human adenovirus type 2|human adenovirus type 26|Y
human adenovirus type 2|human adenovirus type 28|Y
human adenovirus type 2|human adenovirus type 21|Y
human adenovirus type 2|human adenovirus type 52|Y
human adenovirus type 2|human adenovirus type 23|Y
human adenovirus type 2|human adenovirus type 42|Y
human adenovirus type 2|human adenovirus type 32|Y
human adenovirus type 2|human adenovirus type 12|Y
human adenovirus type 2|human adenovirus type 22|Y
American Spinal Injury Association grade D|American Spinal Injury Association grade C|Y
American Spinal Injury Association grade D|American Spinal Injury Association grade B|Y
American Spinal Injury Association grade D|American Spinal Injury Association grade A|Y
broncho-alveolar washing|bronchoalveolar washing|Y
brainstem-evoked response|brain-stem-evoked response|Y
brainstem-evoked response|brain stem-evoked response|Y
tumour necrosis factor receptor associated factor|tumour necrosis factor receptor associated factor-6|Y
tumour necrosis factor receptor associated factor|tumor necrosis factor receptor associated factor|Y
tumour necrosis factor receptor associated factor|tumour necrosis factor receptor associated factor-5|Y
tumour necrosis factor receptor associated factor|tumour necrosis factor receptor-associated factor|Y
tumour necrosis factor receptor associated factor|tumour necrosis factor receptor associated factor 6|Y
tumour necrosis factor receptor associated factor|tumour necrosis factor receptor associated factor 1|Y
tumour necrosis factor receptor associated factor|tumour necrosis factor receptor associated factor-2|Y
tumour necrosis factor receptor associated factor|tumour necrosis factor receptor associated factor 5|Y
tumour necrosis factor receptor associated factor|tumour necrosis factor receptor associated factor 2|Y
tumour necrosis factor receptor associated factor|tumour necrosis factor receptor associated factor-1|Y
trans-lesion synthesis|translesion synthesis|Y
immuno-enzymetric assay|immunoenzymetric assay|Y
deproteinized bovine bone|de-proteinized bovine bone|Y
noncomedo ductal carcinoma in situ|non-comedo ductal carcinoma in situ|Y
CXC chemokine receptor 4|CC chemokine receptor 4|Y
cervico-vaginal lavage|cervicovaginal lavage|Y
deoxy-cytidine diphosphate|deoxycytidine diphosphate|Y
stromal-derived factor-1α|stromal-derived factor-1|Y
stromal-derived factor-1α|stromal-derived factor-1 α|Y
stromal-derived factor-1α|stromal-derived factor-1-α|Y
tumor-associated macrophages|tumor-associated macrophage|Y
lympho-nodular hyperplasia|lymphonodular hyperplasia|Y
retinoic acid-inducible gene-like helicase|retinoic-acid-inducible gene-like helicase|Y
scavenger receptor type B-1|scavenger receptor type B1|Y
acyl amino acid releasing enzyme|acylamino acid releasing enzyme|Y
third degree atrioventricular block|third degree atrio-ventricular block|Y
vasopeptidase inhibitor|vaso-peptidase inhibitor|Y
empirically supported treatments|empirically supported treatment|Y
corticotropin-releasing factor receptor type-1|corticotropin-releasing factor receptor type 1|Y
corticotropin-releasing factor receptor type-1|corticotropin releasing factor receptor type-1|Y
recombinant human interferon-α2b|recombinant human interferon-α 2b|Y
free insulin-like growth factor II|free insulin-like growth factor I|Y
free insulin-like growth factor II|free insulinlike growth factor II|Y
downflow hanging sponge|down-flow hanging sponge|Y
peroxisome proliferator-activated receptor-γ1|peroxisome proliferator-activated receptor-γ 1|Y
peroxisome proliferator-activated receptor-γ1|peroxisome proliferator-activated receptor-γ|Y
peroxisome proliferator-activated receptor-γ1|peroxisome proliferator-activated receptor γ1|Y
peroxisome proliferator-activated receptor-γ1|peroxisome proliferator-activated receptor-γ2|Y
travelling salesman problem|traveling salesman problem|Y
subarachnoid hemorrhage|sub-arachnoid hemorrhage|Y
aldo-keto reductase family 1, member B10|aldo-keto reductase family 1 member B10|Y
antimyolemmal antibody|anti-myolemmal antibody|Y
predicted no-effect concentration|predicted no-effect concentrations|Y
matrix-assisted laser desorption ionisation time-of-flight mass spectrometry|matrix assisted laser desorption ionisation time-of-flight mass spectrometry|Y
matrix-assisted laser desorption ionisation time-of-flight mass spectrometry|matrix-assisted laser desorption ionisation time-of-flight mass spectrometric|Y
matrix-assisted laser desorption ionisation time-of-flight mass spectrometry|matrix-assisted laser desorption ionization time-of-flight mass spectrometry|Y
matrix-assisted laser desorption ionisation time-of-flight mass spectrometry|matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry|Y
anti-aprotinin immunoglobulin G antibody|antiaprotinin immunoglobulin G antibody|Y
anti-cluster of differentiation 3 monoclonal antibody|anti-cluster of differentiation 2 monoclonal antibody|Y
cytosolic phospholipase A(2)-α|cytosolic phospholipase A(2)α|Y
musculo-skeletal disorder|musculoskeletal disorder|Y
anti-epidermal growth factor receptor variant III|antiepidermal growth factor receptor variant III|Y
de-alcoholised red wine|dealcoholised red wine|Y
American Society of Anaesthesiologists class V|American Society of Anaesthesiologists class IV|Y
American Society of Anaesthesiologists class V|American Society of Anaesthesiologists class 2|Y
American Society of Anaesthesiologists class V|American Society of Anaesthesiologists class|Y
American Society of Anaesthesiologists class V|American Society of Anaesthesiologists class I|Y
American Society of Anaesthesiologists class V|American Society of Anaesthesiologists class 3|Y
American Society of Anaesthesiologists class V|American Society of Anaesthesiologists Class V|Y
American Society of Anaesthesiologists class V|American Society of Anesthesiologists class V|Y
American Society of Anaesthesiologists class V|American Society of Anesthesiologists class IV|Y
American Society of Anaesthesiologists class V|American Society of Anaesthesiologists class 5|Y
American Society of Anaesthesiologists class V|American Society of Anaesthesiologists class 1|Y
American Society of Anaesthesiologists class V|American Society of Anaesthesiologists class 4|Y
retinoic-acid-receptor-related orphan receptor γt|retinoic-acid-receptor-related orphan receptor γ-t|Y
retinoic-acid-receptor-related orphan receptor γt|retinoic-acid-receptor-related orphan receptor γ t|Y
retinoic-acid-receptor-related orphan receptor γt|retinoic-acid-receptor-related orphan receptor γT|Y
retinoic-acid-receptor-related orphan receptor γt|retinoic-acid-receptor-related orphan receptor γ|Y
robot assisted laparoscopic radical prostatectomy|robot-assisted laparoscopic radical prostatectomy|Y
hyper-branched polyester|hyperbranched polyester|Y
downflow hanging sponge reactor|down-flow hanging sponge reactor|Y
anti-soluble egg antigen antibody|antisoluble egg antigen antibody|Y
total cavo-pulmonary shunt|total cavopulmonary shunt|Y
thyrotrophin-releasing hormone-like|thyrotropin-releasing hormone-like|Y
alpha-phenyl-N-tert-butylnitrone|alpha-phenyl-N-tert-butyl-nitrone|Y
alpha-phenyl-N-tert-butylnitrone|alpha-phenyl-N-tert-butyl nitrone|Y
Megakaryocyte growth and development factor|megakaryocyte growth and development factor|Y
acute gastric mucosal lesions|acute gastric mucosal lesion|Y
nonsteroidal anti-inflammatories|non-steroidal anti-inflammatories|Y
p-amino-hippuric acid clearance|p-aminohippuric acid clearance|Y
selective angio-embolisation|selective angioembolisation|Y
nonspecific crossreacting antigen|nonspecific cross-reacting antigen|Y
nonspecific crossreacting antigen|non-specific crossreacting antigen|Y
human hepatocellular carcinoma cell line 1A|human hepatocellular carcinoma cell line 1|Y
human hepatocellular carcinoma cell line 1A|human hepatocellular carcinoma cell line 1B|Y
transforming growth factor β-inducible gene-H3|transforming growth factor β-inducible gene H3|Y
arylmethylaminopropanediol|arylmethylamino-propanediol|Y
gamma-aminobutyric acid A receptor-chloride channel complex|gamma-aminobutyric acid receptor-chloride channel complex|Y
interleukin 12 receptor β1 chain|interleukin 12 receptor β 1 chain|Y
poly (A) binding protein nuclear 1|poly(A) binding protein nuclear 1|Y
electromagnetically induced transparency|electromagnetically-induced transparency|Y
interleukin 2 receptor α chain|interleukine 2 receptor α chain|Y
neuron-specific protein B-50|neurone-specific protein B-50|Y
Fas-associated death domain-like interleukin-1 beta converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1 beta-converting enzyme inhibitory protein|Y
Fas-associated death domain-like interleukin-1 beta converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1beta converting enzyme-inhibitory protein|Y
Fas-associated death domain-like interleukin-1 beta converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1beta-converting enzyme inhibitory protein|Y
Fas-associated death domain-like interleukin-1 beta converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1beta converting enzyme inhibitory protein|Y
purinergic 2X7 receptor|purinergic 2X receptor|Y
Phleum pratense protein 11|Phleum pratense protein 1|Y
anti-IL 6 receptor monoclonal antibody|anti-IL6 receptor monoclonal antibody|Y
American Society of Anesthesiologists status II|American Society of Anesthesiologists status IV|Y
American Society of Anesthesiologists status II|American Society of Anesthesiologists Status II|Y
American Society of Anesthesiologists status II|American Society of Anesthesiologists status I|Y
American Society of Anesthesiologists status II|American Society of Anaesthesiologists status I|Y
American Society of Anesthesiologists status II|American Society of Anesthesiologists status III|Y
American Society of Anesthesiologists status II|American Society of Anaesthesiologists status III|Y
American Society of Anesthesiologists status II|American Society of Anaesthesiologists status II|Y
anti-interleukin 2 antibody|anti-interleukin 12 antibody|Y
anti-interleukin 2 antibody|antiinterleukin 2 antibody|Y
delayed type hypersensitivity reaction|delayed type hypersensitivity reactions|Y
fasting hyper-bilirubinaemia|fasting hyper-bilirubinemia|Y
fasting hyper-bilirubinaemia|fasting hyperbilirubinaemia|Y
down-regulated in adenoma|downregulated in adenoma|Y
X-ray absorption fine-structure spectroscopy|X-ray absorption fine structure spectroscopy|Y
X-ray absorption fine-structure spectroscopy|x-ray absorption fine-structure spectroscopy|Y
topological substructural molecular design|topological sub-structural molecular design|Y
technetium-99m diethylenetriaminepentaacetic acid|technetium-99m diethylenetriamine penta-acetic acid|Y
technetium-99m diethylenetriaminepentaacetic acid|technetium-99m diethylenetriamine pentaacetic acid|Y
technetium-99m diethylenetriaminepentaacetic acid|technetium-99m diethylene triamine pentaacetic acid|Y
genito-urinary medicine|genitourinary medicine|Y
classical anti-neutrophil cytoplasmic antibody|classical antineutrophil cytoplasmic antibody|Y
classical anti-neutrophil cytoplasmic antibody|classic anti-neutrophil cytoplasmic antibody|Y
peroxisome proliferator-activated receptor-γ coactivator 1α|peroxisome proliferator-activated receptor γ coactivator 1α|Y
peroxisome proliferator-activated receptor-γ coactivator 1α|peroxisome proliferator-activated receptor-γ coactivator-1α|Y
peroxisome proliferator-activated receptor-γ coactivator 1α|peroxisome proliferator-activated receptor-γ co-activator 1 α|Y
peroxisome proliferator-activated receptor-γ coactivator 1α|peroxisome proliferator-activated receptor-γ coactivator 1 α|Y
peroxisome proliferator-activated receptor-γ coactivator 1α|peroxisome proliferator-activated receptor-γ co-activator 1α|Y
peroxisome proliferator-activated receptor-γ coactivator 1α|peroxisome-proliferator-activated receptor-γ coactivator 1α|Y
glutathione S-transferase 3|glutathione S-transferase M3|Y
caspase 1/interleukin-1beta converting enzyme|caspase 1/interleukin-1beta-converting enzyme|Y
anti-proliferating cell nuclear antigen antibody|antiproliferating cell nuclear antigen antibody|Y
translation elongation factor 1 α|translation elongation factor 1α|Y
sodium dodecyl sulfate-polyacrylamide gel electrophoresis|sodium dodecyl sulfate polyacrylamide gel electrophoresis|Y
multiexpression programming|multi-expression programming|Y
insulin-like growth factor 2|insulinlike growth factor 2|Y
recombinant murine interleukin 3|recombinant murine interleukin 13|Y
chronic cerebro-spinal venous insufficiency|chronic cerebrospinal venous insufficiency|Y
oro-pharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma|Y
deoxyribonucleic acid methyltransferase|deoxyribonucleic acid methyltransferase 1|Y
post-cardiac injury syndrome|postcardiac injury syndrome|Y
stress-activated protein kinase 2a|stress-activated protein kinase 2|Y
steady-state concentrations|steady-state concentration|Y
realtime quantitative RT-PCR|real-time quantitative RT-PCR|Y
realtime quantitative RT-PCR|real time quantitative RT-PCR|Y
aminoterminal pro B-type natriuretic peptide|amino-terminal pro B-type natriuretic peptide|Y
aminoterminal pro B-type natriuretic peptide|aminoterminal proB-type natriuretic peptide|Y
aminoterminal pro B-type natriuretic peptide|amino-terminal proB-type natriuretic peptide|Y
aminoterminal pro B-type natriuretic peptide|aminoterminal pro-B-type natriuretic peptide|Y
reentrant ventricular arrhythmia|re-entrant ventricular arrhythmia|Y
interleukin-15 receptor alpha chain|interleukine-15 receptor alpha chain|Y
relapsing experimental auto-immune encephalomyelitis|relapsing experimental autoimmune encephalomyelitis|Y
haemorrhagic fever with renal syndrome virus|hemorrhagic fever with renal syndrome virus|Y
glycosyl-phosphatidyl-inositol-linked protein|glycosyl-phosphatidyl-inositol linked protein|Y
glycosyl-phosphatidyl-inositol-linked protein|glycosyl-phosphatidylinositol-linked protein|Y
glycosyl-phosphatidyl-inositol-linked protein|glycosylphosphatidylinositol-linked protein|Y
cancer stemlike cell|cancer stem-like cell|Y
multi-locular renal cyst|multilocular renal cyst|Y
immuno-stimulating complex|immunostimulating complex|Y
patello-femoral arthroplasty|patellofemoral arthroplasty|Y
midarm muscle circumference|mid-arm muscle circumference|Y
near infrared fluorescence|near infra-red fluorescence|Y
C-C chemokine ligand 20|C-C chemokine ligand 2|Y
C-C chemokine ligand 20|CC chemokine ligand 20|Y
TIR domain-containing adaptor-inducing IFN-β|TIR domain containing adaptor-inducing IFN-β|Y
TIR domain-containing adaptor-inducing IFN-β|TIR domain-containing adaptor inducing IFN-β|Y
oculo-auricolo-vertebral|oculo-auricolovertebral|Y
dual-energy x-ray absorptiometry scanning|dual-energy X-ray absorptiometry scanning|Y
dual-energy x-ray absorptiometry scanning|dual energy x-ray absorptiometry scanning|Y
counterimmuno-electrophoresis|counterimmunoelectrophoresis|Y
systemic scleroderma|systemic sclerodermia|Y
C-C chemokine ligand-18|C-C chemokine ligand-8|Y
cytochrome P-450 isoenzyme 3A4|cytochrome P450 isoenzyme 3A4|Y
post-sternotomy mediastinitis|poststernotomy mediastinitis|Y
gamma-glutamyltranspeptidase|gammaglutamyltranspeptidase|Y
selenocysteine tRNA gene transcription activating factor|selenocysteine tRNA gene transcription-activating factor|Y
para-neoplastic cerebellar degeneration|paraneoplastic cerebellar degeneration|Y
phosphopantothenoylcysteine|phosphopantothenoyl-cysteine|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-10|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motifs-6|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motifs-19|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-8|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motifs-3|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-7|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-15|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-14|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motifs|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-3|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-20|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motifs-4|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motifs-2|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-2|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motif-9|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motifs-9|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
anti-endomysium antibody|antiendomysium antibody|Y
GDP-mannose mannosyl hydrolase|GDPmannose mannosyl hydrolase|Y
alpha-one anti-trypsin|alpha-one antitrypsin|Y
granulocyte macrophage-colony-stimulating factor receptor α chain|granulocyte-macrophage-colony-stimulating factor receptor α chain|Y
granulocyte macrophage-colony-stimulating factor receptor α chain|granulocyte macrophage-colony-stimulating factor receptor α-chain|Y
desoxycorticosterone acetate|deoxycorticosterone acetate|Y
year since menopause|years since menopause|Y
human papillomavirus type 16|human papillomavirus type 1|Y
human papillomavirus type 16|human papillomavirus type 6|Y
pheromone-biosynthesis activating neuropeptide|pheromone biosynthesis activating neuropeptide|Y
pheromone-biosynthesis activating neuropeptide|pheromone-biosynthesis-activating neuropeptide|Y
excision repair cross complementation group 2|excision repair cross complementation group 5|Y
excision repair cross complementation group 2|excision repair cross complementation group 1|Y
excision repair cross complementation group 2|excision repair cross complementation group 4|Y
Pediatric Risk of Mortality II|Paediatric Risk of Mortality II|Y
intracavitary radiotherapy|intra-cavitary radiotherapy|Y
ammonia mono-oxygenase α subunit|ammonia monooxygenase α subunit|Y
α-melanocyte-stimulating hormone receptor|α-melanocyte stimulating hormone receptor|Y
α-melanocyte-stimulating hormone receptor|melanocyte-stimulating hormone receptor|Y
X-ray repair cross complementing group 1|X-ray repair cross-complementing group 1|Y
X-ray repair cross complementing group 1|x-ray repair cross complementing group 1|Y
peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor gamma 1|Y
peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor gamma-2|Y
peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor gamma2|Y
peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor gamma1|Y
peroxisome proliferator-activated receptor gamma|Peroxisome proliferator-activated receptor gamma|Y
peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor-gamma|Y
peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor gamma-1|Y
peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor gamma 2|Y
gravito-inertial acceleration|gravitoinertial acceleration|Y
N-acetyl galactosamine|N-acetylgalactosamine|Y
temperature programmed desorption-mass spectrometry|temperature programmed desorption mass spectrometry|Y
temperature programmed desorption-mass spectrometry|temperature-programmed desorption-mass spectrometry|Y
temperature programmed desorption-mass spectrometry|temperature programed desorption-mass spectrometry|Y
rest, ice, compression, and elevation|rest, ice, compression and elevation|Y
Actinobacillus pleuropneumoniae-RTX-toxin III|Actinobacillus pleuropneumoniae RTX-toxin III|Y
Actinobacillus pleuropneumoniae-RTX-toxin III|Actinobacillus pleuropneumoniae-RTX-toxin II|Y
Actinobacillus pleuropneumoniae-RTX-toxin III|Actinobacillus pleuropneumoniae-RTX toxin III|Y
soluble cluster of differentiation antigen 21|soluble cluster of differentiation antigen 23|Y
soluble cluster of differentiation antigen 21|soluble cluster of differentiation antigen 28|Y
soluble cluster of differentiation antigen 21|soluble cluster of differentiation antigen 27|Y
soluble cluster of differentiation antigen 21|soluble cluster of differentiation antigen 26|Y
tumor associated glycoprotein E4|tumour associated glycoprotein E4|Y
Bos taurus autosome 20|Bos taurus autosome 2|Y
haemoglobin Roseau-Pointe à Pitre|hemoglobin Roseau-Pointe à Pitre|Y
oxygen content differences|oxygen content difference|Y
protein phosphatase 1|protein phosphatase 1C|Y
plasmin-α 2 plasmin inhibitor complex|plasmin-α2 plasmin inhibitor complex|Y
corticotrophin releasing hormone|corticotropin releasing hormone|Y
anti-albumin antibody|antialbumin antibody|Y
scanning electron microscopy-energy dispersive x-ray spectrometry|scanning electron microscopy-energy-dispersive x-ray spectrometry|Y
scanning electron microscopy-energy dispersive x-ray spectrometry|scanning electron microscopy-energy dispersive X-ray spectrometry|Y
immunoblotting technique|immuno-blotting technique|Y
nonaspirin nonsteroidal anti-inflammatory drugs|non-aspirin non-steroidal anti-inflammatory drugs|Y
intrinsic bursting neurone|intrinsic bursting neuron|Y
solute carrier family 7 member 8|solute carrier family 17 member 8|Y
GLP1 receptor agonist|GLP-1 receptor agonist|Y
atrioventricular conduction time|atrio-ventricular conduction time|Y
poly lactide-co-glycolide|polylactide-co-glycolide|Y
Haemophilus haemolyticus restriction endonuclease II|Haemophilus haemolyticus restriction endonuclease I|Y
visible-near infrared reflectance spectroscopy|visible/near infrared reflectance spectroscopy|Y
prothrombin time international normalised ratio|prothrombin time-international normalised ratio|Y
prothrombin time international normalised ratio|prothrombin time international normalized ratio|Y
anti-human T cell lymphotropic virus-1 antibody|anti-human T cell lymphotropic virus 1 antibody|Y
anti-human T cell lymphotropic virus-1 antibody|anti-human T-cell lymphotropic virus-1 antibody|Y
anti-human T cell lymphotropic virus-1 antibody|anti-human T cell lymphotrophic virus-1 antibody|Y
anti-human T cell lymphotropic virus-1 antibody|anti-human T cell lymphotropic virus-I antibody|Y
α-glucan water dikinase|α-glucan, water dikinase|Y
endothelium-derived hyperpolarizing factor|endothelium derived hyperpolarizing factor|Y
endothelium-derived hyperpolarizing factor|endothelium-derived hyperpolarising factor|Y
endothelium-derived hyperpolarizing factor|endothelium-derived hyperpolarizing factors|Y
immuno-suppressive peptide|immunosuppressive peptide|Y
scanning tunnelling microscopy|scanning tunneling microscopy|Y
anti-toll-like receptor-4 monoclonal antibody|anti-toll-like receptor 4 monoclonal antibody|Y
anti-toll-like receptor-4 monoclonal antibody|anti-toll-like receptor-3 monoclonal antibody|Y
anti-toll-like receptor-4 monoclonal antibody|anti-toll-like receptor-2 monoclonal antibody|Y
anti-toll-like receptor-4 monoclonal antibody|anti-toll like receptor-4 monoclonal antibody|Y
three-color fluorescence in situ hybridisation|three-color fluorescence in situ hybridization|Y
three-color fluorescence in situ hybridisation|three color fluorescence in situ hybridisation|Y
three-color fluorescence in situ hybridisation|three-colour fluorescence in situ hybridisation|Y
three-color fluorescence in situ hybridisation|three-color fluorescence in-situ hybridisation|Y
ischæmic preconditioning|ischæmic pre-conditioning|Y
hetero-cyclic aromatic amine|heterocyclic aromatic amine|Y
tumour-associated fetal antigen|tumor-associated fetal antigen|Y
tumour-associated fetal antigen|tumour-associated foetal antigen|Y
heparin-binding neurotrophic factor|heparin-binding neurotropic factor|Y
phospho-enolpyruvate carboxykinase|phosphoenolpyruvate carboxykinase|Y
Src homology 2 domain-containing protein tyrosine phosphatase 2|src homology 2 domain-containing protein tyrosine phosphatase 2|Y
Src homology 2 domain-containing protein tyrosine phosphatase 2|Src homology 2 domain-containing protein tyrosine phosphatase|Y
Src homology 2 domain-containing protein tyrosine phosphatase 2|Src homology-2 domain-containing protein tyrosine phosphatase 2|Y
Src homology 2 domain-containing protein tyrosine phosphatase 2|Src homology 2 domain-containing protein tyrosine phosphatase 1|Y
Src homology 2 domain-containing protein tyrosine phosphatase 2|Src homology 2 domain containing protein tyrosine phosphatase 2|Y
Src homology 2 domain-containing protein tyrosine phosphatase 2|Src homology 2 domain-containing protein tyrosine phosphatase-2|Y
perigeniculate nucleus|peri-geniculate nucleus|Y
thyroxine radio-immunoassay|thyroxin radio-immunoassay|Y
HIV/sexually-transmitted infection prevention program|HIV/sexually transmitted infection prevention program|Y
HIV/sexually-transmitted infection prevention program|HIV/sexually-transmitted infection prevention programme|Y
soluble intercellular adhesion molecule|soluble intercellular adhesion molecule-2|Y
soluble intercellular adhesion molecule|soluble intercellular adhesion molecule 1|Y
soluble intercellular adhesion molecule|soluble intercellular adhesion molecule-3|Y
Centers for Disease Control and Prevention|Centers for Disease Control and Prevention's|Y
ventilator-associated pneumonia|ventilatory-associated pneumonia|Y
Veterans Administration medical center|Veteran's Administration medical center|Y
Veterans Administration medical center|Veterans' Administration medical center|Y
neuroblastoma apoptosis-related RNA binding protein|neuroblastoma apoptosis-related RNA binding protein-1|Y
neuroblastoma apoptosis-related RNA binding protein|neuroblastoma apoptosis-related RNA binding protein-3|Y
neuroblastoma apoptosis-related RNA binding protein|neuroblastoma apoptosis-related RNA-binding protein|Y
neuroblastoma apoptosis-related RNA binding protein|neuroblastoma apoptosis-related RNA binding protein-2|Y
recombinant interleukine-1-β|recombinant interleukine-1β|Y
recombinant interleukine-1-β|recombinant interleukin-1-β|Y
human adenovirus serotype 27|human adenovirus serotype 2|Y
human adenovirus serotype 27|human adenovirus serotype 7|Y
intraperitoneal hemorrhage|intra-peritoneal hemorrhage|Y
RhoGTPase activating protein 1|Rho GTPase activating protein 1|Y
augmented correlation consistent polarised valence double-zeta basis set|augmented correlation consistent polarized valence double-zeta basis set|Y
augmented correlation consistent polarised valence double-zeta basis set|augmented correlation-consistent polarised valence double-zeta basis set|Y
augmented correlation consistent polarised valence double-zeta basis set|augmented correlation consistent polarised valence double zeta basis set|Y
multichannel intralumenal impedance|multi-channel intralumenal impedance|Y
multichannel intralumenal impedance|multichannel intra-lumenal impedance|Y
iodine 123 meta-iodobenzylguanidine|iodine 123 metaiodobenzylguanidine|Y
photomultiplier tube|photo-multiplier tube|Y
acute non-lymphoblastic leukemia|acute non-lymphoblastic leukaemia|Y
shell crosslinked knedel-like nanoparticle|shell cross-linked knedel-like nanoparticle|Y
shell crosslinked knedel-like nanoparticle|shell-crosslinked knedel-like nanoparticle|Y
phosphorylated extracellular signal-regulated kinase 2|phosphorylated extracellular signal-regulated kinase|Y
phosphorylated extracellular signal-regulated kinase 2|phosphorylated extracellular signal-regulated kinase-2|Y
phosphorylated extracellular signal-regulated kinase 2|phosphorylated extracellular signal-regulated kinase 1|Y
phosphorylated extracellular signal-regulated kinase 2|phosphorylated extracellular signal regulated kinase 2|Y
oral facial digital syndrome type VII|oral facial digital syndrome type II|Y
oral facial digital syndrome type VII|oral facial digital syndrome type VI|Y
bone marrow-derived DCs|bone marrow-derived DC|Y
insulin-like growth factor binding proteins|insulin like growth factor binding proteins|Y
insulin-like growth factor binding proteins|insulin-like growth factor binding protein|Y
doublesex and male abnormal-3 related transcription factor 1|doublesex and male abnormal-3 related transcription factor-1|Y
American Orthopaedic Foot and Ankle Society ankle hindfoot scale|American Orthopedic Foot and Ankle Society ankle-hindfoot scale|Y
American Orthopaedic Foot and Ankle Society ankle hindfoot scale|American Orthopedic Foot and Ankle Society ankle hindfoot scale|Y
American Orthopaedic Foot and Ankle Society ankle hindfoot scale|American Orthopaedic Foot and Ankle Society ankle-hindfoot scale|Y
type I Ehlers-Danlos syndrome|type IX Ehlers-Danlos syndrome|Y
type I Ehlers-Danlos syndrome|type VI Ehlers-Danlos syndrome|Y
Clinical Global Impression Improvement of Illness scale|Clinical Global Impression Improvement of Illness Scale|Y
Clinical Global Impression Improvement of Illness scale|Clinical Global Impression-Improvement of Illness scale|Y
phosphorylated cyclic AMP-responsive element-binding protein|phosphorylated cyclic AMP responsive element-binding protein|Y
methoxypolyethylene glycol|methoxypolyethyleneglycol|Y
pathological tumor-2, node-0, metastasis-0|pathological tumor-2, node-1, metastasis-0|Y
pathological tumor-2, node-0, metastasis-0|pathological tumor-3, node-0, metastasis-0|Y
non-ST-segment elevation acute coronary syndrome|non-ST-segment-elevation acute coronary syndrome|Y
non-ST-segment elevation acute coronary syndrome|non-ST segment elevation acute coronary syndrome|Y
American Society of Anesthesiology Class 3|American Society of Anaesthesiology Class 3|Y
American Society of Anesthesiology Class 3|American Society of Anesthesiology Class 5|Y
American Society of Anesthesiology Class 3|American Society of Anesthesiology class 3|Y
American Society of Anesthesiology Class 3|American Society of Anesthesiology Class I|Y
American Society of Anesthesiology Class 3|American Society of Anesthesiology Class 1|Y
American Society of Anesthesiology Class 3|American Society of Anesthesiology Class V|Y
American Society of Anesthesiology Class 3|American Society of Anesthesiology Class 2|Y
American Society of Anesthesiology Class 3|American Society of Anesthesiology Class 4|Y
immuno-reactive glucagon|immunoreactive glucagon|Y
Src homology 2-containing protein tyrosine phosphatase-1|Src homology 2-containing protein-tyrosine phosphatase-1|Y
Src homology 2-containing protein tyrosine phosphatase-1|Src homology 2-containing protein tyrosine phosphatase 1|Y
Src homology 2-containing protein tyrosine phosphatase-1|Src homology 2-containing protein tyrosine phosphatase-2|Y
Src homology 2-containing protein tyrosine phosphatase-1|Src homology 2-containing protein tyrosine phosphatase|Y
singlet oxygen-sensitised delayed fluorescence|singlet-oxygen-sensitised delayed fluorescence|Y
singlet oxygen-sensitised delayed fluorescence|singlet oxygen-sensitized delayed fluorescence|Y
colo-rectal neoplasia|colorectal neoplasia|Y
technetium 99m-labelled human serum albumin|technetium 99m labelled human serum albumin|Y
technetium 99m-labelled human serum albumin|technetium 99m-labeled human serum albumin|Y
technetium 99m-labelled human serum albumin|technetium-99m-labelled human serum albumin|Y
anticardiolipin antibody|anti-cardiolipin antibody|Y
anticardiolipin antibody|anti cardiolipin antibody|Y
nonmuscle myosin heavy chain B|non-muscle myosin heavy chain B|Y
San Juan Veterans Affairs Medical Center|San Juan Veteran's Affairs Medical Center|Y
San Juan Veterans Affairs Medical Center|San Juan Veterans' Affairs Medical Center|Y
crosslinked enzyme aggregate|cross-linked enzyme aggregate|Y
sex determining region Y, box 10|sex determining region Y box 10|Y
sex determining region Y, box 10|sex determining region Y, box 1|Y
ELONGATED HYPOCOTYL5|ELONGATED HYPOCOTYL 5|Y
ras-related GTP-binding protein 9B|ras-related GTP-binding protein 9|Y
ras-related GTP-binding protein 9B|ras-related GTP-binding protein 39B|Y
ultraweak luminescence|ultra-weak luminescence|Y
cartilage-derived morphogenetic protein 1|cartilage-derived morphogenetic protein 3|Y
cartilage-derived morphogenetic protein 1|cartilage-derived morphogenetic protein-1|Y
cartilage-derived morphogenetic protein 1|cartilage-derived morphogenetic protein|Y
multiple congenital anomalies/mental retardation syndrome|multiple congenital anomalies-mental retardation syndrome|Y
eosinophilic meningoencephalitis|eosinophilic meningo-encephalitis|Y
insulinlike growth factor-binding protein 2|insulinlike growth factor-binding protein-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs-13|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs-5|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motif-16|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloprotease with thrombospondin motif-14|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motif-19|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs-1|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs-3|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motif-15|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motif-1|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloprotease with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs-19|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs-17|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs-8|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motif-14|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs-15|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
American Society of Anaesthesiologists physical status II|American Society of Anaesthesiologists physical status III|Y
American Society of Anaesthesiologists physical status II|American Society of Anaesthesiologists physical status I|Y
American Society of Anaesthesiologists physical status II|American Society of Anesthesiologists physical status I|Y
American Society of Anaesthesiologists physical status II|American Society of Anesthesiologists physical status III|Y
American Society of Anaesthesiologists physical status II|American Society of Anaesthesiologists physical status IV|Y
American Society of Anaesthesiologists physical status II|American Society of Anesthesiologists physical status II|Y
technetium 99m labelled human serum albumin|technetium 99m labeled human serum albumin|Y
technetium 99m labelled human serum albumin|technetium-99m labelled human serum albumin|Y
anti-epidermal growth factor receptor monoclonal antibody|antiepidermal growth factor receptor monoclonal antibody|Y
Clinical Global Impressions-Severity of Illness Scale|Clinical Global Impressions-Severity of Illness scale|Y
hepatocyte nuclear factor-1α|hepatocyte nuclear factor-1 α|Y
hepatocyte nuclear factor-1α|hepatocyte nuclear factor-1-α|Y
src homology 2 domain containing protein tyrosine phosphatase|src homology 2 domain containing protein tyrosine phosphatase-2|Y
src homology 2 domain containing protein tyrosine phosphatase|src homology 2 domain containing protein tyrosine phosphatase 2|Y
src homology 2 domain containing protein tyrosine phosphatase|src homology 2 domain containing protein-tyrosine phosphatase|Y
src homology 2 domain containing protein tyrosine phosphatase|src homology 2 domain-containing protein tyrosine phosphatase|Y
src homology 2 domain containing protein tyrosine phosphatase|src homology 2 domain containing protein tyrosine-phosphatase|Y
src homology 2 domain containing protein tyrosine phosphatase|Src homology 2 domain containing protein tyrosine phosphatase|Y
platelet derived growth factor-β receptor|platelet derived growth factor receptor|Y
platelet derived growth factor-β receptor|platelet-derived growth factor-β receptor|Y
platelet derived growth factor-β receptor|platelet derived growth factor β receptor|Y
electro-chemical impedance spectroscopy|electrochemical impedance spectroscopy|Y
platelet endothelial cell adhesion molecule 1|platelet endothelial cell adhesion molecule|Y
immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome|immunodysregulation, polyendocrinopathy, enteropathy, X linked syndrome|Y
immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome|immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome|Y
immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome|immunodysregulation polyendocrinopathy enteropathy X-linked syndrome|Y
non-hippocampal sclerosis|nonhippocampal sclerosis|Y
matrix-assisted laser desorption ionization-mass spectrometry imaging|matrix-assisted laser desorption ionization mass spectrometry imaging|Y
matrix-assisted laser desorption ionization-mass spectrometry imaging|matrix-assisted laser desorption ionisation-mass spectrometry imaging|Y
matrix-assisted laser desorption ionization-mass spectrometry imaging|matrix assisted laser desorption ionization-mass spectrometry imaging|Y
anti-epidermal growth factor receptor therapy|antiepidermal growth factor receptor therapy|Y
peroxisome proliferator activated receptor-γ-2|peroxisome proliferator activated receptor-γ2|Y
peroxisome proliferator activated receptor-γ-2|peroxisome proliferator-activated receptor-γ-2|Y
peroxisome proliferator activated receptor-γ-2|peroxisome proliferator activated receptor γ-2|Y
peroxisome proliferator activated receptor-γ-2|peroxisome proliferator activated receptor-γ 2|Y
hemoglobin J-Broussais|haemoglobin J-Broussais|Y
electron probe X-ray microanalyser|electron probe X-ray micro-analyser|Y
tumor necrosis factor receptor 1-associated periodic syndrome|tumour necrosis factor receptor-1-associated periodic syndrome|Y
tumor necrosis factor receptor 1-associated periodic syndrome|tumor necrosis factor receptor-1-associated periodic syndrome|Y
tumor necrosis factor receptor 1-associated periodic syndrome|tumour necrosis factor receptor 1-associated periodic syndrome|Y
tumor necrosis factor receptor 1-associated periodic syndrome|tumour necrosis factor receptor-associated periodic syndrome|Y
tumor necrosis factor receptor 1-associated periodic syndrome|tumor necrosis factor receptor-associated periodic syndrome|Y
C. difficile-associated disease|C difficile-associated disease|Y
actosubfragment 1 ATPase|acto-subfragment 1 ATPase|Y
nonrhizomelic chondrodysplasia punctata|non-rhizomelic chondrodysplasia punctata|Y
extrapyramidal symptom|extra-pyramidal symptom|Y
inter-alpha trypsin inhibitor|interalpha trypsin inhibitor|Y
inter-alpha trypsin inhibitor|inter-alphatrypsin inhibitor|Y
Schizosaccharomyces pombe|Schizo-saccharomyces pombe|Y
anti-neutrophil cytoplasmic antibody-related|antineutrophil cytoplasmic antibody-related|Y
natural resistance-associated macrophage protein 1|natural resistance-associated macrophage protein-1|Y
natural resistance-associated macrophage protein 1|natural-resistance-associated macrophage protein 1|Y
natural resistance-associated macrophage protein 1|natural resistance-associated macrophage protein|Y
natural resistance-associated macrophage protein 1|natural resistance associated macrophage protein 1|Y
Purified Protein Derivative|Purified Protein Derivatives|Y
elongation factor-1α protein|elongation factor-1 α protein|Y
cluster of differentiation antigen 96|cluster of differentiation antigen 6|Y
gastrointestinal stromal tumor|gastro-intestinal stromal tumor|Y
anti-interleukin 8 antibody|antiinterleukin 8 antibody|Y
anti-interleukin 8 antibody|anti-interleukin 18 antibody|Y
tumor-associated glycoprotein E4|tumour-associated glycoprotein E4|Y
bioavailable testosterone|bio-available testosterone|Y
human epidermal growth factor receptor 3|human epidermal growth factor receptor 2|Y
nonsuppressible insulin like activity|non-suppressible insulin like activity|Y
anti-hepatocyte growth factor antibody|antihepatocyte growth factor antibody|Y
non-structural protein 2|nonstructural protein 2|Y
preinitiation complex|pre-initiation complex|Y
hyperhomocysteinemia|hyper-homocysteinemia|Y
prostaglandin F(2)alpha|prostaglandin F(2)-alpha|Y
prostaglandin F(2)alpha|prostaglandin F(2) alpha|Y
prostaglandin F(2)alpha|prostaglandin F-(2)alpha|Y
para-nitrophenyl phosphatase|para-nitrophenylphosphatase|Y
intrathoracic blood volume index|intra-thoracic blood volume index|Y
gonadotrophin-releasing hormone analogue|gonadotropin-releasing hormone analogue|Y
gonadotrophin-releasing hormone analogue|gonadotrophin-releasing hormone analogues|Y
gonadotrophin-releasing hormone analogue|gonadotrophin releasing hormone analogue|Y
surface enhanced laser desorption/ionization time-of-flight mass spectrometry|surface enhanced laser desorption ionization time-of-flight mass spectrometry|Y
surface enhanced laser desorption/ionization time-of-flight mass spectrometry|surface-enhanced laser desorption/ionization time-of-flight mass spectrometry|Y
surface enhanced laser desorption/ionization time-of-flight mass spectrometry|surface enhanced laser desorption/ionisation time-of-flight mass spectrometry|Y
coloanal anastomosis|colo-anal anastomosis|Y
RE1 silencing transcription factor|RE-1 silencing transcription factor|Y
American Society of Anaesthesiologists Status 4|American Society of Anaesthesiologists Status 1|Y
American Society of Anaesthesiologists Status 4|American Society of Anaesthesiologists Status 2|Y
American Society of Anaesthesiologists Status 4|American Society of Anaesthesiologists Status I|Y
American Society of Anaesthesiologists Status 4|American Society of Anaesthesiologists status 4|Y
American Society of Anaesthesiologists Status 4|American Society of Anaesthesiologists Status 3|Y
American Society of Anaesthesiologists Status 4|American Society of Anesthesiologists Status 4|Y
hypothalamopituitary-interrenal axis|hypothalamo-pituitary-interrenal axis|Y
RE1-silencing transcription factor|RE-1-silencing transcription factor|Y
pro-atrial natriuretic peptide|proatrial natriuretic peptide|Y
ouabainlike activity|ouabain-like activity|Y
granulo-vacuolar degeneration|granulovacuolar degeneration|Y
familial cold auto-inflammatory syndrome|familial cold autoinflammatory syndrome|Y
monophasic action potential duration at 50% repolarization|monophasic action potential duration at 90% repolarization|Y
spontaneous intra-cerebral haemorrhage|spontaneous intra-cerebral hemorrhage|Y
preeclamptic toxemia|pre-eclamptic toxemia|Y
preeclamptic toxemia|pre eclamptic toxemia|Y
copper superoxide dismutase|copper superoxide dismutase1|Y
Picture Archiving and Communication System|Picture Archiving and Communications Systems|Y
Picture Archiving and Communication System|Picture Archiving and Communication Systems|Y
hemoglobin F-Carlton|haemoglobin F-Carlton|Y
laser-evoked potentials|laser-evoked potential|Y
laparo-endoscopic single site surgery|laparoendoscopic single site surgery|Y
stereotactic radio-surgery|stereotactic radiosurgery|Y
alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate|alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate|Y
alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate|alpha-amino-3-hydroxy-5-methyl-4-isoxazole proprionate|Y
alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate|alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate|Y
S100 calcium binding protein A6|S100 calcium binding protein A16|Y
nonmelanoma skin cancer|non-melanoma skin cancer|Y
quasi-classical trajectory|quasiclassical trajectory|Y
electro-thermal atomic absorption spectrometry|electrothermal atomic absorption spectrometry|Y
high performance liquid chromatography|high performance liquid chromatograph|Y
FAK-related nonkinase|FAK-related non-kinase|Y
technetium-99m diethylene triamine penta-acetic acid|technetium-99m diethylenetriamine penta-acetic acid|Y
technetium-99m diethylene triamine penta-acetic acid|technetium-99m diethylenetriamine pentaacetic acid|Y
technetium-99m diethylene triamine penta-acetic acid|technetium-99m diethylene triamine pentaacetic acid|Y
cluster of differentiation antigen 69|cluster of differentiation antigen 6|Y
cluster of differentiation antigen 69|cluster of differentiation antigen 169|Y
recombinant interleukin-1alpha|recombinant interleukine-1alpha|Y
micro-X-ray absorption near edge structure|micro-X-ray absorption near-edge structure|Y
micro-X-ray absorption near edge structure|micro-x-ray absorption near edge structure|Y
micro-X-ray absorption near edge structure|micro X-ray absorption near edge structure|Y
microtubule-associated protein-2D|microtubule-associated protein-2|Y
receptor-like protein-tyrosine phosphatase ζ|receptor-like protein-tyrosine phosphatase κ|Y
receptor-like protein-tyrosine phosphatase ζ|receptor-like protein-tyrosine phosphatase α|Y
receptor-like protein-tyrosine phosphatase ζ|receptor-like protein-tyrosine phosphatase|Y
receptor-like protein-tyrosine phosphatase ζ|receptor-like protein-tyrosine phosphatase ψ|Y
receptor-like protein-tyrosine phosphatase ζ|receptor-like protein-tyrosine phosphatase η|Y
receptor-like protein-tyrosine phosphatase ζ|receptor-like protein tyrosine phosphatase ζ|Y
receptor-like protein-tyrosine phosphatase ζ|receptor-like protein-tyrosine phosphatase δ|Y
receptor-like protein-tyrosine phosphatase ζ|receptor-like protein-tyrosine phosphatase μ|Y
receptor-like protein-tyrosine phosphatase ζ|receptor-like protein-tyrosine phosphatase-ζ|Y
label-retaining cell|label-retaining cells|Y
non-anemic iron deficiency|nonanemic iron deficiency|Y
pituitary adenylate cyclase-activating polypeptide|Pituitary adenylate cyclase-activating polypeptide|Y
pituitary adenylate cyclase-activating polypeptide|pituitary adenylate cyclase activating polypeptide|Y
ornithine keto-acid transaminase|ornithine ketoacid transaminase|Y
sterol response element binding protein|sterol response element binding protein 1|Y
Bardet-Biedl syndrome gene 12|Bardet-Biedl syndrome gene 2|Y
Bardet-Biedl syndrome gene 12|Bardet-Biedl syndrome gene 1|Y
phospho-endothelial nitric oxide synthase|phospho-endothelial nitric-oxide synthase|Y
phospho-endothelial nitric oxide synthase|phosphoendothelial nitric oxide synthase|Y
zoster immunoglobulin|zoster immuno-globulin|Y
10-ethyl-10-deazaaminopterin|10-ethyl-10-deaza-aminopterin|Y
egg yolk immunoglobulin|egg yolk immunoglobulins|Y
endosomal sorting complex required for transport III|endosomal sorting complex required for transport I|Y
endosomal sorting complex required for transport III|endosomal sorting complex required for transport II|Y
up-flow anaerobic sludge blanket|upflow anaerobic sludge blanket|Y
de-sialylated ovine submaxillary mucin|de-sialylated ovine sub-maxillary mucin|Y
de-sialylated ovine submaxillary mucin|desialylated ovine submaxillary mucin|Y
sub-galeal haemorrhage|sub-galeal hemorrhage|Y
prostaglandin F2 α receptor|prostaglandin F2α receptor|Y
human T cell lymphotropic virus type 1-associated|human T-cell lymphotropic virus type 1-associated|Y
human T cell lymphotropic virus type 1-associated|human T cell lymphotropic virus type I-associated|Y
cytotoxic T lymphocyte antigen 2 β|cytotoxic T lymphocyte antigen 2β|Y
meta-chloro-phenyl-biguanide|meta-chloro-phenylbiguanide|Y
meta-chloro-phenyl-biguanide|meta-chlorophenyl-biguanide|Y
microtubule-associated protein 2c|microtubule-associated protein 2|Y
tissue inhibitors of MMP|tissue inhibitor of MMP|Y
American Orthopedic Foot and Ankle Society hallux metatarsophalangeal-interphalangeal scale|American Orthopaedic Foot and Ankle Society hallux metatarsophalangeal-interphalangeal scale|Y
potassium voltage-gated channel KQT-like subfamily member 4|potassium voltage-gated channel KQT-like subfamily member 1|Y
potassium voltage-gated channel KQT-like subfamily member 4|potassium voltage-gated channel KQT-like subfamily member 3|Y
potassium voltage-gated channel KQT-like subfamily member 4|potassium voltage-gated channel KQT-like subfamily member 5|Y
potassium voltage-gated channel KQT-like subfamily member 4|potassium voltage-gated channel KQT-like subfamily member 2|Y
enteroaggregative Escherichia coli|entero-aggregative Escherichia coli|Y
non-coding ribonucleic acid|noncoding ribonucleic acid|Y
mono-(2-ethylhexyl)phthalate|mono(2-ethylhexyl)phthalate|Y
Salmonella typhisuis|Salmonella typhi-suis|Y
thromboxane A2/prostaglandin H2 receptor|thromboxane A2-prostaglandin H2 receptor|Y
electroconvulsive shock|electro-convulsive shock|Y
steroid 5-α reductase type 1|steroid 5α reductase type 1|Y
multi-gated radionuclide angiography scan|multigated radionuclide angiography scan|Y
interhemispheric fissure|inter-hemispheric fissure|Y
American Society of Anesthesiologists Status 3|American Society of Anesthesiologists Status 2|Y
American Society of Anesthesiologists Status 3|American Society of Anesthesiologists status 3|Y
American Society of Anesthesiologists Status 3|American Society of Anesthesiologists Status I|Y
American Society of Anesthesiologists Status 3|American Society of Anesthesiologists Status 1|Y
American Society of Anesthesiologists Status 3|American Society of Anaesthesiologists Status 3|Y
American Society of Anesthesiologists Status 3|American Society of Anesthesiologists Status 4|Y
peroxisome proliferator activated receptor-gamma 2|peroxisome proliferator activated receptor gamma 2|Y
peroxisome proliferator activated receptor-gamma 2|peroxisome proliferator-activated receptor-gamma 2|Y
peroxisome proliferator activated receptor-gamma 2|peroxisome proliferator activated receptor-gamma-2|Y
combination anti-retroviral therapy|combination antiretroviral therapy|Y
spinocerebellar ataxia type 20|spinocerebellar ataxia type 2|Y
spino-cerebellar ataxia type 2|spinocerebellar ataxia type 2|Y
granulocyte macrophage-colony-stimulating factor receptor α subunit|granulocyte-macrophage-colony-stimulating factor receptor α subunit|Y
granulocyte macrophage-colony-stimulating factor receptor α subunit|granulocyte macrophage colony-stimulating factor receptor α subunit|Y
indirect immuno-fluorescence test|indirect immunofluorescence test|Y
de-differentiated chondrosarcoma|dedifferentiated chondrosarcoma|Y
American Society of Anaesthesiology grade 2|American Society of Anaesthesiology grade 5|Y
American Society of Anaesthesiology grade 2|American Society of Anaesthesiology Grade 2|Y
American Society of Anaesthesiology grade 2|American Society of Anaesthesiology grade 1|Y
American Society of Anaesthesiology grade 2|American Society of Anesthesiology grade 2|Y
American Society of Anaesthesiology grade 2|American Society of Anaesthesiology grade 3|Y
American Society of Anaesthesiology grade 2|American Society of Anaesthesiology grade|Y
American Society of Anaesthesiology grade 2|American Society of Anaesthesiology grade I|Y
American Society of Anaesthesiology grade 2|American Society of Anaesthesiology grade 4|Y
American Society of Anaesthesiology grade 2|American Society of Anaesthesiology grade V|Y
acid sensing ion channel 1|acid sensing ion channel 1b|Y
acid sensing ion channel 1|acid sensing ion channel 1a|Y
cyclin dependent kinase 2-associated protein 1|cyclin-dependent kinase 2-associated protein 1|Y
metered-dose inhaler|metered-dose inhalers|Y
organophosphorus-induced delayed polyneuropathy|organophosphorus induced delayed polyneuropathy|Y
calcium voltage-gated channel subunit alpha1 F|calcium voltage-gated channel subunit alpha 1 F|Y
calcium voltage-gated channel subunit alpha1 F|calcium voltage-gated channel subunit alpha1 S|Y
calcium voltage-gated channel subunit alpha1 F|calcium voltage-gated channel subunit alpha1 C|Y
heparin induced thrombo-cytopenia|heparin induced thrombo-cytopaenia|Y
heparin induced thrombo-cytopenia|heparin induced thrombocytopenia|Y
succinyl-aminoimidazole carboxamide ribotide|succinylaminoimidazole carboxamide ribotide|Y
quadrupole-time-of-flight mass spectrometer|quadrupole time-of-flight mass spectrometer|Y
quadrupole-time-of-flight mass spectrometer|quadrupole-time-of-flight mass spectrometry|Y
dideazatetrahydrofolate|dideaza-tetrahydrofolate|Y
American Society of Anaesthesiology Grade IV|American Society of Anaesthesiology Grade I|Y
American Society of Anaesthesiology Grade IV|American Society of Anaesthesiology grade IV|Y
American Society of Anaesthesiology Grade IV|American Society of Anaesthesiology Grade V|Y
American Society of Anaesthesiology Grade IV|American Society of Anesthesiology Grade I|Y
American Society of Anaesthesiology Grade IV|American Society of Anesthesiology Grade IV|Y
American Society of Anaesthesiology Grade IV|American Society of Anesthesiology Grade V|Y
American Society of Anaesthesiology Grade IV|American Society of Anaesthesiology Grade II|Y
human tissue inhibitor of metalloprotease-3|human tissue inhibitor of metalloprotease-1|Y
human tissue inhibitor of metalloprotease-3|human tissue inhibitor of metalloprotease-2|Y
San Juan Veteran's Affairs Medical Center|San Juan Veterans' Affairs Medical Center|Y
multidrug resistance 1|multi-drug resistance 1|Y
nonstarter lactic acid bacteria|non-starter lactic acid bacteria|Y
preimplantation genetic haplotyping|pre-implantation genetic haplotyping|Y
International Conference on Harmonization|International Conference on Harmonisation|Y
large intra-luminal density|large intraluminal density|Y
TGF-beta-activated kinase 1 binding protein-1|TGF-beta-activated kinase 1-binding protein-1|Y
TGF-beta-activated kinase 1 binding protein-1|TGFbeta-activated kinase 1 binding protein-1|Y
TGF-beta-activated kinase 1 binding protein-1|TGF-beta-activated kinase 1 binding protein 1|Y
maximum expiratory flow rate at 75% of vital capacity|maximum expiratory flow rate at 25% of vital capacity|Y
maximum expiratory flow rate at 75% of vital capacity|maximum expiratory flow rate at 50% of vital capacity|Y
American Society of Anaesthesiology physical status II|American Society of Anesthesiology physical status I|Y
American Society of Anaesthesiology physical status II|American Society of Anaesthesiology physical status I|Y
American Society of Anaesthesiology physical status II|American Society of Anesthesiology physical status III|Y
American Society of Anaesthesiology physical status II|American Society of Anesthesiology physical status II|Y
American Society of Anaesthesiology physical status II|American Society of Anaesthesiology physical status IV|Y
American Society of Anaesthesiology physical status II|American Society of Anaesthesiology physical status III|Y
American Society of Anesthesiology Class III|American Society of Anaesthesiology Class III|Y
American Society of Anesthesiology Class III|American Society of Anesthesiology Class I|Y
American Society of Anesthesiology Class III|American Society of Anesthesiology class III|Y
American Society of Anesthesiology Class III|American Society of Anaesthesiology Class II|Y
American Society of Anesthesiology Class III|American Society of Anesthesiology Class II|Y
Ste20-related proline-alanine-rich kinase|ste20-related proline-alanine-rich kinase|Y
Ste20-related proline-alanine-rich kinase|Ste-20-related proline-alanine-rich kinase|Y
Ste20-related proline-alanine-rich kinase|Ste20-related proline alanine-rich kinase|Y
sequence characterised amplified region marker|sequence-characterised amplified region marker|Y
sequence characterised amplified region marker|sequence characterized amplified region marker|Y
25-hydroxy-vitamin D(3)|25-hydroxyvitamin D(3)|Y
transmembrane 4 superfamily member 2 protein|transmembrane 4 superfamily member 1 protein|Y
transmembrane 4 superfamily member 2 protein|transmembrane 4 superfamily member 5 protein|Y
transmembrane 4 superfamily member 2 protein|transmembrane 4 superfamily member 3 protein|Y
American Society of Anesthesiology status 2|American Society of Anesthesiology status I|Y
American Society of Anesthesiology status 2|American Society of Anesthesiology status 1|Y
American Society of Anesthesiology status 2|American Society of Anesthesiology status V|Y
American Society of Anesthesiology status 2|American Society of Anesthesiology status 3|Y
American Society of Anesthesiology status 2|American Society of Anaesthesiology status 2|Y
American Society of Anesthesiology status 2|American Society of Anesthesiology status|Y
American Society of Anesthesiology status 2|American Society of Anesthesiology status 4|Y
American Society of Anesthesiology status 2|American Society of Anesthesiology status 5|Y
amplified fragment length polymorphisms|amplified fragment length polymorphism|Y
Environmental Protection Agency approved|Environmental Protection Agency-approved|Y
percutaneous transhepatic portal sampling|percutaneous trans-hepatic portal sampling|Y
O-acetyl serine sulfhydrylase|O-acetylserine sulfhydrylase|Y
ubiquitous surface protein A2|ubiquitous surface protein A|Y
Drosophila glutamate receptor IA|Drosophila glutamate receptor I|Y
extended X-ray absorption fine-structure spectroscopy|extended x-ray absorption fine-structure spectroscopy|Y
extended X-ray absorption fine-structure spectroscopy|extended X-ray absorption fine structure spectroscopy|Y
ribosomal protein L27a|ribosomal protein L27|Y
G protein-coupled receptors|G protein-coupled receptor|Y
pregestational diabetes mellitus|pre-gestational diabetes mellitus|Y
radiocephalic fistula|radio-cephalic fistula|Y
naso-tracheal suction|nasotracheal suction|Y
anticyclic citrullinated peptide antibody|anti-cyclic citrullinated peptide antibody|Y
immuno-reactive cholecystokinin|immunoreactive cholecystokinin|Y
guanylyl imidodiphosphate|guanylylimidodiphosphate|Y
cellular inhibitor-of-apoptosis protein|cellular inhibitor-of-apoptosis protein 1|Y
cellular inhibitor-of-apoptosis protein|cellular inhibitor-of-apoptosis protein 2|Y
cellular inhibitor-of-apoptosis protein|cellular inhibitor-of-apoptosis protein-1|Y
cervico-ocular reflex|cervicoocular reflex|Y
afebrile, vital signs stable|afebrile vital signs stable|Y
D,L-buthionine-S,R-sulfoximine|DL-buthionine-S,R-sulfoximine|Y
5-hydroxytryptamine 1A|5-hydroxytryptamine1A|Y
anti-interleukin 1alpha autoantibody|anti-interleukin 1 alpha autoantibody|Y
anti-interleukin 1alpha autoantibody|antiinterleukin 1alpha autoantibody|Y
branched-chain α-keto acid dehydrogenase kinase|branched-chain α-ketoacid dehydrogenase kinase|Y
febrile non-hæmolytic reaction|febrile nonhæmolytic reaction|Y
B cell-specific Moloney murine leukemia virus integration site 1|B-cell-specific Moloney murine leukaemia virus integration site 1|Y
B cell-specific Moloney murine leukemia virus integration site 1|B cell-specific Moloney murine leukaemia virus integration site 1|Y
B cell-specific Moloney murine leukemia virus integration site 1|B-cell-specific Moloney murine leukemia virus integration site 1|Y
maternal-child healthcare|maternal-child health care|Y
neuro-endoscopic third ventriculostomy|neuroendoscopic third ventriculostomy|Y
beta-amyloid precursor protein-cleaving enzyme 2|beta-amyloid precursor protein cleaving enzyme 2|Y
beta-amyloid precursor protein-cleaving enzyme 2|beta amyloid precursor protein-cleaving enzyme 2|Y
beta-amyloid precursor protein-cleaving enzyme 2|beta-amyloid precursor protein-cleaving enzyme|Y
beta-amyloid precursor protein-cleaving enzyme 2|beta-amyloid precursor protein-cleaving enzyme 1|Y
beta-amyloid precursor protein-cleaving enzyme 2|beta-amyloid precursor protein-cleaving enzyme-2|Y
tumour necrosis factor-α protease inhibitor-1|tumor necrosis factor-α protease inhibitor-1|Y
interleukin-3 receptor α-chain|interleukine-3 receptor α-chain|Y
platelet derived endothelial cell growth factor|platelet-derived endothelial cell growth factor|Y
dopamine 1 receptor agonist|dopamine D1 receptor agonist|Y
computerized tomography|computerized tomograph|Y
free insulinlike growth factor 1|free insulin-like growth factor 1|Y
American Society of Anaesthesiology Class III|American Society of Anaesthesiology class III|Y
American Society of Anaesthesiology Class III|American Society of Anaesthesiology Class I|Y
American Society of Anaesthesiology Class III|American Society of Anaesthesiology Class II|Y
American Society of Anaesthesiology Class III|American Society of Anesthesiology Class II|Y
Pseudonitzschia multiseries|Pseudo-nitzschia multiseries|Y
hantavirus cardio-pulmonary syndrome|hantavirus cardiopulmonary syndrome|Y
enzyme linked immuno-sorbent assay|enzyme linked immunosorbent assay|Y
intradialytic parenteral nutrition|intra-dialytic parenteral nutrition|Y
External Quality Assessment Schemes|External Quality Assessment Scheme|Y
nonnegative matrix factorisation|non-negative matrix factorisation|Y
receptor-like protein tyrosine phosphatase eta|receptor-like protein tyrosine phosphatase delta|Y
receptor-like protein tyrosine phosphatase eta|receptor-like protein tyrosine phosphatase-eta|Y
receptor-like protein tyrosine phosphatase eta|receptor-like protein tyrosine phosphatase zeta|Y
receptor-like protein tyrosine phosphatase eta|receptor-like protein-tyrosine phosphatase eta|Y
basic-helix-loop-helix leucine zipper domain|basic helix-loop-helix leucine zipper domain|Y
soluble interleukin-2 receptorα|soluble interleukin-2 receptor α|Y
soluble interleukin-2 receptorα|soluble interleukin-2 receptor-α|Y
nitrobenzylmercaptopurine ribonucleoside|4-nitrobenzylmercaptopurine ribonucleoside|Y
oestrogen receptor α knockout|oestrogen receptor α knock-out|Y
oestrogen receptor α knockout|estrogen receptor α knockout|Y
oestrogen receptor α knockout|oestrogen receptor α knock out|Y
multidimensional pain inventory|multi-dimensional pain inventory|Y
γglutamyl-cysteine synthetase|γglutamylcysteine synthetase|Y
interferon-stimulated gene factor 3 alpha|interferon stimulated gene factor 3 alpha|Y
interferon-stimulated gene factor 3 alpha|interferon-stimulated gene factor 3alpha|Y
interferon-stimulated gene factor 3 alpha|interferon-stimulated gene factor-3 alpha|Y
BCL2 associated X protein|BCL-2 associated X protein|Y
poly(dimethyl siloxane)|poly (dimethyl siloxane)|Y
poly(dimethyl siloxane)|poly(dimethylsiloxane)|Y
technetium-99m diisopropyliminodiacetic acid|technetium-99m-diisopropyliminodiacetic acid|Y
Ng-CAM-related cell adhesion molecule|NgCAM-related cell adhesion molecule|Y
post prandial plasma glucose|postprandial plasma glucose|Y
sex determining region Y-box 10|sex determining region Y-box 1|Y
electroimmunodiffusion|electro-immunodiffusion|Y
verocytotoxin producing Escherichia coli|verocytotoxin-producing Escherichia coli|Y
beta-ketoacyl acyl carrier protein synthase III|beta-ketoacyl acyl carrier protein synthase I|Y
beta-ketoacyl acyl carrier protein synthase III|beta-ketoacyl-acyl carrier protein synthase III|Y
beta-ketoacyl acyl carrier protein synthase III|beta-ketoacyl acyl carrier protein synthase II|Y
trans-epithelial potential difference|transepithelial potential difference|Y
receptor for advanced glycation endproducts|receptor for advanced glycation end-products|Y
receptor for advanced glycation endproducts|receptor for advanced glycation end products|Y
receptor for advanced glycation endproducts|receptor for advanced glycation end product|Y
Ralph H. Johnson Veteran's Administration Medical Center|Ralph H Johnson Veteran's Administration Medical Center|Y
Ralph H. Johnson Veteran's Administration Medical Center|Ralph H. Johnson Veterans Administration Medical Center|Y
Ralph H. Johnson Veteran's Administration Medical Center|Ralph H. Johnson Veterans' Administration Medical Center|Y
Ralph H. Johnson Veteran's Administration Medical Center|Ralph H Johnson Veterans Administration Medical Center|Y
basic helix-loop-helix-leucine zipper domain|basic helix-loop-helix leucine zipper domain|Y
retinoic-acid-receptor-related orphan receptor γ-T|retinoic-acid-receptor-related orphan receptor γ-t|Y
retinoic-acid-receptor-related orphan receptor γ-T|retinoic-acid-receptor-related orphan receptor γ T|Y
retinoic-acid-receptor-related orphan receptor γ-T|retinoic-acid-receptor-related orphan receptor γT|Y
retinoic-acid-receptor-related orphan receptor γ-T|retinoic-acid-receptor-related orphan receptor γ|Y
American Society of Anaesthesiologists grade V|American Society of Anaesthesiologists grade 1|Y
American Society of Anaesthesiologists grade V|American Society of Anaesthesiologists Grade V|Y
American Society of Anaesthesiologists grade V|American Society of Anaesthesiologists grade IV|Y
American Society of Anaesthesiologists grade V|American Society of Anaesthesiologists grade|Y
American Society of Anaesthesiologists grade V|American Society of Anaesthesiologists grade 2|Y
American Society of Anaesthesiologists grade V|American Society of Anaesthesiologists grade I|Y
American Society of Anaesthesiologists grade V|American Society of Anesthesiologists grade V|Y
American Society of Anaesthesiologists grade V|American Society of Anaesthesiologists grade 3|Y
American Society of Anaesthesiologists grade V|American Society of Anaesthesiologists grade 5|Y
American Society of Anaesthesiologists grade V|American Society of Anaesthesiologists grade 4|Y
multi-voxel proton magnetic resonance spectroscopy|multivoxel proton magnetic resonance spectroscopy|Y
quality of well-being scale|quality of wellbeing scale|Y
tauro-ursodeoxycholic acid|tauroursodeoxycholic acid|Y
scavenger receptor B1|scavenger receptor B-1|Y
anti-liver specific protein|antiliver specific protein|Y
heparin-associated thrombocytopenia|heparin-associated thrombocytopaenia|Y
poly(vinylpyrrolidone)|poly(vinyl pyrrolidone)|Y
low density lipoprotein receptor related protein 5|low density lipoprotein receptor related protein 1|Y
low density lipoprotein receptor related protein 5|low density lipoprotein receptor related protein 6|Y
extra-hepatic portal hypertension|extrahepatic portal hypertension|Y
human equilibrative nucleoside transporter 2|human equilibrative nucleoside transporter 1|Y
human equilibrative nucleoside transporter 2|human equilibrative nucleoside transporter|Y
adult anti-social behavior|adult anti-social behaviour|Y
adult anti-social behavior|adult antisocial behavior|Y
nuclear factor erythroid-2-related factor 2|nuclear factor erythroid 2-related factor 2|Y
recombinant human granulocyte colony stimulating factor|recombinant human granulocyte-colony stimulating factor|Y
recombinant human granulocyte colony stimulating factor|recombinant human granulocyte colony-stimulating factor|Y
soluble interleukin-6 receptor alpha|soluble interleukine-6 receptor alpha|Y
subzonal insemination|sub-zonal insemination|Y
immunoglobulin superfamily receptor translocation-associated 2|immunoglobulin superfamily receptor translocation associated 2|Y
antisaccharomyces cerevisiae antibody|anti-saccharomyces cerevisiae antibody|Y
quadrupole time-of-flight mass spectrometer|quadrupole time-of-flight mass spectrometry|Y
fluorophore assisted carbohydrate electrophoresis|fluorophore-assisted carbohydrate electrophoresis|Y
Sepsis-related Organ Failure Assessment score|Sepsis-Related Organ Failure Assessment score|Y
histidinohydroxymerodesmosine|histidino-hydroxymerodesmosine|Y
Krueppel-like factor 5|Kruppel-like factor 5|Y
anti-myelin oligodendrocyte glycoprotein antibody|antimyelin oligodendrocyte glycoprotein antibody|Y
resin-modified glass ionomer cements|resin-modified glass ionomer cement|Y
peroxisome-proliferator-activated receptor-γ coactivator-1 α|peroxisome-proliferator-activated receptor-γ co-activator-1α|Y
peroxisome-proliferator-activated receptor-γ coactivator-1 α|peroxisome-proliferator-activated receptor-γ coactivator 1 α|Y
peroxisome-proliferator-activated receptor-γ coactivator-1 α|peroxisome-proliferator-activated receptor-γ co-activator-1 α|Y
peroxisome-proliferator-activated receptor-γ coactivator-1 α|peroxisome-proliferator-activated receptor γ coactivator-1 α|Y
peroxisome-proliferator-activated receptor-γ coactivator-1 α|peroxisome-proliferator-activated receptor-γ coactivator-1α|Y
peroxisome-proliferator-activated receptor-γ coactivator-1 α|peroxisome proliferator-activated receptor-γ coactivator-1 α|Y
peroxisome-proliferator-activated receptor-γ coactivator-1 α|peroxisome-proliferator-activated receptor-γ co-activator 1 α|Y
peroxisome-proliferator-activated receptor-γ coactivator-1 α|peroxisome proliferator-activated receptor-γ co-activator-1 α|Y
aortoenteric fistula|aorto-enteric fistula|Y
DNA-protein cross-links|DNA-protein cross-link|Y
DNA-protein cross-links|DNA-protein crosslinks|Y
x ray computed tomography|xray computed tomography|Y
mainstream cigarette smoke|main-stream cigarette smoke|Y
antiIL-1 alpha antibody|antiIL-1alpha antibody|Y
antiIL-1 alpha antibody|anti-IL-1 alpha antibody|Y
tumor-1a, node-0, metastasis-0|tumor-1, node-0, metastasis-0|Y
pregnancy-associated glycoprotein|pregnancy-associated glycoproteins|Y
anti-epidermal growth factor receptor antibody|antiepidermal growth factor receptor antibody|Y
deoxyribosyltransferase II|deoxyribosyltransferase I|Y
bio-impedance spectroscopy|bioimpedance spectroscopy|Y
American Orthopedic Foot and Ankle Society ankle-hindfoot scale|American Orthopedic Foot and Ankle Society ankle hindfoot scale|Y
American Orthopedic Foot and Ankle Society ankle-hindfoot scale|American Orthopaedic Foot and Ankle Society ankle-hindfoot scale|Y
osteo-odontokeratoprosthesis|osteoodontokeratoprosthesis|Y
osteo-odontokeratoprosthesis|osteo-odonto-keratoprosthesis|Y
cluster of differentiation antigen 46|cluster of differentiation antigen 6|Y
cluster of differentiation antigen 46|cluster of differentiation antigen 146|Y
stress-activated protein kinase 1b|stress-activated protein kinase 1|Y
alkylacetyl-glycerophosphocholine|alkylacetyl-glycero-phosphocholine|Y
alkylacetyl-glycerophosphocholine|alkyl-acetyl-glycerophosphocholine|Y
post-stimulus time histogram|poststimulus time histogram|Y
skin and soft tissue infections|skin and soft tissue infection|Y
American Society of Anaesthesiology Class 1|American Society of Anaesthesiology Class 2|Y
American Society of Anaesthesiology Class 1|American Society of Anaesthesiology Class 3|Y
American Society of Anaesthesiology Class 1|American Society of Anaesthesiology Class 5|Y
American Society of Anaesthesiology Class 1|American Society of Anaesthesiology Class I|Y
American Society of Anaesthesiology Class 1|American Society of Anesthesiology Class 1|Y
American Society of Anaesthesiology Class 1|American Society of Anaesthesiology Class V|Y
American Society of Anaesthesiology Class 1|American Society of Anaesthesiology Class 4|Y
American Society of Anaesthesiology Class 1|American Society of Anaesthesiology class 1|Y
cardiofaciocutaneous syndrome|cardio-faciocutaneous syndrome|Y
acetyl-CoA decarbonylase/synthase complex|acetyl-CoA decarbonylase synthase complex|Y
a disintegrin and metalloprotease 12|a disintegrin and metalloprotease 12s|Y
chicken luteinizing hormone-releasing hormone-II|chicken luteinizing hormone-releasing hormone-I|Y
chicken luteinizing hormone-releasing hormone-II|chicken luteinising hormone-releasing hormone-II|Y
chicken luteinizing hormone-releasing hormone-II|chicken luteinizing hormone releasing hormone-II|Y
elongation factor-1 α|elongation factor-1α|Y
para-azido-phenylalanine|para-azidophenylalanine|Y
insulin-like growth factor-binding protein-related protein 1|insulin-like growth factor-binding protein related protein 1|Y
insulin-like growth factor-binding protein-related protein 1|insulin-like growth factor binding protein-related protein 1|Y
insulin-like growth factor-binding protein-related protein 1|insulin-like growth factor-binding protein-related protein-1|Y
extra-intracranial arterial bypass|extraintracranial arterial bypass|Y
neurocardiogenic syncope|neuro-cardiogenic syncope|Y
mediolateral oblique|medio-lateral oblique|Y
plasmin-α2-plasmin inhibitor complex|plasmin-α 2-plasmin inhibitor complex|Y
non-ST elevation acute coronary syndrome|non-ST-elevation acute coronary syndrome|Y
voluntary counselling and testing|voluntary counseling and testing|Y
transthoracic needle aspiration|trans-thoracic needle aspiration|Y
branched-chain amino acid|branched-chain amino acids|Y
ras-related GTP-binding protein 24|ras-related GTP-binding protein 4|Y
vestibular-evoked myogenic potentials|vestibular-evoked myogenic potential|Y
three dimensional time-of-flight magnetic resonance angiography|three-dimensional time-of-flight magnetic resonance angiography|Y
GTP binding protein βγ subunit|GTP binding protein β-γ subunit|Y
GTP binding protein βγ subunit|GTP binding protein γ subunit|Y
GTP binding protein βγ subunit|GTP binding protein β subunit|Y
γ-amino-butyric acid receptor|γ-amino-butyric acidB receptor|Y
short-latency somatosensory evoked potential|short latency somatosensory evoked potential|Y
supra-omohyoid neck dissection|supraomohyoid neck dissection|Y
ATP-sensitive K+ channel|ATP-sensitive K+ channels|Y
A disintegrin and metalloproteinase-8|A disintegrin and metalloproteinase-28|Y
neuro-ectodermal tumor|neuroectodermal tumor|Y
neuro-ectodermal tumor|neuro-ectodermal tumour|Y
human osteoblastlike|human osteoblast-like|Y
translation elongation factor 1-α|translation elongation factor 1α|Y
insulin-like growth factor 1 receptor|insulinlike growth factor 1 receptor|Y
TGF-β-activated kinase 1-binding protein 1|TGF-β-activated kinase 1 binding protein 1|Y
TGF-β-activated kinase 1-binding protein 1|TGFβ-activated kinase 1-binding protein 1|Y
TGF-β-activated kinase 1-binding protein 1|TGF-β-activated kinase 1-binding protein-1|Y
serotonin-norepinephrine re-uptake inhibitor|serotonin norepinephrine re-uptake inhibitor|Y
sporulation protein IIGA|sporulation protein IIA|Y
World Health Organization-International Society of Hypertension|World Health Organization/International Society of Hypertension|Y
dielaidoylphosphatidylcholine|dielaidoyl-phosphatidylcholine|Y
NIMA-related kinase-1|NIMA-related kinase-11|Y
glycosylphosphatidylinositol linked protein|glycosyl-phosphatidyl-inositol linked protein|Y
glycosylphosphatidylinositol linked protein|glycosylphosphatidylinositol-linked protein|Y
peroxisome-proliferator-activated receptor α agonist|peroxisome proliferator-activated receptor α agonist|Y
insulin-like growth factor-II messenger RNA-binding protein 3|insulin-like growth factor-II messenger RNA-binding protein 1|Y
insulin-like growth factor-II messenger RNA-binding protein 3|insulin-like growth factor II messenger RNA-binding protein 3|Y
insulin-like growth factor-II messenger RNA-binding protein 3|insulin-like growth factor-II messenger RNA-binding protein|Y
insulin-like growth factor-II messenger RNA-binding protein 3|insulin-like growth factor-II messenger RNA-binding protein 2|Y
insulin-like growth factor-II messenger RNA-binding protein 3|insulin-like growth factor-II messenger RNA-binding protein-3|Y
insulin-like growth factor-II messenger RNA-binding protein 3|insulin-like growth factor-II messenger RNA binding protein 3|Y
cellular Fas-associated death domain-like interleukin-1-β converting enzyme inhibitory protein|cellular Fas-associated death domain-like interleukin-1β converting enzyme-inhibitory protein|Y
cellular Fas-associated death domain-like interleukin-1-β converting enzyme inhibitory protein|cellular Fas-associated death domain-like interleukin-1β converting enzyme inhibitory protein|Y
cellular Fas-associated death domain-like interleukin-1-β converting enzyme inhibitory protein|cellular Fas-associated death domain-like interleukin-1-β converting enzyme-inhibitory protein|Y
X linked agammaglobulinaemia|X linked agammaglobulinemia|Y
ribosomal protein S6|ribosomal protein S16|Y
ribosomal protein S6|ribosomal protein S26|Y
stromal-derived factor-1-alpha|stromal-derived factor-1alpha|Y
cleaved amplified polymorphic sequence|cleaved amplified polymorphic sequences|Y
receptor for advanced glycation end-products|receptor for advanced glycation end products|Y
unilateral laterothoracic exanthem|unilateral latero-thoracic exanthem|Y
interdigitating reticulum cells|interdigitating reticulum cell|Y
fluorine-18-fluoro-deoxyglucose|fluorine-18-fluoro-deoxy-glucose|Y
peroxisome proliferator activated receptor gamma2|peroxisome proliferator activated receptor gamma 2|Y
peroxisome proliferator activated receptor gamma2|peroxisome proliferator-activated receptor gamma2|Y
peroxisome proliferator activated receptor gamma2|peroxisome proliferator activated receptor gamma-2|Y
peroxisome proliferator activated receptor gamma2|peroxisome proliferator activated receptor gamma1|Y
concurrent chemo-radiotherapy|concurrent chemoradiotherapy|Y
Social Behavior and Network Therapy|Social Behaviour and Network Therapy|Y
human T-cell leukaemia virus type-1-infected|human T-cell leukaemia virus type-I-infected|Y
human T-cell leukaemia virus type-1-infected|human T-cell leukemia virus type-1-infected|Y
human T-cell leukaemia virus type-1-infected|human T cell leukaemia virus type-1-infected|Y
ecto-nucleoside diphosphokinase|ectonucleoside diphosphokinase|Y
tumour necrosis factor-related apoptosis inducing ligand receptor|tumor necrosis factor related apoptosis inducing ligand receptor|Y
tumour necrosis factor-related apoptosis inducing ligand receptor|tumor necrosis factor-related apoptosis-inducing ligand receptor|Y
tumour necrosis factor-related apoptosis inducing ligand receptor|tumour necrosis factor-related apoptosis-inducing ligand receptor|Y
tumour necrosis factor-related apoptosis inducing ligand receptor|tumor necrosis factor-related apoptosis inducing ligand receptor|Y
tumour necrosis factor-related apoptosis inducing ligand receptor|tumour necrosis factor related apoptosis inducing ligand receptor|Y
corticotropin releasing hormone receptor|corticotrophin releasing hormone receptor|Y
corticotropin releasing hormone receptor|corticotropin-releasing hormone receptor|Y
corticotropin releasing hormone receptor|corticotropin releasing hormone receptor 2|Y
corticotropin releasing hormone receptor|corticotropin releasing hormone receptor-1|Y
corticotropin releasing hormone receptor|corticotropin releasing hormone receptor-2|Y
corticotropin releasing hormone receptor|corticotropin releasing hormone receptor 1|Y
anti-tissue factor pathway inhibitor|antitissue factor pathway inhibitor|Y
polyhydroxyethylmethacrylate|poly-hydroxyethylmethacrylate|Y
interleukin 4 receptor-α|interleukine 4 receptor-α|Y
dorso-lateral prefrontal cortex|dorsolateral prefrontal cortex|Y
dorso-lateral prefrontal cortex|dorso-lateral pre-frontal cortex|Y
oestrogen receptor β knockout|oestrogen receptor β knock-out|Y
oestrogen receptor β knockout|oestrogen receptor β knock out|Y
oestrogen receptor β knockout|estrogen receptor β knockout|Y
calcium release activated calcium channel|calcium release-activated calcium channel|Y
diaspirin cross-linked hemoglobin|diaspirin cross-linked haemoglobin|Y
hereditary angio-neurotic oedema|hereditary angio-neurotic edema|Y
transforming growth factor-β4|transforming growth factor-β 4|Y
transthoracic needle biopsy|transthorcic needle biopsy|Y
Tumor necrosis factor receptor-associated factor 6|tumor necrosis factor receptor-associated factor 6|Y
intraoperative sonography|intra-operative sonography|Y
catalyzed reporter deposition fluorescence in situ hybridization|catalysed reporter deposition fluorescence in situ hybridization|Y
catalyzed reporter deposition fluorescence in situ hybridization|catalyzed reporter deposition-fluorescence in situ hybridization|Y
gamma-amino-butyric acid type A|gamma-aminobutyric acid type A|Y
beta amyloid precursor protein-cleaving enzyme-2|beta amyloid precursor protein cleaving enzyme-2|Y
beta amyloid precursor protein-cleaving enzyme-2|beta amyloid precursor protein-cleaving enzyme|Y
beta amyloid precursor protein-cleaving enzyme-2|beta amyloid precursor protein-cleaving enzyme-1|Y
beta amyloid precursor protein-cleaving enzyme-2|beta amyloid precursor protein-cleaving enzyme 2|Y
beta amyloid precursor protein-cleaving enzyme-2|beta-amyloid precursor protein-cleaving enzyme-2|Y
25-hydroxy vitamin D3|25-hydroxyvitamin D3|Y
25-hydroxy vitamin D3|25-hydroxy vitamin D|Y
Capillary electrophoresis with laser-induced fluorescence detection|Capillary electrophoresis with laser-induced fluorescence detector|Y
Capillary electrophoresis with laser-induced fluorescence detection|capillary electrophoresis with laser-induced fluorescence detection|Y
never-in-mitosis Aspergillus-related kinase 9|never-in-mitosis Aspergillus-related kinase 6|Y
never-in-mitosis Aspergillus-related kinase 9|never-in-mitosis Aspergillus-related kinase 8|Y
never-in-mitosis Aspergillus-related kinase 9|never-in-mitosis Aspergillus-related kinase 3|Y
never-in-mitosis Aspergillus-related kinase 9|never-in-mitosis Aspergillus-related kinase 2|Y
never-in-mitosis Aspergillus-related kinase 9|never-in-mitosis Aspergillus-related kinase 4|Y
never-in-mitosis Aspergillus-related kinase 9|never-in-mitosis Aspergillus-related kinase 7|Y
never-in-mitosis Aspergillus-related kinase 9|never-in-mitosis Aspergillus-related kinase|Y
nucleotide binding site/leucine-rich repeat|nucleotide-binding site/leucine-rich repeat|Y
nucleotide binding site/leucine-rich repeat|nucleotide binding site-leucine-rich repeat|Y
non-equilibrium steady state|nonequilibrium steady state|Y
anti-idiotype monoclonal antibody|antiidiotype monoclonal antibody|Y
graduated compression stockings|graduated compression stocking|Y
p-nitrophenylacetate|p-nitrophenyl-acetate|Y
p-nitrophenylacetate|p-nitrophenyl acetate|Y
adenosine-triphosphate-binding cassette sub-family B member 1|adenosine triphosphate-binding cassette subfamily B member 1|Y
adenosine-triphosphate-binding cassette sub-family B member 1|adenosine-triphosphate-binding cassette subfamily B member 1|Y
adenosine-triphosphate-binding cassette sub-family B member 1|adenosine triphosphate-binding cassette sub-family B member 1|Y
stromal-derived factor-1alpha|stromal-derived factor-1 alpha|Y
tracheo-esophageal fistula|tracheoesophageal fistula|Y
tracheo-esophageal fistula|tracheo-oesophageal fistula|Y
acute myelogenous leukaemia-associated|acute myelogenous leukemia-associated|Y
Fc γ receptor dependent|Fcγ receptor dependent|Y
anti-interleukin-12 antibody|anti-interleukin-1 antibody|Y
anti-interleukin-12 antibody|anti-interleukin-2 antibody|Y
anti-human T cell lymphotropic virus I antibody|anti-human T cell lymphotropic virus 1 antibody|Y
anti-human T cell lymphotropic virus I antibody|anti-human T-cell lymphotropic virus I antibody|Y
anti-human T cell lymphotropic virus I antibody|anti-human T cell lymphotropic virus-I antibody|Y
anti-human T cell lymphotropic virus I antibody|anti-human T cell lymphotrophic virus I antibody|Y
ultrasound-guided fine needle aspiration cytology|ultrasound-guided fine-needle aspiration cytology|Y
receiver operating characteristics|receiver operating characteristic|Y
ethoxyresorufin deethylase|ethoxyresorufin de-ethylase|Y
ethoxyresorufin deethylase|ethoxy-resorufin deethylase|Y
transforming growth factor-beta 1 level|transforming growth factor-beta1 level|Y
γ-glutamyltransferase|γ-glutamyl transferase|Y
γ-glutamyltransferase|γglutamyltransferase|Y
G-protein α(i) subunit|G-protein α(i2) subunit|Y
G-protein α(i) subunit|G-protein α(i3) subunit|Y
G-protein α(i) subunit|G-protein α(i1) subunit|Y
On-Line Survey Certification and Reporting|On-line Survey Certification and Reporting|Y
α 1-antitrypsin deficiency|α1-antitrypsin deficiency|Y
recombinant human bone morphogenetic protein 7|recombinant human bone morphogenetic protein 6|Y
recombinant human bone morphogenetic protein 7|recombinant human bone morphogenetic protein 2|Y
recombinant human bone morphogenetic protein 7|recombinant human bone morphogenetic protein|Y
recombinant human bone morphogenetic protein 7|recombinant human bone morphogenetic protein 4|Y
phospholipase-C-related inactive protein|phospholipase C-related inactive protein|Y
artificial rupture of membranes|artificial rupture of membrane|Y
human bone morphogenetic protein 12|human bone morphogenetic protein 2|Y
protein kinase, cAMP-dependent, regulatory, type I, alpha|protein kinase, cAMP-dependent, regulatory, type 2, alpha|Y
plasma insulin-like growth factor-I level|plasma insulin-like growth factor-II level|Y
plasma insulin-like growth factor-I level|plasma insulin-like growth factor-1 level|Y
plasma insulin-like growth factor-I level|plasma insulin-like growth factor I level|Y
cholesterol 7alpha-hydroxylase gene|cholesterol 7 alpha-hydroxylase gene|Y
posttransplant lymphoproliferative disease|post-transplant lympho-proliferative disease|Y
posttransplant lymphoproliferative disease|post-transplant lymphoproliferative disease|Y
posttransplant lymphoproliferative disease|posttransplant lympho-proliferative disease|Y
corticotropin releasing factor type 1 receptor|corticotropin-releasing factor type 1 receptor|Y
corticotropin releasing factor type 1 receptor|corticotropin releasing factor type-1 receptor|Y
corticotropin releasing factor type 1 receptor|corticotropin releasing factor type 2 receptor|Y
3-[(3-cholamidopropyl)dimethylammonio]-1-propane sulfonate|3-[(3-cholamidopropyl)dimethylammonio]-1-propane-sulfonate|Y
nonrestorative sleep|non-restorative sleep|Y
receptor-like protein-tyrosine phosphatase delta|receptor-like protein tyrosine phosphatase delta|Y
receptor-like protein-tyrosine phosphatase delta|receptor-like protein-tyrosine phosphatase-delta|Y
receptor-like protein-tyrosine phosphatase delta|receptor-like protein-tyrosine phosphatase eta|Y
Musca domestica glutathione S-transferase-3|Musca domestica glutathione S-transferase-1|Y
Musca domestica glutathione S-transferase-3|Musca domestica glutathione S-transferase-5|Y
Musca domestica glutathione S-transferase-3|Musca domestica glutathione S-transferase-4|Y
Musca domestica glutathione S-transferase-3|Musca domestica glutathione S-transferase-2|Y
Musca domestica glutathione S-transferase-3|Musca domestica glutathione S-transferase|Y
transient receptor potential melastatin 5|transient receptor potential melastatin 4|Y
transient receptor potential melastatin 5|transient receptor potential melastatin 2|Y
transient receptor potential melastatin 5|transient receptor potential melastatin 3|Y
transient receptor potential melastatin 5|transient receptor potential melastatin 6|Y
transient receptor potential melastatin 5|transient receptor potential melastatin 7|Y
transient receptor potential melastatin 5|transient receptor potential melastatin 8|Y
transient receptor potential melastatin 5|transient receptor potential melastatin 1|Y
mass-analyzed threshold ionization spectroscopy|mass analyzed threshold ionization spectroscopy|Y
mass-analyzed threshold ionization spectroscopy|mass-analyzed threshold ionisation spectroscopy|Y
ultrasound guided fine needle aspiration|ultrasound-guided fine needle aspiration|Y
ultrasound guided fine needle aspiration|ultrasound guided fine-needle aspiration|Y
spinal cord evoked potentials|spinal cord evoked potential|Y
continuous veno-venous haemodialysis|continuous veno-venous hemodialysis|Y
intravenous regional anesthesia|intravenous regional anaesthesia|Y
semidefinite programming|semi-definite programming|Y
molluscan insulin-related peptide|molluscan insulin-related peptides|Y
F-18 fluoro-deoxyglucose|F-18 fluorodeoxyglucose|Y
poly-adenosine diphosphate ribosylation|polyadenosine diphosphate ribosylation|Y
cis-dichlorodiammine platinum|cis-dichlorodiammineplatinum|Y
macrophage-inflammatory protein-3α|macrophage-inflammatory protein-3 α|Y
anti-arginine vasopressin antibody|antiarginine vasopressin antibody|Y
pseudo-hypoaldosteronism type I|pseudo-hypoaldosteronism type II|Y
G-protein-coupled oestrogen receptor-1|G-protein-coupled estrogen receptor-1|Y
(123)I-meta-iodobenzylguanidine scintigraphy|(123)I-meta-iodobenzyl-guanidine scintigraphy|Y
(123)I-meta-iodobenzylguanidine scintigraphy|(123)I-metaiodobenzylguanidine scintigraphy|Y
(123)I-meta-iodobenzylguanidine scintigraphy|(123)I-metaiodobenzyl-guanidine scintigraphy|Y
inflammatory pseudo-tumor|inflammatory pseudotumor|Y
inflammatory pseudo-tumor|inflammatory pseudo-tumour|Y
Center for Epidemiologic Studies Depression Scale|Centre for Epidemiologic Studies Depression Scale|Y
multi-cystic encephalopathy|multicystic encephalopathy|Y
therapy-related myelodysplastic syndrome|Therapy-related myelodysplastic syndrome|Y
anti-major histocompatibility complex class II antibody|anti-major histocompatibility complex class I antibody|Y
quasi-linear visco-elastic model|quasi-linear viscoelastic model|Y
fasciculation and elongation protein zeta-1|fasciculation and elongation protein zeta 1|Y
cytokine-induced neutrophil chemoattractant 3|cytokine-induced neutrophil chemoattractant|Y
cytokine-induced neutrophil chemoattractant 3|cytokine-induced neutrophil chemoattractant-3|Y
cytokine-induced neutrophil chemoattractant 3|cytokine-induced neutrophil chemoattractant 2|Y
cytokine-induced neutrophil chemoattractant 3|cytokine-induced neutrophil chemoattractant 1|Y
cytokine-induced neutrophil chemoattractant 3|cytokine induced neutrophil chemoattractant 3|Y
endocscopic carpal tunnel release|endoscopic carpal tunnel release|Y
antineuronal nuclear antibody type 1|anti-neuronal nuclear antibody type 1|Y
oligomycin sensitivity conferring protein|oligomycin-sensitivity conferring protein|Y
oligomycin sensitivity conferring protein|oligomycin sensitivity-conferring protein|Y
solute carrier family 17 member 9|solute carrier family 7 member 9|Y
spatio-temporal convergence|spatiotemporal convergence|Y
hemoglobin Guangzhou-Hangzhou|haemoglobin Guangzhou-Hangzhou|Y
sterol regulatory element binding protein|sterol regulatory element binding protein 1|Y
sterol regulatory element binding protein|sterol regulatory element binding protein-2|Y
para-fluoro-hexahydrosiladiphenidol|parafluoro-hexahydrosiladiphenidol|Y
para-fluoro-hexahydrosiladiphenidol|para-fluorohexahydrosiladiphenidol|Y
macrophage metalloelastase|macrophage metallo-elastase|Y
glomerulo-tubulonephritis|glomerulotubulonephritis|Y
glomerulo-tubulonephritis|glomerulo-tubulo-nephritis|Y
8-hydroxy-2'-deoxyguanosine|8-hydroxy-2'deoxyguanosine|Y
8-hydroxy-2'-deoxyguanosine|8-hydroxy-2-deoxyguanosine|Y
8-hydroxy-2'-deoxyguanosine|8-hydroxyl-2'-deoxyguanosine|Y
beta-1,3-N-acetylglucosaminyltransferase 2|beta1,3N-acetylglucosaminyltransferase 2|Y
L-N6-(1-Iminoethyl)lysine|L-N6-(1-Iminoethyl) lysine|Y
anti-radical activity|antiradical activity|Y
nonspecific lipid transfer protein|non-specific lipid transfer protein|Y
ganglioside-induced differentiation associated protein 1|ganglioside-induced differentiation-associated protein 1|Y
ganglioside-induced differentiation associated protein 1|ganglioside-induced differentiation associated protein-1|Y
Thiobacillus ferrooxidans|Thiobacillus ferro-oxidans|Y
pre-menstrual tension|premenstrual tension|Y
contrast-to-noise ratios|contrast-to-noise ratio|Y
electroencephalograph|electroencephalography|Y
otorhinolaryngological|oto-rhinolaryngological|Y
otorhinolaryngological|otorhino-laryngological|Y
anti-human T cell lymphotropic virus 1 antibody|anti-human T-cell lymphotropic virus 1 antibody|Y
anti-human T cell lymphotropic virus 1 antibody|anti-human T cell lymphotrophic virus 1 antibody|Y
post-operative toxic shock syndrome|postoperative toxic shock syndrome|Y
G protein αq subunit|G protein α q subunit|Y
non-rapid eye movement sleep|nonrapid eye movement sleep|Y
gamma-aminobutyric acidB receptor|gamma-amino butyric acidB receptor|Y
gamma-aminobutyric acidB receptor|gamma-amino-butyric acidB receptor|Y
gamma-aminobutyric acidB receptor|gamma-aminobutyric acid-B receptor|Y
gamma-aminobutyric acidB receptor|gamma-aminobutyric acid B receptor|Y
generalized atrophic benign epidermolysis bullosa|generalised atrophic benign epidermolysis bullosa|Y
calcium voltage-gated channel subunit α 1 F|calcium voltage-gated channel subunit α 1 C|Y
calcium voltage-gated channel subunit α 1 F|calcium voltage-gated channel subunit α1 F|Y
Ehlers Danlos syndrome type VII|Ehlers Danlos syndrome type VI|Y
Ehlers Danlos syndrome type VII|Ehlers Danlos syndrome type VIIB|Y
Ehlers Danlos syndrome type VII|Ehlers Danlos syndrome type VIII|Y
Ehlers Danlos syndrome type VII|Ehlers Danlos syndrome type II|Y
carbapenem-resistant Klebsiella pneumoniae|carbapenem resistant Klebsiella pneumoniae|Y
test retest variability|test re-test variability|Y
chromodomain helicase-DNA-binding protein-7|chromodomain helicase DNA-binding protein-7|Y
oestrogen receptor α knock-out|estrogen receptor α knock-out|Y
cerebral thromboembolic attack|cerebral thrombo-embolic attack|Y
anti-leishmania immunoglobulin G|antileishmania immunoglobulin G|Y
thyrotrophic-stimulating hormone|thyrotropic-stimulating hormone|Y
GTP-binding protein γ-subunit|GTP-binding protein βγ-subunit|Y
corticotrophin-like intermediate-lobe peptide|corticotrophin-like intermediate lobe peptide|Y
corticotrophin-like intermediate-lobe peptide|corticotropin-like intermediate-lobe peptide|Y
percutaneous nephro-ureterolithotomy|percutaneous nephroureterolithotomy|Y
technetium-99m methoxy-isobutyl-isonitrile|technetium-99m methoxyisobutylisonitrile|Y
atlanto-occipital dislocation|atlantooccipital dislocation|Y
A disintegrin and metalloproteinase-3|A disintegrin and metalloproteinase-13|Y
A disintegrin and metalloproteinase-3|A disintegrin and metalloproteinase-33|Y
A disintegrin and metalloproteinase-3|A disintegrin and metalloproteinase-23|Y
urinary stress incontinene|urinary stress incontinence|Y
anti-IL4 receptor monoclonal antibody|anti-IL 4 receptor monoclonal antibody|Y
anti-IL4 receptor monoclonal antibody|anti-IL-4 receptor monoclonal antibody|Y
insulin-like growth factor-binding protein|insulin-like growth factor binding protein|Y
3,3',5'-triiodothyronine|3,3',5-triiodothyronine|Y
β-amyloid precursor protein-cleaving enzyme|β-amyloid precursor protein-cleaving enzyme 2|Y
β-amyloid precursor protein-cleaving enzyme|β-amyloid precursor protein-cleaving enzyme-2|Y
β-amyloid precursor protein-cleaving enzyme|β-amyloid precursor protein cleaving enzyme|Y
β-amyloid precursor protein-cleaving enzyme|β-amyloid precursor protein-cleaving enzyme-1|Y
β-amyloid precursor protein-cleaving enzyme|β amyloid precursor protein-cleaving enzyme|Y
β-amyloid precursor protein-cleaving enzyme|β-amyloid precursor protein-cleaving enzyme 1|Y
5-hydroxytryptamine 4 receptor antagonist|5-hydroxytryptamine 3 receptor antagonist|Y
a disintegrin and metalloproteinase-3|a disintegrin and metalloproteinase-13|Y
a disintegrin and metalloproteinase-3|a disintegrin and metalloproteinase-23|Y
a disintegrin and metalloproteinase-3|a disintegrin and metalloproteinase-33|Y
intra-cellular ice formation|intracellular ice formation|Y
non-multiple endocrine neoplasia, type I|non-multiple endocrine neoplasia, type 1|Y
non-multiple endocrine neoplasia, type I|non-multiple endocrine neoplasia type I|Y
cluster of differentiation antigen 79|cluster of differentiation antigen 79a|Y
cluster of differentiation antigen 79|cluster of differentiation antigen 79b|Y
counterimmuno-electrophoretic|counterimmunoelectrophoretic|Y
membrane-associated guanylate kinase-interacting protein-1|membrane-associated guanylate kinase-interacting protein-2|Y
membrane-associated guanylate kinase-interacting protein-1|membrane-associated guanylate kinase-interacting protein|Y
receptor-activity-modifying protein|receptor-activity-modifying proteins|Y
ADPglucose pyrophosphatase|ADP-glucose pyrophosphatase|Y
class II trans-activator|class II transactivator|Y
atmospheric pressure photo-ionisation mass spectrometry|atmospheric pressure photoionisation mass spectrometry|Y
atmospheric pressure photo-ionisation mass spectrometry|atmospheric pressure photo-ionization mass spectrometry|Y
atmospheric pressure photo-ionisation mass spectrometry|atmospheric pressure photo-ionisation-mass spectrometry|Y
retropharyngeal lymph node|retro-pharyngeal lymph node|Y
dried distillers grain|dried distiller's grain|Y
dried distillers grain|dried distillers' grain|Y
bronchial-associated lymphoid tissue lymphoma|bronchial associated lymphoid tissue lymphoma|Y
bcl2-associated X protein|bcl-2-associated X protein|Y
oculo-auriculo-vertebral spectrum|oculo-auriculovertebral spectrum|Y
tetra-cyclic antidepressant|tetracyclic antidepressant|Y
Shiga toxin producing Escherichia coli|Shigatoxin producing Escherichia coli|Y
γ-amino butyric acid receptor|γ-amino butyric acidB receptor|Y
American Orthopaedic Foot and Ankle Society Midfoot Scale|American Orthopedic Foot and Ankle Society Midfoot Scale|Y
reaction center-light harvesting complex 1|reaction centre-light harvesting complex 1|Y
reaction center-light harvesting complex 1|reaction center-light-harvesting complex 1|Y
reaction center-light harvesting complex 1|reaction center-light harvesting complex I|Y
atmospheric pressure photo-ionization-mass spectrometry|atmospheric pressure photo-ionization mass spectrometry|Y
atmospheric pressure photo-ionization-mass spectrometry|atmospheric pressure photo-ionisation-mass spectrometry|Y
costovertebral angle|costo vertebral angle|Y
vulvar intraepithelial neoplasia grade 2|vulvar intraepithelial neoplasia grade 1|Y
vulvar intraepithelial neoplasia grade 2|vulvar intraepithelial neoplasia grade 3|Y
Soil-borne wheat mosaic virus|Soilborne wheat mosaic virus|Y
murine granulocyte macrophage colony stimulating factor|murine granulocyte-macrophage colony stimulating factor|Y
murine granulocyte macrophage colony stimulating factor|murine granulocyte macrophage colony-stimulating factor|Y
electro-nystagmography|electronystagmography|Y
A disintegrin and metalloprotease 33|A disintegrin and metalloprotease 3|Y
endothelial-leucocyte adhesion molecule-1|endothelial-leukocyte adhesion molecule-1|Y
methyl beta-carboline-3-carboxylate|ethyl beta-carboline-3-carboxylate|Y
asymmetrical dimethylarginine|symmetrical dimethylarginine|Y
super spreading event|superspreading event|Y
3β-hydroxy steroid dehydrogenase deficiency|3 β-hydroxysteroid dehydrogenase deficiency|Y
3β-hydroxy steroid dehydrogenase deficiency|3β-hydroxy steroid-dehydrogenase deficiency|Y
3β-hydroxy steroid dehydrogenase deficiency|3-β-hydroxysteroid dehydrogenase deficiency|Y
3β-hydroxy steroid dehydrogenase deficiency|3β-hydroxysteroid dehydrogenase deficiency|Y
thrombo-angitis obliterans|thromboangitis obliterans|Y
anti-cluster of differentiation 2 monoclonal antibody|anti-cluster of differentiation 25 monoclonal antibody|Y
γ aminobutyric acid receptor|γ amino butyric acid receptor|Y
α melanocyte stimulating hormone receptor|α-melanocyte stimulating hormone receptor|Y
α melanocyte stimulating hormone receptor|melanocyte stimulating hormone receptor|Y
vero toxin producing Escherichia coli|verotoxin producing Escherichia coli|Y
renovascular resistance|reno-vascular resistance|Y
American Society of Anesthesiology physical status 5|American Society of Anesthesiology physical status 1|Y
American Society of Anesthesiology physical status 5|American Society of Anesthesiology physical status 4|Y
American Society of Anesthesiology physical status 5|American Society of Anesthesiology physical status I|Y
American Society of Anesthesiology physical status 5|American Society of Anaesthesiology physical status 5|Y
American Society of Anesthesiology physical status 5|American Society of Anesthesiology physical status 2|Y
American Society of Anesthesiology physical status 5|American Society of Anesthesiology physical status|Y
American Society of Anesthesiology physical status 5|American Society of Anesthesiology physical status 3|Y
interleukin-1α protein|interleukin-1 α protein|Y
anti-inflammatory cytokine|anti-inflammatory cytokines|Y
nitroglycerin mediated dilatation|nitroglycerine mediated dilatation|Y
linear mixed effects modeling|linear mixed effects modelling|Y
multiplex-fluorescence in-situ hybridization|multiplex-fluorescence in-situ hybridisation|Y
multiplex-fluorescence in-situ hybridization|multiplex fluorescence in-situ hybridization|Y
multiplex-fluorescence in-situ hybridization|multiplex-fluorescence in situ hybridization|Y
insulin-like growth factor-binding protein related protein 1|insulin-like growth factor-binding protein related protein-1|Y
insulin-like growth factor-binding protein related protein 1|insulin-like growth factor binding protein related protein 1|Y
pro-interleukin-1 beta|prointerleukin-1 beta|Y
pro-interleukin-1 beta|pro-interleukin-1beta|Y
automated immunonephelometric assay|automated immuno-nephelometric assay|Y
hypoosmotic swelling|hypo-osmotic swelling|Y
non-inherited paternal antigen|noninherited paternal antigen|Y
augmented correlation consistent polarized valence quadruple-zeta basis set|augmented correlation-consistent polarized valence quadruple-zeta basis set|Y
augmented correlation consistent polarized valence quadruple-zeta basis set|augmented correlation consistent polarised valence quadruple-zeta basis set|Y
augmented correlation consistent polarized valence quadruple-zeta basis set|augmented correlation consistent polarized valence quadruple zeta basis set|Y
alpha-aminobutyric acid|alpha-amino butyric acid|Y
alpha-aminobutyric acid|alpha-amino-butyric acid|Y
postheparin lipolytic activity|post-heparin lipolytic activity|Y
Ehlers-Danlos syndrome type VIIC|Ehlers-Danlos syndrome type VII C|Y
International Neuroblastoma Staging System Stage 4|International Neuroblastoma Staging System Stage 3|Y
International Neuroblastoma Staging System Stage 4|International Neuroblastoma Staging System Stage 2|Y
International Neuroblastoma Staging System Stage 4|International Neuroblastoma Staging System Stage I|Y
International Neuroblastoma Staging System Stage 4|International Neuroblastoma Staging System Stage 1|Y
International Neuroblastoma Staging System Stage 4|International Neuroblastoma Staging System stage 4|Y
nonspecific cross-reacting antigen|non-specific cross-reacting antigen|Y
1, 1'-dimethylferrocene|1,1'-dimethylferrocene|Y
methyl cytosine-phosphate-guanosine binding domain 1|methyl cytosine-phosphate-guanosine binding domain 5|Y
methyl cytosine-phosphate-guanosine binding domain 1|methyl cytosine-phosphate-guanosine binding domain 4|Y
methyl cytosine-phosphate-guanosine binding domain 1|methyl cytosine-phosphate-guanosine binding domain 2|Y
methyl cytosine-phosphate-guanosine binding domain 1|methyl cytosine-phosphate-guanosine binding domain|Y
State University of New York Downstate Medical Center|State University of New York, Downstate Medical Center|Y
Becke-3-parameter-Lee-Yang-Parr functional|Becke 3-parameter-Lee-Yang-Parr functional|Y
structural maintenance of chromosome protein 5|structural maintenance of chromosome protein 1|Y
structural maintenance of chromosome protein 5|structural maintenance of chromosome protein 3|Y
over-active bladder syndrome|overactive bladder syndrome|Y
EULAR Sjögren's Syndrome Disease Activity Index|EULAR Sjogren's Syndrome Disease Activity Index|Y
International Committee for Standardization in Hematology|International Committee for Standardization in Haematology|Y
intraoperative neurophysiological monitoring|intra-operative neurophysiological monitoring|Y
purine-rich element-binding protein alpha|purine-rich element binding protein alpha|Y
pre-computed tomography|precomputed tomography|Y
Musca domestica glutathione S-transferase-1|Musca domestica glutathione S-transferase-5|Y
Musca domestica glutathione S-transferase-1|Musca domestica glutathione S-transferase-4|Y
Musca domestica glutathione S-transferase-1|Musca domestica glutathione S-transferase-2|Y
Musca domestica glutathione S-transferase-1|Musca domestica glutathione S-transferase|Y
pentylene-tetrazol kindled|pentylenetetrazol kindled|Y
pentylene-tetrazol kindled|pentylene-tetrazole kindled|Y
recombinant interleukin 7|recombinant interleukin 17|Y
non-ketotic hyperglycinaemia|non-ketotic hyperglycinemia|Y
G-protein α q subunit|G-protein αq subunit|Y
human cytochrome P450 1A2|human cytochrome P-450 1A2|Y
cyclic guanosine 3'5'-monophosphate|cyclic guanosine 3',5'-monophosphate|Y
aorta-gonads-mesonephros|aorta-gonad-mesonephros|Y
A disintegrin and metalloproteinase-17|A disintegrin and metalloproteinase-7|Y
corticotropin-releasing activity|corticotrophin-releasing activity|Y
American Society of Anaesthesiology Class 2|American Society of Anaesthesiology Class 3|Y
American Society of Anaesthesiology Class 2|American Society of Anaesthesiology Class 5|Y
American Society of Anaesthesiology Class 2|American Society of Anaesthesiology Class I|Y
American Society of Anaesthesiology Class 2|American Society of Anaesthesiology Class V|Y
American Society of Anaesthesiology Class 2|American Society of Anaesthesiology class 2|Y
American Society of Anaesthesiology Class 2|American Society of Anaesthesiology Class 4|Y
American Society of Anaesthesiology Class 2|American Society of Anesthesiology Class 2|Y
hairy and enhancer of split-1|hairy and enhancer of split1|Y
cartilage-derived morphogenetic protein 3|cartilage-derived morphogenetic protein-3|Y
cartilage-derived morphogenetic protein 3|cartilage-derived morphogenetic protein|Y
calcium/calmodulin-dependent protein kinase II|calcium/calmodulin dependent protein kinase II|Y
calcium/calmodulin-dependent protein kinase II|calcium/calmodulin-dependent protein kinase IV|Y
calcium/calmodulin-dependent protein kinase II|calcium-calmodulin-dependent protein kinase II|Y
intra-peritoneal hyperthermic perfusion|intraperitoneal hyperthermic perfusion|Y
selective neck dissection|elective neck dissection|Y
oral facial digital syndrome type II|oral facial digital syndrome type III|Y
cis-diaminedichloroplatinum|cis-diamine-dichloroplatinum|Y
cis-diaminedichloroplatinum|cis-diamminedichloroplatinum|Y
cis-diaminedichloroplatinum|cisdiaminedichloroplatinum|Y
Veteran's Health Administration medical center|Veterans' Health Administration medical center|Y
Veteran's Health Administration medical center|Veterans Health Administration medical center|Y
environmental scanning electron microscopy|environmental scanning electron microscope|Y
CD1d-restricted invariant natural killer T cell|CD1d-restricted invariant natural killer T-cell|Y
nearest-neighbour distance|nearest-neighbor distance|Y
American Society of Anesthesiologists grade 3|American Society of Anesthesiologists grade 4|Y
American Society of Anesthesiologists grade 3|American Society of Anesthesiologists grade|Y
American Society of Anesthesiologists grade 3|American Society of Anesthesiologists grade V|Y
American Society of Anesthesiologists grade 3|American Society of Anaesthesiologists grade 3|Y
American Society of Anesthesiologists grade 3|American Society of Anesthesiologists Grade 3|Y
American Society of Anesthesiologists grade 3|American Society of Anesthesiologists grade 2|Y
American Society of Anesthesiologists grade 3|American Society of Anesthesiologists grade I|Y
American Society of Anesthesiologists grade 3|American Society of Anesthesiologists grade 1|Y
American Society of Anesthesiologists grade 3|American Society of Anesthesiologists grade 5|Y
cluster of differentiation antigen 5|cluster of differentiation antigen 54|Y
cluster of differentiation antigen 5|cluster of differentiation antigen 57|Y
cluster of differentiation antigen 5|cluster of differentiation antigen 50|Y
cluster of differentiation antigen 5|cluster of differentiation antigen 53|Y
cluster of differentiation antigen 5|cluster of differentiation antigen 51|Y
cluster of differentiation antigen 5|cluster of differentiation antigen 59|Y
cluster of differentiation antigen 5|cluster of differentiation antigen 35|Y
cluster of differentiation antigen 5|cluster of differentiation antigen 45|Y
cluster of differentiation antigen 5|cluster of differentiation antigen 58|Y
dilauroylphosphatidylethanolamine|dilauroylphosphatidyl-ethanolamine|Y
anticolon cancer monoclonal antibody|anti-colon cancer monoclonal antibody|Y
insulin-like growth factor-II mRNA binding protein 2|insulin-like growth factor-II mRNA binding protein 3|Y
insulin-like growth factor-II mRNA binding protein 2|insulin-like growth factor-II mRNA binding protein 1|Y
insulin-like growth factor-II mRNA binding protein 2|insulin-like growth factor II mRNA binding protein 2|Y
insulin-like growth factor-II mRNA binding protein 2|insulin-like growth factor-II mRNA binding protein|Y
insulin-like growth factor-II mRNA binding protein 2|insulin-like growth factor-II mRNA-binding protein 2|Y
insulin-like growth factor-II mRNA binding protein 2|insulin-like growth factor-II mRNA binding protein-2|Y
anti-human T-cell lymphotropic virus 1 antibody|anti-human T-cell lymphotropic virus-1 antibody|Y
anti-human T-cell lymphotropic virus 1 antibody|anti-human T-cell lymphotropic virus I antibody|Y
anti-human T-cell lymphotropic virus 1 antibody|anti-human T-cell lymphotrophic virus 1 antibody|Y
intra-uterine growth restricted|intrauterine growth restricted|Y
transforming growth factor β1|transforming growth factor β 1|Y
transforming growth factor β1|transforming growth factor β-1|Y
electron-probe X-ray microanalyzer|electron-probe X-ray micro-analyzer|Y
G protein beta3 subunit|G protein beta subunit|Y
matrix-assisted laser desorption/ionization|matrix-assisted laser desorption ionization|Y
matrix-assisted laser desorption/ionization|matrix-assisted laser-desorption/ionization|Y
matrix-assisted laser desorption/ionization|matrix-assisted laser desorption/ionisation|Y
matrix-assisted laser desorption/ionization|matrix-assisted laser desorption-ionization|Y
post-prandial plasma glucose|postprandial plasma glucose|Y
endothelium derived hyperpolarizing factor|endothelium derived hyperpolarising factor|Y
multi-detector computed tomography|multidetector computed tomography|Y
peri-centriolar matrix|pericentriolar matrix|Y
FK506-binding protein 12.6|FK-506-binding protein 12.6|Y
ischemia-modified albumin|ischaemia-modified albumin|Y
anti-fibrillarin autoantibody|antifibrillarin autoantibody|Y
anti-IL 1alpha monoclonal antibody|anti-IL1alpha monoclonal antibody|Y
anti-IL 1alpha monoclonal antibody|anti-IL 1 alpha monoclonal antibody|Y
granulocyte-colony stimulating factor receptor|granulocyte colony stimulating factor receptor|Y
apolipoprotein E-ε 4 allele|apolipoprotein E-ε4 allele|Y
human adenovirus type 48|human adenovirus type 4|Y
human adenovirus type 48|human adenovirus type 8|Y
transient receptor potential vanilloid receptor type 1|transient receptor potential vanilloid receptor type 2|Y
basic multicellular unit|basic multi-cellular unit|Y
technetium-99m-galactosyl neoglycoalbumin|technetium-99m galactosyl neoglycoalbumin|Y
technetium-99m-galactosyl neoglycoalbumin|technetium-99m-galactosyl-neoglycoalbumin|Y
technetium-99m-galactosyl neoglycoalbumin|technetium-99m-galactosylneoglycoalbumin|Y
thermostable direct hemolysin-related hemolysin|thermostable direct haemolysin-related haemolysin|Y
peptide histidine isoleucineamide|peptide histidine isoleucinamide|Y
bilio-intestinal bypass|biliointestinal bypass|Y
haemoglobin Barts disease|hemoglobin Barts disease|Y
haemoglobin Barts disease|haemoglobin Bart's disease|Y
augmented correlation consistent polarised valence triple zeta basis set|augmented correlation-consistent polarised valence triple zeta basis set|Y
augmented correlation consistent polarised valence triple zeta basis set|augmented correlation consistent polarized valence triple zeta basis set|Y
augmented correlation consistent polarised valence triple zeta basis set|augmented correlation consistent polarised valence triple-zeta basis set|Y
nonstructural protein 3|non-structural protein 3|Y
caspase 1/interleukin-1 β-converting enzyme|caspase 1/interleukin-1β-converting enzyme|Y
anti-matrix metalloproteinase-3 antibody|anti-matrix metalloproteinase-9 antibody|Y
anti-matrix metalloproteinase-3 antibody|anti-matrix metalloproteinase-2 antibody|Y
anti-matrix metalloproteinase-3 antibody|anti-matrix metalloproteinase 3 antibody|Y
anti-matrix metalloproteinase-3 antibody|anti-matrix metalloproteinase-1 antibody|Y
anti-matrix metalloproteinase-3 antibody|anti-matrix metalloproteinase-13 antibody|Y
anti-matrix metalloproteinase-3 antibody|anti-matrix metalloproteinase-7 antibody|Y
poly(hydroxybutyrate)|poly-(hydroxybutyrate)|Y
information and communications technology|information and communication technology|Y
N-acylhomoserine lactone|N-acyl homoserine lactone|Y
para-chloromercuriphenyl sulphonate|para-chloromercuriphenylsulphonate|Y
Phleum pratense protein 2|Phleum pratense protein 12|Y
solid freeform fabrication|solid free-form fabrication|Y
disease-modifying anti-rheumatic drug|disease-modifying antirheumatic drug|Y
disease-modifying anti-rheumatic drug|disease-modifying anti-rheumatic drugs|Y
University of California, Los Angeles, Prostate Cancer Index|University of California, Los Angeles Prostate Cancer Index|Y
University of California, Los Angeles, Prostate Cancer Index|University of California Los Angeles Prostate Cancer Index|Y
vasopressin 2 receptor|vasopressin V2 receptor|Y
brain-derived neurotrophic factor|brain-derived neurotropic factor|Y
American Society of Anaesthesiology class I|American Society of Anaesthesiology class III|Y
American Society of Anaesthesiology class I|American Society of Anaesthesiology class IV|Y
American Society of Anaesthesiology class I|American Society of Anaesthesiology class 4|Y
American Society of Anaesthesiology class I|American Society of Anaesthesiology class|Y
American Society of Anaesthesiology class I|American Society of Anaesthesiology Class I|Y
American Society of Anaesthesiology class I|American Society of Anaesthesiology class V|Y
American Society of Anaesthesiology class I|American Society of Anesthesiology class II|Y
American Society of Anaesthesiology class I|American Society of Anaesthesiology class 5|Y
American Society of Anaesthesiology class I|American Society of Anesthesiology class IV|Y
American Society of Anaesthesiology class I|American Society of Anesthesiology class I|Y
American Society of Anaesthesiology class I|American Society of Anaesthesiology class 3|Y
American Society of Anaesthesiology class I|American Society of Anaesthesiology class II|Y
American Society of Anaesthesiology class I|American Society of Anaesthesiology class 2|Y
American Society of Anaesthesiology class I|American Society of Anaesthesiology class 1|Y
insulin-like growth factor 1 level|insulinlike growth factor 1 level|Y
basic helix-loop-helix-leucine zipper protein|basic helix-loop-helix leucine zipper protein|Y
basic helix-loop-helix-leucine zipper protein|basic-helix-loop-helix-leucine zipper protein|Y
fractional rate of protein synthesis|fractional rates of protein synthesis|Y
multilocus variable number tandem repeat analysis|multi-locus variable number tandem repeat analysis|Y
adult T cell leukaemia-derived factor|adult T cell leukemia-derived factor|Y
anti-IL15 monoclonal antibody|anti-IL5 monoclonal antibody|Y
anti-IL15 monoclonal antibody|anti-IL 15 monoclonal antibody|Y
anti-IL15 monoclonal antibody|anti-IL-15 monoclonal antibody|Y
interleukin 1 receptor associated kinase IV|interleukin 1 receptor-associated kinase IV|Y
calcium voltage-gated channel subunit alpha1C|calcium voltage-gated channel subunit alpha 1 C|Y
calcium voltage-gated channel subunit alpha1C|calcium voltage-gated channel subunit alpha1 C|Y
follicle center lymphomas|follicle center lymphoma|Y
mitochondria-rich cells|mitochondria-rich cell|Y
CC chemokine receptor 2B|C-C chemokine receptor 2B|Y
CC chemokine receptor 2B|CC chemokine receptor 2|Y
phosphoenolpyruvate carboxykinase1|phosphoenolpyruvate carboxykinase|Y
polyethyleneglycol 2000|polyethyleneglycol 200|Y
γ-amino butyric acid type-A receptor|γ-aminobutyric acid type-A receptor|Y
precursor T cell acute lymphoblastic leukemia|precursor B cell acute lymphoblastic leukemia|Y
chorionic somato-mammotropin|chorionic somato-mammotrophin|Y
chorionic somato-mammotropin|chorionic somatomammotropin|Y
cytolethal distending toxin|cytolethal distending toxins|Y
Escherichia coli DH5-α|Escherichia coli DH5α|Y
precerebellar neuron|pre-cerebellar neuron|Y
peripheral blood stem cell transplant|peripheral blood stem cell transplants|Y
elongation factor 1-α|elongation factor 1α|Y
International Classification of Functioning Disability and Health|International Classification of Functioning, Disability and Health|Y
toll/IL-1 receptor domain-containing adaptor-inducing IFNβ|toll/IL-1 receptor domain-containing adaptor-inducing IFN-β|Y
toll/IL-1 receptor domain-containing adaptor-inducing IFNβ|Toll/IL-1 receptor domain-containing adaptor-inducing IFNβ|Y
toll/IL-1 receptor domain-containing adaptor-inducing IFNβ|toll-IL-1 receptor domain-containing adaptor-inducing IFNβ|Y
gated blood-pool single photon emission computed tomography|gated blood pool single photon emission computed tomography|Y
University of California, San Francisco|University of California San Francisco|Y
magnetic resonance guided focused ultrasound|magnetic resonance-guided focused ultrasound|Y
scaphotrapezo-trapezoid|scapho-trapezo-trapezoid|Y
branched-chain α-keto acid dehydrogenase|branched-chain α-ketoacid dehydrogenase|Y
flavin containing mono-oxygenase 3|flavin containing monooxygenase 3|Y
tetrabromobisphenol A|tetrabromo-bisphenol A|Y
ubiquitin carboxyterminal hydrolase L-1|ubiquitin carboxy-terminal hydrolase L-1|Y
ubiquitin carboxyterminal hydrolase L-1|ubiquitin carboxy terminal hydrolase L-1|Y
ubiquitin carboxyterminal hydrolase L-1|ubiquitin carboxyterminal hydrolase L1|Y
glycophosphatidyl-inositol-linked protein|glycophosphatidylinositol-linked protein|Y
glycophosphatidyl-inositol-linked protein|glycophosphatidyl inositol-linked protein|Y
purified protein derivative|purified protein derivatives|Y
American Society of Anaesthesiologists class IV|American Society of Anaesthesiologists Class IV|Y
American Society of Anaesthesiologists class IV|American Society of Anaesthesiologists class I|Y
American Society of Anaesthesiologists class IV|American Society of Anesthesiologists class V|Y
American Society of Anaesthesiologists class IV|American Society of Anesthesiologists class IV|Y
American Society of Anaesthesiologists class IV|American Society of Anesthesiologists class I|Y
graft infiltrating cell|graft infiltrating cells|Y
biventricular repair|bi-ventricular repair|Y
vacuolar protein sorting 4|vacuolar protein sorting 4A|Y
vacuolar protein sorting 4|vacuolar protein sorting 34|Y
vacuolar protein sorting 4|vacuolar protein sorting 4B|Y
isotope dilution/gas chromatography-mass spectrometry|isotope dilution gas chromatography-mass spectrometry|Y
isotope dilution/gas chromatography-mass spectrometry|isotope dilution-gas chromatography-mass spectrometry|Y
PEGylated immuno-liposome|PEGylated immunoliposome|Y
hydroxy-eicosatetraenoic acid|hydroxyeicosatetraenoic acid|Y
human adenovirus type 25|human adenovirus type 5|Y
preimplantation genetic diagnosis|pre-implantation genetic diagnosis|Y
hydroxyproline-rich glycoproteins|hydroxyproline-rich glycoprotein|Y
psychophysiological insomnia|psycho-physiological insomnia|Y
Marek's disease tumor-associated surface antigen|Marek's disease tumour-associated surface antigen|Y
Marek's disease tumor-associated surface antigen|Marek's disease tumor associated surface antigen|Y
postdilution hemodiafiltration|post-dilution hemodiafiltration|Y
surface enhanced laser desorption/ionization time-of-flight|surface-enhanced laser desorption/ionization time-of-flight|Y
surface enhanced laser desorption/ionization time-of-flight|surface enhanced laser desorption/ionisation time-of-flight|Y
antihamster immunoglobulin G|anti-hamster immunoglobulin G|Y
orofaciodigital syndrome type IV|orofaciodigital syndrome type V|Y
Treponema pallidum haemagglutination|Treponema pallidum hemagglutination|Y
β-hexachlorocyclohexane|β-hexachloro-cyclohexane|Y
anti-beta(2)-glycoprotein-I antibody|anti-beta (2)-glycoprotein-I antibody|Y
aryl hydrocarbon receptor interacting protein|aryl hydrocarbon receptor-interacting protein|Y
aryl hydrocarbon receptor interacting protein|aryl-hydrocarbon receptor interacting protein|Y
brainstem auditory evoked response|brain-stem auditory evoked response|Y
brainstem auditory evoked response|brain stem auditory evoked response|Y
brainstem auditory evoked response|brainstem auditory evoked responses|Y
C difficile-associated diarrhoea|C difficile-associated diarrhea|Y
C difficile-associated diarrhoea|C. difficile-associated diarrhoea|Y
total rosette forming cells|total rosette forming cell|Y
oral facial digital syndrome type VI|oral facial digital syndrome type V|Y
digoxin-like immunoreactive factors|digoxin-like immunoreactive factor|Y
selected ion flow tube mass spectrometry|selected ion flow tube-mass spectrometry|Y
selected ion flow tube mass spectrometry|selected-ion flow tube mass spectrometry|Y
multislice computed tomography angiography|multi-slice computed tomography angiography|Y
interleukin-2 receptor γ chain|interleukine-2 receptor γ chain|Y
summer-type hypersensitivity pneumonitis|summer-type-hypersensitivity pneumonitis|Y
intracellular Ca2+ concentrations|intracellular Ca2+ concentration|Y
clustered regularly interspaced short palindromic repeats|clustered regularly interspaced short palindromic repeat|Y
ras guanosine triphosphatase activating protein|ras guanosine triphosphatase-activating protein|Y
ras guanosine triphosphatase activating protein|Ras guanosine triphosphatase activating protein|Y
ras guanosine triphosphatase activating protein|ras-guanosine triphosphatase activating protein|Y
anticytomegalovirus antibody|anti-cytomegalovirus antibody|Y
percutaneous cardio-pulmonary support system|percutaneous cardiopulmonary support system|Y
cluster of differentiation 95|cluster of differentiation 9|Y
G protein α1 inhibitory subunit|G protein α inhibitory subunit|Y
anti-matrix metalloproteinase II antibody|anti-matrix metalloproteinase-II antibody|Y
TBP associated factor 10|TBP associated factor 1|Y
lympho-vascular space involvement|lymphovascular space involvement|Y
granulocyte-macrophage-colony-stimulating factor receptor alpha chain|granulocyte-macrophage-colony-stimulating factor receptor alpha-chain|Y
granulocyte-macrophage-colony-stimulating factor receptor alpha chain|granulocyte-macrophage colony-stimulating factor receptor alpha chain|Y
psychoemotional stress|psycho-emotional stress|Y
peroxisome proliferator-activated receptor gamma coactivator 1 alpha protein|peroxisome proliferator activated receptor gamma coactivator 1 alpha protein|Y
peroxisome proliferator-activated receptor gamma coactivator 1 alpha protein|peroxisome proliferator activated receptor gamma coactivator 1alpha protein|Y
peroxisome proliferator-activated receptor gamma coactivator 1 alpha protein|peroxisome proliferator-activated receptor gamma coactivator-1alpha protein|Y
peroxisome proliferator-activated receptor gamma coactivator 1 alpha protein|peroxisome proliferator-activated receptor gamma coactivator 1alpha protein|Y
glycosyl phosphatidyl inositol anchored protein|glycosyl phosphatidylinositol anchored protein|Y
glycosyl phosphatidyl inositol anchored protein|glycosyl phosphatidyl inositol-anchored protein|Y
glycosyl phosphatidyl inositol anchored protein|glycosylphosphatidylinositol anchored protein|Y
glycosyl phosphatidyl inositol anchored protein|glycosylphosphatidyl inositol anchored protein|Y
electric cell substrate impedance sensing|electric cell-substrate impedance sensing|Y
underrepresented minority|under-represented minority|Y
recombinant human interleukin 3|recombinant human interleukin 13|Y
Trail Making Test part B|Trail Making Test, part B|Y
cognitive impairment, no dementia|cognitive impairment no dementia|Y
anti-complement activity|anticomplement activity|Y
cartilage-derived morphogenetic protein-1|Cartilage-derived morphogenetic protein-1|Y
cartilage-derived morphogenetic protein-1|cartilage-derived morphogenetic protein-2|Y
cartilage-derived morphogenetic protein-1|cartilage-derived morphogenetic protein-3|Y
cartilage-derived morphogenetic protein-1|cartilage-derived morphogenetic protein|Y
α4β2 nicotinic acetylcholine receptor|α4-β2 nicotinic acetylcholine receptor|Y
store-operated channel|store-operated channels|Y
porphyrinogen carboxylyase|porphyrinogen carboxy-lyase|Y
intra-peritoneal administration|intraperitoneal administration|Y
ultra performance liquid chromatography-quadrupole time-of-flight mass spectrometry|ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry|Y
ultra performance liquid chromatography-quadrupole time-of-flight mass spectrometry|ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry|Y
ultra performance liquid chromatography-quadrupole time-of-flight mass spectrometry|ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry|Y
ultra performance liquid chromatography-quadrupole time-of-flight mass spectrometry|ultra performance liquid chromatography/quadrupole time-of-flight mass spectrometry|Y
ultra performance liquid chromatography-quadrupole time-of-flight mass spectrometry|ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry|Y
thrombo-embolic complication|thromboembolic complication|Y
oestrogen receptor β knock out mouse|oestrogen receptor β knockout mouse|Y
oestrogen receptor β knock out mouse|estrogen receptor β knock out mouse|Y
1,25-Dihydroxyvitamin D3|1,25-Dihydroxyvitamin D|Y
1,25-Dihydroxyvitamin D3|1,25-Dihydroxyvitamin D-3|Y
alpha-methyl-norepinephrine|alpha-methylnorepinephrine|Y
cytoplasmic polyadenylation element binding protein 1|cytoplasmic polyadenylation element binding protein|Y
cytoplasmic polyadenylation element binding protein 1|cytoplasmic polyadenylation element binding protein 4|Y
cytoplasmic polyadenylation element binding protein 1|cytoplasmic polyadenylation element binding protein 3|Y
cytoplasmic polyadenylation element binding protein 1|cytoplasmic polyadenylation element binding protein 2|Y
human granulocyte colony stimulating factor|human granulocyte colony-stimulating factor|Y
hydroxyheptadecatrienoic acid|hydroxy-heptadecatrienoic acid|Y
pancreatico-duodenal resection|pancreaticoduodenal resection|Y
fiber-reinforced composites|fiber-reinforced composite|Y
antithymosin alpha 1 monoclonal antibody|anti-thymosin alpha 1 monoclonal antibody|Y
intra-pericardial pressure|intrapericardial pressure|Y
Integrated Academic Information Management Systems|Integrated Academic Information Management System|Y
microtubule-associated protein-1a|microtubule-associated protein-1|Y
hyper-triglyceridemia|hypertriglyceridemia|Y
hyper-triglyceridemia|hyper-triglyceridaemia|Y
retinoic acid receptor-related orphan receptor γ-t|retinoic acid receptor-related orphan receptor γ t|Y
retinoic acid receptor-related orphan receptor γ-t|retinoic acid receptor-related orphan receptor γt|Y
retinoic acid receptor-related orphan receptor γ-t|retinoic acid receptor-related orphan receptor γ-T|Y
retinoic acid receptor-related orphan receptor γ-t|retinoic acid receptor-related orphan receptor γ|Y
HTLV-I-associated myelopathy/tropical spastic paraparesis|HTLV-I associated myelopathy/tropical spastic paraparesis|Y
N-(4-hydroxyphenyl)retinamide|N-(4-hydroxyphenyl) retinamide|Y
N-(4-hydroxyphenyl)retinamide|N-(4-hydroxyphenyl)-retinamide|Y
thermoluminescence dosimetry|thermo-luminescence dosimetry|Y
violaxanthin deepoxidase|violaxanthin de-epoxidase|Y
NFkappaB repressing factor|NF-kappaB repressing factor|Y
mitogen activated protein kinase kinase|mitogen activated protein kinase kinase 4|Y
mitogen activated protein kinase kinase|mitogen activated protein kinase kinase-1|Y
mitogen activated protein kinase kinase|mitogen activated protein kinase kinase-4|Y
mitogen activated protein kinase kinase|mitogen activated protein kinase kinase 1|Y
intramuscular connective tissue|intra-muscular connective tissue|Y
weaning-to-oestrus interval|weaning-to-estrus interval|Y
atrioventricular junction ablation|atrio-ventricular junction ablation|Y
5-hydroxytryptamine1B|5-hydroxytryptamine 1B|Y
5-hydroxytryptamine1B|5-hydroxytryptamine1|Y
thyrotrophin-releasing hormone stimulation test|thyrotropin-releasing hormone stimulation test|Y
leucocyte immunoglobulin-like receptor 1|leucocyte immunoglobulin-like receptor-1|Y
leucocyte immunoglobulin-like receptor 1|leukocyte immunoglobulin-like receptor 1|Y
Peroxisome proliferator-activated receptor gamma coactivator 1alpha|peroxisome proliferator-activated receptor gamma co-activator 1alpha|Y
Peroxisome proliferator-activated receptor gamma coactivator 1alpha|peroxisome proliferator-activated receptor gamma coactivator 1alpha|Y
Peroxisome proliferator-activated receptor gamma coactivator 1alpha|peroxisome proliferator-activated receptor gamma coactivator 1 alpha|Y
retinoblastoma related protein|retinoblastoma related protein1|Y
beta-adrenergic receptor mRNA-binding protein|beta-adrenergic receptor mRNA binding protein|Y
intra-operative cholangiography|intraoperative cholangiography|Y
non-Hodgkin's lymphoma|non-Hodgkin's lymphomas|Y
ras-related GTP-binding protein 22A|ras-related GTP-binding protein 2A|Y
ras-related GTP-binding protein 22A|ras-related GTP-binding protein 22|Y
cerebrovascular insufficiency|cerebro-vascular insufficiency|Y
3beta-hydroxysteroid dehydrogenase deficiency|3beta-hydroxysteroid-dehydrogenase deficiency|Y
3beta-hydroxysteroid dehydrogenase deficiency|3-beta-hydroxysteroid dehydrogenase deficiency|Y
3beta-hydroxysteroid dehydrogenase deficiency|3 beta-hydroxysteroid dehydrogenase deficiency|Y
3beta-hydroxysteroid dehydrogenase deficiency|3beta-hydroxy steroid dehydrogenase deficiency|Y
angiotensinconverting enzyme|angiotensin-converting enzyme|Y
angiotensinconverting enzyme|angiotensin converting enzyme|Y
pyruvate dehydrogenase E1 α|pyruvate dehydrogenase E1α|Y
non-permissive temperature|nonpermissive temperature|Y
extra-medullary haematopoiesis|extra-medullary hematopoiesis|Y
dansyl-ethylenediamine|dansylethylenediamine|Y
sub-acute combined degeneration|subacute combined degeneration|Y
laser Doppler fluxometry|laser Doppler fluxmetry|Y
intracranial hematoma|intra-cranial hematoma|Y
vasodilator-stimulated phospho-protein|vasodilator-stimulated phosphoprotein|Y
Rab3 interacting molecule 1alpha|Rab3 interacting molecule 1 alpha|Y
glial maturation factor|glia maturation factor|Y
endothelium-derived contracting factors|endothelium-derived contracting factor|Y
normoactive bowel sounds|normo-active bowel sounds|Y
solid-phase extraction-liquid chromatography/tandem mass spectrometry|solid-phase extraction/liquid chromatography/tandem mass spectrometry|Y
solid-phase extraction-liquid chromatography/tandem mass spectrometry|solid-phase extraction-liquid chromatography-tandem mass spectrometry|Y
solid-phase extraction-liquid chromatography/tandem mass spectrometry|solid-phase extraction liquid chromatography/tandem mass spectrometry|Y
tumor-bearing animal|tumour-bearing animal|Y
preBotzinger complex|pre-Botzinger complex|Y
paranitrophenylphosphate|para-nitrophenylphosphate|Y
tumor necrosis factor receptor-associated factor-1|tumour necrosis factor receptor-associated factor-1|Y
tumor necrosis factor receptor-associated factor-1|tumor necrosis factor receptor-associated factor-5|Y
tumor necrosis factor receptor-associated factor-1|tumor necrosis factor receptor-associated factor|Y
tumor necrosis factor receptor-associated factor-1|tumor necrosis factor receptor-associated factor 1|Y
tumor necrosis factor receptor-associated factor-1|tumor necrosis factor receptor-associated factor-6|Y
tumor necrosis factor receptor-associated factor-1|tumor necrosis factor receptor associated factor-1|Y
hydroxydimethyl-pyrimidine|hydroxydimethylpyrimidine|Y
otospondylomegaepiphyseal dysplasia|otospondylo-megaepiphyseal dysplasia|Y
receptor tyrosine kinase-like orphan receptor 1|receptor tyrosine kinase-like orphan receptor-1|Y
receptor tyrosine kinase-like orphan receptor 1|receptor tyrosine kinase-like orphan receptor 2|Y
inhibitory nonadrenergic noncholinergic|inhibitory non-adrenergic non-cholinergic|Y
semimembranosus muscle|semi-membranosus muscle|Y
pre-load recruitable stroke work|preload recruitable stroke work|Y
25-hydroxyvitamin D(3)|25-hydroxy vitamin D(3)|Y
cytoplasmic antineutrophil cytoplasmic antibody positive|cytoplasmic anti-neutrophil cytoplasmic antibody positive|Y
nucleus tegmenti pedunculo-pontinus|nucleus tegmenti pedunculopontinus|Y
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30|European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30|Y
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30|European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30|Y
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30|European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire-Core 30|Y
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30|European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30|Y
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30|European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30|Y
invariant T cell receptor V α 14|invariant T cell receptor V α14|Y
invariant T cell receptor V α 14|invariant T cell receptor Vα 14|Y
cysteine-cysteine chemokine ligand 4|cysteine-cysteine chemokine ligand 24|Y
inhibitory κB protein|inhibitory κ-B protein|Y
inhibitory κB protein|inhibitory κ B protein|Y
corticotropin releasing factor receptor|corticotropin releasing factor receptor 1|Y
corticotropin releasing factor receptor|corticotropin releasing factor 2 receptor|Y
corticotropin releasing factor receptor|corticotropin releasing factor receptor-1|Y
corticotropin releasing factor receptor|corticotropin releasing factor-1 receptor|Y
trans-trochanteric rotational osteotomy|transtrochanteric rotational osteotomy|Y
gamma-amino-butyric acid type-A|gamma-aminobutyric acid type-A|Y
filtered back projection|filtered backprojection|Y
American Society of Anaesthesiology|American Society of Anesthesiology|Y
human adenovirus serotype 9|human adenovirus serotype 49|Y
human adenovirus serotype 9|human adenovirus serotype 19|Y
human adenovirus serotype 9|human adenovirus serotype 39|Y
rat basophilic leukemia cell|rat basophilic leukemia cells|Y
inhibitory insulin-like growth factor binding protein|inhibitory insulin-like growth factor-binding protein|Y
type I interleukin 1 receptor|type II interleukin 1 receptor|Y
phosphorylated extracellular signal-regulated kinase|phosphorylated extracellular signal-regulated kinase-2|Y
phosphorylated extracellular signal-regulated kinase|phosphorylated extracellular signal-regulated kinase 1|Y
phosphorylated extracellular signal-regulated kinase|phosphorylated extracellular signal regulated kinase|Y
phosphorylated extracellular signal-regulated kinase|phosphorylated extracellular signal-regulated kinase-1|Y
insulin-like growth factor-II messenger RNA binding protein|insulin-like growth factor II messenger RNA binding protein|Y
insulin-like growth factor-II messenger RNA binding protein|insulin-like growth factor-II messenger RNA binding protein 2|Y
insulin-like growth factor-II messenger RNA binding protein|insulin-like growth factor-II messenger RNA-binding protein|Y
insulin-like growth factor-II messenger RNA binding protein|insulin-like growth factor-II messenger RNA binding protein 1|Y
insulin-like growth factor-II messenger RNA binding protein|insulin-like growth factor-II messenger RNA binding protein-1|Y
insulin-like growth factor-II messenger RNA binding protein|insulin-like growth factor-II messenger RNA binding protein-3|Y
insulin-like growth factor-II messenger RNA binding protein|insulin-like growth factor-II messenger RNA binding protein-2|Y
insulin-like growth factor-II messenger RNA binding protein|insulin-like growth factor-II messenger RNA binding protein 3|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell expressed developmentally down-regulated 5|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell expressed, developmentally downregulated 8|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell expressed developmentally down-regulated 2|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell expressed developmentally down-regulated 4|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell expressed developmentally downregulated 8|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell expressed, developmentally downregulated 1|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell expressed developmentally downregulated 9|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell expressed, developmentally downregulated 5|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell expressed developmentally down-regulated 1|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell expressed developmentally down-regulated 8|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell-expressed developmentally down-regulated 1|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell expressed, developmentally downregulated 9|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell expressed developmentally downregulated 4|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell expressed developmentally downregulated 5|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell expressed developmentally downregulated 2|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell expressed, developmentally downregulated 2|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell-expressed developmentally downregulated 1|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell expressed, developmentally down-regulated 1|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell expressed developmentally down-regulated 9|Y
neural precursor cell expressed developmentally downregulated 1|neural precursor cell-expressed, developmentally downregulated 1|Y
anti-IL-2R monoclonal antibody|anti-IL2R monoclonal antibody|Y
anti-IL-2R monoclonal antibody|antiIL-2R monoclonal antibody|Y
anti-IL-2R monoclonal antibody|anti-IL-2 monoclonal antibody|Y
cytoreductive surgery|cyto-reductive surgery|Y
4,4'-methylenebis(2-chloroaniline|4,4'-methylenebis(2-chloroaniline)|Y
sodium chloride cotransporter|sodium chloride co-transporter|Y
intra-operative intraarterial fibrinolytic therapy|intraoperative intra-arterial fibrinolytic therapy|Y
intra-operative intraarterial fibrinolytic therapy|intra-operative intra-arterial fibrinolytic therapy|Y
intra-operative intraarterial fibrinolytic therapy|intraoperative intraarterial fibrinolytic therapy|Y
parietoinsular vestibular cortex|parieto-insular vestibular cortex|Y
inter-occlusal appliance|interocclusal appliance|Y
post-mortem computed tomography|postmortem computed tomography|Y
glutamic oxalacetic transaminase|glutamic oxaloacetic transaminase|Y
peroxisome proliferator-activated receptor γ coactivator 1α protein|peroxisome proliferator-activated receptor γ coactivator-1α protein|Y
aminolevulinate dehydratase|amino-levulinate dehydratase|Y
crosspolarization/magic-angle spinning|cross-polarization/magic-angle spinning|Y
crosspolarization/magic-angle spinning|cross polarization/magic-angle spinning|Y
lymphokine-activated killer cell cytotoxicity|lymphokine-activated killer-cell cytotoxicity|Y
lymphokine-activated killer cell cytotoxicity|lymphokine activated killer cell cytotoxicity|Y
cortical thick ascending limb|cortical thick ascending limbs|Y
para-chloromercuriphenyl sulfonic acid|para-chloromercuriphenylsulfonic acid|Y
normochromatic erythrocyte|normo-chromatic erythrocyte|Y
normotriglyceridemic|normo-triglyceridemic|Y
ultrapurified polymerized bovine haemoglobin|ultra-purified polymerized bovine haemoglobin|Y
ultrapurified polymerized bovine haemoglobin|ultrapurified polymerised bovine haemoglobin|Y
ultrapurified polymerized bovine haemoglobin|ultra-purified polymerized bovine hemoglobin|Y
ultrapurified polymerized bovine haemoglobin|ultrapurified polymerized bovine hemoglobin|Y
potassium chloride cotransporter 1|potassium chloride co-transporter 1|Y
cytotoxic T-lymphocyte-associated antigen-8|cytotoxic T-lymphocyte-associated antigen-4|Y
cytotoxic T-lymphocyte-associated antigen-8|cytotoxic T-lymphocyte-associated antigen 8|Y
cytotoxic T-lymphocyte-associated antigen-8|cytotoxic T lymphocyte-associated antigen-8|Y
sacrospinous ligament|sacro-spinous ligament|Y
intracerebral hematoma|intra-cerebral hematoma|Y
pituitary tumour-transforming gene|pituitary tumor-transforming gene|Y
interleukine-2 receptor α|interleukin-2 receptor α|Y
methyl cytidine-phosphate-guanosine binding domain protein|methyl cytidine-phosphate-guanosine binding domain protein 2|Y
methyl cytidine-phosphate-guanosine binding domain protein|methyl cytidine-phosphate-guanosine binding domain protein 4|Y
methyl cytidine-phosphate-guanosine binding domain protein|methyl cytidine-phosphate-guanosine binding domain protein 1|Y
methyl cytidine-phosphate-guanosine binding domain protein|methyl cytidine-phosphate-guanosine binding domain protein 3|Y
poly(3-hydroxyalkanoates)|poly(3-hydroxyalkanoate)|Y
anti-interleukin-17 antibody|anti-interleukin-7 antibody|Y
anti-interleukin-17 antibody|anti-interleukin-1 antibody|Y
serum β-2 microglobulin value|serum β2 microglobulin value|Y
cellular Fas-associated death domain-like interleukin-1β converting enzyme-inhibitory protein|cellular Fas-associated death domain-like interleukin-1β converting enzyme inhibitory protein|Y
cellular Fas-associated death domain-like interleukin-1β converting enzyme-inhibitory protein|cellular Fas-associated death domain-like interleukin-1-β converting enzyme-inhibitory protein|Y
recombinant human macrophage colony stimulating factor|recombinant human macrophage colony-stimulating factor|Y
recombinant human macrophage colony stimulating factor|recombinant human macrophage-colony stimulating factor|Y
stress-activated protein kinase 1c|stress-activated protein kinase 1|Y
UDP-glucuronosyltransferase 1A10|UDP-glucuronosyltransferase 1A1|Y
left sacro-transverse|left sacrotransverse|Y
tumor necrosis factor-α production|tumour necrosis factor-α production|Y
nonaccidental trauma|non-accidental trauma|Y
surface-enhanced laser desorption/ionisation|surface-enhanced laser desorption/ionization|Y
surface-enhanced laser desorption/ionisation|surface-enhanced laser desorption ionisation|Y
surface-enhanced laser desorption/ionisation|surface-enhanced laser desorption-ionisation|Y
cell adhesion molecule 1|cell adhesion molecule L1|Y
ste20-related proline alanine rich kinase|ste20-related proline alanine-rich kinase|Y
ste20-related proline alanine rich kinase|Ste20-related proline alanine rich kinase|Y
ste20-related proline alanine rich kinase|ste-20-related proline alanine rich kinase|Y
frontotemporal dementia|fronto-temporal dementia|Y
Bcl2-associated X-protein|Bcl-2-associated X-protein|Y
transplant-related coronary-artery disease|transplant-related coronary artery disease|Y
calcium entry blocker|calcium entry blockers|Y
never in mitosis, gene A-related kinase 8|never in mitosis, gene A-related kinase 2|Y
never in mitosis, gene A-related kinase 8|never in mitosis, gene A-related kinase 9|Y
never in mitosis, gene A-related kinase 8|never in mitosis, gene A-related kinase 7|Y
never in mitosis, gene A-related kinase 8|never in mitosis, gene A-related kinase 3|Y
never in mitosis, gene A-related kinase 8|never in mitosis, gene A-related kinase 6|Y
never in mitosis, gene A-related kinase 8|never in mitosis, gene A-related kinase 4|Y
gas chromatography-electron-capture negative-ion mass spectrometry|gas chromatography-electron capture negative-ion mass spectrometry|Y
gas chromatography-electron-capture negative-ion mass spectrometry|gas chromatography-electron-capture negative ion mass spectrometry|Y
fluorine 18-labeled fluorodeoxyglucose|fluorine 18-labelled fluorodeoxyglucose|Y
fluorine 18-labeled fluorodeoxyglucose|fluorine 18-labeled fluoro-deoxyglucose|Y
anti-endothelial cell antibody|antiendothelial cell antibody|Y
denaturing high-pressure liquid chromatography|denaturing high pressure liquid chromatography|Y
trilineage myelodysplasia|tri-lineage myelodysplasia|Y
sperm associated antigen 11|sperm associated antigen 1|Y
cell division cycle related protein-1A|cell division cycle related protein-1|Y
cricoarytenoid joint|crico-arytenoid joint|Y
A disintegrin and metalloproteinase 33|A disintegrin and metalloproteinase 3|Y
duodenogastro-oesophageal reflux|duodeno-gastro-oesophageal reflux|Y
anti-β-2-glycoprotein-I antibody|anti-β2-glycoprotein-I antibody|Y
ruptured abdominal aortic aneurysms|ruptured abdominal aortic aneurysm|Y
enterochromaffin-like cells|enterochromaffin-like cell|Y
serum insulin-like growth factor I level|serum insulin-like growth factor 1 level|Y
serum insulin-like growth factor I level|serum insulin-like growth factor II level|Y
serum insulin-like growth factor I level|serum insulin-like growth factor-I level|Y
potassium chloride cotransporter 2|potassium chloride co-transporter 2|Y
interleukin-13 receptor α 1|interleukine-13 receptor α 1|Y
interleukin-13 receptor α 1|interleukin-13 receptor α1|Y
corticotrophin-releasing hormone receptor type 2|corticotrophin-releasing hormone receptor type-2|Y
corticotrophin-releasing hormone receptor type 2|corticotrophin-releasing-hormone receptor type 2|Y
corticotrophin-releasing hormone receptor type 2|corticotropin-releasing hormone receptor type 2|Y
corticotrophin-releasing hormone receptor type 2|corticotrophin releasing hormone receptor type 2|Y
trans-pupillary thermo therapy|trans-pupillary thermotherapy|Y
myeloid DAP 12-associating lectin 1|myeloid DAP12-associating lectin 1|Y
glossopharyngeal breathing|glosso-pharyngeal breathing|Y
mitogen-activated protein kinase/extracellular signal regulated kinase kinase|mitogen-activated protein kinase-extracellular signal regulated kinase kinase|Y
eleven-nineteen lysine-rich leukemia|eleven-nineteen lysine-rich leukaemia|Y
oculopharyngeal dystrophy|oculo-pharyngeal dystrophy|Y
hemoglobin Showa-Yakushiji|haemoglobin Showa-Yakushiji|Y
multi-drug resistant organism|multidrug resistant organism|Y
cytokine induced neutrophil chemoattractant-3|cytokine-induced neutrophil chemoattractant-3|Y
cytokine induced neutrophil chemoattractant-3|cytokine induced neutrophil chemoattractant-1|Y
cytokine induced neutrophil chemoattractant-3|cytokine induced neutrophil chemoattractant-2|Y
cytokine induced neutrophil chemoattractant-3|cytokine induced neutrophil chemoattractant 3|Y
cytokine induced neutrophil chemoattractant-3|cytokine induced neutrophil chemoattractant|Y
magic-angle spinning solid-state nuclear magnetic resonance|magic angle spinning solid-state nuclear magnetic resonance|Y
magic-angle spinning solid-state nuclear magnetic resonance|magic-angle-spinning solid-state nuclear magnetic resonance|Y
platelet-derived growth factor-A|platelet-derived growth factor-AA|Y
platelet-derived growth factor-A|platelet-derived growth factor-AB|Y
tissue transglutaminase|tissue trans-glutaminase|Y
colony-forming unit granulocyte/macrophage|colony-forming unit-granulocyte/macrophage|Y
colony-forming unit granulocyte/macrophage|colony-forming unit granulocyte macrophage|Y
colony-forming unit granulocyte/macrophage|colony-forming unit granulocyte-macrophage|Y
O-acetyl-serine sulfhydrylase|O-acetylserine sulfhydrylase|Y
American Society of Anesthesiologists Status IV|American Society of Anesthesiologists status IV|Y
American Society of Anesthesiologists Status IV|American Society of Anesthesiologists Status II|Y
American Society of Anesthesiologists Status IV|American Society of Anaesthesiologists Status I|Y
American Society of Anesthesiologists Status IV|American Society of Anesthesiologists Status I|Y
American Society of Anesthesiologists Status IV|American Society of Anaesthesiologists Status IV|Y
inter-pedicular distance|interpedicular distance|Y
antineutrophil cytoplasmic antibody negative|anti-neutrophil cytoplasmic antibody negative|Y
glycophosphatidylinositol linked|glycophosphatidyl inositol linked|Y
glycophosphatidylinositol linked|glycophosphatidyl-inositol linked|Y
MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1|MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2|Y
MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1|MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3|Y
MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1|MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4|Y
electromagnetic immunity|electro-magnetic immunity|Y
adreno-cortical carcinoma|adrenocortical carcinoma|Y
alpha-methylnorepinephrine|alpha-methyl norepinephrine|Y
Na-K-2Cl cotransporter 2|Na-K-Cl cotransporter 2|Y
Na-K-2Cl cotransporter 2|Na-K-2Cl co-transporter 2|Y
cytotoxic T lymphocyte antigen-2α|cytotoxic T lymphocyte antigen-2 α|Y
osteoprotegerin/osteoclastogenesis inhibitory factor|osteoprotegerin/osteoclastogenesis-inhibitory factor|Y
3-deoxy-D-arabino-heptulosonate 7-phosphate|3-deoxy-D-arabino-heptulosonate-7-phosphate|Y
1-(5-isoquinolinylsulfonyl)-2-methyl-piperazine|1-(5-isoquinolinyl-sulfonyl)-2-methylpiperazine|Y
geomagnetic activity|geo-magnetic activity|Y
parathyroid hormone/parathyroid hormone related protein receptor|parathyroid hormone-parathyroid hormone related protein receptor|Y
parathyroid hormone/parathyroid hormone related protein receptor|parathyroid hormone/parathyroid hormone-related protein receptor|Y
sexually transmitted diseases|sexually transmitted disease|Y
recombinant human interleukin 2|recombinant human interleukin 12|Y
Bos taurus autosome 18|Bos taurus autosome 8|Y
Bos taurus autosome 18|Bos taurus autosome 1|Y
trypanosome lymphocyte-triggering factor|trypanosome lymphocyte triggering factor|Y
hydroalcoholic extract|hydro-alcoholic extract|Y
inhibitory post-synaptic potentials|inhibitory post-synaptic potential|Y
IL3 receptor alpha chain|IL-3 receptor alpha chain|Y
immunoreactive material|immuno-reactive material|Y
periventricular-intraventricular hemorrhage|periventricular-intraventricular haemorrhage|Y
γglutamyltranspeptidase|glutamyltranspeptidase|Y
γglutamyltranspeptidase|γglutamyl transpeptidase|Y
γglutamyltranspeptidase|γ-glutamyltranspeptidase|Y
granulocyte-macrophage-colony-stimulating factor receptor alpha-chain|granulocyte-macrophage colony-stimulating factor receptor alpha-chain|Y
granulocyte-macrophage-colony-stimulating factor receptor alpha-chain|granulocyte macrophage-colony-stimulating factor receptor alpha-chain|Y
trivalent oral polio vaccine|trivalent oral poliovaccine|Y
areas under the curve|areas under the curves|Y
areas under the curve|area under the curve|Y
enzyme-linked immunoassay|enzyme-linked immunoassays|Y
sperm-associated antigen 16|sperm-associated antigen 1|Y
adaptive optics scanning laser ophthalmoscopy|adaptive optics scanning laser ophthalmoscope|Y
tumor necrosis factor receptor superfamily member 21|tumor necrosis factor receptor superfamily member 18|Y
tumor necrosis factor receptor superfamily member 21|tumor necrosis factor receptor superfamily member 23|Y
tumor necrosis factor receptor superfamily member 21|tumor necrosis factor receptor superfamily member 17|Y
tumor necrosis factor receptor superfamily member 21|tumor necrosis factor receptor superfamily member 1A|Y
tumor necrosis factor receptor superfamily member 21|tumor necrosis factor receptor superfamily member 25|Y
tumor necrosis factor receptor superfamily member 21|tumor necrosis factor receptor superfamily member 1B|Y
tumor necrosis factor receptor superfamily member 21|tumor necrosis factor receptor superfamily member 12|Y
tumor necrosis factor receptor superfamily member 21|tumor necrosis factor receptor superfamily member 19|Y
Nurses Observation Scale for In-patient Evaluation|Nurses Observation Scale for Inpatient Evaluation|Y
Nurses Observation Scale for In-patient Evaluation|Nurses' Observation Scale for Inpatient Evaluation|Y
mitogen-activated protein kinase organizer 1|mitogen-activated protein kinase organiser 1|Y
formylmethionyl-leucyl-phenylalanine receptor|formylmethionylleucylphenylalanine receptor|Y
degrees of hydrolysis|degree of hydrolysis|Y
pre-hematopoietic stem cell transplantation|prehematopoietic stem cell transplantation|Y
soft independent modelling of class analogy|soft independent modeling of class analogy|Y
human lysosome-associated membrane protein 1|human lysosome-associated membrane protein 2|Y
human lysosome-associated membrane protein 1|human lysosome-associated membrane protein|Y
human lysosome-associated membrane protein 1|human lysosome-associated membrane protein-1|Y
HIV-hepatitis B virus co-infection|HIV-hepatitis B virus coinfection|Y
bronchus associated lymphoid tissue lymphoma|bronchus-associated lymphoid tissue lymphoma|Y
St. Jude Medical-Séguin annuloplasty ring|St. Jude Medical-Seguin annuloplasty ring|Y
St. Jude Medical-Séguin annuloplasty ring|St Jude Medical-Séguin annuloplasty ring|Y
v-ets erythroblastosis virus E26 oncogene homologue 1|v-ets erythroblastosis virus E26 oncogene homolog 1|Y
multiwalled carbon nanotube|multi-walled carbon nanotube|Y
stereotactic electroencephalography|stereotactic electro-encephalography|Y
steroid receptor co-activator 1|steroid receptor coactivator 1|Y
antivascular endothelial growth factor receptor antibody|anti-vascular endothelial growth factor receptor antibody|Y
Charcot-Marie-Tooth disease type 1A|Charcot-Marie-Tooth disease type 1|Y
non-structural protein 5B|non-structural protein 5|Y
non-structural protein 5B|nonstructural protein 5B|Y
lipopolysaccharide factor|lipo-polysaccharide factor|Y
dopant-assisted atmospheric-pressure photoionisation|dopant-assisted atmospheric pressure photoionisation|Y
dopant-assisted atmospheric-pressure photoionisation|dopant-assisted atmospheric-pressure photoionization|Y
17-hydroxycorticosteroids|17-hydroxycorticosteroid|Y
receptor-like protein tyrosine phosphatase delta|receptor-like protein tyrosine phosphatase-delta|Y
Ehlers Danlos syndrome type VI|Ehlers Danlos syndrome type I|Y
pulseless electrical activity|pulse-less electrical activity|Y
randomised clinical trial|randomised clinical trials|Y
pre-infarction angina|preinfarction angina|Y
colony-forming unit-granulocyte/macrophage|colony-forming unit-granulocyte-macrophage|Y
colony-forming unit-granulocyte/macrophage|colony forming unit-granulocyte/macrophage|Y
colony-forming unit-granulocyte/macrophage|colony-forming units-granulocyte/macrophage|Y
direct occipito-posterior position|direct occipitoposterior position|Y
des-gamma-carboxyprothrombin|des-gamma-carboxy-prothrombin|Y
des-gamma-carboxyprothrombin|des-gamma-carboxy prothrombin|Y
intraoperative monitoring|intra-operative monitoring|Y
autoimmune polyendocrinopathy syndrome type 2|autoimmune polyendocrinopathy syndrome type 1|Y
phototherapeutic keratectomy|photo-therapeutic keratectomy|Y
thick ascending limb|thick ascending limbs|Y
Leptospira interrogans, serogroup Icterohaemorrhagiae|Leptospira interrogans serogroup Icterohemorrhagiae|Y
cancer-up regulated gene 2|cancer-upregulated gene 2|Y
luteinising hormone follicle stimulating hormone releasing hormone|luteinizing hormone follicle stimulating hormone releasing hormone|Y
luteinising hormone follicle stimulating hormone releasing hormone|luteinising hormone-follicle stimulating hormone releasing hormone|Y
ubiquitin carboxy-terminal hydrolase-L3|ubiquitin carboxyl-terminal hydrolase-L3|Y
tetra-ethyl-thiuramdisulphide|tetra-ethyl-thiuram disulphide|Y
pulmonary thromboembolic disease|pulmonary thrombo-embolic disease|Y
A β-precursor protein|Aβ-precursor protein|Y
angiotensin converting enzyme inhibitor-treated|angiotensin converting enzyme inhibitor treated|Y
angiotensin converting enzyme inhibitor-treated|angiotensin-converting enzyme inhibitor-treated|Y
human adenovirus serotype 10|human adenovirus serotype 1|Y
multi-anode photomultiplier tube|multianode photomultiplier tube|Y
postoperative urinary retention|post-operative urinary retention|Y
tickborne encephalitis virus|tick borne encephalitis virus|Y
tickborne encephalitis virus|tick-borne encephalitis virus|Y
pigeon breeders lung|pigeon breeders' lung|Y
pigeon breeders lung|pigeon breeder's lung|Y
α-2c adrenergic receptor|α2c adrenergic receptor|Y
NADPH P-450 reductase|NADPH P450 reductase|Y
United States Veterans' Hospital|United States Veterans Hospital|Y
reticulo-endothelial system|reticuloendothelial system|Y
anti-horse immunoglobulin G|antihorse immunoglobulin G|Y
extra-medullary disease|extramedullary disease|Y
cross polarisation magic-angle-spinning nuclear magnetic resonance|cross polarization magic-angle-spinning nuclear magnetic resonance|Y
cross polarisation magic-angle-spinning nuclear magnetic resonance|cross-polarisation magic-angle-spinning nuclear magnetic resonance|Y
cross polarisation magic-angle-spinning nuclear magnetic resonance|cross polarisation/magic-angle-spinning nuclear magnetic resonance|Y
cross polarisation magic-angle-spinning nuclear magnetic resonance|cross polarisation magic-angle spinning nuclear magnetic resonance|Y
diethylaminobenzaldehyde|dimethylaminobenzaldehyde|Y
antihuman lymphocyte globulin|anti-human lymphocyte globulin|Y
human immunodeficiency virus/hepatitis C virus co-infection|human immunodeficiency virus/hepatitis C virus coinfection|Y
human immunodeficiency virus/hepatitis C virus co-infection|human immunodeficiency virus-hepatitis C virus co-infection|Y
Src homology 2-containing protein-tyrosine phosphatase|Src homology 2-containing protein-tyrosine phosphatase-1|Y
Src homology 2-containing protein-tyrosine phosphatase|Src homology 2-containing protein-tyrosine phosphatase 2|Y
Src homology 2-containing protein-tyrosine phosphatase|Src homology 2-containing protein-tyrosine phosphatase 1|Y
Src homology 2-containing protein-tyrosine phosphatase|Src homology 2-containing protein-tyrosine phosphatase-2|Y
Src homology 2-containing protein-tyrosine phosphatase|Src homology 2-containing protein tyrosine phosphatase|Y
nonaqueous reversed-phase liquid chromatography|non-aqueous reversed-phase liquid chromatography|Y
fronto-orbital osteotomy|frontoorbital osteotomy|Y
pseudo-hypoaldosteronism|pseudohypoaldosteronism|Y
macrophage inflammatory protein-related protein-1|macrophage inflammatory protein-related protein-2|Y
antimacrophage serum|anti-macrophage serum|Y
non-typhoidal Salmonella|nontyphoidal Salmonella|Y
granulocyte colony-stimulating factors|granulocyte colony-stimulating factor|Y
recombinant human platelet derived growth factor|recombinant human platelet-derived growth factor|Y
β site amyloid precursor protein-cleaving enzyme|β site amyloid precursor protein cleaving enzyme|Y
β site amyloid precursor protein-cleaving enzyme|β site amyloid precursor protein-cleaving enzyme 1|Y
β site amyloid precursor protein-cleaving enzyme|β site amyloid precursor protein-cleaving enzyme 2|Y
β site amyloid precursor protein-cleaving enzyme|β site amyloid precursor protein-cleaving enzyme-2|Y
β site amyloid precursor protein-cleaving enzyme|β site amyloid precursor protein-cleaving enzyme-1|Y
β site amyloid precursor protein-cleaving enzyme|β-site amyloid precursor protein-cleaving enzyme|Y
proinsulin-like growth factor II|proinsulin-like growth factor I|Y
activity-regulated cytoskeletal-associated protein|activity-regulated cytoskeletal associated protein|Y
activity-regulated cytoskeletal-associated protein|activity regulated cytoskeletal-associated protein|Y
allergic rhinoconjunctivitis|allergic rhino-conjunctivitis|Y
mega voltage computed tomography|megavoltage computed tomography|Y
nicotinamide adenine dinucleotide phosphatase|β-nicotinamide adenine dinucleotide phosphatase|Y
nicotinamide adenine dinucleotide phosphatase|nicotinamide adenine dinucleotide phosphatase I|Y
anti mitochondrial antibody|antimitochondrial antibody|Y
cobblestone area-forming cells|cobblestone area-forming cell|Y
adisintegrin and metalloprotease|disintegrin and metalloprotease|Y
febrile nonhemolytic transfusion reactions|Febrile nonhemolytic transfusion reactions|Y
colony-forming unit-granulocyte-macrophage|colony-forming unit granulocyte-macrophage|Y
colony-forming unit-granulocyte-macrophage|colony-forming units-granulocyte-macrophage|Y
colony-forming unit-granulocyte-macrophage|colony-forming unit/granulocyte-macrophage|Y
galactorrhœa-amenorrhea hyperprolactinæmia syndrome|galactorrhœa-amenorrhoea hyperprolactinæmia syndrome|Y
galactorrhœa-amenorrhea hyperprolactinæmia syndrome|galactorrhœa-amenorrhœa hyperprolactinæmia syndrome|Y
galactorrhœa-amenorrhea hyperprolactinæmia syndrome|galactorrhea-amenorrhea hyperprolactinæmia syndrome|Y
galactorrhœa-amenorrhea hyperprolactinæmia syndrome|galactorrhœa amenorrhea hyperprolactinæmia syndrome|Y
galactorrhœa-amenorrhea hyperprolactinæmia syndrome|galactorrhœa-amenorrhea hyperprolactinemia syndrome|Y
nuclear estrogen receptors|nuclear estrogen receptor|Y
immunoreactive growth hormone|immuno-reactive growth hormone|Y
outer medullary collecting ducts|outer medullary collecting duct|Y
St Jude Medical-Seguin annuloplasty ring|St. Jude Medical-Seguin annuloplasty ring|Y
St Jude Medical-Seguin annuloplasty ring|St Jude Medical-Séguin annuloplasty ring|Y
isotope dilution gas chromatography/mass spectrometry|isotope dilution gas chromatography-mass spectrometry|Y
isotope dilution gas chromatography/mass spectrometry|isotope dilution gas chromatography/mass-spectrometry|Y
isotope dilution gas chromatography/mass spectrometry|isotope dilution-gas chromatography/mass spectrometry|Y
post-translational modifications|post-translational modification|Y
ribosomal protein S12|ribosomal protein S2|Y
intra-luminal somatostatin|intraluminal somatostatin|Y
B-cell leukemia-lymphoma-2|B-cell leukaemia-lymphoma-2|Y
anti-heat shock protein 65 antibody|antiheat shock protein 65 antibody|Y
American Society of Anaesthesiologists Class IV|American Society of Anesthesiologists Class V|Y
American Society of Anaesthesiologists Class IV|American Society of Anaesthesiologists Class II|Y
American Society of Anaesthesiologists Class IV|American Society of Anaesthesiologists Class V|Y
American Society of Anaesthesiologists Class IV|American Society of Anaesthesiologists Class I|Y
American Society of Anaesthesiologists Class IV|American Society of Anesthesiologists Class I|Y
American Society of Anaesthesiologists Class IV|American Society of Anesthesiologists Class IV|Y
autoimmune polyendocrinopathy candidiasis ectodermal dystrophy|auto-immune polyendocrinopathy candidiasis ectodermal dystrophy|Y
ω-3 polyunsaturated fatty acid|ω3 polyunsaturated fatty acid|Y
receptor-like protein-tyrosine phosphatase-delta|receptor-like protein tyrosine phosphatase-delta|Y
receptor-like protein-tyrosine phosphatase-delta|receptor-like protein-tyrosine phosphatase-eta|Y
stretch-activated channel|stretch-activated channels|Y
methyl cytidine-phosphate-guanosine binding domain protein 2|methyl cytidine-phosphate-guanosine binding domain protein 4|Y
methyl cytidine-phosphate-guanosine binding domain protein 2|methyl cytidine-phosphate-guanosine binding domain protein 1|Y
methyl cytidine-phosphate-guanosine binding domain protein 2|methyl cytidine-phosphate-guanosine binding domain protein 3|Y
lymphangioscintigraphy|lymphangio-scintigraphy|Y
50% dextrose in water|5% dextrose in water|Y
haemoglobin Gainesville-GA|hemoglobin Gainesville-GA|Y
endothelial monocyte activating polypeptide III|endothelial monocyte-activating polypeptide III|Y
endothelial monocyte activating polypeptide III|endothelial monocyte activating polypeptide I|Y
endothelial monocyte activating polypeptide III|endothelial monocyte activating polypeptide-III|Y
endothelial monocyte activating polypeptide III|endothelial monocyte activating polypeptide II|Y
multi-voxel proton MR spectroscopy|multivoxel proton MR spectroscopy|Y
human insulinlike growth factor 1|human insulin-like growth factor 1|Y
choledocho-jejunostomy|choledoco-jejunostomy|Y
human transforming growth factor-beta 3|human transforming growth factor-beta3|Y
antithrombomodulin immunoglobulin G|anti-thrombomodulin immunoglobulin G|Y
supraventricular tachy-arrhythmia|supraventricular tachyarrhythmia|Y
sodium-lithium countertransport|sodium-lithium counter-transport|Y
antiIL-10 monoclonal antibody|anti-IL-10 monoclonal antibody|Y
lectin-like oxidized low density lipoprotein receptor-1|lectin-like oxidised low density lipoprotein receptor-1|Y
lectin-like oxidized low density lipoprotein receptor-1|lectin-like oxidized low-density lipoprotein receptor-1|Y
lectin-like oxidized low density lipoprotein receptor-1|lectin-like oxidized low density lipoprotein receptor 1|Y
UDP-glucuronosyl transferase 1A1|UDP-glucuronosyltransferase 1A1|Y
hereditary non-spherocytic hemolytic anaemia|hereditary non-spherocytic hemolytic anemia|Y
hereditary non-spherocytic hemolytic anaemia|hereditary non-spherocytic haemolytic anaemia|Y
hereditary non-spherocytic hemolytic anaemia|hereditary nonspherocytic hemolytic anemia|Y
break-through cancer pain|breakthrough cancer pain|Y
flavin containing monooxygenase 2|flavin containing mono-oxygenase 2|Y
evolutionary multiobjective optimisation|evolutionary multi-objective optimisation|Y
bone marrow-derived macrophage|bone marrow-derived macrophages|Y
cellular inhibitor-of-apoptosis protein 1|cellular inhibitor-of-apoptosis protein 2|Y
cellular inhibitor-of-apoptosis protein 1|cellular inhibitor-of-apoptosis protein-1|Y
American Society of Anesthesiology physical status 1|American Society of Anesthesiology physical status 4|Y
American Society of Anesthesiology physical status 1|American Society of Anesthesiology physical status I|Y
American Society of Anesthesiology physical status 1|American Society of Anaesthesiology physical status 1|Y
American Society of Anesthesiology physical status 1|American Society of Anesthesiology physical status 2|Y
American Society of Anesthesiology physical status 1|American Society of Anesthesiology physical status|Y
American Society of Anesthesiology physical status 1|American Society of Anesthesiology physical status 3|Y
technetium-99m diethylene-triaminepentaacetic acid-galactosyl-human serum albumin|technetium-99m-diethylene-triaminepentaacetic acid-galactosyl human serum albumin|Y
technetium-99m diethylene-triaminepentaacetic acid-galactosyl-human serum albumin|technetium 99m diethylene-triaminepentaacetic acid-galactosyl-human serum albumin|Y
technetium-99m diethylene-triaminepentaacetic acid-galactosyl-human serum albumin|technetium-99m diethylene-triaminepentaacetic acid-galactosyl human serum albumin|Y
technetium-99m diethylene-triaminepentaacetic acid-galactosyl-human serum albumin|technetium-99m diethylene-triaminepentaacetic acid galactosyl human serum albumin|Y
technetium-99m diethylene-triaminepentaacetic acid-galactosyl-human serum albumin|technetium-99m diethylenetriaminepentaacetic acid-galactosyl human serum albumin|Y
peptidyl glycine alpha-amidating mono-oxygenase|peptidylglycine alpha-amidating monooxygenase|Y
peptidyl glycine alpha-amidating mono-oxygenase|peptidylglycine alpha-amidating mono-oxygenase|Y
peptidyl glycine alpha-amidating mono-oxygenase|peptidyl glycine alpha-amidating monooxygenase|Y
ras-related GTP-binding protein 11a|ras-related GTP-binding protein 1a|Y
ras-related GTP-binding protein 11a|ras-related GTP-binding protein 11|Y
hepatocellular cancer|hepato-cellular cancer|Y
antibody directed enzyme prodrug therapy|antibody directed enzyme pro-drug therapy|Y
antimitochondrial antibody positive|anti-mitochondrial antibody positive|Y
sterol regulatory element binding protein-1-a|sterol regulatory element binding protein 1-a|Y
sterol regulatory element binding protein-1-a|sterol regulatory element binding protein-1-c|Y
sterol regulatory element binding protein-1-a|sterol regulatory element-binding protein-1-a|Y
intra-thecal injection|intrathecal injection|Y
non-steroidal anti-inflammatory drug-induced|nonsteroidal antiinflammatory drug-induced|Y
non-steroidal anti-inflammatory drug-induced|nonsteroidal anti-inflammatory drug-induced|Y
non-steroidal anti-inflammatory drug-induced|non-steroidal antiinflammatory drug-induced|Y
non-bacterial thrombotic endocarditis|nonbacterial thrombotic endocarditis|Y
extra-hepatic obstruction|extrahepatic obstruction|Y
non-convulsive generalized status epilepticus|non-convulsive generalised status epilepticus|Y
non-convulsive generalized status epilepticus|nonconvulsive generalized status epilepticus|Y
proline, serine, threonine phosphatase interacting protein|proline serine threonine phosphatase interacting protein|Y
DNA crosslink repair protein 1C|DNA cross-link repair protein 1C|Y
field emission scanning electron microscope|field emission scanning electron microscopy|Y
gastroesophageal junction|gastro-esophageal junction|Y
TATA-binding protein-associated factor 10|TATA-binding protein-associated factor 15|Y
TATA-binding protein-associated factor 10|TATA-binding protein-associated factor 12|Y
TATA-binding protein-associated factor 10|TATA-binding protein associated factor 10|Y
TATA-binding protein-associated factor 10|TATA-binding protein-associated factor 17|Y
TATA-binding protein-associated factor 10|TATA-binding protein-associated factor 11|Y
TATA-binding protein-associated factor 10|TATA-binding protein-associated factor 1|Y
TATA-binding protein-associated factor 10|TATA-binding protein-associated factor-10|Y
anti-human immunodeficiency virus agent|antihuman immunodeficiency virus agent|Y
anti-human immunodeficiency virus agent|anti-human immunodeficiency virus-1 agent|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed, developmentally down-regulated 1|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed developmentally downregulated 2|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed, developmentally downregulated 5|Y
neural precursor cell-expressed, developmentally downregulated 2|neural-precursor cell-expressed, developmentally down-regulated 2|Y
neural precursor cell-expressed, developmentally downregulated 2|neural-precursor cell-expressed, developmentally downregulated 2|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed, developmentally down-regulated 8|Y
neural precursor cell-expressed, developmentally downregulated 2|neural-precursor cell-expressed developmentally downregulated 2|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed, developmentally down-regulated 5|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed, developmentally downregulated 4|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell expressed, developmentally down-regulated 2|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed developmentally downregulated 8|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed developmentally downregulated 5|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed developmentally downregulated 4|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell expressed developmentally downregulated 2|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed, developmentally downregulated 9|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell expressed, developmentally downregulated 2|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed developmentally downregulated 1|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed developmentally down-regulated 2|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed developmentally downregulated 9|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed, developmentally downregulated 8|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed, developmentally downregulated 1|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed, developmentally down-regulated 2|Y
transbronchial lung biopsy|trans-bronchial lung biopsy|Y
experimental autoimmune uveoretinitis|experimental auto-immune uveoretinitis|Y
Eigemannia virescens|Eigenmannia virescens|Y
programmable temperature vaporizing|programmable temperature vapourizing|Y
type IIa sodium-phosphate co-transporter|type IIa sodium phosphate co-transporter|Y
type IIa sodium-phosphate co-transporter|type IIa sodium/phosphate co-transporter|Y
type IIa sodium-phosphate co-transporter|type II sodium-phosphate co-transporter|Y
CC chemokine ligand 8|CXC chemokine ligand 8|Y
CC chemokine ligand 8|C-C chemokine ligand 8|Y
CC chemokine ligand 8|CC chemokine ligand 18|Y
leukaemia-associated inhibitor|leukemia-associated inhibitor|Y
Clostridium difficile associated disease|Clostridium difficile-associated disease|Y
16-slice multi-detector computed tomography|16-slice multidetector computed tomography|Y
Salt Lake City Veteran's Administration Medical Center|Salt Lake City Veterans' Administration Medical Center|Y
Salt Lake City Veteran's Administration Medical Center|Salt Lake City Veterans Administration Medical Center|Y
Wechsler Intelligence Scale for Children - 3rd Edition|Wechsler Intelligence Scale for Children 3rd Edition|Y
Wechsler Intelligence Scale for Children - 3rd Edition|Wechsler Intelligence Scale for Children-3rd Edition|Y
crosspolarization magic angle spinning nuclear magnetic resonance spectroscopy|cross polarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization magic angle spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization magic angle spinning nuclear magnetic resonance spectroscopy|cross polarization magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization magic angle spinning nuclear magnetic resonance spectroscopy|cross polarization/magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization magic angle spinning nuclear magnetic resonance spectroscopy|cross-polarization/magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization magic angle spinning nuclear magnetic resonance spectroscopy|cross-polarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization magic angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization magic angle spinning nuclear magnetic resonance spectroscopy|cross-polarization magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization magic angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization magic angle spinning nuclear magnetic resonance spectroscopy|cross polarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization magic angle spinning nuclear magnetic resonance spectroscopy|crosspolarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
pseudohypoaldosteronism|pseudohypo-aldosteronism|Y
penta-erythritol triacrylate|pentaerythritol triacrylate|Y
digitally reconstructed radiograph|digitally reconstructed radiographs|Y
digitally reconstructed radiograph|digitally reconstructed radiography|Y
Bcl-2 associated X protein|Bcl2 associated X protein|Y
transforming growth factor beta type II receptor|transforming growth factor-beta type II receptor|Y
transforming growth factor beta type II receptor|transforming growth factor beta type I receptor|Y
polytetrafluroethylene|polytetrafluoroethylene|Y
polytetrafluroethylene|polytetraflouroethylene|Y
corticotropin-releasing factor type 1 receptor|corticotropin-releasing factor type-1 receptor|Y
corticotropin-releasing factor type 1 receptor|corticotropin-releasing factor type 2 receptor|Y
calcineurin-inhibitor-induced pain syndrome|calcineurin-inhibitor induced pain syndrome|Y
calcineurin-inhibitor-induced pain syndrome|calcineurin inhibitor-induced pain syndrome|Y
cyclophosphamide doxorubicin|cyclophosphamide, doxorubicin|Y
higher-order aberration|higher-order aberrations|Y
methoxysuccinyl-alanyl-alanyl-prolyl-alanine chloromethyl ketone|methoxysuccinyl-alanyl-alanyl-prolyl-valine chloromethyl ketone|Y
diamidino-phenyl-indole|diamidino-phenylindole|Y
recombinant human transforming growth factor-β3|recombinant human transforming growth factor-β2|Y
recombinant human transforming growth factor-β3|recombinant human transforming growth factor-β1|Y
recombinant human transforming growth factor-β3|recombinant human transforming growth factor β3|Y
recombinant human transforming growth factor-β3|recombinant human transforming growth factor-β|Y
recombinant human transforming growth factor-β3|recombinant human transforming growth factor-β 3|Y
American Society of Anaesthesiology class III|American Society of Anesthesiology class III|Y
American Society of Anaesthesiology class III|American Society of Anesthesiology class II|Y
American Society of Anaesthesiology class III|American Society of Anaesthesiology class II|Y
multicolour fluorescence in-situ hybridisation|multicolour fluorescence in situ hybridisation|Y
multicolour fluorescence in-situ hybridisation|multi-colour fluorescence in-situ hybridisation|Y
antisurface immunoglobulin|anti-surface immunoglobulin|Y
multiple of the median|multiples of the median|Y
β-ketoacyl acyl carrier protein reductase|β-ketoacyl acyl-carrier protein reductase|Y
G-protein α2 inhibitory subunit|G-protein α inhibitory subunit|Y
Penicillin-resistant Streptococcus pneumoniae|penicillin-resistant Streptococcus pneumoniae|Y
electron probe x-ray microanalyzer|electron probe x-ray micro-analyzer|Y
anti-insulin-like growth factor-1 antibody|anti-insulin-like growth factor-I antibody|Y
anti-insulin-like growth factor-1 antibody|anti-insulin-like growth factor 1 antibody|Y
hairy/enhancer of split 1|hairy/enhancer of split1|Y
anti-beta2 glycoprotein-I antibody|anti-beta-2 glycoprotein-I antibody|Y
anti-beta2 glycoprotein-I antibody|anti-beta 2 glycoprotein-I antibody|Y
field emission in-lens-scanning electron microscope|field emission in-lens-scanning electron microscopy|Y
field emission in-lens-scanning electron microscope|field emission in-lens scanning electron microscope|Y
anti-thyroglobulin autoantibody|antithyroglobulin autoantibody|Y
anti-thyroglobulin autoantibody|anti-thyroglobulin auto-antibody|Y
solid phase extraction-high performance liquid chromatography-tandem mass spectrometry|solid phase extraction-high performance liquid chromatography/tandem mass spectrometry|Y
solid phase extraction-high performance liquid chromatography-tandem mass spectrometry|solid-phase extraction-high performance liquid chromatography-tandem mass spectrometry|Y
solid phase extraction-high performance liquid chromatography-tandem mass spectrometry|solid-phase extraction-high-performance liquid chromatography-tandem mass spectrometry|Y
solid phase extraction-high performance liquid chromatography-tandem mass spectrometry|solid-phase extraction-high performance liquid chromatography/tandem mass spectrometry|Y
solid phase extraction-high performance liquid chromatography-tandem mass spectrometry|solid phase extraction-high-performance liquid chromatography-tandem mass spectrometry|Y
psychophysical tuning curves|psychophysical tuning curve|Y
(123)I-meta-iodobenzyl-guanidine scintigraphy|(123)I-metaiodobenzylguanidine scintigraphy|Y
(123)I-meta-iodobenzyl-guanidine scintigraphy|(123)I-metaiodobenzyl-guanidine scintigraphy|Y
(123)I-meta-iodobenzyl-guanidine scintigraphy|123I-meta-iodobenzyl-guanidine scintigraphy|Y
isoelectric focussing|iso-electric focussing|Y
isoelectric focussing|isoelectric focusing|Y
heat-shock protein 90 β|heat-shock protein 90β|Y
luteinizing hormone-follicle-stimulating hormone releasing hormone|luteinising hormone-follicle-stimulating hormone releasing hormone|Y
luteinizing hormone-follicle-stimulating hormone releasing hormone|luteinizing hormone-follicle stimulating hormone releasing hormone|Y
non-muscle myosin heavy chain IIB|nonmuscle myosin heavy chain IIB|Y
non-muscle myosin heavy chain IIB|non-muscle myosin heavy chain II|Y
coactivator-associated arginine methyltransferase 1|coactivator-associated arginine methyltransferase-1|Y
human immunodeficiency virus 2 infection|human immunodeficiency virus 1 infection|Y
Raf kinase inhibitor protein|Raf kinase inhibitory protein|Y
intramolecular stem loop|intra-molecular stem loop|Y
frontal midline theta rhythm|frontal mid-line theta rhythm|Y
non-dermatophyte mold|nondermatophyte mold|Y
non-dermatophyte mold|non-dermatophyte mould|Y
micro-dilution system|microdilution system|Y
calcium concentration|calcium concentrations|Y
pontogeniculooccipital|pontogeniculo-occipital|Y
Information and communication technology|information and communication technology|Y
trans-oesophageal atrial stimulation|trans-esophageal atrial stimulation|Y
radio-iodine treatment|radioiodine treatment|Y
light-harvesting chlorophyll a/b binding protein-I|light-harvesting chlorophyll a/b binding protein|Y
light-harvesting chlorophyll a/b binding protein-I|light-harvesting chlorophyll a/b-binding protein-I|Y
light-harvesting chlorophyll a/b binding protein-I|light harvesting chlorophyll a/b binding protein-I|Y
light-harvesting chlorophyll a/b binding protein-I|light-harvesting chlorophyll a/b binding protein I|Y
light-harvesting chlorophyll a/b binding protein-I|light-harvesting chlorophyll a/b binding protein-II|Y
inter-capillary distance|intercapillary distance|Y
non-twenty-four-hour sleep/wake syndrome|non-twenty-four-hour sleep-wake syndrome|Y
non-twenty-four-hour sleep/wake syndrome|non-twenty-four-hour sleep wake syndrome|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motifs-19|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-8|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-7|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-15|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motifs-18|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-14|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motifs-13|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-3|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-20|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motifs-16|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-2|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motifs-17|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motifs-20|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motif-10|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
focal adhesion kinase-related nonkinase|focal adhesion kinase-related non-kinase|Y
tumor-1b, node-0, metastasis-0|tumor-1, node-0, metastasis-0|Y
ureterosigmoidostomy|uretero-sigmoidostomy|Y
extracytoplasmic function|extra-cytoplasmic function|Y
postmenopausal hormone therapy|post-menopausal hormone therapy|Y
cytochrome P450 isoform 3A4|cytochrome P-450 isoform 3A4|Y
lymphokine-activated killer cell|lymphokine-activated killer cells|Y
matrix assisted laser desorption ionisation time-of-flight mass spectrometry|matrix assisted laser desorption ionisation time-of-flight mass spectrometric|Y
matrix assisted laser desorption ionisation time-of-flight mass spectrometry|matrix assisted laser desorption ionization time-of-flight mass spectrometry|Y
matrix assisted laser desorption ionisation time-of-flight mass spectrometry|matrix assisted laser desorption/ionisation time-of-flight mass spectrometry|Y
chlorophenyl-biguanide|chloro-phenyl-biguanide|Y
chlorophenyl-biguanide|chlorophenylbiguanide|Y
micro-X-ray absorption near-edge structure|micro X-ray absorption near-edge structure|Y
micro-X-ray absorption near-edge structure|micro-x-ray absorption near-edge structure|Y
hepato-biliary imaging|hepatobiliary imaging|Y
recombinant human transforming growth factor-β 1|recombinant human transforming growth factor-β1|Y
recombinant human transforming growth factor-β 1|recombinant human transforming growth factor β 1|Y
recombinant human transforming growth factor-β 1|recombinant human transforming growth factor-β|Y
recombinant human transforming growth factor-β 1|recombinant human transforming growth factor-β 3|Y
recombinant human transforming growth factor-β 1|recombinant human transforming growth factor-β 2|Y
carotid end-arterectomy|carotid endarterectomy|Y
S100 calcium binding protein A13|S100 calcium binding protein A3|Y
S100 calcium binding protein A13|S100 calcium binding protein A1|Y
monocyte chemo-attractant protein|monocyte chemoattractant protein|Y
anti-human thymocyte globulin|antihuman thymocyte globulin|Y
anti-sheep immunoglobulin E|antisheep immunoglobulin E|Y
tubulointerstitial damage|tubulo-interstitial damage|Y
American Society of Anaesthesiologists class 2|American Society of Anaesthesiologists class|Y
American Society of Anaesthesiologists class 2|American Society of Anaesthesiologists Class 2|Y
American Society of Anaesthesiologists class 2|American Society of Anaesthesiologists class I|Y
American Society of Anaesthesiologists class 2|American Society of Anaesthesiologists class 3|Y
American Society of Anaesthesiologists class 2|American Society of Anaesthesiologists class 5|Y
American Society of Anaesthesiologists class 2|American Society of Anesthesiologists class 2|Y
American Society of Anaesthesiologists class 2|American Society of Anaesthesiologists class 1|Y
American Society of Anaesthesiologists class 2|American Society of Anaesthesiologists class 4|Y
anti-social behaviour|anti-social behavior|Y
Palo Alto Veteran's Affairs Medical Center|Palo Alto Veterans' Affairs Medical Center|Y
Palo Alto Veteran's Affairs Medical Center|Palo Alto Veterans Affairs Medical Center|Y
tubularized incised-plate hypospadias repair|tubularised incised-plate hypospadias repair|Y
tubularized incised-plate hypospadias repair|tubularized incised plate hypospadias repair|Y
surface enhanced laser desorption ionization time of flight mass spectrometry|surface-enhanced laser desorption ionization time of flight mass spectrometry|Y
surface enhanced laser desorption ionization time of flight mass spectrometry|surface enhanced laser desorption ionisation time of flight mass spectrometry|Y
university affiliated Veteran's Administration medical center|university affiliated Veterans' Administration medical center|Y
university affiliated Veteran's Administration medical center|university-affiliated Veteran's Administration medical center|Y
university affiliated Veteran's Administration medical center|university affiliated Veterans Administration medical center|Y
university affiliated Veteran's Administration medical center|university-affiliated Veterans Administration medical center|Y
ras-related GTP-binding protein 9|ras-related GTP-binding protein 9A|Y
ras-related GTP-binding protein 9|ras-related GTP-binding protein 39|Y
surface enhanced laser desorption/ionization|surface enhanced laser desorption-ionization|Y
surface enhanced laser desorption/ionization|surface-enhanced laser desorption/ionization|Y
postero-lateral hypothalamus|posterolateral hypothalamus|Y
sex determining region Y box 10|sex determining region Y box 1|Y
polymerase chain reaction-sequencing-based typing|polymerase chain reaction-sequencing based typing|Y
polymerase chain reaction-sequencing-based typing|polymerase chain reaction sequencing-based typing|Y
pontogeniculo-occipital|ponto-geniculo-occipital|Y
interphase fluorescence in situ hybridization|interphase fluorescence in-situ hybridization|Y
interphase fluorescence in situ hybridization|interphase fluorescence in situ hybridisation|Y
microphotodiode array|micro-photodiode array|Y
nonthyroidal illness syndrome|non-thyroidal illness syndrome|Y
percutaneous trans-hepatic obliteration|percutaneous transhepatic obliteration|Y
human adenovirus serotype 32|human adenovirus serotype 2|Y
anti-thymosin alpha 1 monoclonal antibody|anti-thymosin-alpha 1 monoclonal antibody|Y
estimated breeding value|estimated breeding values|Y
paranitrophenyl sulfate|para-nitrophenyl sulfate|Y
Behavior Assessment System for Children, second edition|Behavioral Assessment System for Children, second edition|Y
multireference coupled-cluster theory|multi-reference coupled-cluster theory|Y
stereo-electroencephalography|stereoelectroencephalography|Y
stereo-electroencephalography|stereo-electro-encephalography|Y
latent TGF β binding protein-1|latent TGFβ binding protein-1|Y
angiotensin-converting enzyme inhibitor induced|angiotensin-converting enzyme inhibitor-induced|Y
angiotensin-converting enzyme inhibitor induced|angiotensin converting enzyme inhibitor induced|Y
gonadotropin-releasing hormone antagonist|gonadotrophin-releasing hormone antagonist|Y
gonadotropin-releasing hormone antagonist|gonadotropin releasing hormone antagonist|Y
respiration-correlated computed tomography|respiration correlated computed tomography|Y
randomly amplified polymorphic DNA-analysis|randomly amplified polymorphic DNA analysis|Y
branched chain amino acid|branched chain aminoacid|Y
branched chain amino acid|branched chain amino acids|Y
human tumor necrosis factor-α|human tumour necrosis factor-α|Y
aminopropyltriethoxysilane|amino-propyltriethoxysilane|Y
adult T-cell leukaemia virus-associated antigen|adult T-cell leukaemia-virus-associated antigen|Y
adult T-cell leukaemia virus-associated antigen|adult T cell leukaemia virus-associated antigen|Y
adult T-cell leukaemia virus-associated antigen|adult T-cell leukemia virus-associated antigen|Y
irido corneo endothelial syndrome|iridio corneo endothelial syndrome|Y
post-mastectomy radiation therapy|postmastectomy radiation therapy|Y
neodymium : yttriumaluminum garnet laser|neodymium: yttrium-aluminum garnet laser|Y
neodymium : yttriumaluminum garnet laser|neodymium: yttrium aluminum garnet laser|Y
reaction centre-light-harvesting complex 1|reaction centre-light harvesting complex 1|Y
reaction centre-light-harvesting complex 1|reaction center-light-harvesting complex 1|Y
reaction centre-light-harvesting complex 1|reaction centre-light-harvesting complex I|Y
reaction centre-light-harvesting complex 1|reaction centre light-harvesting complex 1|Y
infectious bovine rhinotracheitis-infectious pustular vulvo-vaginitis virus|infectious bovine rhinotracheitis/infectious pustular vulvovaginitis virus|Y
infectious bovine rhinotracheitis-infectious pustular vulvo-vaginitis virus|infectious bovine rhinotracheitis-infectious pustular vulvovaginitis virus|Y
infectious bovine rhinotracheitis-infectious pustular vulvo-vaginitis virus|infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis virus|Y
solid phase extraction-high performance liquid chromatography|solid-phase extraction-high performance liquid chromatography|Y
solid phase extraction-high performance liquid chromatography|solid phase extraction-high-performance liquid chromatography|Y
thalamocortical relay cell|thalamo-cortical relay cell|Y
anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody|anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody|Y
anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody|anticytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody|Y
anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody|anticytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody|Y
on-line medical record|online medical record|Y
acute myeloid leukaemia-associated|acute myeloid leukemia-associated|Y
Atlanta Veteran's Administration Medical Center|Atlanta Veterans' Administration Medical Center|Y
Atlanta Veteran's Administration Medical Center|Atlanta Veterans Administration Medical Center|Y
chronic idiopathic intestinal pseudoobstruction syndrome|chronic idiopathic intestinal pseudo-obstruction syndrome|Y
matrix metallo-proteinase inhibitor|matrix metalloproteinase inhibitor|Y
Veterans Affairs Medical Centers|Veterans Affairs Medical Center|Y
matrix assisted laser desorption ionization time of flight mass spectrometry|matrix assisted laser desorption ionisation time of flight mass spectrometry|Y
matrix assisted laser desorption ionization time of flight mass spectrometry|matrix assisted laser desorption ionization time of flight mass spectrometric|Y
matrix assisted laser desorption ionization time of flight mass spectrometry|matrix assisted laser desorption/ionization time of flight mass spectrometry|Y
matrix assisted laser desorption ionization time of flight mass spectrometry|matrix-assisted laser desorption ionization time of flight mass spectrometry|Y
epidermal cell-derived thymocyte activating factor|Epidermal cell-derived thymocyte activating factor|Y
epidermal cell-derived thymocyte activating factor|epidermal cell-derived thymocyte-activating factor|Y
epidermal cell-derived thymocyte activating factor|epidermal cell derived thymocyte activating factor|Y
multislice spiral computed tomography|multi-slice spiral computed tomography|Y
diazepam binding inhibitor-like immunoreactivity|diazepam-binding inhibitor-like immunoreactivity|Y
anti-sense oligonucleotide treated|antisense oligonucleotide treated|Y
augmented correlation-consistent polarized valence double zeta basis set|augmented correlation consistent polarized valence double zeta basis set|Y
augmented correlation-consistent polarized valence double zeta basis set|augmented correlation-consistent polarised valence double zeta basis set|Y
augmented correlation-consistent polarized valence double zeta basis set|augmented correlation-consistent polarized valence double-zeta basis set|Y
fluorine 18-labelled fluoro-deoxyglucose|fluorine 18-labelled fluoro-deoxy-glucose|Y
fluorine 18-labelled fluoro-deoxyglucose|fluorine 18-labelled fluorodeoxyglucose|Y
fluorine 18-labelled fluoro-deoxyglucose|fluorine 18-labeled fluoro-deoxyglucose|Y
fluorine 18-labelled fluoro-deoxyglucose|fluorine-18-labelled fluoro-deoxyglucose|Y
fluorine 18-labelled fluoro-deoxyglucose|fluorine 18-labeled fluoro-deoxy-glucose|Y
type I activin receptor|type II activin receptor|Y
hemoglobin Porto Alegre I|hemoglobin Porto Alegre II|Y
nonaggressive intruder|non-aggressive intruder|Y
nitroglycerin mediated vasodilation|nitroglycerine mediated vasodilation|Y
human transforming growth factor beta3|human transforming growth factor beta 3|Y
human transforming growth factor beta3|human transforming growth factor beta|Y
Robotic assister total laparoscopic hysterectomy|Robotic assisted total laparoscopic hysterectomy|Y
mitochondrial transcription factor B1|mitochondrial transcription factor 1|Y
mitochondrial transcription factor B1|mitochondrial transcription factor B|Y
cavotricuspid isthmus dependent atrial flutter|cavo-tricuspid isthmus dependent atrial flutter|Y
multifactor dimensionality reduction|multi-factor dimensionality reduction|Y
cross polarization magic-angle-spinning nuclear magnetic resonance spectroscopy|cross polarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross polarization magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarization magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross polarization magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross polarization magic-angle-spinning nuclear magnetic resonance spectroscopy|cross polarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross polarization magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarization magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross polarization magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization magic-angle-spinning nuclear magnetic resonance spectroscopy|cross polarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
Baltimore Veteran's Affairs Medical Center|Baltimore Veterans Affairs Medical Center|Y
Baltimore Veteran's Affairs Medical Center|Baltimore Veterans' Affairs Medical Center|Y
peptidoglycan recognition protein SA|peptidoglycan recognition protein S|Y
galactorrhœa-amenorrhoea hyperprolactinæmia syndrome|galactorrhœa amenorrhoea hyperprolactinæmia syndrome|Y
galactorrhœa-amenorrhoea hyperprolactinæmia syndrome|galactorrhea-amenorrhoea hyperprolactinæmia syndrome|Y
galactorrhœa-amenorrhoea hyperprolactinæmia syndrome|galactorrhœa-amenorrhoea hyperprolactinemia syndrome|Y
American Society of Anaesthesiologists physical status V|American Society of Anaesthesiologists physical status I|Y
American Society of Anaesthesiologists physical status V|American Society of Anesthesiologists physical status V|Y
American Society of Anaesthesiologists physical status V|American Society of Anaesthesiologists physical status 2|Y
American Society of Anaesthesiologists physical status V|American Society of Anesthesiologists physical status IV|Y
American Society of Anaesthesiologists physical status V|American Society of Anaesthesiologists physical status IV|Y
American Society of Anaesthesiologists physical status V|American Society of Anaesthesiologists physical status 3|Y
American Society of Anaesthesiologists physical status V|American Society of Anaesthesiologists physical status 1|Y
American Society of Anaesthesiologists physical status V|American Society of Anaesthesiologists physical status 4|Y
American Society of Anaesthesiologists physical status V|American Society of Anaesthesiologists physical status 5|Y
nonaqueous capillary electrophoresis-mass spectrometry|non-aqueous capillary electrophoresis-mass spectrometry|Y
para-nitrophenyl sulphate|para-nitrophenylsulphate|Y
ultra-performance liquid chromatography/electrospray ionisation tandem mass spectrometry|ultraperformance liquid chromatography-electrospray ionisation tandem mass spectrometry|Y
ultra-performance liquid chromatography/electrospray ionisation tandem mass spectrometry|ultra performance liquid chromatography-electrospray ionisation tandem mass spectrometry|Y
ultra-performance liquid chromatography/electrospray ionisation tandem mass spectrometry|ultra performance liquid chromatography/electrospray ionization tandem mass spectrometry|Y
ultra-performance liquid chromatography/electrospray ionisation tandem mass spectrometry|ultraperformance liquid chromatography/electrospray ionisation tandem mass spectrometry|Y
ultra-performance liquid chromatography/electrospray ionisation tandem mass spectrometry|ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry|Y
ultra-performance liquid chromatography/electrospray ionisation tandem mass spectrometry|ultra-performance liquid chromatography-electrospray ionisation tandem mass spectrometry|Y
ultra-performance liquid chromatography/electrospray ionisation tandem mass spectrometry|ultra performance liquid chromatography/electrospray ionisation tandem mass spectrometry|Y
ultra-performance liquid chromatography/electrospray ionisation tandem mass spectrometry|ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
anti-hepatitis B surface antigen|antihepatitis B surface antigen|Y
flavin containing monooxygenase 1|flavin containing mono-oxygenase 1|Y
transforming growth factor beta 4|transforming growth factor beta4|Y
c-AMP response element binding protein|cAMP response element binding protein|Y
peroxisome proliferator-activated receptor gamma coactivator 1|peroxisome proliferator-activated receptor gamma co-activator-1|Y
peroxisome proliferator-activated receptor gamma coactivator 1|peroxisome proliferator-activated receptor gamma coactivator-1|Y
peroxisome proliferator-activated receptor gamma coactivator 1|peroxisome proliferator activated receptor gamma co-activator 1|Y
peroxisome proliferator-activated receptor gamma coactivator 1|peroxisome proliferator activated receptor gamma coactivator 1|Y
peroxisome proliferator-activated receptor gamma coactivator 1|peroxisome proliferator-activated receptor gamma co-activator 1|Y
Na(+)/taurocholate cotransporting polypeptide|Na(+)-taurocholate cotransporting polypeptide|Y
Na(+)/taurocholate cotransporting polypeptide|Na(+)/taurocholate co-transporting polypeptide|Y
Na(+)/taurocholate cotransporting polypeptide|Na+/taurocholate cotransporting polypeptide|Y
pituitary tumour derived fibroblast growth factor receptor 4|pituitary tumour derived fibroblast growth factor receptor-4|Y
pituitary tumour derived fibroblast growth factor receptor 4|pituitary tumour-derived fibroblast growth factor receptor 4|Y
pituitary tumour derived fibroblast growth factor receptor 4|pituitary tumor derived fibroblast growth factor receptor 4|Y
syntaxin 4 interacting protein|syntaxin4 interacting protein|Y
action potential duration at 90% repolarisation|action potential duration at 90% repolarization|Y
5-hydroxytryptamine 1A receptor|5-hydroxytryptamine 1 receptor|Y
extracellular Ca2+ concentrations|extracellular Ca2+ concentration|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor-cell-expressed, developmentally downregulated 4|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor-cell-expressed developmentally downregulated 1|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor-cell-expressed developmentally downregulated 8|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor-cell-expressed, developmentally downregulated 9|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor-cell-expressed, developmentally downregulated 1|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor cell-expressed developmentally downregulated 4|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor cell-expressed, developmentally downregulated 4|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor-cell-expressed developmentally down-regulated 8|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor-cell-expressed developmentally downregulated 2|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor cell-expressed developmentally down-regulated 4|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor-cell-expressed developmentally downregulated 9|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor-cell-expressed developmentally down-regulated 5|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor-cell-expressed developmentally down-regulated 9|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor-cell-expressed, developmentally down-regulated 4|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor-cell-expressed, developmentally downregulated 5|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor-cell-expressed developmentally downregulated 5|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor-cell-expressed developmentally down-regulated 1|Y
neural-precursor-cell-expressed developmentally downregulated 4|neural-precursor-cell-expressed, developmentally downregulated 2|Y
gonadotrophin releasing hormone|gonadotropin releasing hormone|Y
interincisor distance|inter-incisor distance|Y
American Society of Anaesthesiologists grade 1|American Society of Anaesthesiologists grade|Y
American Society of Anaesthesiologists grade 1|American Society of Anaesthesiologists Grade 1|Y
American Society of Anaesthesiologists grade 1|American Society of Anaesthesiologists grade 2|Y
American Society of Anaesthesiologists grade 1|American Society of Anaesthesiologists grade I|Y
American Society of Anaesthesiologists grade 1|American Society of Anaesthesiologists grade 3|Y
American Society of Anaesthesiologists grade 1|American Society of Anaesthesiologists grade 5|Y
American Society of Anaesthesiologists grade 1|American Society of Anaesthesiologists grade 4|Y
American Society of Anaesthesiologists grade 1|American Society of Anesthesiologists grade 1|Y
threatened preterm labour|threatened preterm labor|Y
supra-pubic aspiration|suprapubic aspiration|Y
wild-type p53-induced phosphatase 1|wildtype p53-induced phosphatase 1|Y
sub-arachnoid hæmorrhage|subarachnoid hæmorrhage|Y
hepato-portoenterostomy|hepatoportoenterostomy|Y
hepato-portoenterostomy|hepato-porto-enterostomy|Y
antihepatitis B core antibody|anti-hepatitis B core antibody|Y
cardio-vascular event|cardiovascular event|Y
high-grade squamous intra-epithelial lesion|high grade squamous intra-epithelial lesion|Y
anti-insulin-like growth factor I receptor antibody|anti-insulin-like growth factor 1 receptor antibody|Y
anti-insulin-like growth factor I receptor antibody|anti-insulin-like growth factor-I receptor antibody|Y
forkhead-related activator-10|forkhead-related activator-1|Y
isobutylmethyl xanthine|isobutyl methyl xanthine|Y
tumor-infiltrating T lymphocyte|tumour-infiltrating T lymphocyte|Y
auto-immune inner ear disease|autoimmune inner ear disease|Y
human embryonic kidney 293T cell|human embryonic kidney 293 cell|Y
gastroœsophageal sphincter|gastro-œsophageal sphincter|Y
hypoxia-inducible transcription factor 1α|hypoxia-inducible transcription factor 1 α|Y
hypoxia-inducible transcription factor 1α|hypoxia inducible transcription factor 1α|Y
hypoxia-inducible transcription factor 1α|hypoxia-inducible transcription factor-1α|Y
auto-regressive moving average model|autoregressive moving average model|Y
reduced-intensity stem cell transplantation|reduced intensity stem cell transplantation|Y
reduced-intensity stem cell transplantation|reduced-intensity stem-cell transplantation|Y
haemoglobin S-C disease|hemoglobin S-C disease|Y
Fourier transform ion cyclotron resonance mass spectrometer|Fourier transform ion cyclotron resonance mass spectrometry|Y
multigated acquisition|multi-gated acquisition|Y
a disintegrin and metalloprotease-15|a disintegrin and metalloprotease-5|Y
ectoalkaline phosphatase|ecto-alkaline phosphatase|Y
tissue inhibitor of metalloproteinases|tissue inhibitor of metalloproteinase|Y
granulocyte-macrophage colony-stimulating factor level|granulocyte-macrophage colony stimulating factor level|Y
arginine8-vasopressin|arginine-8-vasopressin|Y
dihydroxymethamphetamine|dihydroxy-methamphetamine|Y
intra-uterine pressure catheter|intrauterine pressure catheter|Y
inhibitor of apoptosis|inhibitors of apoptosis|Y
anti-T cell receptor-alphabeta antibody|anti-T cell receptor-alpha/beta antibody|Y
anti-T cell receptor-alphabeta antibody|anti-T cell receptor-alpha beta antibody|Y
IL12 receptor β 1 chain|IL12 receptor β1 chain|Y
IL12 receptor β 1 chain|IL-12 receptor β 1 chain|Y
β-methylamino-alanine|β-methylaminoalanine|Y
anti-double-stranded deoxyribonucleic acid|antidouble-stranded deoxyribonucleic acid|Y
anti-double-stranded deoxyribonucleic acid|anti-double stranded deoxyribonucleic acid|Y
ribosomal protein L32|ribosomal protein L3|Y
masters of science in nursing|master of science in nursing|Y
noninvasive positive pressure ventilation|non-invasive positive pressure ventilation|Y
immuno-fluorescence test|immunofluorescence test|Y
anti-sense oligonucleotide|antisense oligonucleotide|Y
interleukine-3 receptor α subunit|interleukin-3 receptor α subunit|Y
ventricular pre-mature beat|ventricular premature beat|Y
5 α-dihydrotestosterone|5α-dihydrotestosterone|Y
glutamine synthetase II|glutamine synthetase I|Y
post-operative pancreatic fistula|postoperative pancreatic fistula|Y
infrared multi-photon dissociation|infrared multiphoton dissociation|Y
ganglioside-induced differentiation-associated protein-1|ganglioside-induced differentiation-associated protein 1|Y
ganglioside-induced differentiation-associated protein-1|ganglioside-induced differentiation associated protein-1|Y
inferior frontooccipital fasciculus|inferior fronto-occipital fasciculus|Y
gas chromatography-negative ion chemical ionisation mass spectrometry|gas chromatography-negative ion chemical ionisation-mass spectrometry|Y
gas chromatography-negative ion chemical ionisation mass spectrometry|gas chromatography-negative ion chemical ionization mass spectrometry|Y
gas chromatography-negative ion chemical ionisation mass spectrometry|gas chromatography/negative ion chemical ionisation mass spectrometry|Y
high-resolution computerised tomography scan|high-resolution computerized tomography scan|Y
high-resolution computerised tomography scan|high resolution computerised tomography scan|Y
zygomaticomaxillary complex|zygomatico-maxillary complex|Y
peptidoglycan recognition protein LCa|peptidoglycan recognition protein LC|Y
antihypertensive therapy|anti-hypertensive therapy|Y
migrating myoelectric complex|migrating myo-electric complex|Y
American Society of Anaesthesiology Class 3|American Society of Anaesthesiology Class 5|Y
American Society of Anaesthesiology Class 3|American Society of Anaesthesiology Class I|Y
American Society of Anaesthesiology Class 3|American Society of Anaesthesiology Class V|Y
American Society of Anaesthesiology Class 3|American Society of Anaesthesiology class 3|Y
American Society of Anaesthesiology Class 3|American Society of Anaesthesiology Class 4|Y
glycerophosphocholine|glycero-phosphocholine|Y
staphylococcal enterotoxin C2|staphylococcal enterotoxin C|Y
IL4 receptor α-chain|IL-4 receptor α-chain|Y
cluster of differentiation antigen 11c|cluster of differentiation antigen 1c|Y
evolutionary multi-objective optimization|evolutionary multi-objective optimisation|Y
high-resolution computed tomography scan|high resolution computed tomography scan|Y
stirred tank reactors|stirred tank reactor|Y
src homology 2 domain-containing protein-tyrosine phosphatase|src homology 2 domain containing protein-tyrosine phosphatase|Y
src homology 2 domain-containing protein-tyrosine phosphatase|src homology 2 domain-containing protein tyrosine phosphatase|Y
src homology 2 domain-containing protein-tyrosine phosphatase|src homology 2 domain-containing protein-tyrosine phosphatase-1|Y
src homology 2 domain-containing protein-tyrosine phosphatase|src homology-2 domain-containing protein-tyrosine phosphatase|Y
src homology 2 domain-containing protein-tyrosine phosphatase|Src homology 2 domain-containing protein-tyrosine phosphatase|Y
src homology 2 domain-containing protein-tyrosine phosphatase|src homology 2 domain-containing protein-tyrosine phosphatase 1|Y
non bacterial thrombotic endocarditis|nonbacterial thrombotic endocarditis|Y
miniature inverted-repeat transposable elements|miniature inverted-repeat transposable element|Y
miniature inverted-repeat transposable elements|miniature inverted repeat transposable elements|Y
β site amyloid precursor protein cleaving enzyme|β-site amyloid precursor protein cleaving enzyme|Y
β site amyloid precursor protein cleaving enzyme|β site amyloid precursor protein cleaving enzyme-2|Y
β site amyloid precursor protein cleaving enzyme|β site amyloid precursor protein cleaving enzyme 2|Y
acquired immunodeficiency syndrome-defining illness|acquired immunodeficiency syndrome defining illness|Y
anti-disialoganglioside monoclonal antibody|antidisialoganglioside monoclonal antibody|Y
peroxisome proliferator-activated receptor alpha|peroxisome proliferator-activated receptor-alpha|Y
eukaryotic translation elongation factor 1alpha|eukaryotic translation elongation factor 1alpha1|Y
cerebro-spinal fluid volume|cerebrospinal fluid volume|Y
monocarboxylate transporter 1|mono-carboxylate transporter 1|Y
ethyldehydroxysparsomycin|ethyldeshydroxysparsomycin|Y
ethyldehydroxysparsomycin|ethyldehydroxy-sparsomycin|Y
never-in-mitosis Aspergillus-related kinase 2B|never-in-mitosis Aspergillus-related kinase 2|Y
never-in-mitosis Aspergillus-related kinase 2B|never-in-mitosis Aspergillus-related kinase 2A|Y
Bovine placental lactogen|ovine placental lactogen|Y
programmed temperature vaporizer|programmed temperature vapourizer|Y
over-sulfated chondroitin sulfate|oversulfated chondroitin sulfate|Y
human leukocyte antigen-D-related antigen 5|human leukocyte antigen-D-related antigen 2|Y
human leukocyte antigen-D-related antigen 5|human leukocyte antigen-D-related antigen 7|Y
human leukocyte antigen-D-related antigen 5|human leukocyte antigen-D-related antigen 3|Y
human leukocyte antigen-D-related antigen 5|human leukocyte antigen-D-related antigen 6|Y
human leukocyte antigen-D-related antigen 5|human leukocyte antigen-D-related antigen 4|Y
human leukocyte antigen-D-related antigen 5|human leukocyte antigen-D-related antigen 1|Y
human leukocyte antigen-D-related antigen 5|human leukocyte antigen-D-related antigen|Y
auditory brain stem evoked response|auditory brainstem evoked response|Y
Eating Disorders Inventory|Eating Disorder Inventory|Y
heterochromatin protein 1 γ|heterochromatin protein 1γ|Y
hypoxia inducible factor 1 α protein|hypoxia inducible factor 1α protein|Y
endocrine-disrupting compounds|endocrine-disrupting compound|Y
mid-left anterior descending artery|midleft anterior descending artery|Y
adrenocortico-tropin|adrenocortico-trophin|Y
IL-12-receptor β 1 chain|IL-12-receptor β1 chain|Y
cytokine-induced neutrophil chemoattractant 2α|cytokine-induced neutrophil chemoattractant 2|Y
coronary artery bypass graft surgery|coronary artery by-pass graft surgery|Y
Drosophila cyclic AMP response element-binding protein 2-a|Drosophila cyclic AMP response element-binding protein 2-b|Y
Drosophila cyclic AMP response element-binding protein 2-a|Drosophila cyclic AMP response element-binding protein 2|Y
cis-diamine-dichloroplatinum|cis-diammine-dichloroplatinum|Y
cardiopulmonary bypass|cardiopulmonary by-pass|Y
1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|Y
1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine|1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine|Y
spontaneous oto-acoustic emission|spontaneous otoacoustic emission|Y
thyrotrophin releasing-hormone|thyrotropin releasing-hormone|Y
interleukine-6 receptor alpha|interleukin-6 receptor alpha|Y
Tanner-Whitehouse III|Tanner-Whitehouse II|Y
light harvesting chlorophyll a/b-binding protein|light harvesting chlorophyll a/b-binding protein I|Y
light harvesting chlorophyll a/b-binding protein|light harvesting chlorophyll a/b binding protein|Y
light harvesting chlorophyll a/b-binding protein|light harvesting chlorophyll a/b-binding protein-I|Y
light harvesting chlorophyll a/b-binding protein|light-harvesting chlorophyll a/b-binding protein|Y
light harvesting chlorophyll a/b-binding protein|light harvesting chlorophyll-a/b-binding protein|Y
pre-eclamptic toxemia|pre-eclamptic toxaemia|Y
mechanistic target of rapamycin complex|mechanistic target of rapamycin complex 1|Y
metabotropic glutamate receptor subtype 2|metabotropic glutamate receptor subtype 1|Y
metabotropic glutamate receptor subtype 2|metabotropic glutamate receptor subtype 3|Y
metabotropic glutamate receptor subtype 2|metabotropic glutamate receptor subtype 7|Y
metabotropic glutamate receptor subtype 2|metabotropic glutamate receptor subtype 5|Y
metabotropic glutamate receptor subtype 2|metabotropic glutamate receptor subtype 6|Y
metabotropic glutamate receptor subtype 2|metabotropic glutamate receptor subtype 4|Y
hydroxyindole-O-methyltransferase|hydroxyindole-O-methyl-transferase|Y
receptor activator of nuclear factor kappaB|receptor activator of nuclear factor kappa B|Y
receptor activator of nuclear factor kappaB|receptor activator of nuclear factor-kappaB|Y
broncho-pleural fistula|bronchopleural fistula|Y
ultralow-dose computed tomography|ultra-low-dose computed tomography|Y
familial combined hyperlipidaemia|familial combined hyperlipidemia|Y
hemagglutinin-neuraminidase glycoprotein|hemagglutinin/neuraminidase glycoprotein|Y
hemagglutinin-neuraminidase glycoprotein|haemagglutinin-neuraminidase glycoprotein|Y
neutral metalloproteinase|neutral metallo-proteinase|Y
monofluoro-acetic acid|monofluoroacetic acid|Y
soluble cluster of differentiation 154|soluble cluster of differentiation 14|Y
A disintegrin and metalloprotease 3|A disintegrin and metalloprotease 23|Y
A disintegrin and metalloprotease 3|A disintegrin and metalloprotease 13|Y
acireductone dioxygenase 1|aci-reductone dioxygenase 1|Y
American Society of Anesthesiologists physical status 1|American Society of Anesthesiologists physical status 3|Y
American Society of Anesthesiologists physical status 1|American Society of Anesthesiologists physical status V|Y
American Society of Anesthesiologists physical status 1|American Society of Anesthesiologists physical status|Y
American Society of Anesthesiologists physical status 1|American Society of Anesthesiologists physical status I|Y
American Society of Anesthesiologists physical status 1|American Society of Anesthesiologists physical status 2|Y
American Society of Anesthesiologists physical status 1|American Society of Anesthesiologists physical status 4|Y
American Society of Anesthesiologists physical status 1|American Society of Anesthesiologists physical status 5|Y
American Society of Anesthesiologists physical status 1|American Society of Anaesthesiologists physical status 1|Y
multi-facility health care organisation|multi-facility healthcare organisation|Y
poly(A) binding protein nuclear 1|poly-(A) binding protein nuclear 1|Y
receptor for advanced glycation end products|receptor for advanced glycation end product|Y
pyridoxalated polymerized hemoglobin|pyridoxalated polymerized haemoglobin|Y
preproatrial natriuretic peptide|prepro-atrial natriuretic peptide|Y
leukocyte immunoglobulin-like receptor-1|leucocyte immunoglobulin-like receptor-1|Y
leukocyte immunoglobulin-like receptor-1|leukocyte immunoglobulin-like receptor 1|Y
malto-oligosyl trehalose trehalohydrolase|maltooligosyl trehalose trehalohydrolase|Y
human erythroleukaemia|human erythroleukemia|Y
interstitial brachytherapy|interstitial brachy-therapy|Y
magnetic resonance-guided focused ultrasound|magnetic-resonance-guided focused ultrasound|Y
rostroventrolateral medulla|rostro-ventrolateral medulla|Y
person, place, and time|person, place and time|Y
interferon stimulated gene factor 3gamma|interferon-stimulated gene factor 3gamma|Y
interferon stimulated gene factor 3gamma|interferon stimulated gene factor-3gamma|Y
p-chloromercuriphenyl sulfonic acid|p-chloromercuriphenylsulfonic acid|Y
para-hydroxybenzoic acid|parahydroxybenzoic acid|Y
anti-cytotoxic T-lymphocyte antigen 4 antibody|anti-cytotoxic T-lymphocyte antigen-4 antibody|Y
anti-cytotoxic T-lymphocyte antigen 4 antibody|anticytotoxic T-lymphocyte antigen 4 antibody|Y
hypoxia-inducible factor-1α|hypoxia-inducible factor-1 α|Y
expired fraction of anaesthetic agent|expired fraction of anesthetic agent|Y
acousto-optic modulator|acoustooptic modulator|Y
p-chloromercuribenzenesulphonate|p-chloromercuribenzene sulphonate|Y
complementary DNA-amplified fragment length polymorphism|complementary DNA amplified fragment length polymorphism|Y
oculo-auriculo-vertebral dysplasia|oculo-auriculovertebral dysplasia|Y
multiple allergen simultaneous test-chemiluminescent assay|multiple allergens simultaneous test-chemiluminescent assay|Y
antiinterleukin 18 monoclonal antibody|antiinterleukin 8 monoclonal antibody|Y
antiinterleukin 18 monoclonal antibody|anti-interleukin 18 monoclonal antibody|Y
pericentriolar material|peri-centriolar material|Y
Bruininks-Oseretsky Test of Motor Proficiency 2|Bruininks-Oseretsky Test of Motor Proficiency|Y
lymphoepithelioma-like carcinoma|lympho-epithelioma-like carcinoma|Y
lymphoepithelioma-like carcinoma|lymphoepitheliomalike carcinoma|Y
peroxisome proliferator-activated receptor response element|peroxisome proliferator activated receptor response element|Y
cytotoxic T lymphocyte antigen 2α|cytotoxic T lymphocyte antigen 2 α|Y
interferon-gamma-enzyme-linked immunospot assay|interferon-gamma enzyme-linked immunospot assay|Y
glyceraldehyde 3-phosphate dehydrogenase|glyceraldehyde 3 phosphate dehydrogenase|Y
glyceraldehyde 3-phosphate dehydrogenase|glyceraldehyde-3-phosphate dehydrogenase|Y
posterior tibiotalar|posterior tibio-talar|Y
American Society of Anesthesiology Class 5|American Society of Anesthesiology Class I|Y
American Society of Anesthesiology Class 5|American Society of Anaesthesiology Class 5|Y
American Society of Anesthesiology Class 5|American Society of Anesthesiology Class 1|Y
American Society of Anesthesiology Class 5|American Society of Anesthesiology class 5|Y
American Society of Anesthesiology Class 5|American Society of Anesthesiology Class V|Y
American Society of Anesthesiology Class 5|American Society of Anesthesiology Class 2|Y
American Society of Anesthesiology Class 5|American Society of Anesthesiology Class 4|Y
ribosomal protein L35|ribosomal protein L35A|Y
ribosomal protein L35|ribosomal protein L3|Y
ribosomal protein L35|ribosomal protein L5|Y
sub-internal limiting membrane hemorrhage|sub-internal limiting membrane haemorrhage|Y
sub-internal limiting membrane hemorrhage|subinternal limiting membrane hemorrhage|Y
thermosensitive period|thermo-sensitive period|Y
volume-weighted computed tomography dose index|volume weighted computed tomography dose index|Y
accelerated-phase chronic myeloid leukaemia|accelerated phase chronic myeloid leukaemia|Y
accelerated-phase chronic myeloid leukaemia|accelerated-phase chronic myeloid leukemia|Y
backpropagating action potential|back-propagating action potential|Y
backpropagating action potential|back propagating action potential|Y
anti-T cell receptor-α/β antibody|anti-T cell receptor-αβ antibody|Y
IL2 receptor alpha subunit|IL-2 receptor alpha subunit|Y
centrosome and Golgi localized protein kinase N-associated protein|centrosome and Golgi localised protein kinase N-associated protein|Y
centrosome and Golgi localized protein kinase N-associated protein|centrosome- and Golgi-localized protein kinase N-associated protein|Y
localized surface-plasmon resonance spectroscopy|localised surface-plasmon resonance spectroscopy|Y
localized surface-plasmon resonance spectroscopy|localized surface plasmon resonance spectroscopy|Y
pre-chemoradiotherapy|pre-chemo-radiotherapy|Y
pre-chemoradiotherapy|prechemoradiotherapy|Y
peroxisome-proliferator-activated receptor-γ co-activator-1α|peroxisome-proliferator-activated receptor-γ co-activator 1α|Y
peroxisome-proliferator-activated receptor-γ co-activator-1α|peroxisome-proliferator-activated receptor-γ co-activator-1 α|Y
peroxisome-proliferator-activated receptor-γ co-activator-1α|peroxisome-proliferator-activated receptor-γ coactivator-1α|Y
peroxisome-proliferator-activated receptor-γ co-activator-1α|peroxisome-proliferator-activated receptor-γ co-activator 1 α|Y
peroxisome-proliferator-activated receptor-γ co-activator-1α|peroxisome proliferator-activated receptor-γ co-activator-1α|Y
peroxisome-proliferator-activated receptor-γ co-activator-1α|peroxisome proliferator-activated receptor-γ co-activator-1 α|Y
gamma-aminobutyric acidergic|gamma-aminobutyric acid-ergic|Y
leukocyte-associated immunoglobulin-like receptor-1|leukocyte-associated immunoglobulin-like receptor 1|Y
leukocyte-associated immunoglobulin-like receptor-1|leukocyte-associated immunoglobulin-like receptor|Y
leukocyte-associated immunoglobulin-like receptor-1|leucocyte-associated immunoglobulin-like receptor-1|Y
refractory anemia with ringed sideroblasts|refractory anemia with ring sideroblasts|Y
interleukine-13 receptor α 2-chain|interleukine-13 receptor α2-chain|Y
interleukine-13 receptor α 2-chain|interleukin-13 receptor α 2-chain|Y
salmon gonadotropin releasing hormone analogue|salmon gonadotropin releasing hormone analog|Y
salmon gonadotropin releasing hormone analogue|salmon gonadotropin-releasing hormone analogue|Y
orofacial granulomatosis|oro-facial granulomatosis|Y
sterol regulatory element-binding protein 1-c|sterol regulatory element binding protein 1-c|Y
sterol regulatory element-binding protein 1-c|sterol regulatory element-binding protein-1-c|Y
sterol regulatory element-binding protein 1-c|sterol regulatory element-binding protein 1-a|Y
mass analyzed threshold ionization spectroscopy|mass analyzed threshold ionisation spectroscopy|Y
intrahepatic cholestasis|intra-hepatic cholestasis|Y
technetium 99m-labeled human serum albumin|technetium 99m labeled human serum albumin|Y
technetium 99m-labeled human serum albumin|technetium-99m-labeled human serum albumin|Y
laryngotracheal stenosis|laryngo-tracheal stenosis|Y
Activities-Specific Balance Confidence Scale|Activities-specific Balance Confidence Scale|Y
prosthetic arterio-venous access|prosthetic arteriovenous access|Y
scavenger receptor cysteine-rich superfamily|scavenger-receptor cysteine-rich superfamily|Y
S100 calcium binding protein A5|S100 calcium binding protein A15|Y
B-cell chronic lymphatic leukemia|B-cell chronic lymphatic leukaemia|Y
pseudo-autosomal region|pseudoautosomal region|Y
vaso-occlusive crisis|vasoocclusive crisis|Y
hexachloro-cyclohexane|hexa-chloro-cyclohexane|Y
hexachloro-cyclohexane|hexachlorocyclohexane|Y
anti-human immunodeficiency virus antibody|antihuman immunodeficiency virus antibody|Y
anti-human immunodeficiency virus antibody|anti-human immunodeficiency virus-1 antibody|Y
anti-human immunodeficiency virus antibody|anti-human immunodeficiency virus 1 antibody|Y
Salt Lake City Veterans Affairs Medical Center|Salt Lake City Veterans' Affairs Medical Center|Y
Salt Lake City Veterans Affairs Medical Center|Salt Lake City Veteran's Affairs Medical Center|Y
neuro-endocrine differentiation|neuroendocrine differentiation|Y
protein kinase C-dependent signalling pathway|protein kinase C-dependent signaling pathway|Y
pancreaticobiliary maljunction|pancreatico-biliary maljunction|Y
fluorescent amplified fragment length polymorphism|fluorescent-amplified fragment length polymorphism|Y
fluorescent amplified fragment length polymorphism|fluorescent amplified-fragment length polymorphism|Y
fluorescent amplified fragment length polymorphism|fluorescent amplified fragment-length polymorphism|Y
tissue transglutaminase antibody|tissue trans-glutaminase antibody|Y
latency associated transcripts|latency associated transcript|Y
laterally-spreading tumor|laterally-spreading tumour|Y
difluoro-deoxyuridine|difluoro-deoxy-uridine|Y
difluoro-deoxyuridine|difluorodeoxyuridine|Y
anti-intercellular adhesion molecule1 monoclonal antibody|anti-intercellular adhesion molecule-1 monoclonal antibody|Y
anti-intercellular adhesion molecule1 monoclonal antibody|anti-intercellular adhesion molecule 1 monoclonal antibody|Y
NON-EXPRESSOR OF PATHOGENESIS-RELATED GENES 1|NONEXPRESSOR OF PATHOGENESIS-RELATED GENES 1|Y
NON-EXPRESSOR OF PATHOGENESIS-RELATED GENES 1|NONEXPRESSOR OF PATHOGENESIS-RELATED GENES1|Y
NON-EXPRESSOR OF PATHOGENESIS-RELATED GENES 1|NON-EXPRESSOR OF PATHOGENESIS-RELATED GENES1|Y
vaso-intestinal peptide|vasointestinal peptide|Y
non-metric multidimensional scaling|nonmetric multidimensional scaling|Y
non-metric multidimensional scaling|non-metric multi-dimensional scaling|Y
gut-associated lymphoid tissue|gut-associated lymphoid tissues|Y
American Orthopedic Foot and Ankle Society midfoot scale|American Orthopaedic Foot and Ankle Society midfoot scale|Y
nonexpressor of pathenogenesis-related genes-1|non-expressor of pathenogenesis-related genes-1|Y
nonexpressor of pathenogenesis-related genes-1|non-expressor of pathenogenesis-related genes1|Y
nonexpressor of pathenogenesis-related genes-1|nonexpressor of pathenogenesis-related genes1|Y
nonexpressor of pathenogenesis-related genes-1|nonexpressor of pathenogenesis-related genes 1|Y
tumor necrosis factor receptor superfamily member 7|tumor necrosis factor receptor superfamily member 6|Y
tumor necrosis factor receptor superfamily member 7|tumor necrosis factor receptor superfamily member 4|Y
tumor necrosis factor receptor superfamily member 7|tumor necrosis factor receptor superfamily member 17|Y
tumor necrosis factor receptor superfamily member 7|tumor necrosis factor receptor superfamily member 5|Y
tumor necrosis factor receptor superfamily member 7|tumor necrosis factor receptor superfamily member 8|Y
tumor necrosis factor receptor superfamily member 7|tumor necrosis factor receptor superfamily member 9|Y
progressive transformation of germinal centers|Progressive transformation of germinal centers|Y
DNA cross-link repair 1C|DNA crosslink repair 1C|Y
ribosomal protein L28|ribosomal protein L8|Y
α-7 nicotinic acetylcholine receptor|α7 nicotinic acetylcholine receptor|Y
T-cell-receptor γδ-positive|T-cell-receptor γ δ-positive|Y
disease-modifying antirheumatic drug|disease-modifying antirheumatic drugs|Y
acute lymphoblastic leukemia-Berlin-Frankfurt-Münster 1990|acute lymphoblastic leukemia-Berlin-Frankfurt-Munster 1990|Y
staphylococcal cassette chromosome methicillin resistance type II|staphylococcal cassette chromosome methicillin resistance type IV|Y
staphylococcal cassette chromosome methicillin resistance type II|staphylococcal cassette chromosome methicillin resistance type III|Y
staphylococcal cassette chromosome methicillin resistance type II|staphylococcal cassette chromosome methicillin resistance type V|Y
staphylococcal cassette chromosome methicillin resistance type II|staphylococcal cassette chromosome methicillin resistance type I|Y
directly observed treatment, short course|directly observed treatment, short-course|Y
directly observed treatment, short course|directly observed treatment short course|Y
multidetector row CT|multi-detector row CT|Y
nonobstructive azoospermia|non-obstructive azoospermia|Y
γ-aminobutyric acidA-benzodiazepine receptor complex|γ-aminobutyric acid-benzodiazepine receptor complex|Y
γ-aminobutyric acidA-benzodiazepine receptor complex|γ-aminobutyric acidA/benzodiazepine receptor complex|Y
γ-aminobutyric acidA-benzodiazepine receptor complex|γ-aminobutyric acid A-benzodiazepine receptor complex|Y
nuclear ribonucleoprotein|nuclear ribo-nucleoprotein|Y
dimercapto-succinic acid|dimercaptosuccinic acid|Y
ovarian-tumour-domain-containing|ovarian-tumor-domain-containing|Y
x-ray repair cross-complementing protein 1|X-ray repair cross-complementing protein 1|Y
x-ray repair cross-complementing protein 1|x-ray repair cross complementing protein 1|Y
Toll-interleukin1 receptor domain-containing adapter inducing interferon β|Toll-interleukin-1 receptor domain-containing adapter-inducing interferon β|Y
Toll-interleukin1 receptor domain-containing adapter inducing interferon β|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon β|Y
Toll-interleukin1 receptor domain-containing adapter inducing interferon β|Toll-interleukin1 receptor domain-containing adapter-inducing interferon β|Y
Toll-interleukin1 receptor domain-containing adapter inducing interferon β|toll-interleukin1 receptor domain-containing adapter inducing interferon β|Y
complete congenital stationary night blindness|incomplete congenital stationary night blindness|Y
complementarity-determining region|complementarity-determining regions|Y
interleukin 2 receptor γ chain|interleukine 2 receptor γ chain|Y
cytoplasmic anti-proteinase 2|cytoplasmic antiproteinase 2|Y
cluster of differentiation 40|cluster of differentiation 4|Y
non-rapid-eye-movement|nonrapid-eye-movement|Y
antiinterleukin 17 monoclonal antibody|anti-interleukin 17 monoclonal antibody|Y
antiinterleukin 17 monoclonal antibody|antiinterleukin 7 monoclonal antibody|Y
alpha 1-anti-chymotrypsin|alpha1-anti-chymotrypsin|Y
hypo-gamma-globulinæmia|hypo-gammaglobulinæmia|Y
TATA-binding protein associated factor 7|TATA-binding protein associated factor 8|Y
TATA-binding protein associated factor 7|TATA-binding protein associated factor 1|Y
TATA-binding protein associated factor 7|TATA-binding protein associated factor 9|Y
TATA-binding protein associated factor 7|TATA-binding protein associated factor 2|Y
TATA-binding protein associated factor 7|TATA-binding protein associated factor 17|Y
TATA-binding protein associated factor 7|TATA-binding protein associated factor 3|Y
TATA-binding protein associated factor 7|TATA-binding protein associated factor 6|Y
TATA-binding protein associated factor 7|TATA-binding protein associated factor 4|Y
TATA-binding protein associated factor 7|TATA-binding protein associated factor 5|Y
TATA-binding protein associated factor 7|TATA-binding protein-associated factor 7|Y
TATA-binding protein associated factor 7|TATA-binding protein associated factor-7|Y
Src homology 2 domain-containing protein tyrosine phosphatase-1|Src homology 2 domain-containing protein tyrosine phosphatase|Y
Src homology 2 domain-containing protein tyrosine phosphatase-1|src homology 2 domain-containing protein tyrosine phosphatase-1|Y
Src homology 2 domain-containing protein tyrosine phosphatase-1|Src homology 2 domain-containing protein-tyrosine phosphatase-1|Y
Src homology 2 domain-containing protein tyrosine phosphatase-1|Src homology 2 domain-containing protein tyrosine phosphatase 1|Y
Src homology 2 domain-containing protein tyrosine phosphatase-1|Src homology 2 domain-containing protein tyrosine phosphatase-2|Y
pancreatic carcinoma-2|pancreatic carcinoma-28|Y
multicore fiber laser|multi-core fiber laser|Y
subcritical water extraction|sub-critical water extraction|Y
mucosal addressin cell adhesion molecule-1|mucosal addressin cell adhesion molecule|Y
mucosal addressin cell adhesion molecule-1|mucosal addressin cell adhesion molecule 1|Y
functional neuro-muscular stimulation|functional neuromuscular stimulation|Y
intracytoplasmic sperm injection|intra-cytoplasmic sperm injection|Y
high performance liquid chromatographic method|high-performance liquid chromatographic method|Y
antihæmophilic factor|anti-hæmophilic factor|Y
caspase recruitment domain containing protein|caspase recruitment domain-containing protein|Y
Joint Commission for Accreditation of Healthcare Organizations|Joint Commission for Accreditation of Health Care Organizations|Y
Joint Commission for Accreditation of Healthcare Organizations|Joint Commission on Accreditation of Healthcare Organizations|Y
anti-interleukin-10 antibody|anti-interleukin-1 antibody|Y
non-nucleoside reverse transcriptase inhibitor|nonnucleoside reverse transcriptase inhibitor|Y
non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitors|Y
non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse-transcriptase inhibitor|Y
antideoxyribonucleic acid antibody|anti-deoxyribonucleic acid antibody|Y
a disintegrin-like and metalloproteinase with thrombospondin type1 motif 13-deficient|a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13-deficient|Y
transforming growth factor-beta-activated kinase 1-binding protein 1|transforming growth factor-beta-activated kinase 1-binding protein-1|Y
transforming growth factor-beta-activated kinase 1-binding protein 1|transforming growth factor beta-activated kinase 1-binding protein 1|Y
oro-facio-digital syndrome type VI|oro-facio-digital syndrome type V|Y
oro-facio-digital syndrome type VI|oro-facio-digital syndrome type VII|Y
oro-facio-digital syndrome type VI|oro-facio-digital syndrome type I|Y
alkyl-acetyl-glycero-phosphocholine|alkylacetyl-glycero-phosphocholine|Y
alkyl-acetyl-glycero-phosphocholine|alkyl-acetyl-glycerophosphocholine|Y
receptor-like protein tyrosine phosphatase-mu|receptor-like protein-tyrosine phosphatase-mu|Y
receptor-like protein tyrosine phosphatase-mu|receptor-like protein tyrosine phosphatase mu|Y
immuno-chromatographic assay|immunochromatographic assay|Y
trans-cutaneous cardiac pacing|transcutaneous cardiac pacing|Y
intra-abdominal infection|intraabdominal infection|Y
human interferon α 2b|human interferon α2b|Y
veno-occlusive disease|venoocclusive disease|Y
TBP-associated factor-17|TBP-associated factor-7|Y
TBP-associated factor-17|TBP-associated factor-1|Y
peroxisome proliferator-activated receptor-gamma co-activator-1alpha|peroxisome proliferator-activated receptor-gamma coactivator-1 alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator-1alpha|peroxisome proliferator-activated receptor gamma coactivator-1alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator-1alpha|peroxisome proliferator-activated receptor-gamma coactivator 1alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator-1alpha|peroxisome proliferator-activated receptor-gamma co-activator-1 alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator-1alpha|peroxisome proliferator-activated receptor-gamma co-activator 1alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator-1alpha|peroxisome-proliferator-activated receptor-gamma co-activator-1 alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator-1alpha|peroxisome proliferator-activated receptor-gamma coactivator-1alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator-1alpha|peroxisome-proliferator-activated receptor-gamma co-activator-1alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator-1alpha|peroxisome proliferator-activated receptor gamma co-activator-1alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator-1alpha|peroxisome proliferator-activated receptor-gamma co-activator 1 alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator-1alpha|peroxisome-proliferator-activated receptor-gamma coactivator-1alpha|Y
ribosomal protein L27|ribosomal protein L7|Y
inhibitory-κB kinase β|inhibitory-κ B kinase β|Y
ultrasound-guided fine-needle aspiration cytology|ultrasound guided fine-needle aspiration cytology|Y
gas chromatography-mass-selective detection|gas chromatography-mass selective detection|Y
hepatitis-associated aplastic anemia|hepatitis-associated aplastic anaemia|Y
platelet-derived growth factor receptor|platelet-derived growth factor β-receptor|Y
platelet-derived growth factor receptor|platelet-derived growth factor receptor-β|Y
platelet-derived growth factor receptor|platelet-derived growth factor receptor β|Y
platelet-derived growth factor receptor|platelet-derived growth factor β receptor|Y
platelet-derived growth factor receptor|platelet-derived growth factor receptor-α|Y
platelet-derived growth factor receptor|platelet-derived growth factor receptor α|Y
platelet-derived growth factor receptor|platelet-derived growth factor receptors|Y
platelet-derived growth factor receptor|platelet-derived growth factor-β receptor|Y
time-of-flight secondary-ion mass spectrometry|time-of-flight secondary ion mass spectrometry|Y
non-structural protein|nonstructural protein|Y
non-structural protein|non-structural proteins|Y
anodic aluminium oxide|anodic aluminum oxide|Y
gas chromatography/negative-ion chemical ionisation mass spectrometry|gas chromatography/negative ion chemical ionisation mass spectrometry|Y
gas chromatography/negative-ion chemical ionisation mass spectrometry|gas chromatography/negative-ion chemical ionization mass spectrometry|Y
nucleotide binding oligomerisation domain 2|nucleotide binding oligomerisation domain 1|Y
nucleotide binding oligomerisation domain 2|nucleotide binding oligomerisation domain|Y
src homology-2 domain-containing protein tyrosine-phosphatase|src homology 2 domain-containing protein tyrosine-phosphatase|Y
src homology-2 domain-containing protein tyrosine-phosphatase|Src homology-2 domain-containing protein tyrosine-phosphatase|Y
src homology-2 domain-containing protein tyrosine-phosphatase|src homology-2 domain-containing protein tyrosine phosphatase|Y
intracranial self-stimulation|intra-cranial self-stimulation|Y
a disintegrin and metalloproteinase-7|a disintegrin and metalloproteinase-17|Y
American Society of Anesthesiology class 2|American Society of Anesthesiology class 3|Y
American Society of Anesthesiology class 2|American Society of Anesthesiology class|Y
American Society of Anesthesiology class 2|American Society of Anesthesiology class 1|Y
American Society of Anesthesiology class 2|American Society of Anesthesiology class 5|Y
American Society of Anesthesiology class 2|American Society of Anesthesiology class V|Y
American Society of Anesthesiology class 2|American Society of Anesthesiology class 4|Y
American Society of Anesthesiology class 2|American Society of Anesthesiology class I|Y
American Society of Anesthesiology class 2|American Society of Anaesthesiology class 2|Y
American Society of Anesthesiology class 2|American Society of Anesthesiology Class 2|Y
carcino-embryonic antigen positive|carcinoembryonic antigen positive|Y
ubiquitin carboxy-terminal hydrolase L-1|ubiquitin carboxyl-terminal hydrolase L1|Y
ubiquitin carboxy-terminal hydrolase L-1|ubiquitin carboxy terminal hydrolase L-1|Y
pro-myelocytic leukaemia|pro-myelocytic leukemia|Y
trans-abdominal ultrasonography|transabdominal ultrasonography|Y
soluble interleukine-6 receptor-α|soluble interleukin-6 receptor-α|Y
human leukocyte antigen-D-related antigen 2|human leukocyte antigen-D-related antigen 7|Y
human leukocyte antigen-D-related antigen 2|human leukocyte antigen-D-related antigen 3|Y
human leukocyte antigen-D-related antigen 2|human leukocyte antigen-D-related antigen 6|Y
human leukocyte antigen-D-related antigen 2|human leukocyte antigen-D-related antigen 4|Y
human leukocyte antigen-D-related antigen 2|human leukocyte antigen-D-related antigen 1|Y
human leukocyte antigen-D-related antigen 2|human leukocyte antigen-D-related antigen|Y
gap-junction-mediated intercellular coupling|gap junction-mediated intercellular coupling|Y
C-C chemokine ligand-17|C-C chemokine ligand-7|Y
calcium voltage-gated channel subunit α 1 C|calcium voltage-gated channel subunit α1 C|Y
calcium voltage-gated channel subunit α 1 C|calcium voltage-gated channel subunit α1C|Y
B-cell non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster trial 90|B-cell non-Hodgkin's lymphoma-Berlin-Frankfurt-Munster trial 90|Y
noninsulinoma pancreatogenous hypoglycemia syndrome|non-insulinoma pancreatogenous hypoglycemia syndrome|Y
noninsulinoma pancreatogenous hypoglycemia syndrome|non-insulinoma pancreatogenous hypoglycaemia syndrome|Y
killer cell Ig-like receptors|killer cell Ig-like receptor|Y
hyper-cholesterolaemia|hyper-cholesterolemia|Y
intravenous γ globulin|intravenous γglobulin|Y
galactorrhœa amenorrhoea hyperprolactinæmia syndrome|galactorrhœa amenorrhoea hyperprolactinemia syndrome|Y
galactorrhœa amenorrhoea hyperprolactinæmia syndrome|galactorrhœa amenorrhea hyperprolactinæmia syndrome|Y
galactorrhœa amenorrhoea hyperprolactinæmia syndrome|galactorrhea amenorrhoea hyperprolactinæmia syndrome|Y
diffusing capacity of the lungs|diffusing capacity of the lung|Y
human immunodeficiency virus-1 trans-activator protein|human immunodeficiency virus-1 transactivator protein|Y
microtubule-associated protein 2C|microtubule-associated protein 2|Y
secreted protein acidic and rich in cysteine|secreted protein, acidic and rich in cysteine|Y
secreted protein acidic and rich in cysteine|secreted protein acidic and rich in cystein|Y
least significant difference post-hoc test|least significant difference post hoc test|Y
least significant difference post-hoc test|least-significant difference post-hoc test|Y
anti-citrullinated peptide antibody|anticitrullinated peptide antibody|Y
Manual Ability Classification System level V|Manual Ability Classification System level I|Y
Manual Ability Classification System level V|Manual Ability Classification System level IV|Y
Manual Ability Classification System level V|Manual Ability Classification System level|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motifs-19|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motif-8|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motifs-3|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motif-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloproteinase with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motifs-18|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motifs|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motifs-13|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motif-3|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motifs-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motifs-4|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motifs-2|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motif-2|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motifs-9|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motifs-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motifs-20|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloprotease with thrombospondin motifs-6|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
three-dimensional position-specific scoring matrix|three-dimensional position specific scoring matrix|Y
peroxisome proliferator activated receptor γ 1|peroxisome proliferator activated receptor γ1|Y
peroxisome proliferator activated receptor γ 1|peroxisome proliferator activated receptor γ 2|Y
peroxisome proliferator activated receptor γ 1|peroxisome proliferator-activated receptor γ 1|Y
non-twenty-four-hour sleep-wake syndrome|non-twenty-four-hour sleep wake syndrome|Y
intracranial pressure|intra-cranial pressure|Y
potassium voltage-gated channel KQT-like subfamily member 1|potassium voltage-gated channel KQT-like subfamily member 3|Y
potassium voltage-gated channel KQT-like subfamily member 1|potassium voltage-gated channel KQT-like subfamily member 5|Y
potassium voltage-gated channel KQT-like subfamily member 1|potassium voltage-gated channel KQT-like subfamily member 2|Y
nano-structured lipid carrier|nanostructured lipid carrier|Y
neurospecific enolase|neuro-specific enolase|Y
interleukin-2 receptor-α|interleukine-2 receptor-α|Y
interleukine-2 receptor α-subunit|interleukin-2 receptor α-subunit|Y
γhydroxybutyric acid|γ hydroxybutyric acid|Y
γhydroxybutyric acid|γ-hydroxybutyric acid|Y
phosphatidyl-ethanolamine hydroperoxide|phosphatidylethanolamine hydroperoxide|Y
corticosterone methyloxidase I|corticosterone methyloxidase II|Y
eye, ear, nose and throat|eye, ear, nose, and throat|Y
partial pressure of CO2|partial pressure of O2|Y
blood blisterlike aneurysm|blood blister-like aneurysm|Y
American Orthopedic Foot and Ankle Society ankle hindfoot scale|American Orthopaedic Foot and Ankle Society ankle-hindfoot scale|Y
interleukin-18 receptor-α|interleukine-18 receptor-α|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motifs-5|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motifs-3|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motif-16|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motif-19|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motifs-1|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motifs-3|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motif-15|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motif-1|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motifs-13|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motifs-19|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motifs-17|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motifs-8|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motif-14|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motifs-15|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
peptidylglutamyl-peptide hydrolase|peptidylglutamylpeptide hydrolase|Y
peptidylglutamyl-peptide hydrolase|peptidyl-glutamyl-peptide hydrolase|Y
conductor-like polarisable continuum model|conductor-like polarizable continuum model|Y
ultra-small superparamagnetic iron oxide|ultrasmall superparamagnetic iron oxide|Y
photoparoxysmal response|photo-paroxysmal response|Y
TATA-binding protein associated factor 8|TATA-binding protein associated factor 1|Y
TATA-binding protein associated factor 8|TATA-binding protein associated factor 9|Y
TATA-binding protein associated factor 8|TATA-binding protein associated factor 2|Y
TATA-binding protein associated factor 8|TATA-binding protein associated factor 3|Y
TATA-binding protein associated factor 8|TATA-binding protein associated factor-8|Y
TATA-binding protein associated factor 8|TATA-binding protein associated factor 6|Y
TATA-binding protein associated factor 8|TATA-binding protein associated factor 4|Y
TATA-binding protein associated factor 8|TATA-binding protein associated factor 5|Y
TATA-binding protein associated factor 8|TATA-binding protein-associated factor 8|Y
Abelson murine leukemia viral oncogene homolog 2|Abelson murine leukemia viral oncogene homolog 1|Y
mitogen-activated protein kinase-activated protein kinase-3|mitogen-activated protein kinase-activated protein kinase-1|Y
mitogen-activated protein kinase-activated protein kinase-3|mitogen-activated protein kinase-activated protein kinase-2|Y
mitogen-activated protein kinase-activated protein kinase-3|mitogen-activated protein kinase-activated protein kinase-5|Y
mitogen-activated protein kinase-activated protein kinase-3|mitogen-activated protein kinase activated protein kinase-3|Y
mitogen-activated protein kinase-activated protein kinase-3|mitogen activated protein kinase-activated protein kinase-3|Y
IL-13 receptor alpha2-chain|IL-13 receptor alpha 2-chain|Y
standardized patient|standardized patients|Y
proximal subungual onychomycosis|proximal sub-ungual onychomycosis|Y
colonization factor antigen III|colonization factor antigen II|Y
postmenopausal osteoporosis|post-menopausal osteoporosis|Y
quadrupole-time-of-flight mass spectrometry|quadrupole time-of-flight mass spectrometry|Y
steroid 5alpha reductase type 2|steroid 5-alpha reductase type 2|Y
disinfection byproducts|disinfection by-products|Y
B-cell non-Hodgkin's lymphoma|B-cell non-Hodgkin's lymphomas|Y
nuclear factor-κB p50|nuclear factor-κ B p50|Y
American Society of Anaesthesiology status II|American Society of Anesthesiology status I|Y
American Society of Anaesthesiology status II|American Society of Anesthesiology status III|Y
American Society of Anaesthesiology status II|American Society of Anaesthesiology status III|Y
American Society of Anaesthesiology status II|American Society of Anaesthesiology status IV|Y
American Society of Anaesthesiology status II|American Society of Anaesthesiology status I|Y
prepaid group practice|prepaid group practices|Y
triphenylethylene anti-oestrogen binding site|triphenylethylene anti-estrogen binding site|Y
triphenylethylene anti-oestrogen binding site|triphenylethylene antiestrogen binding site|Y
endoscopic ultrasound-guided fine needle aspiration|endoscopic ultrasound-guided fine-needle aspiration|Y
endoscopic ultrasound-guided fine needle aspiration|endoscopic ultrasound guided fine needle aspiration|Y
carboxy-phenylglycine|carboxyphenylglycine|Y
transcription factor IID|transcription factor IIID|Y
serum carcinoembryonic antigen level|serum carcino-embryonic antigen level|Y
transforming growth factor-beta receptor 1|transforming growth factor-beta receptor|Y
transforming growth factor-beta receptor 1|transforming growth factor beta receptor 1|Y
transforming growth factor-beta receptor 1|transforming growth factor-beta receptor I|Y
hyperbranched polyglycerol|hyper-branched polyglycerol|Y
transmembrane 4 superfamily member 1 protein|transmembrane 4 superfamily member 5 protein|Y
transmembrane 4 superfamily member 1 protein|transmembrane 4 superfamily member 3 protein|Y
transmembrane 4 superfamily member 1 protein|transmembrane 4 superfamily member 11 protein|Y
easy ambient sonic-spray ionisation mass spectrometry|easy ambient sonic-spray ionization mass spectrometry|Y
N-formyl methionyl-leucyl-phenylalanine|N-formylmethionyl-leucyl-phenylalanine|Y
augmented correlation consistent polarized valence double ζ basis set|augmented correlation consistent polarized valence double-ζ basis set|Y
augmented correlation consistent polarized valence double ζ basis set|augmented correlation-consistent polarized valence double ζ basis set|Y
augmented correlation consistent polarized valence double ζ basis set|augmented correlation consistent polarised valence double ζ basis set|Y
Wingless-type MMTV integration site family member|Wingless-type MMTV integration site family member 2|Y
Wingless-type MMTV integration site family member|wingless-type MMTV integration site family member|Y
nearpoint of convergence|near point of convergence|Y
dorso-lateral funiculus|dorsolateral funiculus|Y
N-formyl-methionine-leucine-phenylalanine|formyl-methionine-leucine-phenylalanine|Y
medullary thick ascending limb|medullary thick ascending limbs|Y
recombinant interleukin-1β|recombinant interleukine-1β|Y
recombinant interleukin-1β|recombinant interleukin-1-β|Y
recombinant interleukin-1β|recombinant interleukin-1 β|Y
tracheo-oesophageal prosthesis|tracheo-esophageal prosthesis|Y
chronic nonvalvular atrial fibrillation|chronic non-valvular atrial fibrillation|Y
Cortical somatosensory evoked potentials|Cortical somatosensory evoked potential|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor cell-expressed developmentally downregulated 1|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor-cell-expressed developmentally downregulated 8|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor cell-expressed developmentally downregulated 9|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor cell-expressed, developmentally down-regulated 2|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor cell-expressed, developmentally downregulated 2|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor cell-expressed developmentally downregulated 4|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor cell-expressed, developmentally downregulated 4|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural precursor cell-expressed, developmentally down-regulated 8|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor cell-expressed developmentally down-regulated 8|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor cell-expressed developmentally downregulated 2|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor cell-expressed, developmentally downregulated 9|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor cell-expressed, developmentally down-regulated 8|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor cell-expressed, developmentally down-regulated 1|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor cell-expressed developmentally downregulated 8|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural precursor cell-expressed developmentally downregulated 8|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor cell-expressed developmentally downregulated 5|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor cell-expressed, developmentally downregulated 5|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor-cell-expressed, developmentally down-regulated 8|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural precursor cell-expressed, developmentally downregulated 8|Y
neural-precursor cell-expressed, developmentally downregulated 8|neural-precursor cell-expressed, developmentally downregulated 1|Y
thalamo-cortical axon|thalamocortical axon|Y
caspase 1/interleukin-1 beta-converting enzyme|caspase 1/interleukin-1beta-converting enzyme|Y
anti-human T-cell lymphotropic virus type I antibody|anti-human T-cell lymphotropic virus type 1 antibody|Y
anti-human T-cell lymphotropic virus type I antibody|anti-human T-cell lymphotropic virus type-I antibody|Y
anti-human T-cell lymphotropic virus type I antibody|anti-human T cell lymphotropic virus type I antibody|Y
anti-human T-cell lymphotropic virus type I antibody|anti-human T-cell lymphotrophic virus type I antibody|Y
TATA-binding protein associated factor 1|TATA-binding protein associated factor 9|Y
TATA-binding protein associated factor 1|TATA-binding protein associated factor 2|Y
TATA-binding protein associated factor 1|TATA-binding protein associated factor 17|Y
TATA-binding protein associated factor 1|TATA-binding protein associated factor 3|Y
TATA-binding protein associated factor 1|TATA-binding protein associated factor 6|Y
TATA-binding protein associated factor 1|TATA-binding protein associated factor 4|Y
TATA-binding protein associated factor 1|TATA-binding protein associated factor 5|Y
TATA-binding protein associated factor 1|TATA-binding protein associated factor 12|Y
TATA-binding protein associated factor 1|TATA-binding protein associated factor 10|Y
TATA-binding protein associated factor 1|TATA-binding protein associated factor 15|Y
TATA-binding protein associated factor 1|TATA-binding protein associated factor-1|Y
TATA-binding protein associated factor 1|TATA-binding protein-associated factor 1|Y
TATA-binding protein associated factor 1|TATA-binding protein associated factor 11|Y
cerebroocular dysgenesis|cerebro-ocular dysgenesis|Y
infiltrating ductal carcinomas|infiltrating ductal carcinoma|Y
abdominoscrotal hydrocele|abdomino-scrotal hydrocele|Y
γ-amino butyric acid type A|γ-aminobutyric acid type A|Y
cerebrovascular malformation|cerebrovascular malformations|Y
cytotoxic T-lymphocyte antigen-2α|cytotoxic T-lymphocyte antigen-2 α|Y
mini-chromosome maintenance protein 2|minichromosome maintenance protein 2|Y
acoustooptic deflector|acousto-optic deflector|Y
receptor for hyaluronan mediated motility|receptor for hyaluronan-mediated motility|Y
attenuated total reflection Fourier transform infrared spectroscopy|attenuated total-reflection Fourier transform infrared spectroscopy|Y
attenuated total reflection Fourier transform infrared spectroscopy|attenuated total reflection Fourier-transform infrared spectroscopy|Y
entero-hemorrhagic E. coli|entero-haemorrhagic E. coli|Y
entero-hemorrhagic E. coli|entero-hemorrhagic E coli|Y
inter-professional education|interprofessional education|Y
magneto-caloric effect|magnetocaloric effect|Y
para-cresol methyl hydroxylase|para-cresol methylhydroxylase|Y
American Society of Anesthesiologists Status 2|American Society of Anesthesiologists status 2|Y
American Society of Anesthesiologists Status 2|American Society of Anaesthesiologists Status 2|Y
American Society of Anesthesiologists Status 2|American Society of Anesthesiologists Status I|Y
American Society of Anesthesiologists Status 2|American Society of Anesthesiologists Status 1|Y
American Society of Anesthesiologists Status 2|American Society of Anesthesiologists Status 4|Y
diisopropyl fluorophosphatase|di-isopropyl fluorophosphatase|Y
paired pulse transcranial magnetic stimulation|paired pulse trans-cranial magnetic stimulation|Y
human immunodeficiency virus/hepatitis B virus coinfection|human immunodeficiency virus/hepatitis C virus coinfection|Y
human immunodeficiency virus/hepatitis B virus coinfection|human immunodeficiency virus-hepatitis B virus coinfection|Y
cardiothoracic index|cardio-thoracic index|Y
peri-ventricular lesion|periventricular lesion|Y
Salmonella enterica serotype Paratyphi B|Salmonella enterica serotype Paratyphi A|Y
anteroposterior view|antero-posterior view|Y
persistent atrial standstill|persistent atrial stand-still|Y
anti-IL-8 receptor antibody|antiIL-8 receptor antibody|Y
anti-IL-8 receptor antibody|anti-IL8 receptor antibody|Y
electroosmotic flow mobility|electro-osmotic flow mobility|Y
augmented correlation-consistent polarized valence quadruple ζ basis set|augmented correlation-consistent polarised valence quadruple ζ basis set|Y
augmented correlation-consistent polarized valence quadruple ζ basis set|augmented correlation-consistent polarized valence quadruple-ζ basis set|Y
augmented correlation-consistent polarized valence quadruple ζ basis set|augmented correlation consistent polarized valence quadruple ζ basis set|Y
Clinical Global Impressions-Severity Scale|Clinical Global Impressions Severity Scale|Y
Clinical Global Impressions-Severity Scale|Clinical Global Impressions-Severity scale|Y
transforming growth factor beta|transforming growth factor beta2|Y
transforming growth factor beta|transforming growth factor beta1|Y
transforming growth factor beta|transforming growth factor beta4|Y
transforming growth factor beta|transforming growth factor beta3|Y
agranular endoplasmic reticulum|granular endoplasmic reticulum|Y
piezo-electric transducer|piezoelectric transducer|Y
colony-forming units-megakaryocyte|colony-forming unit-megakaryocyte|Y
ribosomal protein L13|ribosomal protein L1|Y
ribosomal protein L13|ribosomal protein L3|Y
ribosomal protein L13|ribosomal protein L13A|Y
nicotinamide adenine dinucleotide phosphate-cytochrome P450 reductase|nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase|Y
nicotinamide adenine dinucleotide phosphate-cytochrome P450 reductase|nicotinamide-adenine dinucleotide phosphate-cytochrome P450 reductase|Y
fluorine-18-labelled fluorodeoxyglucose|fluorine-18-labelled fluoro-deoxy-glucose|Y
fluorine-18-labelled fluorodeoxyglucose|fluorine-18-labelled fluoro-deoxyglucose|Y
receiver-operating characteristic curve analysis|receiver-operating-characteristic curve analysis|Y
agar gel immuno-diffusion|agargel immuno-diffusion|Y
disseminated necrotising leukoencephalopathy|disseminated necrotizing leukoencephalopathy|Y
disseminated necrotising leukoencephalopathy|disseminated necrotising leucoencephalopathy|Y
human adenovirus serotype 2|human adenovirus serotype 52|Y
human adenovirus serotype 2|human adenovirus serotype 25|Y
human adenovirus serotype 2|human adenovirus serotype 22|Y
human adenovirus serotype 2|human adenovirus serotype 26|Y
human adenovirus serotype 2|human adenovirus serotype 12|Y
human adenovirus serotype 2|human adenovirus serotype 42|Y
human adenovirus serotype 2|human adenovirus serotype 21|Y
human adenovirus serotype 2|human adenovirus serotype 28|Y
human adenovirus serotype 2|human adenovirus serotype 24|Y
human adenovirus serotype 2|human adenovirus serotype 23|Y
antisense ribonucleic acid|anti-sense ribonucleic acid|Y
laryngo-tracheoplasty|laryngotracheoplasty|Y
swing-lock removable partial denture|swinglock removable partial denture|Y
tumour necrosis factor receptor associated factor-6|tumour necrosis factor receptor associated factor-5|Y
tumour necrosis factor receptor associated factor-6|tumor necrosis factor receptor associated factor-6|Y
tumour necrosis factor receptor associated factor-6|tumour necrosis factor receptor-associated factor-6|Y
tumour necrosis factor receptor associated factor-6|tumour necrosis factor receptor associated factor 6|Y
tumour necrosis factor receptor associated factor-6|tumour necrosis factor receptor associated factor-2|Y
tumour necrosis factor receptor associated factor-6|tumour necrosis factor receptor associated factor-1|Y
corticotrophin-releasing hormone receptor 2|corticotrophin-releasing hormone receptor-2|Y
corticotrophin-releasing hormone receptor 2|corticotrophin-releasing-hormone receptor 2|Y
corticotrophin-releasing hormone receptor 2|corticotrophin-releasing hormone receptor 1|Y
corticotrophin-releasing hormone receptor 2|corticotrophin-releasing hormone receptor|Y
corticotrophin-releasing hormone receptor 2|corticotropin-releasing hormone receptor 2|Y
corticotrophin-releasing hormone receptor 2|corticotrophin releasing hormone receptor 2|Y
1-deamino-8-D-arginine vasopressin|1-desamino-8-D-arginine vasopressin|Y
corticotropin-releasing hormone type-1 receptor|corticotropin releasing hormone type-1 receptor|Y
corticotropin-releasing hormone type-1 receptor|corticotropin-releasing hormone type 1 receptor|Y
endothelium-derived hyperpolarising factor|endothelium derived hyperpolarising factor|Y
anti-immunoglobulin G antibody|antiimmunoglobulin G antibody|Y
heparin-induced platelet activation assay|heparin induced platelet activation assay|Y
3-methoxy-4-hydroxyphenylglycol|3-methoxy-4-hydroxyphenyl glycol|Y
3-methoxy-4-hydroxyphenylglycol|3-methoxy-4-hydroxy-phenylglycol|Y
3-methoxy-4-hydroxyphenylglycol|3-methoxy-4-hydroxy phenylglycol|Y
generalised linear modelling|generalised linear modeling|Y
stepwise regression analysis|step-wise regression analysis|Y
lysophosphatidylethanolamine|lyso-phosphatidylethanolamine|Y
human lymphocyte antigen B27|human lymphocyte antigen B-27|Y
micro-vascular angina|microvascular angina|Y
patient-controlled epidural anesthesia|patient-controlled epidural anaesthesia|Y
immuno-reactive score|immunoreactive score|Y
acute inflammatory demyelinating polyneuropathy|Acute inflammatory demyelinating polyneuropathy|Y
oral hypoglycemic agent|oral hypoglycaemic agent|Y
semi-permeable membrane device|semipermeable membrane device|Y
sterol regulatory element binding protein cleavage activating protein|sterol regulatory element binding protein cleavage-activating protein|Y
trans-jugular intrahepatic porto-systemic shunting|trans-jugular intra-hepatic portosystemic shunting|Y
trans-jugular intrahepatic porto-systemic shunting|trans-jugular intra-hepatic porto-systemic shunting|Y
trans-jugular intrahepatic porto-systemic shunting|transjugular intrahepatic porto-systemic shunting|Y
trans-jugular intrahepatic porto-systemic shunting|trans-jugular intrahepatic portosystemic shunting|Y
trans-jugular intrahepatic porto-systemic shunting|transjugular intra-hepatic porto-systemic shunting|Y
ubiquitinlike domain|ubiquitin-like domain|Y
ras-related GTP-binding protein 6C|ras-related GTP-binding protein 6|Y
Paediatric Crohn's Disease Activity Index|Pediatric Crohn's Disease Activity Index|Y
phosphatidyl-ethanolamine binding protein-2|phosphatidyl-ethanolamine binding protein 2|Y
phosphatidyl-ethanolamine binding protein-2|phosphatidyl-ethanolamine-binding protein-2|Y
human adenovirus type 4|human adenovirus type 43|Y
human adenovirus type 4|human adenovirus type 40|Y
human adenovirus type 4|human adenovirus type 34|Y
human adenovirus type 4|human adenovirus type 24|Y
human adenovirus type 4|human adenovirus type 46|Y
human adenovirus type 4|human adenovirus type 44|Y
human adenovirus type 4|human adenovirus type 14|Y
human adenovirus type 4|human adenovirus type 49|Y
human adenovirus type 4|human adenovirus type 41|Y
human adenovirus type 4|human adenovirus type 42|Y
human adenovirus type 4|human adenovirus type 47|Y
human adenovirus type 4|human adenovirus type 45|Y
antimannan immunoglobulin G|anti-mannan immunoglobulin G|Y
transobturator tape procedure|trans-obturator tape procedure|Y
hyperpolarization activated cyclic nucleotide-gated channel|hyperpolarization activated cyclic nucleotide gated channel|Y
hyperpolarization activated cyclic nucleotide-gated channel|hyperpolarisation activated cyclic nucleotide-gated channel|Y
hyperpolarization activated cyclic nucleotide-gated channel|hyperpolarization-activated cyclic nucleotide-gated channel|Y
β-site amyloid precursor protein-cleaving enzyme-1|β-site amyloid precursor protein cleaving enzyme-1|Y
β-site amyloid precursor protein-cleaving enzyme-1|β-site amyloid precursor protein-cleaving enzyme-2|Y
β-site amyloid precursor protein-cleaving enzyme-1|β-site amyloid precursor protein-cleaving enzyme 1|Y
β-site amyloid precursor protein-cleaving enzyme-1|β site amyloid precursor protein-cleaving enzyme-1|Y
β-site amyloid precursor protein-cleaving enzyme-1|β-site amyloid precursor protein-cleaving enzyme|Y
insulin/IGF-1 signaling|insulin/IGF1 signaling|Y
insulin/IGF-1 signaling|insulin/IGF-1 signalling|Y
microtubule associated protein-2|microtubule associated protein-2c|Y
microtubule associated protein-2|microtubule associated protein-2C|Y
IL5 receptor α-chain|IL-5 receptor α-chain|Y
dehydro-epiandrosterone sulfate sulfatase|dehydroepiandrosterone sulfate sulfatase|Y
extra-thyroidal extension|extrathyroidal extension|Y
extra-pyramidal syndrome|extrapyramidal syndrome|Y
minimally invasive radio-guided parathyroidectomy|minimally invasive radioguided parathyroidectomy|Y
minimally invasive radio-guided parathyroidectomy|minimally invasive radio guided parathyroidectomy|Y
Trail Making Test part A|Trail Making Test, part A|Y
semiquantitative scoring system|semi-quantitative scoring system|Y
retinoic-acid-receptor-related orphan receptor gamma T|retinoic-acid-receptor-related orphan receptor gamma t|Y
retinoic-acid-receptor-related orphan receptor gamma T|retinoic-acid-receptor-related orphan receptor gamma|Y
retinoic-acid-receptor-related orphan receptor gamma T|retinoic-acid-receptor-related orphan receptor gammaT|Y
retinoic-acid-receptor-related orphan receptor gamma T|retinoic-acid-receptor-related orphan receptor gamma-T|Y
Toll-interleukin 1 receptor domain-containing adapter-inducing interferon-β|Toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
Toll-interleukin 1 receptor domain-containing adapter-inducing interferon-β|toll-interleukin 1 receptor domain-containing adapter-inducing interferon-β|Y
Toll-interleukin 1 receptor domain-containing adapter-inducing interferon-β|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon β|Y
Toll-interleukin 1 receptor domain-containing adapter-inducing interferon-β|Toll-interleukin1 receptor domain-containing adapter-inducing interferon β|Y
Toll-interleukin 1 receptor domain-containing adapter-inducing interferon-β|toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
Toll-interleukin 1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin 1 receptor domain-containing adapter-inducing interferon-β|Y
Toll-interleukin 1 receptor domain-containing adapter-inducing interferon-β|Toll-interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
Toll-interleukin 1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
electrospray ionisation quadrupole ion trap mass spectrometry|electrospray ionisation quadrupole ion trap mass spectrometer|Y
fragile X-associated tremor/ataxia syndrome|Fragile X-associated tremor/ataxia syndrome|Y
fragile X-associated tremor/ataxia syndrome|fragile X-associated tremor ataxia syndrome|Y
fragile X-associated tremor/ataxia syndrome|fragile X-associated tremor-ataxia syndrome|Y
lymphocyte function-associated antigen 3|lymphocyte function-associated antigen 1|Y
lymphocyte function-associated antigen 3|lymphocyte function-associated antigen-3|Y
transesophageal Doppler|trans-esophageal Doppler|Y
beta-aminobutyric acid|beta-amino butyric acid|Y
beta-aminobutyric acid|beta-amino-butyric acid|Y
nonintensive care unit|non-intensive care unit|Y
meta-chlorophenylbiguanide|meta-chloro-phenylbiguanide|Y
meta-chlorophenylbiguanide|meta-chlorophenyl-biguanide|Y
intracavernous pressure|intra-cavernous pressure|Y
potassium-chloride cotransporter|potassium-chloride co-transporter|Y
Neuropsychiatric Inventory-Nursing Home Version|Neuropsychiatric Inventory-Nursing Home version|Y
monophosphoglycerate mutase|mono-phosphoglycerate mutase|Y
hyperthermic intra-peritoneal chemotherapy|hyperthermic intraperitoneal chemotherapy|Y
benzo[a]pyrene diolepoxide-DNA adduct|benzo[a]pyrene diol epoxide-DNA adduct|Y
benzo[a]pyrene diolepoxide-DNA adduct|benzo[a]pyrene diol-epoxide-DNA adduct|Y
prostaglandin-F(2)alpha|prostaglandin-F(2) alpha|Y
tumour associated tissue eosinophilia|tumor associated tissue eosinophilia|Y
RNA III inhibiting peptide|RNAIII inhibiting peptide|Y
anti-IL 8 receptor antibody|anti-IL8 receptor antibody|Y
excitatory post-synaptic current|excitatory postsynaptic current|Y
Bardet-Biedl syndrome gene 11|Bardet-Biedl syndrome gene 1|Y
spleen colony-forming unit|spleen colony-forming units|Y
neurovesical dysfunction|neuro-vesical dysfunction|Y
gas chromatography-negative ion chemical ionization-mass spectrometry|gas chromatography-negative ion chemical ionisation-mass spectrometry|Y
gas chromatography-negative ion chemical ionization-mass spectrometry|gas chromatography-negative ion chemical ionization mass spectrometry|Y
gas chromatography-negative ion chemical ionization-mass spectrometry|gas chromatography-negative-ion chemical ionization-mass spectrometry|Y
gas chromatography-negative ion chemical ionization-mass spectrometry|gas chromatography/negative ion chemical ionization-mass spectrometry|Y
interleukin-6 receptor α|interleukine-6 receptor α|Y
peptidyl-glycine-α-amidating monooxygenase|peptidylglycine-α-amidating monooxygenase|Y
peptidyl-glycine-α-amidating monooxygenase|peptidyl-glycine-α-amidating mono-oxygenase|Y
peptidyl-glycine-α-amidating monooxygenase|peptidyl-glycine α-amidating monooxygenase|Y
peptidyl-glycine-α-amidating monooxygenase|peptidylglycine-α-amidating mono-oxygenase|Y
anti-ethinyl-oestradiol antibody|anti-ethinyl-estradiol antibody|Y
anti-ethinyl-oestradiol antibody|anti-ethinyloestradiol antibody|Y
surface-assisted laser desorption/ionisation-mass spectrometry|surface-assisted laser desorption/ionization-mass spectrometry|Y
surface-assisted laser desorption/ionisation-mass spectrometry|surface-assisted laser desorption/ionisation mass spectrometry|Y
surface-assisted laser desorption/ionisation-mass spectrometry|surface-assisted laser desorption ionisation-mass spectrometry|Y
uterovaginal junction|utero-vaginal junction|Y
immuno-suppressive substance|immunosuppressive substance|Y
betamethasone valerate|beta-methasone valerate|Y
antiinterleukin 13 antibody|antiinterleukin 3 antibody|Y
antiinterleukin 13 antibody|antiinterleukin 1 antibody|Y
antiinterleukin 13 antibody|anti-interleukin 13 antibody|Y
pulmonary veno-occlusive disease|pulmonary venoocclusive disease|Y
gamma-glutamylcysteine synthetase|gammaglutamylcysteine synthetase|Y
nonmethylene-interrupted|non-methylene-interrupted|Y
Sinonasal Outcome Test 20|Sino-nasal Outcome Test 20|Y
ribosomal protein S9|ribosomal protein S19|Y
ribosomal protein S9|ribosomal protein S29|Y
transcription factor AP2γ|transcription factor AP-2γ|Y
transcription factor AP2γ|transcription factor AP 2γ|Y
National Cholesterol Education Program Adult Treatment Panel I|National Cholesterol Education Program Adult Treatment Panel III|Y
National Cholesterol Education Program Adult Treatment Panel I|National Cholesterol Education Program Adult Treatment Panel|Y
National Cholesterol Education Program Adult Treatment Panel I|National Cholesterol Education Program Adult Treatment Panel II|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor-cell-expressed developmentally downregulated 1|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor cell-expressed developmentally downregulated 9|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor cell-expressed developmentally down-regulated 9|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor-cell-expressed, developmentally downregulated 1|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor cell-expressed, developmentally downregulated 2|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor cell-expressed developmentally downregulated 4|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor cell-expressed, developmentally downregulated 4|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor cell-expressed developmentally down-regulated 8|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor cell-expressed developmentally down-regulated 1|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor cell-expressed developmentally downregulated 2|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor cell-expressed, developmentally downregulated 9|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor cell-expressed, developmentally down-regulated 1|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor cell-expressed developmentally downregulated 8|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor cell-expressed developmentally downregulated 5|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor cell-expressed, developmentally downregulated 5|Y
neural-precursor cell-expressed developmentally downregulated 1|neural precursor cell-expressed developmentally down-regulated 1|Y
neural-precursor cell-expressed developmentally downregulated 1|neural precursor cell-expressed developmentally downregulated 1|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor-cell-expressed developmentally down-regulated 1|Y
neural-precursor cell-expressed developmentally downregulated 1|neural precursor cell-expressed, developmentally downregulated 1|Y
neural-precursor cell-expressed developmentally downregulated 1|neural-precursor cell-expressed, developmentally downregulated 1|Y
hypersomnia-sleep apnea|hypersomnia-sleep apnoea|Y
interleukin-2 receptor common γ chain|interleukine-2 receptor common γ chain|Y
procollagen type I C-terminal propeptide|procollagen type I N-terminal propeptide|Y
chronic prostatitis-chronic pelvic pain syndrome|chronic prostatitis/chronic pelvic pain syndrome|Y
human T-cell leukemia virus type 1-infected|human T-cell leukemia virus type I-infected|Y
human T-cell leukemia virus type 1-infected|human T-cell leukemia virus type-1-infected|Y
human T-cell leukemia virus type 1-infected|human T cell leukemia virus type 1-infected|Y
Hereditary hypophosphatemic rickets with hypercalciuria|hereditary hypophosphatemic rickets with hypercalciuria|Y
human Mut-L homolog 1|human MutL homolog 1|Y
technetium-99m methoxy isobutyl isonitrile|technetium-99m methoxyisobutyl isonitrile|Y
technetium-99m methoxy isobutyl isonitrile|technetium-99m-methoxy isobutyl isonitrile|Y
technetium-99m methoxy isobutyl isonitrile|technetium-99m methoxyisobutylisonitrile|Y
choline-deficient, ethionine-supplemented|choline deficient, ethionine-supplemented|Y
choline-deficient, ethionine-supplemented|choline-deficient, ethionine supplemented|Y
choline-deficient, ethionine-supplemented|choline-deficient ethionine-supplemented|Y
anti-interleukin12 neutralising antibody|antiinterleukin-12 neutralising antibody|Y
anti-interleukin12 neutralising antibody|anti-interleukin-12 neutralising antibody|Y
anti-interleukin12 neutralising antibody|anti-interleukin 12 neutralising antibody|Y
radioisotope cisternography|radio-isotope cisternography|Y
interferon-stimulated gene factor 3gamma|interferon-stimulated gene factor-3gamma|Y
anti-interleukin 1 receptor antibody|antiinterleukin 1 receptor antibody|Y
anti-interleukin 1 receptor antibody|anti-interleukin 10 receptor antibody|Y
immuno-reactive atrial natriuretic peptide|immunoreactive atrial natriuretic peptide|Y
anti-polyribosylribitolphosphate antibody|anti-polyribosyl-ribitol phosphate antibody|Y
anti-polyribosylribitolphosphate antibody|antipolyribosylribitolphosphate antibody|Y
anti-polyribosylribitolphosphate antibody|anti-polyribosylribitol phosphate antibody|Y
anti-polyribosylribitolphosphate antibody|anti-polyribosyl ribitol phosphate antibody|Y
intra-ventromedial hypothalamic|intraventromedial hypothalamic|Y
ligand-induced binding sites|ligand-induced binding site|Y
recombinant human granulocyte-macrophage colony-stimulating factor|recombinant human granulocyte-macrophage colony stimulating factor|Y
American Society of Anaesthesiology Class IV|American Society of Anaesthesiology class IV|Y
American Society of Anaesthesiology Class IV|American Society of Anesthesiology Class I|Y
American Society of Anaesthesiology Class IV|American Society of Anaesthesiology Class I|Y
American Society of Anaesthesiology Class IV|American Society of Anesthesiology Class IV|Y
American Society of Anaesthesiology Class IV|American Society of Anaesthesiology Class II|Y
American Society of Anaesthesiology Class IV|American Society of Anaesthesiology Class V|Y
American Society of Anaesthesiology Class IV|American Society of Anesthesiology Class V|Y
γ-amino butyric acidB receptor|γ-aminobutyric acidB receptor|Y
γ-amino butyric acidB receptor|γ-amino butyric acid-B receptor|Y
γ-amino butyric acidB receptor|γ-amino butyric acid B receptor|Y
melanocyte-stimulating hormone release-inhibiting factor-1|melanocyte-stimulating hormone release-inhibiting factor|Y
melanocyte-stimulating hormone release-inhibiting factor-1|melanocyte-stimulating hormone release-inhibiting factor 1|Y
delayed non-matching-to-sample|delayed nonmatching-to-sample|Y
Src homology 2-containing protein-tyrosine phosphatase-1|Src homology 2-containing protein-tyrosine phosphatase 1|Y
Src homology 2-containing protein-tyrosine phosphatase-1|Src homology 2-containing protein-tyrosine phosphatase-2|Y
paraanastomotic aneurism|para-anastomotic aneurism|Y
galactorrhoea-amenorrhœa hyperprolactinæmia syndrome|galactorrhoea-amenorrhœa hyperprolactinemia syndrome|Y
galactorrhoea-amenorrhœa hyperprolactinæmia syndrome|galactorrhoea amenorrhœa hyperprolactinæmia syndrome|Y
galactorrhoea-amenorrhœa hyperprolactinæmia syndrome|galactorrhea-amenorrhœa hyperprolactinæmia syndrome|Y
galactorrhoea-amenorrhœa hyperprolactinæmia syndrome|galactorrhoea-amenorrhea hyperprolactinæmia syndrome|Y
surface enhanced laser desorption/ionization time of flight|surface-enhanced laser desorption/ionization time of flight|Y
surface enhanced laser desorption/ionization time of flight|surface enhanced laser desorption/ionisation time of flight|Y
anti-interleukin-18 monoclonal antibody|anti-interleukin-8 monoclonal antibody|Y
decayed, missing, and filled teeth index|decayed, missing and filled teeth index|Y
immunoglobulin superfamily 4|immunoglobulin superfamily 4B|Y
immunoglobulin superfamily 4|immunoglobulin superfamily 4C|Y
immunoglobulin superfamily 4|immunoglobulin superfamily 4A|Y
American Orthopedic Foot and Ankle Society|American Orthopaedic Foot and Ankle Society|Y
crystallizable fragment gamma receptor IIB|crystallizable fragment gamma receptor IIA|Y
crystallizable fragment gamma receptor IIB|crystallizable fragment gamma receptor IIa|Y
paraacetamidohippuric acid|para-acetamidohippuric acid|Y
United Network for Organ Sharing status 4|United Network for Organ Sharing status 3|Y
United Network for Organ Sharing status 4|United Network for Organ Sharing status I|Y
United Network for Organ Sharing status 4|United Network for Organ Sharing status 1|Y
United Network for Organ Sharing status 4|United Network for Organ Sharing status 2|Y
matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight mass spectrometry|matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight mass spectrometer|Y
matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight mass spectrometry|matrix-assisted laser desorption/ionisation quadrupole ion trap time-of-flight mass spectrometry|Y
matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight mass spectrometry|matrix-assisted laser desorption/ionisation quadrupole ion trap time-of-flight mass spectrometer|Y
nitro-cellulose membrane|nitrocellulose membrane|Y
uni-compartmental knee replacement|unicompartmental knee replacement|Y
sea surface microlayer|sea surface micro-layer|Y
medial forebrain bundle|medial fore-brain bundle|Y
anti-hypertensive treatment|antihypertensive treatment|Y
hereditary hypophosphataemic rickets with hypercalciuria|hereditary hypophosphatemic rickets with hypercalciuria|Y
malignancy associated changes|malignancy associated change|Y
adenosine 3'-5'-monophosphate|adenosine 3'5'-monophosphate|Y
excision repair cross complementing group 1|excision repair cross-complementing group 1|Y
excision repair cross complementing group 1|excision repair cross complementing-group 1|Y
excision repair cross complementing group 1|excision repair cross complementing group 4|Y
excision repair cross complementing group 1|excision repair cross complementing group 5|Y
excision repair cross complementing group 1|excision repair cross complementing group 2|Y
excision repair cross complementing group 1|excision repair cross complementing group 6|Y
experimental auto-immune encephalomyelitis|experimental autoimmune encephalomyelitis|Y
Anatomical Therapeutic Chemical Classification|Anatomic Therapeutic Chemical Classification|Y
membrane-associated guanylate kinase-interacting protein-2|membrane-associated guanylate kinase-interacting protein|Y
high-resolution gas chromatography-mass spectrometry|high-resolution gas chromatography/mass spectrometry|Y
high-resolution gas chromatography-mass spectrometry|high resolution gas chromatography-mass spectrometry|Y
hydroperoxy-octadecadienoic acid|hydroperoxyoctadecadienoic acid|Y
single-chain urokinase-type plasminogen activator|single chain urokinase-type plasminogen activator|Y
pigeon-breeder's lung|pigeon-breeders lung|Y
non-muscle myosin heavy chain|nonmuscle myosin heavy chain|Y
multiple ligation probe amplification|multiplex ligation probe amplification|Y
chronic infantile neurologic cutaneous and articular|chronic infantile neurological cutaneous and articular|Y
para-nitrophenylphosphatase|paranitrophenylphosphatase|Y
para-nitrophenylphosphatase|para-nitrophenyl-phosphatase|Y
American Society of Anaesthesiology physical status V|American Society of Anaesthesiology physical status 4|Y
American Society of Anaesthesiology physical status V|American Society of Anaesthesiology physical status 2|Y
American Society of Anaesthesiology physical status V|American Society of Anesthesiology physical status IV|Y
American Society of Anaesthesiology physical status V|American Society of Anaesthesiology physical status 3|Y
American Society of Anaesthesiology physical status V|American Society of Anaesthesiology physical status I|Y
American Society of Anaesthesiology physical status V|American Society of Anaesthesiology physical status 5|Y
American Society of Anaesthesiology physical status V|American Society of Anaesthesiology physical status 1|Y
American Society of Anaesthesiology physical status V|American Society of Anaesthesiology physical status|Y
American Society of Anaesthesiology physical status V|American Society of Anaesthesiology physical status IV|Y
sub-orbicularis oculi fat pad lift|suborbicularis oculi fat pad lift|Y
transcriptional intermediary factor 1γ|transcriptional intermediary factor 1 γ|Y
insulinlike growth factor 1|insulin-like growth factor 1|Y
super-resolution near-field structure|superresolution near-field structure|Y
noninvasive blood pressure|non-invasive blood pressure|Y
noninvasive blood pressure|non invasive blood pressure|Y
extra-renal Wilms' tumor|extra-renal Wilms' tumour|Y
extra-renal Wilms' tumor|extra-renal Wilms tumor|Y
non-bacterial prostatitis|nonbacterial prostatitis|Y
calcium-ethylene diamine tetra acetic acid|calcium-ethylenediamine tetraacetic acid|Y
nicotinamide adenine dinucleotide phosphatase II|nicotinamide adenine dinucleotide phosphatase I|Y
arbuscular mycorrhizal|arbuscular mycorrhiza|Y
N-acetylglucosaminidase|N-acetyl-glucosaminidase|Y
N-acetylglucosaminidase|N-acetyl glucosaminidase|Y
recombinant human follicle stimulating hormone|recombinant human follicle-stimulating hormone|Y
Salmonella-induced filament|Salmonella-induced filaments|Y
Bos taurus autosome 10|Bos taurus autosome 1|Y
musculus semitendinosus|musculus semi-tendinosus|Y
sino-aortic denervation|sinoaortic denervation|Y
forkhead box class other 3a|forkhead box class other 3|Y
fœtomaternal hæmorrhage|fœto-maternal hæmorrhage|Y
depolymerized holothurian glycosaminoglycan|depolymerised holothurian glycosaminoglycan|Y
Los Angeles County/University of Southern California Medical Center|Los Angeles County University of Southern California Medical Center|Y
Los Angeles County/University of Southern California Medical Center|Los Angeles County-University of Southern California Medical Center|Y
T-type voltage-dependent calcium channel|T-type voltage dependent calcium channel|Y
Radiation Therapy Oncology Group Grade 1|Radiation Therapy Oncology Group Grade 4|Y
Radiation Therapy Oncology Group Grade 1|Radiation Therapy Oncology Group Grade 2|Y
Radiation Therapy Oncology Group Grade 1|Radiation Therapy Oncology Group Grade 3|Y
Radiation Therapy Oncology Group Grade 1|Radiation Therapy Oncology Group Grade 0|Y
intra-hepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma|Y
glycogen-accumulating organism|glycogen-accumulating organisms|Y
manganese (III) tetraphenylporphine sulfonate|manganese(III) tetraphenylporphine sulfonate|Y
antiherpes simplex virus type 1|anti-herpes simplex virus type 1|Y
src homology 2 domain containing protein tyrosine phosphatase-2|src homology 2 domain containing protein tyrosine phosphatase 2|Y
src homology 2 domain containing protein tyrosine phosphatase-2|src homology 2 domain-containing protein tyrosine phosphatase-2|Y
src homology 2 domain containing protein tyrosine phosphatase-2|Src homology 2 domain containing protein tyrosine phosphatase-2|Y
transient-receptor-potential like channel|transient-receptor-potential-like channel|Y
transforming growth factor-β-activated kinase 1|transforming growth factor β-activated kinase 1|Y
transforming growth factor-β-activated kinase 1|transforming growth factor-β-activated kinase-1|Y
amino-imidazoazaarene|aminoimidazoazaarene|Y
aryl hydrocarbon receptor-interacting protein|aryl-hydrocarbon receptor-interacting protein|Y
Neisseria gonorrheae|Neisseria gonorrhoeae|Y
prenylated-protein carboxyl methyltransferase|prenylated protein carboxyl methyltransferase|Y
vulvar intraepithelial neoplasia grade 1|vulvar intraepithelial neoplasia grade 3|Y
Mueller-Lyer illusion|Muller-Lyer illusion|Y
recombinant prourokinase|recombinant pro-urokinase|Y
echinoderm microtubule-associated protein|echinoderm microtubule associated protein|Y
computerised tomography|computerised tomograph|Y
anti-interleukin-12p40 monoclonal antibody|anti-interleukin-12p70 monoclonal antibody|Y
noncontrast helical computed tomography|non-contrast helical computed tomography|Y
flavine mono-oxygenase|flavin mono-oxygenase|Y
Na-K-Cl cotransporter 2|Na-K-Cl co-transporter 2|Y
University of California Davis|University of California, Davis|Y
kinesin family member 18A|kinesin family member 1A|Y
totally extra-peritoneal inguinal hernioplasty|totally extraperitoneal inguinal hernioplasty|Y
male to female transsexual|male to female trans-sexual|Y
non-selective cation current|nonselective cation current|Y
Charcot-Marie-Tooth disease type 2|Charcot-Marie-Tooth disease type 2D|Y
Charcot-Marie-Tooth disease type 2|Charcot-Marie-Tooth disease type 2B|Y
Charcot-Marie-Tooth disease type 2|Charcot-Marie-Tooth disease type 2A|Y
Plasmodium vivax merozoite surface protein|Plasmodium vivax merozoite surface protein 3|Y
Plasmodium vivax merozoite surface protein|Plasmodium vivax merozoite surface protein 9|Y
Plasmodium vivax merozoite surface protein|Plasmodium vivax merozoite surface protein 1|Y
self-assembled monolayer|self-assembled monolayers|Y
intra-discal electro-thermal therapy|intra-discal electrothermal therapy|Y
intra-discal electro-thermal therapy|intradiscal electro-thermal therapy|Y
CXC chemokine receptor 2|CC chemokine receptor 2|Y
enteroinvasive Escherichia coli|entero-invasive Escherichia coli|Y
antiglomerular basement membrane glomerulonephritis|anti-glomerular basement membrane glomerulonephritis|Y
nuclear factor-erythroid 2p45-related factor 2|nuclear factor erythroid 2p45-related factor 2|Y
nuclear factor-erythroid 2p45-related factor 2|nuclear factor-erythroid 2 p45-related factor 2|Y
reduced nicotinamide adenine dinucleotide dehydrogenase subunit 1|reduced nicotinamide adenine dinucleotide dehydrogenase subunit 5|Y
Kruppel-like factor-2|Kruppel-like factor-12|Y
extremely low birth weight|extremely low birthweight|Y
t-butyl hydroperoxide|t-butylhydroperoxide|Y
B cell leukaemia/lymphoma 2|B cell leukemia/lymphoma 2|Y
combined internal medicine-pediatrics|combined internal medicine-paediatrics|Y
Rho GTPase-activating protein 1|RhoGTPase-activating protein 1|Y
acute non-lymphoblastic leukaemias|acute non-lymphoblastic leukaemia|Y
interleukin-13 receptor-α 2 subunit|interleukin-13 receptor-α2 subunit|Y
interleukin-13 receptor-α 2 subunit|interleukine-13 receptor-α 2 subunit|Y
pre-ornithine carbamyltransferase|pre-ornithine carbamyl transferase|Y
pre-ornithine carbamyltransferase|preornithine carbamyltransferase|Y
pre-ornithine carbamyltransferase|pre-ornithine carbamoyltransferase|Y
antiinterleukin 3 antibody|anti-interleukin 3 antibody|Y
α2C adrenergic receptor|α-2C adrenergic receptor|Y
α2C adrenergic receptor|α 2C adrenergic receptor|Y
multi-drug resistance protein|multidrug resistance protein|Y
extra-vehicular activity|extravehicular activity|Y
interstrand cross-links|interstrand cross-link|Y
randomised controlled trials|randomised controlled trial|Y
anticytomegalovirus immunoglobulin G|anti-cytomegalovirus immunoglobulin G|Y
immuno-biologic activity|immunobiologic activity|Y
phytohemagglutinin-P|phytohaemagglutinin-P|Y
T-cell receptor-γ δ-positive|T-cell receptor-γδ-positive|Y
methyl cytosine-phosphate-guanosine binding domain protein 2|methyl cytosine-phosphate-guanosine binding domain protein 3|Y
methyl cytosine-phosphate-guanosine binding domain protein 2|methyl cytosine-phosphate-guanosine binding domain protein 4|Y
methyl cytosine-phosphate-guanosine binding domain protein 2|methyl cytosine-phosphate-guanosine binding domain protein 1|Y
methyl cytosine-phosphate-guanosine binding domain protein 2|methyl cytosine-phosphate-guanosine binding domain protein|Y
human adenovirus serotype 49|human adenovirus serotype 4|Y
S-(2,4-dinitrophenyl)glutathione|S-(2,4-dinitrophenyl)-glutathione|Y
nucleo-acidic protein|nucleoacidic protein|Y
calcitonin-gene-related peptide immunoreactive nerve fiber|calcitonin-gene-related peptide immunoreactive nerve fibre|Y
calcitonin-gene-related peptide immunoreactive nerve fiber|calcitonin gene-related peptide immunoreactive nerve fiber|Y
calcitonin-gene-related peptide immunoreactive nerve fiber|calcitonin-gene-related peptide-immunoreactive nerve fiber|Y
persistent pulmonary hypertension of the newborn|Persistent pulmonary hypertension of the newborn|Y
receptor-like protein-tyrosine phosphatase κ|receptor-like protein-tyrosine phosphatase α|Y
receptor-like protein-tyrosine phosphatase κ|receptor-like protein-tyrosine phosphatase-κ|Y
receptor-like protein-tyrosine phosphatase κ|receptor-like protein tyrosine phosphatase κ|Y
receptor-like protein-tyrosine phosphatase κ|receptor-like protein-tyrosine phosphatase|Y
receptor-like protein-tyrosine phosphatase κ|receptor-like protein-tyrosine phosphatase ψ|Y
receptor-like protein-tyrosine phosphatase κ|receptor-like protein-tyrosine phosphatase η|Y
receptor-like protein-tyrosine phosphatase κ|receptor-like protein-tyrosine phosphatase δ|Y
receptor-like protein-tyrosine phosphatase κ|receptor-like protein-tyrosine phosphatase μ|Y
KNOTTED1-like homeobox|KNOTTED-like homeobox|Y
R-R multiple sclerosis|RR multiple sclerosis|Y
gated blood pool single photon emission computed tomography|gated blood pool single-photon emission computed tomography|Y
excision repair cross complementation group 5|excision repair cross complementation group 1|Y
excision repair cross complementation group 5|excision repair cross complementation group 4|Y
peroxisome-proliferator-activated receptor gamma coactivator-1alpha|peroxisome proliferator-activated receptor gamma coactivator-1alpha|Y
peroxisome-proliferator-activated receptor gamma coactivator-1alpha|peroxisome-proliferator-activated receptor gamma coactivator 1alpha|Y
peroxisome-proliferator-activated receptor gamma coactivator-1alpha|peroxisome proliferator-activated receptor gamma coactivator-1 alpha|Y
peroxisome-proliferator-activated receptor gamma coactivator-1alpha|peroxisome-proliferator-activated receptor-gamma coactivator-1 alpha|Y
peroxisome-proliferator-activated receptor gamma coactivator-1alpha|peroxisome-proliferator-activated receptor-gamma co-activator-1alpha|Y
peroxisome-proliferator-activated receptor gamma coactivator-1alpha|peroxisome proliferator-activated receptor gamma co-activator-1alpha|Y
peroxisome-proliferator-activated receptor gamma coactivator-1alpha|peroxisome-proliferator-activated receptor gamma coactivator 1 alpha|Y
peroxisome-proliferator-activated receptor gamma coactivator-1alpha|peroxisome-proliferator-activated receptor-gamma coactivator-1alpha|Y
peroxisome-proliferator-activated receptor gamma coactivator-1alpha|peroxisome-proliferator-activated receptor gamma coactivator-1 alpha|Y
American Nurses' Association|American Nurses Association|Y
post-transplantation diabetes mellitus|posttransplantation diabetes mellitus|Y
corticotrophin-releasing hormone receptor-2|corticotrophin-releasing-hormone receptor-2|Y
corticotrophin-releasing hormone receptor-2|corticotrophin-releasing hormone receptor-1|Y
corticotrophin-releasing hormone receptor-2|corticotropin-releasing hormone receptor-2|Y
corticotrophin-releasing hormone receptor-2|corticotrophin-releasing hormone receptor|Y
corticotrophin-releasing hormone receptor-2|corticotrophin releasing hormone receptor-2|Y
human adenovirus serotype 19|human adenovirus serotype 1|Y
interleukin 21 receptor|interleukin 1 receptor|Y
interleukin 21 receptor|interleukin 2 receptor|Y
volume-regulated anion channels|volume-regulated anion channel|Y
gamma-amino butyric acid type A|gamma-aminobutyric acid type A|Y
anti-glomerular basement membrane antibody|antiglomerular basement membrane antibody|Y
1,3-bis(2-chlorethyl)-1-nitrosourea|1,3-bis(2-chloroethyl)-1-nitrosourea|Y
microtubule-associated protein-1|microtubule-associated protein-1B|Y
microtubule-associated protein-1|microtubule-associated protein-1A|Y
Minnesota Multiphasic Personality Inventory 2|Minnesota Multiphasic Personality Inventory|Y
tumor-draining lymph nodes|tumor-draining lymph node|Y
paranitrophenylacetate|para-nitrophenylacetate|Y
anti-soluble egg antigen|antisoluble egg antigen|Y
platelet-derived growth factor-beta receptor|platelet-derived growth factor beta receptor|Y
platelet-derived growth factor-beta receptor|platelet derived growth factor-beta receptor|Y
interautogamous interval|inter-autogamous interval|Y
highly purified urinary follicle stimulating hormone|highly purified urinary follicle-stimulating hormone|Y
dinitro-fluorobenzene|dinitrofluorobenzene|Y
purinergic 2X3 receptor|purinergic 2X receptor|Y
autoimmunity-associated behavioural syndrome|autoimmunity associated behavioural syndrome|Y
autoimmunity-associated behavioural syndrome|autoimmunity-associated behavioral syndrome|Y
poly-DL-lactide-poly(ethylene glycol)|poly-DL-lactide-poly(ethylene glycol|Y
microglandular hyperplasia|micro-glandular hyperplasia|Y
trans-jugular intra-hepatic porto-caval shunt|transjugular intra-hepatic porto-caval shunt|Y
trans-jugular intra-hepatic porto-caval shunt|trans-jugular intra-hepatic portocaval shunt|Y
trans-jugular intra-hepatic porto-caval shunt|trans-jugular intrahepatic porto-caval shunt|Y
trans-jugular intra-hepatic porto-caval shunt|trans-jugular intrahepatic portocaval shunt|Y
cysteine-cysteine chemokine ligand 17|cysteine-cysteine chemokine ligand 7|Y
major aorto-pulmonary collateral artery|major aortopulmonary collateral artery|Y
retinoic acid inducible gene I-like receptor|retinoic acid-inducible gene I-like receptor|Y
corticotropin-releasing-hormone receptor-2|corticotrophin-releasing-hormone receptor-2|Y
corticotropin-releasing-hormone receptor-2|corticotropin-releasing hormone receptor-2|Y
corticotropin-releasing-hormone receptor-2|corticotropin-releasing-hormone receptor|Y
corticotropin-releasing-hormone receptor-2|corticotropin-releasing-hormone receptor 2|Y
dural arteriovenous fistula|dural arterio-venous fistula|Y
mass-analyzed threshold ionization spectrum|mass-analyzed threshold ionisation spectrum|Y
insulin-like growth factor-II mRNA binding protein 3|insulin-like growth factor-II mRNA binding protein 1|Y
insulin-like growth factor-II mRNA binding protein 3|insulin-like growth factor-II mRNA-binding protein 3|Y
insulin-like growth factor-II mRNA binding protein 3|insulin-like growth factor-II mRNA binding protein|Y
insulin-like growth factor-II mRNA binding protein 3|insulin-like growth factor II mRNA binding protein 3|Y
insulin-like growth factor-II mRNA binding protein 3|insulin-like growth factor-II mRNA binding protein-3|Y
paroxysmal kinesigenic choreoathetosis|paroxysmal kinesigenic choreo-athetosis|Y
corticotrophin-releasing factor receptor antagonist|corticotrophin releasing factor receptor antagonist|Y
de-epoxy-deoxynivalenol|deepoxy-deoxynivalenol|Y
G protein α(i3) subunit|G protein α(i) subunit|Y
non-insulinoma pancreatogenous hypoglycemia syndrome|non-insulinoma pancreatogenous hypoglycaemia syndrome|Y
thermo-reversible gelation polymer|thermoreversible gelation polymer|Y
testosterone-estrogen binding globulin|testosterone-oestrogen binding globulin|Y
antitubercular treatment|anti-tubercular treatment|Y
auditory brainstem evoked potentials|auditory brainstem evoked potential|Y
trichloro-dibenzofuran|trichlorodibenzofuran|Y
choline deficient, ethionine-supplemented|choline deficient ethionine-supplemented|Y
intertrial coherence|inter-trial coherence|Y
human T cell lymphotropic virus type I-associated myelopathy|human T-cell lymphotropic virus type I-associated myelopathy|Y
tumor necrosis factor receptor superfamily 1B|tumor necrosis factor receptor superfamily 1A|Y
B-cell leukaemia lymphoma 2|B-cell leukemia lymphoma 2|Y
dinitrofluorobenzene|dinitrofluoro-benzene|Y
ultraperformance liquid chromatography-electrospray ionisation tandem mass spectrometry|ultra performance liquid chromatography-electrospray ionisation tandem mass spectrometry|Y
ultraperformance liquid chromatography-electrospray ionisation tandem mass spectrometry|ultra performance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
ultraperformance liquid chromatography-electrospray ionisation tandem mass spectrometry|ultraperformance liquid chromatography/electrospray ionisation tandem mass spectrometry|Y
ultraperformance liquid chromatography-electrospray ionisation tandem mass spectrometry|ultra-performance liquid chromatography-electrospray ionisation tandem mass spectrometry|Y
ultraperformance liquid chromatography-electrospray ionisation tandem mass spectrometry|ultraperformance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
ultraperformance liquid chromatography-electrospray ionisation tandem mass spectrometry|ultra performance liquid chromatography/electrospray ionisation tandem mass spectrometry|Y
ultraperformance liquid chromatography-electrospray ionisation tandem mass spectrometry|ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
non-thyroidal illness|nonthyroidal illness|Y
calcium pyroantimonate|calcium pyro-antimonate|Y
peroxisome proliferator-activated receptor γ coactivator 1α|peroxisome proliferator-activated receptor γ coactivator 1 α|Y
peroxisome proliferator-activated receptor γ coactivator 1α|peroxisome proliferator-activated receptor γ coactivator-1α|Y
peroxisome proliferator-activated receptor γ coactivator 1α|peroxisome-proliferator-activated receptor γ coactivator 1α|Y
peroxisome proliferator-activated receptor γ coactivator 1α|peroxisome proliferator-activated receptor γ coactivator 1|Y
peroxisome proliferator-activated receptor γ coactivator 1α|peroxisome proliferator-activated receptor γ co-activator 1 α|Y
peroxisome proliferator-activated receptor γ coactivator 1α|peroxisome proliferator-activated receptor γ co-activator 1|Y
peroxisome proliferator-activated receptor γ coactivator 1α|peroxisome proliferator-activated receptor γ co-activator 1α|Y
microtubule-associated protein-1 light-chain 3|microtubule-associated protein 1 light-chain 3|Y
microtubule-associated protein-1 light-chain 3|microtubule associated protein-1 light-chain 3|Y
β-ketoacyl acyl carrier protein synthase|β-ketoacyl acyl carrier protein synthase I|Y
β-ketoacyl acyl carrier protein synthase|β-ketoacyl-acyl carrier protein synthase|Y
Clinical Global Impressions-severity scale|Clinical Global Impressions severity scale|Y
Clinical Global Impressions-severity scale|Clinical Global Impressions-Severity scale|Y
saturation-transfer electron paramagnetic resonance|saturation transfer electron paramagnetic resonance|Y
phospholipase C gamma-1|phospholipase Cgamma-1|Y
anti-intercellular adhesion molecule-1 monoclonal antibody|anti-intercellular adhesion molecule 1 monoclonal antibody|Y
anti-neutrophil cytoplasmic autoantibody|antineutrophil cytoplasmic autoantibody|Y
2-hydroxyethylmethacrylate|2-hydroxyethyl methacrylate|Y
American Society of Anesthesiologists status 1|American Society of Anesthesiologists status 2|Y
American Society of Anesthesiologists status 1|American Society of Anesthesiologists status 3|Y
American Society of Anesthesiologists status 1|American Society of Anesthesiologists status 4|Y
American Society of Anesthesiologists status 1|American Society of Anesthesiologists status V|Y
American Society of Anesthesiologists status 1|American Society of Anesthesiologists status I|Y
American Society of Anesthesiologists status 1|American Society of Anesthesiologists status 5|Y
American Society of Anesthesiologists status 1|American Society of Anesthesiologists Status 1|Y
American Society of Anesthesiologists status 1|American Society of Anaesthesiologists status 1|Y
X-linked alpha-thalassemia/mental retardation syndrome|X-linked alpha-thalassemia mental retardation syndrome|Y
phorbol ester-mediated|phorbolester-mediated|Y
G-protein coupled receptors|G-protein coupled receptor|Y
cortico-medullary zone|corticomedullary zone|Y
glycosyl phosphatidyl inositol anchored|glycosyl phosphatidylinositol anchored|Y
postero-inferior cerebellar artery|posteroinferior cerebellar artery|Y
phenyl isothiocyanate|phenylisothiocyanate|Y
adenosine triphosphate pyrophosphatelyase|adenosine triphosphate pyrophosphate-lyase|Y
interleukin-12 receptor β2 chain|interleukin-12 receptor β 2 chain|Y
ultra-weak photon emission|ultraweak photon emission|Y
oligo-asthenoteratozoospermia|oligo-astheno-teratozoospermia|Y
oligo-asthenoteratozoospermia|oligoasthenoteratozoospermia|Y
5-alpha-dihydrotestosterone|5alpha-dihydrotestosterone|Y
diamidinophenylindole|diamidino-phenylindole|Y
filtering face-piece respirator|filtering facepiece respirator|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motifs-3|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motif-15|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motifs-18|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motif-14|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motifs-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motifs|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motifs-13|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motifs-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motifs-4|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motifs-2|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motifs-9|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motifs-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motifs-19|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
a disintegrin and metalloprotease with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
inter-laminar shear strength|interlaminar shear strength|Y
Haematopoietic Cell Transplantation-Specific Comorbidity Index|Hematopoietic Cell Transplantation-Specific Comorbidity Index|Y
non-adrenergic, non-cholinergic|nonadrenergic, non-cholinergic|Y
non-adrenergic, non-cholinergic|non-adrenergic non-cholinergic|Y
beta-ketoacyl acyl-carrier protein reductase|beta-ketoacyl acyl carrier protein reductase|Y
granulocyte-macrophage colony forming cells|granulocyte-macrophage colony-forming cells|Y
signal transducer and activator of transcription-3 protein|signal transducer and activator of transcription 3 protein|Y
signal transducer and activator of transcription-3 protein|signal transducer and activator of transcription protein|Y
tert-butyldimethylsilyl derivative|tert-butyl-dimethylsilyl derivative|Y
tert-butyldimethylsilyl derivative|tert-butyl dimethylsilyl derivative|Y
gastric enterochromaffinlike cell|gastric enterochromaffin-like cell|Y
oestrogen receptor-α knockout|oestrogen receptor-α knock out|Y
oestrogen receptor-α knockout|estrogen receptor-α knockout|Y
oestrogen receptor-α knockout|oestrogen receptor-α knock-out|Y
chicken gonadotropin-releasing hormone|chicken gonadotrophin-releasing hormone|Y
periodic acid-thiocarbohydrazide silver proteinate|periodic acid-thio carbohydrazide silver proteinate|Y
periodic acid-thiocarbohydrazide silver proteinate|periodic acid-thiocarbohydrazide-silver proteinate|Y
cardioacceleratory peptide 2b|cardioacceleratory peptide 2|Y
idiopathic thrombo-cytopaenia|idiopathic thrombo-cytopenia|Y
serum αfetoprotein level|serum αfoetoprotein level|Y
serum αfetoprotein level|serum α-fetoprotein level|Y
glucose-6-phosphatase catalytic subunit 3|glucose-6-phosphatase catalytic subunit 2|Y
human metapneumovirus|human meta-pneumovirus|Y
antiinterleukin 10 antibody|antiinterleukin 1 antibody|Y
antiinterleukin 10 antibody|anti-interleukin 10 antibody|Y
ventilatory associated pneumonia|ventilator associated pneumonia|Y
colony forming units-granulocyte-macrophage|colony-forming units-granulocyte-macrophage|Y
colony forming units-granulocyte-macrophage|colony forming units granulocyte-macrophage|Y
alpha-methyl-paratyrosine|alpha-methyl-para-tyrosine|Y
alpha-methyl-paratyrosine|alpha-methylparatyrosine|Y
transporter associated with antigen processing|transporter associated with antigen processing 1|Y
transporter associated with antigen processing|transporter associated with antigen processing 2|Y
urease-positive thermophilic Campylobacter|urease-positive thermophilic campylobacter|Y
bone γ-carboxyglutamic acid-containing protein|bone γ-carboxyglutamic acid containing protein|Y
Charcot neuro-arthropathy|Charcot neuroarthropathy|Y
colo-rectal metastasis|colorectal metastasis|Y
cycloinulooligosaccharide fructanotransferase|cycloinulo-oligosaccharide fructanotransferase|Y
auto-correlation function analysis|autocorrelation function analysis|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labelling|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling|Y
dystrophin-associated glycoprotein complex|dystrophin associated glycoprotein complex|Y
endotracheal intubation|endo-tracheal intubation|Y
optoelectronic plethysmography|opto-electronic plethysmography|Y
tubero-mammillary nucleus|tubero-mamillary nucleus|Y
chemotherapy induced diarrhoea|chemotherapy induced diarrhea|Y
endoluminal ultrasound|endo-luminal ultrasound|Y
vasopressin 2 receptor agonist|vasopressin V2 receptor agonist|Y
self-amplified spontaneous-emission free electron laser|self-amplified spontaneous-emission free-electron laser|Y
self-amplified spontaneous-emission free electron laser|self-amplified spontaneous emission free electron laser|Y
temperature programmed desorption|temperature programed desorption|Y
glycogen accumulating organisms|glycogen accumulating organism|Y
American Orthopedic Foot and Ankle Society ankle hindfoot score|American Orthopedic Foot and Ankle Society ankle-hindfoot score|Y
American Orthopedic Foot and Ankle Society ankle hindfoot score|American Orthopaedic Foot and Ankle Society ankle hindfoot score|Y
American Orthopedic Foot and Ankle Society ankle hindfoot score|American Orthopedic Foot and Ankle Society ankle-hind foot score|Y
American Orthopedic Foot and Ankle Society ankle hindfoot score|American Orthopaedic Foot and Ankle Society ankle-hindfoot score|Y
isotope-coded affinity tags|isotope-coded affinity tag|Y
pheromone biosynthesis-activating neuropeptide|pheromone biosynthesis activating neuropeptide|Y
pheromone biosynthesis-activating neuropeptide|pheromone-biosynthesis-activating neuropeptide|Y
EuroCollins solution|Euro-Collins solution|Y
toll-IL-1 receptor domain-containing adaptor-inducing IFNbeta|Toll-IL-1 receptor domain-containing adaptor-inducing IFN-beta|Y
toll-IL-1 receptor domain-containing adaptor-inducing IFNbeta|Toll-IL-1 receptor domain-containing adaptor-inducing IFNbeta|Y
toll-IL-1 receptor domain-containing adaptor-inducing IFNbeta|toll-IL-1 receptor domain-containing adaptor-inducing IFN-beta|Y
toll-IL-1 receptor domain-containing adaptor-inducing IFNbeta|toll/IL-1 receptor domain-containing adaptor-inducing IFNbeta|Y
toll-IL-1 receptor domain-containing adaptor-inducing IFNbeta|toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta|Y
technetium-99m methoxyisobutyl isonitrile|technetium-99m methoxyisobutylisonitrile|Y
thyroid growth stimulating immunoglobulin|thyroid growth-stimulating immunoglobulin|Y
thyroid growth stimulating immunoglobulin|thyroid growth stimulating immunoglobulins|Y
degenerate oligonucleotide-primed-polymerase chain reaction|degenerate oligonucleotide-primed polymerase chain reaction|Y
degenerate oligonucleotide-primed-polymerase chain reaction|degenerate oligonucleotide primed-polymerase chain reaction|Y
centrosome and Golgi localised protein kinase N-associated protein|centrosome- and Golgi-localised protein kinase N-associated protein|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1 alpha|peroxisome-proliferator-activated receptor-gamma coactivator 1alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1 alpha|peroxisome-proliferator-activated receptor gamma coactivator 1alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1 alpha|peroxisome proliferator-activated receptor-gamma coactivator 1alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1 alpha|peroxisome-proliferator-activated receptor-gamma coactivator-1 alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1 alpha|peroxisome-proliferator-activated receptor-gamma co-activator 1 alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1 alpha|peroxisome-proliferator-activated receptor-gamma co-activator-1 alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1 alpha|peroxisome-proliferator-activated receptor-gamma co-activator 1alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1 alpha|peroxisome proliferator-activated receptor-gamma coactivator 1 alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1 alpha|peroxisome proliferator-activated receptor-gamma co-activator 1 alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1 alpha|peroxisome-proliferator-activated receptor gamma coactivator 1 alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1 alpha|peroxisome-proliferator-activated receptor-gamma coactivator-1alpha|Y
galactorrhea amenorrhœa hyperprolactinaemia syndrome|galactorrhœa amenorrhœa hyperprolactinaemia syndrome|Y
galactorrhea amenorrhœa hyperprolactinaemia syndrome|galactorrhea-amenorrhœa hyperprolactinaemia syndrome|Y
galactorrhea amenorrhœa hyperprolactinaemia syndrome|galactorrhoea amenorrhœa hyperprolactinemia syndrome|Y
galactorrhea amenorrhœa hyperprolactinaemia syndrome|galactorrhoea amenorrhœa hyperprolactinaemia syndrome|Y
galactorrhea amenorrhœa hyperprolactinaemia syndrome|galactorrhea amenorrhœa hyperprolactinemia syndrome|Y
intra-cranial electroencephalography|intracranial electroencephalography|Y
anti-tuberculous drug|antituberculous drug|Y
catechol orthomethyltransferase|catechol ortho-methyltransferase|Y
para-hydroxyphenylacetaldoxime|para-hydroxyphenyl-acetaldoxime|Y
secondary optokinetic afternystagmus|secondary optokinetic after-nystagmus|Y
depolarizing afterpotential|depolarizing after-potential|Y
depolarizing afterpotential|depolarizing afterpotentials|Y
p-chloromercuriphenylsulphonate|p-chloromercuriphenyl sulphonate|Y
Von Hippel-Lindau tumor suppressor protein|von Hippel-Lindau tumor suppressor protein|Y
Von Hippel-Lindau tumor suppressor protein|Von Hippel-Lindau tumour suppressor protein|Y
Von Hippel-Lindau tumor suppressor protein|Von Hippel-Lindau tumor-suppressor protein|Y
tanned cell hemagglutination|tanned cell haemagglutination|Y
enzyme linked immunoelectrotransfer blot assay|enzyme-linked immunoelectrotransfer blot assay|Y
intra-peritoneal chemotherapy|intraperitoneal chemotherapy|Y
postovulatory follicle|post-ovulatory follicle|Y
3beta-hydroxysteroid-dehydrogenase deficiency|3beta-hydroxy steroid-dehydrogenase deficiency|Y
3beta-hydroxysteroid-dehydrogenase deficiency|3 beta-hydroxysteroid-dehydrogenase deficiency|Y
steroid 5-α reductase type II|steroid 5α reductase type II|Y
steroid 5-α reductase type II|steroid 5-α reductase type I|Y
nearfield acoustic holography|near-field acoustic holography|Y
poly (lactic-co-glycolic acid)|poly(lactic-co-glycolic acid)|Y
branched chain alpha-ketoacid dehydrogenase|branched-chain alpha-ketoacid dehydrogenase|Y
nonmyeloablative stem cell transplantation|non-myeloablative stem cell transplantation|Y
antivascular cell adhesion molecule 1 monoclonal antibody|anti-vascular cell adhesion molecule 1 monoclonal antibody|Y
dense non-aqueous phase liquids|dense non-aqueous phase liquid|Y
pyrithiamin-induced thiamine deficiency|pyrithiamine-induced thiamine deficiency|Y
American Society of Anesthesiology status I|American Society of Anesthesiology status 1|Y
American Society of Anesthesiology status I|American Society of Anesthesiology status V|Y
American Society of Anesthesiology status I|American Society of Anesthesiology status IV|Y
American Society of Anesthesiology status I|American Society of Anesthesiology status III|Y
American Society of Anesthesiology status I|American Society of Anesthesiology status 3|Y
American Society of Anesthesiology status I|American Society of Anaesthesiology status IV|Y
American Society of Anesthesiology status I|American Society of Anaesthesiology status I|Y
American Society of Anesthesiology status I|American Society of Anesthesiology status|Y
American Society of Anesthesiology status I|American Society of Anesthesiology status 4|Y
American Society of Anesthesiology status I|American Society of Anesthesiology status 5|Y
choledochovesical fistula|choledocho-vesical fistula|Y
phosphorylated microtubule associated protein 1B|phosphorylated microtubule associated protein-1B|Y
phosphorylated microtubule associated protein 1B|phosphorylated microtubule-associated protein 1B|Y
complement mediated antibody dependent enhancement|complement mediated antibody-dependent enhancement|Y
complement mediated antibody dependent enhancement|complement-mediated antibody dependent enhancement|Y
nonhydroxyapatite-coated|non-hydroxyapatite-coated|Y
non-homologous end joining pathway|non-homologous endjoining pathway|Y
Maudsley Obsessional Compulsive Inventory|Maudsley Obsessional-Compulsive Inventory|Y
cysteine-cysteine chemokine ligand 8|cysteine-cysteine chemokine ligand 18|Y
human lens epithelial B3 cell|human lens epithelial B-3 cell|Y
electronystagmograph|electronystagmography|Y
gingivobuccal complex|gingivo-buccal complex|Y
reexpansion pulmonary œdema|re-expansion pulmonary œdema|Y
Snf-2-related CBP activator protein|Snf2-related CBP activator protein|Y
choline deficient ethionine-supplemented|choline-deficient ethionine-supplemented|Y
Fas-associated death domain-like interleukin-1 β-converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1β converting enzyme inhibitory protein|Y
Fas-associated death domain-like interleukin-1 β-converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1β-converting enzyme inhibitory protein|Y
Fas-associated death domain-like interleukin-1 β-converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1 β converting enzyme inhibitory protein|Y
Fas-associated death domain-like interleukin-1 β-converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1 β-converting enzyme-inhibitory protein|Y
Fas-associated death domain-like interleukin-1 β-converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1β-converting enzyme-inhibitory protein|Y
intra-uterine membrane|intrauterine membrane|Y
retinohypothalamic tract|retino-hypothalamic tract|Y
American Society of Anesthesiology grade 4|American Society of Anesthesiology Grade 4|Y
American Society of Anesthesiology grade 4|American Society of Anesthesiology grade V|Y
American Society of Anesthesiology grade 4|American Society of Anesthesiology grade 1|Y
American Society of Anesthesiology grade 4|American Society of Anesthesiology grade 2|Y
American Society of Anesthesiology grade 4|American Society of Anesthesiology grade 5|Y
American Society of Anesthesiology grade 4|American Society of Anesthesiology grade 3|Y
American Society of Anesthesiology grade 4|American Society of Anaesthesiology grade 4|Y
American Society of Anesthesiology grade 4|American Society of Anesthesiology grade|Y
American Society of Anesthesiology grade 4|American Society of Anesthesiology grade I|Y
meiosis-activating sterol|meiosis-activating sterols|Y
Candida lactis-condensi|Candida lactiscondensi|Y
electron-probe X-ray micro-analysis|electron-probe X-ray microanalysis|Y
wheatgerm agglutinin-horseradish peroxidase conjugate|wheat germ agglutinin-horseradish peroxidase conjugate|Y
wheatgerm agglutinin-horseradish peroxidase conjugate|wheat-germ agglutinin-horseradish peroxidase conjugate|Y
endothelial-monocyte-activating polypeptide-I|endothelial-monocyte-activating polypeptide-II|Y
endothelial-monocyte-activating polypeptide-I|endothelial monocyte-activating polypeptide-I|Y
endothelial-monocyte-activating polypeptide-I|endothelial-monocyte-activating polypeptide|Y
endothelial-monocyte-activating polypeptide-I|endothelial-monocyte-activating polypeptide-2|Y
endothelial-monocyte-activating polypeptide-I|endothelial-monocyte-activating polypeptide I|Y
antisocial personality disorder|anti-social personality disorder|Y
chlorodeoxyadenosine|chloro-deoxyadenosine|Y
steroid 5alpha reductase type 1|steroid 5-alpha reductase type 1|Y
poly(styrenesulfonate)|poly(styrene sulfonate)|Y
peri-nucleolar compartment|perinucleolar compartment|Y
dihomoγlinolenic acid|dihomoγ-linolenic acid|Y
Anglo Scandinavian Cardiac Outcomes Trial|Anglo-Scandinavian Cardiac Outcomes Trial|Y
beta site amyloid precursor protein-cleaving enzyme-2|beta-site amyloid precursor protein-cleaving enzyme-2|Y
beta site amyloid precursor protein-cleaving enzyme-2|beta site amyloid precursor protein-cleaving enzyme-1|Y
beta site amyloid precursor protein-cleaving enzyme-2|beta site amyloid precursor protein cleaving enzyme-2|Y
beta site amyloid precursor protein-cleaving enzyme-2|beta site amyloid precursor protein-cleaving enzyme 2|Y
beta site amyloid precursor protein-cleaving enzyme-2|beta site amyloid precursor protein-cleaving enzyme|Y
primary optokinetic afternystagmus|primary optokinetic after-nystagmus|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motifs-3|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motif-7|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motif-15|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motifs-18|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motif-14|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motifs|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motif-3|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motif-20|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motifs-4|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motifs-2|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motif-2|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motifs-9|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motif-8|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motifs-8|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motif|Y
post-conceptional age|postconceptional age|Y
G protein alpha1 inhibitory subunit|G protein alpha inhibitory subunit|Y
in-tube solid-phase microextraction|in-tube solid-phase micro-extraction|Y
N-terminal pro brain-type natriuretic peptide|N-terminal pro-brain-type natriuretic peptide|Y
ammonium perfluorooctanoate|ammonium perfluoro-octanoate|Y
videolaryngostroboscopy|videolaryngo-stroboscopy|Y
videolaryngostroboscopy|video-laryngostroboscopy|Y
luteinizing hormone releasing hormone receptor|luteinizing hormone-releasing hormone receptor|Y
luteinizing hormone releasing hormone receptor|luteinising hormone releasing hormone receptor|Y
multi-color fluorescence in situ hybridization|multicolor fluorescence in situ hybridization|Y
multi-color fluorescence in situ hybridization|multi-color fluorescence in-situ hybridization|Y
a disintegrin and metalloproteinase 7|a disintegrin and metalloproteinase 17|Y
intralobar nephrogenic rest|intra-lobar nephrogenic rest|Y
thiazide-sensitive sodium chloride cotransporter|thiazide-sensitive sodium chloride co-transporter|Y
thiazide-sensitive sodium chloride cotransporter|thiazide-sensitive sodium-chloride cotransporter|Y
apobec1-binding protein-1|apobec-1-binding protein-1|Y
haemagglutinin/neuraminidase protein|hemagglutinin/neuraminidase protein|Y
sodium 2-mercaptoethane sulfonate|sodium 2-mercaptoethanesulfonate|Y
peptidyl glycine α-amidating monooxygenase|peptidyl-glycine α-amidating monooxygenase|Y
peptidyl glycine α-amidating monooxygenase|peptidylglycine α-amidating mono-oxygenase|Y
peptidyl glycine α-amidating monooxygenase|peptidyl glycine α-amidating mono-oxygenase|Y
peptidyl glycine α-amidating monooxygenase|peptidylglycine α-amidating monooxygenase|Y
multiple acyl-CoA dehydrogenase deficiency|multiple acyl-CoA-dehydrogenase deficiency|Y
excision repair cross-complementing group 8|excision repair cross-complementing group 1|Y
excision repair cross-complementing group 8|excision repair cross-complementing group 4|Y
excision repair cross-complementing group 8|excision repair cross-complementing group 6|Y
excision repair cross-complementing group 8|excision repair cross-complementing group 3|Y
excision repair cross-complementing group 8|excision repair cross-complementing group 5|Y
pulmonary thrombo-endarterectomy|pulmonary thromboendarterectomy|Y
second order Møller-Plesset perturbation theory|second order Moller-Plesset perturbation theory|Y
second order Møller-Plesset perturbation theory|second-order Møller-Plesset perturbation theory|Y
University of Missouri, Columbia|University of Missouri Columbia|Y
liposome encapsulated haemoglobin|liposome encapsulated hemoglobin|Y
multi-drug resistance protein 1a|multi-drug resistance protein 1|Y
multi-drug resistance protein 1a|multidrug resistance protein 1a|Y
Seattle Veterans' Affairs Medical Center|Seattle Veterans Affairs Medical Center|Y
Seattle Veterans' Affairs Medical Center|Seattle Veteran's Affairs Medical Center|Y
lymphatic mapping and sentinel lymphadenectomy|Lymphatic mapping and sentinel lymphadenectomy|Y
antiinterleukin-12 neutralising antibody|antiinterleukin-12 neutralizing antibody|Y
antiinterleukin-12 neutralising antibody|anti-interleukin-12 neutralising antibody|Y
anti-dinitrophenyl immunoglobulin G|antidinitrophenyl immunoglobulin G|Y
mouse tumour necrosis factor α|mouse tumor necrosis factor α|Y
formyl-methanofuran dehydrogenase|formylmethanofuran dehydrogenase|Y
transhiatal esophagectomy|trans-hiatal esophagectomy|Y
cavotricuspid isthmus|cavo-tricuspid isthmus|Y
Toll/interleukin-1 receptor domain-containing adapter-inducing interferon beta|toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
Toll/interleukin-1 receptor domain-containing adapter-inducing interferon beta|Toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
Toll/interleukin-1 receptor domain-containing adapter-inducing interferon beta|toll/interleukin-1 receptor domain-containing adapter-inducing interferon beta|Y
Toll/interleukin-1 receptor domain-containing adapter-inducing interferon beta|Toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
Toll/interleukin-1 receptor domain-containing adapter-inducing interferon beta|Toll-interleukin-1 receptor domain-containing adapter-inducing interferon beta|Y
Toll/interleukin-1 receptor domain-containing adapter-inducing interferon beta|Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Y
Toll/interleukin-1 receptor domain-containing adapter-inducing interferon beta|Toll/interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
Toll/interleukin-1 receptor domain-containing adapter-inducing interferon beta|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
cytokine-induced neutrophil chemoattractants|cytokine-induced neutrophil chemoattractant|Y
granulocyte-macrophage-colony-stimulating factor receptor|granulocyte macrophage-colony-stimulating factor receptor|Y
granulocyte-macrophage-colony-stimulating factor receptor|granulocyte-macrophage colony-stimulating factor receptor|Y
oligonucleotide/oligosaccharide binding fold|oligonucleotide/oligosaccharide-binding fold|Y
diethylbarbituric acid|dimethylbarbituric acid|Y
conformational sensitive gel electrophoresis|conformation sensitive gel electrophoresis|Y
peroxisome-proliferator-activated receptor-γ coactivator 1 α|peroxisome-proliferator-activated receptor-γ co-activator 1α|Y
peroxisome-proliferator-activated receptor-γ coactivator 1 α|peroxisome-proliferator-activated receptor-γ co-activator-1 α|Y
peroxisome-proliferator-activated receptor-γ coactivator 1 α|peroxisome-proliferator-activated receptor γ coactivator 1 α|Y
peroxisome-proliferator-activated receptor-γ coactivator 1 α|peroxisome proliferator-activated receptor-γ co-activator 1 α|Y
peroxisome-proliferator-activated receptor-γ coactivator 1 α|peroxisome proliferator-activated receptor-γ coactivator 1 α|Y
peroxisome-proliferator-activated receptor-γ coactivator 1 α|peroxisome-proliferator-activated receptor-γ co-activator 1 α|Y
peroxisome-proliferator-activated receptor-γ coactivator 1 α|peroxisome-proliferator-activated receptor-γ coactivator 1α|Y
cytosolic free Ca2+ concentrations|cytosolic free Ca2+ concentration|Y
antiendothelial cell auto-antibody|anti-endothelial cell auto-antibody|Y
antiendothelial cell auto-antibody|antiendothelial cell autoantibody|Y
Kaposi's-sarcoma-associated herpes-virus|Kaposi's-sarcoma-associated herpesvirus|Y
Kaposi's-sarcoma-associated herpes-virus|Kaposi's sarcoma-associated herpes-virus|Y
latency-associated transcripts|latency-associated transcript|Y
continuous veno-venous haemo-diafiltration|continuous veno-venous haemodiafiltration|Y
continuous veno-venous haemo-diafiltration|continuous venovenous haemo-diafiltration|Y
continuous veno-venous haemo-diafiltration|continuous veno-venous hemo-diafiltration|Y
continuous veno-venous haemo-diafiltration|continuous venovenous hemo-diafiltration|Y
granulomonopoietic enhancing activity|granulo-monopoietic enhancing activity|Y
long-acting β-2-agonist|long-acting β2-agonist|Y
lithium-pilocarpine-induced status epilepticus|lithium-pilocarpine induced status epilepticus|Y
lithium-pilocarpine-induced status epilepticus|lithium pilocarpine-induced status epilepticus|Y
lithium-pilocarpine-induced status epilepticus|lithium/pilocarpine-induced status epilepticus|Y
oculo-respiratory syndrome|oculorespiratory syndrome|Y
human hepatocellular carcinoma cell line 2|human hepatocellular carcinoma cell line 3|Y
human hepatocellular carcinoma cell line 2|human hepatocellular carcinoma cell line 1|Y
para-hydroxy-mercuribenzoate|parahydroxy-mercuribenzoate|Y
para-hydroxy-mercuribenzoate|para-hydroxymercuribenzoate|Y
trans-esophageal echo probe|trans-esophageal echoprobe|Y
trans-esophageal echo probe|trans-oesophageal echo probe|Y
anti-gelatine immunoglobulin G|anti-gelatin immunoglobulin G|Y
chemotactic peptide formyl-methionyl-leucyl-phenylalanine|chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine|Y
electro-thermal atomisation atomic absorption spectrometry|electrothermal atomisation atomic absorption spectrometry|Y
electro-thermal atomisation atomic absorption spectrometry|electro-thermal atomization atomic absorption spectrometry|Y
Nashville Veteran's Administration Medical Center|Nashville Veterans Administration Medical Center|Y
Nashville Veteran's Administration Medical Center|Nashville Veterans' Administration Medical Center|Y
long segment Barrett's esophagus|long segment Barrett's oesophagus|Y
fronto-temporal degeneration|frontotemporal degeneration|Y
src-homology-2 domain-containing protein tyrosine phosphatase 2|src-homology-2 domain-containing protein tyrosine phosphatase-2|Y
src-homology-2 domain-containing protein tyrosine phosphatase 2|src homology-2 domain-containing protein tyrosine phosphatase 2|Y
src-homology-2 domain-containing protein tyrosine phosphatase 2|Src-homology-2 domain-containing protein tyrosine phosphatase 2|Y
eucaryotic translation initiation factor|eucaryotic translation initiation factor 5|Y
eucaryotic translation initiation factor|eucaryotic translation initiation factor 2|Y
eucaryotic translation initiation factor|eucaryotic translation initiation factor 3|Y
handling-induced convulsion|handling-induced convulsions|Y
receptor-like protein tyrosine phosphatase-eta|receptor-like protein tyrosine phosphatase-zeta|Y
receptor-like protein tyrosine phosphatase-eta|receptor-like protein tyrosine phosphatase-delta|Y
receptor-like protein tyrosine phosphatase-eta|receptor-like protein-tyrosine phosphatase-eta|Y
xray photo-electron spectroscopy|xray photoelectron spectroscopy|Y
xray photo-electron spectroscopy|x-ray photo-electron spectroscopy|Y
Rouxen-Y hepatico-jejunostomy|Roux-en-Y hepatico-jejunostomy|Y
Rouxen-Y hepatico-jejunostomy|Rouxen-Y hepaticojejunostomy|Y
liquid chromatography-atmospheric pressure photoionization-mass spectrometry|liquid chromatography-atmospheric pressure photoionisation-mass spectrometry|Y
liquid chromatography-atmospheric pressure photoionization-mass spectrometry|liquid chromatography-atmospheric pressure photoionization mass spectrometry|Y
Actinobacillus pleuropneumoniae RTX-toxin III|Actinobacillus pleuropneumoniae RTX-toxin II|Y
anti-interleukin 1 alpha antibody|anti-interleukin 1alpha antibody|Y
benign lymphoepithelial lesion|benign lympho-epithelial lesion|Y
ultra-high-vacuum scanning tunneling microscopy|ultrahigh-vacuum scanning tunneling microscopy|Y
ultra-high-vacuum scanning tunneling microscopy|ultra-high vacuum scanning tunneling microscopy|Y
human leukocyte antigen-D-related antigen 7|human leukocyte antigen-D-related antigen 3|Y
human leukocyte antigen-D-related antigen 7|human leukocyte antigen-D-related antigen 6|Y
human leukocyte antigen-D-related antigen 7|human leukocyte antigen-D-related antigen 4|Y
human leukocyte antigen-D-related antigen 7|human leukocyte antigen-D-related antigen 1|Y
human leukocyte antigen-D-related antigen 7|human leukocyte antigen-D-related antigen|Y
international classification of disease|international classification of diseases|Y
chromatin accessibility complex-17|chromatin accessibility complex-1|Y
human adenovirus type 1|human adenovirus type 10|Y
human adenovirus type 1|human adenovirus type 17|Y
human adenovirus type 1|human adenovirus type 51|Y
human adenovirus type 1|human adenovirus type 15|Y
human adenovirus type 1|human adenovirus type 13|Y
human adenovirus type 1|human adenovirus type 14|Y
human adenovirus type 1|human adenovirus type 18|Y
human adenovirus type 1|human adenovirus type 21|Y
human adenovirus type 1|human adenovirus type 31|Y
human adenovirus type 1|human adenovirus type 16|Y
human adenovirus type 1|human adenovirus type 41|Y
human adenovirus type 1|human adenovirus type 19|Y
human adenovirus type 1|human adenovirus type 12|Y
hand-held dynamometer|handheld dynamometer|Y
three-dimensional fast spoiled gradient echo|three-dimensional fast spoiled gradient-echo|Y
dorso-lateral prostate|dorsolateral prostate|Y
benzo(a)pyrene diol-epoxide DNA adduct|benzo(a)pyrene diolepoxide DNA adduct|Y
mitogen-activated protein kinase-extracellular signal-regulated kinase kinase|mitogen-activated protein kinase-extracellular signal regulated kinase kinase|Y
oxidised nicotinamide-adenine dinucleotide|oxidised nicotinamide adenine dinucleotide|Y
oxidised nicotinamide-adenine dinucleotide|oxidized nicotinamide-adenine dinucleotide|Y
dihydroxyphenylglycine|dihydroxy-phenylglycine|Y
acute exacerbation of chronic bronchitis|acute exacerbations of chronic bronchitis|Y
ADP ribosylation factor nucleotide-binding site opener|ADP-ribosylation factor nucleotide-binding site opener|Y
intra-uterine growth retarded|intrauterine growth retarded|Y
post-segregational killing|postsegregational killing|Y
thiobarbituric acid reacting substance level|thiobarbituric acid-reacting substance level|Y
postweaning multisystemic wasting syndrome|post-weaning multisystemic wasting syndrome|Y
postweaning multisystemic wasting syndrome|Postweaning multisystemic wasting syndrome|Y
dissociation enhanced lanthanide fluoroimmunoassay|dissociation enhanced lanthanide fluoro-immunoassay|Y
oxo-glutarate dehydrogenase|oxoglutarate dehydrogenase|Y
voltage-gated calcium channel α1 subunit|voltage-gated calcium channel α 1 subunit|Y
voltage-gated calcium channel α1 subunit|voltage-gated calcium channel α1-subunit|Y
voltage-gated calcium channel α1 subunit|voltage-gated calcium channel α-1 subunit|Y
soluble interleukin 2 receptor α|soluble interleukin 2 receptorα|Y
electrospray ionisation|electro-spray ionisation|Y
forkhead-related activator-1|forkhead-related activator-11|Y
antiandrogen withdrawal syndrome|anti-androgen withdrawal syndrome|Y
platelet-derived growth factor β-receptor|platelet-derived growth factor β receptor|Y
backscattered electron|back-scattered electron|Y
backscattered electron|backscattered electrons|Y
long-term culture initiating cells|long-term culture initiating cell|Y
thyrotrophin releasing hormone|thyrotropin releasing hormone|Y
estrogen receptor β specific|oestrogen receptor β specific|Y
anti-T-cell receptor-alpha/beta monoclonal antibody|anti-T-cell receptor alpha/beta monoclonal antibody|Y
anti-T-cell receptor-alpha/beta monoclonal antibody|anti-T cell receptor-alpha/beta monoclonal antibody|Y
anti-T-cell receptor-alpha/beta monoclonal antibody|anti-T-cell receptor-alpha beta monoclonal antibody|Y
phosphorylated CaMKII|phosphorylated CaM-KII|Y
phosphorylated CaMKII|phosphorylated CaM KII|Y
abdominoperineal resection|abdomino-perineal resection|Y
anti-beta-2-glycoprotein I antibody|anti-beta2-glycoprotein I antibody|Y
hypoxia-inducible factor-1 β|hypoxia-inducible factor-1β|Y
tracheobronchial epithelial cell|tracheo-bronchial epithelial cell|Y
insulin-like growth factor II messenger RNA binding protein|insulin-like growth factor II messenger RNA binding protein 3|Y
insulin-like growth factor II messenger RNA binding protein|insulin-like growth factor II messenger RNA binding protein 2|Y
insulin-like growth factor II messenger RNA binding protein|insulin-like growth factor II messenger RNA-binding protein|Y
insulin-like growth factor II messenger RNA binding protein|insulin-like growth factor II messenger RNA binding protein 1|Y
atrioventricular block|atrio-ventricular block|Y
enzyme-linked immunotransfer blot|enzyme-linked immuno-transfer blot|Y
apolipoprotein E ε 4 allele|apolipoprotein E ε4 allele|Y
IL-3 receptor α-chain|IL3 receptor α-chain|Y
maximum likelihood expectation maximization|maximum likelihood-expectation maximization|Y
NIMA-related kinase-11S|NIMA-related kinase-11|Y
electro-antennographic detection|electroantennographic detection|Y
immunoreceptor tyrosine based inhibition motif|immuno-receptor tyrosine based inhibition motif|Y
peroxisome proliferator activated receptor gamma co-activator-1|peroxisome proliferator-activated receptor gamma co-activator-1|Y
peroxisome proliferator activated receptor gamma co-activator-1|peroxisome proliferator activated receptor gamma coactivator-1|Y
peroxisome proliferator activated receptor gamma co-activator-1|peroxisome proliferator-activated receptor gamma coactivator-1|Y
peroxisome proliferator activated receptor gamma co-activator-1|peroxisome proliferator activated receptor gamma co-activator 1|Y
peroxisome proliferator activated receptor gamma co-activator-1|peroxisome proliferator activated receptor gamma coactivator 1|Y
quantitative hepatobiliary scintigraphy|quantitative hepato-biliary scintigraphy|Y
sacro-abdominoperineal|sacro-abdomino-perineal|Y
sacro-abdominoperineal|sacroabdominoperineal|Y
operationalised psychodynamic diagnosis|operationalised psychodynamic diagnostics|Y
non-adrenergic, non-cholinergic inhibitory nerve|non-adrenergic non-cholinergic inhibitory nerve|Y
Actinobacillus actinomycetemcomitans|Actinobacillus actino-mycetemcomitans|Y
regenerating gene III|regenerating gene II|Y
immuno-fluorescence technique|immunofluorescence technique|Y
enzyme linked immuno sorbant assay|enzyme linked immunosorbant assay|Y
Radiation Therapy Oncology Group Grade 4|Radiation Therapy Oncology Group Grade 2|Y
Radiation Therapy Oncology Group Grade 4|Radiation Therapy Oncology Group Grade 3|Y
Radiation Therapy Oncology Group Grade 4|Radiation Therapy Oncology Group Grade 0|Y
information, education and communication|information education and communication|Y
T-cell receptor γ-δ cell|T-cell receptor γδ cell|Y
tissue inhibitor of metalloproteinases 2|tissue inhibitor of metalloproteinases 1|Y
tissue inhibitor of metalloproteinases 2|tissue inhibitor of metalloproteinase 2|Y
galactorrhoea amenorrhoea hyperprolactinæmia syndrome|galactorrhea amenorrhea hyperprolactinæmia syndrome|Y
galactorrhoea amenorrhoea hyperprolactinæmia syndrome|galactorrhoea amenorrhea hyperprolactinæmia syndrome|Y
galactorrhoea amenorrhoea hyperprolactinæmia syndrome|galactorrhea amenorrhoea hyperprolactinæmia syndrome|Y
galactorrhoea amenorrhoea hyperprolactinæmia syndrome|galactorrhoea-amenorrhoea hyperprolactinæmia syndrome|Y
Poisson lognormal model|Poisson log-normal model|Y
lipoprotein-associated coagulation inhibitor|Lipoprotein-associated coagulation inhibitor|Y
lipoprotein-associated coagulation inhibitor|lipoprotein associated coagulation inhibitor|Y
corticotrophin releasing hormone receptor 1|corticotrophin-releasing hormone receptor 1|Y
corticotrophin releasing hormone receptor 1|corticotrophin releasing hormone receptor|Y
corticotrophin releasing hormone receptor 1|corticotrophin releasing hormone receptor-1|Y
corticotrophin releasing hormone receptor 1|corticotrophin releasing hormone receptor 2|Y
corticotrophin releasing hormone receptor 1|corticotropin releasing hormone receptor 1|Y
infection associated hemophagocytic syndrome|infection associated haemophagocytic syndrome|Y
infection associated hemophagocytic syndrome|infection-associated hemophagocytic syndrome|Y
calcium release activated calcium current|calcium release-activated calcium current|Y
Hemophilus influenzae type b|Haemophilus influenzae type b|Y
drug-induced thrombocytopenia|drug-induced thrombocytopaenia|Y
pylorus preserving pancreatico-duodenectomy|pylorus preserving pancreato-duodenectomy|Y
pylorus preserving pancreatico-duodenectomy|pylorus-preserving pancreatico-duodenectomy|Y
pylorus preserving pancreatico-duodenectomy|pylorus preserving pancreaticoduodenectomy|Y
hereditary non-polyposis colon cancer|hereditary nonpolyposis colon cancer|Y
nuclear factor of activated T cell|nuclear factor of activated T cells|Y
murmurs, rubs or gallops|murmurs, rubs, or gallops|Y
N-methyl-DL-aspartic acid|N-methyl-D-aspartic acid|Y
N-methyl-DL-aspartic acid|N-methyl-D,L-aspartic acid|Y
laser induced interstitial thermotherapy|laser-induced interstitial thermotherapy|Y
laser induced interstitial thermotherapy|laser induced interstitial thermo-therapy|Y
corticotropin-releasing factor-1 receptor|corticotropin-releasing factor receptor|Y
corticotropin-releasing factor-1 receptor|corticotropin-releasing factor 1 receptor|Y
corticotropin-releasing factor-1 receptor|corticotropin releasing factor-1 receptor|Y
infantile haemangio-endothelioma|infantile hemangio-endothelioma|Y
gastroesophageal sphincter|gastro-esophageal sphincter|Y
University of California Los Angeles-Prostate Cancer Index|University of California-Los Angeles-Prostate Cancer Index|Y
University of California Los Angeles-Prostate Cancer Index|University of California Los Angeles Prostate Cancer Index|Y
familial partial lipodystrophy subtype 3|familial partial lipodystrophy subtype 2|Y
Saint Catherine's Island|Saint Catherines Island|Y
alpha-methylacyl-coenzyme-A racemase|alpha-methyl acyl-coenzyme-A racemase|Y
alpha-methylacyl-coenzyme-A racemase|alpha-methyl-acyl-coenzyme-A racemase|Y
interleukine 13 receptor-α 2 subunit|interleukin 13 receptor-α 2 subunit|Y
interleukine 13 receptor-α 2 subunit|interleukine 13 receptor-α2 subunit|Y
major histocompatibility complex class I-deficient|major histocompatibility complex class 1-deficient|Y
Cip1-interacting zinc finger protein 1|Cip-interacting zinc finger protein 1|Y
methylselenocysteine|methyl-selenocysteine|Y
cellular Fas-associated death domain-like interleukin-1beta converting enzyme inhibitory protein|cellular Fas-associated death domain-like interleukin-1-beta converting enzyme inhibitory protein|Y
cellular Fas-associated death domain-like interleukin-1beta converting enzyme inhibitory protein|cellular Fas-associated death domain-like interleukin-1beta converting enzyme-inhibitory protein|Y
cellular Fas-associated death domain-like interleukin-1beta converting enzyme inhibitory protein|cellular Fas-associated death domain-like interleukin-1-beta converting enzyme-inhibitory protein|Y
cluster of differentiation 14|cluster of differentiation 154|Y
cluster of differentiation 14|cluster of differentiation 147|Y
cluster of differentiation 14|cluster of differentiation 4|Y
fetomaternal hemorrhage|feto-maternal hemorrhage|Y
posttraumatic embitterment disorder|post-traumatic embitterment disorder|Y
receptor-like protein tyrosine phosphatase μ|receptor-like protein tyrosine phosphatase|Y
receptor-like protein tyrosine phosphatase μ|receptor-like protein tyrosine phosphatase κ|Y
receptor-like protein tyrosine phosphatase μ|receptor-like protein tyrosine phosphatase δ|Y
receptor-like protein tyrosine phosphatase μ|receptor-like protein tyrosine phosphatase α|Y
receptor-like protein tyrosine phosphatase μ|receptor-like protein tyrosine phosphatase ζ|Y
receptor-like protein tyrosine phosphatase μ|receptor-like protein-tyrosine phosphatase μ|Y
receptor-like protein tyrosine phosphatase μ|receptor-like protein tyrosine phosphatase η|Y
receptor-like protein tyrosine phosphatase μ|receptor-like protein tyrosine phosphatase-μ|Y
transforming growth factor beta-inducible gene-H3|transforming growth factor beta-inducible gene H3|Y
transforming growth factor beta-inducible gene-H3|transforming growth factor-beta-inducible gene-H3|Y
subminimum inhibitory concentration|sub-minimum inhibitory concentration|Y
extracellular fluid volume|extra-cellular fluid volume|Y
sub-acute cutaneous lupus erythematosus|subacute cutaneous lupus erythematosus|Y
multi-specialty clinic|multispecialty clinic|Y
non-steroidal anti-inflammatory compound|nonsteroidal anti-inflammatory compound|Y
non-steroidal anti-inflammatory compound|non-steroidal antiinflammatory compound|Y
novel erythropoiesis-stimulating protein|novel erythropoiesis stimulating protein|Y
pre-vacuolar compartment|prevacuolar compartment|Y
pylorus preserving pancreatoduodenectomy|pylorus preserving pancreato-duodenectomy|Y
pylorus preserving pancreatoduodenectomy|pylorus-preserving pancreatoduodenectomy|Y
pylorus preserving pancreatoduodenectomy|pylorus preserving pancreaticoduodenectomy|Y
TATA-binding protein-associated factor 15|TATA-binding protein-associated factor-15|Y
TATA-binding protein-associated factor 15|TATA-binding protein-associated factor 5|Y
TATA-binding protein-associated factor 15|TATA-binding protein-associated factor 12|Y
TATA-binding protein-associated factor 15|TATA-binding protein associated factor 15|Y
TATA-binding protein-associated factor 15|TATA-binding protein-associated factor 17|Y
TATA-binding protein-associated factor 15|TATA-binding protein-associated factor 11|Y
TATA-binding protein-associated factor 15|TATA-binding protein-associated factor 1|Y
sub-total gastrectomy|subtotal gastrectomy|Y
velocity-encoded cine magnetic resonance imaging|velocity encoded cine magnetic resonance imaging|Y
transtibial amputation|trans-tibial amputation|Y
mercaptosuccinic acid|mercapto-succinic acid|Y
extra-capsular extension|extracapsular extension|Y
group I phospholipase A2|group II phospholipase A2|Y
interleukin-1beta converting enzyme inhibitor|interleukin-1 beta converting enzyme inhibitor|Y
interleukin-1beta converting enzyme inhibitor|interleukin-1beta-converting enzyme inhibitor|Y
microangiopathic hemolytic anemia|micro-angiopathic hemolytic anemia|Y
renal angiomyolipomas|renal angiomyolipoma|Y
grade IV acute graft-versus-host disease|grade I acute graft-versus-host disease|Y
grade IV acute graft-versus-host disease|grade II acute graft-versus-host disease|Y
guanine nucleotide dissociation inhibitor|guanine nucleotide dissociation inhibitor 1|Y
trans-anal endoscopic microsurgery|transanal endoscopic microsurgery|Y
serum α-feto-protein level|serum α-foeto-protein level|Y
serum α-feto-protein level|serum α-fetoprotein level|Y
Hemoglobin Hopkins-I|Haemoglobin Hopkins-I|Y
peroxisome proliferator-activated receptor-gamma2|peroxisome proliferator-activated receptor gamma2|Y
peroxisome proliferator-activated receptor-gamma2|peroxisome proliferator-activated receptor-gamma 2|Y
peroxisome proliferator-activated receptor-gamma2|peroxisome proliferator-activated receptor-gamma1|Y
peroxisome proliferator-activated receptor-gamma2|peroxisome proliferator-activated receptor-gamma|Y
peroxisome proliferator-activated receptor-gamma2|peroxisome proliferator-activated receptor-gamma-2|Y
flavin-containing monooxygenase|flavine-containing monooxygenase|Y
flavin-containing monooxygenase|flavin-containing mono-oxygenase|Y
flavin-containing monooxygenase|flavin-containing monooxygenases|Y
TATA-binding protein associated factor 9|TATA-binding protein associated factor 2|Y
TATA-binding protein associated factor 9|TATA-binding protein associated factor 3|Y
TATA-binding protein associated factor 9|TATA-binding protein associated factor 6|Y
TATA-binding protein associated factor 9|TATA-binding protein associated factor 4|Y
TATA-binding protein associated factor 9|TATA-binding protein associated factor 5|Y
TATA-binding protein associated factor 9|TATA-binding protein-associated factor 9|Y
TATA-binding protein associated factor 9|TATA-binding protein associated factor-9|Y
Na(+)-Ca(2+) exchange|Na(+)-Ca(2+) exchanger|Y
interleukin-1 beta-converting enzyme inhibitor|interleukin-1 beta converting enzyme inhibitor|Y
interleukin-1 beta-converting enzyme inhibitor|interleukin-1beta-converting enzyme inhibitor|Y
transient receptor potential vanilloid 6|transient receptor potential vanilloid 1|Y
transient receptor potential vanilloid 6|transient receptor potential vanilloid 5|Y
transient receptor potential vanilloid 6|transient receptor potential vanilloid 2|Y
transient receptor potential vanilloid 6|transient receptor potential vanilloid 4|Y
transient receptor potential vanilloid 6|transient receptor potential vanilloid 3|Y
progastrin-releasing peptide|pro-gastrin-releasing peptide|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motif-6|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motifs-20|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motifs-1|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motifs-3|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motif-15|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motif-1|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motif-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motif|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motifs-19|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motifs-17|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motif-8|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motifs-8|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motifs-15|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
A disintegrin and metalloprotease 5|A disintegrin and metalloprotease 15|Y
differential phase-contrast computed tomography|differential phase contrast computed tomography|Y
non-collagenous protein|noncollagenous protein|Y
ovarian tumour domain-containing|ovarian tumor domain-containing|Y
pro-apolipoprotein A-I|proapolipoprotein A-I|Y
pro-apolipoprotein A-I|pro-apolipoprotein A-II|Y
pro-apolipoprotein A-I|pro-apolipoprotein AI|Y
American Society of Anaesthesiology Grade 4|American Society of Anesthesiology Grade 4|Y
American Society of Anaesthesiology Grade 4|American Society of Anaesthesiology Grade 1|Y
American Society of Anaesthesiology Grade 4|American Society of Anaesthesiology Grade I|Y
American Society of Anaesthesiology Grade 4|American Society of Anaesthesiology Grade 3|Y
American Society of Anaesthesiology Grade 4|American Society of Anaesthesiology Grade 2|Y
American Society of Anaesthesiology Grade 4|American Society of Anaesthesiology Grade V|Y
American Society of Anaesthesiology Grade 4|American Society of Anaesthesiology Grade 5|Y
American Society of Anaesthesiology Grade 4|American Society of Anaesthesiology grade 4|Y
nucleotide-binding domain and leucine rich repeat containing receptor|nucleotide-binding domain and leucine rich repeat-containing receptor|Y
nucleotide-binding domain and leucine rich repeat containing receptor|nucleotide-binding domain and leucine-rich repeat containing receptor|Y
cross-polarisation magic angle spinning NMR|cross-polarisation magic-angle spinning NMR|Y
cross-polarisation magic angle spinning NMR|cross-polarisation/magic angle spinning NMR|Y
cross-polarisation magic angle spinning NMR|cross-polarization magic angle spinning NMR|Y
dorsolateral quadrant|dorso-lateral quadrant|Y
semipermeable surface|semi-permeable surface|Y
β-amyloid precursor protein cleaving enzyme 2|β-amyloid precursor protein-cleaving enzyme 2|Y
β-amyloid precursor protein cleaving enzyme 2|β-amyloid precursor protein cleaving enzyme|Y
β-amyloid precursor protein cleaving enzyme 2|β-amyloid precursor protein cleaving enzyme-2|Y
β-amyloid precursor protein cleaving enzyme 2|β-amyloid precursor protein cleaving enzyme 1|Y
β-amyloid precursor protein cleaving enzyme 2|β amyloid precursor protein cleaving enzyme 2|Y
anti-nuclear antibody-negative systemic lupus erythematosus|anti-nuclear antibody negative systemic lupus erythematosus|Y
transcriptional intermediary factor-1 β|transcriptional intermediary factor-1β|Y
cerebro-hepatorenal syndrome|cerebrohepatorenal syndrome|Y
cerebro-hepatorenal syndrome|cerebro-hepato-renal syndrome|Y
antibiotic-associated diarrhoea|antibiotic-associated diarrhea|Y
murine tumour necrosis factor-α|murine tumor necrosis factor-α|Y
fibro-elastic connective tissue|fibroelastic connective tissue|Y
choline-deficient ethionine-supplemented diet|choline-deficient, ethionine-supplemented diet|Y
5-iodo-2'-deoxyuridine|5-iodo-2-deoxyuridine|Y
transforming growth factor beta type I receptor kinase|transforming growth factor-beta type I receptor kinase|Y
desacetylvinblastine amide|desacety-lvinblastine amide|Y
anti-beta2-glycoprotein-1 antibody|anti-beta-2-glycoprotein-1 antibody|Y
chondromyxoid fibroma|chondro-myxoid fibroma|Y
enzyme-linked immuno-adsorbent assay|enzyme-linked immunoadsorbent assay|Y
transforming growth factor beta induced gene|transforming growth factor beta-induced gene|Y
cortico-ponto-cerebellar pathway|cortico-pontocerebellar pathway|Y
American Society of Anesthesiology Grade III|American Society of Anaesthesiology Grade III|Y
American Society of Anesthesiology Grade III|American Society of Anesthesiology grade III|Y
American Society of Anesthesiology Grade III|American Society of Anesthesiology Grade I|Y
American Society of Anesthesiology Grade III|American Society of Anaesthesiology Grade II|Y
American Society of Anesthesiology Grade III|American Society of Anesthesiology Grade II|Y
beta amyloid precursor protein cleaving enzyme-2|beta amyloid precursor protein cleaving enzyme|Y
beta amyloid precursor protein cleaving enzyme-2|beta amyloid precursor protein cleaving enzyme 2|Y
beta amyloid precursor protein cleaving enzyme-2|beta amyloid precursor protein cleaving enzyme-1|Y
beta amyloid precursor protein cleaving enzyme-2|beta-amyloid precursor protein cleaving enzyme-2|Y
peroxisome-proliferator-activated receptor γ coactivator-1α|peroxisome-proliferator-activated receptor γ coactivator-1 α|Y
peroxisome-proliferator-activated receptor γ coactivator-1α|peroxisome-proliferator-activated receptor-γ coactivator-1α|Y
peroxisome-proliferator-activated receptor γ coactivator-1α|peroxisome proliferator-activated receptor γ coactivator-1α|Y
peroxisome-proliferator-activated receptor γ coactivator-1α|peroxisome-proliferator-activated receptor γ coactivator 1α|Y
transcranial color-coded duplex sonography|Transcranial color-coded duplex sonography|Y
transcranial color-coded duplex sonography|transcranial colour-coded duplex sonography|Y
occipitoatlantal dislocation|occipito-atlantal dislocation|Y
glucagon-like peptide|glucagon-like peptides|Y
phorbol ester 12-O-tetradecanoyl phorbol 13-acetate|phorbol ester 12-O-tetradecanoyl phorbol-13-acetate|Y
phorbol ester 12-O-tetradecanoyl phorbol 13-acetate|phorbol ester 12-O-tetradecanoylphorbol 13-acetate|Y
protein inhibitor of activated STAT1|protein inhibitor of activated STAT|Y
chorio-allantoic membrane|chorioallantoic membrane|Y
growth differentiation factor 5|growth differentiation factor 15|Y
L-buthionine-S,R-sulfoximine|L-buthionine-SR-sulfoximine|Y
L-buthionine-S,R-sulfoximine|DL-buthionine-S,R-sulfoximine|Y
amplified fragment-length polymorphism analysis|amplified fragment length polymorphism analysis|Y
atrioventricular nodal|atrio-ventricular nodal|Y
velo-cardio-facial syndrome|velo-cardiofacial syndrome|Y
β amyloid precursor protein cleaving enzyme|β amyloid precursor protein cleaving enzyme-2|Y
β amyloid precursor protein cleaving enzyme|β-amyloid precursor protein cleaving enzyme|Y
β amyloid precursor protein cleaving enzyme|β amyloid precursor protein cleaving enzyme 1|Y
β amyloid precursor protein cleaving enzyme|β amyloid precursor protein cleaving enzyme 2|Y
β amyloid precursor protein cleaving enzyme|β amyloid precursor protein-cleaving enzyme|Y
β amyloid precursor protein cleaving enzyme|β amyloid precursor protein cleaving enzyme-1|Y
C-C chemokine ligand 2|C-C chemokine ligand 24|Y
C-C chemokine ligand 2|C-C chemokine ligand 25|Y
C-C chemokine ligand 2|C-C chemokine ligand 22|Y
C-C chemokine ligand 2|C-C chemokine ligand 21|Y
C-C chemokine ligand 2|CC chemokine ligand 2|Y
precardiopulmonary bypass|pre-cardiopulmonary bypass|Y
single-photon emission computerised tomography|single-photon emission computerized tomography|Y
single-photon emission computerised tomography|single photon emission computerised tomography|Y
von Hippel-Lindau tumor suppressor protein|von Hippel-Lindau tumor-suppressor protein|Y
von Hippel-Lindau tumor suppressor protein|von Hippel-Lindau tumour suppressor protein|Y
Commonwealth Scientific and Industrial Research Organization|Commonwealth Scientific and Industrial Research Organisation|Y
cost-effectiveness ratios|cost-effectiveness ratio|Y
atlanto-axial subluxation|atlantoaxial subluxation|Y
antiglomerular basement membrane nephritis|anti-glomerular basement membrane nephritis|Y
human endogenous retrovirus K-10|human endogenous retrovirus K10|Y
galactose-1-phosphate uridyl transferase|galactose-1-phosphate uridyltransferase|Y
neurodevelopmental technique|neuro-developmental technique|Y
oligodeoxynucleotides containing CpG motifs|Oligodeoxynucleotides containing CpG motifs|Y
laevonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system|Y
laevonorgestrel-releasing intrauterine system|laevonorgestrel-releasing intra-uterine system|Y
laevonorgestrel-releasing intrauterine system|levonorgestrel-releasing intra uterine system|Y
laevonorgestrel-releasing intrauterine system|laevonorgestrel releasing intrauterine system|Y
laevonorgestrel-releasing intrauterine system|laevonorgestrel-releasing intra uterine system|Y
laevonorgestrel-releasing intrauterine system|levonorgestrel-releasing intra-uterine system|Y
intracranial compliance|intra-cranial compliance|Y
craniocervical flexion test|cranio-cervical flexion test|Y
proapolipoprotein A1|pro-apolipoprotein A1|Y
Zinc finger and SCAN domain-containing protein 12|Zinc finger and SCAN domain-containing protein 2|Y
hyperpolarization activated cyclic nucleotide gated channel|hyperpolarization-activated cyclic nucleotide gated channel|Y
hyperpolarization activated cyclic nucleotide gated channel|hyperpolarisation activated cyclic nucleotide gated channel|Y
protein tyrosine phosphatase non-receptor-22|protein tyrosine phosphatase non-receptor 22|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed developmentally down-regulated 8|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed, developmentally downregulated 5|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed developmentally down-regulated 5|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed, developmentally down-regulated 8|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell expressed, developmentally downregulated 1|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural-precursor cell-expressed developmentally down-regulated 1|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed, developmentally down-regulated 5|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed, developmentally downregulated 4|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural-precursor cell-expressed, developmentally down-regulated 1|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell expressed developmentally down-regulated 1|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed developmentally down-regulated 1|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed, developmentally downregulated 9|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed developmentally down-regulated 9|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed developmentally downregulated 1|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell expressed, developmentally down-regulated 1|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed developmentally down-regulated 2|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed developmentally down-regulated 4|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed, developmentally downregulated 8|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed, developmentally downregulated 1|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed, developmentally down-regulated 2|Y
neural precursor cell-expressed, developmentally down-regulated 1|neural-precursor cell-expressed, developmentally downregulated 1|Y
peripheral blood-derived progenitor cell|peripheral-blood-derived progenitor cell|Y
peripheral blood-derived progenitor cell|peripheral blood derived progenitor cell|Y
Kurosawa and Kusanagi hypercholesterolaemic rabbit|Kurosawa and Kusanagi hypercholesterolemic rabbit|Y
11 beta-hydroxysteroid dehydrogenase|11beta-hydroxysteroid dehydrogenase|Y
interleukine 7 receptor α|interleukin 7 receptor α|Y
TNF-α protease inhibitor-1|TNFα protease inhibitor-1|Y
anti-human T cell lymphotrophic virus type-1 antibody|anti-human T cell lymphotropic virus type-1 antibody|Y
anti-human T cell lymphotrophic virus type-1 antibody|anti-human T cell lymphotrophic virus type 1 antibody|Y
anti-human T cell lymphotrophic virus type-1 antibody|anti-human T-cell lymphotrophic virus type-1 antibody|Y
anti-human T cell lymphotrophic virus type-1 antibody|anti-human T cell lymphotrophic virus type-I antibody|Y
granulocyte-macrophage colony-stimulating factor receptor alpha chain|granulocyte-macrophage colony-stimulating factor receptor alpha-chain|Y
extra-corporeal lung assist|extracorporeal lung assist|Y
B-lymphocyte-induced maturation protein 1|B-lymphocyte-induced maturation protein-1|Y
B-lymphocyte-induced maturation protein 1|B lymphocyte-induced maturation protein 1|Y
B-lymphocyte-induced maturation protein 1|B-lymphocyte induced maturation protein 1|Y
medium-chain triacylglycerol|medium-chain triacylglycerols|Y
tumour necrosis factor receptor-1-associated periodic syndrome|tumor necrosis factor receptor-1-associated periodic syndrome|Y
tumour necrosis factor receptor-1-associated periodic syndrome|tumour necrosis factor receptor 1-associated periodic syndrome|Y
tumour necrosis factor receptor-1-associated periodic syndrome|tumour necrosis factor receptor-associated periodic syndrome|Y
tumour necrosis factor receptor-1-associated periodic syndrome|tumor necrosis factor receptor-associated periodic syndrome|Y
lobular intraepithelial neoplasia|lobular intra-epithelial neoplasia|Y
double-stranded-RNA-dependent protein kinase|double-stranded RNA-dependent protein kinase|Y
matrix-assisted laser-desorption ionization|matrix-assisted laser-desorption ionisation|Y
matrix-assisted laser-desorption ionization|matrix-assisted laser desorption ionization|Y
matrix-assisted laser-desorption ionization|matrix-assisted laser-desorption/ionization|Y
American Society of Anesthesiology class 3|American Society of Anesthesiology class|Y
American Society of Anesthesiology class 3|American Society of Anesthesiology class 1|Y
American Society of Anesthesiology class 3|American Society of Anesthesiology class 5|Y
American Society of Anesthesiology class 3|American Society of Anesthesiology class V|Y
American Society of Anesthesiology class 3|American Society of Anesthesiology class 4|Y
American Society of Anesthesiology class 3|American Society of Anesthesiology class I|Y
American Society of Anesthesiology class 3|American Society of Anaesthesiology class 3|Y
floating harbour syndrome|floating harbor syndrome|Y
nuclear Overhauser enhancements|nuclear Overhauser enhancement|Y
N-methyl-N'-nitro-N-nitroso-guanidine|N-methyl-N'-nitro-N-nitrosoguanidine|Y
Phleum pratense allergen 12|Phleum pratense allergen 1|Y
Phleum pratense allergen 12|Phleum pratense allergen 2|Y
melanoma differentiation-associated gene-7|melanoma differentiation-associated gene-5|Y
melanoma differentiation-associated gene-7|melanoma differentiation associated gene-7|Y
American Society of Anaesthesiology status 5|American Society of Anaesthesiology status 4|Y
American Society of Anaesthesiology status 5|American Society of Anaesthesiology status 1|Y
American Society of Anaesthesiology status 5|American Society of Anaesthesiology status 2|Y
American Society of Anaesthesiology status 5|American Society of Anaesthesiology status 3|Y
American Society of Anaesthesiology status 5|American Society of Anaesthesiology status I|Y
American Society of Anaesthesiology status 5|American Society of Anaesthesiology status|Y
American Society of Anaesthesiology status 5|American Society of Anaesthesiology status V|Y
American Society of Anaesthesiology status 5|American Society of Anesthesiology status 5|Y
similar to mothers against decapentaplegic homolog 3|similar to mothers against decapentaplegic homolog|Y
similar to mothers against decapentaplegic homolog 3|similar to mothers against decapentaplegic homolog 4|Y
similar to mothers against decapentaplegic homolog 3|similar to mothers against decapentaplegic homolog 6|Y
similar to mothers against decapentaplegic homolog 3|similar to mothers against decapentaplegic homolog 7|Y
similar to mothers against decapentaplegic homolog 3|similar to mothers against decapentaplegic homolog 1|Y
similar to mothers against decapentaplegic homolog 3|similar to mothers against decapentaplegic homolog 5|Y
similar to mothers against decapentaplegic homolog 3|similar to mothers against decapentaplegic homolog 2|Y
similar to mothers against decapentaplegic homolog 3|similar to mothers against decapentaplegic homolog 8|Y
augmented correlation-consistent polarised-valence triple-zeta basis set|augmented correlation-consistent polarised valence triple-zeta basis set|Y
augmented correlation-consistent polarised-valence triple-zeta basis set|augmented correlation-consistent polarized-valence triple-zeta basis set|Y
NADPH-cytochrome P450 reductase|NADPH-cytochrome P-450 reductase|Y
hepatoporto-enterostomy|hepatoportoenterostomy|Y
hepatoporto-enterostomy|hepato-porto-enterostomy|Y
tumor-4, node-2c, metastasis-0|tumor-4, node-2, metastasis-0|Y
endoscopic trans-thoracic sympathectomy|endoscopic transthoracic sympathectomy|Y
oligo-deoxynucleotide|oligodeoxynucleotide|Y
photo-thermal therapy|photothermal therapy|Y
kinase-insert domain-containing receptor|kinase-insert-domain-containing receptor|Y
kinase-insert domain-containing receptor|kinase-insert domain containing receptor|Y
kinase-insert domain-containing receptor|kinase insert domain-containing receptor|Y
fœto-maternal hemorrhage|fœtomaternal hemorrhage|Y
nonketotic hyperglycinemia|non-ketotic hyperglycinemia|Y
insulinlike growth factor 1-stimulated|insulin-like growth factor 1-stimulated|Y
retinoic-acid-receptor-related orphan receptor alpha|retinoic-acid-receptor-related orphan receptor-alpha|Y
fluorescence photo-bleaching recovery|fluorescence photobleaching recovery|Y
aryl-hydrocarbon receptor interacting protein|aryl-hydrocarbon receptor-interacting protein|Y
tumor necrosis factor receptor associated factor|tumor necrosis factor receptor associated factor-6|Y
tumor necrosis factor receptor associated factor|tumor necrosis factor receptor-associated factor|Y
tumor necrosis factor receptor associated factor|tumor necrosis factor receptor associated factor 6|Y
tumor necrosis factor receptor associated factor|tumor necrosis factor receptor associated factor 5|Y
tumor necrosis factor receptor associated factor|tumor necrosis factor receptor associated factor-5|Y
tumor necrosis factor receptor associated factor|tumor necrosis factor receptor associated factor 1|Y
tumor necrosis factor receptor associated factor|tumor necrosis factor receptor associated factor-1|Y
tumor necrosis factor receptor associated factor|tumor necrosis factor receptor associated factor-2|Y
similar to mothers against decapentaplegic homolog|similar to mothers against decapentaplegic homolog 4|Y
similar to mothers against decapentaplegic homolog|similar to mothers against decapentaplegic homolog 6|Y
similar to mothers against decapentaplegic homolog|similar to mothers against decapentaplegic homolog 7|Y
similar to mothers against decapentaplegic homolog|similar to mothers against decapentaplegic homolog 1|Y
similar to mothers against decapentaplegic homolog|similar to mothers against decapentaplegic homolog 5|Y
similar to mothers against decapentaplegic homolog|similar to mothers against decapentaplegic homolog 2|Y
similar to mothers against decapentaplegic homolog|similar to mothers against decapentaplegic homolog 8|Y
laser assisted subepithelial keratomileusis|laser-assisted subepithelial keratomileusis|Y
laser assisted subepithelial keratomileusis|laser assisted sub-epithelial keratomileusis|Y
Drosophila cyclic AMP response element-binding protein-B|Drosophila cyclic AMP response element-binding protein-A|Y
Drosophila cyclic AMP response element-binding protein-B|Drosophila cyclic AMP response element-binding protein|Y
methyl-cytidine-phosphate-guanosine binding protein|methyl-cytidine-phosphate-guanosine binding protein 2|Y
autonomously functioning thyroid nodule|autonomously functioning thyroid nodules|Y
solid phase extraction-high performance liquid chromatography/tandem mass spectrometry|solid-phase extraction-high performance liquid chromatography-tandem mass spectrometry|Y
solid phase extraction-high performance liquid chromatography/tandem mass spectrometry|solid-phase extraction-high performance liquid chromatography/tandem mass spectrometry|Y
solid phase extraction-high performance liquid chromatography/tandem mass spectrometry|solid phase extraction-high-performance liquid chromatography-tandem mass spectrometry|Y
solid phase extraction-high performance liquid chromatography/tandem mass spectrometry|solid-phase extraction-high-performance liquid chromatography/tandem mass spectrometry|Y
oedema/prot/hyper, preg|edema/prot/hyper, preg|Y
anti-matrix metalloproteinase-9 antibody|anti-matrix metalloproteinase-2 antibody|Y
anti-matrix metalloproteinase-9 antibody|anti-matrix metalloproteinase-1 antibody|Y
anti-matrix metalloproteinase-9 antibody|anti-matrix metalloproteinase-7 antibody|Y
anti-matrix metalloproteinase-9 antibody|anti-matrix metalloproteinase 9 antibody|Y
bacillus Calmette-Guerin-activated killer cell|bacillus Calmette-Guerin activated killer cell|Y
bacillus Calmette-Guerin-activated killer cell|bacillus-Calmette-Guerin-activated killer cell|Y
src homology 2 domain containing protein tyrosine phosphatase 2|src homology 2 domain-containing protein tyrosine phosphatase 2|Y
src homology 2 domain containing protein tyrosine phosphatase 2|Src homology 2 domain containing protein tyrosine phosphatase 2|Y
A disintegrin and metalloproteinase 15|A disintegrin and metalloproteinase 5|Y
benzo(a)pyrene diol epoxide-DNA adduct level|benzo(a)pyrene diol epoxide DNA adduct level|Y
benzo(a)pyrene diol epoxide-DNA adduct level|benzo(a)pyrene diol-epoxide-DNA adduct level|Y
International Neuroblastoma Staging System Stage 3|International Neuroblastoma Staging System stage 3|Y
International Neuroblastoma Staging System Stage 3|International Neuroblastoma Staging System Stage 2|Y
International Neuroblastoma Staging System Stage 3|International Neuroblastoma Staging System Stage I|Y
International Neuroblastoma Staging System Stage 3|International Neuroblastoma Staging System Stage 1|Y
phosphotyrosine phosphatase|phospho-tyrosine phosphatase|Y
cortico-medullary junction|corticomedullary junction|Y
anti-IL-7 monoclonal antibody|anti-IL7 monoclonal antibody|Y
anti-IL-7 monoclonal antibody|antiIL-7 monoclonal antibody|Y
anti-IL-7 monoclonal antibody|anti-IL-17 monoclonal antibody|Y
homozygous alpha 1-proteinase inhibitor deficiency|homozygous alpha-1-proteinase inhibitor deficiency|Y
homozygous alpha 1-proteinase inhibitor deficiency|homozygous alpha 1-protease inhibitor deficiency|Y
ovarian cancer G protein-coupled receptor 1|ovarian cancer G-protein-coupled receptor 1|Y
ovarian cancer G protein-coupled receptor 1|ovarian cancer G protein coupled receptor 1|Y
guanosine triphosphate pyrophosphate-lyase|guanosine triphosphate pyrophosphatelyase|Y
receptor-type protein tyrosine phosphatase-β|receptor-type protein-tyrosine phosphatase-β|Y
receptor-type protein tyrosine phosphatase-β|receptor-type protein tyrosine phosphatase β|Y
multiple endocrine neoplasia 2A syndrome|multiple endocrine neoplasia 2B syndrome|Y
interleukine-5 receptor α chain|interleukine-15 receptor α chain|Y
interleukine-5 receptor α chain|interleukin-5 receptor α chain|Y
Chicken ovalbumin upstream promoter-transcription factor|Chicken ovalbumin upstream promoter-transcription factors|Y
multi-channel surface electromyography|multichannel surface electromyography|Y
pancreas transplants alone|pancreas transplant alone|Y
mitogen-activated protein kinase kinase kinase 2|mitogen-activated protein kinase kinase kinase 3|Y
mitogen-activated protein kinase kinase kinase 2|mitogen-activated protein kinase kinase kinase 1|Y
mitogen-activated protein kinase kinase kinase 2|mitogen-activated protein kinase kinase kinase|Y
mitogen-activated protein kinase kinase kinase 2|mitogen-activated protein kinase kinase kinase 4|Y
anti-pentylenetetrazole|anti-pentylenetetrazol|Y
area under the plasma concentration-time curve|areas under the plasma concentration-time curves|Y
area under the plasma concentration-time curve|area under the plasma concentration-time curves|Y
near infra-red reflectance|near infrared reflectance|Y
formyl-methionyl-leucylphenylalanine|formylmethionyl-leucylphenylalanine|Y
latent transforming growth factor-beta binding protein|latent transforming growth factor-beta binding protein 4|Y
latent transforming growth factor-beta binding protein|latent transforming growth factor-beta binding protein 3|Y
latent transforming growth factor-beta binding protein|latent transforming growth factor beta binding protein|Y
latent transforming growth factor-beta binding protein|latent transforming growth factor-beta binding protein-2|Y
latent transforming growth factor-beta binding protein|latent transforming growth factor-beta binding protein-1|Y
latent transforming growth factor-beta binding protein|latent transforming growth factor-beta binding protein 1|Y
pituitary adenylate cyclase activating peptide|pituitary adenylate cyclase-activating peptide|Y
carboxyterminal amino acid|carboxylterminal amino acid|Y
gap junction protein connexin-43|gap junction protein connexin43|Y
β-human chorionic gonadotropin|β-human chorionic gonadotrophin|Y
intra-partum antibiotic prophylaxis|intrapartum antibiotic prophylaxis|Y
matrix assisted laser desorption/ionisation time of flight mass spectrometric|matrix-assisted laser desorption/ionisation time of flight mass spectrometric|Y
matrix assisted laser desorption/ionisation time of flight mass spectrometric|matrix assisted laser desorption ionisation time of flight mass spectrometric|Y
matrix assisted laser desorption/ionisation time of flight mass spectrometric|matrix assisted laser desorption/ionization time of flight mass spectrometric|Y
matrix assisted laser desorption/ionisation time of flight mass spectrometric|matrix assisted laser desorption/ionisation time of flight mass spectrometry|Y
mitogen activated protein kinase-activated protein kinase 5|mitogen activated protein kinase activated protein kinase 5|Y
mitogen activated protein kinase-activated protein kinase 5|mitogen activated protein kinase-activated protein kinase 1|Y
mitogen activated protein kinase-activated protein kinase 5|mitogen activated protein kinase-activated protein kinase-5|Y
mitogen activated protein kinase-activated protein kinase 5|mitogen activated protein kinase-activated protein kinase 2|Y
mitogen activated protein kinase-activated protein kinase 5|mitogen activated protein kinase-activated protein kinase|Y
mitogen activated protein kinase-activated protein kinase 5|mitogen-activated protein kinase-activated protein kinase 5|Y
mitogen activated protein kinase-activated protein kinase 5|mitogen activated protein kinase-activated protein kinase 3|Y
multibacillary leprosy|multi-bacillary leprosy|Y
transillumination breast spectroscopy|trans-illumination breast spectroscopy|Y
anti-neutrophil cytoplasmic antibody-associated vasculitis|antineutrophil cytoplasmic antibody-associated vasculitis|Y
anti-neutrophil cytoplasmic antibody-associated vasculitis|anti-neutrophil cytoplasmic antibody associated vasculitis|Y
peripheral primitive neuroectodermal tumor|peripheral primitive neuro-ectodermal tumour|Y
UDP-N-acetylglucosamine enolpyruvyl transferase|UDP-N-acetylglucosamine enolpyruvyltransferase|Y
total meso-rectal excision|total mesorectal excision|Y
vasodilator stimulated phospho-protein|vasodilator stimulated phosphoprotein|Y
Phleum pratense protein 12|Phleum pratense protein 1|Y
multiprojection volume reconstruction|multi-projection volume reconstruction|Y
NF-κB-repressing factor|NFκB-repressing factor|Y
oestrogen receptor α-specific|estrogen receptor α-specific|Y
a disintegrin and metalloprotease 19|a disintegrin and metalloprotease 9|Y
anti-β 2-glycoprotein-I antibody|anti-β2-glycoprotein-I antibody|Y
interleukin-11 receptor α subunit|interleukine-11 receptor α subunit|Y
BCL-2-associated X-protein|BCL2-associated X-protein|Y
Ralph H. Johnson Veterans' Affairs Medical Center|Ralph H. Johnson Veterans Affairs Medical Center|Y
Ralph H. Johnson Veterans' Affairs Medical Center|Ralph H Johnson Veterans Affairs Medical Center|Y
Ralph H. Johnson Veterans' Affairs Medical Center|Ralph H. Johnson Veteran's Affairs Medical Center|Y
Ralph H. Johnson Veterans' Affairs Medical Center|Ralph H Johnson Veterans' Affairs Medical Center|Y
West Los Angeles Veterans' Affairs Medical Center|West Los Angeles Veterans Affairs Medical Center|Y
West Los Angeles Veterans' Affairs Medical Center|West Los Angeles Veteran's Affairs Medical Center|Y
regional cerebral metabolic rates for glucose|regional cerebral metabolic rate for glucose|Y
regional cerebral metabolic rates for glucose|Regional cerebral metabolic rates for glucose|Y
extracorporeal bioartificial liver support system|extracorporeal bio-artificial liver support system|Y
supercritical antisolvent|supercritical anti-solvent|Y
matrix-assisted laser desorption ionisation Fourier transform ion cyclotron resonance mass spectrometry|matrix-assisted laser desorption/ionisation Fourier-transform ion cyclotron resonance mass spectrometry|Y
matrix-assisted laser desorption ionisation Fourier transform ion cyclotron resonance mass spectrometry|matrix-assisted laser desorption/ionisation Fourier transform ion cyclotron resonance mass spectrometry|Y
matrix-assisted laser desorption ionisation Fourier transform ion cyclotron resonance mass spectrometry|matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry|Y
matrix-assisted laser desorption ionisation Fourier transform ion cyclotron resonance mass spectrometry|matrix-assisted laser desorption ionization Fourier transform ion cyclotron resonance mass spectrometry|Y
solute carrier family 17 member 1|solute carrier family 7 member 1|Y
human transforming growth factor-β 3|human transforming growth factor-β3|Y
T cell receptor antigen-associated CD3 complex|T-cell receptor antigen-associated CD3 complex|Y
forkhead box class O6|forkhead box class O|Y
stress fiberlike structure|stress fiber-like structure|Y
stress-activated protein kinase-2|stress-activated protein kinase-2a|Y
vancomycin resistance gene C3|vancomycin resistance gene C|Y
anti-asialo GM(1) antibody|antiasialo GM(1) antibody|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally downregulated 4|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally down-regulated 9|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally downregulated 9|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally downregulated 1|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor cell-expressed, developmentally down-regulated 2|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor cell-expressed, developmentally downregulated 2|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor-cell-expressed developmentally down-regulated 8|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor-cell-expressed developmentally downregulated 2|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally down-regulated 1|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor-cell-expressed developmentally down-regulated 5|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally down-regulated 8|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally down-regulated 5|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor-cell-expressed developmentally down-regulated 9|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally down-regulated 4|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally downregulated 5|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor-cell-expressed developmentally down-regulated 1|Y
neural-precursor-cell-expressed, developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally downregulated 2|Y
poly-levo-lactic acid|poly-laevo-lactic acid|Y
poly-levo-lactic acid|poly-levolactic acid|Y
cluster of differentiation antigen 16|cluster of differentiation antigen 6|Y
cluster of differentiation antigen 16|cluster of differentiation antigen 146|Y
cluster of differentiation antigen 16|cluster of differentiation antigen 169|Y
tumour necrosis factor receptor-associated factor-1|tumour necrosis factor receptor-associated factor-6|Y
tumour necrosis factor receptor-associated factor-1|tumour necrosis factor receptor-associated factor|Y
tumour necrosis factor receptor-associated factor-1|tumour necrosis factor receptor-associated factor-2|Y
tumour necrosis factor receptor-associated factor-1|tumour necrosis factor receptor-associated factor 1|Y
tumour necrosis factor receptor-associated factor-1|tumour necrosis factor receptor-associated factor-5|Y
tumour necrosis factor receptor-associated factor-1|tumour necrosis factor receptor associated factor-1|Y
intravascular bronchioloalveolar tumor|intravascular bronchiolo-alveolar tumor|Y
nano-sphere lithography|nanosphere lithography|Y
American Society of Anesthesiologists status 2|American Society of Anesthesiologists status 3|Y
American Society of Anesthesiologists status 2|American Society of Anesthesiologists status 4|Y
American Society of Anesthesiologists status 2|American Society of Anesthesiologists status V|Y
American Society of Anesthesiologists status 2|American Society of Anaesthesiologists status 2|Y
American Society of Anesthesiologists status 2|American Society of Anesthesiologists status I|Y
American Society of Anesthesiologists status 2|American Society of Anesthesiologists status 5|Y
insulin-like growth factor-binding protein related protein-1|insulin-like growth factor-binding protein-related protein-1|Y
insulin-like growth factor-binding protein related protein-1|insulin-like growth factor binding protein related protein-1|Y
lipid-coated microbubble|lipid-coated micro-bubble|Y
granulocyte-macrophage colony-stimulating factor receptor α-chain|granulocyte-macrophage colony-stimulating factor receptor α chain|Y
multiple monitored electroconvulsive therapy|multiple-monitored electroconvulsive therapy|Y
anti-neutrophil cytoplasmic antibody positivity|antineutrophil cytoplasmic antibody positivity|Y
immunobead binding test|immuno-bead binding test|Y
human transforming growth factor β 1|human transforming growth factor β1|Y
CDC28 protein kinase regulatory subunit 1|CDC28 protein kinase regulatory subunit 2|Y
CDC28 protein kinase regulatory subunit 1|CDC28 protein kinase regulatory subunit 1B|Y
Transverse relaxation-optimized spectroscopy|transverse relaxation-optimized spectroscopy|Y
enzyme linked immunoelectrotransfer blot|enzyme-linked immunoelectrotransfer blot|Y
melanocyte-stimulating hormone release inhibiting factor 1|melanocyte-stimulating hormone release inhibiting factor|Y
melanocyte-stimulating hormone release inhibiting factor 1|melanocyte-stimulating hormone release-inhibiting factor 1|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motif-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motifs-18|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motifs-3|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motifs|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motifs-13|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motif-3|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motifs-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motifs-4|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motifs-2|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motif-2|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motifs-9|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motifs-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motifs-20|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
a disintegrin and metalloprotease with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
Eating Disorder Examination-Questionnaire|Eating Disorder Examination Questionnaire|Y
foetal magneto-encephalography|fetal magneto-encephalography|Y
5-hydroxyindole acetic acid|5-hydroxyindoleacetic acid|Y
sympathetic preganglionic neuron|sympathetic pre-ganglionic neuron|Y
human alpha1-antitrypsin|human alpha 1-antitrypsin|Y
sulfonylurea receptor 2A|sulfonylurea receptor 2|Y
heterochromatin protein-1 α|heterochromatin protein-1α|Y
adenosine receptor agonist 5'-(N-ethylcarboxamido)adenosine|adenosine receptor agonist 5'-N-ethylcarboxamidoadenosine|Y
interleukine-13 receptor α 2 subunit|interleukine-13 receptor α2 subunit|Y
interleukine-13 receptor α 2 subunit|interleukin-13 receptor α 2 subunit|Y
type 2 corticotropin-releasing-hormone receptor|type 2 corticotrophin-releasing-hormone receptor|Y
type 2 corticotropin-releasing-hormone receptor|type-2 corticotropin-releasing-hormone receptor|Y
type 2 corticotropin-releasing-hormone receptor|type 2 corticotropin-releasing hormone receptor|Y
trans-cortical motor aphasia|transcortical motor aphasia|Y
cluster of differentiation 154|cluster of differentiation 15|Y
hemoglobin Fannin-Lubbock|haemoglobin Fannin-Lubbock|Y
phosphatidylethanolamine N-methyltransferase|phosphatidylethanolamine methyltransferase|Y
post-concussive syndrome|postconcussive syndrome|Y
cytotoxic T-lymphocyte associated antigen 4|cytotoxic T lymphocyte associated antigen 4|Y
cytotoxic T-lymphocyte associated antigen 4|cytotoxic T-lymphocyte-associated antigen 4|Y
cytotoxic T-lymphocyte associated antigen 4|cytotoxic T-lymphocyte associated antigen-4|Y
anti-nutritional factor|antinutritional factor|Y
cranio-cerebral trauma|craniocerebral trauma|Y
electro-encephalogram|electroencephalogram|Y
motor evoked potential|motor evoked potentials|Y
cell division cycle 25|cell division cycle 25C|Y
cell division cycle 25|cell division cycle 2|Y
cell division cycle 25|cell division cycle 25A|Y
cell division cycle 25|cell division cycle 25B|Y
fetal magneto-encephalography|fetal magnetoencephalography|Y
phenylethanolamine N-methyltransferase|phenylethanolamine N-methyl transferase|Y
phenylethanolamine N-methyltransferase|phenylethanolamine N-methyl-transferase|Y
autonomously replicating sequence-binding factor 1|autonomously replicating sequence binding factor 1|Y
transforming growth factor β4|transforming growth factor β 4|Y
New York Heart Association functional class|New York Heart Association functional class 1|Y
ultra performance liquid chromatography-electrospray ionisation tandem mass spectrometry|ultra performance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
ultra performance liquid chromatography-electrospray ionisation tandem mass spectrometry|ultra performance liquid chromatography/electrospray ionization tandem mass spectrometry|Y
ultra performance liquid chromatography-electrospray ionisation tandem mass spectrometry|ultraperformance liquid chromatography/electrospray ionisation tandem mass spectrometry|Y
ultra performance liquid chromatography-electrospray ionisation tandem mass spectrometry|ultra-performance liquid chromatography-electrospray ionisation tandem mass spectrometry|Y
ultra performance liquid chromatography-electrospray ionisation tandem mass spectrometry|ultraperformance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
ultra performance liquid chromatography-electrospray ionisation tandem mass spectrometry|ultra performance liquid chromatography/electrospray ionisation tandem mass spectrometry|Y
ultra performance liquid chromatography-electrospray ionisation tandem mass spectrometry|ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
insulinlike growth factor-1-stimulated|insulin-like growth factor-1-stimulated|Y
organochlorine pesticide|organo-chlorine pesticide|Y
antiIL-5 monoclonal antibody|antiIL-15 monoclonal antibody|Y
antiIL-5 monoclonal antibody|anti-IL-5 monoclonal antibody|Y
steroid 5-α-reductase type 1|steroid 5α-reductase type 1|Y
tumour necrosis factor-like ligand 1A|tumor necrosis factor-like ligand 1A|Y
phospho-enolpyruvate|phospho-enol-pyruvate|Y
phospho-enolpyruvate|phospho-enol pyruvate|Y
Niemann-Pick type C1 disease|Niemann-Pick type C-1 disease|Y
Niemann-Pick type C1 disease|Niemann-Pick type C disease|Y
double-stranded-RNA-activated protein kinase|double-stranded RNA-activated protein kinase|Y
auto-immune enteropathy|autoimmune enteropathy|Y
complete atrio-ventricular septal defect|complete atrioventricular septal defect|Y
trans-vaginal ultrasound|transvaginal ultrasound|Y
lower gastrointestinal bleeding|lower gastro-intestinal bleeding|Y
transverse relaxation rates|transverse relaxation rate|Y
bromo-deoxyuridine triphosphate|bromodeoxyuridine triphosphate|Y
cholinacetyltransferase|cholineacetyltransferase|Y
antimicrobial resistance|anti-microbial resistance|Y
vaccine associated paralytic poliomyelitis|vaccine-associated paralytic poliomyelitis|Y
radio-isotope dilution|radioisotope dilution|Y
doubly-labelled water|doubly-labeled water|Y
noncollagenous domain 1|non-collagenous domain 1|Y
oculoauriculovertebral spectrum|oculo-auriculovertebral spectrum|Y
American Society of Anaesthesiology status 4|American Society of Anaesthesiology status 1|Y
American Society of Anaesthesiology status 4|American Society of Anaesthesiology status 2|Y
American Society of Anaesthesiology status 4|American Society of Anaesthesiology status 3|Y
American Society of Anaesthesiology status 4|American Society of Anaesthesiology status I|Y
American Society of Anaesthesiology status 4|American Society of Anesthesiology status 4|Y
American Society of Anaesthesiology status 4|American Society of Anaesthesiology status|Y
American Society of Anaesthesiology status 4|American Society of Anaesthesiology status V|Y
post-exercise ischaemia|post-exercise ischemia|Y
computed tomography scan|computed tomography scans|Y
Organization for Economic Cooperation and Development|Organization for Economic Co-operation and Development|Y
Organization for Economic Cooperation and Development|Organisation for Economic Cooperation and Development|Y
luteinising hormone-follicle-stimulating hormone releasing hormone|luteinising hormone-follicle stimulating hormone releasing hormone|Y
uridylyltransferase/uridylyl-removing enzyme|uridylyltransferase-uridylyl-removing enzyme|Y
periictal single-photon emission computed tomography|peri-ictal single-photon emission computed tomography|Y
periictal single-photon emission computed tomography|periictal single photon emission computed tomography|Y
human immunodeficiency virus 1-associated neurocognitive disorder|human immunodeficiency virus-associated neurocognitive disorder|Y
human immunodeficiency virus 1-associated neurocognitive disorder|human immunodeficiency virus 1 associated neurocognitive disorder|Y
intra-uterine pregnancy|intrauterine pregnancy|Y
heparin-induced thrombocytopenia and thrombosis syndrome|Heparin-induced thrombocytopenia and thrombosis syndrome|Y
levonorgestrel intrauterine device|levonorgestrel intra-uterine device|Y
transhepatic cholangiography|trans-hepatic cholangiography|Y
summed pain intensity difference over 6 hours|summed pain intensity difference over 8 hours|Y
summed pain intensity difference over 6 hours|summed pain intensity difference over 3 hours|Y
matrix-assisted laser desorption/ionisation time of flight mass spectrometric|matrix-assisted laser desorption/ionisation time of flight mass spectrometry|Y
matrix-assisted laser desorption/ionisation time of flight mass spectrometric|matrix-assisted laser desorption/ionization time of flight mass spectrometric|Y
matrix-assisted laser desorption/ionisation time of flight mass spectrometric|matrix-assisted laser desorption ionisation time of flight mass spectrometric|Y
intravascular bronchioalveolar tumor|intravascular bronchoalveolar tumor|Y
intravascular bronchioalveolar tumor|intravascular bronchio-alveolar tumor|Y
circulating tumor cell|circulating tumour cell|Y
circulating tumor cell|circulating tumor cells|Y
human T-cell lymphotropic virus type I antibody|human T-cell lymphotropic virus type 1 antibody|Y
human T-cell lymphotropic virus type I antibody|human T-cell lymphotropic virus type-I antibody|Y
hypoxia-inducible transcription factor-1 α|hypoxia inducible transcription factor-1 α|Y
hypoxia-inducible transcription factor-1 α|hypoxia-inducible transcription factor 1 α|Y
hypoxia-inducible transcription factor-1 α|hypoxia-inducible transcription factor-1α|Y
TBP associated factor 12|TBP associated factor 1|Y
TBP associated factor 12|TBP associated factor 2|Y
recombinant human interleukin 12|recombinant human interleukin 1|Y
reticulo-endotheliosis virus|reticuloendotheliosis virus|Y
tubularised incised plate hypospadias repair|tubularised incised-plate hypospadias repair|Y
tubularised incised plate hypospadias repair|tubularized incised plate hypospadias repair|Y
standardized proportional mortality ratio|standardised proportional mortality ratio|Y
sternocleido-mastoid|sterno-cleido-mastoid|Y
Src homology 2-containing protein-tyrosine phosphatase 2|Src homology 2-containing protein tyrosine phosphatase 2|Y
Src homology 2-containing protein-tyrosine phosphatase 2|Src homology 2-containing protein-tyrosine phosphatase 1|Y
Src homology 2-containing protein-tyrosine phosphatase 2|Src homology 2-containing protein-tyrosine phosphatase-2|Y
src homology 2 domain containing protein-tyrosine phosphatase|Src homology 2 domain containing protein-tyrosine phosphatase|Y
topoisomerase II binding protein 1|topoisomerase IIβ binding protein 1|Y
antiphospholipid antibody syndrome|anti-phospholipid antibody syndrome|Y
A disintegrin and metalloproteinase 19|A disintegrin and metalloproteinase 9|Y
cyclic guanosine monophosphate-dependent protein kinase I alpha|cyclic guanosine monophosphate-dependent protein kinase Ialpha|Y
acute ST-elevation myocardial infarction|acute ST elevation myocardial infarction|Y
human transforming growth factor-beta3|human transforming growth factor-beta|Y
San Juan Veteran's Administration Medical Center|San Juan Veterans' Administration Medical Center|Y
San Juan Veteran's Administration Medical Center|San Juan Veterans Administration Medical Center|Y
guanosinetriphosphatase activating protein 1|guanosinetriphosphatase activating protein-1|Y
guanosinetriphosphatase activating protein 1|guanosinetriphosphatase-activating protein 1|Y
guanosinetriphosphatase activating protein 1|guanosinetriphosphatase activating protein|Y
guanosinetriphosphatase activating protein 1|guanosine triphosphatase activating protein 1|Y
single-photon emission computerized tomography|single photon emission computerized tomography|Y
human adenovirus serotype 17|human adenovirus serotype 7|Y
human adenovirus serotype 17|human adenovirus serotype 1|Y
photo-activatable green fluorescent protein|photoactivatable green fluorescent protein|Y
3-dimensional time-of-flight magnetic resonance angiography|2-dimensional time-of-flight magnetic resonance angiography|Y
platelet-derived growth factor BB|platelet-derived growth factor B|Y
infectious bovine rhinotracheitis/infectious pustular vulvovaginitis virus|infectious bovine rhinotracheitis-infectious pustular vulvovaginitis virus|Y
infectious bovine rhinotracheitis/infectious pustular vulvovaginitis virus|infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis virus|Y
insulin-like growth factor-II mRNA binding protein 1|insulin-like growth factor II mRNA binding protein 1|Y
insulin-like growth factor-II mRNA binding protein 1|insulin-like growth factor-II mRNA-binding protein 1|Y
insulin-like growth factor-II mRNA binding protein 1|insulin-like growth factor-II mRNA binding protein-1|Y
insulin-like growth factor-II mRNA binding protein 1|insulin-like growth factor-II mRNA binding protein|Y
cobblestone area forming cell|cobblestone area forming cells|Y
major histocompatability complex|major histo-compatability complex|Y
ras-guanosine triphosphatase-activating protein|ras guanosine triphosphatase-activating protein|Y
ras-guanosine triphosphatase-activating protein|ras-guanosine triphosphatase activating protein|Y
ras-guanosine triphosphatase-activating protein|Ras-guanosine triphosphatase-activating protein|Y
penicillin binding protein 2|penicillin binding protein 2a|Y
carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone|carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone|Y
carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone|carbonyl cyanide p-trifluoromethoxyphenylhydrazone|Y
Legionnaires disease|Legionnaires' disease|Y
intra-cortical facilitation|intracortical facilitation|Y
alpha-ethyltryptamine|alpha-ethyl-tryptamine|Y
methyl cytosine-phosphate-guanosine binding domain 5|methyl cytosine-phosphate-guanosine binding domain 4|Y
methyl cytosine-phosphate-guanosine binding domain 5|methyl cytosine-phosphate-guanosine binding domain 2|Y
methyl cytosine-phosphate-guanosine binding domain 5|methyl cytosine-phosphate-guanosine binding domain|Y
radio guided parathyroidectomy|radioguided parathyroidectomy|Y
granulocyte-macrophage-colony-stimulating factor receptor α chain|granulocyte-macrophage colony-stimulating factor receptor α chain|Y
triphenylethylene anti-estrogen binding site|triphenylethylene antiestrogen binding site|Y
World Health Organization Quality of Life-HIV|World Health Organization Quality of Life HIV|Y
prolyl hydroxylase domain-containing protein 1|prolyl hydroxylase domain-containing protein 2|Y
nontransgenic littermate control mouse|non-transgenic littermate control mouse|Y
plasmonic photothermal therapy|plasmonic photo-thermal therapy|Y
Src homology 2-containing protein tyrosine phosphatase 1|Src homology 2-containing protein tyrosine phosphatase 2|Y
Src homology 2-containing protein tyrosine phosphatase 1|Src homology 2-containing protein-tyrosine phosphatase 1|Y
Src homology 2-containing protein tyrosine phosphatase 1|Src homology 2-containing protein tyrosine phosphatase|Y
truncated BH3-interacting domain death agonist|truncated BH3 interacting domain death agonist|Y
American Society of Anesthesiologists status IV|American Society of Anesthesiologists status V|Y
American Society of Anesthesiologists status IV|American Society of Anesthesiologists status I|Y
American Society of Anesthesiologists status IV|American Society of Anaesthesiologists status IV|Y
American Society of Anesthesiologists status IV|American Society of Anaesthesiologists status I|Y
solid-substrate room temperature phosphorimetry|solid-substrate room-temperature phosphorimetry|Y
inducible costimulator|inducible co-stimulator|Y
post-transcriptional gene silencing|posttranscriptional gene silencing|Y
contagious bovine pleuropneumonia|contagious bovine pleuro-pneumonia|Y
recombinant apolipoprotein(a)|recombinant apolipoprotein (a)|Y
anti-β2-glycoprotein-1 antibody|anti-β-2-glycoprotein-1 antibody|Y
transforming growth factor-beta type II receptor|transforming growth factor-beta type I receptor|Y
transesophageal echocardiography|trans-esophageal echocardiography|Y
beta-ketoacyl acyl carrier protein synthase I|beta-ketoacyl acyl carrier protein synthase|Y
beta-ketoacyl acyl carrier protein synthase I|beta-ketoacyl-acyl carrier protein synthase I|Y
beta-ketoacyl acyl carrier protein synthase I|beta-ketoacyl acyl carrier protein synthase II|Y
TIR domain containing adaptor-inducing IFN-β|TIR domain containing adaptor inducing IFN-β|Y
neo-vascular membrane|neovascular membrane|Y
anti-cyclooxygenase 1|anticyclooxygenase 1|Y
IL-5 receptor alpha-chain|IL-15 receptor alpha-chain|Y
quantitative electro-encephalogram|quantitative electroencephalogram|Y
G protein coupled oestrogen receptor 1|G protein coupled estrogen receptor 1|Y
non-specific ulcerative colitis|nonspecific ulcerative colitis|Y
MHC class II transactivator|MHC class II trans-activator|Y
cross polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
killer immunoglobulin-like receptor 2DL3|killer immunoglobulin-like receptor 2DL5|Y
killer immunoglobulin-like receptor 2DL3|killer immunoglobulin-like receptor 2DL1|Y
killer immunoglobulin-like receptor 2DL3|killer immunoglobulin-like receptor 2DL4|Y
killer immunoglobulin-like receptor 2DL3|killer immunoglobulin-like receptor 2DS3|Y
killer immunoglobulin-like receptor 2DL3|killer immunoglobulin-like receptor 2DL2|Y
Quality of Life in Reflux and Dyspepsia Questionnaire|Quality of Life in Reflux and Dyspepsia questionnaire|Y
TATA-binding protein associated factor-6|TATA-binding protein associated factor-8|Y
TATA-binding protein associated factor-6|TATA-binding protein associated factor 6|Y
TATA-binding protein associated factor-6|TATA-binding protein associated factor-5|Y
TATA-binding protein associated factor-6|TATA-binding protein associated factor-3|Y
TATA-binding protein associated factor-6|TATA-binding protein associated factor-1|Y
TATA-binding protein associated factor-6|TATA-binding protein associated factor-9|Y
TATA-binding protein associated factor-6|TATA-binding protein-associated factor-6|Y
TATA-binding protein associated factor-6|TATA-binding protein associated factor-2|Y
TATA-binding protein associated factor-6|TATA-binding protein associated factor-4|Y
TATA-binding protein associated factor-6|TATA-binding protein associated factor-7|Y
Durham Veterans' Affairs Medical Center|Durham Veterans Affairs Medical Center|Y
human T cell leukaemia virus type I-infected|human T cell leukaemia virus type-I-infected|Y
human T cell leukaemia virus type I-infected|human T cell leukaemia virus type 1-infected|Y
human T cell leukaemia virus type I-infected|human T cell leukemia virus type I-infected|Y
human T cell leukaemia virus type I-infected|human T-cell leukaemia virus type I-infected|Y
venous thromboembolic disease|venous thrombo-embolic disease|Y
corneal cross-linking|corneal crosslinking|Y
chemotactic peptide N-formylmethionyl-leucyl-phenylalanine|chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine|Y
chemotactic peptide N-formylmethionyl-leucyl-phenylalanine|chemotactic peptide N-formylmethionylleucylphenylalanine|Y
insulin-like growth factor II mRNA-binding protein 2|insulin-like growth factor II mRNA binding protein 2|Y
insulin-like growth factor II mRNA-binding protein 2|insulin-like growth factor II mRNA-binding protein|Y
insulin-like growth factor II mRNA-binding protein 2|insulin-like growth factor II mRNA-binding protein 1|Y
insulin-like growth factor II mRNA-binding protein 2|insulin-like growth factor II mRNA-binding protein 3|Y
insulin-like growth factor II mRNA-binding protein 2|insulin-like growth factor-II mRNA-binding protein 2|Y
insulin-like growth factor II mRNA-binding protein 2|insulin-like growth factor II mRNA-binding protein-2|Y
selective amygdalo-hippocampectomy|selective amygdalohippocampectomy|Y
electrospray ionisation quadrupole time-of-flight mass spectrometry|electrospray ionization quadrupole time-of-flight mass spectrometry|Y
electrospray ionisation quadrupole time-of-flight mass spectrometry|electrospray ionisation quadrupole time-of-flight mass spectrometer|Y
intracortical inhibition|intra-cortical inhibition|Y
anti-matrix metalloproteinase 1 antibody|anti-matrix metalloproteinase 3 antibody|Y
anti-matrix metalloproteinase 1 antibody|anti-matrix metalloproteinase 2 antibody|Y
anti-matrix metalloproteinase 1 antibody|anti-matrix metalloproteinase 13 antibody|Y
anti-matrix metalloproteinase 1 antibody|anti-matrix metalloproteinase 7 antibody|Y
anti-matrix metalloproteinase 1 antibody|anti-matrix metalloproteinase-1 antibody|Y
anti-matrix metalloproteinase 1 antibody|anti-matrix metalloproteinase 9 antibody|Y
directly observed treatment - short course|directly observed treatment - short-course|Y
directly observed treatment - short course|directly observed treatment-short course|Y
directly observed treatment - short course|directly observed treatment short course|Y
nonocclusive mesenteric ischemia|non-occlusive mesenteric ischemia|Y
nonocclusive mesenteric ischemia|non occlusive mesenteric ischemia|Y
type VIII Ehlers-Danlos syndrome|type VII Ehlers-Danlos syndrome|Y
low socio-economic status|low socioeconomic status|Y
embryonal carcinoma derived growth factor|embryonal carcinoma-derived growth factor|Y
principal co-ordinates analysis|principal co-ordinate analysis|Y
miniature inverted-repeat transposable element|miniature inverted repeat transposable element|Y
vegeto-vascular dystonia|vegetovascular dystonia|Y
proliferating cell nuclear antigen-labeling index|proliferating cell nuclear antigen labeling index|Y
proliferating cell nuclear antigen-labeling index|proliferating cell nuclear antigen-labelling index|Y
transforming growth factor beta receptor type 2|transforming growth factor beta receptor type I|Y
transforming growth factor beta receptor type 2|transforming growth factor-beta receptor type 2|Y
transforming growth factor beta receptor type 2|transforming growth factor beta receptor type 1|Y
noncontact bridging plate|non-contact bridging plate|Y
surface-enhanced laser desorption/ionisation time-of-flight|surface-enhanced laser desorption/ionization time-of-flight|Y
surface-enhanced laser desorption/ionisation time-of-flight|surface enhanced laser desorption/ionisation time-of-flight|Y
para-magnetic relaxation enhancement|paramagnetic relaxation enhancement|Y
spinocerebellar ataxia type 6|spinocerebellar ataxia type 16|Y
angle resolved photoemission spectroscopy|angle-resolved photoemission spectroscopy|Y
phosphorylated extracellular signal regulated kinase-1|phosphorylated extracellular signal regulated kinase-2|Y
phosphorylated extracellular signal regulated kinase-1|phosphorylated extracellular signal regulated kinase 1|Y
phosphorylated extracellular signal regulated kinase-1|phosphorylated extracellular signal regulated kinase|Y
phosphorylated extracellular signal regulated kinase-1|phosphorylated extracellular signal-regulated kinase-1|Y
posttraumatic stress symptom|post-traumatic stress symptom|Y
pro-collagen type-III aminoterminal peptide|procollagen type-III amino-terminal peptide|Y
pro-collagen type-III aminoterminal peptide|pro-collagen type III aminoterminal peptide|Y
pro-collagen type-III aminoterminal peptide|pro-collagen type-III amino-terminal peptide|Y
abdominal sacrocolpopexy|abdominal sacro-colpopexy|Y
carbonic anhydrase related protein XI|carbonic anhydrase related protein X|Y
crossed radio-immunoelectrophoresis|crossed radio-immuno-electrophoresis|Y
crossed radio-immunoelectrophoresis|crossed radioimmunoelectrophoresis|Y
TNF receptor-associated periodic syndrome|TNF-receptor-associated periodic syndrome|Y
TNF receptor-associated periodic syndrome|TNF receptor associated periodic syndrome|Y
American Society of Anesthesiology class|American Society of Anaesthesiology class|Y
American Society of Anesthesiology class|American Society of Anesthesiology class 1|Y
American Society of Anesthesiology class|American Society of Anesthesiology class 5|Y
American Society of Anesthesiology class|American Society of Anesthesiology class V|Y
American Society of Anesthesiology class|American Society of Anesthesiology class 4|Y
American Society of Anesthesiology class|American Society of Anesthesiology class I|Y
International Neuroblastoma Staging System stage I|International Neuroblastoma Staging System stage 2|Y
International Neuroblastoma Staging System stage I|International Neuroblastoma Staging System stage|Y
International Neuroblastoma Staging System stage I|International Neuroblastoma Staging System stage III|Y
International Neuroblastoma Staging System stage I|International Neuroblastoma Staging System stage 1|Y
International Neuroblastoma Staging System stage I|International Neuroblastoma Staging System stage 3|Y
International Neuroblastoma Staging System stage I|International Neuroblastoma Staging System stage II|Y
International Neuroblastoma Staging System stage I|International Neuroblastoma Staging System Stage I|Y
International Neuroblastoma Staging System stage I|International Neuroblastoma Staging System stage 4|Y
International Neuroblastoma Staging System stage I|International Neuroblastoma Staging System stage IV|Y
intra-ocular retinal prosthesis|intraocular retinal prosthesis|Y
dendritic cell-specific intercellular adhesion molecule 3 grabbing non-integrin|dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin|Y
dendritic cell-specific intercellular adhesion molecule 3 grabbing non-integrin|dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin|Y
dendritic cell-specific intercellular adhesion molecule 3 grabbing non-integrin|dendritic cell-specific intercellular adhesion molecule 3 grabbing nonintegrin|Y
modified antigen-capture enzyme-linked immunosorbent assay|modified antigen capture enzyme-linked immunosorbent assay|Y
mini-chromosome maintenance protein|minichromosome maintenance protein|Y
anti-insulin-like growth factor-I antibody|anti-insulin-like growth factor I antibody|Y
malignant fibrous histiocytoma|malignant fibrous histocytoma|Y
laser-desorption ionisation time-of-flight mass spectrometry|laser desorption ionisation time-of-flight mass spectrometry|Y
laser-desorption ionisation time-of-flight mass spectrometry|laser-desorption ionization time-of-flight mass spectrometry|Y
prepro-insulin-like growth factor|preproinsulin-like growth factor|Y
nonrinse conditioner|non-rinse conditioner|Y
lympho-myeloid complex|lymphomyeloid complex|Y
laevonorgestrel releasing intra-uterine system|levonorgestrel releasing intrauterine system|Y
laevonorgestrel releasing intra-uterine system|laevonorgestrel-releasing intra-uterine system|Y
laevonorgestrel releasing intra-uterine system|levonorgestrel releasing intra-uterine system|Y
laevonorgestrel releasing intra-uterine system|laevonorgestrel releasing intrauterine system|Y
laevonorgestrel releasing intra-uterine system|laevonorgestrel releasing intra uterine system|Y
hemoglobin L-Gaslini|haemoglobin L-Gaslini|Y
anti-interleukin 17 antibody|anti-interleukin 7 antibody|Y
anti-interleukin 17 antibody|antiinterleukin 17 antibody|Y
anti-interleukin 17 antibody|anti-interleukin 1 antibody|Y
interleukin-7 receptor α|interleukine-7 receptor α|Y
oligodendrocyte-like cell|oligodendrocyte-like cells|Y
countercurrent immunoelectrophoresis|countercurrent immuno-electrophoresis|Y
countercurrent immunoelectrophoresis|counter-current immunoelectrophoresis|Y
non-governmental organization|non-governmental organizations|Y
anti-IL-1alpha antibody|antiIL-1alpha antibody|Y
anti-IL-1alpha antibody|anti-IL1alpha antibody|Y
anti-IL-1alpha antibody|anti-IL-1 alpha antibody|Y
anti-IL 13 monoclonal antibody|anti-IL13 monoclonal antibody|Y
antineural cell adhesion molecule|anti-neural cell adhesion molecule|Y
germinal vesicle breakdown|germinal vesicle break down|Y
carbonyl cyanide p-trifluoromethoxy-phenylhydrazone|carbonyl cyanide p-trifluoromethoxyphenyl hydrazone|Y
carbonyl cyanide p-trifluoromethoxy-phenylhydrazone|carbonyl cyanide p-trifluoromethoxyphenylhydrazone|Y
forkhead box class O1|forkhead box class O|Y
forkhead box class O1|forkhead box class O1A|Y
super-paramagnetic iron oxide|superparamagnetic iron oxide|Y
pancreaticojejunostomy|pancreatico-jejunostomy|Y
human thyroid receptor β1|human thyroid receptor β-1|Y
anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody|anticytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody|Y
anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody|anticytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody|Y
Olea europaea protein 10|Olea europaea protein 1|Y
X-ray repair cross-complementing group 1|x-ray repair cross-complementing group 1|Y
1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane|1,1,1-trichloro-2,2-bis-(p-chlorophenyl)ethane|Y
1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane|1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane|Y
cytoreductive nephrectomy|cyto-reductive nephrectomy|Y
interleukine-6 receptor alpha subunit|interleukin-6 receptor alpha subunit|Y
altered states of consciousness|altered state of consciousness|Y
lymphoma associated haemophagocytic syndrome|lymphoma-associated haemophagocytic syndrome|Y
lymphoma associated haemophagocytic syndrome|lymphoma associated hemophagocytic syndrome|Y
chromatin immunoprecipitation assay|chromatin immuno-precipitation assay|Y
giant serotonin containing neurone|giant serotonin containing neuron|Y
radiostereometric analysis|radio-stereometric analysis|Y
ribonucleic acid polymerase I|ribonucleic acid polymerase II|Y
anteroventral third ventricle|antero-ventral third ventricle|Y
N-isopropyl-p-[123I] iodoamphetamine|N-isopropyl-p-[123I]iodoamphetamine|Y
non-invasive ventilation|noninvasive ventilation|Y
nonnutritive sucking|non-nutritive sucking|Y
steroid receptor co-activator 2|steroid receptor coactivator 2|Y
delta-aminolaevulinate|delta-aminolevulinate|Y
interferon-stimulated gene factor-3alpha|interferon-stimulated gene factor 3alpha|Y
interferon-stimulated gene factor-3alpha|interferon-stimulated gene factor-3 alpha|Y
interferon-stimulated gene factor-3alpha|interferon stimulated gene factor-3alpha|Y
catastrophic anti-phospholipid syndrome|catastrophic antiphospholipid syndrome|Y
aldosterone-producing adenoma|aldosterone-producing adenomas|Y
recombinant human transforming growth factor β 2|recombinant human transforming growth factor β 3|Y
recombinant human transforming growth factor β 2|recombinant human transforming growth factor β 1|Y
recombinant human transforming growth factor β 2|recombinant human transforming growth factor β2|Y
recombinant human transforming growth factor β 2|recombinant human transforming growth factor-β 2|Y
recombinant human transforming growth factor β 2|recombinant human transforming growth factor β|Y
hematoxylin-eosin stain|haematoxylin-eosin stain|Y
hematoxylin-eosin stain|hematoxylineosin stain|Y
signal transducer and activator of transcription 1 protein|signal transducer and activator of transcription 3 protein|Y
signal transducer and activator of transcription 1 protein|signal transducer and activator of transcription protein|Y
receptor-like protein-tyrosine phosphatase-mu|receptor-like protein-tyrosine phosphatase mu|Y
anti-brush border antibody|antibrush border antibody|Y
anti-IL-12p70 monoclonal antibody|antiIL-12p70 monoclonal antibody|Y
augmented correlation-consistent polarised valence quadruple-ζ basis set|augmented correlation-consistent polarised valence quadruple ζ basis set|Y
augmented correlation-consistent polarised valence quadruple-ζ basis set|augmented correlation-consistent polarized valence quadruple-ζ basis set|Y
augmented correlation-consistent polarised valence quadruple-ζ basis set|augmented correlation consistent polarised valence quadruple-ζ basis set|Y
thymus-derived lymphocytes|thymus-derived lymphocyte|Y
Staphylococcus cohnii subspecies urealyticus|Staphylococcus cohnii subspecies urealyticum|Y
extracapsular cataract extraction|extra-capsular cataract extraction|Y
TGF-β-activated kinase 1 binding protein 1|TGFβ-activated kinase 1 binding protein 1|Y
TGF-β-activated kinase 1 binding protein 1|TGF-β-activated kinase 1 binding protein-1|Y
intraductal hyperplasia|intraductal hyperlasia|Y
CX3C chemokine receptor 1|CXC chemokine receptor 1|Y
allogeneic effect factor|allogenic effect factor|Y
enzyme-linked immunosorbant assay|enzyme-linked immuno sorbant assay|Y
enzyme-linked immunosorbant assay|enzymelinked immunosorbant assay|Y
enzyme-linked immunosorbant assay|enzyme-linked immuno-sorbant assay|Y
Ureaplasma urealyticum|Urea-plasma urealyticum|Y
sub-clinical hepatic encephalopathy|subclinical hepatic encephalopathy|Y
steroid receptor co-activator 3|steroid receptor coactivator 3|Y
alpha-hexachlorocyclohexane|alpha-hexachloro-cyclohexane|Y
killer cell immunoglobulin-like receptor|killer cell immunoglobulinlike receptor|Y
killer cell immunoglobulin-like receptor|killer-cell immunoglobulin-like receptor|Y
killer cell immunoglobulin-like receptor|killer cell immunoglobulin-like receptors|Y
peptidylglycine alpha-amidating monooxygenase|peptidylglycine alpha-amidating mono-oxygenase|Y
peptidylglycine alpha-amidating monooxygenase|peptidyl glycine alpha-amidating monooxygenase|Y
peptidylglycine alpha-amidating monooxygenase|peptidyl-glycine alpha-amidating monooxygenase|Y
peptidylglycine alpha-amidating monooxygenase|peptidylglycine-alpha-amidating monooxygenase|Y
platelet-derived growth factor receptor-β|platelet-derived growth factor receptor β|Y
platelet-derived growth factor receptor-β|platelet-derived growth factor receptor-α|Y
platelet-derived growth factor receptor-β|platelet derived growth factor receptor-β|Y
methyl cytosine-phosphate-guanosine binding domain protein 3|methyl cytosine-phosphate-guanosine binding domain protein 4|Y
methyl cytosine-phosphate-guanosine binding domain protein 3|methyl cytosine-phosphate-guanosine binding domain protein 1|Y
methyl cytosine-phosphate-guanosine binding domain protein 3|methyl cytosine-phosphate-guanosine binding domain protein|Y
Ras-guanosine triphosphatase activating protein|Ras guanosine triphosphatase activating protein|Y
Ras-guanosine triphosphatase activating protein|ras-guanosine triphosphatase activating protein|Y
Ras-guanosine triphosphatase activating protein|Ras-guanosine triphosphatase-activating protein|Y
in situ end-labeling|in situ end-labelling|Y
exchanger inhibitory peptide|exchange inhibitory peptide|Y
intracytoplasmatic sperm injection|intra-cytoplasmatic sperm injection|Y
δ-aminolevulinic acid|δ-aminolaevulinic acid|Y
multixenobiotic resistance|multi-xenobiotic resistance|Y
adenosine triphosphate-binding cassette subfamily B member 1|adenosine-triphosphate-binding cassette subfamily B member 1|Y
adenosine triphosphate-binding cassette subfamily B member 1|adenosine triphosphate-binding cassette sub-family B member 1|Y
alpha-melanocyte-stimulating hormone receptor|alpha-melanocyte stimulating hormone receptor|Y
spontaneous otoacoustic emission|spontaneous oto acoustic emission|Y
swimming induced pulmonary edema|swimming induced pulmonary oedema|Y
maternal serum alphafetoprotein|maternal serum alpha-fetoprotein|Y
maternal serum alphafetoprotein|maternal serum alpha fetoprotein|Y
Polygalacturonase-inhibiting proteins|Polygalacturonase-inhibiting protein|Y
interleukin-4 receptor α chain|interleukine-4 receptor α chain|Y
three dimensional volumetric interpolated breath-hold examination sequence|three-dimensional volumetric interpolated breath-hold examination sequence|Y
hepatoiminodiacetic acid|hepato-iminodiacetic acid|Y
antihamster immunoglobulin M|anti-hamster immunoglobulin M|Y
type VII collagen gene|type II collagen gene|Y
oxo-phytodienoic acid|oxophytodienoic acid|Y
pro-platelet formation|proplatelet formation|Y
N-isopropyl-p-[123I]iodoamphetamine|N-isopropyl-p-[123I]-iodoamphetamine|Y
gastro-esophageal fundoplication|gastro-oesophageal fundoplication|Y
gastro-esophageal fundoplication|gastroesophageal fundoplication|Y
A disintegrin and metalloproteinase-29|A disintegrin and metalloproteinase-9|Y
anti-streptolysin test|antistreptolysin test|Y
homozygous α1PI deficiency|homozygous α1-PI deficiency|Y
extented Hückel tight binding calculation|extented Huckel tight binding calculation|Y
extented Hückel tight binding calculation|extented Hückel tight-binding calculation|Y
Wechsler Intelligence Scale for Children, Revised|Wechsler Intelligence Scale for Children Revised|Y
lyso-phosphatidic acid|lysophosphatidic acid|Y
pulsed electro-magnetic field|pulsed electromagnetic field|Y
hypoglycaemia associated autonomic failure|hypoglycaemia-associated autonomic failure|Y
hypoglycaemia associated autonomic failure|hypoglycemia associated autonomic failure|Y
spasmolytic polypeptide-expressing metaplasia|spasmolytic polypeptide expressing metaplasia|Y
Partial pressure of carbon dioxide in arterial blood|partial pressure of carbon dioxide in arterial blood|Y
interleukine-6 receptor α-chain|interleukin-6 receptor α-chain|Y
delayed afterdepolarisation|delayed after depolarisation|Y
delayed afterdepolarisation|delayed after-depolarisation|Y
pointwise linear regression|point-wise linear regression|Y
melanocyte-stimulating hormone release inhibiting factor|melanocyte-stimulating hormone release-inhibiting factor|Y
adrenocorticotrophic hormone-dependent Cushing's syndrome|adrenocorticotropic hormone-dependent Cushing's syndrome|Y
adrenocorticotrophic hormone-dependent Cushing's syndrome|adrenocorticotrophic hormone-independent Cushing's syndrome|Y
adrenocorticotrophic hormone-dependent Cushing's syndrome|adrenocorticotrophic hormone-dependent Cushing syndrome|Y
non-syndromic mental retardation|nonsyndromic mental retardation|Y
N-acetyl-galactosamine|N-acetylgalactosamine|Y
airway hyperresponsiveness|airway hyper-responsiveness|Y
glutamine: fructose-6-phosphate amidotransferase-2|glutamine: fructose-6-phosphate amidotransferase-1|Y
prostaglandin G/H synthase II|prostaglandin G/H synthase I|Y
University of California, Los Angeles Medical Center|University of California Los Angeles Medical Center|Y
peri-peduncular nucleus|peripeduncular nucleus|Y
multiwavelength anomalous diffraction|multi-wavelength anomalous diffraction|Y
bovine viral diarrhoea-mucosal disease virus|bovine viral diarrhea-mucosal disease virus|Y
sex-determining region Y-type high mobility group-box 9|sex-determining region Y-type high mobility group box 9|Y
post-pill amenorrhea|post-pill amenorrhoea|Y
gastro-œsophageal junction|gastroœsophageal junction|Y
pseudoexfoliation material|pseudo-exfoliation material|Y
multi-attribute utility theory|multiattribute utility theory|Y
peptidylglycine-α-amidating monooxygenase|peptidyl-glycine-α-amidating mono-oxygenase|Y
peptidylglycine-α-amidating monooxygenase|peptidylglycine-α-amidating mono-oxygenase|Y
peptidylglycine-α-amidating monooxygenase|peptidylglycine α-amidating monooxygenase|Y
opioid receptor-like1|opioid receptor-like|Y
extrapyramidal side effect|extra-pyramidal side effect|Y
generalised multifactor dimensionality reduction|generalized multifactor dimensionality reduction|Y
Charcot-Marie-Tooth disease type 4B1|Charcot-Marie-Tooth disease type 4B|Y
Haemaphysalis leporis-palustris|Haemaphysalis leporispalustris|Y
promyelocytic leukaemia-retinoic acid receptor-α|promyelocytic leukaemia/retinoic acid receptor-α|Y
promyelocytic leukaemia-retinoic acid receptor-α|promyelocytic leukemia-retinoic acid receptor-α|Y
promyelocytic leukaemia-retinoic acid receptor-α|promyelocytic leukaemia-retinoic acid receptor α|Y
fluorescent labelled antibody|fluorescent labeled antibody|Y
standard deviation of normal RR intervals|standard deviation of normal R-R intervals|Y
FAR-RED IMPAIRED RESPONSE 1|FAR-RED IMPAIRED RESPONSE1|Y
interleukin 1β-converting enzyme|interleukin 1 β-converting enzyme|Y
interleukine-13 receptor α1-chain|interleukin-13 receptor α1-chain|Y
xanthine oxido-reductase|xanthine oxidoreductase|Y
eucaryotic elongation factor 1 α|eucaryotic elongation factor 1α|Y
intra-rater reliability|intrarater reliability|Y
postmenopausal hormone|post-menopausal hormone|Y
loco-regional control|locoregional control|Y
ultraviolet light irradiation|ultra-violet light irradiation|Y
broncho-biliary fistula|bronchobiliary fistula|Y
primary graft nonfunction|primary graft non-function|Y
non-linear dielectric spectroscopy|nonlinear dielectric spectroscopy|Y
chicken luteinizing hormone-releasing hormone|chicken luteinizing hormone-releasing hormone-I|Y
chicken luteinizing hormone-releasing hormone|chicken luteinising hormone-releasing hormone|Y
chicken luteinizing hormone-releasing hormone|chicken luteinizing hormone releasing hormone|Y
chicken luteinizing hormone-releasing hormone|chicken luteinizing hormone-releasing hormone I|Y
cyclin kinase subunit 1B|cyclin kinase subunit 1|Y
cost-related medication nonadherence|cost-related medication non-adherence|Y
solid-phase extraction-liquid chromatography/mass spectrometry|solid-phase extraction-liquid chromatography-mass spectrometry|Y
pancreato-gastrostomy|pancreatogastrostomy|Y
interleukine 11 receptor α chain|interleukin 11 receptor α chain|Y
dystrophin-associated proteins|dystrophin-associated protein|Y
T-cell receptor-gammadelta-positive|T-cell receptor-gamma delta-positive|Y
branched-chain alpha-keto acid dehydrogenase complex|branched-chain alpha-ketoacid dehydrogenase complex|Y
branched-chain alpha-keto acid dehydrogenase complex|branched chain alpha-keto acid dehydrogenase complex|Y
Niemann-Pick type C1|Niemann-Pick type C-1|Y
Bilateral periventricular nodular heterotopia|bilateral periventricular nodular heterotopia|Y
gas chromatography-electron capture negative ion mass spectrometry|gas chromatography/electron capture negative ion mass spectrometry|Y
gas chromatography-electron capture negative ion mass spectrometry|gas chromatography-electron capture negative-ion mass spectrometry|Y
gas chromatography-electron capture negative ion mass spectrometry|gas chromatography-electron-capture negative ion mass spectrometry|Y
X-ray repair cross-complementing protein 1|X-ray repair cross complementing protein 1|Y
X-ray repair cross-complementing protein 1|X-ray repair cross-complementing protein 2|Y
intracorneal ring segment|intra-corneal ring segment|Y
killer cell immunoglobulinlike receptor|killer cell immunoglobulin-like receptors|Y
corticotropin-releasing factor receptor 1|corticotropin-releasing factor receptor-1|Y
corticotropin-releasing factor receptor 1|corticotropin releasing factor receptor 1|Y
corticotropin-releasing factor receptor 1|corticotropin-releasing factor receptor|Y
corticotropin-releasing factor receptor 1|corticotrophin-releasing factor receptor 1|Y
surface enhanced laser desorption ionization time-of-flight mass spectrometry|surface-enhanced laser desorption ionization time-of-flight mass spectrometry|Y
surface enhanced laser desorption ionization time-of-flight mass spectrometry|surface enhanced laser desorption ionisation time-of-flight mass spectrometry|Y
anti-human T cell lymphotropic virus type-1 antibody|anti-human T-cell lymphotropic virus type-1 antibody|Y
anti-human T cell lymphotropic virus type-1 antibody|anti-human T cell lymphotropic virus type-I antibody|Y
anti-human T cell lymphotropic virus type-1 antibody|anti-human T cell lymphotropic virus type 1 antibody|Y
oral anti-coagulation|oral anticoagulation|Y
switch/sucrose nonfermentable complex|switch/sucrose non-fermentable complex|Y
switch/sucrose nonfermentable complex|switch/sucrose non fermentable complex|Y
Sarcoptes scabiei varietas ovis|Sarcoptes scabiei varietas bovis|Y
interleukin 1 receptor-associated kinase|interleukin 1 receptor associated kinase|Y
interleukin 1 receptor-associated kinase|interleukin-1 receptor-associated kinase|Y
interleukin 1 receptor-associated kinase|interleukin 1 receptor-associated kinase 4|Y
mammalian gonadotrophin releasing hormone|mammalian gonadotrophin-releasing hormone|Y
mammalian gonadotrophin releasing hormone|mammalian gonadotropin releasing hormone|Y
x-ray absorption fine structure spectroscopy|X-ray absorption fine structure spectroscopy|Y
x-ray absorption fine structure spectroscopy|x-ray absorption fine-structure spectroscopy|Y
HTLV-I associated myelopathy/tropical spastic paraparesis|HTLV-1 associated myelopathy/tropical spastic paraparesis|Y
3 β-hydroxysteroid dehydrogenase deficiency|3-β-hydroxysteroid dehydrogenase deficiency|Y
3 β-hydroxysteroid dehydrogenase deficiency|3β-hydroxysteroid dehydrogenase deficiency|Y
sulfated glycosaminoglycans|sulfated glycosaminoglycan|Y
oestrogen receptor β knock-out|estrogen receptor β knock-out|Y
matrix-assisted laser desorption ionisation-mass spectrometry|matrix assisted laser desorption ionisation-mass spectrometry|Y
matrix-assisted laser desorption ionisation-mass spectrometry|matrix-assisted laser desorption ionisation mass spectrometry|Y
matrix-assisted laser desorption ionisation-mass spectrometry|matrix-assisted laser desorption/ionisation-mass spectrometry|Y
matrix-assisted laser desorption ionisation-mass spectrometry|matrix-assisted laser desorption ionization-mass spectrometry|Y
surface-assisted laser desorption ionisation time-of-flight mass spectrometry|surface-assisted laser desorption/ionisation time-of-flight mass spectrometry|Y
surface-assisted laser desorption ionisation time-of-flight mass spectrometry|surface-assisted laser desorption ionization time-of-flight mass spectrometry|Y
interleukin 1 receptor associated kinase|interleukin-1 receptor associated kinase|Y
interleukin 1 receptor associated kinase|interleukin 1 receptor associated kinase 4|Y
hyper-lipoproteinemia|hyperlipoproteinemia|Y
hyper-lipoproteinemia|hyper-lipoproteinaemia|Y
post-synaptic density protein 95|postsynaptic density protein 95|Y
3-hydroxy-3-methylglutaryl-CoA|3-hydroxy-3-methyl-glutaryl-CoA|Y
online analytical processing|on-line analytical processing|Y
areas under the plasma concentration-time curves|area under the plasma concentration-time curves|Y
T-cell receptor γ δ cell|T-cell receptor γδ cell|Y
electro-chemiluminescence|electrochemiluminescence|Y
spondylo-epiphyseal dysplasia tarda|spondyloepiphyseal dysplasia tarda|Y
mitogen extracellular signal-regulated kinase-1|mitogen extracellular signal regulated kinase-1|Y
mitogen extracellular signal-regulated kinase-1|mitogen extracellular signal-regulated kinase 1|Y
streptozotocin-induced diabetes mellitus|streptozotocine-induced diabetes mellitus|Y
trichorhinophalangeal syndrome type III|trichorhinophalangeal syndrome type II|Y
trichorhinophalangeal syndrome type III|tricho-rhino-phalangeal syndrome type III|Y
IL7 receptor alpha chain|IL-7 receptor alpha chain|Y
Phleum pratense allergen 13|Phleum pratense allergen 1|Y
Wechsler Intelligence Scale for Children Fourth Edition|Wechsler Intelligence Scale for Children-Fourth Edition|Y
Wechsler Intelligence Scale for Children Fourth Edition|Wechsler Intelligence Scale for Children, Fourth Edition|Y
Wechsler Intelligence Scale for Children Fourth Edition|Wechsler Intelligence Scale for Children - Fourth Edition|Y
inhibitory-κ B kinase|inhibitory-κB kinase|Y
lateral spinothalamic tract|lateral spino-thalamic tract|Y
delayed traumatic intracerebral hemorrhage|delayed traumatic intracerebral hæmorrhage|Y
delayed traumatic intracerebral hemorrhage|delayed traumatic intracerebral haemorrhage|Y
transjugular intra-hepatic portosystemic shunting|trans-jugular intra-hepatic portosystemic shunting|Y
transjugular intra-hepatic portosystemic shunting|trans-jugular intra-hepatic porto-systemic shunting|Y
transjugular intra-hepatic portosystemic shunting|transjugular intrahepatic porto-systemic shunting|Y
transjugular intra-hepatic portosystemic shunting|trans-jugular intrahepatic portosystemic shunting|Y
transjugular intra-hepatic portosystemic shunting|transjugular intra-hepatic porto-systemic shunting|Y
technetium-99m diethylenetriamine penta-acetic acid|technetium-99m diethylenetriamine pentaacetic acid|Y
technetium-99m diethylenetriamine penta-acetic acid|technetium-99m diethylene triamine pentaacetic acid|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell-expressed developmentally downregulated 2|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell expressed developmentally downregulated 8|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell-expressed developmentally down-regulated 5|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell-expressed, developmentally down-regulated 8|Y
neural precursor cell-expressed developmentally down-regulated 8|neural-precursor cell-expressed developmentally down-regulated 8|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell-expressed, developmentally down-regulated 5|Y
neural precursor cell-expressed developmentally down-regulated 8|neural-precursor cell-expressed, developmentally down-regulated 8|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell expressed, developmentally down-regulated 8|Y
neural precursor cell-expressed developmentally down-regulated 8|neural-precursor cell-expressed developmentally downregulated 8|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell-expressed developmentally downregulated 8|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell-expressed developmentally downregulated 5|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell-expressed developmentally downregulated 4|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell expressed developmentally down-regulated 8|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell-expressed developmentally down-regulated 1|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell-expressed developmentally down-regulated 9|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell-expressed developmentally downregulated 1|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell-expressed developmentally down-regulated 2|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell-expressed developmentally down-regulated 4|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell-expressed developmentally downregulated 9|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell-expressed, developmentally downregulated 8|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell-expressed developmentally down-regulated 8|neural precursor cell-expressed, developmentally down-regulated 2|Y
adult T cell leukemia derived factor|adult T cell leukaemia derived factor|Y
American Society of Anaesthesiologists Status 1|American Society of Anaesthesiologists Status 2|Y
American Society of Anaesthesiologists Status 1|American Society of Anaesthesiologists Status I|Y
American Society of Anaesthesiologists Status 1|American Society of Anesthesiologists Status 1|Y
American Society of Anaesthesiologists Status 1|American Society of Anaesthesiologists status 1|Y
American Society of Anaesthesiologists Status 1|American Society of Anaesthesiologists Status 3|Y
ste20-related proline alanine-rich kinase|ste-20-related proline alanine-rich kinase|Y
ste20-related proline alanine-rich kinase|ste20-related proline-alanine-rich kinase|Y
ste20-related proline alanine-rich kinase|Ste20-related proline alanine-rich kinase|Y
pedunculopontine nucleus|pedunculo-pontine nucleus|Y
NFκB repressing factor|NF-κB repressing factor|Y
internally displaced persons|internally displaced person|Y
heat-shock protein 90 α|heat-shock protein 90α|Y
radio-contrast medium|radiocontrast medium|Y
muco-cutaneous leishmaniasis|mucocutaneous leishmaniasis|Y
short interval intra-cortical inhibition|short-interval intra-cortical inhibition|Y
short interval intra-cortical inhibition|short interval intracortical inhibition|Y
retinoic acid receptor-related orphan receptor-γ|retinoic acid receptor-related orphan receptor|Y
retinoic acid receptor-related orphan receptor-γ|retinoic acid receptor-related orphan receptor-α|Y
retinoic acid receptor-related orphan receptor-γ|retinoic acid receptor-related orphan receptor γ|Y
vitamin D3-up-regulated protein 1|vitamin D3-upregulated protein 1|Y
insulin induced hypoglycemia|insulin induced hypoglycaemia|Y
insulin-like growth factor-I|insulin-like growth factor-II|Y
American Society of Anesthesiologists physical status 3|American Society of Anesthesiologists physical status V|Y
American Society of Anesthesiologists physical status 3|American Society of Anesthesiologists physical status|Y
American Society of Anesthesiologists physical status 3|American Society of Anesthesiologists physical status I|Y
American Society of Anesthesiologists physical status 3|American Society of Anesthesiologists physical status 2|Y
American Society of Anesthesiologists physical status 3|American Society of Anesthesiologists physical status 4|Y
American Society of Anesthesiologists physical status 3|American Society of Anaesthesiologists physical status 3|Y
American Society of Anesthesiologists physical status 3|American Society of Anesthesiologists physical status 5|Y
cerebrospinal fluid level|cerebro-spinal fluid level|Y
nuclear factor κ B p50 subunit|nuclear factor κB p50 subunit|Y
Clinical Global Impressions Severity of Illness|Clinical Global Impressions-Severity of Illness|Y
trans-metatarsal amputation|transmetatarsal amputation|Y
ultra-high-resolution optical coherence tomography|ultra-high resolution optical coherence tomography|Y
oculo-oscillo-dynamography|oculo-oscillodynamography|Y
multi-drug resistance protein 2|multidrug resistance protein 2|Y
transverse micro-radiography|transverse microradiography|Y
chronic idiopathic intestinal pseudoobstruction|chronic idiopathic intestinal pseudo-obstruction|Y
autoimmune liver disease|auto-immune liver disease|Y
scanning tunnelling microscope|scanning tunneling microscope|Y
atlanto-axial dislocation|atlantoaxial dislocation|Y
premature rupture of membranes|premature rupture of membrane|Y
molt-inhibiting hormone|moult-inhibiting hormone|Y
spinocerebellar ataxia type 2|spinocerebellar ataxia type 12|Y
spinocerebellar ataxia type 2|spinocerebellar ataxia type 21|Y
spinocerebellar ataxia type 2|spinocerebellar ataxia type 22|Y
ursodeoxycholyl-sarcosine|ursodeoxycholylsarcosine|Y
chromosome region maintenance 1-independent|chromosome region maintenance 1-dependent|Y
transjugular intrahepatic porto-systemic shunt|transjugular intra-hepatic porto-systemic shunt|Y
transjugular intrahepatic porto-systemic shunt|transjugular intrahepatic portosystemic shunt|Y
transjugular intrahepatic porto-systemic shunt|trans-jugular intrahepatic porto-systemic shunt|Y
transjugular intrahepatic porto-systemic shunt|transjugular intra-hepatic portosystemic shunt|Y
transjugular intrahepatic porto-systemic shunt|trans-jugular intra-hepatic porto-systemic shunt|Y
transjugular intrahepatic porto-systemic shunt|trans-jugular intrahepatic portosystemic shunt|Y
anterolateral myocardial infarction|antero-lateral myocardial infarction|Y
prointerleukin-1 alpha|prointerleukin-1alpha|Y
prointerleukin-1 alpha|pro-interleukin-1 alpha|Y
hypoxia inducible factor 1β|hypoxia inducible factor 1 β|Y
FK-506 binding protein 38|FK506 binding protein 38|Y
tracheo-bronchopathia osteo-chondroplastica|tracheo-bronchopathia osteochondroplastica|Y
tracheo-bronchopathia osteo-chondroplastica|tracheobronchopathia osteochondroplastica|Y
cyclin dependent kinase-interacting protein 1|cyclin-dependent kinase-interacting protein 1|Y
cyclin dependent kinase-interacting protein 1|cyclin dependent kinase interacting protein 1|Y
serotonin–norepinephrine reuptake inhibitor|serotonin norepinephrine reuptake inhibitor|Y
hereditary angio-edema|hereditary angio-oedema|Y
hereditary angio-edema|hereditary angioedema|Y
transforming growth factor-α-Pseudomonas exotoxin-40|transforming growth factor α-Pseudomonas exotoxin-40|Y
transforming growth factor-α-Pseudomonas exotoxin-40|transforming growth factor-α-Pseudomonas exotoxin 40|Y
antiinterleukin 4 monoclonal antibody|anti-interleukin 4 monoclonal antibody|Y
immuno-competent cell|immunocompetent cell|Y
sociopathic personality disorder|socio-pathic personality disorder|Y
metabotropic glutamate receptor subtype 1|metabotropic glutamate receptor subtype 3|Y
metabotropic glutamate receptor subtype 1|metabotropic glutamate receptor subtype 7|Y
metabotropic glutamate receptor subtype 1|metabotropic glutamate receptor subtype 5|Y
metabotropic glutamate receptor subtype 1|metabotropic glutamate receptor subtype 6|Y
metabotropic glutamate receptor subtype 1|metabotropic glutamate receptor subtype 4|Y
protein kinase C βII|protein kinase C β II|Y
protein kinase C βII|protein kinase C β-II|Y
stepwise logistic regression|step-wise logistic regression|Y
combined sewer overflow|combined sewer overflows|Y
para-aminobenzoyl glutamic|para-aminobenzoylglutamic|Y
adreno-corticotrophin|adreno-corticotropin|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell expressed, developmentally down-regulated 9|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell expressed developmentally down-regulated 2|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell expressed developmentally down-regulated 4|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell expressed developmentally downregulated 8|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell-expressed developmentally down-regulated 5|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell-expressed, developmentally down-regulated 5|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell expressed developmentally downregulated 9|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell expressed, developmentally down-regulated 2|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell expressed, developmentally down-regulated 8|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell-expressed developmentally downregulated 5|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell expressed, developmentally downregulated 5|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell expressed developmentally down-regulated 1|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell expressed developmentally down-regulated 8|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell expressed developmentally downregulated 4|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell expressed developmentally downregulated 5|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell expressed developmentally downregulated 2|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell expressed, developmentally down-regulated 4|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell expressed, developmentally down-regulated 1|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell expressed developmentally down-regulated 9|Y
neural precursor cell expressed developmentally down-regulated 5|neural precursor cell expressed, developmentally down-regulated 5|Y
homeodomain interacting protein kinase-2|homeodomain interacting protein kinase 2|Y
homeodomain interacting protein kinase-2|homeodomain-interacting protein kinase-2|Y
American Society of Anesthesiology Grade 4|American Society of Anesthesiology Grade I|Y
American Society of Anesthesiology Grade 4|American Society of Anesthesiology Grade V|Y
American Society of Anesthesiology Grade 4|American Society of Anesthesiology Grade 5|Y
American Society of Anesthesiology Grade 4|American Society of Anesthesiology Grade 2|Y
American Society of Anesthesiology Grade 4|American Society of Anesthesiology Grade 3|Y
American Society of Anesthesiology Grade 4|American Society of Anesthesiology Grade 1|Y
human adenovirus type 5|human adenovirus type 50|Y
human adenovirus type 5|human adenovirus type 51|Y
human adenovirus type 5|human adenovirus type 15|Y
human adenovirus type 5|human adenovirus type 35|Y
human adenovirus type 5|human adenovirus type 52|Y
human adenovirus type 5|human adenovirus type 45|Y
guanosinetriphosphatase activating protein-1|guanosinetriphosphatase activating protein|Y
guanosinetriphosphatase activating protein-1|guanosinetriphosphatase-activating protein-1|Y
guanosinetriphosphatase activating protein-1|guanosine triphosphatase activating protein-1|Y
trypsin-like immunoreactivity|trypsinlike immunoreactivity|Y
intranuclear inclusion|intra-nuclear inclusion|Y
differential reinforcement of low rate|differential reinforcement of low rates|Y
reticulo-histiocytic system|reticulohistiocytic system|Y
Björk-Shiley convexo-concave valve|Björk-Shiley convexoconcave valve|Y
ρ-guanine nucleotide dissociation inhibitor 1|ρ-guanine nucleotide dissociation inhibitor 2|Y
ρ-guanine nucleotide dissociation inhibitor 1|ρ-guanine nucleotide dissociation inhibitor-1|Y
ρ-guanine nucleotide dissociation inhibitor 1|guanine nucleotide dissociation inhibitor 1|Y
squamous intraepithelial lesion|squamous intra-epithelial lesion|Y
tumor necrosis factor receptor-associated factor-5|tumor necrosis factor receptor-associated factor|Y
tumor necrosis factor receptor-associated factor-5|tumor necrosis factor receptor associated factor-5|Y
tumor necrosis factor receptor-associated factor-5|tumor necrosis factor receptor-associated factor-6|Y
tumor necrosis factor receptor-associated factor-5|tumor necrosis factor receptor-associated factor 5|Y
tumor necrosis factor receptor-associated factor-5|tumour necrosis factor receptor-associated factor-5|Y
expressed sequence tags|expressed sequence tag|Y
magic angle spinning solid-state nuclear magnetic resonance|magic angle spinning solid state nuclear magnetic resonance|Y
multiwall carbon nanotube|multi-wall carbon nanotube|Y
International Neuroblastoma Staging System stage 2|International Neuroblastoma Staging System stage|Y
International Neuroblastoma Staging System stage 2|International Neuroblastoma Staging System stage 1|Y
International Neuroblastoma Staging System stage 2|International Neuroblastoma Staging System stage 3|Y
International Neuroblastoma Staging System stage 2|International Neuroblastoma Staging System Stage 2|Y
International Neuroblastoma Staging System stage 2|International Neuroblastoma Staging System stage 4|Y
extracellular domain|extra-cellular domain|Y
natural resistance-associated macrophage protein-1|natural resistance-associated macrophage protein|Y
natural resistance-associated macrophage protein-1|natural resistance associated macrophage protein-1|Y
natural resistance-associated macrophage protein-1|natural-resistance-associated macrophage protein-1|Y
trans-activator protein|transactivator protein|Y
infra-red emission detection|infrared emission detection|Y
inter-rater reliability|interrater reliability|Y
tumor associated macrophage|tumour associated macrophage|Y
voltage-gated calcium channel alpha1 subunit|voltage-gated calcium channel alpha 1 subunit|Y
voltage-gated calcium channel alpha1 subunit|voltage-gated calcium channel alpha-1 subunit|Y
voltage-gated calcium channel alpha1 subunit|voltage-gated calcium channel alpha1-subunit|Y
rocket immunoelectrophoresis|rocket immuno-electrophoresis|Y
temporo-mandibular dysfunction|temporomandibular dysfunction|Y
IL12 receptor beta2 chain|IL-12 receptor beta2 chain|Y
International Conference on Harmonization E5 guideline|International Conference on Harmonisation E5 guideline|Y
interleukine-13 receptor α 1|interleukine-13 receptor α1|Y
50% tumour control dose|50% tumor control dose|Y
hereditary cerebral haemorrhage with amyloidosis|hereditary cerebral hemorrhage with amyloidosis|Y
graft-versus-leukemia/lymphoma effect|graft-versus-leukaemia/lymphoma effect|Y
ribosomal protein L39|ribosomal protein L3|Y
ribosomal protein L39|ribosomal protein L9|Y
sulphobutyl ether-beta-cyclodextrin|sulphobutylether-beta-cyclodextrin|Y
anti-thyroid-stimulating hormone receptor antibody|antithyroid-stimulating hormone receptor antibody|Y
lymphatic vessel endothelial hyaluronan receptor|lymphatic vessel endothelial hyaluronan receptor 1|Y
granulocyte-macrophage colony-stimulating-factor|granulocyte-macrophage colony-stimulating factor|Y
random amplified polymorphic DNA primer|randomly amplified polymorphic DNA primer|Y
wingless-type MMTV integration site family member 7A|wingless-type MMTV integration site family member 5A|Y
wingless-type MMTV integration site family member 7A|Wingless-type MMTV integration site family member 7A|Y
wingless-type MMTV integration site family member 7A|wingless-type MMTV integration site family member 3A|Y
wingless-type MMTV integration site family member 7A|wingless-type MMTV integration site family member 7B|Y
epidemic methicillin-resistant Staphylococcus aureus-12|epidemic methicillin-resistant Staphylococcus aureus-1|Y
epidemic methicillin-resistant Staphylococcus aureus-12|epidemic methicillin-resistant Staphylococcus aureus-2|Y
epidemic methicillin-resistant Staphylococcus aureus-12|epidemic methicillin-resistant Staphylococcus aureus-15|Y
epidemic methicillin-resistant Staphylococcus aureus-12|epidemic methicillin-resistant Staphylococcus aureus-17|Y
epidemic methicillin-resistant Staphylococcus aureus-12|epidemic methicillin-resistant Staphylococcus aureus-16|Y
sterol response element binding protein 1|sterol response element binding protein 1a|Y
sterol response element binding protein 1|sterol response element binding protein 1-a|Y
sterol response element binding protein 1|sterol response element binding protein 1c|Y
sterol response element binding protein 1|sterol response element binding protein 1-c|Y
transdermal therapeutic system|trans-dermal therapeutic system|Y
catechol-O-methyl transferase|catechol-O-methyltransferase|Y
endothelial monocyte-activating polypeptide III|endothelial monocyte-activating polypeptide I|Y
endothelial monocyte-activating polypeptide III|endothelial-monocyte-activating polypeptide III|Y
endothelial monocyte-activating polypeptide III|endothelial monocyte-activating polypeptide II|Y
endothelial monocyte-activating polypeptide III|endothelial monocyte-activating polypeptide-III|Y
multidetector computed tomographic scan|multi-detector computed tomographic scan|Y
off-pump coronary artery by-pass|off-pump coronary artery bypass|Y
integrin cytoplasmic domain associated protein-1|integrin cytoplasmic domain-associated protein-1|Y
integrin cytoplasmic domain associated protein-1|integrin cytoplasmic domain associated protein 1|Y
bronchial hyperresponsiveness|bronchial hyper-responsiveness|Y
overwhelming post splenectomy infection|overwhelming postsplenectomy infection|Y
tumor-initiating cell|tumour-initiating cell|Y
spinobulbar muscular atrophy|spino-bulbar muscular atrophy|Y
computed tomography osteo-absorptiometry|computed tomography osteoabsorptiometry|Y
nucleosome remodeling and deacetylase complex|nucleosome remodelling and deacetylase complex|Y
multicolor fluorescence in-situ hybridization|multicolor fluorescence in situ hybridization|Y
multicolor fluorescence in-situ hybridization|multi-color fluorescence in-situ hybridization|Y
interleukine-13 receptor α1 subunit|interleukin-13 receptor α1 subunit|Y
mitogen-activated protein kinase kinase kinase-4|mitogen-activated protein kinase kinase kinase-1|Y
mitogen-activated protein kinase kinase kinase-4|mitogen-activated protein kinase kinase kinase|Y
mitogen-activated protein kinase kinase kinase-4|mitogen-activated protein kinase kinase kinase 4|Y
cluster of differentiation antigen 271|cluster of differentiation antigen 71|Y
cluster of differentiation antigen 271|cluster of differentiation antigen 27|Y
cluster of differentiation antigen 271|cluster of differentiation antigen 21|Y
extralobar sequestration|extra-lobar sequestration|Y
nucleolar organizing regions|nucleolar organizing region|Y
trichodentoosseous syndrome|trichodento-osseous syndrome|Y
trichodentoosseous syndrome|trichodento osseous syndrome|Y
interleukin-15 receptor α chain|interleukine-15 receptor α chain|Y
interleukin-15 receptor α chain|interleukin-5 receptor α chain|Y
tumour necrosis factor receptor associated factor-5|tumor necrosis factor receptor associated factor-5|Y
tumour necrosis factor receptor associated factor-5|tumour necrosis factor receptor associated factor-2|Y
tumour necrosis factor receptor associated factor-5|tumour necrosis factor receptor associated factor 5|Y
tumour necrosis factor receptor associated factor-5|tumour necrosis factor receptor-associated factor-5|Y
tumour necrosis factor receptor associated factor-5|tumour necrosis factor receptor associated factor-1|Y
posttransplantation lymphoproliferative disease|post-transplantation lymphoproliferative disease|Y
posttransplantation lymphoproliferative disease|posttransplantation lympho-proliferative disease|Y
autoimmune lymphoproliferative syndrome|autoimmune lympho-proliferative syndrome|Y
autoimmune lymphoproliferative syndrome|auto-immune lymphoproliferative syndrome|Y
epoxy-eicosatrienoic acid|epoxyeicosatrienoic acid|Y
enzyme-linked immunoelectrotransfer blot assay|enzyme-linked immuno-electrotransfer blot assay|Y
enzyme-linked immunoelectrotransfer blot assay|enzyme-linked immunoelectro-transfer blot assay|Y
lymphvascular space invasion|lymphovascular space invasion|Y
nonspecific cytotoxic cell receptor protein|nonspecific cytotoxic cell receptor protein 1|Y
nonspecific cytotoxic cell receptor protein|non-specific cytotoxic cell receptor protein|Y
focused-ion-beam scanning electron microscopy|focused-ion beam scanning electron microscopy|Y
extracellular signal-regulated protein kinase-5|extracellular signal-regulated protein kinase 5|Y
extracellular signal-regulated protein kinase-5|extracellular signal-regulated protein kinase|Y
aseptic meningo-encephalitis|aseptic meningoencephalitis|Y
human transforming growth factor beta 1|human transforming growth factor beta1|Y
symmetrical tonic neck reflex|asymmetrical tonic neck reflex|Y
augmented correlation consistent polarised valence quadruple ζ basis set|augmented correlation-consistent polarised valence quadruple ζ basis set|Y
augmented correlation consistent polarised valence quadruple ζ basis set|augmented correlation consistent polarized valence quadruple ζ basis set|Y
augmented correlation consistent polarised valence quadruple ζ basis set|augmented correlation consistent polarised valence quadruple-ζ basis set|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motif-6|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motif-19|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motifs-1|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motif-15|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motif-1|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloprotease with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motif-9|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motif|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motifs-19|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motifs-17|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motif-8|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motif-14|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motifs-15|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motif-16|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
solid phase micro extraction|solid phase microextraction|Y
carbonic anhydrase related protein IX|carbonic anhydrase related protein X|Y
oxysterol binding protein related protein 2|oxysterol binding protein related protein|Y
oxysterol binding protein related protein 2|oxysterol binding protein related protein 9|Y
healthcare associated methicillin-resistant Staphylococcus aureus|health care associated methicillin-resistant Staphylococcus aureus|Y
healthcare associated methicillin-resistant Staphylococcus aureus|health-care associated methicillin-resistant Staphylococcus aureus|Y
healthcare associated methicillin-resistant Staphylococcus aureus|healthcare-associated methicillin-resistant Staphylococcus aureus|Y
healthcare associated methicillin-resistant Staphylococcus aureus|health-care-associated methicillin-resistant Staphylococcus aureus|Y
healthcare associated methicillin-resistant Staphylococcus aureus|health care-associated methicillin-resistant Staphylococcus aureus|Y
nonlinear regression|non-linear regression|Y
G-protein-coupled receptor|G-protein-coupled receptors|Y
bradykinin 2 receptor|bradykinin B2 receptor|Y
portocaval transposition|porto-caval transposition|Y
oligo(phenylene-ethynylene)|oligo(phenyleneethynylene)|Y
non-tuberculous mycobacteriosis|nontuberculous mycobacteriosis|Y
nucleotide-binding domain and leucine rich repeat-containing receptor|nucleotide-binding domain and leucine-rich repeat-containing receptor|Y
peroxisome proliferator activated receptor γ co-activator-1|peroxisome proliferator activated receptor γ co-activator 1|Y
peroxisome proliferator activated receptor γ co-activator-1|peroxisome proliferator activated receptor γ coactivator-1|Y
peroxisome proliferator activated receptor γ co-activator-1|peroxisome proliferator-activated receptor γ co-activator-1|Y
Bos taurus autosome 4|Bos taurus autosome 14|Y
Bos taurus autosome 4|Bos taurus autosome 24|Y
multidimensional scaling|multi-dimensional scaling|Y
Neurobehavioural Functioning Inventory|Neurobehavioral Functioning Inventory|Y
soluble receptor activator of nuclear factor kappa B ligand|soluble receptor activator of nuclear factor kappa-B ligand|Y
soluble receptor activator of nuclear factor kappa B ligand|soluble receptor activator of nuclear factor-kappa B ligand|Y
soluble receptor activator of nuclear factor kappa B ligand|soluble receptor activator of nuclear factor kappaB ligand|Y
non-typeable Haemophilus influenzae|nontypeable Haemophilus influenzae|Y
non-typeable Haemophilus influenzae|non-typeable Hemophilus influenzae|Y
scanning electron microscopy-energy-dispersive x-ray spectrometry|scanning electron microscopy-energy-dispersive X-ray spectrometry|Y
alpha-phenyl-tert-butyl-nitrone|alpha-phenyl-tert-butylnitrone|Y
anti-T cell receptor-alpha/beta antibody|anti-T cell receptor-alpha beta antibody|Y
anti-T cell receptor-alpha/beta antibody|anti-T-cell receptor-alpha/beta antibody|Y
anti-T cell receptor-alpha/beta antibody|anti-T cell receptor alpha/beta antibody|Y
post anesthesia recovery unit|postanesthesia recovery unit|Y
glutaraldehyde-crosslinked collagen|glutaraldehyde-cross-linked collagen|Y
calcitonin-gene-related peptide immunoreactive nerve|calcitonin gene-related peptide immunoreactive nerve|Y
calcitonin-gene-related peptide immunoreactive nerve|calcitonin-gene-related peptide-immunoreactive nerve|Y
neoplastic angioendotheliosis|neoplastic angio-endotheliosis|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labelling assay|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labelling assay|terminal-deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling assay|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labelling assay|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labelling assay|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labelling assay|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling assay|Y
recombinant humanised monoclonal antibody|recombinant humanized monoclonal antibody|Y
multidetector computed tomography-coronary angiography|multi-detector computed tomography-coronary angiography|Y
multidetector computed tomography-coronary angiography|multidetector computed tomography coronary angiography|Y
anti-cytotoxic T-lymphocyte antigen-4 antibody|anticytotoxic T-lymphocyte antigen-4 antibody|Y
Epstein-Barr virus determined nuclear antigen|Epstein-Barr virus-determined nuclear antigen|Y
ubiquitin-like modifier activating enzyme 1|ubiquitin-like modifier activating enzyme 3|Y
ubiquitin-like modifier activating enzyme 1|ubiquitin-like modifier activating enzyme 7|Y
ubiquitin-like modifier activating enzyme 1|ubiquitin-like modifier activating enzyme 2|Y
ubiquitin-like modifier activating enzyme 1|ubiquitin-like modifier activating enzyme 4|Y
ubiquitin-like modifier activating enzyme 1|ubiquitin-like modifier activating enzyme 5|Y
ubiquitin-like modifier activating enzyme 1|ubiquitin-like modifier activating enzyme 6|Y
electromagnetic compatibility|electro-magnetic compatibility|Y
leucaemia-inhibiting factor|leucemia-inhibiting factor|Y
potassium-chloride co-transport|potassium-chloride cotransport|Y
calcium-calmodulin-dependent protein kinase IV|calcium/calmodulin-dependent protein kinase IV|Y
calcium-calmodulin-dependent protein kinase IV|calcium-calmodulin-dependent protein kinase II|Y
indirect Coomb's test|indirect Coombs test|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor-cell-expressed developmentally downregulated 1|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor-cell-expressed developmentally downregulated 8|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor-cell-expressed, developmentally down-regulated 9|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor-cell-expressed, developmentally downregulated 9|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor-cell-expressed, developmentally downregulated 1|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor cell-expressed developmentally downregulated 4|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor cell-expressed, developmentally downregulated 4|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor-cell-expressed developmentally downregulated 2|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor-cell-expressed, developmentally down-regulated 1|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor-cell-expressed developmentally downregulated 9|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor-cell-expressed, developmentally down-regulated 8|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor-cell-expressed, developmentally down-regulated 5|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor cell-expressed, developmentally down-regulated 4|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor-cell-expressed, developmentally down-regulated 4|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor-cell-expressed, developmentally downregulated 5|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor-cell-expressed developmentally downregulated 5|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor-cell-expressed, developmentally downregulated 4|neural-precursor-cell-expressed, developmentally downregulated 2|Y
genetically modified organism|genetically modified organisms|Y
beta-ketoacyl-acyl carrier protein synthase III|beta-ketoacyl-acyl carrier protein synthase II|Y
beta-ketoacyl-acyl carrier protein synthase III|beta-ketoacyl-acyl carrier protein synthase I|Y
anti-reticulin antibody|antireticulin antibody|Y
alveolar type I cell|alveolar type II cell|Y
Pantothenate kinase-associated neurodegeneration|pantothenate kinase-associated neurodegeneration|Y
experimental autoimmune encephalitis|experimental auto-immune encephalitis|Y
standard errors of measurement|standard error of measurement|Y
a disintegrin and metalloproteinase 12|a disintegrin and metalloproteinase 12s|Y
kinesin family member 2A|kinesin family member 21A|Y
β-site amyloid precursor protein cleaving enzyme 2|β-site amyloid precursor protein-cleaving enzyme 2|Y
β-site amyloid precursor protein cleaving enzyme 2|β-site amyloid precursor protein cleaving enzyme-2|Y
β-site amyloid precursor protein cleaving enzyme 2|β-site amyloid precursor protein cleaving enzyme|Y
β-site amyloid precursor protein cleaving enzyme 2|β-site amyloid precursor protein cleaving enzyme 1|Y
β-site amyloid precursor protein cleaving enzyme 2|β site amyloid precursor protein cleaving enzyme 2|Y
meta-tetrahydroxyphenylchlorin|metatetrahydroxyphenylchlorin|Y
postoperative liver failure|post-operative liver failure|Y
uncoordinated protein 45|uncoordinated protein 5|Y
uncoordinated protein 45|uncoordinated protein 4|Y
estrogen receptor β knock-out|estrogen receptor β knockout|Y
para-influenza type 3 virus|parainfluenza type 3 virus|Y
sub-wavelength grating|subwavelength grating|Y
gastric cardiac adenocarcinoma|gastric cardia adenocarcinoma|Y
intra-cardiac echocardiography|intracardiac echocardiography|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motif-15|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motif-14|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motifs|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motif-3|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motif-20|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motifs-4|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motifs-2|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motif-2|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motifs-9|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motifs-17|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-7|a disintegrin and metalloprotease with thrombospondin motif|Y
severe fever with thrombocytopenia syndrome|severe fever with thrombocytopaenia syndrome|Y
prepercutaneous coronary intervention|pre-percutaneous coronary intervention|Y
tumour-draining lymphnode lymphocyte|tumor-draining lymphnode lymphocyte|Y
tumour-draining lymphnode lymphocyte|tumour-draining lymph node lymphocyte|Y
post-partum haemorrhage|post-partum hemorrhage|Y
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1|procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2|Y
translational vestibulo-ocular reflex|translational vestibuloocular reflex|Y
beta-methyl-iodophenyl pentadecanoic acid|beta-methyliodophenylpentadecanoic acid|Y
beta-methyl-iodophenyl pentadecanoic acid|beta-methyl-iodophenyl-pentadecanoic acid|Y
lymphokine-activated killer cell therapy|lymphokine activated killer cell therapy|Y
lymphokine-activated killer cell therapy|lymphokine-activated killer-cell therapy|Y
antineural cell adhesion molecule antibody|anti-neural cell adhesion molecule antibody|Y
TGFbeta-activated kinase 1 binding protein 1|TGFbeta-activated kinase 1 binding protein-1|Y
TGFbeta-activated kinase 1 binding protein 1|TGFbeta-activated kinase 1-binding protein 1|Y
TGFbeta-activated kinase 1 binding protein 1|TGF-beta-activated kinase 1 binding protein 1|Y
teratocarcinoma cell line|terato-carcinoma cell line|Y
homozygous alpha-1 proteinase inhibitor deficiency|homozygous alpha-1-proteinase inhibitor deficiency|Y
homozygous alpha-1 proteinase inhibitor deficiency|homozygous alpha-1 protease inhibitor deficiency|Y
ventricular cerebro-spinal fluid|ventricular cerebrospinal fluid|Y
HIV counseling and testing|HIV counselling and testing|Y
augmented correlation consistent polarized valence double-zeta basis set|augmented correlation consistent polarized valence double zeta basis set|Y
augmented correlation consistent polarized valence double-zeta basis set|augmented correlation-consistent polarized valence double-zeta basis set|Y
supra-ventricular premature beat|supraventricular premature beat|Y
angiotensin converting enzyme inhibitor-induced|angiotensin-converting enzyme inhibitor-induced|Y
angiotensin converting enzyme inhibitor-induced|angiotensin converting enzyme inhibitor induced|Y
phosphorylated glycogen synthase kinase-3 beta|phosphorylated glycogen synthase kinase-3beta|Y
phosphorylated glycogen synthase kinase-3 beta|phosphorylated glycogen synthase kinase 3 beta|Y
preantiretroviral therapy|pre-antiretroviral therapy|Y
interleukin-15 receptor alpha subunit|interleukine-15 receptor alpha subunit|Y
granulocyte-macrophage-colony-stimulating factor|granulocyte-macrophage colony-stimulating factor|Y
granulocyte-macrophage-colony-stimulating factor|granulocyte macrophage-colony-stimulating factor|Y
granulocyte-macrophage colony stimulating factor|granulocyte macrophage colony stimulating factor|Y
granulocyte-macrophage colony stimulating factor|granulocyte/macrophage colony stimulating factor|Y
granulocyte-macrophage colony stimulating factor|granulocyte-macrophage colony-stimulating factor|Y
granulocyte-macrophage colony stimulating factor|Granulocyte-macrophage colony stimulating factor|Y
continuous venovenous hæmofiltration|continuous venovenous hæmo-filtration|Y
Schizo-saccharomyces octosporus|Schizosaccharomyces octosporus|Y
phosphorylated cyclic-AMP response element-binding protein|phosphorylated cyclic AMP response element-binding protein|Y
Plasmodium falciparum subtilisin-like protease-1|Plasmodium falciparum subtilisin-like protease-2|Y
5HT1B receptor agonist|5-HT1B receptor agonist|Y
integrin cytoplasmic domain-associated protein 1|integrin cytoplasmic domain-associated protein-1|Y
integrin cytoplasmic domain-associated protein 1|integrin cytoplasmic domain associated protein 1|Y
complement C3B inactivator|complement 3B inactivator|Y
IL-2 receptor alpha chain|IL2 receptor alpha chain|Y
DC-specific ICAM-3-grabbing non-integrin|DC-specific ICAM-3-grabbing nonintegrin|Y
behavioral assessment and research system|behavioural assessment and research system|Y
anti-IL-12 monoclonal antibody|antiIL-12 monoclonal antibody|Y
anti-IL-12 monoclonal antibody|anti-IL-2 monoclonal antibody|Y
flavin mono-oxygenase|flavin monooxygenase|Y
human embryonic fibroblast|human embryonic fibroblasts|Y
sex determining region Y, box 8|sex determining region Y box 8|Y
intrabone marrow-bone marrow transplantation|intra-bone marrow-bone marrow transplantation|Y
hypoxia-inducible factor-1 α protein|hypoxia-inducible factor-1α protein|Y
aminoacyl tRNA synthetase-interacting multifunctional protein 1|aminoacyl-tRNA synthetase-interacting multifunctional protein 1|Y
aminoacyl tRNA synthetase-interacting multifunctional protein 1|aminoacyl tRNA synthetase-interacting multifunctional protein 2|Y
aminoacyl tRNA synthetase-interacting multifunctional protein 1|aminoacyl tRNA synthetase-interacting multi-functional protein 1|Y
United States Pharmacopoeia|United States Pharmacopeia|Y
Na(+)/H(+) exchanger-regulatory factor-1|Na(+)/H(+) exchanger-regulatory factor 1|Y
Na(+)/H(+) exchanger-regulatory factor-1|Na(+)/H(+) exchanger regulatory factor-1|Y
voltage-gated calcium channel alpha 1 subunit|voltage-gated calcium channel alpha-1 subunit|Y
voltage-gated calcium channel alpha 1 subunit|voltage-gated calcium channel alpha 1-subunit|Y
tumour-associated surface antigen|tumor-associated surface antigen|Y
Seattle Veterans Affairs Medical Center|Seattle Veteran's Affairs Medical Center|Y
thyroid stimulating immunoglobulin|thyroid stimulating immunoglobulins|Y
urethrovesical junction|urethro-vesical junction|Y
tissue inhibitor of metalloproteinases 1|tissue inhibitor of metalloproteinase 1|Y
tissue inhibitor of metalloproteinases 1|tissue inhibitor of metalloproteinases-1|Y
tubulo-interstitial nephritis|tubulointerstitial nephritis|Y
5-aminolaevulinic acid|5-aminolevulinic acid|Y
CC chemokine ligand 11|C-C chemokine ligand 11|Y
extra-esophageal reflux|extra-oesophageal reflux|Y
extra-esophageal reflux|extraesophageal reflux|Y
levodopa induced dyskinesia|laevodopa induced dyskinesia|Y
levodopa induced dyskinesia|levo-dopa induced dyskinesia|Y
manganese (III) tetraphenylporphine sulphonate|manganese(III) tetraphenylporphine sulphonate|Y
tumor microenvironment|tumor micro-environment|Y
neuro-vascular bundle|neurovascular bundle|Y
human leukocyte antigen-D-related antigen 3|human leukocyte antigen-D-related antigen 6|Y
human leukocyte antigen-D-related antigen 3|human leukocyte antigen-D-related antigen 4|Y
human leukocyte antigen-D-related antigen 3|human leukocyte antigen-D-related antigen 1|Y
human leukocyte antigen-D-related antigen 3|human leukocyte antigen-D-related antigen|Y
nor-dihydroguaiaretic acid|nordihydroguaiaretic acid|Y
tumour-necrosis-factor-receptor-associated factor|tumor-necrosis-factor-receptor-associated factor|Y
nonsegmented negative strand RNA virus|non-segmented negative strand RNA virus|Y
Clinical Global Impressions severity scale|Clinical Global Impressions Severity scale|Y
visual acuity right eye|visual acuity, right eye|Y
hyperparathyroidism-jaw tumor syndrome|hyperparathyroidism-jaw tumour syndrome|Y
anti-epidermal growth factor receptor|antiepidermal growth factor receptor|Y
transactive response DNA-binding protein 43|transactive response DNA-binding protein-43|Y
epidemic methicillin-resistant Staphylococcus aureus-1|epidemic methicillin-resistant Staphylococcus aureus-2|Y
epidemic methicillin-resistant Staphylococcus aureus-1|epidemic methicillin-resistant Staphylococcus aureus-4|Y
epidemic methicillin-resistant Staphylococcus aureus-1|epidemic methicillin-resistant Staphylococcus aureus-5|Y
epidemic methicillin-resistant Staphylococcus aureus-1|epidemic methicillin-resistant Staphylococcus aureus-8|Y
epidemic methicillin-resistant Staphylococcus aureus-1|epidemic methicillin-resistant Staphylococcus aureus-9|Y
epidemic methicillin-resistant Staphylococcus aureus-1|epidemic methicillin-resistant Staphylococcus aureus-3|Y
epidemic methicillin-resistant Staphylococcus aureus-1|epidemic methicillin-resistant Staphylococcus aureus-15|Y
epidemic methicillin-resistant Staphylococcus aureus-1|epidemic methicillin-resistant Staphylococcus aureus-17|Y
epidemic methicillin-resistant Staphylococcus aureus-1|epidemic methicillin-resistant Staphylococcus aureus-16|Y
ultrasound-guided fine-needle-aspiration biopsy|ultrasound-guided fine-needle aspiration biopsy|Y
scanning electron microscopy x-ray energy dispersive spectrometry|scanning electron microscopy X-ray energy dispersive spectrometry|Y
scanning electron microscopy x-ray energy dispersive spectrometry|scanning electron microscopy/x-ray energy dispersive spectrometry|Y
G protein-coupled receptor kinase|G protein-coupled receptor kinases|Y
chemically modified tetracyclines|chemically modified tetracycline|Y
retinitis pigmentosa GTPase regulator interacting protein|retinitis pigmentosa GTPase regulator-interacting protein|Y
Core Assessment Programme for Intracerebral Transplantations|Core Assessment Program for Intracerebral Transplantations|Y
anti-hemophilic globulin|anti-haemophilic globulin|Y
anti-hemophilic globulin|antihemophilic globulin|Y
anti-IL-6R monoclonal antibody|antiIL-6R monoclonal antibody|Y
anti-IL-6R monoclonal antibody|anti-IL6R monoclonal antibody|Y
wingless-type MMTV integration site family member 5A|Wingless-type MMTV integration site family member 5A|Y
wingless-type MMTV integration site family member 5A|wingless-type MMTV integration site family member 3A|Y
matrix assisted laser desorption ionisation time of flight mass spectrometry|matrix assisted laser desorption ionisation time of flight mass spectrometric|Y
matrix assisted laser desorption ionisation time of flight mass spectrometry|matrix assisted laser desorption/ionisation time of flight mass spectrometry|Y
matrix assisted laser desorption ionisation time of flight mass spectrometry|matrix-assisted laser desorption ionisation time of flight mass spectrometry|Y
combined spinal-epidural anesthesia|combined spinal-epidural anaesthesia|Y
single photon emission computer tomography|single photon emission computed tomography|Y
anti-tachycardia pacing therapy|antitachycardia pacing therapy|Y
benzyloxyresorufin-O-dealkylase|benzyloxy-resorufin-O-dealkylase|Y
benzyloxyresorufin-O-dealkylase|benzyloxy resorufin-O-dealkylase|Y
anti-phospho-extracellular signal regulated kinase|anti-phospho-extracellular signal-regulated kinase|Y
antisense oligonucleotide-treated|anti-sense oligonucleotide-treated|Y
Human granulocyte-macrophage colony-stimulating factor|human granulocyte-macrophage colony-stimulating factor|Y
oxidized low-density lipoprotein receptor|oxidized low-density lipoprotein receptor-1|Y
oxidized low-density lipoprotein receptor|oxidized low-density lipoprotein receptor 1|Y
5-hydroxytryptamine3|5-hydroxytryptamine 3|Y
5-hydroxytryptamine3|5-hydroxytryptamine-3|Y
17-dimethylaminoethylamino-17-demethoxygeldanamycin|17-(dimethylaminoethylamino)-17-demethoxygeldanamycin|Y
Bayley Scales of Infant Development|Bayley Scale of Infant Development|Y
nuclear receptor corepressor 2|nuclear receptor co-repressor 2|Y
mouse tumour necrosis factor-α|mouse tumor necrosis factor-α|Y
intra-ventricular block|intraventricular block|Y
attenuated total reflectance Fourier transform infra red spectroscopy|attenuated total reflectance Fourier-transform infra red spectroscopy|Y
attenuated total reflectance Fourier transform infra red spectroscopy|attenuated total reflectance-Fourier transform infrared spectroscopy|Y
attenuated total reflectance Fourier transform infra red spectroscopy|attenuated total reflectance Fourier-transform infrared spectroscopy|Y
attenuated total reflectance Fourier transform infra red spectroscopy|attenuated total reflectance-Fourier transform infra red spectroscopy|Y
attenuated total reflectance Fourier transform infra red spectroscopy|attenuated total reflectance Fourier transform infrared spectroscopy|Y
attenuated total reflectance Fourier transform infra red spectroscopy|attenuated total reflectance Fourier transform infra-red spectroscopy|Y
corrected QT intervals|corrected QT interval|Y
galactorrhœa-amenorrhœa hyperprolactinæmia syndrome|galactorrhœa-amenorrhœa hyperprolactinemia syndrome|Y
galactorrhœa-amenorrhœa hyperprolactinæmia syndrome|galactorrhœa amenorrhœa hyperprolactinæmia syndrome|Y
galactorrhœa-amenorrhœa hyperprolactinæmia syndrome|galactorrhea-amenorrhœa hyperprolactinæmia syndrome|Y
cyclophosphamide, methotrexate, fluorouracil, vincristine, prednisone|cyclophosphamide, methotrexate, 5 fluorouracil, vincristine, prednisone|Y
G protein α2 inhibitory subunit|G protein α inhibitory subunit|Y
antiidiotype antibody|anti-idiotype antibody|Y
hydroxy-methylglutaryl coenzyme A reductase inhibitor|hydroxymethylglutaryl coenzyme A reductase inhibitor|Y
hydroxy-methylglutaryl coenzyme A reductase inhibitor|hydroxy-methylglutaryl-coenzyme A reductase inhibitor|Y
precultured heart fragment|precultured heart fragments|Y
recombinant interleukin 10|recombinant interleukin 1|Y
matrix-assisted laser desorption/ionisation mass spectrometry|matrix-assisted laser desorption-ionisation mass spectrometry|Y
matrix-assisted laser desorption/ionisation mass spectrometry|matrix-assisted laser desorption ionisation mass spectrometry|Y
matrix-assisted laser desorption/ionisation mass spectrometry|matrix-assisted laser desorption/ionization mass spectrometry|Y
matrix-assisted laser desorption/ionisation mass spectrometry|matrix-assisted laser desorption/ionisation-mass spectrometry|Y
matrix-assisted laser desorption/ionisation mass spectrometry|matrix assisted laser desorption/ionisation mass spectrometry|Y
slow hyperpolarising after-potential|slow hyperpolarising afterpotential|Y
lymphocyte immuno-fluorescence test|lymphocyte immunofluorescence test|Y
forced expiratory volume in 1 s|forced expiratory volume in 1s|Y
feto-acinar pancreatic protein|fetoacinar pancreatic protein|Y
neuromuscular disorder|neuro-muscular disorder|Y
acute non-lymphocytic leukemia|acute non-lymphocytic leukaemia|Y
acute non-lymphocytic leukemia|acute nonlymphocytic leukemia|Y
para-aminophenyl phosphate|para-aminophenylphosphate|Y
para-aminophenyl phosphate|para-amino-phenyl phosphate|Y
delayed enhancement magnetic resonance imaging|delayed-enhancement magnetic resonance imaging|Y
insulin-like growth factor receptor type 2|insulin-like growth factor receptor type 1|Y
insulin-like growth factor receptor type 2|insulinlike growth factor receptor type 2|Y
insulin-like growth factor receptor type 2|insulin-like growth factor receptor type I|Y
immunoreceptor tyrosine-based activation motifs|immunoreceptor tyrosine-based activation motif|Y
immunoreceptor tyrosine-based activation motifs|immuno-receptor tyrosine-based activation motif|Y
American Society of Anaesthesiologists grade III|American Society of Anaesthesiologists Grade III|Y
American Society of Anaesthesiologists grade III|American Society of Anaesthesiologists grade II|Y
American Society of Anaesthesiologists grade III|American Society of Anaesthesiologists grade I|Y
American Society of Anaesthesiologists grade III|American Society of Anesthesiologists grade III|Y
American Society of Anaesthesiologists grade III|American Society of Anesthesiologists grade II|Y
laryngopharyngeal reflux|laryngo-pharyngeal reflux|Y
nonmethylene interrupted fatty acid|non-methylene interrupted fatty acid|Y
laser-induced interstitial thermotherapy|laser-induced interstitial thermo-therapy|Y
anti-interleukin-1 alpha monoclonal antibody|anti-interleukin-1alpha monoclonal antibody|Y
anti-interleukin-1 alpha monoclonal antibody|anti-interleukin 1 alpha monoclonal antibody|Y
mitogen activated protein kinase-activated protein kinase-1|mitogen-activated protein kinase-activated protein kinase-1|Y
mitogen activated protein kinase-activated protein kinase-1|mitogen activated protein kinase activated protein kinase-1|Y
mitogen activated protein kinase-activated protein kinase-1|mitogen activated protein kinase-activated protein kinase 1|Y
mitogen activated protein kinase-activated protein kinase-1|mitogen activated protein kinase-activated protein kinase-5|Y
mitogen activated protein kinase-activated protein kinase-1|mitogen activated protein kinase-activated protein kinase-2|Y
mitogen activated protein kinase-activated protein kinase-1|mitogen activated protein kinase-activated protein kinase-3|Y
mitogen activated protein kinase-activated protein kinase-1|mitogen activated protein kinase-activated protein kinase|Y
orthogonal-field alternating gel electrophoresis|orthogonal field alternating gel electrophoresis|Y
recombinant human transforming growth factor-beta 3|recombinant human transforming growth factor-beta 1|Y
recombinant human transforming growth factor-beta 3|recombinant human transforming growth factor-beta3|Y
recombinant human transforming growth factor-beta 3|recombinant human transforming growth factor-beta 2|Y
recombinant human transforming growth factor-beta 3|recombinant human transforming growth factor-beta|Y
recombinant human transforming growth factor-beta 3|recombinant human transforming growth factor beta 3|Y
nonstructural protein 4|nonstructural protein 4B|Y
nonstructural protein 4|non-structural protein 4|Y
S-adenosyl-methionine decarboxylase|S-adenosylmethionine decarboxylase|Y
Danish Verapamil Infarction Trial I|Danish Verapamil Infarction Trial II|Y
anti-polyribosyl-ribitol phosphate antibody|anti-polyribosylribitol phosphate antibody|Y
anti-polyribosyl-ribitol phosphate antibody|anti-polyribosyl ribitol phosphate antibody|Y
anti-human serum albumine|anti-human serum albumin|Y
poly-chlorinated biphenyl|polychlorinated biphenyl|Y
dentatorubro-pallidoluysian atrophy|dentatorubro-pallido-luysian atrophy|Y
dentatorubro-pallidoluysian atrophy|dentato-rubro-pallidoluysian atrophy|Y
ubiquitin-like modifier activating enzyme 3|ubiquitin-like modifier activating enzyme 7|Y
ubiquitin-like modifier activating enzyme 3|ubiquitin-like modifier activating enzyme 2|Y
ubiquitin-like modifier activating enzyme 3|ubiquitin-like modifier activating enzyme 4|Y
ubiquitin-like modifier activating enzyme 3|ubiquitin-like modifier activating enzyme 5|Y
ubiquitin-like modifier activating enzyme 3|ubiquitin-like modifier activating enzyme 6|Y
tick borne encephalitis|tickborne encephalitis|Y
international normalized ratio|international normalized ratios|Y
multi-reference coupled-cluster method|multireference coupled-cluster method|Y
intramyocellular lipid|intra-myocellular lipid|Y
medial preoptic area-anterior hypothalamus|medial preoptic area/anterior hypothalamus|Y
frontoethmoidal meningoencephalocele|fronto-ethmoidal meningoencephalocele|Y
Xray fluorescence spectroscopy|X-ray fluorescence spectroscopy|Y
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome|thrombotic thrombocytopenic purpura-hemolytic uremic syndrome|Y
antiinterleukin 1alpha antibody|anti-interleukin 1alpha antibody|Y
anti-retroviral therapy|antiretroviral therapy|Y
United States veterans hospital|United States veterans' hospital|Y
man-made mineral fiber|man-made mineral fibers|Y
intracellular free Ca2+ concentration|intracellular free Ca2+ concentrations|Y
tumor-infiltrating leukocyte|tumor-infiltrating leukocytes|Y
hystero-salpingoscintigraphy|hysterosalpingoscintigraphy|Y
Clinical Global Impressions Severity scale|Clinical Global Impressions Severity Scale|Y
Clinical Global Impressions Severity scale|Clinical Global Impressions-Severity scale|Y
laser desorption/ionization time of flight mass spectrometry|laser desorption/ionisation time of flight mass spectrometry|Y
laser desorption/ionization time of flight mass spectrometry|laser desorption ionization time of flight mass spectrometry|Y
laser desorption/ionization time of flight mass spectrometry|laser desorption-ionization time of flight mass spectrometry|Y
quasi frequency modulated|quasifrequency modulated|Y
autoimmune blistering disease|auto-immune blistering disease|Y
spontaneous pneumomediastinum|spontaneous pneumo-mediastinum|Y
calcium- and diacylglycerol-regulated guanine nucleotide exchange factor I|calcium- and diacylglycerol-regulated guanine nucleotide exchange factor Ib|Y
calcium- and diacylglycerol-regulated guanine nucleotide exchange factor I|calcium- and diacylglycerol-regulated guanine nucleotide exchange factor|Y
calcium- and diacylglycerol-regulated guanine nucleotide exchange factor I|calcium- and diacylglycerol-regulated guanine nucleotide exchange factor II|Y
calcium- and diacylglycerol-regulated guanine nucleotide exchange factor I|calcium- and diacylglycerol-regulated guanine nucleotide exchange factor III|Y
calcium- and diacylglycerol-regulated guanine nucleotide exchange factor I|calcium- and diacylglycerol-regulated guanine nucleotide exchange factor Ia|Y
Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico-1|Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-3|Y
Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico-1|Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-2|Y
Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico-1|Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico|Y
receiver operating characteristic curves|receiver operating characteristic curve|Y
flavine-containing mono-oxygenase|flavine-containing monooxygenase|Y
flavine-containing mono-oxygenase|flavin-containing mono-oxygenase|Y
ribosomal protein L37|ribosomal protein L37a|Y
ribosomal protein L37|ribosomal protein L3|Y
ribosomal protein L37|ribosomal protein L7|Y
immunoreactive arginine vasopressin|immuno-reactive arginine vasopressin|Y
oesophago-gastrectomy|esophago-gastrectomy|Y
murine tumor necrosis factor α|murine tumour necrosis factor α|Y
cough-specific quality-of-life questionnaire|cough specific quality-of-life questionnaire|Y
micro-x-ray absorption near edge structure|micro x-ray absorption near edge structure|Y
micro-x-ray absorption near edge structure|micro-x-ray absorption near-edge structure|Y
submental electromyogram|sub-mental electromyogram|Y
spontaneous inhibitory postsynaptic current|spontaneous inhibitory post-synaptic current|Y
Maslach Burnout Inventory|Maslach Burn-out Inventory|Y
krueppel-like factor 6|kruppel-like factor 6|Y
oxidized low-density lipoprotein|oxidized low-density lipoproteins|Y
latent transforming growth factor beta binding protein-1|latent transforming growth factor beta binding protein|Y
latent transforming growth factor beta binding protein-1|latent transforming growth factor beta binding protein-3|Y
latent transforming growth factor beta binding protein-1|latent transforming growth factor-beta binding protein-1|Y
latent transforming growth factor beta binding protein-1|latent transforming growth factor beta binding protein-4|Y
latent transforming growth factor beta binding protein-1|latent transforming growth factor beta binding protein-2|Y
latent transforming growth factor beta binding protein-1|latent transforming growth factor beta binding protein 1|Y
latent transforming growth factor beta binding protein-1|latent transforming growth factor beta-binding protein-1|Y
cell death-inducing DNA fragmentation factor-α-like effector A|cell death-inducing DNA fragmentation factor α-like effector A|Y
IL12 receptor β1 chain|IL-12 receptor β1 chain|Y
clear to auscultation bilaterlly|clear to auscultation bilaterally|Y
methyl-azoxymethanol|methyl-azoxy-methanol|Y
non-expressor of pathenogenesis-related genes-1|non-expressor of pathenogenesis-related genes1|Y
non-expressor of pathenogenesis-related genes-1|non-expressor of pathenogenesis-related genes 1|Y
non-expressor of pathenogenesis-related genes-1|nonexpressor of pathenogenesis-related genes1|Y
enterohemorrhagic Escherichia coli O157:H7|enterohaemorrhagic Escherichia coli O157:H7|Y
granulocyte colony-stimulating factor receptor|granulocyte colony-stimulating-factor receptor|Y
granulocyte colony-stimulating factor receptor|granulocyte colony stimulating factor receptor|Y
(123)I-metaiodobenzylguanidine scintigraphy|(123)I-metaiodobenzyl-guanidine scintigraphy|Y
(123)I-metaiodobenzylguanidine scintigraphy|123I-metaiodobenzylguanidine scintigraphy|Y
surface-assisted laser desorption ionization-mass spectrometry|surface-assisted laser desorption/ionization-mass spectrometry|Y
surface-assisted laser desorption ionization-mass spectrometry|surface-assisted laser desorption ionization mass spectrometry|Y
surface-assisted laser desorption ionization-mass spectrometry|surface-assisted laser desorption ionisation-mass spectrometry|Y
nuclear factor-κB p65|nuclear factor-κ B p65|Y
photocatalytic oxidation|photo-catalytic oxidation|Y
signal transducers and activators of transcription|signal transducer and activator of transcription|Y
β amyloid precursor protein-cleaving enzyme 2|β-amyloid precursor protein-cleaving enzyme 2|Y
β amyloid precursor protein-cleaving enzyme 2|β amyloid precursor protein-cleaving enzyme 1|Y
β amyloid precursor protein-cleaving enzyme 2|β amyloid precursor protein cleaving enzyme 2|Y
β amyloid precursor protein-cleaving enzyme 2|β amyloid precursor protein-cleaving enzyme|Y
β amyloid precursor protein-cleaving enzyme 2|β amyloid precursor protein-cleaving enzyme-2|Y
RNA arbitrarily-primed polymerase chain reaction|RNA arbitrarily primed polymerase chain reaction|Y
B-lymphocyte-induced maturation protein-1|B-lymphocyte induced maturation protein-1|Y
B-lymphocyte-induced maturation protein-1|B lymphocyte-induced maturation protein-1|Y
para-neoplastic syndrome|paraneoplastic syndrome|Y
intracardiac defibrillator|intra-cardiac defibrillator|Y
recombinant human IL-12|recombinant human IL-2|Y
post-exercise ischemia|postexercise ischemia|Y
post-prandial hypotension|postprandial hypotension|Y
arterio-hepatic dysplasia|arteriohepatic dysplasia|Y
123I-β-methyl-iodophenyl pentadecanoic acid|(123)I-β-methyl-iodophenyl pentadecanoic acid|Y
intravascular ultrasound|intra-vascular ultrasound|Y
γ-aminobutyric acid type-A|γ-amino-butyric acid type-A|Y
human T-cell lymphotropic virus type 1-associated|human T-cell lymphotropic virus type I-associated|Y
activin receptor type 2|activin receptor type 2A|Y
activin receptor type 2|activin receptor type 2B|Y
ileo-sigmoid anastomosis|ileosigmoid anastomosis|Y
UDP-glucuronosyltransferase 2B1|UDP-glucuronosyltransferase 2B15|Y
UDP-glucuronosyltransferase 2B1|UDP-glucuronosyltransferase 2B10|Y
poly(styrenesulphonate)|poly(styrene sulphonate)|Y
TATA-binding protein associated factor-15|TATA-binding protein-associated factor-15|Y
TATA-binding protein associated factor-15|TATA-binding protein associated factor-17|Y
TATA-binding protein associated factor-15|TATA-binding protein associated factor 15|Y
TATA-binding protein associated factor-15|TATA-binding protein associated factor-5|Y
TATA-binding protein associated factor-15|TATA-binding protein associated factor-1|Y
TATA-binding protein associated factor-15|TATA-binding protein associated factor-10|Y
TATA-binding protein associated factor-15|TATA-binding protein associated factor-11|Y
TATA-binding protein associated factor-15|TATA-binding protein associated factor-12|Y
leukemia inhibitory factor receptor-β|leukaemia inhibitory factor receptor-β|Y
intra-muscular γ-globulin|intramuscular γ-globulin|Y
fibreoptic endoscopic evaluation of swallowing|fiberoptic endoscopic evaluation of swallowing|Y
hypoxia-inducible factor 1β|hypoxia-inducible factor 1 β|Y
intraoperative suture adjustment|intra-operative suture adjustment|Y
hemoglobin Bart's hydrops fetalis|hemoglobin Barts hydrops fetalis|Y
human transforming growth factor β1|human transforming growth factor β|Y
adrenocorticotropic hormone-dependent Cushing's syndrome|adrenocorticotropic hormone-dependent Cushing syndrome|Y
adrenocorticotropic hormone-dependent Cushing's syndrome|adrenocorticotropic hormone-independent Cushing's syndrome|Y
anti-silencing function 1|antisilencing function 1|Y
nonselective cation channel 1|non-selective cation channel 1|Y
serum follicle-stimulating hormone level|serum follicle stimulating hormone level|Y
enzyme-linked-immunosorbant assay|enzyme-linked-immuno-sorbant assay|Y
C-C chemokine receptor 2B|C-C chemokine receptor 2|Y
switch-sucrose non fermentable complex|switch-sucrose nonfermentable complex|Y
other personality disorders|other personality disorder|Y
Federal Employees Health Benefit|Federal Employees Health Benefits|Y
epidemic methicillin-resistant Staphylococcus aureus-2|epidemic methicillin-resistant Staphylococcus aureus-4|Y
epidemic methicillin-resistant Staphylococcus aureus-2|epidemic methicillin-resistant Staphylococcus aureus-5|Y
epidemic methicillin-resistant Staphylococcus aureus-2|epidemic methicillin-resistant Staphylococcus aureus-8|Y
epidemic methicillin-resistant Staphylococcus aureus-2|epidemic methicillin-resistant Staphylococcus aureus-9|Y
epidemic methicillin-resistant Staphylococcus aureus-2|epidemic methicillin-resistant Staphylococcus aureus-3|Y
src homology 2 domain-containing protein tyrosine phosphatase substrate-1|Src homology 2 domain-containing protein tyrosine phosphatase substrate-1|Y
src homology 2 domain-containing protein tyrosine phosphatase substrate-1|src homology 2 domain-containing protein-tyrosine phosphatase substrate-1|Y
src homology 2 domain-containing protein tyrosine phosphatase substrate-1|src homology 2 domain containing protein tyrosine phosphatase substrate-1|Y
src homology 2 domain-containing protein tyrosine phosphatase substrate-1|src homology 2 domain-containing protein tyrosine phosphatase substrate 1|Y
interleukin-3 receptor α-subunit|interleukine-3 receptor α-subunit|Y
chronic kidney disease-mineral and bone disorder|chronic kidney disease mineral and bone disorder|Y
interleukine-13 receptor alpha1|interleukin-13 receptor alpha1|Y
interleukine-13 receptor alpha1|interleukine-13 receptor alpha 1|Y
anti-IL-13 monoclonal antibody|anti-IL13 monoclonal antibody|Y
anti-IL-13 monoclonal antibody|antiIL-13 monoclonal antibody|Y
Eating Disorders Examination|Eating Disorder Examination|Y
tumor-necrosis-factor-α production|tumour-necrosis-factor-α production|Y
non-expressor of pathenogenesis-related genes1|non-expressor of pathenogenesis-related genes 1|Y
non-expressor of pathenogenesis-related genes1|nonexpressor of pathenogenesis-related genes1|Y
non-expressor of pathenogenesis-related genes1|nonexpressor of pathenogenesis-related genes 1|Y
diffusion capacity of lung for carbon monoxide|diffusing capacity of lung for carbon monoxide|Y
non-A non-B hepatitis|non-A, non-B hepatitis|Y
bronchiolo-alveolar carcinoma|bronchioloalveolar carcinoma|Y
transplantable hepato-cellular carcinoma|transplantable hepatocellular carcinoma|Y
human immunodeficiency virus/hepatitis C virus coinfection|human immunodeficiency virus-hepatitis C virus coinfection|Y
multimedia messaging service|multi-media messaging service|Y
reno-vascular disease|renovascular disease|Y
Krueppel-associated box-associated protein 1|Kruppel-associated box-associated protein 1|Y
Krueppel-associated box-associated protein 1|krueppel-associated box-associated protein 1|Y
immobilised metal affinity chromatography|immobilized metal affinity chromatography|Y
transtracheal aspiration|trans-tracheal aspiration|Y
allergic bronchopulmonary mycosis|allergic broncho-pulmonary mycosis|Y
preextracorporeal membrane oxygenation|pre-extracorporeal membrane oxygenation|Y
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30|European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30|Y
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30|European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core-30|Y
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30|European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30|Y
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30|European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire Core-30|Y
human adenovirus serotype 7|human adenovirus serotype 47|Y
human adenovirus serotype 7|human adenovirus serotype 37|Y
transforming growth factor-β type I receptor|transforming growth factor β type I receptor|Y
transforming growth factor-β type I receptor|transforming growth factor-β type II receptor|Y
Toll-IL-1 receptor domain-containing adaptor-inducing IFN-beta|Toll-IL-1 receptor domain-containing adaptor-inducing IFNbeta|Y
Toll-IL-1 receptor domain-containing adaptor-inducing IFN-beta|Toll/IL-1 receptor domain-containing adaptor-inducing IFNbeta|Y
Toll-IL-1 receptor domain-containing adaptor-inducing IFN-beta|toll-IL-1 receptor domain-containing adaptor-inducing IFN-beta|Y
mouse mammary tumor virus long terminal repeat|mouse mammary tumor virus-long terminal repeat|Y
pregnancy specific β 1 glycoprotein|pregnancy specific β1 glycoprotein|Y
invariant T-cell receptor V α 14|invariant T-cell receptor Vα 14|Y
lactate dehydrogenase 4|lactate dehydrogenase C4|Y
radiation induced tumour suppressor gene 1|radiation-induced tumour suppressor gene 1|Y
radiation induced tumour suppressor gene 1|radiation induced tumour suppressor gene-1|Y
radiation induced tumour suppressor gene 1|radiation induced tumor suppressor gene 1|Y
photoaffinity labeling|photo-affinity labeling|Y
phosphatidyl choline-specific phospholipase C|phosphatidylcholine-specific phospholipase C|Y
Haemophilus influenzae-murium|Hemophilus influenzae-murium|Y
Haemophilus influenzae-murium|Haemophilus influenza-murium|Y
anti-interleukin 17 monoclonal antibody|anti-interleukin 7 monoclonal antibody|Y
olivo-cochlear bundle|olivocochlear bundle|Y
pro-surfactant protein C|prosurfactant protein C|Y
transforming growth factor-β-inducible gene H3|transforming growth factor β-inducible gene H3|Y
IL-1 beta-converting enzyme|IL-1beta-converting enzyme|Y
non-selective cation conductance|nonselective cation conductance|Y
C-C chemokine ligand 8|C-C chemokine ligand 18|Y
crosspolarisation/magic angle spinning|cross-polarisation/magic angle spinning|Y
crosspolarisation/magic angle spinning|cross polarisation/magic angle spinning|Y
A disintegrin and metalloproteinase 28|A disintegrin and metalloproteinase 8|Y
stromal derived factor-1-alpha|stromal derived factor-1alpha|Y
anti-tachycardia pacing|antitachycardia pacing|Y
vascular endothelial growth factor receptor|vascular endothelial growth factor receptor 1|Y
vascular endothelial growth factor receptor|vascular endothelial growth factor receptor 3|Y
vascular endothelial growth factor receptor|vascular endothelial growth factor receptor 2|Y
2',3'-cyclic nucleotide 3'-phosphodiesterase|2',3'-Cyclic nucleotide 3'-phosphodiesterase|Y
days post fertilization|days postfertilization|Y
sacrococcygeal teratoma|sacro-coccygeal teratoma|Y
days postimplantation|days post implantation|Y
days postimplantation|days post-implantation|Y
thermogravimetry-differential thermal analysis|thermogravimetry/differential thermal analysis|Y
tumor necrosis factor related apoptosis inducing ligand receptor|tumor necrosis factor related apoptosis-inducing ligand receptor|Y
tumor necrosis factor related apoptosis inducing ligand receptor|tumor necrosis factor-related apoptosis inducing ligand receptor|Y
tumor necrosis factor related apoptosis inducing ligand receptor|tumour necrosis factor related apoptosis inducing ligand receptor|Y
ras-related GTP-binding protein 3D|ras-related GTP-binding protein 3|Y
recombinant human tumor necrosis factor α|recombinant human tumor necrosis factor|Y
recombinant human tumor necrosis factor α|recombinant human tumour necrosis factor α|Y
recombinant human tumor necrosis factor α|recombinant human tumor necrosis factor β|Y
recombinant human tumor necrosis factor α|recombinant human tumor necrosis factor-α|Y
intra-peritoneal hæmorrhage|intraperitoneal hæmorrhage|Y
scaffold attachment factor B|scaffold attachment factor B2|Y
scaffold attachment factor B|scaffold attachment factor B1|Y
Tousled-like kinase 1|Tousled-like kinase 1B|Y
transforming growth factor-beta receptor type II|transforming growth factor beta receptor type II|Y
transforming growth factor-beta receptor type II|transforming growth factor-beta receptor type III|Y
transforming growth factor-beta receptor type II|transforming growth factor-beta receptor type I|Y
iso-electric interval|isoelectric interval|Y
intraoperative electron beam radiation therapy|intra-operative electron beam radiation therapy|Y
accelerated phase chronic myeloid leukaemia|accelerated phase chronic myeloid leukemia|Y
nonnucleoside inhibitor|non-nucleoside inhibitor|Y
hereditary sensory and autonomic neuropathy type 2|hereditary sensory and autonomic neuropathy type I|Y
hereditary sensory and autonomic neuropathy type 2|hereditary sensory and autonomic neuropathy type 1|Y
hereditary sensory and autonomic neuropathy type 2|hereditary sensory and autonomic neuropathy type 4|Y
hereditary sensory and autonomic neuropathy type 2|hereditary sensory and autonomic neuropathy type 3|Y
hereditary sensory and autonomic neuropathy type 2|hereditary sensory and autonomic neuropathy type V|Y
Community Periodontal Index of Treatment Needs|Community Periodontal Index of Treatment Need|Y
oligophosphoglyceroyl-ATP|oligophosphoglycerol-ATP|Y
hyperpolarization-activated current|hyperpolarization-activated currents|Y
pancreatic intraepithelial neoplasia|pancreatic intra-epithelial neoplasia|Y
postendoplasmic reticulum compartment|post-endoplasmic reticulum compartment|Y
recto-vaginal fistula|rectovaginal fistula|Y
antiIL-2R alpha monoclonal antibody|anti-IL-2R alpha monoclonal antibody|Y
random-amplified polymorphic DNA polymerase chain reaction|random amplified polymorphic DNA polymerase chain reaction|Y
random-amplified polymorphic DNA polymerase chain reaction|random-amplified polymorphic DNA-polymerase chain reaction|Y
germinal center-associated nuclear protein|germinal centre-associated nuclear protein|Y
germinal center-associated nuclear protein|germinal center associated nuclear protein|Y
urinary neutrophil gelatinase-associated lipocalin|urinary neutrophil gelatinase associated lipocalin|Y
bacteriocin-like inhibitory substance|bacteriocin-like inhibitory substances|Y
ras-related GTP-binding protein 14|ras-related GTP-binding protein 4|Y
ras-related GTP-binding protein 14|ras-related GTP-binding protein 1|Y
human chorionic gonadotropin-stimulated|human chorionic gonadotrophin-stimulated|Y
lymphokine-activated killer-cell cytotoxicity|lymphokine activated killer-cell cytotoxicity|Y
intra-thoracic blood volume|intrathoracic blood volume|Y
Consortium to Establish a Registry for Alzheimer's Disease Neuropsychological Assessment Battery|Consortium to Establish a Registry for Alzheimer's Disease-Neuropsychological Assessment Battery|Y
mitochondrial transcription factor B2|mitochondrial transcription factor B|Y
matrix-assisted laser desorption ionization mass spectrometry imaging|matrix-assisted laser desorption ionisation mass spectrometry imaging|Y
matrix-assisted laser desorption ionization mass spectrometry imaging|matrix assisted laser desorption ionization mass spectrometry imaging|Y
bio-available phosphorus|bioavailable phosphorus|Y
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30|European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core-30|Y
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30|European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30|Y
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30|European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30|Y
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30|European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30|Y
α2c adrenergic receptor|α 2c adrenergic receptor|Y
solute carrier family 7 member 7|solute carrier family 17 member 7|Y
digitally-reconstructed radiograph|digitally-reconstructed radiography|Y
matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight mass spectrometer|matrix-assisted laser desorption/ionisation quadrupole ion trap time-of-flight mass spectrometry|Y
matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight mass spectrometer|matrix-assisted laser desorption/ionisation quadrupole ion trap time-of-flight mass spectrometer|Y
intraaortic counterpulsation|intra-aortic counterpulsation|Y
micropositron emission tomography|micro-positron emission tomography|Y
spin-component-scaled second-order Møller-Plesset perturbation theory|spin-component-scaled second-order Moller-Plesset perturbation theory|Y
focused-ion beam scanning electron microscopy|focused ion beam scanning electron microscopy|Y
antierythropoietin antibody|anti-erythropoietin antibody|Y
levonorgestrel releasing intrauterine system|levonorgestrel-releasing intrauterine system|Y
levonorgestrel releasing intrauterine system|levonorgestrel releasing intra-uterine system|Y
levonorgestrel releasing intrauterine system|laevonorgestrel releasing intrauterine system|Y
levonorgestrel releasing intrauterine system|levonorgestrel releasing intra uterine system|Y
levonorgestrel releasing intrauterine system|laevonorgestrel releasing intra uterine system|Y
TGF-beta-activated kinase 1-binding protein-1|TGF-beta-activated kinase 1-binding protein 1|Y
TGF-beta-activated kinase 1-binding protein-1|TGFbeta-activated kinase 1-binding protein-1|Y
amplified fragment length polymorphism analysis|amplified-fragment length polymorphism analysis|Y
American Society of Anesthesiologists class III|American Society of Anesthesiologists class II|Y
American Society of Anesthesiologists class III|American Society of Anaesthesiologists class III|Y
American Society of Anesthesiologists class III|American Society of Anesthesiologists Class III|Y
American Society of Anesthesiologists class III|American Society of Anesthesiologists class I|Y
interpenetrating polymer networks|interpenetrating polymer network|Y
cytokine-induced neutrophil chemoattractant|cytokine-induced neutrophil chemoattractant-3|Y
cytokine-induced neutrophil chemoattractant|cytokine-induced neutrophil chemoattractant-1|Y
cytokine-induced neutrophil chemoattractant|cytokine-induced neutrophil chemoattractant 2|Y
cytokine-induced neutrophil chemoattractant|cytokine-induced neutrophil chemoattractant 1|Y
cytokine-induced neutrophil chemoattractant|cytokine induced neutrophil chemoattractant|Y
cytokine-induced neutrophil chemoattractant|cytokine-induced neutrophil chemoattractant-2|Y
non-verbal learning disability|nonverbal learning disability|Y
European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire-Core 30|European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire-Core 30|Y
European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire-Core 30|European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30|Y
European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire-Core 30|European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30|Y
European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire-Core 30|European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire Core-30|Y
nucleoside/nucleotide reverse transcriptase inhibitor|nucleoside/nucleotide reverse-transcriptase inhibitor|Y
transforming growth factor-β-activated kinase 1-binding protein-1|transforming growth factor-β-activated kinase 1-binding protein 1|Y
transforming growth factor-β-activated kinase 1-binding protein-1|transforming growth factor β-activated kinase 1-binding protein-1|Y
cross-polarisation/magic-angle spinning NMR|cross-polarisation magic-angle spinning NMR|Y
cross-polarisation/magic-angle spinning NMR|cross-polarisation/magic-angle-spinning NMR|Y
cross-polarisation/magic-angle spinning NMR|cross-polarisation/magic angle spinning NMR|Y
cross-polarisation/magic-angle spinning NMR|cross-polarization/magic-angle spinning NMR|Y
nonsense-mediated mRNA decay|non-sense-mediated mRNA decay|Y
antiinterleukin 5 antibody|antiinterleukin 15 antibody|Y
antiinterleukin 5 antibody|anti-interleukin 5 antibody|Y
matrix metalloproteinase 3|matrix metalloproteinase 13|Y
src homology 2 domain-containing protein tyrosine phosphatase|src homology 2 domain-containing protein tyrosine phosphatase 2|Y
src homology 2 domain-containing protein tyrosine phosphatase|src homology 2 domain-containing protein tyrosine-phosphatase|Y
src homology 2 domain-containing protein tyrosine phosphatase|Src homology 2 domain-containing protein tyrosine phosphatase|Y
src homology 2 domain-containing protein tyrosine phosphatase|src homology 2 domain-containing protein tyrosine phosphatase-1|Y
src homology 2 domain-containing protein tyrosine phosphatase|src homology 2 domain-containing protein tyrosine phosphatase-2|Y
src homology 2 domain-containing protein tyrosine phosphatase|src homology-2 domain-containing protein tyrosine phosphatase|Y
src homology 2 domain-containing protein tyrosine phosphatase|src homology 2 domain-containing protein tyrosine phosphatase 1|Y
β-2 microglobulin value|β2 microglobulin value|Y
immunoperoxidase technique|immuno-peroxidase technique|Y
gas chromatography/negative ion chemical ionisation-mass spectrometry|gas chromatography-negative ion chemical ionisation-mass spectrometry|Y
gas chromatography/negative ion chemical ionisation-mass spectrometry|gas chromatography/negative ion chemical ionisation mass spectrometry|Y
gas chromatography/negative ion chemical ionisation-mass spectrometry|gas chromatography/negative ion chemical ionization-mass spectrometry|Y
gas chromatography/negative ion chemical ionisation-mass spectrometry|gas chromatography/negative ion chemical ionisation/mass spectrometry|Y
chloro-phenylbiguanide|chloro-phenyl-biguanide|Y
chloro-phenylbiguanide|chlorophenylbiguanide|Y
internal mammary lymph node|internal mammary lymph nodes|Y
p-aminomethylbenzoic acid|p-aminomethyl benzoic acid|Y
health care pre-payment plan|health care prepayment plan|Y
Bone morphogenetic protein type I receptor|Bone morphogenetic protein type II receptor|Y
lymphokine activated killer-cell cytotoxicity|lymphokine activated killer cell cytotoxicity|Y
antihistocompatibility leucocyte antigen class II antibody|antihistocompatibility leucocyte antigen class I antibody|Y
antihistocompatibility leucocyte antigen class II antibody|anti-histocompatibility leucocyte antigen class II antibody|Y
antihistocompatibility leucocyte antigen class II antibody|anti-histocompatibility leucocyte antigen class I antibody|Y
receptor-like protein-tyrosine phosphatase α|receptor-like protein-tyrosine phosphatase-α|Y
receptor-like protein-tyrosine phosphatase α|receptor-like protein-tyrosine phosphatase|Y
receptor-like protein-tyrosine phosphatase α|receptor-like protein tyrosine phosphatase α|Y
receptor-like protein-tyrosine phosphatase α|receptor-like protein-tyrosine phosphatase ψ|Y
receptor-like protein-tyrosine phosphatase α|receptor-like protein-tyrosine phosphatase η|Y
receptor-like protein-tyrosine phosphatase α|receptor-like protein-tyrosine phosphatase δ|Y
receptor-like protein-tyrosine phosphatase α|receptor-like protein-tyrosine phosphatase μ|Y
cluster of differentiation 25|cluster of differentiation 2|Y
levonorgestrel-releasing intra-uterine device|laevonorgestrel-releasing intra-uterine device|Y
levonorgestrel-releasing intra-uterine device|levonorgestrel-releasing intrauterine device|Y
levonorgestrel-releasing intra-uterine device|levonorgestrel releasing intra-uterine device|Y
levonorgestrel-releasing intra-uterine device|laevonorgestrel-releasing intrauterine device|Y
organophosphorus compound-induced delayed neurotoxicity|organophosphorus-compound-induced delayed neurotoxicity|Y
non-digestible carbohydrate|nondigestible carbohydrate|Y
ribosomal protein S4|ribosomal protein S24|Y
ribosomal protein S4|ribosomal protein S14|Y
B-cell leukaemia/lymphoma-2 protein|B-cell leukemia/lymphoma-2 protein|Y
p-amino-hippuric acid|p-aminohippuric acid|Y
epidemic methicillin-resistant Staphylococcus aureus-4|epidemic methicillin-resistant Staphylococcus aureus-5|Y
epidemic methicillin-resistant Staphylococcus aureus-4|epidemic methicillin-resistant Staphylococcus aureus-8|Y
epidemic methicillin-resistant Staphylococcus aureus-4|epidemic methicillin-resistant Staphylococcus aureus-9|Y
epidemic methicillin-resistant Staphylococcus aureus-4|epidemic methicillin-resistant Staphylococcus aureus-3|Y
interferon-inducible T-cell alpha chemoattractant|interferon-inducible T cell alpha chemoattractant|Y
interferon-inducible T-cell alpha chemoattractant|interferon-inducible T-cell alpha-chemoattractant|Y
fibroblast growth factor 2|fibroblast growth factor 23|Y
transepidermal water loss|trans-epidermal water loss|Y
ventro-intermediate nucleus|ventrointermediate nucleus|Y
nonmultiple endocrine neoplasia|non-multiple endocrine neoplasia|Y
repressor element 1-silencing transcription factor|repressor element 1 silencing transcription factor|Y
carboxy terminal region|carboxyl terminal region|Y
oto-acoustic emission|otoacoustic emission|Y
type II phosphatidyl inositol 4-kinase|type II phosphatidylinositol 4-kinase|Y
small-conductance calcium-activated potassium|small conductance calcium-activated potassium|Y
macromolecular creatine kinase type 2|macro-molecular creatine kinase type 2|Y
uncoordinated protein 47|uncoordinated protein 7|Y
uncoordinated protein 47|uncoordinated protein 4|Y
recombinant follicle stimulating hormone|recombinant follicle-stimulating hormone|Y
laryngo-onycho-cutaneous syndrome|laryngo-onychocutaneous syndrome|Y
tumor associated fibroblast|tumour associated fibroblast|Y
regulatory subunit 1α|regulatory subunit 1-α|Y
regulatory subunit 1α|regulatory subunit 1 α|Y
crosspolarisation magic angle spinning|cross-polarisation magic angle spinning|Y
crosspolarisation magic angle spinning|cross polarisation magic angle spinning|Y
long-term repopulating haematopoietic stem cell|long-term repopulating hematopoietic stem cell|Y
intraparenchymal hæmorrhage|intra-parenchymal hæmorrhage|Y
liquid chromatography/atmospheric pressure chemical ionization ion trap mass spectrometry|liquid chromatography/atmospheric pressure chemical ionization-ion trap mass spectrometry|Y
liquid chromatography/atmospheric pressure chemical ionization ion trap mass spectrometry|liquid chromatography/atmospheric pressure chemical ionisation-ion trap mass spectrometry|Y
liquid chromatography/atmospheric pressure chemical ionization ion trap mass spectrometry|liquid chromatography-atmospheric pressure chemical ionization-ion trap mass spectrometry|Y
liquid chromatography/atmospheric pressure chemical ionization ion trap mass spectrometry|liquid chromatography/atmospheric pressure chemical ionisation ion trap mass spectrometry|Y
liquid chromatography/atmospheric pressure chemical ionization ion trap mass spectrometry|liquid chromatography-atmospheric pressure chemical ionization ion-trap mass spectrometry|Y
anti-IL1alpha monoclonal antibody|anti-IL1 alpha monoclonal antibody|Y
anti-IL1alpha monoclonal antibody|anti-IL-1alpha monoclonal antibody|Y
anti-multidrug resistance|antimultidrug resistance|Y
American Society of Anaesthesiology physical status 4|American Society of Anesthesiology physical status 4|Y
American Society of Anaesthesiology physical status 4|American Society of Anaesthesiology physical status 2|Y
American Society of Anaesthesiology physical status 4|American Society of Anaesthesiology physical status 3|Y
American Society of Anaesthesiology physical status 4|American Society of Anaesthesiology physical status I|Y
American Society of Anaesthesiology physical status 4|American Society of Anaesthesiology physical status 5|Y
American Society of Anaesthesiology physical status 4|American Society of Anaesthesiology physical status 1|Y
American Society of Anaesthesiology physical status 4|American Society of Anaesthesiology physical status|Y
forkhead related activator-10|forkhead related activator-1|Y
columnar lined esophagus|columnar lined oesophagus|Y
recombinant human transforming growth factor-β2|recombinant human transforming growth factor-β1|Y
recombinant human transforming growth factor-β2|recombinant human transforming growth factor-β|Y
recombinant human transforming growth factor-β2|recombinant human transforming growth factor β2|Y
recombinant human transforming growth factor-β2|recombinant human transforming growth factor-β 2|Y
ultra-purified polymerized bovine haemoglobin|ultra-purified polymerized bovine hemoglobin|Y
ultra-purified polymerized bovine haemoglobin|ultra-purified polymerised bovine haemoglobin|Y
ultra-purified polymerized bovine haemoglobin|ultrapurified polymerized bovine hemoglobin|Y
FADD-like interleukin-1β-converting enzyme|FADD-like interleukin 1β-converting enzyme|Y
FADD-like interleukin-1β-converting enzyme|FADD-like interleukin-1 β-converting enzyme|Y
FADD-like interleukin-1β-converting enzyme|FADD-like interleukin-1-β-converting enzyme|Y
hexadecyltrimethylammonium|hexadecyl-trimethylammonium|Y
interleukin 13 receptor-α 2 subunit|interleukin 13 receptor-α2 subunit|Y
immuno-electro-osmophoresis|immunoelectro-osmophoresis|Y
immuno-electro-osmophoresis|immuno-electro-osmo-phoresis|Y
acute cerebro-vascular disease|acute cerebrovascular disease|Y
microtubule-associated protein light chain-3|microtubule-associated protein-1 light chain-3|Y
microtubule-associated protein light chain-3|microtubule associated protein light chain-3|Y
microtubule-associated protein light chain-3|microtubule-associated protein 1 light chain-3|Y
microtubule-associated protein light chain-3|microtubule-associated protein light chain 3|Y
hereditary onychoosteodysplasia|hereditary onycho-osteodysplasia|Y
multi-drug resistance protein 1|multidrug resistance protein 1|Y
antigliadin antibody|anti gliadin antibody|Y
antigliadin antibody|anti-gliadin antibody|Y
platelet derived growth factor receptor β|platelet-derived growth factor receptor β|Y
platelet derived growth factor receptor β|platelet derived growth factor receptor|Y
platelet derived growth factor receptor β|platelet derived growth factor receptor-β|Y
Wechsler Intelligence Scale for Children-Revised|Wechsler Intelligence Scale for Children Revised|Y
Wechsler Intelligence Scale for Children-Revised|Wechsler Intelligence Scale for Children - Revised|Y
atrioventricular bundle|atrio-ventricular bundle|Y
non-methylene-interrupted fatty acid|nonmethylene-interrupted fatty acid|Y
trans-epithelial potential|transepithelial potential|Y
excitatory junction currents|excitatory junction current|Y
quasi-elastic neutron scattering|quasielastic neutron scattering|Y
pro-surfactant protein B|prosurfactant protein B|Y
CC chemokine ligand 5|CC chemokine ligand 25|Y
CC chemokine ligand 5|C-C chemokine ligand 5|Y
American Society of Anaesthesiology Grade 1|American Society of Anaesthesiology Grade I|Y
American Society of Anaesthesiology Grade 1|American Society of Anaesthesiology Grade 3|Y
American Society of Anaesthesiology Grade 1|American Society of Anaesthesiology Grade 2|Y
American Society of Anaesthesiology Grade 1|American Society of Anaesthesiology grade 1|Y
American Society of Anaesthesiology Grade 1|American Society of Anaesthesiology Grade V|Y
American Society of Anaesthesiology Grade 1|American Society of Anaesthesiology Grade 5|Y
American Society of Anaesthesiology Grade 1|American Society of Anesthesiology Grade 1|Y
phase transition temperatures|phase transition temperature|Y
velocity autocorrelation function|velocity auto-correlation function|Y
phosphorylated mitogen activated protein kinase|phosphorylated mitogen-activated protein kinase|Y
atrial tachy-arrhythmia|atrial tachyarrhythmia|Y
lymphoreticular system|lympho-reticular system|Y
spondylo-costal dysostosis|spondylocostal dysostosis|Y
primary intracerebral hemorrhage|primary intra-cerebral hemorrhage|Y
subacute necrotizing encephalomyelopathy|subacute necrotising encephalomyelopathy|Y
gastroesophageal pressure gradient|gastro-esophageal pressure gradient|Y
combined oral contraceptives|combined oral contraceptive|Y
interleukin-4 receptor alpha chain|interleukine-4 receptor alpha chain|Y
disease modifying antirheumatic drugs|disease modifying anti-rheumatic drugs|Y
disease modifying antirheumatic drugs|disease modifying antirheumatic drug|Y
anti-cytoplasmic antibody|anticytoplasmic antibody|Y
ribosomal protein L29|ribosomal protein L9|Y
nonhydroxyapatite coated|non-hydroxyapatite coated|Y
transmission immunoelectron microscopy|transmission immuno-electron microscopy|Y
extracellular signal regulated protein kinase|extracellular signal-regulated protein kinase|Y
G protein-coupled receptor kinase 2-mediated|G protein-coupled receptor kinase-2-mediated|Y
G protein-coupled receptor kinase 2-mediated|G protein-coupled receptor kinase 2 mediated|Y
G protein-coupled receptor kinase 2-mediated|G-protein-coupled receptor kinase 2-mediated|Y
protein tyrosine phosphatase 1C|protein tyrosine phosphatase 1|Y
kruppel-like factor-12|kruppel-like factor-2|Y
tracheo-bronchial foreign body|tracheobronchial foreign body|Y
gamma-hexachloro-cyclohexane|gamma-hexachlorocyclohexane|Y
anti-interleukin 4 antibody|antiinterleukin 4 antibody|Y
uncoordinated protein 7|uncoordinated protein 76|Y
uncoordinated protein 7|uncoordinated protein 37|Y
uncoordinated protein 7|uncoordinated protein 17|Y
extra-anatomic bypass|extraanatomic bypass|Y
pseudo-stratified ventricular epithelium|pseudostratified ventricular epithelium|Y
inhibitory post-synaptic current|inhibitory postsynaptic current|Y
American Society of Health System Pharmacists|American Society of Health-System Pharmacists|Y
Clinical Global Impressions Improvement scale|Clinical Global Impressions Improvement Scale|Y
Clinical Global Impressions Improvement scale|Clinical Global Impressions-Improvement scale|Y
non-heart-beating donors|non-heart-beating donor|Y
intra-muscular pressure|intramuscular pressure|Y
TATA-binding protein associated factor 2|TATA-binding protein associated factor 3|Y
TATA-binding protein associated factor 2|TATA-binding protein-associated factor 2|Y
TATA-binding protein associated factor 2|TATA-binding protein associated factor 6|Y
TATA-binding protein associated factor 2|TATA-binding protein associated factor 4|Y
TATA-binding protein associated factor 2|TATA-binding protein associated factor 5|Y
TATA-binding protein associated factor 2|TATA-binding protein associated factor 12|Y
TATA-binding protein associated factor 2|TATA-binding protein associated factor-2|Y
hypoxia inducible transcription factor 1 α|hypoxia inducible transcription factor-1 α|Y
hypoxia inducible transcription factor 1 α|hypoxia-inducible transcription factor 1 α|Y
hypoxia inducible transcription factor 1 α|hypoxia inducible transcription factor 1α|Y
hypoxia inducible transcription factor 1 α|hypoxia inducible transcription factor 1|Y
1-beta-D-arabinofuranosyl-cytosine|1-beta-D-arabinofuranosylcytosine|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell expressed developmentally down-regulated 2|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell-expressed, developmentally downregulated 5|Y
neural precursor cell-expressed developmentally downregulated 2|neural-precursor cell-expressed, developmentally downregulated 2|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell-expressed developmentally down-regulated 5|Y
neural precursor cell-expressed developmentally downregulated 2|neural-precursor cell-expressed developmentally downregulated 2|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell-expressed, developmentally downregulated 4|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell-expressed developmentally downregulated 8|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell-expressed developmentally downregulated 5|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell-expressed developmentally downregulated 4|Y
neural precursor cell-expressed developmentally downregulated 2|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell-expressed developmentally down-regulated 1|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell expressed developmentally downregulated 2|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell-expressed, developmentally downregulated 9|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell expressed, developmentally downregulated 2|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell-expressed developmentally down-regulated 9|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell-expressed developmentally downregulated 1|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell-expressed developmentally down-regulated 2|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell-expressed developmentally down-regulated 4|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell-expressed developmentally downregulated 9|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell-expressed, developmentally downregulated 8|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell-expressed, developmentally downregulated 1|Y
neural precursor cell-expressed developmentally downregulated 2|neural precursor cell-expressed, developmentally down-regulated 2|Y
anti-CTLA4 monoclonal antibody|anti-CTLA-4 monoclonal antibody|Y
denaturating gradient gel electrophoresis|denaturing gradient gel electrophoresis|Y
interleukine 2 receptor-α|interleukin 2 receptor-α|Y
interferon-inducible T cell alpha chemoattractant|interferon-inducible T cell alpha-chemoattractant|Y
postmenopausal woman|post-menopausal woman|Y
varicella zoster immunoglobulin|varicella zoster immuno-globulin|Y
intrauterine foreign body|intra-uterine foreign body|Y
corticotropin-releasing-hormone receptor type-2|corticotropin-releasing hormone receptor type-2|Y
corticotropin-releasing-hormone receptor type-2|corticotrophin-releasing-hormone receptor type-2|Y
corticotropin-releasing-hormone receptor type-2|corticotropin-releasing-hormone receptor type 2|Y
medium chain tri-glyceride|medium chain triglyceride|Y
thalamo-cortical relay neurone|thalamo-cortical relay neuron|Y
American Society of Anaesthesiology Grade I|American Society of Anaesthesiology Grade III|Y
American Society of Anaesthesiology Grade I|American Society of Anaesthesiology Grade 3|Y
American Society of Anaesthesiology Grade I|American Society of Anaesthesiology Grade 2|Y
American Society of Anaesthesiology Grade I|American Society of Anaesthesiology Grade V|Y
American Society of Anaesthesiology Grade I|American Society of Anesthesiology Grade I|Y
American Society of Anaesthesiology Grade I|American Society of Anesthesiology Grade IV|Y
American Society of Anaesthesiology Grade I|American Society of Anaesthesiology Grade 5|Y
American Society of Anaesthesiology Grade I|American Society of Anaesthesiology grade I|Y
American Society of Anaesthesiology Grade I|American Society of Anaesthesiology Grade II|Y
American Society of Anaesthesiology Grade I|American Society of Anesthesiology Grade II|Y
T-cell receptor gammadelta-positive|T-cell receptor gamma delta-positive|Y
mid-upper arm circumference|midupper arm circumference|Y
anti-TCR αβ monoclonal antibody|anti-TCR α β monoclonal antibody|Y
anti-TCR αβ monoclonal antibody|anti-TCR α/β monoclonal antibody|Y
anti-EGF-R monoclonal antibody|anti-EGFR monoclonal antibody|Y
type II regulatory subunit|type I regulatory subunit|Y
IL-5 receptor α-chain|IL-15 receptor α-chain|Y
nucleus praepositus hypoglossi|nucleus prepositus hypoglossi|Y
complete atrio-ventricular block|complete atrioventricular block|Y
insulinlike growth factor-1-mediated|insulin-like growth factor-1-mediated|Y
retinoic acid receptor-related orphan receptor gamma t|retinoic acid receptor-related orphan receptor gamma T|Y
retinoic acid receptor-related orphan receptor gamma t|retinoic acid receptor-related orphan receptor gammat|Y
hypo-gammaglobulinæmia|hypogammaglobulinæmia|Y
Rho guanine nucleotide dissociation inhibitor 2|Rho guanine nucleotide dissociation inhibitor α|Y
intra-ventricular haemorrhage|intra-ventricular hemorrhage|Y
forkhead box class other 1a|forkhead box class other 1|Y
human T cell leukemia virus type-1-infected|human T cell leukemia virus type-I-infected|Y
human T cell leukemia virus type-1-infected|human T-cell leukemia virus type-1-infected|Y
human T cell leukemia virus type-1-infected|human T cell leukaemia virus type-1-infected|Y
human T cell leukemia virus type-1-infected|human T cell leukemia virus type 1-infected|Y
oxysterol binding protein related protein|oxysterol binding protein related protein 9|Y
treatment decision making|treatment decisionmaking|Y
anti-cyclooxygenase 1 antibody|anticyclooxygenase 1 antibody|Y
International Obesity Taskforce cutoff|International Obesity Taskforce cut-off|Y
Disrupted Iin Schizophrenia-1|Disrupted in Schizophrenia-1|Y
peroxisome proliferator activated receptor|peroxisome proliferator activated receptors|Y
peroxisome proliferator activated receptor|peroxisome proliferator-activated receptor|Y
a disintegrin and metalloproteinase-29|a disintegrin and metalloproteinase-9|Y
N-methyl-N'-nitro-N- nitrosoguanidine|N-methyl-N'-nitro-N-nitrosoguanidine|Y
cluster of differentiation 38|cluster of differentiation 3|Y
cluster of differentiation 38|cluster of differentiation 8|Y
event-related functional magnetic resonance imaging|Event-related functional magnetic resonance imaging|Y
anti-toll-like receptor 4 monoclonal antibody|anti-toll-like receptor 2 monoclonal antibody|Y
anti-toll-like receptor 4 monoclonal antibody|anti-toll-like receptor 3 monoclonal antibody|Y
anti-toll-like receptor 4 monoclonal antibody|anti-toll like receptor 4 monoclonal antibody|Y
anti-prolactin receptor antibody|antiprolactin receptor antibody|Y
excision repair cross-complementation group 8|excision repair cross-complementation group 6|Y
excision repair cross-complementation group 8|excision repair cross-complementation group 3|Y
poly(2-hydroxyethylmethacrylate)|poly(2-hydroxyethyl methacrylate)|Y
staphylococcal enterotoxin C3|staphylococcal enterotoxin C|Y
American Society of Anaesthesiologists physical status III|American Society of Anaesthesiologists physical status I|Y
American Society of Anaesthesiologists physical status III|American Society of Anesthesiologists physical status III|Y
American Society of Anaesthesiologists physical status III|American Society of Anesthesiologists physical status II|Y
video enhanced contrast differential interference contrast microscopy|video enhanced contrast differential interference contrast microscope|Y
microaggregated human serum albumin|micro-aggregated human serum albumin|Y
continuous sub-cutaneous insulin infusion|continuous subcutaneous insulin infusion|Y
antithyroglobulin auto-antibody|antithyroglobulin autoantibody|Y
antithyroglobulin auto-antibody|anti-thyroglobulin auto-antibody|Y
lymphocyte function associated antigen 1|lymphocyte function associated antigen-1|Y
lymphocyte function associated antigen 1|lymphocyte function-associated antigen 1|Y
multi-disciplinary treatment plan|multidisciplinary treatment plan|Y
dual-color chromogenic in-situ hybridisation|dual-colour chromogenic in-situ hybridisation|Y
dual-color chromogenic in-situ hybridisation|dual-color chromogenic in situ hybridisation|Y
dual-color chromogenic in-situ hybridisation|dual-color chromogenic in-situ hybridization|Y
multi-variate linear regression|multivariate linear regression|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motifs-18|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motif-14|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motif-15|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motifs-13|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motif-3|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motifs-16|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motif-2|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motifs-17|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motifs-15|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
cyclic nucleotide phosphodiesterases|cyclic nucleotide phosphodiesterase|Y
receptor-like protein tyrosine phosphatase|receptor-like protein tyrosine phosphatase-α|Y
receptor-like protein tyrosine phosphatase|receptor-like protein tyrosine phosphatase κ|Y
receptor-like protein tyrosine phosphatase|receptor-like protein tyrosine phosphatase δ|Y
receptor-like protein tyrosine phosphatase|receptor-like protein-tyrosine phosphatase|Y
receptor-like protein tyrosine phosphatase|receptor-like protein tyrosine phosphatase-η|Y
receptor-like protein tyrosine phosphatase|receptor-like protein tyrosine phosphatase α|Y
receptor-like protein tyrosine phosphatase|receptor-like protein tyrosine phosphatase-δ|Y
receptor-like protein tyrosine phosphatase|receptor-like protein tyrosine phosphatase-κ|Y
receptor-like protein tyrosine phosphatase|receptor-like protein tyrosine phosphatase ζ|Y
receptor-like protein tyrosine phosphatase|receptor-like protein tyrosine phosphatase-ψ|Y
receptor-like protein tyrosine phosphatase|receptor-like protein tyrosine phosphatase η|Y
receptor-like protein tyrosine phosphatase|receptor-like protein tyrosine phosphatase-μ|Y
signal transducer and activator of transcription 4|signal transducer and activator of transcription 1|Y
signal transducer and activator of transcription 4|signal transducer and activator of transcription 5|Y
signal transducer and activator of transcription 4|signal transducer and activator of transcription 2|Y
signal transducer and activator of transcription 4|signal transducer and activator of transcription|Y
signal transducer and activator of transcription 4|signal transducer and activator of transcription 6|Y
signal transducer and activator of transcription 4|signal transducer and activator of transcription 3|Y
trauma-focused cognitive behavioral therapy|trauma-focused cognitive-behavioral therapy|Y
trauma-focused cognitive behavioral therapy|trauma focused cognitive behavioral therapy|Y
trauma-focused cognitive behavioral therapy|trauma-focused cognitive behavioural therapy|Y
anti-tissue factor pathway inhibitor antibody|antitissue factor pathway inhibitor antibody|Y
American Society of Anaesthesiology grade 5|American Society of Anaesthesiology grade 1|Y
American Society of Anaesthesiology grade 5|American Society of Anesthesiology grade 5|Y
American Society of Anaesthesiology grade 5|American Society of Anaesthesiology grade 3|Y
American Society of Anaesthesiology grade 5|American Society of Anaesthesiology grade|Y
American Society of Anaesthesiology grade 5|American Society of Anaesthesiology Grade 5|Y
American Society of Anaesthesiology grade 5|American Society of Anaesthesiology grade I|Y
American Society of Anaesthesiology grade 5|American Society of Anaesthesiology grade 4|Y
American Society of Anaesthesiology grade 5|American Society of Anaesthesiology grade V|Y
surface enhanced laser desorption-ionization|surface enhanced laser desorption-ionisation|Y
surface enhanced laser desorption-ionization|surface-enhanced laser desorption-ionization|Y
laser-assisted sub-epithelial keratomileusis|laser-assisted subepithelial keratomileusis|Y
laser-assisted sub-epithelial keratomileusis|laser assisted sub-epithelial keratomileusis|Y
Toll-IL-1 receptor domain-containing adaptor-inducing IFNbeta|Toll/IL-1 receptor domain-containing adaptor-inducing IFNbeta|Y
Toll-IL-1 receptor domain-containing adaptor-inducing IFNbeta|toll-IL-1 receptor domain-containing adaptor-inducing IFN-beta|Y
plasma insulin-like growth factor-II level|plasma insulin-like growth factor II level|Y
prepositus hypoglossi|praepositus hypoglossi|Y
cardiorespiratory fitness|cardio-respiratory fitness|Y
excitatory post-synaptic potential|excitatory postsynaptic potential|Y
excitatory post-synaptic potential|excitatory post-synaptic potentials|Y
guanosinetriphosphatase-activating protein 1|guanosinetriphosphatase-activating protein-1|Y
guanosinetriphosphatase-activating protein 1|guanosinetriphosphatase-activating protein|Y
guanosinetriphosphatase-activating protein 1|guanosine triphosphatase-activating protein 1|Y
oligodeoxy-nucleotide|oligodeoxynucleotide|Y
corticotropin releasing factor type-1 receptor|corticotropin-releasing factor type-1 receptor|Y
corticotropin releasing factor type-1 receptor|corticotropin releasing factor type-2 receptor|Y
dorsolateral septal nucleus|dorso-lateral septal nucleus|Y
percutaneous trans-luminal balloon angioplasty|percutaneous transluminal balloon angioplasty|Y
sulfobutyl ether β-cyclodextrin|sulfobutylether β-cyclodextrin|Y
islet-like cell cluster|isletlike cell cluster|Y
cross polarisation/magic-angle spinning nuclear magnetic resonance|cross polarisation/magic angle spinning nuclear magnetic resonance|Y
cross polarisation/magic-angle spinning nuclear magnetic resonance|cross polarization/magic-angle spinning nuclear magnetic resonance|Y
cross polarisation/magic-angle spinning nuclear magnetic resonance|cross polarisation/magic-angle-spinning nuclear magnetic resonance|Y
cross polarisation/magic-angle spinning nuclear magnetic resonance|cross polarisation magic-angle spinning nuclear magnetic resonance|Y
cross polarisation/magic-angle spinning nuclear magnetic resonance|cross-polarisation/magic-angle spinning nuclear magnetic resonance|Y
mitogen activated protein kinase kinase 4|mitogen-activated protein kinase kinase 4|Y
mitogen activated protein kinase kinase 4|mitogen activated protein kinase kinase-4|Y
mitogen activated protein kinase kinase 4|mitogen activated protein kinase kinase 1|Y
Field emission in-lens scanning electron microscopy|field emission in-lens scanning electron microscopy|Y
TGFbeta-activated kinase 1 binding protein-1|TGFbeta-activated kinase 1-binding protein-1|Y
hypertext markup language|hypertext mark-up language|Y
peroxisome proliferator-activated receptor γ coactivator 1 α|peroxisome proliferator-activated receptor γ co-activator-1 α|Y
peroxisome proliferator-activated receptor γ coactivator 1 α|peroxisome-proliferator-activated receptor γ coactivator 1 α|Y
peroxisome proliferator-activated receptor γ coactivator 1 α|peroxisome proliferator-activated receptor-γ co-activator 1 α|Y
peroxisome proliferator-activated receptor γ coactivator 1 α|peroxisome proliferator-activated receptor-γ coactivator 1 α|Y
peroxisome proliferator-activated receptor γ coactivator 1 α|peroxisome proliferator-activated receptor γ coactivator 1|Y
peroxisome proliferator-activated receptor γ coactivator 1 α|peroxisome proliferator-activated receptor γ coactivator-1 α|Y
peroxisome proliferator-activated receptor γ coactivator 1 α|peroxisome proliferator-activated receptor γ co-activator 1 α|Y
peroxisome proliferator-activated receptor γ coactivator 1 α|peroxisome proliferator-activated receptor γ co-activator 1α|Y
anti-interleukin-18 antibody|anti-interleukin-1 antibody|Y
anti-interleukin-18 antibody|anti-interleukin-8 antibody|Y
spine-associated Rap GTPase activating protein|spine-associated Rap GTPase-activating protein|Y
intra-ocular vision aid|intraocular vision aid|Y
ribosomal protein L21|ribosomal protein L1|Y
nucleotide binding oligomerisation domain-like receptor|nucleotide-binding oligomerisation domain-like receptor|Y
nucleotide binding oligomerisation domain-like receptor|nucleotide binding oligomerization domain-like receptor|Y
three-color fluorescence in situ hybridization|three color fluorescence in situ hybridization|Y
three-color fluorescence in situ hybridization|three-colour fluorescence in situ hybridization|Y
three-color fluorescence in situ hybridization|three-color fluorescence in-situ hybridization|Y
recombinant human interleukin 1α|recombinant human interleukin 1|Y
fluorine 18-labelled fluoro-deoxy-glucose|fluorine 18-labelled fluorodeoxyglucose|Y
fluorine 18-labelled fluoro-deoxy-glucose|fluorine-18-labelled fluoro-deoxy-glucose|Y
fluorine 18-labelled fluoro-deoxy-glucose|fluorine 18-labeled fluoro-deoxyglucose|Y
fluorine 18-labelled fluoro-deoxy-glucose|fluorine 18-labeled fluoro-deoxy-glucose|Y
estrogen receptor-β knock-out|oestrogen receptor-β knock-out|Y
estrogen receptor-β knock-out|estrogen receptor-β knockout|Y
Bos taurus autosome 2|Bos taurus autosome 29|Y
Bos taurus autosome 2|Bos taurus autosome 28|Y
Bos taurus autosome 2|Bos taurus autosome 22|Y
Bos taurus autosome 2|Bos taurus autosome 24|Y
Bos taurus autosome 2|Bos taurus autosome 21|Y
esophagorespiratory fistula|esophago-respiratory fistula|Y
N,N-diethylnitrosamine|N,N-dimethylnitrosamine|Y
anteroposterior movement|antero-posterior movement|Y
biological anti-oxidant potential|biological antioxidant potential|Y
gas chromatography-high resolution mass spectrometry|gas chromatography/high resolution mass spectrometry|Y
magic angle spinning nuclear magnetic resonance|magic-angle spinning nuclear magnetic resonance|Y
chemotherapy induced peripheral neurotoxicity|chemotherapy-induced peripheral neurotoxicity|Y
post-poliomyelitis syndrome|postpoliomyelitis syndrome|Y
modular extracorporeal liver support|modular extra-corporeal liver support|Y
protein tyrosine phosphatase non-receptor type 22|protein tyrosine phosphatase non-receptor-type 22|Y
protein tyrosine phosphatase non-receptor type 22|protein tyrosine phosphatase nonreceptor type 22|Y
countercurrent chromatography|counter-current chromatography|Y
3-methyl-cholanthrene|3-methylcholanthrene|Y
intra-operative imprint cytology|intraoperative imprint cytology|Y
American Society of Anesthesiology status 1|American Society of Anesthesiology status V|Y
American Society of Anesthesiology status 1|American Society of Anaesthesiology status 1|Y
American Society of Anesthesiology status 1|American Society of Anesthesiology status 3|Y
American Society of Anesthesiology status 1|American Society of Anesthesiology status|Y
American Society of Anesthesiology status 1|American Society of Anesthesiology status 4|Y
American Society of Anesthesiology status 1|American Society of Anesthesiology status 5|Y
interleukin-4 receptor-α subunit|interleukine-4 receptor-α subunit|Y
aortobifemoral bypass|aorto-bifemoral bypass|Y
mitogen activated protein kinase activated protein kinase 3|mitogen activated protein kinase activated protein kinase 5|Y
mitogen activated protein kinase activated protein kinase 3|mitogen-activated protein kinase activated protein kinase 3|Y
mitogen activated protein kinase activated protein kinase 3|mitogen activated protein kinase activated protein kinase-3|Y
mitogen activated protein kinase activated protein kinase 3|mitogen activated protein kinase activated protein kinase|Y
mitogen activated protein kinase activated protein kinase 3|mitogen activated protein kinase activated protein kinase 2|Y
mitogen activated protein kinase activated protein kinase 3|mitogen activated protein kinase activated protein kinase 1|Y
mitogen activated protein kinase activated protein kinase 3|mitogen activated protein kinase-activated protein kinase 3|Y
long-term culture-initiating cell|long-term culture-initiating cells|Y
ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid|ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid|Y
fraction of labelled mitoses|fraction of labeled mitoses|Y
fibrosarcoma derived tumor rejection antigen|fibrosarcoma-derived tumor rejection antigen|Y
fibrosarcoma derived tumor rejection antigen|fibrosarcoma derived tumour rejection antigen|Y
multispecific organic anion transporter|multi-specific organic anion transporter|Y
anti-transthyretin antibody|antitransthyretin antibody|Y
cluster of differentiation antigen 26|cluster of differentiation antigen 6|Y
oestrogen receptor-β knock-out|oestrogen receptor-β knockout|Y
caudomedial neostriatum|caudo-medial neostriatum|Y
information-motivation-behavioural skills model|information-motivation-behavioral skills model|Y
tumor necrosis factor receptor superfamily member 18|tumor necrosis factor receptor superfamily member 17|Y
tumor necrosis factor receptor superfamily member 18|tumor necrosis factor receptor superfamily member 1A|Y
tumor necrosis factor receptor superfamily member 18|tumor necrosis factor receptor superfamily member 8|Y
tumor necrosis factor receptor superfamily member 18|tumor necrosis factor receptor superfamily member 1B|Y
tumor necrosis factor receptor superfamily member 18|tumor necrosis factor receptor superfamily member 12|Y
tumor necrosis factor receptor superfamily member 18|tumor necrosis factor receptor superfamily member 19|Y
gastro-oesophageal reflux disease-related|gastro-esophageal reflux disease-related|Y
gastro-oesophageal reflux disease-related|gastroesophageal reflux disease-related|Y
type II heparin-induced thrombocytopaenia|type II heparin induced thrombocytopaenia|Y
type II heparin-induced thrombocytopaenia|type II heparin-induced thrombocytopenia|Y
multi-row detector computed tomography|multirow detector computed tomography|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 3|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 3|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-4|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 3|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-1|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 3|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 4|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 3|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 3|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2|Y
antisense oligodeoxynucleotide|anti-sense oligodeoxynucleotide|Y
anti-granulocyte macrophage colony-stimulating factor autoantibody|anti-granulocyte-macrophage colony-stimulating factor auto-antibody|Y
anti-granulocyte macrophage colony-stimulating factor autoantibody|anti-granulocyte-macrophage colony-stimulating factor autoantibody|Y
C-C chemokine ligand 17|CC chemokine ligand 17|Y
C-C chemokine ligand 17|C-C chemokine ligand 7|Y
proliferating cell nuclear antigen labelling index|proliferating cell nuclear antigen labeling index|Y
proliferating cell nuclear antigen labelling index|proliferating cell nuclear antigen-labelling index|Y
indirect antiglobulin technique|indirect anti-globulin technique|Y
American Society of Anaesthesiologists status 3|American Society of Anesthesiologists status 3|Y
American Society of Anaesthesiologists status 3|American Society of Anaesthesiologists status 2|Y
American Society of Anaesthesiologists status 3|American Society of Anaesthesiologists status 4|Y
American Society of Anaesthesiologists status 3|American Society of Anaesthesiologists status I|Y
American Society of Anaesthesiologists status 3|American Society of Anaesthesiologists status 1|Y
American Society of Anaesthesiologists status 3|American Society of Anaesthesiologists Status 3|Y
American Society of Anaesthesiologists status 3|American Society of Anaesthesiologists status 5|Y
fœtal magnetoencephalography|fœtal magneto-encephalography|Y
non-aqueous reversed-phase|nonaqueous reversed-phase|Y
whole abdominopelvic irradiation|whole abdomino-pelvic irradiation|Y
anti-prion protein antibody|antiprion protein antibody|Y
1-methyl-3-isobutyl xanthine|1-methyl-3-isobutylxanthine|Y
complement 4b binding protein|complement C4b binding protein|Y
benzo[a]pyrene diolepoxide DNA adduct level|benzo[a]pyrene diolepoxide-DNA adduct level|Y
benzo[a]pyrene diolepoxide DNA adduct level|benzo[a]pyrene diol-epoxide DNA adduct level|Y
benzo[a]pyrene diolepoxide DNA adduct level|benzo[a]pyrene diol epoxide DNA adduct level|Y
transforming growth factor beta2|transforming growth factor beta 2|Y
transforming growth factor beta2|transforming growth factor beta-2|Y
anti-nuclear antibody|antinuclear antibody|Y
tricep skin-fold thickness|tricep skinfold thickness|Y
tricep skin-fold thickness|triceps skin-fold thickness|Y
5-nitro-2-(3-phenylpropylamino) benzoic acid|5-nitro-2-(3-phenylpropylamino)benzoic acid|Y
5-nitro-2-(3-phenylpropylamino) benzoic acid|5-nitro-2-(3-phenylpropylamino)-benzoic acid|Y
expanded polytetrafluorethylene|expanded polytetrafluoroethylene|Y
testosterone-repressed prostate message-2|testosterone-repressed prostate message 2|Y
testosterone-repressed prostate message-2|testosterone repressed prostate message-2|Y
tuberomamillary nucleus|tubero-mamillary nucleus|Y
cost-related non-adherence|cost-related nonadherence|Y
drug-drug interaction|drug-drug interactions|Y
Electrically evoked auditory brainstem responses|electrically evoked auditory brainstem responses|Y
broncho-alveolar fluid|bronchoalveolar fluid|Y
tuberoinfundibular dopamine|tubero-infundibular dopamine|Y
antagonist 2-methyl-6-(phenylethynyl)-pyridine|antagonist 2-methyl-6-(phenylethynyl)pyridine|Y
postrecurrence survival|post-recurrence survival|Y
sub-oesophageal ganglion|sub-esophageal ganglion|Y
cocaine-amphetamine regulated transcript|cocaine-amphetamine-regulated transcript|Y
cocaine-amphetamine regulated transcript|cocaine amphetamine regulated transcript|Y
International Classification of Impairments Disabilities and Handicaps|International Classification of Impairments, Disabilities and Handicaps|Y
International Classification of Impairments Disabilities and Handicaps|International Classification of Impairments, Disabilities, and Handicaps|Y
craniocerebello-cardiac syndrome|craniocerebellocardiac syndrome|Y
craniocerebello-cardiac syndrome|cranio-cerebello-cardiac syndrome|Y
atrioventricular canal defect|atrio-ventricular canal defect|Y
spin-component-scaled second order Møller-Plesset theory|spin-component-scaled second-order Møller-Plesset theory|Y
spin-component-scaled second order Møller-Plesset theory|spin-component-scaled second order Moller-Plesset theory|Y
potassium pyro-antimonate|potassium pyroantimonate|Y
antituberculosis treatment|anti-tuberculosis treatment|Y
Behavioural Assessment and Research System|Behavioral Assessment and Research System|Y
nonservice connected|non-service connected|Y
transforming growth factor-β-1|transforming growth factor-β1|Y
laser induced interstitial thermo-therapy|laser-induced interstitial thermo-therapy|Y
extra-ocular movement|extraocular movement|Y
recurrent sino-pulmonary infection|recurrent sinopulmonary infection|Y
plasma ultra-filtrate|plasma ultrafiltrate|Y
subacute myeloopticoneuropathy|subacute myelo-opticoneuropathy|Y
interhospital transfer|inter-hospital transfer|Y
American Society of Anesthesiology status V|American Society of Anesthesiology status IV|Y
American Society of Anesthesiology status V|American Society of Anesthesiology status 3|Y
American Society of Anesthesiology status V|American Society of Anaesthesiology status IV|Y
American Society of Anesthesiology status V|American Society of Anesthesiology status|Y
American Society of Anesthesiology status V|American Society of Anesthesiology status 4|Y
American Society of Anesthesiology status V|American Society of Anaesthesiology status V|Y
American Society of Anesthesiology status V|American Society of Anesthesiology status 5|Y
Allium sativum agglutinin II|Allium sativum agglutinin I|Y
Toll-interleukin-1 receptor domain-containing adapter-inducing interferon β|Toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
Toll-interleukin-1 receptor domain-containing adapter-inducing interferon β|Toll/interleukin-1 receptor domain-containing adapter-inducing interferon β|Y
Toll-interleukin-1 receptor domain-containing adapter-inducing interferon β|toll-interleukin1 receptor domain-containing adapter-inducing interferon β|Y
Toll-interleukin-1 receptor domain-containing adapter-inducing interferon β|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon β|Y
Toll-interleukin-1 receptor domain-containing adapter-inducing interferon β|Toll-interleukin1 receptor domain-containing adapter-inducing interferon β|Y
Toll-interleukin-1 receptor domain-containing adapter-inducing interferon β|toll-interleukin-1 receptor domain-containing adapter-inducing interferon β|Y
Toll-interleukin-1 receptor domain-containing adapter-inducing interferon β|Toll-interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
Toll-interleukin-1 receptor domain-containing adapter-inducing interferon β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon β|Y
segmental bronchoprovocation|segmental broncho-provocation|Y
mouse T cell associated serine proteinase 1|mouse T cell associated serine proteinase-1|Y
mouse T cell associated serine proteinase 1|mouse T-cell associated serine proteinase 1|Y
human cationic amino acid transporter 2A|human cationic amino acid transporter 2B|Y
oxidised low density lipoprotein receptor-1|oxidised low-density lipoprotein receptor-1|Y
oxidised low density lipoprotein receptor-1|oxidised low density lipoprotein receptor 1|Y
oxidised low density lipoprotein receptor-1|oxidized low density lipoprotein receptor-1|Y
acromiohumeral interval|acromio-humeral interval|Y
laparoscopy assisted vaginal hysterectomy|laparoscopy-assisted vaginal hysterectomy|Y
subcommissural organ|sub-commissural organ|Y
gap-junction-mediated intercellular communication|gap junction-mediated intercellular communication|Y
adrenocorticotropic hormone|adreno-corticotropic hormone|Y
anti-interleukin-5 neutralizing antibody|anti-interleukin-6 neutralizing antibody|Y
anti-interleukin-5 neutralizing antibody|anti-interleukin-4 neutralizing antibody|Y
anti-interleukin-5 neutralizing antibody|anti-interleukin-8 neutralizing antibody|Y
TIR domain-containing adaptor inducing IFN-β|TIR domain containing adaptor inducing IFN-β|Y
trans-catheter chemo-embolization|trans-catheter chemoembolization|Y
trans-catheter chemo-embolization|transcatheter chemo-embolization|Y
δ-hexachlorocyclohexane|δ-hexachloro-cyclohexane|Y
anti-vascular cell adhesion molecule-1 monoclonal antibody|anti-vascular cell adhesion molecule 1 monoclonal antibody|Y
vector auto-regressive model|vector autoregressive model|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|toll-interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|toll-interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|Toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|Toll-interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|toll/interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|toll-interleukin-1 receptor domain-containing adapter-inducing interferon beta|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|toll-interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|toll/interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Y
intracardiac catheter recording|intra-cardiac catheter recording|Y
beta-site amyloid precursor protein-cleaving enzyme|beta-site amyloid precursor protein-cleaving enzyme-2|Y
beta-site amyloid precursor protein-cleaving enzyme|beta-site amyloid precursor protein-cleaving enzyme 1|Y
beta-site amyloid precursor protein-cleaving enzyme|beta site amyloid precursor protein-cleaving enzyme|Y
beta-site amyloid precursor protein-cleaving enzyme|beta-site amyloid precursor protein-cleaving enzyme 2|Y
beta-site amyloid precursor protein-cleaving enzyme|beta-site amyloid precursor protein cleaving enzyme|Y
beta-site amyloid precursor protein-cleaving enzyme|beta-site amyloid precursor protein-cleaving enzyme-1|Y
sub-arachnoid haemorrhage|sub-arachnoid hemorrhage|Y
World Health Organization Quality of Life Questionnaire|World Health Organisation Quality of Life Questionnaire|Y
antigelatin immunoglobulin E|anti-gelatin immunoglobulin E|Y
American Orthopaedic Foot and Ankle Society hallux score|American Orthopedic Foot and Ankle Society hallux score|Y
shiga-toxin producing Escherichia coli|shigatoxin producing Escherichia coli|Y
toluene orthomonooxygenase|toluene ortho-monooxygenase|Y
epithelial Na(+) channel|epithelial Na(+) channels|Y
multinucleoside resistance|multi-nucleoside resistance|Y
antimitochondrial antibody negative|anti-mitochondrial antibody negative|Y
oesophago-duodenal anastomosis|esophago-duodenal anastomosis|Y
bovine carbonic anhydrase II|bovine carbonic anhydrase III|Y
colony forming unit-spleen|colony forming units-spleen|Y
non-specific oesophageal motility disorder|non-specific esophageal motility disorder|Y
non-specific oesophageal motility disorder|nonspecific esophageal motility disorder|Y
embryonic lethal abnormal vision-like protein|embryonic-lethal abnormal vision-like protein|Y
BRI1-associated kinase-1|BRI1-associated kinase1|Y
single photon emission computer tomography scan|single photon emission computed tomography scan|Y
increased intracranial pressure|increased intra-cranial pressure|Y
atrio-ventricular plane displacement|atrioventricular plane displacement|Y
sulfobutyl ether beta-cyclodextrin|sulfobutylether beta-cyclodextrin|Y
Nationwide Inpatient Sample|Nationwide In-patient Sample|Y
25-Item National Eye Institute Visual Function Questionnaire|25-item National Eye Institute Visual Function Questionnaire|Y
25-Item National Eye Institute Visual Function Questionnaire|25-Item National Eye Institute-Visual Function Questionnaire|Y
alpha 2-plasmin inhibitor/plasmin complex|alpha2-plasmin inhibitor/plasmin complex|Y
alpha 2-plasmin inhibitor/plasmin complex|alpha 2 plasmin inhibitor/plasmin complex|Y
prostaglandin F(2) alpha|prostaglandin F-(2) alpha|Y
serum insulin-like growth factor 1 level|serum insulin-like growth factor-1 level|Y
serum insulin-like growth factor 1 level|serum insulinlike growth factor 1 level|Y
signal transducer and activator of transcription 5B|signal transducer and activator of transcription 5A|Y
signal transducer and activator of transcription 5B|signal transducer and activator of transcription-5B|Y
signal transducer and activator of transcription 5B|signal transducer and activator of transcription 5a|Y
signal transducer and activator of transcription 5B|signal transducer and activator of transcription 5|Y
signal transducer and activator of transcription 5B|signal transducer and activator of transcription 5b|Y
drug induced thrombocytopaenia|drug induced thrombocytopenia|Y
uPAR-associated protein|uPA-R-associated protein|Y
uPAR-associated protein|u-PAR-associated protein|Y
nonallergic rhinitis|non-allergic rhinitis|Y
posterolateral bundle|postero-lateral bundle|Y
123I-metaiodobenzyl-guanidine scintigraphy|(123)I-metaiodobenzyl-guanidine scintigraphy|Y
123I-metaiodobenzyl-guanidine scintigraphy|123I-metaiodobenzylguanidine scintigraphy|Y
123I-metaiodobenzyl-guanidine scintigraphy|123I-meta-iodobenzyl-guanidine scintigraphy|Y
non-infectious haemagglutinin|non-infectious hemagglutinin|Y
krüppel-like factor 3|krüppel-like factor 13|Y
days postinoculation|days post-inoculation|Y
days postinoculation|days post inoculation|Y
T cell receptor-γ δ-positive|T cell receptor-γδ-positive|Y
phosphoinositide-dependent protein kinase-1|phosphoinositide-dependent protein kinase 1|Y
phosphoinositide-dependent protein kinase-1|3-phosphoinositide-dependent protein kinase-1|Y
recombination fractions|recombination fraction|Y
postmeiotic segregation 1|post-meiotic segregation 1|Y
enzyme linked immunoabsorbent assay|enzyme linked immuno-absorbent assay|Y
malto-oligosyl trehalose synthase|maltooligosyl trehalose synthase|Y
FADD-like interleukin 1β-converting enzyme|FADD-like interleukin 1β converting enzyme|Y
noncontingent reinforcement|non-contingent reinforcement|Y
U2 osteosarcoma cell|U-2 osteosarcoma cell|Y
multiplanar reformatted image|multi-planar reformatted image|Y
insulin-like growth factor 2 receptor|insulinlike growth factor 2 receptor|Y
mouse T-cell associated serine proteinase-1|mouse T cell associated serine proteinase-1|Y
mouse T-cell associated serine proteinase-1|mouse T-cell associated serine proteinase 1|Y
mouse T-cell associated serine proteinase-1|mouse T-cell-associated serine proteinase-1|Y
stromal derived factor 1-α|stromal derived factor 1α|Y
S-T segment depression|ST segment depression|Y
spontaneous peri-renal haematoma|spontaneous peri-renal hematoma|Y
forkhead box class O3|forkhead box class O3A|Y
forkhead box class O3|forkhead box class O|Y
human promyelocytic leukemia cell|human promyelocytic leukemia cells|Y
immunoreactive secretin|immunoreactive secretion|Y
latent transforming growth factor-β binding protein-1|latent transforming growth factor β binding protein-1|Y
latent transforming growth factor-β binding protein-1|latent transforming growth factor-β binding protein 1|Y
staphylococcal superantigen-like protein 7|staphylococcal superantigen-like protein|Y
staphylococcal superantigen-like protein 7|staphylococcal superantigen-like protein 5|Y
recombinant human tumor necrosis factor|recombinant human tumor necrosis factor-β|Y
recombinant human tumor necrosis factor|recombinant human tumor necrosis factor β|Y
recombinant human tumor necrosis factor|recombinant human tumor necrosis factor-α|Y
insulin-like growth factor-II mRNA-binding protein-2|insulin-like growth factor-II mRNA-binding protein-1|Y
insulin-like growth factor-II mRNA-binding protein-2|insulin-like growth factor-II mRNA-binding protein|Y
insulin-like growth factor-II mRNA-binding protein-2|insulin-like growth factor-II mRNA-binding protein-3|Y
insulin-like growth factor-II mRNA-binding protein-2|insulin-like growth factor-II mRNA-binding protein 2|Y
insulin-like growth factor-II mRNA-binding protein-2|insulin-like growth factor II mRNA-binding protein-2|Y
insulin-like growth factor-II mRNA-binding protein-2|insulin-like growth factor-II mRNA binding protein-2|Y
aspartylhydroxaminic acid|aspartyl-hydroxaminic acid|Y
human adenovirus serotype 8|human adenovirus serotype 18|Y
human adenovirus serotype 8|human adenovirus serotype 38|Y
human adenovirus serotype 8|human adenovirus serotype 48|Y
human adenovirus serotype 8|human adenovirus serotype 28|Y
microtensile bond strength|micro-tensile bond strength|Y
peptide nucleic acid-peptide chimaera|peptide nucleic acid-peptide chimera|Y
American Society of Anaesthesiologists class|American Society of Anaesthesiologists Class|Y
American Society of Anaesthesiologists class|American Society of Anaesthesiologists class I|Y
American Society of Anaesthesiologists class|American Society of Anaesthesiologists class 3|Y
American Society of Anaesthesiologists class|American Society of Anesthesiologists class|Y
American Society of Anaesthesiologists class|American Society of Anaesthesiologists class 5|Y
American Society of Anaesthesiologists class|American Society of Anaesthesiologists class 1|Y
American Society of Anaesthesiologists class|American Society of Anaesthesiologists class 4|Y
non-depolarising neuromuscular blocking agent|non-depolarizing neuromuscular blocking agent|Y
non-depolarising neuromuscular blocking agent|nondepolarising neuromuscular blocking agent|Y
N-acetylglucosaminyltransferase VB|N-acetylglucosaminyltransferase V|Y
B-lineage acute lymphoblastic leukemia|B-lineage acute lymphoblastic leukaemia|Y
Yersinia enterocolitica serotype O:8|Yersinia enterocolitica serotype O8|Y
endothelial monocyte activating polypeptide-I|endothelial monocyte activating polypeptide I|Y
endothelial monocyte activating polypeptide-I|endothelial monocyte activating polypeptide-II|Y
endothelial monocyte activating polypeptide-I|endothelial monocyte-activating polypeptide-I|Y
endothelial monocyte activating polypeptide-I|endothelial monocyte activating polypeptide-2|Y
endothelial monocyte activating polypeptide-I|endothelial monocyte activating polypeptide|Y
endothelial monocyte activating polypeptide-I|endothelial monocyte activating polypeptide-III|Y
National Hospital Organization Kinki-chuo Chest Medical Center|National Hospital Organization Kinki-Chuo Chest Medical Center|Y
noncontact tonometry|non-contact tonometry|Y
American Society of Anaesthesiology class IV|American Society of Anaesthesiology class V|Y
American Society of Anaesthesiology class IV|American Society of Anesthesiology class IV|Y
American Society of Anaesthesiology class IV|American Society of Anesthesiology class V|Y
American Society of Anaesthesiology class IV|American Society of Anesthesiology class I|Y
American Society of Anaesthesiology class IV|American Society of Anaesthesiology class II|Y
high-resolution computerized tomography scan|high resolution computerized tomography scan|Y
phosphatase and tensin homologue-induced putative kinase 1|phosphatase and tensin homolog-induced putative kinase 1|Y
hemoglobin Roseau-Pointe-à-Pitre|haemoglobin Roseau-Pointe-à-Pitre|Y
non–rapid eye movement|nonrapid eye movement|Y
difluorodeoxy-uridine|difluoro-deoxy-uridine|Y
difluorodeoxy-uridine|difluorodeoxyuridine|Y
anti-IL-4 monoclonal antibody|antiIL-4 monoclonal antibody|Y
anti-IL-4 monoclonal antibody|anti-IL4 monoclonal antibody|Y
American Society of Anesthesiologists status 3|American Society of Anesthesiologists status 4|Y
American Society of Anesthesiologists status 3|American Society of Anesthesiologists status V|Y
American Society of Anesthesiologists status 3|American Society of Anesthesiologists status I|Y
American Society of Anesthesiologists status 3|American Society of Anesthesiologists status 5|Y
cross polarization magic-angle-spinning nuclear magnetic resonance|cross-polarization magic-angle-spinning nuclear magnetic resonance|Y
cross polarization magic-angle-spinning nuclear magnetic resonance|cross polarization/magic-angle-spinning nuclear magnetic resonance|Y
Endoscopic ultrasound-guided fine-needle aspiration|endoscopic ultrasound-guided fine-needle aspiration|Y
methionyl-tRNA formyl transferase|methionyl-tRNA formyltransferase|Y
plasma membrane calcium adenosine triphosphatase|plasma membrane calcium adenosine triphosphatase 2|Y
nonpreganglionic Edinger-Westphal nucleus|non-preganglionic Edinger-Westphal nucleus|Y
nucleotide binding site-leucine rich repeat|nucleotide binding site-leucine-rich repeat|Y
hamster kidney cell line 1A|hamster kidney cell line 1|Y
anti-human T-cell lymphotrophic virus-1 antibody|anti-human T-cell lymphotropic virus-1 antibody|Y
anti-human T-cell lymphotrophic virus-1 antibody|anti-human T-cell lymphotrophic virus-I antibody|Y
anti-human T-cell lymphotrophic virus-1 antibody|anti-human T-cell lymphotrophic virus 1 antibody|Y
anti-human T-cell lymphotrophic virus-1 antibody|anti-human T cell lymphotrophic virus-1 antibody|Y
activated Cdc42-associated tyrosine kinase 2|activated Cdc42-associated tyrosine kinase 1|Y
activated Cdc42-associated tyrosine kinase 2|activated Cdc42-associated tyrosine kinase-2|Y
activated Cdc42-associated tyrosine kinase 2|activated Cdc42 associated tyrosine kinase 2|Y
cluster of differentiation 99|cluster of differentiation 9|Y
heparin induced thrombocytopenia syndrome|heparin induced thrombocytopaenia syndrome|Y
heparin induced thrombocytopenia syndrome|heparin-induced thrombocytopenia syndrome|Y
caseinolytic protease X|caseinolytic protease XP|Y
American Society of Anaesthesiology Grade III|American Society of Anaesthesiology grade III|Y
American Society of Anaesthesiology Grade III|American Society of Anaesthesiology Grade II|Y
American Society of Anaesthesiology Grade III|American Society of Anesthesiology Grade II|Y
N-acetylated-alpha-linked acidic dipeptidase|N-acetylated alpha-linked acidic dipeptidase|Y
lymphoepithelial Kazal-type-related inhibitor|lympho-epithelial Kazal-type-related inhibitor|Y
murine T-cell associated serine proteinase 1|murine T-cell associated serine proteinase-1|Y
murine T-cell associated serine proteinase 1|murine T cell associated serine proteinase 1|Y
murine T-cell associated serine proteinase 1|murine T-cell-associated serine proteinase 1|Y
human transforming growth factor beta|human transforming growth factor beta2|Y
human transforming growth factor beta|human transforming growth factor beta1|Y
ras-related GTP-binding protein 3C|ras-related GTP-binding protein 3|Y
laser micro-dissection|laser microdissection|Y
adult T cell leukaemia-virus-associated antigen|adult T cell leukemia-virus-associated antigen|Y
adult T cell leukaemia-virus-associated antigen|adult T-cell leukaemia-virus-associated antigen|Y
adult T cell leukaemia-virus-associated antigen|adult T cell leukaemia virus-associated antigen|Y
central anticholinergic syndrome|central anti-cholinergic syndrome|Y
liposome-encapsulated haemoglobin|liposome-encapsulated hemoglobin|Y
invariant T cell receptor Vα-14|invariant T cell receptor Vα14|Y
anti-asialo-GM1 antibody|anti-asialo-GM-1 antibody|Y
RNA arbitrarily primed polymerase chain reaction|RNA-arbitrarily primed polymerase chain reaction|Y
RNA arbitrarily primed polymerase chain reaction|RNA arbitrarily primed-polymerase chain reaction|Y
leukocyte-derived neutrophil chemotactic factor-2|leukocyte-derived neutrophil chemotactic factor-1|Y
leukocyte-derived neutrophil chemotactic factor-2|leukocyte-derived neutrophil chemotactic factor 2|Y
Atlanta Veterans Affairs Medical Center|Atlanta Veteran's Affairs Medical Center|Y
Atlanta Veterans Affairs Medical Center|Atlanta Veterans' Affairs Medical Center|Y
antituberculous therapy|anti-tuberculous therapy|Y
glycosyl-phosphatidylinositol anchored|glycosyl-phosphatidyl-inositol anchored|Y
glycosyl-phosphatidylinositol anchored|glycosyl-phosphatidyl inositol anchored|Y
glycosyl-phosphatidylinositol anchored|glycosylphosphatidylinositol anchored|Y
chronic infantile neurological, cutaneous and articular syndrome|chronic infantile neurological cutaneous and articular syndrome|Y
anti-sulfatide antibody|antisulfatide antibody|Y
Clinical Evaluation of Language Fundamentals-Revised|Clinical Evaluation of Language Fundamentals-revised|Y
Floating-Harbor syndrome|Floating-Harbour syndrome|Y
contagious caprine pleuropneumonia|contagious caprine pleuro-pneumonia|Y
demineralized freeze-dried bone allograft|demineralized freeze-dried bone allografts|Y
demineralized freeze-dried bone allograft|demineralised freeze-dried bone allograft|Y
demineralized freeze-dried bone allograft|demineralized freeze dried bone allograft|Y
Bcl2 associated X-protein|Bcl-2 associated X-protein|Y
Physicians Desk Reference|Physician's Desk Reference|Y
Physicians Desk Reference|Physicians' Desk Reference|Y
galacto-oligosaccharides|galacto-oligosaccharide|Y
supercritical fluid chromatography|super-critical fluid chromatography|Y
murine erythroleukemia|murine erythroleukaemia|Y
multilayer feed-forward neural network|multi-layer feed-forward neural network|Y
beta-phenyl-ethylamine|beta-phenylethylamine|Y
aortofemoral bypass graft|aorto-femoral bypass graft|Y
nonmuscle myosin heavy chain II|nonmuscle myosin heavy chain IIB|Y
nonmuscle myosin heavy chain II|nonmuscle myosin heavy chain IIA|Y
nonmuscle myosin heavy chain II|non-muscle myosin heavy chain II|Y
human T-cell leukaemia virus type-I-infected|human T cell leukaemia virus type-I-infected|Y
human T-cell leukaemia virus type-I-infected|human T-cell leukemia virus type-I-infected|Y
human T-cell leukaemia virus type-I-infected|human T-cell leukaemia virus type I-infected|Y
cholesterol side-chain cleavage cytochrome P-450|cholesterol side-chain cleavage cytochrome P450|Y
Eating Attitudes Test|Eating Attitude Test|Y
Shiga-like toxin-producing Escherichia coli|Shiga-like-toxin-producing Escherichia coli|Y
flexible fiber-optic laryngoscopy|flexible fiberoptic laryngoscopy|Y
human tumor necrosis factor-β|human tumour necrosis factor-β|Y
infection-associated haemophagocytic syndrome|infection associated haemophagocytic syndrome|Y
infection-associated haemophagocytic syndrome|infection-associated hemophagocytic syndrome|Y
antivascular endothelial growth factor antibody|anti-vascular endothelial growth factor antibody|Y
N-terminal proatrial natriuretic peptide|N-terminal pro-atrial natriuretic peptide|Y
insulin-like growth factor binding protein-related protein 1|insulin-like growth factor binding protein-related protein-1|Y
insulin-like growth factor binding protein-related protein 1|insulin-like growth factor binding protein related protein 1|Y
non-linear mixed-effects model|nonlinear mixed-effects model|Y
beta-amyloid precursor protein-cleaving enzyme-1|beta amyloid precursor protein-cleaving enzyme-1|Y
beta-amyloid precursor protein-cleaving enzyme-1|beta-amyloid precursor protein-cleaving enzyme|Y
beta-amyloid precursor protein-cleaving enzyme-1|beta-amyloid precursor protein cleaving enzyme-1|Y
beta-amyloid precursor protein-cleaving enzyme-1|beta-amyloid precursor protein-cleaving enzyme 1|Y
beta-amyloid precursor protein-cleaving enzyme-1|beta-amyloid precursor protein-cleaving enzyme-2|Y
Brahma related gene 1-associated factor 60b|Brahma related gene 1-associated factor 60c|Y
Brahma related gene 1-associated factor 60b|Brahma related gene 1-associated factor 60|Y
Brahma related gene 1-associated factor 60b|Brahma related gene 1-associated factor 60a|Y
factor VII coagulant activity|factor VIII coagulant activity|Y
San Juan Veterans' Administration Medical Center|San Juan Veterans Administration Medical Center|Y
non-specific crossreacting antigen|non-specific cross-reacting antigen|Y
trans-cranial Doppler|transcranial Doppler|Y
major post-synaptic density protein|major postsynaptic density protein|Y
electrospray ionisation Fourier transform ion cyclotron resonance mass spectrometer|electrospray ionisation Fourier transform ion cyclotron resonance mass spectrometry|Y
toxin-coregulated pilus subunit A|toxin-co-regulated pilus subunit A|Y
interleukin-13 receptor alpha1-chain|interleukine-13 receptor alpha1-chain|Y
American Society of Anaesthesiologists Status 2|American Society of Anaesthesiologists Status I|Y
American Society of Anaesthesiologists Status 2|American Society of Anaesthesiologists status 2|Y
American Society of Anaesthesiologists Status 2|American Society of Anaesthesiologists Status 3|Y
tert-butyl-hydroquinone|tert-butylhydroquinone|Y
TSH binding inhibitory immunoglobulins|TSH binding inhibitor immunoglobulins|Y
TSH binding inhibitory immunoglobulins|TSH binding inhibitory immunoglobulin|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell expressed, developmentally downregulated 8|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell expressed developmentally down-regulated 2|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell expressed developmentally down-regulated 4|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell expressed, developmentally downregulated 1|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell expressed developmentally downregulated 9|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell expressed, developmentally down-regulated 2|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell expressed, developmentally down-regulated 8|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell expressed, developmentally downregulated 5|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell expressed developmentally down-regulated 1|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell expressed developmentally down-regulated 8|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell expressed, developmentally downregulated 9|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell-expressed, developmentally downregulated 9|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell expressed, developmentally downregulated 2|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell-expressed developmentally down-regulated 9|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell expressed, developmentally down-regulated 4|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell expressed, developmentally down-regulated 1|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell expressed developmentally down-regulated 9|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell expressed, developmentally down-regulated 9|neural precursor cell expressed, developmentally down-regulated 5|Y
medical anti-shock trousers|medical anti-shock trouser|Y
abdomino-pelvic computed tomography|abdominopelvic computed tomography|Y
TGFbeta receptor type II|TGF-beta receptor type II|Y
X-linked thrombocytopenia|X-linked thrombocytopaenia|Y
X-linked thrombocytopenia|X-linked thrombo-cytopenia|Y
matrix assisted laser desorption-ionisation mass spectrometry|matrix-assisted laser desorption-ionisation mass spectrometry|Y
matrix assisted laser desorption-ionisation mass spectrometry|matrix assisted laser desorption ionisation mass spectrometry|Y
matrix assisted laser desorption-ionisation mass spectrometry|matrix assisted laser desorption/ionisation mass spectrometry|Y
matrix assisted laser desorption-ionisation mass spectrometry|matrix assisted laser desorption-ionization mass spectrometry|Y
laparoscopic assisted vaginal hysterectomy|laparoscopic-assisted vaginal hysterectomy|Y
interleukin 13 receptor|interleukin 1 receptor|Y
interleukin 13 receptor|interleukin 3 receptor|Y
delta-9-tetrahydrocannabinol|delta9-tetrahydrocannabinol|Y
17 alpha-methyltestosterone|17alpha-methyltestosterone|Y
interferon regulatory factor 1|interferon regulatory factor 10|Y
a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13 deficiency|a disintegrin-like and metalloproteinase with thrombospondin type1 motif 13 deficiency|Y
Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-3|Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-2|Y
Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-3|Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico|Y
secreted phosphoprotein 24|secreted phosphoprotein 2|Y
photoacoustic tomography|photo-acoustic tomography|Y
neuro-muscular tension|neuromuscular tension|Y
proliferative vitreo-retinopathy|proliferative vitreoretinopathy|Y
negative intra-thoracic pressure|negative intrathoracic pressure|Y
electroencephalographic response|electro-encephalographic response|Y
Joint Commission on Accreditation of Healthcare Organizations'|Joint Commission on Accreditation of Healthcare Organizations|Y
glycosyl-phosphatidyl-inositol-anchored protein|glycosylphosphatidylinositol-anchored protein|Y
glycosyl-phosphatidyl-inositol-anchored protein|glycosyl-phosphatidyl-inositol anchored protein|Y
glycosyl-phosphatidyl-inositol-anchored protein|glycosyl-phosphatidylinositol-anchored protein|Y
glycosyl-phosphatidyl-inositol-anchored protein|glycosylphosphatidyl-inositol-anchored protein|Y
healthcare associated pneumonia|health care associated pneumonia|Y
healthcare associated pneumonia|health-care associated pneumonia|Y
arabino-xylo-oligosaccharide|arabinoxylo-oligosaccharide|Y
tumor necrosis factor α production|tumour necrosis factor α production|Y
α-2 Heremans Schmid glycoprotein|α2 Heremans Schmid glycoprotein|Y
poly(propylene fumarate)|poly (propylene fumarate)|Y
tyrosine aminotransferase|tyrosine amino transferase|Y
senescence associated beta-galactosidase|senescence-associated beta-galactosidase|Y
senescence associated beta-galactosidase|senescence associated beta galactosidase|Y
intra-uterine transplantation|intrauterine transplantation|Y
cartilage-derived morphogenetic protein-2|cartilage-derived morphogenetic protein-3|Y
cartilage-derived morphogenetic protein-2|cartilage-derived morphogenetic protein|Y
vestibulo-ocular response|vestibuloocular response|Y
American Society of Anesthesiology grade III|American Society of Anaesthesiology grade II|Y
American Society of Anesthesiology grade III|American Society of Anaesthesiology grade III|Y
American Society of Anesthesiology grade III|American Society of Anesthesiology grade I|Y
American Society of Anesthesiology grade III|American Society of Anesthesiology grade II|Y
interfraction interval|inter-fraction interval|Y
intra-vaginal ejaculation latency time|intravaginal ejaculation latency time|Y
Epstein-Barr virus immortalised cell line|Epstein-Barr virus-immortalised cell line|Y
Epstein-Barr virus immortalised cell line|Epstein-Barr virus immortalized cell line|Y
IL12 receptor beta1 chain|IL-12 receptor beta1 chain|Y
postreplication repair|post-replication repair|Y
capillary isoelectric focusing electrospray ionization mass spectrometry|capillary isoelectric focusing-electrospray ionization mass spectrometry|Y
capillary isoelectric focusing electrospray ionization mass spectrometry|capillary isoelectric focusing electrospray ionisation mass spectrometry|Y
coloileo-colonic junction|coloileocolonic junction|Y
ribosomal protein L24|ribosomal protein L4|Y
corticotrophin-releasing factor receptor-1|corticotrophin releasing factor receptor-1|Y
corticotrophin-releasing factor receptor-1|corticotropin-releasing factor receptor-1|Y
corticotrophin-releasing factor receptor-1|corticotrophin-releasing factor receptor 1|Y
neural-precursor-cell-expressed developmentally downregulated 1|neural-precursor-cell-expressed developmentally downregulated 8|Y
neural-precursor-cell-expressed developmentally downregulated 1|neural-precursor-cell-expressed, developmentally downregulated 9|Y
neural-precursor-cell-expressed developmentally downregulated 1|neural-precursor-cell-expressed, developmentally downregulated 1|Y
neural-precursor-cell-expressed developmentally downregulated 1|neural-precursor-cell-expressed developmentally down-regulated 8|Y
neural-precursor-cell-expressed developmentally downregulated 1|neural-precursor cell-expressed developmentally down-regulated 1|Y
neural-precursor-cell-expressed developmentally downregulated 1|neural-precursor-cell-expressed developmentally downregulated 2|Y
neural-precursor-cell-expressed developmentally downregulated 1|neural-precursor-cell-expressed, developmentally down-regulated 1|Y
neural-precursor-cell-expressed developmentally downregulated 1|neural-precursor-cell-expressed developmentally downregulated 9|Y
neural-precursor-cell-expressed developmentally downregulated 1|neural-precursor-cell-expressed developmentally down-regulated 5|Y
neural-precursor-cell-expressed developmentally downregulated 1|neural-precursor-cell-expressed developmentally down-regulated 9|Y
neural-precursor-cell-expressed developmentally downregulated 1|neural-precursor-cell-expressed, developmentally downregulated 5|Y
neural-precursor-cell-expressed developmentally downregulated 1|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor-cell-expressed developmentally downregulated 1|neural-precursor-cell-expressed developmentally downregulated 5|Y
neural-precursor-cell-expressed developmentally downregulated 1|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor-cell-expressed developmentally downregulated 1|neural-precursor-cell-expressed developmentally down-regulated 1|Y
neural-precursor-cell-expressed developmentally downregulated 1|neural-precursor cell-expressed, developmentally downregulated 1|Y
neural-precursor-cell-expressed developmentally downregulated 1|neural-precursor-cell-expressed, developmentally downregulated 2|Y
prostaglandin-like substances|prostaglandin-like substance|Y
preproapolipoprotein A-II|preproapolipoprotein A-I|Y
procollagen type-III amino-terminal peptide|procollagen type III amino-terminal peptide|Y
procollagen type-III amino-terminal peptide|pro-collagen type-III amino-terminal peptide|Y
immunoreactive plasma|immuno-reactive plasma|Y
intracisternal A particle|intra-cisternal A particle|Y
American Society of Anaesthesiologists physical status I|American Society of Anesthesiologists physical status I|Y
American Society of Anaesthesiologists physical status I|American Society of Anaesthesiologists physical status 2|Y
American Society of Anaesthesiologists physical status I|American Society of Anesthesiologists physical status IV|Y
American Society of Anaesthesiologists physical status I|American Society of Anaesthesiologists physical status IV|Y
American Society of Anaesthesiologists physical status I|American Society of Anesthesiologists physical status II|Y
American Society of Anaesthesiologists physical status I|American Society of Anaesthesiologists physical status 3|Y
American Society of Anaesthesiologists physical status I|American Society of Anaesthesiologists physical status 1|Y
American Society of Anaesthesiologists physical status I|American Society of Anaesthesiologists physical status 4|Y
American Society of Anaesthesiologists physical status I|American Society of Anaesthesiologists physical status 5|Y
cytoplasmic anti-neutrophil cytoplasmic antibody positive|cytoplasmic anti-neutrophil cytoplasmic antibody-positive|Y
American Society of Anesthesiologists Class V|American Society of Anesthesiologists Class 1|Y
American Society of Anesthesiologists Class V|American Society of Anaesthesiologists Class V|Y
American Society of Anesthesiologists Class V|American Society of Anesthesiologists class V|Y
American Society of Anesthesiologists Class V|American Society of Anesthesiologists Class I|Y
American Society of Anesthesiologists Class V|American Society of Anesthesiologists Class|Y
American Society of Anesthesiologists Class V|American Society of Anesthesiologists Class 3|Y
American Society of Anesthesiologists Class V|American Society of Anesthesiologists Class 2|Y
American Society of Anesthesiologists Class V|American Society of Anesthesiologists Class IV|Y
American Society of Anesthesiologists Class V|American Society of Anesthesiologists Class 4|Y
transcranial alternating-current stimulation|transcranial alternating current stimulation|Y
RanGTPase-activating protein|Ran-GTPase-activating protein|Y
RanGTPase-activating protein|Ran GTPase-activating protein|Y
anti-gelatin immunoglobulin E|anti-gelatine immunoglobulin E|Y
temperature-programmed oxidation|temperature-programed oxidation|Y
dopamine2 receptor antagonist|dopamine receptor antagonist|Y
adenoassociated virus serotype 2|adeno-associated virus serotype 2|Y
spermidine/spermine-N(1)-acetyltransferase|spermidine-spermine-N(1)-acetyltransferase|Y
spermidine/spermine-N(1)-acetyltransferase|spermidine/spermine N(1)-acetyltransferase|Y
watery diarrhea, hypokalemia, achlorhydria syndrome|watery diarrhoea, hypokalaemia, achlorhydria syndrome|Y
somatosensory evoked magnetic fields|somatosensory evoked magnetic field|Y
5-fluoro-2'-deoxyuridine-5'-monophosphate|5-fluoro-2'-deoxyuridine 5'-monophosphate|Y
anterior sub-capsular cataract|anterior subcapsular cataract|Y
nitroglycerine-mediated vasodilation|nitroglycerin-mediated vasodilation|Y
Na-K-Cl co-transporter-1|Na-K-Cl cotransporter-1|Y
Na-K-Cl co-transporter-1|Na-K-2Cl co-transporter-1|Y
nuclear factor erythroid 2p45-related factor 2|nuclear factor erythroid 2p45-related factor-2|Y
nuclear factor erythroid 2p45-related factor 2|nuclear factor erythroid 2-p45-related factor 2|Y
nuclear factor erythroid 2p45-related factor 2|nuclear factor erythroid 2 p45-related factor 2|Y
lympho-plasmacytoid lymphoma|lymphoplasmacytoid lymphoma|Y
γ-amino-butyric acid B receptor|γ-amino-butyric acidB receptor|Y
γ-amino-butyric acid B receptor|γ-aminobutyric acid B receptor|Y
adrenocortical hormone|adreno-cortical hormone|Y
extra-lobar pulmonary sequestration|extralobar pulmonary sequestration|Y
photoionisation detector|photo-ionisation detector|Y
anti-smooth muscle antibody|antismooth muscle antibody|Y
fan-beam dual energy x-ray absorptiometry|fan beam dual energy x-ray absorptiometry|Y
fan-beam dual energy x-ray absorptiometry|fanbeam dual energy x-ray absorptiometry|Y
fan-beam dual energy x-ray absorptiometry|fan-beam dual-energy x-ray absorptiometry|Y
fan-beam dual energy x-ray absorptiometry|fan-beam dual energy X-ray absorptiometry|Y
penicillin-resistant Streptococcus pneumoniae|penicillin resistant Streptococcus pneumoniae|Y
matrix-assisted laser desorption/ionisation Fourier-transform ion cyclotron resonance mass spectrometry|matrix-assisted laser desorption/ionisation Fourier transform ion cyclotron resonance mass spectrometry|Y
matrix-assisted laser desorption/ionisation Fourier-transform ion cyclotron resonance mass spectrometry|matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry|Y
matrix-assisted laser desorption/ionisation Fourier-transform ion cyclotron resonance mass spectrometry|matrix-assisted laser desorption/ionization Fourier-transform ion cyclotron resonance mass spectrometry|Y
γ aminobutyric acid transporter|γ amino butyric acid transporter|Y
Proton magnetic resonance spectroscopic imaging|proton magnetic resonance spectroscopic imaging|Y
reverse post-optokinetic nystagmus|reversed post-optokinetic nystagmus|Y
reverse post-optokinetic nystagmus|reverse postoptokinetic nystagmus|Y
insulin-like growth factor type-1 receptor|insulin-like growth factor type 1 receptor|Y
hyper-homocysteinæmia|hyperhomocysteinæmia|Y
genomewide linkage analysis|genome-wide linkage analysis|Y
insulin/IGF1 signaling|insulin/IGF1 signalling|Y
human tumour necrosis factor α|human tumor necrosis factor α|Y
enzyme linked immuno-transfer blot|enzyme linked immunotransfer blot|Y
upper gastro-intestinal tract|upper gastrointestinal tract|Y
extra-corporeal life support|extracorporeal life support|Y
penicillinase producing Neisseria gonorrhoeae|penicillinase-producing Neisseria gonorrhoeae|Y
penicillinase producing Neisseria gonorrhoeae|penicillinase producing neisseria gonorrhoeae|Y
oligo(phenylene ethynylene)|oligo(phenyleneethynylene)|Y
Trail Making Test, Part A|Trail Making Test Part A|Y
electrohydraulic lithotripsy|electro-hydraulic lithotripsy|Y
acid-sensing ion channel 2|acid-sensing ion channel 2b|Y
acid-sensing ion channel 2|acid-sensing ion channel 2a|Y
CC chemokine receptor 6|C-C chemokine receptor 6|Y
N-nitroso-N-ethylurea|N-nitroso-N-methylurea|Y
examination under anaesthesia|examination under anesthesia|Y
beta-phenylethylamine|beta-phenyl ethylamine|Y
transcriptional intermediary factor 1 β|transcriptional intermediary factor 1β|Y
eleven-nineteen lysine rich leukemia|eleven-nineteen lysine rich leukaemia|Y
microvascular bleeding|micro-vascular bleeding|Y
granulocyte-macrophage colony-forming units|granulocyte-macrophage colony-forming unit|Y
IL13 receptor α2-chain|IL-13 receptor α2-chain|Y
IL13 receptor α2-chain|IL13 receptor α 2-chain|Y
interferon α2b-induced|interferon α-2b-induced|Y
gastro-intestinal transit time|gastrointestinal transit time|Y
rabbit antichicken immunoglobulin G|rabbit anti-chicken immunoglobulin G|Y
non-tuberculous mycobacterium|nontuberculous mycobacterium|Y
relapsing-remitting experimental allergic encephalomyelitis|relapsing remitting experimental allergic encephalomyelitis|Y
entero-hemorrhagic Escherichia coli|enterohemorrhagic Escherichia coli|Y
entero-hemorrhagic Escherichia coli|entero-haemorrhagic Escherichia coli|Y
aspartate aminotransferase to platelet ratio index|aspartate-aminotransferase to platelet ratio index|Y
ribosome-inactivating proteins|ribosome-inactivating protein|Y
immunoglobulin A anti-transglutaminase|immunoglobulin A antitransglutaminase|Y
dithio-bis-succinimidylpropionate|dithiobis-succinimidylpropionate|Y
right midclavicular line|right mid-clavicular line|Y
human leucocyte antigen class I|human leucocyte antigen class II|Y
glycosylphosphatidyl inositol-linked|glycosyl phosphatidyl inositol-linked|Y
glycosylphosphatidyl inositol-linked|glycosylphosphatidylinositol-linked|Y
Impact of Events Scale|Impact of Event Scale|Y
anti-human leucocyte antigen-G-specific antibody|anti-human leucocyte antigen-G specific antibody|Y
anti-human leucocyte antigen-G-specific antibody|anti-human leukocyte antigen-G-specific antibody|Y
World Health Organization Quality of Life 100|World Health Organization Quality of Life-100|Y
2,2-dimethyl-5-hydroxyl-1-pyrrolidenyloxl|2,2-dimethyl-5-hydroxy-1-pyrrolidenyloxyl|Y
ubiquitin-conjugating enzyme 13|ubiquitin-conjugating enzyme 1|Y
ubiquitin-conjugating enzyme 13|ubiquitin-conjugating enzyme 3|Y
anti-Müllerian hormone|antiMüllerian hormone|Y
operationalized psychodynamic diagnostics|operationalised psychodynamic diagnostics|Y
operationalized psychodynamic diagnostics|operationalized psychodynamic diagnosis|Y
plasma insulin-like growth factor-1 level|plasma insulin-like growth factor 1 level|Y
p-nitrophenyl phosphate|p-nitrophenylphosphate|Y
cross-polarisation/magic-angle-spinning nuclear magnetic resonance|cross-polarisation magic-angle-spinning nuclear magnetic resonance|Y
cross-polarisation/magic-angle-spinning nuclear magnetic resonance|cross polarisation/magic-angle-spinning nuclear magnetic resonance|Y
cross-polarisation/magic-angle-spinning nuclear magnetic resonance|cross-polarization/magic-angle-spinning nuclear magnetic resonance|Y
cross-polarisation/magic-angle-spinning nuclear magnetic resonance|cross-polarisation/magic-angle spinning nuclear magnetic resonance|Y
American Society of Anaesthesiologists Grade I|American Society of Anaesthesiologists Grade|Y
American Society of Anaesthesiologists Grade I|American Society of Anaesthesiologists Grade 2|Y
American Society of Anaesthesiologists Grade I|American Society of Anaesthesiologists Grade V|Y
American Society of Anaesthesiologists Grade I|American Society of Anaesthesiologists Grade III|Y
American Society of Anaesthesiologists Grade I|American Society of Anaesthesiologists Grade IV|Y
American Society of Anaesthesiologists Grade I|American Society of Anesthesiologists Grade IV|Y
American Society of Anaesthesiologists Grade I|American Society of Anaesthesiologists Grade 1|Y
American Society of Anaesthesiologists Grade I|American Society of Anaesthesiologists grade I|Y
American Society of Anaesthesiologists Grade I|American Society of Anesthesiologists Grade II|Y
American Society of Anaesthesiologists Grade I|American Society of Anaesthesiologists Grade 3|Y
American Society of Anaesthesiologists Grade I|American Society of Anaesthesiologists Grade II|Y
American Society of Anaesthesiologists Grade I|American Society of Anaesthesiologists Grade 4|Y
American Society of Anaesthesiologists Grade I|American Society of Anesthesiologists Grade I|Y
American Society of Anaesthesiologists Grade I|American Society of Anaesthesiologists Grade 5|Y
interleukine-5 receptor-α chain|interleukin-5 receptor-α chain|Y
γ-aminobutyric acidB receptor|γ-amino-butyric acidB receptor|Y
γ-aminobutyric acidB receptor|γ-aminobutyric acid-B receptor|Y
γ-aminobutyric acidB receptor|γ-aminobutyric acid B receptor|Y
anticolon carcinoma monoclonal antibody|anti-colon carcinoma monoclonal antibody|Y
Prausnitz-Kustner reaction|Prausnitz-Kuestner reaction|Y
giant depolarizing potential|giant depolarizing potentials|Y
oestrogen receptor-α knockout mouse|estrogen receptor-α knockout mouse|Y
tissue inhibitor of MMPs|tissue inhibitor of MMP|Y
chronic disease self-management programme|chronic disease self-management program|Y
promyelocytic leukaemia/retinoic acid receptor α|promyelocytic leukaemia/retinoic acid receptor-α|Y
promyelocytic leukaemia/retinoic acid receptor α|promyelocytic leukemia/retinoic acid receptor α|Y
promyelocytic leukaemia/retinoic acid receptor α|promyelocytic leukaemia-retinoic acid receptor α|Y
human tissue inhibitor of metalloprotease-1|human tissue inhibitor of metalloprotease-2|Y
continuous veno-venous haemodiafiltration|continuous venovenous hemodiafiltration|Y
continuous veno-venous haemodiafiltration|continuous venovenous haemo-diafiltration|Y
continuous veno-venous haemodiafiltration|continuous veno-venous hemo-diafiltration|Y
tracheo-bronchopathia osteochondroplastica|tracheobronchopathia osteochondroplastica|Y
corticotrophin-releasing hormone receptor type-2|corticotropin-releasing hormone receptor type-2|Y
corticotrophin-releasing hormone receptor type-2|corticotrophin releasing hormone receptor type-2|Y
corticotrophin-releasing hormone receptor type-2|corticotrophin-releasing-hormone receptor type-2|Y
adrenocorticotropic hormone-dependent Cushing syndrome|adrenocorticotropic hormone-independent Cushing syndrome|Y
adrenocorticotropic hormone-dependent Cushing syndrome|adrenocorticotrophic hormone-dependent Cushing syndrome|Y
human equilibrative nucleoside transporter 1|human equilibrative nucleoside transporter|Y
hepatitis B virus co-infection|hepatitis B virus coinfection|Y
germinated barley food-stuff|germinated barley foodstuff|Y
hemagglutinin/neuraminidase glycoprotein|haemagglutinin/neuraminidase glycoprotein|Y
hereditary sensory and autonomic neuropathy type I|hereditary sensory and autonomic neuropathy type IV|Y
hereditary sensory and autonomic neuropathy type I|hereditary sensory and autonomic neuropathy type 1|Y
hereditary sensory and autonomic neuropathy type I|hereditary sensory and autonomic neuropathy type 4|Y
hereditary sensory and autonomic neuropathy type I|hereditary sensory and autonomic neuropathy type 3|Y
hereditary sensory and autonomic neuropathy type I|hereditary sensory and autonomic neuropathy type V|Y
hereditary sensory and autonomic neuropathy type I|hereditary sensory and autonomic neuropathy type II|Y
hereditary sensory and autonomic neuropathy type I|hereditary sensory and autonomic neuropathy type III|Y
neural precursor cell expressed, developmentally downregulated 8|neural precursor cell expressed developmentally downregulated 8|Y
neural precursor cell expressed, developmentally downregulated 8|neural precursor cell-expressed, developmentally down-regulated 8|Y
neural precursor cell expressed, developmentally downregulated 8|neural precursor cell expressed, developmentally downregulated 1|Y
neural precursor cell expressed, developmentally downregulated 8|neural precursor cell expressed developmentally downregulated 9|Y
neural precursor cell expressed, developmentally downregulated 8|neural precursor cell expressed, developmentally down-regulated 2|Y
neural precursor cell expressed, developmentally downregulated 8|neural precursor cell expressed, developmentally down-regulated 8|Y
neural precursor cell expressed, developmentally downregulated 8|neural precursor cell-expressed developmentally downregulated 8|Y
neural precursor cell expressed, developmentally downregulated 8|neural precursor cell expressed, developmentally downregulated 5|Y
neural precursor cell expressed, developmentally downregulated 8|neural precursor cell expressed developmentally down-regulated 8|Y
neural precursor cell expressed, developmentally downregulated 8|neural precursor cell expressed, developmentally downregulated 9|Y
neural precursor cell expressed, developmentally downregulated 8|neural precursor cell expressed developmentally downregulated 4|Y
neural precursor cell expressed, developmentally downregulated 8|neural precursor cell expressed developmentally downregulated 5|Y
neural precursor cell expressed, developmentally downregulated 8|neural precursor cell expressed developmentally downregulated 2|Y
neural precursor cell expressed, developmentally downregulated 8|neural precursor cell expressed, developmentally downregulated 2|Y
neural precursor cell expressed, developmentally downregulated 8|neural precursor cell expressed, developmentally down-regulated 4|Y
neural precursor cell expressed, developmentally downregulated 8|neural precursor cell expressed, developmentally down-regulated 1|Y
neural precursor cell expressed, developmentally downregulated 8|neural precursor cell-expressed, developmentally downregulated 8|Y
neural precursor cell expressed, developmentally downregulated 8|neural precursor cell expressed, developmentally down-regulated 5|Y
type 2 heparin-induced thrombocytopaenia|type 2 heparin-induced thrombocytopenia|Y
type 2 heparin-induced thrombocytopaenia|type 2 heparin induced thrombocytopaenia|Y
bilateral vestibular loss|bi-lateral vestibular loss|Y
cation-independent mannose 6-phosphate receptor|cation-dependent mannose 6-phosphate receptor|Y
cation-independent mannose 6-phosphate receptor|cation-independent mannose-6-phosphate receptor|Y
molecularly imprinted polymers|molecularly imprinted polymer|Y
three colour fluorescence in situ hybridization|three colour fluorescence in-situ hybridization|Y
three colour fluorescence in situ hybridization|three color fluorescence in situ hybridization|Y
three colour fluorescence in situ hybridization|three colour fluorescence in situ hybridisation|Y
three colour fluorescence in situ hybridization|three-colour fluorescence in situ hybridization|Y
uncoordinated protein 5|uncoordinated protein 15|Y
uncoordinated protein 5|uncoordinated protein 52|Y
uncoordinated protein 5|uncoordinated protein 54|Y
uncoordinated protein 5|uncoordinated protein 51|Y
anti-neutrophil cytoplasm autoantibodies|antineutrophil cytoplasm autoantibodies|Y
microtubule associated protein-1 light chain 3|microtubule associated protein-1 light chain-3|Y
microtubule associated protein-1 light chain 3|microtubule associated protein 1 light chain 3|Y
microtubule associated protein-1 light chain 3|microtubule associated protein light chain 3|Y
microtubule associated protein-1 light chain 3|microtubule associated protein-1 light-chain 3|Y
Wechsler Intelligence Scale for Children - Third Edition|Wechsler Intelligence Scale for Children-Third Edition|Y
Wechsler Intelligence Scale for Children - Third Edition|Wechsler Intelligence Scale for Children Third Edition|Y
O-acetyl serine sulphydrylase|O-acetylserine sulphydrylase|Y
type I IL-1 receptor|type II IL-1 receptor|Y
fan beam dual energy x-ray absorptiometry|fanbeam dual energy x-ray absorptiometry|Y
fan beam dual energy x-ray absorptiometry|fan beam dual energy X-ray absorptiometry|Y
fan beam dual energy x-ray absorptiometry|fan beam dual-energy x-ray absorptiometry|Y
GTPase-activating protein|GTPase-activating proteins|Y
electrocorticography|electro-corticography|Y
noninherited maternal antigen|non-inherited maternal antigen|Y
cellular Fas-associated death domain-like interleukin-1β converting enzyme inhibitory protein|cellular Fas-associated death domain-like interleukin-1-β converting enzyme-inhibitory protein|Y
phospholipase Cgamma|phospholipase Cgamma2|Y
pre-pro-corticotropin releasing factor|pre-pro-corticotrophin releasing factor|Y
NONEXPRESSOR OF PATHOGENESIS-RELATED GENES 1|NONEXPRESSOR OF PATHOGENESIS-RELATED GENES1|Y
NONEXPRESSOR OF PATHOGENESIS-RELATED GENES 1|NON-EXPRESSOR OF PATHOGENESIS-RELATED GENES1|Y
NONEXPRESSOR OF PATHOGENESIS-RELATED GENES 1|NONEXPRESSOR OF PATHOGENESIS-RELATED GENES-1|Y
nonaqueous capillary electrophoresis|non-aqueous capillary electrophoresis|Y
rhino-cerebral mucormycosis|rhinocerebral mucormycosis|Y
flow sensitive alternating inversion recovery|flow-sensitive alternating inversion recovery|Y
type 2 heparin induced thrombocytopenia|type 2 heparin induced thrombocytopaenia|Y
dual antiplatelet therapy|dual anti-platelet therapy|Y
CC chemokine receptor type 5|C-C chemokine receptor type 5|Y
dopant-assisted atmospheric pressure photoionisation|dopant-assisted atmospheric pressure photoionization|Y
post-percutaneous endoscopic gastrostomy|postpercutaneous endoscopic gastrostomy|Y
osteoclast-like cell|osteoclast-like cells|Y
intraoperative parathyroid hormone|intra-operative parathyroid hormone|Y
cortico-pontocerebellar pathway|corticopontocerebellar pathway|Y
intra-stromal corneal ring segment|intrastromal corneal ring segment|Y
immunofluorometric assay|immuno-fluorometric assay|Y
serum glutamic oxaloacetic transaminase|serum glutamic oxalacetic transaminase|Y
extra-corporeal photochemotherapy|extra-corporeal photo-chemotherapy|Y
extra-corporeal photochemotherapy|extracorporeal photochemotherapy|Y
human germinal-centre-associated lymphoma|human germinal centre-associated lymphoma|Y
human germinal-centre-associated lymphoma|human germinal-center-associated lymphoma|Y
pre--pro-somatostatin messenger ribonucleic acid|pre-prosomatostatin messenger ribonucleic acid|Y
β-adrenergic receptor mRNA binding protein|β-adrenergic receptor mRNA-binding protein|Y
Durham Veterans Affairs Medical Center|Durham Veteran's Affairs Medical Center|Y
foeto-maternal hemorrhage|feto-maternal hemorrhage|Y
foeto-maternal hemorrhage|foeto-maternal haemorrhage|Y
augmented correlation-consistent polarized valence triple ζ basis set|augmented correlation consistent polarized valence triple ζ basis set|Y
augmented correlation-consistent polarized valence triple ζ basis set|augmented correlation-consistent polarized valence triple-ζ basis set|Y
augmented correlation-consistent polarized valence triple ζ basis set|augmented correlation-consistent polarised valence triple ζ basis set|Y
International Neuroblastoma Staging System Stage II|International Neuroblastoma Staging System stage II|Y
International Neuroblastoma Staging System Stage II|International Neuroblastoma Staging System Stage I|Y
International Neuroblastoma Staging System Stage II|International Neuroblastoma Staging System Stage III|Y
sympathetic pre-ganglionic neuron|sympathetic pre-ganglionic neurone|Y
intratumoral microvessel density|intra-tumoral microvessel density|Y
anti-human T-cell lymphotropic virus-1 antibody|anti-human T-cell lymphotropic virus-I antibody|Y
1,2-dimethylhydrazine|1,2-dimethyl hydrazine|Y
Hemophilus influenzae type B|Haemophilus influenzae type B|Y
affected sibling pairs|affected sibling pair|Y
glucagonlike peptide 1 receptor agonist|glucagon-like peptide 1 receptor agonist|Y
hyperreactive malarial splenomegaly|hyper-reactive malarial splenomegaly|Y
fluorodeoxyglucose positron emission tomography-computed tomography scan|fluorodeoxyglucose-positron emission tomography-computed tomography scan|Y
matrix-assisted laser desorption ionisation|matrix-assisted laser-desorption ionisation|Y
matrix-assisted laser desorption ionisation|matrix assisted laser desorption ionisation|Y
matrix-assisted laser desorption ionisation|matrix-assisted laser desorption ionization|Y
matrix-assisted laser desorption ionisation|matrix-assisted laser desorption-ionisation|Y
matrix-assisted laser desorption ionisation|matrix-assisted laser desorption/ionisation|Y
5-hydroxytryptamine1A|5-hydroxytryptamine1|Y
5-hydroxytryptamine1A|5-hydroxytryptamine-1A|Y
cyclin-dependent kinase inhibitor 1|cyclin-dependent kinase inhibitor 1A|Y
cyclin-dependent kinase inhibitor 1|cyclin-dependent kinase inhibitor 1C|Y
extra-pulmonary tuberculosis|extrapulmonary tuberculosis|Y
sub-internal limiting membrane haemorrhage|subinternal limiting membrane hemorrhage|Y
diffusing capacity of the lung for carbon monoxide|diffusion capacity of the lung for carbon monoxide|Y
pyelonephritis-associated pilus protein F|pyelonephritis-associated pilus protein E|Y
pyelonephritis-associated pilus protein F|pyelonephritis-associated pilus protein C|Y
pyelonephritis-associated pilus protein F|pyelonephritis-associated pilus protein A|Y
pyelonephritis-associated pilus protein F|pyelonephritis-associated pilus protein G|Y
pyelonephritis-associated pilus protein F|pyelonephritis-associated pilus protein D|Y
pyelonephritis-associated pilus protein F|pyelonephritis-associated pilus protein B|Y
antimuscle specific kinase antibody|anti-muscle specific kinase antibody|Y
multichannel intra-luminal impedance|multi-channel intra-luminal impedance|Y
complementarity determining region|complementarity determining regions|Y
pedunculopontine tegmental nucleus|pedunculo-pontine tegmental nucleus|Y
myelo-proliferative disease|myeloproliferative disease|Y
adaptive servo-ventilation|adaptive servoventilation|Y
glucagon-like peptide-1 receptor antagonist|glucagon-like peptide 1 receptor antagonist|Y
pyridoxalated polymerised stroma-free haemoglobin|pyridoxalated polymerized stroma-free haemoglobin|Y
multi-echo magnetic resonance imaging sequence|multiecho magnetic resonance imaging sequence|Y
American Society of Anaesthesiologists Class 2|American Society of Anaesthesiologists Class|Y
American Society of Anaesthesiologists Class 2|American Society of Anaesthesiologists Class 4|Y
American Society of Anaesthesiologists Class 2|American Society of Anaesthesiologists Class 3|Y
American Society of Anaesthesiologists Class 2|American Society of Anaesthesiologists Class V|Y
American Society of Anaesthesiologists Class 2|American Society of Anaesthesiologists Class I|Y
American Society of Anaesthesiologists Class 2|American Society of Anaesthesiologists Class 5|Y
American Society of Anaesthesiologists Class 2|American Society of Anaesthesiologists Class 1|Y
American Society of Anaesthesiologists Class 2|American Society of Anesthesiologists Class 2|Y
lipolysis-stimulated lipoprotein receptor|lipolysis stimulated lipoprotein receptor|Y
malignancy-associated hypercalcemia|malignancy-associated hypercalcaemia|Y
insulin-like growth factor-binding protein-related protein-1|insulin-like growth factor binding protein-related protein-1|Y
lung adeno-carcinoma cell|lung adenocarcinoma cell|Y
American Society of Anesthesiology status IV|American Society of Anaesthesiology status IV|Y
American Society of Anesthesiology status IV|American Society of Anaesthesiology status I|Y
American Society of Anesthesiology status IV|American Society of Anaesthesiology status V|Y
alpha-fluoro-methyl histidine|alpha-fluoromethyl histidine|Y
sodium/lithium countertransport|sodium/lithium counter-transport|Y
rat hypothalamic growth hormone-releasing factor|rat hypothalamic growth-hormone-releasing factor|Y
rat hypothalamic growth hormone-releasing factor|rat hypothalamic growth hormone releasing factor|Y
Sulfolobus islandicus rod-shaped virus 1|Sulfolobus islandicus rod-shaped virus 2|Y
follicular-fluid meiosis-activating sterol|follicular fluid meiosis-activating sterol|Y
follicular-fluid meiosis-activating sterol|follicular-fluid meiosis activating sterol|Y
short tandem repeat polymorphism|short tandem repeat polymorphisms|Y
extracellular signal-regulated kinases|extracellular signal-regulated kinase|Y
university affiliated Veterans' Administration Medical Center|university affiliated Veterans Administration Medical Center|Y
university affiliated Veterans' Administration Medical Center|university-affiliated Veterans' Administration Medical Center|Y
university affiliated Veterans' Administration Medical Center|university-affiliated Veterans Administration Medical Center|Y
university affiliated Veterans' Administration Medical Center|university affiliated Veteran's Administration Medical Center|Y
IL-13 receptor alpha 1 chain|IL-13 receptor alpha1 chain|Y
intra-cerebral haematoma|intra-cerebral hematoma|Y
intra-aortic balloon pump|intraaortic balloon pump|Y
maternal/child health care|maternal/child healthcare|Y
γ glutamyl transpeptidase|γglutamyl transpeptidase|Y
gastro-duodenal ulcer|gastroduodenal ulcer|Y
Hb S-beta-thalassemia|Hb S-beta-thalassaemia|Y
gamma-amino butyric acid-B receptor|gamma-amino butyric acidB receptor|Y
gamma-amino butyric acid-B receptor|gamma-aminobutyric acid-B receptor|Y
intersymbol interference|inter-symbol interference|Y
germinal centre-associated nuclear protein|germinal centre associated nuclear protein|Y
fluorine-18 labelled fluoro-deoxy-glucose|fluorine-18 labeled fluoro-deoxyglucose|Y
fluorine-18 labelled fluoro-deoxy-glucose|fluorine-18-labelled fluoro-deoxy-glucose|Y
fluorine-18 labelled fluoro-deoxy-glucose|fluorine-18 labeled fluoro-deoxy-glucose|Y
fluorine-18 labelled fluoro-deoxy-glucose|fluorine-18 labelled fluoro-deoxyglucose|Y
fluorine-18 labelled fluoro-deoxy-glucose|fluorine-18 labelled fluorodeoxyglucose|Y
p-chloromercuriphenyl sulphonic acid|p-chloromercuriphenylsulphonic acid|Y
streptavidin peroxidase immuno-histochemistry|streptavidin-peroxidase immuno-histochemistry|Y
streptavidin peroxidase immuno-histochemistry|streptavidin peroxidase immunohistochemistry|Y
class II-associated invariant chain-derived peptide|class II-associated invariant chain derived peptide|Y
Charcot-Marie-Tooth type 2|Charcot-Marie-Tooth type 2A|Y
Charcot-Marie-Tooth type 2|Charcot-Marie-Tooth type 2D|Y
American Society of Anaesthesiologists Grade|American Society of Anaesthesiologists Grade 2|Y
American Society of Anaesthesiologists Grade|American Society of Anesthesiologists Grade|Y
American Society of Anaesthesiologists Grade|American Society of Anaesthesiologists Grade V|Y
American Society of Anaesthesiologists Grade|American Society of Anaesthesiologists grade|Y
American Society of Anaesthesiologists Grade|American Society of Anaesthesiologists Grade 1|Y
American Society of Anaesthesiologists Grade|American Society of Anaesthesiologists Grade 3|Y
American Society of Anaesthesiologists Grade|American Society of Anaesthesiologists Grade 4|Y
American Society of Anaesthesiologists Grade|American Society of Anaesthesiologists Grade 5|Y
peroxisome proliferator activated receptor γ1|peroxisome proliferator activated receptor γ2|Y
peroxisome proliferator activated receptor γ1|peroxisome proliferator-activated receptor γ1|Y
intra-epidermal nerve fiber density|intraepidermal nerve fiber density|Y
multi-focal atrial tachycardia|multifocal atrial tachycardia|Y
undercarboxylated osteocalcin|under-carboxylated osteocalcin|Y
large conductance calcium-activated potassium channels|large conductance calcium-activated potassium channel|Y
poly(d,l-lactide-co-glycolide)|poly(dl-lactide-co-glycolide)|Y
cationic amino acid transporter 2|cationic amino acid transporter 2A|Y
cationic amino acid transporter 2|cationic amino acid transporter 2B|Y
anti-cytomegalovirus therapy|anticytomegalovirus therapy|Y
extended x-ray absorption fine-structure spectroscopy|extended x-ray absorption fine structure spectroscopy|Y
sporulation in the absence of Spo eleven-gene 3|sporulation in the absence of Spo eleven-gene 1|Y
sporulation in the absence of Spo eleven-gene 3|sporulation in the absence of Spo eleven-gene 2|Y
sporulation protein IID|sporulation protein IIID|Y
post-menopausal oestrogen/progestin intervention|post-menopausal estrogen/progestin intervention|Y
post-menopausal oestrogen/progestin intervention|post-menopausal oestrogen progestin intervention|Y
post-menopausal oestrogen/progestin intervention|post-menopausal oestrogen-progestin intervention|Y
spinocerebellar ataxia type 11|spinocerebellar ataxia type 1|Y
tumor promoter 12-0-tetradecanoyl phorbol-13-acetate|tumor promoter 12-0-tetradecanoyl-phorbol-13-acetate|Y
pancreato-duodenectomy|pancreatoduodenectomy|Y
hypoxia inducible transcription factor-1 α|hypoxia inducible transcription factor-1α|Y
self microemulsifying drug delivery system|self micro emulsifying drug delivery system|Y
self microemulsifying drug delivery system|self micro-emulsifying drug delivery system|Y
trophoblast-lymphocyte cross-reactive antigen|trophoblast lymphocyte cross-reactive antigen|Y
collagen cross-linking|collagen crosslinking|Y
uncoordinated protein 93|uncoordinated protein 3|Y
carbonyl cyanide m-chlorophenyl-hydrazone|carbonyl cyanide m-chlorophenylhydrazone|Y
carbonyl cyanide m-chlorophenyl-hydrazone|carbonyl cyanide m-chlorophenyl hydrazone|Y
oculo-dentodigital dysplasia|oculo-dento-digital dysplasia|Y
oculo-dentodigital dysplasia|oculodentodigital dysplasia|Y
neural-precursor-cell-expressed developmentally downregulated 8|neural-precursor-cell-expressed, developmentally downregulated 9|Y
neural-precursor-cell-expressed developmentally downregulated 8|neural-precursor-cell-expressed, developmentally downregulated 1|Y
neural-precursor-cell-expressed developmentally downregulated 8|neural-precursor-cell-expressed developmentally down-regulated 8|Y
neural-precursor-cell-expressed developmentally downregulated 8|neural-precursor cell-expressed developmentally down-regulated 8|Y
neural-precursor-cell-expressed developmentally downregulated 8|neural-precursor-cell-expressed developmentally downregulated 2|Y
neural-precursor-cell-expressed developmentally downregulated 8|neural-precursor cell-expressed developmentally downregulated 8|Y
neural-precursor-cell-expressed developmentally downregulated 8|neural-precursor-cell-expressed developmentally downregulated 9|Y
neural-precursor-cell-expressed developmentally downregulated 8|neural-precursor-cell-expressed developmentally down-regulated 5|Y
neural-precursor-cell-expressed developmentally downregulated 8|neural-precursor-cell-expressed, developmentally down-regulated 8|Y
neural-precursor-cell-expressed developmentally downregulated 8|neural-precursor-cell-expressed developmentally down-regulated 9|Y
neural-precursor-cell-expressed developmentally downregulated 8|neural-precursor-cell-expressed, developmentally downregulated 5|Y
neural-precursor-cell-expressed developmentally downregulated 8|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor-cell-expressed developmentally downregulated 8|neural-precursor-cell-expressed developmentally downregulated 5|Y
neural-precursor-cell-expressed developmentally downregulated 8|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor-cell-expressed developmentally downregulated 8|neural-precursor-cell-expressed developmentally down-regulated 1|Y
neural-precursor-cell-expressed developmentally downregulated 8|neural-precursor-cell-expressed, developmentally downregulated 2|Y
atrioventricular nodal re-entrant tachycardia|atrioventricular nodal reentrant tachycardia|Y
antiproliferative antibody|anti-proliferative antibody|Y
Center for Medicare and Medicaid Services|Centers for Medicare and Medicaid Services|Y
α-fluoromethylhistidine|α-fluoromethyl-histidine|Y
α-fluoromethylhistidine|α-fluoromethyl histidine|Y
m-chloro-phenyl-biguanide|m-chloro-phenylbiguanide|Y
m-chloro-phenyl-biguanide|m-chlorophenyl-biguanide|Y
antiproteinase 3 antineutrophil cytoplasmic antibody|anti-proteinase 3 antineutrophil cytoplasmic antibody|Y
adeno-associated viral vector|adeno-associated viral vectors|Y
laterally spreading tumour|laterally spreading tumor|Y
Björk-Shiley convexo concave valve|Björk-Shiley convexoconcave valve|Y
antinucleocapsid monoclonal antibody|anti-nucleocapsid monoclonal antibody|Y
continuous venovenous hemofiltration|continuous veno-venous hemofiltration|Y
interleukin 2 receptor α-chain|interleukine 2 receptor α-chain|Y
anti-ricin immunoglobulin G|antiricin immunoglobulin G|Y
EBV-encoded small RNA|EBV-encoded small RNAs|Y
tumour-induced hypercalcemia|tumour-induced hypercalcaemia|Y
tumour-induced hypercalcemia|tumor-induced hypercalcemia|Y
TATA-binding protein-associated factor-15|TATA-binding protein-associated factor-17|Y
TATA-binding protein-associated factor-15|TATA-binding protein-associated factor-5|Y
TATA-binding protein-associated factor-15|TATA-binding protein-associated factor-12|Y
TATA-binding protein-associated factor-15|TATA-binding protein-associated factor-10|Y
TATA-binding protein-associated factor-15|TATA-binding protein-associated factor-1|Y
leukaemia/lymphoma related factor|leukemia/lymphoma related factor|Y
recombinant interleukin 15|recombinant interleukin 1|Y
hydro-ureteronephrosis|hydroureteronephrosis|Y
American Society of Anaesthesiologists Grade 2|American Society of Anaesthesiologists Grade V|Y
American Society of Anaesthesiologists Grade 2|American Society of Anesthesiologists Grade 2|Y
American Society of Anaesthesiologists Grade 2|American Society of Anaesthesiologists Grade 1|Y
American Society of Anaesthesiologists Grade 2|American Society of Anaesthesiologists grade 2|Y
American Society of Anaesthesiologists Grade 2|American Society of Anaesthesiologists Grade 3|Y
American Society of Anaesthesiologists Grade 2|American Society of Anaesthesiologists Grade 4|Y
American Society of Anaesthesiologists Grade 2|American Society of Anaesthesiologists Grade 5|Y
human adenovirus serotype 34|human adenovirus serotype 4|Y
temperature-programmed desorption|temperature-programed desorption|Y
tubulointerstitial nephritis and uveitis syndrome|tubulo-interstitial nephritis and uveitis syndrome|Y
embryonal rhabdomyosarcoma|embryonal rhabdo-myosarcoma|Y
dual-color chromogenic in situ hybridization|dual-colour chromogenic in situ hybridization|Y
dual-color chromogenic in situ hybridization|dual-color chromogenic in situ hybridisation|Y
dual-color chromogenic in situ hybridization|dual-color chromogenic in-situ hybridization|Y
alpha1A adrenergic receptor|alpha1 adrenergic receptor|Y
isobutyl methyl xanthine|isobutyl methylxanthine|Y
salmon gonadotropin-releasing hormone analog|salmon gonadotropin releasing hormone analog|Y
salmon gonadotropin-releasing hormone analog|salmon gonadotropin-releasing hormone analogue|Y
salmon gonadotropin-releasing hormone analog|salmon gonadotrophin-releasing hormone analog|Y
adeno-associated virus|adenoassociated virus|Y
nonspecific genital infection|non-specific genital infection|Y
killer immunoglobulin-like receptor 2DL5|killer immunoglobulin-like receptor 2DL1|Y
killer immunoglobulin-like receptor 2DL5|killer immunoglobulin-like receptor 2DL4|Y
killer immunoglobulin-like receptor 2DL5|killer immunoglobulin-like receptor 2DL2|Y
human interferon-α2b|human interferon-α-2b|Y
human interferon-α2b|human interferon-α 2b|Y
attenuated familial adenomatous polyposis|Attenuated familial adenomatous polyposis|Y
velocity encoded cine magnetic resonance|velocity-encoded cine magnetic resonance|Y
lesion simulating disease 1|lesion simulating disease1|Y
American Society of Anesthesiology grade V|American Society of Anaesthesiology grade IV|Y
American Society of Anesthesiology grade V|American Society of Anesthesiology grade 1|Y
American Society of Anesthesiology grade V|American Society of Anesthesiology grade 2|Y
American Society of Anesthesiology grade V|American Society of Anesthesiology grade 5|Y
American Society of Anesthesiology grade V|American Society of Anesthesiology grade IV|Y
American Society of Anesthesiology grade V|American Society of Anesthesiology Grade V|Y
American Society of Anesthesiology grade V|American Society of Anesthesiology grade 3|Y
American Society of Anesthesiology grade V|American Society of Anaesthesiology grade V|Y
American Society of Anesthesiology grade V|American Society of Anesthesiology grade|Y
American Society of Anesthesiology grade V|American Society of Anesthesiology grade I|Y
blood retinal barrier|blood retina barrier|Y
recombinant granulocyte-macrophage colony stimulating factor|recombinant granulocyte macrophage colony stimulating factor|Y
recombinant granulocyte-macrophage colony stimulating factor|recombinant granulocyte-macrophage colony-stimulating factor|Y
multifluor fluorescence in-situ hybridization|multifluor fluorescence in-situ hybridisation|Y
multifluor fluorescence in-situ hybridization|multi-fluor fluorescence in-situ hybridization|Y
multifluor fluorescence in-situ hybridization|multifluor fluorescence in situ hybridization|Y
muco-cutaneous lymph node syndrome|mucocutaneous lymph node syndrome|Y
basement-membrane-specific chondroitin sulfate proteoglycan|basement membrane-specific chondroitin sulfate proteoglycan|Y
transforming growth factor alpha protein|transforming growth factor-alpha protein|Y
low density lipo-protein|low density lipoprotein|Y
tumor-draining lymphnode lymphocyte|tumor-draining lymph node lymphocyte|Y
delayed non-matching to sample|delayed nonmatching to sample|Y
simulated aerial combat maneuvers|simulated aerial combat maneuver|Y
non-ketotic hyperglycaemia|non-ketotic hyperglycemia|Y
TATA-binding protein associated factor 17|TATA-binding protein associated factor-17|Y
TATA-binding protein associated factor 17|TATA-binding protein associated factor 12|Y
TATA-binding protein associated factor 17|TATA-binding protein associated factor 10|Y
TATA-binding protein associated factor 17|TATA-binding protein associated factor 15|Y
TATA-binding protein associated factor 17|TATA-binding protein-associated factor 17|Y
TATA-binding protein associated factor 17|TATA-binding protein associated factor 11|Y
pseudomembranous colitis|pseudo-membranous colitis|Y
life-sustaining treatment|life-sustaining treatments|Y
primed in-situ labeling|primed in-situ labelling|Y
American Society of Anesthesiology Class I|American Society of Anaesthesiology Class I|Y
American Society of Anesthesiology Class I|American Society of Anesthesiology Class IV|Y
American Society of Anesthesiology Class I|American Society of Anesthesiology Class 1|Y
American Society of Anesthesiology Class I|American Society of Anaesthesiology Class II|Y
American Society of Anesthesiology Class I|American Society of Anesthesiology class I|Y
American Society of Anesthesiology Class I|American Society of Anesthesiology Class V|Y
American Society of Anesthesiology Class I|American Society of Anesthesiology Class II|Y
American Society of Anesthesiology Class I|American Society of Anesthesiology Class 2|Y
American Society of Anesthesiology Class I|American Society of Anesthesiology Class 4|Y
intracranial athero-sclerotic disease|intracranial atherosclerotic disease|Y
avidinbiotin peroxidase complex|avidin-biotin peroxidase complex|Y
a disintegrin and metalloprotease 17|a disintegrin and metalloprotease 7|Y
immuno-reactive parathyroid hormone|immunoreactive parathyroid hormone|Y
broncho-alveolar lavage|bronchoalveolar lavage|Y
hemoglobin G-Knoxville-I|haemoglobin G-Knoxville-I|Y
Epstein-Barr virus-associated hemophagocytic syndrome|Epstein-Barr virus-associated haemophagocytic syndrome|Y
multiple subpial transection|multiple sub-pial transection|Y
micro-endoscopic discectomy|microendoscopic discectomy|Y
sex-determining region Y, box 5|sex-determining region Y box 5|Y
phospho-glycogen synthase kinase-3beta|phospho-glycogen synthase kinase-3 beta|Y
collision induced dissociation tandem mass spectrometry|collision-induced dissociation tandem mass spectrometry|Y
International Neuroblastoma Staging System stage|International Neuroblastoma Staging System stage 1|Y
International Neuroblastoma Staging System stage|International Neuroblastoma Staging System stage 3|Y
International Neuroblastoma Staging System stage|International Neuroblastoma Staging System stage 4|Y
hemoglobin Matsue-Oki|haemoglobin Matsue-Oki|Y
tumor-induced hypercalcaemia|tumour-induced hypercalcaemia|Y
tumor-induced hypercalcaemia|tumor-induced hypercalcemia|Y
International Reference Preparations|International Reference Preparation|Y
fan beam dual x-ray absorptiometry|fanbeam dual x-ray absorptiometry|Y
Moller-Plesset second-order perturbation theory|Moeller-Plesset second-order perturbation theory|Y
Moller-Plesset second-order perturbation theory|Møller-Plesset second-order perturbation theory|Y
Moller-Plesset second-order perturbation theory|Moller-Plesset second order perturbation theory|Y
polysialylated neural cell-adhesion molecule|polysialylated neural cell adhesion molecule|Y
interclass correlation coefficient|inter-class correlation coefficient|Y
epizootic hemorrhagic disease virus serotype 1|epizootic hemorrhagic disease virus serotype 2|Y
95% confidence interval|95% confidence intervals|Y
American Society of Anesthesiologists Status II|American Society of Anesthesiologists Status III|Y
American Society of Anesthesiologists Status II|American Society of Anaesthesiologists Status I|Y
American Society of Anesthesiologists Status II|American Society of Anesthesiologists Status I|Y
American Society of Anesthesiologists Status II|American Society of Anaesthesiologists Status II|Y
heterochromatin protein 1α|heterochromatin protein 1|Y
heterochromatin protein 1α|heterochromatin protein 1 α|Y
peroxidase antiperoxidase method|peroxidase anti-peroxidase method|Y
ethoxyresorufin-O-dealkylase|methoxyresorufin-O-dealkylase|Y
surface-assisted laser desorption-ionization|surface-assisted laser desorption/ionization|Y
surface-assisted laser desorption-ionization|surface-assisted laser desorption ionization|Y
surface-assisted laser desorption-ionization|surface-assisted laser desorption-ionisation|Y
pea seed-borne mosaic virus|pea seedborne mosaic virus|Y
bio-artificial liver support system|bioartificial liver support system|Y
B-cell leukemia-lymphoma 2|B-cell leukaemia-lymphoma 2|Y
post-prandial lipaemia|post-prandial lipemia|Y
immuno-magnetic separation|immunomagnetic separation|Y
inter-stimulation interval|interstimulation interval|Y
tumor-1, node-1, metastasis-0|tumor-1c, node-1, metastasis-0|Y
American Society of Anesthesiologists Grade III|American Society of Anaesthesiologists Grade III|Y
American Society of Anesthesiologists Grade III|American Society of Anesthesiologists Grade II|Y
American Society of Anesthesiologists Grade III|American Society of Anaesthesiologists Grade II|Y
American Society of Anesthesiologists Grade III|American Society of Anesthesiologists Grade I|Y
American Society of Anesthesiologists Grade III|American Society of Anesthesiologists grade III|Y
side-stream dark-field imaging|side-stream darkfield imaging|Y
delayed afterdepolarizations|delayed afterdepolarization|Y
anti-T cell receptor-α β monoclonal antibody|anti-T cell receptor-α/β monoclonal antibody|Y
anti-T cell receptor-α β monoclonal antibody|anti-T cell receptor α β monoclonal antibody|Y
anti-T cell receptor-α β monoclonal antibody|anti-T-cell receptor-α β monoclonal antibody|Y
chemotherapy-induced diarrhoea|chemotherapy-induced diarrhea|Y
anti-β (2)-glycoprotein-I antibody|anti-β(2)-glycoprotein-I antibody|Y
ribosomal protein S5|ribosomal protein S15|Y
ribosomal protein S5|ribosomal protein S25|Y
intracellular free Ca2+ levels|intracellular free Ca2+ level|Y
light-harvesting chlorophyll a/b-protein I|light-harvesting chlorophyll a/b protein I|Y
light-harvesting chlorophyll a/b-protein I|light harvesting chlorophyll a/b-protein I|Y
standardized proportionate mortality ratio|standardised proportionate mortality ratio|Y
PGC-1-related co-activator|PGC-1-related coactivator|Y
solid phase extraction-liquid chromatography-electrospray-tandem mass spectrometry|solid-phase extraction-liquid chromatography-electrospray-tandem mass spectrometry|Y
solid phase extraction-liquid chromatography-electrospray-tandem mass spectrometry|solid phase extraction-liquid chromatography-electrospray tandem mass spectrometry|Y
photoplethysmographic|photo-plethysmographic|Y
aldo-keto reductase family 1 member C3|aldo-keto reductase family 1, member C3|Y
capillary electrophoresis time-of-flight/mass spectrometry|capillary electrophoresis-time-of-flight/mass spectrometry|Y
capillary electrophoresis time-of-flight/mass spectrometry|capillary electrophoresis time-of-flight mass spectrometry|Y
spontaneous peri-renal hematoma|spontaneous perirenal hematoma|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motif-20|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motif-19|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motifs-1|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motifs-3|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motif-15|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motif-1|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motif-9|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motif|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motif-8|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motifs-8|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motif-14|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
SECONDARY WALL ASSOCIATED NAC DOMAIN PROTEIN 1|SECONDARY WALL-ASSOCIATED NAC DOMAIN PROTEIN 1|Y
post-menopausal estrogen/progestin intervention|post-menopausal estrogen-progestin intervention|Y
post-menopausal estrogen/progestin intervention|post-menopausal estrogen progestin intervention|Y
immobilized pH gradient|immobilized pH gradients|Y
anti-tubular basement membrane|antitubular basement membrane|Y
neural-precursor cell-expressed developmentally downregulated 9|neural-precursor-cell-expressed, developmentally downregulated 9|Y
neural-precursor cell-expressed developmentally downregulated 9|neural-precursor cell-expressed developmentally down-regulated 9|Y
neural-precursor cell-expressed developmentally downregulated 9|neural-precursor cell-expressed, developmentally downregulated 2|Y
neural-precursor cell-expressed developmentally downregulated 9|neural-precursor cell-expressed developmentally downregulated 4|Y
neural-precursor cell-expressed developmentally downregulated 9|neural-precursor cell-expressed, developmentally downregulated 4|Y
neural-precursor cell-expressed developmentally downregulated 9|neural-precursor cell-expressed developmentally down-regulated 8|Y
neural-precursor cell-expressed developmentally downregulated 9|neural-precursor cell-expressed developmentally down-regulated 1|Y
neural-precursor cell-expressed developmentally downregulated 9|neural-precursor cell-expressed developmentally downregulated 2|Y
neural-precursor cell-expressed developmentally downregulated 9|neural-precursor cell-expressed, developmentally downregulated 9|Y
neural-precursor cell-expressed developmentally downregulated 9|neural-precursor cell-expressed developmentally downregulated 8|Y
neural-precursor cell-expressed developmentally downregulated 9|neural-precursor cell-expressed developmentally downregulated 5|Y
neural-precursor cell-expressed developmentally downregulated 9|neural-precursor cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally downregulated 9|neural-precursor-cell-expressed developmentally downregulated 9|Y
neural-precursor cell-expressed developmentally downregulated 9|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor cell-expressed developmentally downregulated 9|neural-precursor cell-expressed, developmentally downregulated 5|Y
neural-precursor cell-expressed developmentally downregulated 9|neural precursor cell-expressed, developmentally downregulated 9|Y
neural-precursor cell-expressed developmentally downregulated 9|neural-precursor-cell-expressed developmentally down-regulated 9|Y
neural-precursor cell-expressed developmentally downregulated 9|neural precursor cell-expressed developmentally down-regulated 9|Y
neural-precursor cell-expressed developmentally downregulated 9|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor cell-expressed developmentally downregulated 9|neural precursor cell-expressed developmentally downregulated 9|Y
neural-precursor cell-expressed developmentally downregulated 9|neural-precursor cell-expressed, developmentally downregulated 1|Y
multicatalytic proteinase complex|multi-catalytic proteinase complex|Y
adrenocorticotrophic hormone-independent Cushing syndrome|adrenocorticotrophic hormone-independent Cushing's syndrome|Y
adrenocorticotrophic hormone-independent Cushing syndrome|adrenocorticotropic hormone-independent Cushing syndrome|Y
adrenocorticotrophic hormone-independent Cushing syndrome|adrenocorticotrophic hormone-dependent Cushing syndrome|Y
proline iminopeptidase|proline imino-peptidase|Y
interleukin 7 receptor α subunit|interleukine 7 receptor α subunit|Y
Src homology region 2 domain-containing phosphatase-1|Src homology region 2 domain-containing phosphatase 1|Y
Src homology region 2 domain-containing phosphatase-1|Src homology region 2 domain-containing phosphatase-2|Y
Src homology region 2 domain-containing phosphatase-1|Src homology region 2 domain-containing phosphatase|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|toll/interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|toll/interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|Toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|toll-interleukin-1 receptor domain-containing adapter-inducing interferon beta|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|toll/interleukin-1 receptor domain-containing adapter-inducing interferon beta|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|toll-interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|Toll/interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|toll/interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Y
hyperthermo-chemoradiotherapy|hyperthermo-chemo-radiotherapy|Y
hyperthermo-chemoradiotherapy|hyperthermochemoradiotherapy|Y
brain stem evoked response|brainstem evoked response|Y
soluble intercellular adhesion molecule-2|soluble intercellular adhesion molecule-3|Y
colony stimulating factor|colony stimulating factors|Y
carboxy terminal domain|carboxyl terminal domain|Y
carboxyterminal amino acid residue|carboxylterminal amino acid residue|Y
American Society of Anaesthesiology Grade 3|American Society of Anaesthesiology Grade 2|Y
American Society of Anaesthesiology Grade 3|American Society of Anaesthesiology Grade V|Y
American Society of Anaesthesiology Grade 3|American Society of Anaesthesiology grade 3|Y
American Society of Anaesthesiology Grade 3|American Society of Anaesthesiology Grade 5|Y
American Society of Anaesthesiology Grade 3|American Society of Anesthesiology Grade 3|Y
microvillus membrane|microvillous membrane|Y
human adenovirus serotype 43|human adenovirus serotype 4|Y
G-protein coupled oestrogen receptor-1|G-protein coupled estrogen receptor-1|Y
projections to latent structures|projection to latent structures|Y
tumor necrosis factor α protein|tumour necrosis factor α protein|Y
DNA-protein cross-link|DNA-protein crosslink|Y
gamma-amino butyric acid type B receptor|gamma-amino butyric acid type A receptor|Y
gamma-amino butyric acid type B receptor|gamma-aminobutyric acid type B receptor|Y
gamma-amino butyric acid type B receptor|gamma-amino-butyric acid type B receptor|Y
endocrine gland-derived vascular endothelial growth factor|endocrine gland derived vascular endothelial growth factor|Y
endocrine gland-derived vascular endothelial growth factor|Endocrine gland-derived vascular endothelial growth factor|Y
endocrine gland-derived vascular endothelial growth factor|endocrine-gland-derived vascular endothelial growth factor|Y
bronchiolitis obliterans organizing pneumonia|bronchiolitis obliterans-organizing pneumonia|Y
bronchiolitis obliterans organizing pneumonia|bronchiolitis obliterans organising pneumonia|Y
methyl-dimethylaminoazobenzene|methyldimethylaminoazobenzene|Y
pylorus-preserving pancreaticoduodenectomy|pylorus-preserving pancreatoduodenectomy|Y
pylorus-preserving pancreaticoduodenectomy|pylorus-preserving pancreatico-duodenectomy|Y
pylorus-preserving pancreaticoduodenectomy|Pylorus-preserving pancreaticoduodenectomy|Y
pylorus-preserving pancreaticoduodenectomy|pylorus preserving pancreaticoduodenectomy|Y
anti-T-cell receptor alphabeta antibody|anti-T-cell receptor alpha/beta antibody|Y
anti-T-cell receptor alphabeta antibody|anti-T-cell receptor alpha beta antibody|Y
multilocular cystic nephroma|multi-locular cystic nephroma|Y
carboxyl terminus of Hsc70-interacting protein|carboxyl terminus of Hsp70-interacting protein|Y
kinesin family member 1A|kinesin family member 21A|Y
vestibulocollic reflex|vestibulo-collic reflex|Y
self micro emulsifying drug delivery system|self micro-emulsifying drug delivery system|Y
posttransfusion hepatitis|post-transfusion hepatitis|Y
solute carrier family 7 member 10|solute carrier family 7 member 1|Y
femoroacetabular impingement|femoro-acetabular impingement|Y
Royal British Nurses Association|Royal British Nurses' Association|Y
kruppel associated box|krueppel associated box|Y
American Society of Anaesthesiologists Class|American Society of Anaesthesiologists Class 4|Y
American Society of Anaesthesiologists Class|American Society of Anaesthesiologists Class 3|Y
American Society of Anaesthesiologists Class|American Society of Anaesthesiologists Class V|Y
American Society of Anaesthesiologists Class|American Society of Anaesthesiologists Class I|Y
American Society of Anaesthesiologists Class|American Society of Anaesthesiologists Class 5|Y
American Society of Anaesthesiologists Class|American Society of Anaesthesiologists Class 1|Y
American Society of Anaesthesiologists Class|American Society of Anesthesiologists Class|Y
limits of quantification|limit of quantification|Y
striatooccipital ratio|striato-occipital ratio|Y
src homology 2 domain containing protein tyrosine-phosphatase|src homology 2 domain-containing protein tyrosine-phosphatase|Y
src homology 2 domain containing protein tyrosine-phosphatase|Src homology 2 domain containing protein tyrosine-phosphatase|Y
multi-region hybridisation assay|multiregion hybridisation assay|Y
interleukine 13 receptor α 2 chain|interleukine 13 receptor α2 chain|Y
interleukine 13 receptor α 2 chain|interleukin 13 receptor α 2 chain|Y
laser assisted subepithelial keratectomy|laser-assisted subepithelial keratectomy|Y
laser assisted subepithelial keratectomy|laser assisted sub-epithelial keratectomy|Y
gamma-amino butyric acidB receptor|gamma-amino butyric acid B receptor|Y
apolipoprotein-A1-mediated|apolipoprotein-A-1-mediated|Y
recombinant human transforming growth factor β1|recombinant human transforming growth factor-β1|Y
recombinant human transforming growth factor β1|recombinant human transforming growth factor β 1|Y
recombinant human transforming growth factor β1|recombinant human transforming growth factor β3|Y
recombinant human transforming growth factor β1|recombinant human transforming growth factor β2|Y
recombinant human transforming growth factor β1|recombinant human transforming growth factor β|Y
receptor-like protein-tyrosine phosphatase-α|receptor-like protein tyrosine phosphatase-α|Y
receptor-like protein-tyrosine phosphatase-α|receptor-like protein-tyrosine phosphatase-ψ|Y
receptor-like protein-tyrosine phosphatase-α|receptor-like protein-tyrosine phosphatase-κ|Y
receptor-like protein-tyrosine phosphatase-α|receptor-like protein-tyrosine phosphatase|Y
receptor-like protein-tyrosine phosphatase-α|receptor-like protein-tyrosine phosphatase-δ|Y
receptor-like protein-tyrosine phosphatase-α|receptor-like protein-tyrosine phosphatase-μ|Y
receptor-like protein-tyrosine phosphatase-α|receptor-like protein-tyrosine phosphatase-η|Y
receptor-like protein-tyrosine phosphatase-α|receptor-like protein-tyrosine phosphatase-ζ|Y
cranio-cerebral injury|craniocerebral injury|Y
alpha-methyl-testosterone|alpha-methyltestosterone|Y
anti-beta2 glycoprotein 1 antibody|anti-beta 2 glycoprotein 1 antibody|Y
anti-beta2 glycoprotein 1 antibody|anti-beta-2 glycoprotein 1 antibody|Y
type 1 anti-neuronal nuclear antibody|type 1 antineuronal nuclear antibody|Y
anti-CD3 monoclonal antibody|anti-CD33 monoclonal antibody|Y
N-tropic murine leukemia virus|N-tropic murine leukaemia virus|Y
alpha-difluoromethyl-ornithine|alpha-difluoromethylornithine|Y
retinoic-acid-receptor-related orphan receptor γ-t|retinoic-acid-receptor-related orphan receptor γ t|Y
retinoic-acid-receptor-related orphan receptor γ-t|retinoic-acid-receptor-related orphan receptor γ|Y
lamprey gonadotropin releasing hormone III|lamprey gonadotropin releasing hormone I|Y
lamprey gonadotropin releasing hormone III|lamprey gonadotropin-releasing hormone III|Y
lamprey gonadotropin releasing hormone III|lamprey gonadotropin releasing hormone-III|Y
antineutrophil cytoplasmic antibody associated vasculitis|antineutrophil cytoplasmic antibody-associated vasculitis|Y
antineutrophil cytoplasmic antibody associated vasculitis|anti-neutrophil cytoplasmic antibody associated vasculitis|Y
latent TGFβ binding protein-1|latent TGF-β binding protein-1|Y
formylpeptide receptor-like 1|formyl peptide receptor-like 1|Y
formylpeptide receptor-like 1|formyl-peptide receptor-like 1|Y
co-stimulating activity|costimulating activity|Y
functional gastro-intestinal disorder|functional gastrointestinal disorder|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motif-14|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloproteinase with thrombospondin motifs-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motifs|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motifs-13|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motifs-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motifs-4|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motifs-2|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motifs-9|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motifs-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloproteinase with thrombospondin motifs-8|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
a disintegrin and metalloprotease with thrombospondin motifs-18|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1|apolipoprotein B mRNA-editing enzyme catalytic polypeptide 3B|Y
apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1|apolipoprotein B mRNA-editing enzyme catalytic polypeptide|Y
post-tetanic potentiation|posttetanic potentiation|Y
plasmid-mediated quinolone resistance gene|plasmid mediated quinolone resistance gene|Y
tumour colony forming unit|tumor colony forming unit|Y
angiotensin-converting enzyme inhibitors|angiotensin-converting enzyme inhibitor|Y
angiotensin-converting enzyme inhibitors|Angiotensin-converting enzyme inhibitors|Y
angiotensin-converting enzyme inhibitors|angiotensin converting enzyme inhibitors|Y
atrioventricular nodal reentry tachycardia|atrioventricular nodal re-entry tachycardia|Y
puromycin N-acetyl transferase gene|puromycin N-acetyltransferase gene|Y
antihistocompatibility leucocyte antigen antibody|anti-histocompatibility leucocyte antigen antibody|Y
corticotropin-releasing factor type-1 receptor|corticotropin-releasing factor type-2 receptor|Y
vancomycin resistance gene C2|vancomycin resistance gene C|Y
fluorescein 5-isothiocyanate|fluorescein 5'-isothiocyanate|Y
post-junctional membrane|postjunctional membrane|Y
non-erosive reflux disease|nonerosive reflux disease|Y
temporomandibular joint disease|temporo-mandibular joint disease|Y
minimally invasive direct coronary artery bypass grafting|Minimally invasive direct coronary artery bypass grafting|Y
nonphytin phosphorus|non-phytin phosphorus|Y
vertical vestibulo-ocular reflex|vertical vestibuloocular reflex|Y
rabbit antithymocyte globulin|rabbit anti-thymocyte globulin|Y
fluorine-18 labeled fluoro-deoxyglucose|fluorine-18 labeled fluoro-deoxy-glucose|Y
fluorine-18 labeled fluoro-deoxyglucose|fluorine-18 labelled fluoro-deoxyglucose|Y
fluorine-18 labeled fluoro-deoxyglucose|fluorine-18 labeled fluorodeoxyglucose|Y
anti-IL1 receptor antibody|anti-IL-1 receptor antibody|Y
anti-IL1 receptor antibody|anti-IL 1 receptor antibody|Y
anti-IL1 receptor antibody|anti-IL10 receptor antibody|Y
depomedroxyprogesterone acetate|depo-medroxyprogesterone acetate|Y
bcl-2-associated X-protein|bcl2-associated X-protein|Y
methyl cytidine-phosphate-guanosine binding domain 4|methyl cytidine-phosphate-guanosine binding domain|Y
methyl cytidine-phosphate-guanosine binding domain 4|methyl cytidine-phosphate-guanosine binding domain 1|Y
methyl cytidine-phosphate-guanosine binding domain 4|methyl cytidine-phosphate-guanosine binding domain 2|Y
methyl cytidine-phosphate-guanosine binding domain 4|methyl cytidine-phosphate-guanosine binding domain 5|Y
β-amyloid precursor protein-cleaving enzyme 2|β-amyloid precursor protein-cleaving enzyme-2|Y
β-amyloid precursor protein-cleaving enzyme 2|β-amyloid precursor protein-cleaving enzyme 1|Y
regulatory subunit I-α|regulatory subunit Iα|Y
non-agglutinating fimbria|nonagglutinating fimbria|Y
chloro-deoxyadenosine|chloro-deoxy-adenosine|Y
electron probe X-ray microanalyzer|electron probe X-ray micro-analyzer|Y
intraperitoneal glucose tolerance test|intra-peritoneal glucose tolerance test|Y
American Conference of Govermental Industrial Hygienists|American Conference of Governmental Industrial Hygienists|Y
ristocetin induced platelet agglutination|ristocetin-induced platelet agglutination|Y
triethylenethio-phosphoramide|triethylenethiophosphoramide|Y
lamprey gonadotropin-releasing hormone-III|lamprey gonadotropin-releasing hormone III|Y
lamprey gonadotropin-releasing hormone-III|lamprey gonadotropin-releasing hormone-I|Y
lamprey gonadotropin-releasing hormone-III|lamprey gonadotropin releasing hormone-III|Y
post-synaptic density|postsynaptic density|Y
digital micro-mirror device|digital micromirror device|Y
pituitary tumour transforming gene|pituitary tumor transforming gene|Y
neural precursor cell expressed developmentally down-regulated 2|neural precursor cell expressed developmentally down-regulated 4|Y
neural precursor cell expressed developmentally down-regulated 2|neural precursor cell expressed developmentally downregulated 8|Y
neural precursor cell expressed developmentally down-regulated 2|neural precursor cell expressed developmentally downregulated 9|Y
neural precursor cell expressed developmentally down-regulated 2|neural precursor cell expressed, developmentally down-regulated 2|Y
neural precursor cell expressed developmentally down-regulated 2|neural precursor cell expressed, developmentally down-regulated 8|Y
neural precursor cell expressed developmentally down-regulated 2|neural precursor cell expressed developmentally down-regulated 1|Y
neural precursor cell expressed developmentally down-regulated 2|neural precursor cell expressed developmentally down-regulated 8|Y
neural precursor cell expressed developmentally down-regulated 2|neural precursor cell expressed developmentally downregulated 4|Y
neural precursor cell expressed developmentally down-regulated 2|neural precursor cell expressed developmentally downregulated 5|Y
neural precursor cell expressed developmentally down-regulated 2|neural precursor cell expressed developmentally downregulated 2|Y
neural precursor cell expressed developmentally down-regulated 2|neural precursor cell expressed, developmentally downregulated 2|Y
neural precursor cell expressed developmentally down-regulated 2|neural precursor cell expressed, developmentally down-regulated 4|Y
neural precursor cell expressed developmentally down-regulated 2|neural precursor cell expressed, developmentally down-regulated 1|Y
neural precursor cell expressed developmentally down-regulated 2|neural precursor cell-expressed developmentally down-regulated 2|Y
neural precursor cell expressed developmentally down-regulated 2|neural precursor cell expressed developmentally down-regulated 9|Y
neural precursor cell expressed developmentally down-regulated 2|neural precursor cell-expressed, developmentally down-regulated 2|Y
neural precursor cell expressed developmentally down-regulated 2|neural precursor cell expressed, developmentally down-regulated 5|Y
cancer-upregulated gene 2|cancer-up-regulated gene 2|Y
CC chemokine receptor 4|C-C chemokine receptor 4|Y
nonheart beating donor|non-heart beating donor|Y
sub-acute stent thrombosis|subacute stent thrombosis|Y
Rush-Presbyterian-Saint Luke's Medical Centre|Rush-Presbyterian-Saint Luke's Medical Center|Y
Rush-Presbyterian-Saint Luke's Medical Centre|Rush Presbyterian-Saint Luke's Medical Centre|Y
ρ-guanine nucleotide dissociation inhibitor 2|ρ guanine nucleotide dissociation inhibitor 2|Y
antiinterleukin 6 receptor monoclonal antibody|anti-interleukin 6 receptor monoclonal antibody|Y
antiinterleukin 6 receptor monoclonal antibody|antiinterleukin 2 receptor monoclonal antibody|Y
American Society of Anaesthesiology class 4|American Society of Anaesthesiology class|Y
American Society of Anaesthesiology class 4|American Society of Anaesthesiology class V|Y
American Society of Anaesthesiology class 4|American Society of Anaesthesiology class 5|Y
American Society of Anaesthesiology class 4|American Society of Anesthesiology class 4|Y
American Society of Anaesthesiology class 4|American Society of Anaesthesiology class 3|Y
American Society of Anaesthesiology class 4|American Society of Anaesthesiology class 2|Y
American Society of Anaesthesiology class 4|American Society of Anaesthesiology Class 4|Y
American Society of Anaesthesiology class 4|American Society of Anaesthesiology class 1|Y
extra-renal Wilms' tumour|extra-renal Wilms tumour|Y
thyreostimulating hormone|thyreo-stimulating hormone|Y
peroxisome-proliferator-activated receptor-γ co-activator 1α|peroxisome-proliferator-activated receptor-γ co-activator-1 α|Y
peroxisome-proliferator-activated receptor-γ co-activator 1α|peroxisome proliferator-activated receptor-γ co-activator 1 α|Y
peroxisome-proliferator-activated receptor-γ co-activator 1α|peroxisome proliferator-activated receptor-γ co-activator 1α|Y
peroxisome-proliferator-activated receptor-γ co-activator 1α|peroxisome-proliferator-activated receptor-γ co-activator 1 α|Y
peroxisome-proliferator-activated receptor-γ co-activator 1α|peroxisome-proliferator-activated receptor-γ coactivator 1α|Y
β amyloid precursor protein cleaving enzyme-2|β-amyloid precursor protein cleaving enzyme-2|Y
β amyloid precursor protein cleaving enzyme-2|β amyloid precursor protein cleaving enzyme 2|Y
β amyloid precursor protein cleaving enzyme-2|β amyloid precursor protein cleaving enzyme-1|Y
β amyloid precursor protein cleaving enzyme-2|β amyloid precursor protein-cleaving enzyme-2|Y
interleukine 3 receptor α-chain|interleukin 3 receptor α-chain|Y
insulinlike growth factor binding protein 5|insulinlike growth factor binding protein 1|Y
insulinlike growth factor binding protein 5|insulinlike growth factor binding protein 4|Y
insulinlike growth factor binding protein 5|insulinlike growth factor binding protein 3|Y
tumor control dose 50%|tumour control dose 50%|Y
time trade-off method|time tradeoff method|Y
maximal midexpiratory flow|maximal mid-expiratory flow|Y
transforming growth factor-β 2|transforming growth factor-β2|Y
mercapto-acetyltriglycine|mercaptoacetyltriglycine|Y
peroxisome-proliferator-activated receptor β|peroxisome-proliferator-activated receptor-β|Y
peroxisome-proliferator-activated receptor β|peroxisome proliferator-activated receptor β|Y
Children's Yale-Brown Obsessive-Compulsive Scale|Children's Yale-Brown Obsessive Compulsive Scale|Y
Children's Yale-Brown Obsessive-Compulsive Scale|Children's Yale Brown Obsessive-Compulsive Scale|Y
ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry|ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry|Y
ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry|ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry|Y
ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry|ultra performance liquid chromatography/quadrupole time-of-flight mass spectrometry|Y
ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry|ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry|Y
prostaglandin I synthase|prostaglandin I2 synthase|Y
mitogen activated protein kinase activated protein kinase 5|mitogen activated protein kinase activated protein kinase|Y
mitogen activated protein kinase activated protein kinase 5|mitogen activated protein kinase activated protein kinase 2|Y
mitogen activated protein kinase activated protein kinase 5|mitogen-activated protein kinase activated protein kinase 5|Y
mitogen activated protein kinase activated protein kinase 5|mitogen activated protein kinase activated protein kinase 1|Y
antihypertensive medication|anti-hypertensive medication|Y
randomized controlled trials|randomized controlled trial|Y
staphylococcal cassette chromosome mec type IV|staphylococcal cassette chromosome mec type V|Y
staphylococcal cassette chromosome mec type IV|staphylococcal cassette chromosome mec type I|Y
staphylococcal cassette chromosome mec type IV|staphylococcal cassette chromosome mec type II|Y
endothelial-monocyte-activating polypeptide-II|endothelial-monocyte-activating polypeptide II|Y
endothelial-monocyte-activating polypeptide-II|endothelial monocyte-activating polypeptide-II|Y
IL3 receptor-α chain|IL-3 receptor-α chain|Y
tumor necrosis factor receptor-1-associated periodic syndrome|tumour necrosis factor receptor 1-associated periodic syndrome|Y
tumor necrosis factor receptor-1-associated periodic syndrome|tumour necrosis factor receptor-associated periodic syndrome|Y
tumor necrosis factor receptor-1-associated periodic syndrome|tumor necrosis factor receptor-associated periodic syndrome|Y
post-rotatory nystagmus|postrotatory nystagmus|Y
tubero-infundibular dopamine neuron|tuberoinfundibular dopamine neuron|Y
tubero-infundibular dopamine neuron|tubero-infundibular dopamine neurone|Y
α-fluoro-methyl histidine|α-fluoromethyl histidine|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloproteinase with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motifs-13|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motif-3|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motifs-16|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motifs-4|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motif-2|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motifs-17|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloproteinase with thrombospondin motif-14|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
complement mediated antibody-dependent enhancement|complement-mediated antibody-dependent enhancement|Y
leukocyte-associated immunoglobulin-like receptor 1|leukocyte-associated immunoglobulin-like receptor|Y
leukocyte-associated immunoglobulin-like receptor 1|leucocyte-associated immunoglobulin-like receptor 1|Y
auto-transfusion system|autotransfusion system|Y
interleukin-1β converting enzyme inhibitor|interleukin-1 β converting enzyme inhibitor|Y
interleukin-1β converting enzyme inhibitor|interleukin-1β-converting enzyme inhibitor|Y
transactivation domain|trans-activation domain|Y
protein phosphatase magnesium-dependent 1 D|protein phosphatase magnesium-dependent 1D|Y
protein phosphatase magnesium-dependent 1 D|protein phosphatase magnesium-dependent 1 d|Y
protein phosphatase magnesium-dependent 1 D|protein phosphatase magnesium-dependent 1 δ|Y
benzo(a)pyrene-diol-epoxide DNA adduct level|benzo(a)pyrene diol-epoxide DNA adduct level|Y
benzo(a)pyrene-diol-epoxide DNA adduct level|benzo(a)pyrene-diol-epoxide-DNA adduct level|Y
immuno-fluorescence antibody|immunofluorescence antibody|Y
University of California-Los Angeles Prostate Cancer Index|University of California-Los Angeles-Prostate Cancer Index|Y
University of California-Los Angeles Prostate Cancer Index|University of California Los Angeles Prostate Cancer Index|Y
matrix assisted laser desorption ionisation-mass spectrometry|matrix assisted laser desorption ionisation mass spectrometry|Y
matrix assisted laser desorption ionisation-mass spectrometry|matrix assisted laser desorption ionization-mass spectrometry|Y
matrix assisted laser desorption ionisation-mass spectrometry|matrix assisted laser desorption/ionisation-mass spectrometry|Y
exercise-induced hypoxaemia|exercise-induced hypoxemia|Y
West Los Angeles Veterans Affairs Medical Center|West Los Angeles Veteran's Affairs Medical Center|Y
permeability constants|permeability constant|Y
cross polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarization/magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
anti-matrix metalloproteinase-2 antibody|anti-matrix metalloproteinase 2 antibody|Y
anti-matrix metalloproteinase-2 antibody|anti-matrix metalloproteinase-1 antibody|Y
anti-matrix metalloproteinase-2 antibody|anti-matrix metalloproteinase-7 antibody|Y
apolipoprotein A-1-mediated|apolipoprotein A1-mediated|Y
zinc dimethyldithiocarbamate|zinc diethyldithiocarbamate|Y
postmastectomy radiotherapy|post-mastectomy radiotherapy|Y
cross polarization magic angle spinning nuclear magnetic resonance|cross-polarization magic angle spinning nuclear magnetic resonance|Y
cross polarization magic angle spinning nuclear magnetic resonance|cross polarization/magic angle spinning nuclear magnetic resonance|Y
T-cell receptor γδ-positive|T-cell receptor γ δ-positive|Y
non-rapid eye movement|nonrapid eye movement|Y
eutectic mixture of local anesthetic|eutectic mixture of local anesthetics|Y
hydroxyethylmethacrylate|hydroxy-ethylmethacrylate|Y
CC chemokine ligand 7|CC chemokine ligand 17|Y
CC chemokine ligand 7|C-C chemokine ligand 7|Y
anti-granulocyte-macrophage colony-stimulating factor auto-antibody|anti-granulocyte-macrophage colony-stimulating factor autoantibody|Y
receptor-like protein tyrosine phosphatase-α|receptor-like protein tyrosine phosphatase-η|Y
receptor-like protein tyrosine phosphatase-α|receptor-like protein tyrosine phosphatase α|Y
receptor-like protein tyrosine phosphatase-α|receptor-like protein tyrosine phosphatase-δ|Y
receptor-like protein tyrosine phosphatase-α|receptor-like protein tyrosine phosphatase-κ|Y
receptor-like protein tyrosine phosphatase-α|receptor-like protein tyrosine phosphatase-ψ|Y
receptor-like protein tyrosine phosphatase-α|receptor-like protein tyrosine phosphatase-μ|Y
intracranial vertebral artery|intra-cranial vertebral artery|Y
fluorine-18-labeled fluoro-deoxyglucose|fluorine-18-labelled fluoro-deoxy-glucose|Y
fluorine-18-labeled fluoro-deoxyglucose|fluorine-18-labelled fluoro-deoxyglucose|Y
fluorine-18-labeled fluoro-deoxyglucose|fluorine-18-labeled fluoro-deoxy-glucose|Y
immuno-reactive secretion|immunoreactive secretion|Y
influenzalike illness|influenza-like illness|Y
heat shock protein 90 α|heat shock protein 90α|Y
endoscopic sub-mucosal dissection|endoscopic submucosal dissection|Y
corticotropin-releasing-factor|corticotrophin-releasing-factor|Y
ras-related GTP-binding protein 1c|ras-related GTP-binding protein 1|Y
guanosinetriphosphatase activating protein|guanosine triphosphatase activating protein|Y
guanosinetriphosphatase activating protein|guanosinetriphosphatase-activating protein|Y
xenotropic murine leukemia virus-related virus|xenotropic murine leukaemia virus-related virus|Y
diisopropyl phosphorofluoridate|diisopropylphosphorofluoridate|Y
American Society of Anesthesiologists Grade|American Society of Anesthesiologists Grade 5|Y
American Society of Anesthesiologists Grade|American Society of Anesthesiologists Grade 2|Y
American Society of Anesthesiologists Grade|American Society of Anesthesiologists Grade V|Y
American Society of Anesthesiologists Grade|American Society of Anesthesiologists grade|Y
American Society of Anesthesiologists Grade|American Society of Anesthesiologists Grade 3|Y
American Society of Anesthesiologists Grade|American Society of Anesthesiologists Grade I|Y
American Society of Anesthesiologists Grade|American Society of Anesthesiologists Grade 1|Y
gastro-esophageal sphincter|gastro-oesophageal sphincter|Y
cytotoxic T-lymphocyte antigen 2β|cytotoxic T-lymphocyte antigen 2 β|Y
nondestructive evaluation|non-destructive evaluation|Y
size exclusion chromatography/multi-angle laser light scattering|size exclusion chromatography-multiangle laser light scattering|Y
size exclusion chromatography/multi-angle laser light scattering|size-exclusion chromatography/multiangle laser light scattering|Y
size exclusion chromatography/multi-angle laser light scattering|size exclusion chromatography-multi-angle laser light scattering|Y
size exclusion chromatography/multi-angle laser light scattering|size exclusion chromatography/multiangle laser light scattering|Y
size exclusion chromatography/multi-angle laser light scattering|size-exclusion chromatography/multi-angle laser light scattering|Y
Saint Radboud University Hospital|Sint Radboud University Hospital|Y
pseudocholinesterase|pseudo-cholinesterase|Y
real-time quantitative reverse transcription polymerase chain reaction|real-time quantitative reverse transcription-polymerase chain reaction|Y
real-time quantitative reverse transcription polymerase chain reaction|real-time quantitative reverse-transcription polymerase chain reaction|Y
Veterans' Administration Medical Center|Veterans Administration Medical Center|Y
short consensus repeat 2|short consensus repeat 20|Y
gonadotropin-releasing hormone analogue|gonadotrophin-releasing hormone analogues|Y
metabotropic glutamate receptor 1|metabotropic glutamate receptor 1α|Y
near infrared fluorescent imaging|near infra-red fluorescent imaging|Y
Epstein-Barr virus cell surface antigen 1|Epstein-Barr virus cell surface antigen 2|Y
Epstein-Barr virus cell surface antigen 1|Epstein-Barr virus cell surface antigen 3|Y
Epstein-Barr virus cell surface antigen 1|Epstein-Barr virus cell surface antigen|Y
Epstein-Barr virus cell surface antigen 1|Epstein-Barr virus cell surface antigen 5|Y
Epstein-Barr virus cell surface antigen 1|Epstein-Barr virus cell surface antigen 4|Y
nonsteroidal anti-inflammatory agent|nonsteroidal antiinflammatory agent|Y
nonsteroidal anti-inflammatory agent|non-steroidal anti-inflammatory agent|Y
methyl-cytosine-phosphate-guanosine binding protein 2|methyl-cytosine-phosphate-guanosine binding protein|Y
human T-cell lymphotrophic virus|human T-cell lymphotropic virus|Y
quantitative structure reactivity relationship|quantitative structure activity relationship|Y
flavin-containing monooxygenase 1|flavin-containing mono-oxygenase 1|Y
microtubule associated protein 1 light-chain 3|microtubule-associated protein 1 light-chain 3|Y
microtubule associated protein 1 light-chain 3|microtubule associated protein 1 light chain 3|Y
microtubule associated protein 1 light-chain 3|microtubule associated protein-1 light-chain 3|Y
microtubule associated protein 1 light-chain 3|microtubule associated protein light-chain 3|Y
surface-assisted laser desorption/ionization mass spectrometry|surface-assisted laser desorption/ionization-mass spectrometry|Y
surface-assisted laser desorption/ionization mass spectrometry|surface-assisted laser desorption/ionisation mass spectrometry|Y
surface-assisted laser desorption/ionization mass spectrometry|surface-assisted laser desorption ionization mass spectrometry|Y
phycoerythrin-labeled|phycoerythrin-labelled|Y
Family Planning Associations|Family Planning Association|Y
never in mitosis, gene A-related kinase 2|never in mitosis, gene A-related kinase 9|Y
never in mitosis, gene A-related kinase 2|never in mitosis, gene A-related kinase 7|Y
never in mitosis, gene A-related kinase 2|never in mitosis, gene A-related kinase 3|Y
never in mitosis, gene A-related kinase 2|never in mitosis, gene A-related kinase 6|Y
never in mitosis, gene A-related kinase 2|never in mitosis, gene A-related kinase 4|Y
sterol regulatory element binding protein 1-a|sterol regulatory element binding protein 1|Y
sterol regulatory element binding protein 1-a|sterol regulatory element binding protein 1-c|Y
sterol regulatory element binding protein 1-a|sterol regulatory element-binding protein 1-a|Y
dynamic cardio-myoplasty|dynamic cardiomyoplasty|Y
immune thrombo-cytopenia|immune thrombo-cytopaenia|Y
immune thrombo-cytopenia|immune thrombocytopenia|Y
cross polarisation/magic angle spinning nuclear magnetic resonance|cross polarization/magic angle spinning nuclear magnetic resonance|Y
cross polarisation/magic angle spinning nuclear magnetic resonance|cross-polarisation/magic angle spinning nuclear magnetic resonance|Y
human adenovirus serotype 52|human adenovirus serotype 5|Y
levonorgestrel intra-uterine system|laevonorgestrel intra-uterine system|Y
levonorgestrel intra-uterine system|levonorgestrel intrauterine system|Y
anti-herpes simplex virus type 1 antibody|antiherpes simplex virus type 1 antibody|Y
anti-herpes simplex virus type 1 antibody|anti-herpes simplex virus type 2 antibody|Y
hemi-nested polymerase chain reaction|heminested polymerase chain reaction|Y
human hepatocellular carcinoma cell line 3|human hepatocellular carcinoma cell line 1|Y
a disintegrin and metalloproteinase 3|a disintegrin and metalloproteinase 23|Y
a disintegrin and metalloproteinase 3|a disintegrin and metalloproteinase 33|Y
a disintegrin and metalloproteinase 3|a disintegrin and metalloproteinase 13|Y
major histocompatibility complex class I molecules|major histocompatibility complex class II molecule|Y
American Society of Anaesthesiologists score|American Society of Anesthesiologists score|Y
anti-chondroitin sulfate monoclonal antibody|antichondroitin sulfate monoclonal antibody|Y
cyclophosphamide epirubicin and fluorouracil|cyclophosphamide, epirubicin, and fluorouracil|Y
tumor-promoting agent|tumour-promoting agent|Y
estrogen receptor α knockout|estrogen receptor α knock-out|Y
estrogen receptor α knockout|estrogen receptor α knock out|Y
male germ cell rac GTPase activating protein|male germ cell rac GTPase-activating protein|Y
oto-spondylo-mega-epiphyseal dysplasia|oto-spondylo-megaepiphyseal dysplasia|Y
Toll/IL-1 receptor domain-containing adaptor-inducing IFNbeta|toll/IL-1 receptor domain-containing adaptor-inducing IFNbeta|Y
Toll/IL-1 receptor domain-containing adaptor-inducing IFNbeta|toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta|Y
intra-class correlation coefficient|intraclass correlation coefficient|Y
serum and glucocorticoid-inducible kinase 1|serum- and glucocorticoid-inducible kinase 1|Y
serum and glucocorticoid-inducible kinase 1|serum and glucocorticoid-inducible kinase-1|Y
electron-probe x-ray microanalyser|electron-probe x-ray micro-analyser|Y
loop electrosurgical excision procedure|loop electro-surgical excision procedure|Y
vacuum ultraviolet radiation|vacuum ultra-violet radiation|Y
proline-serine-threonine phosphatase-interacting protein|proline-serine-threonine phosphatase-interacting protein-1|Y
proline-serine-threonine phosphatase-interacting protein|proline-serine-threonine phosphatase-interacting protein 1|Y
Orthopedic Foundation for Animals|Orthopaedic Foundation for Animals|Y
uridine diphospho-glucuronosyl transferase|uridine diphosphoglucuronosyltransferase|Y
uridine diphospho-glucuronosyl transferase|uridine diphospho-glucuronosyltransferase|Y
pre-Boetzinger complex|pre-Botzinger complex|Y
periarteriolar lymphatic sheaths|periarteriolar lymphatic sheath|Y
cranio-mandibular joint|craniomandibular joint|Y
thyrotrophin-releasing hormone|thyrotropin-releasing hormone|Y
dicyclohexylcarbodi-imide|dicyclohexylcarbodiimide|Y
insulin-like growth factor-II receptor|insulin-like growth factor-I receptor|Y
electrostatic capacity|electro-static capacity|Y
Structured Clinical Interview for DSM IV|Structured Clinical Interview for DSM-IV|Y
gastro-intestinal transit|gastrointestinal transit|Y
recurrent urinary tract infection|recurrent urinary tract infections|Y
pentylenetetrazol-kindled|pentylene tetrazol-kindled|Y
pentylenetetrazol-kindled|pentylenetetrazole-kindled|Y
pentylenetetrazol-kindled|pentylene-tetrazol-kindled|Y
cell-penetrating peptides|cell-penetrating peptide|Y
phospholipase-C-related catalytically inactive protein|phospholipase C-related catalytically inactive protein|Y
interleukin-11 receptor alpha subunit|interleukine-11 receptor alpha subunit|Y
thermoluminescence dosemeter|thermoluminescence dosemeters|Y
Wiskott-Aldrich syndrome protein homology 2|Wiskott-Aldrich syndrome protein homology 1|Y
peroxisome-proliferator-activated receptor-β|peroxisome proliferator-activated receptor-β|Y
trans-mural myocardial infarction|transmural myocardial infarction|Y
autolysed antigen-extracted allogeneic bone|autolysed antigen extracted allogeneic bone|Y
autolysed antigen-extracted allogeneic bone|autolyzed antigen-extracted allogeneic bone|Y
anti-T-cell receptor alpha/beta monoclonal antibody|anti-T-cell receptor alpha beta monoclonal antibody|Y
anti-T-cell receptor alpha/beta monoclonal antibody|anti-T cell receptor alpha/beta monoclonal antibody|Y
bacterial multicomponent mono-oxygenase|bacterial multicomponent monooxygenase|Y
intradermal reaction|intra-dermal reaction|Y
glycogen synthase kinase 3|glycogen synthase kinase 3β|Y
glycogen synthase kinase 3|glycogen synthase kinase 3α|Y
catalysed reporter deposition-fluorescence in situ hybridisation|catalysed reporter deposition fluorescence in situ hybridisation|Y
catalysed reporter deposition-fluorescence in situ hybridisation|catalysed reporter deposition-fluorescence in situ hybridization|Y
non-histone chromosomal protein|nonhistone chromosomal protein|Y
anti-intercellular adhesion molecule1 antibody|anti-intercellular adhesion molecule-1 antibody|Y
tanned-red-cell hemagglutination inhibition immunoassay|tanned-red-cell haemagglutination inhibition immunoassay|Y
inpatient rehabilitation facility|in-patient rehabilitation facility|Y
tumor necrosis factor-β production|tumour necrosis factor-β production|Y
polarization-division multiplexing quadrature phase shift keying|polarization division multiplexing quadrature phase shift keying|Y
polarization-division multiplexing quadrature phase shift keying|polarisation-division multiplexing quadrature phase shift keying|Y
polarization-division multiplexing quadrature phase shift keying|polarization-division-multiplexing quadrature phase shift keying|Y
retinoic-acid-receptor-related orphan receptor γ t|retinoic-acid-receptor-related orphan receptor γ T|Y
retinoic-acid-receptor-related orphan receptor γ t|retinoic-acid-receptor-related orphan receptor γ|Y
creatine phospho-kinase|creatine phosphokinase|Y
non-aqueous reversed phase high-performance liquid chromatography|nonaqueous reversed-phase high-performance liquid chromatography|Y
non-aqueous reversed phase high-performance liquid chromatography|non-aqueous reversed-phase high-performance liquid chromatography|Y
non-aqueous reversed phase high-performance liquid chromatography|non-aqueous reversed phase high performance liquid chromatography|Y
non-aqueous reversed phase high-performance liquid chromatography|nonaqueous reversed phase high performance liquid chromatography|Y
matrix assisted laser desorption ionization mass spectrometry|matrix-assisted laser desorption ionization mass spectrometry|Y
matrix assisted laser desorption ionization mass spectrometry|matrix assisted laser desorption ionisation mass spectrometry|Y
matrix assisted laser desorption ionization mass spectrometry|matrix assisted laser desorption ionization-mass spectrometry|Y
matrix assisted laser desorption ionization mass spectrometry|matrix assisted laser desorption-ionization mass spectrometry|Y
matrix assisted laser desorption ionization mass spectrometry|matrix assisted laser desorption/ionization mass spectrometry|Y
temperature programmed desorption mass spectrometry|temperature programed desorption mass spectrometry|Y
γ-glutamyl cysteine synthetase|γ-glutamylcysteine synthetase|Y
γ-glutamyl cysteine synthetase|γglutamyl cysteine synthetase|Y
distal inter-phalangeal joint|distal interphalangeal joint|Y
mitogen-activated protein kinase kinase kinase 3|mitogen-activated protein kinase kinase kinase 1|Y
mitogen-activated protein kinase kinase kinase 3|mitogen-activated protein kinase kinase kinase|Y
mitogen-activated protein kinase kinase kinase 3|mitogen activated protein kinase kinase kinase 3|Y
mitogen-activated protein kinase kinase kinase 3|mitogen-activated protein kinase kinase kinase 4|Y
nuclear-factor erythroid 2-related factor 2|nuclear factor erythroid 2-related factor 2|Y
anti-IL-6 receptor monoclonal antibody|antiIL-6 receptor monoclonal antibody|Y
anti-IL-6 receptor monoclonal antibody|anti-IL6 receptor monoclonal antibody|Y
hepatitis C virus genotype 3a|hepatitis C virus genotype 3|Y
B-cell-specific Moloney murine leukaemia virus integration site 1|B cell-specific Moloney murine leukaemia virus integration site 1|Y
B-cell-specific Moloney murine leukaemia virus integration site 1|B-cell-specific Moloney murine leukemia virus integration site 1|Y
maximum expiratory flow rate at 25% of vital capacity|maximum expiratory flow rate at 50% of vital capacity|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon-beta|toll-interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon-beta|toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon-beta|toll-interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon-beta|toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon-beta|toll/interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Y
Women's Health and Aging Study I|Women's Health and Aging Study II|Y
nonaqueous reversed-phase high-performance liquid chromatography|non-aqueous reversed-phase high-performance liquid chromatography|Y
nonaqueous reversed-phase high-performance liquid chromatography|non-aqueous reversed-phase high performance liquid chromatography|Y
robust multiarray analysis|robust multi-array analysis|Y
Barrett's esophageal adenocarcinoma|Barrett's oesophageal adenocarcinoma|Y
dextranomer hyaluronic acid co-polymer|dextranomer hyaluronic acid copolymer|Y
IkappaB kinase complex|I-kappaB kinase complex|Y
serum insulin-like growth factor-1 level|serum insulin-like growth factor-I level|Y
human immunodeficiency virus type 1 subtype E|human immunodeficiency virus type 1 subtype G|Y
human immunodeficiency virus type 1 subtype E|human immunodeficiency virus type 1 subtype B|Y
human immunodeficiency virus type 1 subtype E|human immunodeficiency virus type 1 subtype|Y
human immunodeficiency virus type 1 subtype E|human immunodeficiency virus type 1 subtype C|Y
human immunodeficiency virus type 1 subtype E|human immunodeficiency virus type 1 subtype A|Y
human immunodeficiency virus type 1 subtype E|human immunodeficiency virus type 1 subtype D|Y
human immunodeficiency virus type 1 subtype E|human immunodeficiency virus type 1 subtype F|Y
ouabain-like immunoreactivity|ouabainlike immunoreactivity|Y
near infra-red fluorescence imaging|near infrared fluorescence imaging|Y
suprachoroidal hemorrhage|supra-choroidal hemorrhage|Y
granulocyte macrophage-colony stimulating factor|granulocyte macrophage colony stimulating factor|Y
granulocyte macrophage-colony stimulating factor|granulocyte/macrophage-colony stimulating factor|Y
granulocyte macrophage-colony stimulating factor|granulocyte macrophage-colony-stimulating factor|Y
intra-uterine transfusion|intrauterine transfusion|Y
ubiquitous surface protein A|ubiquitous surface protein A1|Y
forkhead box other 3a|forkhead box other 3|Y
A disintegrin and metalloproteinase 3|A disintegrin and metalloproteinase 13|Y
A disintegrin and metalloproteinase 3|A disintegrin and metalloproteinase 23|Y
interleukin-13 receptor-α2 subunit|interleukine-13 receptor-α2 subunit|Y
ortho-toluoylcholine|ortho-toluoyl choline|Y
interleukin 13 receptor α 2 subunit|interleukine 13 receptor α 2 subunit|Y
interleukin 13 receptor α 2 subunit|interleukin 13 receptor α2 subunit|Y
faction of inspired oxygen|fraction of inspired oxygen|Y
follicle stimulating hormone releasing factor|follicle-stimulating hormone releasing factor|Y
receptor-type protein-tyrosine phosphatase-β|receptor-type protein-tyrosine phosphatase β|Y
prostaglandin I-2 synthase|prostaglandin I2 synthase|Y
proton transfer reaction mass spectrometry|proton transfer reaction mass spectrometer|Y
anterodorsal thalami nucleus|anterodorsal thalamic nucleus|Y
X-ray repair cross-complementation group 1|X-ray repair cross complementation group 1|Y
X-ray repair cross-complementation group 1|x-ray repair cross-complementation group 1|Y
gonadotrophin-releasing hormone agonist|gonadotropin-releasing hormone agonist|Y
post-encephalitic parkinsonism|postencephalitic parkinsonism|Y
extra-cranial carotid artery disease|extracranial carotid artery disease|Y
plasma insulin-like growth factor 1 level|plasma insulinlike growth factor 1 level|Y
plasma insulin-like growth factor 1 level|plasma insulin-like growth factor I level|Y
Schedule of Affective Disorders and Schizophrenia-Lifetime Version|Schedule for Affective Disorders and Schizophrenia-Lifetime Version|Y
nonaltered auditory feedback|non-altered auditory feedback|Y
congenital hypo-myelinating neuropathy|congenital hypomyelinating neuropathy|Y
osteoarticular infection|osteo-articular infection|Y
human adenovirus serotype 25|human adenovirus serotype 5|Y
thyroxin radioimmunoassay|thyroxin radio-immunoassay|Y
inositol 1,4,5-trisphosphate receptor|inositol 1,4,5-trisphosphate receptors|Y
A disintegrin and metalloprotease-19|A disintegrin and metalloprotease-9|Y
receptor-like protein tyrosine phosphatase-zeta|receptor-like protein tyrosine phosphatase zeta|Y
receptor-like protein tyrosine phosphatase-zeta|receptor-like protein-tyrosine phosphatase-zeta|Y
B-lymphocyte induced maturation protein-1|B lymphocyte induced maturation protein-1|Y
B-lymphocyte induced maturation protein-1|B-lymphocyte induced maturation protein 1|Y
peptide nucleic acid-DNA chimaera|peptide nucleic acid-DNA chimera|Y
α-methyl-acyl-coenzyme-A racemase|α-methylacyl-coenzyme-A racemase|Y
prostaglandin F-2alpha|prostaglandin F-2 alpha|Y
prostaglandin F-2alpha|prostaglandin F2alpha|Y
multilinear regression|multi-linear regression|Y
synchrotron radiation-excited x-ray fluorescence|synchrotron radiation-excited X-ray fluorescence|Y
IL-2 receptor α-subunit|IL2 receptor α-subunit|Y
a disintegrin and metalloproteinase 19|a disintegrin and metalloproteinase 9|Y
degrees of polymerization|degree of polymerization|Y
expressed sequence tag|expressed sequenced tag|Y
intraosseous pressure|intra-osseous pressure|Y
IL-1beta converting enzyme|IL-1 beta converting enzyme|Y
mitogen-activated protein kinase kinase-1|mitogen-activated protein kinase kinase-4|Y
mitogen-activated protein kinase kinase-1|mitogen activated protein kinase kinase-1|Y
mitogen-activated protein kinase kinase-1|mitogen-activated protein kinase kinase-3|Y
mitogen-activated protein kinase kinase-1|mitogen-activated protein kinase kinase|Y
mitogen-activated protein kinase kinase-1|mitogen-activated protein kinase kinase-2|Y
mitogen-activated protein kinase kinase-1|mitogen-activated protein kinase kinase-7|Y
mitogen-activated protein kinase kinase-1|mitogen-activated protein kinase kinase 1|Y
insulin-like growth factor II mRNA binding protein 1|insulin-like growth factor II mRNA binding protein 2|Y
insulin-like growth factor II mRNA binding protein 1|insulin-like growth factor II mRNA-binding protein 1|Y
insulin-like growth factor II mRNA binding protein 1|insulin-like growth factor II mRNA binding protein|Y
insulin-like growth factor II mRNA binding protein 1|insulin-like growth factor II mRNA binding protein 3|Y
2-arachidonylglycerol|2-arachidonoylglycerol|Y
Fourier transform infrared|Fourier transform infra red|Y
Fourier transform infrared|Fourier transform infra-red|Y
small-conductance calcium-activated potassium channel|small conductance calcium-activated potassium channel|Y
surface-enhanced laser desorption ionisation time-of-flight mass spectrometry|surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry|Y
surface-enhanced laser desorption ionisation time-of-flight mass spectrometry|surface-enhanced laser desorption ionization time-of-flight mass spectrometry|Y
surface-enhanced laser desorption ionisation time-of-flight mass spectrometry|surface enhanced laser desorption ionisation time-of-flight mass spectrometry|Y
Na-K-2Cl co-transporter 2|Na-K-Cl co-transporter 2|Y
ventriculo-atrial conduction|ventriculoatrial conduction|Y
γ-aminobutyric acid transporter|γ-amino-butyric acid transporter|Y
γ-aminobutyric acid transporter|γ-amino butyric acid transporter|Y
gastroœsophageal pressure gradient|gastro-œsophageal pressure gradient|Y
peptide nucleic acid-fluorescence in situ hybridisation|peptide nucleic acid fluorescence in situ hybridisation|Y
peptide nucleic acid-fluorescence in situ hybridisation|peptide nucleic acid-fluorescence in situ hybridization|Y
Vibrio cholerae O1 El-Tor|Vibrio cholerae O1 ElTor|Y
lithium-pilocarpine induced status epilepticus|lithium/pilocarpine induced status epilepticus|Y
non-selective cation channel|nonselective cation channel|Y
anti-synthetase syndrome|antisynthetase syndrome|Y
esophago-duodenal anastomosis|esophagoduodenal anastomosis|Y
X-ray repair cross complementing protein 1|x-ray repair cross complementing protein 1|Y
X-ray repair cross complementing protein 1|X-ray repair cross complementing protein 2|Y
dihydroxy-phenylethanol|dihydroxyphenylethanol|Y
frontal mid-line θ rhythm|frontal midline θ rhythm|Y
Yo-Yo Intermittent Recovery Test level 1|Yo-Yo Intermittent Recovery Test level 2|Y
tumour necrosis factor related apoptosis-inducing ligand|tumor necrosis factor related apoptosis-inducing ligand|Y
tumour necrosis factor related apoptosis-inducing ligand|tumour necrosis factor-related apoptosis-inducing ligand|Y
tumour necrosis factor related apoptosis-inducing ligand|tumour necrosis factor related apoptosis inducing ligand|Y
augmented correlation-consistent polarized valence triple zeta basis set|augmented correlation-consistent polarised valence triple zeta basis set|Y
augmented correlation-consistent polarized valence triple zeta basis set|augmented correlation consistent polarized valence triple zeta basis set|Y
augmented correlation-consistent polarized valence triple zeta basis set|augmented correlation-consistent polarized valence triple-zeta basis set|Y
Rab-interacting lysosomal protein|Rab7-interacting lysosomal protein|Y
supercritical fluid chromatography/mass spectrometry|supercritical fluid chromatography-mass spectrometry|Y
poly(ethylene terephthalate)|poly-(ethylene terephthalate)|Y
poly(ethylene terephthalate)|poly(ethyleneterephthalate)|Y
poly(ethylene terephthalate)|poly (ethylene terephthalate)|Y
tissue-bound angiotensin converting enzyme|tissue-bound angiotensin-converting enzyme|Y
tissue-bound angiotensin converting enzyme|tissue bound angiotensin converting enzyme|Y
interferon-alfa-2b-induced|interferon-alfa2b-induced|Y
three-dimensional volumetric interpolated breath-hold examination|three dimensional volumetric interpolated breath-hold examination|Y
dioleoylphosphatidylcholine|dioleoylphosphatidyl-choline|Y
anti-phospholipid antibody|antiphospholipid antibody|Y
non starch polysaccharide|nonstarch polysaccharide|Y
chemotherapy induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy|Y
chlorambucil, vinblastine, procarbazine and prednisolone|chlorambucil, vinblastine, procarbazine and prednisone|Y
acid-sensing ion channel 1a|acid-sensing ion channel 1|Y
sporulation protein IIIJ|sporulation protein IIJ|Y
electro-phoretic deposition|electrophoretic deposition|Y
nucleotide-binding domain and leucine-rich repeat containing protein|nucleotide-binding domain and leucine-rich repeat-containing protein|Y
G-protein-coupled oestrogen receptor 1|G-protein-coupled estrogen receptor 1|Y
sterically stabilized liposome|sterically stabilized liposomes|Y
lymphokine activated killer cells|lymphokine activated killer cell|Y
temporo-mandibular joint dysfunction|temporomandibular joint dysfunction|Y
non-fermentative bacillus|nonfermentative bacillus|Y
intra-molecular chaperone|intramolecular chaperone|Y
alpha-difluoromethyl ornithine|alpha-difluoromethylornithine|Y
near point accomodation|near point accommodation|Y
enzyme linked immuno-absorbant assay|enzyme linked immunoabsorbant assay|Y
American Society of Anaesthesiology Grade 2|American Society of Anaesthesiology Grade V|Y
American Society of Anaesthesiology Grade 2|American Society of Anaesthesiology Grade 5|Y
American Society of Anaesthesiology Grade 2|American Society of Anesthesiology Grade 2|Y
type IIa sodium phosphate co-transporter|type IIa sodium phosphate cotransporter|Y
type IIa sodium phosphate co-transporter|type IIa sodium/phosphate co-transporter|Y
type IIa sodium phosphate co-transporter|type II sodium phosphate co-transporter|Y
peroxisome-proliferator-activated receptor-γ co-activator-1 α|peroxisome-proliferator-activated receptor γ coactivator-1 α|Y
peroxisome-proliferator-activated receptor-γ co-activator-1 α|peroxisome-proliferator-activated receptor-γ coactivator-1α|Y
peroxisome-proliferator-activated receptor-γ co-activator-1 α|peroxisome proliferator-activated receptor-γ coactivator-1 α|Y
peroxisome-proliferator-activated receptor-γ co-activator-1 α|peroxisome-proliferator-activated receptor-γ co-activator 1 α|Y
peroxisome-proliferator-activated receptor-γ co-activator-1 α|peroxisome proliferator-activated receptor-γ co-activator-1α|Y
peroxisome-proliferator-activated receptor-γ co-activator-1 α|peroxisome proliferator-activated receptor-γ co-activator-1 α|Y
pressurized metered dose inhalers|pressurized metered dose inhaler|Y
high resolution gas chromatography-high resolution mass spectrometry|high resolution gas chromatography/high resolution mass spectrometry|Y
polymorphonuclear neutrophil granulocytes|Polymorphonuclear neutrophil granulocytes|Y
polymorphonuclear neutrophil granulocytes|polymorphonuclear neutrophil granulocyte|Y
polymorphonuclear neutrophil granulocytes|polymorphonuclear neutrophilic granulocytes|Y
erythroid burst-forming units|erythroid burst-forming unit|Y
phosphorylated calcium-calmodulin dependent protein kinase II|phosphorylated calcium-calmodulin-dependent protein kinase II|Y
phosphorylated calcium-calmodulin dependent protein kinase II|phosphorylated calcium/calmodulin dependent protein kinase II|Y
inductively coupled plasma-quadrupole mass spectrometry|inductively coupled plasma quadrupole mass spectrometry|Y
[3H]N-methylscopolamine|[3H]N-methyl scopolamine|Y
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide|1-ethyl-3-(3-dimethylaminopropyl)carbodiimide|Y
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide|1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide|Y
receptor-like protein-tyrosine phosphatase-ψ|receptor-like protein-tyrosine phosphatase-κ|Y
receptor-like protein-tyrosine phosphatase-ψ|receptor-like protein-tyrosine phosphatase|Y
receptor-like protein-tyrosine phosphatase-ψ|receptor-like protein-tyrosine phosphatase-δ|Y
receptor-like protein-tyrosine phosphatase-ψ|receptor-like protein-tyrosine phosphatase-μ|Y
receptor-like protein-tyrosine phosphatase-ψ|receptor-like protein-tyrosine phosphatase ψ|Y
receptor-like protein-tyrosine phosphatase-ψ|receptor-like protein tyrosine phosphatase-ψ|Y
receptor-like protein-tyrosine phosphatase-ψ|receptor-like protein-tyrosine phosphatase-η|Y
receptor-like protein-tyrosine phosphatase-ψ|receptor-like protein-tyrosine phosphatase-ζ|Y
gastroentero-pancreatic|gastroenteropancreatic|Y
gastroentero-pancreatic|gastro-entero-pancreatic|Y
v-rel reticuloendotheliosis viral oncogene homolog A|v-rel reticuloendotheliosis viral oncogene homologue A|Y
v-rel reticuloendotheliosis viral oncogene homolog A|v-rel reticuloendotheliosis viral oncogene homolog B|Y
neuro-psychiatric SLE|neuropsychiatric SLE|Y
interleukine-18 receptor alpha|interleukin-18 receptor alpha|Y
trauma focused cognitive behavioural therapy|trauma focused cognitive behavioral therapy|Y
trauma focused cognitive behavioural therapy|trauma-focused cognitive behavioural therapy|Y
neuro-intermediate lobe|neurointermediate lobe|Y
immunoelectroosmophoresis|immunoelectro-osmophoresis|Y
non-muscle myosin heavy chain IIA|nonmuscle myosin heavy chain IIA|Y
non-muscle myosin heavy chain IIA|non-muscle myosin heavy chain II|Y
high-performance liquid chromatography-evaporative light scattering detection|high performance liquid chromatography-evaporative light scattering detection|Y
augmented correlation-consistent polarized valence quadruple-zeta basis set|augmented correlation-consistent polarized valence quadruple zeta basis set|Y
augmented correlation-consistent polarized valence quadruple-zeta basis set|augmented correlation-consistent polarised valence quadruple-zeta basis set|Y
anti-sheep immunoglobulin G|antisheep immunoglobulin G|Y
enzyme-linked immuno-absorbent assay|enzyme-linked immunoabsorbent assay|Y
orthophenylenediamine|ortho-phenylenediamine|Y
Shiga toxin-producing Escherichia coli|Shigatoxin-producing Escherichia coli|Y
G-protein α inhibitory subunit|G-protein α1 inhibitory subunit|Y
G-protein α inhibitory subunit|G-protein α3 inhibitory subunit|Y
ribosomal protein S17|ribosomal protein S7|Y
single strand conformation polymorphism|single strand conformational polymorphism|Y
University of Washington Quality-of-Life questionnaire|University of Washington Quality-of-Life Questionnaire|Y
ras-related GTP-binding protein 10|ras-related GTP-binding protein 1|Y
steroid receptor co-activator|steroid receptor coactivator|Y
platelet-derived growth factor receptor β|platelet-derived growth factor receptor α|Y
interleukine-13 receptor alpha1 subunit|interleukin-13 receptor alpha1 subunit|Y
extraskeletal myxoid chondrosarcoma|extra-skeletal myxoid chondrosarcoma|Y
contra-lateral breast cancer|contralateral breast cancer|Y
zinc finger homeodomain enhancer-binding protein-1|zinc finger homeodomain enhancer-binding protein|Y
zinc finger homeodomain enhancer-binding protein-1|zinc finger homeodomain enhancer-binding protein-2|Y
polylactide co-glycolide|polylactide coglycolide|Y
nonspecific interstitial pneumonitis|non-specific interstitial pneumonitis|Y
sulfachlorpyridazine|sulfachloropyridazine|Y
posttransplantation lymphoproliferative disorder|post-transplantation lympho-proliferative disorder|Y
posttransplantation lymphoproliferative disorder|post-transplantation lymphoproliferative disorder|Y
posttransplantation lymphoproliferative disorder|post transplantation lymphoproliferative disorders|Y
posttransplantation lymphoproliferative disorder|posttransplantation lympho-proliferative disorder|Y
Joint Commission for Accreditation of Health Care Organizations|Joint Commission on Accreditation of Health Care Organizations|Y
pre-axial polydactyly type IV|preaxial polydactyly type IV|Y
hexa-fluoro-isopropanol|hexafluoro-isopropanol|Y
cranio-facial anomaly|craniofacial anomaly|Y
Occupational Safety and Health Administration's|Occupational Safety and Health Administration|Y
retinoblastoma protein-interacting zinc finger|retinoblastoma protein-interacting zinc-finger|Y
retinoblastoma protein-interacting zinc finger|retinoblastoma protein-interacting zinc finger 2|Y
retinoblastoma protein-interacting zinc finger|retinoblastoma protein-interacting zinc finger 1|Y
capillary electrophoresis-time-of-flight mass spectrometry|capillary electrophoresis-time-of-flight/mass spectrometry|Y
capillary electrophoresis-time-of-flight mass spectrometry|capillary electrophoresis-time-of-flight-mass spectrometry|Y
capillary electrophoresis-time-of-flight mass spectrometry|capillary electrophoresis time-of-flight mass spectrometry|Y
quantitative ultra-sound index|quantitative ultrasound index|Y
anti-interleukin-5 antibody|anti-interleukin-15 antibody|Y
anti-T-cell receptor-alpha beta antibody|anti-T-cell receptor-alphabeta antibody|Y
anti-T-cell receptor-alpha beta antibody|anti-T cell receptor-alpha beta antibody|Y
anti-T-cell receptor-alpha beta antibody|anti-T-cell receptor-alpha/beta antibody|Y
anti-T-cell receptor-alpha beta antibody|anti-T-cell receptor alpha beta antibody|Y
extracellular-signal regulated protein kinase 5|extracellular-signal-regulated protein kinase 5|Y
placental lactogen-II|placental lactogen-I|Y
craniocervical malformation|cranio-cervical malformation|Y
technetium-99m galactosyl neoglycoalbumin|technetium-99m galactosylneoglycoalbumin|Y
technetium-99m galactosyl neoglycoalbumin|technetium-99m galactosyl-neoglycoalbumin|Y
lisdexamfetamine dimesylate|lis-dexamfetamine dimesylate|Y
ovine submaxillary mucin|bovine submaxillary mucin|Y
endoscopic ultrasound guided fine-needle aspiration|endoscopic ultrasound-guided fine-needle aspiration|Y
endoscopic ultrasound guided fine-needle aspiration|endoscopic ultrasound guided fine needle aspiration|Y
ductal intraepithelial neoplasia|ductal intra-epithelial neoplasia|Y
quantitative fluorescence in-situ hybridisation|quantitative fluorescence in situ hybridisation|Y
quantitative fluorescence in-situ hybridisation|quantitative fluorescence in-situ hybridization|Y
malignancy-associated changes|malignancy-associated change|Y
alpha-glucosyltransferase|alpha-glucosyl transferase|Y
interferon-alpha2b-induced|interferon-alpha-2b-induced|Y
cluster of differentiation 147|cluster of differentiation 17|Y
tumour-to-background ratio|tumor-to-background ratio|Y
leucocyte-associated immunoglobulin-like receptor-1|leucocyte-associated immunoglobulin-like receptor 1|Y
intravascular bronchiolo-alveolar tumour|intravascular bronchiolo-alveolar tumor|Y
magic-angle spinning nuclear magnetic resonance|magic-angle-spinning nuclear magnetic resonance|Y
histamine-releasing factor|histamine-releasing factors|Y
melatonin receptor 1A|melatonin receptor 1|Y
scanning electron microscopy/X-ray energy dispersive spectrometry|scanning electron microscopy X-ray energy dispersive spectrometry|Y
scanning electron microscopy/X-ray energy dispersive spectrometry|scanning electron microscopy/x-ray energy dispersive spectrometry|Y
right ventricular preejection period|right ventricular pre-ejection period|Y
poly-laevo-lactic acid|poly-laevolactic acid|Y
non-invasive positive pressure ventilation|non-invasive positive-pressure ventilation|Y
multiple-monitored electroconvulsive therapy|multiple-monitored electro-convulsive therapy|Y
Chronic Disease Self-Management Programme|Chronic Disease Self-Management Program|Y
Na-K-2Cl cotransporter-2|Na-K-Cl cotransporter-2|Y
Na-K-2Cl cotransporter-2|Na-K-2Cl co-transporter-2|Y
para-aminohippurate clearance|paraaminohippurate clearance|Y
chronic intestinal pseudoobstruction|chronic intestinal pseudo-obstruction|Y
walleye epidermal hyperplasia virus type 1|walleye epidermal hyperplasia virus type 2|Y
cellular immunodeficiency|cellular immuno-deficiency|Y
hemoglobin A2-Monreale|haemoglobin A2-Monreale|Y
transient receptor potential vanilloid type 4|transient receptor potential vanilloid type 5|Y
transient receptor potential vanilloid type 4|transient receptor potential vanilloid type 1|Y
transient receptor potential vanilloid type 4|transient receptor potential vanilloid type 2|Y
transient receptor potential vanilloid type 4|transient receptor potential vanilloid type 3|Y
hyperglycæmic hyperosmolar non-ketotic syndrome|hyperglycæmic hyperosmolar nonketotic syndrome|Y
hyperglycæmic hyperosmolar non-ketotic syndrome|hyperglycemic hyperosmolar non-ketotic syndrome|Y
transforming growth factor beta signalling pathway|transforming growth factor beta signaling pathway|Y
transforming growth factor beta signalling pathway|transforming growth factor-beta signalling pathway|Y
desaminotyrosylfibrinopeptide A|desaminotyrosyl-fibrinopeptide A|Y
multicolour fluorescence in situ hybridisation|multi-colour fluorescence in situ hybridisation|Y
Agrobacterium tumefaciens mediated transformation|Agrobacterium tumefaciens-mediated transformation|Y
trifluoro-methylphenylpiperazine|trifluoro-methylphenyl piperazine|Y
trifluoro-methylphenylpiperazine|trifluoromethylphenylpiperazine|Y
dimethylarginine dimethylaminohydrolase|dimethylarginine dimethylamino-hydrolase|Y
laevonorgestrel-releasing intra-uterine device|levonorgestrel-releasing intrauterine device|Y
laevonorgestrel-releasing intra-uterine device|laevonorgestrel releasing intra-uterine device|Y
laevonorgestrel-releasing intra-uterine device|laevonorgestrel-releasing intrauterine device|Y
calcium/calmodulin-dependent kinase kinase|calcium-calmodulin-dependent kinase kinase|Y
calcium/calmodulin-dependent kinase kinase|calcium/calmodulin dependent kinase kinase|Y
micro-computed tomography|microcomputed tomography|Y
pituitary tumor-derived fibroblast growth factor receptor 4|pituitary tumor-derived fibroblast growth factor receptor-4|Y
pituitary tumor-derived fibroblast growth factor receptor 4|pituitary tumour-derived fibroblast growth factor receptor 4|Y
pituitary tumor-derived fibroblast growth factor receptor 4|pituitary tumor derived fibroblast growth factor receptor 4|Y
healthcare associated infection|health care associated infection|Y
healthcare associated infection|health-care associated infection|Y
peroxisome proliferator activated receptor gamma coactivator 1 alpha protein|peroxisome proliferator activated receptor gamma coactivator 1alpha protein|Y
peroxisome proliferator activated receptor gamma coactivator 1 alpha protein|peroxisome proliferator-activated receptor gamma coactivator 1alpha protein|Y
1-palmitoyl-2-oleoyl phosphatidylcholine|1-palmitoyl-2-oleoylphosphatidylcholine|Y
1-palmitoyl-2-oleoyl phosphatidylcholine|1-palmitoyl-2-oleoyl-phosphatidylcholine|Y
broncho-pulmonary dysplasia|bronchopulmonary dysplasia|Y
video-laryngo-stroboscopy|videolaryngo-stroboscopy|Y
video-laryngo-stroboscopy|video-laryngostroboscopy|Y
tumor-infiltrating lymphocyte|tumour-infiltrating lymphocyte|Y
ouabainlike compound|ouabain-like compound|Y
multifluor fluorescence in-situ hybridisation|multifluor fluorescence in situ hybridisation|Y
multifluor fluorescence in-situ hybridisation|multi-fluor fluorescence in-situ hybridisation|Y
multi-locus variable number tandem repeat analysis|multi-locus variable-number tandem repeat analysis|Y
multi-locus variable number tandem repeat analysis|multi-locus variable number tandem-repeat analysis|Y
Reis-Bücklers' corneal dystrophy|Reis-Bücklers corneal dystrophy|Y
silver stained nucleolar organiser region|silver-stained nucleolar organiser region|Y
silver stained nucleolar organiser region|silver stained nucleolar organizer region|Y
IL-13 receptor α1 chain|IL-13 receptor α 1 chain|Y
eucaryotic translation initiation factor 5|eucaryotic translation initiation factor 2|Y
eucaryotic translation initiation factor 5|eucaryotic translation initiation factor 3|Y
N-acetyl-muramyl-L-alanyl-D-isoglutamine|N-acetylmuramyl-L-alanyl-D-isoglutamine|Y
hypo-gamma globulinemia|hypo-gamma globulinaemia|Y
hypo-gamma globulinemia|hypo-gammaglobulinemia|Y
phosphatidylinositol bis-phosphate|phosphatidyl inositol bis-phosphate|Y
phosphatidylinositol bis-phosphate|phosphatidyl-inositol bis-phosphate|Y
anti-neutrophil cytoplasmic antibody positive|antineutrophil cytoplasmic antibody positive|Y
anti-neutrophil cytoplasmic antibody positive|anti-neutrophil cytoplasmic antibody-positive|Y
krüppel-like factor-2|krüppel-like factor-12|Y
International Veterinary Students' Association|International Veterinary Students Association|Y
microphotoelectric plethysmography|micro-photoelectric plethysmography|Y
hysterosalpingoscintigraphy|hysterosalpingo-scintigraphy|Y
anti phospholipid antibody|antiphospholipid antibody|Y
neural-precursor-cell-expressed, developmentally down-regulated 9|neural-precursor-cell-expressed, developmentally downregulated 9|Y
neural-precursor-cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed developmentally down-regulated 9|Y
neural-precursor-cell-expressed, developmentally down-regulated 9|neural-precursor-cell-expressed, developmentally downregulated 1|Y
neural-precursor-cell-expressed, developmentally down-regulated 9|neural-precursor-cell-expressed developmentally down-regulated 8|Y
neural-precursor-cell-expressed, developmentally down-regulated 9|neural-precursor cell-expressed, developmentally downregulated 9|Y
neural-precursor-cell-expressed, developmentally down-regulated 9|neural-precursor-cell-expressed, developmentally down-regulated 1|Y
neural-precursor-cell-expressed, developmentally down-regulated 9|neural-precursor-cell-expressed developmentally downregulated 9|Y
neural-precursor-cell-expressed, developmentally down-regulated 9|neural-precursor-cell-expressed developmentally down-regulated 5|Y
neural-precursor-cell-expressed, developmentally down-regulated 9|neural-precursor-cell-expressed, developmentally down-regulated 8|Y
neural-precursor-cell-expressed, developmentally down-regulated 9|neural-precursor-cell-expressed, developmentally down-regulated 5|Y
neural-precursor-cell-expressed, developmentally down-regulated 9|neural-precursor-cell-expressed developmentally down-regulated 9|Y
neural-precursor-cell-expressed, developmentally down-regulated 9|neural-precursor-cell-expressed, developmentally down-regulated 4|Y
neural-precursor-cell-expressed, developmentally down-regulated 9|neural-precursor-cell-expressed, developmentally downregulated 5|Y
neural-precursor-cell-expressed, developmentally down-regulated 9|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor-cell-expressed, developmentally down-regulated 9|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor-cell-expressed, developmentally down-regulated 9|neural-precursor-cell-expressed developmentally down-regulated 1|Y
neural-precursor-cell-expressed, developmentally down-regulated 9|neural-precursor-cell-expressed, developmentally downregulated 2|Y
5-hydroxytryptamine1d|5-hydroxytryptamine1|Y
return-to-zero differential phase shift keying|return-to-zero differential phase-shift keying|Y
anti-asialo-GM(1) antibody|antiasialo-GM(1) antibody|Y
transforming growth factor-beta4|transforming growth factor-beta 4|Y
transforming growth factor-beta4|transforming growth factor-beta|Y
radio-immunoprecipitation|radioimmunoprecipitation|Y
src homology 2 domain-containing protein tyrosine phosphatase 2|src homology 2 domain-containing protein tyrosine phosphatase-2|Y
src homology 2 domain-containing protein tyrosine phosphatase 2|src homology-2 domain-containing protein tyrosine phosphatase 2|Y
src homology 2 domain-containing protein tyrosine phosphatase 2|src homology 2 domain-containing protein tyrosine phosphatase 1|Y
Biopharmaceutics Classification System Class 3|Biopharmaceutics Classification System Class|Y
Biopharmaceutics Classification System Class 3|Biopharmaceutics Classification System Class 2|Y
Biopharmaceutics Classification System Class 3|Biopharmaceutics Classification System Class 4|Y
Biopharmaceutics Classification System Class 3|Biopharmaceutics Classification System Class 1|Y
electron probe micro-analysis|electron probe microanalysis|Y
hyperpolarisation-activated cyclic nucleotide-gated channel|hyperpolarisation-activated cyclic nucleotide gated channel|Y
hyperpolarisation-activated cyclic nucleotide-gated channel|hyperpolarisation activated cyclic nucleotide-gated channel|Y
hyperpolarisation-activated cyclic nucleotide-gated channel|hyperpolarization-activated cyclic nucleotide-gated channel|Y
1-(gamma-glutamylamino)cyclopropane-1-carboxylic acid|1-(gamma-L-glutamylamino)cyclopropane-1-carboxylic acid|Y
non-specific vaginitis|nonspecific vaginitis|Y
cystic fibrosis trans-membrane regulator|cystic fibrosis transmembrane regulator|Y
Fc-gamma receptor-mediated|Fcgamma receptor-mediated|Y
angiotensinconverting enzyme inhibitor|angiotensin converting enzyme inhibitor|Y
angiotensinconverting enzyme inhibitor|angiotensin-converting enzyme inhibitor|Y
intraoperative neuromonitoring|intra-operative neuromonitoring|Y
TATA-binding protein associated factor 3|TATA-binding protein-associated factor 3|Y
TATA-binding protein associated factor 3|TATA-binding protein associated factor 6|Y
TATA-binding protein associated factor 3|TATA-binding protein associated factor 4|Y
TATA-binding protein associated factor 3|TATA-binding protein associated factor 5|Y
TATA-binding protein associated factor 3|TATA-binding protein associated factor-3|Y
forced mid expiratory flow|forced midexpiratory flow|Y
ischemia modified albumin|ischaemia modified albumin|Y
intra-vesical pressure|intravesical pressure|Y
bio-prosthetic heart valve|bioprosthetic heart valve|Y
polysialylated neural cell adhesion molecule|polysialylated-neural cell adhesion molecule|Y
dentatorubro-pallido-luysian atrophy|dentato-rubro-pallido-luysian atrophy|Y
trifunctional protein|tri-functional protein|Y
oro-facio-digital syndrome type V|oro-facio-digital syndrome type IV|Y
comodulation masking release|co-modulation masking release|Y
transpulmonary gradient|trans-pulmonary gradient|Y
dehydro-epiandrosterone sulfate|dehydroepiandrosterone sulfate|Y
retinoblastoma protein-interacting zinc-finger|retinoblastoma protein-interacting zinc-finger 1|Y
tissue inhibitor of metalloproteinase-1|tissue inhibitor of metalloproteinases-1|Y
chitolipooligosaccharide|chitolipo-oligosaccharide|Y
docosa-hexaenoic acid|docosahexaenoic acid|Y
adult T cell leukemia-virus-associated antigen|adult T cell leukemia virus-associated antigen|Y
adult T cell leukemia-virus-associated antigen|adult T-cell leukemia-virus-associated antigen|Y
antiguinea pig immunoglobulin G|anti-guinea pig immunoglobulin G|Y
pseudoexfoliation syndrome|pseudo-exfoliation syndrome|Y
di-isopropylphosphoryl|diisopropylphosphoryl|Y
generalised principal component analysis|generalized principal component analysis|Y
immuno-electrophoretic analysis|immunoelectrophoretic analysis|Y
beta amyloid precursor protein-cleaving enzyme|beta amyloid precursor protein-cleaving enzyme-1|Y
beta amyloid precursor protein-cleaving enzyme|beta amyloid precursor protein-cleaving enzyme 1|Y
beta amyloid precursor protein-cleaving enzyme|beta amyloid precursor protein-cleaving enzyme 2|Y
beta amyloid precursor protein-cleaving enzyme|beta-amyloid precursor protein-cleaving enzyme|Y
beta amyloid precursor protein-cleaving enzyme|beta amyloid precursor protein cleaving enzyme|Y
interleukin-13 receptor α2-chain|interleukine-13 receptor α2-chain|Y
interleukin-13 receptor α2-chain|interleukin-13 receptor α 2-chain|Y
antibothropic fraction|anti-bothropic fraction|Y
nonhistone chromatin protein|non-histone chromatin protein|Y
transactivation response element|trans-activation response element|Y
tubulo-cisternal endoplasmic reticulum|tubulocisternal endoplasmic reticulum|Y
nitroglycerin-mediated dilatation|nitroglycerine-mediated dilatation|Y
sporulation in the absence of Spo eleven-gene 1|sporulation in the absence of Spo eleven-gene 2|Y
inositol triphosphate|inositol trisphosphate|Y
galactose-1-phosphate uridylyltransferase|galactose-1-phosphate uridyltransferase|Y
outpatient cardiac rehabilitation|out-patient cardiac rehabilitation|Y
anticitrullinated protein antibody|anti-citrullinated protein antibody|Y
temperature programmed oxidation|temperature programed oxidation|Y
alveolar macrophage-derived growth factor|alveolar macrophage derived growth factor|Y
hemoglobin S-C disease|hemoglobin SC disease|Y
prothrombin fragment F1+2|prothrombin fragment 1+2|Y
hypothalamo-pituitary adrenal axis|hypothalamopituitary adrenal axis|Y
tetra-ethyl-thiuramdisulfide|tetra-ethyl-thiuram disulfide|Y
endo-bronchial ultrasonography|endobronchial ultrasonography|Y
superspreading event|super-spreading event|Y
poly(A)-binding protein nuclear 1|poly (A)-binding protein nuclear 1|Y
androgen-sterilized rats|androgen-sterilized rat|Y
major breakpoint cluster region|major break-point cluster region|Y
retinoic acid receptor beta|retinoic acid receptor beta2|Y
glycosyl phosphatidylinositol anchored protein|glycosylphosphatidyl-inositol anchored protein|Y
glycosyl phosphatidylinositol anchored protein|glycosyl-phosphatidylinositol anchored protein|Y
glycosyl phosphatidylinositol anchored protein|glycosyl phosphatidylinositol-anchored protein|Y
glycosyl phosphatidylinositol anchored protein|glycosylphosphatidylinositol anchored protein|Y
glycosyl phosphatidylinositol anchored protein|glycosylphosphatidyl inositol anchored protein|Y
anti-hepatitis C virus-positive|antihepatitis C virus-positive|Y
cytosolic phospholipase A(2)|cytosolic phospholipase A(2)α|Y
excision repair cross-complementing group 1|excision repair cross-complementing group 4|Y
excision repair cross-complementing group 1|excision repair cross-complementing group 6|Y
excision repair cross-complementing group 1|excision repair cross-complementing-group 1|Y
excision repair cross-complementing group 1|excision repair cross-complementing group 3|Y
excision repair cross-complementing group 1|excision repair cross-complementing group 5|Y
juvenile nasopharyngeal angiofibroma|juvenile naso-pharyngeal angiofibroma|Y
liquid chromatography-ion trap mass spectrometry|liquid chromatography-ion trap-mass spectrometry|Y
liquid chromatography-ion trap mass spectrometry|liquid chromatography-ion-trap mass spectrometry|Y
liquid chromatography-ion trap mass spectrometry|liquid chromatography/ion trap mass spectrometry|Y
programmed-temperature vaporization|programmed-temperature vapourization|Y
beta amyloid precursor protein-cleaving enzyme-1|beta amyloid precursor protein-cleaving enzyme 1|Y
beta amyloid precursor protein-cleaving enzyme-1|beta amyloid precursor protein cleaving enzyme-1|Y
transepicondylar axis|trans-epicondylar axis|Y
alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate|alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate|Y
post-operative mortality|postoperative mortality|Y
anti-granulocyte-macrophage colony-stimulating-factor antibody|anti-granulocyte-macrophage colony-stimulating factor antibody|Y
ureteroneocystostomy|uretero-neocystostomy|Y
fluorescent-labeled antibody|fluorescent-labelled antibody|Y
monoacetoxy-scirpenol|monoacetoxyscirpenol|Y
insulin-like growth factor-I level|insulin-like growth factor-II level|Y
transvaginal hysterectomy|trans-vaginal hysterectomy|Y
American Society of Anaesthesiologists Grade V|American Society of Anaesthesiologists Grade IV|Y
American Society of Anaesthesiologists Grade V|American Society of Anesthesiologists Grade IV|Y
American Society of Anaesthesiologists Grade V|American Society of Anaesthesiologists Grade 1|Y
American Society of Anaesthesiologists Grade V|American Society of Anesthesiologists Grade V|Y
American Society of Anaesthesiologists Grade V|American Society of Anaesthesiologists Grade 3|Y
American Society of Anaesthesiologists Grade V|American Society of Anaesthesiologists Grade 4|Y
American Society of Anaesthesiologists Grade V|American Society of Anaesthesiologists Grade 5|Y
organochlorine compound|organo-chlorine compound|Y
symmetry-adapted cluster-configuration interaction|symmetry adapted cluster-configuration interaction|Y
crosspolarisation magic-angle spinning|cross-polarisation magic-angle spinning|Y
crosspolarisation magic-angle spinning|cross polarisation magic-angle spinning|Y
centromedian nucleus|centro-median nucleus|Y
proinsulin-like growth factor-I|proinsulin-like growth factor-II|Y
food protein-induced enterocolitis syndrome|food-protein-induced enterocolitis syndrome|Y
a disintegrin and metalloproteinase with thrombospondin motif-20|a disintegrin and metalloproteinase with thrombospondin motifs-20|Y
a disintegrin and metalloproteinase with thrombospondin motif-20|a disintegrin and metalloproteinase with thrombospondin motif-1|Y
a disintegrin and metalloproteinase with thrombospondin motif-20|a disintegrin and metalloprotease with thrombospondin motif-20|Y
a disintegrin and metalloproteinase with thrombospondin motif-20|a disintegrin and metalloprotease with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-20|a disintegrin and metalloproteinase with thrombospondin motif-9|Y
a disintegrin and metalloproteinase with thrombospondin motif-20|a disintegrin and metalloproteinase with thrombospondin motif|Y
a disintegrin and metalloproteinase with thrombospondin motif-20|a disintegrin and metalloprotease with thrombospondin motifs-20|Y
a disintegrin and metalloproteinase with thrombospondin motif-20|a disintegrin and metalloproteinase with thrombospondin motif-8|Y
a disintegrin and metalloproteinase with thrombospondin motif-20|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloproteinase with thrombospondin motif-20|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloproteinase with thrombospondin motif-20|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-20|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motif-20|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-20|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motif-20|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-20|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-20|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
Internal External Locus of Control Scale|Internal-External Locus of Control Scale|Y
Internal External Locus of Control Scale|Internal/External Locus of Control Scale|Y
Becke3-Lee-Yang-Parr|Becke-3-Lee-Yang-Parr|Y
Becke3-Lee-Yang-Parr|Becke 3-Lee-Yang-Parr|Y
Medical Outcomes Study 36-Item Short Form Health Survey Version 2|Medical Outcomes Study 36 Item Short Form Health Survey Version 2|Y
Medical Outcomes Study 36-Item Short Form Health Survey Version 2|Medical Outcomes Study 36-Item Short-Form Health Survey Version 2|Y
guanosine triphosphatase activating protein|guanosine triphosphatase activating protein-1|Y
guanosine triphosphatase activating protein|guanosine triphosphatase-activating protein|Y
guanosine triphosphatase activating protein|guanosine triphosphatase activating protein 1|Y
pea seed borne mosaic virus|pea seedborne mosaic virus|Y
α 2 plasmin inhibitor/plasmin complex|α2 plasmin inhibitor/plasmin complex|Y
α-1A-adrenergic receptor|α1A-adrenergic receptor|Y
heparan sulfate glycosaminoglycan|heparan sulfate glycosaminoglycans|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay|terminal-deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling assay|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay|terminal-deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labelling assay|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling assay|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling assay|Y
International Neuroblastoma Staging System stage III|International Neuroblastoma Staging System stage II|Y
International Neuroblastoma Staging System stage III|International Neuroblastoma Staging System Stage III|Y
microtubule-associated protein 2D|microtubule-associated protein 2|Y
multivitamin infusion|multi-vitamin infusion|Y
intragastric pressure|intra-gastric pressure|Y
murine granulocyte-macrophage colony stimulating factor|murine granulocyte-macrophage colony-stimulating factor|Y
multi-channel intra-lumenal impedance|multi-channel intralumenal impedance|Y
multi-channel intra-lumenal impedance|multichannel intra-lumenal impedance|Y
preharvest sprouting|pre-harvest sprouting|Y
experimental autoimmune uveitis|experimental auto-immune uveitis|Y
interleukin-7 receptor α chain|interleukine-7 receptor α chain|Y
potassium-chloride cotransporter 3|potassium-chloride co-transporter 3|Y
meticillin-resistant S. pseudintermedius|methicillin-resistant S. pseudintermedius|Y
meticillin-resistant S. pseudintermedius|meticillin resistant S. pseudintermedius|Y
human adenovirus serotype 16|human adenovirus serotype 1|Y
human adenovirus serotype 16|human adenovirus serotype 6|Y
experimental autoimmune myocarditis|experimental auto-immune myocarditis|Y
American Society of Anaesthesiology class|American Society of Anaesthesiology class V|Y
American Society of Anaesthesiology class|American Society of Anaesthesiology class 5|Y
American Society of Anaesthesiology class|American Society of Anaesthesiology class 3|Y
American Society of Anaesthesiology class|American Society of Anaesthesiology class 2|Y
American Society of Anaesthesiology class|American Society of Anaesthesiology class 1|Y
aminoglycoside antibiotic induced deafness|aminoglycoside antibiotic-induced deafness|Y
chloroaluminum sulphonated phthalocyanine|chloro-aluminum sulphonated phthalocyanine|Y
cytosolic branched chain aminotransferase|cytosolic branched-chain aminotransferase|Y
intercuspal position|inter-cuspal position|Y
ultrananocrystalline diamond|ultra-nanocrystalline diamond|Y
α2-Heremans-Schmid glycoprotein|α-2-Heremans-Schmid glycoprotein|Y
interleukin-18 receptor α chain|interleukine-18 receptor α chain|Y
surface-assisted laser desorption/ionisation time-of-flight mass spectrometry|surface-assisted laser desorption/ionization time-of-flight mass spectrometry|Y
transient lower esophageal sphincter relaxations|transient lower oesophageal sphincter relaxation|Y
transient lower esophageal sphincter relaxations|transient lower esophageal sphincter relaxation|Y
transient lower esophageal sphincter relaxations|Transient lower esophageal sphincter relaxations|Y
cytokine-induced neutrophil chemoattractant 2alpha|cytokine-induced neutrophil chemoattractant-2alpha|Y
tachykinin-related peptides|tachykinin-related peptide|Y
latent TGFβ binding protein 1|latent TGF-β binding protein 1|Y
latent TGFβ binding protein 1|latent TGF β binding protein 1|Y
nearfield acoustical holography|near-field acoustical holography|Y
bone morphogenetic protein receptor 1A|bone morphogenetic protein receptor 1|Y
α-2 Heremans-Schmid glycoprotein|α2 Heremans-Schmid glycoprotein|Y
eukaryotic translation elongation factor 1 α|eukaryotic translation elongation factor 1α|Y
eukaryotic translation elongation factor 1 α|eukaryotic translation elongation factor 1α1|Y
eukaryotic translation elongation factor 1 α|eukaryotic translation elongation factor 1 α 1|Y
Ste20-related proline alanine rich kinase|Ste-20-related proline alanine rich kinase|Y
Ste20-related proline alanine rich kinase|Ste20-related proline alanine-rich kinase|Y
platelet-derived growth factor β receptor|platelet-derived growth factor-β receptor|Y
platelet-derived growth factor β receptor|platelet derived growth factor β receptor|Y
recombinant murine interleukin 18|recombinant murine interleukin 1|Y
purinergic 2Y2 receptor|purinergic 2Y receptor|Y
purinergic 2Y2 receptor|purinergic 2Y12 receptor|Y
hydroxy-tryptamine receptor|hydroxytryptamine receptor|Y
anti-T-cell receptor alpha beta monoclonal antibody|anti-T cell receptor alpha beta monoclonal antibody|Y
anti-T-cell receptor alpha beta monoclonal antibody|anti-T-cell receptor-alpha beta monoclonal antibody|Y
N-(ethoxycarbonyl)-2-ethoxy-1,2-dihydroquinoline|N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline|Y
chronic noncancer pain|chronic non-cancer pain|Y
temperature-programmed desorption-mass spectrometry|temperature-programed desorption-mass spectrometry|Y
xeroderma pigmentosum complementation group A|xeroderma pigmentosum complementation group D|Y
xeroderma pigmentosum complementation group A|xeroderma pigmentosum complementation group C|Y
xeroderma pigmentosum complementation group A|xeroderma pigmentosum complementation group G|Y
xeroderma pigmentosum complementation group A|xeroderma pigmentosum complementation group E|Y
American Society of Anesthesiologists Class 1|American Society of Anesthesiologists Class I|Y
American Society of Anesthesiologists Class 1|American Society of Anaesthesiologists Class 1|Y
American Society of Anesthesiologists Class 1|American Society of Anesthesiologists Class|Y
American Society of Anesthesiologists Class 1|American Society of Anesthesiologists Class 3|Y
American Society of Anesthesiologists Class 1|American Society of Anesthesiologists Class 2|Y
American Society of Anesthesiologists Class 1|American Society of Anesthesiologists class 1|Y
American Society of Anesthesiologists Class 1|American Society of Anesthesiologists Class 4|Y
anticyclic citrullinated peptide|anti-cyclic citrullinated peptide|Y
matrix-assisted laser desorption ionization time-of-flight mass spectrometric|matrix-assisted laser desorption ionisation time-of-flight mass spectrometric|Y
matrix-assisted laser desorption ionization time-of-flight mass spectrometric|matrix assisted laser desorption ionization time-of-flight mass spectrometric|Y
matrix-assisted laser desorption ionization time-of-flight mass spectrometric|matrix-assisted laser desorption ionization time-of-flight mass spectrometry|Y
matrix-assisted laser desorption ionization time-of-flight mass spectrometric|matrix-assisted laser desorption/ionization time-of-flight mass spectrometric|Y
molecularly imprinted solid-phase extraction|molecularly imprinted solid phase extraction|Y
molecularly imprinted solid-phase extraction|molecularly-imprinted solid-phase extraction|Y
adenylate cyclase-haemolysin|adenylate cyclase-hemolysin|Y
surface-enhanced laser desorption/ionisation time of flight mass spectrometry|surface-enhanced laser desorption ionisation time of flight mass spectrometry|Y
surface-enhanced laser desorption/ionisation time of flight mass spectrometry|surface-enhanced laser desorption/ionization time of flight mass spectrometry|Y
surface-enhanced laser desorption/ionisation time of flight mass spectrometry|surface enhanced laser desorption/ionisation time of flight mass spectrometry|Y
interleukine-4 receptor-α chain|interleukin-4 receptor-α chain|Y
interleukine-13 receptor α 2 chain|interleukine-13 receptor α2 chain|Y
interleukine-13 receptor α 2 chain|interleukin-13 receptor α 2 chain|Y
immunoreactive inhibin|immuno-reactive inhibin|Y
outpatient commitment|out-patient commitment|Y
β-amyloid precursor protein-cleaving enzyme-2|β-amyloid precursor protein cleaving enzyme-2|Y
β-amyloid precursor protein-cleaving enzyme-2|β-amyloid precursor protein-cleaving enzyme-1|Y
β-amyloid precursor protein-cleaving enzyme-2|β amyloid precursor protein-cleaving enzyme-2|Y
nontranscribed spacer|non-transcribed spacer|Y
dipeptidyl-amino-peptidase IV|dipeptidyl-amino-peptidase I|Y
never in mitosis, gene A-related kinase 9|never in mitosis, gene A-related kinase 7|Y
never in mitosis, gene A-related kinase 9|never in mitosis, gene A-related kinase 3|Y
never in mitosis, gene A-related kinase 9|never in mitosis, gene A-related kinase 6|Y
never in mitosis, gene A-related kinase 9|never in mitosis, gene A-related kinase 4|Y
α-1 antitrypsin deficiency|α1 antitrypsin deficiency|Y
intraluminal thrombus|intra-luminal thrombus|Y
coefficient of variations|coefficients of variations|Y
coefficient of variations|coefficient of variation|Y
C-C chemokine ligand 24|C-C chemokine ligand 4|Y
C-C chemokine ligand 24|CC chemokine ligand 24|Y
Fcγ receptor dependent|Fc-γ receptor dependent|Y
transmembrane voltage|trans-membrane voltage|Y
tumor necrosis factor-related apoptosis-inducing ligand receptor|tumor necrosis factor-related apoptosis-inducing ligand receptor 1|Y
tumor necrosis factor-related apoptosis-inducing ligand receptor|tumour necrosis factor-related apoptosis-inducing ligand receptor|Y
tumor necrosis factor-related apoptosis-inducing ligand receptor|tumor necrosis factor related apoptosis-inducing ligand receptor|Y
tumor necrosis factor-related apoptosis-inducing ligand receptor|tumor necrosis factor-related apoptosis-inducing ligand receptor-1|Y
tumor necrosis factor-related apoptosis-inducing ligand receptor|tumor necrosis factor-related apoptosis inducing ligand receptor|Y
tumor necrosis factor-related apoptosis-inducing ligand receptor|tumour necrosis factor-related apoptosis-inducing ligand receptor-1|Y
tumor necrosis factor-related apoptosis-inducing ligand receptor|tumour necrosis factor-related apoptosis-inducing ligand receptor 1|Y
antiinterleukin-6 neutralizing antibody|anti-interleukin-6 neutralizing antibody|Y
antigalactosyl antibody|anti-galactosyl antibody|Y
neural-precursor-cell-expressed, developmentally downregulated 9|neural-precursor-cell-expressed, developmentally downregulated 1|Y
neural-precursor-cell-expressed, developmentally downregulated 9|neural-precursor cell-expressed, developmentally downregulated 9|Y
neural-precursor-cell-expressed, developmentally downregulated 9|neural-precursor-cell-expressed developmentally downregulated 2|Y
neural-precursor-cell-expressed, developmentally downregulated 9|neural-precursor-cell-expressed, developmentally down-regulated 1|Y
neural-precursor-cell-expressed, developmentally downregulated 9|neural-precursor-cell-expressed developmentally downregulated 9|Y
neural-precursor-cell-expressed, developmentally downregulated 9|neural-precursor-cell-expressed, developmentally down-regulated 8|Y
neural-precursor-cell-expressed, developmentally downregulated 9|neural-precursor-cell-expressed, developmentally down-regulated 5|Y
neural-precursor-cell-expressed, developmentally downregulated 9|neural-precursor-cell-expressed developmentally down-regulated 9|Y
neural-precursor-cell-expressed, developmentally downregulated 9|neural-precursor-cell-expressed, developmentally down-regulated 4|Y
neural-precursor-cell-expressed, developmentally downregulated 9|neural-precursor-cell-expressed, developmentally downregulated 5|Y
neural-precursor-cell-expressed, developmentally downregulated 9|neural-precursor-cell-expressed developmentally downregulated 5|Y
neural-precursor-cell-expressed, developmentally downregulated 9|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor-cell-expressed, developmentally downregulated 9|neural-precursor-cell-expressed, developmentally downregulated 2|Y
growth differentiation factor 9B|growth differentiation factor 9|Y
peroxisome-proliferator-activated receptor γ coactivator-1 α|peroxisome proliferator-activated receptor γ co-activator-1 α|Y
peroxisome-proliferator-activated receptor γ coactivator-1 α|peroxisome-proliferator-activated receptor γ coactivator 1 α|Y
peroxisome-proliferator-activated receptor γ coactivator-1 α|peroxisome proliferator-activated receptor γ coactivator-1 α|Y
thromboxane A2/prostaglandin H2 receptor antagonist|thromboxane A2-prostaglandin H2 receptor antagonist|Y
insulin-like growth factor-II messenger RNA binding protein 2|insulin-like growth factor-II messenger RNA-binding protein 2|Y
insulin-like growth factor-II messenger RNA binding protein 2|insulin-like growth factor-II messenger RNA binding protein 1|Y
insulin-like growth factor-II messenger RNA binding protein 2|insulin-like growth factor II messenger RNA binding protein 2|Y
insulin-like growth factor-II messenger RNA binding protein 2|insulin-like growth factor-II messenger RNA binding protein-2|Y
insulin-like growth factor-II messenger RNA binding protein 2|insulin-like growth factor-II messenger RNA binding protein 3|Y
Wilms tumor protein 1|Wilm's tumor protein 1|Y
American Spinal Injury Association grade C|American Spinal Injury Association grade B|Y
American Spinal Injury Association grade C|American Spinal Injury Association grade A|Y
continuous veno-venous haemofiltration|continuous veno-venous hemofiltration|Y
carbon dioxide tension|carbon dioxide tensions|Y
killer cell-activating receptor-associated protein|killer cell activating receptor-associated protein|Y
Minneapolis Veterans Affairs Medical Center|Minneapolis Veteran's Affairs Medical Center|Y
Minneapolis Veterans Affairs Medical Center|Minneapolis Veterans' Affairs Medical Center|Y
gap junction intercellular communication|gap junctional intercellular communication|Y
nicotinamide adenine dinucleotide phosphate oxidase 2|nicotinamide adenine dinucleotide phosphate oxidase 4|Y
nicotinamide adenine dinucleotide phosphate oxidase 2|nicotinamide adenine dinucleotide phosphate oxidase 1|Y
nicotinamide adenine dinucleotide phosphate oxidase 2|nicotinamide adenine dinucleotide phosphate oxidase|Y
macrocephaly cutis marmorata telangiectatica congenita|macrocephaly-cutis marmorata telangiectatica congenita|Y
BCL2 associated X-protein|BCL-2 associated X-protein|Y
type II 5'-deiodinase|type I 5'-deiodinase|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural-precursor cell-expressed, developmentally down-regulated 2|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural-precursor cell-expressed developmentally downregulated 4|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural-precursor cell-expressed developmentally down-regulated 8|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural-precursor cell-expressed developmentally down-regulated 1|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural-precursor cell-expressed developmentally downregulated 2|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural-precursor cell-expressed, developmentally downregulated 9|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural-precursor cell-expressed, developmentally down-regulated 8|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural-precursor cell-expressed, developmentally down-regulated 1|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural-precursor cell-expressed developmentally downregulated 8|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural-precursor cell-expressed developmentally downregulated 5|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural-precursor cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural-precursor-cell-expressed developmentally downregulated 9|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural-precursor cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural-precursor-cell-expressed developmentally down-regulated 9|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural precursor cell-expressed developmentally down-regulated 9|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural precursor cell-expressed developmentally downregulated 9|Y
neural-precursor cell-expressed developmentally down-regulated 9|neural precursor cell-expressed, developmentally down-regulated 9|Y
isotope dilution-gas chromatography/mass-spectrometry|isotope dilution gas chromatography/mass-spectrometry|Y
isotope dilution-gas chromatography/mass-spectrometry|isotope dilution-gas chromatography/mass spectrometry|Y
vaginal birth after caesarean|vaginal birth after cesarean|Y
pathological tumor-3, pathological node-0|pathological tumor-2, pathological node-0|Y
nucleotide-binding oligomerization domain-like receptor|nucleotide-binding oligomerisation domain-like receptor|Y
nucleotide-binding oligomerization domain-like receptor|nucleotide binding oligomerization domain-like receptor|Y
human adenovirus type 9|human adenovirus type 39|Y
human adenovirus type 9|human adenovirus type 49|Y
human adenovirus type 9|human adenovirus type 19|Y
thrombolysis in myocardial infarction grade 1|thrombolysis in myocardial infarction grade 3|Y
thrombolysis in myocardial infarction grade 1|thrombolysis in myocardial infarction grade 0|Y
thrombolysis in myocardial infarction grade 1|thrombolysis in myocardial infarction grade 2|Y
cranio-spinal irradiation|craniospinal irradiation|Y
IL7 receptor α-chain|IL-7 receptor α-chain|Y
transforming growth factor beta1|transforming growth factor beta-1|Y
transforming growth factor beta1|transforming growth factor beta 1|Y
terminal-deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling assay|terminal-deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay|Y
terminal-deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling assay|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labelling assay|Y
lower oesophageal mucosal ring|lower esophageal mucosal ring|Y
phosphorylated microtubule associated protein-1B|phosphorylated microtubule-associated protein-1B|Y
spontaneously hypertensive rate|spontaneously hypertensive rat|Y
micro-neutralisation test|microneutralisation test|Y
antimicrobial prophylaxis|anti-microbial prophylaxis|Y
voltage-gated calcium channel α 1 subunit|voltage-gated calcium channel α-1 subunit|Y
voltage-gated calcium channel α 1 subunit|voltage-gated calcium channel α 1-subunit|Y
fibro-muscular dysplasia|fibromuscular dysplasia|Y
non-canonical amino acid|noncanonical amino acid|Y
dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin|dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin|Y
dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin|dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin|Y
dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin|dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin|Y
electroencephalographic|electro-encephalographic|Y
non-proliferative diabetic retinopathy|nonproliferative diabetic retinopathy|Y
murine γherpesvirus-68|murine γ-herpesvirus-68|Y
murine γherpesvirus-68|murine γ herpesvirus-68|Y
axillo-bifemoral bypass|axillobifemoral bypass|Y
N-(7-diamethylamino-4-methyl-3-coumarinyl) maleimide|N-(7-dimethylamino-4-methyl-3-coumarinyl) maleimide|Y
theca interstitial cell|thecal interstitial cell|Y
formylmethionyl-leucyl-phenylalanine|formylmethionyl-leucylphenylalanine|Y
tri-iodo benzoic acid|tri-iodobenzoic acid|Y
α 2-plasmin inhibitor/plasmin complex|α2-plasmin inhibitor/plasmin complex|Y
uro-genital tuberculosis|urogenital tuberculosis|Y
5-hydroxytryptamine6 receptor|5-hydroxytryptamine receptor|Y
Arbeitsgemeinschaft für Osteosynthesefragen|Arbeitsgemeinschaft fur Osteosynthesefragen|Y
corticotrophin-releasing-hormone|corticotropin-releasing-hormone|Y
tensile bond strength|µtensile bond strength|Y
transient receptor potential vanilloid receptor 2|transient receptor potential vanilloid receptor 4|Y
transient receptor potential vanilloid receptor 2|transient receptor potential vanilloid receptor 6|Y
transient receptor potential vanilloid receptor 2|transient receptor potential vanilloid receptor 1|Y
transient receptor potential vanilloid receptor 2|transient receptor potential vanilloid receptor 5|Y
Ramaria flavobrunnescens|Ramaria flavo-brunnescens|Y
lymphangioleiomyomatosis|lymphangio-leiomyomatosis|Y
epidermal cell-derived thymocyte-activating factor|epidermal cell derived thymocyte-activating factor|Y
anti-T cell receptor-α/β monoclonal antibody|anti-T cell receptor α/β monoclonal antibody|Y
anti-T cell receptor-α/β monoclonal antibody|anti-T-cell receptor-α/β monoclonal antibody|Y
apo-horseradish peroxidase|apohorseradish peroxidase|Y
uteroplacental blood flow|utero-placental blood flow|Y
intra-cranial hematoma|intra-cranial haematoma|Y
quasi-frequency-modulated|quasifrequency-modulated|Y
oro-facio-digital syndrome type III|oro-facio-digital syndrome type II|Y
hyper-homocysteinaemia|hyper-homocysteinemia|Y
extraosseous Ewing sarcoma|extra-osseous Ewing sarcoma|Y
cortico-basal ganglionic degeneration|corticobasal ganglionic degeneration|Y
ATP-binding cassette sub-family G member 2|ATP-binding cassette subfamily G member 2|Y
hexaperi-hexabenzocoronene|hexa-peri-hexabenzocoronene|Y
peroxisome proliferator-activated receptor gamma 1|peroxisome proliferator-activated receptor gamma1|Y
peroxisome proliferator-activated receptor gamma 1|peroxisome proliferator-activated receptor-gamma 1|Y
peroxisome proliferator-activated receptor gamma 1|peroxisome proliferator activated receptor gamma 1|Y
peroxisome proliferator-activated receptor gamma 1|peroxisome proliferator-activated receptor gamma-1|Y
peroxisome proliferator-activated receptor gamma 1|peroxisome proliferator-activated receptor gamma 2|Y
tumour associated trypsin inhibitor|tumor associated trypsin inhibitor|Y
N-methylnicotinamide|N'-methylnicotinamide|Y
N-methylnicotinamide|N1-methylnicotinamide|Y
non gonococcal urethritis|nongonococcal urethritis|Y
rabbit antigoat immunoglobulin G|rabbit anti-goat immunoglobulin G|Y
non-melanomatous skin cancer|nonmelanomatous skin cancer|Y
laser desorption ionization time-of-flight mass spectrometry|laser desorption/ionization time-of-flight mass spectrometry|Y
laser desorption ionization time-of-flight mass spectrometry|laser desorption-ionization time-of-flight mass spectrometry|Y
laser desorption ionization time-of-flight mass spectrometry|laser desorption ionisation time-of-flight mass spectrometry|Y
laser desorption ionization time-of-flight mass spectrometry|laser-desorption ionization time-of-flight mass spectrometry|Y
transcatheter chemo-embolisation|transcatheter chemoembolisation|Y
transcatheter chemo-embolisation|trans-catheter chemo-embolisation|Y
a disintegrin and metalloproteinase with thrombospondin motifs-20|a disintegrin and metalloproteinase with thrombospondin motifs-1|Y
a disintegrin and metalloproteinase with thrombospondin motifs-20|a disintegrin and metalloproteinase with thrombospondin motifs-3|Y
a disintegrin and metalloproteinase with thrombospondin motifs-20|a disintegrin and metalloprotease with thrombospondin motif-20|Y
a disintegrin and metalloproteinase with thrombospondin motifs-20|a disintegrin and metalloprotease with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-20|a disintegrin and metalloprotease with thrombospondin motifs-20|Y
a disintegrin and metalloproteinase with thrombospondin motifs-20|a disintegrin and metalloproteinase with thrombospondin motifs-8|Y
a disintegrin and metalloproteinase with thrombospondin motifs-20|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-20|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motifs-20|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motifs-20|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-20|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-20|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-20|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-20|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motifs-20|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-20|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
dorsomedial striatum|dorso-medial striatum|Y
intra-epithelial lymphocyte|intraepithelial lymphocyte|Y
dixydroxy-phenylethanol elenolic acid|dixydroxyphenylethanol elenolic acid|Y
aorto-iliac reconstruction|aortoiliac reconstruction|Y
interleukin-1 receptor-associated kinase|interleukin-1 receptor associated kinase|Y
interleukin-1 receptor-associated kinase|interleukin-1 receptor-associated kinase 4|Y
liquid chromatography/atmospheric pressure chemical ionization-ion trap mass spectrometry|liquid chromatography/atmospheric pressure chemical ionisation-ion trap mass spectrometry|Y
liquid chromatography/atmospheric pressure chemical ionization-ion trap mass spectrometry|liquid chromatography-atmospheric pressure chemical ionization-ion trap mass spectrometry|Y
liquid chromatography/atmospheric pressure chemical ionization-ion trap mass spectrometry|liquid chromatography/atmospheric pressure chemical ionisation ion trap mass spectrometry|Y
liquid chromatography/atmospheric pressure chemical ionization-ion trap mass spectrometry|liquid chromatography-atmospheric pressure chemical ionisation-ion trap mass spectrometry|Y
3-morpholinosydnonimine|3-morpholino sydnonimine|Y
extended Huckel molecular orbital calculation|extended Hückel molecular orbital calculation|Y
tumor necrosis factor receptor superfamily member 23|tumor necrosis factor receptor superfamily member 25|Y
tumor necrosis factor receptor superfamily member 23|tumor necrosis factor receptor superfamily member 12|Y
intra-ocular transfer|intraocular transfer|Y
estrogen receptor regulated|oestrogen receptor regulated|Y
ornithine transcarbamoylase|ornithine transcarbamylase|Y
bioelectrical impedance|bio-electrical impedance|Y
tumor necrosis factor receptor associated factor-6|tumor necrosis factor receptor associated factor 6|Y
tumor necrosis factor receptor associated factor-6|tumor necrosis factor receptor associated factor-5|Y
tumor necrosis factor receptor associated factor-6|tumor necrosis factor receptor-associated factor-6|Y
tumor necrosis factor receptor associated factor-6|tumor necrosis factor receptor associated factor-1|Y
tumor necrosis factor receptor associated factor-6|tumor necrosis factor receptor associated factor-2|Y
cytosolic free Ca2+ level|cytosolic free Ca2+ levels|Y
alpha-acetyl-lysine methyl ester|alpha-acetyllysine methyl ester|Y
calcium binding site II|calcium binding site III|Y
calcium binding site II|calcium binding site I|Y
corrected Q-T interval|corrected QT interval|Y
standardized uptake values|standardized uptake value|Y
non-linear least-square|nonlinear least-square|Y
clathrin-coated vesicles|clathrin-coated vesicle|Y
solid-phase extraction-high-performance liquid chromatography|solid-phase extraction-high performance liquid chromatography|Y
solid-phase extraction-high-performance liquid chromatography|solid phase extraction-high-performance liquid chromatography|Y
trans-myocardial laser revascularisation|trans-myocardial laser revascularization|Y
trans-myocardial laser revascularisation|transmyocardial laser revascularisation|Y
long-term nonprogressor|long-term nonprogressors|Y
methyl cytidine-phosphate-guanosine binding domain protein 4|methyl cytidine-phosphate-guanosine binding domain protein 1|Y
methyl cytidine-phosphate-guanosine binding domain protein 4|methyl cytidine-phosphate-guanosine binding domain protein 3|Y
RR multiple sclerosis|R/R multiple sclerosis|Y
gadolinium-diethylene-triamine pentaacetic acid|gadolinium-diethylene-triamine-pentaacetic acid|Y
gadolinium-diethylene-triamine pentaacetic acid|gadolinium-diethylenetriamine pentaacetic acid|Y
gadolinium-diethylene-triamine pentaacetic acid|gadolinium-diethylene triamine pentaacetic acid|Y
hydroxymethyglutaryl coenzyme A reductase|hydroxymethylglutaryl coenzyme A reductase|Y
corticotrophin-releasing-hormone receptor-2|corticotrophin-releasing-hormone receptor 2|Y
corticotrophin-releasing-hormone receptor-2|corticotrophin-releasing-hormone receptor|Y
tracheo-innominate artery fistula|tracheoinnominate artery fistula|Y
pathological tumor-2a|pathological tumor-2|Y
robot-assisted laparoscopic prostatectomy|robot assisted laparoscopic prostatectomy|Y
postpartum urinary retention|post-partum urinary retention|Y
ST segment elevation|S-T segment elevation|Y
tumor necrosis factor receptor superfamily member 12A|tumor necrosis factor receptor superfamily member 1A|Y
tumor necrosis factor receptor superfamily member 12A|tumor necrosis factor receptor superfamily member 12|Y
adreno-corticotrophic hormone|adreno-corticotropic hormone|Y
macrophage-inflammatory protein-1 β|macrophage-inflammatory protein-1β|Y
TBP associated factor-10|TBP associated factor-1|Y
benzo(a)pyrene diol-epoxide DNA adduct level|benzo(a)pyrene diol epoxide DNA adduct level|Y
benzo(a)pyrene diol-epoxide DNA adduct level|benzo(a)pyrene diol-epoxide-DNA adduct level|Y
human-chorionic-gonadotrophin-stimulated|human-chorionic-gonadotropin-stimulated|Y
post-nuclear supernatant|postnuclear supernatant|Y
spontaneous intracerebral hematoma|spontaneous intra-cerebral hematoma|Y
surface-enhanced laser desorption/ionization|Surface-enhanced laser desorption/ionization|Y
surface-enhanced laser desorption/ionization|surface-enhanced laser desorption-ionization|Y
surface-enhanced laser desorption/ionization|surface-enhanced laser desorption ionization|Y
antiglutamic acid decarboxylase 65 antibody|anti-glutamic acid decarboxylase 65 antibody|Y
tubulo-interstitial nephropathy|tubulointerstitial nephropathy|Y
electrospray ionization quadrupole time-of-flight mass spectrometry|electrospray ionization quadrupole time-of-flight mass spectrometer|Y
ste-20-related proline-alanine-rich kinase|ste-20-related proline alanine-rich kinase|Y
ste-20-related proline-alanine-rich kinase|ste20-related proline-alanine-rich kinase|Y
ste-20-related proline-alanine-rich kinase|Ste-20-related proline-alanine-rich kinase|Y
galactorrhea amenorrhea hyperprolactinæmia syndrome|galactorrhoea amenorrhea hyperprolactinæmia syndrome|Y
galactorrhea amenorrhea hyperprolactinæmia syndrome|galactorrhea amenorrhea hyperprolactinemia syndrome|Y
galactorrhea amenorrhea hyperprolactinæmia syndrome|galactorrhea-amenorrhea hyperprolactinæmia syndrome|Y
galactorrhea amenorrhea hyperprolactinæmia syndrome|galactorrhœa amenorrhea hyperprolactinæmia syndrome|Y
galactorrhea amenorrhea hyperprolactinæmia syndrome|galactorrhea amenorrhoea hyperprolactinæmia syndrome|Y
galactorrhea amenorrhea hyperprolactinæmia syndrome|galactorrhea amenorrhœa hyperprolactinæmia syndrome|Y
5-hydroxytryptamine4|5-hydroxytryptamine 4|Y
non-methylene interrupted|nonmethylene interrupted|Y
preproadrenomedullin|prepro-adrenomedullin|Y
peroxisome proliferator activated receptor γ co-activator 1|peroxisome proliferator-activated receptor γ co-activator 1|Y
retro-bulbar neuritis|retrobulbar neuritis|Y
gamma-amino-butyric acidA|gamma-aminobutyric acidA|Y
three colour fluorescence in-situ hybridization|three color fluorescence in-situ hybridization|Y
three colour fluorescence in-situ hybridization|three colour fluorescence in-situ hybridisation|Y
three colour fluorescence in-situ hybridization|three-colour fluorescence in-situ hybridization|Y
bacteria-associated haemophagocytic syndrome|bacteria-associated hemophagocytic syndrome|Y
pre-hydrolysis liquor|prehydrolysis liquor|Y
anti-insulin-like growth factor-1 receptor antibody|anti-insulin-like growth factor 1 receptor antibody|Y
anti-insulin-like growth factor-1 receptor antibody|anti-insulin-like growth factor-I receptor antibody|Y
50% effective concentration|50% effective concentrations|Y
calcium release-activated calcium channel|calcium-release-activated calcium channel|Y
anti-matrix metalloproteinase 3 antibody|anti-matrix metalloproteinase 2 antibody|Y
anti-matrix metalloproteinase 3 antibody|anti-matrix metalloproteinase 13 antibody|Y
anti-matrix metalloproteinase 3 antibody|anti-matrix metalloproteinase 7 antibody|Y
anti-matrix metalloproteinase 3 antibody|anti-matrix metalloproteinase 9 antibody|Y
somatosensory evoked potential|somatosensory evoked potentials|Y
somatosensory evoked potential|somato-sensory evoked potential|Y
Paediatric Index of Mortality|Pediatric Index of Mortality|Y
neurocutaneous melanosis|neuro-cutaneous melanosis|Y
trans-tubular potassium gradient|transtubular potassium gradient|Y
calcium voltage-gated channel subunit alpha 1 F|calcium voltage-gated channel subunit alpha 1 C|Y
murmumrs, rubs, gallops|murmurs, rubs, gallops|Y
monosodium urate crystal induced inflammation|monosodium urate crystal-induced inflammation|Y
postdecapitation reflex|post-decapitation reflex|Y
pre-ornithine carbamyl transferase|pre-ornithine carbamoyl transferase|Y
Phaseolus vulgaris leuco-agglutinin|Phaseolus vulgaris leucoagglutinin|Y
poly(ethylene glycol) 400|poly(ethylene glycol) 4000|Y
p-hydroxy-mercuribenzoate|p-hydroxymercuribenzoate|Y
intra-cervical device|intracervical device|Y
enzyme linked immuno sorbent assay|enzyme linked immunosorbent assay|Y
American Society of Anaesthesiology Class 5|American Society of Anaesthesiology Class I|Y
American Society of Anaesthesiology Class 5|American Society of Anaesthesiology Class V|Y
American Society of Anaesthesiology Class 5|American Society of Anaesthesiology class 5|Y
American Society of Anaesthesiology Class 5|American Society of Anaesthesiology Class 4|Y
retinoblastoma protein-interacting zinc finger protein 2|retinoblastoma protein-interacting zinc finger protein 1|Y
retinoblastoma protein-interacting zinc finger protein 2|retinoblastoma protein-interacting zinc finger protein|Y
placental form of glutathione-S-transferase|placental form of glutathione S-transferase|Y
X-linked hypophosphataemic rickets|X-linked hypophosphatemic rickets|Y
microelectrode recording|micro-electrode recording|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon β|toll-interleukin 1 receptor domain-containing adapter-inducing interferon-β|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon β|toll-interleukin1 receptor domain-containing adapter-inducing interferon β|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon β|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon β|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon β|toll/interleukin1 receptor domain-containing adapter-inducing interferon β|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon β|Toll-interleukin1 receptor domain-containing adapter-inducing interferon β|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon β|toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon β|toll-interleukin-1 receptor domain-containing adapter-inducing interferon β|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon β|toll-interleukin1 receptor domain-containing adapter inducing interferon β|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon β|toll/interleukin 1 receptor domain-containing adapter-inducing interferon β|Y
sodium glucose co-transporter|sodium glucose cotransporter|Y
Bos taurus autosome 29|Bos taurus autosome 9|Y
adenosine-5-diphosphate|adenosine-5'-diphosphate|Y
broncho-alveolar cell|bronchoalveolar cell|Y
University of California Santa Barbara|University of California, Santa Barbara|Y
nasoendotracheal tube|naso-endotracheal tube|Y
anti-perinuclear factor|antiperinuclear factor|Y
methyl cytidine-phosphate-guanosine binding domain|methyl cytidine-phosphate-guanosine binding domain 1|Y
methyl cytidine-phosphate-guanosine binding domain|methyl cytidine-phosphate-guanosine binding domain 2|Y
methyl cytidine-phosphate-guanosine binding domain|methyl cytidine-phosphate-guanosine binding domain 5|Y
bone-added osteotome sinus floor elevation|bone added osteotome sinus floor elevation|Y
atomic absorption spectrophotometer|atomic absorption spectro-photometer|Y
retrograde intrarenal surgery|retrograde intra-renal surgery|Y
new-born hearing screening|newborn hearing screening|Y
burst-forming units-erythroid|burst-forming unit-erythroid|Y
multi-focal giant cell encephalitis|multifocal giant cell encephalitis|Y
thymic stroma-derived T-cell growth factor|thymic stroma-derived T cell growth factor|Y
T cell receptor γδ cell|T cell receptor γ-δ cell|Y
T cell receptor γδ cell|T cell receptor γ δ cell|Y
intra-muscular gammaglobulin|intra-muscular gamma-globulin|Y
intra-muscular gammaglobulin|intra-muscular gamma globulin|Y
intra-muscular gammaglobulin|intramuscular gammaglobulin|Y
social behavior and network therapy|social behaviour and network therapy|Y
NADPH: cytochrome P450 reductase|NADPH: cytochrome P-450 reductase|Y
NADPH: cytochrome P450 reductase|NADPH:cytochrome P450 reductase|Y
capacitive micro-machined ultrasonic transducer|capacitive micromachined ultrasonic transducer|Y
intraoperative echocardiography|intra-operative echocardiography|Y
stable xenon enhanced computed tomography|stable xenon-enhanced computed tomography|Y
intra-discal electrothermal therapy|intradiscal electrothermal therapy|Y
poly-adenosine-diphosphate-ribose polymerase|poly-adenosine diphosphate-ribose polymerase|Y
tert-butyldimethylsilyl|tert-butyl-dimethylsilyl|Y
murine erythro-leukaemia cell|murine erythro-leukemia cell|Y
cardiothoracic intensive care unit|cardio-thoracic intensive care unit|Y
pre-B-cell leukaemia transcription factor 1|pre-B-cell leukemia transcription factor 1|Y
pre-B-cell leukaemia transcription factor 1|pre-B-cell leukaemia transcription factor-1|Y
anti-interleukin 2 monoclonal antibody|anti-interleukin 12 monoclonal antibody|Y
anti-interleukin 2 monoclonal antibody|antiinterleukin 2 monoclonal antibody|Y
non-iron-deficiency anaemia|non-iron-deficiency anemia|Y
hyperhomocyst(e)inaemia|hyper-homocyst(e)inaemia|Y
hyperhomocyst(e)inaemia|hyperhomocyst(e)inemia|Y
corticotrophin-releasing factor|corticotropin-releasing factor|Y
TSH binding inhibitor immunoglobulins|TSH binding inhibitor immunoglobulin|Y
Fc γ receptor-dependent|Fcγ receptor-dependent|Y
gamma-amino-butyric acid-B receptor|gamma-amino-butyric acidB receptor|Y
gamma-amino-butyric acid-B receptor|gamma-aminobutyric acid-B receptor|Y
apoptosis-linked gene-2-interacting protein X|apoptosis-linked gene-2 interacting protein X|Y
apoptosis-linked gene-2-interacting protein X|apoptosis-linked gene 2-interacting protein X|Y
interleukin-15 receptor α|interleukin-5 receptor α|Y
interleukin-15 receptor α|interleukine-15 receptor α|Y
xanthine-guanine phosphoribosyl transferase|xanthine-guanine phosphoribosyltransferase|Y
technetium 99m labeled human serum albumin|technetium-99m labeled human serum albumin|Y
intra-vitreal bevacizumab|intravitreal bevacizumab|Y
lymphokine activated killers|lymphokine activated killer|Y
anticytomegalovirus immunoglobulin|anti-cytomegalovirus immunoglobulin|Y
aurine tri-carboxylic acid|aurin tri-carboxylic acid|Y
phosphoramid mustard|phosphoramide mustard|Y
quasi randomised controlled trial|quasirandomised controlled trial|Y
DOXP reductoisomerase|DOXP reducto-isomerase|Y
DOXP reductoisomerase|DXP reductoisomerase|Y
photosensitive epilepsy|photo-sensitive epilepsy|Y
two dimensional time of flight magnetic resonance angiography|two-dimensional time of flight magnetic resonance angiography|Y
Radiation Therapy Oncology Group Grade 2|Radiation Therapy Oncology Group Grade 3|Y
Radiation Therapy Oncology Group Grade 2|Radiation Therapy Oncology Group Grade 0|Y
interleukin 11 receptor α|interleukine 11 receptor α|Y
Incontinence Quality-of-Life Questionnaire|Incontinence Quality-of-Life questionnaire|Y
preimplantation genetic screening|pre-implantation genetic screening|Y
guanine phosphoribosyl transferase|guanine phosphoribosyltransferase|Y
ribosomal protein L6|ribosomal protein L16|Y
ribosomal protein L6|ribosomal protein L26|Y
ribosomal protein L6|ribosomal protein L36|Y
neuro-critical care unit|neurocritical care unit|Y
α-naphthyl-isothiocyanate|α-naphthylisothiocyanate|Y
receptor-operated channel|receptor-operated channels|Y
electrospray interface|electro-spray interface|Y
epithelial neutrophil-activating peptide-78|epithelial neutrophil-activating peptide 78|Y
human pancreatic growth hormone-releasing factor|human pancreatic growth hormone releasing factor|Y
human pancreatic growth hormone-releasing factor|human pancreatic growth-hormone-releasing factor|Y
human pancreatic growth hormone-releasing factor|Human pancreatic growth hormone-releasing factor|Y
S100 calcium binding protein A16|S100 calcium binding protein A1|Y
nasopharyngeal secretion|naso-pharyngeal secretion|Y
mitogen-activated protein kinase activated protein kinase-5|mitogen-activated protein kinase activated protein kinase-2|Y
mitogen-activated protein kinase activated protein kinase-5|mitogen-activated protein kinase-activated protein kinase-5|Y
mitogen-activated protein kinase activated protein kinase-5|mitogen-activated protein kinase activated protein kinase-3|Y
mitogen-activated protein kinase activated protein kinase-5|mitogen-activated protein kinase activated protein kinase-1|Y
mitogen-activated protein kinase activated protein kinase-5|mitogen-activated protein kinase activated protein kinase 5|Y
mitogen-activated protein kinase activated protein kinase-5|mitogen-activated protein kinase activated protein kinase|Y
platelet-derived growth factor receptor beta|platelet derived growth factor receptor beta|Y
platelet-derived growth factor receptor beta|platelet-derived growth factor receptor-beta|Y
chromosomal region maintenance 1-dependent|chromosomal region maintenance 1-independent|Y
insulin/insulin-like growth factor signaling|insulin/insulin-like growth factor-1 signaling|Y
insulin/insulin-like growth factor signaling|insulin/insulin-like growth factor 1 signaling|Y
insulin/insulin-like growth factor signaling|insulin/insulin-like growth factor signalling|Y
mitogen-activated protein kinase activated protein kinase-2|mitogen-activated protein kinase-activated protein kinase-2|Y
mitogen-activated protein kinase activated protein kinase-2|mitogen-activated protein kinase activated protein kinase 2|Y
mitogen-activated protein kinase activated protein kinase-2|mitogen-activated protein kinase activated protein kinase-3|Y
mitogen-activated protein kinase activated protein kinase-2|mitogen-activated protein kinase activated protein kinase-1|Y
mitogen-activated protein kinase activated protein kinase-2|mitogen activated protein kinase activated protein kinase-2|Y
mitogen-activated protein kinase activated protein kinase-2|mitogen-activated protein kinase activated protein kinase|Y
tumor necrosis factor alpha|tumor necrosis factoralpha|Y
galactorrhœa amenorrhoea hyperprolactinemia syndrome|galactorrhœa amenorrhea hyperprolactinaemia syndrome|Y
galactorrhœa amenorrhoea hyperprolactinemia syndrome|galactorrhœa amenorrhea hyperprolactinemia syndrome|Y
galactorrhœa amenorrhoea hyperprolactinemia syndrome|galactorrhœa amenorrhoea hyperprolactinaemia syndrome|Y
galactorrhœa amenorrhoea hyperprolactinemia syndrome|galactorrhœa-amenorrhoea hyperprolactinemia syndrome|Y
anti-secretory factor|antisecretory factor|Y
trinucleotide repeat|tri-nucleotide repeat|Y
vibrational predissociation|vibrational pre-dissociation|Y
growth hormone-releasing hormone receptor|growth hormone releasing hormone receptor|Y
virus-associated haemophagocytic syndrome|virus associated haemophagocytic syndrome|Y
virus-associated haemophagocytic syndrome|virus-associated hemophagocytic syndrome|Y
intracranial reinforcement|intra-cranial reinforcement|Y
verocytotoxin-producing Escherichia coli 0157|verocytotoxin producing Escherichia coli 0157|Y
matrix-assisted laser-desorption ionisation|matrix-assisted laser-desorption/ionisation|Y
7,12-dimethylbenz[a]-anthracene|7,12-dimethylbenz[a]anthracene|Y
hemoglobin Barts disease|hemoglobin Bart's disease|Y
thallium-201 single-photon emission computed tomography|thallium-201 single photon emission computed tomography|Y
thallium-201 single-photon emission computed tomography|thallium 201 single-photon emission computed tomography|Y
Streptomyces clavuligerus deacetoxycephalosporin C synthase|Streptomyces clavuligerus deacetoxycephalosporin C synthetase|Y
mitogen/extracellular-signal-regulated kinase kinase-5|mitogen extracellular-signal-regulated kinase kinase-5|Y
mitogen/extracellular-signal-regulated kinase kinase-5|mitogen/extracellular-signal-regulated kinase kinase 5|Y
infrared light emitting diode|infra-red light emitting diode|Y
galactorrhœa amenorrhœa hyperprolactinemia syndrome|galactorrhœa amenorrhœa hyperprolactinaemia syndrome|Y
galactorrhœa amenorrhœa hyperprolactinemia syndrome|galactorrhœa-amenorrhœa hyperprolactinemia syndrome|Y
galactorrhœa amenorrhœa hyperprolactinemia syndrome|galactorrhœa amenorrhœa hyperprolactinæmia syndrome|Y
galactorrhœa amenorrhœa hyperprolactinemia syndrome|galactorrhœa amenorrhea hyperprolactinemia syndrome|Y
galactorrhœa amenorrhœa hyperprolactinemia syndrome|galactorrhea amenorrhœa hyperprolactinemia syndrome|Y
interleukin-2 receptor α chain|interleukine-2 receptor α chain|Y
adult T-cell leukemia-derived factor|adult T-cell leukaemia-derived factor|Y
malignant mixed Müllerian tumor|malignant mixed Müllerian tumour|Y
recessive X-linked ichthyosis|recessive X-linked icthyosis|Y
B cell leukaemia/lymphoma-2 protein|B cell leukemia/lymphoma-2 protein|Y
plasmin anti-plasmin complex|plasmin antiplasmin complex|Y
Cocaine- and amphetamine-regulated transcript|cocaine- and amphetamine-regulated transcript|Y
radiation induced tumor suppressor gene-1|radiation-induced tumor suppressor gene-1|Y
radiation induced tumor suppressor gene-1|radiation induced tumour suppressor gene-1|Y
radiation induced tumor suppressor gene-1|radiation induced tumor suppressor gene 1|Y
corticomedullary contrast|cortico-medullary contrast|Y
somatotrophic hormone|somatotropic hormone|Y
tumor necrosis factor-related apoptosis-inducing ligand receptor 1|tumour necrosis factor-related apoptosis-inducing ligand receptor|Y
tumor necrosis factor-related apoptosis-inducing ligand receptor 1|tumor necrosis factor-related apoptosis-inducing ligand-receptor 1|Y
tumor necrosis factor-related apoptosis-inducing ligand receptor 1|tumor necrosis factor-related apoptosis-inducing ligand receptor-1|Y
tumor necrosis factor-related apoptosis-inducing ligand receptor 1|tumour necrosis factor-related apoptosis-inducing ligand-receptor 1|Y
tumor necrosis factor-related apoptosis-inducing ligand receptor 1|tumour necrosis factor-related apoptosis-inducing ligand receptor-1|Y
tumor necrosis factor-related apoptosis-inducing ligand receptor 1|tumour necrosis factor-related apoptosis-inducing ligand receptor 1|Y
glycogen synthase kinase-3 α|glycogen synthase kinase-3α|Y
pre-supplementary motor area|presupplementary motor area|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motifs-1|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motif-15|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motif-1|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motif-9|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motif|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motifs-19|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motifs-17|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motif-8|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motif-14|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motifs-15|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motif-19|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
organophosphate induced delayed polyneuropathy|organophosphate-induced delayed polyneuropathy|Y
hemoglobin Necker Enfants-Malades|haemoglobin Necker Enfants-Malades|Y
neural precursor cell expressed developmentally down-regulated 4|neural precursor cell expressed developmentally downregulated 8|Y
neural precursor cell expressed developmentally down-regulated 4|neural precursor cell expressed developmentally downregulated 9|Y
neural precursor cell expressed developmentally down-regulated 4|neural precursor cell expressed, developmentally down-regulated 2|Y
neural precursor cell expressed developmentally down-regulated 4|neural precursor cell expressed, developmentally down-regulated 8|Y
neural precursor cell expressed developmentally down-regulated 4|neural precursor cell-expressed developmentally downregulated 4|Y
neural precursor cell expressed developmentally down-regulated 4|neural precursor cell expressed developmentally down-regulated 1|Y
neural precursor cell expressed developmentally down-regulated 4|neural precursor cell expressed developmentally down-regulated 8|Y
neural precursor cell expressed developmentally down-regulated 4|neural precursor cell expressed developmentally downregulated 4|Y
neural precursor cell expressed developmentally down-regulated 4|neural precursor cell expressed developmentally downregulated 5|Y
neural precursor cell expressed developmentally down-regulated 4|neural precursor cell expressed developmentally downregulated 2|Y
neural precursor cell expressed developmentally down-regulated 4|neural precursor cell expressed, developmentally down-regulated 4|Y
neural precursor cell expressed developmentally down-regulated 4|neural precursor cell expressed, developmentally down-regulated 1|Y
neural precursor cell expressed developmentally down-regulated 4|neural precursor cell expressed developmentally down-regulated 9|Y
neural precursor cell expressed developmentally down-regulated 4|neural precursor cell-expressed developmentally down-regulated 4|Y
neural precursor cell expressed developmentally down-regulated 4|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell expressed developmentally down-regulated 4|neural precursor cell expressed, developmentally down-regulated 5|Y
acid-sensing ion channel-2|acid-sensing ion channel-2b|Y
acid-sensing ion channel-2|acid-sensing ion channel-2a|Y
adenosine monophosphate-activated kinase|adenosine monophosphate activated kinase|Y
25-item National Eye Institute-Visual Function Questionnaire|25-item National Eye Institute Visual Function Questionnaire|Y
25-item National Eye Institute-Visual Function Questionnaire|25-Item National Eye Institute-Visual Function Questionnaire|Y
cardio-myopathic hamster|cardiomyopathic hamster|Y
Hb-S-beta thalassaemia|Hb-S-beta thalassemia|Y
isotope dilution gas chromatography-mass spectrometry|isotope dilution-gas chromatography-mass spectrometry|Y
nuclear factor erythroid 2 p-45-related factor-2|nuclear factor erythroid 2p45-related factor-2|Y
nuclear factor erythroid 2 p-45-related factor-2|nuclear factor erythroid 2 p45-related factor-2|Y
ursodeoxycholic acid|ursodesoxycholic acid|Y
estrogen-receptor-regulated|oestrogen-receptor-regulated|Y
toll/interleukin 1 receptor domain-containing adapter-inducing interferon-β|toll-interleukin 1 receptor domain-containing adapter-inducing interferon-β|Y
toll/interleukin 1 receptor domain-containing adapter-inducing interferon-β|toll/interleukin1 receptor domain-containing adapter-inducing interferon β|Y
toll/interleukin 1 receptor domain-containing adapter-inducing interferon-β|toll/interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
toll/interleukin 1 receptor domain-containing adapter-inducing interferon-β|toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
toll/interleukin 1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin 1 receptor domain-containing adapter-inducing interferon-β|Y
toll/interleukin 1 receptor domain-containing adapter-inducing interferon-β|toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
toll/interleukin 1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
toll/interleukin 1 receptor domain-containing adapter-inducing interferon-β|toll/interleukin 1 receptor domain-containing adapter-inducing interferon β|Y
anti-constipation regimen|anticonstipation regimen|Y
butylated hydroxyanisole|butylated hydroxy anisole|Y
subcritical fluid chromatography|sub-critical fluid chromatography|Y
didodecyldimethylammonium bromide|didodecyl-dimethylammonium bromide|Y
Michael E DeBakey Veterans Affairs Medical Center|Michael E DeBakey Veterans' Affairs Medical Center|Y
Michael E DeBakey Veterans Affairs Medical Center|Michael E. DeBakey Veterans' Affairs Medical Center|Y
Michael E DeBakey Veterans Affairs Medical Center|Michael E. DeBakey Veteran's Affairs Medical Center|Y
Michael E DeBakey Veterans Affairs Medical Center|Michael E DeBakey Veteran's Affairs Medical Center|Y
Michael E DeBakey Veterans Affairs Medical Center|Michael E. DeBakey Veterans Affairs Medical Center|Y
reaction center light-harvesting complex I|reaction centre light-harvesting complex I|Y
reaction center light-harvesting complex I|reaction center-light-harvesting complex I|Y
purinergic 2Y receptor|purinergic 2Y1 receptor|Y
conjunctivodacryocystorhinostomy|conjunctivo-dacryocystorhinostomy|Y
soluble cluster of differentiation 44|soluble cluster of differentiation 4|Y
antigelatin immunoglobulin G|anti-gelatin immunoglobulin G|Y
metered dose inhalers|metered dose inhaler|Y
Plasmodium vivax merozoite surface protein 3|Plasmodium vivax merozoite surface protein 9|Y
Plasmodium vivax merozoite surface protein 3|Plasmodium vivax merozoite surface protein 1|Y
anti-major histocompatibility complex class II monoclonal antibody|anti-major histocompatibility complex class I monoclonal antibody|Y
intraventricular pressure|intra-ventricular pressure|Y
trauma-focused cognitive-behavioral therapy|trauma-focused cognitive-behavioural therapy|Y
trauma-focused cognitive-behavioral therapy|trauma focused cognitive-behavioral therapy|Y
tumor necrosis factor-α|tumour necrosis factor-α|Y
Leptospira interrogans, serogroup Pyrogenes|Leptospira interrogans serogroup Pyrogenes|Y
matrix-assisted laser desorption ionization mass spectrometry|matrix-assisted laser desorption ionisation mass spectrometry|Y
matrix-assisted laser desorption ionization mass spectrometry|matrix-assisted laser desorption/ionization mass spectrometry|Y
matrix-assisted laser desorption ionization mass spectrometry|matrix-assisted laser desorption-ionization mass spectrometry|Y
matrix-assisted laser desorption ionization mass spectrometry|matrix-assisted laser desorption ionization-mass spectrometry|Y
haemoglobin Barts hydrops|hemoglobin Barts hydrops|Y
haemoglobin Barts hydrops|haemoglobin Bart's hydrops|Y
beta adrenergic receptor|beta2 adrenergic receptor|Y
interbreath interval|inter-breath interval|Y
inter-follicular epidermis|interfollicular epidermis|Y
polyhaemoglobin-superoxide dismutase-catalase|polyhemoglobin-superoxide dismutase-catalase|Y
pursed-lips breathing|pursed-lip breathing|Y
anti-interleukin-1 antibody|anti-interleukin-15 antibody|Y
anti-interleukin-1 antibody|anti-interleukin-13 antibody|Y
insecticide-treated net|insecticide-treated nets|Y
posttransplant lympho-proliferative disorder|post-transplant lymphoproliferative disorder|Y
posttransplant lympho-proliferative disorder|posttransplant lymphoproliferative disorder|Y
posttransplant lympho-proliferative disorder|post transplant lymphoproliferative disorder|Y
latent transforming growth factor β binding protein-1|latent transforming growth factor β binding protein 1|Y
latent transforming growth factor β binding protein-1|latent transforming growth factor β-binding protein-1|Y
summed pain intensity difference at 60 minutes post-dose|summed pain intensity difference at 30 minutes post-dose|Y
transforming growth factor β receptor I|transforming growth factor β receptor II|Y
postero-lateral lumbar fusion|posterolateral lumbar fusion|Y
arylamine N-acetyltransferases|arylamine N-acetyltransferase|Y
dithiobissuccinimidylpropionate|dithiobis-succinimidylpropionate|Y
transcranial color-coded sonography|transcranial colour-coded sonography|Y
multi-slice computed tomography|multislice computed tomography|Y
Agrobacterium tumefaciens-mediated transformation|Agrobacterium-tumefaciens-mediated transformation|Y
Philadelphia Veteran's Affairs Medical Center|Philadelphia Veterans' Affairs Medical Center|Y
Philadelphia Veteran's Affairs Medical Center|Philadelphia Veterans Affairs Medical Center|Y
high performance liquid chromatography-hydride generation-atomic fluorescence spectrometry|high-performance liquid chromatography-hydride generation-atomic fluorescence spectrometry|Y
self nano-emulsifying drug delivery system|self nano emulsifying drug delivery system|Y
type III InsP(3) receptor|type II InsP(3) receptor|Y
glutathione synthetase|glutathione synthetase2|Y
combined antiretroviral treatment|combined anti-retroviral treatment|Y
transforming growth factor-beta-activated kinase-1|transforming growth factor-beta activated kinase-1|Y
transforming growth factor-beta-activated kinase-1|transforming growth factor-beta-activated kinase 1|Y
transforming growth factor-beta-activated kinase-1|transforming growth factor beta-activated kinase-1|Y
mesoporous bioactive glass|meso-porous bioactive glass|Y
mesoporous bioactive glass|mesoporous bio-active glass|Y
krüppel-like factor-3|krüppel-like factor-13|Y
apparent diffusion co-efficient|apparent diffusion coefficient|Y
neodymium: yttrium-aluminum-garnet laser|neodymium: yttrium-aluminum garnet laser|Y
neodymium: yttrium-aluminum-garnet laser|neodymium:yttrium-aluminum-garnet laser|Y
microtubule associated protein-1 light chain 3-II|microtubule-associated protein-1 light chain 3-II|Y
microtubule associated protein-1 light chain 3-II|microtubule associated protein 1 light chain 3-II|Y
thyroid-stimulating hormone receptor antibody|thyroid stimulating hormone receptor antibody|Y
ras guanosine triphosphatase-activating protein|Ras guanosine triphosphatase-activating protein|Y
sulphobutylether beta-cyclodextrin|sulphobutyl ether beta-cyclodextrin|Y
hairy/enhancer of split-1|hairy/enhancer of split1|Y
gonadotropin-releasing hormones|gonadotropin-releasing hormone|Y
latent transforming growth factor-beta binding protein 4|latent transforming growth factor-beta binding protein 3|Y
latent transforming growth factor-beta binding protein 4|latent transforming growth factor-beta binding protein 1|Y
latent transforming growth factor-beta binding protein 4|latent transforming growth factor beta binding protein 4|Y
tumour necrosis factor-α protein|tumor necrosis factor-α protein|Y
cross-polarisation magic-angle-spinning nuclear magnetic resonance|cross-polarisation magic-angle spinning nuclear magnetic resonance|Y
cross-polarisation magic-angle-spinning nuclear magnetic resonance|cross-polarization magic-angle-spinning nuclear magnetic resonance|Y
intra-operative cholangiogram|intraoperative cholangiogram|Y
anti-interleukin 3 monoclonal antibody|anti-interleukin 13 monoclonal antibody|Y
anti-interleukin 3 monoclonal antibody|antiinterleukin 3 monoclonal antibody|Y
catalysed reporter deposition fluorescence in situ hybridisation|catalysed reporter deposition fluorescence in situ hybridization|Y
intra-uterine foetal demise|intra-uterine fetal demise|Y
hereditary sensory and autonomic neuropathy type IV|hereditary sensory and autonomic neuropathy type V|Y
hereditary sensory and autonomic neuropathy type IV|hereditary sensory and autonomic neuropathy type II|Y
peripherally inserted central venous catheter|peripherally inserted central venous catheters|Y
probrain natriuretic peptide level|pro-brain natriuretic peptide level|Y
space occupying lesion|spaceoccupying lesion|Y
acute gastroenteritis|acute gastro-enteritis|Y
follicle-stimulating hormones|follicle-stimulating hormone|Y
placental conditioned medium|placenta conditioned medium|Y
A β precursor protein|Aβ precursor protein|Y
bone morphogenetic protein receptor type 1B|bone morphogenetic protein receptor type 1|Y
bone morphogenetic protein receptor type 1B|bone morphogenetic protein receptor type 1A|Y
Vibrio cholerae O1 biotype El Tor|Vibrio cholerae O1 biotype ElTor|Y
very-long-chain acyl-coenzyme A synthetase|very long-chain acyl-coenzyme A synthetase|Y
intracranial hæmatoma|intra-cranial hæmatoma|Y
liquid chromatography-atmospheric pressure photoionisation-mass spectrometry|liquid chromatography-atmospheric pressure photoionisation mass spectrometry|Y
Kruppel-like factor 15|Kruppel-like factor 5|Y
central line associated bloodstream infection|central line-associated bloodstream infection|Y
giant serotonin-containing neurone|giant serotonin-containing neuron|Y
preneoplastic lesion|pre-neoplastic lesion|Y
4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl|4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl|Y
cross-polarization/magic-angle spinning nuclear magnetic resonance|cross polarization/magic-angle spinning nuclear magnetic resonance|Y
cross-polarization/magic-angle spinning nuclear magnetic resonance|cross-polarization/magic angle spinning nuclear magnetic resonance|Y
cross-polarization/magic-angle spinning nuclear magnetic resonance|cross-polarization magic-angle spinning nuclear magnetic resonance|Y
cross-polarization/magic-angle spinning nuclear magnetic resonance|cross-polarization/magic-angle-spinning nuclear magnetic resonance|Y
cross-polarization/magic-angle spinning nuclear magnetic resonance|cross-polarisation/magic-angle spinning nuclear magnetic resonance|Y
American Society of Anesthesiology physical status 4|American Society of Anesthesiology physical status I|Y
American Society of Anesthesiology physical status 4|American Society of Anesthesiology physical status 2|Y
American Society of Anesthesiology physical status 4|American Society of Anesthesiology physical status|Y
American Society of Anesthesiology physical status 4|American Society of Anesthesiology physical status 3|Y
interleukin-13 receptor alpha-1 chain|interleukine-13 receptor alpha-1 chain|Y
interleukin-13 receptor alpha-1 chain|interleukin-13 receptor alpha1 chain|Y
caseinolytic protease P|caseinolytic protease XP|Y
ocular counter-rolling|ocular counterrolling|Y
multiparameter flow cytometry|multi-parameter flow cytometry|Y
macrophage inflammatory protein 1β|macrophage inflammatory protein 1|Y
electrically evoked compound action potential|Electrically evoked compound action potential|Y
electrically evoked compound action potential|electrically evoked compound-action potential|Y
human leukocyte antigen class I-specific|human leucocyte antigen class I-specific|Y
B-cell acute lymphoblastic leukaemia|B-cell acute lymphoblastic leukemia|Y
multidrug resistance associated protein-3|multidrug resistance associated protein|Y
multidrug resistance associated protein-3|multidrug resistance associated protein 3|Y
haemoglobin D-Camperdown|hemoglobin D-Camperdown|Y
matrix-assisted laser desorption-ionisation mass spectrometry|matrix-assisted laser desorption ionisation mass spectrometry|Y
matrix-assisted laser desorption-ionisation mass spectrometry|matrix-assisted laser desorption-ionization mass spectrometry|Y
alpha-methyltestosterone|alpha-methyl testosterone|Y
secondary hyperparathyroidism|secondary hyper-parathyroidism|Y
anti-beta-2 glycoprotein-1 antibody|anti-beta2 glycoprotein-1 antibody|Y
transcranial stimulation|trans-cranial stimulation|Y
hepatopancreatoduodenectomy|hepatopancreato-duodenectomy|Y
hepatopancreatoduodenectomy|hepato-pancreatoduodenectomy|Y
p-nitrophenyl phosphorylcholine|p-nitrophenylphosphorylcholine|Y
Organization for Economic Co-operation and Development|Organisation for Economic Co-operation and Development|Y
5-(N,N-dimethyl)amiloride|5-(N,N-dimethyl)-amiloride|Y
non-steroidal anti-inflammatory drug|non-steroidal antiinflammatory drug|Y
non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drugs|Y
expressed prostatic secretion|expressed prostatic secretions|Y
sodium-coupled neutral amino acid transporter-2|sodium-coupled neutral amino acid transporter|Y
sodium-coupled neutral amino acid transporter-2|sodium coupled neutral amino acid transporter-2|Y
sodium-coupled neutral amino acid transporter-2|sodium-coupled neutral amino acid transporter 2|Y
sodium-coupled neutral amino acid transporter-2|sodium-coupled neutral amino acid transporter-3|Y
sodium-coupled neutral amino acid transporter-2|sodium-coupled neutral amino acid transporter-1|Y
fibroblast growth factor 8b|fibroblast growth factor 8|Y
meta-iodo-benzylguanidine|meta-iodo-benzyl-guanidine|Y
meta-iodo-benzylguanidine|meta-iodo-benzyl guanidine|Y
meta-iodo-benzylguanidine|metaiodo-benzylguanidine|Y
beta amyloid precursor protein-cleaving enzyme 1|beta amyloid precursor protein-cleaving enzyme 2|Y
beta amyloid precursor protein-cleaving enzyme 1|beta amyloid precursor protein cleaving enzyme 1|Y
beta amyloid precursor protein-cleaving enzyme 1|beta-amyloid precursor protein-cleaving enzyme 1|Y
death-effector domain-containing DNA binding protein|death effector domain-containing DNA binding protein|Y
ultrasound-guided fine needle aspiration biopsy|ultrasound-guided fine-needle aspiration biopsy|Y
health-care-associated infection|healthcare-associated infection|Y
3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate|3'-O-(4-benzoylbenzoyl)adenosine 5'-triphosphate|Y
3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate|3'-O-(4-benzoyl)benzoyl adenosine 5'-triphosphate|Y
human germinal centre associated lymphoma|human germinal centre-associated lymphoma|Y
human germinal centre associated lymphoma|human germinal center associated lymphoma|Y
levonorgestrel-releasing intrauterine system|laevonorgestrel-releasing intra-uterine system|Y
levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intra uterine system|Y
levonorgestrel-releasing intrauterine system|laevonorgestrel-releasing intra uterine system|Y
levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intra-uterine system|Y
branched chain α-ketoacid dehydrogenase complex|branched chain α-keto acid dehydrogenase complex|Y
branched chain α-ketoacid dehydrogenase complex|branched-chain α-ketoacid dehydrogenase complex|Y
matrix assisted laser desorption ionisation mass spectrometry|matrix-assisted laser desorption ionisation mass spectrometry|Y
matrix assisted laser desorption ionisation mass spectrometry|matrix assisted laser desorption/ionisation mass spectrometry|Y
pseudo-pseudohypoparathyroidism|pseudopseudohypoparathyroidism|Y
pseudo-pseudohypoparathyroidism|pseudo-pseudo-hypoparathyroidism|Y
5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide|5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide|Y
Manual Ability Classification System level I|Manual Ability Classification System level IV|Y
Manual Ability Classification System level I|Manual Ability Classification System level|Y
Manual Ability Classification System level I|Manual Ability Classification System level III|Y
Manual Ability Classification System level I|Manual Ability Classification System level II|Y
similar to mothers against decapentaplegic homolog 4|similar to mothers against decapentaplegic homolog 6|Y
similar to mothers against decapentaplegic homolog 4|similar to mothers against decapentaplegic homolog 7|Y
similar to mothers against decapentaplegic homolog 4|similar to mothers against decapentaplegic homolog 1|Y
similar to mothers against decapentaplegic homolog 4|similar to mothers against decapentaplegic homolog 5|Y
similar to mothers against decapentaplegic homolog 4|similar to mothers against decapentaplegic homolog 2|Y
similar to mothers against decapentaplegic homolog 4|similar to mothers against decapentaplegic homolog 8|Y
4',6-diamidino-2-phenylindole|4',6'-diamidino-2-phenylindole|Y
4',6-diamidino-2-phenylindole|4'6-diamidino-2-phenylindole|Y
triiodothyronine radioimmunoassay|triiodothyronine radio-immunoassay|Y
forced midexpiratory flow|forced mid-expiratory flow|Y
orthogonal field alternation gel electrophoresis|orthogonal field alternating gel electrophoresis|Y
epidemic methicillin-resistant Staphylococcus aureus-5|epidemic methicillin-resistant Staphylococcus aureus-8|Y
epidemic methicillin-resistant Staphylococcus aureus-5|epidemic methicillin-resistant Staphylococcus aureus-9|Y
epidemic methicillin-resistant Staphylococcus aureus-5|epidemic methicillin-resistant Staphylococcus aureus-3|Y
epidemic methicillin-resistant Staphylococcus aureus-5|epidemic methicillin-resistant Staphylococcus aureus-15|Y
sodium coupled neutral amino acid transporter 1|sodium coupled neutral amino acid transporter 2|Y
sodium coupled neutral amino acid transporter 1|sodium-coupled neutral amino acid transporter 1|Y
sodium coupled neutral amino acid transporter 1|sodium coupled neutral amino acid transporter|Y
sodium coupled neutral amino acid transporter 1|sodium coupled neutral amino acid transporter-1|Y
signal transducer and activator of transcription 1|signal transducer and activator of transcription 5|Y
signal transducer and activator of transcription 1|signal transducer and activator of transcription 2|Y
signal transducer and activator of transcription 1|signal transducer and activator of transcription|Y
signal transducer and activator of transcription 1|signal transducer and activator of transcription-1|Y
signal transducer and activator of transcription 1|signal transducer and activator of transcription 6|Y
signal transducer and activator of transcription 1|signal transducer and activator of transcription 3|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-3|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motif-15|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motif-1|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-13|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motif-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motif|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-17|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-19|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-17|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motif-8|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-8|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motif-14|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-15|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motifs-1|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
drug-metabolizing enzymes|drug-metabolizing enzyme|Y
poly adenosine diphosphate-ribose polymerase|poly-adenosine diphosphate-ribose polymerase|Y
hemoglobin S-Antilles|haemoglobin S-Antilles|Y
calcium-binding epidermal growth factor-like domain|calcium binding epidermal growth factor-like domain|Y
fiberoptic bronchoscope|fiber-optic bronchoscope|Y
anti-IL10 monoclonal antibody|anti-IL 10 monoclonal antibody|Y
anti-IL10 monoclonal antibody|anti-IL-10 monoclonal antibody|Y
guanosinetriphosphatase-activating protein-1|guanosine triphosphatase-activating protein-1|Y
guanosinetriphosphatase-activating protein-1|guanosinetriphosphatase-activating protein|Y
Short Musculoskeletal Functional Assessment|Short Musculoskeletal Function Assessment|Y
nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine|nitric oxide synthase inhibitor NG-monomethyl-L-arginine|Y
13,14-dihydro-15-keto-prostaglandin F2alpha|13,14-dihydro-15-keto prostaglandin F2alpha|Y
13,14-dihydro-15-keto-prostaglandin F2alpha|13,14-dihydro-15-keto-prostaglandin F2 alpha|Y
spinocerebellar ataxia 7|spinocerebellar ataxia 17|Y
simplified acute physiology score III|simplified acute physiology score II|Y
calcitonin-gene-related peptide immunoreactive nerve fibre|calcitonin-gene-related peptide-immunoreactive nerve fibre|Y
calcitonin-gene-related peptide immunoreactive nerve fibre|calcitonin gene-related peptide immunoreactive nerve fibre|Y
diethyldithiocarbamate|dimethyldithiocarbamate|Y
trans-hiatal oesophagectomy|trans-hiatal esophagectomy|Y
rapid thoraco-abdominal compression|rapid thoracoabdominal compression|Y
krueppel-associated box|kruppel-associated box|Y
alpha2 plasmin inhibitor/plasmin complex|alpha2-plasmin inhibitor/plasmin complex|Y
alpha2 plasmin inhibitor/plasmin complex|alpha 2 plasmin inhibitor/plasmin complex|Y
variant-specific surface proteins|variant-specific surface protein|Y
antiidiotypic monoclonal antibody|anti-idiotypic monoclonal antibody|Y
formyltetrahydrofolate|formyltetra-hydrofolate|Y
Phleum pratense protein 1|Phleum pratense protein 13|Y
human antihuman antibody|human anti-human antibody|Y
anti-glycoprotein IIb/IIIa antibody|antiglycoprotein IIb/IIIa antibody|Y
GH-releasing peptide|GH-releasing peptides|Y
glycosyl phosphatidylinositol anchored|glycosylphosphatidylinositol anchored|Y
slow after-hyperpolarisation|slow afterhyperpolarisation|Y
intracellular action potential|intra-cellular action potential|Y
classification and regression trees|classification and regression tree|Y
Src homology 2 domain-containing protein tyrosine-phosphatase|src homology 2 domain-containing protein tyrosine-phosphatase|Y
Src homology 2 domain-containing protein tyrosine-phosphatase|Src homology-2 domain-containing protein tyrosine-phosphatase|Y
Src homology 2 domain-containing protein tyrosine-phosphatase|Src homology 2 domain-containing protein tyrosine phosphatase|Y
Src homology 2 domain-containing protein tyrosine-phosphatase|Src homology 2 domain containing protein tyrosine-phosphatase|Y
multiplex-fluorescence in-situ hybridisation|multiplex fluorescence in-situ hybridisation|Y
multiplex-fluorescence in-situ hybridisation|multiplex-fluorescence in situ hybridisation|Y
sexually transmitted infection|sexually transmitted infections|Y
insulin-like growth factor I-stimulated|insulinlike growth factor I-stimulated|Y
estrogen receptor β protein|oestrogen receptor β protein|Y
atrioventricular interval|atrio-ventricular interval|Y
non-arteritic anterior ischæmic optic neuropathy|nonarteritic anterior ischæmic optic neuropathy|Y
non-arteritic anterior ischæmic optic neuropathy|non-arteritic anterior ischemic optic neuropathy|Y
thromboxane A(2)/prostaglandin H(2) receptor antagonist|thromboxane A(2)-prostaglandin H(2) receptor antagonist|Y
pentylenetetrazol kindled|pentylene tetrazol kindled|Y
pentylenetetrazol kindled|pentylenetetrazole kindled|Y
receptor-like protein tyrosine phosphatase mu|receptor-like protein-tyrosine phosphatase mu|Y
posterior sagittal anorectoplasty|posterior sagittal ano-rectoplasty|Y
laser evoked potentials|laser evoked potential|Y
cardiac resynchronisation therapy|cardiac re-synchronisation therapy|Y
acute myelo-monoblastic leukemia|acute myelo-monoblastic leukaemia|Y
acute myelo-monoblastic leukemia|acute myelomonoblastic leukemia|Y
intervening sequences|intervening sequence|Y
oxygenated haemoglobin|oxygenated hemoglobin|Y
123I-beta-methyl-iodophenyl pentadecanoic acid|123I-beta-methyl-iodophenylpentadecanoic acid|Y
123I-beta-methyl-iodophenyl pentadecanoic acid|(123)I-beta-methyl-iodophenyl pentadecanoic acid|Y
Internal-External Locus of Control Scale|Internal/External Locus of Control Scale|Y
Significance Analysis of Microarrays|Significance Analysis of Microarray|Y
acute graft versus host disease grade II|acute graft versus host disease grade I|Y
acute graft versus host disease grade II|acute graft versus host disease grade IV|Y
acute graft versus host disease grade II|acute graft versus host disease grade III|Y
light harvesting chlorophyll a/b protein|light harvesting chlorophyll a/b protein-I|Y
light harvesting chlorophyll a/b protein|light-harvesting chlorophyll a/b protein|Y
light harvesting chlorophyll a/b protein|light harvesting chlorophyll a/b protein I|Y
estrogen receptor-β knock out|estrogen receptor-β knockout|Y
estrogen receptor-β knock out|oestrogen receptor-β knock out|Y
cochlear traveling wave velocity measurement|cochlear travelling wave velocity measurement|Y
isovaleryl coenzyme A|iso-valeryl coenzyme A|Y
non-occlusive mesenteric ischaemia|non-occlusive mesenteric ischemia|Y
antidisialoganglioside|anti-disialoganglioside|Y
cardio-metabolic syndrome|cardiometabolic syndrome|Y
subsyndromal depression|sub-syndromal depression|Y
antibiotic associated diarrhoea|antibiotic associated diarrhea|Y
maximum mid-expiratory flow|maximum midexpiratory flow|Y
post-transplant lymphoproliferative disorder|posttransplant lymphoproliferative disorder|Y
post-transplant lymphoproliferative disorder|post transplant lymphoproliferative disorder|Y
hypo-gamma globulinaemia|hypo-gammaglobulinaemia|Y
cross reacting material|crossreacting material|Y
fasting hyper-bilirubinemia|fasting hyperbilirubinemia|Y
deoxy-corticosterone glucoside|deoxycorticosterone glucoside|Y
calcitonin gene-related peptide immunoreactive nerve fiber|calcitonin gene-related peptide-immunoreactive nerve fiber|Y
calcitonin gene-related peptide immunoreactive nerve fiber|calcitonin gene-related peptide immunoreactive nerve fibre|Y
TransAtlantic InterSociety Consensus|TransAtlantic Inter-Society Consensus|Y
intracerebral hemorrhage-induced brain injury|intracerebral haemorrhage-induced brain injury|Y
intraperitoneal free cancer cell|intra-peritoneal free cancer cell|Y
Marek's disease tumour-associated surface antigen|Marek's disease tumour associated surface antigen|Y
antiglutamic acid decarboxylase antibody|anti-glutamic acid decarboxylase antibody|Y
soluble receptor activator of nuclear factor κ B ligand|soluble receptor activator of nuclear factor κ-B ligand|Y
soluble receptor activator of nuclear factor κ B ligand|soluble receptor activator of nuclear factor κB ligand|Y
soluble receptor activator of nuclear factor κ B ligand|soluble receptor activator of nuclear factor-κ B ligand|Y
anti-lymphocyte globulin|antilymphocyte globulin|Y
augmented correlation-consistent polarised valence triple-ζ basis set|augmented correlation-consistent polarized valence triple-ζ basis set|Y
augmented correlation-consistent polarised valence triple-ζ basis set|augmented correlation-consistent polarised-valence triple-ζ basis set|Y
augmented correlation-consistent polarised valence triple-ζ basis set|augmented correlation-consistent polarised valence triple ζ basis set|Y
augmented correlation-consistent polarised valence triple-ζ basis set|augmented correlation consistent polarised valence triple-ζ basis set|Y
receptor-like protein-tyrosine phosphatase-κ|receptor-like protein-tyrosine phosphatase|Y
receptor-like protein-tyrosine phosphatase-κ|receptor-like protein-tyrosine phosphatase-δ|Y
receptor-like protein-tyrosine phosphatase-κ|receptor-like protein-tyrosine phosphatase-μ|Y
receptor-like protein-tyrosine phosphatase-κ|receptor-like protein tyrosine phosphatase-κ|Y
receptor-like protein-tyrosine phosphatase-κ|receptor-like protein-tyrosine phosphatase-η|Y
receptor-like protein-tyrosine phosphatase-κ|receptor-like protein-tyrosine phosphatase-ζ|Y
ventral posterolateral thalamic nucleus|ventral postero-lateral thalamic nucleus|Y
human colon carcinoma cell|human colon carcinoma cells|Y
University of California, Davis Medical Center|University of California Davis Medical Center|Y
University of California, Davis Medical Center|University of California, Davis, Medical Center|Y
anti-interleukin-1alpha autoantibody|anti-interleukin-1 alpha autoantibody|Y
25-hydroxy-vitamin D3|25-hydroxy-vitamin D|Y
25-hydroxy-vitamin D3|25-hydroxyvitamin D3|Y
human leucocyte antigen DR5|human leucocyte antigen DR|Y
antiinterleukin 8 antibody|antiinterleukin 18 antibody|Y
melanoma-differentiation-associated gene 5|melanoma differentiation-associated gene 5|Y
melanoma-differentiation-associated gene 5|melanoma-differentiation-associated gene-5|Y
chemotherapy-induced anaemia|chemotherapy-induced anemia|Y
neural precursor cell-expressed, developmentally downregulated 5|neural precursor cell-expressed developmentally down-regulated 5|Y
neural precursor cell-expressed, developmentally downregulated 5|neural precursor cell-expressed, developmentally down-regulated 8|Y
neural precursor cell-expressed, developmentally downregulated 5|neural precursor cell-expressed, developmentally down-regulated 5|Y
neural precursor cell-expressed, developmentally downregulated 5|neural precursor cell-expressed, developmentally downregulated 4|Y
neural precursor cell-expressed, developmentally downregulated 5|neural precursor cell-expressed developmentally downregulated 8|Y
neural precursor cell-expressed, developmentally downregulated 5|neural-precursor cell-expressed developmentally downregulated 5|Y
neural precursor cell-expressed, developmentally downregulated 5|neural precursor cell-expressed developmentally downregulated 5|Y
neural precursor cell-expressed, developmentally downregulated 5|neural precursor cell-expressed developmentally downregulated 4|Y
neural precursor cell-expressed, developmentally downregulated 5|neural precursor cell expressed, developmentally downregulated 5|Y
neural precursor cell-expressed, developmentally downregulated 5|neural-precursor cell-expressed, developmentally downregulated 5|Y
neural precursor cell-expressed, developmentally downregulated 5|neural precursor cell expressed developmentally downregulated 5|Y
neural precursor cell-expressed, developmentally downregulated 5|neural precursor cell-expressed, developmentally downregulated 9|Y
neural precursor cell-expressed, developmentally downregulated 5|neural precursor cell-expressed developmentally downregulated 1|Y
neural precursor cell-expressed, developmentally downregulated 5|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural precursor cell-expressed, developmentally downregulated 5|neural precursor cell-expressed developmentally downregulated 9|Y
neural precursor cell-expressed, developmentally downregulated 5|neural precursor cell-expressed, developmentally downregulated 8|Y
neural precursor cell-expressed, developmentally downregulated 5|neural precursor cell-expressed, developmentally downregulated 1|Y
neural precursor cell-expressed, developmentally downregulated 5|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell-expressed, developmentally downregulated 5|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell-expressed, developmentally downregulated 5|neural precursor cell-expressed, developmentally down-regulated 2|Y
neural precursor cell-expressed, developmentally downregulated 5|neural precursor cell expressed, developmentally down-regulated 5|Y
nonylphenol polyethoxylate|nonyl-phenol polyethoxylate|Y
type II transforming growth factor-β receptor|type II transforming growth factor β receptor|Y
crossed radioimmuno-electrophoresis|crossed radio-immuno-electrophoresis|Y
crossed radioimmuno-electrophoresis|crossed radioimmunoelectrophoresis|Y
real time quantitative reverse-transcription polymerase chain reaction|real-time quantitative reverse-transcription polymerase chain reaction|Y
Yo-Yo Intermittent Recovery Test Level 2|Yo-Yo Intermittent Recovery Test level 2|Y
laevonorgestrel-releasing intra-uterine system|laevonorgestrel-releasing intra uterine system|Y
laevonorgestrel-releasing intra-uterine system|levonorgestrel-releasing intra-uterine system|Y
acto-heavy meromyosin ATPase|actoheavy meromyosin ATPase|Y
non-accidental head injury|nonaccidental head injury|Y
Bos taurus autosome 7|Bos taurus autosome 17|Y
extra-cellular volume|extracellular volume|Y
galactorrhoea amenorrhea hyperprolactinæmia syndrome|galactorrhoea amenorrhœa hyperprolactinæmia syndrome|Y
galactorrhoea amenorrhea hyperprolactinæmia syndrome|galactorrhea amenorrhoea hyperprolactinæmia syndrome|Y
galactorrhoea amenorrhea hyperprolactinæmia syndrome|galactorrhoea-amenorrhea hyperprolactinæmia syndrome|Y
major histocompatibility complex class II antigen|major histocompatibility complex class I antigen|Y
silencing mediator for retinoid and thyroid hormone receptors|silencing mediator for retinoid and thyroid hormone receptor|Y
sub-total parathyroidectomy|subtotal parathyroidectomy|Y
galactooligosaccharide|galacto-oligosaccharide|Y
Michael E DeBakey Veterans' Affairs Medical Center|Michael E. DeBakey Veterans' Affairs Medical Center|Y
Michael E DeBakey Veterans' Affairs Medical Center|Michael E DeBakey Veteran's Affairs Medical Center|Y
Michael E DeBakey Veterans' Affairs Medical Center|Michael E. DeBakey Veterans Affairs Medical Center|Y
laryngo-onychocutaneous syndrome|laryngoonychocutaneous syndrome|Y
methylcarbamylcholine|methyl-carbamylcholine|Y
Children's Yale-Brown Obsessive Compulsive Scale|Children's Yale Brown Obsessive Compulsive Scale|Y
high grade squamous intra-epithelial lesion|high grade squamous intraepithelial lesion|Y
high-resolution magic angle spinning nuclear magnetic resonance spectroscopy|high resolution magic angle spinning nuclear magnetic resonance spectroscopy|Y
intranucleus accumbens|intra-nucleus accumbens|Y
loco-regional anesthesia|loco-regional anaesthesia|Y
caudomedial hyperstriatum ventrale|caudo-medial hyperstriatum ventrale|Y
neural precursor cell expressed developmentally downregulated 8|neural precursor cell expressed, developmentally downregulated 1|Y
neural precursor cell expressed developmentally downregulated 8|neural precursor cell expressed developmentally downregulated 9|Y
neural precursor cell expressed developmentally downregulated 8|neural precursor cell expressed, developmentally down-regulated 8|Y
neural precursor cell expressed developmentally downregulated 8|neural precursor cell-expressed developmentally downregulated 8|Y
neural precursor cell expressed developmentally downregulated 8|neural precursor cell expressed, developmentally downregulated 5|Y
neural precursor cell expressed developmentally downregulated 8|neural precursor cell expressed developmentally down-regulated 1|Y
neural precursor cell expressed developmentally downregulated 8|neural precursor cell expressed developmentally down-regulated 8|Y
neural precursor cell expressed developmentally downregulated 8|neural precursor cell expressed, developmentally downregulated 9|Y
neural precursor cell expressed developmentally downregulated 8|neural precursor cell expressed developmentally downregulated 4|Y
neural precursor cell expressed developmentally downregulated 8|neural precursor cell expressed developmentally downregulated 5|Y
neural precursor cell expressed developmentally downregulated 8|neural precursor cell expressed developmentally downregulated 2|Y
neural precursor cell expressed developmentally downregulated 8|neural precursor cell expressed, developmentally downregulated 2|Y
neural precursor cell expressed developmentally downregulated 8|neural precursor cell expressed developmentally down-regulated 9|Y
neural precursor cell expressed developmentally downregulated 8|neural precursor cell-expressed, developmentally downregulated 8|Y
β-site amyloid precursor protein-cleaving enzyme 2|β site amyloid precursor protein-cleaving enzyme 2|Y
β-site amyloid precursor protein-cleaving enzyme 2|β-site amyloid precursor protein-cleaving enzyme-2|Y
β-site amyloid precursor protein-cleaving enzyme 2|β-site amyloid precursor protein-cleaving enzyme 1|Y
β-site amyloid precursor protein-cleaving enzyme 2|β-site amyloid precursor protein-cleaving enzyme|Y
oestrogen receptor-β protein|estrogen receptor-β protein|Y
antiglomerular endothelial cell antibody|anti-glomerular endothelial cell antibody|Y
transforming growth factor alpha-Pseudomonas exotoxin-40|transforming growth factor alpha-Pseudomonas exotoxin 40|Y
transforming growth factor alpha-Pseudomonas exotoxin-40|transforming growth factor-alpha-Pseudomonas exotoxin-40|Y
ultrafiltration rate|ultra-filtration rate|Y
Src homology 2 domain-containing protein tyrosine phosphatase substrate-1|Src homology 2 domain-containing protein tyrosine phosphatase substrate 1|Y
Src homology 2 domain-containing protein tyrosine phosphatase substrate-1|Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1|Y
Src homology 2 domain-containing protein tyrosine phosphatase substrate-1|Src homology 2 domain containing protein tyrosine phosphatase substrate-1|Y
hereditary sensory and autonomic neuropathy type 1|hereditary sensory and autonomic neuropathy type 4|Y
hereditary sensory and autonomic neuropathy type 1|hereditary sensory and autonomic neuropathy type 3|Y
hereditary sensory and autonomic neuropathy type 1|hereditary sensory and autonomic neuropathy type V|Y
RPM1-interacting protein4|RPM1-interacting protein 4|Y
quantitative fluorescence in situ hybridisation|quantitative fluorescence in situ hybridization|Y
crosspolarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation/magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarisation/magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
lumbar microdiscectomy|lumbar micro-discectomy|Y
pyelonephritis-associated pilus protein E|pyelonephritis-associated pilus protein C|Y
pyelonephritis-associated pilus protein E|pyelonephritis-associated pilus protein A|Y
pyelonephritis-associated pilus protein E|pyelonephritis-associated pilus protein G|Y
pyelonephritis-associated pilus protein E|pyelonephritis-associated pilus protein D|Y
pyelonephritis-associated pilus protein E|pyelonephritis-associated pilus protein B|Y
terminal-deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling assay|Y
terminal-deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling assay|Y
chondromalacia patella|chondromalacia patellae|Y
caudal ventrolateral medulla|caudal ventro-lateral medulla|Y
α-naphthylisothiocyanate|α-naphthyl isothiocyanate|Y
mitogen-activated protein kinase kinase-4|mitogen-activated protein kinase kinase 4|Y
mitogen-activated protein kinase kinase-4|mitogen-activated protein kinase kinase-3|Y
mitogen-activated protein kinase kinase-4|mitogen-activated protein kinase kinase|Y
mitogen-activated protein kinase kinase-4|mitogen activated protein kinase kinase-4|Y
mitogen-activated protein kinase kinase-4|mitogen-activated protein kinase kinase-2|Y
mitogen-activated protein kinase kinase-4|mitogen-activated protein kinase kinase-7|Y
post-transplantation lympho-proliferative disorder|post-transplantation lymphoproliferative disorder|Y
post-transplantation lympho-proliferative disorder|posttransplantation lympho-proliferative disorder|Y
multidirectional instability|multi-directional instability|Y
peripheral quantitative computerized tomography|peripheral quantitative computerised tomography|Y
Systems Biology Mark-up Language|Systems Biology Markup Language|Y
American Society of Anaesthesiology Class I|American Society of Anesthesiology Class IV|Y
American Society of Anaesthesiology Class I|American Society of Anaesthesiology Class II|Y
American Society of Anaesthesiology Class I|American Society of Anaesthesiology Class V|Y
American Society of Anaesthesiology Class I|American Society of Anaesthesiology Class 4|Y
American Society of Anaesthesiology Class I|American Society of Anesthesiology Class II|Y
cytosolic phospholipase A2 α|cytosolic phospholipase A2α|Y
Online Survey Certification and Reporting|On-line Survey Certification and Reporting|Y
bronchiolitis obliterans-organizing pneumonia|bronchiolitis obliterans-organising pneumonia|Y
vocalisation after-discharge|vocalisation afterdischarge|Y
cluster of differentiation 18|cluster of differentiation 8|Y
laser desorption/ionisation time of flight mass spectrometry|laser desorption-ionisation time of flight mass spectrometry|Y
laser desorption/ionisation time of flight mass spectrometry|laser desorption ionisation time of flight mass spectrometry|Y
inter-αtrypsin inhibitor|inter-α-trypsin inhibitor|Y
calcitonin-gene-related peptide-immunoreactive nerve fibre|calcitonin gene-related peptide-immunoreactive nerve fibre|Y
calcitonin-gene-related peptide-immunoreactive nerve fibre|calcitonin-gene-related peptide-immunoreactive nerve fiber|Y
foeto-pelvic disproportion|feto-pelvic disproportion|Y
post-myocardial infarction|postmyocardial infarction|Y
real time quantitative reverse transcription-polymerase chain reaction|real-time quantitative reverse transcription-polymerase chain reaction|Y
Second-order Moller-Plesset perturbation theory|second-order Moller-Plesset perturbation theory|Y
Recombinant human granulocyte colony-stimulating factor|recombinant human granulocyte colony-stimulating factor|Y
out-patient department|outpatient department|Y
multidrug resistance protein 1|multidrug resistance protein 1a|Y
technetium-99m-galactosyl-neoglycoalbumin|technetium-99m-galactosylneoglycoalbumin|Y
technetium-99m-galactosyl-neoglycoalbumin|technetium-99m galactosyl-neoglycoalbumin|Y
human leucocyte antigen DP|human leucocyte antigen D|Y
broncho-pulmonary aspergillosis|bronchopulmonary aspergillosis|Y
anti-proteinase 3 antineutrophil cytoplasmic antibody|anti-proteinase-3 antineutrophil cytoplasmic antibody|Y
standard error of measurements|standard error of measurement|Y
alcoholic keto-acidosis|alcoholic ketoacidosis|Y
anti-IL 7 monoclonal antibody|anti-IL7 monoclonal antibody|Y
anti-IL 7 monoclonal antibody|anti-IL 17 monoclonal antibody|Y
antiglycoprotein IIb-IIIa antibody|anti-glycoprotein IIb-IIIa antibody|Y
cyclic AMP-dependent signaling pathway|cyclic AMP-dependent signalling pathway|Y
C-type lectin-like protein|C-type lectin-like proteins|Y
mitogen extracellular signal-regulated kinase kinase 5|mitogen extracellular-signal-regulated kinase kinase 5|Y
mitogen extracellular signal-regulated kinase kinase 5|mitogen extracellular signal-regulated kinase kinase 6|Y
mitogen extracellular signal-regulated kinase kinase 5|mitogen extracellular signal-regulated kinase kinase-5|Y
mitogen extracellular signal-regulated kinase kinase 5|mitogen/extracellular signal-regulated kinase kinase 5|Y
transient receptor potential vanilloid type 5|transient receptor potential vanilloid type 1|Y
transient receptor potential vanilloid type 5|transient receptor potential vanilloid type 2|Y
transient receptor potential vanilloid type 5|transient receptor potential vanilloid type 3|Y
resonance-enhanced multi-photon ionization|resonance enhanced multi-photon ionization|Y
resonance-enhanced multi-photon ionization|resonance-enhanced multi-photon ionisation|Y
low grade intraepithelial lesion|low grade intra-epithelial lesion|Y
matrix-assisted laser desorption ionisation time-of-flight mass spectrometric|matrix assisted laser desorption ionisation time-of-flight mass spectrometric|Y
matrix-assisted laser desorption ionisation time-of-flight mass spectrometric|matrix-assisted laser desorption/ionisation time-of-flight mass spectrometric|Y
anti-human T cell lymphotrophic virus type 1 antibody|anti-human T cell lymphotrophic virus type I antibody|Y
anti-human T cell lymphotrophic virus type 1 antibody|anti-human T-cell lymphotrophic virus type 1 antibody|Y
anti-human T cell lymphotrophic virus type 1 antibody|anti-human T cell lymphotropic virus type 1 antibody|Y
Na-K-Cl cotransporter-1|Na-K-2Cl cotransporter-1|Y
antiribosomal P antibody|anti-ribosomal P antibody|Y
sex hormone binding globulin|sex hormone binding globuline|Y
pyelonephritis-associated pilus protein C|pyelonephritis-associated pilus protein A|Y
pyelonephritis-associated pilus protein C|pyelonephritis-associated pilus protein G|Y
pyelonephritis-associated pilus protein C|pyelonephritis-associated pilus protein D|Y
pyelonephritis-associated pilus protein C|pyelonephritis-associated pilus protein B|Y
effect of electroacupuncture|effects of electroacupuncture|Y
recombinant human interleukin 1 β|recombinant human interleukin 1β|Y
atrioventricular delay|atrio-ventricular delay|Y
deoxyfructo-serotonin|deoxyfructoserotonin|Y
deoxyfructo-serotonin|desoxyfructo-serotonin|Y
dentato-rubro-pallido-luysian atrophy|dentato-rubro-pallidoluysian atrophy|Y
dentato-rubro-pallido-luysian atrophy|dentato-ruburo-pallido-luysian atrophy|Y
Center for Epidemiological Studies-Depression|Center for Epidemiologic Studies-Depression|Y
retinoic-acid-receptor-related orphan receptor-α|retinoic-acid-receptor-related orphan receptor α|Y
retinoic-acid-receptor-related orphan receptor-α|retinoic-acid-receptor-related orphan receptor|Y
retinoic-acid-receptor-related orphan receptor-α|retinoic-acid-receptor-related orphan receptor-γ|Y
Wilm's tumour protein 1|Wilm's tumor protein 1|Y
pre-replication complex|prereplication complex|Y
melanocyte-stimulating hormone release-inhibiting factor|melanocyte-stimulating hormone release-inhibiting factor 1|Y
postbronchodilator forced expiratory volume|post-bronchodilator forced expiratory volume|Y
human uroepithelial cell|human uro-epithelial cell|Y
cardio-respiratory function|cardiorespiratory function|Y
Adolescent Obsessive Compulsive Drinking Scale|Adolescent Obsessive-Compulsive Drinking Scale|Y
subacute myelooptic neuropathy|subacute myelo-optic neuropathy|Y
phosphatidyl ethanolamine-binding protein-2|phosphatidyl ethanolamine-binding protein 2|Y
phosphatidyl ethanolamine-binding protein-2|phosphatidyl-ethanolamine-binding protein-2|Y
ultrafiltration capacity|ultra-filtration capacity|Y
disease-modifying antirheumatic drugs|disease-modifying anti-rheumatic drugs|Y
poly-hydroxy-butyrate|poly-hydroxybutyrate|Y
denaturing high performance liquid chromatography|denaturing high-performance liquid chromatography|Y
denaturing high performance liquid chromatography|Denaturing high performance liquid chromatography|Y
signal transducer and activator of transcription 5A|signal transducer and activator of transcription 5a|Y
signal transducer and activator of transcription 5A|signal transducer and activator of transcription 5|Y
signal transducer and activator of transcription 5A|signal transducer and activator of transcription 5b|Y
mandibulo-acral dysplasia|mandibuloacral dysplasia|Y
phosphatidyl-ethanolamine-binding protein 2|phosphatidyl ethanolamine-binding protein 2|Y
phosphatidyl-ethanolamine-binding protein 2|phosphatidyl-ethanolamine binding protein 2|Y
phosphatidyl-ethanolamine-binding protein 2|phosphatidyl-ethanolamine-binding protein-2|Y
anti-human T cell lymphotrophic virus-I antibody|anti-human T-cell lymphotrophic virus-I antibody|Y
anti-human T cell lymphotrophic virus-I antibody|anti-human T cell lymphotrophic virus-1 antibody|Y
anti-human T cell lymphotrophic virus-I antibody|anti-human T cell lymphotropic virus-I antibody|Y
anti-human T cell lymphotrophic virus-I antibody|anti-human T cell lymphotrophic virus I antibody|Y
formyl-methionyl-leucyl-phenylalanine-lysine|N-formyl-methionyl-leucyl-phenylalanine-lysine|Y
infectious laryngotracheitis virus|infectious laryngo-tracheitis virus|Y
spatiotemporal image correlation|spatio-temporal image correlation|Y
organic light-emitting diodes|organic light-emitting diode|Y
anti-matrix metalloprotease-1 antibody|anti-matrix metalloprotease-13 antibody|Y
light-harvesting chlorophyll a/b binding protein|light harvesting chlorophyll a/b binding protein|Y
light-harvesting chlorophyll a/b binding protein|light-harvesting chlorophyll a/b-binding protein|Y
light-harvesting chlorophyll a/b binding protein|light-harvesting chlorophyll a/b binding protein I|Y
coefficients of variation|coefficients of variations|Y
coefficients of variation|coefficient of variation|Y
assisted reproduction technique|assisted reproduction techniques|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1alpha|peroxisome-proliferator-activated receptor gamma coactivator 1alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1alpha|peroxisome proliferator-activated receptor-gamma coactivator 1alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1alpha|peroxisome proliferator-activated receptor-gamma co-activator 1alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1alpha|peroxisome-proliferator-activated receptor-gamma coactivator-1 alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1alpha|peroxisome-proliferator-activated receptor-gamma co-activator 1 alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1alpha|peroxisome-proliferator-activated receptor-gamma co-activator-1alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1alpha|peroxisome-proliferator-activated receptor-gamma co-activator 1alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1alpha|peroxisome proliferator-activated receptor-gamma coactivator 1 alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1alpha|peroxisome-proliferator-activated receptor gamma coactivator 1 alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator 1alpha|peroxisome-proliferator-activated receptor-gamma coactivator-1alpha|Y
immuno-globulin heavy chain|immunoglobulin heavy chain|Y
NIMA-related kinase 11S|NIMA-related kinase 11|Y
Escherichia coli K-12 strain|Escherichia coli K12 strain|Y
random amplified polymorphic DNA polymerase chain reaction|Random amplified polymorphic DNA polymerase chain reaction|Y
random amplified polymorphic DNA polymerase chain reaction|random amplified polymorphic DNA-polymerase chain reaction|Y
random amplified polymorphic DNA polymerase chain reaction|randomly amplified polymorphic DNA polymerase chain reaction|Y
extraprostatic extension|extra-prostatic extension|Y
matrix assisted laser desorption ionisation mass spectrometry imaging|matrix assisted laser desorption ionisation-mass spectrometry imaging|Y
matrix assisted laser desorption ionisation mass spectrometry imaging|matrix-assisted laser desorption ionisation mass spectrometry imaging|Y
matrix assisted laser desorption ionisation mass spectrometry imaging|matrix assisted laser desorption ionization mass spectrometry imaging|Y
Charcot-Marie-Tooth type X1 disease|Charcot-Marie-Tooth type X disease|Y
B lymphocyte-induced maturation protein-1|B lymphocyte-induced maturation protein 1|Y
B lymphocyte-induced maturation protein-1|B lymphocyte induced maturation protein-1|Y
Family History Research Diagnostic Criteria|Family History-Research Diagnostic Criteria|Y
Toll-IL-1 receptor domain-containing adaptor-inducing IFNβ|Toll-IL-1 receptor domain-containing adaptor-inducing IFN-β|Y
Toll-IL-1 receptor domain-containing adaptor-inducing IFNβ|Toll/IL-1 receptor domain-containing adaptor-inducing IFNβ|Y
Toll-IL-1 receptor domain-containing adaptor-inducing IFNβ|toll-IL-1 receptor domain-containing adaptor-inducing IFNβ|Y
post-transplant lympho-proliferative disease|post-transplant lymphoproliferative disease|Y
post-transplant lympho-proliferative disease|posttransplant lympho-proliferative disease|Y
O-(beta-hydroxyethyl)-rutosides|O-(beta-hydroxyethyl)-rutoside|Y
Actinobacillus pleuropneumoniae RTX-toxin II|Actinobacillus pleuropneumoniae-RTX-toxin II|Y
generalized estimating equation|generalized estimating equations|Y
intracardiac infection|intra-cardiac infection|Y
hairy enhancer of split-1|hairy enhancer of split1|Y
non-structural protein 5A|nonstructural protein 5A|Y
non-structural protein 5A|non-structural protein 5|Y
ultra-purified polymerised bovine hemoglobin|ultrapurified polymerised bovine haemoglobin|Y
ultra-purified polymerised bovine hemoglobin|ultra-purified polymerized bovine hemoglobin|Y
ultra-purified polymerised bovine hemoglobin|ultra-purified polymerised bovine haemoglobin|Y
ultra-purified polymerised bovine hemoglobin|ultrapurified polymerised bovine hemoglobin|Y
ultra conserved region|ultraconserved region|Y
insulinlike growth factor I-mediated|insulin-like growth factor I-mediated|Y
adenovirus type 12 E1A|adenovirus type 12 E1|Y
absolute bioavailability|absolute bio-availability|Y
adenosine triphosphate binding cassette transporter G1|adenosine triphosphate binding cassette transporter A1|Y
adenosine triphosphate binding cassette transporter G1|adenosine triphosphate binding cassette transporter 1|Y
adenosine triphosphate binding cassette transporter G1|adenosine triphosphate binding cassette transporter G2|Y
brainstem auditory evoked potentials|brainstem auditory evoked potential|Y
insulin-like growth factor-II mRNA-binding protein-1|insulin-like growth factor-II mRNA-binding protein 1|Y
insulin-like growth factor-II mRNA-binding protein-1|insulin-like growth factor-II mRNA binding protein-1|Y
insulin-like growth factor-II mRNA-binding protein-1|insulin-like growth factor-II mRNA-binding protein|Y
insulin-like growth factor-II mRNA-binding protein-1|insulin-like growth factor-II mRNA-binding protein-3|Y
insulin-like growth factor-II mRNA-binding protein-1|insulin-like growth factor II mRNA-binding protein-1|Y
intramedullary nailing|intra-medullary nailing|Y
sum of pain intensity difference|sum of pain intensity differences|Y
complete-active-space self-consistent field method|complete active-space self-consistent field method|Y
steroid 5-alpha-reductase type I|steroid 5-alpha-reductase type II|Y
purified phospholipid|purified phospholipids|Y
methyl-beta-carboline-3-carboxylate|ethyl-beta-carboline-3-carboxylate|Y
recombinant human transforming growth factor beta|recombinant human transforming growth factor beta1|Y
recombinant human transforming growth factor beta|recombinant human transforming growth factor beta2|Y
recombinant human transforming growth factor beta|recombinant human transforming growth factor beta3|Y
recombinant human transforming growth factor beta|recombinant human transforming growth factor beta 2|Y
recombinant human transforming growth factor beta|recombinant human transforming growth factor-beta|Y
recombinant human transforming growth factor beta|recombinant human transforming growth factor beta 3|Y
recombinant human transforming growth factor beta|recombinant human transforming growth factor beta 1|Y
fluorescent whitening agent|fluorescent whitening agents|Y
99mTc labeled red blood cell|99mTc labelled red blood cell|Y
anti-IL2R monoclonal antibody|anti-IL2 monoclonal antibody|Y
anti-IL2R monoclonal antibody|anti-IL 2R monoclonal antibody|Y
corticotrophin releasing activity|corticotropin releasing activity|Y
anticollagen antibody|anti-collagen antibody|Y
multi-detector row computed tomography|multidetector row computed tomography|Y
arabinoxylooligosaccharide|arabinoxylo-oligosaccharide|Y
ubiquitin-conjugating enzyme 18|ubiquitin-conjugating enzyme 8|Y
ubiquitin-conjugating enzyme 18|ubiquitin-conjugating enzyme 1|Y
eukaryotic elongation factor 1A1|eukaryotic elongation factor 1A-1|Y
eukaryotic elongation factor 1A1|eukaryotic elongation factor 1A|Y
succinylaminoimidazole carboxamide riboside|succinylaminoimidazole carboxamide ribotide|Y
erythroid progenitor|erythroid progenitors|Y
tumour necrosis factor receptor-associated factor-6|tumour necrosis factor receptor-associated factor|Y
tumour necrosis factor receptor-associated factor-6|tumour necrosis factor receptor-associated factor-2|Y
tumour necrosis factor receptor-associated factor-6|tumour necrosis factor receptor-associated factor 6|Y
tumour necrosis factor receptor-associated factor-6|tumor necrosis factor receptor-associated factor-6|Y
tumour necrosis factor receptor-associated factor-6|tumour necrosis factor receptor-associated factor-5|Y
Placement of Aortic Transcatheter Valves, Cohort B|Placement of Aortic Transcatheter Valves, Cohort A|Y
anti-pentylenetetrazol|antipentylenetetrazol|Y
antimyelin-associated glycoprotein antibody|anti-myelin-associated glycoprotein antibody|Y
carpo-metacarpal joint|carpometacarpal joint|Y
Accident and Emergency departments|Accident and Emergency department|Y
Floating Harbour syndrome|Floating Harbor syndrome|Y
antero-lateral thigh perforator flap|anterolateral thigh perforator flap|Y
American Society of Anesthesiologists Grade 5|American Society of Anesthesiologists Grade 2|Y
American Society of Anesthesiologists Grade 5|American Society of Anesthesiologists Grade V|Y
American Society of Anesthesiologists Grade 5|American Society of Anesthesiologists Grade 3|Y
American Society of Anesthesiologists Grade 5|American Society of Anesthesiologists Grade I|Y
American Society of Anesthesiologists Grade 5|American Society of Anaesthesiologists Grade 5|Y
American Society of Anesthesiologists Grade 5|American Society of Anesthesiologists Grade 1|Y
American Society of Anesthesiologists Grade 5|American Society of Anesthesiologists grade 5|Y
alpha 2-HS glycoprotein|alpha2-HS glycoprotein|Y
feline pan-leukopaenia|feline pan-leukopenia|Y
pre-ganglionic neuron|pre-ganglionic neurone|Y
pre-ganglionic neuron|preganglionic neuron|Y
ADP-ribosylation factor nucleotide-binding site opener|ADP-ribosylation factor nucleotide-binding-site opener|Y
ADP ribosyltransferase|ADP ribosyl transferase|Y
anti-human immunodeficiency virus-1 antibody|anti-human immunodeficiency virus 1 antibody|Y
Wolf-Hirschhorn syndrome candidate 1-like 1|Wolf-Hirschhorn syndrome candidate 1-like 2|Y
cluster of differentiation 11|cluster of differentiation 11A|Y
5-(N,N-hexamethylene) amiloride|5-(N,N-hexamethylene)amiloride|Y
near infrared interactance|near infra-red interactance|Y
guanosine triphosphate binding protein α subunit|guanosine triphosphate-binding protein α subunit|Y
mitogen extracellular-signal-regulated kinase kinase 5|mitogen extracellular-signal-regulated kinase kinase-5|Y
mitogen extracellular-signal-regulated kinase kinase 5|mitogen/extracellular-signal-regulated kinase kinase 5|Y
anti-interleukin 12 antibody|antiinterleukin 12 antibody|Y
anti-interleukin 12 antibody|anti-interleukin 1 antibody|Y
β-site amyloid precursor protein cleaving enzyme-1|β-site amyloid precursor protein cleaving enzyme-2|Y
β-site amyloid precursor protein cleaving enzyme-1|β-site amyloid precursor protein cleaving enzyme|Y
β-site amyloid precursor protein cleaving enzyme-1|β-site amyloid precursor protein cleaving enzyme 1|Y
antibovine serum albumin|anti-bovine serum albumin|Y
carcinoembryonic antigen-related cell adhesion molecule-1|carcinoembryonic antigen-related cell adhesion molecule 1|Y
carcinoembryonic antigen-related cell adhesion molecule-1|carcinoembryonic antigen-related cell-adhesion molecule-1|Y
carcinoembryonic antigen-related cell adhesion molecule-1|carcinoembryonic antigen-related cell adhesion molecule|Y
neural-precursor-cell-expressed, developmentally downregulated 1|neural-precursor-cell-expressed developmentally downregulated 2|Y
neural-precursor-cell-expressed, developmentally downregulated 1|neural-precursor-cell-expressed, developmentally down-regulated 1|Y
neural-precursor-cell-expressed, developmentally downregulated 1|neural-precursor cell-expressed, developmentally down-regulated 1|Y
neural-precursor-cell-expressed, developmentally downregulated 1|neural-precursor-cell-expressed developmentally downregulated 9|Y
neural-precursor-cell-expressed, developmentally downregulated 1|neural-precursor-cell-expressed, developmentally down-regulated 8|Y
neural-precursor-cell-expressed, developmentally downregulated 1|neural-precursor-cell-expressed, developmentally down-regulated 5|Y
neural-precursor-cell-expressed, developmentally downregulated 1|neural-precursor-cell-expressed, developmentally down-regulated 4|Y
neural-precursor-cell-expressed, developmentally downregulated 1|neural-precursor-cell-expressed, developmentally downregulated 5|Y
neural-precursor-cell-expressed, developmentally downregulated 1|neural-precursor-cell-expressed developmentally downregulated 5|Y
neural-precursor-cell-expressed, developmentally downregulated 1|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor-cell-expressed, developmentally downregulated 1|neural-precursor-cell-expressed developmentally down-regulated 1|Y
neural-precursor-cell-expressed, developmentally downregulated 1|neural-precursor cell-expressed, developmentally downregulated 1|Y
neural-precursor-cell-expressed, developmentally downregulated 1|neural-precursor-cell-expressed, developmentally downregulated 2|Y
United States Pharmacopœia Drug Information|United States Pharmacopeia Drug Information|Y
p-cresol methylhydroxylase|p-cresol methyl-hydroxylase|Y
p-cresol methylhydroxylase|p-cresol methyl hydroxylase|Y
latent transforming growth factor-beta binding protein 3|latent transforming growth factor-beta binding protein 1|Y
latent transforming growth factor-beta binding protein 3|latent transforming growth factor beta binding protein 3|Y
interleukin 7 receptor-α|interleukine 7 receptor-α|Y
immuno-reactive proinsulin|immunoreactive proinsulin|Y
multiple intralumenal impedance|multiple intra-lumenal impedance|Y
anti-rat cytochrome P450, family 2, subfamily C, polypeptide 11 antibody|anti-rat cytochrome P450, family 2, subfamily C, polypeptide 6 antibody|Y
excision repair cross complementing-group 6|excision repair cross complementing-group 1|Y
excision repair cross complementing-group 6|excision repair cross-complementing-group 6|Y
excision repair cross complementing-group 6|excision repair cross complementing-group 2|Y
excision repair cross complementing-group 6|excision repair cross complementing-group 4|Y
excision repair cross complementing-group 6|excision repair cross complementing group 6|Y
α7 nicotinic acetylcholine receptor|α 7 nicotinic acetylcholine receptor|Y
inositol-requiring enzyme 1 alpha|inositol-requiring enzyme 1alpha|Y
gamma aminobutyric acid receptor agonist|gamma amino-butyric acid receptor agonist|Y
interglobular domain|inter-globular domain|Y
recombinant interleukine 1-β|recombinant interleukine 1β|Y
recombinant interleukine 1-β|recombinant interleukin 1-β|Y
Veterans Affairs medical center|Veteran's Affairs medical center|Y
Veterans Affairs medical center|Veterans' Affairs medical center|Y
inter-aural time difference|interaural time difference|Y
CC chemokine ligand 25|C-C chemokine ligand 25|Y
CC chemokine ligand 25|CC chemokine ligand 2|Y
inter-digestive migrating motor complex|interdigestive migrating motor complex|Y
interleukine-6 receptor-α|interleukin-6 receptor-α|Y
metaiodobenzyl-guanidine scan|metaiodobenzylguanidine scan|Y
metaiodobenzyl-guanidine scan|meta-iodobenzyl-guanidine scan|Y
galactorrhea amenorrhea hyperprolactinemia syndrome|galactorrhœa amenorrhea hyperprolactinemia syndrome|Y
galactorrhea amenorrhea hyperprolactinemia syndrome|galactorrhea amenorrhœa hyperprolactinemia syndrome|Y
multiple endocrine neoplasia type 2|multiple endocrine neoplasia type 2A|Y
multiple endocrine neoplasia type 2|multiple endocrine neoplasia type 2B|Y
beta-site amyloid precursor protein cleaving enzyme-2|beta-site amyloid precursor protein-cleaving enzyme-2|Y
beta-site amyloid precursor protein cleaving enzyme-2|beta site amyloid precursor protein cleaving enzyme-2|Y
beta-site amyloid precursor protein cleaving enzyme-2|beta-site amyloid precursor protein cleaving enzyme|Y
beta-site amyloid precursor protein cleaving enzyme-2|beta-site amyloid precursor protein cleaving enzyme 2|Y
beta-site amyloid precursor protein cleaving enzyme-2|beta-site amyloid precursor protein cleaving enzyme-1|Y
tumor necrosis factor receptor superfamily member 6|tumor necrosis factor receptor superfamily member 4|Y
tumor necrosis factor receptor superfamily member 6|tumor necrosis factor receptor superfamily member 6b|Y
tumor necrosis factor receptor superfamily member 6|tumor necrosis factor receptor superfamily member 5|Y
tumor necrosis factor receptor superfamily member 6|tumor necrosis factor receptor superfamily member 8|Y
tumor necrosis factor receptor superfamily member 6|tumor necrosis factor receptor superfamily member 9|Y
ribosomal protein S24|ribosomal protein S2|Y
neuron specific enolase|neurone specific enolase|Y
sirolimus-eluting stents|sirolimus-eluting stent|Y
ventroposterior lateral|ventro-posterior lateral|Y
myo-adenylate deaminase|myoadenylate deaminase|Y
malignant lympho-epithelial lesion|malignant lymphoepithelial lesion|Y
non-specific interstitial pneumonia|nonspecific interstitial pneumonia|Y
internal transcribed spacers|internal transcribed spacer|Y
nonstarch polysaccharide|non-starch polysaccharide|Y
juvenile chronic polyarthritis|juvenile chronic poly-arthritis|Y
head-down tilt bed rest|head-down tilt bedrest|Y
partial atrio-ventricular septal defect|partial atrioventricular septal defect|Y
trans-jugular intra-hepatic portosystemic shunting|trans-jugular intra-hepatic porto-systemic shunting|Y
trans-jugular intra-hepatic portosystemic shunting|trans-jugular intrahepatic portosystemic shunting|Y
trans-jugular intra-hepatic portosystemic shunting|transjugular intra-hepatic porto-systemic shunting|Y
glomerulosclerosis index|glomerulo-sclerosis index|Y
hexamethylphosphoric triamide|hexamethyl-phosphoric triamide|Y
type II Ehlers Danlos syndrome|type III Ehlers Danlos syndrome|Y
antiidiotopic monoclonal antibody|anti-idiotopic monoclonal antibody|Y
benzo[a]pyrene diol epoxide DNA adduct|benzo[a]pyrene diolepoxide DNA adduct|Y
recommended international nonproprietary name|recommended international non-proprietary name|Y
anti-human T-cell lymphotropic virus I antibody|anti-human T-cell lymphotrophic virus I antibody|Y
anti-human T-cell lymphotropic virus I antibody|anti-human T-cell lymphotropic virus-I antibody|Y
immuno-enzymometric assay|immunoenzymometric assay|Y
amino-imidazole ribonucleotide|aminoimidazole ribonucleotide|Y
Leyton Obsessional Inventory-Child Version|Leyton Obsessional Inventory--Child Version|Y
rotating frame Overhauser effect spectroscopy|rotating-frame Overhauser effect spectroscopy|Y
electron probe x-ray microanalysis|electron probe x-ray micro analysis|Y
electron probe x-ray microanalysis|electron probe x-ray micro-analysis|Y
American Society of Anaesthesiologists Grade III|American Society of Anesthesiologists Grade II|Y
American Society of Anaesthesiologists Grade III|American Society of Anaesthesiologists Grade II|Y
technetium-99m-labelled|technetium-99m-labeled|Y
delayed cerebral ischemia|delayed cerebral ischaemia|Y
peptidyl-glycine-α-amidating mono-oxygenase|peptidylglycine-α-amidating mono-oxygenase|Y
peptidyl-glycine-α-amidating mono-oxygenase|peptidyl-glycine α-amidating mono-oxygenase|Y
mitogen-activated protein kinase-activated protein kinase-1|mitogen-activated protein kinase-activated protein kinase-2|Y
mitogen-activated protein kinase-activated protein kinase-1|mitogen-activated protein kinase-activated protein kinase-5|Y
mitogen-activated protein kinase-activated protein kinase-1|mitogen-activated protein kinase-activated protein kinase 1|Y
mitogen-activated protein kinase-activated protein kinase-1|mitogen-activated protein kinase activated protein kinase-1|Y
inappropriate anti-diuretic hormone secretion syndrome|inappropriate antidiuretic hormone secretion syndrome|Y
antibody forming cells|antibody forming cell|Y
anti-ovalbumin immunoglobulin E|antiovalbumin immunoglobulin E|Y
periodic leg movement in sleep|periodic leg movements in sleep|Y
randomized clinical trial|randomized clinical trials|Y
recombinant human tumor necrosis factor-β|recombinant human tumour necrosis factor-β|Y
recombinant human tumor necrosis factor-β|recombinant human tumor necrosis factor β|Y
recombinant human tumor necrosis factor-β|recombinant human tumor necrosis factor-α|Y
multi-channel intraluminal impedance|multi-channel intra-luminal impedance|Y
cardiofaciocutaneous|cardio-faciocutaneous|Y
homeodomain interacting protein kinase 2|homeodomain-interacting protein kinase 2|Y
circulating intercellular adhesion molecule 3|circulating intercellular adhesion molecule 2|Y
circulating intercellular adhesion molecule 3|circulating intercellular adhesion molecule-3|Y
streptococcal cell wall|streptococcal cell walls|Y
c-Kit receptor tyrosine kinase|cKit receptor tyrosine kinase|Y
hemolytic disease of the newborn|haemolytic disease of the newborn|Y
Kabuki makeup syndrome|Kabuki make-up syndrome|Y
purinergic 2X2 receptor|purinergic 2X receptor|Y
TGF-beta-activated kinase 1-binding protein 1|TGFbeta-activated kinase 1-binding protein 1|Y
TGF-beta-activated kinase 1-binding protein 1|TGF-beta-activated kinase 1 binding protein 1|Y
hepatosplenic schistosomiasis|hepato-splenic schistosomiasis|Y
technetium-99m diethylenetriamine pentaacetic acid|technetium-99m diethylene triamine pentaacetic acid|Y
laevo-dopa-induced dyskinesia|levo-dopa-induced dyskinesia|Y
laevo-dopa-induced dyskinesia|laevodopa-induced dyskinesia|Y
olivo-ponto-cerebellar atrophy|olivoponto-cerebellar atrophy|Y
olivo-ponto-cerebellar atrophy|olivo-pontocerebellar atrophy|Y
tumor necrosis factor receptor-associated factor|tumour necrosis factor receptor-associated factor|Y
tumor necrosis factor receptor-associated factor|tumor necrosis factor receptor-associated factor 2|Y
tumor necrosis factor receptor-associated factor|tumor necrosis factor receptor-associated factor 1|Y
tumor necrosis factor receptor-associated factor|tumor necrosis factor receptor-associated factor-6|Y
tumor necrosis factor receptor-associated factor|tumor necrosis factor receptor-associated factor 5|Y
tumor necrosis factor receptor-associated factor|tumor necrosis factor receptor-associated factor 6|Y
toll/interleukin-1 receptor domain-containing adaptor inducing IFN-β|Toll/interleukin-1 receptor domain-containing adaptor inducing IFN-β|Y
toll/interleukin-1 receptor domain-containing adaptor inducing IFN-β|toll-interleukin-1 receptor domain-containing adaptor inducing IFN-β|Y
anti-varicella zoster virus antibody|antivaricella zoster virus antibody|Y
secondary immuno-deficiency|secondary immunodeficiency|Y
haemoglobin C-Makassar|hemoglobin C-Makassar|Y
neuro-cutaneous melanocytosis|neurocutaneous melanocytosis|Y
University of Texas, Southwestern Medical Center|University of Texas Southwestern Medical Center|Y
poly-galacturonic acid|polygalacturonic acid|Y
para-nitrophenylacetate|para-nitrophenyl acetate|Y
medial pre-frontal cortex|medial prefrontal cortex|Y
climbing fiber response|climbing fiber responses|Y
ultrasonically nebulised distilled water|ultrasonically nebulized distilled water|Y
non-sustained ventricular tachycardia|nonsustained ventricular tachycardia|Y
anti-human serum albumine antibody|anti-human serum albumin antibody|Y
invariant T-cell receptor Vα14|invariant T-cell receptor Vα 14|Y
invariant T-cell receptor Vα14|invariant T-cell receptor Vα-14|Y
anterior pituitary glands|anterior pituitary gland|Y
Escherichia coli strain K-12|Escherichia coli strain K12|Y
flow cytometric cross-match|flow cytometric crossmatch|Y
γ-aminobutyric acid-benzodiazepine receptor complex|γ-aminobutyric acid/benzodiazepine receptor complex|Y
γ-aminobutyric acid-benzodiazepine receptor complex|γ-aminobutyric acid A-benzodiazepine receptor complex|Y
university affiliated Veterans Affairs medical center|university affiliated Veterans' Affairs medical center|Y
university affiliated Veterans Affairs medical center|university affiliated Veteran's Affairs medical center|Y
university affiliated Veterans Affairs medical center|university-affiliated Veterans Affairs medical center|Y
multi-valvular involvement|multivalvular involvement|Y
anti-mitochondrial antibody|antimitochondrial antibody|Y
interleukine-15 receptor-α|interleukin-15 receptor-α|Y
interleukine-15 receptor-α|interleukine-5 receptor-α|Y
early neo-natal death|early neonatal death|Y
pregnancy-specific glycoproteins|pregnancy-specific glycoprotein|Y
p-chloromercuriphenylsulfonate|p-chloromercuriphenyl sulfonate|Y
macrolide-lincosamide-streptogramin resistance|macrolide-lincosamide-streptogramin B resistance|Y
radioimmuno-scintigraphy|radioimmunoscintigraphy|Y
conjugated equine estrogen|conjugated equine oestrogen|Y
promyelocytic leukaemia/retinoic acid receptor-α|promyelocytic leukemia/retinoic acid receptor-α|Y
Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events|Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events|Y
similar to mothers against decapentaplegic homolog 6|similar to mothers against decapentaplegic homolog 7|Y
similar to mothers against decapentaplegic homolog 6|similar to mothers against decapentaplegic homolog 1|Y
similar to mothers against decapentaplegic homolog 6|similar to mothers against decapentaplegic homolog 5|Y
similar to mothers against decapentaplegic homolog 6|similar to mothers against decapentaplegic homolog 2|Y
similar to mothers against decapentaplegic homolog 6|similar to mothers against decapentaplegic homolog 8|Y
matrix metalloproteinase 1|matrix metalloproteinase 13|Y
tubulointerstitial fibrosis|tubulo-interstitial fibrosis|Y
yttria-stabilized tetragonal zirconia polycrystal|yttria-stabilised tetragonal zirconia polycrystal|Y
yttria-stabilized tetragonal zirconia polycrystal|yttria stabilized tetragonal zirconia polycrystal|Y
polarization division multiplexing quadrature phase shift keying|polarisation division multiplexing quadrature phase shift keying|Y
insulin-like growth factor receptor|insulinlike growth factor receptor|Y
Osteopathia striata with cranial sclerosis|osteopathia striata with cranial sclerosis|Y
glass carbon electrode|glassy carbon electrode|Y
transsphenoidal surgery|trans-sphenoidal surgery|Y
thermoluminescent dosemeter|thermoluminescent dosemeters|Y
Von Hippel-Lindau tumour-suppressor protein|von Hippel-Lindau tumour-suppressor protein|Y
Von Hippel-Lindau tumour-suppressor protein|Von Hippel-Lindau tumour suppressor protein|Y
Von Hippel-Lindau tumour-suppressor protein|Von Hippel-Lindau tumor-suppressor protein|Y
A disintegrin and metalloprotease 19|A disintegrin and metalloprotease 9|Y
murine T-cell-associated serine proteinase-1|murine T-cell associated serine proteinase-1|Y
murine T-cell-associated serine proteinase-1|murine T-cell-associated serine proteinase 1|Y
dihydro-orotate dehydrogenase|dihydroorotate dehydrogenase|Y
staphylococcal superantigen-like protein|staphylococcal superantigen-like protein 5|Y
superoxide anion radicals|superoxide anion radical|Y
SECONDARY WALL-ASSOCIATED NAC DOMAIN PROTEIN 1|SECONDARY WALL-ASSOCIATED NAC DOMAIN PROTEIN1|Y
Waldenström's macroglobulinaemia|Waldenströms macroglobulinaemia|Y
Waldenström's macroglobulinaemia|Waldenström's macroglobulinemia|Y
computerized tomograms|computerized tomogram|Y
human adenovirus type 17|human adenovirus type 7|Y
beta-amyloid peptide|beta-amyloid peptides|Y
anti-citrullinated protein/peptide antibody|anticitrullinated protein/peptide antibody|Y
single-strand selective monofunctional uracil-DNA glycosylase 1|single-strand-selective monofunctional uracil-DNA glycosylase 1|Y
a disintegrin and metalloprotease 5|a disintegrin and metalloprotease 15|Y
para-hydroxyphenylpyruvic|parahydroxyphenylpyruvic|Y
International Standard Organization|International Standards Organization|Y
neural Wiskott-Aldrich syndrome protein|neuronal Wiskott-Aldrich syndrome protein|Y
inhibitory κ B kinase-β|inhibitory κB kinase-β|Y
surface enhanced laser desorption-ionisation|surface-enhanced laser desorption-ionisation|Y
augmented correlation consistent polarized valence triple ζ basis set|augmented correlation consistent polarized valence triple-ζ basis set|Y
augmented correlation consistent polarized valence triple ζ basis set|augmented correlation consistent polarised valence triple ζ basis set|Y
extracellular-signal-regulated protein kinase 5|extracellular-signal-regulated protein kinase|Y
extracellular-signal-regulated protein kinase 5|extracellular signal-regulated protein kinase 5|Y
pulmonary and activation regulated chemokine|pulmonary and activation-regulated chemokine|Y
total knee arthroplasty|total knee arthoplasty|Y
sub-ureteric Teflon injection|subureteric Teflon injection|Y
Charcot-Marie-Tooth neuropathy type 2|Charcot-Marie-Tooth neuropathy type 2A|Y
paroxysmal dystonic choreoathetosis|paroxysmal dystonic choreo-athetosis|Y
sodium-taurocholate co-transporting polypeptide|sodium taurocholate co-transporting polypeptide|Y
sodium-taurocholate co-transporting polypeptide|sodium-taurocholate cotransporting polypeptide|Y
recombinant P-selectin glycoprotein ligand immunoglobulin|recombinant P-selectin glycoprotein ligand-immunoglobulin|Y
Na-K-2Cl cotransporter|Na-K-Cl cotransporter|Y
Na-K-2Cl cotransporter|Na-K-2Cl co-transporter|Y
sex determining region Y box 3|sex determining region Y, box 3|Y
multi-detector computed tomography scan|multidetector computed tomography scan|Y
technetium-99m-diethylene-triaminepentaacetic acid-galactosyl human serum albumin|technetium-99m diethylene-triaminepentaacetic acid-galactosyl human serum albumin|Y
technetium-99m-diethylene-triaminepentaacetic acid-galactosyl human serum albumin|technetium-99m diethylene-triaminepentaacetic acid galactosyl human serum albumin|Y
technetium-99m-diethylene-triaminepentaacetic acid-galactosyl human serum albumin|technetium-99m diethylenetriaminepentaacetic acid-galactosyl human serum albumin|Y
degenerate oligonucleotide-primed polymerase chain reaction|degenerate oligonucleotide primed polymerase chain reaction|Y
interleukine 5 receptor-α|interleukin 5 receptor-α|Y
protein induced by vitamin K absence or antagonist II|protein induced by vitamin K absence or antagonist-II|Y
dehydroxymethyl-epoxyquinomicin|dehydroxymethyl-epoxy-quinomicin|Y
dehydroxymethyl-epoxyquinomicin|dehydroxymethylepoxyquinomicin|Y
cross polarization/magic-angle spinning nuclear magnetic resonance|cross polarization/magic-angle-spinning nuclear magnetic resonance|Y
cross polarization/magic-angle spinning nuclear magnetic resonance|cross polarization/magic angle spinning nuclear magnetic resonance|Y
acute tubulointerstitial nephritis|acute tubulo interstitial nephritis|Y
3-beta-hydroxysteroid dehydrogenase deficiency|3 beta-hydroxysteroid dehydrogenase deficiency|Y
3-beta-hydroxysteroid dehydrogenase deficiency|3beta-hydroxy steroid dehydrogenase deficiency|Y
monitored anaesthesia care|monitored anesthesia care|Y
Clinical Global Impression Improvement of Illness Scale|Clinical Global Impression-Improvement of Illness Scale|Y
C-C chemokine receptor 5|CC chemokine receptor 5|Y
human mitochondrial transcription factor B1|human mitochondrial transcription factor B|Y
human mitochondrial transcription factor B1|human mitochondrial transcription factor B2|Y
purinergic 2Y1 receptor|purinergic 2Y12 receptor|Y
scrapie-associated fibrils|scrapie-associated fibril|Y
non-English speaking background|non-English speaking backgrounds|Y
5-methoxy-N,N-dimethyl-tryptamine|5-methoxy-N,N-dimethyltryptamine|Y
α-methylparatyrosine|α-methyl-paratyrosine|Y
duodeno-gastro-oesophageal reflux|duodeno-gastro-esophageal reflux|Y
Kellgren-Lawrence grade III|Kellgren-Lawrence grade II|Y
intraoperative intra-arterial fibrinolytic therapy|intra-operative intra-arterial fibrinolytic therapy|Y
intraoperative intra-arterial fibrinolytic therapy|intraoperative intraarterial fibrinolytic therapy|Y
hereditary cerebral haemorrhage with amyloidosis, Icelandic-type|hereditary cerebral hemorrhage with amyloidosis, Icelandic-type|Y
anti-IL-6 receptor antibody|anti-IL6 receptor antibody|Y
anti-IL-6 receptor antibody|antiIL-6 receptor antibody|Y
phosphorylated calcium/calmodulin-dependent protein kinase II|phosphorylated calcium-calmodulin-dependent protein kinase II|Y
phosphorylated calcium/calmodulin-dependent protein kinase II|phosphorylated calcium/calmodulin dependent protein kinase II|Y
female to male transsexual|female to male trans-sexual|Y
trypsin inhibitor activity|trypsin inhibitory activity|Y
soluble interleukin-6 receptor-alpha|soluble interleukine-6 receptor-alpha|Y
radioguided parathyroidectomy|radio-guided parathyroidectomy|Y
percutaneous ultra-sonic lithotripsy|percutaneous ultrasonic lithotripsy|Y
IL13 receptor alpha2 chain|IL-13 receptor alpha2 chain|Y
neural-precursor cell-expressed, developmentally down-regulated 2|neural-precursor cell-expressed, developmentally downregulated 2|Y
neural-precursor cell-expressed, developmentally down-regulated 2|neural-precursor cell-expressed, developmentally downregulated 4|Y
neural-precursor cell-expressed, developmentally down-regulated 2|neural-precursor cell-expressed developmentally down-regulated 8|Y
neural-precursor cell-expressed, developmentally down-regulated 2|neural-precursor cell-expressed developmentally down-regulated 1|Y
neural-precursor cell-expressed, developmentally down-regulated 2|neural-precursor cell-expressed developmentally downregulated 2|Y
neural-precursor cell-expressed, developmentally down-regulated 2|neural-precursor cell-expressed, developmentally downregulated 9|Y
neural-precursor cell-expressed, developmentally down-regulated 2|neural-precursor cell-expressed, developmentally down-regulated 8|Y
neural-precursor cell-expressed, developmentally down-regulated 2|neural-precursor cell-expressed, developmentally down-regulated 1|Y
neural-precursor cell-expressed, developmentally down-regulated 2|neural-precursor cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally down-regulated 2|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor cell-expressed, developmentally down-regulated 2|neural-precursor cell-expressed, developmentally downregulated 5|Y
neural-precursor cell-expressed, developmentally down-regulated 2|neural-precursor cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally down-regulated 2|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor cell-expressed, developmentally down-regulated 2|neural precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor cell-expressed, developmentally down-regulated 2|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural-precursor cell-expressed, developmentally down-regulated 2|neural precursor cell-expressed, developmentally down-regulated 2|Y
neural-precursor cell-expressed, developmentally down-regulated 2|neural-precursor cell-expressed, developmentally downregulated 1|Y
neural-precursor cell-expressed, developmentally down-regulated 2|neural-precursor-cell-expressed, developmentally downregulated 2|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-4|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-1|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 4|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2|Y
sub-apical compartment|subapical compartment|Y
anti-interleukin 6 antibody|antiinterleukin 6 antibody|Y
papulo-necrotic tuberculid|papulonecrotic tuberculid|Y
papulo-necrotic tuberculid|papulo-necrotic tuberculide|Y
pre-Bötzinger complex|preBötzinger complex|Y
antiinterleukin 12 neutralizing antibody|antiinterleukin-12 neutralizing antibody|Y
antiinterleukin 12 neutralizing antibody|anti-interleukin 12 neutralizing antibody|Y
thyrotropin releasing hormone receptor-2|thyrotropin-releasing hormone receptor-2|Y
thyrotropin releasing hormone receptor-2|thyrotropin releasing hormone receptor 2|Y
thyrotropin releasing hormone receptor-2|thyrotropin releasing hormone receptor-1|Y
hypertensive disorder of pregnancy|hypertensive disorders of pregnancy|Y
ischaemic cardiopathy|ischemic cardiopathy|Y
donor S-nitroso-N-acetyl-DL-penicillamine|donor S-nitroso-N-acetyl-D,L-penicillamine|Y
transforming growth factor-β activated kinase-1|transforming growth factor-β-activated kinase-1|Y
Schedule for Clinical Assessment in Neuropsychiatry|Schedules for Clinical Assessment in Neuropsychiatry|Y
heat shock protein 90-β|heat shock protein 90β|Y
fibroblast growth factor receptor 2b|fibroblast growth factor receptor 2|Y
oxygen-derived free radicals|oxygen-derived free radical|Y
abnormal spindle-like microcephaly-associated|abnormal spindle-like microcephaly associated|Y
concomitant chemo-radiotherapy|concomitant chemoradiotherapy|Y
computed tomography/positron emission tomography|computed tomography-positron emission tomography|Y
anti-IL-1 receptor antibody|antiIL-1 receptor antibody|Y
anti-IL-1 receptor antibody|anti-IL-10 receptor antibody|Y
non-major histocompatibility complex|nonmajor histocompatibility complex|Y
autolyzed antigen extracted allogeneic bone|autolysed antigen extracted allogeneic bone|Y
autolyzed antigen extracted allogeneic bone|autolyzed antigen-extracted allogeneic bone|Y
cytochrome c oxidase subunit III|cytochrome c oxidase subunit II|Y
antirabbit immunoglobulin G antibody|anti-rabbit immunoglobulin G antibody|Y
calcium-binding proteins parvalbumin|calcium-binding protein parvalbumin|Y
proliferating cell nuclear antigens|proliferating cell nuclear antigen|Y
transforming growth factor beta-induced gene|transforming growth factor-beta-induced gene|Y
IL-13 receptor α 2 chain|IL13 receptor α 2 chain|Y
IL-13 receptor α 2 chain|IL-13 receptor α2 chain|Y
oxidised low-density lipoprotein receptor-1|oxidized low-density lipoprotein receptor-1|Y
TNF-alpha protease inhibitor-1|TNFalpha protease inhibitor-1|Y
chromatin immuno-precipitation|chromatin immunoprecipitation|Y
human papillomavirus immortalised cell line|human papillomavirus immortalized cell line|Y
phorbol ester 12-O-tetradecanoyl phorbol-13-acetate|phorbol ester 12-O-tetradecanoylphorbol-13-acetate|Y
phorbol ester 12-O-tetradecanoyl phorbol-13-acetate|phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate|Y
socio-technical system|sociotechnical system|Y
deproteinised polysaccharide-protein complex|deproteinized polysaccharide-protein complex|Y
1-oleyl-2-acetylglycerol|1-oleoyl-2-acetylglycerol|Y
post-transplantation lymphoproliferative disease|posttransplantation lympho-proliferative disease|Y
chloro-aluminum sulfonated phthalocyanine|chloroaluminum sulfonated phthalocyanine|Y
neoplastic angioendotheliomatosis|neoplastic angio-endotheliomatosis|Y
anti-T cell receptor alpha beta monoclonal antibody|anti-T cell receptor alpha/beta monoclonal antibody|Y
anti-T cell receptor alpha beta monoclonal antibody|anti-T cell receptor-alpha beta monoclonal antibody|Y
biventricular assist device|bi-ventricular assist device|Y
receptor-like protein tyrosine phosphatase zeta|receptor-like protein-tyrosine phosphatase zeta|Y
hepatic porto-enterostomy|hepatic portoenterostomy|Y
standard operating procedures|standard operating procedure|Y
antideoxyribonuclease|anti-deoxyribonuclease|Y
peptidyl-glycine α-amidating monooxygenase|peptidylglycine α-amidating mono-oxygenase|Y
peptidyl-glycine α-amidating monooxygenase|peptidylglycine α-amidating monooxygenase|Y
peptidyl-glycine α-amidating monooxygenase|peptidyl-glycine α-amidating mono-oxygenase|Y
poly-beta-hydroxy-butyrate|poly-beta-hydroxybutyrate|Y
thalamocortical relay neuron|thalamo-cortical relay neuron|Y
anti-IL6 receptor antibody|anti-IL 6 receptor antibody|Y
trans-jugular intra-hepatic porto-systemic shunting|transjugular intrahepatic porto-systemic shunting|Y
trans-jugular intra-hepatic porto-systemic shunting|trans-jugular intrahepatic portosystemic shunting|Y
trans-jugular intra-hepatic porto-systemic shunting|transjugular intra-hepatic porto-systemic shunting|Y
deoxycholate citrate agar|desoxycholate citrate agar|Y
human adenovirus serotype 26|human adenovirus serotype 6|Y
esophagogastroduodenoscopy|esophagogastro-duodenoscopy|Y
esophagogastroduodenoscopy|esophago-gastroduodenoscopy|Y
ileo-caecal sphincter|ileo-cecal sphincter|Y
encephaloduroarteriosynangiosis|encephaloduro-arteriosynangiosis|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motif-1|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motifs-13|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloprotease with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motif-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motif|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motifs-19|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motifs-17|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motif-8|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motifs-8|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motifs-15|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motifs-3|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
suborbicularis oculi fat lift|sub-orbicularis oculi fat lift|Y
negative regulatory element|negative regulatory elements|Y
growth hormone release inhibiting hormone|growth hormone release-inhibiting hormone|Y
growth hormone release inhibiting hormone|growth hormone-release inhibiting hormone|Y
intra-pulmonary artery|intrapulmonary artery|Y
similar to mothers against decapentaplegic homolog 7|similar to mothers against decapentaplegic homolog 1|Y
similar to mothers against decapentaplegic homolog 7|similar to mothers against decapentaplegic homolog 5|Y
similar to mothers against decapentaplegic homolog 7|similar to mothers against decapentaplegic homolog 2|Y
similar to mothers against decapentaplegic homolog 7|similar to mothers against decapentaplegic homolog 8|Y
sub-scapular skinfold|subscapular skinfold|Y
highly active anti-retroviral treatment|highly active antiretroviral treatment|Y
Drosophila cyclic AMP response element-binding protein-A|Drosophila cyclic AMP response element-binding protein|Y
enzyme linked immuno-sorbant assay|enzyme linked immunosorbant assay|Y
anti-streptolysin O titer|antistreptolysin O titer|Y
highly active anti-retroviral therapy|highly active antiretroviral therapy|Y
nonhomologous endjoining repair|non-homologous endjoining repair|Y
apolipoprotein B mRNA editing enzyme catalytic polypeptide|apolipoprotein B mRNA editing enzyme-catalytic polypeptide|Y
apolipoprotein B mRNA editing enzyme catalytic polypeptide|apolipoprotein B mRNA-editing enzyme catalytic polypeptide|Y
congenital nephrotic syndrome of the Finnish type|Congenital nephrotic syndrome of the Finnish type|Y
spontaneous intracerebral hemorrhage|spontaneous intra-cerebral hemorrhage|Y
non-muscle myosin heavy-chain-IIA|non-muscle myosin heavy-chain-II|Y
ubiquitin carboxyl-terminal hydrolase-L3|ubiquitin carboxyl-terminal hydrolase L3|Y
ubiquitin carboxyl-terminal hydrolase-L3|ubiquitin carboxyl-terminal hydrolase-L1|Y
nonobese diabetic-severe combined immunodeficient mouse|non-obese diabetic-severe combined immunodeficient mouse|Y
nonobese diabetic-severe combined immunodeficient mouse|nonobese diabetic severe combined immunodeficient mouse|Y
UDP-glucuronosyl transferase 2B10|UDP-glucuronosyltransferase 2B10|Y
B lymphocyte-induced maturation protein 1|B lymphocyte induced maturation protein 1|Y
x-ray repair cross-complementing group 1|x-ray repair cross complementing group 1|Y
summed pain intensity difference over 8 hours|summed pain intensity difference over 3 hours|Y
intra-testicular testosterone|intratesticular testosterone|Y
robust multi-array average|robust multiarray average|Y
cis-diamminedichloroplatinum|cis-diammine-dichloroplatinum|Y
hypothalamopituitary-thyroid axis|hypothalamo-pituitary-thyroid axis|Y
gastro esophageal reflux disease|gastroesophageal reflux disease|Y
type-2 corticotropin releasing hormone receptor|type-2 corticotrophin releasing hormone receptor|Y
type-2 corticotropin releasing hormone receptor|type 2 corticotropin releasing hormone receptor|Y
type-2 corticotropin releasing hormone receptor|type-2 corticotropin-releasing hormone receptor|Y
European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire-Core 30|European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire Core-30|Y
European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire-Core 30|European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30|Y
European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire-Core 30|European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30|Y
European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire-Core 30|European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30|Y
crosspolarisation/magic-angle spinning|cross polarisation/magic-angle spinning|Y
crosspolarisation/magic-angle spinning|cross-polarisation/magic-angle spinning|Y
Epstein-Barr virus-encoded ribonucleic acid|Epstein-Barr virus encoded ribonucleic acid|Y
ubiquitin carboxyl terminal hydrolase|ubiquitin carboxy terminal hydrolase|Y
chronic nonspherocytic hemolytic anemia|chronic non spherocytic hemolytic anemia|Y
venous thromboembolic event|venous thrombo-embolic event|Y
nerve-growth factor-like immunoreactivity|nerve growth factor-like immunoreactivity|Y
matrix assisted laser desorption ionization|matrix assisted laser desorption ionisation|Y
matrix assisted laser desorption ionization|matrix-assisted laser desorption ionization|Y
signal transducer and activator of transcription 3 protein|signal transducer and activator of transcription protein|Y
neuromuscular junction|neuro-muscular junction|Y
electron-probe X-ray micro analysis|electron-probe X-ray microanalysis|Y
cross-polarisation magic-angle spinning nuclear magnetic resonance|cross-polarization magic-angle spinning nuclear magnetic resonance|Y
cross-polarisation magic-angle spinning nuclear magnetic resonance|cross polarisation magic-angle spinning nuclear magnetic resonance|Y
cross-polarisation magic-angle spinning nuclear magnetic resonance|cross-polarisation/magic-angle spinning nuclear magnetic resonance|Y
Dahl salt-sensitive rat|Dahl salt-sensitive rats|Y
human adenovirus type 36|human adenovirus type 6|Y
microtubule-associated protein 2|microtubule-associated protein 2d|Y
serum β2-microglobulin value|serum β-2-microglobulin value|Y
serum β2-microglobulin value|serum β 2-microglobulin value|Y
Sepulveda Veterans Administration Medical Center|Sepulveda Veterans' Administration Medical Center|Y
insecticide-treated bed net|insecticide-treated bednet|Y
enterochromaffin-like cell carcinoid|enterochromaffinlike cell carcinoid|Y
low density lipoprotein receptor related protein 1|low density lipoprotein receptor related protein 6|Y
low density lipoprotein receptor related protein 1|low density lipoprotein receptor related protein 1B|Y
atrioventricular junction|atrio-ventricular junction|Y
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine|Y
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|Y
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine|Y
gamma glutamyltranspeptidase|gammaglutamyltranspeptidase|Y
polymerase chain reaction with confronting two-pair primers|Polymerase chain reaction with confronting two-pair primers|Y
interleukin-15 receptor-α|interleukin-5 receptor-α|Y
femoro-popliteal bypass|femoropopliteal bypass|Y
intraventral tegmental area|intra-ventral tegmental area|Y
antihæmophilic factor C|anti-hæmophilic factor C|Y
non-epileptic control|nonepileptic control|Y
IL-12-receptor beta 1|IL-12-receptor beta1|Y
4'-(hydroxymethyl)-4,5',8-trimethylpsoralen|4'-hydroxymethyl-4,5',8-trimethylpsoralen|Y
intraparenchymal hemorrhage|intra-parenchymal hemorrhage|Y
microcytotoxicity assay|micro-cytotoxicity assay|Y
Rab3-interacting molecule 1α|Rab3-interacting molecule 1 α|Y
tumor-necrosis factor-α|tumour-necrosis factor-α|Y
autoimmune bullous disease|auto-immune bullous disease|Y
99mTc macro-aggregated albumin|99mTc macroaggregated albumin|Y
University of California, Los Angeles Prostate Cancer Index|University of California Los Angeles Prostate Cancer Index|Y
transjugular intra-hepatic porto-systemic shunt|transjugular intrahepatic portosystemic shunt|Y
transjugular intra-hepatic porto-systemic shunt|trans-jugular intrahepatic porto-systemic shunt|Y
transjugular intra-hepatic porto-systemic shunt|transjugular intra-hepatic portosystemic shunt|Y
transjugular intra-hepatic porto-systemic shunt|trans-jugular intra-hepatic porto-systemic shunt|Y
transjugular intra-hepatic porto-systemic shunt|trans-jugular intra-hepatic portosystemic shunt|Y
interleukine-1β receptor|interleukin-1β receptor|Y
xeroderma pigmentosum complementation group D|xeroderma pigmentosum complementation group C|Y
xeroderma pigmentosum complementation group D|xeroderma pigmentosum complementation group G|Y
xeroderma pigmentosum complementation group D|xeroderma pigmentosum complementation group E|Y
melphalan prednisone|melphalan, prednisone|Y
xenotropic murine leukæmia-related virus|xenotropic murine leukemia-related virus|Y
radio-pharmaceutical uptake|radiopharmaceutical uptake|Y
recombinant adeno-associated virus vector|recombinant adeno-associated virus vectors|Y
multilocus VNTR analysis|multi-locus VNTR analysis|Y
promyelocytic leukemia-retinoic acid receptor-alpha|promyelocytic leukaemia-retinoic acid receptor-alpha|Y
promyelocytic leukemia-retinoic acid receptor-alpha|promyelocytic leukemia/retinoic acid receptor-alpha|Y
promyelocytic leukemia-retinoic acid receptor-alpha|promyelocytic leukemia-retinoic acid receptor alpha|Y
multi-polar electro-coagulation|multi-polar electrocoagulation|Y
trans-lesion DNA synthesis|translesion DNA synthesis|Y
antikeratin antibody|anti-keratin antibody|Y
retinal image multi-scale analysis|retinal image multiscale analysis|Y
retinoblastoma protein-interacting zinc finger 2|retinoblastoma protein-interacting zinc finger 1|Y
transforming growth factor β receptor-II|transforming growth factor-β receptor-II|Y
transforming growth factor β receptor-II|transforming growth factor β receptor II|Y
transactivation response|trans-activation response|Y
a disintegrin and metalloprotease-8|a disintegrin and metalloprotease-28|Y
post-dilution hemodiafiltration|post-dilution haemodiafiltration|Y
matrix assisted laser desorption ionisation time-of-flight mass spectrometric|matrix assisted laser desorption/ionisation time-of-flight mass spectrometric|Y
matrix assisted laser desorption ionisation time-of-flight mass spectrometric|matrix assisted laser desorption ionization time-of-flight mass spectrometric|Y
high resolution computerised tomography scan|high resolution computerized tomography scan|Y
Na(+)/H(+) exchanger-regulatory factor 1|Na(+)/H(+) exchanger regulatory factor 1|Y
postchorionic villus sampling|post-chorionic villus sampling|Y
corticotrophin releasing factor receptor-1|corticotrophin releasing factor receptor 1|Y
corticotrophin releasing factor receptor-1|corticotropin releasing factor receptor-1|Y
haemoglobin Brie Comté Robert|hemoglobin Brie Comté Robert|Y
molybdo-pterin cofactor|molybdopterin cofactor|Y
Hb S/beta thalassaemia|Hb S/beta thalassemia|Y
American Society of Anaesthesiologists class I|American Society of Anesthesiologists class II|Y
American Society of Anaesthesiologists class I|American Society of Anaesthesiologists class 3|Y
American Society of Anaesthesiologists class I|American Society of Anesthesiologists class IV|Y
American Society of Anaesthesiologists class I|American Society of Anaesthesiologists class 5|Y
American Society of Anaesthesiologists class I|American Society of Anaesthesiologists Class I|Y
American Society of Anaesthesiologists class I|American Society of Anaesthesiologists class III|Y
American Society of Anaesthesiologists class I|American Society of Anaesthesiologists class 1|Y
American Society of Anaesthesiologists class I|American Society of Anaesthesiologists class 4|Y
American Society of Anaesthesiologists class I|American Society of Anesthesiologists class I|Y
prosurfactant protein|pro-surfactant protein|Y
chicken luteinising hormone releasing hormone|chicken luteinising hormone-releasing hormone|Y
chicken luteinising hormone releasing hormone|chicken luteinizing hormone releasing hormone|Y
chicken luteinising hormone releasing hormone|chicken luteinising hormone releasing hormone I|Y
receptor-like protein tyrosine phosphatase κ|receptor-like protein tyrosine phosphatase δ|Y
receptor-like protein tyrosine phosphatase κ|receptor-like protein tyrosine phosphatase α|Y
receptor-like protein tyrosine phosphatase κ|receptor-like protein tyrosine phosphatase-κ|Y
receptor-like protein tyrosine phosphatase κ|receptor-like protein tyrosine phosphatase ζ|Y
receptor-like protein tyrosine phosphatase κ|receptor-like protein tyrosine phosphatase η|Y
apparent life-threatening events|apparent life-threatening event|Y
transforming growth factor α-Pseudomonas exotoxin-40|transforming growth factor α-Pseudomonas exotoxin 40|Y
mycosporine-like amino acid|mycosporine-like amino acids|Y
interleukin-13 receptor alpha 1|interleukin-13 receptor alpha1|Y
interleukin-13 receptor alpha 1|interleukine-13 receptor alpha 1|Y
IL-1 receptor-associated kinase|IL1 receptor-associated kinase|Y
TBP-associated factor-1|TBP-associated factor-11|Y
TBP-associated factor-1|TBP-associated factor-12|Y
TBP-associated factor-1|TBP-associated factor-15|Y
TBP-associated factor-1|TBP-associated factor-10|Y
matrix assisted laser desorption ionization time-of-flight mass spectrometry|matrix assisted laser desorption ionization time-of-flight mass spectrometric|Y
matrix assisted laser desorption ionization time-of-flight mass spectrometry|matrix-assisted laser desorption ionization time-of-flight mass spectrometry|Y
matrix assisted laser desorption ionization time-of-flight mass spectrometry|matrix assisted laser desorption/ionization time-of-flight mass spectrometry|Y
cross polarization magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarization magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross polarization magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
O-acetylserine sulphydrylase|O-acetyl-serine sulphydrylase|Y
solute carrier family 7 member 6|solute carrier family 17 member 6|Y
gonadotropin releasing hormone associated peptide|gonadotropin-releasing hormone associated peptide|Y
fetal thymus organ cultures|fetal thymus organ culture|Y
antiIL-10 receptor MAb|anti-IL-10 receptor MAb|Y
thymic stromal-derived lymphopoietin receptor|thymic stromal derived lymphopoietin receptor|Y
electrophoretically mediated microanalysis|eletrophoretically mediated microanalysis|Y
immunoglobulin G2 antibody|immunoglobulin G2a antibody|Y
immunoglobulin G2 antibody|immunoglobulin G2b antibody|Y
immunoglobulin G2 antibody|immunoglobulin G antibody|Y
Philadelphia Veterans' Affairs Medical Center|Philadelphia Veterans Affairs Medical Center|Y
5alpha-dihydrotestosterone|5 alpha-dihydrotestosterone|Y
cervicomedullary junction|cervico-medullary junction|Y
retinoic acid receptor-related orphan receptor γ t|retinoic acid receptor-related orphan receptor γt|Y
retinoic acid receptor-related orphan receptor γ t|retinoic acid receptor-related orphan receptor γ T|Y
retinoic acid receptor-related orphan receptor γ t|retinoic acid receptor-related orphan receptor γ|Y
estrogen receptor α protein|oestrogen receptor α protein|Y
DNA repair protein O(6)-alkylguanine-DNA alkyltransferase|DNA repair protein O6-alkylguanine-DNA alkyltransferase|Y
multiplex fluorescence in situ hybridization|multiplex fluorescence in-situ hybridization|Y
multiplex fluorescence in situ hybridization|multiplex-fluorescence in situ hybridization|Y
multiplex fluorescence in situ hybridization|multiplex fluorescence in situ hybridisation|Y
receptor activator of NF-kappa B|receptor activator of NF-kappaB|Y
interferon stimulated gene factor-3|interferon stimulated gene factor-3γ|Y
interferon stimulated gene factor-3|interferon stimulated gene factor-3α|Y
human basic fibroblast growth factor fusion protein 2|human basic fibroblast growth factor fusion protein 1|Y
endothelial monocyte-activating polypeptide I|endothelial monocyte-activating polypeptide 2|Y
endothelial monocyte-activating polypeptide I|endothelial monocyte activating polypeptide I|Y
endothelial monocyte-activating polypeptide I|endothelial monocyte-activating polypeptide-I|Y
endothelial monocyte-activating polypeptide I|endothelial monocyte-activating polypeptide II|Y
endothelial monocyte-activating polypeptide I|endothelial-monocyte-activating polypeptide I|Y
multiple endocrine neoplasia type 2A syndrome|multiple endocrine neoplasia type 2B syndrome|Y
Bacillus amyloliquefaciens strain I endonuclease|Bacillus amyloliquefaciens strain HI endonuclease|Y
neuronal apoptosis inhibitory protein|neuronal apoptosis inhibitor protein|Y
myocardial perfusion single-photon-emission computerised tomography|myocardial perfusion single-photon emission computerised tomography|Y
myocardial perfusion single-photon-emission computerised tomography|myocardial perfusion single-photon-emission computerized tomography|Y
intra-cellular domain|intracellular domain|Y
light-harvesting chlorophyll a/b protein I|light-harvesting chlorophyll a/b protein|Y
light-harvesting chlorophyll a/b protein I|light-harvesting chlorophyll a/b protein II|Y
light-harvesting chlorophyll a/b protein I|light harvesting chlorophyll a/b protein I|Y
light-harvesting chlorophyll a/b protein I|light-harvesting chlorophyll a/b protein-I|Y
remaining dentine thickness|remaining dentin thickness|Y
platelet-type 12-lipoxygenase|platelet-type 12S-lipoxygenase|Y
hereditary non-polyposis colorectal carcinoma|hereditary nonpolyposis colorectal carcinoma|Y
hereditary non-polyposis colorectal carcinoma|Hereditary non-polyposis colorectal carcinoma|Y
sleep onset REM period|sleep onset REM periods|Y
enzyme-linked-immuno-sorbent assay|enzyme-linked-immunosorbent assay|Y
aci-reductone dioxygenase|acireductone dioxygenase|Y
radioresistant DNA synthesis|radio-resistant DNA synthesis|Y
natural-resistance-associated macrophage protein 1|natural-resistance-associated macrophage protein-1|Y
human chorionic gonadotropin-β subunit|human chorionic gonadotrophin-β subunit|Y
pancreaticoduodenectomy|pancreatico-duodenectomy|Y
recombination activating gene|recombination activating genes|Y
meta-iodobenzylguanidine scan|metaiodobenzylguanidine scan|Y
meta-iodobenzylguanidine scan|meta-iodobenzyl-guanidine scan|Y
C-C chemokine ligand 25|C-C chemokine ligand 5|Y
sidestream darkfield imaging|side-stream darkfield imaging|Y
β site amyloid precursor protein-cleaving enzyme 1|β site amyloid precursor protein-cleaving enzyme 2|Y
β site amyloid precursor protein-cleaving enzyme 1|β-site amyloid precursor protein-cleaving enzyme 1|Y
β site amyloid precursor protein-cleaving enzyme 1|β site amyloid precursor protein-cleaving enzyme-1|Y
Src homology-2 domain-containing protein tyrosine phosphatase|Src homology-2 domain-containing protein tyrosine-phosphatase|Y
Src homology-2 domain-containing protein tyrosine phosphatase|Src homology 2 domain-containing protein tyrosine phosphatase|Y
Src homology-2 domain-containing protein tyrosine phosphatase|Src homology-2 domain-containing protein-tyrosine phosphatase|Y
Src homology-2 domain-containing protein tyrosine phosphatase|Src homology-2 domain-containing protein tyrosine phosphatase 2|Y
Src homology-2 domain-containing protein tyrosine phosphatase|Src homology-2 domain-containing protein tyrosine phosphatase-2|Y
Src homology-2 domain-containing protein tyrosine phosphatase|src homology-2 domain-containing protein tyrosine phosphatase|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling|terminal-deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labelling|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling|terminal-deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling|Y
anti-oxidative activity|antioxidative activity|Y
anti-beta 2-glycoprotein I antibody|anti-beta2-glycoprotein I antibody|Y
ribosomal protein L40|ribosomal protein L4|Y
stapled hemorrhoidopexy|stapled haemorrhoidopexy|Y
peptidylglycine-α-amidating mono-oxygenase|peptidylglycine α-amidating mono-oxygenase|Y
beta transducin repeat containing protein|beta transducin repeat-containing protein|Y
beta transducin repeat containing protein|beta-transducin repeat containing protein|Y
corticotropin-releasing factor receptor type 1|corticotropin releasing factor receptor type 1|Y
human promyelocytic leukaemia|human promyelocytic leukemia|Y
α1 antitrypsin deficiency|α 1 antitrypsin deficiency|Y
atrio-ventricular reentrant tachycardia|atrioventricular reentrant tachycardia|Y
anti-arrhythmic peptide|antiarrhythmic peptide|Y
post-meiotic segregation|postmeiotic segregation|Y
gamma-aminobutyric acid-B|gamma-aminobutyric acidB|Y
tumor necrosis factor receptor superfamily member 4|tumor necrosis factor receptor superfamily member 5|Y
tumor necrosis factor receptor superfamily member 4|tumor necrosis factor receptor superfamily member 8|Y
tumor necrosis factor receptor superfamily member 4|tumor necrosis factor receptor superfamily member 9|Y
anti-granulocyte macrophage colony-stimulating factor antibody|anti-granulocyte macrophage colony stimulating factor antibody|Y
anti-granulocyte macrophage colony-stimulating factor antibody|anti-granulocyte-macrophage colony-stimulating factor antibody|Y
charge coupled devices|charge coupled device|Y
Ran GTPase activating protein|RanGTPase activating protein|Y
retained foetal membrane|retained fetal membrane|Y
insulin-like growth factor II messenger RNA-binding protein 1|insulin-like growth factor-II messenger RNA-binding protein 1|Y
insulin-like growth factor II messenger RNA-binding protein 1|insulin-like growth factor II messenger RNA-binding protein 3|Y
insulin-like growth factor II messenger RNA-binding protein 1|insulin-like growth factor II messenger RNA-binding protein 2|Y
insulin-like growth factor II messenger RNA-binding protein 1|insulin-like growth factor II messenger RNA-binding protein-1|Y
insulin-like growth factor II messenger RNA-binding protein 1|insulin-like growth factor II messenger RNA-binding protein|Y
insulin-like growth factor II messenger RNA-binding protein 1|insulin-like growth factor II messenger RNA binding protein 1|Y
nuclear factor erythroid 2p45-related factor-2|nuclear factor erythroid 2 p45-related factor-2|Y
head-down tilt bed-rest|head-down tilt bedrest|Y
neuro-epithelial body|neuroepithelial body|Y
TNFR-associated factor-2|TNF-R-associated factor-2|Y
pedunculo-pontine tegmentum|pedunculopontine tegmentum|Y
catalysed reporter deposition fluorescence in situ hybridization|catalysed reporter deposition-fluorescence in situ hybridization|Y
estrogen receptor-β knockout mouse|estrogen receptor-β knock-out mouse|Y
estrogen receptor-β knockout mouse|estrogen receptor-β knock out mouse|Y
estrogen receptor-β knockout mouse|oestrogen receptor-β knockout mouse|Y
anticolorectal cancer monoclonal antibody|anti-colorectal cancer monoclonal antibody|Y
endothelial monocyte-activating polypeptide 2|endothelial monocyte activating polypeptide 2|Y
endothelial monocyte-activating polypeptide 2|endothelial monocyte-activating polypeptide-2|Y
light-harvesting chlorophyll a/b binding protein II|light harvesting chlorophyll a/b binding protein II|Y
light-harvesting chlorophyll a/b binding protein II|light-harvesting chlorophyll a/b-binding protein II|Y
light-harvesting chlorophyll a/b binding protein II|light-harvesting chlorophyll a/b binding protein I|Y
light-harvesting chlorophyll a/b binding protein II|light-harvesting chlorophyll a/b binding protein-II|Y
peroxisome proliferator activated receptor gamma 2|peroxisome proliferator activated receptor gamma-2|Y
peroxisome proliferator activated receptor gamma 2|peroxisome proliferator activated receptor gamma 1|Y
peroxisome proliferator activated receptor gamma 2|peroxisome proliferator-activated receptor gamma 2|Y
adenosine triphosphate binding cassette transporter A1|adenosine triphosphate binding cassette transporter 1|Y
STE20-related proline alanine rich kinase|STE20-related proline alanine-rich kinase|Y
STE20-related proline alanine rich kinase|STE-20-related proline alanine rich kinase|Y
Vibrio cholerae O1 ElTor|Vibrio cholerae O1 El Tor|Y
anti-interleukin-6 neutralizing antibody|anti-interleukin-4 neutralizing antibody|Y
anti-interleukin-6 neutralizing antibody|anti-interleukin-6 neutralising antibody|Y
anti-interleukin-6 neutralizing antibody|anti-interleukin-8 neutralizing antibody|Y
anti-interleukin-6 neutralizing antibody|anti-interleukin 6 neutralizing antibody|Y
2-amino-3-methylimidazo[4,5-f] quinoline|2-amino-3-methylimidazo [4,5-f]quinoline|Y
2-amino-3-methylimidazo[4,5-f] quinoline|2-amino-3-methylimidazo[4,5-f]-quinoline|Y
2-amino-3-methylimidazo[4,5-f] quinoline|2-amino-3-methyl-imidazo[4,5-f]quinoline|Y
2-amino-3-methylimidazo[4,5-f] quinoline|2-amino-3-methylimidazo[4,5-f]quinoline|Y
2-amino-3-methylimidazo[4,5-f] quinoline|2-amino-3-methylimidazo-[4,5-f]quinoline|Y
receptor-like protein-tyrosine phosphatase-zeta|receptor-like protein-tyrosine phosphatase zeta|Y
receptor-like protein-tyrosine phosphatase-zeta|receptor-like protein-tyrosine phosphatase-eta|Y
human T-cell lymphotropic virus type 1 antibody|human T-cell lymphotropic virus type-1 antibody|Y
alcohol dehydrogenase 1C|alcohol dehydrogenase 1|Y
platelet-derived growth factor B|platelet-derived growth factor AB|Y
preprosomatostatin mRNA|prepro-somatostatin mRNA|Y
preprosomatostatin mRNA|pre-prosomatostatin mRNA|Y
insulin-like growth factor binding protein related protein-1|insulin-like growth factor binding protein-related protein-1|Y
insulin-like growth factor binding protein related protein-1|insulin-like growth factor binding protein related protein 1|Y
musculoskeletal pain|musculo-skeletal pain|Y
peroxisome proliferator-activated receptor gamma co-activator 1alpha|peroxisome proliferator-activated receptor gamma coactivator-1alpha|Y
peroxisome proliferator-activated receptor gamma co-activator 1alpha|peroxisome-proliferator-activated receptor gamma coactivator 1alpha|Y
peroxisome proliferator-activated receptor gamma co-activator 1alpha|peroxisome proliferator-activated receptor-gamma coactivator 1alpha|Y
peroxisome proliferator-activated receptor gamma co-activator 1alpha|peroxisome proliferator-activated receptor gamma coactivator 1alpha|Y
peroxisome proliferator-activated receptor gamma co-activator 1alpha|peroxisome proliferator-activated receptor-gamma co-activator 1alpha|Y
peroxisome proliferator-activated receptor gamma co-activator 1alpha|peroxisome proliferator-activated receptor gamma coactivator 1 alpha|Y
peroxisome proliferator-activated receptor gamma co-activator 1alpha|peroxisome proliferator-activated receptor gamma co-activator-1alpha|Y
peroxisome proliferator-activated receptor gamma co-activator 1alpha|peroxisome proliferator-activated receptor gamma co-activator 1 alpha|Y
peroxisome proliferator-activated receptor gamma co-activator 1alpha|peroxisome proliferator-activated receptor-gamma co-activator 1 alpha|Y
cancer-associated haemolytic uraemic syndrome|cancer-associated haemolytic-uraemic syndrome|Y
cancer-associated haemolytic uraemic syndrome|cancer-associated hemolytic uremic syndrome|Y
spinocerebellar ataxia 12|spinocerebellar ataxia 2|Y
spinocerebellar ataxia 12|spinocerebellar ataxia 1|Y
peroxisome-proliferator-activated receptor-beta|peroxisome-proliferator-activated receptor beta|Y
peroxisome-proliferator-activated receptor-beta|peroxisome proliferator-activated receptor-beta|Y
non-tender, non-distended|non-tender non-distended|Y
human transforming growth factor β 2|human transforming growth factor β2|Y
differential interference contrast microscope|differential interference contrast microscopy|Y
insulin-like growth factor-II messenger RNA-binding protein 1|insulin-like growth factor-II messenger RNA-binding protein|Y
insulin-like growth factor-II messenger RNA-binding protein 1|insulin-like growth factor-II messenger RNA-binding protein 2|Y
insulin-like growth factor-II messenger RNA-binding protein 1|insulin-like growth factor-II messenger RNA binding protein 1|Y
insulin-like growth factor-II messenger RNA-binding protein 1|insulin-like growth factor-II messenger RNA-binding protein-1|Y
thyroid releasing hormone stimulation test|thyroid releasing hormone-stimulation test|Y
chlorodinitrobenzene|chloro-dinitrobenzene|Y
lymphatico-venous anastomosis|lymphaticovenous anastomosis|Y
retinoic-acid-receptor-related orphan receptor gamma t|retinoic-acid-receptor-related orphan receptor gamma|Y
retinoic-acid-receptor-related orphan receptor gamma t|retinoic-acid-receptor-related orphan receptor gammat|Y
retinoic-acid-receptor-related orphan receptor gamma t|retinoic-acid-receptor-related orphan receptor gamma-t|Y
hepatic epithelioid hemangioendothelioma|hepatic epithelioid hemangio-endothelioma|Y
hepatic epithelioid hemangioendothelioma|hepatic epithelioid haemangio-endothelioma|Y
non-digestible oligosaccharides|nondigestible oligosaccharides|Y
horse antithymocyte globulin|horse anti-thymocyte globulin|Y
epithelial sodium channel|epithelial sodium channels|Y
antibody-forming cell|antibody-forming cells|Y
transforming growth factor β induced gene|transforming growth factor β-induced gene|Y
human T-cell lymphoma/leukaemia virus type 1|human T-cell lymphoma/leukemia virus type 1|Y
human T-cell lymphoma/leukaemia virus type 1|human T-cell lymphoma/leukaemia virus type 2|Y
human T-cell lymphoma/leukaemia virus type 1|human T-cell lymphoma/leukaemia virus type I|Y
gonadotropin-releasing hormone analogs|gonadotropin-releasing hormone analog|Y
Baltimore Veterans Affairs Medical Center|Baltimore Veterans' Affairs Medical Center|Y
non-structural protein 1|nonstructural protein 1|Y
multilocus sequence type|multi-locus sequence type|Y
overwhelming post-splenectomy infection|overwhelming postsplenectomy infection|Y
fibro-cystic dysplasia|fibrocystic dysplasia|Y
self-amplified spontaneous-emission free-electron laser|self-amplified spontaneous emission free-electron laser|Y
bio-electric impedance|bioelectric impedance|Y
promyelocytic leukemia|pro-myelocytic leukemia|Y
antiIL-15 monoclonal antibody|anti-IL-15 monoclonal antibody|Y
tumour-necrosis factor α|tumor-necrosis factor α|Y
augmented correlation-consistent polarized valence triple-ζ basis set|augmented correlation-consistent polarized-valence triple-ζ basis set|Y
augmented correlation-consistent polarized valence triple-ζ basis set|augmented correlation consistent polarized valence triple-ζ basis set|Y
human papillomavirus 11|human papillomavirus 1|Y
parachloromercuribenzoate|para-chloromercuribenzoate|Y
enzyme-linked immunoelectrotransfer blot|enzyme-linked immuno-electrotransfer blot|Y
enzyme-linked immunoelectrotransfer blot|enzyme-linked immunoelectro-transfer blot|Y
mitogen activated protein kinase activated protein kinase-1|mitogen activated protein kinase activated protein kinase-3|Y
mitogen activated protein kinase activated protein kinase-1|mitogen activated protein kinase activated protein kinase|Y
mitogen activated protein kinase activated protein kinase-1|mitogen-activated protein kinase activated protein kinase-1|Y
mitogen activated protein kinase activated protein kinase-1|mitogen activated protein kinase activated protein kinase-2|Y
mitogen activated protein kinase activated protein kinase-1|mitogen activated protein kinase activated protein kinase 1|Y
febrile non-hemolytic reaction|febrile nonhemolytic reaction|Y
febrile non-hemolytic reaction|febrile non-haemolytic reaction|Y
bis(sulfosuccinimidyl) suberate|bis(sulfosuccinimidyl)suberate|Y
minisatellite associated sequence amplification|minisatellite-associated sequence amplification|Y
murine T-cell associated serine proteinase-1|murine T cell associated serine proteinase-1|Y
neural-precursor cell-expressed, developmentally downregulated 2|neural-precursor cell-expressed developmentally downregulated 4|Y
neural-precursor cell-expressed, developmentally downregulated 2|neural-precursor cell-expressed, developmentally downregulated 4|Y
neural-precursor cell-expressed, developmentally downregulated 2|neural-precursor cell-expressed developmentally downregulated 2|Y
neural-precursor cell-expressed, developmentally downregulated 2|neural-precursor cell-expressed, developmentally downregulated 9|Y
neural-precursor cell-expressed, developmentally downregulated 2|neural-precursor-cell-expressed developmentally downregulated 2|Y
neural-precursor cell-expressed, developmentally downregulated 2|neural-precursor cell-expressed, developmentally down-regulated 8|Y
neural-precursor cell-expressed, developmentally downregulated 2|neural-precursor cell-expressed, developmentally down-regulated 1|Y
neural-precursor cell-expressed, developmentally downregulated 2|neural-precursor cell-expressed developmentally downregulated 8|Y
neural-precursor cell-expressed, developmentally downregulated 2|neural-precursor cell-expressed developmentally downregulated 5|Y
neural-precursor cell-expressed, developmentally downregulated 2|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor cell-expressed, developmentally downregulated 2|neural-precursor cell-expressed, developmentally downregulated 5|Y
neural-precursor cell-expressed, developmentally downregulated 2|neural-precursor cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally downregulated 2|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural-precursor cell-expressed, developmentally downregulated 2|neural precursor cell-expressed, developmentally down-regulated 2|Y
neural-precursor cell-expressed, developmentally downregulated 2|neural-precursor cell-expressed, developmentally downregulated 1|Y
neural-precursor cell-expressed, developmentally downregulated 2|neural-precursor-cell-expressed, developmentally downregulated 2|Y
phosphorylated microtubule-associated protein 1B|phosphorylated microtubule-associated protein-1B|Y
xray computed tomography|x-ray computed tomography|Y
beta-hydroxy-butyrate|beta-hydroxybutyrate|Y
ribosomal protein L41|ribosomal protein L1|Y
ribosomal protein L41|ribosomal protein L4|Y
pre-heparin lipoprotein lipase mass|preheparin lipoprotein lipase mass|Y
angiontensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor|Y
angiontensin converting enzyme inhibitor|angiotensin converting enzyme inhibitors|Y
calcitonin gene-related peptide-immunoreactive nerve fibre|calcitonin gene-related peptide-immunoreactive nerve fiber|Y
calcitonin gene-related peptide-immunoreactive nerve fibre|calcitonin gene-related peptide immunoreactive nerve fibre|Y
G protein βγ subunit|G protein β-γ subunit|Y
early light-inducible protein|early light-inducible proteins|Y
peroxisome proliferator-activated receptor-γ co-activator-1|peroxisome proliferator-activated receptor-γ coactivator-1α|Y
peroxisome proliferator-activated receptor-γ co-activator-1|peroxisome proliferator-activated receptor-γ coactivator-1|Y
peroxisome proliferator-activated receptor-γ co-activator-1|peroxisome proliferator-activated receptor γ co-activator-1|Y
peroxisome proliferator-activated receptor-γ co-activator-1|peroxisome proliferator-activated receptor-γ co-activator-1α|Y
peroxisome proliferator-activated receptor-γ co-activator-1|peroxisome proliferator-activated receptor-γ co-activator-1 α|Y
American Society of Anaesthesiologists Class II|American Society of Anaesthesiologists Class III|Y
American Society of Anaesthesiologists Class II|American Society of Anaesthesiologists Class I|Y
American Society of Anaesthesiologists Class II|American Society of Anesthesiologists Class I|Y
American Society of Anaesthesiologists Class II|American Society of Anesthesiologists Class III|Y
American Society of Anaesthesiologists Class II|American Society of Anesthesiologists Class II|Y
Krüppel-like factor 2|Krüppel-like factor 12|Y
hepatic arterial chemoembolisation|hepatic arterial chemo-embolisation|Y
Orthopedic Research and Education Foundation|Orthopaedic Research and Education Foundation|Y
light harvesting chlorophyll a/b binding protein-II|light harvesting chlorophyll a/b-binding protein-II|Y
light harvesting chlorophyll a/b binding protein-II|light harvesting chlorophyll a/b binding protein II|Y
light harvesting chlorophyll a/b binding protein-II|light harvesting chlorophyll a/b binding protein-I|Y
light harvesting chlorophyll a/b binding protein-II|light-harvesting chlorophyll a/b binding protein-II|Y
TATA-binding protein-associated factor 3|TATA-binding protein-associated factor 5|Y
TATA-binding protein-associated factor 3|TATA-binding protein-associated factor 2|Y
TATA-binding protein-associated factor 3|TATA-binding protein-associated factor 7|Y
TATA-binding protein-associated factor 3|TATA-binding protein-associated factor 9|Y
TATA-binding protein-associated factor 3|TATA-binding protein-associated factor 8|Y
TATA-binding protein-associated factor 3|TATA-binding protein-associated factor 6|Y
TATA-binding protein-associated factor 3|TATA-binding protein-associated factor 1|Y
TATA-binding protein-associated factor 3|TATA-binding protein-associated factor 4|Y
TATA-binding protein-associated factor 3|TATA-binding protein-associated factor-3|Y
bronchial associated lymphoid tissue hyperplasia|bronchial-associated lymphoid tissue hyperplasia|Y
human lysosome-associated membrane protein 2|human lysosome-associated membrane protein|Y
human lysosome-associated membrane protein 2|human lysosome-associated membrane protein-2|Y
non-structural carbohydrate|nonstructural carbohydrate|Y
self-consistent-charge density functional tight binding method|self-consistent charge density functional tight binding method|Y
familial defective apolipoprotein B100|familial defective apolipoprotein B-100|Y
insulin-like growth factor II messenger RNA-binding protein 3|insulin-like growth factor II messenger RNA-binding protein 2|Y
insulin-like growth factor II messenger RNA-binding protein 3|insulin-like growth factor II messenger RNA binding protein 3|Y
insulin-like growth factor II messenger RNA-binding protein 3|insulin-like growth factor II messenger RNA-binding protein-3|Y
insulin-like growth factor II messenger RNA-binding protein 3|insulin-like growth factor II messenger RNA-binding protein|Y
ras-related GTP-binding protein 13|ras-related GTP-binding protein 1|Y
ras-related GTP-binding protein 13|ras-related GTP-binding protein 3|Y
Na-K-2Cl cotransporter 1|Na-K-2Cl co-transporter 1|Y
Na-K-2Cl cotransporter 1|Na-K-Cl cotransporter 1|Y
semistructured interview|semi-structured interview|Y
human adenovirus serotype 41|human adenovirus serotype 4|Y
human adenovirus serotype 41|human adenovirus serotype 1|Y
Nod factor IV, Rhizobium meliloti|Nod factor V, Rhizobium meliloti|Y
hypoxia inducible factor 1 α|hypoxia inducible factor 1α|Y
mitogen-activated protein kinase-activated protein kinase-2|mitogen-activated protein kinase-activated protein kinase 2|Y
mitogen-activated protein kinase-activated protein kinase-2|mitogen-activated protein kinase-activated protein kinase-5|Y
mitogen-activated protein kinase-activated protein kinase-2|mitogen activated protein kinase-activated protein kinase-2|Y
sensori-neural hearing loss|sensorineural hearing loss|Y
sterol response element binding protein 1a|sterol response element binding protein 1-a|Y
sterol response element binding protein 1a|sterol response element binding protein 1c|Y
phosphorylated extracellular signal-regulated kinase-2|phosphorylated extracellular signal regulated kinase-2|Y
phosphorylated extracellular signal-regulated kinase-2|phosphorylated extracellular signal-regulated kinase-1|Y
least-significant-difference post-hoc test|least-significant-difference post hoc test|Y
least-significant-difference post-hoc test|least-significant difference post-hoc test|Y
ribulose-1,5-bisphosphate carboxylase/oxygenase|ribulose-1,5-bisphosphate carboxylase-oxygenase|Y
ribulose-1,5-bisphosphate carboxylase/oxygenase|ribulose 1,5-bisphosphate carboxylase/oxygenase|Y
neural-precursor cell-expressed developmentally downregulated 4|neural-precursor cell-expressed, developmentally downregulated 4|Y
neural-precursor cell-expressed developmentally downregulated 4|neural-precursor cell-expressed developmentally down-regulated 8|Y
neural-precursor cell-expressed developmentally downregulated 4|neural-precursor cell-expressed developmentally down-regulated 1|Y
neural-precursor cell-expressed developmentally downregulated 4|neural-precursor cell-expressed developmentally downregulated 2|Y
neural-precursor cell-expressed developmentally downregulated 4|neural-precursor cell-expressed, developmentally downregulated 9|Y
neural-precursor cell-expressed developmentally downregulated 4|neural precursor cell-expressed, developmentally downregulated 4|Y
neural-precursor cell-expressed developmentally downregulated 4|neural-precursor cell-expressed developmentally downregulated 8|Y
neural-precursor cell-expressed developmentally downregulated 4|neural-precursor cell-expressed developmentally downregulated 5|Y
neural-precursor cell-expressed developmentally downregulated 4|neural-precursor cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally downregulated 4|neural precursor cell-expressed developmentally downregulated 4|Y
neural-precursor cell-expressed developmentally downregulated 4|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor cell-expressed developmentally downregulated 4|neural-precursor cell-expressed, developmentally downregulated 5|Y
neural-precursor cell-expressed developmentally downregulated 4|neural-precursor cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally downregulated 4|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor cell-expressed developmentally downregulated 4|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally downregulated 4|neural precursor cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally downregulated 4|neural-precursor cell-expressed, developmentally downregulated 1|Y
sector-field inductively coupled plasma mass spectrometry|sector-field inductively coupled plasma-mass spectrometry|Y
sector-field inductively coupled plasma mass spectrometry|sector field inductively coupled plasma mass spectrometry|Y
adducted thumb-clubfoot syndrome|adducted thumb-club foot syndrome|Y
gamma-lipotropic pituitary hormone|gamma-lipotrophic pituitary hormone|Y
protein phosphatase magnesium-dependent 1D|protein phosphatase magnesium-dependent 1d|Y
calcium-calmodulin-dependent kinase kinase|calcium-calmodulin dependent kinase kinase|Y
heart rate corrected QT interval|heart rate corrected Q-T interval|Y
neural precursor cell-expressed developmentally down-regulated 5|neural precursor cell-expressed, developmentally down-regulated 8|Y
neural precursor cell-expressed developmentally down-regulated 5|neural precursor cell-expressed, developmentally down-regulated 5|Y
neural precursor cell-expressed developmentally down-regulated 5|neural precursor cell-expressed developmentally downregulated 8|Y
neural precursor cell-expressed developmentally down-regulated 5|neural-precursor cell-expressed developmentally downregulated 5|Y
neural precursor cell-expressed developmentally down-regulated 5|neural precursor cell-expressed developmentally downregulated 5|Y
neural precursor cell-expressed developmentally down-regulated 5|neural precursor cell-expressed developmentally downregulated 4|Y
neural precursor cell-expressed developmentally down-regulated 5|neural precursor cell-expressed developmentally down-regulated 1|Y
neural precursor cell-expressed developmentally down-regulated 5|neural precursor cell expressed developmentally downregulated 5|Y
neural precursor cell-expressed developmentally down-regulated 5|neural precursor cell-expressed developmentally down-regulated 9|Y
neural precursor cell-expressed developmentally down-regulated 5|neural precursor cell-expressed developmentally downregulated 1|Y
neural precursor cell-expressed developmentally down-regulated 5|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural precursor cell-expressed developmentally down-regulated 5|neural precursor cell-expressed developmentally down-regulated 2|Y
neural precursor cell-expressed developmentally down-regulated 5|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural precursor cell-expressed developmentally down-regulated 5|neural precursor cell-expressed developmentally down-regulated 4|Y
neural precursor cell-expressed developmentally down-regulated 5|neural precursor cell-expressed developmentally downregulated 9|Y
neural precursor cell-expressed developmentally down-regulated 5|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell-expressed developmentally down-regulated 5|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell-expressed developmentally down-regulated 5|neural precursor cell-expressed, developmentally down-regulated 2|Y
neural precursor cell-expressed developmentally down-regulated 5|neural precursor cell expressed, developmentally down-regulated 5|Y
ras-related GTP-binding protein 5c|ras-related GTP-binding protein 5|Y
insulinlike growth factor binding protein 1|insulinlike growth factor binding protein 4|Y
insulinlike growth factor binding protein 1|insulinlike growth factor binding protein 3|Y
TGFβ inhibitory element|TGF-β inhibitory element|Y
TGFβ inhibitory element|TGF β inhibitory element|Y
cyclic adenosine monophosphate response element binding protein 1|cyclic adenosine monophosphate response element binding protein|Y
familial chronic muco-cutaneous candidiasis|familial chronic mucocutaneous candidiasis|Y
staphylococcal superantigen-like protein 10|staphylococcal superantigen-like protein 11|Y
T-cell-receptor γ-δ cell|T-cell-receptor γδ cell|Y
sex-determining region Y box 7|sex-determining region Y, box 7|Y
neural-precursor cell-expressed, developmentally downregulated 4|neural-precursor cell-expressed developmentally downregulated 2|Y
neural-precursor cell-expressed, developmentally downregulated 4|neural-precursor cell-expressed, developmentally downregulated 9|Y
neural-precursor cell-expressed, developmentally downregulated 4|neural precursor cell-expressed, developmentally downregulated 4|Y
neural-precursor cell-expressed, developmentally downregulated 4|neural-precursor cell-expressed, developmentally down-regulated 8|Y
neural-precursor cell-expressed, developmentally downregulated 4|neural-precursor cell-expressed, developmentally down-regulated 1|Y
neural-precursor cell-expressed, developmentally downregulated 4|neural-precursor cell-expressed developmentally downregulated 8|Y
neural-precursor cell-expressed, developmentally downregulated 4|neural-precursor cell-expressed developmentally downregulated 5|Y
neural-precursor cell-expressed, developmentally downregulated 4|neural-precursor cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally downregulated 4|neural precursor cell-expressed developmentally downregulated 4|Y
neural-precursor cell-expressed, developmentally downregulated 4|neural-precursor cell-expressed, developmentally downregulated 5|Y
neural-precursor cell-expressed, developmentally downregulated 4|neural-precursor cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally downregulated 4|neural-precursor-cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally downregulated 4|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural-precursor cell-expressed, developmentally downregulated 4|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally downregulated 4|neural-precursor cell-expressed, developmentally downregulated 1|Y
multi-drug resistance-associated protein|multi-drug resistance associated protein|Y
multi-drug resistance-associated protein|multidrug resistance-associated protein|Y
multi-drug resistance-associated protein|multidrug resistance-associated proteins|Y
interleukin 2 receptor α|interleukine 2 receptor α|Y
anti-beta(2)-glycoprotein I antibody|anti-beta (2)-glycoprotein I antibody|Y
transient lower oesophageal sphincter relaxation|transient lower esophageal sphincter relaxation|Y
histamine H3 receptor|histamine 3 receptor|Y
squamous cell carcinomas of the head and neck|squamous cell carcinoma of the head and neck|Y
lyso-phosphatidyl-choline|lyso-phosphatidylcholine|Y
anti-IL7 receptor antibody|anti-IL 7 receptor antibody|Y
anti-IL7 receptor antibody|anti-IL-7 receptor antibody|Y
pre-autophagosomal structure|preautophagosomal structure|Y
intra-uterine exchange transfusion|intrauterine exchange transfusion|Y
antihepatitis B antibody|anti-hepatitis B antibody|Y
mitogen-activated protein kinase kinase kinase-1|mitogen-activated protein kinase kinase kinase 1|Y
mitogen-activated protein kinase kinase kinase-1|mitogen-activated protein kinase kinase kinase|Y
antityrosine hydroxylase antibody|anti-tyrosine hydroxylase antibody|Y
stromal-derived factor 1 alpha|stromal-derived factor 1alpha|Y
phosphorylated glycogen synthase kinase-3beta|phosphorylated glycogen synthase kinase 3beta|Y
anti-topoisomerase I|anti-topo-isomerase I|Y
ortho-phenylene diamine|ortho-phenylenediamine|Y
lymphoma-associated haemophagocytic syndrome|lymphoma-associated hemophagocytic syndrome|Y
8-anilino-1-naphthalene sulfonate|8-anilino-1-naphthalenesulfonate|Y
Platelet activating factor-acetylhydrolase|Platelet-activating factor-acetylhydrolase|Y
Platelet activating factor-acetylhydrolase|platelet activating factor-acetylhydrolase|Y
BRG-1-associated factor|BRG1-associated factor|Y
dual-colour chromogenic in situ hybridization|dual-colour chromogenic in-situ hybridization|Y
IL4 receptor alpha chain|IL-4 receptor alpha chain|Y
submarine groundwater discharge|submarine ground-water discharge|Y
anti-IL-4 receptor antibody|anti-IL4 receptor antibody|Y
anti-IL-4 receptor antibody|antiIL-4 receptor antibody|Y
flavin-containing mono-oxygenase 4|flavin-containing monooxygenase 4|Y
transforming growth factor-beta type I receptor|transforming growth factor beta type I receptor|Y
beta-site amyloid precursor protein-cleaving enzyme-2|beta-site amyloid precursor protein-cleaving enzyme 2|Y
beta-site amyloid precursor protein-cleaving enzyme-2|beta-site amyloid precursor protein-cleaving enzyme-1|Y
adenosine 5'-triphosphate|adenosine 5-triphosphate|Y
sub-antimicrobial dose doxycycline|subantimicrobial dose doxycycline|Y
glycosyl phosphatidyl inositol-linked|glycosyl phosphatidylinositol-linked|Y
neuronal precursor cell-expressed developmentally down regulated 4|neuronal precursor cell-expressed developmentally downregulated 4-2|Y
neuronal precursor cell-expressed developmentally down regulated 4|neuronal precursor cell-expressed developmentally downregulated 4|Y
neuronal precursor cell-expressed developmentally down regulated 4|neural precursor cell-expressed developmentally downregulated 4|Y
neuronal precursor cell-expressed developmentally down regulated 4|neuronal precursor cell-expressed developmentally down-regulated 4|Y
millimeters of mercury|millimeter of mercury|Y
peroxisome-proliferator-activated receptor beta|peroxisome proliferator-activated receptor beta|Y
Occupational Safety and Health Adminstration|Occupational Safety and Health Administration|Y
American Society of Anaesthesiology class V|American Society of Anaesthesiology Class V|Y
American Society of Anaesthesiology class V|American Society of Anaesthesiology class 5|Y
American Society of Anaesthesiology class V|American Society of Anesthesiology class IV|Y
American Society of Anaesthesiology class V|American Society of Anesthesiology class V|Y
American Society of Anaesthesiology class V|American Society of Anaesthesiology class 3|Y
American Society of Anaesthesiology class V|American Society of Anaesthesiology class 2|Y
American Society of Anaesthesiology class V|American Society of Anaesthesiology class 1|Y
polyphosphate-accumulating organisms|polyphosphate-accumulating organism|Y
thyrotrophin binding inhibiting immunoglobulins|thyrotropin binding inhibiting immunoglobulins|Y
ventricular extra-stimulus|ventricular extrastimulus|Y
Atlanta Veteran's Affairs Medical Center|Atlanta Veterans' Affairs Medical Center|Y
peroxisome proliferator-activated receptor gamma-2|peroxisome proliferator-activated receptor gamma2|Y
peroxisome proliferator-activated receptor gamma-2|peroxisome proliferator activated receptor gamma-2|Y
peroxisome proliferator-activated receptor gamma-2|peroxisome proliferator-activated receptor-gamma-2|Y
peroxisome proliferator-activated receptor gamma-2|peroxisome proliferator-activated receptor gamma-1|Y
peroxisome proliferator-activated receptor gamma-2|peroxisome proliferator-activated receptor gamma 2|Y
United Network for Organ Sharing status 3|United Network for Organ Sharing status I|Y
United Network for Organ Sharing status 3|United Network for Organ Sharing status 1|Y
United Network for Organ Sharing status 3|United Network for Organ Sharing status 2|Y
nonsteroidal antiinflammatory compound|nonsteroidal anti-inflammatory compound|Y
nonsteroidal antiinflammatory compound|non-steroidal antiinflammatory compound|Y
arterio-venous oxygen difference|arteriovenous oxygen difference|Y
multi-planar reformation|multiplanar reformation|Y
macro-aggregated albumin|macroaggregated albumin|Y
interleukin 12 receptor β2|interleukin 12 receptor β 2|Y
mitogen-activated protein kinase/ERK kinase 1|mitogen-activated protein kinase/ERK kinase-1|Y
oestrogen receptor-α knock out|estrogen receptor-α knock out|Y
tumour necrosis factor receptor-associated factor|tumour necrosis factor receptor-associated factor 5|Y
tumour necrosis factor receptor-associated factor|tumour necrosis factor receptor-associated factor-2|Y
tumour necrosis factor receptor-associated factor|tumour necrosis factor receptor-associated factor 6|Y
tumour necrosis factor receptor-associated factor|tumour necrosis factor receptor-associated factor 2|Y
tumour necrosis factor receptor-associated factor|tumour necrosis factor receptor-associated factor 1|Y
tumour necrosis factor receptor-associated factor|tumour necrosis factor receptor-associated factor-5|Y
inter-aural temporal disparity|interaural temporal disparity|Y
antihyaluronidase titer|anti-hyaluronidase titer|Y
ras-related GTP-binding protein 1a|ras-related GTP-binding protein 1|Y
fluorine 18 fluoro-deoxy-glucose|fluorine 18 fluoro-deoxyglucose|Y
leukocyte-derived neutrophil chemotactic factor 1|leukocyte-derived neutrophil chemotactic factor-1|Y
leukocyte-derived neutrophil chemotactic factor 1|leukocyte-derived neutrophil chemotactic factor 2|Y
standardized incidence ratios|standardized incidence ratio|Y
intra-carotid amobarbital procedure|intracarotid amobarbital procedure|Y
oestrogen receptor-β knock out mouse|estrogen receptor-β knock out mouse|Y
oestrogen receptor-β knock out mouse|oestrogen receptor-β knockout mouse|Y
receptor-like protein tyrosine phosphatase δ|receptor-like protein tyrosine phosphatase α|Y
receptor-like protein tyrosine phosphatase δ|receptor-like protein tyrosine phosphatase-δ|Y
receptor-like protein tyrosine phosphatase δ|receptor-like protein tyrosine phosphatase ζ|Y
receptor-like protein tyrosine phosphatase δ|receptor-like protein-tyrosine phosphatase δ|Y
receptor-like protein tyrosine phosphatase δ|receptor-like protein tyrosine phosphatase η|Y
acid sensing ion channel-2b|acid sensing ion channel-2|Y
chaperonin containing TCP1|chaperonin containing TCP-1|Y
tumour associated lymphocyte|tumor associated lymphocyte|Y
stato-acoustic ganglion|statoacoustic ganglion|Y
agonist (S)-3,5-dihydroxyphenylglycine|agonist (RS)-3,5-dihydroxyphenylglycine|Y
non-obese diabetic-severe combined immunodeficient mouse|non-obese diabetic severe combined immunodeficient mouse|Y
cardio-respiratory arrest|cardiorespiratory arrest|Y
human adenovirus serotype 15|human adenovirus serotype 1|Y
human adenovirus serotype 15|human adenovirus serotype 5|Y
post-concussion symptom|post-concussion symptoms|Y
post-concussion symptom|postconcussion symptom|Y
pro-B acute lymphoblastic leukemia|pro-B acute lymphoblastic leukaemia|Y
pro-B acute lymphoblastic leukemia|proB acute lymphoblastic leukemia|Y
inter-atrial septal aneurysm|interatrial septal aneurysm|Y
hereditary angioœdema|hereditary angio-œdema|Y
Hanks balanced salt solution|Hank's balanced salt solution|Y
dipeptidylaminopeptidase IV|dipeptidylaminopeptidase I|Y
intra-cellular multiplication|intracellular multiplication|Y
anti-IL 2 monoclonal antibody|anti-IL2 monoclonal antibody|Y
anti-IL 2 monoclonal antibody|anti-IL 12 monoclonal antibody|Y
anti-IL 2 monoclonal antibody|anti-IL 2R monoclonal antibody|Y
extracorporeal shockwave treatment|extra-corporeal shockwave treatment|Y
123I-metaiodobenzylguanidine scintigraphy|123I-meta-iodobenzyl-guanidine scintigraphy|Y
hypo-osmotic swelling test|hypoosmotic swelling test|Y
corticotropin releasing hormone type 1 receptor|corticotropin releasing hormone type-1 receptor|Y
corticotropin releasing hormone type 1 receptor|corticotropin-releasing hormone type 1 receptor|Y
cluster of differentiation 14 receptor|cluster of differentiation 4 receptor|Y
three-dimensional computed tomography-angiography|three dimensional computed tomography-angiography|Y
three-dimensional computed tomography-angiography|three-dimensional computed tomography angiography|Y
terminal-deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling|terminal-deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling|Y
terminal-deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling|Y
immunofluorescence in situ hybridization|immuno-fluorescence in situ hybridization|Y
immunofluorescence in situ hybridization|immunofluorescence in situ hybridisation|Y
aniridia-Wilms' tumour association|aniridia-Wilms' tumor association|Y
aniridia-Wilms' tumour association|aniridia-Wilms tumour association|Y
stromal derived factor-1 α|stromal derived factor-1α|Y
Waldenström macroglobulinaemia|Waldenströms macroglobulinaemia|Y
Waldenström macroglobulinaemia|Waldenström macroglobulinemia|Y
assisted reproductive techniques|assisted reproductive technique|Y
electroimmuno-transfer blot assay|electroimmunotransfer blot assay|Y
postrepolarisation refractoriness|post-repolarisation refractoriness|Y
shiga toxin-producing Escherichia coli|shigatoxin-producing Escherichia coli|Y
gonadotrophin-releasing hormone|gonadotropin-releasing hormone|Y
platelet derived growth factor receptor|platelet derived growth factor receptor-β|Y
platelet derived growth factor receptor|platelet derived growth factor β receptor|Y
subacute coronary disease|sub-acute coronary disease|Y
polymerase-chain-reaction-based restriction fragment length polymorphism|polymerase-chain-reaction-based restriction fragment-length polymorphism|Y
Center for Epidemiologic Studies Depression|Center for Epidemiologic Studies-Depression|Y
peri-suprachiasmatic nucleus|perisuprachiasmatic nucleus|Y
sodium glucose co-transporter 1|sodium glucose cotransporter 1|Y
ribosomal protein S13|ribosomal protein S3|Y
hereditary non-polyposis colon cancer syndrome|hereditary nonpolyposis colon cancer syndrome|Y
laser-assisted sub-epithelial keratectomy|laser-assisted subepithelial keratectomy|Y
laser-assisted sub-epithelial keratectomy|laser assisted sub-epithelial keratectomy|Y
anti-proteinase 3 antibody|antiproteinase 3 antibody|Y
Src homology 2 domain-containing protein-tyrosine phosphatase substrate 1|Src homology 2 domain-containing protein tyrosine phosphatase substrate 1|Y
Src homology 2 domain-containing protein-tyrosine phosphatase substrate 1|Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1|Y
Src homology 2 domain-containing protein-tyrosine phosphatase substrate 1|src homology 2 domain-containing protein-tyrosine phosphatase substrate 1|Y
American Society of Anaesthesiologists Grade IV|American Society of Anesthesiologists Grade IV|Y
American Society of Anaesthesiologists Grade IV|American Society of Anaesthesiologists grade IV|Y
American Society of Anaesthesiologists Grade IV|American Society of Anesthesiologists Grade V|Y
American Society of Anaesthesiologists Grade IV|American Society of Anaesthesiologists Grade II|Y
American Society of Anaesthesiologists Grade IV|American Society of Anesthesiologists Grade I|Y
human corticotrophin releasing hormone|human corticotropin releasing hormone|Y
peroxisome proliferator-activated receptor-α agonist|peroxisome proliferator activated receptor-α agonist|Y
peroxisome proliferator-activated receptor-α agonist|peroxisome proliferator-activated receptor α agonist|Y
non-alcoholic cirrhosis|nonalcoholic cirrhosis|Y
cold circadian rhythm-RNA binding protein|cold-circadian rhythm-RNA binding protein|Y
gamma-aminobutyric acid receptor chloride channel complex|gamma-aminobutyric acid receptor-chloride channel complex|Y
suppressor of auxin resistance1 homolog A|suppressor of auxin resistance1 homolog B|Y
nonenzymatic glycosylation|non-enzymatic glycosylation|Y
cytoplasmic polyadenylation element binding protein|cytoplasmic polyadenylation element binding protein 4|Y
cytoplasmic polyadenylation element binding protein|cytoplasmic polyadenylation element binding protein 3|Y
cytoplasmic polyadenylation element binding protein|cytoplasmic polyadenylation element binding protein 2|Y
pharyngo-cutaneous fistula|pharyngocutaneous fistula|Y
transthoracic lung biopsy|trans-thoracic lung biopsy|Y
trans-oesophageal atrial pacing|trans-esophageal atrial pacing|Y
human immunodeficiency virus type 1 subtype G|human immunodeficiency virus type 1 subtype B|Y
human immunodeficiency virus type 1 subtype G|human immunodeficiency virus type 1 subtype|Y
human immunodeficiency virus type 1 subtype G|human immunodeficiency virus type 1 subtype C|Y
human immunodeficiency virus type 1 subtype G|human immunodeficiency virus type 1 subtype A|Y
human immunodeficiency virus type 1 subtype G|human immunodeficiency virus type 1 subtype D|Y
human immunodeficiency virus type 1 subtype G|human immunodeficiency virus type 1 subtype F|Y
cytochrome P-450 reductase|cytochrome P450 reductase|Y
Ras guanosine triphosphatase activating protein|Ras guanosine triphosphatase-activating protein|Y
Endoscopic retrograde cholangio-pancreatography|endoscopic retrograde cholangio-pancreatography|Y
ventriculo-peritoneal shunt|ventriculoperitoneal shunt|Y
Meckels diverticulum|Meckels' diverticulum|Y
Meckels diverticulum|Meckel's diverticulum|Y
calcium voltage-gated channel subunit alpha1 F protein|calcium voltage-gated channel subunit alpha1 C protein|Y
transforming growth factor β type I receptor|transforming growth factor β type II receptor|Y
interleukin-1 β converting enzyme|interleukin-1β converting enzyme|Y
Social Dysfunction and Aggression Scale 9|Social Dysfunction and Aggression Scale-9|Y
Saccharomyces cerevisiae redoxyendonuclease gene 2|Saccharomyces cerevisiae redoxyendonuclease gene 1|Y
p38α mitogen-activated protein kinase|p38 α mitogen-activated protein kinase|Y
p38α mitogen-activated protein kinase|p38-α mitogen-activated protein kinase|Y
sulphobutyl ether β-cyclodextrin|sulphobutylether β-cyclodextrin|Y
human leucocyte antigen DR3|human leucocyte antigen DR|Y
American Society of Anesthesiology class 1|American Society of Anesthesiology Class 1|Y
American Society of Anesthesiology class 1|American Society of Anesthesiology class 5|Y
American Society of Anesthesiology class 1|American Society of Anesthesiology class V|Y
American Society of Anesthesiology class 1|American Society of Anesthesiology class 4|Y
American Society of Anesthesiology class 1|American Society of Anesthesiology class I|Y
American Society of Anesthesiology class 1|American Society of Anaesthesiology class 1|Y
glutathione S-transferase P1|glutathione S-transferase P|Y
interleukin 7 receptor α chain|interleukine 7 receptor α chain|Y
oestrogen-progestogen therapy|estrogen-progestogen therapy|Y
bioidentical hormone replacement therapy|bio-identical hormone replacement therapy|Y
sex-determining region Y-related high-mobility-group box 9|sex-determining region Y-related high-mobility-group-box 9|Y
ribosomal protein L12|ribosomal protein L1|Y
day post-fertilization|days post-fertilization|Y
tumour necrosis factor receptor-associated protein 1|tumour necrosis factor receptor-associated protein-1|Y
tumour necrosis factor receptor-associated protein 1|tumor necrosis factor receptor-associated protein 1|Y
light-harvesting chlorophyll a/b protein-II|light-harvesting chlorophyll a/b protein II|Y
light-harvesting chlorophyll a/b protein-II|light-harvesting chlorophyll a/b protein-I|Y
light-harvesting chlorophyll a/b protein-II|light harvesting chlorophyll a/b protein-II|Y
anticonvulsant hypersensitivity syndrome|anti-convulsant hypersensitivity syndrome|Y
endothelial-monocyte-activating polypeptide II|endothelial-monocyte-activating polypeptide III|Y
endothelial-monocyte-activating polypeptide II|endothelial monocyte-activating polypeptide II|Y
endothelial-monocyte-activating polypeptide II|endothelial-monocyte-activating polypeptide I|Y
plasmin α 2-plasmin inhibitor complex|plasmin α2-plasmin inhibitor complex|Y
procollagen type-I N-terminal propeptide|procollagen type I N-terminal propeptide|Y
angular vestibuloocular reflex|angular vestibulo-ocular reflex|Y
human immunodeficiency virus type 1 subtype B|human immunodeficiency virus type 1 subtype|Y
human immunodeficiency virus type 1 subtype B|human immunodeficiency virus type 1 subtype C|Y
human immunodeficiency virus type 1 subtype B|human immunodeficiency virus type 1 subtype A|Y
human immunodeficiency virus type 1 subtype B|human immunodeficiency virus type 1 subtype D|Y
human immunodeficiency virus type 1 subtype B|human immunodeficiency virus type 1 subtype F|Y
tumor-derived adhesion factor|tumour-derived adhesion factor|Y
roentgeno-endovascular dilatation|roentgenoendovascular dilatation|Y
small nuclear ribonucleoprotein-associated protein|small nuclear ribonucleoprotein-associated protein N|Y
Wingless-type MMTV integration site family|wingless-type MMTV integration site family|Y
cluster designation 13|cluster designation 103|Y
pancreatico-duodenal artery|pancreaticoduodenal artery|Y
serum ornithine carbamoyltransferase|serum ornithine carbamyltransferase|Y
serine protease inhibitor Kazal type 1|serine protease inhibitor, Kazal type 1|Y
transcatheter aortic valve implantation procedure|trans-catheter aortic valve implantation procedure|Y
mouse alpha-fetoprotein|mouse alpha-foetoprotein|Y
X-ray repair cross complementation group 1|x-ray repair cross complementation group 1|Y
pigeon-breeders' lung|pigeon-breeders lung|Y
upper gastro-intestinal endoscopy|upper gastrointestinal endoscopy|Y
bidirectional reflectance distribution function model|bi-directional reflectance distribution function model|Y
MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2|MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3|Y
MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2|MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4|Y
multi-reference coupled cluster method|multireference coupled cluster method|Y
uncoordinated protein 33|uncoordinated protein 3|Y
undifferentiated spondyloarthropathy|undifferentiated spondylo-arthropathy|Y
direct immuno-fluorescence assay|direct immunofluorescence assay|Y
soluble receptor activator of nuclear factor kappa-B ligand|soluble receptor activator of nuclear factor kappaB ligand|Y
histidine-containing phosphotransfer protein|histidine containing phosphotransfer protein|Y
S-nitroso-N-acetylpenicillamine|S-nitroso-N-acetyl penicillamine|Y
obstetrician-gynaecologist|obstetrician-gynecologist|Y
insulin-like growth factor II mRNA binding protein 2|insulin-like growth factor II mRNA binding protein-2|Y
insulin-like growth factor II mRNA binding protein 2|insulin-like growth factor II mRNA binding protein|Y
insulin-like growth factor II mRNA binding protein 2|insulin-like growth factor II mRNA binding protein 3|Y
thoracoabdominal aneurysm|thoraco-abdominal aneurysm|Y
Radiation Therapy Oncology Group Grade 3|Radiation Therapy Oncology Group Grade 0|Y
spinocerebellar ataxia type 4|spinocerebellar ataxia type 14|Y
peroxisome proliferator-activated receptor-β|peroxisome proliferator-activated receptor-γ|Y
peroxisome proliferator-activated receptor-β|peroxisome proliferator-activated receptor|Y
peroxisome proliferator-activated receptor-β|peroxisome proliferator-activated receptor β|Y
anti-chromatin antibody|antichromatin antibody|Y
N-terminal pro-brain type natriuretic peptide|N-terminal pro-brain-type natriuretic peptide|Y
transforming growth factor β-activated kinase 1|transforming growth factor β-activated kinase-1|Y
Eating Disorders Inventory-2|Eating Disorder Inventory-2|Y
TBP associated factor 15|TBP associated factor 1|Y
TBP associated factor 15|TBP associated factor 5|Y
Fuchs heterochromic iridocyclitis|Fuch's heterochromic iridocyclitis|Y
Plasmodium falciparum mitogen-activated kinase|Plasmodium falciparum mitogen-activated kinase-1|Y
Plasmodium falciparum mitogen-activated kinase|Plasmodium falciparum mitogen-activated kinase-2|Y
pyridoxalated polymerized stroma-free hemoglobin|pyridoxalated polymerized stroma-free haemoglobin|Y
antimyelin-associated glycoprotein neuropathy|anti-myelin-associated glycoprotein neuropathy|Y
antimyelin-associated glycoprotein neuropathy|antimyelin associated glycoprotein neuropathy|Y
insulin-like growth factor receptor type II|insulin-like growth factor receptor type I|Y
interleukin-1β-converting enzyme|interleukin-1 β-converting enzyme|Y
interleukin-6 receptor alpha chain|interleukine-6 receptor alpha chain|Y
American Society of Anesthesiologists grade 4|American Society of Anesthesiologists grade|Y
American Society of Anesthesiologists grade 4|American Society of Anesthesiologists grade V|Y
American Society of Anesthesiologists grade 4|American Society of Anesthesiologists grade 2|Y
American Society of Anesthesiologists grade 4|American Society of Anesthesiologists grade I|Y
American Society of Anesthesiologists grade 4|American Society of Anaesthesiologists grade 4|Y
American Society of Anesthesiologists grade 4|American Society of Anesthesiologists grade 1|Y
American Society of Anesthesiologists grade 4|American Society of Anesthesiologists grade 5|Y
uveitis-glaucoma-hyphema syndrome|uveitis-glaucoma-hyphaema syndrome|Y
interleukine-4 receptor-alpha chain|interleukin-4 receptor-alpha chain|Y
anti-toll-like receptor 2 monoclonal antibody|anti-toll like receptor 2 monoclonal antibody|Y
anti-toll-like receptor 2 monoclonal antibody|anti-toll-like receptor-2 monoclonal antibody|Y
anti-toll-like receptor 2 monoclonal antibody|anti-toll-like receptor 3 monoclonal antibody|Y
peroxisome proliferator-activated receptor-γ coactivator-1α|peroxisome-proliferator-activated receptor-γ coactivator-1α|Y
peroxisome proliferator-activated receptor-γ coactivator-1α|peroxisome proliferator-activated receptor γ coactivator-1α|Y
peroxisome proliferator-activated receptor-γ coactivator-1α|peroxisome proliferator-activated receptor-γ coactivator-1|Y
peroxisome proliferator-activated receptor-γ coactivator-1α|peroxisome proliferator-activated receptor-γ coactivator-1 α|Y
peroxisome proliferator-activated receptor-γ coactivator-1α|peroxisome proliferator-activated receptor-γ co-activator-1α|Y
peroxisome proliferator-activated receptor-γ coactivator-1α|peroxisome proliferator-activated receptor-γ co-activator-1 α|Y
esophagogastro-duodenoscopy|esophago-gastro-duodenoscopy|Y
esophagogastro-duodenoscopy|oesophagogastro-duodenoscopy|Y
human transforming growth factor-β 1|human transforming growth factor-β1|Y
intramembrane particle|intra-membrane particle|Y
Clinical Global Impressions Improvement Scale|Clinical Global Impressions-Improvement Scale|Y
postdiscography computed tomography|post-discography computed tomography|Y
salmon gonadotropin releasing hormone analog|salmon gonadotrophin releasing hormone analog|Y
immuno-diffusion procedure|immunodiffusion procedure|Y
peri-operative major cardio-vascular event|perioperative major cardio-vascular event|Y
peri-operative major cardio-vascular event|peri-operative major cardiovascular event|Y
peri-operative major cardio-vascular event|perioperative major cardiovascular event|Y
methylphosphonothioate|methylphosphonothiolate|Y
glycosaminoglycan polysulfuric acid|glycosamino-glycan polysulfuric acid|Y
spinocerebellar ataxia 14|spinocerebellar ataxia 4|Y
spinocerebellar ataxia 14|spinocerebellar ataxia 1|Y
staphylococcal cassette chromosome methicillin resistance type IV|staphylococcal cassette chromosome methicillin resistance type III|Y
staphylococcal cassette chromosome methicillin resistance type IV|staphylococcal cassette chromosome methicillin resistance type V|Y
staphylococcal cassette chromosome methicillin resistance type IV|staphylococcal cassette chromosome methicillin resistance type I|Y
heparin-induced thrombo-cytopenia|heparin-induced thrombocytopenia|Y
heparin-induced thrombo-cytopenia|heparin-induced thrombo-cytopaenia|Y
arterial O2 partial pressure|arterial CO2 partial pressure|Y
macrophage inflammatory protein 1 α|macrophage inflammatory protein 1α|Y
intrauterine growth restriction|intra-uterine growth restriction|Y
stress-induced anti-nociception|stress-induced antinociception|Y
withdrawal induced antihypertensive phenomenon|withdrawal-induced antihypertensive phenomenon|Y
post-infectious encephalitis|postinfectious encephalitis|Y
endoscopic retrograde cholangiopancreaticography|endoscopic retrograde cholangiopancreatography|Y
American Society of Anaesthesiology grade 1|American Society of Anesthesiology grade 1|Y
American Society of Anaesthesiology grade 1|American Society of Anaesthesiology grade 3|Y
American Society of Anaesthesiology grade 1|American Society of Anaesthesiology grade|Y
American Society of Anaesthesiology grade 1|American Society of Anaesthesiology grade I|Y
American Society of Anaesthesiology grade 1|American Society of Anaesthesiology grade 4|Y
American Society of Anaesthesiology grade 1|American Society of Anaesthesiology grade V|Y
fluoro-deoxyglucose positron emission tomography|fluorodeoxyglucose positron emission tomography|Y
fluoro-deoxyglucose positron emission tomography|fluoro-deoxy-glucose positron emission tomography|Y
recombinant human transforming growth factor beta1|recombinant human transforming growth factor-beta1|Y
recombinant human transforming growth factor beta1|recombinant human transforming growth factor beta2|Y
recombinant human transforming growth factor beta1|recombinant human transforming growth factor beta3|Y
recombinant human transforming growth factor beta1|recombinant human transforming growth factor beta 1|Y
non-protein sulfhydryl|non-protein sulfhydryls|Y
conjugated equine oestrogens|conjugated equine oestrogen|Y
American Society of Anesthesiologists|American Society of Anesthesiologists'|Y
American Society of Anesthesiologists|American Society of Anaesthesiologists|Y
never-in-mitosis Aspergillus-related kinase 6|never-in-mitosis Aspergillus-related kinase 8|Y
never-in-mitosis Aspergillus-related kinase 6|never-in-mitosis Aspergillus-related kinase 3|Y
never-in-mitosis Aspergillus-related kinase 6|never-in-mitosis Aspergillus-related kinase 2|Y
never-in-mitosis Aspergillus-related kinase 6|never-in-mitosis Aspergillus-related kinase 4|Y
never-in-mitosis Aspergillus-related kinase 6|never-in-mitosis Aspergillus-related kinase 7|Y
never-in-mitosis Aspergillus-related kinase 6|never-in-mitosis Aspergillus-related kinase|Y
anti-endothelial cell autoantibody|anti-endothelial cell auto-antibody|Y
anti-endothelial cell autoantibody|antiendothelial cell autoantibody|Y
TATA-binding protein associated factor-8|TATA-binding protein-associated factor-8|Y
TATA-binding protein associated factor-8|TATA-binding protein associated factor-5|Y
TATA-binding protein associated factor-8|TATA-binding protein associated factor-3|Y
TATA-binding protein associated factor-8|TATA-binding protein associated factor-1|Y
TATA-binding protein associated factor-8|TATA-binding protein associated factor-9|Y
TATA-binding protein associated factor-8|TATA-binding protein associated factor-2|Y
TATA-binding protein associated factor-8|TATA-binding protein associated factor-4|Y
TATA-binding protein associated factor-8|TATA-binding protein associated factor-7|Y
augmented correlation-consistent polarised valence triple zeta basis set|augmented correlation-consistent polarised valence triple-zeta basis set|Y
pharyngo esophageal junction|pharyngo oesophageal junction|Y
Behavior Assessment System for Children-second edition|Behavioral Assessment System for Children-second edition|Y
cisplatinum diamminedichloride|cis-platinum diamminedichloride|Y
cisplatinum diamminedichloride|cis platinum diamminedichloride|Y
platelet derived growth factor beta receptor|platelet-derived growth factor beta receptor|Y
platelet derived growth factor beta receptor|platelet derived growth factor-beta receptor|Y
cDNA amplified fragment length polymorphism|cDNA amplified fragment-length polymorphism|Y
cDNA amplified fragment length polymorphism|cDNA-amplified fragment length polymorphism|Y
sporulation protein VD|sporulation protein VID|Y
small cardioactive peptideB|small cardioactive peptide|Y
17alpha,20beta-dihydroxy-4-pregnen-3-one|17 alpha,20 beta-dihydroxy-4-pregnen-3-one|Y
platelet activating factor antagonistic activity|platelet-activating factor antagonistic activity|Y
converting enzyme inhibitor|converting enzyme inhibitors|Y
Charcot-Marie-Tooth neuropathy type 1|Charcot-Marie-Tooth neuropathy type 1A|Y
Charcot-Marie-Tooth neuropathy type 1|Charcot-Marie-Tooth neuropathy type 1a|Y
glycosylphosphatidylinositol-linked|glycosyl phosphatidylinositol-linked|Y
para-influenza virus type 3|parainfluenza virus type 3|Y
branched-chain alpha-keto acid dehydrogenase kinase|branched-chain alpha-ketoacid dehydrogenase kinase|Y
TWIK-related arachidonic acid stimulated K(+) channel|TWIK-related arachidonic acid stimulated K+ channel|Y
steroid 5α reductase type I|steroid 5α reductase type II|Y
steroid 5α reductase type I|steroid 5-α reductase type I|Y
type-2 corticotrophin releasing hormone receptor|type-2 corticotrophin-releasing hormone receptor|Y
type-2 corticotrophin releasing hormone receptor|type 2 corticotrophin releasing hormone receptor|Y
bcl2 associated X-protein|bcl-2 associated X-protein|Y
sub-clinical mastitis|subclinical mastitis|Y
galactorrhea-amenorrhea hyperprolactinæmia syndrome|galactorrhea-amenorrhœa hyperprolactinæmia syndrome|Y
galactorrhea-amenorrhea hyperprolactinæmia syndrome|galactorrhoea-amenorrhoea hyperprolactinæmia syndrome|Y
galactorrhea-amenorrhea hyperprolactinæmia syndrome|galactorrhea-amenorrhoea hyperprolactinæmia syndrome|Y
galactorrhea-amenorrhea hyperprolactinæmia syndrome|galactorrhoea-amenorrhea hyperprolactinæmia syndrome|Y
heterochromatin protein 1|heterochromatin protein 1γ|Y
heterochromatin protein 1|heterochromatin protein 1β|Y
microtubule-associated protein-2C|microtubule-associated protein-2|Y
BRI1-associated kinase 1|BRI1-associated kinase1|Y
guanosine triphosphatase-activating protein-1|guanosine triphosphatase activating protein-1|Y
guanosine triphosphatase-activating protein-1|guanosine triphosphatase-activating protein|Y
guanosine triphosphatase-activating protein-1|guanosine triphosphatase-activating protein 1|Y
human interferon α-2b|human interferon α2b|Y
polymerase chain reaction-based restriction fragment length polymorphism|polymerase chain reaction-based restriction fragment-length polymorphism|Y
chicken luteinizing hormone-releasing hormone-I|chicken luteinising hormone-releasing hormone-I|Y
chicken luteinizing hormone-releasing hormone-I|chicken luteinizing hormone-releasing hormone I|Y
familial benign hypocalciuric hypercalcæmia|familial benign hypocalciuric hypercalcemia|Y
preclinical Cushing's syndrome|pre-clinical Cushing's syndrome|Y
high-energy shock wave therapy|high-energy shockwave therapy|Y
particle enhanced nephelometric immuno-assay|particle-enhanced nephelometric immuno-assay|Y
particle enhanced nephelometric immuno-assay|particle enhanced nephelometric immunoassay|Y
non-muscle myosin heavy chain-IIA|non-muscle myosin heavy chain-II|Y
American Association for Health, Physical Education and Recreation|American Association for Health, Physical Education, and Recreation|Y
gastro-esophageal junction|gastro-oesophageal junction|Y
TGFβ-activated kinase 1 binding protein-1|TGFβ-activated kinase 1-binding protein-1|Y
TGFβ-activated kinase 1 binding protein-1|TGFβ-activated kinase 1 binding protein 1|Y
TGFβ-activated kinase 1 binding protein-1|TGF-β-activated kinase 1 binding protein-1|Y
platelet additive solution III|platelet additive solution II|Y
cross-polarization magic angle spinning|crosspolarization magic angle spinning|Y
interleukin 12 receptor|interleukin 1 receptor|Y
interleukin 12 receptor|interleukin 2 receptor|Y
acrocephalosyndactyly|acrocephalo-syndactyly|Y
cerebrovascular resistance|cerebro-vascular resistance|Y
ultralow anterior resection|ultra-low anterior resection|Y
Kasai porto-enterostomy|Kasai portoenterostomy|Y
trans-catheter closure|transcatheter closure|Y
glycogen storage disease type 1a|glycogen storage disease type 1|Y
transcription initiation factor IIB|transcription initiation factor IIIB|Y
transcription initiation factor IIB|transcription initiation factor IB|Y
hypothalamo-pituitary-gonadal axis|hypothalamopituitary-gonadal axis|Y
methyl-malonyl coenzyme A|methylmalonyl coenzyme A|Y
crossed cerebellar diaschisis|crossed cerebellar diachisis|Y
non-high-density lipoprotein cholesterol|non-high-density-lipoprotein cholesterol|Y
peroxisome proliferator-activated receptor γ-2|peroxisome proliferator-activated receptor γ|Y
peroxisome proliferator-activated receptor γ-2|peroxisome proliferator-activated receptor γ2|Y
peroxisome proliferator-activated receptor γ-2|peroxisome proliferator-activated receptor-γ-2|Y
peroxisome proliferator-activated receptor γ-2|peroxisome proliferator-activated receptor γ 2|Y
peroxisome proliferator-activated receptor γ-2|peroxisome proliferator-activated receptor γ-1|Y
peroxisome proliferator-activated receptor γ-2|peroxisome proliferator activated receptor γ-2|Y
interleukine-13 receptor α2 chain|interleukin-13 receptor α2 chain|Y
Ralph H. Johnson Veterans Affairs Medical Center|Ralph H Johnson Veterans Affairs Medical Center|Y
Ralph H. Johnson Veterans Affairs Medical Center|Ralph H Johnson Veteran's Affairs Medical Center|Y
Ralph H. Johnson Veterans Affairs Medical Center|Ralph H. Johnson Veteran's Affairs Medical Center|Y
Ralph H. Johnson Veterans Affairs Medical Center|Ralph H Johnson Veterans' Affairs Medical Center|Y
Autographa californica MNPV|Autographa californica NPV|Y
anti-single stranded DNA antibody|antisingle stranded DNA antibody|Y
RETINOBLASTOMA RELATED1|RETINOBLASTOMA RELATED|Y
benzo[a]pyrene-diol-epoxide-DNA adduct level|benzo[a]pyrene diol-epoxide-DNA adduct level|Y
benzo[a]pyrene-diol-epoxide-DNA adduct level|benzo[a]pyrene-diol-epoxide DNA adduct level|Y
bio-electrical impedance analysis|bioelectrical impedance analysis|Y
signal transducer and activator of transcription-5B|signal transducer and activator of transcription-5|Y
signal transducer and activator of transcription-5B|signal transducer and activator of transcription-5b|Y
S100 calcium binding protein A4|S100 calcium binding protein A14|Y
Wechsler Intelligence Scale for Children - 4th Edition|Wechsler Intelligence Scale for Children-4th Edition|Y
Wechsler Intelligence Scale for Children - 4th Edition|Wechsler Intelligence Scale for Children 4th Edition|Y
senescence-associated beta-galactosidase|senescence-associated beta galactosidase|Y
cuffed oro-pharyngeal airway|cuffed oropharyngeal airway|Y
atrio-ventricular septal defect|atrioventricular septal defect|Y
glycophosphatidylinositol anchored|glycophosphatidyl-inositol anchored|Y
glycophosphatidylinositol anchored|glycophosphatidyl inositol anchored|Y
acetylcholine receptor inducing activity|acetylcholine receptor-inducing activity|Y
immunocyto-chemically|immunocytochemically|Y
Rickettsialike organism|Rickettsia-like organism|Y
inverted terminal repeat|inverted terminal repeats|Y
post endoscopic retrograde cholangio-pancreatography pancreatitis|postendoscopic retrograde cholangio-pancreatography pancreatitis|Y
post endoscopic retrograde cholangio-pancreatography pancreatitis|post-endoscopic retrograde cholangio-pancreatography pancreatitis|Y
3'-azido-3'-deoxythymidine|3'-azido-3'deoxythymidine|Y
interleukine-11 receptor α chain|interleukin-11 receptor α chain|Y
light harvesting chlorophyll a/b protein-I|light harvesting chlorophyll a/b protein I|Y
light harvesting chlorophyll a/b protein-I|light-harvesting chlorophyll a/b protein-I|Y
light harvesting chlorophyll a/b protein-I|light harvesting chlorophyll a/b protein-II|Y
gastroenteropancreatic|gastro-enteropancreatic|Y
gonadotropin releasing hormone analogue|gonadotrophin releasing hormone analogue|Y
proislet amyloid polypeptide|pro-islet amyloid polypeptide|Y
anti-mouse lymphocyte serum|antimouse lymphocyte serum|Y
infra-red light-emitting diode|infrared light-emitting diode|Y
transurethral prostatic resection|trans urethral prostatic resection|Y
peri-ventricular leucomalacia|periventricular leucomalacia|Y
β-site amyloid precursor protein cleaving enzyme-2|β-site amyloid precursor protein cleaving enzyme|Y
β-site amyloid precursor protein cleaving enzyme-2|β site amyloid precursor protein cleaving enzyme-2|Y
β-site amyloid precursor protein cleaving enzyme-2|β-site amyloid precursor protein-cleaving enzyme-2|Y
insulin-like growth factor II level|insulin-like growth factor I level|Y
gamma-aminobutyric acid release|gamma-amino butyric acid release|Y
peroxisome proliferator activated receptor γ coactivator-1|peroxisome proliferator-activated receptor γ coactivator-1|Y
digital imaging fiber-optic trans-illumination|digital imaging fibre-optic trans-illumination|Y
digital imaging fiber-optic trans-illumination|digital imaging fiberoptic transillumination|Y
digital imaging fiber-optic trans-illumination|digital imaging fiber-optic transillumination|Y
mannose 6-phosphate/insulin-like growth factor-II receptor|mannose 6-phosphate/insulin-like growth factor II receptor|Y
chicken luteinising hormone-releasing hormone-II|chicken luteinising hormone releasing hormone-II|Y
chicken luteinising hormone-releasing hormone-II|chicken luteinising hormone-releasing hormone-I|Y
chicken luteinising hormone-releasing hormone-II|chicken luteinising hormone-releasing hormone II|Y
atrioventricular reentrant tachycardia|atrioventricular re entrant tachycardia|Y
atrioventricular reentrant tachycardia|atrioventricular re-entrant tachycardia|Y
glycosylphosphatidyl-inositol anchored protein|glycosyl-phosphatidylinositol anchored protein|Y
glycosylphosphatidyl-inositol anchored protein|glycosyl-phosphatidyl-inositol anchored protein|Y
glycosylphosphatidyl-inositol anchored protein|glycosylphosphatidylinositol anchored protein|Y
glycosylphosphatidyl-inositol anchored protein|glycosylphosphatidyl inositol anchored protein|Y
glycosylphosphatidyl-inositol anchored protein|glycosylphosphatidyl-inositol-anchored protein|Y
recombinant human GM-CSF|recombinant human G-CSF|Y
recombinant human GM-CSF|recombinant human M-CSF|Y
no-observed-effect levels|no-observed-effect level|Y
insulin-like growth factor receptor II|insulin-like growth factor receptor I|Y
speech and language therapist|speech and language therapists|Y
sterol response element-binding protein-1-c|sterol response element binding protein-1-c|Y
sterol response element-binding protein-1-c|sterol response element-binding protein 1-c|Y
sterol response element-binding protein-1-c|sterol response element-binding protein-1-a|Y
compensatory antiinflammatory response syndrome|compensatory anti-inflammatory response syndrome|Y
matrix metalloprotease 13|matrix metalloprotease 1|Y
matrix metalloprotease 13|matrix metalloprotease 3|Y
nicotinamide-adenine dinucleotide-linked|nicotinamide-adenine dinucleotide linked|Y
nicotinamide-adenine dinucleotide-linked|nicotinamide adenine dinucleotide-linked|Y
preprothyrotropin-releasing hormone|prepro-thyrotropin-releasing hormone|Y
gamma-amino butyric acid type-A receptor|gamma-amino butyric acid type A receptor|Y
sodium-coupled neutral amino acid transporter|sodium-coupled neutral amino acid transporter 1|Y
sodium-coupled neutral amino acid transporter|sodium-coupled neutral amino acid transporter 2|Y
sodium-coupled neutral amino acid transporter|sodium coupled neutral amino acid transporter|Y
sodium-coupled neutral amino acid transporter|sodium-coupled neutral amino acid transporter-3|Y
sodium-coupled neutral amino acid transporter|sodium-coupled neutral amino acid transporter-1|Y
sodium-coupled neutral amino acid transporter|sodium-coupled neutral amino acid transporter 3|Y
tertbutylhydroperoxide|tert-butylhydroperoxide|Y
haemoglobin Daneshgah-Tehran|hemoglobin Daneshgah-Tehran|Y
diffusion-weighted magnetic resonance imaging|Diffusion-weighted magnetic resonance imaging|Y
diffusion-weighted magnetic resonance imaging|diffusion weighted magnetic resonance imaging|Y
loco-regional recurrence rate|locoregional recurrence rate|Y
Chinese hamster lung fibroblasts|Chinese hamster lung fibroblast|Y
lectin-like oxidized low-density lipoprotein receptor 1|lectin-like oxidized low-density lipoprotein receptor|Y
lectin-like oxidized low-density lipoprotein receptor 1|lectin-like oxidised low-density lipoprotein receptor 1|Y
lectin-like oxidized low-density lipoprotein receptor 1|lectin-like oxidized low-density lipoprotein receptor-1|Y
lectin-like oxidized low-density lipoprotein receptor 1|lectin-like oxidized low density lipoprotein receptor 1|Y
multi-facility health-care organization|multi-facility healthcare organization|Y
post-ejaculatory interval|postejaculatory interval|Y
magic angle spinning solid-state nuclear magnetic resonance spectroscopy|magic-angle spinning solid-state nuclear magnetic resonance spectroscopy|Y
hydroxyapatite deposition disease|hydroxy-apatite deposition disease|Y
beta site amyloid precursor protein cleaving enzyme|beta site amyloid precursor protein cleaving enzyme-1|Y
beta site amyloid precursor protein cleaving enzyme|beta site amyloid precursor protein cleaving enzyme-2|Y
beta site amyloid precursor protein cleaving enzyme|beta site amyloid precursor protein cleaving enzyme 2|Y
beta site amyloid precursor protein cleaving enzyme|beta site amyloid precursor protein-cleaving enzyme|Y
beta site amyloid precursor protein cleaving enzyme|beta-site amyloid precursor protein cleaving enzyme|Y
beta site amyloid precursor protein cleaving enzyme|beta site amyloid precursor protein cleaving enzyme 1|Y
C-C chemokine receptor|CC chemokine receptor|Y
fibroblast growth factor receptor 3 gene|fibroblast growth factor receptor 2 gene|Y
thyroxine binding pre-albumin|thyroxin binding pre-albumin|Y
translation elongation factor-1δ|translation elongation factor-1 δ|Y
cytotoxic T lymphocyte antigen 2beta|cytotoxic T lymphocyte antigen 2 beta|Y
intra-venous magnesium sulfate|intravenous magnesium sulfate|Y
insulin-like growth factor I|insulin-like growth factor II|Y
nucleotide-binding domain and leucine-rich repeat-containing receptor|nucleotide-binding domain and leucine-rich repeat containing receptor|Y
restorative proctocolectomy|restorative procto-colectomy|Y
bi-level positive airway pressure|bilevel positive airway pressure|Y
oral facial digital syndrome type IV|oral facial digital syndrome type V|Y
perceived behavioral control|perceived behavioural control|Y
Eutectic Mixture of Local Anesthetics|Eutectic Mixture of Local Anaesthetics|Y
gastrin-releasing peptide receptors|gastrin-releasing peptide receptor|Y
laser-induced thermo-therapy|laser-induced thermotherapy|Y
tetraethylammonium ions|tetraethylammonium ion|Y
peroxisome proliferator-activated receptor γ co-activator-1 α|peroxisome proliferator-activated receptor γ coactivator-1α|Y
peroxisome proliferator-activated receptor γ co-activator-1 α|peroxisome proliferator-activated receptor-γ coactivator-1 α|Y
peroxisome proliferator-activated receptor γ co-activator-1 α|peroxisome proliferator-activated receptor γ co-activator-1|Y
peroxisome proliferator-activated receptor γ co-activator-1 α|peroxisome proliferator-activated receptor γ coactivator-1 α|Y
peroxisome proliferator-activated receptor γ co-activator-1 α|peroxisome proliferator-activated receptor γ co-activator 1 α|Y
peroxisome proliferator-activated receptor γ co-activator-1 α|peroxisome proliferator-activated receptor-γ co-activator-1α|Y
peroxisome proliferator-activated receptor γ co-activator-1 α|peroxisome proliferator-activated receptor γ co-activator-1α|Y
peroxisome proliferator-activated receptor γ co-activator-1 α|peroxisome proliferator-activated receptor-γ co-activator-1 α|Y
peroxisome proliferator-activated receptor γ co-activator-1 α|peroxisome proliferator-activated receptor γ co-activator 1α|Y
α-thalassaemia/mental retardation syndrome X-linked|α thalassaemia/mental retardation syndrome X-linked|Y
α-thalassaemia/mental retardation syndrome X-linked|α-thalassemia/mental retardation syndrome X-linked|Y
Panax pseudoginseng subspecies himalaicus|Panax pseudo-ginseng subspecies himalaicus|Y
anti-fluorescein monoclonal antibody|antifluorescein monoclonal antibody|Y
anti-matrix metallopeptidase-1 antibody|anti-matrix metallopeptidase-13 antibody|Y
neuro-psychiatric symptom|neuropsychiatric symptom|Y
transforming growth factor beta receptor|transforming growth factor-beta receptor|Y
transforming growth factor beta receptor|transforming growth factor beta receptor 1|Y
galactorrhea-amenorrhœa hyperprolactinemia syndrome|galactorrhoea-amenorrhœa hyperprolactinemia syndrome|Y
galactorrhea-amenorrhœa hyperprolactinemia syndrome|galactorrhœa-amenorrhœa hyperprolactinemia syndrome|Y
galactorrhea-amenorrhœa hyperprolactinemia syndrome|galactorrhea-amenorrhœa hyperprolactinaemia syndrome|Y
galactorrhea-amenorrhœa hyperprolactinemia syndrome|galactorrhea-amenorrhœa hyperprolactinæmia syndrome|Y
galactorrhea-amenorrhœa hyperprolactinemia syndrome|galactorrhoea-amenorrhœa hyperprolactinaemia syndrome|Y
galactorrhea-amenorrhœa hyperprolactinemia syndrome|galactorrhea amenorrhœa hyperprolactinemia syndrome|Y
bacteriocinlike substance|bacteriocin-like substance|Y
granulocyte-macrophage colony-forming cells|granulocyte-macrophage colony-forming cell|Y
European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire Core-30|European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core-30|Y
European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire Core-30|European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30|Y
European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire Core-30|European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30|Y
European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire Core-30|European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire Core-30|Y
postendoscopic retrograde cholangio-pancreatography pancreatitis|post-endoscopic retrograde cholangio-pancreatography pancreatitis|Y
headshaking nystagmus|head-shaking nystagmus|Y
American Orthopaedic Foot and Ankle Society Hallux Score|American Orthopedic Foot and Ankle Society Hallux Score|Y
endosomal sorting complex required for transport|endosomal sorting complex required for transport I|Y
endosomal sorting complex required for transport|endosomal sorting complex required for transport-0|Y
mitochondrial membrane potential|mitochondria membrane potential|Y
porcine pregnancy-associated glycoprotein|porcine pregnancy-associated glycoprotein 2|Y
porcine pregnancy-associated glycoprotein|porcine pregnancy-associated glycoprotein-2|Y
benzoylarginine ethyl ester|benzoylarginine methyl ester|Y
peroxisome proliferator-activated receptor gamma2|peroxisome proliferator-activated receptor gamma1|Y
peroxisome proliferator-activated receptor gamma2|peroxisome proliferator-activated receptor gamma 2|Y
post-tetanic depression|posttetanic depression|Y
transforming growth factor alpha-Pseudomonas exotoxin 40|transforming growth factor-alpha-Pseudomonas exotoxin 40|Y
neurosecretory granule|neuro-secretory granule|Y
surface-enhanced laser desorption/ionization time of flight|surface-enhanced laser desorption/ionisation time of flight|Y
interleukine-7 receptor α subunit|interleukin-7 receptor α subunit|Y
matrix assisted laser desorption/ionisation time-of-flight mass spectrometric|matrix assisted laser desorption/ionisation time-of-flight mass spectrometry|Y
matrix assisted laser desorption/ionisation time-of-flight mass spectrometric|matrix assisted laser desorption/ionization time-of-flight mass spectrometric|Y
matrix assisted laser desorption/ionisation time-of-flight mass spectrometric|matrix-assisted laser desorption/ionisation time-of-flight mass spectrometric|Y
human T-cell leukemia virus type I-infected|human T-cell leukemia virus type-I-infected|Y
human T-cell leukemia virus type I-infected|human T cell leukemia virus type I-infected|Y
human T-cell leukemia virus type I-infected|human T-cell leukaemia virus type I-infected|Y
β-ketoacyl-acyl carrier protein synthase II|β-ketoacyl acyl carrier protein synthase II|Y
β-ketoacyl-acyl carrier protein synthase II|β-ketoacyl-acyl carrier protein synthase III|Y
β-ketoacyl-acyl carrier protein synthase II|β-ketoacyl-acyl carrier protein synthase I|Y
Mitogen-activated protein kinase kinase 1|mitogen-activated protein kinase kinase 1|Y
alpha2macroglobulin receptor associated protein|alpha2macroglobulin receptor-associated protein|Y
alpha2macroglobulin receptor associated protein|alpha2-macroglobulin receptor associated protein|Y
alpha2macroglobulin receptor associated protein|alpha2 macroglobulin receptor associated protein|Y
neural plakophilin-related armadillo-repeat protein|neural plakophilin-related armadillo repeat protein|Y
Epstein-Barr virus cell surface antigen 2|Epstein-Barr virus cell surface antigen 3|Y
Epstein-Barr virus cell surface antigen 2|Epstein-Barr virus cell surface antigen|Y
Epstein-Barr virus cell surface antigen 2|Epstein-Barr virus cell surface antigen 5|Y
Epstein-Barr virus cell surface antigen 2|Epstein-Barr virus cell surface antigen 4|Y
γ-amino butyric acid-B receptor|γ-aminobutyric acid-B receptor|Y
interdialytic weight gain|inter-dialytic weight gain|Y
geranylgeranyl disphosphate|geranylgeranyl diphosphate|Y
anti-hepatitis B core antigen|antihepatitis B core antigen|Y
laevonorgestrel releasing intrauterine device|levonorgestrel releasing intrauterine device|Y
laevonorgestrel releasing intrauterine device|levonorgestrel releasing intra-uterine device|Y
laevonorgestrel releasing intrauterine device|laevonorgestrel releasing intra-uterine device|Y
laevonorgestrel releasing intrauterine device|laevonorgestrel-releasing intrauterine device|Y
nonischæmic cardiomyopathy|non-ischæmic cardiomyopathy|Y
dichloro-diphenyl-trichloro-ethane|dichloro-diphenyl-trichloroethane|Y
respiratory inductance plethysmography|respiratory inductance plethysmograph|Y
phosphorylated extracellular signal regulated kinase-2|phosphorylated extracellular signal regulated kinase|Y
phosphorylated extracellular signal regulated kinase-2|phosphorylated extracellular signal regulated kinase 2|Y
stromal derived factor-1 alpha|stromal derived factor-1alpha|Y
haemagglutination inhibiting|hemagglutination inhibiting|Y
tumor necrosis factor related apoptosis-inducing ligand|tumor necrosis factor-related apoptosis-inducing ligand|Y
tumor necrosis factor related apoptosis-inducing ligand|tumor necrosis factor related apoptosis inducing ligand|Y
membranocystic lesion|membrano-cystic lesion|Y
upper gastro-intestinal series|upper gastrointestinal series|Y
gastro-oesophageal reflux disease|gastro-esophageal reflux disease|Y
3-dimensional computed tomography-angiography|3-dimensional computed tomography angiography|Y
insulinlike growth factor-I-mediated|insulin-like growth factor-I-mediated|Y
oligophosphoglyceroyl-adenosine triphosphate|oligophosphoglycerol-adenosine triphosphate|Y
N-phosphonacetyl-L-aspartate|N-phosphonoacetyl-L-aspartate|Y
NIMA-related kinase 2A|NIMA-related kinase 2|Y
m-chlorophenylbiguanide|m-chloro-phenylbiguanide|Y
m-chlorophenylbiguanide|m-chlorophenyl-biguanide|Y
American Society of Anesthesiology Class IV|American Society of Anaesthesiology Class V|Y
American Society of Anesthesiology Class IV|American Society of Anesthesiology class IV|Y
American Society of Anesthesiology Class IV|American Society of Anesthesiology Class V|Y
American Society of Anesthesiology Class IV|American Society of Anesthesiology Class II|Y
polychlorinated dibenzo-p-dioxins|polychlorinated dibenzo-p-dioxin|Y
spin-component-scaled second-order Møller-Plesset theory|spin-component-scaled second-order Moller-Plesset theory|Y
Colony-stimulating factor|Colony-stimulating factors|Y
bis-chloroethylnitrosourea|bischloroethylnitrosourea|Y
stereotyped behavior|stereotyped behaviour|Y
endoplasmic reticulum-associated degradation|endoplasmic reticulum associated degradation|Y
anti-T-cell receptor α/β antibody|anti-T-cell receptor αβ antibody|Y
paraaminohippuric acid clearance|para-aminohippuric acid clearance|Y
human papillomavirus 1|human papillomavirus 16|Y
multiword expression|multi-word expression|Y
tetrasodium pyrophosphate|tetra-sodium pyrophosphate|Y
NIMA-related kinase 11|NIMA-related kinase 1|Y
NIMA-related kinase 11|NIMA-related kinase 11L|Y
fibrocalculous pancreatic diabetes|fibro-calculous pancreatic diabetes|Y
TATA-binding protein-associated factor-17|TATA-binding protein associated factor-17|Y
TATA-binding protein-associated factor-17|TATA-binding protein-associated factor 17|Y
TATA-binding protein-associated factor-17|TATA-binding protein-associated factor-12|Y
TATA-binding protein-associated factor-17|TATA-binding protein-associated factor-10|Y
TATA-binding protein-associated factor-17|TATA-binding protein-associated factor-7|Y
TATA-binding protein-associated factor-17|TATA-binding protein-associated factor-1|Y
suppression of cycloheximide resistance gene 1|suppression of cycloheximide resistance gene 2|Y
electron microscopic in situ hybridisation|electron microscopic in situ hybridization|Y
electron microscopic in situ hybridisation|electron microscopic in-situ hybridisation|Y
anti-T cell receptor α/β antibody|anti-T cell receptor αβ antibody|Y
complement regulator acquiring surface protein|complement regulator-acquiring surface protein|Y
human T-cell lymphotropic virus I antibody|human T-cell lymphotropic virus 1 antibody|Y
human T-cell lymphotropic virus I antibody|human T-cell lymphotropic virus-I antibody|Y
transvaginal ultrasonography|trans-vaginal ultrasonography|Y
lyso-bisphosphatidic acid|lyso-bis-phosphatidic acid|Y
lyso-bisphosphatidic acid|lysobisphosphatidic acid|Y
amine oxidase, copper-containing 3|amine oxidase copper-containing 3|Y
hypoxia inducible factor-1 α protein|hypoxia inducible factor-1α protein|Y
arterio-venous access|arteriovenous access|Y
antihuman immunodeficiency virus drug|anti-human immunodeficiency virus drug|Y
hyperpolarisation-activated cyclic nucleotide gated channel|hyperpolarization-activated cyclic nucleotide gated channel|Y
hyperpolarisation-activated cyclic nucleotide gated channel|hyperpolarisation activated cyclic nucleotide gated channel|Y
macrophage inflammatory protein-1β|macrophage inflammatory protein-1 β|Y
intravenous vasopressin|intra-venous vasopressin|Y
matrix-assisted laser desorption/ionization time of flight|matrix assisted laser desorption/ionization time of flight|Y
carbonic anhydrase III|carbonic anhydrase II|Y
immunochromatographic test|immuno-chromatographic test|Y
rosette-forming cell|rosette-forming cells|Y
multicolony-stimulating factor|multi-colony-stimulating factor|Y
levonorgestrel releasing intrauterine device|levonorgestrel-releasing intrauterine device|Y
levonorgestrel releasing intrauterine device|levonorgestrel releasing intra-uterine device|Y
levonorgestrel releasing intrauterine device|laevonorgestrel releasing intra-uterine device|Y
angiotensin converting enzymes|angiotensin converting enzyme|Y
Alpha-hemolytic streptococci|Alpha-haemolytic streptococci|Y
ear, nose, and throat|ear, nose and throat|Y
interleukine 13 receptor α2 chain|interleukin 13 receptor α2 chain|Y
retinoic-acid-receptor-related orphan receptor γ T|retinoic-acid-receptor-related orphan receptor γT|Y
retinoic-acid-receptor-related orphan receptor γ T|retinoic-acid-receptor-related orphan receptor γ|Y
anti-disialoganglioside antibody|antidisialoganglioside antibody|Y
chicken luteinising hormone-releasing hormone|chicken luteinising hormone-releasing hormone-I|Y
chicken luteinising hormone-releasing hormone|chicken luteinising hormone-releasing hormone I|Y
haemoglobin Décines-Charpieu|hemoglobin Décines-Charpieu|Y
vinylcyclohexene diepoxide|vinylcyclohexene di-epoxide|Y
granulocyte macrophage colony stimulating factor|granulocyte macrophage colony-stimulating factor|Y
granulocyte macrophage colony stimulating factor|granulocyte/macrophage colony stimulating factor|Y
high performance liquid chromatography-thermospray mass spectrometry|high-performance liquid chromatography-thermospray mass spectrometry|Y
high performance liquid chromatography-thermospray mass spectrometry|high performance liquid chromatography/thermospray mass spectrometry|Y
small noncleaved cell lymphoma|small non-cleaved cell lymphoma|Y
human adenovirus type 6|human adenovirus type 46|Y
human adenovirus type 6|human adenovirus type 26|Y
human adenovirus type 6|human adenovirus type 16|Y
nuclear factor erythroid 2-p45-related factor 2|nuclear factor erythroid 2 p45-related factor 2|Y
immuno-reactive calcitonin|immunoreactive calcitonin|Y
thoraco-abdominal aortic aneurysm|thoracoabdominal aortic aneurysm|Y
chicken luteinizing hormone releasing hormone-II|chicken luteinising hormone releasing hormone-II|Y
chicken luteinizing hormone releasing hormone-II|chicken luteinizing hormone releasing hormone II|Y
hepato-pancreato-duodenectomy|hepatopancreato-duodenectomy|Y
hepato-pancreato-duodenectomy|hepato-pancreatoduodenectomy|Y
depo-medroxy progesterone acetate|depo-medroxyprogesterone acetate|Y
macrophage inflammatory protein-1α|macrophage inflammatory protein-1 α|Y
immunodysregulation, polyendocrinopathy, enteropathy, X linked syndrome|immunodysregulation polyendocrinopathy enteropathy X linked syndrome|Y
immunodysregulation, polyendocrinopathy, enteropathy, X linked syndrome|immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome|Y
laparoscopic assisted distal gastrectomy|laparoscopic-assisted distal gastrectomy|Y
antiIL-1alpha monoclonal antibody|anti-IL-1alpha monoclonal antibody|Y
anticytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody|anticytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody|Y
diethylenetriaminepentaacetate|diethylenetriaminepenta-acetate|Y
diethylenetriaminepentaacetate|diethylenetriamine pentaacetate|Y
light-harvesting chlorophyll a/b-binding protein I|light harvesting chlorophyll a/b-binding protein I|Y
light-harvesting chlorophyll a/b-binding protein I|light-harvesting chlorophyll a/b-binding protein-I|Y
light-harvesting chlorophyll a/b-binding protein I|light-harvesting chlorophyll a/b-binding protein II|Y
light-harvesting chlorophyll a/b-binding protein I|light-harvesting chlorophyll a/b-binding protein|Y
light-harvesting chlorophyll a/b-binding protein I|light-harvesting chlorophyll a/b binding protein I|Y
ventricular ectopic beat|vetricular ectopic beat|Y
Paediatric Risk of Mortality II|Paediatric Risk of Mortality III|Y
anti-β 2 glycoprotein I antibody|anti-β2 glycoprotein I antibody|Y
phosphatidylinositol 4,5-bisphosphate|phosphatidylinositol 4,5-biphosphate|Y
D-Ala2,MePhe4,Gly-ol5]enkephalin|[D-Ala2,MePhe4,Gly-ol5]enkephalin|Y
light-emitting diodes|light-emitting diode|Y
genetically engineered microorganisms|genetically engineered microorganism|Y
non-starch polysaccharide|non-starch polysaccharides|Y
cross-polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross-polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarization/magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross-polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarization/magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
American Society of Anesthesiology class III|American Society of Anesthesiology class II|Y
American Society of Anesthesiology class III|American Society of Anesthesiology class I|Y
American Society of Anesthesiology class III|American Society of Anaesthesiology class II|Y
activating signal co-integrator-1|activating signal cointegrator-1|Y
glial cell-line-derived neurotrophic factor|glial cell-line derived neurotrophic factor|Y
glial cell-line-derived neurotrophic factor|glial cell line-derived neurotrophic factor|Y
glial cell-line-derived neurotrophic factor|glial-cell-line-derived neurotrophic factor|Y
stress-activated protein kinase-1c|stress-activated protein kinase-1|Y
receptor activator of NFkappaB|receptor activator of NF-kappaB|Y
interleukin 2 receptor α-subunit|interleukine 2 receptor α-subunit|Y
right ventricular outflow tract|right ventricular out-flow tract|Y
Anatomic Therapeutic Chemical Classification System|Anatomical Therapeutic Chemical Classification System|Y
quantitative electro-encephalography|quantitative electroencephalography|Y
anti smooth muscle antibody|antismooth muscle antibody|Y
tetrahydroamino-acridine|tetrahydroaminoacridine|Y
phosphatidyl inositol-specific phospholipase C|phosphatidyl-inositol-specific phospholipase C|Y
American Society of Anesthesiology Class 1|American Society of Anesthesiology Class V|Y
American Society of Anesthesiology Class 1|American Society of Anesthesiology Class 2|Y
American Society of Anesthesiology Class 1|American Society of Anesthesiology Class 4|Y
nonlinear least square|non-linear least square|Y
nonlinear least square|nonlinear least squares|Y
2,4,6-trinitrobenzene sulfonate|2,4,6-trinitrobenzenesulfonate|Y
type I NAD(P)H dehydrogenase|type II NAD(P)H dehydrogenase|Y
purinergic 2X1 receptor|purinergic 2X receptor|Y
β-2 adrenergic receptor|β2 adrenergic receptor|Y
peroxisome proliferator activated receptor γ2|peroxisome proliferator activated receptor-γ2|Y
peroxisome proliferator activated receptor γ2|peroxisome proliferator activated receptor γ 2|Y
peroxisome proliferator activated receptor γ2|peroxisome proliferator-activated receptor γ2|Y
peroxisome proliferator activated receptor γ2|peroxisome proliferator activated receptor γ-2|Y
peri-intraventricular hemorrhage|peri-intraventricular haemorrhage|Y
Narcissus pseudonarcissus|Narcissus pseudo-narcissus|Y
cerebello-pontine angle tumor|cerebellopontine angle tumor|Y
cerebello-pontine angle tumor|cerebello-pontine angle tumour|Y
antinucleolar antibody|anti-nucleolar antibody|Y
non-steroidal antiinflammatory agent|nonsteroidal antiinflammatory agent|Y
non-steroidal antiinflammatory agent|non-steroidal anti-inflammatory agent|Y
anti-T-cell receptor-αβ antibody|anti-T-cell receptor-α/β antibody|Y
anti-T-cell receptor-αβ antibody|anti-T-cell receptor-α β antibody|Y
liquid chromatography/atmospheric pressure chemical ionisation-ion trap mass spectrometry|liquid chromatography-atmospheric pressure chemical ionization-ion trap mass spectrometry|Y
liquid chromatography/atmospheric pressure chemical ionisation-ion trap mass spectrometry|liquid chromatography/atmospheric pressure chemical ionisation ion trap mass spectrometry|Y
liquid chromatography/atmospheric pressure chemical ionisation-ion trap mass spectrometry|liquid chromatography-atmospheric pressure chemical ionisation-ion trap mass spectrometry|Y
IL4 receptor α chain|IL-4 receptor α chain|Y
x-ray absorption near-edge structure analysis|X-ray absorption near-edge structure analysis|Y
x-ray absorption near-edge structure analysis|x-ray absorption near edge structure analysis|Y
interferon-stimulated gene factor-3|interferon-stimulated gene factor-3α|Y
interferon-stimulated gene factor-3|interferon-stimulated gene factor-3γ|Y
TATA-binding protein-associated factor-5|TATA-binding protein-associated factor 5|Y
TATA-binding protein-associated factor-5|TATA-binding protein-associated factor-8|Y
TATA-binding protein-associated factor-5|TATA-binding protein associated factor-5|Y
TATA-binding protein-associated factor-5|TATA-binding protein-associated factor-6|Y
TATA-binding protein-associated factor-5|TATA-binding protein-associated factor-3|Y
TATA-binding protein-associated factor-5|TATA-binding protein-associated factor-4|Y
TATA-binding protein-associated factor-5|TATA-binding protein-associated factor-9|Y
TATA-binding protein-associated factor-5|TATA-binding protein-associated factor-7|Y
TATA-binding protein-associated factor-5|TATA-binding protein-associated factor-2|Y
TATA-binding protein-associated factor-5|TATA-binding protein-associated factor-1|Y
three color fluorescence in situ hybridization|three color fluorescence in situ hybridisation|Y
three color fluorescence in situ hybridization|three color fluorescence in-situ hybridization|Y
electro-magnetic field|electromagnetic field|Y
heparin-induced thrombocytopenia antibody|heparin-induced thrombocytopaenia antibody|Y
scorpion Buthus martensii Karsch|scorpion Buthus martensi Karsch|Y
self-propagating high temperature synthesis|self-propagating high-temperature synthesis|Y
trichodento-osseous syndrome|tricho-dento-osseous syndrome|Y
monocyte chemotactic and activating factor|Monocyte chemotactic and activating factor|Y
adrenocorticotrophic hormone-independent Cushing's syndrome|adrenocorticotropic hormone-independent Cushing's syndrome|Y
surface-assisted laser desorption ionisation mass spectrometry|surface-assisted laser desorption/ionisation mass spectrometry|Y
surface-assisted laser desorption ionisation mass spectrometry|surface-assisted laser desorption ionization mass spectrometry|Y
surface-assisted laser desorption ionisation mass spectrometry|surface-assisted laser desorption ionisation-mass spectrometry|Y
human adenovirus serotype 47|human adenovirus serotype 4|Y
tricho-rhino-phalangeal syndrome type I|tricho-rhino-phalangeal syndrome type II|Y
tricho-rhino-phalangeal syndrome type I|tricho-rhino-phalangeal syndrome type III|Y
nuclear factor-erythroid 2-related factor 2|nuclear factor erythroid 2-related factor 2|Y
Chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting|Y
sinoaortic denervated|sino-aortic denervated|Y
cross-correlated relaxation induced polarization transfer|cross-correlated relaxation induced polarisation transfer|Y
cross-correlated relaxation induced polarization transfer|cross-correlated relaxation-induced polarization transfer|Y
confluent and reticulated papillomatosis|confluent and reticulate papillomatosis|Y
tert-butylhydroquinone|tert-butyl hydroquinone|Y
American Society of Anesthesiology class II|American Society of Anesthesiology class IV|Y
American Society of Anesthesiology class II|American Society of Anesthesiology class I|Y
American Society of Anesthesiology class II|American Society of Anaesthesiology class II|Y
American Society of Anesthesiology class II|American Society of Anesthesiology Class II|Y
matrix assisted laser desorption ionization time-of-flight mass spectrometric|matrix assisted laser desorption/ionization time-of-flight mass spectrometric|Y
sub-foveal choroidal neo-vascularisation|sub-foveal choroidal neovascularisation|Y
sub-foveal choroidal neo-vascularisation|subfoveal choroidal neo-vascularisation|Y
sub-foveal choroidal neo-vascularisation|sub-foveal choroidal neo-vascularization|Y
oculo-dento-osseous dysplasia|oculodento-osseous dysplasia|Y
gene directed enzyme pro-drug therapy|gene directed enzyme prodrug therapy|Y
recombinant human transforming growth factor-β1|recombinant human transforming growth factor-β|Y
electron microscopic in situ hybridization|electron microscopic in-situ hybridization|Y
hereditary breast/ovarian cancer syndrome|hereditary breast-ovarian cancer syndrome|Y
magneto-encephalography|magnetoencephalography|Y
anti-T cell receptor α/β monoclonal antibody|anti-T cell receptor α β monoclonal antibody|Y
anti-T cell receptor α/β monoclonal antibody|anti-T-cell receptor α/β monoclonal antibody|Y
estrogen receptor-regulated|oestrogen receptor-regulated|Y
crossed-radioimmunoelectrophoresis|crossed-radioimmuno-electrophoresis|Y
crossed-radioimmunoelectrophoresis|crossed-radio-immunoelectrophoresis|Y
TGFbeta-activated kinase 1-binding protein-1|TGFbeta-activated kinase 1-binding protein 1|Y
human adenovirus serotype 18|human adenovirus serotype 1|Y
para-chloromercuribenzenesulfonate|para-chloromercuribenzene sulfonate|Y
para-chloromercuribenzenesulfonate|parachloromercuribenzenesulfonate|Y
polyadenosine diphosphate ribose polymerase 1|polyadenosine diphosphate ribose polymerase|Y
anti-interleukin-17 monoclonal antibody|anti-interleukin-7 monoclonal antibody|Y
high proliferative potential colony-forming cells|high proliferative potential colony-forming cell|Y
serum alpha-foeto-protein level|serum alpha-feto-protein level|Y
beta site amyloid precursor protein cleaving enzyme-1|beta site amyloid precursor protein-cleaving enzyme-1|Y
beta site amyloid precursor protein cleaving enzyme-1|beta site amyloid precursor protein cleaving enzyme-2|Y
beta site amyloid precursor protein cleaving enzyme-1|beta site amyloid precursor protein cleaving enzyme 1|Y
beta site amyloid precursor protein cleaving enzyme-1|beta-site amyloid precursor protein cleaving enzyme-1|Y
chest compression-only cardiopulmonary resuscitation|chest-compression-only cardiopulmonary resuscitation|Y
anti-interleukin 8 monoclonal antibody|antiinterleukin 8 monoclonal antibody|Y
anti-interleukin 8 monoclonal antibody|anti-interleukin 18 monoclonal antibody|Y
growth hormone release-inhibiting hormone|growth-hormone release-inhibiting hormone|Y
Src homology 2-containing protein tyrosine phosphatase 2|Src homology 2-containing protein tyrosine phosphatase-2|Y
Src homology 2-containing protein tyrosine phosphatase 2|Src homology 2-containing protein tyrosine phosphatase|Y
myelomonoblastic leukemia|myelo-monoblastic leukemia|Y
multi-parametric magnetic resonance imaging|multiparametric magnetic resonance imaging|Y
haemagglutinin/neuraminidase glycoprotein|haemagglutinin-neuraminidase glycoprotein|Y
human pituitary tumor transforming gene|human pituitary tumour transforming gene|Y
tumor to background ratio|tumour to background ratio|Y
anti-IL1 alpha monoclonal antibody|anti-IL-1 alpha monoclonal antibody|Y
anti-IL1 alpha monoclonal antibody|anti-IL 1 alpha monoclonal antibody|Y
interferon-α2b-induced|interferon-α-2b-induced|Y
radiation-induced tumour suppressor gene-1|radiation-induced tumour suppressor gene 1|Y
radiation-induced tumour suppressor gene-1|radiation-induced tumor suppressor gene-1|Y
radiation-induced tumour suppressor gene-1|radiation induced tumour suppressor gene-1|Y
deoxyribonucleic acid methyltransferase 3A|deoxyribonucleic acid methyltransferase 3B|Y
bronchiolitis obliterans-organising pneumonia|bronchiolitis obliterans organising pneumonia|Y
human leukocyte antigen-D-related antigen 6|human leukocyte antigen-D-related antigen 4|Y
human leukocyte antigen-D-related antigen 6|human leukocyte antigen-D-related antigen 1|Y
human leukocyte antigen-D-related antigen 6|human leukocyte antigen-D-related antigen|Y
genetic suppressor element|genetic suppressor elements|Y
TBP associated factor 1|TBP associated factor 11|Y
TBP associated factor 1|TBP associated factor 17|Y
anti-herpes simplex virus|antiherpes simplex virus|Y
Palo Alto Veterans' Administration Medical Center|Palo Alto Veteran's Administration Medical Center|Y
Palo Alto Veterans' Administration Medical Center|Palo Alto Veterans Administration Medical Center|Y
anti-phenolic glycolipid 1 antibody|antiphenolic glycolipid 1 antibody|Y
inflammatory polyarthritis|inflammatory poly-arthritis|Y
S100 calcium binding protein A2|S100 calcium binding protein A12|Y
multi-drug resistance associated protein|multidrug resistance associated protein|Y
cross-polarisation/magic angle spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarisation/magic angle spinning nuclear magnetic resonance spectroscopy|cross-polarization/magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarisation/magic angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarisation/magic angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarisation/magic angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarisation/magic angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarisation/magic angle spinning nuclear magnetic resonance spectroscopy|cross polarisation/magic angle spinning nuclear magnetic resonance spectroscopy|Y
ecto-protein kinase A|ectoprotein kinase A|Y
11-nor-9-carboxy-delta 9-tetrahydrocannabinol|11-nor-9-carboxy-delta9-tetrahydrocannabinol|Y
endocrine-disrupting chemical|endocrine-disrupting chemicals|Y
estrogen receptor β knock out|oestrogen receptor β knock out|Y
estrogen receptor β knock out|estrogen receptor β knockout|Y
transforming growth factor beta-inducible gene H3|transforming growth factor-beta-inducible gene H3|Y
three-dimensional stereotactic surface projection|three-dimensional stereotactic surface projections|Y
TBP-associated factor-5|TBP-associated factor-15|Y
tetracycline transactivator|tetracycline trans-activator|Y
beta-lipotropic pituitary hormone|beta-lipotrophic pituitary hormone|Y
intestinal intraepithelial lymphocyte|intestinal intra-epithelial lymphocyte|Y
Na(+)-taurocholate cotransporting polypeptide|Na(+)-taurocholate co-transporting polypeptide|Y
Na(+)-taurocholate cotransporting polypeptide|Na+-taurocholate cotransporting polypeptide|Y
tracheo-esophageal prosthesis|tracheoesophageal prosthesis|Y
cross polarisation/magic-angle-spinning nuclear magnetic resonance|cross polarization/magic-angle-spinning nuclear magnetic resonance|Y
ventrolateral medulla|ventro-lateral medulla|Y
brainstem evoked response|brain-stem evoked response|Y
mitogen-activated protein kinase-activated protein kinase 2|mitogen-activated protein kinase activated protein kinase 2|Y
mitogen-activated protein kinase-activated protein kinase 2|mitogen activated protein kinase-activated protein kinase 2|Y
mitogen-activated protein kinase-activated protein kinase 2|mitogen-activated protein kinase-activated protein kinase 1|Y
mitogen-activated protein kinase-activated protein kinase 2|mitogen-activated protein kinase-activated protein kinase 5|Y
matrix assisted laser desorption ionisation|matrix assisted laser desorption/ionisation|Y
latent transforming growth factor-β binding protein 1|latent transforming growth factor β binding protein 1|Y
anti-IL-1 alpha monoclonal antibody|anti-IL-1alpha monoclonal antibody|Y
early summer meningoencephalitis|early summer meningo-encephalitis|Y
peroxisome proliferator activated receptor-alpha agonist|peroxisome proliferator-activated receptor-alpha agonist|Y
cerebro-spinal protein|cerebrospinal protein|Y
peroxisome-proliferator-activated receptor γ coactivator 1 α|peroxisome-proliferator-activated receptor γ coactivator 1α|Y
peroxisome-proliferator-activated receptor γ coactivator 1 α|peroxisome proliferator-activated receptor γ co-activator 1 α|Y
peroxisome-proliferator-activated receptor γ coactivator 1 α|peroxisome-proliferator-activated receptor-γ co-activator 1 α|Y
pathological tumor-1, node-1, metastasis-0|pathological tumor-2, node-1, metastasis-0|Y
pathological tumor-1, node-1, metastasis-0|pathological tumor-4, node-1, metastasis-0|Y
pathological tumor-1, node-1, metastasis-0|pathological tumor-3, node-1, metastasis-0|Y
neural-precursor-cell-expressed developmentally down-regulated 8|neural-precursor cell-expressed developmentally down-regulated 8|Y
neural-precursor-cell-expressed developmentally down-regulated 8|neural-precursor-cell-expressed developmentally downregulated 2|Y
neural-precursor-cell-expressed developmentally down-regulated 8|neural-precursor-cell-expressed, developmentally down-regulated 1|Y
neural-precursor-cell-expressed developmentally down-regulated 8|neural-precursor cell-expressed, developmentally down-regulated 8|Y
neural-precursor-cell-expressed developmentally down-regulated 8|neural-precursor cell-expressed developmentally downregulated 8|Y
neural-precursor-cell-expressed developmentally down-regulated 8|neural-precursor-cell-expressed developmentally downregulated 9|Y
neural-precursor-cell-expressed developmentally down-regulated 8|neural-precursor-cell-expressed developmentally down-regulated 5|Y
neural-precursor-cell-expressed developmentally down-regulated 8|neural-precursor-cell-expressed, developmentally down-regulated 8|Y
neural-precursor-cell-expressed developmentally down-regulated 8|neural-precursor-cell-expressed, developmentally down-regulated 5|Y
neural-precursor-cell-expressed developmentally down-regulated 8|neural-precursor-cell-expressed developmentally down-regulated 9|Y
neural-precursor-cell-expressed developmentally down-regulated 8|neural-precursor-cell-expressed, developmentally down-regulated 4|Y
neural-precursor-cell-expressed developmentally down-regulated 8|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor-cell-expressed developmentally down-regulated 8|neural-precursor-cell-expressed developmentally downregulated 5|Y
neural-precursor-cell-expressed developmentally down-regulated 8|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor-cell-expressed developmentally down-regulated 8|neural-precursor-cell-expressed developmentally down-regulated 1|Y
ornithine transcarbamoylase deficiency|ornithine transcarbamylase deficiency|Y
L-N-monomethyl arginine|L-NG-monomethyl arginine|Y
neodymium:yttrium aluminum garnet laser|neodymium: yttrium aluminum garnet laser|Y
nonparametric linkage|non-parametric linkage|Y
resonance enhanced multi-photon ionisation|resonance enhanced multi-photon ionization|Y
resonance enhanced multi-photon ionisation|resonance enhanced multiphoton ionisation|Y
resonance enhanced multi-photon ionisation|resonance-enhanced multi-photon ionisation|Y
cytoplasmic autoantibodies|cytoplasmic auto-antibodies|Y
alpha-one-anti-trypsin|alpha-one-antitrypsin|Y
mitogen-activated protein kinase activated protein kinase 3|mitogen-activated protein kinase activated protein kinase 2|Y
mitogen-activated protein kinase activated protein kinase 3|mitogen-activated protein kinase activated protein kinase 1|Y
mitogen-activated protein kinase activated protein kinase 3|mitogen-activated protein kinase activated protein kinase-3|Y
mitogen-activated protein kinase activated protein kinase 3|mitogen-activated protein kinase activated protein kinase 5|Y
mitogen-activated protein kinase activated protein kinase 3|mitogen-activated protein kinase activated protein kinase|Y
aniridia-Wilms' tumor association|aniridia-Wilms tumor association|Y
helper T lymphocyte precursors|helper T lymphocyte precursor|Y
solute carrier family 7 member 2|solute carrier family 17 member 2|Y
tumor-1, node-0, metastasis-0|tumor-1c, node-0, metastasis-0|Y
quasilinear viscoelastic theory|quasi-linear viscoelastic theory|Y
peroxisome proliferator-activated receptor gamma co-activator-1|peroxisome proliferator-activated receptor-gamma coactivator-1|Y
peroxisome proliferator-activated receptor gamma co-activator-1|peroxisome proliferator activated receptor gamma coactivator-1|Y
peroxisome proliferator-activated receptor gamma co-activator-1|peroxisome proliferator-activated receptor gamma coactivator-1|Y
peroxisome proliferator-activated receptor gamma co-activator-1|peroxisome proliferator-activated receptor-gamma co-activator-1|Y
peroxisome proliferator-activated receptor gamma co-activator-1|peroxisome proliferator-activated receptor gamma co-activator 1|Y
peroxisome proliferator-activated receptor gamma co-activator-1|Peroxisome proliferator-activated receptor gamma coactivator-1|Y
autocorrelation function|auto-correlation function|Y
endosomal sorting complex required for transport I|endosomal sorting complex required for transport II|Y
percutaneous dilatational tracheostomy|percutaneous dilatational tracheotomy|Y
flash evoked potentials|flash evoked potential|Y
unified modelling language|unified modeling language|Y
tissue-type plasminogen activator antigen|tissue-type plasminogen activator-antigen|Y
A disintegrin and metalloprotease 17|A disintegrin and metalloprotease 7|Y
poly[N-(2-hydroxypropyl)methacrylamide|poly[N-(2-hydroxypropyl)methacrylamide]|Y
antihuman immunodeficiency virus|anti-human immunodeficiency virus|Y
5HT1B receptor antagonist|5-HT1B receptor antagonist|Y
chromatin accessibility complex-15|chromatin accessibility complex-1|Y
transforming growth factor beta receptor-II|transforming growth factor beta receptor II|Y
transforming growth factor beta receptor-II|transforming growth factor-beta receptor-II|Y
antigoat immunoglobulin G|anti-goat immunoglobulin G|Y
non-Hodgkin's malignant lymphoma|nonHodgkin's malignant lymphoma|Y
natural resistance associated macrophage protein-1|natural resistance associated macrophage protein 1|Y
neural precursor cell-expressed, developmentally down-regulated 8|neural-precursor cell-expressed developmentally down-regulated 8|Y
neural precursor cell-expressed, developmentally down-regulated 8|neural precursor cell-expressed, developmentally down-regulated 5|Y
neural precursor cell-expressed, developmentally down-regulated 8|neural precursor cell-expressed, developmentally downregulated 4|Y
neural precursor cell-expressed, developmentally down-regulated 8|neural-precursor cell-expressed, developmentally down-regulated 8|Y
neural precursor cell-expressed, developmentally down-regulated 8|neural precursor cell expressed, developmentally down-regulated 8|Y
neural precursor cell-expressed, developmentally down-regulated 8|neural precursor cell-expressed developmentally downregulated 8|Y
neural precursor cell-expressed, developmentally down-regulated 8|neural precursor cell expressed developmentally down-regulated 8|Y
neural precursor cell-expressed, developmentally down-regulated 8|neural precursor cell-expressed developmentally down-regulated 1|Y
neural precursor cell-expressed, developmentally down-regulated 8|neural precursor cell-expressed, developmentally downregulated 9|Y
neural precursor cell-expressed, developmentally down-regulated 8|neural precursor cell-expressed developmentally down-regulated 9|Y
neural precursor cell-expressed, developmentally down-regulated 8|neural precursor cell-expressed developmentally down-regulated 2|Y
neural precursor cell-expressed, developmentally down-regulated 8|neural precursor cell-expressed developmentally down-regulated 4|Y
neural precursor cell-expressed, developmentally down-regulated 8|neural precursor cell-expressed, developmentally downregulated 8|Y
neural precursor cell-expressed, developmentally down-regulated 8|neural precursor cell-expressed, developmentally downregulated 1|Y
neural precursor cell-expressed, developmentally down-regulated 8|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell-expressed, developmentally down-regulated 8|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell-expressed, developmentally down-regulated 8|neural precursor cell-expressed, developmentally down-regulated 2|Y
laser desorption-ionisation time of flight mass spectrometry|laser desorption-ionization time of flight mass spectrometry|Y
laser desorption-ionisation time of flight mass spectrometry|laser desorption ionisation time of flight mass spectrometry|Y
Drosophila cyclic AMP response element-binding protein 2-b|Drosophila cyclic AMP response element-binding protein 2|Y
bone morphogenetic protein receptor 1|bone morphogenetic protein receptor 1B|Y
corrected preejection period|corrected pre-ejection period|Y
neo-aortoiliac system|neoaortoiliac system|Y
cell death-inducing DNA fragmentation factor-alpha-like effector A|cell death-inducing DNA fragmentation factor alpha-like effector A|Y
oculo-auricolovertebral|oculoauricolovertebral|Y
retinoblastoma protein-interacting zinc-finger 1|retinoblastoma protein-interacting zinc finger 1|Y
Nurses Association of the American College of Obstetricians and Gynecologists|Nurses' Association of the American College of Obstetricians and Gynecologists|Y
anti-toll like receptor 3 monoclonal antibody|anti-toll like receptor-3 monoclonal antibody|Y
anti-toll like receptor 3 monoclonal antibody|anti-toll like receptor 2 monoclonal antibody|Y
anti-toll like receptor 3 monoclonal antibody|anti-toll-like receptor 3 monoclonal antibody|Y
anti-toll like receptor 3 monoclonal antibody|anti-toll like receptor 4 monoclonal antibody|Y
calcium-activated adenosine triphosphatase|calcium activated adenosine triphosphatase|Y
pathological tumor-2, node-1, metastasis-0|pathological tumor-4, node-1, metastasis-0|Y
pathological tumor-2, node-1, metastasis-0|pathological tumor-3, node-1, metastasis-0|Y
peroxisome proliferator-activated receptor-gamma coactivator-1 alpha|peroxisome proliferator-activated receptor gamma coactivator-1alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator-1 alpha|peroxisome proliferator-activated receptor gamma coactivator-1 alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator-1 alpha|peroxisome proliferator-activated receptor-gamma coactivator 1alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator-1 alpha|peroxisome proliferator-activated receptor-gamma co-activator-1 alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator-1 alpha|peroxisome-proliferator-activated receptor-gamma coactivator-1 alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator-1 alpha|peroxisome-proliferator-activated receptor-gamma co-activator-1 alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator-1 alpha|peroxisome proliferator-activated receptor-gamma coactivator-1alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator-1 alpha|peroxisome proliferator-activated receptor-gamma coactivator 1 alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator-1 alpha|peroxisome proliferator-activated receptor-gamma co-activator 1 alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator-1 alpha|peroxisome-proliferator-activated receptor-gamma coactivator-1alpha|Y
adenosine diphosphate ribosylation factor|adenosine diphosphate ribosylation factor 1|Y
human transforming growth factor-beta1|human transforming growth factor-beta|Y
human transforming growth factor-beta1|human transforming growth factor-beta 1|Y
histidine triad nucleotide binding protein|histidine triad nucleotide binding protein1|Y
anti-dinitrophenyl antibody|antidinitrophenyl antibody|Y
anemia-inducing factor|anaemia-inducing factor|Y
spermidine/spermine N1-acetyltransferase|spermidine/spermine N(1)-acetyltransferase|Y
spermidine/spermine N1-acetyltransferase|spermidine-spermine N1-acetyltransferase|Y
United Kingdom Central Council for Nursing, Midwifery and Health Visiting|United Kingdom Central Council for Nursing Midwifery and Health Visiting|Y
matrix-assisted laser desorption/ionisation quadrupole ion trap time-of-flight mass spectrometry|matrix-assisted laser desorption/ionisation quadrupole ion trap time-of-flight mass spectrometer|Y
apolipoprotein E allele ε 4|apolipoprotein E allele ε4|Y
platelet-derived growth factor AB|platelet-derived growth factor A|Y
antityrosine hydroxylase|anti-tyrosine hydroxylase|Y
nuclear receptor co-repressor 1|nuclear receptor corepressor 1|Y
mitogen-activated protein kinase activated protein kinase 2|mitogen-activated protein kinase activated protein kinase 1|Y
mitogen-activated protein kinase activated protein kinase 2|mitogen activated protein kinase activated protein kinase 2|Y
mitogen-activated protein kinase activated protein kinase 2|mitogen-activated protein kinase activated protein kinase 5|Y
mitogen-activated protein kinase activated protein kinase 2|mitogen-activated protein kinase activated protein kinase|Y
American Society of Anesthesiologists physical status V|American Society of Anesthesiologists physical status|Y
American Society of Anesthesiologists physical status V|American Society of Anesthesiologists physical status I|Y
American Society of Anesthesiologists physical status V|American Society of Anesthesiologists physical status IV|Y
American Society of Anesthesiologists physical status V|American Society of Anaesthesiologists physical status IV|Y
American Society of Anesthesiologists physical status V|American Society of Anesthesiologists physical status 2|Y
American Society of Anesthesiologists physical status V|American Society of Anesthesiologists physical status 4|Y
American Society of Anesthesiologists physical status V|American Society of Anesthesiologists physical status 5|Y
STE-20-related proline-alanine-rich kinase|STE20-related proline-alanine-rich kinase|Y
ethyleneglycol monoethyl ether|ethyleneglycol monomethyl ether|Y
anti-matrix metalloproteinase 2 antibody|anti-matrix metalloproteinase 7 antibody|Y
anti-matrix metalloproteinase 2 antibody|anti-matrix metalloproteinase 9 antibody|Y
uncoordinated protein 60|uncoordinated protein 6|Y
autoimmunity associated behavioural syndrome|autoimmunity associated behavioral syndrome|Y
upper gastro-intestinal haemorrhage|upper gastro-intestinal hemorrhage|Y
B-cell leukaemia/lymphoma 2|B-cell leukemia/lymphoma 2|Y
interleukin-11 receptor α-chain|interleukine-11 receptor α-chain|Y
major histocompatibility complex class I-related chain B|major histocompatibility complex class I-related chain A|Y
antiurease immunoglobulin Y|anti-urease immunoglobulin Y|Y
American College of Cardiology National Cardiovascular Data Registry|American College of Cardiology-National Cardiovascular Data Registry|Y
nonsteroidal antiinflammatory drug-induced|non steroidal anti inflammatory drug-induced|Y
nonsteroidal antiinflammatory drug-induced|nonsteroidal anti-inflammatory drug-induced|Y
nonsteroidal antiinflammatory drug-induced|non-steroidal antiinflammatory drug-induced|Y
vancomycin resistance gene C1|vancomycin resistance gene C|Y
myristoylated alanine-rich C kinase substrate protein|myristoylated alanine-rich C-kinase substrate protein|Y
NADPH: cytochrome P-450 reductase|NADPH:cytochrome P-450 reductase|Y
angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitors|Y
Androctonus australis Hector toxin III|Androctonus australis Hector toxin II|Y
cranio-vertebral junction|craniovertebral junction|Y
bone marrow-derived dendritic cells|bone marrow-derived dendritic cell|Y
superporous hydrogel|super-porous hydrogel|Y
interleukine 4 receptor α|interleukin 4 receptor α|Y
methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate|methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate|Y
IL3 receptor α chain|IL-3 receptor α chain|Y
neural precursor cell expressed, developmentally downregulated 1|neural precursor cell expressed developmentally downregulated 9|Y
neural precursor cell expressed, developmentally downregulated 1|neural precursor cell expressed, developmentally down-regulated 2|Y
neural precursor cell expressed, developmentally downregulated 1|neural precursor cell expressed, developmentally down-regulated 8|Y
neural precursor cell expressed, developmentally downregulated 1|neural precursor cell expressed, developmentally downregulated 5|Y
neural precursor cell expressed, developmentally downregulated 1|neural precursor cell expressed developmentally down-regulated 1|Y
neural precursor cell expressed, developmentally downregulated 1|neural precursor cell expressed, developmentally downregulated 9|Y
neural precursor cell expressed, developmentally downregulated 1|neural precursor cell expressed developmentally downregulated 4|Y
neural precursor cell expressed, developmentally downregulated 1|neural precursor cell expressed developmentally downregulated 5|Y
neural precursor cell expressed, developmentally downregulated 1|neural precursor cell expressed developmentally downregulated 2|Y
neural precursor cell expressed, developmentally downregulated 1|neural precursor cell expressed, developmentally downregulated 2|Y
neural precursor cell expressed, developmentally downregulated 1|neural precursor cell-expressed developmentally downregulated 1|Y
neural precursor cell expressed, developmentally downregulated 1|neural precursor cell expressed, developmentally down-regulated 4|Y
neural precursor cell expressed, developmentally downregulated 1|neural precursor cell expressed, developmentally down-regulated 1|Y
neural precursor cell expressed, developmentally downregulated 1|neural precursor cell-expressed, developmentally downregulated 1|Y
neural precursor cell expressed, developmentally downregulated 1|neural precursor cell expressed, developmentally down-regulated 5|Y
duodeno-gastric reflux|duodenogastric reflux|Y
worm-like chain model|wormlike chain model|Y
ω 3 polyunsaturated fatty acid|ω3 polyunsaturated fatty acid|Y
A disintegrin and metalloprotease 12s|A disintegrin and metalloprotease 12|Y
delayed-nonmatch-to-sample|delayed-non-match-to-sample|Y
male-to-female transsexual|male-to-female trans-sexual|Y
lyso-phosphatidylcholine|lyso-phosphatidyl choline|Y
lyso-phosphatidylcholine|lysophosphatidylcholine|Y
International Conference on Harmonization guideline|International Conference on Harmonisation guideline|Y
β2-microglobulin value|β-2-microglobulin value|Y
β2-microglobulin value|β 2-microglobulin value|Y
calcium binding protein parvalbumin|calcium binding proteins parvalbumin|Y
excision repair cross-complementing group 4|excision repair cross-complementing group 6|Y
excision repair cross-complementing group 4|excision repair cross complementing group 4|Y
excision repair cross-complementing group 4|excision repair cross-complementing group 3|Y
excision repair cross-complementing group 4|excision repair cross-complementing group 5|Y
excision repair cross-complementing group 4|excision repair cross-complementing-group 4|Y
FADD-like interleukin-1 β-converting enzyme|FADD-like interleukin-1-β-converting enzyme|Y
glycophosphatidyl-inositol-linked|glycophosphatidylinositol-linked|Y
guanylylimidodiphosphate|guanylyl-imidodiphosphate|Y
intra-abdominal testis|intraabdominal testis|Y
self-consistent-field molecular orbital calculation|self-consistent field molecular orbital calculation|Y
ultra-violet spectroscopy|ultraviolet spectroscopy|Y
Orthopedic Research & Education Foundation|Orthopaedic Research & Education Foundation|Y
endothelial monocyte activating polypeptide I|endothelial monocyte activating polypeptide 2|Y
endothelial monocyte activating polypeptide I|endothelial monocyte activating polypeptide|Y
endothelial monocyte activating polypeptide I|endothelial monocyte activating polypeptide II|Y
high resolution magic-angle-spinning nuclear magnetic resonance|high resolution magic-angle spinning nuclear magnetic resonance|Y
high resolution magic-angle-spinning nuclear magnetic resonance|high-resolution magic-angle-spinning nuclear magnetic resonance|Y
spinocerebellar ataxia type 3|spino-cerebellar ataxia type 3|Y
spinocerebellar ataxia type 3|spinocerebellar ataxia type 13|Y
primary anti-phospholipid syndrome|primary antiphospholipid syndrome|Y
Rab3 interacting molecule 1 α|Rab3 interacting molecule 1α|Y
vesico-ureteric reflux|vesicoureteric reflux|Y
serous tubal intra-epithelial carcinoma|serous tubal intraepithelial carcinoma|Y
pentylene tetrazole kindled|pentylene tetrazol kindled|Y
pentylene tetrazole kindled|pentylenetetrazole kindled|Y
sex-determining region Y, box 6|sex-determining region Y box 6|Y
posttransplant lymphoproliferative disorder|post transplant lymphoproliferative disorder|Y
forkhead related activator-11|forkhead related activator-1|Y
radio-ligand binding assay|radioligand binding assay|Y
tyrosine kinase substrate with 4 SH3 domains|tyrosine kinase substrate with 5 SH3 domains|Y
carbapenemase-producing Enterobacteriaceae|carbapenemase producing Enterobacteriaceae|Y
fluoro-hexahydrosiladifenidol|fluorohexahydrosiladifenidol|Y
acousto-optic tunable filter|acoustooptic tunable filter|Y
vulvovaginal candidiasis|vulvo-vaginal candidiasis|Y
free-response receiver operating characteristic|free response receiver operating characteristic|Y
ribulose 1,5-bisphosphate carboxylase-oxygenase|ribulose-1,5-bisphosphate carboxylase-oxygenase|Y
ribulose 1,5-bisphosphate carboxylase-oxygenase|ribulose 1,5-bisphosphate carboxylase/oxygenase|Y
beta-chlornaltrexamine|beta-chloronaltrexamine|Y
cross-validated squared correlation coefficient|cross validated squared correlation coefficient|Y
tumour-associated fibroblast|tumor-associated fibroblast|Y
technetium 99m diethylene-triaminepentaacetic acid-galactosyl-human serum albumin|technetium 99m diethylenetriaminepentaacetic acid-galactosyl human serum albumin|Y
technetium 99m diethylene-triaminepentaacetic acid-galactosyl-human serum albumin|technetium-99m diethylene-triaminepentaacetic acid-galactosyl human serum albumin|Y
technetium 99m diethylene-triaminepentaacetic acid-galactosyl-human serum albumin|technetium 99m diethylene-triaminepenta-acetic acid-galactosyl human serum albumin|Y
technetium 99m diethylene-triaminepentaacetic acid-galactosyl-human serum albumin|technetium 99m diethylene-triaminepentaacetic acid galactosyl human serum albumin|Y
progesterone-releasing intravaginal device|progesterone releasing intravaginal device|Y
sub-endothelial space|subendothelial space|Y
recombinant human tumour necrosis factor α|recombinant human tumour necrosis factor β|Y
recombinant human tumour necrosis factor α|recombinant human tumour necrosis factor-α|Y
IL13 receptor α2 chain|IL13 receptor α 2 chain|Y
IL13 receptor α2 chain|IL-13 receptor α2 chain|Y
voltage-dependent Ca2+ channels|voltage-dependent Ca2+ channel|Y
ras-related GTP-binding protein 27A|ras-related GTP-binding protein 2A|Y
ras-related GTP-binding protein 27A|ras-related GTP-binding protein 27|Y
recombinant interleukine-1 β|recombinant interleukine-1β|Y
recombinant interleukine-1 β|recombinant interleukin-1 β|Y
methyl cytosine-phosphate-guanosine binding domain protein 4|methyl cytosine-phosphate-guanosine binding domain protein 1|Y
methyl cytosine-phosphate-guanosine binding domain protein 4|methyl cytosine-phosphate-guanosine binding domain protein|Y
cluster of differentiation antigen 62|cluster of differentiation antigen 6|Y
International Neuroblastoma Staging System stage 1|International Neuroblastoma Staging System stage 3|Y
International Neuroblastoma Staging System stage 1|International Neuroblastoma Staging System Stage 1|Y
International Neuroblastoma Staging System stage 1|International Neuroblastoma Staging System stage 4|Y
glycophosphatidyl-inositol-anchored protein|glycophosphatidyl inositol-anchored protein|Y
glycophosphatidyl-inositol-anchored protein|glycophosphatidyl-inositol anchored protein|Y
glycophosphatidyl-inositol-anchored protein|glycophosphatidylinositol-anchored protein|Y
International Neuroblastoma Staging System stage 3|International Neuroblastoma Staging System stage 4|Y
neural-precursor cell-expressed developmentally down-regulated 8|neural-precursor cell-expressed developmentally down-regulated 1|Y
neural-precursor cell-expressed developmentally down-regulated 8|neural-precursor cell-expressed developmentally downregulated 2|Y
neural-precursor cell-expressed developmentally down-regulated 8|neural-precursor cell-expressed, developmentally down-regulated 8|Y
neural-precursor cell-expressed developmentally down-regulated 8|neural-precursor cell-expressed, developmentally down-regulated 1|Y
neural-precursor cell-expressed developmentally down-regulated 8|neural-precursor cell-expressed developmentally downregulated 8|Y
neural-precursor cell-expressed developmentally down-regulated 8|neural precursor cell-expressed developmentally downregulated 8|Y
neural-precursor cell-expressed developmentally down-regulated 8|neural-precursor cell-expressed developmentally downregulated 5|Y
neural-precursor cell-expressed developmentally down-regulated 8|neural-precursor cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally down-regulated 8|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor cell-expressed developmentally down-regulated 8|neural-precursor-cell-expressed, developmentally down-regulated 8|Y
neural-precursor cell-expressed developmentally down-regulated 8|neural-precursor cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally down-regulated 8|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor cell-expressed developmentally down-regulated 8|neural-precursor cell-expressed, developmentally down-regulated 5|Y
liquid chromatography/ion trap-mass spectrometry|liquid chromatography-ion trap-mass spectrometry|Y
liquid chromatography/ion trap-mass spectrometry|liquid chromatography/ion trap mass spectrometry|Y
poststreptococcal glomerulonephritis|post streptococcal glomerulonephritis|Y
megavoltage computed tomography|mega-voltage computed tomography|Y
trophoblast lymphocyte crossreactive antigen|trophoblast lymphocyte cross-reactive antigen|Y
signal transducer and activator of transcription-5|signal transducer and activator of transcription-3|Y
signal transducer and activator of transcription-5|signal transducer and activator of transcription 5|Y
signal transducer and activator of transcription-5|signal transducer and activator of transcription|Y
signal transducer and activator of transcription-5|signal transducer and activator of transcription-6|Y
signal transducer and activator of transcription-5|signal transducer and activator of transcription-1|Y
signal transducer and activator of transcription-5|signal transducer and activator of transcription-5b|Y
brain stem evoked potential|brainstem evoked potential|Y
isoelectrofocusing gel|iso-electrofocusing gel|Y
preoperative biliary drainage|pre-operative biliary drainage|Y
familial exudative vitreo-retinopathy|familial exudative vitreoretinopathy|Y
methicillin resistant S. pseudintermedius|methicillin-resistant S. pseudintermedius|Y
methicillin resistant S. pseudintermedius|meticillin resistant S. pseudintermedius|Y
fusion associated small transmembrane protein|fusion-associated small transmembrane protein|Y
receptor-type protein-tyrosine phosphatase-beta|receptor-type protein-tyrosine phosphatase beta|Y
receptor-type protein-tyrosine phosphatase-beta|receptor-type protein tyrosine phosphatase-beta|Y
anti-interleukin 5 monoclonal antibody|anti-interleukin 15 monoclonal antibody|Y
anti-interleukin 5 monoclonal antibody|antiinterleukin 5 monoclonal antibody|Y
N-methyl-N-nitrosourea|N-ethyl-N-nitrosourea|Y
paraneoplastic encephalomyelitis|para-neoplastic encephalomyelitis|Y
interferon-induced transmembrane protein-1|interferon-induced transmembrane protein 1|Y
interferon-induced transmembrane protein-1|interferon induced transmembrane protein-1|Y
heart-cut multidimensional gas chromatography|heart-cut multi-dimensional gas chromatography|Y
wild-type p53 induced phosphatase 1|wildtype p53 induced phosphatase 1|Y
periarterial nerve stimulation|peri-arterial nerve stimulation|Y
dihydroxyeicosatrienoic acid|dihydroxy-eicosatrienoic acid|Y
American Society of Anaesthesiology Class II|American Society of Anaesthesiology class II|Y
American Society of Anaesthesiology Class II|American Society of Anesthesiology Class II|Y
Escherichia coli heat-stable enterotoxin b|Escherichia coli heat-stable enterotoxin|Y
guanine adenine thymine adenine-binding protein 3|guanine adenine thymine adenine-binding protein 4|Y
guanine adenine thymine adenine-binding protein 3|guanine adenine thymine adenine-binding protein 1|Y
ribosomal protein L31|ribosomal protein L1|Y
ribosomal protein L31|ribosomal protein L3|Y
adult T cell leukemia virus-associated antigen|adult T cell leukaemia virus-associated antigen|Y
adult T cell leukemia virus-associated antigen|adult T-cell leukemia virus-associated antigen|Y
anti-matrix metalloproteinase 13 antibody|anti-matrix metalloproteinase-13 antibody|Y
anti-matrix metalloproteinase 13 antibody|anti-matrix metalloprotease 13 antibody|Y
mitogen- and stress-activated protein kinase 1|mitogen- and stress-activated protein kinase-1|Y
midupper arm circumference|mid upper arm circumference|Y
ras-related GTP-binding protein 17|ras-related GTP-binding protein 1|Y
ras-related GTP-binding protein 17|ras-related GTP-binding protein 7|Y
liquid chromatography/electrospray-mass spectrometry|liquid chromatography/electrospray mass spectrometry|Y
liquid chromatography/electrospray-mass spectrometry|liquid chromatography-electrospray-mass spectrometry|Y
liquid chromatography/electrospray-mass spectrometry|liquid chromatography/electrospray/mass spectrometry|Y
anti-matrix metalloproteinase 7 antibody|anti-matrix metalloproteinase-7 antibody|Y
anti-matrix metalloproteinase 7 antibody|anti-matrix metalloproteinase 9 antibody|Y
estrogen receptor mediated|oestrogen receptor mediated|Y
anti-TCR-α/β monoclonal antibody|anti-TCR-αβ monoclonal antibody|Y
galactorrhoea-amenorrhœa hyperprolactinemia syndrome|galactorrhea-amenorrhœa hyperprolactinaemia syndrome|Y
galactorrhoea-amenorrhœa hyperprolactinemia syndrome|galactorrhoea amenorrhœa hyperprolactinemia syndrome|Y
galactorrhoea-amenorrhœa hyperprolactinemia syndrome|galactorrhoea-amenorrhœa hyperprolactinaemia syndrome|Y
physiologically based pharmacokinetic|physiologically based pharmacokinetics|Y
retinoic acid receptor-related orphan receptor|retinoic acid receptor-related orphan receptor α|Y
retinoic acid receptor-related orphan receptor|retinoic acid receptor-related orphan receptor-α|Y
retinoic acid receptor-related orphan receptor|retinoic acid receptor-related orphan receptor γ|Y
intrathoracic metastasis|intra-thoracic metastasis|Y
third complementarity-determining regions|third complementarity determining regions|Y
corticotrophin releasing factor receptor antagonist|corticotropin releasing factor receptor antagonist|Y
orthophthaldialdehyde|ortho-phthaldialdehyde|Y
tumour-associated antigen|tumor-associated antigen|Y
NG-nitro-L-arginine methyl ester|N-nitro-L-arginine methyl ester|Y
flavin containing monooxygenase 5|flavin containing mono-oxygenase 5|Y
platelet-derived growth factor receptor-α|platelet-derived growth factor receptor α|Y
anti-interleukin-1alpha antibody|anti-interleukin-1 alpha antibody|Y
dermatofibrosarcoma protuberans|dermato-fibrosarcoma protuberans|Y
signal transducer and transcriptional activator 4|signal transducer and transcriptional activator-4|Y
signal transducer and transcriptional activator 4|signal transducer and transcriptional activator 5|Y
fanbeam dual energy x-ray absorptiometry|fanbeam dual energy X-ray absorptiometry|Y
fanbeam dual energy x-ray absorptiometry|fanbeam dual-energy x-ray absorptiometry|Y
macrophage-inflammatory protein-1α|macrophage-inflammatory protein-1 α|Y
antihæmophilic globulin|anti-hæmophilic globulin|Y
G protein α(i) subunit|G protein α(i1) subunit|Y
G protein α(i) subunit|G protein α(i2) subunit|Y
interleukine-13 receptor alpha 1-subunit|interleukin-13 receptor alpha 1-subunit|Y
lateral vestibulospinal tract|lateral vestibulo-spinal tract|Y
cytochrome P-450 2B-10|cytochrome P-450 2B10|Y
major histocompatibility complex class I-related chain A|major histocompatibility-complex class I-related chain A|Y
2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine|2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine|Y
three dimensional quantitative computed tomography|three-dimensional quantitative computed tomography|Y
interleukin-7 receptor α-chain|interleukine-7 receptor α-chain|Y
opioid induced hyperalgesia|opioid induced hyperalgaesia|Y
large conductance calcium-activated potassium channel|large conductance calcium activated potassium channel|Y
large conductance calcium-activated potassium channel|large-conductance calcium-activated potassium channel|Y
mitogen activated protein kinase-activated protein kinase 1|mitogen activated protein kinase-activated protein kinase 2|Y
mitogen activated protein kinase-activated protein kinase 1|mitogen-activated protein kinase-activated protein kinase 1|Y
mitogen activated protein kinase-activated protein kinase 1|mitogen activated protein kinase-activated protein kinase|Y
mitogen activated protein kinase-activated protein kinase 1|mitogen activated protein kinase activated protein kinase 1|Y
mitogen activated protein kinase-activated protein kinase 1|mitogen activated protein kinase-activated protein kinase 3|Y
magnetic resonance cholangiopancreatography|magnetic resonance cholangio-pancreatography|Y
antihistocompatibility leucocyte antigen class I antibody|anti-histocompatibility leucocyte antigen class II antibody|Y
antihistocompatibility leucocyte antigen class I antibody|anti-histocompatibility leucocyte antigen class I antibody|Y
sporulation protein IIA|sporulation protein IIAC|Y
Human papillomavirus type 18|Human papillomavirus type 8|Y
inductively coupled plasma mass spectrometer|inductively coupled plasma-mass spectrometer|Y
inductively coupled plasma mass spectrometer|inductively coupled plasma mass spectrometry|Y
methyl cytidine-phosphate-guanosine binding domain protein 1|methyl cytidine-phosphate-guanosine binding domain protein 3|Y
oestrogen receptor β knock-out mouse|estrogen receptor β knock-out mouse|Y
oestrogen receptor β knock-out mouse|oestrogen receptor β knockout mouse|Y
malignant angioendotheliomatosis|malignant angio-endotheliomatosis|Y
haemoglobin M-Kankakee|hemoglobin M-Kankakee|Y
sexually transmitted infection prevention programme|sexually transmitted infection prevention program|Y
Src homology 2 domain-containing protein-tyrosine phosphatase 1|Src homology 2 domain-containing protein-tyrosine phosphatase-1|Y
Src homology 2 domain-containing protein-tyrosine phosphatase 1|Src homology 2 domain-containing protein-tyrosine phosphatase|Y
Src homology 2 domain-containing protein-tyrosine phosphatase 1|Src homology 2 domain-containing protein tyrosine phosphatase 1|Y
Src homology 2 domain-containing protein-tyrosine phosphatase 1|src homology 2 domain-containing protein-tyrosine phosphatase 1|Y
modulatory calcineurin interacting protein-1|modulatory calcineurin interacting protein 1|Y
modulatory calcineurin interacting protein-1|modulatory calcineurin-interacting protein-1|Y
β-site amyloid precursor protein cleaving enzyme|β-site amyloid precursor protein cleaving enzyme 1|Y
β-site amyloid precursor protein cleaving enzyme|β-site amyloid precursor protein-cleaving enzyme|Y
2',5'-oligoadenylates|2',5'-oligoadenylate|Y
Schizosaccharomyces japonicus|Schizo-saccharomyces japonicus|Y
beta site amyloid precursor protein-cleaving enzyme-1|beta site amyloid precursor protein-cleaving enzyme 1|Y
beta site amyloid precursor protein-cleaving enzyme-1|beta site amyloid precursor protein-cleaving enzyme|Y
beta site amyloid precursor protein-cleaving enzyme-1|beta-site amyloid precursor protein-cleaving enzyme-1|Y
neural-precursor cell-expressed developmentally down-regulated 1|neural-precursor cell-expressed developmentally downregulated 2|Y
neural-precursor cell-expressed developmentally down-regulated 1|neural-precursor-cell-expressed, developmentally down-regulated 1|Y
neural-precursor cell-expressed developmentally down-regulated 1|neural-precursor cell-expressed, developmentally down-regulated 8|Y
neural-precursor cell-expressed developmentally down-regulated 1|neural-precursor cell-expressed, developmentally down-regulated 1|Y
neural-precursor cell-expressed developmentally down-regulated 1|neural-precursor cell-expressed developmentally downregulated 8|Y
neural-precursor cell-expressed developmentally down-regulated 1|neural-precursor cell-expressed developmentally downregulated 5|Y
neural-precursor cell-expressed developmentally down-regulated 1|neural-precursor cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally down-regulated 1|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor cell-expressed developmentally down-regulated 1|neural precursor cell-expressed developmentally down-regulated 1|Y
neural-precursor cell-expressed developmentally down-regulated 1|neural-precursor cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally down-regulated 1|neural precursor cell-expressed developmentally downregulated 1|Y
neural-precursor cell-expressed developmentally down-regulated 1|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor cell-expressed developmentally down-regulated 1|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural-precursor cell-expressed developmentally down-regulated 1|neural-precursor-cell-expressed developmentally down-regulated 1|Y
neural-precursor cell-expressed developmentally down-regulated 1|neural-precursor cell-expressed, developmentally downregulated 1|Y
never-in-mitosis Aspergillus-related kinase 8|never-in-mitosis Aspergillus-related kinase 3|Y
never-in-mitosis Aspergillus-related kinase 8|never-in-mitosis Aspergillus-related kinase 2|Y
never-in-mitosis Aspergillus-related kinase 8|never-in-mitosis Aspergillus-related kinase 4|Y
never-in-mitosis Aspergillus-related kinase 8|never-in-mitosis Aspergillus-related kinase 7|Y
never-in-mitosis Aspergillus-related kinase 8|never-in-mitosis Aspergillus-related kinase|Y
receptor-like protein-tyrosine phosphatase zeta|receptor-like protein-tyrosine phosphatase eta|Y
neural-precursor cell-expressed developmentally downregulated 2|neural-precursor cell-expressed, developmentally downregulated 9|Y
neural-precursor cell-expressed developmentally downregulated 2|neural-precursor-cell-expressed developmentally downregulated 2|Y
neural-precursor cell-expressed developmentally downregulated 2|neural-precursor cell-expressed developmentally downregulated 8|Y
neural-precursor cell-expressed developmentally downregulated 2|neural-precursor cell-expressed developmentally downregulated 5|Y
neural-precursor cell-expressed developmentally downregulated 2|neural-precursor cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally downregulated 2|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor cell-expressed developmentally downregulated 2|neural-precursor cell-expressed, developmentally downregulated 5|Y
neural-precursor cell-expressed developmentally downregulated 2|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor cell-expressed developmentally downregulated 2|neural precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor cell-expressed developmentally downregulated 2|neural-precursor cell-expressed, developmentally downregulated 1|Y
neural-precursor cell-expressed developmentally downregulated 2|neural-precursor-cell-expressed, developmentally downregulated 2|Y
x-ray photoelectron spectroscopic|x-ray photo-electron spectroscopic|Y
x-ray photoelectron spectroscopic|x-ray photo electron spectroscopic|Y
transforming growth factor beta1 level|transforming growth factor beta 1 level|Y
transforming growth factor beta1 level|transforming growth factor beta-1 level|Y
latent membrane protein 2A|latent membrane protein 2|Y
pressurized metered-dose inhalers|pressurized metered-dose inhaler|Y
carbonic anhydrase I|carbonic anhydrase II|Y
carbonic anhydrase I|carbonic anhydrase VI|Y
carbonic anhydrase I|carbonic anhydrase IX|Y
cytochrome P-450 isoenzyme 1A2|cytochrome P450 isoenzyme 1A2|Y
antifibrillarin antibody|anti-fibrillarin antibody|Y
protein phosphatase magnesium-dependent 1 d|protein phosphatase magnesium-dependent 1 δ|Y
protein phosphatase magnesium-dependent 1 d|protein phosphatase magnesium-dependent 1d|Y
polymerase chain reaction-sequence-specific primer|polymerase chain reaction/sequence-specific primer|Y
polymerase chain reaction-sequence-specific primer|polymerase chain reaction-sequence specific primer|Y
tumour necrosis factor-related apoptosis-inducing ligand|tumor necrosis factor-related apoptosis-inducing ligand|Y
tumour necrosis factor-related apoptosis-inducing ligand|tumour necrosis factor-related apoptosis inducing ligand|Y
outer membrane protein P2|outer membrane protein 2|Y
dengue hemorrhagic fever/dengue shock syndrome|dengue haemorrhagic fever/dengue shock syndrome|Y
dengue hemorrhagic fever/dengue shock syndrome|dengue hemorrhagic fever-dengue shock syndrome|Y
F18-fluorodeoxyglucose|F-18-fluorodeoxyglucose|Y
cholylglycylamidofluorescein|cholylglycylamido-fluorescein|Y
semivolatile organic compound|semi-volatile organic compound|Y
solute carrier family 1 member 2|solute carrier family 17 member 2|Y
transforming-growth-factor-β-activated kinase 1|transforming-growth-factor-β-activated kinase-1|Y
acid sensing ion channel-2a|acid sensing ion channel-2|Y
synaptosome-associated protein of 25 kDa|Synaptosome-associated protein of 25 kDa|Y
Childrens Cancer Group|Children's Cancer Group|Y
human adenovirus serotype 51|human adenovirus serotype 1|Y
human adenovirus serotype 51|human adenovirus serotype 5|Y
nucleotide-binding oligomerisation domain-like receptor family|nucleotide binding oligomerisation domain-like receptor family|Y
nucleotide-binding oligomerisation domain-like receptor family|nucleotide-binding oligomerization domain-like receptor family|Y
anti-matrix metallopeptidase 13 antibody|anti-matrix metallopeptidase-13 antibody|Y
adrenocorticotropic hormone-independent Cushing's syndrome|adrenocorticotropic hormone-independent Cushing syndrome|Y
heat shock protein 90|heat shock protein 90α|Y
heat shock protein 90|heat shock protein 90β|Y
tissue inhibitor of metalloproteinases-3|tissue inhibitor of metalloproteinases-1|Y
tissue inhibitor of metalloproteinases-3|tissue inhibitor of metalloproteinase-3|Y
neural precursor cell-expressed, developmentally down-regulated 5|neural precursor cell-expressed, developmentally downregulated 4|Y
neural precursor cell-expressed, developmentally down-regulated 5|neural precursor cell-expressed developmentally downregulated 5|Y
neural precursor cell-expressed, developmentally down-regulated 5|neural precursor cell expressed, developmentally downregulated 5|Y
neural precursor cell-expressed, developmentally down-regulated 5|neural-precursor cell-expressed, developmentally downregulated 5|Y
neural precursor cell-expressed, developmentally down-regulated 5|neural precursor cell-expressed developmentally down-regulated 1|Y
neural precursor cell-expressed, developmentally down-regulated 5|neural precursor cell-expressed, developmentally downregulated 9|Y
neural precursor cell-expressed, developmentally down-regulated 5|neural precursor cell-expressed developmentally down-regulated 9|Y
neural precursor cell-expressed, developmentally down-regulated 5|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural precursor cell-expressed, developmentally down-regulated 5|neural precursor cell-expressed developmentally down-regulated 2|Y
neural precursor cell-expressed, developmentally down-regulated 5|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural precursor cell-expressed, developmentally down-regulated 5|neural precursor cell-expressed developmentally down-regulated 4|Y
neural precursor cell-expressed, developmentally down-regulated 5|neural precursor cell-expressed, developmentally downregulated 8|Y
neural precursor cell-expressed, developmentally down-regulated 5|neural precursor cell-expressed, developmentally downregulated 1|Y
neural precursor cell-expressed, developmentally down-regulated 5|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell-expressed, developmentally down-regulated 5|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell-expressed, developmentally down-regulated 5|neural precursor cell-expressed, developmentally down-regulated 2|Y
neural precursor cell-expressed, developmentally down-regulated 5|neural precursor cell expressed, developmentally down-regulated 5|Y
technetium-99m-galactosylneoglycoalbumin|technetium-99m galactosylneoglycoalbumin|Y
secreted modular calcium binding protein 1|secreted modular calcium-binding protein 1|Y
secreted modular calcium binding protein 1|secreted modular calcium binding protein-1|Y
peroxisome proliferator-activated receptor-gamma coactivator-1|peroxisome proliferator-activated receptor gamma coactivator-1|Y
peroxisome proliferator-activated receptor-gamma coactivator-1|peroxisome proliferator-activated receptor-gamma co-activator-1|Y
Na-K-2Cl co-transporter 1|Na-K-Cl co-transporter 1|Y
capillary electrophoresis-electrospray ionisation-time-of-flight mass spectrometry|capillary electrophoresis electrospray ionisation time-of-flight mass spectrometry|Y
capillary electrophoresis-electrospray ionisation-time-of-flight mass spectrometry|capillary electrophoresis-electrospray ionisation time-of-flight mass spectrometry|Y
capillary electrophoresis-electrospray ionisation-time-of-flight mass spectrometry|capillary electrophoresis-electrospray ionization-time-of-flight mass spectrometry|Y
capillary electrophoresis-electrospray ionisation-time-of-flight mass spectrometry|capillary electrophoresis-electrospray ionisation-time of flight mass spectrometry|Y
murine interleukin-12|murine interleukin-2|Y
sex-determining region Y-type high-mobility-group-box 9|sex-determining region Y-type high-mobility-group box 9|Y
trans-obturator vaginal tape|transobturator vaginal tape|Y
Ran-GTPase activating protein|RanGTPase activating protein|Y
levo-dopa-induced dyskinesia|levodopa-induced dyskinesia|Y
extra-skeletal Ewing sarcoma|extraskeletal Ewing sarcoma|Y
interleukin-12 receptor β 2|interleukin-12 receptor β2|Y
hydroxymethyl-chrysene|hydroxymethylchrysene|Y
matrix assisted laser desorption ionisation time of flight mass spectrometric|matrix assisted laser desorption ionization time of flight mass spectrometric|Y
matrix assisted laser desorption ionisation time of flight mass spectrometric|matrix-assisted laser desorption ionisation time of flight mass spectrometric|Y
Src homology 2 domain-containing protein tyrosine phosphatase substrate 1|Src homology 2 domain containing protein tyrosine phosphatase substrate 1|Y
Src homology 2 domain-containing protein tyrosine phosphatase substrate 1|src homology 2 domain-containing protein tyrosine phosphatase substrate 1|Y
multi-locus variable-number tandem-repeat analysis|multi-locus variable-number tandem repeat analysis|Y
multi-locus variable-number tandem-repeat analysis|multi-locus variable number tandem-repeat analysis|Y
γ-aminobutyric acidA/benzodiazepine receptor complex|γ-aminobutyric acid/benzodiazepine receptor complex|Y
γ-aminobutyric acidA/benzodiazepine receptor complex|γ-aminobutyric acid A/benzodiazepine receptor complex|Y
atrioventricular conduction system|atrio-ventricular conduction system|Y
glycosyl-phosphatidylinositol-linked protein|glycosylphosphatidylinositol-linked protein|Y
glycosyl-phosphatidylinositol-linked protein|glycosylphosphatidyl inositol-linked protein|Y
crosspolarization/magic angle spinning|cross polarization/magic angle spinning|Y
crosspolarization/magic angle spinning|cross-polarization/magic angle spinning|Y
high grade intraepithelial neoplasia|high grade intra-epithelial neoplasia|Y
collision-induced dissociation-tandem mass spectrometry|collision-induced dissociation tandem mass spectrometry|Y
interleukine-7 receptor-α|interleukin-7 receptor-α|Y
lymphokine-activated killer precursor cell|lymphokine activated killer precursor cell|Y
human T-cell lymphoma/leukemia virus type 2|human T-cell lymphoma/leukemia virus type 1|Y
human T-cell lymphoma/leukemia virus type 2|human T-cell lymphoma/leukaemia virus type 2|Y
human T-cell lymphoma/leukemia virus type 2|human T-cell lymphoma/leukemia virus type I|Y
intracellular polysaccharide|intra-cellular polysaccharide|Y
OFF-GEL electrophoresis|OFFGEL electrophoresis|Y
insulinlike growth factor-1 deficiency|insulin-like growth factor-1 deficiency|Y
hypoxia-inducible factor 1α|hypoxia-inducible factor 1 α|Y
131I-meta-iodobenzylguanidine|131I-metaiodobenzylguanidine|Y
poly (allylamine hydrochloride)|poly(allylamine hydrochloride)|Y
maxillomandibular advancement|maxillo-mandibular advancement|Y
Na(+)-taurocholate co-transporting polypeptide|Na+-taurocholate co-transporting polypeptide|Y
Na(+)-taurocholate co-transporting polypeptide|Na(+)/taurocholate co-transporting polypeptide|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motif-1|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motif-9|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motif|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motifs-19|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motifs-17|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motif-8|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motif-14|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motifs-15|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motif-15|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
prepro-corticotropin-releasing factor|preprocorticotropin-releasing factor|Y
prepro-corticotropin-releasing factor|prepro-corticotrophin-releasing factor|Y
prepro-corticotropin-releasing factor|pre-pro-corticotropin-releasing factor|Y
crossed-radio-immuno-electrophoresis|crossed-radioimmuno-electrophoresis|Y
crossed-radio-immuno-electrophoresis|crossed-radio-immunoelectrophoresis|Y
organophosphate pesticide|organo-phosphate pesticide|Y
adenosine-5-triphosphate|adenosine-5'-triphosphate|Y
flavin-containing mono-oxygenase 2|flavin-containing monooxygenase 2|Y
cross-polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross-polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross-polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarisation magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
American Society of Anesthesiology status III|American Society of Anaesthesiology status III|Y
TDH-related haemolysin|TDH-related hemolysin|Y
Albany Veterans Administration Medical Center|Albany Veterans' Administration Medical Center|Y
Albany Veterans Administration Medical Center|Albany Veteran's Administration Medical Center|Y
three colour fluorescence in situ hybridisation|three color fluorescence in situ hybridisation|Y
three colour fluorescence in situ hybridisation|three-colour fluorescence in situ hybridisation|Y
three colour fluorescence in situ hybridisation|three colour fluorescence in-situ hybridisation|Y
gadolinium-diethylene-triamine-pentaacetic acid|gadolinium-diethylenetriamine-pentaacetic acid|Y
C-C chemokine ligand 4|CC chemokine ligand 4|Y
Clostridium difficile-associated diarrhoea|Clostridium difficile-associated diarrhea|Y
anti-herpes simplex virus antibody|antiherpes simplex virus antibody|Y
tissue-bound angiotensin-converting enzyme|tissue bound angiotensin-converting enzyme|Y
germinal center associated nuclear protein|germinal centre associated nuclear protein|Y
peroxisome proliferator-activated receptor-gamma 2|peroxisome proliferator-activated receptor-gamma 1|Y
peroxisome proliferator-activated receptor-gamma 2|peroxisome proliferator-activated receptor-gamma|Y
peroxisome proliferator-activated receptor-gamma 2|peroxisome proliferator-activated receptor-gamma-2|Y
peroxisome proliferator-activated receptor-gamma 2|peroxisome proliferator-activated receptor gamma 2|Y
Kruppel-like factor 13|Kruppel-like factor 3|Y
anti-human T-cell lymphotrophic virus type-1 antibody|anti-human T-cell lymphotrophic virus type-I antibody|Y
anti-human T-cell lymphotrophic virus type-1 antibody|anti-human T-cell lymphotrophic virus type 1 antibody|Y
anti-human T-cell lymphotrophic virus type-1 antibody|anti-human T-cell lymphotropic virus type-1 antibody|Y
hepatic nuclear factor-4 α|hepatic nuclear factor-4α|Y
Vogel-Fulcher-Tammann law|Vogel-Fulcher-Tamman law|Y
multifocal intraocular lens|multi-focal intraocular lens|Y
dihydroxy-acid dehydratase|dihydroxyacid dehydratase|Y
university affiliated Veterans Administration Medical Center|university-affiliated Veterans' Administration Medical Center|Y
university affiliated Veterans Administration Medical Center|university-affiliated Veteran's Administration Medical Center|Y
university affiliated Veterans Administration Medical Center|university-affiliated Veterans Administration Medical Center|Y
university affiliated Veterans Administration Medical Center|university affiliated Veteran's Administration Medical Center|Y
endothelium-dependent hyperpolarization factor|endothelium-dependent hyperpolarisation factor|Y
Androctonus australis Hector toxin II|Androctonus australis Hector toxin I|Y
liquid chromatography-electrospray ionisation-tandem mass spectrometry|liquid chromatography-electrospray ionisation tandem mass spectrometry|Y
liquid chromatography-electrospray ionisation-tandem mass spectrometry|liquid chromatography-electrospray ionization-tandem mass spectrometry|Y
interleukin 1 β protein|interleukin 1β protein|Y
α2B-adrenergic receptor|α 2B-adrenergic receptor|Y
switch-sucrose non-fermentable complex|switch-sucrose nonfermentable complex|Y
4'-(9-acridinylamino)-methanesulfon-m-anisidide|4'-(9-acridinylamino) methanesulfon-m-anisidide|Y
4'-(9-acridinylamino)-methanesulfon-m-anisidide|4'-(9-acridinylamino)methanesulfon-m-anisidide|Y
Ste-20-related proline alanine-rich kinase|ste-20-related proline alanine-rich kinase|Y
Ste-20-related proline alanine-rich kinase|Ste-20-related proline-alanine-rich kinase|Y
Ste-20-related proline alanine-rich kinase|Ste-20-related proline alanine rich kinase|Y
Ste-20-related proline alanine-rich kinase|Ste20-related proline alanine-rich kinase|Y
Phleum pratense allergen 5a|Phleum pratense allergen 5|Y
poly-betahydroxybutyrate|poly-beta-hydroxybutyrate|Y
Walter and Eliza Hall Institute 3 cell|Walter and Eliza Hall Institute 3B cell|Y
human immunodeficiency virus type 1 subtype|human immunodeficiency virus type 1 subtype C|Y
human immunodeficiency virus type 1 subtype|human immunodeficiency virus type 1 subtype A|Y
human immunodeficiency virus type 1 subtype|human immunodeficiency virus type 1 subtype D|Y
human immunodeficiency virus type 1 subtype|human immunodeficiency virus type 1 subtype F|Y
random amplified polymorphic DNA|random amplified polymorphic DNAs|Y
cortical collecting tubules|cortical collecting tubule|Y
human adenovirus type 38|human adenovirus type 8|Y
crosspolarization/magic angle spinning nuclear magnetic resonance spectroscopy|cross polarization magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization/magic angle spinning nuclear magnetic resonance spectroscopy|cross polarization/magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization/magic angle spinning nuclear magnetic resonance spectroscopy|cross-polarization/magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization/magic angle spinning nuclear magnetic resonance spectroscopy|cross-polarization magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization/magic angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization/magic angle spinning nuclear magnetic resonance spectroscopy|cross polarisation/magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization/magic angle spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
postinfectious irritable bowel syndrome|post-infectious irritable bowel syndrome|Y
ATP-sensitive potassium channels|ATP-sensitive potassium channel|Y
cytotoxic T-lymphocyte antigen-2 β|cytotoxic T-lymphocyte antigen-2β|Y
a disintegrin and metalloprotease-7|a disintegrin and metalloprotease-17|Y
TATA-binding protein-associated factor 5|TATA-binding protein-associated factor 2|Y
TATA-binding protein-associated factor 5|TATA-binding protein associated factor 5|Y
TATA-binding protein-associated factor 5|TATA-binding protein-associated factor 7|Y
TATA-binding protein-associated factor 5|TATA-binding protein-associated factor 9|Y
TATA-binding protein-associated factor 5|TATA-binding protein-associated factor 8|Y
TATA-binding protein-associated factor 5|TATA-binding protein-associated factor 6|Y
TATA-binding protein-associated factor 5|TATA-binding protein-associated factor 1|Y
TATA-binding protein-associated factor 5|TATA-binding protein-associated factor 4|Y
ubiquitin carboxyl-terminal hydrolase L3|ubiquitin carboxy-terminal hydrolase L3|Y
ubiquitin carboxyl-terminal hydrolase L3|ubiquitin carboxyl-terminal hydrolase L1|Y
ubiquitin carboxyl-terminal hydrolase L3|ubiquitin carboxyl-terminal hydrolase L5|Y
dengue haemorrhagic fever/dengue shock syndrome|dengue haemorrhagic fever-dengue shock syndrome|Y
Na(+)/Ca(2+) exchanger|Na(+)/Ca(2+) exchange|Y
gonadotropin releasing hormone agonist|gonadotrophin releasing hormone agonist|Y
anti-interleukin 6 neutralising antibody|anti-interleukin-6 neutralising antibody|Y
anti-interleukin 6 neutralising antibody|anti-interleukin 6 neutralizing antibody|Y
anti-interleukin 6 neutralising antibody|antiinterleukin 6 neutralising antibody|Y
toll-interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
toll-interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Toll-interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Y
toll-interleukin-1 receptor domain-containing adapter-inducing interferon-beta|toll/interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Y
toll-interleukin-1 receptor domain-containing adapter-inducing interferon-beta|toll-interleukin-1 receptor domain-containing adapter-inducing interferon beta|Y
toll-interleukin-1 receptor domain-containing adapter-inducing interferon-beta|toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
toll-interleukin-1 receptor domain-containing adapter-inducing interferon-beta|toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
gastrointestinal bleeding|gastro-intestinal bleeding|Y
fluorine-18-labelled fluoro-deoxy-glucose|fluorine-18-labelled fluoro-deoxyglucose|Y
fluorine-18-labelled fluoro-deoxy-glucose|fluorine-18-labeled fluoro-deoxy-glucose|Y
hyperpolarising afterpotential|hyperpolarising after-potential|Y
intra-abdominal adipose tissue|intraabdominal adipose tissue|Y
non-myeloablative stem cell transplantation|non-myeloablative stem-cell transplantation|Y
phosphorylated glycogen synthase kinase-3β|phosphorylated glycogen synthase kinase-3 β|Y
phosphorylated glycogen synthase kinase-3β|phosphorylated glycogen synthase kinase 3β|Y
potassium voltage-gated channel KQT-like subfamily member 3|potassium voltage-gated channel KQT-like subfamily member 5|Y
potassium voltage-gated channel KQT-like subfamily member 3|potassium voltage-gated channel KQT-like subfamily member 2|Y
Basso, Beattie, and Bresnahan locomotor rating scale|Basso, Beattie and Bresnahan locomotor rating scale|Y
genitourinary sphincter|genito-urinary sphincter|Y
epidemic methicillin-resistant Staphylococcus aureus-8|epidemic methicillin-resistant Staphylococcus aureus-9|Y
epidemic methicillin-resistant Staphylococcus aureus-8|epidemic methicillin-resistant Staphylococcus aureus-3|Y
anti-human T-cell lymphotrophic virus-I antibody|anti-human T-cell lymphotrophic virus I antibody|Y
anti-human T-cell lymphotrophic virus-I antibody|anti-human T-cell lymphotropic virus-I antibody|Y
noncontact tonometer|non-contact tonometer|Y
anti-filaggrin autoantibody|antifilaggrin autoantibody|Y
pathological tumor-2, pathological node-0, metastasis-0|pathological tumor-3, pathological node-0, metastasis-0|Y
pathological tumor-2, pathological node-0, metastasis-0|pathological tumor-4, pathological node-0, metastasis-0|Y
aminoimidazoazaarene|aminoimidazo-azaarene|Y
poly (epsilon-caprolactone)|poly(epsilon-caprolactone)|Y
IL-13 receptor alpha1|IL-13 receptor alpha 1|Y
erbium,chromium:YSGG laser|erbium, chromium:YSGG laser|Y
interleukine-13 receptor-α 2 subunit|interleukine-13 receptor-α2 subunit|Y
haemoglobin Old Dominion Burton-upon-Trent|hemoglobin Old Dominion Burton-upon-Trent|Y
human transforming growth factor β|human transforming growth factor β2|Y
human transforming growth factor β|human transforming growth factor β3|Y
ultra performance liquid chromatography-electrospray ionization tandem mass spectrometry|ultra performance liquid chromatography/electrospray ionization tandem mass spectrometry|Y
ultra performance liquid chromatography-electrospray ionization tandem mass spectrometry|ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry|Y
ultra performance liquid chromatography-electrospray ionization tandem mass spectrometry|ultra-performance liquid chromatography-electrospray ionisation tandem mass spectrometry|Y
ultra performance liquid chromatography-electrospray ionization tandem mass spectrometry|ultraperformance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
ultra performance liquid chromatography-electrospray ionization tandem mass spectrometry|ultra performance liquid chromatography/electrospray ionisation tandem mass spectrometry|Y
ultra performance liquid chromatography-electrospray ionization tandem mass spectrometry|ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
augmented correlation consistent polarized valence double zeta basis set|augmented correlation consistent polarised valence double zeta basis set|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|toll-interleukin 1 receptor domain-containing adapter-inducing interferon-β|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon β|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|Toll-interleukin1 receptor domain-containing adapter-inducing interferon β|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|toll-interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin 1 receptor domain-containing adapter-inducing interferon-β|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|Toll-interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
mitogen activated protein kinase-activated protein kinase-5|mitogen-activated protein kinase-activated protein kinase-5|Y
mitogen activated protein kinase-activated protein kinase-5|mitogen activated protein kinase-activated protein kinase-2|Y
mitogen activated protein kinase-activated protein kinase-5|mitogen activated protein kinase-activated protein kinase-3|Y
mitogen activated protein kinase-activated protein kinase-5|mitogen activated protein kinase-activated protein kinase|Y
broncho-alveolar macrophage|bronchoalveolar macrophage|Y
human lysosome-associated membrane protein|human lysosome-associated membrane protein-1|Y
human lysosome-associated membrane protein|human lysosome-associated membrane protein-2|Y
potassium voltage-gated channel KQT-like subfamily member 5|potassium voltage-gated channel KQT-like subfamily member 2|Y
university-affiliated Veteran's Affairs medical center|university affiliated Veteran's Affairs medical center|Y
university-affiliated Veteran's Affairs medical center|university-affiliated Veterans' Affairs medical center|Y
university-affiliated Veteran's Affairs medical center|university-affiliated Veterans Affairs medical center|Y
5-nitro-2-(3-phenylpropylamino)benzoic acid|5-nitro-2-(3-phenylpropylamino)-benzoic acid|Y
persistent fasting hyperglycemia|persistent fasting hyperglycaemia|Y
p-chloromercuribenzene sulfonate|p-chloromercuribenzenesulfonate|Y
pregnancy specific β-1-glycoprotein|pregnancy specific β1-glycoprotein|Y
sub-superficial musculo-aponeurotic system|sub-superficial musculoaponeurotic system|Y
two-dimensional fast spoiled gradient echo|two-dimensional fast spoiled gradient-echo|Y
transcription factor IIA|transcription factor IIIA|Y
Pediatric Quality of Life Inventory|Paediatric Quality of Life Inventory|Y
hand-held echocardiography|handheld echocardiography|Y
intravascular lymphoma|intra-vascular lymphoma|Y
von Willebrand factor|von Wille-brand factor|Y
Marek's disease tumour associated surface antigen|Marek's disease tumor associated surface antigen|Y
nitro-arginine-methyl ester|nitro-arginine-methylester|Y
thermoluminescence dosimeter|thermo-luminescence dosimeter|Y
cross-polarization/magic angle spinning nuclear magnetic resonance|cross-polarization magic angle spinning nuclear magnetic resonance|Y
cross-polarization/magic angle spinning nuclear magnetic resonance|cross polarization/magic angle spinning nuclear magnetic resonance|Y
cross-polarization/magic angle spinning nuclear magnetic resonance|cross-polarisation/magic angle spinning nuclear magnetic resonance|Y
sperm-associated antigen 1|sperm-associated antigen 11|Y
phosphonoacetic acid|phosphono-acetic acid|Y
para-hydroxymercuriphenyl sulfonate|para-hydroxymercuriphenylsulfonate|Y
retinoic acid receptor-related orphan receptor γt|retinoic acid receptor-related orphan receptor γT|Y
retinoic acid receptor-related orphan receptor γt|retinoic acid receptor-related orphan receptor γ|Y
Ralph H Johnson Veteran's Administration Medical Center|Ralph H. Johnson Veterans Administration Medical Center|Y
Ralph H Johnson Veteran's Administration Medical Center|Ralph H Johnson Veterans Administration Medical Center|Y
Ralph H Johnson Veteran's Administration Medical Center|Ralph H Johnson Veterans' Administration Medical Center|Y
CC chemokine ligand 18|C-C chemokine ligand 18|Y
recommended dietary intake|recommended dietary intakes|Y
digoxin-like immunoreactive factor|digoxinlike immunoreactive factor|Y
human monocytotrophic ehrlichiosis|human monocytotropic ehrlichiosis|Y
perfluoro-octanoic acid|perfluorooctanoic acid|Y
epidermal cell derived thymocyte activating factor|epidermal cell derived thymocyte-activating factor|Y
myocyte enhancer factor 2D|myocyte enhancer factor 2|Y
vascular malformations|vascular malformation|Y
endoscopic transthoracic sympathicotomy|endoscopic trans-thoracic sympathicotomy|Y
voltage-operated calcium channels|voltage-operated calcium channel|Y
anti-ovalbumin immunoglobulin A|antiovalbumin immunoglobulin A|Y
human immunodeficiency virus antibody positive|human immunodefiency virus antibody positive|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase|mitogen-activated protein kinase-extracellular signal-regulated kinase|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase|mitogen-activated protein kinase extracellular signal-regulated kinase|Y
inter-canthal distance|intercanthal distance|Y
C-C chemokine ligand 22|CC chemokine ligand 22|Y
Toll/interleukin-1 receptor domain-containing adapter-inducing interferon β|toll/interleukin1 receptor domain-containing adapter-inducing interferon β|Y
Toll/interleukin-1 receptor domain-containing adapter-inducing interferon β|Toll-interleukin1 receptor domain-containing adapter-inducing interferon β|Y
Toll/interleukin-1 receptor domain-containing adapter-inducing interferon β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
Toll/interleukin-1 receptor domain-containing adapter-inducing interferon β|toll/interleukin-1 receptor domain-containing adapter-inducing interferon β|Y
Toll/interleukin-1 receptor domain-containing adapter-inducing interferon β|Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
Toll/interleukin-1 receptor domain-containing adapter-inducing interferon β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon β|Y
µ-tensile bond strength|µtensile bond strength|Y
sodium potassium 2 chloride cotransporter 1|sodium potassium 2 chloride cotransporter|Y
sodium potassium 2 chloride cotransporter 1|sodium potassium 2 chloride cotransporter 2|Y
sodium potassium 2 chloride cotransporter 1|sodium potassium chloride cotransporter 1|Y
protease-activated receptors|protease-activated receptor|Y
light and accomodation|light and accommodation|Y
hydrogenated phosphatidyl inositol|hydrogenated phosphatidylinositol|Y
posterolateral corner|postero-lateral corner|Y
recombinant murine interleukin 14|recombinant murine interleukin 1|Y
recombinant murine interleukin 14|recombinant murine interleukin 4|Y
neural-precursor cell-expressed, developmentally downregulated 9|neural-precursor cell-expressed, developmentally down-regulated 8|Y
neural-precursor cell-expressed, developmentally downregulated 9|neural-precursor cell-expressed, developmentally down-regulated 1|Y
neural-precursor cell-expressed, developmentally downregulated 9|neural-precursor cell-expressed developmentally downregulated 8|Y
neural-precursor cell-expressed, developmentally downregulated 9|neural-precursor cell-expressed developmentally downregulated 5|Y
neural-precursor cell-expressed, developmentally downregulated 9|neural-precursor-cell-expressed developmentally downregulated 9|Y
neural-precursor cell-expressed, developmentally downregulated 9|neural-precursor cell-expressed, developmentally downregulated 5|Y
neural-precursor cell-expressed, developmentally downregulated 9|neural-precursor cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally downregulated 9|neural precursor cell-expressed, developmentally downregulated 9|Y
neural-precursor cell-expressed, developmentally downregulated 9|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural-precursor cell-expressed, developmentally downregulated 9|neural precursor cell-expressed developmentally downregulated 9|Y
neural-precursor cell-expressed, developmentally downregulated 9|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural-precursor cell-expressed, developmentally downregulated 9|neural-precursor cell-expressed, developmentally downregulated 1|Y
paired immunoglobulin-like type 2 receptor α|paired immunoglobulin-like type-2 receptor α|Y
computer-assisted telephone interviewing|computer assisted telephone interviewing|Y
cell division cycle 2|cell division cycle 42|Y
2-amino-3-methylimidazo [4,5-f]quinoline|2-amino-3-methylimidazo[4,5-f]-quinoline|Y
2-amino-3-methylimidazo [4,5-f]quinoline|2-amino-3-methyl-imidazo[4,5-f]quinoline|Y
2-amino-3-methylimidazo [4,5-f]quinoline|2-amino-3-methylimidazo[4,5-f]quinoline|Y
2-amino-3-methylimidazo [4,5-f]quinoline|2-amino-3-methylimidazo-[4,5-f]quinoline|Y
transjugular intra-hepatic porto-caval shunt|trans-jugular intra-hepatic portocaval shunt|Y
transjugular intra-hepatic porto-caval shunt|transjugular intrahepatic portocaval shunt|Y
transjugular intra-hepatic porto-caval shunt|trans-jugular intrahepatic porto-caval shunt|Y
anti-polymer antibody|antipolymer antibody|Y
anti-estrogen binding site|antiestrogen binding site|Y
anti-estrogen binding site|anti-oestrogen binding site|Y
S-phenyl mercapturic acid|S-phenylmercapturic acid|Y
secreted modular calcium-binding protein 1|secreted modular calcium-binding protein-1|Y
double-quantum-filtered correlation spectroscopy|double-quantum filtered correlation spectroscopy|Y
microtubule-associated protein 1 light-chain 3B|microtubule-associated protein 1 light-chain 3|Y
microtubule-associated protein 1 light-chain 3B|microtubule-associated protein 1 light chain 3B|Y
backscattered electron imaging|back-scattered electron imaging|Y
allele-specific competitive blocker-polymerase chain reaction|allele-specific competitive blocker polymerase chain reaction|Y
idiopathic refractory sideroblastic anemia|idiopathic refractory sideroblastic anæmia|Y
antiinterleukin 15 antibody|antiinterleukin 1 antibody|Y
antiinterleukin 15 antibody|anti-interleukin 15 antibody|Y
voltage-gated K+ channels|voltage-gated K+ channel|Y
terminal inverted repeat|terminal inverted repeats|Y
human adenovirus type 8|human adenovirus type 18|Y
human adenovirus type 8|human adenovirus type 28|Y
glycophosphatidylinositol-linked|glycophosphatidyl inositol-linked|Y
post transcriptional gene silencing|posttranscriptional gene silencing|Y
hyper-eosinophilic syndrome|hypereosinophilic syndrome|Y
glycolipid-enriched microdomain|glycolipid-enriched microdomains|Y
luteinizing hormone-releasing hormone receptor|luteinising hormone-releasing hormone receptor|Y
intima media thickness|intima medial thickness|Y
sterol response element binding protein-1-c|sterol response element binding protein-1-a|Y
sterol response element binding protein-1-c|sterol response element binding protein 1-c|Y
fronto-temporal lobar degeneration|frontotemporal lobar degeneration|Y
estrogen receptor-α knock out|estrogen receptor-α knockout|Y
cross-polarization magic-angle spinning nuclear magnetic resonance|cross-polarization magic-angle-spinning nuclear magnetic resonance|Y
cross-polarization magic-angle spinning nuclear magnetic resonance|cross-polarization magic angle spinning nuclear magnetic resonance|Y
preexcitation syndrome|pre-excitation syndrome|Y
pharyngo-upper oesophageal sphincter contractile reflex|pharyngo-upper-oesophageal sphincter contractile reflex|Y
pharyngo-upper oesophageal sphincter contractile reflex|pharyngo-upper esophageal sphincter contractile reflex|Y
glycosyl phosphatidyl inositol-anchored protein|glycosyl phosphatidylinositol-anchored protein|Y
glycosyl phosphatidyl inositol-anchored protein|glycosylphosphatidyl inositol-anchored protein|Y
glycosyl phosphatidyl inositol-anchored protein|glycosylphosphatidylinositol-anchored protein|Y
haemoglobin St. Antoine|hemoglobin St. Antoine|Y
shiga toxin producing Escherichia coli|shigatoxin producing Escherichia coli|Y
health care-associated infection|healthcare-associated infection|Y
Gc protein-derived macrophage-activating factor|Gc protein-derived macrophage activating factor|Y
attenuated total reflection-infrared spectroscopy|attenuated total reflection infrared spectroscopy|Y
photo activated localization microscopy|photoactivated localization microscopy|Y
American Society of Anesthesiologists Grade 2|American Society of Anesthesiologists Grade V|Y
American Society of Anesthesiologists Grade 2|American Society of Anesthesiologists Grade 3|Y
American Society of Anesthesiologists Grade 2|American Society of Anesthesiologists Grade I|Y
American Society of Anesthesiologists Grade 2|American Society of Anesthesiologists grade 2|Y
American Society of Anesthesiologists Grade 2|American Society of Anesthesiologists Grade 1|Y
intracranial stimulation|intra-cranial stimulation|Y
interleukin-2 receptor γ-chain|interleukine-2 receptor γ-chain|Y
pneumoencephalography|pneumo-encephalography|Y
combined internal medicine/paediatrics|combined internal medicine/pediatrics|Y
gastro-esophageal reflux disease|gastroesophageal reflux disease|Y
trans-jugular intra-hepatic portocaval shunt|transjugular intrahepatic portocaval shunt|Y
trans-jugular intra-hepatic portocaval shunt|trans-jugular intrahepatic porto-caval shunt|Y
trans-jugular intra-hepatic portocaval shunt|trans-jugular intrahepatic portocaval shunt|Y
non-specific esterase|nonspecific esterase|Y
poly-β-hydroxy-butyrate|poly-β-hydroxybutyrate|Y
electro-convulsive shock therapy|electroconvulsive shock therapy|Y
post enucleation socket syndrome|postenucleation socket syndrome|Y
pathological tumor-3, node-1, metastasis-1|pathological tumor-3, node-1, metastasis-0|Y
anti-human T-cell lymphotrophic virus 1 antibody|anti-human T cell lymphotrophic virus 1 antibody|Y
anti-human T-cell lymphotrophic virus 1 antibody|anti-human T-cell lymphotrophic virus I antibody|Y
musculo-tendinous structure|musculotendinous structure|Y
immunomodulatory oligo-nucleotide|immunomodulatory oligonucleotide|Y
high resolution magic-angle spinning nuclear magnetic resonance|high-resolution magic-angle spinning nuclear magnetic resonance|Y
high resolution magic-angle spinning nuclear magnetic resonance|high resolution magic angle spinning nuclear magnetic resonance|Y
programmed temperature vaporization|programmed temperature vapourization|Y
thyroid hormone receptor beta1|thyroid hormone receptor beta|Y
International Federation of Gynecology and Obstetrics stage IIb|International Federation of Gynecology and Obstetrics stage IIB|Y
light harvesting chlorophyll a/b-binding protein-II|light harvesting chlorophyll a/b-binding protein-I|Y
light harvesting chlorophyll a/b-binding protein-II|light-harvesting chlorophyll a/b-binding protein-II|Y
sex determining region Y box 1|sex determining region Y, box 1|Y
desisopropylpropranolol|desisopropyl-propranolol|Y
4,4'-diisothiocyanatostilbene-2,2'-disulphonate|4,4'-diisothiocyanostilbene-2,2'-disulphonate|Y
colony-forming units-spleen|colony-forming unit-spleen|Y
a disintegrin and metalloproteinase 5|a disintegrin and metalloproteinase 15|Y
generalized additive model|generalized additive models|Y
X ray computed tomography|Xray computed tomography|Y
tumour necrosis factor receptor-associated factor 5|tumour necrosis factor receptor-associated factor 6|Y
tumour necrosis factor receptor-associated factor 5|tumour necrosis factor receptor-associated factor 2|Y
tumour necrosis factor receptor-associated factor 5|tumour necrosis factor receptor associated factor 5|Y
tumour necrosis factor receptor-associated factor 5|tumor necrosis factor receptor-associated factor 5|Y
tumour necrosis factor receptor-associated factor 5|tumour necrosis factor receptor-associated factor 1|Y
tumour necrosis factor receptor-associated factor 5|tumour necrosis factor receptor-associated factor-5|Y
para-phenylenediamine|paraphenylenediamine|Y
nonobese diabetic severe combined immunodeficient mouse|non-obese diabetic severe combined immunodeficient mouse|Y
beta-amyloid precursor protein cleaving enzyme 2|beta amyloid precursor protein cleaving enzyme 2|Y
beta-amyloid precursor protein cleaving enzyme 2|beta-amyloid precursor protein cleaving enzyme|Y
beta-amyloid precursor protein cleaving enzyme 2|beta-amyloid precursor protein cleaving enzyme 1|Y
beta-amyloid precursor protein cleaving enzyme 2|beta-amyloid precursor protein cleaving enzyme-2|Y
microtubule-associated protein light chain 3-II|microtubule-associated protein-1 light chain 3-II|Y
microtubule-associated protein light chain 3-II|microtubule-associated protein 1 light chain 3-II|Y
transpulmonary pressure|trans-pulmonary pressure|Y
1-oleoyl-2-acetyl glycerol|1-oleoyl-2-acetylglycerol|Y
computational fluid dynamic|computational fluid dynamics|Y
antihepatitis B core antigen positive|anti-hepatitis B core antigen positive|Y
nonfiber carbohydrate|non-fiber carbohydrate|Y
β amyloid precursor protein-cleaving enzyme 1|β amyloid precursor protein-cleaving enzyme-1|Y
β amyloid precursor protein-cleaving enzyme 1|β amyloid precursor protein cleaving enzyme 1|Y
β amyloid precursor protein-cleaving enzyme 1|β amyloid precursor protein-cleaving enzyme|Y
β amyloid precursor protein-cleaving enzyme 1|β-amyloid precursor protein-cleaving enzyme 1|Y
neural-precursor-cell-expressed developmentally downregulated 2|neural-precursor-cell-expressed developmentally downregulated 9|Y
neural-precursor-cell-expressed developmentally downregulated 2|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor-cell-expressed developmentally downregulated 2|neural-precursor-cell-expressed developmentally down-regulated 5|Y
neural-precursor-cell-expressed developmentally downregulated 2|neural-precursor-cell-expressed developmentally down-regulated 9|Y
neural-precursor-cell-expressed developmentally downregulated 2|neural-precursor-cell-expressed, developmentally downregulated 5|Y
neural-precursor-cell-expressed developmentally downregulated 2|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor-cell-expressed developmentally downregulated 2|neural-precursor-cell-expressed developmentally downregulated 5|Y
neural-precursor-cell-expressed developmentally downregulated 2|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor-cell-expressed developmentally downregulated 2|neural-precursor-cell-expressed developmentally down-regulated 1|Y
neural-precursor-cell-expressed developmentally downregulated 2|neural-precursor-cell-expressed, developmentally downregulated 2|Y
G-protein coupled estrogen receptor 1|G-protein coupled oestrogen receptor 1|Y
uncoordinated protein 68|uncoordinated protein 6|Y
in-hospital mortality|inhospital mortality|Y
IL2 receptor α subunit|IL-2 receptor α subunit|Y
antihuman herpesvirus 6 immunoglobulin G|anti-human herpesvirus 6 immunoglobulin G|Y
antihuman herpesvirus 6 immunoglobulin G|anti-human herpes virus 6 immunoglobulin G|Y
transforming growth factor β inhibitory element|transforming growth factor-β inhibitory element|Y
soluble receptor activator of nuclear factor-κB ligand|soluble receptor activator of nuclear factor κB ligand|Y
soluble receptor activator of nuclear factor-κB ligand|soluble receptor activator of nuclear factor-κ B ligand|Y
health care associated methicillin-resistant Staphylococcus aureus|health-care associated methicillin-resistant Staphylococcus aureus|Y
health care associated methicillin-resistant Staphylococcus aureus|healthcare-associated methicillin-resistant Staphylococcus aureus|Y
health care associated methicillin-resistant Staphylococcus aureus|health care-associated methicillin-resistant Staphylococcus aureus|Y
atmospheric pressure photoionisation|atmospheric pressure photo-ionisation|Y
pro-collagen III peptide|procollagen III peptide|Y
eggs per gram of faeces|eggs per gram of feces|Y
non-multiple endocrine neoplasia type 1|non-multiple endocrine neoplasia, type 1|Y
non-multiple endocrine neoplasia type 1|nonmultiple endocrine neoplasia type 1|Y
surface-enhanced laser desorption/ionisation time of flight|surface enhanced laser desorption/ionisation time of flight|Y
acid- and alcohol-fast bacillus|acid and alcohol-fast bacillus|Y
extra-ocular muscle impairment|extraocular muscle impairment|Y
nonalcoholic steatohepatitis|non-alcoholic steatohepatitis|Y
pharyngo-upper-oesophageal sphincter contractile reflex|pharyngo-upper-esophageal sphincter contractile reflex|Y
cocaine amphetamine-regulated transcript|cocaine-amphetamine-regulated transcript|Y
cocaine amphetamine-regulated transcript|cocaine amphetamine regulated transcript|Y
choline glycerophospholipids|choline glycerophospholipid|Y
T-cell-receptor-gammadelta-positive|T-cell-receptor-gamma delta-positive|Y
random-amplified polymorphic DNA profile|random amplified polymorphic DNA profile|Y
formyl-tetra-hydrofolate|formyltetra-hydrofolate|Y
intraarticular pressure|intra-articular pressure|Y
electro-optic modulator|electrooptic modulator|Y
long-term marrow cultures|long-term marrow culture|Y
interferon-stimulated gene factor-3gamma|interferon stimulated gene factor-3gamma|Y
estrogen receptor β-specific|oestrogen receptor β-specific|Y
5'-N-ethylcarboxamidoadenosine|5'-N-ethylcarboxamido-adenosine|Y
γ-amino butyric acid B receptor|γ-aminobutyric acid B receptor|Y
tunnel magnetoresistance|tunnel magneto-resistance|Y
tricyclic anti-depressant|tricyclic antidepressant|Y
tricyclic anti-depressant|tri-cyclic anti-depressant|Y
Wechsler Intelligence Scale for Children, Third Edition|Wechsler Intelligence Scale for Children Third Edition|Y
TATA-binding protein-associated factor 2|TATA-binding protein-associated factor 12|Y
TATA-binding protein-associated factor 2|TATA-binding protein-associated factor 7|Y
TATA-binding protein-associated factor 2|TATA-binding protein-associated factor 9|Y
TATA-binding protein-associated factor 2|TATA-binding protein-associated factor 8|Y
TATA-binding protein-associated factor 2|TATA-binding protein-associated factor 6|Y
TATA-binding protein-associated factor 2|TATA-binding protein-associated factor 1|Y
TATA-binding protein-associated factor 2|TATA-binding protein-associated factor 4|Y
TATA-binding protein-associated factor 2|TATA-binding protein-associated factor-2|Y
multimicroelectrode plate|multi-microelectrode plate|Y
multidrug resistance|multi-drug resistance|Y
proprioceptive neuro-muscular facilitation|proprioceptive neuromuscular facilitation|Y
extra-renal Wilm's tumour|extrarenal Wilm's tumour|Y
extra-renal Wilm's tumour|extra-renal Wilms tumour|Y
extra-renal Wilm's tumour|extra-renal Wilm's tumor|Y
Krüppel-like factor 15|Krüppel-like factor 5|Y
intracluster correlation coefficient|intra-cluster correlation coefficient|Y
thrombo-haemorrhagic syndrome|thrombo-hemorrhagic syndrome|Y
arterio-sclerotic heart disease|arteriosclerotic heart disease|Y
reverse tri-iodothyronine|reverse triiodothyronine|Y
soluble cluster of differentiation antigen 23|soluble cluster of differentiation antigen 28|Y
soluble cluster of differentiation antigen 23|soluble cluster of differentiation antigen 27|Y
soluble cluster of differentiation antigen 23|soluble cluster of differentiation antigen 83|Y
soluble cluster of differentiation antigen 23|soluble cluster of differentiation antigen 36|Y
soluble cluster of differentiation antigen 23|soluble cluster of differentiation antigen 26|Y
soluble cluster of differentiation antigen 23|soluble cluster of differentiation antigen 30|Y
coat protein complex I|coat protein complex II|Y
antisense oligodeoxyribonucleotide|antisense oligodeoxyribonucleotides|Y
7 alpha-methyl-19-nortestosterone|7alpha-methyl-19-nortestosterone|Y
poly(D,L-lactide-co-glycolide)|poly(DL-lactide-co-glycolide)|Y
megakaryocyte colony-forming unit|megakaryocyte colony-forming units|Y
electro-spray ionisation-triple quadrupole mass spectrometry|electro-spray ionization-triple quadrupole mass spectrometry|Y
glycosyl-phosphatidyl-inositol anchored|glycosylphosphatidyl-inositol anchored|Y
hyperpolarisation activated cyclic nucleotide-gated channel|hyperpolarisation activated cyclic nucleotide gated channel|Y
surface photovoltage|surface photo-voltage|Y
Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto|Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motif-9|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motif|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motifs-19|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motifs-17|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motif-8|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motifs-8|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motif-14|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motifs-15|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
ribosomal protein L16|ribosomal protein L1|Y
antitriiodothyronine antibody|anti-triiodothyronine antibody|Y
calcium-activated potassium channel|calcium-activated potassium channels|Y
cerebral auto-regulation|cerebral autoregulation|Y
4'-(9-acridinylamino) methanesulfon-m-anisidide|4'-(9-acridinylamino)methanesulfon-m-anisidide|Y
agargel immunodiffusion|agargel immuno-diffusion|Y
pre-integration complex|preintegration complex|Y
IL-13 receptor α 2-chain|IL-13 receptor α2-chain|Y
IL-13 receptor α 2-chain|IL13 receptor α 2-chain|Y
muscarinic cholinergic receptor|muscarinic cholinergic receptors|Y
insulin-like growth factor II mRNA-binding protein|insulin-like growth factor II mRNA-binding protein 1|Y
insulin-like growth factor II mRNA-binding protein|insulin-like growth factor II mRNA binding protein|Y
insulin-like growth factor II mRNA-binding protein|insulin-like growth factor II mRNA-binding protein 3|Y
insulin-like growth factor II mRNA-binding protein|insulin-like growth factor II mRNA-binding protein-3|Y
insulin-like growth factor II mRNA-binding protein|insulin-like growth factor-II mRNA-binding protein|Y
insulin-like growth factor II mRNA-binding protein|insulin-like growth factor II mRNA-binding protein-1|Y
insulin-like growth factor II mRNA-binding protein|insulin-like growth factor II mRNA-binding protein-2|Y
interdigital transducer|inter-digital transducer|Y
bovine serum albumin|bovine serum albumine|Y
adenosine triphosphate binding cassette transporter 1|adenosine triphosphate binding cassette transporter|Y
activated prothrombin complex concentrate|activated prothrombin complex concentrates|Y
ribosomal protein L1|ribosomal protein L11|Y
ribosomal protein L1|ribosomal protein L15|Y
ribosomal protein L1|ribosomal protein L14|Y
ribosomal protein L1|ribosomal protein L17|Y
ribosomal protein L1|ribosomal protein L10|Y
ribosomal protein L1|ribosomal protein L18|Y
ribosomal protein L1|ribosomal protein L19|Y
multidrug resistance-associated protein 2|multidrug resistance-associated protein|Y
multidrug resistance-associated protein 2|multidrug resistance-associated protein 1|Y
multidrug resistance-associated protein 2|multidrug resistance associated protein 2|Y
multidrug resistance-associated protein 2|multidrug resistance-associated protein 3|Y
galactorrhœa amenorrhœa hyperprolactinaemia syndrome|galactorrhœa amenorrhea hyperprolactinaemia syndrome|Y
galactorrhœa amenorrhœa hyperprolactinaemia syndrome|galactorrhœa-amenorrhœa hyperprolactinaemia syndrome|Y
inter-orbital distance|interorbital distance|Y
adult T-cell leukemia derived factor|adult T-cell leukaemia derived factor|Y
anti-Saccharomyces cerevisiae antibodies|anti–Saccharomyces cerevisiae antibodies|Y
TNF-receptor-associated periodic syndrome|TNF-receptor associated periodic syndrome|Y
T cell receptor Valpha|T cell receptor alpha|Y
cross polarization magic angle spinning nuclear magnetic resonance spectroscopy|cross polarization/magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization magic angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization magic angle spinning nuclear magnetic resonance spectroscopy|cross-polarization magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization magic angle spinning nuclear magnetic resonance spectroscopy|cross polarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization magic angle spinning nuclear magnetic resonance spectroscopy|crosspolarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
American Society of Anesthesiologists class 4|American Society of Anesthesiologists class 3|Y
American Society of Anesthesiologists class 4|American Society of Anesthesiologists class 5|Y
American Society of Anesthesiologists class 4|American Society of Anesthesiologists class|Y
American Society of Anesthesiologists class 4|American Society of Anesthesiologists class V|Y
American Society of Anesthesiologists class 4|American Society of Anesthesiologists class 2|Y
American Society of Anesthesiologists class 4|American Society of Anaesthesiologists class 4|Y
American Society of Anesthesiologists class 4|American Society of Anesthesiologists class I|Y
American Society of Anesthesiologists class 4|American Society of Anesthesiologists class 1|Y
American Society of Anesthesiologists class 4|American Society of Anesthesiologists Class 4|Y
cluster of differentiation antigen 61|cluster of differentiation antigen 6|Y
Vogel-Fulcher-Tammann equation|Vogel-Fulcher-Tamman equation|Y
anti-IL-12p40 antibody|antiIL-12p40 antibody|Y
ideopathic hypertrophic subaortic stenosis|idiopathic hypertrophic subaortic stenosis|Y
Kruppel-like factor 12|Kruppel-like factor 2|Y
galactorrhœa-amenorrhœa hyperprolactinemia syndrome|galactorrhœa-amenorrhœa hyperprolactinaemia syndrome|Y
galactorrhœa-amenorrhœa hyperprolactinemia syndrome|galactorrhœa-amenorrhea hyperprolactinemia syndrome|Y
galactorrhœa amenorrhea hyperprolactinæmia syndrome|galactorrhœa amenorrhœa hyperprolactinæmia syndrome|Y
galactorrhœa amenorrhea hyperprolactinæmia syndrome|galactorrhœa amenorrhea hyperprolactinemia syndrome|Y
heparin induced thrombocytopaenia syndrome|heparin-induced thrombocytopaenia syndrome|Y
murine granulocyte macrophage colony-stimulating factor|murine granulocyte-macrophage colony-stimulating factor|Y
closed cranio-cerebral trauma|closed craniocerebral trauma|Y
sex determining region Y, box 5|sex determining region Y box 5|Y
retro-peritoneoscopic nephrectomy|retroperitoneoscopic nephrectomy|Y
Reis-Bückler's corneal dystrophy|Reis-Bücklers corneal dystrophy|Y
benzo[a]pyrene diolepoxide-DNA adduct level|benzo[a]pyrene diol-epoxide-DNA adduct level|Y
benzo[a]pyrene diolepoxide-DNA adduct level|benzo[a]pyrene diol epoxide-DNA adduct level|Y
radioimmuno-precipitation assay|radioimmunoprecipitation assay|Y
pylorus preserving pancreato-duodenectomy|pylorus-preserving pancreato-duodenectomy|Y
asymmetric dimethylarginine|symmetric dimethylarginine|Y
outpatient substance abuse treatment|out-patient substance abuse treatment|Y
post-inertia dyskinesia|postinertia dyskinesia|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motifs-13|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motif-3|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motifs-16|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motifs-4|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motifs-2|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motif-2|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloproteinase with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motifs-9|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motifs-17|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motifs-20|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
transient receptor potential vanilloid type 1|transient receptor potential vanilloid type 2|Y
transient receptor potential vanilloid type 1|transient receptor potential vanilloid type 3|Y
extracellular volume expansion|extra-cellular volume expansion|Y
peroxisome proliferator-activated receptor gamma coactivator-1alpha|peroxisome proliferator-activated receptor gamma coactivator-1 alpha|Y
peroxisome proliferator-activated receptor gamma coactivator-1alpha|peroxisome proliferator-activated receptor gamma coactivator 1alpha|Y
peroxisome proliferator-activated receptor gamma coactivator-1alpha|peroxisome proliferator-activated receptor gamma coactivator 1 alpha|Y
peroxisome proliferator-activated receptor gamma coactivator-1alpha|peroxisome proliferator-activated receptor-gamma coactivator-1alpha|Y
peroxisome proliferator-activated receptor gamma coactivator-1alpha|peroxisome proliferator-activated receptor gamma co-activator-1alpha|Y
peroxisome proliferator-activated receptor gamma coactivator-1alpha|peroxisome-proliferator-activated receptor gamma coactivator-1 alpha|Y
Disability of the Arm, Shoulder and Hand questionnaire|Disability of the Arm, Shoulder and Hand Questionnaire|Y
3 beta-hydroxysteroid dehydrogenase deficiency|3 beta-hydroxysteroid-dehydrogenase deficiency|Y
3 beta-hydroxysteroid dehydrogenase deficiency|3beta-hydroxy steroid dehydrogenase deficiency|Y
anti-IL5 monoclonal antibody|anti-IL 5 monoclonal antibody|Y
anti-IL5 monoclonal antibody|anti-IL-5 monoclonal antibody|Y
cortico-spinal neuron|corticospinal neuron|Y
receptor-like protein-tyrosine phosphatase|receptor-like protein-tyrosine phosphatase-δ|Y
receptor-like protein-tyrosine phosphatase|receptor-like protein-tyrosine phosphatase-μ|Y
receptor-like protein-tyrosine phosphatase|receptor-like protein-tyrosine phosphatase ψ|Y
receptor-like protein-tyrosine phosphatase|receptor-like protein-tyrosine phosphatase η|Y
receptor-like protein-tyrosine phosphatase|receptor-like protein-tyrosine phosphatase δ|Y
receptor-like protein-tyrosine phosphatase|receptor-like protein-tyrosine phosphatase μ|Y
receptor-like protein-tyrosine phosphatase|receptor-like protein-tyrosine phosphatase-η|Y
receptor-like protein-tyrosine phosphatase|receptor-like protein-tyrosine phosphatase-ζ|Y
B-cell leukemia lymphoma-2|B-cell leukaemia lymphoma-2|Y
p38 alpha mitogen-activated protein kinase|p38-alpha mitogen-activated protein kinase|Y
p38 alpha mitogen-activated protein kinase|p38alpha mitogen-activated protein kinase|Y
dose nonuniformity ratio|dose non-uniformity ratio|Y
gamma amino butyric acidA|gamma aminobutyric acidA|Y
ethylenevinylacetate co-polymer|ethylenevinylacetate copolymer|Y
mitogen-activated protein kinase-activated protein kinase-5|mitogen-activated protein kinase-activated protein kinase 5|Y
soluble receptor activator of nuclear factor κ-B ligand|soluble receptor activator of nuclear factor κB ligand|Y
surface-enhanced laser desorption-ionization|surface-enhanced laser desorption ionization|Y
surface-enhanced laser desorption-ionization|surface-enhanced laser desorption-ionisation|Y
anti-CD20 monoclonal antibody|anti-CD2 monoclonal antibody|Y
Na+/taurocholate co-transporting polypeptide|Na+-taurocholate co-transporting polypeptide|Y
Na+/taurocholate co-transporting polypeptide|Na(+)/taurocholate co-transporting polypeptide|Y
Na+/taurocholate co-transporting polypeptide|Na+/taurocholate cotransporting polypeptide|Y
European Organisation for Research and Treatment of Cancer|European Organization for Research and Treatment of Cancer|Y
distal spleno-renal shunt|distal splenorenal shunt|Y
N-formyl-methionyl-leucyl-phenylalanine|N-formyl-methionyl-leucyl-phenyl-alanine|Y
N-formyl-methionyl-leucyl-phenylalanine|N-formyl-methionyl-leucylphenylalanine|Y
N-formyl-methionyl-leucyl-phenylalanine|N-formylmethionyl-leucyl-phenylalanine|Y
antibody directed enzyme pro-drug therapy|antibody-directed enzyme pro-drug therapy|Y
Rho-guanine nucleotide dissociation inhibitor 1|Rho-guanine nucleotide dissociation inhibitor-1|Y
endoplasmic reticulum|endo-plasmic reticulum|Y
GTP-binding protein β-γ subunit|GTP-binding protein βγ subunit|Y
interferon alfa2b-induced|interferon alfa-2b-induced|Y
non-arteritic anterior ischaemic optic neuropathy|nonarteritic anterior ischemic optic neuropathy|Y
non-arteritic anterior ischaemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy|Y
burst forming units-erythroid|burst forming unit-erythroid|Y
A disintegrin and metalloprotease-5|A disintegrin and metalloprotease-15|Y
micro X-ray absorption near-edge structure|micro X-ray absorption near edge structure|Y
a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13 inhibitor|a disintegrin-like and metalloproteinase with thrombospondin type1 motif 13 inhibitor|Y
prostaglandin F-(2)alpha|prostaglandin F-(2) alpha|Y
triple intrathecal therapy|triple intra-thecal therapy|Y
positron emission tomography|positron emission tomograph|Y
dorsal spino-cerebellar tract|dorsal spinocerebellar tract|Y
gonadotrophin-releasing hormone-agonist|gonadotropin-releasing hormone-agonist|Y
University of California, Los Angeles|University of California Los Angeles|Y
latent transforming growth factor β-binding protein 1|latent transforming growth factor β binding protein 1|Y
latent transforming growth factor β-binding protein 1|latent transforming growth factor β-binding protein-1|Y
polydimethylsiloxane|poly-dimethylsiloxane|Y
opsono-phagocytic activity|opsonophagocytic activity|Y
human adenovirus serotype 4|human adenovirus serotype 40|Y
human adenovirus serotype 4|human adenovirus serotype 46|Y
human adenovirus serotype 4|human adenovirus serotype 44|Y
human adenovirus serotype 4|human adenovirus serotype 48|Y
human adenovirus serotype 4|human adenovirus serotype 42|Y
human adenovirus serotype 4|human adenovirus serotype 45|Y
human adenovirus serotype 4|human adenovirus serotype 24|Y
human adenovirus serotype 4|human adenovirus serotype 14|Y
knotted1-like homeobox|knotted-like homeobox|Y
IkappaB kinase alpha|I-kappaB kinase alpha|Y
augmented correlation-consistent polarized-valence triple-ζ basis set|augmented correlation-consistent polarised-valence triple-ζ basis set|Y
aminomethylcyclohexane-carboxylic acid|aminomethylcyclohexanecarboxylic acid|Y
inter-maxillary fixation|intermaxillary fixation|Y
acquired angio-oedema|acquired angio-edema|Y
poly (ethyleneoxide)|poly (ethylene oxide)|Y
tumour necrosis factor receptor associated factor 6|tumour necrosis factor receptor associated factor 1|Y
tumour necrosis factor receptor associated factor 6|tumor necrosis factor receptor associated factor 6|Y
tumour necrosis factor receptor associated factor 6|tumour necrosis factor receptor-associated factor 6|Y
tumour necrosis factor receptor associated factor 6|tumour necrosis factor receptor associated factor 5|Y
tumour necrosis factor receptor associated factor 6|tumour necrosis factor receptor associated factor 2|Y
naso-tracheal intubation|nasotracheal intubation|Y
color coded duplex sonography|colour coded duplex sonography|Y
multi-angle light scattering|multiangle light scattering|Y
interleukine 4 receptor-α subunit|interleukin 4 receptor-α subunit|Y
non-specific esophageal motility disorder|nonspecific esophageal motility disorder|Y
5-hydroxytryptamine 1 receptor|5-hydroxytryptamine 1D receptor|Y
5-hydroxytryptamine 1 receptor|5-hydroxytryptamine 1B receptor|Y
5-hydroxytryptamine 1 receptor|5-hydroxytryptamine 1F receptor|Y
area under the concentration-time curve|area under the concentration-time curves|Y
cross-polarisation magic-angle spinning NMR|cross-polarisation magic-angle-spinning NMR|Y
cross-polarisation magic-angle spinning NMR|cross-polarization magic-angle spinning NMR|Y
enterically transmitted non-A non-B hepatitis|enterically-transmitted non-A non-B hepatitis|Y
transcoronary ablation of septal hypertrophy|Transcoronary ablation of septal hypertrophy|Y
bone-marrow-derived mesenchymal stem cell|bone marrow-derived mesenchymal stem cell|Y
three color fluorescence in situ hybridisation|three color fluorescence in-situ hybridisation|Y
Na(+)/H(+) exchanger regulatory factor-1|Na(+)/H(+) exchanger regulatory factor 1|Y
hypoxia inducible transcription factor 1α|hypoxia inducible transcription factor 1|Y
hypoxia inducible transcription factor 1α|hypoxia inducible transcription factor-1α|Y
type II sodium/phosphate co-transporter|type IIa sodium/phosphate co-transporter|Y
fluorine-18 labeled fluoro-deoxy-glucose|fluorine-18 labelled fluoro-deoxyglucose|Y
fluorine-18 labeled fluoro-deoxy-glucose|fluorine-18-labeled fluoro-deoxy-glucose|Y
heparin-induced thrombocytopaenia|heparin-induced thrombocytopenia|Y
heparin-induced thrombocytopaenia|heparin-induced thrombo-cytopaenia|Y
benzo(a)pyrene diol epoxide DNA adduct|benzo(a)pyrene diolepoxide DNA adduct|Y
gas chromatography/negative ion chemical ionization/mass spectrometry|gas chromatography/negative ion chemical ionization-mass spectrometry|Y
gas chromatography/negative ion chemical ionization/mass spectrometry|gas chromatography/negative ion chemical ionisation/mass spectrometry|Y
gas chromatography/negative ion chemical ionization/mass spectrometry|gas chromatography/negative ion chemical ionization mass spectrometry|Y
anticytotoxic T-lymphocyte antigen 4 monoclonal antibody|anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody|Y
transforming growth factor-beta-activated kinase 1-binding protein-1|transforming growth factor beta-activated kinase 1-binding protein-1|Y
non-word repetition task|nonword repetition task|Y
pyelonephritis-associated pilus protein A|pyelonephritis-associated pilus protein G|Y
pyelonephritis-associated pilus protein A|pyelonephritis-associated pilus protein D|Y
pyelonephritis-associated pilus protein A|pyelonephritis-associated pilus protein B|Y
LIM domain containing 1|LIM domains containing 1|Y
carcinoembryonic antigen level|carcino-embryonic antigen level|Y
prointerleukin-1 beta|prointerleukin-1beta|Y
synthetic tumour associated glycoconjugate|synthetic tumour-associated glycoconjugate|Y
synthetic tumour associated glycoconjugate|synthetic tumor associated glycoconjugate|Y
melanoma-associated antigen|melanoma-associated antigens|Y
fasting hyperbilirubinemia|fasting hyperbilirubinaemia|Y
Veterans Administration Medical Center|Veteran's Administration Medical Center|Y
human T-cell lymphoma/leukemia virus type 1|human T-cell lymphoma/leukemia virus type I|Y
multi-gated radionuclide angiography|multigated radionuclide angiography|Y
transforming growth factor-beta receptor|transforming growth factor-beta receptor I|Y
maximal electroshock-induced seizures|maximal electroshock-induced seizure|Y
Musca domestica glutathione S-transferase-5|Musca domestica glutathione S-transferase-4|Y
Musca domestica glutathione S-transferase-5|Musca domestica glutathione S-transferase-2|Y
Musca domestica glutathione S-transferase-5|Musca domestica glutathione S-transferase|Y
mossy fibre sprouting|mossy fibres sprouting|Y
sulfobutyl ether-β-cyclodextrin|sulfobutylether-β-cyclodextrin|Y
thyrotrophin releasing hormone-like|thyrotropin releasing hormone-like|Y
endocrine disrupting chemicals|endocrine disrupting chemical|Y
recombinant human transforming growth factor β 3|recombinant human transforming growth factor β 1|Y
recombinant human transforming growth factor β 3|recombinant human transforming growth factor β3|Y
recombinant human transforming growth factor β 3|recombinant human transforming growth factor-β 3|Y
recombinant human transforming growth factor β 3|recombinant human transforming growth factor β|Y
AV nodal re-entrant tachycardia|AV nodal reentrant tachycardia|Y
sub-esophageal ganglion|subesophageal ganglion|Y
FMRFamide-like immunoreactivity|FMRF-amide-like immunoreactivity|Y
guanosine triphosphatase|guanosinetriphosphatase|Y
guanosine triphosphatase|guanosine triphosphatases|Y
eukaryotic translation elongation factor 1α|eukaryotic translation elongation factor 1α1|Y
eukaryotic translation elongation factor 1α|eukaryotic translation elongation factor 1B|Y
eukaryotic translation elongation factor 1α|eukaryotic translation elongation factor 1A|Y
oestrogen-dependent cat uterine protein|estrogen-dependent cat uterine protein|Y
intra-cardiac electrogram|intracardiac electrogram|Y
multi gated acquisition scan|multigated acquisition scan|Y
International Neuroblastoma Staging System Stage 2|International Neuroblastoma Staging System Stage I|Y
International Neuroblastoma Staging System Stage 2|International Neuroblastoma Staging System Stage 1|Y
mossy fibers sprouting|mossy fiber sprouting|Y
multi-somatoform disorder|multisomatoform disorder|Y
cold-induced autoinflammatory syndrome 1|cold-induced auto-inflammatory syndrome 1|Y
cold-induced autoinflammatory syndrome 1|cold induced autoinflammatory syndrome 1|Y
cold-induced autoinflammatory syndrome 1|cold-induced autoinflammatory syndrome-1|Y
Bronx Veterans' Affairs Medical Center|Bronx Veterans Affairs Medical Center|Y
trans-catheter aortic-valve implantation procedure|trans-catheter aortic valve implantation procedure|Y
beta site amyloid precursor protein cleaving enzyme-2|beta site amyloid precursor protein cleaving enzyme 2|Y
intracerebroventricular|intracerebro-ventricular|Y
antigen presenting cells|antigen presenting cell|Y
Standard Pseudoisochromatic Plates part 2|Standard Pseudoisochromatic Plates Part 2|Y
Standard Pseudoisochromatic Plates part 2|Standard Pseudoisochromatic Plates-part 2|Y
cerebellopontine angle|cerebello-pontine angle|Y
para-nitrophenylphosphate|para-nitrophenyl phosphate|Y
matrix assisted laser desorption/ionisation|matrix-assisted laser desorption/ionisation|Y
giant migrating contraction|giant migrating contractions|Y
prointerleukin-1alpha|pro-interleukin-1alpha|Y
ultra performance liquid chromatography/mass spectrometry|ultraperformance liquid chromatography/mass spectrometry|Y
ultra performance liquid chromatography/mass spectrometry|ultra performance liquid chromatography-mass spectrometry|Y
ultra performance liquid chromatography/mass spectrometry|ultra-performance liquid chromatography/mass spectrometry|Y
dihydropyridine receptor|dihydro-pyridine receptor|Y
collagen type VII α 1|collagen type II α 1|Y
collagen type VII α 1|collagen type VIII α 1|Y
interleukin 1 receptor|interleukin 1β receptor|Y
interleukin 1 receptor|interleukin 11 receptor|Y
interleukin 1 receptor|interleukin 15 receptor|Y
interleukin 1 receptor|interleukin 18 receptor|Y
programmable temperature vapourising|programmable temperature vaporising|Y
alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone|alpha-(4-Pyridyl-1-oxide)-N-tert-butylnitrone|Y
alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone|alpha-(4-pyridyl-1-oxide)-N-tert-butyl nitrone|Y
penicillinase-producing Neisseria gonorrhoeae|Penicillinase-producing Neisseria gonorrhoeae|Y
electrochemical geooxidation|electrochemical geo-oxidation|Y
high-resolution magic-angle spinning nuclear magnetic resonance|high-resolution magic-angle-spinning nuclear magnetic resonance|Y
high-resolution magic-angle spinning nuclear magnetic resonance|high-resolution magic angle spinning nuclear magnetic resonance|Y
American Society of Anaesthesiology grade IV|American Society of Anesthesiology grade IV|Y
American Society of Anaesthesiology grade IV|American Society of Anaesthesiology grade I|Y
American Society of Anaesthesiology grade IV|American Society of Anaesthesiology grade II|Y
American Society of Anaesthesiology grade IV|American Society of Anaesthesiology grade V|Y
American Society of Anaesthesiology grade IV|American Society of Anesthesiology grade I|Y
hysterosalpingography|hystero-salpingography|Y
meningio-angiomatosis|meningioangiomatosis|Y
weapons of mass destruction|weapon of mass destruction|Y
feto-maternal haemorrhage|feto-maternal hemorrhage|Y
feto-maternal haemorrhage|foeto-maternal haemorrhage|Y
hypoglycaemia-associated autonomic failure|hypoglycemia-associated autonomic failure|Y
profile of mood states|profile of mood state|Y
multiple sclerosis-associated retrovirus|multiple-sclerosis-associated retrovirus|Y
radiation-induced tumour suppressor gene 1|radiation-induced tumor suppressor gene 1|Y
vesicular stomatitis virus glycoprotein G|vesicular stomatitis virus glycoprotein|Y
adult T-cell leukaemia-virus-associated antigen|adult T-cell leukemia-virus-associated antigen|Y
asialoagalacto-human chorionic gonadotropin|asialo-agalacto-human chorionic gonadotropin|Y
non-selective cation channel 2|nonselective cation channel 2|Y
immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome|immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome|Y
congenital dyserythropoietic anemia type II|congenital dyserythropoietic anemia type I|Y
a disintegrin and metalloproteinase-9|a disintegrin and metalloproteinase-19|Y
C/EBP homologous protein|CEBP homologous protein|Y
cancer-associated haemolytic-uraemic syndrome|cancer-associated hemolytic-uremic syndrome|Y
intra-operative angiography|intraoperative angiography|Y
α-hexachlorocyclohexane|α-hexachloro-cyclohexane|Y
human herpes virus type 8|human herpesvirus type 8|Y
Phleum pratense allergen 5|Phleum pratense allergen 5b|Y
galactorrhea-amenorrhœa hyperprolactinaemia syndrome|galactorrhœa-amenorrhœa hyperprolactinaemia syndrome|Y
galactorrhea-amenorrhœa hyperprolactinaemia syndrome|galactorrhoea-amenorrhœa hyperprolactinaemia syndrome|Y
transforming growth factor beta receptor II|transforming growth factor-beta receptor II|Y
gonadotrophin surge-attenuating factor|gonadotropin surge-attenuating factor|Y
WAP four disulfide core domain 2|WAP four disulfide core domain 12|Y
post-handgrip circulatory arrest|posthandgrip circulatory arrest|Y
rest/stress myocardial perfusion imaging|rest-stress myocardial perfusion imaging|Y
tumor micro-environment|tumour micro-environment|Y
insulin-like growth factor-II messenger RNA-binding protein-2|insulin-like growth factor-II messenger RNA-binding protein|Y
insulin-like growth factor-II messenger RNA-binding protein-2|insulin-like growth factor-II messenger RNA-binding protein 2|Y
insulin-like growth factor-II messenger RNA-binding protein-2|insulin-like growth factor II messenger RNA-binding protein-2|Y
insulin-like growth factor-II messenger RNA-binding protein-2|insulin-like growth factor-II messenger RNA-binding protein-1|Y
insulin-like growth factor-II messenger RNA-binding protein-2|insulin-like growth factor-II messenger RNA-binding protein-3|Y
insulin-like growth factor-II messenger RNA-binding protein-2|insulin-like growth factor-II messenger RNA binding protein-2|Y
transesophageal echo|trans-esophageal echo|Y
anti-insulin-like growth factor I antibody|anti-insulin-like growth factor 1 antibody|Y
N-terminal-pro-brain-type natriuretic peptide|N-terminal pro-brain-type natriuretic peptide|Y
anti retroviral therapy|antiretroviral therapy|Y
Bjork-Shiley convexoconcave heart valve|Bjork-Shiley convexo-concave heart valve|Y
microbial surface component recognizing adhesive matrix molecule|microbial surface component recognising adhesive matrix molecule|Y
non-functioning pituitary adenoma|nonfunctioning pituitary adenoma|Y
GTP binding protein βgamma subunit|GTP binding protein gamma subunit|Y
gastric inhibitory polypeptide-dependent Cushing syndrome|gastric inhibitory polypeptide-dependent Cushing's syndrome|Y
arterial partial pressure of CO2|arterial partial pressure of O2|Y
recombinant human soluble TNF receptor type II|recombinant human soluble TNF receptor type I|Y
superficial spreading melanomas|superficial spreading melanoma|Y
American Orthopedic Foot and Ankle Society hindfoot score|American Orthopaedic Foot and Ankle Society hindfoot score|Y
oro-facio-digital syndrome type II|oro-facio-digital syndrome type VII|Y
oro-facio-digital syndrome type II|oro-facio-digital syndrome type I|Y
graft-versus-leukemia activity|graft-versus-leukaemia activity|Y
ventroposterior nucleus|ventro-posterior nucleus|Y
standardised mortality ratio|standardised mortality ratios|Y
Fas-associated death domain-like interleukin-1β converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1β-converting enzyme inhibitory protein|Y
Fas-associated death domain-like interleukin-1β converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1 β converting enzyme inhibitory protein|Y
Fas-associated death domain-like interleukin-1β converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1β converting enzyme-inhibitory protein|Y
Fas-associated death domain-like interleukin-1β converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1β-converting enzyme-inhibitory protein|Y
duodenum preserving pancreatic head resection|duodenum-preserving pancreatic head resection|Y
neuroblastoma apoptosis-related RNA binding protein-1|neuroblastoma apoptosis-related RNA binding protein-3|Y
neuroblastoma apoptosis-related RNA binding protein-1|neuroblastoma apoptosis-related RNA binding protein-2|Y
intramaxillary fixation|intra-maxillary fixation|Y
peroxisome proliferator activated receptors|peroxisome proliferator-activated receptors|Y
gastro-esophageal reflux disease-related|gastroesophageal reflux disease-related|Y
serine palmitoyl transferase|serine palmitoyltransferase|Y
high resolution magic angle spinning nuclear magnetic resonance|high-resolution magic angle spinning nuclear magnetic resonance|Y
SNF2-related CREB-binding protein activator protein|SNF-2-related CREB-binding protein activator protein|Y
galactorrhoea amenorrhœa hyperprolactinæmia syndrome|galactorrhoea amenorrhœa hyperprolactinemia syndrome|Y
galactorrhoea amenorrhœa hyperprolactinæmia syndrome|galactorrhea amenorrhœa hyperprolactinæmia syndrome|Y
bronchiolitis obliterans organizing pneumonia syndrome|bronchiolitis obliterans organising pneumonia syndrome|Y
hydroxyapatite ceramic|hydroxyapatite ceramics|Y
galactorrhoea amenorrhœa hyperprolactinemia syndrome|galactorrhoea amenorrhœa hyperprolactinaemia syndrome|Y
galactorrhoea amenorrhœa hyperprolactinemia syndrome|galactorrhea amenorrhœa hyperprolactinemia syndrome|Y
anti-colorectal carcinoma monoclonal antibody|anticolorectal carcinoma monoclonal antibody|Y
transiently evoked otoacoustic emission|transiently evoked otoacoustic emissions|Y
transiently evoked otoacoustic emission|transiently evoked oto-acoustic emission|Y
human pituitary tumor-transforming gene|human pituitary tumour-transforming gene|Y
American Society of Anesthesiologists status 4|American Society of Anesthesiologists status V|Y
American Society of Anesthesiologists status 4|American Society of Anesthesiologists status I|Y
American Society of Anesthesiologists status 4|American Society of Anaesthesiologists status 4|Y
American Society of Anesthesiologists status 4|American Society of Anesthesiologists status 5|Y
American Society of Anesthesiologists status 4|American Society of Anesthesiologists Status 4|Y
micro-vascular density|microvascular density|Y
stereotactic radiotherapy|stereo-tactic radiotherapy|Y
uncoordinated protein 4|uncoordinated protein 44|Y
uncoordinated protein 4|uncoordinated protein 54|Y
uncoordinated protein 4|uncoordinated protein 64|Y
uncoordinated protein 4|uncoordinated protein 43|Y
uncoordinated protein 4|uncoordinated protein 42|Y
uncoordinated protein 4|uncoordinated protein 40|Y
non-steroidal anti-inflammatory agents|non-steroidal anti-inflammatory agent|Y
insulin-like growth factor II mRNA binding protein-2|insulin-like growth factor II mRNA binding protein|Y
insulin-like growth factor II mRNA binding protein-2|insulin-like growth factor II mRNA binding protein-3|Y
insulin-like growth factor II mRNA binding protein-2|insulin-like growth factor II mRNA-binding protein-2|Y
insulin-like growth factor II mRNA binding protein-2|insulin-like growth factor-II mRNA binding protein-2|Y
Shiga toxin-producing Escherichia coli O157|Shiga toxin producing Escherichia coli O157|Y
ras-related GTP-binding protein 8B|ras-related GTP-binding protein 8|Y
recombinant interleukin-1α|recombinant interleukine-1α|Y
recombinant interleukin-1α|recombinant interleukin-1 α|Y
staphylococcal cassette chromosome mec type V|staphylococcal cassette chromosome mec type I|Y
guanosine triphosphatase activating protein-1|guanosine triphosphatase activating protein 1|Y
slow-reacting complement-requiring neutralising antibody|slow-reacting complement-requiring neutralizing antibody|Y
stable xenon-enhanced computed tomography|stable-xenon-enhanced computed tomography|Y
galactorrhœa amenorrhœa hyperprolactinæmia syndrome|galactorrhea amenorrhœa hyperprolactinæmia syndrome|Y
clinico-electroencephalographic|clinicoelectroencephalographic|Y
surface micro-hardness|surface microhardness|Y
intra-tumoral microvessel density|intra-tumoural microvessel density|Y
multicolony stimulating factor|multi-colony stimulating factor|Y
interleukine-15 receptor α-chain|interleukin-15 receptor α-chain|Y
interleukine-15 receptor α-chain|interleukine-5 receptor α-chain|Y
spinocerebellar ataxia 17|spinocerebellar ataxia 1|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motif-3|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motifs-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motifs-4|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motifs-2|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motifs-9|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motifs-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motifs-13|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
para-chloromercuriphenylsulfonic acid|parachloromercuriphenylsulfonic acid|Y
packed red blood cell|packed red blood cells|Y
interpremolar distance|inter-premolar distance|Y
Bjork-Shiley convexoconcave valve|Bjork-Shiley convexo concave valve|Y
Bjork-Shiley convexoconcave valve|Bjork-Shiley convexo-concave valve|Y
luteinizing hormone-releasing hormone analog|luteinizing hormone-releasing hormone analogue|Y
Rab3-interacting molecule 1 alpha|Rab3-interacting molecule 1alpha|Y
augmented correlation consistent polarized valence triple zeta basis set|augmented correlation consistent polarized valence triple-zeta basis set|Y
lymphocyte function-associated antigen-1|lymphocyte function associated antigen-1|Y
lymphocyte function-associated antigen-1|lymphocyte function-associated antigen 1|Y
lymphocyte function-associated antigen-1|lymphocyte function-associated antigen-3|Y
fanbeam dual energy X-ray absorptiometry|fan beam dual energy X-ray absorptiometry|Y
fanbeam dual energy X-ray absorptiometry|fan-beam dual energy X-ray absorptiometry|Y
fanbeam dual energy X-ray absorptiometry|fanbeam dual-energy X-ray absorptiometry|Y
insulinlike growth factor binding protein-2|insulinlike growth factor-binding protein-2|Y
human transforming growth factor beta2|human transforming growth factor beta 2|Y
perinuclear-anti-neutrophil cytoplasmic antibody|perinuclear anti-neutrophil cytoplasmic antibody|Y
anti-T-cell receptor-alphabeta antibody|anti-T-cell receptor-alpha/beta antibody|Y
galactorrhea amenorrhoea hyperprolactinæmia syndrome|galactorrhea-amenorrhoea hyperprolactinæmia syndrome|Y
velocardiofacial syndrome|velo-cardiofacial syndrome|Y
gas chromatography/mass spectrometry-selected ion monitoring|gas chromatography-mass spectrometry-selected ion monitoring|Y
gas chromatography/mass spectrometry-selected ion monitoring|gas chromatography/mass spectrometry/selected ion monitoring|Y
gas chromatography/mass spectrometry-selected ion monitoring|gas chromatography/mass spectrometry selected ion monitoring|Y
dimethylaminostyrylmethylpyridiniumiodine|dimethylaminostyryl-methyl-pyridiniumiodine|Y
Musca domestica glutathione S-transferase-6A|Musca domestica glutathione S-transferase-6B|Y
anti-T cell receptor alphabeta antibody|anti-T cell receptor alpha beta antibody|Y
anti-T cell receptor alphabeta antibody|anti-T cell receptor alpha/beta antibody|Y
central posterior/pre-pacemaker nucleus|central posterior/prepacemaker nucleus|Y
near infrared spectroscopy|near infra-red spectroscopy|Y
X-ray photoelectron spectroscopic|X-ray photo electron spectroscopic|Y
X-ray photoelectron spectroscopic|X-ray photo-electron spectroscopic|Y
localised surface-plasmon resonance spectroscopy|localised surface plasmon resonance spectroscopy|Y
hemoglobin A2-Babinga|haemoglobin A2-Babinga|Y
G protein alpha inhibitory subunit|G protein alpha2 inhibitory subunit|Y
G protein alpha inhibitory subunit|G protein alpha3 inhibitory subunit|Y
mass analyzed threshold ionisation spectroscopy|mass-analyzed threshold ionisation spectroscopy|Y
anthranilate synthetase component I|anthranilate synthetase component II|Y
thyrotropin releasing hormone receptor type 1|thyrotropin releasing hormone receptor type 2|Y
thyrotropin releasing hormone receptor type 1|thyrotropin-releasing hormone receptor type 1|Y
methionyl-lysyl-bradykinin|methionyl-lysylbradykinin|Y
biotinylated dextranamine|biotinylated dextran amine|Y
biotinylated dextranamine|biotinylated dextran-amine|Y
TGFβ-activated kinase 1-binding protein-1|TGFβ-activated kinase 1-binding protein 1|Y
TGFβ-activated kinase 1-binding protein-1|TGF-β-activated kinase 1-binding protein-1|Y
matrix-assisted laser desorption/ionization-mass spectrometry|matrix-assisted laser desorption/ionization mass spectrometry|Y
matrix-assisted laser desorption/ionization-mass spectrometry|matrix-assisted laser desorption/ionisation-mass spectrometry|Y
matrix-assisted laser desorption/ionization-mass spectrometry|matrix-assisted laser desorption ionization-mass spectrometry|Y
matrix-assisted laser desorption/ionization-mass spectrometry|matrix assisted laser desorption/ionization-mass spectrometry|Y
human leukocyte antigen DQ8|human leukocyte antigen DQ|Y
recombinant interleukine 1β|recombinant interleukin 1β|Y
recombinant interleukine 1β|recombinant interleukine 1 β|Y
intrauterine growth retardation|intra-uterine growth retardation|Y
military anti-shock trouser|military anti-shock trousers|Y
military anti-shock trouser|military antishock trouser|Y
pentylene-tetrazole kindled|pentylenetetrazole kindled|Y
interleukine 13 receptor α2-chain|interleukine 13 receptor α 2-chain|Y
interleukine 13 receptor α2-chain|interleukin 13 receptor α2-chain|Y
somatosensory evoked fields|somatosensory evoked field|Y
TATA-binding protein associated factor-17|TATA-binding protein associated factor-1|Y
TATA-binding protein associated factor-17|TATA-binding protein associated factor-10|Y
TATA-binding protein associated factor-17|TATA-binding protein associated factor-11|Y
TATA-binding protein associated factor-17|TATA-binding protein associated factor-12|Y
TATA-binding protein associated factor-17|TATA-binding protein associated factor-7|Y
rostral ventromedial medulla|rostral ventro-medial medulla|Y
malignancy associated hypercalcemia|malignancy associated hypercalcaemia|Y
unilateral salpingo-oophorectomy|unilateral salpingooophorectomy|Y
IL-15 receptor alpha chain|IL-5 receptor alpha chain|Y
classical antineutrophil cytoplasmic antibody positivity|classic antineutrophil cytoplasmic antibody positivity|Y
Fcγ-receptor-mediated|Fc γ-receptor-mediated|Y
Fcγ-receptor-mediated|Fc-γ-receptor-mediated|Y
ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry|ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry|Y
ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry|ultra performance liquid chromatography/quadrupole time-of-flight mass spectrometry|Y
ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry|ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry|Y
translation elongation factor-1 α|translation elongation factor-1α|Y
aspartate transcarbamoylase|aspartate transcarbamylase|Y
normo-cholesterolaemic|normo-cholesterolemic|Y
mitogen-activated protein kinase activated protein kinase 1|mitogen-activated protein kinase-activated protein kinase 1|Y
mitogen-activated protein kinase activated protein kinase 1|mitogen-activated protein kinase activated protein kinase-1|Y
mitogen-activated protein kinase activated protein kinase 1|mitogen-activated protein kinase activated protein kinase 5|Y
mitogen-activated protein kinase activated protein kinase 1|mitogen-activated protein kinase activated protein kinase|Y
mitogen-activated protein kinase activated protein kinase 1|mitogen activated protein kinase activated protein kinase 1|Y
eating behaviour disorder|eating behavior disorder|Y
rho guanine nucleotide dissociation inhibitor-α|rho guanine nucleotide dissociation inhibitor α|Y
rho guanine nucleotide dissociation inhibitor-α|Rho guanine nucleotide dissociation inhibitor-α|Y
neural precursor cell expressed developmentally downregulated 9|neural precursor cell expressed, developmentally downregulated 5|Y
neural precursor cell expressed developmentally downregulated 9|neural precursor cell expressed developmentally down-regulated 1|Y
neural precursor cell expressed developmentally downregulated 9|neural precursor cell expressed developmentally down-regulated 8|Y
neural precursor cell expressed developmentally downregulated 9|neural precursor cell expressed, developmentally downregulated 9|Y
neural precursor cell expressed developmentally downregulated 9|neural precursor cell expressed developmentally downregulated 4|Y
neural precursor cell expressed developmentally downregulated 9|neural precursor cell expressed developmentally downregulated 5|Y
neural precursor cell expressed developmentally downregulated 9|neural precursor cell expressed developmentally downregulated 2|Y
neural precursor cell expressed developmentally downregulated 9|neural precursor cell-expressed, developmentally downregulated 9|Y
neural precursor cell expressed developmentally downregulated 9|neural precursor cell expressed, developmentally downregulated 2|Y
neural precursor cell expressed developmentally downregulated 9|neural precursor cell-expressed developmentally down-regulated 9|Y
neural precursor cell expressed developmentally downregulated 9|neural precursor cell expressed developmentally down-regulated 9|Y
neural precursor cell expressed developmentally downregulated 9|neural precursor cell-expressed developmentally downregulated 9|Y
solute carrier family 17 member 3|solute carrier family 7 member 3|Y
proline serine threonine phosphatase-interacting protein-1|proline serine threonine phosphatase-interacting protein 1|Y
1,3-bis-(2-chloroethyl)-1-nitrosourea|1,3-bis(2-chloroethyl)-1-nitrosourea|Y
alpha-difluoromethylarginine|alpha-difluoromethyl-arginine|Y
postictal depression|post-ictal depression|Y
limbic system-associated membrane protein|limbic-system-associated membrane protein|Y
hemoglobin Hopkins-II|haemoglobin Hopkins-II|Y
human immunodeficiency virus associated nephropathy|human immunodeficiency virus-associated nephropathy|Y
epistatic mini-array profile|epistatic miniarray profile|Y
laryngovideostroboscopy|laryngo-videostroboscopy|Y
esophago-gastric junction|oesophago-gastric junction|Y
esophago-gastric junction|esophagogastric junction|Y
cross polarization magic-angle spinning|crosspolarization magic-angle spinning|Y
matrix-assisted laser-desorption/ionisation|matrix-assisted laser-desorption/ionization|Y
matrix-assisted laser-desorption/ionisation|matrix-assisted laser desorption/ionisation|Y
fasciculo-ventricular|fasciculoventricular|Y
pathological tumor-3, pathological node-0, metastasis-0|pathological tumor-4, pathological node-0, metastasis-0|Y
orthoaminoazotoluene|ortho-aminoazotoluene|Y
inhibinlike material|inhibin-like material|Y
American Society of Anesthesiology grade 1|American Society of Anesthesiology grade 2|Y
American Society of Anesthesiology grade 1|American Society of Anesthesiology grade 5|Y
American Society of Anesthesiology grade 1|American Society of Anesthesiology grade 3|Y
American Society of Anesthesiology grade 1|American Society of Anesthesiology grade|Y
American Society of Anesthesiology grade 1|American Society of Anesthesiology grade I|Y
American Society of Anesthesiology grade 1|American Society of Anesthesiology Grade 1|Y
intra-uterine catheter|intrauterine catheter|Y
ras-related GTP-binding protein 6B|ras-related GTP-binding protein 6|Y
haemoglobin Roseau Pointe-a-Pitre|hemoglobin Roseau Pointe-a-Pitre|Y
socioeconomic status|socio-economic status|Y
NIMA-related kinase-2B|NIMA-related kinase-2|Y
mitogen-activated protein kinase kinase 4|mitogen-activated protein kinase kinase|Y
mitogen-activated protein kinase kinase 4|mitogen-activated protein kinase kinase 3|Y
mitogen-activated protein kinase kinase 4|mitogen-activated protein kinase kinase 2|Y
mitogen-activated protein kinase kinase 4|mitogen-activated protein kinase kinase 7|Y
mitogen-activated protein kinase kinase 4|mitogen-activated protein kinase kinase 6|Y
mitogen-activated protein kinase kinase 4|mitogen-activated protein kinase kinase 1|Y
ras-related GTP-binding protein 39B|ras-related GTP-binding protein 3B|Y
ras-related GTP-binding protein 39B|ras-related GTP-binding protein 39|Y
uncoordinated protein 76|uncoordinated protein 6|Y
γ-aminobutyric acid type A receptor-associated protein|γ-aminobutyric acid type A-receptor-associated protein|Y
phosphatidyl-ethanolamine binding protein 2|phosphatidylethanolamine binding protein 2|Y
chemoreceptor trigger zone|chemo-receptor trigger zone|Y
American Society of Anesthesiologists class 3|American Society of Anesthesiologists class 5|Y
American Society of Anesthesiologists class 3|American Society of Anaesthesiologists class 3|Y
American Society of Anesthesiologists class 3|American Society of Anesthesiologists class|Y
American Society of Anesthesiologists class 3|American Society of Anesthesiologists class V|Y
American Society of Anesthesiologists class 3|American Society of Anesthesiologists class 2|Y
American Society of Anesthesiologists class 3|American Society of Anesthesiologists Class 3|Y
American Society of Anesthesiologists class 3|American Society of Anesthesiologists class I|Y
American Society of Anesthesiologists class 3|American Society of Anesthesiologists class 1|Y
motives for smoking scale|motive for smoking scale|Y
intra-cranial hypotension syndrome|intracranial hypotension syndrome|Y
antiurease immunoglobulin G|anti-urease immunoglobulin G|Y
magnetic resonance-guided focused ultrasound surgery|magnetic resonance guided focused ultrasound surgery|Y
5'-N-ethylcarboxamide adenosine|5'-N-ethylcarboxamideadenosine|Y
Utility based Quality of Life-Heart Questionnaire|Utility-based Quality of Life-Heart Questionnaire|Y
T-prolymphocytic leukaemia|T-prolymphocytic leukemia|Y
vasoactive intestinal peptide receptor 1|vasoactive intestinal peptide receptor 2|Y
ultra-fast shape recognition|ultrafast shape recognition|Y
sub-paraventricular area|subparaventricular area|Y
STE20-related proline alanine-rich kinase|STE20-related proline-alanine-rich kinase|Y
interleukin-5 receptor α|interleukine-5 receptor α|Y
recombinant interleukin 18|recombinant interleukin 8|Y
recombinant interleukin 18|recombinant interleukin 1|Y
anti-chondroitin sulfate antibody|antichondroitin sulfate antibody|Y
Drosophila cyclic AMP response element-binding protein|Drosophila cyclic AMP response element-binding protein 2|Y
endo-cervical glandular dysplasia|endocervical glandular dysplasia|Y
transmembrane tumour necrosis factor α|transmembrane tumor necrosis factor α|Y
transfarnesylthiosalicylic acid|trans-farnesylthiosalicylic acid|Y
nucleoside reverse transcriptase inhibitor|nucleotide reverse transcriptase inhibitor|Y
mitogen extracellular signal regulated kinase-1|mitogen extracellular signal regulated kinase 1|Y
aluminum sulfonated phthalocyanine|aluminium sulfonated phthalocyanine|Y
amino-terminal pro B-type natriuretic peptide|aminoterminal proB-type natriuretic peptide|Y
amino-terminal pro B-type natriuretic peptide|amino-terminal pro-B-type natriuretic peptide|Y
amino-terminal pro B-type natriuretic peptide|amino-terminal proB-type natriuretic peptide|Y
conserved noncoding element|conserved non-coding element|Y
Medical Outcomes Study 36 Item Short Form Health Survey Version 2|Medical Outcomes Study 36 Item Short-Form Health Survey Version 2|Y
sperm associated antigen 1|sperm associated antigen 16|Y
receptor-like protein-tyrosine phosphatase-δ|receptor-like protein-tyrosine phosphatase-μ|Y
receptor-like protein-tyrosine phosphatase-δ|receptor-like protein tyrosine phosphatase-δ|Y
receptor-like protein-tyrosine phosphatase-δ|receptor-like protein-tyrosine phosphatase δ|Y
receptor-like protein-tyrosine phosphatase-δ|receptor-like protein-tyrosine phosphatase-η|Y
receptor-like protein-tyrosine phosphatase-δ|receptor-like protein-tyrosine phosphatase-ζ|Y
Salt Lake City Veterans' Affairs Medical Center|Salt Lake City Veteran's Affairs Medical Center|Y
ribosomal protein S28|ribosomal protein S2|Y
ribosomal protein S28|ribosomal protein S8|Y
polyunsaturated fatty acid|poly-unsaturated fatty acid|Y
tissue Doppler echocardiography|tissue Doppler echo-cardiography|Y
inner medullary collecting ducts|inner medullary collecting duct|Y
anti-human leucocyte antigen-G specific antibody|anti-human leukocyte antigen-G specific antibody|Y
de-proteinised bovine bone|deproteinised bovine bone|Y
FADD-like interleukin-1-beta-converting enzyme|FADD-like interleukin-1beta-converting enzyme|Y
FADD-like interleukin-1-beta-converting enzyme|FADD-like interleukin-1 beta-converting enzyme|Y
thyroid-stimulating immunoglobulins|thyroid-stimulating immunoglobulin|Y
Escherichia coli strain DH5-α|Escherichia coli strain DH5α|Y
FADD-like interleukin-1beta-converting enzyme|FADD-like interleukin-1 beta-converting enzyme|Y
Na+-taurocholate co-transporting polypeptide|Na+-taurocholate cotransporting polypeptide|Y
pro-interleukin-1alpha|pro-interleukin-1 alpha|Y
estrogen receptor-α agonist|oestrogen receptor-α agonist|Y
urethral hyper-mobility|urethral hypermobility|Y
recombinant interleukin 1β|recombinant interleukin 1-β|Y
recombinant interleukin 1β|recombinant interleukin 1 β|Y
recombinant interleukin 1β|recombinant interleukin 1|Y
enzyme-linked immunofiltration assay|enzyme-linked immuno-filtration assay|Y
crystallizable fragment gamma receptor IIA|crystallizable fragment gamma receptor IIa|Y
γbenzene hexachloride|benzene hexachloride|Y
γbenzene hexachloride|γ benzene hexachloride|Y
γbenzene hexachloride|γ-benzene hexachloride|Y
multisequence magnetic resonance imaging|multi-sequence magnetic resonance imaging|Y
apolipoprotein-AI-mediated|apolipoprotein-A-I-mediated|Y
Bos taurus autosome 9|Bos taurus autosome 19|Y
technetium-99m labelled|technetium-99m labeled|Y
liquid chromatography-atmospheric pressure chemical ionization-ion trap mass spectrometry|liquid chromatography-atmospheric pressure chemical ionization ion-trap mass spectrometry|Y
liquid chromatography-atmospheric pressure chemical ionization-ion trap mass spectrometry|liquid chromatography-atmospheric pressure chemical ionisation-ion trap mass spectrometry|Y
atypical glandular cells of undetermined significance|Atypical glandular cells of undetermined significance|Y
receptor-like protein-tyrosine phosphatase eta|receptor-like protein-tyrosine phosphatase-eta|Y
American Society of Anesthesiologists physical status|American Society of Anesthesiologists physical status I|Y
American Society of Anesthesiologists physical status|American Society of Anesthesiologists physical status 2|Y
American Society of Anesthesiologists physical status|American Society of Anesthesiologists physical status 4|Y
American Society of Anesthesiologists physical status|American Society of Anesthesiologists physical status 5|Y
supra-choroidal hemorrhage|supra-choroidal haemorrhage|Y
sodium potassium chloride cotransporter|sodium potassium 2 chloride cotransporter|Y
sodium potassium chloride cotransporter|sodium potassium chloride cotransporter 2|Y
sodium potassium chloride cotransporter|sodium potassium chloride cotransporter 1|Y
neuroblastoma apoptosis-related RNA binding protein-3|neuroblastoma apoptosis-related RNA binding protein-2|Y
recombinant interleukine 1 β|recombinant interleukin 1 β|Y
anti-low density lipoprotein receptor antibody|anti-low-density lipoprotein receptor antibody|Y
transforming growth factor β 2|transforming growth factor β2|Y
exercise-induced pulmonary hemorrhage|exercise-induced pulmonary haemorrhage|Y
gastro-intestinal tract|gastrointestinal tract|Y
tumor-associated transplantation antigens|tumor-associated transplantation antigen|Y
tumor-associated transplantation antigens|tumour-associated transplantation antigen|Y
nuclear factor kappaB|nuclear factor kappaB1|Y
capillary electrophoresis-time-of-flight/mass spectrometry|capillary electrophoresis-time-of-flight-mass spectrometry|Y
ecto-adenosine triphosphatase|ecto-adenosinetriphosphatase|Y
cysteine-rich secretory protein|cysteine-rich secretory proteins|Y
hand, foot, and mouth disease|hand, foot and mouth disease|Y
crossreactive carbohydrate determinant|cross-reactive carbohydrate determinant|Y
photodynamic therapy|photo-dynamic therapy|Y
glucose-dependent insulinotropic polypeptide-receptor|glucose-dependent insulinotropic polypeptide receptor|Y
anti-T cell receptor alpha beta antibody|anti-T cell receptor-alpha beta antibody|Y
anti-T cell receptor alpha beta antibody|anti-T cell receptor alpha/beta antibody|Y
anti-T cell receptor alpha beta antibody|anti-T-cell receptor alpha beta antibody|Y
anti-matrix metalloprotease 3 antibody|anti-matrix metalloprotease 13 antibody|Y
1-methyl-4-phenylpyridinium|1-methyl-4-phenyl-pyridinium|Y
yo-yo intermittent recovery test level 1|yo-yo intermittent recovery test level 2|Y
γ aminobutyric acid receptor agonist|γ amino-butyric acid receptor agonist|Y
leukemia-associated antigen|leukaemia-associated antigen|Y
Xenopus cytosolic thyroid hormone-binding protein|Xenopus cytosolic thyroid-hormone-binding protein|Y
unfavorable non-Hodgkin lymphoma|unfavourable non-Hodgkin lymphoma|Y
granulocyte colony stimulating factor|granulocytecolony stimulating factor|Y
human T cell leukemia virus type-I-infected|human T cell leukaemia virus type-I-infected|Y
human T cell leukemia virus type-I-infected|human T-cell leukemia virus type-I-infected|Y
human T cell leukemia virus type-I-infected|human T cell leukemia virus type I-infected|Y
extra-vascular lung water index|extravascular lung water index|Y
Src homology 2 domain-containing protein tyrosine phosphatase|Src homology 2 domain-containing protein-tyrosine phosphatase|Y
Src homology 2 domain-containing protein tyrosine phosphatase|Src homology 2 domain-containing protein tyrosine phosphatase 1|Y
Src homology 2 domain-containing protein tyrosine phosphatase|Src homology 2 domain containing protein tyrosine phosphatase|Y
Src homology 2 domain-containing protein tyrosine phosphatase|Src homology 2 domain-containing protein tyrosine phosphatase-2|Y
postsurgical gastroparesis syndrome|post-surgical gastroparesis syndrome|Y
American Society of Anaesthesiologists Class 4|American Society of Anaesthesiologists Class 3|Y
American Society of Anaesthesiologists Class 4|American Society of Anaesthesiologists Class V|Y
American Society of Anaesthesiologists Class 4|American Society of Anaesthesiologists Class I|Y
American Society of Anaesthesiologists Class 4|American Society of Anaesthesiologists Class 5|Y
American Society of Anaesthesiologists Class 4|American Society of Anaesthesiologists Class 1|Y
American Society of Anaesthesiologists Class 4|American Society of Anaesthesiologists class 4|Y
American Society of Anaesthesiologists Class 4|American Society of Anesthesiologists Class 4|Y
granulocyte-macrophage-colony-stimulating factor receptor alpha subunit|granulocyte macrophage-colony-stimulating factor receptor alpha subunit|Y
granulocyte-macrophage-colony-stimulating factor receptor alpha subunit|granulocyte-macrophage colony-stimulating factor receptor alpha subunit|Y
anti-beta-2-glycoprotein 1 antibody|anti-beta2-glycoprotein 1 antibody|Y
spinocerebellar ataxia 3|spinocerebellar ataxia 13|Y
spinocerebellar ataxia 3|spino-cerebellar ataxia 3|Y
transforming growth factor-beta activated kinase-1|transforming growth factor-beta activated kinase 1|Y
parasitized erythrocyte|parasitized erythrocytes|Y
percutaneous cardio-pulmonary support|percutaneous cardiopulmonary support|Y
crosspolarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarization magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|cross polarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|cross polarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarization magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
tumour-necrosis-factor-α|tumor-necrosis-factor-α|Y
man-made vitreous fibers|man-made vitreous fiber|Y
Na-K-Cl cotransporter|Na-K-Cl co-transporter|Y
intra-diskal electro-thermal therapy|intra-diskal electrothermal therapy|Y
intra-diskal electro-thermal therapy|intradiskal electro-thermal therapy|Y
lymphovascular invasion|lympho-vascular invasion|Y
calcium/calmodulin dependent protein kinase kinase beta|calcium/calmodulin-dependent protein kinase kinase beta|Y
ultra-performance liquid chromatography-mass spectrometry|ultra performance liquid chromatography-mass spectrometry|Y
ultra-performance liquid chromatography-mass spectrometry|ultraperformance liquid chromatography-mass spectrometry|Y
ultra-performance liquid chromatography-mass spectrometry|ultra-performance liquid chromatography/mass spectrometry|Y
peroxisome-proliferator-activated receptor gamma coactivator 1alpha|peroxisome proliferator-activated receptor gamma coactivator 1alpha|Y
peroxisome-proliferator-activated receptor gamma coactivator 1alpha|peroxisome proliferator-activated receptor gamma coactivator 1 alpha|Y
peroxisome-proliferator-activated receptor gamma coactivator 1alpha|peroxisome-proliferator-activated receptor-gamma co-activator 1alpha|Y
peroxisome-proliferator-activated receptor gamma coactivator 1alpha|peroxisome-proliferator-activated receptor gamma coactivator 1 alpha|Y
peroxisome-proliferator-activated receptor gamma coactivator 1alpha|peroxisome-proliferator-activated receptor gamma coactivator-1 alpha|Y
secreted phosphoprotein-24|secreted phosphoprotein-2|Y
vascular endothelial cell adhesion molecule-1|vascular endothelial cell adhesion molecule|Y
capillary electrophoresis-electrospray ionization-time of flight mass spectrometry|capillary electrophoresis electrospray ionization time of flight mass spectrometry|Y
capillary electrophoresis-electrospray ionization-time of flight mass spectrometry|capillary electrophoresis-electrospray ionization-time-of-flight mass spectrometry|Y
capillary electrophoresis-electrospray ionization-time of flight mass spectrometry|capillary electrophoresis-electrospray ionisation time of flight mass spectrometry|Y
capillary electrophoresis-electrospray ionization-time of flight mass spectrometry|capillary electrophoresis-electrospray ionization time of flight mass spectrometry|Y
capillary electrophoresis-electrospray ionization-time of flight mass spectrometry|capillary electrophoresis-electrospray ionisation-time of flight mass spectrometry|Y
anti-human T-cell lymphotropic virus type 1 antibody|anti-human T-cell lymphotrophic virus type 1 antibody|Y
anti-human T-cell lymphotropic virus type 1 antibody|anti-human T-cell lymphotropic virus type-1 antibody|Y
anti-human T-cell lymphotropic virus type 1 antibody|anti-human T cell lymphotropic virus type 1 antibody|Y
recombinant murine interleukin 13|recombinant murine interleukin 1|Y
virus associated hemophagocytic syndrome|virus associated haemophagocytic syndrome|Y
virus associated hemophagocytic syndrome|virus-associated hemophagocytic syndrome|Y
G protein coupled receptor|G protein coupled receptors|Y
formylmethionyl-leucylphenylalanine|formylmethionylleucylphenylalanine|Y
deepidermized dermis|de-epidermized dermis|Y
post-axial polydactyly type A|postaxial polydactyly type A|Y
enterochromaffin-like cell hyperplasia|enterochromaffinlike cell hyperplasia|Y
American Orthopedic Foot and Ankle Society ankle-hindfoot score|American Orthopaedic Foot and Ankle Society ankle-hind foot score|Y
American Orthopedic Foot and Ankle Society ankle-hindfoot score|American Orthopaedic Foot and Ankle Society ankle hindfoot score|Y
American Orthopedic Foot and Ankle Society ankle-hindfoot score|American Orthopedic Foot and Ankle Society ankle-hind foot score|Y
American Orthopedic Foot and Ankle Society ankle-hindfoot score|American Orthopaedic Foot and Ankle Society ankle-hindfoot score|Y
mechano-electrical transduction|mechanoelectrical transduction|Y
radioligand receptor assay|radio-ligand receptor assay|Y
interpregnancy interval|inter-pregnancy interval|Y
ubiquitin conjugating enzyme 2C|ubiquitin conjugating enzyme E2C|Y
multi-channel surface electromyogram|multichannel surface electromyogram|Y
capillary electrophoresis-laser induced fluorescence|capillary electrophoresis-laser-induced fluorescence|Y
gas chromatography-negative ion chemical ionisation-mass spectrometry|gas-chromatography-negative ion chemical ionisation-mass spectrometry|Y
gas chromatography-negative ion chemical ionisation-mass spectrometry|gas chromatography-negative-ion chemical ionisation-mass spectrometry|Y
adducted thumb clubfoot syndrome|adducted thumb club foot syndrome|Y
ultraperformance liquid chromatography/mass spectrometry|ultraperformance liquid chromatography-mass spectrometry|Y
ultraperformance liquid chromatography/mass spectrometry|ultra-performance liquid chromatography/mass spectrometry|Y
thermomechanical analysis|thermo-mechanical analysis|Y
single strand conformational polymorphism analysis|single-strand conformational polymorphism analysis|Y
single strand conformational polymorphism analysis|single strand conformation polymorphism analysis|Y
myeloid DAP 12 associating lectin-1|myeloid DAP12 associating lectin-1|Y
American Orthopedic Foot and Ankle Society forefoot score|American Orthopaedic Foot and Ankle Society forefoot score|Y
Toll/interleukin-1 receptor domain-containing adaptor inducing IFN-β|Toll-interleukin-1 receptor domain-containing adaptor inducing IFN-β|Y
ras-related GTP-binding protein 25|ras-related GTP-binding protein 5|Y
antiIL-18 monoclonal antibody|anti-IL-18 monoclonal antibody|Y
antiIL-18 monoclonal antibody|antiIL-8 monoclonal antibody|Y
agonist R-phenylisopropyl-adenosine|agonist R-phenylisopropyladenosine|Y
bi-ventricular pacing|biventricular pacing|Y
human T lymphotropic virus type 1-associated|human T lymphotropic virus type I-associated|Y
human T lymphotropic virus type 1-associated|human T-lymphotropic virus type 1-associated|Y
Fisher's protected least significant difference test|Fisher protected least significant difference test|Y
in-situ end-labelling|in-situ end-labeling|Y
pathogen-associated molecular patterns|pathogen-associated molecular pattern|Y
intracellular Ca(2+) concentration|intracellular Ca(2+) concentrations|Y
voltage-gated sodium channel alpha subunit|voltage-gated sodium channel alpha-subunit|Y
anticentromere antibody|anti-centromere antibody|Y
health care-associated pneumonia|healthcare-associated pneumonia|Y
spinocerebellar ataxia 15|spinocerebellar ataxia 5|Y
spinocerebellar ataxia 15|spinocerebellar ataxia 1|Y
human chorionic gonadotropin associated factor|human chorionic gonadotropin-associated factor|Y
nucleotide-binding site/leucine-rich repeat|nucleotide-binding site-leucine-rich repeat|Y
nucleotide-binding site/leucine-rich repeat|nucleotide-binding site leucine-rich repeat|Y
α-methyl-para-tyrosine|α-methyl-paratyrosine|Y
American Society of Anaesthesiology score|American Society of Anesthesiology score|Y
British antilewisite|British anti-lewisite|Y
high-performance liquid chromatography-thermospray mass spectrometry|high-performance liquid chromatography/thermospray mass spectrometry|Y
estrogen receptor-α protein|oestrogen receptor-α protein|Y
staphylococcal cassette chromosome mec type I|staphylococcal cassette chromosome mec type II|Y
staphylococcal cassette chromosome mec type I|staphylococcal cassette chromosome mec type III|Y
Des-gamma-carboxyprothrombin|Des-gamma-carboxy prothrombin|Y
theory of planned behavior|theory of planned behaviour|Y
tumour necrosis factor receptor associated factor 1|tumour necrosis factor receptor associated factor 5|Y
tumour necrosis factor receptor associated factor 1|tumour necrosis factor receptor associated factor 2|Y
tumour necrosis factor receptor associated factor 1|tumor necrosis factor receptor associated factor 1|Y
tumour necrosis factor receptor associated factor 1|tumour necrosis factor receptor-associated factor 1|Y
tumour necrosis factor receptor associated factor 1|tumour necrosis factor receptor associated factor-1|Y
type-2 corticotrophin-releasing hormone receptor|type-2 corticotropin-releasing hormone receptor|Y
type-2 corticotrophin-releasing hormone receptor|type-2 corticotrophin-releasing-hormone receptor|Y
type-2 corticotrophin-releasing hormone receptor|type 2 corticotrophin-releasing hormone receptor|Y
prothrombin time/international normalized ratio|prothrombin time-international normalized ratio|Y
prothrombin time/international normalized ratio|prothrombin time international normalized ratio|Y
Angiotensin converting enzyme inhibitors|Angiotensin-converting enzyme inhibitors|Y
Angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors|Y
interferon-stimulated gene factor 3|interferon-stimulated gene factor 3γ|Y
interferon-stimulated gene factor 3|interferon-stimulated gene factor 3α|Y
neurolinguistic programming|neuro-linguistic programming|Y
dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin|dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin|Y
dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin|dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin|Y
dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin|dendritic cell-specific intercellular adhesion molecule 3 grabbing nonintegrin|Y
receptor-like protein tyrosine phosphatase-η|receptor-like protein tyrosine phosphatase-δ|Y
receptor-like protein tyrosine phosphatase-η|receptor-like protein tyrosine phosphatase-κ|Y
receptor-like protein tyrosine phosphatase-η|receptor-like protein tyrosine phosphatase-ψ|Y
receptor-like protein tyrosine phosphatase-η|receptor-like protein tyrosine phosphatase η|Y
receptor-like protein tyrosine phosphatase-η|receptor-like protein tyrosine phosphatase-μ|Y
receptor-like protein tyrosine phosphatase-η|receptor-like protein-tyrosine phosphatase-η|Y
interleukine-13 receptor α2 subunit|interleukin-13 receptor α2 subunit|Y
human adenovirus serotype 35|human adenovirus serotype 5|Y
corticotrophin-releasing-hormone receptor 2|corticotrophin-releasing-hormone receptor|Y
corticotrophin-releasing-hormone receptor 2|corticotropin-releasing-hormone receptor 2|Y
extracellular signal-regulated kinase 2|extracellular signal-regulated kinase 1/2|Y
anti-neuroblastoma monoclonal antibody|antineuroblastoma monoclonal antibody|Y
histocompatibility locus|histo-compatibility locus|Y
7-methoxyresorufin O-dealkylase|7-ethoxyresorufin O-dealkylase|Y
ubiquitin carboxyl-terminal hydrolase-L1|ubiquitin carboxyl-terminal hydrolase L1|Y
intraarterial vasopressin|intra-arterial vasopressin|Y
Rutherford back-scattering spectroscopy|Rutherford backscattering spectroscopy|Y
phenolsulfonphthalein|phenol-sulfonphthalein|Y
electrophysiological abnormality|electro-physiological abnormality|Y
hematopoiesis-associated factor|haematopoiesis-associated factor|Y
diiodothyropropionic acid|di-iodothyropropionic acid|Y
capillary electrophoresis electrospray ionisation time-of-flight mass spectrometry|capillary electrophoresis-electrospray ionisation time-of-flight mass spectrometry|Y
capillary electrophoresis electrospray ionisation time-of-flight mass spectrometry|capillary electrophoresis electrospray ionization time-of-flight mass spectrometry|Y
capillary electrophoresis electrospray ionisation time-of-flight mass spectrometry|capillary electrophoresis electrospray ionisation time of flight mass spectrometry|Y
matrix-assisted laser desorption/ionization mass spectrometry|matrix-assisted laser desorption-ionization mass spectrometry|Y
matrix-assisted laser desorption/ionization mass spectrometry|matrix assisted laser desorption/ionization mass spectrometry|Y
ras-related GTP-binding protein 11|ras-related GTP-binding protein 1|Y
ras-related GTP-binding protein 11|ras-related GTP-binding protein 11b|Y
5-hydroxytryptamine 1A receptor antagonist|5-hydroxytryptamine 1D receptor antagonist|Y
5-hydroxytryptamine 1A receptor antagonist|5-hydroxytryptamine 1B receptor antagonist|Y
A disintegrin and metalloprotease-13|A disintegrin and metalloprotease-3|Y
pyrroloquinoline quinone|pyrrolo-quinoline quinone|Y
intra-oral vertical ramus osteotomy|intraoral vertical ramus osteotomy|Y
size exclusion chromatography-multiangle laser light scattering|size-exclusion chromatography-multiangle laser light scattering|Y
size exclusion chromatography-multiangle laser light scattering|size exclusion chromatography-multi-angle laser light scattering|Y
size exclusion chromatography-multiangle laser light scattering|size exclusion chromatography/multiangle laser light scattering|Y
size exclusion chromatography-multiangle laser light scattering|size-exclusion chromatography-multi-angle laser light scattering|Y
nuclear receptor co-repressor|nuclear receptor corepressor|Y
Los Angeles County University of Southern California Medical Center|Los Angeles County + University of Southern California Medical Center|Y
Los Angeles County University of Southern California Medical Center|Los Angeles County-University of Southern California Medical Center|Y
β-ketoacyl acyl carrier protein synthase II|β-ketoacyl acyl carrier protein synthase I|Y
β-ketoacyl acyl carrier protein synthase II|β-ketoacyl acyl carrier protein synthase III|Y
extra-cellular polymeric substance|extracellular polymeric substance|Y
stereotactic radiosurgery|stereo-tactic radiosurgery|Y
human endogenous retrovirus K-113|human endogenous retrovirus K113|Y
digital imaging fibre-optic trans-illumination|digital imaging fibre-optic transillumination|Y
fluorine 18-fluoro-deoxyglucose|fluorine 18-fluoro-deoxy-glucose|Y
G protein-coupled oestrogen receptor-1|G protein-coupled estrogen receptor-1|Y
sacro-laeva posterior|sacrolaeva posterior|Y
spheno-occipital synchondrosis|sphenooccipital synchondrosis|Y
homeodomain-interacting protein kinase-2|homeodomain-interacting protein kinase 2|Y
interleukine-6 receptor α chain|interleukin-6 receptor α chain|Y
university-affiliated Veterans' Administration Medical Center|university-affiliated Veteran's Administration Medical Center|Y
university-affiliated Veterans' Administration Medical Center|university-affiliated Veterans Administration Medical Center|Y
isolated perfused lung|isolated perfused lungs|Y
electro-chemical detection|electrochemical detection|Y
solid-phase extraction/liquid chromatography/tandem mass spectrometry|solid phase extraction/liquid chromatography/tandem mass spectrometry|Y
solid-phase extraction/liquid chromatography/tandem mass spectrometry|solid-phase extraction liquid chromatography/tandem mass spectrometry|Y
slow reacting complement requiring neutralising antibody|slow reacting complement requiring neutralizing antibody|Y
American Society of Anesthesiologists Status III|American Society of Anesthesiologists Status I|Y
American Society of Anesthesiologists Status III|American Society of Anesthesiologists status III|Y
American Society of Anesthesiologists Status III|American Society of Anaesthesiologists Status II|Y
bioartificial pancreas|bio-artificial pancreas|Y
interleukine-13 receptor α1|interleukin-13 receptor α1|Y
World Health Organisation Quality of Life-Brief Version|World Health Organization Quality of Life-Brief Version|Y
World Health Organisation Quality of Life-Brief Version|World Health Organisation Quality of Life-Brief version|Y
hypothalamopituitary disconnection|hypothalamo-pituitary disconnection|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|Toll-interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|Toll/interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|Toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|Toll-interleukin-1 receptor domain-containing adapter-inducing interferon beta|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon-beta|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
NAD(P)H:quinone oxidoreductase 1|NAD(P)H: quinone oxidoreductase 1|Y
transvaginal gamete intra-fallopian transfer|transvaginal gamete intrafallopian transfer|Y
non ketotic hyperglycemia|nonketotic hyperglycemia|Y
aniridia-Wilms tumour association|aniridia-Wilms tumor association|Y
para-fluorophenylalanine|parafluorophenylalanine|Y
Subjective Wellbeing Inventory|Subjective Well-being Inventory|Y
receptor-like protein tyrosine phosphatase-psi|receptor-like protein tyrosine phosphatase psi|Y
receptor-like protein tyrosine phosphatase-psi|receptor-like protein-tyrosine phosphatase-psi|Y
Krueppel associated box|Kruppel associated box|Y
technetium 99m diethylenetriaminepentaacetic acid-galactosyl human serum albumin|technetium-99m diethylene-triaminepentaacetic acid-galactosyl human serum albumin|Y
technetium 99m diethylenetriaminepentaacetic acid-galactosyl human serum albumin|technetium-99m diethylenetriaminepentaacetic acid-galactosyl human serum albumin|Y
technetium 99m diethylenetriaminepentaacetic acid-galactosyl human serum albumin|technetium 99m diethylene-triaminepenta-acetic acid-galactosyl human serum albumin|Y
technetium 99m diethylenetriaminepentaacetic acid-galactosyl human serum albumin|technetium 99m diethylene-triaminepentaacetic acid galactosyl human serum albumin|Y
transactivation response DNA-binding protein-43|transactivation response DNA-binding protein 43|Y
pharyngo-esophageal segment|pharyngo-oesophageal segment|Y
pharyngo-esophageal segment|pharyngoesophageal segment|Y
electronic speckle pattern interferometer|electronic speckle pattern interferometry|Y
International Committee for Standardisation in Haematology|International Committee for Standardization in Haematology|Y
inducible cyclooxygenase|inducible cyclo-oxygenase|Y
human chorionic gonadotrophin-stimulated|human chorionic gonadotrophin stimulated|Y
para-nitroso-dimethylaniline|para-nitrosodimethylaniline|Y
radio-enzymatic assay|radioenzymatic assay|Y
sixteen-detector row computed tomography|sixteen-detector-row computed tomography|Y
Trail Making Test, Part B|Trail Making Test Part B|Y
proinsulin-like material|proinsulinlike material|Y
angioimmunoblastic lymphadenopathy with dysproteinaemia|angioimmunoblastic lymphadenopathy with dysproteinemia|Y
heterochromatin protein 1 β|heterochromatin protein 1β|Y
methyl-accepting chemotaxis proteins|methyl-accepting chemotaxis protein|Y
never in mitosis, gene A-related kinase 7|never in mitosis, gene A-related kinase 3|Y
never in mitosis, gene A-related kinase 7|never in mitosis, gene A-related kinase 6|Y
never in mitosis, gene A-related kinase 7|never in mitosis, gene A-related kinase 4|Y
excision repair cross complementing-group 1|excision repair cross complementing-group 2|Y
excision repair cross complementing-group 1|excision repair cross complementing-group 4|Y
excision repair cross complementing-group 1|excision repair cross-complementing-group 1|Y
inductively coupled plasma quadrupole mass spectrometry|inductively-coupled plasma quadrupole mass spectrometry|Y
scapholunate advanced collapse|scapho-lunate advanced collapse|Y
intramitochondrial crystalline inclusion|intra-mitochondrial crystalline inclusion|Y
three-colour fluorescence in situ hybridization|three-colour fluorescence in situ hybridisation|Y
three-colour fluorescence in situ hybridization|three-colour fluorescence in-situ hybridization|Y
Plasmodium falciparum multidrug resistance gene|Plasmodium falciparum multidrug resistance gene 1|Y
peroxisome proliferator activated receptor-γ2|peroxisome proliferator-activated receptor-γ2|Y
peroxisome proliferator activated receptor-γ2|peroxisome proliferator activated receptor-γ 2|Y
granulo-monopoietic enhancing factor|granulomonopoietic enhancing factor|Y
high-resolution computed tomographic scan|high resolution computed tomographic scan|Y
temperature-programed desorption-mass spectrometry|temperature programed desorption-mass spectrometry|Y
temperature-programed desorption-mass spectrometry|temperature-programed desorption mass spectrometry|Y
temperature-programed desorption-mass spectrometry|temperature-programed-desorption-mass spectrometry|Y
human metapneumovirus fusion protein|human meta-pneumovirus fusion protein|Y
apolipoprotein A-I Paris|apolipoprotein AI Paris|Y
gas chromatography-negative ion chemical ionization mass spectrometry|gas chromatography/negative ion chemical ionization mass spectrometry|Y
pro-interleukin-I alpha|prointerleukin-I alpha|Y
interferon sensitivity determining region|interferon sensitivity-determining region|Y
pathological tumor-2|pathological tumor-2b|Y
tricho-rhino-phalangeal syndrome type II|tricho-rhino-phalangeal syndrome type III|Y
FK506 binding protein 5|FK506 binding protein 52|Y
FK506 binding protein 5|FK506 binding protein 51|Y
autopositive end-expiratory pressure|auto-positive end-expiratory pressure|Y
Src homology 2 domain containing protein-tyrosine phosphatase|Src homology 2 domain-containing protein-tyrosine phosphatase|Y
Src homology 2 domain containing protein-tyrosine phosphatase|Src homology 2 domain containing protein tyrosine phosphatase|Y
procollagen type I N-terminal propeptide|Procollagen type I N-terminal propeptide|Y
peri-ictal single-photon emission computed tomography|peri-ictal single photon emission computed tomography|Y
extra-corporeal photo-chemotherapy|extracorporeal photo-chemotherapy|Y
Fc-γ receptor-mediated|Fcγ receptor-mediated|Y
acquired idiopathic sideroblastic anæmia|acquired idiopathic sideroblastic anemia|Y
DC-specific ICAM 3 grabbing non-integrin|DC-specific ICAM 3 grabbing nonintegrin|Y
syntaxin4-interacting protein|syntaxin 4-interacting protein|Y
American Society of Anaesthesiologists Class 3|American Society of Anaesthesiologists class 3|Y
American Society of Anaesthesiologists Class 3|American Society of Anaesthesiologists Class V|Y
American Society of Anaesthesiologists Class 3|American Society of Anaesthesiologists Class I|Y
American Society of Anaesthesiologists Class 3|American Society of Anaesthesiologists Class 5|Y
American Society of Anaesthesiologists Class 3|American Society of Anaesthesiologists Class 1|Y
American Society of Anaesthesiologists Class 3|American Society of Anesthesiologists Class 3|Y
O-desmethyl encainide|O-demethyl encainide|Y
multi-facility healthcare organization|multi-facility health care organization|Y
indwelling venous catheter|in-dwelling venous catheter|Y
cardio-renal syndrome|cardiorenal syndrome|Y
receptor-like protein-tyrosine phosphatase-μ|receptor-like protein-tyrosine phosphatase μ|Y
receptor-like protein-tyrosine phosphatase-μ|receptor-like protein tyrosine phosphatase-μ|Y
receptor-like protein-tyrosine phosphatase-μ|receptor-like protein-tyrosine phosphatase-η|Y
receptor-like protein-tyrosine phosphatase-μ|receptor-like protein-tyrosine phosphatase-ζ|Y
poly(ethylene glycol) 600|poly(ethylene glycol) 6000|Y
large-conductance calcium activated potassium channel|large conductance calcium activated potassium channel|Y
large-conductance calcium activated potassium channel|large-conductance calcium-activated potassium channel|Y
ubiquitin-like modifier activating enzyme 7|ubiquitin-like modifier activating enzyme 2|Y
ubiquitin-like modifier activating enzyme 7|ubiquitin-like modifier activating enzyme 4|Y
ubiquitin-like modifier activating enzyme 7|ubiquitin-like modifier activating enzyme 5|Y
ubiquitin-like modifier activating enzyme 7|ubiquitin-like modifier activating enzyme 6|Y
American Society of Anaesthesiology Class V|American Society of Anesthesiology Class V|Y
American Society of Anaesthesiology Class V|American Society of Anaesthesiology Class 4|Y
activin type IIB receptor|activin type II receptor|Y
sodium glucose co-transporter 2|sodium glucose cotransporter 2|Y
calcitonin gene-related peptide-immunoreactive nerve fiber|calcitonin-gene-related peptide-immunoreactive nerve fiber|Y
Pseudomonas aeruginosa strain PAO-1|Pseudomonas aeruginosa strain PAO1|Y
matrix-assisted laser desorption/ionisation time of flight mass spectrometry|matrix assisted laser desorption/ionisation time of flight mass spectrometry|Y
matrix-assisted laser desorption/ionisation time of flight mass spectrometry|matrix-assisted laser desorption/ionization time of flight mass spectrometry|Y
matrix-assisted laser desorption/ionisation time of flight mass spectrometry|matrix-assisted laser desorption ionisation time of flight mass spectrometry|Y
cross-reacting carbohydrate determinant|crossreacting carbohydrate determinant|Y
tuberoinfundibular dopaminergic neuron|tubero-infundibular dopaminergic neuron|Y
Organisation to Assess Strategies for Ischemic Syndromes|Organization to Assess Strategies for Ischemic Syndromes|Y
American Society of Anesthesiology grade 2|American Society of Anesthesiology grade 5|Y
American Society of Anesthesiology grade 2|American Society of Anesthesiology grade 3|Y
American Society of Anesthesiology grade 2|American Society of Anesthesiology Grade 2|Y
American Society of Anesthesiology grade 2|American Society of Anesthesiology grade|Y
American Society of Anesthesiology grade 2|American Society of Anesthesiology grade I|Y
multi-systemic therapy|multisystemic therapy|Y
rho guanine nucleotide dissociation inhibitor α|Rho guanine nucleotide dissociation inhibitor α|Y
receptor-like protein-tyrosine phosphatase kappa|receptor-like protein-tyrosine phosphatase-kappa|Y
receptor-like protein-tyrosine phosphatase kappa|receptor-like protein tyrosine phosphatase kappa|Y
hepatic fibrinogen/angiopoietin-related protein|hepatic fibrinogen-angiopoietin-related protein|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon-β|toll-interleukin1 receptor domain-containing adapter-inducing interferon β|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon-β|toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon-β|toll-interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon-β|toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
topoisomerase IIβ binding protein 1|topoisomerase II β binding protein 1|Y
unilateral salpingooophorectomy|unilateral salpingo oophorectomy|Y
13,14-dihydro-15-keto prostaglandin F2alpha|13,14-dihydro-15-keto prostaglandin F2 alpha|Y
pituitary tumor-derived fibroblast growth factor receptor-4|pituitary tumour-derived fibroblast growth factor receptor-4|Y
pituitary tumor-derived fibroblast growth factor receptor-4|pituitary tumor derived fibroblast growth factor receptor-4|Y
5'-bromo-2'-deoxyuridine|5-bromo-2'-deoxyuridine|Y
intrauterine contraception|intra-uterine contraception|Y
50% inhibitory concentrations|50% inhibitory concentration|Y
F-18-fluorodeoxy-glucose|F-18-fluorodeoxyglucose|Y
cerebro-vascular accident|cerebrovascular accident|Y
cardioankle vascular index|cardio-ankle vascular index|Y
interleukine-15 receptor-alpha|interleukin-15 receptor-alpha|Y
NF-κB essential modulator|NFκB essential modulator|Y
N-succinimidyl 3-(2-pyridyldithio)propionate|N-succinimidyl-3-(2-pyridyldithio)propionate|Y
glial cell-line derived neurotrophic factor|glial cell line derived neurotrophic factor|Y
colored dissolved organic matter|colorued dissolved organic matter|Y
cluster of differentiation antigen 138|cluster of differentiation antigen 18|Y
recombinant human transforming growth factor-beta 1|recombinant human transforming growth factor-beta1|Y
recombinant human transforming growth factor-beta 1|recombinant human transforming growth factor-beta 2|Y
recombinant human transforming growth factor-beta 1|recombinant human transforming growth factor-beta|Y
recombinant human transforming growth factor-beta 1|recombinant human transforming growth factor beta 1|Y
anodised aluminum oxide|anodised aluminium oxide|Y
infantile hemangioendothelioma|infantile hemangio-endothelioma|Y
tracheoesophageal fistula|tracheo esophageal fistula|Y
anti-tissue factor pathway inhibitor IgG|antitissue factor pathway inhibitor IgG|Y
serum- and glucocorticoid-inducible kinase 1|serum- and glucocorticoid-inducible kinase-1|Y
dissociation-enhanced lanthanide fluoro-immunoassay|dissociation enhanced lanthanide fluoro-immunoassay|Y
hypoglycemia-associated autonomic failure|hypoglycemia associated autonomic failure|Y
hand, foot and mouth disease|hand foot and mouth disease|Y
vertebrobasilar system|vertebro-basilar system|Y
non-injecting heroin user|noninjecting heroin user|Y
atrioventricular reentry tachycardia|atrioventricular re-entry tachycardia|Y
antiacetylcholinesterase antibody|anti-acetylcholinesterase antibody|Y
American Society of Anesthesiologists Grade IV|American Society of Anesthesiologists Grade V|Y
American Society of Anesthesiologists Grade IV|American Society of Anesthesiologists Grade II|Y
American Society of Anesthesiologists Grade IV|American Society of Anesthesiologists Grade I|Y
single-strand-selective monofunctional uracil-DNA glycosylase 1|single strand-selective monofunctional uracil-DNA glycosylase 1|Y
pregnancy-specific β-1 glycoprotein|pregnancy-specific β1 glycoprotein|Y
pre-dialysis mean arterial pressure|predialysis mean arterial pressure|Y
polymeric Ig receptor|polymeric IgA receptor|Y
irreversibly sickled cell|irreversibly sickled cells|Y
beta-transducin repeat-containing protein|beta transducin repeat-containing protein|Y
beta-transducin repeat-containing protein|beta-transducin repeat containing protein|Y
common atrio-ventricular orifice|common atrioventricular orifice|Y
poly(ADP ribose) synthetase|poly (ADP ribose) synthetase|Y
obscure gastro-intestinal bleeding|obscure gastrointestinal bleeding|Y
orthogonal array of particles|orthogonal arrays of particles|Y
human T-cell leukemia virus type-1-infected|human T-cell leukemia virus type-I-infected|Y
peroxisome proliferator-activated receptor-γ 1|peroxisome proliferator-activated receptor-γ|Y
peroxisome proliferator-activated receptor-γ 1|peroxisome proliferator-activated receptor-γ 2|Y
peroxisome proliferator-activated receptor-γ 1|peroxisome proliferator-activated receptor γ 1|Y
peroxisome proliferator-activated receptor gamma coactivator-1 alpha|peroxisome proliferator-activated receptor gamma coactivator 1alpha|Y
peroxisome proliferator-activated receptor gamma coactivator-1 alpha|peroxisome proliferator-activated receptor-gamma co-activator-1 alpha|Y
peroxisome proliferator-activated receptor gamma coactivator-1 alpha|peroxisome proliferator-activated receptor gamma coactivator 1 alpha|Y
peroxisome proliferator-activated receptor gamma coactivator-1 alpha|peroxisome proliferator-activated receptor-gamma coactivator-1alpha|Y
peroxisome proliferator-activated receptor gamma coactivator-1 alpha|peroxisome proliferator-activated receptor gamma co-activator-1alpha|Y
peroxisome proliferator-activated receptor gamma coactivator-1 alpha|peroxisome proliferator-activated receptor gamma co-activator 1 alpha|Y
peroxisome proliferator-activated receptor gamma coactivator-1 alpha|peroxisome-proliferator-activated receptor gamma coactivator-1 alpha|Y
intraabdominal pressure|intra-abdominal pressure|Y
hyper-homocyst(e)inaemia|hyper-homocyst(e)inemia|Y
1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one|1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one|Y
C difficile-associated diarrhea|C. difficile-associated diarrhea|Y
anti-human T cell lymphotrophic virus-1 antibody|anti-human T cell lymphotrophic virus 1 antibody|Y
Vicker's hardness number|Vickers hardness number|Y
noninsulin-dependent diabetes|non-insulin-dependent diabetes|Y
wild type angiotensin I-converting enzyme|wild-type angiotensin I-converting enzyme|Y
wild type angiotensin I-converting enzyme|wild type angiotensin I converting enzyme|Y
corticotropin-releasing factor receptor-1|corticotropin-releasing factor receptor|Y
corticotropin-releasing factor receptor-1|corticotropin releasing factor receptor-1|Y
fibroblast growth factor receptor 2IIIb|fibroblast growth factor receptor 2-IIIb|Y
enzyme linked immunoadsorbent assay|enzyme linked immuno-adsorbent assay|Y
Human granulocyte colony-stimulating factor|human granulocyte colony-stimulating factor|Y
triggering receptor expressed on myeloid cell-1|triggering receptor expressed on myeloid cell-2|Y
self-expandable metallic stent|self-expandable metallic stents|Y
bovine trophoblast protein-1|ovine trophoblast protein-1|Y
patients with spondyloarthropathy|patients with spondylarthropathy|Y
Ralph H. Johnson Veterans Administration Medical Center|Ralph H. Johnson Veterans' Administration Medical Center|Y
Ralph H. Johnson Veterans Administration Medical Center|Ralph H Johnson Veterans Administration Medical Center|Y
Ralph H. Johnson Veterans Administration Medical Center|Ralph H Johnson Veterans' Administration Medical Center|Y
dual energy X-ray absorptiometry scanning|dual-energy X-ray absorptiometry scanning|Y
dual energy X-ray absorptiometry scanning|dual energy x-ray absorptiometry scanning|Y
kinase-insert domain containing receptor|kinase insert domain containing receptor|Y
N-acetyl-neuraminic acid|N-acetylneuraminic acid|Y
type II transforming growth factor beta receptor|type II transforming growth factor-beta receptor|Y
classical antineutrophil cytoplasmic antibody|classic antineutrophil cytoplasmic antibody|Y
x-ray repair cross complementation group 1|x-ray repair cross-complementation group 1|Y
sterol regulatory element-binding protein cleavage-activating protein|sterol regulatory element binding protein cleavage-activating protein|Y
nucleotide binding oligomerization domain-like receptor family|nucleotide binding oligomerisation domain-like receptor family|Y
nucleotide binding oligomerization domain-like receptor family|nucleotide-binding oligomerization domain-like receptor family|Y
ammonia monooxygenase|ammonia mono-oxygenase|Y
intrahepatic atresia|intra-hepatic atresia|Y
technetium-99m labelled polyclonal human immunoglobulin G|technetium-99m-labelled polyclonal human immunoglobulin G|Y
neural precursor cell-expressed, developmentally downregulated 4|neuronal precursor cell-expressed developmentally downregulated 4|Y
neural precursor cell-expressed, developmentally downregulated 4|neural precursor cell-expressed developmentally downregulated 8|Y
neural precursor cell-expressed, developmentally downregulated 4|neural precursor cell-expressed developmentally downregulated 5|Y
neural precursor cell-expressed, developmentally downregulated 4|neural precursor cell-expressed developmentally downregulated 4|Y
neural precursor cell-expressed, developmentally downregulated 4|neural precursor cell expressed developmentally downregulated 4|Y
neural precursor cell-expressed, developmentally downregulated 4|neural-precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell-expressed, developmentally downregulated 4|neural precursor cell-expressed, developmentally downregulated 9|Y
neural precursor cell-expressed, developmentally downregulated 4|neural precursor cell-expressed developmentally downregulated 1|Y
neural precursor cell-expressed, developmentally downregulated 4|neural precursor cell expressed, developmentally down-regulated 4|Y
neural precursor cell-expressed, developmentally downregulated 4|neural precursor cell-expressed developmentally down-regulated 4|Y
neural precursor cell-expressed, developmentally downregulated 4|neural precursor cell-expressed developmentally downregulated 9|Y
neural precursor cell-expressed, developmentally downregulated 4|neural precursor cell-expressed, developmentally downregulated 8|Y
neural precursor cell-expressed, developmentally downregulated 4|neural precursor cell-expressed, developmentally downregulated 1|Y
neural precursor cell-expressed, developmentally downregulated 4|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell-expressed, developmentally downregulated 4|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell-expressed, developmentally downregulated 4|neural precursor cell-expressed, developmentally down-regulated 2|Y
fragile X-associated tremor ataxia syndrome|fragile X-associated tremor-ataxia syndrome|Y
prostaglandin E-2 binding site|prostaglandin E2 binding site|Y
excision repair cross-complementation group 6|excision repair cross-complementation group 3|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon β|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon β|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon β|toll/interleukin1 receptor domain-containing adapter-inducing interferon β|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon β|Toll-interleukin1 receptor domain-containing adapter-inducing interferon β|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon β|toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon β|toll-interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon β|toll-interleukin-1 receptor domain-containing adapter-inducing interferon β|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon β|toll/interleukin-1 receptor domain-containing adapter-inducing interferon β|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon β|toll-interleukin1 receptor domain-containing adapter inducing interferon β|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon β|toll/interleukin 1 receptor domain-containing adapter-inducing interferon β|Y
transforming growth factor β signalling pathway|transforming growth factor β signaling pathway|Y
transforming growth factor β signalling pathway|transforming growth factor-β signalling pathway|Y
soluble interleukin 2 receptor|soluble interleukin 2 receptorα|Y
ribosomal protein S20|ribosomal protein S2|Y
invariant T cell receptor V α14|invariant T cell receptor Vα14|Y
dehydro-epiandrosterone level|dehydroepiandrosterone level|Y
attenuated total reflectance-Fourier transform infra-red spectroscopy|attenuated total reflectance-Fourier transform infrared spectroscopy|Y
attenuated total reflectance-Fourier transform infra-red spectroscopy|attenuated total reflectance-Fourier transform infra red spectroscopy|Y
attenuated total reflectance-Fourier transform infra-red spectroscopy|attenuated total reflectance Fourier transform infrared spectroscopy|Y
attenuated total reflectance-Fourier transform infra-red spectroscopy|attenuated total reflectance Fourier transform infra-red spectroscopy|Y
glycogen synthase kinase-3 β|glycogen synthase kinase-3β|Y
augmented correlation consistent polarized valence triple-ζ basis set|augmented correlation consistent polarised valence triple-ζ basis set|Y
cross-polarization magic-angle-spinning nuclear magnetic resonance|cross-polarization/magic-angle-spinning nuclear magnetic resonance|Y
oxidised nicotinamide-adenine dinucleotide phosphate|oxidized nicotinamide-adenine dinucleotide phosphate|Y
oxidised nicotinamide-adenine dinucleotide phosphate|oxidised nicotinamide adenine dinucleotide phosphate|Y
interleukin 4 receptor α subunit|interleukine 4 receptor α subunit|Y
Trans-Atlantic Inter-Society Consensus|TransAtlantic Inter-Society Consensus|Y
latent transforming growth factor beta binding protein|latent transforming growth factor beta binding protein-3|Y
latent transforming growth factor beta binding protein|latent transforming growth factor beta binding protein-4|Y
latent transforming growth factor beta binding protein|latent transforming growth factor beta binding protein-2|Y
latent transforming growth factor beta binding protein|latent transforming growth factor beta binding protein 1|Y
latent transforming growth factor beta binding protein|latent transforming growth factor beta binding protein 2|Y
latent transforming growth factor beta binding protein|latent transforming growth factor beta binding protein 4|Y
latent transforming growth factor beta binding protein|latent transforming growth factor beta binding protein 3|Y
polyethyleneglycol 600|polyethyleneglycol 6000|Y
National Cholesterol Education Program Adult Treatment Panel III|National Cholesterol Education Program Adult Treatment Panel II|Y
interleukine-13 receptor alpha-1 chain|interleukine-13 receptor alpha1 chain|Y
multi-leaf collimator|multileaf collimator|Y
recombinant human transforming growth factor β 1|recombinant human transforming growth factor β|Y
peptidylglycine alpha-amidating mono-oxygenase|peptidyl glycine alpha-amidating monooxygenase|Y
peptidylglycine alpha-amidating mono-oxygenase|peptidylglycine-alpha-amidating mono-oxygenase|Y
peptidylglycine alpha-amidating mono-oxygenase|peptidyl-glycine alpha-amidating monooxygenase|Y
similar to mothers against decapentaplegic homolog 1|similar to mothers against decapentaplegic homolog 5|Y
similar to mothers against decapentaplegic homolog 1|similar to mothers against decapentaplegic homolog 2|Y
similar to mothers against decapentaplegic homolog 1|similar to mothers against decapentaplegic homolog 8|Y
dopant-assisted atmospheric-pressure photoionization|dopant-assisted atmospheric pressure photoionization|Y
insulin-like growth factor II messenger RNA-binding protein 2|insulin-like growth factor-II messenger RNA-binding protein 2|Y
insulin-like growth factor II messenger RNA-binding protein 2|insulin-like growth factor II messenger RNA-binding protein-2|Y
insulin-like growth factor II messenger RNA-binding protein 2|insulin-like growth factor II messenger RNA binding protein 2|Y
insulin-like growth factor II messenger RNA-binding protein 2|insulin-like growth factor II messenger RNA-binding protein|Y
cross-polarisation magic-angle-spinning NMR|cross-polarisation/magic-angle-spinning NMR|Y
cross-polarisation magic-angle-spinning NMR|cross-polarization magic-angle-spinning NMR|Y
lymphokine-activated killer|lymphokine-activated killers|Y
arterio-venous malformation|arteriovenous malformation|Y
major histocompatibility complex class I-related|major histocompatibility-complex class I-related|Y
malignant myoepithelioma|malignant myo-epithelioma|Y
nuclear factor-κ B p50 subunit|nuclear factor-κB p50 subunit|Y
cellular inhibitor of apoptosis protein-1|cellular inhibitor of apoptosis protein|Y
cellular inhibitor of apoptosis protein-1|cellular inhibitor of apoptosis protein 1|Y
cellular inhibitor of apoptosis protein-1|cellular inhibitor of apoptosis protein-2|Y
atomic absorption spectrophotometry|atomic absorption spectro-photometry|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labelling|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling|Y
liquid chromatography/electrospray mass spectrometry|liquid chromatography/electrospray/mass spectrometry|Y
submacular hemorrhage|sub-macular hemorrhage|Y
American Society of Anesthesiologists class II|American Society of Anesthesiologists class IV|Y
American Society of Anesthesiologists class II|American Society of Anaesthesiologists class III|Y
American Society of Anesthesiologists class II|American Society of Anesthesiologists Class II|Y
American Society of Anesthesiologists class II|American Society of Anesthesiologists class I|Y
glycophosphatidyl inositol anchored protein|glycophosphatidyl inositol-anchored protein|Y
glycophosphatidyl inositol anchored protein|glycophosphatidyl-inositol anchored protein|Y
glycophosphatidyl inositol anchored protein|glycophosphatidylinositol anchored protein|Y
mouse erythroleukemia cell|mouse erythro-leukemia cell|Y
killer immunoglobulin-like receptor 2DL1|killer immunoglobulin-like receptor 2DL4|Y
killer immunoglobulin-like receptor 2DL1|killer immunoglobulin-like receptor 2DS1|Y
killer immunoglobulin-like receptor 2DL1|killer immunoglobulin-like receptor 2DL2|Y
augmented correlation consistent polarised valence triple ζ basis set|augmented correlation-consistent polarised valence triple ζ basis set|Y
augmented correlation consistent polarised valence triple ζ basis set|augmented correlation consistent polarised valence triple-ζ basis set|Y
posttraumatic seizure|post-traumatic seizure|Y
methoxyresorufin-O-dealkylase|methoxy-resorufin-O-dealkylase|Y
β human chorionic gonadotrophin|β human chorionic gonadotropin|Y
glycosamino-glycan polysulfate|glycosaminoglycan polysulfate|Y
levonorgestrel releasing intra-uterine system|laevonorgestrel releasing intrauterine system|Y
levonorgestrel releasing intra-uterine system|levonorgestrel releasing intra uterine system|Y
levonorgestrel releasing intra-uterine system|levonorgestrel-releasing intra-uterine system|Y
guanosinetriphosphatase-activating protein|guanosine triphosphatase-activating protein|Y
glucocorticoid receptor-interacting protein 1|glucocorticoid receptor interacting protein 1|Y
glucocorticoid receptor-interacting protein 1|glucocorticoid receptor-interacting protein-1|Y
antiIL-2R monoclonal antibody|antiIL-2 monoclonal antibody|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling|Y
laser desorption/ionization time-of-flight mass spectrometry|laser desorption-ionization time-of-flight mass spectrometry|Y
laser desorption/ionization time-of-flight mass spectrometry|laser desorption/ionisation time-of-flight mass spectrometry|Y
cerebrobuccal connective|cerebro-buccal connective|Y
enzyme-linked immunosorbent assays|enzyme-linked immunosorbent assay|Y
field emission in-lens scanning electron microscopy|field emission in-lens-scanning electron microscopy|Y
field emission in-lens scanning electron microscopy|field emission in-lens scanning electron microscope|Y
Biopharmaceutics Classification System Class|Biopharmaceutics Classification System Class 2|Y
Biopharmaceutics Classification System Class|Biopharmaceutics Classification System Class 4|Y
Biopharmaceutics Classification System Class|Biopharmaceutics Classification System Class 1|Y
second-order Moller-Plesset perturbation theory|second order Moller-Plesset perturbation theory|Y
second-order Moller-Plesset perturbation theory|second-order Møller-Plesset perturbation theory|Y
augmented correlation consistent polarized valence triple-zeta basis set|augmented correlation-consistent polarized valence triple-zeta basis set|Y
augmented correlation consistent polarized valence triple-zeta basis set|augmented correlation consistent polarised valence triple-zeta basis set|Y
lymphoproliferative response|lympho-proliferative response|Y
puromycin N-acetyl transferase|puromycin N-acetyltransferase|Y
X-ray absorption near-edge structure analysis|X-ray absorption near edge structure analysis|Y
heterochromatin protein 1-β|heterochromatin protein 1β|Y
cross polarization magic angle spinning|crosspolarization magic angle spinning|Y
electron-probe x-ray microanalyzer|electron-probe x-ray micro-analyzer|Y
interleukine-11 receptor α|interleukin-11 receptor α|Y
fibrosarcoma-derived tumour rejection antigen|fibrosarcoma-derived tumor rejection antigen|Y
fibrosarcoma-derived tumour rejection antigen|fibrosarcoma derived tumour rejection antigen|Y
excision repair cross-complementing-group 6|excision repair cross-complementing group 6|Y
excision repair cross-complementing-group 6|excision repair cross-complementing-group 2|Y
excision repair cross-complementing-group 6|excision repair cross-complementing-group 1|Y
excision repair cross-complementing-group 6|excision repair cross-complementing-group 4|Y
interleukine-3 receptor α|interleukin-3 receptor α|Y
95% confidence limits|95% confidence limit|Y
American Society of Anesthesiology grade 5|American Society of Anesthesiology Grade 5|Y
American Society of Anesthesiology grade 5|American Society of Anesthesiology grade 3|Y
American Society of Anesthesiology grade 5|American Society of Anesthesiology grade|Y
American Society of Anesthesiology grade 5|American Society of Anesthesiology grade I|Y
university-affiliated Veteran's Administration Medical Center|university-affiliated Veterans Administration Medical Center|Y
university-affiliated Veteran's Administration Medical Center|university affiliated Veteran's Administration Medical Center|Y
corticotrophin-releasing-hormone receptor type 2|corticotrophin-releasing-hormone receptor type-2|Y
corticotrophin-releasing-hormone receptor type 2|corticotropin-releasing-hormone receptor type 2|Y
9-(2-phosphonylmethoxyethyl) adenine|9-(2-phosphonylmethoxyethyl)adenine|Y
reduced intensity stem cell transplantation|reduced intensity stem-cell transplantation|Y
augmented correlation consistent polarized valence quadruple-ζ basis set|augmented correlation-consistent polarized valence quadruple-ζ basis set|Y
augmented correlation consistent polarized valence quadruple-ζ basis set|augmented correlation consistent polarized valence quadruple ζ basis set|Y
augmented correlation consistent polarized valence quadruple-ζ basis set|augmented correlation consistent polarised valence quadruple-ζ basis set|Y
Hb S-beta thalassemia|Hb S-beta thalassaemia|Y
histamine releasing factor|histamine releasing factors|Y
uretero-pelvic junction obstruction|ureteropelvic junction obstruction|Y
reaction centre light-harvesting complex I|reaction centre-light-harvesting complex I|Y
reaction centre light-harvesting complex I|reaction centre light-harvesting complex 1|Y
anticomplement immunofluorescence test|anti-complement immunofluorescence test|Y
electrically evoked auditory brainstem responses|electrically evoked auditory brain stem response|Y
electrically evoked auditory brainstem responses|electrically evoked auditory brainstem response|Y
inhibitory κ B kinase β|inhibitory κB kinase β|Y
radio-immuno-detection|radioimmuno-detection|Y
catheter associated blood stream infection|catheter-associated blood stream infection|Y
catheter associated blood stream infection|catheter associated bloodstream infection|Y
anti-β-2 glycoprotein 1 antibody|anti-β2 glycoprotein 1 antibody|Y
peroxisome proliferator-activated receptor-γ|peroxisome proliferator-activated receptor γ|Y
peroxisome proliferator-activated receptor-γ|peroxisome proliferator-activated receptor-γ 2|Y
peroxisome proliferator-activated receptor-γ|peroxisome proliferator-activated receptor-γ-2|Y
peroxisome proliferator-activated receptor-γ|peroxisome proliferator-activated receptor-γ2|Y
peroxisome proliferator-activated receptor-γ|peroxisome proliferator-activated receptor|Y
matrix-assisted laser desorption/ionisation Fourier transform ion cyclotron resonance mass spectrometry|matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry|Y
matrix-assisted laser desorption/ionisation Fourier transform ion cyclotron resonance mass spectrometry|matrix-assisted laser desorption/ionization Fourier-transform ion cyclotron resonance mass spectrometry|Y
matrix-assisted laser desorption/ionisation Fourier transform ion cyclotron resonance mass spectrometry|matrix-assisted laser desorption ionization Fourier transform ion cyclotron resonance mass spectrometry|Y
3-(3,4-dichlorophenyl)-1,1-dimethylurea|3-(3,4-dichlorophenyl)-1,1-dimethyl urea|Y
nonstructural protein 5|nonstructural protein 5A|Y
nonstructural protein 5|non-structural protein 5|Y
nonstructural protein 5|nonstructural protein 5B|Y
transcription factor μE3|transcription factor E3|Y
gas chromatography-mass spectrometry-selected-ion monitoring|gas chromatography-mass spectrometry-selected ion monitoring|Y
procollagen type III|pro-collagen type III|Y
[3H]quinuclidinyl benzilate|[3H]quinuclidinylbenzilate|Y
pregnancy-specific β 1 glycoprotein|pregnancy-specific β1 glycoprotein|Y
non-valvular atrial fibrillation|nonvalvular atrial fibrillation|Y
endothelial monocyte activating polypeptide-II|endothelial monocyte-activating polypeptide-II|Y
endothelial monocyte activating polypeptide-II|endothelial monocyte activating polypeptide-III|Y
endothelial monocyte activating polypeptide-II|endothelial monocyte activating polypeptide II|Y
multi-canonical Monte Carlo method|multicanonical Monte Carlo method|Y
L-buthionine-(S,R)-sulfoximine|DL-buthionine-(S,R)-sulfoximine|Y
prepro-atrial natriuretic peptide|pre-pro-atrial natriuretic peptide|Y
immuno-suppressive factor|immunosuppressive factor|Y
Nurses Observation Scale for Inpatient Evaluation|Nurses' Observation Scale for Inpatient Evaluation|Y
recombinant human transforming growth factor β3|recombinant human transforming growth factor β2|Y
recombinant human transforming growth factor β3|recombinant human transforming growth factor β|Y
nucleotide-binding site-leucine-rich repeat|nucleotide-binding site leucine-rich repeat|Y
nucleotide-binding site-leucine-rich repeat|nucleotide binding site-leucine-rich repeat|Y
American Society of Anaesthesiology Grade V|American Society of Anesthesiology Grade IV|Y
American Society of Anaesthesiology Grade V|American Society of Anesthesiology Grade V|Y
American Society of Anaesthesiology Grade V|American Society of Anaesthesiology Grade 5|Y
American Society of Anaesthesiology Grade V|American Society of Anaesthesiology grade V|Y
X-linked thrombocytopaenia|X-linked thrombo-cytopaenia|Y
traveling-salesman problem|travelling-salesman problem|Y
first dorsal interosseus|first dorsal interosseous|Y
penicillinase producing strains of Neisseria gonorrhoeae|penicillinase-producing strains of Neisseria gonorrhoeae|Y
soluble IL-2 receptors|soluble IL-2 receptor|Y
fibroblast growth factor-inducible molecule 14|fibroblast growth factor-inducible molecule-14|Y
non-ischemic cardiomyopathy|non-ischaemic cardiomyopathy|Y
non-ischemic cardiomyopathy|nonischemic cardiomyopathy|Y
hairy enhancer of split1|hairy enhancer of split 1|Y
microtubule-associated protein-1 light chain 3-II|microtubule-associated protein 1 light chain 3-II|Y
multireference coupled cluster theory|multi-reference coupled cluster theory|Y
near infrared fluorescent|near infra-red fluorescent|Y
post-activation potentiation|postactivation potentiation|Y
ribonucleic acid polymerase II|ribonucleic acid polymerase III|Y
trans-esophageal echo-probe|trans-esophageal echoprobe|Y
trans-esophageal echo-probe|trans-oesophageal echo-probe|Y
Bos taurus autosome 13|Bos taurus autosome 3|Y
Bos taurus autosome 13|Bos taurus autosome 1|Y
α thalassaemia/mental retardation syndrome X-linked|α thalassemia/mental retardation syndrome X-linked|Y
articulotrochanteric distance|articulo-trochanteric distance|Y
neodymium: yttrium-aluminum garnet laser|neodymium:yttrium-aluminum garnet laser|Y
neodymium: yttrium-aluminum garnet laser|neodymium: yttrium aluminum garnet laser|Y
American Society of Anesthesiology class 5|American Society of Anaesthesiology class 5|Y
American Society of Anesthesiology class 5|American Society of Anesthesiology class V|Y
American Society of Anesthesiology class 5|American Society of Anesthesiology class 4|Y
American Society of Anesthesiology class 5|American Society of Anesthesiology class I|Y
phosphorylated cAMP response element-binding protein|phosphorylated cAMP responsive element-binding protein|Y
phosphorylated cAMP response element-binding protein|phosphorylated cAMP-response element-binding protein|Y
phosphorylated cAMP response element-binding protein|phosphorylated cAMP response element binding protein|Y
recombinant human interleukin 11|recombinant human interleukin 1|Y
Zollinger-Ellison tumour|Zollinger-Ellison tumor|Y
anti-acetylcholinesterase activity|antiacetylcholinesterase activity|Y
spontaneously hypertensive rats of the stroke prone strain|spontaneously hypertensive rats of the stroke-prone strain|Y
senescence associated secretory phenotype|senescence-associated secretory phenotype|Y
disto-buccal developmental groove|distobuccal developmental groove|Y
anticytotoxic T-lymphocyte antigen 4 antibody|anticytotoxic T-lymphocyte antigen-4 antibody|Y
American Society of Anaesthesiologists Status I|American Society of Anesthesiologists Status I|Y
American Society of Anaesthesiologists Status I|American Society of Anaesthesiologists Status IV|Y
American Society of Anaesthesiologists Status I|American Society of Anaesthesiologists status I|Y
American Society of Anaesthesiologists Status I|American Society of Anaesthesiologists Status 3|Y
American Society of Anaesthesiologists Status I|American Society of Anaesthesiologists Status II|Y
calcium voltage-gated channel subunit α1 C|calcium voltage-gated channel subunit α1 F|Y
calcium voltage-gated channel subunit α1 C|calcium voltage-gated channel subunit α1C|Y
multivoxel magnetic resonance spectroscopy|multi-voxel magnetic resonance spectroscopy|Y
electron probe micro-analyser|electron probe microanalyser|Y
idiopathic intracranial hypertension|idiopathic intra-cranial hypertension|Y
dengue hemorrhagic fever-dengue shock syndrome|dengue haemorrhagic fever-dengue shock syndrome|Y
acute respiratory viral infection|acute respiratory viral infections|Y
methylglyoxal bis-(guanylhydrazone)|methylglyoxal bis(guanylhydrazone)|Y
leukaemia inhibitory factor receptor β|leukemia inhibitory factor receptor β|Y
nonshivering thermogenesis|non-shivering thermogenesis|Y
National Vocational Qualifications|National Vocational Qualification|Y
ATP-sensitive K(+) channel|ATP-sensitive K(+) channels|Y
hereditary sensory and autonomic neuropathy type 4|hereditary sensory and autonomic neuropathy type 3|Y
hereditary sensory and autonomic neuropathy type 4|hereditary sensory and autonomic neuropathy type V|Y
Nashville Veterans' Affairs Medical Center|Nashville Veteran's Affairs Medical Center|Y
Nashville Veterans' Affairs Medical Center|Nashville Veterans Affairs Medical Center|Y
multilaminar vesicle|multi-laminar vesicle|Y
abbreviated new drug applications|abbreviated new drug application|Y
receptor-like protein tyrosine phosphatase α|receptor-like protein tyrosine phosphatase ζ|Y
receptor-like protein tyrosine phosphatase α|receptor-like protein tyrosine phosphatase η|Y
glycosyl-phosphatidylinositol anchored protein|glycosyl-phosphatidyl-inositol anchored protein|Y
glycosyl-phosphatidylinositol anchored protein|glycosylphosphatidylinositol anchored protein|Y
glycosyl-phosphatidylinositol anchored protein|glycosylphosphatidyl inositol anchored protein|Y
glycosyl-phosphatidylinositol anchored protein|glycosyl-phosphatidylinositol-anchored protein|Y
anti-IL1 alpha antibody|anti-IL1alpha antibody|Y
anti-IL1 alpha antibody|anti-IL 1 alpha antibody|Y
anti-IL1 alpha antibody|anti-IL-1 alpha antibody|Y
immunoglobulin gamma|immunoglobulin gamma2|Y
antimalaria campaign|anti-malaria campaign|Y
aluminium sulphonated phthalocyanine|aluminum sulphonated phthalocyanine|Y
mitogen-activated protein kinase upstream kinase|mitogen-activated protein kinase-upstream kinase|Y
post-menopausal oestrogen progestin intervention|post-menopausal estrogen progestin intervention|Y
post-menopausal oestrogen progestin intervention|post-menopausal oestrogen-progestin intervention|Y
post-menopausal oestrogen progestin intervention|postmenopausal estrogen progestin intervention|Y
fluorine-18 labelled fluoro-deoxyglucose|fluorine-18-labelled fluoro-deoxyglucose|Y
fluorine-18 labelled fluoro-deoxyglucose|fluorine-18 labelled fluorodeoxyglucose|Y
toll-IL-1 receptor domain-containing adaptor-inducing IFN-beta|toll/IL-1 receptor domain-containing adaptor-inducing IFNbeta|Y
toll-IL-1 receptor domain-containing adaptor-inducing IFN-beta|toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta|Y
Ca2+-calmodulin-dependent protein kinase IV|Ca2+/calmodulin-dependent protein kinase IV|Y
non-homologous end joining|non-homologous endjoining|Y
human immunodeficiency virus-hepatitis C virus co-infection|human immunodeficiency virus-hepatitis C virus coinfection|Y
laser desorption ionization time of flight mass spectrometry|laser-desorption ionization time of flight mass spectrometry|Y
laser desorption ionization time of flight mass spectrometry|laser desorption-ionization time of flight mass spectrometry|Y
laser desorption ionization time of flight mass spectrometry|laser desorption ionisation time of flight mass spectrometry|Y
anti-hemophilic factor C|anti-haemophilic factor C|Y
anti-hemophilic factor C|antihemophilic factor C|Y
stress-activated protein kinase 2b|stress-activated protein kinase 2|Y
β-ketoacyl-acyl carrier protein synthase III|β-ketoacyl acyl carrier protein synthase III|Y
β-ketoacyl-acyl carrier protein synthase III|β-ketoacyl-acyl carrier protein synthase I|Y
cytotoxic T lymphocyte antigen-2 β|cytotoxic T lymphocyte antigen-2β|Y
three color fluorescence in-situ hybridization|three-color fluorescence in-situ hybridization|Y
three color fluorescence in-situ hybridization|three color fluorescence in-situ hybridisation|Y
glutamate oxaloacetate transaminase|glutamate oxalacetate transaminase|Y
penicillinase-resistant penicillins|penicillinase-resistant penicillin|Y
Src-homology-2 domain-containing protein tyrosine phosphatase-2|src-homology-2 domain-containing protein tyrosine phosphatase-2|Y
Src-homology-2 domain-containing protein tyrosine phosphatase-2|Src homology-2 domain-containing protein tyrosine phosphatase-2|Y
Src-homology-2 domain-containing protein tyrosine phosphatase-2|Src-homology-2 domain-containing protein tyrosine phosphatase 2|Y
transcription factor IIIB|transcription factor IIB|Y
electroosmotic flow velocity|electro-osmotic flow velocity|Y
major histo-compatibility complex class II molecule|major histocompatibility complex class II molecule|Y
major histo-compatibility complex class II molecule|major histo-compatibility complex class-II molecule|Y
(18)fluorine-labeled|(18)fluorine-labelled|Y
lumbo-radicular syndrome|lumboradicular syndrome|Y
trans-junctional voltage|transjunctional voltage|Y
4-hydroxy-3-methoxyphenylglycol|4-hydroxy-3-methoxyphenyl glycol|Y
capillary electrophoresis-time of flight-mass spectrometry|capillary electrophoresis-time of flight/mass spectrometry|Y
human adenovirus type 27|human adenovirus type 7|Y
HIV/sexually transmitted infection prevention program|HIV/sexually transmitted infection prevention programme|Y
sixteen-slice multidetector computed tomography|sixteen-slice multi-detector computed tomography|Y
oral premalignant lesion|oral pre-malignant lesion|Y
anti-histocompatibility leukocyte antigen antibody|anti-histocompatibility leucocyte antigen antibody|Y
surface-generalized Born continuum solvation model|surface-generalised Born continuum solvation model|Y
surface-generalized Born continuum solvation model|surface generalized Born continuum solvation model|Y
molecularly imprinted solid phase extraction|molecularly-imprinted solid phase extraction|Y
tissue inhibitor of matrix metalloproteinase|tissue inhibitors of matrix metalloproteinase|Y
tissue inhibitor of matrix metalloproteinase|tissue inhibitor of matrix metalloproteinase-1|Y
Fas-associated death domain-like interleukin-1β-converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1 β converting enzyme inhibitory protein|Y
Fas-associated death domain-like interleukin-1β-converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1 β-converting enzyme-inhibitory protein|Y
Fas-associated death domain-like interleukin-1β-converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1β converting enzyme-inhibitory protein|Y
Fas-associated death domain-like interleukin-1β-converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1β-converting enzyme-inhibitory protein|Y
α-1-protease inhibitor|α1-protease inhibitor|Y
staphylococcal enterotoxin C|staphylococcal enterotoxin C1|Y
American Society of Anaesthesiology status 1|American Society of Anaesthesiology status 2|Y
American Society of Anaesthesiology status 1|American Society of Anaesthesiology status 3|Y
American Society of Anaesthesiology status 1|American Society of Anaesthesiology status I|Y
American Society of Anaesthesiology status 1|American Society of Anaesthesiology status|Y
American Society of Anaesthesiology status 1|American Society of Anaesthesiology status V|Y
phospho-glycogen synthase kinase 3β|phospho-glycogen synthase kinase 3 β|Y
intra-flagellar transport|intraflagellar transport|Y
anti-T cell receptor α β antibody|anti-T cell receptor αβ antibody|Y
post-inflammatory hyperpigmentation|postinflammatory hyperpigmentation|Y
hyperornithinemia hyperammonemia homocitrullinuria syndrome|hyperornithinaemia hyperammonaemia homocitrullinuria syndrome|Y
γ-aminobutyric acid receptor chloride channel complex|γ-aminobutyric acid receptor-chloride channel complex|Y
8-anilino-1-naphthalenesulfonic acid|8-anilino-1-naphthalene-sulfonic acid|Y
glycosylphosphatidylinositol linked|glycosyl phosphatidylinositol linked|Y
peroxisome proliferator-activated receptor-γ co-activator 1 α|peroxisome proliferator-activated receptor-γ coactivator-1 α|Y
peroxisome proliferator-activated receptor-γ co-activator 1 α|peroxisome proliferator-activated receptor-γ coactivator 1 α|Y
peroxisome proliferator-activated receptor-γ co-activator 1 α|peroxisome proliferator-activated receptor γ co-activator 1 α|Y
peroxisome proliferator-activated receptor-γ co-activator 1 α|peroxisome proliferator-activated receptor-γ co-activator 1α|Y
peroxisome proliferator-activated receptor-γ co-activator 1 α|peroxisome-proliferator-activated receptor-γ co-activator 1 α|Y
peroxisome proliferator-activated receptor-γ co-activator 1 α|peroxisome proliferator-activated receptor-γ co-activator-1α|Y
peroxisome proliferator-activated receptor-γ co-activator 1 α|peroxisome proliferator-activated receptor-γ co-activator-1 α|Y
peroxisome proliferator-activated receptor-γ co-activator 1 α|peroxisome proliferator-activated receptor γ co-activator 1α|Y
morpholino oligonucleotide|morpholino oligo-nucleotide|Y
G protein-coupled receptor kinase-2 mediated|G protein-coupled receptor kinase-2-mediated|Y
G protein-coupled receptor kinase-2 mediated|G protein-coupled receptor kinase 2 mediated|Y
ethylmethanesulfonate|methylmethanesulfonate|Y
cartilage-derived morphogenetic protein-3|cartilage-derived morphogenetic protein|Y
vitamin D3-up-regulated protein-1|vitamin D3-upregulated protein-1|Y
calculated bio-available testosterone|calculated bioavailable testosterone|Y
Escherichia coli restriction endonuclease I|Escherichia coli restriction endonuclease|Y
Escherichia coli restriction endonuclease I|Escherichia coli restriction endonuclease II|Y
intracerebral hæmatoma|intra-cerebral hæmatoma|Y
levonorgestrel-releasing intra uterine system|laevonorgestrel-releasing intra uterine system|Y
levonorgestrel-releasing intra uterine system|levonorgestrel releasing intra uterine system|Y
levonorgestrel-releasing intra uterine system|levonorgestrel-releasing intra-uterine system|Y
immuno-fluorescence in situ hybridization|immuno-fluorescence in situ hybridisation|Y
toll-interleukin-1 receptor domain-containing adaptor inducing IFN-β|Toll-interleukin-1 receptor domain-containing adaptor inducing IFN-β|Y
artificial genitourinary sphincter|artificial genito-urinary sphincter|Y
tele-methyl-histamine|tele-methylhistamine|Y
fasting hyperbilirubinæmia|fasting hyper-bilirubinæmia|Y
crosspolarization magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization magic-angle-spinning nuclear magnetic resonance spectroscopy|cross polarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarization magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarization magic-angle-spinning nuclear magnetic resonance spectroscopy|cross polarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
pregnenolone-16alpha-carbonitrile|pregnenolone-16 alpha-carbonitrile|Y
anti-human T-cell lymphotrophic virus type-I antibody|anti-human T-cell lymphotropic virus type-I antibody|Y
anti-human T-cell lymphotrophic virus type-I antibody|anti-human T-cell lymphotrophic virus type I antibody|Y
anti-human T-cell lymphotrophic virus type-I antibody|anti-human T cell lymphotrophic virus type-I antibody|Y
neoadjuvant hormone therapy|neo-adjuvant hormone therapy|Y
clinical global impressions-improvement scale|clinical global impressions improvement scale|Y
proteasome subunit beta type 1|proteasome subunit beta type 10|Y
sequence-tagged site|sequence-tagged sites|Y
methylation sensitive amplified polymorphism|methylation-sensitive amplified polymorphism|Y
trans-esophageal atrial stimulation|transesophageal atrial stimulation|Y
ste-20-related proline alanine-rich kinase|ste-20-related proline alanine rich kinase|Y
hemoglobin Riverdale-Bronx|haemoglobin Riverdale-Bronx|Y
Toll-interleukin 1 receptor domain-containing adapter-inducing interferon β|Toll-interleukin1 receptor domain-containing adapter-inducing interferon β|Y
Toll-interleukin 1 receptor domain-containing adapter-inducing interferon β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon β|Y
galactorrhœa amenorrhea hyperprolactinaemia syndrome|galactorrhœa amenorrhea hyperprolactinemia syndrome|Y
galactorrhœa amenorrhea hyperprolactinaemia syndrome|galactorrhœa-amenorrhea hyperprolactinaemia syndrome|Y
galactorrhœa amenorrhea hyperprolactinaemia syndrome|galactorrhœa amenorrhoea hyperprolactinaemia syndrome|Y
gamma-aminobutyric acid-benzodiazepine receptor complex|gamma-aminobutyric acid A-benzodiazepine receptor complex|Y
gamma-aminobutyric acid-benzodiazepine receptor complex|gamma-aminobutyric acid/benzodiazepine receptor complex|Y
gamma-aminobutyric acid-benzodiazepine receptor complex|gamma-aminobutyric acidA-benzodiazepine receptor complex|Y
periodic lateralised epileptiform discharges|periodic lateralized epileptiform discharges|Y
formin homology domain-containing protein 1|formin homology domain-containing protein-1|Y
formin homology domain-containing protein 1|formin homology domain containing protein 1|Y
immunoreactive prostaglandin E2|immunoreactive prostaglandin E|Y
interleukin-2 receptor common γ-chain|interleukine-2 receptor common γ-chain|Y
multi-gated acquisition scan|multigated acquisition scan|Y
lymphoproliferative disease|lympho-proliferative disease|Y
Growth hormone-releasing peptides|Growth hormone-releasing peptide|Y
inhibitory guanine nucleotide-binding protein|inhibitory guanine nucleotide binding protein|Y
haematoxylin and eosin|hematoxylin and eosin|Y
size exclusion chromatography-inductively coupled plasma mass spectrometry|size-exclusion chromatography-inductively coupled plasma mass spectrometry|Y
size exclusion chromatography-inductively coupled plasma mass spectrometry|size exclusion chromatography-inductively coupled plasma-mass spectrometry|Y
central serous chorioretinopathy|central serous chorio-retinopathy|Y
total internal reflection fluorescence microscope|total internal reflection fluorescence microscopy|Y
dermo-epidermal junction|dermoepidermal junction|Y
hereditary sensory and autonomic neuropathy type 3|hereditary sensory and autonomic neuropathy type V|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloprotease with thrombospondin motif-20|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloprotease with thrombospondin motifs-4|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloprotease with thrombospondin motifs-2|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloprotease with thrombospondin motif-2|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloprotease with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloprotease with thrombospondin motifs-9|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motif-3|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
antiinterleukin-12 neutralizing antibody|anti-interleukin-12 neutralizing antibody|Y
neuroepithelial cell|neuro-epithelial cell|Y
prostaglandin-like substance|prostaglandinlike substance|Y
β-amyloid precursor protein cleaving enzyme|β-amyloid precursor protein cleaving enzyme-2|Y
β-amyloid precursor protein cleaving enzyme|β-amyloid precursor protein cleaving enzyme 1|Y
tumour necrosis factor receptor-associated factor-2|tumour necrosis factor receptor associated factor-2|Y
tumour necrosis factor receptor-associated factor-2|tumour necrosis factor receptor-associated factor 2|Y
tumour necrosis factor receptor-associated factor-2|tumour necrosis factor receptor-associated factor-5|Y
molecularly-imprinted solid-phase extraction|molecularly-imprinted solid phase extraction|Y
human leucocyte antigen D|human leucocyte antigen DR|Y
numbers needed to treat|number needed to treat|Y
six transmembrane epithelial antigen of the prostate 3|six transmembrane epithelial antigen of the prostate 1|Y
six transmembrane epithelial antigen of the prostate 3|six transmembrane epithelial antigen of the prostate 4|Y
never-in-mitosis Aspergillus-related kinase 3|never-in-mitosis Aspergillus-related kinase 2|Y
never-in-mitosis Aspergillus-related kinase 3|never-in-mitosis Aspergillus-related kinase 4|Y
never-in-mitosis Aspergillus-related kinase 3|never-in-mitosis Aspergillus-related kinase 7|Y
never-in-mitosis Aspergillus-related kinase 3|never-in-mitosis Aspergillus-related kinase|Y
American Society of Anaesthesiology physical status 2|American Society of Anaesthesiology physical status 3|Y
American Society of Anaesthesiology physical status 2|American Society of Anaesthesiology physical status I|Y
American Society of Anaesthesiology physical status 2|American Society of Anaesthesiology physical status 5|Y
American Society of Anaesthesiology physical status 2|American Society of Anaesthesiology physical status 1|Y
American Society of Anaesthesiology physical status 2|American Society of Anaesthesiology physical status|Y
American Society of Anaesthesiology physical status 2|American Society of Anesthesiology physical status 2|Y
solute carrier family 7 member 4|solute carrier family 17 member 4|Y
solute carrier family 7 member 4|solute carrier family 7 member 14|Y
unusual estrogen-binding protein|unusual oestrogen-binding protein|Y
pentylene-tetrazole-kindled|pentylenetetrazole-kindled|Y
pentylene-tetrazole-kindled|pentylene-tetrazol-kindled|Y
thermoencephaloscopy|thermo-encephaloscopy|Y
calcium voltage-gated channel subunit alpha 1 C|calcium voltage-gated channel subunit alpha1 C|Y
superheated water extraction|super-heated water extraction|Y
cluster of differentiation antigen 6|cluster of differentiation antigen 86|Y
cluster of differentiation antigen 6|cluster of differentiation antigen 67|Y
cluster of differentiation antigen 6|cluster of differentiation antigen 64|Y
cluster of differentiation antigen 6|cluster of differentiation antigen 36|Y
cluster of differentiation antigen 6|cluster of differentiation antigen 66|Y
cGMP-dependent protein kinase Ialpha|cGMP-dependent protein kinase I alpha|Y
enterically-transmitted non-A non-B hepatitis|enterically-transmitted non-A, non-B hepatitis|Y
non-competitive antagonist|noncompetitive antagonist|Y
nonsteroidal aromatase inhibitor|non-steroidal aromatase inhibitor|Y
delayed enhancement cardiac magnetic resonance|delayed-enhancement cardiac magnetic resonance|Y
α1a-adrenergic receptor|α-1a-adrenergic receptor|Y
alpha-naphthyl acetate esterase|alpha-naphthylacetate esterase|Y
quadrupole time of flight mass spectrometry|quadrupole time of flight mass spectrometer|Y
antiendomysial antibody|anti-endomysial antibody|Y
fan beam dual energy X-ray absorptiometry|fan beam dual-energy X-ray absorptiometry|Y
fan beam dual energy X-ray absorptiometry|fan-beam dual energy X-ray absorptiometry|Y
src homology 2 domain-containing protein-tyrosine phosphatase substrate-1|Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1|Y
src homology 2 domain-containing protein-tyrosine phosphatase substrate-1|src homology 2 domain-containing protein-tyrosine phosphatase substrate 1|Y
fluorine 18-labeled fluoro-deoxyglucose|fluorine 18-labeled fluoro-deoxy-glucose|Y
formin-homology-domain-containing protein 1|formin-homology-domain-containing protein-1|Y
Pediatric Risk of Mortality score|Paediatric Risk of Mortality score|Y
anti-granulocyte macrophage-colony stimulating factor autoantibody|anti-granulocyte macrophage-colony stimulating factor auto-antibody|Y
SCID repopulating cells|SCID repopulating cell|Y
American Society of Anesthesiology physical status I|American Society of Anesthesiology physical status IV|Y
American Society of Anesthesiology physical status I|American Society of Anaesthesiology physical status I|Y
American Society of Anesthesiology physical status I|American Society of Anesthesiology physical status III|Y
American Society of Anesthesiology physical status I|American Society of Anesthesiology physical status II|Y
American Society of Anesthesiology physical status I|American Society of Anesthesiology physical status 2|Y
American Society of Anesthesiology physical status I|American Society of Anesthesiology physical status|Y
American Society of Anesthesiology physical status I|American Society of Anaesthesiology physical status IV|Y
American Society of Anesthesiology physical status I|American Society of Anesthesiology physical status 3|Y
midleft anterior descending artery|mid left anterior descending artery|Y
a disintegrin and metalloprotease with thrombospondin motif-20|a disintegrin and metalloprotease with thrombospondin motifs-2|Y
a disintegrin and metalloprotease with thrombospondin motif-20|a disintegrin and metalloprotease with thrombospondin motif-2|Y
a disintegrin and metalloprotease with thrombospondin motif-20|a disintegrin and metalloprotease with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motif-20|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motif-20|a disintegrin and metalloprotease with thrombospondin motifs-20|Y
a disintegrin and metalloprotease with thrombospondin motif-20|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motif-20|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motif-20|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motif-20|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motif-20|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-20|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motif-20|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
methylthioadenosine triphosphate|methylthio-adenosine triphosphate|Y
post-anaesthesia recovery unit|post-anesthesia recovery unit|Y
X-linked hyperimmunoglobulin M syndrome|X-linked hyper-immunoglobulin M syndrome|Y
peptidylglycine α-amidating mono-oxygenase|peptidyl glycine α-amidating mono-oxygenase|Y
peptidylglycine α-amidating mono-oxygenase|peptidylglycine α-amidating monooxygenase|Y
peptidylglycine α-amidating mono-oxygenase|peptidyl-glycine α-amidating mono-oxygenase|Y
dentato-rubro-pallidoluysian atrophy|dentato-rubropallidoluysian atrophy|Y
peptide nucleic acid fluorescence in situ hybridization|peptide nucleic acid fluorescence in situ hybridisation|Y
peptide nucleic acid fluorescence in situ hybridization|peptide nucleic acid-fluorescence in situ hybridization|Y
electro-mobility shift assay|electromobility shift assay|Y
pterygopalatine fossa|pterygo-palatine fossa|Y
neuronal precursor cell-expressed developmentally downregulated 4-2|neuronal precursor cell-expressed developmentally downregulated 4|Y
neuronal precursor cell-expressed developmentally downregulated 4-2|neuronal precursor cell-expressed developmentally down-regulated 4|Y
wingless-type MMTV integration site family member 9a|Wingless-type MMTV integration site family member 9a|Y
peroxisome-proliferator-activated receptor-γ coactivator-1α|peroxisome-proliferator-activated receptor-γ coactivator 1α|Y
anti-topo-isomerase-I|anti-topoisomerase-I|Y
TBP associated factor-5|TBP associated factor-15|Y
ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry|ultra performance liquid chromatography/quadrupole time-of-flight mass spectrometry|Y
ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry|ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry|Y
major histocompatibility complex class I protein|major histocompatibility complex class II protein|Y
transesophageal echoprobe|trans-esophageal echoprobe|Y
antiasialo GM1 antibody|antiasialo GM-1 antibody|Y
antiasialo GM1 antibody|anti-asialo GM1 antibody|Y
antiIL-12 monoclonal antibody|antiIL-2 monoclonal antibody|Y
Mycobacterium xenopei|Mycobacterium xenopi|Y
haemoglobin Gainesville-Ga|hemoglobin Gainesville-Ga|Y
Becke three parameter Lee-Yang-Parr functional|Becke three-parameter Lee-Yang-Parr functional|Y
minimally invasive radioguided parathyroidectomy|minimally invasive radio guided parathyroidectomy|Y
isovolumic contraction time|iso-volumic contraction time|Y
electron-probe x-ray micro-analysis|electron-probe x-ray microanalysis|Y
tumor necrosis factor receptor associated factor 6|tumor necrosis factor receptor associated factor 5|Y
tumor necrosis factor receptor associated factor 6|tumor necrosis factor receptor associated factor 1|Y
tumor necrosis factor receptor associated factor 6|tumor necrosis factor receptor-associated factor 6|Y
American Society of Anesthesiologists status V|American Society of Anesthesiologists status I|Y
American Society of Anesthesiologists status V|American Society of Anaesthesiologists status IV|Y
American Society of Anesthesiologists status V|American Society of Anesthesiologists status 5|Y
interleukin 13 receptor α 2 chain|interleukin 13 receptor α2 chain|Y
radio contrast-induced nephropathy|radiocontrast-induced nephropathy|Y
retinoic-acid-receptor-related orphan receptor gamma|retinoic-acid-receptor-related orphan receptor-gamma|Y
retinoic-acid-receptor-related orphan receptor gamma|retinoic-acid-receptor-related orphan receptor gammaT|Y
retinoic-acid-receptor-related orphan receptor gamma|retinoic-acid-receptor-related orphan receptor gammat|Y
retinoic-acid-receptor-related orphan receptor gamma|retinoic-acid-receptor-related orphan receptor gamma-T|Y
retinoic-acid-receptor-related orphan receptor gamma|retinoic-acid-receptor-related orphan receptor gamma-t|Y
transforming-growth-factor-beta-activated kinase-1|transforming-growth-factor-beta-activated kinase 1|Y
oculo-auricolovertebral dysplasia|oculo-auricolo-vertebral dysplasia|Y
2,3-dimercapto-1-propane sulfonate|2,3-dimercapto-1-propanesulfonate|Y
signal transducer and activator of transcription protein|signal transducers and activators of transcription protein|Y
α1-antitrypsin deficiency|α-1-antitrypsin deficiency|Y
branched chain alpha ketoacid dehydrogenase deficiency|branched chain alphaketoacid dehydrogenase deficiency|Y
glycogen synthase kinase 3β|glycogen synthase kinase 3 β|Y
meso-caval interposition shunt|mesocaval interposition shunt|Y
immunoglobulin γ 2 antibody|immunoglobulin γ2 antibody|Y
phospho-extracellular-signal-regulated kinase|phospho-extracellular signal-regulated kinase|Y
American Society of Anaesthesiologists grade IV|American Society of Anaesthesiologists grade II|Y
American Society of Anaesthesiologists grade IV|American Society of Anaesthesiologists grade I|Y
American Society of Anaesthesiologists grade IV|American Society of Anesthesiologists grade V|Y
American Society of Anaesthesiologists grade IV|American Society of Anesthesiologists grade I|Y
carbohydrate deficient glycoprotein syndrome type 1a|carbohydrate deficient glycoprotein syndrome type 1|Y
rhamnogalacturonan II|rhamnogalacturonan I|Y
midlatency auditory evoked potential|mid-latency auditory evoked potential|Y
encephalo-myo-synangiosis|encephalo-myosynangiosis|Y
interleukin-18 receptor-alpha|interleukine-18 receptor-alpha|Y
noradrenaline re-uptake inhibitor|noradrenaline reuptake inhibitor|Y
phosphorylated cAMP responsive element-binding protein|phosphorylated cAMP responsive element binding protein|Y
peroxisome proliferator-activated receptor gamma1|peroxisome proliferator-activated receptor-gamma1|Y
peroxisome proliferator-activated receptor gamma1|peroxisome proliferator activated receptor gamma1|Y
peroxisome proliferator-activated receptor gamma1|peroxisome proliferator-activated receptor gamma-1|Y
interleukine 13 receptor α 2-chain|interleukin 13 receptor α 2-chain|Y
voltage-operated Ca2+ channels|voltage-operated Ca2+ channel|Y
cross polarization/magic angle spinning nuclear magnetic resonance spectroscopy|cross-polarization/magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization/magic angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization/magic angle spinning nuclear magnetic resonance spectroscopy|cross polarisation/magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarization/magic angle spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
electron probe X-ray micro analysis|electron probe X-ray microanalysis|Y
multiresolution wavelet transform|multi-resolution wavelet transform|Y
non-specific cytotoxic cell receptor protein 1|nonspecific cytotoxic cell receptor protein 1|Y
non-specific cytotoxic cell receptor protein 1|non-specific cytotoxic cell receptor protein|Y
non-specific cytotoxic cell receptor protein 1|non-specific cytotoxic cell receptor protein-1|Y
quasilinear viscoelastic model|quasi-linear viscoelastic model|Y
senescence associated beta galactosidase|senescence-associated beta galactosidase|Y
Locusta migratoria tachykinin IV|Locusta migratoria tachykinin I|Y
soluble cluster of differentiation antigen 28|soluble cluster of differentiation antigen 27|Y
soluble cluster of differentiation antigen 28|soluble cluster of differentiation antigen 86|Y
soluble cluster of differentiation antigen 28|soluble cluster of differentiation antigen 83|Y
soluble cluster of differentiation antigen 28|soluble cluster of differentiation antigen 80|Y
soluble cluster of differentiation antigen 28|soluble cluster of differentiation antigen 26|Y
mitogen activated protein kinase-dependent signaling pathway|mitogen-activated protein kinase-dependent signaling pathway|Y
mitogen activated protein kinase-dependent signaling pathway|mitogen activated protein kinase-dependent signalling pathway|Y
α2C-adrenergic receptor|α 2C-adrenergic receptor|Y
intraabdominal injury|intra-abdominal injury|Y
cyclic guanosine monophosphate-dependent protein kinase Iα|cyclic guanosine monophosphate-dependent protein kinase I|Y
insulinlike growth factor 1-mediated|insulin-like growth factor 1-mediated|Y
tumor-associated foetal antigen|tumor-associated fetal antigen|Y
tumor-associated foetal antigen|tumour-associated foetal antigen|Y
cortical auditory evoked potentials|cortical auditory evoked potential|Y
electroencephalography study|electro-encephalography study|Y
disseminated superficial actinic porokeratosis|Disseminated superficial actinic porokeratosis|Y
ATP-binding cassette sub-family B member-1|ATP-binding cassette sub-family B member 1|Y
ATP-binding cassette sub-family B member-1|ATP-binding cassette subfamily B member-1|Y
non-aqueous reversed-phase high-performance liquid chromatography|non-aqueous reversed-phase high performance liquid chromatography|Y
src homology 2 domain-containing protein-tyrosine phosphatase-1|src homology 2 domain-containing protein tyrosine phosphatase-1|Y
src homology 2 domain-containing protein-tyrosine phosphatase-1|Src homology 2 domain-containing protein-tyrosine phosphatase-1|Y
src homology 2 domain-containing protein-tyrosine phosphatase-1|src homology 2 domain-containing protein-tyrosine phosphatase 1|Y
selected-ion flow-tube mass spectrometry|selected-ion flow tube mass spectrometry|Y
tumour-associated trypsin inhibitor|tumor-associated trypsin inhibitor|Y
Fas-associated death domain-like interleukin-1 beta-converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1beta-converting enzyme inhibitory protein|Y
Fas-associated death domain-like interleukin-1 beta-converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein|Y
Fas-associated death domain-like interleukin-1 beta-converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1beta converting enzyme inhibitory protein|Y
anti-matrix metalloproteinase-1 antibody|anti-matrix metalloproteinase-13 antibody|Y
anti-matrix metalloproteinase-1 antibody|anti-matrix metalloproteinase-7 antibody|Y
sterol response element binding protein 1-a|sterol response element binding protein-1-a|Y
sterol response element binding protein 1-a|sterol response element-binding protein 1-a|Y
sterol response element binding protein 1-a|sterol response element binding protein 1-c|Y
interferon induced transmembrane protein 1|interferon-induced transmembrane protein 1|Y
interferon induced transmembrane protein 1|interferon induced transmembrane protein-1|Y
transforming growth factor β-induced gene|transforming growth factor-β-induced gene|Y
human leukocyte antigen-D-related antigen 4|human leukocyte antigen-D-related antigen 1|Y
human leukocyte antigen-D-related antigen 4|human leukocyte antigen-D-related antigen|Y
pre-prosomatostatin messenger ribonucleic acid|preprosomatostatin messenger ribonucleic acid|Y
reaction centre-light harvesting complex 1|reaction centre-light harvesting complex I|Y
antiinterleukin 7 antibody|anti-interleukin 7 antibody|Y
antiinterleukin 7 antibody|antiinterleukin 17 antibody|Y
tracheoinnominate fistula|tracheo-innominate fistula|Y
γ-glutamyl-transpeptidase|γ-glutamyltranspeptidase|Y
ultrapurified polymerised bovine haemoglobin|ultra-purified polymerised bovine haemoglobin|Y
ultrapurified polymerised bovine haemoglobin|ultrapurified polymerised bovine hemoglobin|Y
depolarising afterpotential|depolarising after-potential|Y
oto-rhinolaryngology|oto-rhino-laryngology|Y
sterol regulatory element binding protein 1|sterol regulatory element binding protein 1-c|Y
sterol regulatory element binding protein 1|sterol regulatory element binding protein 1c|Y
v-rel reticuloendotheliosis viral oncogene homologue A|v-rel reticuloendotheliosis viral oncogene homologue B|Y
anti-T-cell receptor-α/β monoclonal antibody|anti-T-cell receptor α/β monoclonal antibody|Y
anti-T-cell receptor-α/β monoclonal antibody|anti-T-cell receptor-α β monoclonal antibody|Y
gadolinium diethylenetriamine pentaacetic acid|gadolinium-diethylenetriamine pentaacetic acid|Y
trifluoromethyl-phenylpiperazine|trifluoromethylphenylpiperazine|Y
TATA-binding protein-associated factor-8|TATA-binding protein-associated factor 8|Y
TATA-binding protein-associated factor-8|TATA-binding protein-associated factor-6|Y
TATA-binding protein-associated factor-8|TATA-binding protein-associated factor-3|Y
TATA-binding protein-associated factor-8|TATA-binding protein-associated factor-4|Y
TATA-binding protein-associated factor-8|TATA-binding protein-associated factor-9|Y
TATA-binding protein-associated factor-8|TATA-binding protein-associated factor-7|Y
TATA-binding protein-associated factor-8|TATA-binding protein-associated factor-2|Y
TATA-binding protein-associated factor-8|TATA-binding protein-associated factor-1|Y
TSH-binding inhibitor immunoglobulin|TSH-binding inhibitory immunoglobulin|Y
TSH-binding inhibitor immunoglobulin|TSH-binding inhibitor immunoglobulins|Y
src homology 2 domain containing protein tyrosine phosphatase substrate-1|src homology 2 domain containing protein tyrosine phosphatase substrate 1|Y
src homology 2 domain containing protein tyrosine phosphatase substrate-1|Src homology 2 domain containing protein tyrosine phosphatase substrate-1|Y
gas chromatography/electron-capture negative ion mass spectrometry|gas chromatography/electron capture negative ion mass spectrometry|Y
gas chromatography/electron-capture negative ion mass spectrometry|gas chromatography-electron-capture negative ion mass spectrometry|Y
nonpharmaceutical intervention|non-pharmaceutical intervention|Y
light-harvesting chlorophyll a/b protein|light-harvesting chlorophyll a/b protein-I|Y
homozygous α-1 proteinase inhibitor deficiency|homozygous α-1 protease inhibitor deficiency|Y
homozygous α-1 proteinase inhibitor deficiency|homozygous α-1-proteinase inhibitor deficiency|Y
tumor necrosis factor receptor superfamily member 10c|tumor necrosis factor receptor superfamily member 10a|Y
tumor necrosis factor receptor superfamily member 10c|tumor necrosis factor receptor superfamily member 10b|Y
tumor necrosis factor receptor superfamily member 10c|tumor necrosis factor receptor superfamily member 10d|Y
transmissible subacute spongiform encephalopathy|transmissible sub-acute spongiform encephalopathy|Y
corticotrophin-releasing hormone receptor-1|corticotrophin-releasing hormone receptor 1|Y
corticotrophin-releasing hormone receptor-1|corticotropin-releasing hormone receptor-1|Y
corticotrophin-releasing hormone receptor-1|corticotrophin-releasing hormone receptor|Y
corticotrophin-releasing hormone receptor-1|corticotrophin releasing hormone receptor-1|Y
vibroacoustic disease|vibro-acoustic disease|Y
secreted modular calcium binding protein-1|secreted modular calcium-binding protein-1|Y
internal carotid posterior communicating artery|internal carotid-posterior communicating artery|Y
anti-IL 18 monoclonal antibody|anti-IL 8 monoclonal antibody|Y
anti-IL 18 monoclonal antibody|anti-IL18 monoclonal antibody|Y
encephaloduro-arteriosynangiosis|encephaloduro-arterio-synangiosis|Y
microtubule-associated protein-2c|microtubule-associated protein-2|Y
para-fluorohexahydrosiladifenidol|parafluorohexahydrosiladifenidol|Y
para-fluorohexahydrosiladifenidol|para-fluoro-hexahydrosiladifenidol|Y
Wechsler Intelligence Scale for Children-Fourth Edition|Wechsler Intelligence Scale for Children - Fourth Edition|Y
multi-colour fluorescence in situ hybridisation|multi-colour fluorescence in-situ hybridisation|Y
cGMP-dependent protein kinase I|cGMP-dependent protein kinase Iα|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motifs-4|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motifs-2|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motifs-9|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motifs-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloprotease with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
American Society of Anaesthesiologists status 2|American Society of Anaesthesiologists status 4|Y
American Society of Anaesthesiologists status 2|American Society of Anaesthesiologists status I|Y
American Society of Anaesthesiologists status 2|American Society of Anaesthesiologists status 1|Y
American Society of Anaesthesiologists status 2|American Society of Anaesthesiologists status 5|Y
human immunodeficiency virus type 1 subtype C|human immunodeficiency virus type 1 subtype A|Y
human immunodeficiency virus type 1 subtype C|human immunodeficiency virus type 1 subtype D|Y
human immunodeficiency virus type 1 subtype C|human immunodeficiency virus type 1 subtype F|Y
retinoic acid receptor-related orphan receptor α|retinoic acid receptor-related orphan receptor-α|Y
retinoic acid receptor-related orphan receptor α|retinoic acid receptor-related orphan receptor γ|Y
beta amyloid precursor protein-cleaving enzyme 2|beta amyloid precursor protein cleaving enzyme 2|Y
interleukin-13 receptor α2 subunit|interleukin-13 receptor α 2 subunit|Y
ribonucleic acid polymerase sigma factor 1|ribonucleic acid polymerase sigma factor|Y
glycosyl phosphatidylinositol-anchored protein|glycosylphosphatidyl inositol-anchored protein|Y
glycosyl phosphatidylinositol-anchored protein|glycosylphosphatidylinositol-anchored protein|Y
glycosyl phosphatidylinositol-anchored protein|glycosyl-phosphatidylinositol-anchored protein|Y
glycosyl phosphatidylinositol-anchored protein|glycosylphosphatidyl-inositol-anchored protein|Y
Sprouty-related, EVH1 domain containing protein 2|Sprouty-related, EVH1 domain containing protein 1|Y
parainfluenza virus type 4|parainfluenza virus type 4A|Y
anti-muellerian hormone|anti-mullerian hormone|Y
transverse relaxation-optimized spectroscopy|transverse relaxation optimized spectroscopy|Y
infectious bovine rhinotracheitis-infectious pustular vulvovaginitis virus|infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis virus|Y
antiinterleukin 1 antibody|antiinterleukin 18 antibody|Y
antiinterleukin 1 antibody|antiinterleukin 12 antibody|Y
antiinterleukin 1 antibody|antiinterleukin 17 antibody|Y
antiinterleukin 1 antibody|anti-interleukin 1 antibody|Y
methylaminoisobutyric acid|methylamino-isobutyric acid|Y
non-Hodgkin's lymphoma-Berlin-Frankfurt-Munster trial 90|non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster trial 90|Y
gonadotropin-releasing-hormone-associated peptide|gonadotropin-releasing hormone-associated peptide|Y
pulmonary arteriovenous fistula|pulmonary arterio-venous fistula|Y
anti-interleukin 3 antibody|anti-interleukin 13 antibody|Y
extracellular signal-regulated kinase1/2|extracellular signal-regulated kinases 1/2|Y
extracellular signal-regulated kinase1/2|extracellular signal-regulated kinase 1/2|Y
extracellular signal-regulated kinase1/2|extracellular signal-regulated kinase-1/2|Y
graft-infiltrating cell|graft-infiltrating cells|Y
nearest neighbour distance|nearest neighbor distance|Y
3-methoxy-4-hydroxyphenylethyleneglycol|3-methoxy-4-hydroxy-phenylethyleneglycol|Y
3-methoxy-4-hydroxyphenylethyleneglycol|3-methoxy-4-hydroxyphenylethylene glycol|Y
gonadotrophin releasing factor|gonadotropin releasing factor|Y
continuous venovenous hemodiafiltration|continuous venovenous haemo-diafiltration|Y
continuous venovenous hemodiafiltration|continuous veno-venous hemo-diafiltration|Y
continuous venovenous hemodiafiltration|continuous venovenous hemo-diafiltration|Y
American Society of Anaesthesiologists grade|American Society of Anaesthesiologists grade 2|Y
American Society of Anaesthesiologists grade|American Society of Anaesthesiologists grade I|Y
American Society of Anaesthesiologists grade|American Society of Anesthesiologists grade|Y
American Society of Anaesthesiologists grade|American Society of Anaesthesiologists grade 3|Y
American Society of Anaesthesiologists grade|American Society of Anaesthesiologists grade 5|Y
American Society of Anaesthesiologists grade|American Society of Anaesthesiologists grade 4|Y
ras-related GTP-binding protein 9A|ras-related GTP-binding protein 39A|Y
bi-directional pyrophosphorolysis-activated polymerization allele-specific amplification|bidirectional pyrophosphorolysis-activated polymerization allele-specific amplification|Y
human adenovirus serotype 46|human adenovirus serotype 6|Y
granulocyte macrophage-colony-stimulating factor receptor alpha subunit|granulocyte macrophage colony-stimulating factor receptor alpha subunit|Y
United Network for Organ Sharing status II|United Network for Organ Sharing status I|Y
hemoglobin Roseau Pointe-à-Pitre|haemoglobin Roseau Pointe-à-Pitre|Y
anti-IL-10 receptor MAb|anti-IL10 receptor MAb|Y
tubulo-villous adenoma|tubulovillous adenoma|Y
naso-pharyngeal temperature|nasopharyngeal temperature|Y
sex determining region Y, box 7|sex determining region Y box 7|Y
generalized tonic clonic seizure|generalized tonic clonic seizures|Y
corticotrophin-releasing hormone receptor 1|corticotrophin-releasing hormone receptor|Y
corticotrophin-releasing hormone receptor 1|corticotropin-releasing hormone receptor 1|Y
arteriovenous fistula|arterovenous fistula|Y
laparoscopic Roux-en-Y gastric bypass|laparoscopic Rouxen-Y gastric bypass|Y
type III collagen gene|type II collagen gene|Y
right occipito-anterior|right occipitoanterior|Y
Src homology 2-containing protein tyrosine phosphatase-2|Src homology 2-containing protein-tyrosine phosphatase-2|Y
Src homology 2-containing protein tyrosine phosphatase-2|Src homology 2-containing protein tyrosine phosphatase|Y
ubiquitin-conjugating enzyme 2|ubiquitin-conjugating enzyme 2C|Y
thrombo-hemorrhagic syndrome|thrombohemorrhagic syndrome|Y
electro-hydraulic lithotripter|electrohydraulic lithotripter|Y
cholesteryl ester hydroperoxides|cholesteryl ester hydroperoxide|Y
synthetic tumor-associated glycoconjugate|synthetic tumour-associated glycoconjugate|Y
synthetic tumor-associated glycoconjugate|synthetic tumor associated glycoconjugate|Y
Src homology-2 domain-containing protein-tyrosine phosphatase|src homology-2 domain-containing protein-tyrosine phosphatase|Y
Src homology-2 domain-containing protein-tyrosine phosphatase|Src homology 2 domain-containing protein-tyrosine phosphatase|Y
src homology 2 domain-containing protein tyrosine phosphatase-1|src homology 2 domain-containing protein tyrosine phosphatase-2|Y
src homology 2 domain-containing protein tyrosine phosphatase-1|src homology 2 domain-containing protein tyrosine phosphatase 1|Y
augmented correlation-consistent polarized valence quadruple zeta basis set|augmented correlation consistent polarized valence quadruple zeta basis set|Y
augmented correlation-consistent polarized valence quadruple zeta basis set|augmented correlation-consistent polarised valence quadruple zeta basis set|Y
insulin-like growth factor II receptor|insulin-like growth factor I receptor|Y
delta-hexachlorocyclohexane|delta-hexachloro-cyclohexane|Y
dopamine1 receptor antagonist|dopamine receptor antagonist|Y
ectoadenosine deaminase|ecto-adenosine deaminase|Y
oligo-astheno-teratozoospermia|oligoastheno-teratozoospermia|Y
C-terminal trans-activation domain|C-terminal transactivation domain|Y
recombinant human interleukin 13|recombinant human interleukin 1|Y
radiation-induced tumor suppressor gene-1|radiation-induced tumor suppressor gene 1|Y
sub-foveal choroidal neovascularisation|subfoveal choroidal neovascularisation|Y
latent transforming growth factor beta binding protein-3|latent transforming growth factor beta binding protein-4|Y
latent transforming growth factor beta binding protein-3|latent transforming growth factor beta binding protein-2|Y
latent transforming growth factor beta binding protein-3|latent transforming growth factor beta binding protein 3|Y
solid-phase extraction-high performance liquid chromatography-tandem mass spectrometry|solid-phase extraction-high-performance liquid chromatography-tandem mass spectrometry|Y
solid-phase extraction-high performance liquid chromatography-tandem mass spectrometry|solid-phase extraction-high performance liquid chromatography/tandem mass spectrometry|Y
solid-phase extraction-high performance liquid chromatography-tandem mass spectrometry|solid phase extraction-high-performance liquid chromatography-tandem mass spectrometry|Y
solid-phase extraction-high performance liquid chromatography-tandem mass spectrometry|solid-phase extraction-high-performance liquid chromatography/tandem mass spectrometry|Y
magnetoencephalographic spike|magneto-encephalographic spike|Y
spinocerebellar ataxia|spino-cerebellar ataxia|Y
induction of anaesthesia|induction of anesthesia|Y
Michael E. DeBakey Veterans' Affairs Medical Center|Michael E. DeBakey Veteran's Affairs Medical Center|Y
Michael E. DeBakey Veterans' Affairs Medical Center|Michael E. DeBakey Veterans Affairs Medical Center|Y
hepatitis associated aplastic anemia|hepatitis associated aplastic anaemia|Y
oestrogen receptor α knock out|estrogen receptor α knock out|Y
electrically evoked auditory brain stem response|electrically evoked auditory brainstem response|Y
TATA-binding protein associated factor 6|TATA-binding protein associated factor 4|Y
TATA-binding protein associated factor 6|TATA-binding protein associated factor 5|Y
TATA-binding protein associated factor 6|TATA-binding protein-associated factor 6|Y
activity regulated cytoskeleton associated protein|activity-regulated cytoskeleton associated protein|Y
activity regulated cytoskeleton associated protein|activity regulated cytoskeleton-associated protein|Y
hyper-viscosity syndrome|hyperviscosity syndrome|Y
grazing incidence small angle X-ray scattering|grazing-incidence small angle X-ray scattering|Y
grazing incidence small angle X-ray scattering|grazing incidence small-angle X-ray scattering|Y
pseudo-exfoliative syndrome|pseudoexfoliative syndrome|Y
human immunodeficiency virus type 1 subtype A|human immunodeficiency virus type 1 subtype D|Y
human immunodeficiency virus type 1 subtype A|human immunodeficiency virus type 1 subtype F|Y
posttraumatic syringomyelia|post-traumatic syringomyelia|Y
solid-phase extraction-liquid chromatography-tandem mass spectrometry|solid phase extraction-liquid chromatography-tandem mass spectrometry|Y
cross polarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross polarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|cross polarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross polarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|cross polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|cross polarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross polarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross polarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
postherpetic neuritis|post-herpetic neuritis|Y
myocardial perfusion single photon emission computerised tomography|myocardial perfusion single photon emission computerized tomography|Y
myocardial perfusion single photon emission computerised tomography|myocardial perfusion single-photon emission computerised tomography|Y
flow velocity waveform|flow velocity waveforms|Y
American Society of Anesthesiology status 3|American Society of Anaesthesiology status 3|Y
American Society of Anesthesiology status 3|American Society of Anesthesiology status|Y
American Society of Anesthesiology status 3|American Society of Anesthesiology status 4|Y
American Society of Anesthesiology status 3|American Society of Anesthesiology status 5|Y
Bronx Veteran's Affairs Medical Center|Bronx Veterans Affairs Medical Center|Y
spinocerebellar ataxia type 5|spinocerebellar ataxia type 15|Y
spinocerebellar ataxia 2|spino-cerebellar ataxia 2|Y
homozygous alpha1PI deficiency|homozygous alpha1-PI deficiency|Y
glycosyl-phosphatidyl inositol-anchored|glycosyl-phosphatidylinositol-anchored|Y
choledocojejunostomy|choledoco-jejunostomy|Y
serum- and glucocorticoid-inducible kinase-1|serum and glucocorticoid-inducible kinase-1|Y
CC chemokine ligand 19|C-C chemokine ligand 19|Y
adenovirus type 12 E1|adenovirus type 12 E1B|Y
somato-sensory evoked response|somatosensory evoked response|Y
human T-cell lymphoma/leukemia virus type II|human T-cell lymphoma/leukaemia virus type II|Y
human T-cell lymphoma/leukemia virus type II|human T-cell lymphoma/leukemia virus type I|Y
human T-cell lymphoma/leukemia virus type II|human T-cell lymphoma/leukaemia virus type I|Y
mitochondrial neurogastrointestinal encephalomyopathy|mitochondrial neurogastro-intestinal encephalomyopathy|Y
mitochondrial neurogastrointestinal encephalomyopathy|mitochondrial neurogastrointestinal encephalo-myopathy|Y
mitochondrial neurogastrointestinal encephalomyopathy|mitochondrial neuro-gastrointestinal encephalomyopathy|Y
hypoxia inducible factor-1α|hypoxia inducible factor-1 α|Y
anti-interleukin 2 receptor antibody|antiinterleukin 2 receptor antibody|Y
reference-strand mediated conformation analysis|reference strand mediated conformation analysis|Y
p65 nuclear factor-κ B subunit|p65 nuclear factor-κB subunit|Y
ultra-purified polymerized bovine hemoglobin|ultrapurified polymerized bovine hemoglobin|Y
IL-12 receptor beta1|IL-12 receptor beta 1|Y
cross-reacting antigens|cross-reacting antigen|Y
technetium-99m diethylene-triaminepentaacetic acid-galactosyl human serum albumin|technetium-99m diethylene-triaminepentaacetic acid galactosyl human serum albumin|Y
technetium-99m diethylene-triaminepentaacetic acid-galactosyl human serum albumin|technetium-99m diethylenetriaminepentaacetic acid-galactosyl human serum albumin|Y
technetium-99m diethylene-triaminepentaacetic acid-galactosyl human serum albumin|technetium 99m diethylene-triaminepenta-acetic acid-galactosyl human serum albumin|Y
technetium-99m diethylene-triaminepentaacetic acid-galactosyl human serum albumin|technetium 99m diethylene-triaminepentaacetic acid galactosyl human serum albumin|Y
cationic anti-microbial protein 18|cationic antimicrobial protein 18|Y
cluster of differentiation 103|cluster of differentiation 10|Y
epifluorescence microscopy|epi-fluorescence microscopy|Y
soluble receptor activator of nuclear factor-kappa B ligand|soluble receptor activator of nuclear factor-kappaB ligand|Y
anti-human herpesvirus-6 immunoglobulin G|anti-human herpesvirus 6 immunoglobulin G|Y
anti-human herpesvirus-6 immunoglobulin G|anti-human herpes virus-6 immunoglobulin G|Y
anti-human herpesvirus-6 immunoglobulin G|anti-human herpesvirus-6 immunoglobulin M|Y
brachiocephalic occlusion|brachio-cephalic occlusion|Y
Clinical Global Impression of Change|Clinical Global Impressions of Change|Y
uvulo-palato-pharyngoplasty|uvulopalato-pharyngoplasty|Y
gastro-intestinal anastomosis|gastrointestinal anastomosis|Y
α-melanocyte stimulating hormone receptor|melanocyte stimulating hormone receptor|Y
4,4'-diisothiocyanatostilbene-2,2'-disulfonate|4,4'-diisothiocyanato-stilbene-2,2'-disulfonate|Y
neuromuscular disease|neuro-muscular disease|Y
complement-mediated antibody-dependent enhancement|complement-mediated antibody dependent enhancement|Y
solid phase micro-extraction|solid phase microextraction|Y
peritonsillar abscess|peri-tonsillar abscess|Y
centrosome- and Golgi-localized protein kinase N-associated protein|centrosome- and Golgi-localised protein kinase N-associated protein|Y
1-anilino-8-naphthalenesulfonate|1-anilino-8-naphthalene sulfonate|Y
core-binding factor α-1|core-binding factor α1|Y
multi-detector computed tomography-coronary angiography|multi-detector computed tomography coronary angiography|Y
primary anti-phospholipid antibody syndrome|primary antiphospholipid antibody syndrome|Y
4-acetamido-4'-isothiocyanostilbene-2,2'-disulfonic acid|4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid|Y
wheat germ agglutinin-horseradish peroxidase conjugate|Wheat germ agglutinin-horseradish peroxidase conjugate|Y
wheat germ agglutinin-horseradish peroxidase conjugate|wheat-germ agglutinin-horseradish peroxidase conjugate|Y
tumour necrosis factor-related apoptosis-inducing ligand receptor|tumor necrosis factor related apoptosis-inducing ligand receptor|Y
tumour necrosis factor-related apoptosis-inducing ligand receptor|tumor necrosis factor-related apoptosis-inducing ligand receptor-1|Y
tumour necrosis factor-related apoptosis-inducing ligand receptor|tumor necrosis factor-related apoptosis inducing ligand receptor|Y
tumour necrosis factor-related apoptosis-inducing ligand receptor|tumour necrosis factor-related apoptosis-inducing ligand receptor-1|Y
tumour necrosis factor-related apoptosis-inducing ligand receptor|tumour necrosis factor-related apoptosis-inducing ligand receptor 1|Y
matrix-assisted laser desorption-ionization mass spectrometry|matrix assisted laser desorption-ionization mass spectrometry|Y
audio computer assisted self-interviewing|audio-computer assisted self-interviewing|Y
audio computer assisted self-interviewing|audio computer-assisted self-interviewing|Y
intravascular lymphomatosis|intra-vascular lymphomatosis|Y
American Society of Anesthesiologists class 5|American Society of Anesthesiologists class|Y
American Society of Anesthesiologists class 5|American Society of Anesthesiologists class V|Y
American Society of Anesthesiologists class 5|American Society of Anaesthesiologists class 5|Y
American Society of Anesthesiologists class 5|American Society of Anesthesiologists class 2|Y
American Society of Anesthesiologists class 5|American Society of Anesthesiologists class I|Y
American Society of Anesthesiologists class 5|American Society of Anesthesiologists class 1|Y
directly observed treatment, short-course|directly observed treatment short-course|Y
calcitonin gene-related peptide immunoreactive nerve|calcitonin gene-related peptide-immunoreactive nerve|Y
acute non-lymphocytic leucemia|acute nonlymphocytic leucemia|Y
acute non-lymphocytic leucemia|acute non-lymphocytic leucaemia|Y
Escherichia coli DH5 α|Escherichia coli DH5α|Y
spheno-palatine ganglion|sphenopalatine ganglion|Y
oto-rhino-laryngological|oto-rhinolaryngological|Y
oto-rhino-laryngological|otorhino-laryngological|Y
extradimensional shift|extra-dimensional shift|Y
tricyclic antidepressant|tri-cyclic antidepressant|Y
cytokine-induced neutrophil chemoattractant-3|cytokine-induced neutrophil chemoattractant-1|Y
cytokine-induced neutrophil chemoattractant-3|cytokine-induced neutrophil chemoattractant-2|Y
subacute myelo-opticoneuropathy|subacute myelo-optico-neuropathy|Y
neural precursor cell expressed, developmentally down-regulated 2|neural precursor cell expressed, developmentally down-regulated 8|Y
neural precursor cell expressed, developmentally down-regulated 2|neural precursor cell expressed, developmentally downregulated 5|Y
neural precursor cell expressed, developmentally down-regulated 2|neural precursor cell expressed developmentally down-regulated 1|Y
neural precursor cell expressed, developmentally down-regulated 2|neural precursor cell expressed developmentally down-regulated 8|Y
neural precursor cell expressed, developmentally down-regulated 2|neural precursor cell expressed, developmentally downregulated 9|Y
neural precursor cell expressed, developmentally down-regulated 2|neural precursor cell expressed developmentally downregulated 2|Y
neural precursor cell expressed, developmentally down-regulated 2|neural precursor cell expressed, developmentally downregulated 2|Y
neural precursor cell expressed, developmentally down-regulated 2|neural precursor cell expressed, developmentally down-regulated 4|Y
neural precursor cell expressed, developmentally down-regulated 2|neural precursor cell expressed, developmentally down-regulated 1|Y
neural precursor cell expressed, developmentally down-regulated 2|neural precursor cell-expressed developmentally down-regulated 2|Y
neural precursor cell expressed, developmentally down-regulated 2|neural precursor cell expressed developmentally down-regulated 9|Y
neural precursor cell expressed, developmentally down-regulated 2|neural precursor cell-expressed, developmentally down-regulated 2|Y
neural precursor cell expressed, developmentally down-regulated 2|neural precursor cell expressed, developmentally down-regulated 5|Y
cytochrome P450 monooxygenases|cytochrome P450 monooxygenase|Y
axillofemoral bypass|axillofemoral by-pass|Y
axillofemoral bypass|axillo-femoral bypass|Y
elongation factor 1 α protein|elongation factor 1α protein|Y
Chronic prostatitis/chronic pelvic pain syndrome|chronic prostatitis/chronic pelvic pain syndrome|Y
magnetoencephalograph|magnetoencephalography|Y
anti-β 2 glycoprotein 1 antibody|anti-β2 glycoprotein 1 antibody|Y
immunoreactive human growth hormone|immuno-reactive human growth hormone|Y
dense nonaqueous phase liquid|dense non-aqueous phase liquid|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon β|toll/interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon β|toll-interleukin-1 receptor domain-containing adapter-inducing interferon β|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon β|toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon β|toll/interleukin-1 receptor domain-containing adapter-inducing interferon β|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon β|toll/interleukin 1 receptor domain-containing adapter-inducing interferon β|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon β|Y
duodenogastroesophageal reflux|duodeno-gastroesophageal reflux|Y
cluster of differentiation 4|cluster of differentiation 34|Y
cluster of differentiation 4|cluster of differentiation 44|Y
Picture Archiving and Communications Systems|Picture Archiving and Communication Systems|Y
mitogen- and stress-activated protein kinase-2|mitogen- and stress-activated protein kinase-1|Y
capillary electrophoresis-electrospray ionisation time-of-flight mass spectrometry|capillary electrophoresis electrospray ionization time-of-flight mass spectrometry|Y
capillary electrophoresis-electrospray ionisation time-of-flight mass spectrometry|capillary electrophoresis-electrospray ionization-time-of-flight mass spectrometry|Y
capillary electrophoresis-electrospray ionisation time-of-flight mass spectrometry|capillary electrophoresis-electrospray ionisation time of flight mass spectrometry|Y
sodium phosphate cotransporter|sodium phosphate co-transporter|Y
core binding factor α-1|core binding factor α1|Y
alpha4-beta2 nicotinic acetylcholine receptor|alpha4beta2 nicotinic acetylcholine receptor|Y
muco-epidermoid carcinoma|mucoepidermoid carcinoma|Y
neural-precursor-cell-expressed, developmentally down-regulated 1|neural-precursor cell-expressed, developmentally down-regulated 1|Y
neural-precursor-cell-expressed, developmentally down-regulated 1|neural-precursor-cell-expressed developmentally down-regulated 5|Y
neural-precursor-cell-expressed, developmentally down-regulated 1|neural-precursor-cell-expressed, developmentally down-regulated 8|Y
neural-precursor-cell-expressed, developmentally down-regulated 1|neural-precursor-cell-expressed, developmentally down-regulated 5|Y
neural-precursor-cell-expressed, developmentally down-regulated 1|neural-precursor-cell-expressed developmentally down-regulated 9|Y
neural-precursor-cell-expressed, developmentally down-regulated 1|neural-precursor-cell-expressed, developmentally down-regulated 4|Y
neural-precursor-cell-expressed, developmentally down-regulated 1|neural-precursor-cell-expressed, developmentally downregulated 5|Y
neural-precursor-cell-expressed, developmentally down-regulated 1|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor-cell-expressed, developmentally down-regulated 1|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor-cell-expressed, developmentally down-regulated 1|neural-precursor-cell-expressed developmentally down-regulated 1|Y
neural-precursor-cell-expressed, developmentally down-regulated 1|neural-precursor cell-expressed, developmentally downregulated 1|Y
neural-precursor-cell-expressed, developmentally down-regulated 1|neural-precursor-cell-expressed, developmentally downregulated 2|Y
testosterone-oestrogen-binding globulin|testosterone-estrogen-binding globulin|Y
hæmorrhagic shock-encephalopathy syndrome|hæmorrhagic shock encephalopathy syndrome|Y
tumor promoter 12-0-tetradecanoyl-phorbol-13-acetate|tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate|Y
tumour necrosis factor β|tumor necrosis factor β|Y
Ras-guanosine triphosphatase-activating protein|Ras guanosine triphosphatase-activating protein|Y
uncoordinated protein 32|uncoordinated protein 3|Y
secondary wall-associated NAC domain protein 1|secondary wall-associated NAC domain protein1|Y
secondary wall-associated NAC domain protein 1|secondary wall associated NAC domain protein 1|Y
alpha thalassaemia/mental retardation syndrome X-linked|alpha thalassemia/mental retardation syndrome X-linked|Y
alpha thalassaemia/mental retardation syndrome X-linked|alpha-thalassaemia/mental retardation syndrome X-linked|Y
melanin-concentrating hormone receptor-1|melanin concentrating hormone receptor-1|Y
melanin-concentrating hormone receptor-1|melanin-concentrating hormone receptor 1|Y
pre-β1-high density lipoprotein|preβ1-high density lipoprotein|Y
pre-β1-high density lipoprotein|pre-β 1-high density lipoprotein|Y
para-nitrophenylsulfate|para-nitrophenyl sulfate|Y
Müllerian-inhibiting substance type II receptor|Mullerian-inhibiting substance type II receptor|Y
retinoblastoma protein-interacting zinc finger protein 1|retinoblastoma protein-interacting zinc-finger protein 1|Y
retinoblastoma protein-interacting zinc finger protein 1|retinoblastoma protein-interacting zinc finger protein|Y
transforming growth factor-β-activated kinase 1-binding protein 1|transforming growth factor β-activated kinase 1-binding protein 1|Y
high mobility group protein IC|high mobility group protein I-C|Y
anti-B-cell leukemia/lymphoma 2|anti-B-cell leukaemia/lymphoma 2|Y
health-care associated methicillin-resistant Staphylococcus aureus|healthcare-associated methicillin-resistant Staphylococcus aureus|Y
health-care associated methicillin-resistant Staphylococcus aureus|health-care-associated methicillin-resistant Staphylococcus aureus|Y
IL4 receptor-α chain|IL-4 receptor-α chain|Y
microtubule associated protein 2c|microtubule associated protein 2|Y
postero-lateral thoracotomy|posterolateral thoracotomy|Y
dicyclohexylcarbodiimide|dicyclohexylcarbo-diimide|Y
Escherichia coli restriction enzyme KI|Escherichia coli restriction enzyme I|Y
International Organization for Standardisation|International Organization for Standardization|Y
malignant mixed müllerian tumor|malignant mixed müllerian tumour|Y
insulin-like growth factor II messenger RNA binding protein 3|insulin-like growth factor II messenger RNA binding protein 2|Y
insulin-like growth factor II messenger RNA binding protein 3|insulin-like growth factor II messenger RNA binding protein 1|Y
insulin-like growth factor II messenger RNA binding protein 3|insulin-like growth factor-II messenger RNA binding protein 3|Y
tumour infiltrating macrophage|tumor infiltrating macrophage|Y
extra-medullary hematopoiesis|extramedullary hematopoiesis|Y
anti-a disintegrin-like and metalloproteinase with thrombospondin type1 motif 13 antibody|anti-a disintegrin-like and metalloproteinase with thrombospondin type1 motif 13 autoantibody|Y
laser-desorption ionization time of flight mass spectrometry|laser-desorption ionisation time of flight mass spectrometry|Y
sulfobutylether-beta-cyclodextrin|sulfobutyl ether-beta-cyclodextrin|Y
non-muscle myosin heavy-chain II|non-muscle myosin heavy-chain IIB|Y
cytotoxic T lymphocyte-associated antigen 8|cytotoxic T-lymphocyte-associated antigen 8|Y
cytotoxic T lymphocyte-associated antigen 8|cytotoxic T lymphocyte-associated antigen-8|Y
cytotoxic T lymphocyte-associated antigen 8|cytotoxic T lymphocyte-associated antigen 4|Y
HIV-1 associated neurocognitive disorder|HIV-1-associated neurocognitive disorder|Y
random amplified polymorphic DNA marker|randomly amplified polymorphic DNA marker|Y
pursed lip breathing|pursed lips breathing|Y
glucose transporter 1|glucose transporter 10|Y
glucose transporter 1|glucose transporter 12|Y
glucose transporter 1|glucose transporter 11|Y
tetra-methylammonium|tetra-methyl ammonium|Y
T cell receptor-gammadelta-positive|T cell receptor-gamma delta-positive|Y
peroxisome proliferator activated receptor γ 2|peroxisome proliferator-activated receptor γ 2|Y
peroxisome proliferator activated receptor γ 2|peroxisome proliferator activated receptor γ-2|Y
peroxisome proliferator activated receptor γ 2|peroxisome proliferator activated receptor-γ 2|Y
American Society of Anaesthesiologists class 3|American Society of Anaesthesiologists class 5|Y
American Society of Anaesthesiologists class 3|American Society of Anaesthesiologists class 1|Y
American Society of Anaesthesiologists class 3|American Society of Anaesthesiologists class 4|Y
anti-toll-like receptor-3 monoclonal antibody|anti-toll like receptor-3 monoclonal antibody|Y
anti-toll-like receptor-3 monoclonal antibody|anti-toll-like receptor-2 monoclonal antibody|Y
anti-toll-like receptor-3 monoclonal antibody|anti-toll-like receptor 3 monoclonal antibody|Y
IL7 receptor α chain|IL-7 receptor α chain|Y
anticarcinoembryonic antigen|anti-carcinoembryonic antigen|Y
secreted amyloid precursor protein-alpha|secreted amyloid precursor protein alpha|Y
lectin-like oxidized low-density lipoprotein receptor|lectin-like oxidized low-density lipoprotein receptor-1|Y
interleukine-2 receptor α-chain|interleukin-2 receptor α-chain|Y
catheter-associated blood stream infection|catheter-associated bloodstream infection|Y
G protein α inhibitory subunit|G protein α3 inhibitory subunit|Y
multipolar electrocoagulation|multi-polar electrocoagulation|Y
demineralised freeze-dried bone allograft|demineralised freeze dried bone allograft|Y
cross-polarization/magic angle spinning nuclear magnetic resonance spectroscopy|cross-polarization magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarization/magic angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarization/magic angle spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
N-omega-nitro-L-arginine|Nomega-nitro-L-arginine|Y
technetium-99m galactosylneoglycoalbumin|technetium-99m galactosyl-neoglycoalbumin|Y
cytosolic phosphoenolpyruvate carboxykinase|cytosolic phosphoenol-pyruvate carboxykinase|Y
Fas-associated death domain-like interleukin-1beta converting enzyme-inhibitory protein|Fas-associated death domain-like interleukin-1beta-converting enzyme inhibitory protein|Y
Fas-associated death domain-like interleukin-1beta converting enzyme-inhibitory protein|Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein|Y
Fas-associated death domain-like interleukin-1beta converting enzyme-inhibitory protein|Fas-associated death domain-like interleukin-1beta converting enzyme inhibitory protein|Y
a disintegrin and metalloprotease with thrombospondin motifs-4|a disintegrin and metalloprotease with thrombospondin motifs-2|Y
a disintegrin and metalloprotease with thrombospondin motifs-4|a disintegrin and metalloprotease with thrombospondin motif-2|Y
a disintegrin and metalloprotease with thrombospondin motifs-4|a disintegrin and metalloprotease with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motifs-4|a disintegrin and metalloprotease with thrombospondin motifs-9|Y
a disintegrin and metalloprotease with thrombospondin motifs-4|a disintegrin and metalloprotease with thrombospondin motifs-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-4|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-4|a disintegrin and metalloprotease with thrombospondin motifs-20|Y
a disintegrin and metalloprotease with thrombospondin motifs-4|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motifs-4|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motifs-4|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motifs-4|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-4|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-4|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-4|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloprotease with thrombospondin motifs-4|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-4|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motifs-4|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motifs-4|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
non-photochemical quenching|nonphotochemical quenching|Y
American Society of Anaesthesiologists Class V|American Society of Anaesthesiologists Class I|Y
American Society of Anaesthesiologists Class V|American Society of Anaesthesiologists Class 5|Y
American Society of Anaesthesiologists Class V|American Society of Anaesthesiologists Class 1|Y
American Society of Anaesthesiologists Class V|American Society of Anesthesiologists Class IV|Y
gamma-aminobutyric-acid type A-receptor-associated protein|gamma-aminobutyric acid type A-receptor-associated protein|Y
gamma-aminobutyric acid type A-receptor-associated protein|gamma-aminobutyric acid type A receptor-associated protein|Y
transforming growth factor beta-activated kinase 1|transforming growth factor-beta-activated kinase 1|Y
transforming growth factor beta-activated kinase 1|transforming growth factor beta-activated kinase-1|Y
crosspolarization magic-angle spinning|cross-polarization magic-angle spinning|Y
female-to-male trans-sexual|female-to-male transsexual|Y
quantitative fluorescence in-situ hybridization|quantitative fluorescence in situ hybridization|Y
capillary electrophoresis electrospray ionization time of flight mass spectrometry|capillary electrophoresis electrospray ionization time-of-flight mass spectrometry|Y
capillary electrophoresis electrospray ionization time of flight mass spectrometry|capillary electrophoresis electrospray ionisation time of flight mass spectrometry|Y
capillary electrophoresis electrospray ionization time of flight mass spectrometry|capillary electrophoresis-electrospray ionisation time of flight mass spectrometry|Y
capillary electrophoresis electrospray ionization time of flight mass spectrometry|capillary electrophoresis-electrospray ionization time of flight mass spectrometry|Y
S100 calcium binding protein A11|S100 calcium binding protein A1|Y
duodenojejunal junction|duodeno-jejunal junction|Y
interdigitating cells|interdigitating cell|Y
sympathetic over-activity|sympathetic overactivity|Y
retinoic acid receptor-related orphan receptor γ T|retinoic acid receptor-related orphan receptor γT|Y
retinoic acid receptor-related orphan receptor γ T|retinoic acid receptor-related orphan receptor γ-T|Y
retinoic acid receptor-related orphan receptor γ T|retinoic acid receptor-related orphan receptor γ|Y
peri-ictal single photon emission computed tomography|periictal single photon emission computed tomography|Y
transfusion associated graft-versus-host disease|transfusion-associated graft-versus-host disease|Y
bone marrow micro-environment|bone marrow microenvironment|Y
transforming growth factor beta signaling pathway|transforming growth factor-beta signaling pathway|Y
insulin/insulin-like growth factor-1 signalling|insulin/insulin-like growth factor 1 signalling|Y
insulin/insulin-like growth factor-1 signalling|insulin/insulin-like growth factor-1 signaling|Y
insulin/insulin-like growth factor-1 signalling|insulin/insulin-like growth factor signalling|Y
non-inflammatory acute renal failure|noninflammatory acute renal failure|Y
small conductance calcium-activated potassium channel|small conductance calcium activated potassium channel|Y
1,1, 1-trichloroethane|1,1,1-trichloroethane|Y
Wechsler Intelligence Scale for Children Revised|Wechsler Intelligence Scale for Children - Revised|Y
post-natal depression|postnatal depression|Y
antiMullerian hormone|anti-Mullerian hormone|Y
secreted a disintegrin and metalloprotease 28|secreted a disintegrin and metalloproteinase 28|Y
single radial haemolysis|single radial hemolysis|Y
lympho-proliferative disorder|lymphoproliferative disorder|Y
2,3,7,8-tetrachlorodibenzo-p-dioxin|2,3,7,8-tetrachloro-dibenzo-p-dioxin|Y
2,3,7,8-tetrachlorodibenzo-p-dioxin|2,3,7,8-tetrachlorodibenzo- p-dioxin|Y
123I-beta-methyl-iodophenylpentadecanoic acid|(123)I-beta-methyl-iodophenylpentadecanoic acid|Y
preornithine carbamoyltransferase|preornithine carbamyltransferase|Y
preornithine carbamoyltransferase|pre-ornithine carbamoyltransferase|Y
dopamine D-1 receptor antagonist|dopamine D1 receptor antagonist|Y
matrix assisted laser desorption ionization-mass spectrometry|matrix-assisted laser desorption ionization-mass spectrometry|Y
matrix assisted laser desorption ionization-mass spectrometry|matrix assisted laser desorption/ionization-mass spectrometry|Y
transforming growth factor-beta-inducible gene H3|transforming growth factor-beta-inducible gene-H3|Y
non–small cell lung carcinoma|nonsmall cell lung carcinoma|Y
passive haemagglutination test|passive hemagglutination test|Y
murine erythro-leukemia cell|murine erythroleukemia cell|Y
haemoglobin Boyle Heights|hemoglobin Boyle Heights|Y
levonorgestrel-releasing intrauterine device|laevonorgestrel-releasing intrauterine device|Y
receptor-like protein tyrosine phosphatase psi|receptor-like protein-tyrosine phosphatase psi|Y
corticotrophin releasing factor receptor 1|corticotropin releasing factor receptor 1|Y
corticotrophin releasing factor receptor 1|corticotrophin-releasing factor receptor 1|Y
optokinetic nystagmus|opto-kinetic nystagmus|Y
anti-granulocyte macrophage colony stimulating factor antibody|anti-granulocyte macrophage-colony stimulating factor antibody|Y
immunoglobulin G4 antibody|immunoglobulin G antibody|Y
peroxisome proliferator-activated receptor-gamma coactivator 1alpha|peroxisome proliferator-activated receptor gamma coactivator 1alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator 1alpha|peroxisome proliferator-activated receptor-gamma co-activator 1alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator 1alpha|peroxisome proliferator-activated receptor gamma coactivator 1 alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator 1alpha|peroxisome proliferator-activated receptor-gamma coactivator-1alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator 1alpha|peroxisome-proliferator-activated receptor-gamma co-activator 1alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator 1alpha|peroxisome proliferator-activated receptor-gamma coactivator 1 alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator 1alpha|peroxisome proliferator-activated receptor-gamma co-activator 1 alpha|Y
multidrug resistance-associated protein|multidrug resistance-associated proteins|Y
multidrug resistance-associated protein|multidrug resistance-associated protein 1|Y
multidrug resistance-associated protein|multidrug resistance-associated protein 3|Y
brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein 1|brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein-1|Y
posterior cricoarytenoid muscle|posterior crico-arytenoid muscle|Y
alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid|alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid|Y
transcatheter arterial chemo-embolization|transcatheter arterial chemo-embolisation|Y
mitogen activated protein kinase activated protein kinase-3|mitogen-activated protein kinase activated protein kinase-3|Y
mitogen activated protein kinase activated protein kinase-3|mitogen activated protein kinase-activated protein kinase-3|Y
mitogen activated protein kinase activated protein kinase-3|mitogen activated protein kinase activated protein kinase|Y
mitogen activated protein kinase activated protein kinase-3|mitogen activated protein kinase activated protein kinase-2|Y
insulin-like growth factor II messenger RNA-binding protein-1|insulin-like growth factor II messenger RNA-binding protein-2|Y
insulin-like growth factor II messenger RNA-binding protein-1|insulin-like growth factor-II messenger RNA-binding protein-1|Y
insulin-like growth factor II messenger RNA-binding protein-1|insulin-like growth factor II messenger RNA-binding protein-3|Y
insulin-like growth factor II messenger RNA-binding protein-1|insulin-like growth factor II messenger RNA-binding protein|Y
L-trans-pyrrolidine-2,4-dicarboxylic acid|L-trans-pyrrolidine-2, 4-dicarboxylic acid|Y
α 1-anti-chymotrypsin|α1-anti-chymotrypsin|Y
α 1-anti-chymotrypsin|α 1-antichymotrypsin|Y
staphylococcal cassette chromosome mec type II|staphylococcal cassette chromosome mec type III|Y
galactorrhea-amenorrhœa hyperprolactinæmia syndrome|galactorrhea amenorrhœa hyperprolactinæmia syndrome|Y
α-1-acid glycoprotein|α1-acid glycoprotein|Y
steroid 5α-reductase type I|steroid 5α-reductase type II|Y
steroid 5α-reductase type I|steroid 5-α-reductase type I|Y
protein inhibitor of activated STAT|protein inhibitor of activated STAT3|Y
nonobese diabetes resistant mouse|non-obese diabetes resistant mouse|Y
photoelectron spectroscopy|photo-electron spectroscopy|Y
immunodysregulation polyendocrinopathy enteropathy X-linked syndrome|immunodysregulation polyendocrinopathy enteropathy X linked syndrome|Y
Seattle Veterans Administration Medical Center|Seattle Veterans' Administration Medical Center|Y
Seattle Veterans Administration Medical Center|Seattle Veteran's Administration Medical Center|Y
sinovenous thrombosis|sino-venous thrombosis|Y
prepro-gonadotropin-releasing hormone|prepro-gonadotrophin-releasing hormone|Y
signal-to-noise ratio|signal-to-noise ratios|Y
myocyte enhancer factor 2A|myocyte enhancer factor 2|Y
latent transforming growth factor-beta binding protein-2|latent transforming growth factor-beta binding protein-1|Y
latent transforming growth factor-beta binding protein-2|latent transforming growth factor beta binding protein-2|Y
transiently evoked otoacoustic emissions|transiently evoked oto-acoustic emission|Y
interatrial shunting|inter-atrial shunting|Y
noncarboxymethyllysine|non-carboxymethyllysine|Y
nonfractionated heparin|non-fractionated heparin|Y
standardized response means|standardized response mean|Y
autoimmune polyglandular syndrome type 2|autoimmune polyglandular syndrome type 1|Y
American Society of Anaesthesiologists Grade 1|American Society of Anaesthesiologists Grade 3|Y
American Society of Anaesthesiologists Grade 1|American Society of Anaesthesiologists Grade 4|Y
American Society of Anaesthesiologists Grade 1|American Society of Anaesthesiologists Grade 5|Y
American Society of Anaesthesiologists Grade 1|American Society of Anesthesiologists Grade 1|Y
Joint Commission on Accreditation of Healthcare Organizations|Joint Commission on Accreditation of Health Care Organizations|Y
Kaposi's sarcoma-associated herpes virus|Kaposi's sarcoma-associated herpesvirus|Y
Kaposi's sarcoma-associated herpes virus|Kaposi's sarcoma-associated herpes-virus|Y
apoptosis-linked gene-2 interacting protein X|apoptosis-linked gene 2 interacting protein X|Y
Southeast Asian ovalocytosis|South-east Asian ovalocytosis|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloprotease with thrombospondin motif-2|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloprotease with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloprotease with thrombospondin motifs-9|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloprotease with thrombospondin motifs-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloprotease with thrombospondin motifs-20|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
a disintegrin and metalloprotease with thrombospondin motifs-2|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
human transforming growth factor-beta(1)|human transforming growth factor beta(1)|Y
medium-sized spiny neurone|medium-sized spiny neuron|Y
epidemic methicillin-resistant Staphylococcus aureus-9|epidemic methicillin-resistant Staphylococcus aureus-3|Y
immunity-related guanosine triphosphatase|immunity-related guanosinetriphosphatase|Y
peroxisome proliferator-activated receptor γ|peroxisome proliferator-activated receptor γ2|Y
peroxisome proliferator-activated receptor γ|peroxisome proliferator-activated receptor γ1|Y
peroxisome proliferator-activated receptor γ|peroxisome proliferator-activated receptor γ 2|Y
peroxisome proliferator-activated receptor γ|peroxisome proliferator-activated receptor γ-1|Y
peroxisome proliferator-activated receptor γ|peroxisome proliferator-activated receptor|Y
peroxisome proliferator-activated receptor γ|peroxisome proliferator-activated receptor γ 1|Y
peroxisome proliferator-activated receptor γ|peroxisome proliferator-activated receptor β|Y
digoxin-induced hyperkalemia|digoxin-induced hyperkalaemia|Y
multidrug resistance associated protein|multidrug resistance associated protein 2|Y
multidrug resistance associated protein|multidrug resistance associated protein 3|Y
multidrug resistance associated protein|multidrug resistance associated protein 1|Y
interleukine-13 receptor α 1-subunit|interleukin-13 receptor α 1-subunit|Y
prurutic urticarial papules and plaques of pregnancy|pruritic urticarial papules and plaques of pregnancy|Y
Carbapenemase producing Enterobacteriaceae|carbapenemase producing Enterobacteriaceae|Y
Shiga-toxin producing Escherichia coli|Shigatoxin producing Escherichia coli|Y
thromboxane A(2)/prostaglandin H(2) receptor|thromboxane A(2)-prostaglandin H(2) receptor|Y
iso-electric focusing|iso-electric focussing|Y
iso-electric focusing|isoelectric focusing|Y
corticotropin releasing factor receptor 1|corticotropin releasing factor receptor-1|Y
programmed temperature vaporisation|programmed temperature vapourisation|Y
electro-chemical geo-oxidation|electrochemical geo-oxidation|Y
recombinant human bone morphogenetic protein 6|recombinant human bone morphogenetic protein 2|Y
recombinant human bone morphogenetic protein 6|recombinant human bone morphogenetic protein|Y
recombinant human bone morphogenetic protein 6|recombinant human bone morphogenetic protein 4|Y
noticeable difference|noticeable differences|Y
antinerve growth factor antibody|anti-nerve growth factor antibody|Y
suprachiasmatic nucleus|supra-chiasmatic nucleus|Y
panretinal photocoagulation|pan-retinal photocoagulation|Y
pulmonary thrombo-embolism|pulmonary thromboembolism|Y
matrix-assisted laser desorption ionization time-of-flight mass spectrometry|matrix-assisted laser desorption/ionization time-of-flight mass spectrometry|Y
Fas-associated death domain-like interleukin-1 β converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1 β-converting enzyme-inhibitory protein|Y
Fas-associated death domain-like interleukin-1 β converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1β converting enzyme-inhibitory protein|Y
human insulinlike growth factor 2|human insulin-like growth factor 2|Y
tumor necrosis factor receptor superfamily member 17|tumor necrosis factor receptor superfamily member 1A|Y
tumor necrosis factor receptor superfamily member 17|tumor necrosis factor receptor superfamily member 1B|Y
tumor necrosis factor receptor superfamily member 17|tumor necrosis factor receptor superfamily member 12|Y
tumor necrosis factor receptor superfamily member 17|tumor necrosis factor receptor superfamily member 19|Y
labile aggregation stimulating substance|labile aggregation-stimulating substance|Y
anti-histocompatibility leucocyte antigen class II antibody|anti-histocompatibility leukocyte antigen class II antibody|Y
anti-histocompatibility leucocyte antigen class II antibody|anti-histocompatibility leucocyte antigen class I antibody|Y
TATA-binding protein associated factor 4|TATA-binding protein associated factor 5|Y
TATA-binding protein associated factor 4|TATA-binding protein-associated factor 4|Y
TATA-binding protein associated factor 4|TATA-binding protein associated factor-4|Y
platelet-derived growth factor receptor alpha|Platelet-derived growth factor receptor alpha|Y
platelet-derived growth factor receptor alpha|platelet-derived growth factor receptor-alpha|Y
pro-coagulant factor VIII|procoagulant factor VIII|Y
gerodermia osteodysplastica|geroderma osteodysplastica|Y
upper gastro-intestinal hemorrhage|upper gastrointestinal hemorrhage|Y
tumour promoting agent|tumor promoting agent|Y
baso-lateral membrane|basolateral membrane|Y
subtilisin-like proprotein convertase|subtilisin-like proprotein convertases|Y
colony-forming units granulocyte-macrophage|colony-forming unit granulocyte-macrophage|Y
colony-forming units granulocyte-macrophage|colony-forming units-granulocyte-macrophage|Y
colony-forming units granulocyte-macrophage|colony forming units granulocyte-macrophage|Y
university affiliated Veterans' Administration medical center|university-affiliated Veterans' Administration medical center|Y
university affiliated Veterans' Administration medical center|university affiliated Veterans Administration medical center|Y
university affiliated Veterans' Administration medical center|university-affiliated Veterans Administration medical center|Y
trans-activation responsive element|transactivation responsive element|Y
size-exclusion chromatography-multiangle laser light scattering|size-exclusion chromatography/multiangle laser light scattering|Y
size-exclusion chromatography-multiangle laser light scattering|size exclusion chromatography-multi-angle laser light scattering|Y
size-exclusion chromatography-multiangle laser light scattering|size-exclusion chromatography/multi-angle laser light scattering|Y
size-exclusion chromatography-multiangle laser light scattering|size-exclusion chromatography-multi-angle laser light scattering|Y
parietal epithelial cell|parietal epithelial cells|Y
inhaled corticosteroid|inhaled corticosteroids|Y
fluorine-18 fluorodeoxyglucose positron emission tomography|fluorine-18-fluorodeoxyglucose positron emission tomography|Y
TBP associated factor-15|TBP associated factor-1|Y
carboxylterminal amino acid sequence|carboxyterminal amino acid sequence|Y
glycosyl phosphatidyl inositol linked|glycosyl phosphatidylinositol linked|Y
atrioventricular malformation|atrio-ventricular malformation|Y
electron-probe x-ray microanalysis|electron-probe x-ray micro analysis|Y
scanning electronmicroscopy|scanning electron microscopy|Y
treatment decision-making|treatment decisionmaking|Y
pseudo-angiomatous stromal hyperplasia|pseudoangiomatous stromal hyperplasia|Y
Janus kinase-signal transducer and activator of transcription|Janus kinase/signal transducer and activator of transcription|Y
anti-tubercular therapy|antitubercular therapy|Y
a disintegrin and metalloproteinase 28|a disintegrin and metalloproteinase 8|Y
nonmetric multidimensional scaling|nonmetric multi-dimensional scaling|Y
radio-sensitivity test|radiosensitivity test|Y
mitochondrial neurogastro-intestinal encephalomyopathy|mitochondrial neurogastrointestinal encephalo-myopathy|Y
mitochondrial neurogastro-intestinal encephalomyopathy|mitochondrial neuro-gastrointestinal encephalomyopathy|Y
oculo-auriculo-vertebral|oculo-auriculovertebral|Y
anti-beta2-glycoprotein-I antibody|anti-beta 2-glycoprotein-I antibody|Y
anti-beta2-glycoprotein-I antibody|anti-beta-2-glycoprotein-I antibody|Y
anti-interleukin 10 antibody|anti-interleukin 1 antibody|Y
neuroendocrine-specific protein-reticulon|neuroendocrine-specific protein reticulon|Y
Moeller-Plesset second-order perturbation theory|Moeller-Plesset second order perturbation theory|Y
krueppel-like factor 5|kruppel-like factor 5|Y
Phleum pratense allergen 1|Phleum pratense allergen 11|Y
tumor necrosis factor receptor associated factor 5|tumor necrosis factor receptor associated factor-5|Y
tumor necrosis factor receptor associated factor 5|tumour necrosis factor receptor associated factor 5|Y
tumor necrosis factor receptor associated factor 5|tumor necrosis factor receptor associated factor 1|Y
tumor necrosis factor receptor associated factor 5|tumor necrosis factor receptor-associated factor 5|Y
leukemia-inhibiting factor|leukaemia-inhibiting factor|Y
tumor necrosis factor receptor-associated factor 2|tumor necrosis factor receptor-associated factor 1|Y
tumor necrosis factor receptor-associated factor 2|tumour necrosis factor receptor-associated factor 2|Y
tumor necrosis factor receptor-associated factor 2|tumor necrosis factor receptor-associated factor 5|Y
tumor necrosis factor receptor-associated factor 2|tumor necrosis factor receptor-associated factor 6|Y
cytoplasmic antineutrophil cytoplasmic antibody|cytoplasmic anti-neutrophil cytoplasmic antibody|Y
brain derived neurotropic factor|brain derived neurotrophic factor|Y
hypertrophic pulmonary osteo-arthropathy|hypertrophic pulmonary osteoarthropathy|Y
signal transducer and activator of transcription-3|signal transducer and activator of transcription|Y
signal transducer and activator of transcription-3|signal transducer and activator of transcription-6|Y
signal transducer and activator of transcription-3|signal transducer and activator of transcription-1|Y
signal transducer and activator of transcription-3|signal transducer and activator of transcription 3|Y
photo-affinity labeling|photo-affinity labelling|Y
microtubule-associated proteins|microtubule-associated protein|Y
human T-cell lymphotropic virus type-1 antibody|human T-cell lymphotropic virus type-I antibody|Y
TIR domain-containing adaptor inducing IFN-beta|TIR domain containing adaptor inducing IFN-beta|Y
TIR domain-containing adaptor inducing IFN-beta|TIR domain-containing adaptor-inducing IFN-beta|Y
Nashville Veterans Administration Medical Center|Nashville Veterans' Administration Medical Center|Y
afterhyperpolarizing potential|after-hyperpolarizing potential|Y
anaesthesia-resistant memory|anesthesia-resistant memory|Y
Parker's rat coronavirus|Parker's rat corona virus|Y
poly(ethylene oxide)|poly (ethylene oxide)|Y
amnioallantoic fluid|amnio-allantoic fluid|Y
American Society of Anesthesiologists class|American Society of Anesthesiologists class V|Y
American Society of Anesthesiologists class|American Society of Anesthesiologists class 2|Y
American Society of Anesthesiologists class|American Society of Anesthesiologists Class|Y
American Society of Anesthesiologists class|American Society of Anesthesiologists class I|Y
American Society of Anesthesiologists class|American Society of Anesthesiologists class 1|Y
cotton-tail rabbit papillomavirus|cottontail rabbit papillomavirus|Y
nonoxidative leucine disposal|non-oxidative leucine disposal|Y
transforming growth factor-β type II receptor|transforming growth factor β type II receptor|Y
Roux-en-Y hepatico-jejunostomy|Roux-en-Y hepaticojejunostomy|Y
insecticide treated bednet|insecticide treated bed-net|Y
insecticide treated bednet|insecticide treated bed net|Y
tubulointerstitial lesion|tubulo-interstitial lesion|Y
haemoglobin F-M-Fort Ripley|hemoglobin F-M-Fort Ripley|Y
non-muscle myosin heavy-chain-II|non-muscle myosin heavy-chain-IIB|Y
Epstein-Barr virus-immortalised cell line|Epstein-Barr virus-immortalized cell line|Y
tumor-associated lymphocyte|tumour-associated lymphocyte|Y
tumor-associated lymphocyte|tumor-associated lymphocytes|Y
transforming growth factor|transforming growth factors|Y
inter-vertebral disc disease|intervertebral disc disease|Y
tumour necrosis factor α|tumor necrosis factor α|Y
transjugular intrahepatic portocaval shunt|trans-jugular intrahepatic porto-caval shunt|Y
transjugular intrahepatic portocaval shunt|trans-jugular intrahepatic portocaval shunt|Y
interleukine 11 receptor α-chain|interleukin 11 receptor α-chain|Y
uvulopalatopharyngoplasty|uvulopalato-pharyngoplasty|Y
aortoiliac occlusive disease|aorto-iliac occlusive disease|Y
Na-K-Cl cotransporter-2|Na-K-Cl co-transporter-2|Y
aluminum oxyhydroxide|aluminum oxy-hydroxide|Y
sterol carrier protein 2|sterol carrier protein2|Y
poly(hydroxyethyl methacrylate)|poly-(hydroxyethyl methacrylate)|Y
dipalmitylphosphatidylcholine|dipalmitoylphosphatidylcholine|Y
spine-associated Rap guanosine triphosphatase activating protein|spine-associated Rap guanosine triphosphatase-activating protein|Y
CC chemokine receptor|CXC chemokine receptor|Y
matrix assisted laser desorption/ionization time of flight mass spectrometric|matrix assisted laser desorption ionization time of flight mass spectrometric|Y
matrix assisted laser desorption/ionization time of flight mass spectrometric|matrix assisted laser desorption/ionization time of flight mass spectrometry|Y
matrix assisted laser desorption/ionization time of flight mass spectrometric|matrix-assisted laser desorption/ionization time of flight mass spectrometric|Y
TATA-binding protein associated factor 5|TATA-binding protein associated factor 15|Y
TATA-binding protein associated factor 5|TATA-binding protein associated factor-5|Y
flexible fiber-optic bronchoscopy|flexible fiberoptic bronchoscopy|Y
intrauterine fetal death|intra-uterine fetal death|Y
methylazoxy-methanol|methyl-azoxy-methanol|Y
mitogen activated protein kinase kinase-1|mitogen activated protein kinase kinase-4|Y
mitogen activated protein kinase kinase-1|mitogen activated protein kinase kinase 1|Y
calcium calmodulin-dependent protein kinase kinase beta|calcium/calmodulin-dependent protein kinase kinase beta|Y
calcium calmodulin-dependent protein kinase kinase beta|calcium-calmodulin-dependent protein kinase kinase beta|Y
National Cholesterol Education Program Adult Treatment Panel|National Cholesterol Education Program Adult Treatment Panel II|Y
peroxisome proliferator-activated receptor gamma coactivator 1alpha|peroxisome proliferator-activated receptor-gamma co-activator 1alpha|Y
peroxisome proliferator-activated receptor gamma coactivator 1alpha|peroxisome proliferator-activated receptor gamma coactivator 1 alpha|Y
peroxisome proliferator-activated receptor gamma coactivator 1alpha|peroxisome proliferator-activated receptor gamma co-activator-1alpha|Y
peroxisome proliferator-activated receptor gamma coactivator 1alpha|peroxisome proliferator-activated receptor-gamma coactivator 1 alpha|Y
peroxisome proliferator-activated receptor gamma coactivator 1alpha|peroxisome proliferator-activated receptor gamma co-activator 1 alpha|Y
peroxisome proliferator-activated receptor gamma coactivator 1alpha|peroxisome-proliferator-activated receptor gamma coactivator 1 alpha|Y
Bos taurus autosome 14|Bos taurus autosome 1|Y
robust multi-chip average|robust multichip average|Y
Wingless-type MMTV integration site family member 7A|Wingless-type MMTV integration site family member 5A|Y
Wingless-type MMTV integration site family member 7A|Wingless-type MMTV integration site family member 7B|Y
adrenoleucodystrophy|adreno-leucodystrophy|Y
gap junction mediated intercellular communication|gap junction-mediated intercellular communication|Y
anti-matrix metalloprotease-3 antibody|anti-matrix metalloprotease-13 antibody|Y
Veteran's Affairs Medical Center|Veterans Affairs Medical Center|Y
thiazide-sensitive NaCl co-transporter|thiazide-sensitive Na-Cl co-transporter|Y
α-methylacyl-coenzyme A racemase|α-methyl-acyl-coenzyme A racemase|Y
α-methylacyl-coenzyme A racemase|α-methyl acyl-coenzyme A racemase|Y
inter-alphatrypsin inhibitor|inter-alpha-trypsin inhibitor|Y
chicken luteinising hormone releasing hormone-II|chicken luteinising hormone releasing hormone II|Y
light harvesting chlorophyll protein I|light harvesting chlorophyll protein II|Y
Society of Gynaecologic Oncologists|Society of Gynecologic Oncologists|Y
hyperinsulinism-hyperammonaemia syndrome|hyperinsulinism-hyperammonemia syndrome|Y
alpha-putrescinyl-thymine|alpha-putrescinylthymine|Y
human gonadotropin releasing hormone associated peptide|human gonadotrophin releasing hormone associated peptid|Y
human gonadotropin releasing hormone associated peptide|human gonadotropin releasing hormone associated peptid|Y
human gonadotropin releasing hormone associated peptide|human gonadotrophin releasing hormone associated peptide|Y
non-nutritive swallowing|nonnutritive swallowing|Y
transcript-derived fragment|transcript-derived fragments|Y
ultrarapid metaboliser|ultra-rapid metaboliser|Y
nuclear factor κ B p65|nuclear factor κB p65|Y
pentoxy resorufin-O-dealkylase|pentoxyresorufin-O-dealkylase|Y
transjugular intrahepatic portosystemic shunt|trans-jugular intrahepatic porto-systemic shunt|Y
transjugular intrahepatic portosystemic shunt|transjugular intra-hepatic portosystemic shunt|Y
transjugular intrahepatic portosystemic shunt|trans-jugular intra-hepatic portosystemic shunt|Y
transjugular intrahepatic portosystemic shunt|trans-jugular intrahepatic portosystemic shunt|Y
postpercutaneous transluminal coronary angioplasty|post-percutaneous transluminal coronary angioplasty|Y
extracellular-signal-regulated protein kinase|extracellular signal-regulated protein kinase|Y
complex chromosomal rearrangement|complex chromosomal rearrangements|Y
S-nitrosoglutathione|S-nitroso-glutathione|Y
cholyl-glycylamido-fluorescein|cholylglycylamido-fluorescein|Y
delayed traumatic intracerebral hæmatoma|delayed traumatic intracerebral hematoma|Y
anti-TCR alpha beta monoclonal antibody|anti-TCR alphabeta monoclonal antibody|Y
poly (dimethyl siloxane)|poly (dimethylsiloxane)|Y
matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry|matrix-assisted laser desorption/ionization Fourier-transform ion cyclotron resonance mass spectrometry|Y
matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry|matrix-assisted laser desorption ionization Fourier transform ion cyclotron resonance mass spectrometry|Y
nano-flow liquid chromatography/tandem mass spectrometry|nano-flow liquid chromatography-tandem mass spectrometry|Y
nano-flow liquid chromatography/tandem mass spectrometry|nano-flow liquid chromatography tandem mass spectrometry|Y
recombinant human megakaryocyte growth and development factor|Recombinant human megakaryocyte growth and development factor|Y
matrix assisted laser desorption ionisation-mass spectrometry imaging|matrix-assisted laser desorption ionisation-mass spectrometry imaging|Y
matrix assisted laser desorption ionisation-mass spectrometry imaging|matrix assisted laser desorption ionization-mass spectrometry imaging|Y
Veteran's Integrated Service Network|Veterans Integrated Service Network|Y
Rouxen-Y hepaticojejunostomy|Roux-en-Y hepaticojejunostomy|Y
tension-free vaginal tape obturator procedure|tension-free vaginal tape-obturator procedure|Y
sequence-characterised amplified region marker|sequence-characterized amplified region marker|Y
type VII Ehlers-Danlos syndrome|type VIIC Ehlers-Danlos syndrome|Y
type VII Ehlers-Danlos syndrome|type VI Ehlers-Danlos syndrome|Y
peroxisome proliferator-activated receptor γ coactivator-1α|peroxisome proliferator-activated receptor γ coactivator-1|Y
peroxisome proliferator-activated receptor γ coactivator-1α|peroxisome proliferator-activated receptor γ co-activator-1|Y
peroxisome proliferator-activated receptor γ coactivator-1α|peroxisome proliferator-activated receptor γ coactivator-1 α|Y
peroxisome proliferator-activated receptor γ coactivator-1α|peroxisome proliferator-activated receptor γ co-activator-1α|Y
technetium-99m labelled red blood cell|technetium-99m labeled red blood cell|Y
orofaciodigital syndrome type VI|orofaciodigital syndrome type VII|Y
orofaciodigital syndrome type VI|orofaciodigital syndrome type V|Y
insulin-like growth factor-II messenger RNA-binding protein|insulin-like growth factor-II messenger RNA-binding protein 2|Y
insulin-like growth factor-II messenger RNA-binding protein|insulin-like growth factor-II messenger RNA-binding protein-1|Y
insulin-like growth factor-II messenger RNA-binding protein|insulin-like growth factor II messenger RNA-binding protein|Y
insulin-like growth factor-II messenger RNA-binding protein|insulin-like growth factor-II messenger RNA-binding protein-3|Y
anti-hepatitis C virus|antihepatitis C virus|Y
circulating intercellular adhesion molecule 2|circulating intercellular adhesion molecule-2|Y
post-traumatic stress symptomatology|posttraumatic stress symptomatology|Y
Schizosaccharomyces japonicus varietas japonicus|Schizo-saccharomyces japonicus varietas japonicus|Y
mucosa-associated lymphoid tissue type lymphoma|mucosa-associated lymphoid tissue-type lymphoma|Y
neonatal onset multisystem inflammatory disease|neonatal onset multi-system inflammatory disease|Y
nitric oxide metabolite|nitric oxide metabolites|Y
oestrogen-responsive finger protein|estrogen-responsive finger protein|Y
multiple congenital anomaly-mental retardation syndrome|multiple congenital anomaly/mental retardation syndrome|Y
transesophageal atrial pacing|trans-esophageal atrial pacing|Y
estrogen receptor β knock-out mouse|estrogen receptor β knockout mouse|Y
tumour associated surface antigen|tumor associated surface antigen|Y
two-electron reduced density matrix method|two-electron reduced-density matrix method|Y
branched-chain alpha-ketoacid dehydrogenase complex|branched chain alpha-ketoacid dehydrogenase complex|Y
non-penetrating deep sclerectomy|nonpenetrating deep sclerectomy|Y
radio-immunosorbent technique|radioimmunosorbent technique|Y
N-methyl-D-aspartate receptor|N-methyl-D-aspartate receptors|Y
transport protein particle I|transport protein particle II|Y
singlet-oxygen-sensitised delayed fluorescence|singlet-oxygen-sensitized delayed fluorescence|Y
beta-amyloid precursor protein-cleaving enzyme|beta-amyloid precursor protein cleaving enzyme|Y
beta-amyloid precursor protein-cleaving enzyme|beta-amyloid precursor protein-cleaving enzyme 1|Y
beta-amyloid precursor protein-cleaving enzyme|beta-amyloid precursor protein-cleaving enzyme-2|Y
ultrafast computed tomography|ultra-fast computed tomography|Y
peroxisome proliferator activated receptor gamma-2|peroxisome proliferator activated receptor-gamma-2|Y
intra-muscular injection|intramuscular injection|Y
human T-cell leukaemia|human T-cell leukemia|Y
cytochrome P450 2B10|cytochrome P-450 2B10|Y
carboxymethyl dextran benzylamide sulfonate|carboxymethyl dextran benzylamine sulfonate|Y
fasciculation and elongation protein ζ 1|fasciculation and elongation protein ζ-1|Y
alpha thalassemia/mental retardation syndrome X-linked|alpha-thalassemia/mental retardation syndrome X-linked|Y
post-partum hemorrhage|postpartum hemorrhage|Y
antibody dependent cell-mediated cytotoxicity|antibody-dependent cell-mediated cytotoxicity|Y
antibody dependent cell-mediated cytotoxicity|antibody dependent cell mediated cytotoxicity|Y
acute lymphocytic meningo-encephalitis|acute lymphocytic meningoencephalitis|Y
oestrogen receptor β knockout mouse|estrogen receptor β knockout mouse|Y
neural-precursor cell-expressed, developmentally down-regulated 8|neural-precursor cell-expressed, developmentally down-regulated 1|Y
neural-precursor cell-expressed, developmentally down-regulated 8|neural-precursor cell-expressed developmentally downregulated 8|Y
neural-precursor cell-expressed, developmentally down-regulated 8|neural-precursor cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally down-regulated 8|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor cell-expressed, developmentally down-regulated 8|neural-precursor cell-expressed, developmentally downregulated 5|Y
neural-precursor cell-expressed, developmentally down-regulated 8|neural-precursor-cell-expressed, developmentally down-regulated 8|Y
neural-precursor cell-expressed, developmentally down-regulated 8|neural-precursor cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally down-regulated 8|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor cell-expressed, developmentally down-regulated 8|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural-precursor cell-expressed, developmentally down-regulated 8|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor cell-expressed, developmentally down-regulated 8|neural precursor cell-expressed, developmentally downregulated 8|Y
neural-precursor cell-expressed, developmentally down-regulated 8|neural-precursor cell-expressed, developmentally downregulated 1|Y
entero-aggregative E. coli|enteroaggregative E. coli|Y
cross-polarisation/magic-angle-spinning NMR|cross-polarization/magic-angle-spinning NMR|Y
mitogen-activated protein kinase-extracellular signal-regulated kinase|mitogen-activated protein kinase extracellular signal-regulated kinase|Y
mitogen-activated protein kinase-extracellular signal-regulated kinase|mitogen-activated protein kinase-extracellular signal regulated kinase|Y
anti-interleukin 4 receptor antibody|antiinterleukin 4 receptor antibody|Y
antidiuretic hormone|anti-diuretic hormone|Y
intra-vitreal injection|intravitreal injection|Y
TATA-binding protein associated factor 12|TATA-binding protein-associated factor 12|Y
TATA-binding protein associated factor 12|TATA-binding protein associated factor 10|Y
TATA-binding protein associated factor 12|TATA-binding protein associated factor 15|Y
TATA-binding protein associated factor 12|TATA-binding protein associated factor 11|Y
TATA-binding protein associated factor 12|TATA-binding protein associated factor-12|Y
glucocorticoid receptor interacting protein 1|glucocorticoid receptor interacting protein-1|Y
intraventricular conduction time|intra-ventricular conduction time|Y
human chorionic gonadotropin β|human chorionic gonadotrophin β|Y
minichromosome maintenance complex|mini-chromosome maintenance complex|Y
formyl peptide receptor-like-1|formylpeptide receptor-like-1|Y
3,3'-dithiobis(sulfosuccinimidyl propionate)|3,3'-dithiobis(sulfosuccinimidyl) propionate|Y
multilocus enzyme electrophoresis|multi-locus enzyme electrophoresis|Y
Epstein-Barr virus-determined nuclear antigen|Epstein-Barr-virus-determined nuclear antigen|Y
germinal centre B-cell-like diffuse large B-cell lymphoma|germinal center B-cell-like diffuse large B-cell lymphoma|Y
germinal centre B-cell-like diffuse large B-cell lymphoma|germinal centre B cell-like diffuse large B-cell lymphoma|Y
aortobronchial fistula|aorto-bronchial fistula|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon β|toll-interleukin-1 receptor domain-containing adapter-inducing interferon β|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon β|Toll-interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon β|Y
phosphotransferase system regulation domain 1|phosphotransferase system regulation domain 2|Y
phosphotransferase system regulation domain 1|phosphotransferase system regulation domain|Y
bone anchored hearing aids|bone anchored hearing aid|Y
pregnancy-specific glycoprotein 2|pregnancy-specific glycoprotein 12|Y
heat-shock protein 90β|heat-shock protein 90-β|Y
rat phaeochromocytoma|rat pheochromocytoma|Y
sodium iso-nonanoyl oxybenzene sulfonate|sodium isononanoyl oxybenzene sulfonate|Y
lamprey gonadotropin releasing hormone I|lamprey gonadotropin-releasing hormone I|Y
lamprey gonadotropin releasing hormone I|lamprey gonadotropin releasing hormone-I|Y
tumor necrosis factor related apoptosis-inducing ligand receptor|tumour necrosis factor related apoptosis inducing ligand receptor|Y
augmented correlation-consistent polarised valence double ζ basis set|augmented correlation-consistent polarized valence double ζ basis set|Y
augmented correlation-consistent polarised valence double ζ basis set|augmented correlation-consistent polarised valence double-ζ basis set|Y
augmented correlation-consistent polarised valence double ζ basis set|augmented correlation consistent polarised valence double ζ basis set|Y
mitogen activated protein kinase-activated protein kinase 2|mitogen activated protein kinase-activated protein kinase-2|Y
mitogen activated protein kinase-activated protein kinase 2|mitogen activated protein kinase-activated protein kinase|Y
mitogen activated protein kinase-activated protein kinase 2|mitogen activated protein kinase activated protein kinase 2|Y
mitogen activated protein kinase-activated protein kinase 2|mitogen activated protein kinase-activated protein kinase 3|Y
platelet derived growth factor receptor beta|platelet derived growth factor receptor-beta|Y
American Society of Anaesthesiologists Class III|American Society of Anaesthesiologists Class I|Y
American Society of Anaesthesiologists Class III|American Society of Anaesthesiologists class III|Y
American Society of Anaesthesiologists Class III|American Society of Anesthesiologists Class III|Y
American Society of Anaesthesiologists Class III|American Society of Anesthesiologists Class II|Y
soluble vascular cell adhesion molecule 1|soluble vascular cell adhesion molecule|Y
placental growth factor|placenta growth factor|Y
immuno-cytochemically|immunocytochemically|Y
angiotensin-converting-enzyme inhibition|angiotensin-converting enzyme inhibition|Y
transient receptor potential vanilloid 1|transient receptor potential vanilloid 5|Y
transient receptor potential vanilloid 1|transient receptor potential vanilloid 2|Y
transient receptor potential vanilloid 1|transient receptor potential vanilloid 4|Y
transient receptor potential vanilloid 1|transient receptor potential vanilloid 3|Y
anti-IL-7 receptor antibody|antiIL-7 receptor antibody|Y
anti-transferrin receptor antibody|antitransferrin receptor antibody|Y
signal transducer and activator of transcription 5a|signal transducer and activator of transcription 5|Y
signal transducer and activator of transcription 5a|signal transducer and activator of transcription 5b|Y
digital imaging fiberoptic transillumination|digital imaging fiber-optic transillumination|Y
vaginal birth after caesarean section|vaginal birth after cesarean section|Y
crosspolarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarization magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|cross polarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cold-induced auto-inflammatory syndrome 1|cold induced auto-inflammatory syndrome 1|Y
antituberculosis therapy|anti-tuberculosis therapy|Y
intra-venous transfusion|intravenous transfusion|Y
grade I acute graft-versus-host disease|grade III acute graft-versus-host disease|Y
grade I acute graft-versus-host disease|grade II acute graft-versus-host disease|Y
guanine adenine thymine adenine-binding protein 4|guanine adenine thymine adenine-binding protein 1|Y
γ-hexachloro-cyclohexane|γ-hexachlorocyclohexane|Y
enterocutaneous fistula|entero-cutaneous fistula|Y
post-antibiotic effect|postantibiotic effect|Y
summed pain intensity difference over 60 minutes|summed pain intensity difference over 30 minutes|Y
high-resolution gas chromatography/mass spectrometry|high resolution gas chromatography/mass spectrometry|Y
trans-catheter aortic-valve implantation|trans-catheter aortic valve implantation|Y
non-esterified fatty acid|nonesterified fatty acid|Y
Medical Literature Analysis and Retrieval System On-line|Medical Literature Analysis and Retrieval System Online|Y
extra-cellular acidification rate|extracellular acidification rate|Y
attenuated total reflectance Fourier-transform infra red spectroscopy|attenuated total reflectance Fourier-transform infra-red spectroscopy|Y
attenuated total reflectance Fourier-transform infra red spectroscopy|attenuated total reflectance Fourier-transform infrared spectroscopy|Y
attenuated total reflectance Fourier-transform infra red spectroscopy|attenuated total reflectance Fourier transform infrared spectroscopy|Y
noninvasive mechanical ventilation|non-invasive mechanical ventilation|Y
subclinical Cushing syndrome|sub-clinical Cushing syndrome|Y
receptor protein tyrosine phosphatase zeta|receptor protein tyrosine phosphatase beta|Y
receptor protein tyrosine phosphatase zeta|receptor protein tyrosine phosphatase eta|Y
polyA binding protein nuclear 1|poly-A binding protein nuclear 1|Y
Fc gamma-receptor-mediated|Fcgamma-receptor-mediated|Y
recombinant interleukin 2|recombinant interleukin 12|Y
recombinant interleukin 2|recombinant interleukin 21|Y
activated Cdc42 associated tyrosine kinase-1|activated Cdc42-associated tyrosine kinase-1|Y
activated Cdc42 associated tyrosine kinase-1|activated Cdc42 associated tyrosine kinase 1|Y
activated Cdc42 associated tyrosine kinase-1|activated Cdc42 associated tyrosine kinase-2|Y
ras-related GTP-binding protein 33A|ras-related GTP-binding protein 33|Y
ras-related GTP-binding protein 33A|ras-related GTP-binding protein 3A|Y
tissue inhibitors of metalloproteases|tissue inhibitor of metalloproteases|Y
anti-interleukin-6 receptor monoclonal antibody|anti-interleukin 6 receptor monoclonal antibody|Y
anti-interleukin-6 receptor monoclonal antibody|anti-interleukin-2 receptor monoclonal antibody|Y
anti-interleukin-6 receptor monoclonal antibody|anti-interleukin-8 receptor monoclonal antibody|Y
anti-interleukin-6 receptor monoclonal antibody|anti-interleukin-4 receptor monoclonal antibody|Y
salmon gonadotrophin-releasing hormone analogue|salmon gonadotropin-releasing hormone analogue|Y
salmon gonadotrophin-releasing hormone analogue|salmon gonadotrophin-releasing hormone analog|Y
Wechsler Intelligence Scale for Children-4th Edition|Wechsler Intelligence Scale for Children 4th Edition|Y
postero-lateral fusion|posterolateral fusion|Y
sodium coupled neutral amino acid transporter 2|sodium coupled neutral amino acid transporter-2|Y
sodium coupled neutral amino acid transporter 2|sodium-coupled neutral amino acid transporter 2|Y
sodium coupled neutral amino acid transporter 2|sodium coupled neutral amino acid transporter|Y
dihydro-cytochalasin B|dihydrocytochalasin B|Y
neuronal nicotinic acetylcholine receptor alpha 4 subunit|neuronal nicotinic acetylcholine receptor alpha4 subunit|Y
FMRFamide-related peptide|FMRFamide-related peptides|Y
zinc finger homeodomain enhancer-binding protein|zinc finger homeodomain enhancer-binding protein-2|Y
random amplified polymorphic DNA pattern|randomly amplified polymorphic DNA pattern|Y
pre-ganglionic nerve stimulation|preganglionic nerve stimulation|Y
surface-assisted laser desorption/ionization time-of-flight mass spectrometry|surface-assisted laser desorption ionization time-of-flight mass spectrometry|Y
peri-acetabular osteotomy|periacetabular osteotomy|Y
acromandibular dysplasia|acro-mandibular dysplasia|Y
United States Pharmacopeia Drug Information|United States Pharmacopoeia Drug Information|Y
nucleoside reverse transcriptase inhibitor-associated|nucleoside reverse-transcriptase inhibitor-associated|Y
mouse T-cell-associated serine proteinase 1|mouse T-cell associated serine proteinase 1|Y
mouse T-cell-associated serine proteinase 1|mouse T-cell-associated serine proteinase-1|Y
voltage-gated calcium channel α1-subunit|voltage-gated calcium channel α 1-subunit|Y
receptor protein tyrosine phosphatase beta|receptor protein tyrosine phosphatase eta|Y
clinico-pathological conference|clinicopathological conference|Y
tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate|tumor promoter 12-O-tetradecanoylphorbol-13-acetate|Y
cross-correlated relaxation induced polarisation transfer|cross-correlated relaxation-induced polarisation transfer|Y
zinc finger, BED-type containing 6|zinc finger BED-type containing 6|Y
ubiquitinlike protein|ubiquitin-like protein|Y
human leucocyte antigen DR6|human leucocyte antigen DR|Y
capillary electrophoresis electrospray ionization time-of-flight mass spectrometry|capillary electrophoresis-electrospray ionization-time-of-flight mass spectrometry|Y
benzo[a]pyrene diol-epoxide DNA adduct|benzo[a]pyrene diolepoxide DNA adduct|Y
activating signal co-integrator 2|activating signal cointegrator 2|Y
stromal-derived factor 1 α|stromal-derived factor 1α|Y
vitello-intestinal duct|vitellointestinal duct|Y
yttria stabilised tetragonal zirconia polycrystal|yttria-stabilised tetragonal zirconia polycrystal|Y
yttria stabilised tetragonal zirconia polycrystal|yttria stabilized tetragonal zirconia polycrystal|Y
melanin concentrating hormone receptor-1|melanin concentrating hormone receptor 1|Y
protein kinase Cα protein|protein kinase C α protein|Y
protein kinase Cα protein|protein kinase C-α protein|Y
human leucocyte antigen DR1|human leucocyte antigen DR|Y
human leucocyte antigen DR1|human leucocyte antigen DR-1|Y
strip immuno-blot assay|strip immunoblot assay|Y
transforming growth factor-beta-activated kinase 1|transforming growth factor-beta activated kinase 1|Y
receptor-like protein-tyrosine phosphatase-kappa|receptor-like protein tyrosine phosphatase-kappa|Y
isolated intra-peritoneal fluid|isolated intraperitoneal fluid|Y
2-acetyl-4-tetrahydroxybutyl imidazole|2-acetyl-4-tetrahydroxybutylimidazole|Y
inter-auricular septal defect|interauricular septal defect|Y
malonyl coenzyme A:acyl carrier protein transacylase|malonyl-coenzyme A:acyl carrier protein transacylase|Y
beta site amyloid precursor protein cleaving enzyme 2|beta site amyloid precursor protein-cleaving enzyme 2|Y
beta site amyloid precursor protein cleaving enzyme 2|beta-site amyloid precursor protein cleaving enzyme 2|Y
beta site amyloid precursor protein cleaving enzyme 2|beta site amyloid precursor protein cleaving enzyme 1|Y
American Orthopaedic Foot and Ankle Society ankle-hind foot score|American Orthopaedic Foot and Ankle Society ankle hindfoot score|Y
American Orthopaedic Foot and Ankle Society ankle-hind foot score|American Orthopedic Foot and Ankle Society ankle-hind foot score|Y
American Orthopaedic Foot and Ankle Society ankle-hind foot score|American Orthopaedic Foot and Ankle Society ankle-hindfoot score|Y
preprogalanin messenger RNA|prepro-galanin messenger RNA|Y
TATA-binding protein-associated factor 12|TATA-binding protein-associated factor 17|Y
TATA-binding protein-associated factor 12|TATA-binding protein-associated factor 11|Y
TATA-binding protein-associated factor 12|TATA-binding protein-associated factor-12|Y
TATA-binding protein-associated factor 12|TATA-binding protein-associated factor 1|Y
toll/interleukin 1 receptor domain-containing adapter-inducing interferon beta|Toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
toll/interleukin 1 receptor domain-containing adapter-inducing interferon beta|toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
toll/interleukin 1 receptor domain-containing adapter-inducing interferon beta|toll/interleukin-1 receptor domain-containing adapter-inducing interferon beta|Y
toll/interleukin 1 receptor domain-containing adapter-inducing interferon beta|toll-interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
toll/interleukin 1 receptor domain-containing adapter-inducing interferon beta|toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
toll/interleukin 1 receptor domain-containing adapter-inducing interferon beta|Toll/interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
toll/interleukin 1 receptor domain-containing adapter-inducing interferon beta|toll/interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Y
thoraco-abdominal computed tomography|thoracoabdominal computed tomography|Y
surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry|surface-enhanced laser desorption/ionization time-of-flight mass spectrometry|Y
surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry|surface enhanced laser desorption/ionisation time-of-flight mass spectrometry|Y
gas chromatography/mass spectrometry/selected ion monitoring|gas chromatography/mass spectrometry selected ion monitoring|Y
glycosylphosphatidyl inositol-anchored protein|glycosylphosphatidylinositol-anchored protein|Y
glycosylphosphatidyl inositol-anchored protein|glycosylphosphatidyl inositol anchored protein|Y
glycosylphosphatidyl inositol-anchored protein|glycosyl-phosphatidylinositol-anchored protein|Y
glycosylphosphatidyl inositol-anchored protein|glycosylphosphatidyl-inositol-anchored protein|Y
interferon stimulated gene factor 3 alpha|interferon stimulated gene factor 3alpha|Y
interferon stimulated gene factor 3 alpha|interferon stimulated gene factor-3 alpha|Y
American Society of Anesthesiologists status I|American Society of Anesthesiologists Status I|Y
American Society of Anesthesiologists status I|American Society of Anaesthesiologists status IV|Y
American Society of Anesthesiologists status I|American Society of Anaesthesiologists status I|Y
American Society of Anesthesiologists status I|American Society of Anesthesiologists status 5|Y
American Society of Anesthesiologists status I|American Society of Anesthesiologists status III|Y
American Society of Anesthesiologists status I|American Society of Anaesthesiologists status II|Y
anti-neutrophil cytoplasmic antibody|antineutrophil cytoplasmic antibody|Y
recombinant human transforming growth factor-β|recombinant human transforming growth factor-β 3|Y
recombinant human transforming growth factor-β|recombinant human transforming growth factor-β 2|Y
recombinant human transforming growth factor-β|recombinant human transforming growth factor-α|Y
recombinant human transforming growth factor-β|recombinant human transforming growth factor β|Y
antiglycoprotein Ib monoclonal antibody|anti-glycoprotein Ib monoclonal antibody|Y
toll/interleukin-1 receptor domain-containing adapter-inducing interferon-β|toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
toll/interleukin-1 receptor domain-containing adapter-inducing interferon-β|toll-interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
toll/interleukin-1 receptor domain-containing adapter-inducing interferon-β|toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
toll/interleukin-1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
toll/interleukin-1 receptor domain-containing adapter-inducing interferon-β|toll/interleukin-1 receptor domain-containing adapter-inducing interferon β|Y
toll/interleukin-1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
[35S]-t-butylbicyclophosphorothionate|[35S]t-butylbicyclophosphorothionate|Y
α1-anti-chymotrypsin|α-1-anti-chymotrypsin|Y
human T cell leukaemia virus type-I-infected|human T cell leukaemia virus type-1-infected|Y
myo-adenylate deaminase deficiency|myoadenylate deaminase deficiency|Y
hamster kidney cell line 1|hamster kidney cell line 1B|Y
estrogen receptor-mediated|oestrogen receptor-mediated|Y
alpha1-anti-chymotrypsin|alpha-1-anti-chymotrypsin|Y
rat insulinoma cell line 5F|rat insulinoma cell line m5F|Y
basic helix-loop-helix leucine zipper protein|basic-helix-loop-helix leucine zipper protein|Y
a disintegrin and metalloprotease-29|a disintegrin and metalloprotease-9|Y
trans-jugular intrahepatic porto-systemic shunt|trans-jugular intra-hepatic porto-systemic shunt|Y
trans-jugular intrahepatic porto-systemic shunt|trans-jugular intra-hepatic portosystemic shunt|Y
trans-jugular intrahepatic porto-systemic shunt|trans-jugular intrahepatic portosystemic shunt|Y
haemoglobin Barts hydrops foetalis|haemoglobin Bart's hydrops foetalis|Y
intra-amniotic infection|intraamniotic infection|Y
macro-molecular creatine kinase type 1|macromolecular creatine kinase type 1|Y
A disintegrin and metalloprotease 29|A disintegrin and metalloprotease 9|Y
stress-activated protein kinases|stress-activated protein kinase|Y
balloon occluded retrograde transvenous obliteration|balloon-occluded retrograde transvenous obliteration|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloprotease with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloprotease with thrombospondin motifs-9|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloprotease with thrombospondin motifs-20|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloprotease with thrombospondin motif-2|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
multi-component reaction|multicomponent reaction|Y
monoclonal antibody immobilization of platelet antigens|monoclonal antibody immobilization of platelet antigen|Y
sodium-calcium exchange|sodium-calcium exchanger|Y
double-stranded RNA-activated protein kinase|double stranded RNA-activated protein kinase|Y
C-C chemokine ligand-5|C-C chemokine ligand-25|Y
benzo[a]pyrene diol epoxide|benzo[a]pyrene diolepoxide|Y
trinitrobenzenesulfonate|trinitrobenzene sulfonate|Y
postnecrotic cirrhosis|post-necrotic cirrhosis|Y
reflection coefficients|reflection coefficient|Y
interleukin 1 beta-converting enzyme|interleukin 1beta-converting enzyme|Y
tumor necrosis factor receptor associated factor-5|tumor necrosis factor receptor associated factor-1|Y
tumor necrosis factor receptor associated factor-5|tumor necrosis factor receptor associated factor-2|Y
anti-interleukin 12 monoclonal antibody|antiinterleukin 12 monoclonal antibody|Y
anti-toll like receptor-3 monoclonal antibody|anti-toll like receptor-2 monoclonal antibody|Y
anti-toll like receptor-3 monoclonal antibody|anti-toll like receptor-4 monoclonal antibody|Y
signal transducer and activator of transcription 5|signal transducer and activator of transcription 2|Y
signal transducer and activator of transcription 5|signal transducer and activator of transcription|Y
signal transducer and activator of transcription 5|signal transducer and activator of transcription 5b|Y
signal transducer and activator of transcription 5|signal transducer and activator of transcription 6|Y
signal transducer and activator of transcription 5|signal transducer and activator of transcription 3|Y
endoscopic retrograde cholangio-pancreatography|endoscopic retrograde cholangiopancreatography|Y
endoscopic retrograde cholangio-pancreatography|endoscopic retrograde cholangio pancreatography|Y
matrix metallopeptidase 1|matrix metallopeptidase 13|Y
perfluorocarboxylate|perfluoro-carboxylate|Y
transforming growth factor beta receptor type II|transforming growth factor beta receptor type I|Y
transforming growth factor beta receptor type II|transforming growth factor beta receptor type III|Y
American Society of Anesthesiologists class V|American Society of Anesthesiologists class IV|Y
American Society of Anesthesiologists class V|American Society of Anesthesiologists class 2|Y
American Society of Anesthesiologists class V|American Society of Anesthesiologists class I|Y
American Society of Anesthesiologists class V|American Society of Anesthesiologists class 1|Y
α thalassemia/mental retardation syndrome X-linked|α-thalassemia/mental retardation syndrome X-linked|Y
5-hydroxytryptamine7 receptor|5-hydroxytryptamine receptor|Y
American Society of Anaesthesiologists grade 2|American Society of Anaesthesiologists grade I|Y
American Society of Anaesthesiologists grade 2|American Society of Anaesthesiologists grade 3|Y
American Society of Anaesthesiologists grade 2|American Society of Anesthesiologists grade 2|Y
American Society of Anaesthesiologists grade 2|American Society of Anaesthesiologists grade 5|Y
American Society of Anaesthesiologists grade 2|American Society of Anaesthesiologists grade 4|Y
choledocho-duodenostomy|choledochoduodenostomy|Y
patellofemoral syndrome|patello-femoral syndrome|Y
Waldenströms macroglobulinemia|Waldenströms macroglobulinaemia|Y
Waldenströms macroglobulinemia|Waldenström macroglobulinemia|Y
Waldenströms macroglobulinemia|Waldenström's macroglobulinemia|Y
extra-intracranial bypass|extraintracranial bypass|Y
hydroxypropyl-beta-cyclodextrin|hydroxy-propyl-beta-cyclodextrin|Y
American Society of Anaesthesiology class 5|American Society of Anaesthesiology class 3|Y
American Society of Anaesthesiology class 5|American Society of Anaesthesiology class 2|Y
American Society of Anaesthesiology class 5|American Society of Anaesthesiology class 1|Y
retinoic-acid-receptor-related orphan receptor α|retinoic-acid-receptor-related orphan receptor γ|Y
retinoic-acid-receptor-related orphan receptor α|retinoic-acid-receptor-related orphan receptor|Y
transient receptor potential melastatin 4|transient receptor potential melastatin 2|Y
transient receptor potential melastatin 4|transient receptor potential melastatin 3|Y
transient receptor potential melastatin 4|transient receptor potential melastatin 6|Y
transient receptor potential melastatin 4|transient receptor potential melastatin 7|Y
transient receptor potential melastatin 4|transient receptor potential melastatin 8|Y
transient receptor potential melastatin 4|transient receptor potential melastatin 1|Y
Toll-interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Y
Toll-interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
Toll-interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Toll-interleukin-1 receptor domain-containing adapter-inducing interferon beta|Y
Toll-interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Y
Toll-interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
toll/interleukin-1 receptor domain-containing adapter-inducing interferon-beta|toll/interleukin-1 receptor domain-containing adapter-inducing interferon beta|Y
toll/interleukin-1 receptor domain-containing adapter-inducing interferon-beta|toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
toll/interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Y
toll/interleukin-1 receptor domain-containing adapter-inducing interferon-beta|toll/interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Y
toll/interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
platelet-derived growth factor type-β receptor|platelet-derived growth factor type β receptor|Y
hepatocyte nuclear factor 1α|hepatocyte nuclear factor 1|Y
hepatocyte nuclear factor 1α|hepatocyte nuclear factor 1 α|Y
3'-untranslated region|3'untranslated region|Y
β2 adrenergic receptor|β adrenergic receptor|Y
Rho guanine nucleotide dissociation inhibitor α|Rho guanine nucleotide dissociation inhibitor-α|Y
presqualene diphosphate|presqualene disphosphate|Y
hyper-branched polymer|hyperbranched polymer|Y
polymerase chain reaction/sequence-specific priming|polymerase chain reaction-sequence-specific priming|Y
vasodilator-stimulated phosphoprotein phosphorylation assay|vasodilator-stimulated phosphoprotein-phosphorylation assay|Y
TATA-binding protein associated factor 10|TATA-binding protein associated factor 15|Y
TATA-binding protein associated factor 10|TATA-binding protein associated factor-10|Y
TATA-binding protein associated factor 10|TATA-binding protein associated factor 11|Y
thyrotrophin-releasing-hormone|thyrotropin-releasing-hormone|Y
Locusta migratoria tachykinin II|Locusta migratoria tachykinin III|Y
Locusta migratoria tachykinin II|Locusta migratoria tachykinin I|Y
2-amino-3-methylimidazo[4,5-f]-quinoline|2-amino-3-methyl-imidazo[4,5-f]quinoline|Y
2-amino-3-methylimidazo[4,5-f]-quinoline|2-amino-3-methylimidazo[4,5-f]quinoline|Y
2-amino-3-methylimidazo[4,5-f]-quinoline|2-amino-3-methylimidazo-[4,5-f]quinoline|Y
chronic thromboembolic pulmonary hypertension|chronic thrombo-embolic pulmonary hypertension|Y
low-pressure gas chromatography/tandem mass spectrometry|low-pressure gas chromatography-tandem mass spectrometry|Y
chicken luteinizing hormone releasing hormone|chicken luteinizing hormone releasing hormone I|Y
neural precursor cell expressed, developmentally down-regulated 8|neural precursor cell expressed, developmentally downregulated 5|Y
neural precursor cell expressed, developmentally down-regulated 8|neural precursor cell expressed developmentally down-regulated 1|Y
neural precursor cell expressed, developmentally down-regulated 8|neural precursor cell expressed developmentally down-regulated 8|Y
neural precursor cell expressed, developmentally down-regulated 8|neural precursor cell expressed, developmentally downregulated 9|Y
neural precursor cell expressed, developmentally down-regulated 8|neural precursor cell expressed, developmentally downregulated 2|Y
neural precursor cell expressed, developmentally down-regulated 8|neural precursor cell expressed, developmentally down-regulated 4|Y
neural precursor cell expressed, developmentally down-regulated 8|neural precursor cell expressed, developmentally down-regulated 1|Y
neural precursor cell expressed, developmentally down-regulated 8|neural precursor cell expressed developmentally down-regulated 9|Y
neural precursor cell expressed, developmentally down-regulated 8|neural precursor cell-expressed, developmentally downregulated 8|Y
neural precursor cell expressed, developmentally down-regulated 8|neural precursor cell expressed, developmentally down-regulated 5|Y
anti-human herpesvirus 6 immunoglobulin G|anti-human herpes virus 6 immunoglobulin G|Y
liquid chromatography ion-trap mass spectrometry|liquid chromatography-ion-trap mass spectrometry|Y
liquid chromatography ion-trap mass spectrometry|liquid chromatography/ion-trap mass spectrometry|Y
ATP-tumor chemosensitivity assay|ATP-tumour chemosensitivity assay|Y
augmented correlation-consistent polarised valence triple-zeta basis set|augmented correlation-consistent polarized valence triple-zeta basis set|Y
augmented correlation-consistent polarised valence triple-zeta basis set|augmented correlation consistent polarised valence triple-zeta basis set|Y
oro-mandibular dystonia|oromandibular dystonia|Y
polyphosphoinositide|poly-phosphoinositide|Y
Q-T interval dispersion|QT interval dispersion|Y
popliteo-fibular ligament|popliteofibular ligament|Y
American Society of Anesthesiology class IV|American Society of Anesthesiology class V|Y
American Society of Anesthesiology class IV|American Society of Anesthesiology class I|Y
Pituitary adenylate cyclase-activating polypeptide|Pituitary adenylate cyclase activating polypeptide|Y
attenuated total reflectance-Fourier transform infrared spectroscopy|attenuated total reflectance-Fourier transform infra red spectroscopy|Y
attenuated total reflectance-Fourier transform infrared spectroscopy|attenuated total reflectance Fourier transform infrared spectroscopy|Y
attenuated total reflectance-Fourier transform infrared spectroscopy|attenuated total reflectance Fourier transform infra-red spectroscopy|Y
matrix-assisted laser desorption ionization|matrix-assisted laser desorption-ionization|Y
hypogamma-globulinemia|hypogammaglobulinemia|Y
hypogamma-globulinemia|hypo-gamma-globulinemia|Y
hypogamma-globulinemia|hypogamma-globulinaemia|Y
multi-facility health-care organisation|multi-facility healthcare organisation|Y
anti-hepatitis A virus|antihepatitis A virus|Y
oculokinetic perimetry|oculo-kinetic perimetry|Y
IL-12 receptor beta2|IL-12 receptor beta 2|Y
interferon-stimulated gene factor 3alpha|interferon stimulated gene factor 3alpha|Y
anti-kappa light-chain monoclonal antibody|anti-kappa-light-chain monoclonal antibody|Y
anti-kappa light-chain monoclonal antibody|anti-kappa light chain monoclonal antibody|Y
stem cell transplants|stem cell transplant|Y
anti-embolic stocking|antiembolic stocking|Y
endothelial monocyte-activating polypeptide-I|endothelial monocyte-activating polypeptide-II|Y
endothelial monocyte-activating polypeptide-I|endothelial monocyte-activating polypeptide-2|Y
endothelial monocyte-activating polypeptide-I|endothelial monocyte-activating polypeptide-III|Y
Portland Veterans Affairs Medical Center|Portland Veterans' Affairs Medical Center|Y
Portland Veterans Affairs Medical Center|Portland Veteran's Affairs Medical Center|Y
Salmonella choleraesuis|Salmonella cholerae-suis|Y
Unified Huntington's Disease Rating Scale|Unified Huntington Disease Rating Scale|Y
antiinterleukin 13 monoclonal antibody|anti-interleukin 13 monoclonal antibody|Y
antiinterleukin 13 monoclonal antibody|antiinterleukin 3 monoclonal antibody|Y
epidermal growth factor receptor tyrosine kinase inhibitor-resistant|epidermal growth factor receptor-tyrosine kinase inhibitor-resistant|Y
umbilicoplacental embolisation|umbilico-placental embolisation|Y
isolated rabbit sinoatrial|isolated rabbit sino-atrial|Y
high speed countercurrent chromatography|high speed counter-current chromatography|Y
thyrotrophin releasing hormone receptor|thyrotropin releasing hormone receptor|Y
poly-β-hydroxybutyrate|poly-βhydroxybutyrate|Y
TATA-binding protein-associated factor 7|TATA-binding protein-associated factor 9|Y
TATA-binding protein-associated factor 7|TATA-binding protein-associated factor 8|Y
TATA-binding protein-associated factor 7|TATA-binding protein-associated factor 6|Y
TATA-binding protein-associated factor 7|TATA-binding protein-associated factor 17|Y
TATA-binding protein-associated factor 7|TATA-binding protein-associated factor 1|Y
TATA-binding protein-associated factor 7|TATA-binding protein-associated factor 4|Y
TATA-binding protein-associated factor 7|TATA-binding protein-associated factor-7|Y
TATA-binding protein associated factor 15|TATA-binding protein associated factor 11|Y
idiopathic thrombo-cytopenia|idiopathic thrombocytopenia|Y
retinoblastoma protein-interacting zinc-finger gene|retinoblastoma protein-interacting zinc finger gene|Y
glycophosphatidyl inositol-anchored protein|glycophosphatidylinositol-anchored protein|Y
ultra-violet photoelectron spectroscopy|ultraviolet photoelectron spectroscopy|Y
beta amyloid precursor protein cleaving enzyme|beta amyloid precursor protein cleaving enzyme 1|Y
beta amyloid precursor protein cleaving enzyme|beta amyloid precursor protein cleaving enzyme 2|Y
beta amyloid precursor protein cleaving enzyme|beta-amyloid precursor protein cleaving enzyme|Y
beta amyloid precursor protein cleaving enzyme|beta amyloid precursor protein cleaving enzyme-1|Y
mannose 6-phosphate receptors|mannose 6-phosphate receptor|Y
cervical intra-epithelial neoplasia|cervical intraepithelial neoplasia|Y
p-aminohippurate clearance|p-amino-hippurate clearance|Y
ultra-purified polymerised bovine haemoglobin|ultrapurified polymerised bovine hemoglobin|Y
diffusion-weighted image|diffusion-weighted images|Y
creatinephosphokinase|creatine phosphokinase|Y
aminoacyl-tRNA synthetase complex-interacting multifunctional protein 1|aminoacyl tRNA synthetase complex-interacting multifunctional protein 1|Y
aminoacyl-tRNA synthetase complex-interacting multifunctional protein 1|aminoacyl-tRNA synthetase complex-interacting multifunctional protein 2|Y
mitogen extracellular signal-regulated kinase kinase 6|mitogen/extracellular signal-regulated kinase kinase 6|Y
C. difficile-associated diarrhea|C. difficile-associated diarrhoea|Y
phosphorylated glycogen synthase kinase 3 beta|phosphorylated glycogen synthase kinase 3beta|Y
antiovalbumin immunoglobulin G|anti-ovalbumin immunoglobulin G|Y
infrared coagulation|infra-red coagulation|Y
tumor necrosis factor receptor superfamily member 1A|tumor necrosis factor receptor superfamily member 1B|Y
tumor necrosis factor receptor superfamily member 1A|tumor necrosis factor receptor superfamily member 12|Y
tumor necrosis factor receptor superfamily member 1A|tumor necrosis factor receptor superfamily member 19|Y
cytosolic phospholipase A(2)-alpha|cytosolic phospholipase A(2)alpha|Y
ultra performance liquid chromatography/electrospray ionization tandem mass spectrometry|ultraperformance liquid chromatography/electrospray ionisation tandem mass spectrometry|Y
ultra performance liquid chromatography/electrospray ionization tandem mass spectrometry|ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry|Y
ultra performance liquid chromatography/electrospray ionization tandem mass spectrometry|ultraperformance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
ultra performance liquid chromatography/electrospray ionization tandem mass spectrometry|ultra performance liquid chromatography/electrospray ionisation tandem mass spectrometry|Y
ultra performance liquid chromatography/electrospray ionization tandem mass spectrometry|ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
slow acting antirheumatic drug|slow acting anti-rheumatic drug|Y
Kellgren-Lawrence grade II|Kellgren-Lawrence grade I|Y
photoelectric plethysmography|photo-electric plethysmography|Y
interleukin-13 receptor α 2 chain|interleukin-13 receptor α2 chain|Y
non-matching to sample|nonmatching to sample|Y
Charlson Co-morbidity Index|Charlson Comorbidity Index|Y
thyrotrophin-releasing hormone receptor-1|thyrotropin-releasing hormone receptor-1|Y
thyrotrophin-releasing hormone receptor-1|thyrotrophin-releasing hormone receptor 1|Y
thyrotrophin-releasing hormone receptor-1|thyrotrophin-releasing hormone receptor|Y
Kruppel-like factor-3|Kruppel-like factor-13|Y
glyceraldehyde-3-phosphate dehydrogenases|glyceraldehyde-3-phosphate dehydrogenase|Y
7,12-dimethyl-benz[a]anthracene|7,12-dimethylbenz[a]anthracene|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motif|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motifs-19|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motif-8|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motifs-8|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motif-14|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motif-9|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
voltage-sensitive Ca2+ channel|voltage-sensitive Ca2+ channels|Y
luteinising hormone-releasing hormone receptor|luteinising hormone releasing hormone receptor|Y
laryngotracheal separation|laryngo-tracheal separation|Y
ultra-high resolution optical coherence tomography|ultrahigh resolution optical coherence tomography|Y
superresolution near-field structure|super resolution near-field structure|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloproteinase with thrombospondin motif-8|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloproteinase with thrombospondin motifs-8|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloproteinase with thrombospondin motif-14|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motif|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
post-antifungal effect|postantifungal effect|Y
insulin-like growth factor-II mRNA-binding protein 1|insulin-like growth factor II mRNA-binding protein 1|Y
insulin-like growth factor-II mRNA-binding protein 1|insulin-like growth factor-II mRNA-binding protein 3|Y
insulin-like growth factor-II mRNA-binding protein 1|insulin-like growth factor-II mRNA-binding protein|Y
insulin-like growth factor-II mRNA-binding protein 1|insulin-like growth factor-II mRNA-binding protein 2|Y
days postfertilization|days post-fertilization|Y
chicken luteinising hormone releasing hormone I|chicken luteinising hormone releasing hormone II|Y
chicken luteinising hormone releasing hormone I|chicken luteinising hormone-releasing hormone I|Y
chicken luteinising hormone releasing hormone I|chicken luteinizing hormone releasing hormone I|Y
sterol response element binding protein-1-a|sterol response element-binding protein-1-a|Y
auditory brainstem evoked potential|auditory brain stem evoked potential|Y
auditory brainstem evoked potential|auditory brain-stem evoked potential|Y
stromal derived factor 1 α|stromal derived factor 1α|Y
B cell leukaemia/lymphoma 2 protein|B cell leukemia/lymphoma 2 protein|Y
Clinical Global Impressions-Improvement scale|Clinical Global Impressions-Improvement Scale|Y
complete active space self-consistent field method|complete active-space self-consistent field method|Y
bio-concentration factor|bioconcentration factor|Y
slow hyperpolarizing after-potential|slow hyperpolarizing afterpotential|Y
prothrombin time-international normalised ratio|prothrombin time-international normalized ratio|Y
tubulo-interstitial nephritis antigen|tubulointerstitial nephritis antigen|Y
interleukin-1 beta-converting enzyme|interleukin-1beta-converting enzyme|Y
third complementarity determining regions|third complementarity determining region|Y
cotranscriptional cleavage|co-transcriptional cleavage|Y
chromatin accessibility complex-16|chromatin accessibility complex-1|Y
sodium glucose co-transporter 3|sodium glucose cotransporter 3|Y
recombinant human transforming growth factor β2|recombinant human transforming growth factor β|Y
pantothenate kinase-associated neurodegeneration|pantothenate kinase associated neurodegeneration|Y
peripheral neuro-epithelioma|peripheral neuroepithelioma|Y
dendritic cell-tumor fusion|dendritic cell-tumour fusion|Y
sterol regulatory element binding protein-2|sterol regulatory element-binding protein-2|Y
bis(p-nitrophenyl)phosphate|bis(p-nitrophenyl) phosphate|Y
floating-harbour syndrome|floating-harbor syndrome|Y
trans-cutaneous electrical stimulation|transcutaneous electrical stimulation|Y
poly-hydroxybutyrate|poly-βhydroxybutyrate|Y
lympho-granuloma venereum|lymphogranuloma venereum|Y
electro-myostimulation|electromyostimulation|Y
American Society of Anesthesiologists physical status I|American Society of Anesthesiologists physical status IV|Y
American Society of Anesthesiologists physical status I|American Society of Anesthesiologists physical status III|Y
American Society of Anesthesiologists physical status I|American Society of Anaesthesiologists physical status IV|Y
American Society of Anesthesiologists physical status I|American Society of Anesthesiologists physical status 2|Y
American Society of Anesthesiologists physical status I|American Society of Anesthesiologists physical status II|Y
American Society of Anesthesiologists physical status I|American Society of Anesthesiologists physical status 4|Y
American Society of Anesthesiologists physical status I|American Society of Anesthesiologists physical status 5|Y
cross-polarization/magic angle spinning NMR|cross-polarisation/magic angle spinning NMR|Y
cross-polarization/magic angle spinning NMR|cross-polarization magic angle spinning NMR|Y
cross-polarization/magic angle spinning NMR|cross-polarization/magic-angle spinning NMR|Y
5-carboxamidotryptamine|5-carboxyamidotryptamine|Y
mesangiocapillary glomerulonephritis type iv|mesangiocapillary glomerulonephritis type ii|Y
neonatal allo-immune thrombocytopaenia|neonatal allo-immune thrombocytopenia|Y
pathological tumor-3, node-2, metastasis-0|pathological tumor-3, node-0, metastasis-0|Y
pathological tumor-3, node-2, metastasis-0|pathological tumor-3, node-1, metastasis-0|Y
prolapsed intervertebral disc|pro lapsed intervertebral disc|Y
anti-IL-18 monoclonal antibody|anti-IL-8 monoclonal antibody|Y
anti-IL-18 monoclonal antibody|anti-IL18 monoclonal antibody|Y
aorto-esophageal fistula|aorto-oesophageal fistula|Y
aorto-esophageal fistula|aortoesophageal fistula|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-4|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-1|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-4|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 4|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-4|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-4|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2|Y
anti-β(2)-glycoprotein I antibody|anti-β (2)-glycoprotein I antibody|Y
zinc finger and BTB domain containing 7B|zinc finger and BTB domain containing 7A|Y
IL-15 receptor α chain|IL-5 receptor α chain|Y
intrauterine fetal demise|intra-uterine fetal demise|Y
American Society of Anesthesiologists class IV|American Society of Anesthesiologists class I|Y
American Society of Anesthesiologists class IV|American Society of Anesthesiologists Class IV|Y
gastro-bronchial fistula|gastrobronchial fistula|Y
β site amyloid precursor protein-cleaving enzyme 2|β site amyloid precursor protein-cleaving enzyme-2|Y
β site amyloid precursor protein-cleaving enzyme 2|β site amyloid precursor protein cleaving enzyme 2|Y
L-N6-(1-iminoethyl)lysine|L-N6-(1-iminoethyl)-lysine|Y
glial cell line-derived neurotrophic factor|glial cell line derived neurotrophic factor|Y
proximal femoral nail anti-rotation|proximal femoral nail antirotation|Y
dorso-medial hypothalamic nucleus lesion|dorsomedial hypothalamic nucleus lesion|Y
TATA-binding protein-associated factor 9|TATA-binding protein-associated factor 8|Y
TATA-binding protein-associated factor 9|TATA-binding protein-associated factor 6|Y
TATA-binding protein-associated factor 9|TATA-binding protein-associated factor 1|Y
TATA-binding protein-associated factor 9|TATA-binding protein-associated factor 4|Y
TATA-binding protein-associated factor 9|TATA-binding protein-associated factor-9|Y
methane monooxygenase reductase|methane mono-oxygenase reductase|Y
TNFR-associated factor 2|TNF-R-associated factor 2|Y
lympho-vascular space invasion|lymphovascular space invasion|Y
border-line arterial hypertension|borderline arterial hypertension|Y
subacute ruminal acidosis|sub-acute ruminal acidosis|Y
endothelial-monocyte-activating polypeptide III|endothelial-monocyte-activating polypeptide I|Y
ATP binding cassette transporter A1|ATP binding cassette transporter 1|Y
vasoactive intestinal peptide-secreting tumour|vasoactive intestinal peptide-secreting tumor|Y
random amplified polymorphic DNA analysis|random-amplified polymorphic DNA analysis|Y
random amplified polymorphic DNA analysis|randomly amplified polymorphic DNA analysis|Y
antiganglioside M1 antibody|anti-ganglioside M1 antibody|Y
intrapulmonary chemoreceptor|intra-pulmonary chemoreceptor|Y
glossopharyngeal neuralgia|glosso-pharyngeal neuralgia|Y
Schizosaccharomyces japonicus varietas versatilis|Schizo-saccharomyces japonicus varietas versatilis|Y
neuro-endocrine tumor|neuro-endocrine tumour|Y
neuro-endocrine tumor|neuroendocrine tumor|Y
evoked auditory brainstem response|evoked auditory brain stem response|Y
evoked auditory brainstem response|evoked auditory brain-stem response|Y
receptor-like protein tyrosine phosphatase-alpha|receptor-like protein tyrosine phosphatase alpha|Y
receptor-like protein tyrosine phosphatase-alpha|receptor-like protein-tyrosine phosphatase-alpha|Y
heart-cutting multidimensional gas chromatography|heart-cutting multi-dimensional gas chromatography|Y
cranio-facial stenosis|craniofacial stenosis|Y
nonfluorescent chlorophyll catabolite|non-fluorescent chlorophyll catabolite|Y
paramonochlorophenol|para-monochlorophenol|Y
enzyme-linked immuno-electrotransfer blot|enzyme-linked immunoelectro-transfer blot|Y
intra-cerebro-ventricular|intracerebro-ventricular|Y
gadolinium-diethylenetriamine-pentaacetic acid|gadolinium-diethylenetriamine pentaacetic acid|Y
microtubule-associated protein-1 light chain-3|microtubule-associated protein-1 light chain-3B|Y
microtubule-associated protein-1 light chain-3|microtubule associated protein-1 light chain-3|Y
microtubule-associated protein-1 light chain-3|microtubule-associated protein 1 light chain-3|Y
glycogen synthase kinase 3α|glycogen synthase kinase 3 α|Y
anti-idiotypic antibody|antiidiotypic antibody|Y
cytosolic phospholipase A2-α|cytosolic phospholipase A2α|Y
multilocus microsatellite typing|multi-locus microsatellite typing|Y
Pseudomonas aeruginosa|Pseudo-monas aeruginosa|Y
benzo[a]pyrene diol-epoxide-DNA adduct level|benzo[a]pyrene diol-epoxide DNA adduct level|Y
benzo[a]pyrene diol-epoxide-DNA adduct level|benzo[a]pyrene diol epoxide-DNA adduct level|Y
gamma-aminobutyric acid A-benzodiazepine receptor complex|gamma-aminobutyric acidA-benzodiazepine receptor complex|Y
anti-IL 8 monoclonal antibody|anti-IL8 monoclonal antibody|Y
sub-epithelial infiltrate|subepithelial infiltrate|Y
glycosylphosphatidylinositol-anchored protein|glycosylphosphatidylinositol anchored protein|Y
glycosylphosphatidylinositol-anchored protein|glycosyl-phosphatidylinositol-anchored protein|Y
glycosylphosphatidylinositol-anchored protein|glycosylphosphatidyl-inositol-anchored protein|Y
human T-cell lymphotropic virus 1 antibody|human T-cell lymphotropic virus-1 antibody|Y
β site amyloid precursor protein-cleaving enzyme-2|β site amyloid precursor protein cleaving enzyme-2|Y
β site amyloid precursor protein-cleaving enzyme-2|β-site amyloid precursor protein-cleaving enzyme-2|Y
β site amyloid precursor protein-cleaving enzyme-2|β site amyloid precursor protein-cleaving enzyme-1|Y
poly (dimethylsiloxane)|poly(dimethylsiloxane)|Y
interleukine-18 receptor α|interleukin-18 receptor α|Y
deglycosylated human chorionic gonadotrophin|deglycosylated human chorionic gonadotropin|Y
molecular weight cut-off|molecular weight cutoff|Y
anti-CD2 monoclonal antibody|anti-CD25 monoclonal antibody|Y
peptidyl glycine α-amidating mono-oxygenase|peptidylglycine α-amidating monooxygenase|Y
peptidyl glycine α-amidating mono-oxygenase|peptidyl-glycine α-amidating mono-oxygenase|Y
non-muscle myosin heavy chain-IIB|non-muscle myosin heavy chain-II|Y
anti-interleukin 6 receptor monoclonal antibody|anti-interleukin 2 receptor monoclonal antibody|Y
anti-interleukin 6 receptor monoclonal antibody|anti-interleukin 4 receptor monoclonal antibody|Y
TNM pathologic stage N1b|TNM pathologic stage N1|Y
TNM pathologic stage N1b|TNM pathologic stage N1bi|Y
murine T cell associated serine proteinase 1|murine T cell associated serine proteinase-1|Y
peroxisome proliferator-activated receptor-γ coactivator-1|peroxisome proliferator-activated receptor-γ coactivator-1 α|Y
peroxisome proliferator-activated receptor-γ coactivator-1|peroxisome proliferator-activated receptor γ coactivator-1|Y
peroxisome proliferator-activated receptor-γ coactivator-1|peroxisome proliferator-activated receptor-γ co-activator-1α|Y
flat panel volumetric computed tomography|flat-panel volumetric computed tomography|Y
insulin autoantibody|insulin auto-antibody|Y
American Spinal Injury Association Impairment Scale grade D|American Spinal Injury Association Impairment Scale grade B|Y
American Spinal Injury Association Impairment Scale grade D|American Spinal Injury Association Impairment Scale grade C|Y
American Spinal Injury Association Impairment Scale grade D|American Spinal Injury Association Impairment Scale grade A|Y
anti-IL 10 receptor MAb|anti-IL10 receptor MAb|Y
antiacetylcholine receptor antibody|anti-acetylcholine receptor antibody|Y
complete metabolic panel|complete metabolic panels|Y
radiocontrast induced nephropathy|radio-contrast induced nephropathy|Y
radiocontrast induced nephropathy|radio contrast induced nephropathy|Y
fronto-nasal dysplasia|frontonasal dysplasia|Y
light harvesting chlorophyll a/b-binding protein I|light harvesting chlorophyll a/b-binding protein-I|Y
light harvesting chlorophyll a/b-binding protein I|light harvesting chlorophyll a/b binding protein I|Y
cerebro-spinal fluid pressure|cerebrospinal fluid pressure|Y
vincristine, Adriamycin and cyclophosphamide|vincristine, Adriamycin, and cyclophosphamide|Y
Toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|toll/interleukin-1 receptor domain-containing adapter-inducing interferon beta|Y
Toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|Toll/interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Y
Toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|Toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
Toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|Toll-interleukin-1 receptor domain-containing adapter-inducing interferon beta|Y
Toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Y
Toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|Toll/interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
Toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
Toll/interleukin1 receptor domain-containing adapter-inducing interferon beta|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
invariant T cell receptor Vα14|invariant T cell receptor Vα 14|Y
intra-dialytic hypotension|intradialytic hypotension|Y
granulocyte macrophage colony-stimulating factor receptor alpha subunit|granulocyte-macrophage colony-stimulating factor receptor alpha subunit|Y
inositol 1,4,5-triphosphate|inositol 1,4,5-trisphosphate|Y
recombinant interleukin 1 α|recombinant interleukine 1 α|Y
American Society of Anaesthesiologists class 5|American Society of Anaesthesiologists class 1|Y
American Society of Anaesthesiologists class 5|American Society of Anaesthesiologists Class 5|Y
American Society of Anaesthesiologists class 5|American Society of Anaesthesiologists class 4|Y
retinoic acid receptor-related orphan receptor γT|retinoic acid receptor-related orphan receptor γ-T|Y
retinoic acid receptor-related orphan receptor γT|retinoic acid receptor-related orphan receptor γ|Y
obstetrician-gynecologist|obstetrician-gynecologists|Y
light harvesting chlorophyll a/b binding protein II|light harvesting chlorophyll a/b binding protein I|Y
ATP-binding cassette sub-family B member 1|ATP-binding cassette subfamily B member 1|Y
university affiliated Veterans' Affairs medical center|university affiliated Veteran's Affairs medical center|Y
university affiliated Veterans' Affairs medical center|university-affiliated Veterans' Affairs medical center|Y
three dimensional computed tomography-angiography|three dimensional computed tomography angiography|Y
nonphytate phosphorus|non-phytate phosphorus|Y
human hepatocellular carcinoma cell line 1|human hepatocellular carcinoma cell line 1B|Y
interphase fluorescence in-situ hybridization|interphase fluorescence in-situ hybridisation|Y
Autonomously functioning thyroid nodules|autonomously functioning thyroid nodules|Y
anti-human T cell lymphotropic virus-I antibody|anti-human T-cell lymphotropic virus-I antibody|Y
cytokine induced neutrophil chemoattractant-1|cytokine-induced neutrophil chemoattractant-1|Y
cytokine induced neutrophil chemoattractant-1|cytokine induced neutrophil chemoattractant 1|Y
cytokine induced neutrophil chemoattractant-1|cytokine induced neutrophil chemoattractant-2|Y
cytokine induced neutrophil chemoattractant-1|cytokine induced neutrophil chemoattractant|Y
chicken anaemia agent|chicken anemia agent|Y
human adenovirus serotype 12|human adenovirus serotype 1|Y
Houston Veterans' Affairs Medical Center|Houston Veterans Affairs Medical Center|Y
respiratory inductive plethysmograph|respiratory inductive plethysmography|Y
alcoholic steato-hepatitis|alcoholic steatohepatitis|Y
anti-herpes simplex virus type 2|antiherpes simplex virus type 2|Y
double quantum filtered correlation spectroscopy|double-quantum filtered correlation spectroscopy|Y
immuno-fluorescence microscopy|immunofluorescence microscopy|Y
insulin-like growth factor II mRNA-binding protein 1|insulin-like growth factor II mRNA-binding protein 3|Y
insulin-like growth factor II mRNA-binding protein 1|insulin-like growth factor II mRNA-binding protein-1|Y
X-linked α-thalassemia mental retardation syndrome|X-linked α-thalassemia/mental retardation syndrome|Y
microcomputed tomography scan|micro-computed tomography scan|Y
mixed leukocyte-tumour cell culture|mixed leukocyte-tumor cell culture|Y
chronic air-flow obstruction|chronic airflow obstruction|Y
paired-pulse trans-cranial magnetic stimulation|paired pulse trans-cranial magnetic stimulation|Y
estrogen receptor-β knockout|oestrogen receptor-β knockout|Y
toll/IL-1 receptor domain-containing adaptor-inducing IFNbeta|toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta|Y
neointimal hyperplasia|neo-intimal hyperplasia|Y
retiform hemangio-endothelioma|retiform haemangio-endothelioma|Y
retiform hemangio-endothelioma|retiform hemangioendothelioma|Y
erythroblastic leukemia viral oncogene homolog B|erythroblastic leukemia viral oncogene homolog 3|Y
erythroblastic leukemia viral oncogene homolog B|erythroblastic leukemia viral oncogene homolog 2|Y
erythroblastic leukemia viral oncogene homolog B|erythroblastic leukemia viral oncogene homolog A|Y
erythroblastic leukemia viral oncogene homolog B|erythroblastic leukemia viral oncogene homolog 4|Y
matrix-assisted laser desorption/ionization time-of-flight mass spectrometric|matrix-assisted laser desorption/ionization time-of-flight mass spectrometry|Y
matrix-assisted laser desorption/ionization time-of-flight mass spectrometric|matrix assisted laser desorption/ionization time-of-flight mass spectrometric|Y
matrix-assisted laser desorption/ionization time-of-flight mass spectrometric|matrix-assisted laser desorption/ionisation time-of-flight mass spectrometric|Y
trans-pupillary thermotherapy|transpupillary thermotherapy|Y
trans-pupillary thermotherapy|trans-pupillary thermo-therapy|Y
bacillus Calmette-Guerin activated killer cell|bacillus-Calmette-Guerin activated killer cell|Y
Wilm's tumor protein-1|Wilm's tumour protein-1|Y
intrapartum stillbirth|intra-partum stillbirth|Y
anti-mannan immunoglobulin M|antimannan immunoglobulin M|Y
transforming growth factor beta(1) level|transforming growth factor-beta(1) level|Y
American Orthopaedic Foot and Ankle Society ankle hindfoot score|American Orthopaedic Foot and Ankle Society ankle-hindfoot score|Y
insulinlike growth factor receptor type 1|insulin-like growth factor receptor type 1|Y
insulinlike growth factor receptor type 1|insulinlike growth factor receptor type 2|Y
esophago-gastroduodenoscopy|esophago-gastro-duodenoscopy|Y
esophago-gastroduodenoscopy|oesophago-gastroduodenoscopy|Y
beta site amyloid precursor protein-cleaving enzyme 1|beta-site amyloid precursor protein-cleaving enzyme 1|Y
beta site amyloid precursor protein-cleaving enzyme 1|beta site amyloid precursor protein-cleaving enzyme 2|Y
beta site amyloid precursor protein-cleaving enzyme 1|beta site amyloid precursor protein-cleaving enzyme|Y
beta site amyloid precursor protein-cleaving enzyme 1|beta site amyloid precursor protein cleaving enzyme 1|Y
anti-IL 10 receptor antibody|anti-IL 1 receptor antibody|Y
anti-IL 10 receptor antibody|anti-IL10 receptor antibody|Y
6-thioguanine nucleotides|6-thioguanine nucleotide|Y
thiazide-sensitive Na-Cl cotransporter|thiazide-sensitive Na-Cl co-transporter|Y
interleukin-15 receptor α-chain|interleukin-5 receptor α-chain|Y
juxta-glomerular apparatus|juxtaglomerular apparatus|Y
encephaloduro-arterio-synangiosis|encephalo-duro-arterio-synangiosis|Y
epigallocatechin gallate|epi-gallocatechin gallate|Y
epigallocatechin gallate|epigallo-catechin gallate|Y
hemoglobin Bart's hydrops|hemoglobin Barts hydrops|Y
hemoglobin Bart's hydrops|haemoglobin Bart's hydrops|Y
anti-human herpesvirus 8 antibody|antihuman herpesvirus 8 antibody|Y
anti-human herpesvirus 8 antibody|anti-human herpes virus 8 antibody|Y
carnitine palmityltransferase|carnitine palmitoyltransferase|Y
single-strand conformational polymorphism analysis|single-strand conformation polymorphism analysis|Y
pseudohypoaldosteronism type II|pseudo-hypoaldosteronism type II|Y
esophago-gastro-duodenoscopy|oesophago-gastro-duodenoscopy|Y
airway hyper-reactivity|airway hyperreactivity|Y
perioperative myocardial infarction|peri-operative myocardial infarction|Y
UDP-glucuronosyl-transferase 1A1|UDP-glucuronosyltransferase 1A1|Y
postadrenocorticotropic hormone|post-adrenocorticotropic hormone|Y
hyper-immunoglobulin D syndrome|hyperimmunoglobulin D syndrome|Y
human pituitary tumour transforming gene|human pituitary tumour-transforming gene|Y
corticotropin releasing factor type 2 receptor|corticotropin-releasing factor type 2 receptor|Y
corticotropin releasing factor type 2 receptor|corticotropin releasing factor type-2 receptor|Y
Elastic van Gieson stain|Elastica van Gieson stain|Y
cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy|Y
cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy|cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy|Y
cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy|Y
non-translated region|nontranslated region|Y
trans-thoracic impedance|transthoracic impedance|Y
carcinoembryonic antigen-related cell adhesion molecule 1|carcinoembryonic antigen-related cell-adhesion molecule 1|Y
carcinoembryonic antigen-related cell adhesion molecule 1|carcinoembryonic antigen-related cell adhesion molecule|Y
endoscopic naso-biliary drainage|endoscopic nasobiliary drainage|Y
peptidoglycan recognition protein LB|peptidoglycan recognition protein L|Y
American Society of Anaesthesiologists Class I|American Society of Anesthesiologists Class I|Y
American Society of Anaesthesiologists Class I|American Society of Anesthesiologists Class II|Y
American Society of Anaesthesiologists Class I|American Society of Anaesthesiologists Class 5|Y
American Society of Anaesthesiologists Class I|American Society of Anaesthesiologists Class 1|Y
American Society of Anaesthesiologists Class I|American Society of Anesthesiologists Class IV|Y
killer immunoglobulin-like receptor 2DL4|killer immunoglobulin-like receptor 2DS4|Y
killer immunoglobulin-like receptor 2DL4|killer immunoglobulin-like receptor 2DL2|Y
competitive direct enzyme-linked immunosorbent assay|competitive indirect enzyme-linked immunosorbent assay|Y
polymerase chain reaction/sequence-specific primer|polymerase chain reaction/sequence specific primer|Y
anticyclooxygenase 2|anti-cyclooxygenase 2|Y
nondialysable material|non-dialysable material|Y
apoptosis-linked gene 2-interacting protein X|apoptosis-linked gene 2 interacting protein X|Y
electro-corticograph|electro-corticography|Y
nonhomologous endjoining pathway|non-homologous endjoining pathway|Y
laparoscopic anti-reflux surgery|laparoscopic antireflux surgery|Y
estrogen related receptor α|oestrogen related receptor α|Y
Kaposi's sarcoma-associated herpesvirus|Kaposi's sarcoma-associated herpes-virus|Y
trabecular meshwork inducible gluco-corticoid response|trabecular meshwork inducible glucocorticoid response|Y
light harvesting chlorophyll a/b binding protein|light harvesting chlorophyll a/b binding protein-I|Y
light harvesting chlorophyll a/b binding protein|light harvesting chlorophyll a/b binding protein I|Y
7-chloro-4-nitrobenzo-2-oxa-1,3-diazole|7-chloro-4-nitrobenz-2-oxa-1,3-diazole|Y
cellular retinol-binding protein type I|cellular retinol-binding protein type II|Y
antithyroid stimulating hormone receptor antibody|antithyroid-stimulating hormone receptor antibody|Y
oral submucous fibrosis|oral sub-mucous fibrosis|Y
poly(A) binding protein II|poly (A) binding protein II|Y
poly(A) binding protein II|poly(A) binding protein I|Y
transcriptional intermediary factor 1α|transcriptional intermediary factor 1 α|Y
transcriptional intermediary factor 1α|transcriptional intermediary factor 1-α|Y
Brahma related gene 1-associated factor 60c|Brahma related gene 1-associated factor 60|Y
Brahma related gene 1-associated factor 60c|Brahma related gene 1-associated factor 60a|Y
intravoxel incoherent motion|intra-voxel incoherent motion|Y
sodium coupled neutral amino acid transporter-2|sodium coupled neutral amino acid transporter|Y
sodium coupled neutral amino acid transporter-2|sodium coupled neutral amino acid transporter-1|Y
isoursodeoxycholic acid|iso-ursodeoxycholic acid|Y
intestinal ischaemia-reperfusion|intestinal ischemia-reperfusion|Y
a disintegrin and metalloprotease with thrombospondin motif-4|a disintegrin and metalloprotease with thrombospondin motifs-9|Y
a disintegrin and metalloprotease with thrombospondin motif-4|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motif-4|a disintegrin and metalloproteinase with thrombospondin motif-14|Y
a disintegrin and metalloprotease with thrombospondin motif-4|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motif-4|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloprotease with thrombospondin motif-4|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motif-4|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motif-4|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motif-4|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motif-4|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motif-4|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloprotease with thrombospondin motif-4|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motif-4|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motif-4|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motif-4|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motif-4|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-4|a disintegrin and metalloprotease with thrombospondin motif|Y
tumor-associated transplantation antigen|tumour-associated transplantation antigen|Y
auditory evoked magnetic fields|auditory evoked magnetic field|Y
intraperitoneal insemination|intra-peritoneal insemination|Y
mitogen-activated protein kinase kinase kinase 1|mitogen-activated protein kinase kinase kinase|Y
mitogen-activated protein kinase kinase kinase 1|mitogen-activated protein kinase kinase kinase 4|Y
abdominopelvic computed tomography scan|abdomino-pelvic computed tomography scan|Y
inhibitory-κ B kinase-β|inhibitory-κB kinase-β|Y
anti-allergen immunoglobulin G|antiallergen immunoglobulin G|Y
Lowenstein-Jensen medium|Loewenstein-Jensen medium|Y
carboxyterminal trans-activation domain|carboxy terminal trans-activation domain|Y
carboxyterminal trans-activation domain|carboxy-terminal trans-activation domain|Y
carboxyterminal trans-activation domain|carboxyterminal transactivation domain|Y
C-C chemokine ligand 21|CC chemokine ligand 21|Y
human T-cell lymphoma/leukaemia virus type 2|human T-cell lymphoma/leukaemia virus type I|Y
gadolinium-diethylenetriamine pentaacetic acid|gadolinium-diethylene triamine pentaacetic acid|Y
anti-T cell receptor-α β antibody|anti-T cell receptor-αβ antibody|Y
neuronal precursor cell-expressed developmentally downregulated 4|neural precursor cell-expressed developmentally downregulated 4|Y
neuronal precursor cell-expressed developmentally downregulated 4|neuronal precursor cell-expressed developmentally down-regulated 4|Y
neuronal precursor cell-expressed developmentally downregulated 4|neural precursor cell-expressed developmentally down-regulated 4|Y
tumour-associated tissue eosinophilia|tumor-associated tissue eosinophilia|Y
cytotoxic T lymphocyte associated antigen 4|cytotoxic T lymphocyte associated antigen-4|Y
cytotoxic T lymphocyte associated antigen 4|cytotoxic T lymphocyte-associated antigen 4|Y
cholesterol 7 alpha-hydroxylase|cholesterol 7alpha-hydroxylase|Y
Serological analysis of recombinant cDNA expression libraries|serological analysis of recombinant cDNA expression libraries|Y
interleukine-13 receptor α1 chain|interleukine-13 receptor α-1 chain|Y
interleukine-13 receptor α1 chain|interleukin-13 receptor α1 chain|Y
anti-T cell receptor alpha/beta monoclonal antibody|anti-T cell receptor-alpha/beta monoclonal antibody|Y
extrauterine pregnancy|extra-uterine pregnancy|Y
(-)epigallocatechin-3-gallate|(-)-epigallocatechin-3-gallate|Y
poly(ethylene glycol) 2000|poly(ethylene glycol) 200|Y
cross-polarization magic-angle-spinning NMR|cross-polarization magic-angle spinning NMR|Y
cross-polarization magic-angle-spinning NMR|cross-polarization/magic-angle-spinning NMR|Y
American Society of Anaesthesiologists physical status 2|American Society of Anesthesiologists physical status 2|Y
American Society of Anaesthesiologists physical status 2|American Society of Anaesthesiologists physical status 3|Y
American Society of Anaesthesiologists physical status 2|American Society of Anaesthesiologists physical status 1|Y
American Society of Anaesthesiologists physical status 2|American Society of Anaesthesiologists physical status 4|Y
American Society of Anaesthesiologists physical status 2|American Society of Anaesthesiologists physical status 5|Y
3beta-hydroxy steroid-dehydrogenase deficiency|3 beta-hydroxysteroid-dehydrogenase deficiency|Y
3beta-hydroxy steroid-dehydrogenase deficiency|3beta-hydroxy steroid dehydrogenase deficiency|Y
enzymelinked immunosorbant assay|enzyme linked immunosorbant assay|Y
Krüppel-like factor-12|Krüppel-like factor-2|Y
receptor-like protein tyrosine phosphatase-δ|receptor-like protein tyrosine phosphatase-κ|Y
receptor-like protein tyrosine phosphatase-δ|receptor-like protein tyrosine phosphatase-ψ|Y
receptor-like protein tyrosine phosphatase-δ|receptor-like protein tyrosine phosphatase-μ|Y
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core-30|European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30|Y
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core-30|European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30|Y
IL-12 receptor beta 1 chain|IL-12 receptor beta1 chain|Y
Mitogen-activated protein kinase|Mitogen-activated protein kinases|Y
intra-parenchymal haemorrhage|intra-parenchymal hemorrhage|Y
optical coherence tomography|optical coherence tomograph|Y
anti-lipopolysaccharide|antilipopolysaccharide|Y
plasmon-waveguide resonance spectroscopy|plasmon-wave guide resonance spectroscopy|Y
transtracheal oxygen|trans-tracheal oxygen|Y
anti-Muellerian hormone|anti-Mullerian hormone|Y
peroxisome proliferator-activated receptor-gamma co-activator-1 alpha|peroxisome proliferator-activated receptor-gamma co-activator 1alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator-1 alpha|peroxisome-proliferator-activated receptor-gamma coactivator-1 alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator-1 alpha|peroxisome-proliferator-activated receptor-gamma co-activator-1 alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator-1 alpha|peroxisome proliferator-activated receptor-gamma coactivator-1alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator-1 alpha|peroxisome-proliferator-activated receptor-gamma co-activator-1alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator-1 alpha|peroxisome proliferator-activated receptor gamma co-activator-1alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator-1 alpha|peroxisome proliferator-activated receptor-gamma coactivator 1 alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator-1 alpha|peroxisome proliferator-activated receptor-gamma co-activator 1 alpha|Y
hypereosinophilia syndrome|hyper-eosinophilia syndrome|Y
venoarteriolar response|veno-arteriolar response|Y
chaperonin-containing TCP1|chaperonin-containing TCP-1|Y
interleukine-13 receptor alpha1 chain|interleukin-13 receptor alpha1 chain|Y
squamo-columnar junction|squamocolumnar junction|Y
brain-stem evoked potential|brainstem evoked potential|Y
ribosomal protein L3|ribosomal protein L23|Y
ribosomal protein L3|ribosomal protein L38|Y
ribosomal protein L3|ribosomal protein L30|Y
ribosomal protein L3|ribosomal protein L36|Y
Krueppel-like factor-6|Kruppel-like factor-6|Y
anti-latex immunoglobulin E antibody|antilatex immunoglobulin E antibody|Y
mitogen-activated protein kinase signaling pathway|mitogen-activated protein kinase signalling pathway|Y
photoactivated localization microscopy|photo-activated localization microscopy|Y
antithyroglobulin antibody|anti-thyroglobulin antibody|Y
cytokine-induced neutrophil chemoattractant-1|cytokine-induced neutrophil chemoattractant 1|Y
cytokine-induced neutrophil chemoattractant-1|cytokine-induced neutrophil chemoattractant-2|Y
S100 calcium binding protein A10|S100 calcium binding protein A1|Y
non-aqueous reversed-phase liquid chromatography|non-aqueous reversed phase liquid chromatography|Y
TBP-associated factor 11|TBP-associated factor 1|Y
multi-detector-row computed tomography|multidetector-row computed tomography|Y
thyroparathyroidectomy|thyro-parathyroidectomy|Y
Epstein-Barr virus cell surface antigen 3|Epstein-Barr virus cell surface antigen|Y
Epstein-Barr virus cell surface antigen 3|Epstein-Barr virus cell surface antigen 5|Y
Epstein-Barr virus cell surface antigen 3|Epstein-Barr virus cell surface antigen 4|Y
gonadotropin-releasing hormone analog|gonadotrophin-releasing hormone analog|Y
stromal derived factor-1α|stromal derived factor-1|Y
stromal derived factor-1α|stromal derived factor-1-α|Y
sublemniscal pre-pacemaker nucleus|sublemniscal prepacemaker nucleus|Y
augmented correlation-consistent polarised valence quadruple-zeta basis set|augmented correlation consistent polarised valence quadruple-zeta basis set|Y
augmented correlation-consistent polarised valence quadruple-zeta basis set|augmented correlation-consistent polarised valence quadruple zeta basis set|Y
IL-2 receptor α chain|IL2 receptor α chain|Y
neural-precursor cell-expressed, developmentally down-regulated 1|neural-precursor cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally down-regulated 1|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor cell-expressed, developmentally down-regulated 1|neural-precursor cell-expressed, developmentally downregulated 5|Y
neural-precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed developmentally down-regulated 1|Y
neural-precursor cell-expressed, developmentally down-regulated 1|neural-precursor cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally down-regulated 1|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor cell-expressed, developmentally down-regulated 1|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural-precursor cell-expressed, developmentally down-regulated 1|neural-precursor-cell-expressed developmentally down-regulated 1|Y
neural-precursor cell-expressed, developmentally down-regulated 1|neural precursor cell-expressed, developmentally downregulated 1|Y
neural-precursor cell-expressed, developmentally down-regulated 1|neural-precursor cell-expressed, developmentally downregulated 1|Y
endothelial-monocyte-activating polypeptide|endothelial-monocyte-activating polypeptide-2|Y
endothelial-monocyte-activating polypeptide|endothelial-monocyte-activating polypeptide I|Y
endothelial-monocyte-activating polypeptide|endothelial-monocyte activating polypeptide|Y
intracytoplasmic membrane|intra-cytoplasmic membrane|Y
activated carbon fibers|activated carbon fiber|Y
oro-pharyngeal leak pressure|oropharyngeal leak pressure|Y
myristoyl-lysophosphatidylcholine|myristoyllysophosphatidylcholine|Y
hereditary non-spherocytic hemolytic anemia|hereditary non-spherocytic haemolytic anaemia|Y
hereditary non-spherocytic hemolytic anemia|hereditary nonspherocytic hemolytic anemia|Y
adrenomyelodystrophy|adreno-myelodystrophy|Y
spontaneous preterm birth|spontaneous pre-term birth|Y
anterior chamber associated immune deviation|anterior chamber-associated immune deviation|Y
c-Jun NH2-terminal kinase|c-Jun NH2-terminal kinases|Y
de-sialylated ovine sub-maxillary mucin|desialylated ovine sub-maxillary mucin|Y
programmed-temperature vaporiser|programmed-temperature vapouriser|Y
surface-enhanced laser desorption ionization time-of-flight mass spectrometry|surface-enhanced laser desorption/ionization time-of-flight mass spectrometry|Y
electrospray ionisation quadrupole time-of-flight mass spectrometer|electrospray ionization quadrupole time-of-flight mass spectrometer|Y
transforming growth factor-beta1 level|transforming growth factor-beta-1 level|Y
augmented correlation consistent polarized valence double-ζ basis set|augmented correlation consistent polarised valence double-ζ basis set|Y
augmented correlation consistent polarized valence double-ζ basis set|augmented correlation-consistent polarized valence double-ζ basis set|Y
thiazide-sensitive sodium-chloride co-transporter|thiazide-sensitive sodium chloride co-transporter|Y
thiazide-sensitive sodium-chloride co-transporter|thiazide-sensitive sodium-chloride cotransporter|Y
activated Cdc42-associated tyrosine kinase-1|activated Cdc42-associated tyrosine kinase 1|Y
activated Cdc42-associated tyrosine kinase-1|activated Cdc42-associated tyrosine kinase-2|Y
TATA-binding protein-associated factor 8|TATA-binding protein-associated factor 6|Y
TATA-binding protein-associated factor 8|TATA-binding protein-associated factor 1|Y
TATA-binding protein-associated factor 8|TATA-binding protein-associated factor 4|Y
peroxisome proliferator-activated receptor-γ coactivator-1 α|peroxisome proliferator-activated receptor-γ coactivator 1 α|Y
peroxisome proliferator-activated receptor-γ coactivator-1 α|peroxisome proliferator-activated receptor γ coactivator-1 α|Y
peroxisome proliferator-activated receptor-γ coactivator-1 α|peroxisome proliferator-activated receptor-γ co-activator-1α|Y
peroxisome proliferator-activated receptor-γ coactivator-1 α|peroxisome proliferator-activated receptor-γ co-activator-1 α|Y
anticarcinoembryonic antigen antibody|anti-carcinoembryonic antigen antibody|Y
immunoreactive gastrin|immuno-reactive gastrin|Y
calcium voltage-gated channel subunit alpha1 S|calcium voltage-gated channel subunit alpha1 C|Y
human platelet alloantigen|human platelet allo-antigen|Y
venricular tachycardia|ventricular tachycardia|Y
veratryl-glycerol-β-guaiacyl ether|veratrylglycerol-β-guaiacyl ether|Y
Src homology 2 domain containing protein tyrosine-phosphatase|Src homology 2 domain containing protein tyrosine phosphatase|Y
B-cell leukemia/lymphoma 2 protein|B-cell leukaemia/lymphoma 2 protein|Y
diisopropylethylamine|di-isopropylethylamine|Y
auriculo-temporal nerve|auriculotemporal nerve|Y
Rush-Presbyterian-Saint Luke's Medical Center|Rush Presbyterian-Saint Luke's Medical Center|Y
IL-5 receptor alpha chain|IL5 receptor alpha chain|Y
organic anion transporting polypeptide 2B1|organic anion transporting polypeptide 2|Y
organic anion transporting polypeptide 2B1|organic anion transporting polypeptide 1|Y
organic anion transporting polypeptide 2B1|organic anion-transporting polypeptide 2B1|Y
upper gastro-intestinal tract bleeding|upper gastrointestinal tract bleeding|Y
nonseminomatous testicular tumor|non-seminomatous testicular tumor|Y
hand held dynamometer|handheld dynamometer|Y
laparoscopically-assisted vaginal hysterectomy|laparoscopically assisted vaginal hysterectomy|Y
β site amyloid precursor protein cleaving enzyme-2|β site amyloid precursor protein cleaving enzyme 2|Y
murmurs, gallops, or rubs|mumurs, gallops, or rubs|Y
anti-human immunodeficiency virus-1 activity|anti-human immunodeficiency virus activity|Y
anti-human immunodeficiency virus-1 activity|anti-human immunodeficiency virus 1 activity|Y
killer immunoglobulin-like receptor 2DS4|killer immunoglobulin-like receptor 2DS1|Y
killer immunoglobulin-like receptor 2DS4|killer immunoglobulin-like receptor 2DS3|Y
killer immunoglobulin-like receptor 2DS4|killer immunoglobulin-like receptor 2DS2|Y
macrophage colony stimulating factor|macrophagecolony stimulating factor|Y
video electroencephalogram|video electro-encephalogram|Y
cytochrome P-450 2B10|cytochrome P-450 2B1|Y
augmented correlation consistent polarised valence quadruple-zeta basis set|augmented correlation consistent polarised valence quadruple zeta basis set|Y
levodopa-induced dyskinesia|laevodopa-induced dyskinesia|Y
transmembrane tumour necrosis factor-α|transmembrane tumor necrosis factor-α|Y
carbonyl cyanide m-chlorophenylhydrazone|carbonyl cyanide m-chlorophenyl hydrazone|Y
non-homologous endjoining|nonhomologous endjoining|Y
non-homologous endjoining|non-homologous end-joining|Y
2-amino-3,8-dimethyl-imidazo[4,5-f]quinoxaline|2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline|Y
2-amino-3,8-dimethyl-imidazo[4,5-f]quinoxaline|2-amino-3,8-di-methylimidazo[4,5-f]quinoxaline|Y
macrophage-inflammatory protein 1β|macrophage-inflammatory protein 1 β|Y
gamma-glutamylphosphate reductase|gamma-glutamyl phosphate reductase|Y
parahippocampal cortex|para-hippocampal cortex|Y
tumor-4, node-not assessable, metastasis-not assessable|tumor-2, node-not assessable, metastasis-not assessable|Y
American Society of Anaesthesiology grade 3|American Society of Anaesthesiology grade|Y
American Society of Anaesthesiology grade 3|American Society of Anesthesiology grade 3|Y
American Society of Anaesthesiology grade 3|American Society of Anaesthesiology grade I|Y
American Society of Anaesthesiology grade 3|American Society of Anaesthesiology grade 4|Y
American Society of Anaesthesiology grade 3|American Society of Anaesthesiology grade V|Y
anti-extractable nuclear antigen antibody|antiextractable nuclear antigen antibody|Y
bone-anchored hearing aid|bone-anchored hearing aids|Y
peptidylglycine alpha-hydroxylating monooxygenase|peptidylglycine-alpha-hydroxylating monooxygenase|Y
intravenous drug use|intravenous drug user|Y
axillofemoral by-pass|axillo-femoral by-pass|Y
non-cardiogenic pulmonary edema|non-cardiogenic pulmonary oedema|Y
non-cardiogenic pulmonary edema|noncardiogenic pulmonary edema|Y
thyrotropin-releasing hormone receptor-2|thyrotropin-releasing hormone receptor-1|Y
thyrotropin-releasing hormone receptor-2|thyrotropin-releasing hormone receptor 2|Y
nucleotide-binding domain and leucine-rich repeat-containing protein|nucleotide-binding domain and leucine-rich-repeat-containing protein|Y
interaural time delay|inter-aural time delay|Y
Transient lower esophageal sphincter relaxations|Transient lower oesophageal sphincter relaxations|Y
macro-nodular cirrhosis|macronodular cirrhosis|Y
spin-component-scaled second order Moller-Plesset theory|spin-component-scaled second-order Moller-Plesset theory|Y
interleukin-1 β converting enzyme inhibitor|interleukin-1 β-converting enzyme inhibitor|Y
Heliothis virescens chemosensory protein 2|Heliothis virescens chemosensory protein 3|Y
Heliothis virescens chemosensory protein 2|Heliothis virescens chemosensory protein 1|Y
sucrose non-fermenting 1|sucrose nonfermenting 1|Y
pseudo-membraneous colitis|pseudo-membranous colitis|Y
anti-IL 10 receptor mAb|anti-IL10 receptor mAb|Y
parahydroxybenzoic acid ester|para-hydroxybenzoic acid ester|Y
oro-antral communication|oroantral communication|Y
interleukin-5 receptor α-chain|interleukine-5 receptor α-chain|Y
university-affiliated Veteran's Administration medical center|university-affiliated Veterans' Administration medical center|Y
university-affiliated Veteran's Administration medical center|university affiliated Veterans Administration medical center|Y
university-affiliated Veteran's Administration medical center|university-affiliated Veterans Administration medical center|Y
corticotrophin-releasing hormone|corticotropin-releasing hormone|Y
mucosa associated lymphoid tissue lymphoma|mucosa-associated lymphoid tissue lymphoma|Y
Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial|Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial|Y
para-hydroxymercuriphenylsulphonate|para-hydroxymercuriphenyl sulphonate|Y
Novel erythropoiesis stimulating protein|novel erythropoiesis stimulating protein|Y
hæmorrhagic shock encephalopathy syndrome|hemorrhagic shock encephalopathy syndrome|Y
kruppel-like factor 2|kruppel-like factor 12|Y
excision repair cross complementation group 1|excision repair cross complementation group 4|Y
thermogravimetry-differential scanning calorimetry|thermogravimetry/differential scanning calorimetry|Y
human transforming growth factor β 3|human transforming growth factor β3|Y
augmented correlation-consistent polarised valence double-zeta basis set|augmented correlation-consistent polarised valence double zeta basis set|Y
augmented correlation-consistent polarised valence double-zeta basis set|augmented correlation-consistent polarized valence double-zeta basis set|Y
pseudolupus erythematosus|pseudo-lupus erythematosus|Y
type II nicotinamide adeninedinucleotide phosphate dehydrogenase|type I nicotinamide adeninedinucleotide phosphate dehydrogenase|Y
monoacetyldiaminodiphenylsulfone|monoacetyl-diaminodiphenylsulfone|Y
World Health Organization Quality of Life-Brief version|World Health Organization Quality of Life-Brief Version|Y
World Health Organization Quality of Life-Brief version|World Health Organisation Quality of Life-Brief version|Y
World Health Organization Quality of Life-Brief version|World Health Organization Quality of Life-brief version|Y
heparin-induced thrombocytopenia syndrome|heparin-induced thrombocytopaenia syndrome|Y
liquid chromatography-electrospray ionization tandem mass spectrometry|liquid chromatography-electrospray ionisation tandem mass spectrometry|Y
liquid chromatography-electrospray ionization tandem mass spectrometry|liquid chromatography-electrospray ionization-tandem mass spectrometry|Y
sodium potassium 2 chloride cotransporter|sodium potassium 2 chloride cotransporter 2|Y
meta-chlorophenyl-piperazine|meta-chlorophenylpiperazine|Y
glucagon-like peptide 1 receptor|glucagonlike peptide 1 receptor|Y
human mitochondrial transcription factor B|human mitochondrial transcription factor B2|Y
endothelial-monocyte-activating polypeptide-2|endothelial monocyte-activating polypeptide-2|Y
American Society of Anesthesiologists Class I|American Society of Anesthesiologists Class III|Y
American Society of Anesthesiologists Class I|American Society of Anesthesiologists Class II|Y
American Society of Anesthesiologists Class I|American Society of Anesthesiologists Class|Y
American Society of Anesthesiologists Class I|American Society of Anesthesiologists Class 3|Y
American Society of Anesthesiologists Class I|American Society of Anesthesiologists class I|Y
American Society of Anesthesiologists Class I|American Society of Anesthesiologists Class 2|Y
American Society of Anesthesiologists Class I|American Society of Anesthesiologists Class IV|Y
American Society of Anesthesiologists Class I|American Society of Anesthesiologists Class 4|Y
interprofessional learning|inter-professional learning|Y
Heliothis virescens chemosensory protein 3|Heliothis virescens chemosensory protein 1|Y
Charcot-Marie-Tooth disease type 1B|Charcot-Marie-Tooth disease type 1|Y
methionyllysylbradykinin|methionyl-lysylbradykinin|Y
phosphorylated cyclic AMP responsive element-binding protein|phosphorylated cyclic AMP response element-binding protein|Y
phosphorylated cyclic AMP responsive element-binding protein|phosphorylated cyclic AMP responsive element binding protein|Y
interleukine 2 receptor common γ chain|interleukin 2 receptor common γ chain|Y
whey acidic protein four disulfide core domain 12|whey acidic protein four disulfide core domain 2|Y
multi-angle laser light scattering|multiangle laser light scattering|Y
cytidylyl-transferase|cytidylyltransferase|Y
chicken luteinising hormone-releasing hormone-I|chicken luteinising hormone-releasing hormone I|Y
mitogen extracellular-signal-regulated kinase kinase-5|mitogen extracellular signal-regulated kinase kinase-5|Y
N-terminal-pro B-type natriuretic peptide|N-terminal-proB-type natriuretic peptide|Y
N-terminal-pro B-type natriuretic peptide|N-terminal-pro-B-type natriuretic peptide|Y
N-terminal-pro B-type natriuretic peptide|N-terminal pro B-type natriuretic peptide|Y
roll-over protective structure|rollover protective structure|Y
Shigatoxin-producing Escherichia coli|Shiga-toxin-producing Escherichia coli|Y
eukaryotic translation elongation factor-1 α 1|eukaryotic translation elongation factor-1α1|Y
eukaryotic translation elongation factor-1 α 1|eukaryotic translation elongation factor 1 α 1|Y
hereditary sensory and autonomic neuropathy type II|hereditary sensory and autonomic neuropathy type III|Y
Bos taurus autosome 19|Bos taurus autosome 1|Y
fibroblast growth factor 23|fibroblast growth factor 3|Y
three dimensional computed tomography angiography|three-dimensional computed tomography angiography|Y
anti-interleukin-12 neutralising antibody|anti-interleukin 12 neutralising antibody|Y
anti-interleukin-12 neutralising antibody|anti-interleukin-12 neutralizing antibody|Y
oestrogen-receptor-mediated|estrogen-receptor-mediated|Y
Escherichia coli strain BL-21|Escherichia coli strain BL21|Y
xylose lysine deoxycholate agar|xylose lysine desoxycholate agar|Y
Wechsler Intelligence Scale for Children 4th Edition|Wechsler Intelligence Scale for Children, 4th Edition|Y
Epstein-Barr virus-immortalized cell line|Epstein-Barr virus immortalized cell line|Y
insulin-like growth factor II mRNA binding protein|insulin-like growth factor II mRNA binding protein-3|Y
insulin-like growth factor II mRNA binding protein|insulin-like growth factor-II mRNA binding protein|Y
insulin-like growth factor II mRNA binding protein|insulin-like growth factor II mRNA binding protein 3|Y
space-occupying lesions|space-occupying lesion|Y
immunocompromised host|immuno-compromised host|Y
trans-theoretical model|transtheoretical model|Y
acid sensing ion channel-1a|acid sensing ion channel-1|Y
5HT1A receptor antagonist|5-HT1A receptor antagonist|Y
a disintegrin and metalloprotease with thrombospondin motifs-9|a disintegrin and metalloprotease with thrombospondin motifs-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-9|a disintegrin and metalloproteinase with thrombospondin motifs-19|Y
a disintegrin and metalloprotease with thrombospondin motifs-9|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-9|a disintegrin and metalloprotease with thrombospondin motifs-20|Y
a disintegrin and metalloprotease with thrombospondin motifs-9|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motifs-9|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motifs-9|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-9|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-9|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-9|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-9|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motifs-9|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motifs-9|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motifs-9|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
a disintegrin and metalloprotease with thrombospondin motifs-9|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
neural-precursor cell-expressed developmentally downregulated 8|neural precursor cell-expressed developmentally downregulated 8|Y
neural-precursor cell-expressed developmentally downregulated 8|neural-precursor cell-expressed developmentally downregulated 5|Y
neural-precursor cell-expressed developmentally downregulated 8|neural-precursor cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally downregulated 8|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor cell-expressed developmentally downregulated 8|neural-precursor cell-expressed, developmentally downregulated 5|Y
neural-precursor cell-expressed developmentally downregulated 8|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor cell-expressed developmentally downregulated 8|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor cell-expressed developmentally downregulated 8|neural precursor cell-expressed, developmentally downregulated 8|Y
neural-precursor cell-expressed developmentally downregulated 8|neural-precursor cell-expressed, developmentally downregulated 1|Y
polymeric immunoglobulin receptor|polymeric immuno-globulin receptor|Y
gas chromatography/mass spectrometry selected ion monitoring|gas chromatography mass spectrometry selected ion monitoring|Y
myelo-monoblastic leukaemia|myelo-monoblastic leukemia|Y
beta-methyliodophenylpentadecanoic acid|beta-methyl-iodophenyl-pentadecanoic acid|Y
beta-methyliodophenylpentadecanoic acid|betamethyliodophenylpentadecanoic acid|Y
metabotropic glutamate receptor subtype 3|metabotropic glutamate receptor subtype 7|Y
metabotropic glutamate receptor subtype 3|metabotropic glutamate receptor subtype 5|Y
metabotropic glutamate receptor subtype 3|metabotropic glutamate receptor subtype 6|Y
metabotropic glutamate receptor subtype 3|metabotropic glutamate receptor subtype 4|Y
phospho-extracellular signal regulated kinase|phospho-extracellular signal-regulated kinase|Y
cytotoxic T lymphocyte-associated antigen-4|cytotoxic T-lymphocyte-associated antigen-4|Y
cytotoxic T lymphocyte-associated antigen-4|cytotoxic T lymphocyte associated antigen-4|Y
cytotoxic T lymphocyte-associated antigen-4|cytotoxic T lymphocyte-associated antigen-8|Y
cytotoxic T lymphocyte-associated antigen-4|cytotoxic T lymphocyte-associated antigen 4|Y
haemoglobin Roseau-Pointe a Pitre|hemoglobin Roseau-Pointe a Pitre|Y
recombinant human tumour necrosis factor-β|recombinant human tumour necrosis factor β|Y
recombinant human tumour necrosis factor-β|recombinant human tumour necrosis factor-α|Y
5' untranslated regions|5' untranslated region|Y
corticotropin-releasing factor receptor|corticotropin-releasing factor 2 receptor|Y
corticotropin-releasing factor receptor|corticotropin-releasing factor 1 receptor|Y
interleukin-1 receptor-associated kinase IV|interleukin 1 receptor-associated kinase IV|Y
American Society of Anesthesiology physical status IV|American Society of Anaesthesiology physical status I|Y
American Society of Anesthesiology physical status IV|American Society of Anesthesiology physical status II|Y
American Society of Anesthesiology physical status IV|American Society of Anaesthesiology physical status IV|Y
extracellular signal-regulated kinases 1/2|extracellular signal-regulated kinase 1/2|Y
ribosomal protein S25|ribosomal protein S2|Y
unfavourable non-Hodgkin's lymphoma|unfavorable non-Hodgkin's lymphoma|Y
Folinic acid, Fluorouracil, and Oxaliplatin 6th variation regimen|Folinic acid, Fluorouracil, and Oxaliplatin 7th variation regimen|Y
shiga-toxin-producing Escherichia coli|shigatoxin-producing Escherichia coli|Y
anti-carbohydrate monoclonal antibody|anticarbohydrate monoclonal antibody|Y
non-linear capacitance|nonlinear capacitance|Y
antibody-secreting cell|antibody-secreting cells|Y
myocyte-specific enhancer binding factor 2|myocyte-specific enhancer-binding factor 2|Y
Sint Radboud University Medical Centre|Saint Radboud University Medical Centre|Y
vacuolar protein sorting 15|vacuolar protein sorting 1|Y
endothelial monocyte-activating polypeptide II|endothelial monocyte-activating polypeptide-II|Y
endothelial monocyte-activating polypeptide II|endothelial monocyte activating polypeptide II|Y
interleukin 1β receptor|interleukine 1β receptor|Y
Italian Society of Haematology|Italian Society of Hematology|Y
alpha-glucan, water dikinase|alpha-glucan water dikinase|Y
vitamin D3 upregulated protein 1|vitamin D3 up-regulated protein 1|Y
anti-matrix metalloprotease-13 antibody|anti-matrix metalloproteinase-13 antibody|Y
secondary wall associated NAC domain protein1|secondary wall-associated NAC domain protein1|Y
secondary wall associated NAC domain protein1|secondary wall associated NAC domain protein 1|Y
spore-specific protein C, Bacillus megaterium|spore-specific protein A, Bacillus megaterium|Y
human leukocyte antigen D-related antigen|human leukocyte antigen-D-related antigen|Y
human leukocyte antigen D-related antigen|human leucocyte antigen D-related antigen|Y
factor VIII pro-coagulant activity|factor VIII procoagulant activity|Y
non-steroidal antiinflammatory drugs|non-steroidal antiinflammatory drug|Y
non-steroidal antiinflammatory drugs|non-steroidal anti-inflammatory drugs|Y
excision repair cross complementing-group 2|excision repair cross complementing-group 4|Y
excision repair cross complementing-group 2|excision repair cross-complementing-group 2|Y
excision repair cross complementing-group 2|excision repair cross complementing group 2|Y
retinoblastoma protein-interacting zinc-finger protein 1|retinoblastoma protein-interacting zinc-finger protein|Y
anti-interleukin-2 receptor monoclonal antibody|anti-interleukin-8 receptor monoclonal antibody|Y
anti-interleukin-2 receptor monoclonal antibody|anti-interleukin 2 receptor monoclonal antibody|Y
anti-interleukin-2 receptor monoclonal antibody|anti-interleukin-4 receptor monoclonal antibody|Y
fractionated stereo-tactic radiotherapy|fractionated stereotactic radiotherapy|Y
locoregional therapy|loco-regional therapy|Y
G protein coupled estrogen receptor-1|G protein coupled oestrogen receptor-1|Y
thoraco-lumbo-sacral orthosis|thoraco-lumbosacral orthosis|Y
Defense Mechanisms Inventory|Defense Mechanism Inventory|Y
flavin-containing mono-oxygenase 3|flavin-containing monooxygenase 3|Y
defective interfering particle|defective interfering particles|Y
soluble cluster of differentiation antigen 27|soluble cluster of differentiation antigen 26|Y
gonadotrophin releasing-hormone|gonadotropin releasing-hormone|Y
intraarterial digital subtraction angiography|intra-arterial digital subtraction angiography|Y
total dissolved solid|total dissolved solids|Y
SUMO-1-specific protease 1|SUMO1-specific protease 1|Y
para-chloromercuribenzene sulphonate|para-chloromercuribenzenesulphonate|Y
tubulo-interstitial fibroblast|tubulointerstitial fibroblast|Y
digital imaging fiber-optic transillumination|digital imaging fibre-optic transillumination|Y
cross-polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross-polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross-polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
amino-phosphovaleric acid|aminophosphovaleric acid|Y
Src homology 2 domain-containing protein-tyrosine phosphatase-1|Src homology 2 domain-containing protein-tyrosine phosphatase|Y
arterio-venous difference|arteriovenous difference|Y
uncoordinated protein 3|uncoordinated protein 37|Y
uncoordinated protein 3|uncoordinated protein 31|Y
uncoordinated protein 3|uncoordinated protein 43|Y
uncoordinated protein 3|uncoordinated protein 13|Y
uncoordinated protein 3|uncoordinated protein 38|Y
uncoordinated protein 3|uncoordinated protein 30|Y
a disintegrin and metalloprotease with thrombospondin motifs-17|a disintegrin and metalloprotease with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-17|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motifs-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-17|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motifs-17|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-17|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-17|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-17|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-17|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-17|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-17|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motifs-17|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-17|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-17|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
γ-aminobutyric acid type B receptor|γ-amino butyric acid type B receptor|Y
anti-human leukocyte antigen-G-specific antibody|anti-human leukocyte antigen-G specific antibody|Y
Membrane-type matrix metalloproteinases|Membrane-type matrix metalloproteinase|Y
sino-aortic deafferentation|sinoaortic deafferentation|Y
transcatheter aortic valve implantation|trans-catheter aortic valve implantation|Y
central primitive neuro-ectodermal tumor|central primitive neuro-ectodermal tumour|Y
central primitive neuro-ectodermal tumor|central primitive neuroectodermal tumor|Y
Basso, Beattie, and Bresnahan Locomotor Rating Scale|Basso, Beattie and Bresnahan Locomotor Rating Scale|Y
tri-calcium aluminate|tricalcium aluminate|Y
a disintegrin and metalloproteinase 9|a disintegrin and metalloproteinase 29|Y
Seventh-Day Adventist|Seventh-Day Adventists|Y
attenuated total reflectance Fourier-transform infra-red spectroscopy|attenuated total reflectance Fourier-transform infrared spectroscopy|Y
attenuated total reflectance Fourier-transform infra-red spectroscopy|attenuated total reflectance Fourier transform infrared spectroscopy|Y
attenuated total reflectance Fourier-transform infra-red spectroscopy|attenuated total reflectance Fourier transform infra-red spectroscopy|Y
Usher syndrome type 1|Usher syndrome type 1C|Y
radiation-induced tumor suppressor gene 1|radiation induced tumor suppressor gene 1|Y
fructooligosaccharide|fructo-oligosaccharide|Y
retinoic acid receptor-related orphan receptor γ-T|retinoic acid receptor-related orphan receptor γ|Y
posteroventral pallidotomy|postero-ventral pallidotomy|Y
human leucocyte antigen DR|human leucocyte antigen DR2|Y
human leucocyte antigen DR|human leucocyte antigen DR4|Y
human leucocyte antigen DR|human leucocyte antigen DR7|Y
5-bromo-2'-deoxyuridine|5-bromo-2-deoxyuridine|Y
5-bromo-2'-deoxyuridine|5-bromo-2'deoxyuridine|Y
fanbeam dual X-ray absorptiometry|fan beam dual X-ray absorptiometry|Y
fanbeam dual X-ray absorptiometry|fan-beam dual X-ray absorptiometry|Y
transforming growth factor-beta signalling pathway|transforming growth factor-beta signaling pathway|Y
preproapolipoprotein AI|preproapolipoprotein A-I|Y
hyper-homocyst(e)inemia|hyperhomocyst(e)inemia|Y
para-chloromercuriphenyl sulfonate|para-chloromercuriphenylsulfonate|Y
voltage dependent anion selective channel 1|voltage dependent anion selective channel 2|Y
voltage dependent anion selective channel 1|voltage dependent anion selective channel 3|Y
voltage dependent anion selective channel 1|voltage dependent anion selective channel|Y
a disintegrin and metalloprotease 13|a disintegrin and metalloprotease 3|Y
A disintegrin and metalloprotease-9|A disintegrin and metalloprotease-29|Y
endothelial monocyte activating polypeptide 2|endothelial monocyte activating polypeptide-2|Y
endothelial monocyte activating polypeptide 2|endothelial monocyte activating polypeptide|Y
recombinant human transforming growth factor-β 3|recombinant human transforming growth factor-β 2|Y
neo-adjuvant hormonal therapy|neoadjuvant hormonal therapy|Y
transient receptor potential vanilloid 5|transient receptor potential vanilloid 2|Y
transient receptor potential vanilloid 5|transient receptor potential vanilloid 4|Y
transient receptor potential vanilloid 5|transient receptor potential vanilloid 3|Y
human adenovirus serotype 13|human adenovirus serotype 1|Y
EBV-associated haemophagocytic syndrome|EBV-associated hemophagocytic syndrome|Y
anti-interleukin-4 neutralizing antibody|anti-interleukin-8 neutralizing antibody|Y
directly observed treatment - short-course|directly observed treatment short-course|Y
non-aqueous reversed phase high performance liquid chromatography|non-aqueous reversed-phase high performance liquid chromatography|Y
non-aqueous reversed phase high performance liquid chromatography|nonaqueous reversed phase high performance liquid chromatography|Y
American Orthopedic Foot and Ankle Society score|American Orthopaedic Foot and Ankle Society score|Y
oestrogen-stimulated neurophysin|estrogen-stimulated neurophysin|Y
heat shock protein 90α|heat shock protein 90-α|Y
fan-beam dual-energy X-ray absorptiometry|fan-beam dual-energy x-ray absorptiometry|Y
fan-beam dual-energy X-ray absorptiometry|fan beam dual-energy X-ray absorptiometry|Y
fan-beam dual-energy X-ray absorptiometry|fan-beam dual energy X-ray absorptiometry|Y
fan-beam dual-energy X-ray absorptiometry|fanbeam dual-energy X-ray absorptiometry|Y
spaceoccupying lesion|space-occupying lesion|Y
nonarteritic anterior ischemic optic neuropathy|nonarteritic anterior ischæmic optic neuropathy|Y
nonarteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy|Y
N-terminal-proB-type natriuretic peptide|N-terminal-pro-B-type natriuretic peptide|Y
N-terminal-proB-type natriuretic peptide|N-terminal proB-type natriuretic peptide|Y
triple knockout mouse|triple knock-out mouse|Y
Clinical Global Impression-Improvement|Clinical Global Impressions-Improvement|Y
heat-shock protein 90-α|heat-shock protein 90α|Y
microtubule organizing centers|microtubule organizing center|Y
visual evoked potentials|visual evoked potential|Y
retinoic acid-related orphan receptor beta|retinoic acid-related orphan receptor beta 2|Y
human gonadotrophin releasing hormone associated peptid|human gonadotropin releasing hormone associated peptid|Y
human gonadotrophin releasing hormone associated peptid|human gonadotrophin releasing hormone associated peptide|Y
X-linked hyper-immunoglobulin-M syndrome|X-linked hyperimmunoglobulin-M syndrome|Y
X-linked hyper-immunoglobulin-M syndrome|X-linked hyper-immunoglobulin M syndrome|Y
nano-flow liquid chromatography-tandem mass spectrometry|nano-flow liquid chromatography tandem mass spectrometry|Y
preprocorticotropin-releasing factor|preprocorticotrophin-releasing factor|Y
double-stranded RNA-dependent protein kinase|double-stranded RNA dependent protein kinase|Y
non-fluent progressive aphasia|nonfluent progressive aphasia|Y
solid-phase extraction-high-performance liquid chromatography-tandem mass spectrometry|solid-phase extraction-high performance liquid chromatography/tandem mass spectrometry|Y
solid-phase extraction-high-performance liquid chromatography-tandem mass spectrometry|solid phase extraction-high-performance liquid chromatography-tandem mass spectrometry|Y
solid-phase extraction-high-performance liquid chromatography-tandem mass spectrometry|solid-phase extraction-high-performance liquid chromatography/tandem mass spectrometry|Y
subgaleal hemorrhage|sub-galeal hemorrhage|Y
pituitary tumour-derived fibroblast growth factor receptor-4|pituitary tumour derived fibroblast growth factor receptor-4|Y
pituitary tumour-derived fibroblast growth factor receptor-4|pituitary tumour-derived fibroblast growth factor receptor 4|Y
oculodento-osseous dysplasia|oculodentoosseous dysplasia|Y
CC chemokine ligand 24|CC chemokine ligand 2|Y
CC chemokine ligand 24|CC chemokine ligand 4|Y
glutamate ionotropic receptor AMPA type subunit 1|glutamate ionotropic receptor AMPA type subunit 4|Y
glutamate ionotropic receptor AMPA type subunit 1|glutamate ionotropic receptor AMPA type subunit 3|Y
glutamate ionotropic receptor AMPA type subunit 1|glutamate ionotropic receptor AMPA type subunit 2|Y
pulmonary arterio-venous malformation|pulmonary arteriovenous malformation|Y
American Society of Anesthesiology Grade I|American Society of Anesthesiology Grade IV|Y
American Society of Anesthesiology Grade I|American Society of Anesthesiology Grade V|Y
American Society of Anesthesiology Grade I|American Society of Anesthesiology Grade 5|Y
American Society of Anesthesiology Grade I|American Society of Anesthesiology Grade 2|Y
American Society of Anesthesiology Grade I|American Society of Anaesthesiology Grade II|Y
American Society of Anesthesiology Grade I|American Society of Anesthesiology Grade II|Y
American Society of Anesthesiology Grade I|American Society of Anesthesiology grade I|Y
American Society of Anesthesiology Grade I|American Society of Anesthesiology Grade 3|Y
American Society of Anesthesiology Grade I|American Society of Anesthesiology Grade 1|Y
long-term nonprogressors|long-term non-progressors|Y
colony forming unit/granulocyte-macrophage|colony forming unit/granulocyte macrophage|Y
colony forming unit/granulocyte-macrophage|colony-forming unit/granulocyte-macrophage|Y
corticotrophin releasing hormone receptor|corticotrophin-releasing hormone receptor|Y
corticotrophin releasing hormone receptor|corticotrophin releasing hormone receptor-1|Y
corticotrophin releasing hormone receptor|corticotrophin releasing hormone receptor 2|Y
corticotrophin releasing hormone receptor|corticotrophin releasing hormone receptor-2|Y
neural precursor cell-expressed developmentally downregulated 8|neural precursor cell-expressed developmentally downregulated 5|Y
neural precursor cell-expressed developmentally downregulated 8|neural precursor cell-expressed developmentally downregulated 4|Y
neural precursor cell-expressed developmentally downregulated 8|neural precursor cell expressed developmentally down-regulated 8|Y
neural precursor cell-expressed developmentally downregulated 8|neural precursor cell-expressed developmentally down-regulated 1|Y
neural precursor cell-expressed developmentally downregulated 8|neural precursor cell-expressed, developmentally downregulated 9|Y
neural precursor cell-expressed developmentally downregulated 8|neural precursor cell-expressed developmentally down-regulated 9|Y
neural precursor cell-expressed developmentally downregulated 8|neural precursor cell-expressed developmentally downregulated 1|Y
neural precursor cell-expressed developmentally downregulated 8|neural precursor cell-expressed developmentally down-regulated 2|Y
neural precursor cell-expressed developmentally downregulated 8|neural precursor cell-expressed developmentally down-regulated 4|Y
neural precursor cell-expressed developmentally downregulated 8|neural precursor cell-expressed developmentally downregulated 9|Y
neural precursor cell-expressed developmentally downregulated 8|neural precursor cell-expressed, developmentally downregulated 8|Y
neural precursor cell-expressed developmentally downregulated 8|neural precursor cell-expressed, developmentally downregulated 1|Y
farnesoic acid O-methyltransferase|farnesoic acid O-methyl transferase|Y
cyclo-oxigenase-2 inhibitor|cyclooxigenase-2 inhibitor|Y
glycophosphatidyl-inositol-anchored|glycophosphatidylinositol-anchored|Y
ribosomal protein L4|ribosomal protein L14|Y
meso-porous bioactive glass|meso-porous bio-active glass|Y
multi-lumen central venous catheter|multilumen central venous catheter|Y
particle-induced X-ray-emission analysis|particle-induced X-ray emission analysis|Y
neural-precursor cell-expressed developmentally downregulated 5|neural-precursor cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally downregulated 5|neural precursor cell-expressed developmentally downregulated 5|Y
neural-precursor cell-expressed developmentally downregulated 5|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor cell-expressed developmentally downregulated 5|neural-precursor cell-expressed, developmentally downregulated 5|Y
neural-precursor cell-expressed developmentally downregulated 5|neural-precursor-cell-expressed developmentally down-regulated 5|Y
neural-precursor cell-expressed developmentally downregulated 5|neural-precursor-cell-expressed, developmentally downregulated 5|Y
neural-precursor cell-expressed developmentally downregulated 5|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor cell-expressed developmentally downregulated 5|neural-precursor-cell-expressed developmentally downregulated 5|Y
neural-precursor cell-expressed developmentally downregulated 5|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural-precursor cell-expressed developmentally downregulated 5|neural-precursor cell-expressed, developmentally downregulated 1|Y
polyradiculoneuropathy|polyradiculo-neuropathy|Y
interferon-inducible T-cell α-chemoattractant|interferon-inducible T-cell α chemoattractant|Y
interferon-inducible T-cell α-chemoattractant|interferon-inducible T cell α-chemoattractant|Y
occipitofrontal circumference|occipito-frontal circumference|Y
directly observed treatment short-course|directly observed treatment short course|Y
human immunodeficiency virus type 2 infection|human immunodeficiency virus type 1 infection|Y
receptor-like protein tyrosine phosphatase alpha|receptor-like protein-tyrosine phosphatase alpha|Y
microparticle enzyme immunoassay II|microparticle enzyme immunoassay I|Y
hyperpolarization-activated cyclic nucleotide gated channel|hyperpolarization-activated cyclic nucleotide-gated channel|Y
reduced-intensity stem-cell transplantation|reduced intensity stem-cell transplantation|Y
UT squamous cell carcinoma-5|UT squamous cell carcinoma-15|Y
post-enucleation socket syndrome|postenucleation socket syndrome|Y
Mitogen- and stress-activated protein kinase-1|mitogen- and stress-activated protein kinase-1|Y
activated partial thromboplastin times|activated partial thromboplastin time|Y
quasi-frequency modulated|quasifrequency modulated|Y
interferon-inducible transmembrane protein 1|interferon-inducible transmembrane protein-1|Y
post-reinforcement pause|postreinforcement pause|Y
polypyrimidine tract binding protein-associated splicing factor|polypyrimidine tract-binding protein-associated splicing factor|Y
estrogen receptor-α knock-out|estrogen receptor-α knockout|Y
estrogen receptor-α knock-out|oestrogen receptor-α knock-out|Y
phosphorylated extracellular signal-regulated kinase 1|phosphorylated extracellular signal regulated kinase 1|Y
phosphorylated extracellular signal-regulated kinase 1|phosphorylated extracellular signal-regulated kinase-1|Y
non-bullous congenital ichthyosiform erythroderma|nonbullous congenital ichthyosiform erythroderma|Y
temperature programed desorption-mass spectrometry|temperature programed desorption mass spectrometry|Y
significance analysis of microarrays|significance analysis of microarray|Y
iso-tactic polypropylene|isotactic polypropylene|Y
ischaemic pre-conditioning|ischemic pre-conditioning|Y
protein kinase C-β-II|protein kinase C-βII|Y
sudden sensorineural hearing loss|sudden sensori-neural hearing loss|Y
phosphatidylethanolamine binding protein 2|phosphatidylethanolamine binding protein 1|Y
phosphatidylethanolamine binding protein 2|phosphatidylethanolamine binding protein|Y
metabotropic glutamate receptor subtype 7|metabotropic glutamate receptor subtype 5|Y
metabotropic glutamate receptor subtype 7|metabotropic glutamate receptor subtype 6|Y
metabotropic glutamate receptor subtype 7|metabotropic glutamate receptor subtype 4|Y
erythroid Kruppel-like factor|erythroid Krueppel-like factor|Y
NONEXPRESSOR OF PATHOGENESIS-RELATED GENES1|NON-EXPRESSOR OF PATHOGENESIS-RELATED GENES1|Y
NONEXPRESSOR OF PATHOGENESIS-RELATED GENES1|NONEXPRESSOR OF PATHOGENESIS-RELATED GENES-1|Y
peroxisome proliferator-activated receptor-gamma co-activator 1alpha|peroxisome-proliferator-activated receptor-gamma co-activator 1 alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator 1alpha|peroxisome proliferator-activated receptor-gamma coactivator-1alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator 1alpha|peroxisome-proliferator-activated receptor-gamma co-activator 1alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator 1alpha|peroxisome proliferator-activated receptor-gamma coactivator 1 alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator 1alpha|peroxisome proliferator-activated receptor gamma co-activator 1 alpha|Y
peroxisome proliferator-activated receptor-gamma co-activator 1alpha|peroxisome proliferator-activated receptor-gamma co-activator 1 alpha|Y
bursal antisteroidogenic peptide|bursal anti-steroidogenic peptide|Y
photosensitivity dermatitis-actinic reticuloid syndrome|photosensitivity dermatitis/actinic reticuloid syndrome|Y
phorbol ester 12-O-tetradecanoylphorbol-13-acetate|phorbol ester 12-0-tetradecanoylphorbol-13-acetate|Y
phorbol ester 12-O-tetradecanoylphorbol-13-acetate|phorbol ester 12-O-tetradecanoylphorbol 13-acetate|Y
phorbol ester 12-O-tetradecanoylphorbol-13-acetate|phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate|Y
pseudoepileptic seizure|pseudo-epileptic seizure|Y
anti-double stranded deoxyribonucleic acid antibody|anti-double-stranded deoxyribonucleic acid antibody|Y
least-significant-difference post hoc test|least-significant difference post hoc test|Y
university-affiliated Veterans' Administration medical center|university affiliated Veterans Administration medical center|Y
university-affiliated Veterans' Administration medical center|university-affiliated Veterans Administration medical center|Y
gonadotropin-releasing hormone associated peptide|gonadotropin-releasing hormone-associated peptide|Y
hyperhomocyst(e)inæmia|hyper-homocyst(e)inæmia|Y
gastroepiploic artery|gastro-epiploic artery|Y
p38-alpha mitogen-activated protein kinase|p38alpha mitogen-activated protein kinase|Y
ultra performance liquid chromatography-mass spectrometry|ultraperformance liquid chromatography-mass spectrometry|Y
alpha2macroglobulin receptor-associated protein|alpha2 macroglobulin receptor-associated protein|Y
alpha2macroglobulin receptor-associated protein|alpha2-macroglobulin receptor-associated protein|Y
human anti-murine antibody|human antimurine antibody|Y
cardio-metabolic risk|cardiometabolic risk|Y
hepatopulmonary syndrome|hepato-pulmonary syndrome|Y
inspired oxygen concentrations|inspired oxygen concentration|Y
Shiga toxin-producing Escherichia coli O26|Shiga toxin producing Escherichia coli O26|Y
cold induced autoinflammatory syndrome 1|cold induced auto-inflammatory syndrome 1|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|toll-interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|toll-interleukin-1 receptor domain-containing adapter-inducing interferon β|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|Toll-interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon-β|toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
insecticide-treated bednet|insecticide-treated bed-net|Y
technetium-99m labeled human serum albumin|technetium-99m-labeled human serum albumin|Y
technetium-99m labeled human serum albumin|technetium-99m labelled human serum albumin|Y
nonxanthine phosphodiesterase inhibitor|non-xanthine phosphodiesterase inhibitor|Y
pathological tumor-3, node-0, metastasis-0|pathological tumor-3, node-1, metastasis-0|Y
corticotropin-releasing factor receptor subtype 1|corticotropin releasing factor receptor subtype 1|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-1|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 4|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-1|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-1|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2|Y
nucleotide binding oligomerisation domain 1|nucleotide binding oligomerisation domain|Y
chorio-retinal dysplasia|chorioretinal dysplasia|Y
hyperglycæmic hyperosmolar nonketotic syndrome|hyperglycemic hyperosmolar nonketotic syndrome|Y
glutamate-receptor interacting protein 1|glutamate receptor interacting protein 1|Y
primed in situ labeling|primed in situ labelling|Y
bromovinyldesoxyuridine|bromovinyldeoxyuridine|Y
pregnancy-specific glycoprotein 6|pregnancy-specific glycoprotein 16|Y
3-methoxy-4-hydroxy-phenylethyleneglycol|3-methoxy-4-hydroxyphenylethylene glycol|Y
hemoglobin Roseau-Pointe-a-Pitre|haemoglobin Roseau-Pointe-a-Pitre|Y
arrhythmogenic right ventricular dysplasia/cardiomyopathy|arrhythmogenic right ventricular dysplasia-cardiomyopathy|Y
arrhythmogenic right ventricular dysplasia/cardiomyopathy|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Y
phosphotransferase system regulation domain 2|phosphotransferase system regulation domain|Y
intra-operative intra-arterial fibrinolytic therapy|intraoperative intraarterial fibrinolytic therapy|Y
N-acetylneuraminic acid|N-acetyl neuraminic acid|Y
5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole|5,6-dichloro-1-beta-D-ribofuranosyl benzimidazole|Y
Brahma related gene 1-associated factor 60|Brahma related gene 1-associated factor 60a|Y
sulphobutylether-β-cyclodextrin|sulphobutyl ether-β-cyclodextrin|Y
American Society of Anesthesiologists physical status IV|American Society of Anaesthesiologists physical status IV|Y
American Society of Anesthesiologists physical status IV|American Society of Anesthesiologists physical status II|Y
perinuclear antineutrophil cytoplasmic antibody|perinuclear anti neutrophil cytoplasmic antibody|Y
perinuclear antineutrophil cytoplasmic antibody|perinuclear anti-neutrophil cytoplasmic antibody|Y
stromal-derived factor 1-α|stromal-derived factor 1α|Y
matrix assisted laser desorption/ionisation time of flight mass spectrometry|matrix assisted laser desorption/ionization time of flight mass spectrometry|Y
interferon-stimulated gene factor-3 alpha|interferon stimulated gene factor-3 alpha|Y
natural auto-antibody|natural autoantibody|Y
free insulin-like growth factor-II|free insulin-like growth factor-I|Y
long terminal repeat transactivation|long terminal repeat trans-activation|Y
gastrointestinal illness|gastro-intestinal illness|Y
subependymal giant cell astrocytoma|subependymal giant cell astrocytomas|Y
liquid chromatography-atmospheric pressure chemical ionisation ion-trap mass spectrometry|liquid chromatography/atmospheric pressure chemical ionisation ion trap mass spectrometry|Y
liquid chromatography-atmospheric pressure chemical ionisation ion-trap mass spectrometry|liquid chromatography-atmospheric pressure chemical ionization ion-trap mass spectrometry|Y
liquid chromatography-atmospheric pressure chemical ionisation ion-trap mass spectrometry|liquid chromatography-atmospheric pressure chemical ionisation-ion trap mass spectrometry|Y
cytosolic Ca2+ concentration|cytosolic Ca2+ concentrations|Y
Hb-S/beta thalassemia|Hb-S/beta thalassaemia|Y
T-cell-receptor-γ δ-positive|T-cell-receptor-γδ-positive|Y
tumor-associated antigens|tumor-associated antigen|Y
colony-forming unit-erythroid|colony-forming units-erythroid|Y
nitrate nonutilising mutant|nitrate non-utilising mutant|Y
B lymphocyte induced maturation protein-1|B lymphocyte induced maturation protein 1|Y
paroxysmal non-kinesigenic dyskinesia|paroxysmal nonkinesigenic dyskinesia|Y
human T cell leukaemia virus type-1-infected|human T cell leukaemia virus type 1-infected|Y
IL-13 receptor alpha 2 chain|IL-13 receptor alpha2 chain|Y
hæmato-encephalic barrier|hæmatoencephalic barrier|Y
posttetanic hyperpolarisation|post-tetanic hyperpolarisation|Y
eating disorder examination-questionnaire|eating disorder examination questionnaire|Y
chicken luteinising hormone releasing hormone II|chicken luteinising hormone-releasing hormone II|Y
chicken luteinising hormone releasing hormone II|chicken luteinizing hormone releasing hormone II|Y
5-hydroxytryptamine 1D receptor antagonist|5-hydroxytryptamine 1B receptor antagonist|Y
proline-serine-threonine phosphatase-interacting protein-1|proline-serine-threonine phosphatase-interacting protein 1|Y
cervical intraepithelial neoplasms|cervical intraepithelial neoplasm|Y
polarisation-division multiplexing quadrature phase shift keying|polarisation-division-multiplexing quadrature phase shift keying|Y
polarisation-division multiplexing quadrature phase shift keying|polarisation division multiplexing quadrature phase shift keying|Y
epidemic methicillin-resistant Staphylococcus aureus-15|epidemic methicillin-resistant Staphylococcus aureus-17|Y
epidemic methicillin-resistant Staphylococcus aureus-15|epidemic methicillin-resistant Staphylococcus aureus-16|Y
postantibiotic sub-MIC effect|post-antibiotic sub-MIC effect|Y
hemoglobin F-Sassari|haemoglobin F-Sassari|Y
glycosyl-phosphatidyl-inositol anchored protein|glycosylphosphatidylinositol anchored protein|Y
American Society of Anesthesiologists Grade V|American Society of Anesthesiologists grade V|Y
American Society of Anesthesiologists Grade V|American Society of Anesthesiologists Grade 3|Y
American Society of Anesthesiologists Grade V|American Society of Anesthesiologists Grade I|Y
American Society of Anesthesiologists Grade V|American Society of Anesthesiologists Grade 1|Y
calcium release-activated calcium current|calcium-release-activated calcium current|Y
insulin-like growth factor receptor 2|insulinlike growth factor receptor 2|Y
alpha1-protease inhibitor|alpha 1-protease inhibitor|Y
alpha1-protease inhibitor|alpha-1-protease inhibitor|Y
corticotropin releasing factor 2 receptor|corticotropin-releasing factor 2 receptor|Y
electro-myographic biofeedback|electromyographic biofeedback|Y
post-transplantation lymphoproliferative disorder|posttransplantation lympho-proliferative disorder|Y
immuno-reactive corticotropin releasing factor|immuno-reactive corticotropin-releasing factor|Y
immuno-reactive corticotropin releasing factor|immunoreactive corticotropin releasing factor|Y
matrix-assisted laser desorption/ionisation-mass spectrometry|matrix assisted laser desorption/ionisation-mass spectrometry|Y
anti-IL-2 monoclonal antibody|anti-IL2 monoclonal antibody|Y
anti-IL-2 monoclonal antibody|antiIL-2 monoclonal antibody|Y
acute generalised exanthematous pustulosis|acute generalized exanthematous pustulosis|Y
phospho-glycogen synthase kinase 3 beta|phospho-glycogen synthase kinase 3beta|Y
neurodegenerative disease|neuro-degenerative disease|Y
antiinterleukin 8 autoantibody|anti-interleukin 8 autoantibody|Y
endothelial monocyte-activating polypeptide-II|endothelial monocyte-activating polypeptide-III|Y
peroxisome proliferator-activated receptors|Peroxisome proliferator-activated receptors|Y
peroxisome proliferator-activated receptors|peroxisome proliferator-activated receptor|Y
receptor-like protein-tyrosine phosphatase ψ|receptor-like protein-tyrosine phosphatase η|Y
receptor-like protein-tyrosine phosphatase ψ|receptor-like protein-tyrosine phosphatase δ|Y
receptor-like protein-tyrosine phosphatase ψ|receptor-like protein-tyrosine phosphatase μ|Y
tert-butylhydroperoxide|tert-butyl hydroperoxide|Y
proteolysis targeting chimeric molecule|proteolysis targeting chimeric molecule-1|Y
proteolysis targeting chimeric molecule|proteolysis targeting chimeric molecule C|Y
non-haemagglutinating|non-hemagglutinating|Y
fluorine-18-labelled fluoro-deoxyglucose|fluorine-18-labeled fluoro-deoxy-glucose|Y
matrix-assisted laser desorption-ionisation|matrix-assisted laser desorption/ionisation|Y
matrix-assisted laser desorption-ionisation|matrix-assisted laser desorption-ionization|Y
TransAtlantic InterSociety Consensus classification|TransAtlantic Inter-Society Consensus classification|Y
tumor necrosis factor receptor superfamily member 10a|tumor necrosis factor receptor superfamily member 11a|Y
tumor necrosis factor receptor superfamily member 10a|tumor necrosis factor receptor superfamily member 10b|Y
tumor necrosis factor receptor superfamily member 10a|tumor necrosis factor receptor superfamily member 10d|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motifs-17|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motifs-8|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motif-14|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motifs-15|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-19|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
ammonia mono-oxygenase alpha subunit|ammonia monooxygenase alpha subunit|Y
non-ketotic hyperglycemia|nonketotic hyperglycemia|Y
c-Jun N-terminal kinases|c-Jun N-terminal kinase|Y
cytotoxic T-lymphocyte-associated antigen-4|cytotoxic T-lymphocyte-associated antigen 4|Y
cytotoxic T-lymphocyte-associated antigen-4|cytotoxic T-lymphocyte associated antigen-4|Y
eukaryotic translation elongation factor 1α1|eukaryotic translation elongation factor-1α1|Y
eukaryotic translation elongation factor 1α1|eukaryotic translation elongation factor 1 α 1|Y
anti-IL-8 monoclonal antibody|antiIL-8 monoclonal antibody|Y
anti-IL-8 monoclonal antibody|anti-IL8 monoclonal antibody|Y
velopharyngeal incompetence|velo-pharyngeal incompetence|Y
Wechsler Intelligence Scale for Children 3rd Edition|Wechsler Intelligence Scale for Children-3rd Edition|Y
Wechsler Intelligence Scale for Children 3rd Edition|Wechsler Intelligence Scale for Children, 3rd Edition|Y
peroxisome proliferator-activated receptor γ coactivator-1|peroxisome proliferator-activated receptor γ co-activator-1|Y
peroxisome proliferator-activated receptor γ coactivator-1|peroxisome proliferator-activated receptor γ coactivator 1|Y
peroxisome proliferator-activated receptor γ coactivator-1|peroxisome proliferator-activated receptor γ coactivator-1 α|Y
peroxisome proliferator-activated receptor γ coactivator-1|peroxisome proliferator-activated receptor γ co-activator-1α|Y
ultraperformance liquid chromatography/electrospray ionisation tandem mass spectrometry|ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry|Y
ultraperformance liquid chromatography/electrospray ionisation tandem mass spectrometry|ultra-performance liquid chromatography-electrospray ionisation tandem mass spectrometry|Y
ultraperformance liquid chromatography/electrospray ionisation tandem mass spectrometry|ultraperformance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
ultraperformance liquid chromatography/electrospray ionisation tandem mass spectrometry|ultra performance liquid chromatography/electrospray ionisation tandem mass spectrometry|Y
vasoactive intestinal peptide receptor type 2|vasoactive intestinal peptide receptor type 1|Y
endobronchial ultrasound|endo-bronchial ultrasound|Y
core binding factor α1|core binding factor α 1|Y
hepatic epithelioid hemangio-endothelioma|hepatic epithelioid haemangio-endothelioma|Y
IL-1 receptor associated kinase|IL1 receptor associated kinase|Y
prostaglandin F(2) α|prostaglandin F-(2) α|Y
neural-precursor cell-expressed developmentally down-regulated 4|neural precursor cell-expressed developmentally downregulated 4|Y
neural-precursor cell-expressed developmentally down-regulated 4|neural-precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor cell-expressed developmentally down-regulated 4|neural-precursor cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally down-regulated 4|neural-precursor-cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally down-regulated 4|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor cell-expressed developmentally down-regulated 4|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally down-regulated 4|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural-precursor cell-expressed developmentally down-regulated 4|neural precursor cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally down-regulated 4|neural precursor cell-expressed, developmentally down-regulated 4|Y
ubiquitin C-terminal hydrolase|ubiquitin C-terminal hydrolases|Y
oro-coecal transit time|oro-cecal transit time|Y
in vitro fertilization-intracytoplasmic sperm injection|in vitro fertilisation-intracytoplasmic sperm injection|Y
lymphoma associated hemophagocytic syndrome|lymphoma-associated hemophagocytic syndrome|Y
anterolateral thigh flap|antero-lateral thigh flap|Y
tetanus and diphtheria|tetanus and diptheria|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 4|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 4|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2|Y
thermoluminescent dosimetry|thermo-luminescent dosimetry|Y
leukocyte sialoglycoprotein|leukocyte sialoglyco-protein|Y
[18F]-fluorodeoxyglucose|[18F]fluorodeoxyglucose|Y
opiate-like substance|opiatelike substance|Y
pharyngo-upper-esophageal sphincter contractile reflex|pharyngo-upper esophageal sphincter contractile reflex|Y
Laparoscopic-assisted vaginal hysterectomy|laparoscopic-assisted vaginal hysterectomy|Y
xeroderma pigmentosum complementation group C|xeroderma pigmentosum complementation group G|Y
xeroderma pigmentosum complementation group C|xeroderma pigmentosum complementation group E|Y
meta-chlorophenylpiperazine|metachlorophenylpiperazine|Y
meta-chlorophenylpiperazine|meta-chlorophenyl piperazine|Y
metacognitions questionnaire|meta-cognitions questionnaire|Y
TNF receptor associated periodic syndrome|TNF-receptor associated periodic syndrome|Y
Hartmann-Shack wavefront sensor|Hartmann-Shack wave-front sensor|Y
murine γ-herpesvirus 68|murine γherpesvirus 68|Y
quasi-randomised controlled trial|quasirandomised controlled trial|Y
recombinant interleukin 17|recombinant interleukin 1|Y
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1|aminoacyl tRNA synthetase complex-interacting multifunctional protein 2|Y
orofacio-digital syndrome|orofaciodigital syndrome|Y
orofacio-digital syndrome|oro-facio-digital syndrome|Y
antihypertensive drug|anti-hypertensive drug|Y
endothelium-derived relaxing factor|endothelium-derived relaxing factors|Y
benzyloxyresorufin O-dealkylase|benzyloxy-resorufin O-dealkylase|Y
benzyloxyresorufin O-dealkylase|benzyloxy resorufin O-dealkylase|Y
transforming growth factor beta receptor type I|transforming growth factor-beta receptor type I|Y
transforming growth factor beta receptor type I|transforming growth factor beta receptor type III|Y
transforming growth factor beta receptor type I|transforming growth factor beta receptor type 1|Y
noninvasive programmed stimulation|non invasive programmed stimulation|Y
transforming growth factor β-activated kinase 1-binding protein-1|transforming growth factor β-activated kinase 1-binding protein 1|Y
kruppel-like factor 3|kruppel-like factor 13|Y
three-dimensional time of flight magnetic resonance angiography|three dimensional time of flight magnetic resonance angiography|Y
branched-chain alpha-keto acid|branched-chain alpha-ketoacid|Y
antiprotamine immunoglobulin G|anti-protamine immunoglobulin G|Y
oestrogen/progestogen therapy|estrogen/progestogen therapy|Y
super-conducting quantum-interference device|super-conducting quantum interference device|Y
Bunodosoma granulifera toxin II|Bunodosoma granulifera toxin III|Y
2-arachidonoyl glycerol|2-arachidonoylglycerol|Y
isolated perfused rat livers|isolated perfused rat liver|Y
x-ray absorption near-edge structure spectrum|x-ray absorption near edge structure spectrum|Y
x-ray absorption near-edge structure spectrum|X-ray absorption near-edge structure spectrum|Y
prepro-gonadotrophin releasing hormone|prepro-gonadotropin releasing hormone|Y
krüppel-like factor 2|krüppel-like factor 12|Y
hematoxylin/eosin stain|hematoxylineosin stain|Y
hematoxylin/eosin stain|haematoxylin/eosin stain|Y
sex-determining region Y box 1|sex-determining region Y, box 1|Y
sex-determining region Y box 1|sex-determining region Y box 10|Y
tri-cyclic antidepressant|tri-cyclic anti-depressant|Y
non-steroidal antiinflammatory drug|nonsteroidal antiinflammatory drug|Y
estrogen receptor α specific|oestrogen receptor α specific|Y
tetracycline controlled trans-activator|tetracycline controlled transactivator|Y
glycosyl-phosphatidyl-inositol-anchored|glycosyl-phosphatidylinositol-anchored|Y
glycosyl-phosphatidyl-inositol-anchored|glycosylphosphatidyl-inositol-anchored|Y
antiherpes simplex virus type 1 antibody|antiherpes simplex virus type 2 antibody|Y
cancer up regulated gene 2|cancer upregulated gene 2|Y
anti-tissue transglutaminase|antitissue transglutaminase|Y
interleukin-1 β protein|interleukin-1β protein|Y
neural precursor cell-expressed developmentally downregulated 5|neural precursor cell-expressed developmentally downregulated 4|Y
neural precursor cell-expressed developmentally downregulated 5|neural precursor cell expressed, developmentally downregulated 5|Y
neural precursor cell-expressed developmentally downregulated 5|neural-precursor cell-expressed, developmentally downregulated 5|Y
neural precursor cell-expressed developmentally downregulated 5|neural precursor cell-expressed developmentally down-regulated 1|Y
neural precursor cell-expressed developmentally downregulated 5|neural precursor cell expressed developmentally downregulated 5|Y
neural precursor cell-expressed developmentally downregulated 5|neural precursor cell-expressed, developmentally downregulated 9|Y
neural precursor cell-expressed developmentally downregulated 5|neural precursor cell-expressed developmentally down-regulated 9|Y
neural precursor cell-expressed developmentally downregulated 5|neural precursor cell-expressed developmentally downregulated 1|Y
neural precursor cell-expressed developmentally downregulated 5|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural precursor cell-expressed developmentally downregulated 5|neural precursor cell-expressed developmentally down-regulated 2|Y
neural precursor cell-expressed developmentally downregulated 5|neural precursor cell-expressed developmentally down-regulated 4|Y
neural precursor cell-expressed developmentally downregulated 5|neural precursor cell-expressed developmentally downregulated 9|Y
neural precursor cell-expressed developmentally downregulated 5|neural precursor cell-expressed, developmentally downregulated 8|Y
neural precursor cell-expressed developmentally downregulated 5|neural precursor cell-expressed, developmentally downregulated 1|Y
corticotropin-releasing hormone receptor-2|corticotropin-releasing hormone receptor-1|Y
corticotropin-releasing hormone receptor-2|corticotropin-releasing hormone receptor|Y
corticotropin-releasing hormone receptor-2|corticotropin-releasing hormone receptor 2|Y
corticotropin-releasing hormone receptor-2|corticotropin releasing hormone receptor-2|Y
cluster of differentiation 3|cluster of differentiation 33|Y
cluster of differentiation 3|cluster of differentiation 31|Y
cluster of differentiation 3|cluster of differentiation 34|Y
cluster of differentiation 3|cluster of differentiation 63|Y
psycho-organic syndrome|psychoorganic syndrome|Y
follicle-stimulating hormone releasing factor|follicle-stimulating hormone-releasing factor|Y
fiberoptic bronchoscopy|fiber-optic bronchoscopy|Y
transforming growth factor β signaling pathway|transforming growth factor-β signaling pathway|Y
insulin-like growth factor-II mRNA binding protein-1|insulin-like growth factor-II mRNA binding protein|Y
insulin-like growth factor-II mRNA binding protein-1|insulin-like growth factor-II mRNA binding protein-3|Y
insulin-like growth factor-II mRNA binding protein-1|insulin-like growth factor-II mRNA binding protein-2|Y
tri-carboxylic acid cycle|tricarboxylic acid cycle|Y
cognitive-behaviour modification|cognitive-behavior modification|Y
transjugular intrahepatic porto-systemic shunting|trans-jugular intrahepatic portosystemic shunting|Y
transjugular intrahepatic porto-systemic shunting|transjugular intra-hepatic porto-systemic shunting|Y
ischemic cerebrovascular disease|ischemic cerebrovascular diseases|Y
dual-colour chromogenic in-situ hybridisation|dual-colour chromogenic in-situ hybridization|Y
sterol regulatory element binding protein 1-c|sterol regulatory element binding protein-1-c|Y
sterol regulatory element binding protein 1-c|sterol regulatory element binding protein 1c|Y
non-transferrin bound iron|nontransferrin bound iron|Y
multidrug resistance-associated protein 1|multidrug-resistance-associated protein 1|Y
multidrug resistance-associated protein 1|multidrug resistance associated protein 1|Y
multidrug resistance-associated protein 1|multidrug resistance-associated protein 3|Y
abdomino-scrotal hydrocele|abdomino-scrotal hydrocoele|Y
β amyloid precursor protein-cleaving enzyme-1|β-amyloid precursor protein-cleaving enzyme-1|Y
β amyloid precursor protein-cleaving enzyme-1|β amyloid precursor protein-cleaving enzyme|Y
β amyloid precursor protein-cleaving enzyme-1|β amyloid precursor protein cleaving enzyme-1|Y
β amyloid precursor protein-cleaving enzyme-1|β amyloid precursor protein-cleaving enzyme-2|Y
methyl tertbutyl ether|methyl tert-butyl ether|Y
methyl tertbutyl ether|methyl tert butyl ether|Y
trans-radial intervention|transradial intervention|Y
microtubule-associated protein-2d|microtubule-associated protein-2|Y
calcitonin gene-related peptide-immunoreactive nerve|calcitonin-gene-related peptide-immunoreactive nerve|Y
serum α-foetoprotein level|serum α-foeto-protein level|Y
serum α-foetoprotein level|serum αfoetoprotein level|Y
serum α-foetoprotein level|serum α-fetoprotein level|Y
heparin binding epidermal growth factor-like growth factor|heparin-binding epidermal growth factor-like growth factor|Y
pro-gastrin releasing peptide|progastrin releasing peptide|Y
multidrug resistance associated protein 2|multidrug resistance associated protein 3|Y
multidrug resistance associated protein 2|multidrug resistance associated protein 1|Y
intradiscal electro-thermal therapy|intradiscal electrothermal therapy|Y
inter-atrial pressure gradient|interatrial pressure gradient|Y
N-myristoyl transferase|N-myristoyltransferase|Y
oro-cecal transit time|orocecal transit time|Y
2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine|2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine|Y
2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine|2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine|Y
2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine|2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine|Y
2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine|2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine|Y
degenerate oligonucleotide primed polymerase chain reaction|degenerate oligonucleotide primed-polymerase chain reaction|Y
N-ethyl-N'-nitro-N-nitrosoguanidine|N-methyl-N'-nitro-N-nitrosoguanidine|Y
counter-current immuno-electrophoresis|countercurrent immuno-electrophoresis|Y
counter-current immuno-electrophoresis|counter-current immunoelectrophoresis|Y
transmembrane 4 superfamily member 5 protein|transmembrane 4 superfamily member 3 protein|Y
retinoic acid receptor-related orphan receptor gammaT|retinoic acid receptor-related orphan receptor gamma-T|Y
retinoic acid receptor-related orphan receptor gammaT|retinoic acid receptor-related orphan receptor gamma T|Y
retinoic acid receptor-related orphan receptor gammaT|retinoic acid receptor-related orphan receptor gammat|Y
premessenger ribonucleic acid|pre-messenger ribonucleic acid|Y
colony forming unit/granulocyte macrophage|colony forming unit granulocyte macrophage|Y
colony forming unit/granulocyte macrophage|colony forming unit-granulocyte macrophage|Y
intra-class correlation|intraclass correlation|Y
duodeno-gastroesophageal reflux|duodeno-gastro-esophageal reflux|Y
heparin-induced platelet activation test|heparin induced platelet activation test|Y
nucleus dorso-medialis|nucleus dorsomedialis|Y
recombinant interleukin 13|recombinant interleukin 3|Y
recombinant interleukin 13|recombinant interleukin 1|Y
interferon-inducible T-cell alpha-chemoattractant|interferon-inducible T cell alpha-chemoattractant|Y
ethylenediamine-tetra-methylene phosphonic acid|ethylenediamine-tetra-methylenephosphonic acid|Y
interleukine 13 receptor-α2 subunit|interleukin 13 receptor-α2 subunit|Y
neural precursor cell-expressed developmentally downregulated 4|neural precursor cell-expressed developmentally down-regulated 1|Y
neural precursor cell-expressed developmentally downregulated 4|neural precursor cell expressed developmentally downregulated 4|Y
neural precursor cell-expressed developmentally downregulated 4|neural precursor cell-expressed, developmentally downregulated 9|Y
neural precursor cell-expressed developmentally downregulated 4|neural precursor cell-expressed developmentally down-regulated 9|Y
neural precursor cell-expressed developmentally downregulated 4|neural precursor cell-expressed developmentally downregulated 1|Y
neural precursor cell-expressed developmentally downregulated 4|neuronal precursor cell-expressed developmentally down-regulated 4|Y
neural precursor cell-expressed developmentally downregulated 4|neural precursor cell-expressed developmentally down-regulated 2|Y
neural precursor cell-expressed developmentally downregulated 4|neural precursor cell-expressed developmentally down-regulated 4|Y
neural precursor cell-expressed developmentally downregulated 4|neural precursor cell-expressed developmentally downregulated 9|Y
neural precursor cell-expressed developmentally downregulated 4|neural precursor cell-expressed, developmentally downregulated 8|Y
neural precursor cell-expressed developmentally downregulated 4|neural precursor cell-expressed, developmentally downregulated 1|Y
neural precursor cell-expressed developmentally downregulated 4|neural precursor cell-expressed, developmentally down-regulated 4|Y
IL-12 receptor beta2 chain|IL-12 receptor beta 2 chain|Y
American Society of Anaesthesiology status 2|American Society of Anaesthesiology status 3|Y
American Society of Anaesthesiology status 2|American Society of Anaesthesiology status I|Y
American Society of Anaesthesiology status 2|American Society of Anaesthesiology status|Y
American Society of Anaesthesiology status 2|American Society of Anaesthesiology status V|Y
intrathecal methotrexate|intra-thecal methotrexate|Y
stromal derived factor 1α|stromal derived factor 1|Y
activity-regulated cytoskeleton-associated protein|activity-regulated cytoskeleton associated protein|Y
activity-regulated cytoskeleton-associated protein|activity regulated cytoskeleton-associated protein|Y
cartilage-derived morphogenetic protein|cartilage-derived morphogenetic proteins|Y
multiplanar reconstruction image|multi-planar reconstruction image|Y
electron-probe X-ray microanalyser|electron-probe X-ray micro-analyser|Y
technetium-99m diethylene-triaminepentaacetic acid galactosyl human serum albumin|technetium-99m diethylenetriaminepentaacetic acid-galactosyl human serum albumin|Y
technetium-99m diethylene-triaminepentaacetic acid galactosyl human serum albumin|technetium 99m diethylene-triaminepentaacetic acid galactosyl human serum albumin|Y
oestrogen receptor α agonist|estrogen receptor α agonist|Y
International Programme on Chemical Safety|International Program on Chemical Safety|Y
CC chemokine receptor 1|CXC chemokine receptor 1|Y
CC chemokine receptor 1|C-C chemokine receptor 1|Y
poly(ethylene glycol)-200|poly(ethylene glycol)-2000|Y
pyruvate dehydrogenase-E1α|pyruvate dehydrogenase-E1 α|Y
Krüppel-like factor 3|Krüppel-like factor 13|Y
non-homologous endjoining pathway|non-homologous end-joining pathway|Y
interleukin-4 receptor-α|interleukine-4 receptor-α|Y
programme budgeting and marginal analysis|program budgeting and marginal analysis|Y
carboxy terminal trans-activation domain|carboxy-terminal trans-activation domain|Y
non-seminomatous testicular tumour|non-seminomatous testicular tumor|Y
melanoma differentiation associated gene 5|melanoma differentiation associated gene-5|Y
melanoma differentiation associated gene 5|melanoma differentiation-associated gene 5|Y
extracorporeal photochemotherapy|extracorporeal photo-chemotherapy|Y
intraluminal brachytherapy|intra-luminal brachytherapy|Y
perinuclear anti neutrophil cytoplasmic antibody|perinuclear anti-neutrophil cytoplasmic antibody|Y
single photon emission computed tomography|single-photon emission computed tomography|Y
a disintegrin and metalloprotease with thrombospondin motifs-12|a disintegrin and metalloprotease with thrombospondin motifs-20|Y
a disintegrin and metalloprotease with thrombospondin motifs-12|a disintegrin and metalloprotease with thrombospondin motifs-14|Y
a disintegrin and metalloprotease with thrombospondin motifs-12|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motifs-12|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-12|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-12|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-12|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-12|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motifs-12|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-12|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motifs-12|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-12|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motifs-12|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-12|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-12|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
a disintegrin and metalloprotease with thrombospondin motifs-12|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
hereditary angio edema|hereditary angioedema|Y
vasopressin 2 receptor antagonist|vasopressin V2 receptor antagonist|Y
opioid-induced hyperalgaesia|opioid-induced hyperalgesia|Y
corticotropin releasing factor receptor type 1|corticotropin releasing factor receptor type-1|Y
recombinant interleukine-1α|recombinant interleukine-1 α|Y
human leukocyte antigen-D-related antigen 1|human leukocyte antigen-D-related antigen|Y
neural precursor cell expressed, developmentally downregulated 5|neural precursor cell expressed, developmentally downregulated 9|Y
neural precursor cell expressed, developmentally downregulated 5|neural precursor cell expressed developmentally downregulated 4|Y
neural precursor cell expressed, developmentally downregulated 5|neural precursor cell expressed developmentally downregulated 5|Y
neural precursor cell expressed, developmentally downregulated 5|neural precursor cell expressed developmentally downregulated 2|Y
neural precursor cell expressed, developmentally downregulated 5|neural precursor cell expressed, developmentally downregulated 2|Y
neural precursor cell expressed, developmentally downregulated 5|neural precursor cell expressed, developmentally down-regulated 4|Y
neural precursor cell expressed, developmentally downregulated 5|neural precursor cell expressed, developmentally down-regulated 1|Y
neural precursor cell expressed, developmentally downregulated 5|neural precursor cell expressed, developmentally down-regulated 5|Y
neural precursor cell expressed developmentally down-regulated 1|neural precursor cell expressed developmentally down-regulated 8|Y
neural precursor cell expressed developmentally down-regulated 1|neural precursor cell-expressed developmentally down-regulated 1|Y
neural precursor cell expressed developmentally down-regulated 1|neural precursor cell expressed developmentally downregulated 4|Y
neural precursor cell expressed developmentally down-regulated 1|neural precursor cell expressed developmentally downregulated 5|Y
neural precursor cell expressed developmentally down-regulated 1|neural precursor cell expressed developmentally downregulated 2|Y
neural precursor cell expressed developmentally down-regulated 1|neural precursor cell-expressed developmentally downregulated 1|Y
neural precursor cell expressed developmentally down-regulated 1|neural precursor cell expressed, developmentally down-regulated 4|Y
neural precursor cell expressed developmentally down-regulated 1|neural precursor cell expressed, developmentally down-regulated 1|Y
neural precursor cell expressed developmentally down-regulated 1|neural precursor cell expressed developmentally down-regulated 9|Y
neural precursor cell expressed developmentally down-regulated 1|neural precursor cell expressed, developmentally down-regulated 5|Y
alternariol mono-methyl ether|alternariol monomethyl ether|Y
UDP-glucose ceramide glucosyltransferase|UDP-glucose:ceramide glucosyltransferase|Y
TATA-binding protein-associated factor 6|TATA-binding protein-associated factor 1|Y
TATA-binding protein-associated factor 6|TATA-binding protein-associated factor 4|Y
TATA-binding protein-associated factor 6|TATA-binding protein-associated factor-6|Y
autoregressive integrated moving average|auto-regressive integrated moving average|Y
viscero-motor response|visceromotor response|Y
formin homology domain-containing protein-1|formin homology domain containing protein-1|Y
metabotropic glutamate receptor 1α|metabotropic glutamate receptor 1 α|Y
nonsteroidal anti-inflammatory drug-induced|non-steroidal antiinflammatory drug-induced|Y
Walleye dermal sarcoma virus|Wall-eye dermal sarcoma virus|Y
nonneovascular glaucoma|non-neovascular glaucoma|Y
4-hydroxy-3-nitrophenylacetyl|4-hydroxy-3-nitrophenyl acetyl|Y
receptor-like protein-tyrosine phosphatase η|receptor-like protein-tyrosine phosphatase δ|Y
receptor-like protein-tyrosine phosphatase η|receptor-like protein-tyrosine phosphatase μ|Y
receptor-like protein-tyrosine phosphatase η|receptor-like protein tyrosine phosphatase η|Y
receptor-like protein-tyrosine phosphatase η|receptor-like protein-tyrosine phosphatase-η|Y
epidermal cell thymocyte-activating factor|epidermal cell thymocyte activating factor|Y
interferon stimulated gene factor 3alpha|interferon stimulated gene factor-3alpha|Y
ubiquitin carboxyl-terminal hydrolase L1|ubiquitin carboxyl-terminal hydrolase L5|Y
Professional Standards Review Organizations|Professional Standards Review Organization|Y
aluminium hydroxide gel|aluminum hydroxide gel|Y
interleukin 7 receptor α-chain|interleukine 7 receptor α-chain|Y
homozygous α-1-protease inhibitor deficiency|homozygous α 1-protease inhibitor deficiency|Y
homozygous α-1-protease inhibitor deficiency|homozygous α-1 protease inhibitor deficiency|Y
homozygous α-1-protease inhibitor deficiency|homozygous α-1-proteinase inhibitor deficiency|Y
post-anesthetic recovery unit|postanesthetic recovery unit|Y
toll-interleukin-1 receptor domain-containing adapter-inducing interferon-β|toll-interleukin-1 receptor domain-containing adapter-inducing interferon β|Y
toll-interleukin-1 receptor domain-containing adapter-inducing interferon-β|Toll-interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
toll-interleukin-1 receptor domain-containing adapter-inducing interferon-β|toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
G-protein-coupled receptor kinase|G-protein-coupled receptor kinases|Y
ubiquitin-conjugating enzyme E2C|ubiquitin-conjugating enzyme 2C|Y
acute graft versus host disease grade I|acute graft versus host disease grade IV|Y
acute graft versus host disease grade I|acute graft versus host disease grade III|Y
ultrahigh vacuum scanning tunneling microscopy|ultrahigh-vacuum scanning tunneling microscopy|Y
ultrahigh vacuum scanning tunneling microscopy|ultra-high vacuum scanning tunneling microscopy|Y
N-butyl-N-(4-hydroxybutyl) nitrosamine|N-butyl-N-(4-hydroxybutyl)nitrosamine|Y
trans-cutaneous electric nerve stimulation|trans-cutaneous electrical nerve stimulation|Y
trans-cutaneous electric nerve stimulation|transcutaneous electric nerve stimulation|Y
Fc gamma receptor-mediated|Fcgamma receptor-mediated|Y
hypersensitivity reaction|hyper-sensitivity reaction|Y
rabbit antihuman thymocyte globulin|rabbit anti-human thymocyte globulin|Y
X-ray repair cross complementing protein 2|X-ray repair cross-complementing protein 2|Y
carbonyl cyanide p-trifluoromethoxyphenyl hydrazone|carbonyl cyanide p-trifluoromethoxyphenylhydrazone|Y
Strongylocentrotus purpuratus epidermal growth factor III|Strongylocentrotus purpuratus epidermal growth factor II|Y
Strongylocentrotus purpuratus epidermal growth factor III|Strongylocentrotus purpuratus epidermal growth factor I|Y
Brg1-associated factor|Brg-1-associated factor|Y
American Society of Anesthesiology Grade IV|American Society of Anesthesiology grade IV|Y
American Society of Anesthesiology Grade IV|American Society of Anesthesiology Grade V|Y
American Society of Anesthesiology Grade IV|American Society of Anesthesiology Grade II|Y
acute non lymphocytic leukemia|acute nonlymphocytic leukemia|Y
light emitting diodes|light emitting diode|Y
corticotropin releasing hormone receptor type 2|corticotropin-releasing hormone receptor type 2|Y
corticotropin releasing hormone receptor type 2|corticotrophin releasing hormone receptor type 2|Y
corticotropin releasing hormone receptor type 2|corticotropin releasing hormone receptor type-2|Y
retroperitoneal approach|retro-peritoneal approach|Y
non-muscle myosin heavy chain A|nonmuscle myosin heavy chain A|Y
gamma-aminobutyric acidA|gamma-amino butyric acidA|Y
peroxisome proliferator-activated receptor γ2|peroxisome proliferator-activated receptor γ1|Y
peroxisome proliferator-activated receptor γ2|peroxisome proliferator-activated receptor γ 2|Y
peroxisome proliferator-activated receptor γ2|peroxisome proliferator-activated receptor-γ2|Y
S100 calcium binding protein A15|S100 calcium binding protein A1|Y
noninvasive ventilation|non invasive ventilation|Y
epidermal derived thymocyte-activating factor|epidermal derived thymocyte activating factor|Y
epidermal derived thymocyte-activating factor|epidermal-derived thymocyte-activating factor|Y
receptor-type protein-tyrosine phosphatase beta|receptor-type protein tyrosine phosphatase beta|Y
toll-interleukin-1 receptor domain-containing adapter-inducing interferon beta|toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
toll-interleukin-1 receptor domain-containing adapter-inducing interferon beta|toll-interleukin1 receptor domain-containing adapter inducing interferon beta|Y
toll-interleukin-1 receptor domain-containing adapter-inducing interferon beta|toll/interleukin-1 receptor domain-containing adapter-inducing interferon beta|Y
toll-interleukin-1 receptor domain-containing adapter-inducing interferon beta|toll-interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
toll-interleukin-1 receptor domain-containing adapter-inducing interferon beta|Toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
toll-interleukin-1 receptor domain-containing adapter-inducing interferon beta|Toll-interleukin-1 receptor domain-containing adapter-inducing interferon beta|Y
phospholipase Cgamma-2|phospholipase Cgamma2|Y
immuno-fluorescence in situ hybridisation|immunofluorescence in situ hybridisation|Y
aromatase cytochrome P450|aromatase cytochrome P-450|Y
healthcare-associated pneumonia|health-care-associated pneumonia|Y
angiotensin-converting enzyme inhibition|angiotensin converting enzyme inhibition|Y
American Society of Anesthesiologists physical status III|American Society of Anesthesiologists physical status II|Y
protein tyrosine phosphatase 1D|protein tyrosine phosphatase 1|Y
beta-adrenergic receptor adenylate cyclase|beta-adrenergic receptor-adenylate cyclase|Y
corticotropin-releasing hormone receptor type 2|corticotropin-releasing hormone receptor type-2|Y
corticotropin-releasing hormone receptor type 2|corticotropin-releasing-hormone receptor type 2|Y
myofascial pain dysfunction syndrome|myofacial pain dysfunction syndrome|Y
receptor-type protein-tyrosine phosphatase β|receptor-type protein tyrosine phosphatase β|Y
erythroid colony-forming cell|erythroid colony-forming cells|Y
platelet-derived growth factor receptor-beta|platelet derived growth factor receptor-beta|Y
Plasmodium vivax merozoite surface protein 9|Plasmodium vivax merozoite surface protein 1|Y
anti-beta-2 glycoprotein I antibody|anti-beta2 glycoprotein I antibody|Y
granulocyte/macrophage-colony stimulating factor|granulocyte/macrophage colony stimulating factor|Y
American Society of Anesthesiology grade IV|American Society of Anaesthesiology grade I|Y
American Society of Anesthesiology grade IV|American Society of Anaesthesiology grade V|Y
American Society of Anesthesiology grade IV|American Society of Anesthesiology grade I|Y
American Society of Anesthesiology grade IV|American Society of Anesthesiology grade II|Y
lamprey gonadotropin-releasing hormone III|lamprey gonadotropin-releasing hormone I|Y
flavin containing mono-oxygenase|flavin containing monooxygenase|Y
glutaraldehyde cross-linked collagen|glutaraldehyde crosslinked collagen|Y
immuno-reactive trypsinogen|immunoreactive trypsinogen|Y
kinase insert domain containing receptor|kinase insert domain-containing receptor|Y
src homology-2 domain-containing protein-tyrosine phosphatase|src homology-2 domain-containing protein tyrosine phosphatase|Y
bovine luteinizing hormone|ovine luteinizing hormone|Y
anteroventral cochlear nucleus|antero-ventral cochlear nucleus|Y
oestrogen receptor-β knockout|oestrogen receptor-β knock out|Y
lympho-proliferative disease virus|lymphoproliferative disease virus|Y
single strand conformation polymorphism analysis|single-strand conformation polymorphism analysis|Y
monocyte-derived macrophages|monocyte-derived macrophage|Y
beta-ketoacyl-acyl carrier protein synthase|beta-ketoacyl acyl carrier protein synthase|Y
beta-ketoacyl-acyl carrier protein synthase|beta-ketoacyl-acyl carrier protein synthase I|Y
Ralph H Johnson Veterans Affairs Medical Center|Ralph H Johnson Veteran's Affairs Medical Center|Y
Ralph H Johnson Veterans Affairs Medical Center|Ralph H. Johnson Veteran's Affairs Medical Center|Y
Ralph H Johnson Veterans Affairs Medical Center|Ralph H Johnson Veterans' Affairs Medical Center|Y
acute non-lymphoblastic leucemia|acute nonlymphoblastic leucemia|Y
adrenogenital syndrome|adreno-genital syndrome|Y
Aphanizomenon flos-aquae|Aphanizomenon flosaquae|Y
fluorine-18 fluoro-deoxy-glucose|fluorine-18 fluoro-deoxyglucose|Y
β2 microglobulin value|β 2 microglobulin value|Y
intra-uterine adhesion|intrauterine adhesion|Y
technetium-99m diethylenetriaminepentaacetic acid-galactosyl human serum albumin|technetium 99m diethylene-triaminepenta-acetic acid-galactosyl human serum albumin|Y
oculo-dento-digital dysplasia|oculodento-digital dysplasia|Y
α 1 antichymotrypsin|α 1 anti-chymotrypsin|Y
β-site amyloid precursor protein cleaving enzyme 1|β-site amyloid precursor protein-cleaving enzyme 1|Y
latent transforming growth factor-beta binding protein-1|latent transforming growth factor-beta binding protein 1|Y
vestibular evoked myogenic potential|vestibular evoked myogenic potentials|Y
light-harvesting chlorophyll a/b-binding protein-I|light harvesting chlorophyll a/b-binding protein-I|Y
light-harvesting chlorophyll a/b-binding protein-I|light-harvesting chlorophyll a/b-binding protein|Y
light-harvesting chlorophyll a/b-binding protein-I|light-harvesting chlorophyll a/b-binding protein-II|Y
T box transcription factor 21|T box transcription factor 2|Y
multi-cellular spheroid|multicellular spheroid|Y
spatiotemporal image correlation spectroscopy|spatio-temporal image correlation spectroscopy|Y
poly(A)-binding protein II|poly (A)-binding protein II|Y
tumor necrosis factor receptor superfamily member 25|tumor necrosis factor receptor superfamily member 5|Y
tumor necrosis factor receptor superfamily member 25|tumor necrosis factor receptor superfamily member 12|Y
type 2 insulinlike growth factor receptor|type 1 insulinlike growth factor receptor|Y
type 2 insulinlike growth factor receptor|type 2 insulin-like growth factor receptor|Y
cAMP receptor protein|c-AMP receptor protein|Y
gastrointestinal therapeutic system|gastro-intestinal therapeutic system|Y
naturally occurring radioactive material|naturally occurring radioactive materials|Y
tetrachlorosalicylanilide|tetrachlorsalicylanilide|Y
leucine-rich amelogenin peptid|leucine-rich amelogenin peptide|Y
mitogen activated protein kinase-activated protein kinase-2|mitogen activated protein kinase-activated protein kinase-3|Y
mitogen activated protein kinase-activated protein kinase-2|mitogen activated protein kinase-activated protein kinase|Y
mitogen activated protein kinase-activated protein kinase-2|mitogen activated protein kinase activated protein kinase-2|Y
ubiquitin-like proteins|ubiquitin-like protein|Y
CC chemokine ligand 3|C-C chemokine ligand 3|Y
prostaglandin F2alpha metabolite|prostaglandin F2 alpha metabolite|Y
CB17 severe combined immunodeficient mouse|CB-17 severe combined immunodeficient mouse|Y
adenotonsillar hypertrophy|adeno-tonsillar hypertrophy|Y
pro-interleukin-1beta|prointerleukin-1beta|Y
semi-tendinosus gracilis graft|semitendinosus gracilis graft|Y
neuromuscular blocker|neuro-muscular blocker|Y
corticotropin-releasing hormone receptor-1|corticotropin-releasing hormone receptor|Y
corticotropin-releasing hormone receptor-1|corticotropin releasing hormone receptor-1|Y
corticotropin-releasing hormone receptor-1|corticotropin-releasing hormone receptor 1|Y
anti-human herpes virus-8 antibody|anti-human herpesvirus-8 antibody|Y
ras-related GTP-binding protein 4|ras-related GTP-binding protein 4A|Y
ras-related GTP-binding protein 4|ras-related GTP-binding protein 4b|Y
ras-related GTP-binding protein 4|ras-related GTP-binding protein 34|Y
gadolinium tetraazacyclododecane tetraacetic acid|gadolinium tetra-azacyclododecane tetra-acetic acid|Y
gadolinium tetraazacyclododecane tetraacetic acid|gadolinium tetra-azacyclododecane tetraacetic acid|Y
American Spinal Injury Association Impairment Scale grade B|American Spinal Injury Association Impairment Scale grade C|Y
American Spinal Injury Association Impairment Scale grade B|American Spinal Injury Association Impairment Scale grade A|Y
ribosomal protein L8|ribosomal protein L38|Y
ribosomal protein L8|ribosomal protein L18|Y
lectin-like oxidised low-density lipoprotein receptor-1|lectin-like oxidised low-density lipoprotein receptor 1|Y
lectin-like oxidised low-density lipoprotein receptor-1|lectin-like oxidised low density lipoprotein receptor-1|Y
lectin-like oxidised low-density lipoprotein receptor-1|lectin-like oxidized low-density lipoprotein receptor-1|Y
nonmilk extrinsic sugar|non-milk extrinsic sugar|Y
ras-related GTP-binding protein 1|ras-related GTP-binding protein 21|Y
ras-related GTP-binding protein 1|ras-related GTP-binding protein 18|Y
ras-related GTP-binding protein 1|ras-related GTP-binding protein 1b|Y
sterol regulatory element-binding protein 2|sterol regulatory element-binding protein-2|Y
microtubule associated protein 2|microtubule associated protein 2D|Y
microtubule associated protein 2|microtubule associated protein 2C|Y
Conners Adult ADHD Rating Scale|Conners' Adult ADHD Rating Scale|Y
human chorionic gonadotrophin β-subunit|human chorionic gonadotropin β-subunit|Y
melanin concentrating hormone receptor 1|melanin-concentrating hormone receptor 1|Y
hereditary cerebral haemorrhage with amyloidosis, Dutch-type|hereditary cerebral hemorrhage with amyloidosis, Dutch-type|Y
human transforming growth factor-beta 2|human transforming growth factor-beta2|Y
non-convulsive generalised status epilepticus|nonconvulsive generalised status epilepticus|Y
chorio-retinal degeneration|chorioretinal degeneration|Y
class II major histocompatibility complex|class I major histocompatibility complex|Y
Fas-associated death domain-like interleukin-1beta-converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein|Y
Fas-associated death domain-like interleukin-1beta-converting enzyme inhibitory protein|Fas-associated death domain-like interleukin-1beta converting enzyme inhibitory protein|Y
neural-precursor-cell-expressed developmentally downregulated 9|neural-precursor-cell-expressed developmentally down-regulated 5|Y
neural-precursor-cell-expressed developmentally downregulated 9|neural-precursor-cell-expressed developmentally down-regulated 9|Y
neural-precursor-cell-expressed developmentally downregulated 9|neural-precursor-cell-expressed, developmentally downregulated 5|Y
neural-precursor-cell-expressed developmentally downregulated 9|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor-cell-expressed developmentally downregulated 9|neural-precursor-cell-expressed developmentally downregulated 5|Y
neural-precursor-cell-expressed developmentally downregulated 9|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor-cell-expressed developmentally downregulated 9|neural-precursor-cell-expressed developmentally down-regulated 1|Y
neural-precursor-cell-expressed developmentally downregulated 9|neural-precursor-cell-expressed, developmentally downregulated 2|Y
intra-coronary brachytherapy|intracoronary brachytherapy|Y
multi-detector row computed tomography scan|multidetector row computed tomography scan|Y
multi-detector row computed tomography scan|multi-detector-row computed tomography scan|Y
non-anterior myocardial infarction|nonanterior myocardial infarction|Y
growth-associated protein B50|growth-associated protein B-50|Y
dihomo-γ-linolenic acid|dihomoγ-linolenic acid|Y
methylchloroisothiazolinone|methylchloro-isothiazolinone|Y
TATA-binding protein associated factor-5|TATA-binding protein associated factor-3|Y
TATA-binding protein associated factor-5|TATA-binding protein associated factor-1|Y
TATA-binding protein associated factor-5|TATA-binding protein associated factor-9|Y
TATA-binding protein associated factor-5|TATA-binding protein associated factor-2|Y
TATA-binding protein associated factor-5|TATA-binding protein associated factor-4|Y
TATA-binding protein associated factor-5|TATA-binding protein associated factor-7|Y
American Society of Anesthesiology class V|American Society of Anesthesiology class 4|Y
American Society of Anesthesiology class V|American Society of Anesthesiology class I|Y
American Society of Anesthesiology class V|American Society of Anesthesiology Class V|Y
laser desorption ionisation time-of-flight mass spectrometry|laser desorption/ionisation time-of-flight mass spectrometry|Y
antiinterleukin 12 monoclonal antibody|antiinterleukin 2 monoclonal antibody|Y
recombinant human transforming growth factor α|recombinant human transforming growth factor-α|Y
recombinant human transforming growth factor α|recombinant human transforming growth factor β|Y
artificial cerebrospinal fluid|artificial cerebro-spinal fluid|Y
carcinoembryonic antigen-related cell-adhesion molecule-1|carcinoembryonic antigen-related cell-adhesion molecule 1|Y
micro x-ray absorption near edge structure|micro X-ray absorption near edge structure|Y
human T-cell lymphotropic virus-I antibody|human T-cell lymphotropic virus-1 antibody|Y
p-fluorophenylalanine|p-fluoro-phenylalanine|Y
haemagglutinin-esterase|hemagglutinin-esterase|Y
2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline|2-amino-3,8-di-methylimidazo[4,5-f]quinoxaline|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labelling assay|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling assay|Y
hexachlorocyclo-hexane|hexachlorocyclohexane|Y
cultured epithelial autografts|cultured epithelial autograft|Y
never-in-mitosis Aspergillus-related kinase 2|never-in-mitosis Aspergillus-related kinase 4|Y
never-in-mitosis Aspergillus-related kinase 2|never-in-mitosis Aspergillus-related kinase 2A|Y
never-in-mitosis Aspergillus-related kinase 2|never-in-mitosis Aspergillus-related kinase 7|Y
never-in-mitosis Aspergillus-related kinase 2|never-in-mitosis Aspergillus-related kinase|Y
TATA-binding protein associated factor-3|TATA-binding protein associated factor-1|Y
TATA-binding protein associated factor-3|TATA-binding protein associated factor-9|Y
TATA-binding protein associated factor-3|TATA-binding protein-associated factor-3|Y
TATA-binding protein associated factor-3|TATA-binding protein associated factor-2|Y
TATA-binding protein associated factor-3|TATA-binding protein associated factor-4|Y
TATA-binding protein associated factor-3|TATA-binding protein associated factor-7|Y
peroxisome proliferator-activated receptor-γ 2|peroxisome proliferator-activated receptor-γ-2|Y
peroxisome proliferator-activated receptor-γ 2|peroxisome proliferator-activated receptor γ 2|Y
peroxisome proliferator-activated receptor-γ 2|peroxisome proliferator-activated receptor-γ2|Y
peroxisome proliferator-activated receptor-γ 2|peroxisome proliferator activated receptor-γ 2|Y
eucaryotic translation initiation factor 2|eucaryotic translation initiation factor 2B|Y
eucaryotic translation initiation factor 2|eucaryotic translation initiation factor 3|Y
normo-cholesterolemic|normocholesterolemic|Y
Department of Veterans Affairs|Department of Veterans' Affairs|Y
ribosomal protein L15|ribosomal protein L5|Y
fluorescent amplified-fragment length polymorphism|fluorescent amplified-fragment-length polymorphism|Y
multi-fluor fluorescence in situ hybridization|multi-fluor fluorescence in situ hybridisation|Y
multi-fluor fluorescence in situ hybridization|multi-fluor fluorescence in-situ hybridization|Y
multi-fluor fluorescence in situ hybridization|multifluor fluorescence in situ hybridization|Y
dehydrophenylalanine|dehydro-phenylalanine|Y
electroneurodiagnostic technologist|electro-neurodiagnostic technologist|Y
prothrombin time-international normalized ratio|prothrombin time international normalized ratio|Y
antiIL-17 monoclonal antibody|antiIL-7 monoclonal antibody|Y
antiIL-17 monoclonal antibody|anti-IL-17 monoclonal antibody|Y
ultra-violet radiation-induced mutation|ultraviolet radiation-induced mutation|Y
American Society of Anesthesiology class 4|American Society of Anesthesiology class I|Y
American Society of Anesthesiology class 4|American Society of Anesthesiology Class 4|Y
endothelial monocyte-activating polypeptide-2|endothelial monocyte activating polypeptide-2|Y
noncrystallographic symmetry|non-crystallographic symmetry|Y
inter-response interval|interresponse interval|Y
human adenovirus serotype 50|human adenovirus serotype 5|Y
a disintegrin and metalloprotease with thrombospondin motifs-20|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motifs-20|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-20|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-20|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-20|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
secreted protein, acidic and rich in cysteine|secreted protein acidic and rich in cystein|Y
tumour necrosis factor receptor-associated factor 6|tumour necrosis factor receptor-associated factor 2|Y
tumour necrosis factor receptor-associated factor 6|tumour necrosis factor receptor-associated factor 1|Y
tumour necrosis factor receptor-associated factor 6|tumor necrosis factor receptor-associated factor 6|Y
laser interstitial thermo-therapy|laser interstitial thermotherapy|Y
matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry|matrix assisted laser desorption/ionisation time-of-flight mass spectrometry|Y
matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry|matrix-assisted laser desorption/ionization time-of-flight mass spectrometry|Y
matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry|matrix-assisted laser desorption/ionisation time-of-flight mass spectrometric|Y
glycosylphosphatidylinositol-linked protein|glycosyl phosphatidyl inositol-linked protein|Y
glycosylphosphatidylinositol-linked protein|glycosylphosphatidyl inositol-linked protein|Y
Hemophilus parainfluenzae|Haemophilus parainfluenzae|Y
simultaneous pancreas-kidney transplantation|simultaneous pancreas/kidney transplantation|Y
amino-terminal pro-brain-type natriuretic peptide|aminoterminal pro-brain-type natriuretic peptide|Y
American Society of Anaesthesiologists grade II|American Society of Anaesthesiologists grade I|Y
American Society of Anaesthesiologists grade II|American Society of Anaesthesiologists Grade II|Y
American Society of Anaesthesiologists grade II|American Society of Anesthesiologists grade III|Y
American Society of Anaesthesiologists grade II|American Society of Anesthesiologists grade I|Y
American Society of Anaesthesiologists grade II|American Society of Anesthesiologists grade II|Y
TATA-binding protein-associated factor 17|TATA-binding protein-associated factor 11|Y
TATA-binding protein-associated factor 17|TATA-binding protein-associated factor 1|Y
antitubular basement membrane disease|anti-tubular basement membrane disease|Y
β-tricalciumphosphate|β-tricalcium-phosphate|Y
β-tricalciumphosphate|β-tricalcium phosphate|Y
tris(2,3-dibromopropyl)phosphate|tris(2,3-dibromopropyl) phosphate|Y
branched-chain alpha-keto acid dehydrogenase|branched-chain alpha-ketoacid dehydrogenase|Y
branched-chain alpha-keto acid dehydrogenase|Branched-chain alpha-keto acid dehydrogenase|Y
light harvesting chlorophyll a/b protein II|light-harvesting chlorophyll a/b protein II|Y
light harvesting chlorophyll a/b protein II|light harvesting chlorophyll a/b protein I|Y
light harvesting chlorophyll a/b protein II|light harvesting chlorophyll a/b protein-II|Y
γ-amino-butyric acidB receptor|γ-amino-butyric acid-B receptor|Y
eating disorder inventory|eating disorders inventory|Y
hypothalamo-neurohypophyseal system|hypothalamoneurohypophyseal system|Y
mass analyzed threshold ionisation spectrum|mass-analyzed threshold ionisation spectrum|Y
endothelial monocyte-activating polypeptide-III|endothelial monocyte activating polypeptide-III|Y
single photon emission computed tomography scan|single-photon emission computed tomography scan|Y
anti-tubular basement membrane nephritis|antitubular basement membrane nephritis|Y
S100 calcium binding protein A14|S100 calcium binding protein A1|Y
Na-K-Cl co-transporter-2|Na-K-2Cl co-transporter-2|Y
A(3) adenosine receptor|A(3) adenosine receptors|Y
extra-vascular lung water|extravascular lung water|Y
combination anti-retroviral treatment|combination antiretroviral treatment|Y
Bos taurus autosome 8|Bos taurus autosome 28|Y
American Society of Anaesthesiology grade|American Society of Anaesthesiology grade I|Y
American Society of Anaesthesiology grade|American Society of Anaesthesiology grade 4|Y
American Society of Anaesthesiology grade|American Society of Anaesthesiology grade V|Y
American Society of Anaesthesiology grade|American Society of Anesthesiology grade|Y
preligand assembly domain|pre-ligand assembly domain|Y
levonorgestrel releasing intra-uterine device|laevonorgestrel releasing intra-uterine device|Y
inositol-requiring enzyme 1 α|inositol-requiring enzyme 1α|Y
fluorescent amplified fragment-length polymorphism analysis|fluorescent amplified fragment length polymorphism analysis|Y
non-collagenous 1 domain|noncollagenous 1 domain|Y
polyaluminum chloride|poly-aluminum chloride|Y
killer immunoglobulin-like receptors|killer immunoglobulin-like receptor|Y
prepro-corticotrophin-releasing factor|pre-pro-corticotrophin-releasing factor|Y
prepro-corticotrophin-releasing factor|preprocorticotrophin-releasing factor|Y
radio-immune precipitation|radioimmune precipitation|Y
epidemic methicillin-resistant Staphylococcus aureus-17|epidemic methicillin-resistant Staphylococcus aureus-16|Y
Pseudomonas aeruginosa PAO-1|Pseudomonas aeruginosa PAO1|Y
structural maintenance of chromosomes|structural maintenance of chromosome|Y
recombinant human interleukin-1 β|recombinant human interleukin-1β|Y
β-amyloid precursor protein cleaving enzyme 1|β amyloid precursor protein cleaving enzyme 1|Y
β-amyloid precursor protein cleaving enzyme 1|β-amyloid precursor protein-cleaving enzyme 1|Y
attenuated total reflectance Fourier-transform infrared spectroscopy|attenuated total reflectance Fourier transform infrared spectroscopy|Y
attenuated total reflectance Fourier-transform infrared spectroscopy|attenuated total reflectance Fourier transform infra-red spectroscopy|Y
Fc-γ-receptor-dependent|Fcγ-receptor-dependent|Y
matrix assisted laser desorption ionization time of flight mass spectrometric|matrix-assisted laser desorption ionization time of flight mass spectrometric|Y
haemoglobin-based oxygen carrier|hemoglobin-based oxygen carrier|Y
angiofollicular hyperplasia|angio-follicular hyperplasia|Y
glycophosphatidyl inositol-anchored|glycophosphatidylinositol-anchored|Y
genitourinary system|genito-urinary system|Y
para-aminobenzoylglutamic|para-aminobenzoyl-glutamic|Y
million international unit|million international units|Y
short interspersed element|short interspersed elements|Y
calcium/calmodulin dependent kinase kinase|calcium-calmodulin dependent kinase kinase|Y
IL1 receptor antagonist|IL-1 receptor antagonist|Y
lyso-phosphatidyl ethanolamine|lyso-phosphatidylethanolamine|Y
hemoglobin-based oxygen carrier|hemoglobin-based oxygen carriers|Y
pre-formed metal crown|preformed metal crown|Y
oestrogen/progestin therapy|estrogen/progestin therapy|Y
International Classification of Impairments, Disabilities and Handicaps|International Classification of Impairments, Disabilities, and Handicaps|Y
neural precursor cell expressed developmentally down-regulated 8|neural precursor cell expressed developmentally downregulated 4|Y
neural precursor cell expressed developmentally down-regulated 8|neural precursor cell expressed developmentally downregulated 5|Y
neural precursor cell expressed developmentally down-regulated 8|neural precursor cell expressed developmentally downregulated 2|Y
neural precursor cell expressed developmentally down-regulated 8|neural precursor cell expressed, developmentally down-regulated 4|Y
neural precursor cell expressed developmentally down-regulated 8|neural precursor cell expressed, developmentally down-regulated 1|Y
neural precursor cell expressed developmentally down-regulated 8|neural precursor cell expressed developmentally down-regulated 9|Y
neural precursor cell expressed developmentally down-regulated 8|neural precursor cell expressed, developmentally down-regulated 5|Y
a disintegrin and metalloprotease-13|a disintegrin and metalloprotease-3|Y
non-specific cytotoxic cell|nonspecific cytotoxic cell|Y
neural-precursor cell-expressed developmentally down-regulated 2|neural-precursor cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed developmentally down-regulated 2|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor cell-expressed developmentally down-regulated 2|neural precursor cell-expressed developmentally down-regulated 2|Y
neural-precursor cell-expressed developmentally down-regulated 2|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural-precursor cell-expressed developmentally down-regulated 2|neural precursor cell-expressed, developmentally down-regulated 2|Y
American Society of Anesthesiology Grade V|American Society of Anesthesiology Grade 5|Y
American Society of Anesthesiology Grade V|American Society of Anesthesiology Grade 2|Y
American Society of Anesthesiology Grade V|American Society of Anesthesiology Grade 3|Y
American Society of Anesthesiology Grade V|American Society of Anesthesiology Grade 1|Y
γ-glutamylcysteine synthetase|γglutamylcysteine synthetase|Y
inductively coupled plasma/mass spectrometry|inductively coupled plasma mass spectrometry|Y
post-translational modification|posttranslational modification|Y
epidermal-derived thymocyte activating factor|epidermal derived thymocyte activating factor|Y
epidermal-derived thymocyte activating factor|epidermal-derived thymocyte-activating factor|Y
promyelocytic leukemia/retinoic acid receptor α|promyelocytic leukemia/retinoic acid receptor-α|Y
promyelocytic leukemia/retinoic acid receptor α|promyelocytic leukemia-retinoic acid receptor α|Y
single photon emission computerized tomography|single photon emission computerised tomography|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|toll-interleukin1 receptor domain-containing adapter inducing interferon beta|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|toll/interleukin-1 receptor domain-containing adapter-inducing interferon beta|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|toll-interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Toll-interleukin-1 receptor domain-containing adapter-inducing interferon beta|Y
toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
helicase-like transcription factor|helicaselike transcription factor|Y
American Society of Anaesthesiologists grade I|American Society of Anaesthesiologists grade 3|Y
American Society of Anaesthesiologists grade I|American Society of Anaesthesiologists grade 5|Y
American Society of Anaesthesiologists grade I|American Society of Anesthesiologists grade I|Y
American Society of Anaesthesiologists grade I|American Society of Anesthesiologists grade II|Y
American Society of Anaesthesiologists grade I|American Society of Anaesthesiologists grade 4|Y
aminoethoxy-vinylglycine|aminoethoxyvinylglycine|Y
aminoethoxy-vinylglycine|aminoethoxy-vinyl-glycine|Y
pylorus-preserving pancreatoduodenectomy|pylorus-preserving pancreato-duodenectomy|Y
extra-cellular polysaccharide|extracellular polysaccharide|Y
hexafluoro-isopropanol|hexafluoroisopropanol|Y
anti-interleukin 7 monoclonal antibody|antiinterleukin 7 monoclonal antibody|Y
multicriteria decision analysis|multi-criteria decision analysis|Y
corticotrophin-releasing hormone receptor|corticotropin-releasing hormone receptor|Y
corticotrophin-releasing hormone receptor|corticotrophin-releasing-hormone receptor|Y
aminoglycoside adenylyltransferase fragment A2|aminoglycoside adenylyltransferase fragment A1|Y
insulin-like growth factor II mRNA-binding protein 3|insulin-like growth factor II mRNA-binding protein-3|Y
insulin-like growth factor II mRNA-binding protein 3|insulin-like growth factor-II mRNA-binding protein 3|Y
insulin-like growth factor II mRNA-binding protein 3|insulin-like growth factor II mRNA binding protein 3|Y
tetrahydroxy-cholestanoic acid|tetrahydroxycholestanoic acid|Y
non-homologous end joining DNA repair|nonhomologous end joining DNA repair|Y
tumor necrosis factor-related apoptosis-inducing ligand-receptor 1|tumour necrosis factor-related apoptosis-inducing ligand-receptor 1|Y
tumor necrosis factor-related apoptosis-inducing ligand-receptor 1|tumour necrosis factor-related apoptosis-inducing ligand receptor 1|Y
recombinant murine interleukin 1|recombinant murine interleukin 10|Y
type 2 corticotropin releasing hormone receptor|type 2 corticotrophin releasing hormone receptor|Y
type 2 corticotropin releasing hormone receptor|type 2 corticotropin-releasing hormone receptor|Y
graduated drivers licensing|graduated driver's licensing|Y
graduated drivers licensing|graduated driver licensing|Y
Bos taurus autosome 16|Bos taurus autosome 6|Y
Bos taurus autosome 16|Bos taurus autosome 1|Y
extrarenal Wilm's tumor|extrarenal Wilm's tumour|Y
extrarenal Wilm's tumor|extra-renal Wilm's tumor|Y
extrarenal Wilm's tumor|extrarenal Wilms tumor|Y
crossreacting determinant|cross-reacting determinant|Y
crossreacting determinant|cross reacting determinant|Y
Drosophila glutamate receptor II|Drosophila glutamate receptor I|Y
hypoxia inducible transcription factor-1α|hypoxia-inducible transcription factor-1α|Y
growth associated protein B50|growth associated protein B-50|Y
anti-interleukin 12 neutralising antibody|anti-interleukin 12 neutralizing antibody|Y
sodium orthophenylphenate|sodium ortho-phenylphenate|Y
antiurease immunoglobulin A|anti-urease immunoglobulin A|Y
thermogravimetric analyser|thermo-gravimetric analyser|Y
cross polarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross polarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross polarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
transient receptor potential vanilloid receptor 4|transient receptor potential vanilloid receptor 6|Y
transient receptor potential vanilloid receptor 4|transient receptor potential vanilloid receptor 1|Y
transient receptor potential vanilloid receptor 4|transient receptor potential vanilloid receptor 5|Y
antiarginine vasopressin|anti-arginine vasopressin|Y
American Society of Anesthesiologists grade|American Society of Anesthesiologists grade V|Y
American Society of Anesthesiologists grade|American Society of Anesthesiologists grade 2|Y
American Society of Anesthesiologists grade|American Society of Anesthesiologists grade I|Y
American Society of Anesthesiologists grade|American Society of Anesthesiologists grade 1|Y
American Society of Anesthesiologists grade|American Society of Anesthesiologists grade 5|Y
programmed-temperature vaporisation|programmed-temperature vapourisation|Y
viable but nonculturable|viable but non-culturable|Y
ras-related GTP-binding protein 8|ras-related GTP-binding protein 8A|Y
ras-related GTP-binding protein 8|ras-related GTP-binding protein 18|Y
ras-related GTP-binding protein 8|ras-related GTP-binding protein 38|Y
chronic hemodialysis|chronic haemodialysis|Y
O-desmethyl-venlafaxine|O-desmethylvenlafaxine|Y
repetitive-sequence-based polymerase chain reaction|repetitive sequence-based polymerase chain reaction|Y
a disintegrin and metalloprotease with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motif-14|Y
a disintegrin and metalloprotease with thrombospondin motifs-14|a disintegrin and metalloprotease with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motifs-14|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-14|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-14|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-14|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-14|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motifs-14|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motifs-14|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloprotease with thrombospondin motifs-14|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motifs-14|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-14|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-14|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
polyglandular autoimmune syndrome|polyglandular auto-immune syndrome|Y
internuclear bridging|inter-nuclear bridging|Y
neuro-muscular blocking agent|neuromuscular blocking agent|Y
thyroxine-binding pre-albumin|thyroxin-binding pre-albumin|Y
methane-thiosulfonate|methanethiosulfonate|Y
perioperative major cardio-vascular event|peri-operative major cardiovascular event|Y
perioperative major cardio-vascular event|perioperative major cardiovascular event|Y
peroxisome proliferator-activated receptor-γ-2|peroxisome proliferator-activated receptor-γ2|Y
activated-leukocyte cell adhesion molecule|activated leukocyte cell adhesion molecule|Y
augmented correlation consistent polarised valence double-ζ basis set|augmented correlation-consistent polarised valence double-ζ basis set|Y
augmented correlation consistent polarised valence double-ζ basis set|augmented correlation consistent polarised valence double ζ basis set|Y
prostatic intraepithelial neoplasia|prostatic intra-epithelial neoplasia|Y
tumour necrosis factor receptor associated factor-2|tumour necrosis factor receptor associated factor 2|Y
tumour necrosis factor receptor associated factor-2|tumour necrosis factor receptor associated factor-1|Y
tumour necrosis factor receptor associated factor-2|tumor necrosis factor receptor associated factor-2|Y
TNM pathologic stage N1|TNM pathologic stage N1a|Y
methyl cytosine-phosphate-guanosine binding domain 4|methyl cytosine-phosphate-guanosine binding domain 2|Y
methyl cytosine-phosphate-guanosine binding domain 4|methyl cytosine-phosphate-guanosine binding domain|Y
multivariate curve resolution-alternating least-squares|multivariate curve resolution-alternating least squares|Y
recombinant human tumor necrosis factor β|recombinant human tumour necrosis factor β|Y
American Society of Anaesthesiology physical status 3|American Society of Anaesthesiology physical status I|Y
American Society of Anaesthesiology physical status 3|American Society of Anaesthesiology physical status 5|Y
American Society of Anaesthesiology physical status 3|American Society of Anaesthesiology physical status 1|Y
American Society of Anaesthesiology physical status 3|American Society of Anaesthesiology physical status|Y
American Society of Anaesthesiology physical status 3|American Society of Anesthesiology physical status 3|Y
intra-cranial aneurysm|intracranial aneurysm|Y
nucleoside diphosphate linked moiety X motif 5|nucleoside diphosphate-linked moiety X motif 5|Y
nucleoside diphosphate linked moiety X motif 5|nucleoside diphosphate linked moiety X motif 9|Y
similar to mothers against decapentaplegic homolog 5|similar to mothers against decapentaplegic homolog 2|Y
similar to mothers against decapentaplegic homolog 5|similar to mothers against decapentaplegic homolog 8|Y
University of Hawai'i|University of Hawaii|Y
portacaval anastomosis|porta-caval anastomosis|Y
distal radioulnar joint|distal radio-ulnar joint|Y
Ehlers Danlos syndrome type IV|Ehlers Danlos syndrome type I|Y
pro-collagen type III aminoterminal peptide|procollagen type III aminoterminal peptide|Y
pro-collagen type III aminoterminal peptide|procollagen type III amino-terminal peptide|Y
ice recrystallisation inhibition|ice re-crystallisation inhibition|Y
lithium pilocarpine-induced status epilepticus|lithium/pilocarpine-induced status epilepticus|Y
microparticle enzyme immunoassay|micro-particle enzyme immunoassay|Y
interleukin-6 receptor α subunit|interleukine-6 receptor α subunit|Y
medial patellofemoral ligament|medial patello-femoral ligament|Y
a disintegrin and metalloprotease 8|a disintegrin and metalloprotease 28|Y
velocity of circumferential fibre shortening|velocity of circumferential fiber shortening|Y
Incontinence Quality of Life questionnaire|Incontinence Quality of Life Questionnaire|Y
macrophage inflammatory protein 1α|macrophage inflammatory protein 1|Y
olivoponto-cerebellar atrophy|olivopontocerebellar atrophy|Y
cluster of differentiation antigen 19|cluster of differentiation antigen 169|Y
stress-activated protein kinase-1|stress-activated protein kinase-1b|Y
gastro-oesophageal pressure gradient|gastro-esophageal pressure gradient|Y
optico-spinal multiple sclerosis|opticospinal multiple sclerosis|Y
anti-human T-cell lymphotropic virus type-I antibody|anti-human T-cell lymphotropic virus type-1 antibody|Y
anti-human T-cell lymphotropic virus type-I antibody|anti-human T cell lymphotropic virus type-I antibody|Y
pattern reversal visual evoked potentials|pattern reversal visual evoked potential|Y
rostro-ventro-lateral medulla|rostro-ventrolateral medulla|Y
classic anti-neutrophil cytoplasmic antibody|classic antineutrophil cytoplasmic antibody|Y
neural-precursor cell-expressed, developmentally downregulated 5|neural-precursor-cell-expressed, developmentally down-regulated 5|Y
neural-precursor cell-expressed, developmentally downregulated 5|neural-precursor cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally downregulated 5|neural-precursor-cell-expressed, developmentally downregulated 5|Y
neural-precursor cell-expressed, developmentally downregulated 5|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor cell-expressed, developmentally downregulated 5|neural-precursor-cell-expressed developmentally downregulated 5|Y
neural-precursor cell-expressed, developmentally downregulated 5|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural-precursor cell-expressed, developmentally downregulated 5|neural-precursor cell-expressed, developmentally downregulated 1|Y
surface-assisted laser desorption/ionization|surface-assisted laser desorption ionization|Y
surface-assisted laser desorption/ionization|surface-assisted laser desorption/ionisation|Y
adrenocorticotropin hormone|adreno-corticotropin hormone|Y
insulin-like growth factor receptor type 1|insulin-like growth factor receptor type I|Y
alpha-putrescinyl thymine|alpha-putrescinylthymine|Y
anti-bovine serum albumin antibody|antibovine serum albumin antibody|Y
latent transforming growth factor beta-binding protein 1|latent transforming growth factor beta binding protein 1|Y
latent transforming growth factor beta-binding protein 1|latent transforming growth factor beta-binding protein-1|Y
head and neck squamous cell carcinoma|head and neck squamous cell carcinomas|Y
tumor necrosis factor receptor superfamily member 5|tumor necrosis factor receptor superfamily member 8|Y
tumor necrosis factor receptor superfamily member 5|tumor necrosis factor receptor superfamily member 9|Y
toxin coregulated pilus subunit A|toxin co-regulated pilus subunit A|Y
quasi-elastic light scattering|quasielastic light scattering|Y
antioxidized low density lipoprotein|anti-oxidized low density lipoprotein|Y
transjugular intra-hepatic portosystemic shunt|trans-jugular intra-hepatic porto-systemic shunt|Y
transjugular intra-hepatic portosystemic shunt|trans-jugular intra-hepatic portosystemic shunt|Y
transjugular intra-hepatic portosystemic shunt|trans-jugular intrahepatic portosystemic shunt|Y
terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling|terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling|Y
glutamate ionotropic receptor AMPA type subunit 4|glutamate ionotropic receptor AMPA type subunit 3|Y
glutamate ionotropic receptor AMPA type subunit 4|glutamate ionotropic receptor AMPA type subunit 2|Y
inositoltrisphosphate|inositol trisphosphate|Y
ATP binding cassette transporter 1|ATP binding cassette transporter G1|Y
Hb S/beta-thalassemia|Hb S/beta-thalassaemia|Y
human lysosome-associated membrane protein-1|human lysosome-associated membrane protein-2|Y
metaiodobenzylguanidine|metaiodo-benzylguanidine|Y
auditory brainstem evoked response|auditory brain-stem evoked response|Y
esophago-respiratory fistula|oesophago-respiratory fistula|Y
signal-averaged electrocardiograms|signal-averaged electrocardiogram|Y
acid sensing ion channel-1|acid sensing ion channel-1b|Y
vagino-cervical stimulation|vaginocervical stimulation|Y
glucagon-like peptide 1 receptor antagonist|glucagonlike peptide 1 receptor antagonist|Y
corticotropin-releasing hormone receptor|corticotropin-releasing hormone receptor 2|Y
corticotropin-releasing hormone receptor|corticotropin-releasing hormone receptor 1|Y
corticotropin-releasing hormone receptor|corticotropin-releasing-hormone receptor|Y
methanol extraction residue of Bacillus Calmette-Guerin|methanol extraction residue of bacillus Calmette-Guerin|Y
spinocerebellar ataxia type 15|spinocerebellar ataxia type 1|Y
salmon gonadotrophin releasing hormone analog|salmon gonadotrophin-releasing hormone analog|Y
medical anti-shock trouser|medical antishock trouser|Y
trans-abdominal sonography|transabdominal sonography|Y
peroxisome proliferator-activated receptor γ1|peroxisome proliferator-activated receptor γ-1|Y
peroxisome proliferator-activated receptor γ1|peroxisome proliferator-activated receptor γ 1|Y
sub-window factor analysis|subwindow factor analysis|Y
thyrotropin releasing hormone receptor 2|thyrotropin-releasing hormone receptor 2|Y
thyrotropin releasing hormone receptor 2|thyrotropin releasing hormone receptor 1|Y
anti-nuclear antibody negative systemic lupus erythematosus|antinuclear antibody negative systemic lupus erythematosus|Y
peroxisome proliferator-activated receptor beta|peroxisome proliferator-activated receptor-beta|Y
runt-related transcription factor 2 protein|runt-related transcription factor 3 protein|Y
latent transforming growth factor beta binding protein-4|latent transforming growth factor beta binding protein-2|Y
latent transforming growth factor beta binding protein-4|latent transforming growth factor beta binding protein 4|Y
paroxysmal depolarizing shift|paroxysmal depolarizing shifts|Y
vasopressin V1A receptor|vasopressin 1A receptor|Y
alpha melanocyte stimulating hormone receptor|alpha-melanocyte stimulating hormone receptor|Y
TATA-binding protein associated factor-1|TATA-binding protein associated factor-10|Y
TATA-binding protein associated factor-1|TATA-binding protein associated factor-9|Y
TATA-binding protein associated factor-1|TATA-binding protein associated factor-2|Y
TATA-binding protein associated factor-1|TATA-binding protein associated factor-11|Y
TATA-binding protein associated factor-1|TATA-binding protein associated factor-4|Y
TATA-binding protein associated factor-1|TATA-binding protein associated factor-12|Y
TATA-binding protein associated factor-1|TATA-binding protein-associated factor-1|Y
TATA-binding protein associated factor-1|TATA-binding protein associated factor-7|Y
surface-enhanced laser desorption ionisation time of flight mass spectrometry|surface-enhanced laser desorption ionization time of flight mass spectrometry|Y
surface-enhanced laser desorption ionisation time of flight mass spectrometry|surface enhanced laser desorption ionisation time of flight mass spectrometry|Y
technetium 99m diethylene-triaminepenta-acetic acid-galactosyl human serum albumin|technetium 99m diethylene-triaminepentaacetic acid galactosyl human serum albumin|Y
mouse erythro-leukemia cell|mouse erythro-leukaemia cell|Y
antiinterleukin-6 neutralising antibody|anti-interleukin-6 neutralising antibody|Y
disintegrations per minute|disintegration per minute|Y
random amplified polymorphic DNA-polymerase chain reaction|random-amplified polymorphic DNA-polymerase chain reaction|Y
random amplified polymorphic DNA-polymerase chain reaction|randomly amplified polymorphic DNA-polymerase chain reaction|Y
anti-human T cell lymphotrophic virus I antibody|anti-human T cell lymphotrophic virus 1 antibody|Y
anti-human T cell lymphotrophic virus I antibody|anti-human T-cell lymphotrophic virus I antibody|Y
β-amyloid precursor protein-cleaving enzyme-1|β-amyloid precursor protein-cleaving enzyme 1|Y
American Society of Anaesthesiology physical status I|American Society of Anaesthesiology physical status 5|Y
American Society of Anaesthesiology physical status I|American Society of Anaesthesiology physical status 1|Y
American Society of Anaesthesiology physical status I|American Society of Anesthesiology physical status II|Y
American Society of Anaesthesiology physical status I|American Society of Anaesthesiology physical status|Y
American Society of Anaesthesiology physical status I|American Society of Anaesthesiology physical status IV|Y
American Society of Anaesthesiology physical status I|American Society of Anaesthesiology physical status III|Y
mitogen-activated protein kinase kinase kinase|mitogen-activated protein kinase kinase kinase 4|Y
neural-precursor-cell-expressed developmentally down-regulated 5|neural-precursor-cell-expressed, developmentally down-regulated 8|Y
neural-precursor-cell-expressed developmentally down-regulated 5|neural-precursor-cell-expressed, developmentally down-regulated 5|Y
neural-precursor-cell-expressed developmentally down-regulated 5|neural-precursor-cell-expressed developmentally down-regulated 9|Y
neural-precursor-cell-expressed developmentally down-regulated 5|neural-precursor-cell-expressed, developmentally down-regulated 4|Y
neural-precursor-cell-expressed developmentally down-regulated 5|neural-precursor-cell-expressed, developmentally downregulated 5|Y
neural-precursor-cell-expressed developmentally down-regulated 5|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor-cell-expressed developmentally down-regulated 5|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor-cell-expressed developmentally down-regulated 5|neural-precursor-cell-expressed developmentally downregulated 5|Y
neural-precursor-cell-expressed developmentally down-regulated 5|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural-precursor-cell-expressed developmentally down-regulated 5|neural-precursor-cell-expressed developmentally down-regulated 1|Y
desialylated ovine submaxillary mucin|desialylated ovine sub-maxillary mucin|Y
anti-ethinyl-estradiol antibody|anti-ethinylestradiol antibody|Y
para-chloromercuriphenylsulfonate|parachloromercuriphenylsulfonate|Y
anti-toll like receptor 2 monoclonal antibody|anti-toll like receptor-2 monoclonal antibody|Y
anti-toll like receptor 2 monoclonal antibody|anti-toll like receptor 4 monoclonal antibody|Y
trans-radial approach|transradial approach|Y
TBP-associated factor 5|TBP-associated factor 15|Y
matrix-assisted laser desorption/ionization Fourier-transform ion cyclotron resonance mass spectrometry|matrix-assisted laser desorption ionization Fourier transform ion cyclotron resonance mass spectrometry|Y
Toll/interleukin-1 receptor domain-containing adaptor inducing IFN-beta|Toll-interleukin-1 receptor domain-containing adaptor inducing IFN-beta|Y
deoxycylindrospermopsin|deoxy-cylindrospermopsin|Y
myocyte enhancer factor 2|myocyte enhancer factor 2C|Y
myocyte enhancer factor 2|myocyte enhancer factor 2B|Y
2-amino-3-methyl-imidazo[4,5-f]quinoline|2-amino-3-methylimidazo[4,5-f]quinoline|Y
2-amino-3-methyl-imidazo[4,5-f]quinoline|2-amino-3-methylimidazo-[4,5-f]quinoline|Y
cross-polarization magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarization magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross-polarization magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross-polarization magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
krüppel-like factor 5|krüppel-like factor 15|Y
multi-locus sequence analysis|multilocus sequence analysis|Y
solid-phase extraction-gas chromatography-mass spectrometry|solid-phase extraction-gas chromatography/mass spectrometry|Y
hereditary nonpolyposis colorectal cancer syndrome|hereditary non-polyposis colorectal cancer syndrome|Y
surface-assisted laser desorption ionization|surface-assisted laser desorption ionisation|Y
meta-iodo-benzyl-guanidine scan|meta-iodobenzyl-guanidine scan|Y
fan-beam dual x-ray absorptiometry|fanbeam dual x-ray absorptiometry|Y
tumor infiltrating lymphocytes|tumor infiltrating lymphocyte|Y
phosphorylated cAMP-responsive element binding protein|phosphorylated cAMP-response element binding protein|Y
phosphorylated cAMP-responsive element binding protein|phosphorylated cAMP responsive element binding protein|Y
least significant difference post hoc test|least-significant difference post hoc test|Y
Core Assessment Program for Intracerebral Transplantation|Core Assessment Program for Intracerebral Transplantations|Y
interleukin 5 receptor α chain|interleukine 5 receptor α chain|Y
American Orthopedic Foot and Ankle Society Hallux Metatarsophalangeal-Interphalangeal Scale|American Orthopaedic Foot and Ankle Society Hallux Metatarsophalangeal-Interphalangeal Scale|Y
nicotinamide adenine dinucleotide phosphate oxidase 4|nicotinamide adenine dinucleotide phosphate oxidase 1|Y
nicotinamide adenine dinucleotide phosphate oxidase 4|nicotinamide adenine dinucleotide phosphate oxidase|Y
microtubule-associated protein-1 light chain-3B|microtubule-associated protein-1 light chain 3B|Y
microtubule-associated protein-1 light chain-3B|microtubule-associated protein 1 light chain-3B|Y
calcium/calmodulin-dependent protein kinase kinase beta|calcium-calmodulin-dependent protein kinase kinase beta|Y
2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane|2-beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motifs-8|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motif-14|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motifs-15|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-17|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
phosphorylated extracellular signal regulated kinase 1|phosphorylated extracellular signal regulated kinase|Y
phosphorylated extracellular signal regulated kinase 1|phosphorylated extracellular signal regulated kinase 2|Y
hypogammaglobulinemia|hypo-gammaglobulinemia|Y
anti-mucin-1 antibody|anti-mucin1 antibody|Y
chicken ovalbumin upstream promoter transcription factor|chicken ovalbumin upstream promoter transcription factors|Y
pyelonephritis-associated pilus protein G|pyelonephritis-associated pilus protein D|Y
pyelonephritis-associated pilus protein G|pyelonephritis-associated pilus protein B|Y
stir bar sorptive extraction-thermal desorption-gas chromatography/mass spectrometry|stir bar sorptive extraction-thermal desorption-gas chromatography-mass spectrometry|Y
Calcifying epithelial odontogenic tumor|Calcifying epithelial odontogenic tumour|Y
p-aminohippuric acid|p-amino hippuric acid|Y
microtubule-associated protein-1 light chain 3B|microtubule-associated protein 1 light chain 3B|Y
insulin-like growth factor II mRNA binding protein-3|insulin-like growth factor II mRNA-binding protein-3|Y
insulin-like growth factor II mRNA binding protein-3|insulin-like growth factor II mRNA binding protein 3|Y
insulin-like growth factor II mRNA binding protein-3|insulin-like growth factor-II mRNA binding protein-3|Y
α-naphthylacetate esterase|α-naphthyl acetate esterase|Y
post-weaning colibacillosis|postweaning colibacillosis|Y
Na-K-2Cl cotransporter-1|Na-K-2Cl co-transporter-1|Y
prostaglandin E2 receptor|prostaglandin E receptor|Y
Arbeitsgemeinschaft fur Osteosynthesefragen system|Arbeitsgemeinschaft für Osteosynthesefragen system|Y
human T cell leukaemia virus type 1-infected|human T cell leukemia virus type 1-infected|Y
glycophosphatidyl-inositol anchored protein|glycophosphatidylinositol anchored protein|Y
cationic anti-microbial protein 57|cationic antimicrobial protein 57|Y
neuro-developmental treatment|neurodevelopmental treatment|Y
pre-registration house officer|preregistration house officer|Y
germinal center B cell-like diffuse large B-cell lymphoma|germinal center B-cell-like diffuse large B-cell lymphoma|Y
germinal center B cell-like diffuse large B-cell lymphoma|germinal centre B cell-like diffuse large B-cell lymphoma|Y
erythrocyte membrane|erythrocyte membranes|Y
filtered back-projection|filtered backprojection|Y
swimming-induced pulmonary edema|swimming-induced pulmonary oedema|Y
human T-cell leucemia|human T-cell leucaemia|Y
malonyl CoA:acyl carrier protein transacylase|malonyl-CoA:acyl carrier protein transacylase|Y
post-menopausal estrogen-progestin intervention|post-menopausal estrogen progestin intervention|Y
post-menopausal estrogen-progestin intervention|post-menopausal oestrogen-progestin intervention|Y
lamprey gonadotropin-releasing hormone I|lamprey gonadotropin-releasing hormone-I|Y
interleukin 1 receptor-associated kinase 4|interleukin-1 receptor-associated kinase 4|Y
interleukin 1 receptor-associated kinase 4|interleukin 1 receptor associated kinase 4|Y
University of California, Irvine|University of California Irvine|Y
West Los Angeles Veteran's Administration Medical Center|West Los Angeles Veterans Administration Medical Center|Y
human papillomavirus type 1|human papillomavirus type 31|Y
human papillomavirus type 1|human papillomavirus type 11|Y
Biopharmaceutics Classification System Class 2|Biopharmaceutics Classification System Class 4|Y
Biopharmaceutics Classification System Class 2|Biopharmaceutics Classification System Class 1|Y
particle-induced X-ray emission analysis|particle induced X-ray emission analysis|Y
interleukine 13 receptor α2 subunit|interleukine 13 receptor α 2 subunit|Y
interleukine 13 receptor α2 subunit|interleukin 13 receptor α2 subunit|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motifs-8|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motif-14|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motif-8|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
intra-ocular pressure|intraocular pressure|Y
Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein|Fas-associated death domain-like interleukin-1beta converting enzyme inhibitory protein|Y
1,3-bis(2-chloroethyl)-1-nitrosourea|1,3-bis (2-chloroethyl)-1-nitrosourea|Y
fluoro-deoxy-glucose positron-emission tomography|fluoro-deoxy-glucose positron emission tomography|Y
primary intra-cerebral hemorrhage|primary intra-cerebral haemorrhage|Y
A disintegrin and metalloprotease-7|A disintegrin and metalloprotease-17|Y
subretinal neovascularisation|sub-retinal neovascularisation|Y
thyrotropic stimulating hormone|thyrotrophic stimulating hormone|Y
ETS2 repressor factor|ETS-2 repressor factor|Y
phosphorylated cAMP-response element binding protein|phosphorylated cAMP-response element-binding protein|Y
phosphorylated cAMP-response element binding protein|phosphorylated cAMP response element binding protein|Y
Epstein-Barr virus cell surface antigen|Epstein-Barr virus cell surface antigen 5|Y
Epstein-Barr virus cell surface antigen|Epstein-Barr virus cell surface antigen 4|Y
vero toxin-producing Escherichia coli|verotoxin-producing Escherichia coli|Y
Minneapolis Veteran's Affairs Medical Center|Minneapolis Veterans' Affairs Medical Center|Y
TSH binding inhibitory immunoglobulin|TSH binding inhibitor immunoglobulin|Y
miniature inverted repeat transposable elements|miniature inverted repeat transposable element|Y
multidetector computed tomography coronary angiography|multi-detector computed tomography coronary angiography|Y
sperm associated antigen 6|sperm associated antigen 16|Y
CC chemokine ligand 20|CC chemokine ligand 2|Y
prepacemaker nucleus|pre-pacemaker nucleus|Y
recombinant human granulocyte-colony stimulating factor|Recombinant human granulocyte-colony stimulating factor|Y
neonatal-onset multi-system inflammatory disease|neonatal onset multi-system inflammatory disease|Y
peroxisome proliferator activated receptor gamma coactivator-1|peroxisome proliferator-activated receptor gamma coactivator-1|Y
peroxisome proliferator activated receptor gamma coactivator-1|peroxisome proliferator activated receptor gamma co-activator 1|Y
peroxisome proliferator activated receptor gamma coactivator-1|peroxisome proliferator activated receptor gamma coactivator 1|Y
interferon alpha-2b-induced|interferon alpha2b-induced|Y
hepato-jugular reflux|hepatojugular reflux|Y
American Society of Anesthesiologists Grade II|American Society of Anaesthesiologists Grade II|Y
American Society of Anesthesiologists Grade II|American Society of Anesthesiologists Grade I|Y
American Society of Anesthesiologists Grade II|American Society of Anesthesiologists grade II|Y
nuclear factor erythroid 2 p45-related factor 2|nuclear factor erythroid 2 p45-related factor-2|Y
nuclear factor erythroid 2 p45-related factor 2|nuclear factor-erythroid 2 p45-related factor 2|Y
interferon-inducible T-cell α chemoattractant|interferon-inducible T cell α chemoattractant|Y
polyethyleneglycol 400|polyethyleneglycol 4000|Y
nonossifying fibroma|non-ossifying fibroma|Y
trans-oesophageal echoprobe|trans-esophageal echoprobe|Y
trans-oesophageal echoprobe|trans-oesophageal echo-probe|Y
trans-oesophageal echoprobe|trans-oesophageal echo probe|Y
A disintegrin and metalloproteinase-19|A disintegrin and metalloproteinase-9|Y
multidetector row computed tomography scan|multidetector-row computed tomography scan|Y
feline panleucopenia|feline pan-leucopenia|Y
GDP/GTP exchange protein|GDP/GTP exchange proteins|Y
microtubule associated protein 1 light chain 3-II|microtubule-associated protein 1 light chain 3-II|Y
insulinlike growth factor-I deficiency|insulin-like growth factor-I deficiency|Y
C-type lectin-like domain|C-type lectin-like domains|Y
glycosyl phosphatidylinositol-anchored|glycosyl phosphatidyl inositol-anchored|Y
glycosyl phosphatidylinositol-anchored|glycosylphosphatidylinositol-anchored|Y
tumor necrosis factor receptor-associated factor 1|tumor necrosis factor receptor associated factor 1|Y
tumor necrosis factor receptor-associated factor 1|tumor necrosis factor receptor-associated factor 5|Y
tumor necrosis factor receptor-associated factor 1|tumour necrosis factor receptor-associated factor 1|Y
tumor necrosis factor receptor-associated factor 1|tumor necrosis factor receptor-associated factor 6|Y
ultra performance liquid chromatography/quadrupole time-of-flight mass spectrometry|ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry|Y
ethylenediaminetetra(methylenephosphonic acid)|ethylenediaminetetra(methylene phosphonic acid)|Y
Albany Veterans' Administration Medical Center|Albany Veteran's Administration Medical Center|Y
neural-precursor-cell-expressed, developmentally down-regulated 8|neural-precursor-cell-expressed, developmentally down-regulated 5|Y
neural-precursor-cell-expressed, developmentally down-regulated 8|neural-precursor-cell-expressed developmentally down-regulated 9|Y
neural-precursor-cell-expressed, developmentally down-regulated 8|neural-precursor-cell-expressed, developmentally down-regulated 4|Y
neural-precursor-cell-expressed, developmentally down-regulated 8|neural-precursor-cell-expressed, developmentally downregulated 5|Y
neural-precursor-cell-expressed, developmentally down-regulated 8|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor-cell-expressed, developmentally down-regulated 8|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor-cell-expressed, developmentally down-regulated 8|neural-precursor-cell-expressed developmentally down-regulated 1|Y
neural-precursor-cell-expressed, developmentally down-regulated 8|neural-precursor-cell-expressed, developmentally downregulated 2|Y
C-C chemokine receptor 3|CC chemokine receptor 3|Y
transforming growth factor-beta receptor type III|transforming growth factor-beta receptor type I|Y
transforming growth factor-beta receptor type III|transforming growth factor beta receptor type III|Y
IL-12 receptor β 1 chain|IL-12 receptor β1 chain|Y
Bos taurus autosome 15|Bos taurus autosome 1|Y
yttrium-stabilized tetragonal zirconia polycrystal|yttrium-stabilised tetragonal zirconia polycrystal|Y
ecto-cyclic AMP-independent protein kinase|ecto-cyclic AMP independent protein kinase|Y
ventriculocisternal perfusion|ventriculo-cisternal perfusion|Y
flash visual evoked potential|flash visual evoked potentials|Y
insulin-like growth factor II messenger RNA-binding protein-2|insulin-like growth factor II messenger RNA-binding protein-3|Y
insulin-like growth factor II messenger RNA-binding protein-2|insulin-like growth factor II messenger RNA-binding protein|Y
spinocerebellar ataxia type 7|spinocerebellar ataxia type 17|Y
neuron-specific nuclear protein-positive|neuron-specific nuclear protein positive|Y
French-American-British Cooperative group|French-American-British Co-operative group|Y
magic angle spinning-nuclear magnetic resonance spectroscopy|magic angle spinning nuclear magnetic resonance spectroscopy|Y
nucleus ventro-oralis posterior|nucleus ventrooralis posterior|Y
interleukine 2 receptor α subunit|interleukin 2 receptor α subunit|Y
TGFβ-activated kinase 1 binding protein 1|TGFβ-activated kinase 1-binding protein 1|Y
anti-interleukin-8 receptor monoclonal antibody|anti-interleukin-4 receptor monoclonal antibody|Y
rabbit antirat thymocyte serum|rabbit anti-rat thymocyte serum|Y
β-ketoacyl acyl carrier protein synthase I|β-ketoacyl acyl carrier protein synthase III|Y
β-ketoacyl acyl carrier protein synthase I|β-ketoacyl-acyl carrier protein synthase I|Y
leukemia associated inhibitor|leukaemia associated inhibitor|Y
atrioventricular nodal re-entry|atrioventricular nodal reentry|Y
cellular Fas-associated death domain-like interleukin-1-beta converting enzyme inhibitory protein|cellular Fas-associated death domain-like interleukin-1beta converting enzyme-inhibitory protein|Y
cellular Fas-associated death domain-like interleukin-1-beta converting enzyme inhibitory protein|cellular Fas-associated death domain-like interleukin-1-beta converting enzyme-inhibitory protein|Y
cough specific quality of life questionnaire|cough-specific quality of life questionnaire|Y
cross-reactive idiotype|cross-reactive idiotypes|Y
photo activated localisation microscopy|photoactivated localisation microscopy|Y
lumbosacral radicular syndrome|lumbo-sacral radicular syndrome|Y
catheter-associated bloodstream infection|catheter associated bloodstream infection|Y
N-formylmethionylleucylphenylalanine|N-formylmethionyl-leucylphenylalanine|Y
nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase|nicotinamide-adenine dinucleotide phosphate-cytochrome P450 reductase|Y
degrees of substitution|degree of substitution|Y
oligomycin-sensitivity conferring protein|oligomycin-sensitivity-conferring protein|Y
beta-ketoacyl-acyl carrier protein synthase II|beta-ketoacyl-acyl carrier protein synthase I|Y
beta-ketoacyl-acyl carrier protein synthase II|beta-ketoacyl acyl carrier protein synthase II|Y
TIR domain containing adaptor-inducing IFN-beta|TIR domain containing adaptor inducing IFN-beta|Y
TIR domain containing adaptor-inducing IFN-beta|TIR domain-containing adaptor-inducing IFN-beta|Y
antiinterleukin 18 antibody|anti-interleukin 18 antibody|Y
maximum inspiratory flow rate at 50% of vital capacity|maximum inspiratory flow rate at 75% of vital capacity|Y
maximum inspiratory flow rate at 50% of vital capacity|maximum inspiratory flow rate at 25% of vital capacity|Y
electromechanical energy|electro-mechanical energy|Y
desacetylvinblastine|desacety-lvinblastine|Y
Stueve-Wiedemann syndrome|Stuve-Wiedemann syndrome|Y
death inducing signalling complex|death inducing signaling complex|Y
inductively coupled plasma source mass spectrometry|inductively coupled plasma-source mass spectrometry|Y
recombinant human interleukin 1|recombinant human interleukin 1β|Y
recombinant human interleukin 1|recombinant human interleukin 18|Y
recombinant human interleukin 1|recombinant human interleukin 10|Y
recombinant human interleukin 1|recombinant human interleukin 15|Y
thrombolysis in myocardial infarction grade 3|thrombolysis in myocardial infarction grade 0|Y
thrombolysis in myocardial infarction grade 3|thrombolysis in myocardial infarction grade 2|Y
mitogen-activated protein kinase kinase-3|mitogen-activated protein kinase kinase|Y
mitogen-activated protein kinase kinase-3|mitogen-activated protein kinase kinase 3|Y
mitogen-activated protein kinase kinase-3|mitogen-activated protein kinase kinase-2|Y
mitogen-activated protein kinase kinase-3|mitogen-activated protein kinase kinase-7|Y
American Society of Anaesthesiology status III|American Society of Anaesthesiology status I|Y
augmented correlation-consistent polarized valence double ζ basis set|augmented correlation-consistent polarized valence double-ζ basis set|Y
peroxisome-proliferator-activated receptor γ coactivator 1α|peroxisome-proliferator-activated receptor-γ coactivator 1α|Y
methyl-cholanthrene-induced sarcoma|methylcholanthrene-induced sarcoma|Y
toxin coregulated pilus|toxin co-regulated pilus|Y
chromodomain helicase DNA-binding protein 7|chromodomain helicase DNA-binding protein-7|Y
spinocerebellar ataxia 13|spinocerebellar ataxia 1|Y
branched chain alpha-ketoacid dehydrogenase complex|branched chain alpha-keto acid dehydrogenase complex|Y
type-2 corticotropin-releasing hormone receptor|type-2 corticotropin-releasing-hormone receptor|Y
type-2 corticotropin-releasing hormone receptor|type 2 corticotropin-releasing hormone receptor|Y
American Society of Anesthesiology class I|American Society of Anaesthesiology class II|Y
neural precursor cell-expressed developmentally down-regulated 1|neural precursor cell-expressed developmentally down-regulated 9|Y
neural precursor cell-expressed developmentally down-regulated 1|neural precursor cell-expressed developmentally downregulated 1|Y
neural precursor cell-expressed developmentally down-regulated 1|neural precursor cell expressed, developmentally down-regulated 1|Y
neural precursor cell-expressed developmentally down-regulated 1|neural precursor cell-expressed developmentally down-regulated 2|Y
neural precursor cell-expressed developmentally down-regulated 1|neural precursor cell-expressed developmentally down-regulated 4|Y
neural precursor cell-expressed developmentally down-regulated 1|neural precursor cell-expressed developmentally downregulated 9|Y
neural precursor cell-expressed developmentally down-regulated 1|neural precursor cell-expressed, developmentally downregulated 1|Y
neural precursor cell-expressed developmentally down-regulated 1|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell-expressed developmentally down-regulated 1|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell-expressed developmentally down-regulated 1|neural precursor cell-expressed, developmentally down-regulated 2|Y
messenger ribonucleoprotein particles|messenger ribonucleoprotein particle|Y
trauma focused cognitive behavioral therapy|trauma focused cognitive-behavioral therapy|Y
antepartum haemorrhage|antepartum hemorrhage|Y
Graves ophthalmopathy|Grave's ophthalmopathy|Y
ribosomal protein L5|ribosomal protein L25|Y
fluorine 18 fluorodeoxyglucose|fluorine 18 fluoro-deoxyglucose|Y
gas chromatography-negative-ion chemical ionization-mass spectrometry|gas chromatography-negative-ion chemical ionisation-mass spectrometry|Y
interleukin 5 receptor|interleukin 15 receptor|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon-β|toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon β|Y
six transmembrane epithelial antigen of the prostate 1|six transmembrane epithelial antigen of the prostate 4|Y
Manual Ability Classification System level IV|Manual Ability Classification System level II|Y
phorbolester-mediated|phorbol-ester-mediated|Y
capillary electrophoresis-inductively coupled plasma-mass spectrometry|capillary electrophoresis-inductively coupled plasma mass spectrometry|Y
5HT1A receptor agonist|5-HT1A receptor agonist|Y
velo-pharyngeal insufficiency|velopharyngeal insufficiency|Y
hereditary motor sensory neuropathy|hereditary motor sensor neuropathy|Y
oestrogen-related receptor α|estrogen-related receptor α|Y
ischemic pre-conditioning|ischemic preconditioning|Y
gamma-aminobutyric acid/benzodiazepine receptor complex|gamma-aminobutyric acidA/benzodiazepine receptor complex|Y
uncoordinated protein 86|uncoordinated protein 6|Y
γ-aminobutyric acid type A-receptor-associated protein|γ-aminobutyric-acid type A-receptor-associated protein|Y
antihepatocyte growth factor|anti-hepatocyte growth factor|Y
γglutamylcysteine synthetase|γglutamyl cysteine synthetase|Y
cluster designation 28|cluster designation 8|Y
American Society of Anesthesiologists Class III|American Society of Anesthesiologists Class II|Y
glycosyl-phosphatidylinositol biosynthesis|glycosylphosphatidylinositol biosynthesis|Y
human transforming growth factor-beta|human transforming growth factor-beta2|Y
C-C chemokine receptor 2|C-C chemokine receptor 2b|Y
C-C chemokine receptor 2|CC chemokine receptor 2|Y
integrated electromyography|integrated electro-myography|Y
Src homology region 2 domain-containing phosphatase 1|Src homology region 2 domain-containing phosphatase 2|Y
Src homology region 2 domain-containing phosphatase 1|Src homology region 2 domain-containing phosphatase|Y
trans-oesophageal echocardiography|trans-esophageal echocardiography|Y
fructo-oligosaccharides|fructo-oligosaccharide|Y
spermatocyte/spermatid-specific thioredoxin|spermatocyte/spermatid-specific thioredoxin-3|Y
spermatocyte/spermatid-specific thioredoxin|spermatocyte/spermatid-specific thioredoxin-1|Y
spermatocyte/spermatid-specific thioredoxin|spermatocyte/spermatid-specific thioredoxin-2|Y
micro-autoradiography|microautoradiography|Y
Pseudonitzschia pungens forma multiseries|Pseudo-nitzschia pungens forma multiseries|Y
mitochondrial neurogastrointestinal encephalo-myopathy|mitochondrial neuro-gastrointestinal encephalomyopathy|Y
human adenovirus type 37|human adenovirus type 7|Y
thyrotrophin releasing factor|thyrotropin releasing factor|Y
cross-reacting material|crossreacting material|Y
transient receptor potential vanilloid 2|transient receptor potential vanilloid 4|Y
transient receptor potential vanilloid 2|transient receptor potential vanilloid 3|Y
leukaemia associated antigen|leukemia associated antigen|Y
anti-a disintegrin-like and metalloproteinase with thrombospondin type1 motif 13 autoantibody|anti-a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13 autoantibody|Y
mitogen-activated protein kinase kinase|mitogen-activated protein kinase kinase 3|Y
mitogen-activated protein kinase kinase|mitogen-activated protein kinase kinase 2|Y
mitogen-activated protein kinase kinase|mitogen-activated protein kinase kinase 7|Y
mitogen-activated protein kinase kinase|mitogen-activated protein kinase kinase 6|Y
mitogen-activated protein kinase kinase|mitogen-activated protein kinase kinase-2|Y
mitogen-activated protein kinase kinase|mitogen-activated protein kinase kinase-7|Y
mitogen-activated protein kinase kinase|mitogen-activated protein kinase kinase 1|Y
γ-aminobutyric acid type A receptor|γ-amino butyric acid type A receptor|Y
intrauterine pressure|intra-uterine pressure|Y
peptidyl glycine alpha-amidating monooxygenase|peptidyl-glycine alpha-amidating monooxygenase|Y
scanning transmission electron microscope|scanning transmission electron microscopy|Y
fetopelvic disproportion|feto-pelvic disproportion|Y
poly(ADP)-ribose synthetase|poly(ADP)ribose synthetase|Y
poly(ADP)-ribose synthetase|poly (ADP)-ribose synthetase|Y
slowly adapting receptor|slowly adapting receptors|Y
adreno-corticotrophin hormone|adreno-corticotropin hormone|Y
American Society of Anaesthesiology physical status 5|American Society of Anaesthesiology physical status 1|Y
American Society of Anaesthesiology physical status 5|American Society of Anaesthesiology physical status|Y
lightweight aggregate|light-weight aggregate|Y
GTP-binding protein β subunit|GTP-binding protein βγ subunit|Y
endothelin-converting enzyme|endothelin-converting enzymes|Y
pre-B-cell leukemia transcription factor 1|pre-B-cell leukemia transcription factor-1|Y
spermatocyte/spermatid-specific thioredoxin-3|spermatocyte/spermatid-specific thioredoxin-1|Y
spermatocyte/spermatid-specific thioredoxin-3|spermatocyte/spermatid-specific thioredoxin-2|Y
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2|aminoacyl tRNA synthetase complex-interacting multifunctional protein-2|Y
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2|aminoacyl-tRNA synthetase complex-interacting multifunctional protein 2|Y
trans-esophageal echo|trans-oesophageal echo|Y
Smoothed Pseudo Wigner Ville Distribution|Smoothed Pseudo Wigner-Ville Distribution|Y
beta-site amyloid precursor protein-cleaving enzyme 1|beta-site amyloid precursor protein cleaving enzyme 1|Y
beta-site amyloid precursor protein-cleaving enzyme 1|beta-site amyloid precursor protein-cleaving enzyme 2|Y
beta-site amyloid precursor protein-cleaving enzyme 1|beta-site amyloid precursor protein-cleaving enzyme-1|Y
Pediatric Risk of Mortality III score|Paediatric Risk of Mortality III score|Y
matched unrelated donors|matched unrelated donor|Y
phosphorylated cyclic AMP response element-binding protein|phosphorylated cyclic AMP response element binding protein|Y
high-dose arabinosylcytosine|high-dose arabinosyl cytosine|Y
healthcare-associated methicillin-resistant Staphylococcus aureus|health-care-associated methicillin-resistant Staphylococcus aureus|Y
healthcare-associated methicillin-resistant Staphylococcus aureus|health care-associated methicillin-resistant Staphylococcus aureus|Y
Musca domestica glutathione S-transferase-4|Musca domestica glutathione S-transferase-2|Y
Musca domestica glutathione S-transferase-4|Musca domestica glutathione S-transferase|Y
tumor-specific antigen|tumour-specific antigen|Y
basic metabolic panel|basic metabolic panels|Y
sub-sarcolemmal mitochondrion|subsarcolemmal mitochondrion|Y
Palo Alto Veterans' Affairs Medical Center|Palo Alto Veterans Affairs Medical Center|Y
self-amplified spontaneous emission free-electron laser|self-amplified spontaneous emission free electron laser|Y
electrocerebral silence|electro-cerebral silence|Y
poly(DL-lactide-co-glycolide)|poly(L-lactide-co-glycolide)|Y
vibroacoustic stimulation|vibro-acoustic stimulation|Y
poly-hydroxyethyl methacrylate|poly-hydroxyethylmethacrylate|Y
cerebrospinal fluid angiotensin converting enzyme|cerebrospinal fluid angiotensin-converting enzyme|Y
17 alpha-hydroxyprogesterone|17alpha-hydroxyprogesterone|Y
multidrug-resistance-associated protein 1|multidrug-resistance associated protein 1|Y
calcium- and diacylglycerol-regulated guanine nucleotide exchange factor Ib|calcium- and diacylglycerol-regulated guanine nucleotide exchange factor|Y
calcium- and diacylglycerol-regulated guanine nucleotide exchange factor Ib|calcium- and diacylglycerol-regulated guanine nucleotide exchange factor II|Y
calcium- and diacylglycerol-regulated guanine nucleotide exchange factor Ib|calcium- and diacylglycerol-regulated guanine nucleotide exchange factor III|Y
calcium- and diacylglycerol-regulated guanine nucleotide exchange factor Ib|calcium- and diacylglycerol-regulated guanine nucleotide exchange factor Ia|Y
thyroxin binding prealbumin|thyroxin binding pre-albumin|Y
incident-photon-to-current conversion efficiency|incident photon-to-current conversion efficiency|Y
ras-related GTP-binding protein 5b|ras-related GTP-binding protein 5|Y
a disintegrin and metalloproteinase with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motifs-15|Y
a disintegrin and metalloproteinase with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motifs-8|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
fan-beam dual-energy x-ray absorptiometry|fanbeam dual-energy x-ray absorptiometry|Y
fan-beam dual-energy x-ray absorptiometry|fan beam dual-energy x-ray absorptiometry|Y
polarization-division-multiplexing quadrature phase shift keying|polarisation-division-multiplexing quadrature phase shift keying|Y
cGMP-dependent protein kinase Ibeta|cGMP-dependent protein kinase I beta|Y
alpha2 adrenergic receptor|alpha2C adrenergic receptor|Y
branched-chain α-keto acid dehydrogenase complex|branched chain α-keto acid dehydrogenase complex|Y
branched-chain α-keto acid dehydrogenase complex|branched-chain α-ketoacid dehydrogenase complex|Y
inwardly rectifying K+ channel|inwardly rectifying K+ channels|Y
contour clamped homogeneous electric field electrophoresis|contour-clamped homogeneous electric field electrophoresis|Y
a disintegrin and metalloproteinase with thrombospondin motif-14|a disintegrin and metalloproteinase with thrombospondin motif-4|Y
a disintegrin and metalloproteinase with thrombospondin motif-14|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloproteinase with thrombospondin motif-14|a disintegrin and metalloproteinase with thrombospondin motifs-15|Y
a disintegrin and metalloproteinase with thrombospondin motif-14|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloproteinase with thrombospondin motif-14|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-14|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motif-14|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motif-14|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motif-14|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motif-14|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-14|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motif-14|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motif-14|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-14|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motif-14|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motif-14|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
Toll-interleukin1 receptor domain-containing adapter inducing interferon beta|toll-interleukin1 receptor domain-containing adapter inducing interferon beta|Y
Toll-interleukin1 receptor domain-containing adapter inducing interferon beta|Toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
Toll-interleukin1 receptor domain-containing adapter inducing interferon beta|Toll-interleukin-1 receptor domain-containing adapter-inducing interferon beta|Y
Toll-interleukin1 receptor domain-containing adapter inducing interferon beta|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
sporulation protein IIE|sporulation protein IIIE|Y
A disintegrin and metalloproteinase 17|A disintegrin and metalloproteinase 7|Y
transforming growth factors-beta|transforming growth factor-beta|Y
volume-weighted computed tomographic dose index|volume weighted computed tomographic dose index|Y
never-in-mitosis Aspergillus-related kinase 4|never-in-mitosis Aspergillus-related kinase 7|Y
never-in-mitosis Aspergillus-related kinase 4|never-in-mitosis Aspergillus-related kinase|Y
solid-phase extraction-high performance liquid chromatography/tandem mass spectrometry|solid-phase extraction-high-performance liquid chromatography/tandem mass spectrometry|Y
adenosine-triphosphate-binding cassette subfamily B member 1|adenosine triphosphate-binding cassette sub-family B member 1|Y
cross-polarization magic-angle spinning nuclear magnetic resonance spectroscopy|cross-polarization magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarization magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarization magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
x-ray absorption near-edge structure spectroscopy|x-ray absorption near edge structure spectroscopy|Y
x-ray absorption near-edge structure spectroscopy|X-ray absorption near-edge structure spectroscopy|Y
Nomega-nitro-L-arginine|N omega-nitro-L-arginine|Y
random amplified polymorphic DNA method|randomly amplified polymorphic DNA method|Y
17beta-hydroxysteroid dehydrogenase|17 beta-hydroxysteroid dehydrogenase|Y
short arm of chromosome 11|short arm of chromosome 1|Y
American Society of Anaesthesiologists Grade 3|American Society of Anaesthesiologists Grade 4|Y
American Society of Anaesthesiologists Grade 3|American Society of Anaesthesiologists grade 3|Y
American Society of Anaesthesiologists Grade 3|American Society of Anesthesiologists Grade 3|Y
American Society of Anaesthesiologists Grade 3|American Society of Anaesthesiologists Grade 5|Y
G-protein-coupled receptor kinase 2 mediated|G protein-coupled receptor kinase 2 mediated|Y
G-protein-coupled receptor kinase 2 mediated|G-protein-coupled receptor kinase 2-mediated|Y
elongation factor 1α|elongation factor 1 α|Y
ras-related GTP-binding protein 27C|ras-related GTP-binding protein 27|Y
tumor colony-forming units|tumor colony-forming unit|Y
nucleoside diphosphate-linked moiety X motif 9|nucleoside diphosphate-linked moiety X motif 5|Y
nucleoside diphosphate-linked moiety X motif 9|nucleoside diphosphate linked moiety X motif 9|Y
human antimouse antibody|human anti-mouse antibody|Y
Plasmodium falciparum mitogen-activated kinase-1|Plasmodium falciparum mitogen-activated kinase-2|Y
methyl cytosine-phosphate-guanosine binding domain 2|methyl cytosine-phosphate-guanosine binding domain|Y
Word Intelligibility by Picture Identification test|Word Intelligibility by Picture Identification Test|Y
mammalian gonadotrophin-releasing hormone|mammalian gonadotropin-releasing hormone|Y
cancer-associated hemolytic uremic syndrome|cancer-associated hemolytic-uremic syndrome|Y
src homology 2 domain-containing protein-tyrosine phosphatase substrate 1|src homology 2 domain-containing protein tyrosine phosphatase substrate 1|Y
non-pigmented epithelium|nonpigmented epithelium|Y
methionine enkephalin-like immunoreactivity|methionine-enkephalin-like immunoreactivity|Y
medio-basal hypothalamic|mediobasal hypothalamic|Y
nonstructural protein 4B|non-structural protein 4B|Y
endoscopic retrograde cholangiopancreatography-related|endoscopic retrograde cholangio-pancreatography-related|Y
non-homologous endjoining repair|non-homologous end-joining repair|Y
non-homologous endjoining repair|non-homologous end joining repair|Y
electroimmunotransfer blot|electro-immunotransfer blot|Y
electroimmunotransfer blot|electroimmuno-transfer blot|Y
mitogen-activated protein kinase activated protein kinase-3|mitogen-activated protein kinase activated protein kinase-1|Y
mitogen-activated protein kinase activated protein kinase-3|mitogen-activated protein kinase activated protein kinase|Y
protein tyrosine phosphatase 1|protein tyrosine phosphatase 1B|Y
myocardial perfusion single photon emission computerized tomography|myocardial perfusion single-photon emission computerized tomography|Y
nanoelectrospray ionisation|nano-electrospray ionisation|Y
ribosomal protein L17|ribosomal protein L7|Y
tumor-infiltrating macrophage|tumour-infiltrating macrophage|Y
augmented correlation-consistent polarised valence double-ζ basis set|augmented correlation-consistent polarized valence double-ζ basis set|Y
American Society of Anaesthesiology status 3|American Society of Anaesthesiology status I|Y
American Society of Anaesthesiology status 3|American Society of Anaesthesiology status|Y
American Society of Anaesthesiology status 3|American Society of Anaesthesiology status V|Y
dehydroepiandrosterone|dehydroepi-androsterone|Y
dehydroepiandrosterone|dehydro-epiandrosterone|Y
phosphorylated p70S6 kinase|phosphorylated p70 S6 kinase|Y
phosphorylated p70S6 kinase|phosphorylated p70-S6 kinase|Y
photo-electron diffraction|photoelectron diffraction|Y
1-ethyl-3-(dimethylaminopropyl)-carbodiimide|1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide|Y
electrospray ionization quadrupole-time of flight mass spectrometry|electrospray ionisation quadrupole-time of flight mass spectrometry|Y
postatrophic hyperplasia|post-atrophic hyperplasia|Y
Ehlers Danlos syndrome type I|Ehlers Danlos syndrome type II|Y
corticotropin-releasing-factor receptor|corticotrophin-releasing-factor receptor|Y
postanesthesia recovery unit|post-anesthesia recovery unit|Y
mannose binding lectin associated serine protease|mannose binding lectin-associated serine protease|Y
antineutrophil cytoplasmic antibody|anti neutrophil cytoplasmic antibody|Y
colony-forming units-granulocyte macrophage|colony-forming units-granulocyte-macrophage|Y
colony-forming units-granulocyte macrophage|colony-forming units-granulocyte/macrophage|Y
glycosyl phosphatidyl inositol-linked protein|glycosylphosphatidyl inositol-linked protein|Y
mitogen-activated protein kinase kinase 3|mitogen-activated protein kinase kinase 2|Y
mitogen-activated protein kinase kinase 3|mitogen-activated protein kinase kinase 7|Y
mitogen-activated protein kinase kinase 3|mitogen-activated protein kinase kinase 6|Y
mitogen-activated protein kinase kinase 3|mitogen-activated protein kinase kinase 1|Y
International Neuroblastoma Staging System stage II|International Neuroblastoma Staging System stage IV|Y
beta-amyloid precursor protein cleaving enzyme-1|beta-amyloid precursor protein cleaving enzyme|Y
beta-amyloid precursor protein cleaving enzyme-1|beta-amyloid precursor protein cleaving enzyme 1|Y
beta-amyloid precursor protein cleaving enzyme-1|beta amyloid precursor protein cleaving enzyme-1|Y
beta-amyloid precursor protein cleaving enzyme-1|beta-amyloid precursor protein cleaving enzyme-2|Y
toll-interleukin-1 receptor domain-containing adaptor inducing IFN-beta|Toll-interleukin-1 receptor domain-containing adaptor inducing IFN-beta|Y
trans-urethral microwave thermotherapy|transurethral microwave thermotherapy|Y
trans-urethral microwave thermotherapy|trans-urethral microwave thermo-therapy|Y
A disintegrin and metalloprotease-28|A disintegrin and metalloprotease-8|Y
formylpeptide receptor-like-1|formyl-peptide receptor-like-1|Y
β-site amyloid precursor protein-cleaving enzyme-2|β-site amyloid precursor protein-cleaving enzyme|Y
ribosomal protein L23|ribosomal protein L23A|Y
NMDA receptor antagonist DL-2-amino-5-phosphonovalerate|NMDA receptor antagonist D-2-amino-5-phosphonovalerate|Y
para-testicular rhabdomyosarcoma|paratesticular rhabdomyosarcoma|Y
cross-linked fibrin degradation product|crosslinked fibrin degradation product|Y
alpha-2-HS glycoprotein|alpha2-HS glycoprotein|Y
chicken luteinizing hormone-releasing hormone I|chicken luteinising hormone-releasing hormone I|Y
chicken luteinizing hormone-releasing hormone I|chicken luteinizing hormone releasing hormone I|Y
leucine zipper and sterile-alpha motif protein kinase 1|leucine zipper and sterile-alpha motif protein kinase|Y
anti-immunoglobulin antibody|antiimmunoglobulin antibody|Y
Atlanta Veterans' Administration Medical Center|Atlanta Veterans Administration Medical Center|Y
5-(N-ethyl-N-isopropyl)-amiloride|5-(N-ethyl-N-isopropyl)amiloride|Y
gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid|gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid|Y
ras-related GTP-binding protein 5a|ras-related GTP-binding protein 5|Y
DOXP reducto-isomerase|DXP reducto-isomerase|Y
mitral annular calcium|mitral anular calcium|Y
β amyloid precursor protein cleaving enzyme 1|β amyloid precursor protein cleaving enzyme 2|Y
β amyloid precursor protein cleaving enzyme 1|β amyloid precursor protein cleaving enzyme-1|Y
Verticillium albo-atrum|Verticillium alboatrum|Y
alpha-naphthyl-isothiocyanate|alpha-naphthylisothiocyanate|Y
lumbo-sacral orthosis|lumbosacral orthosis|Y
transversal micro-radiography|transversal microradiography|Y
peri-lymphatic fistula|perilymphatic fistula|Y
von Hippel-Lindau tumour-suppressor protein|von Hippel-Lindau tumor-suppressor protein|Y
von Hippel-Lindau tumour-suppressor protein|von Hippel-Lindau tumour suppressor protein|Y
triplex-forming oligonucleotides|triplex-forming oligonucleotide|Y
extracellular signal-regulated kinase 1/2|extracellular signal-regulated kinase 1|Y
extracellular signal-regulated kinase 1/2|extracellular signal-regulated kinase-1/2|Y
bioelectrochemical system|bio-electrochemical system|Y
multidrug resistance associated protein 3|multidrug resistance associated protein 1|Y
multidrug resistance associated protein 3|multidrug resistance-associated protein 3|Y
thyrotropin releasing hormone receptor type 2|thyrotropin-releasing hormone receptor type 2|Y
miniature inhibitory postsynaptic current|miniature inhibitory post-synaptic current|Y
insulin-like growth factor-II messenger RNA binding protein 1|insulin-like growth factor-II messenger RNA binding protein-1|Y
insulin-like growth factor-II messenger RNA binding protein 1|insulin-like growth factor II messenger RNA binding protein 1|Y
insulin-like growth factor-II messenger RNA binding protein 1|insulin-like growth factor-II messenger RNA binding protein 3|Y
sialic acid-binding immunglobulin-like lectin|sialic acid binding immunglobulin-like lectin|Y
insulin-like growth factor-I-stimulated|insulinlike growth factor-I-stimulated|Y
autoerythrocyte sensitisation|auto-erythrocyte sensitisation|Y
non-pigmented epithelial cell|nonpigmented epithelial cell|Y
disease modifying anti-rheumatic drugs|disease modifying anti-rheumatic drug|Y
voltage dependent anion selective channel 2|voltage dependent anion selective channel 3|Y
voltage dependent anion selective channel 2|voltage dependent anion selective channel|Y
pituitary tumor derived fibroblast growth factor receptor-4|pituitary tumour derived fibroblast growth factor receptor-4|Y
pituitary tumor derived fibroblast growth factor receptor-4|pituitary tumor derived fibroblast growth factor receptor 4|Y
transient receptor potential melastatin 2|transient receptor potential melastatin 3|Y
transient receptor potential melastatin 2|transient receptor potential melastatin 6|Y
transient receptor potential melastatin 2|transient receptor potential melastatin 7|Y
transient receptor potential melastatin 2|transient receptor potential melastatin 8|Y
transient receptor potential melastatin 2|transient receptor potential melastatin 1|Y
sinonasal outcome test|sino-nasal outcome test|Y
soybean trypsin inhibitor|soyabean trypsin inhibitor|Y
corticotropin releasing factor|corticotrophin releasing factor|Y
nicotinamide adenine dinucleotide phosphate diaphorase|nicotinamide adenine di-nucleotide phosphate diaphorase|Y
haemoglobin Quong-Sze|hemoglobin Quong-Sze|Y
post-partum thyroiditis|postpartum thyroiditis|Y
poly-electrolyte solution|polyelectrolyte solution|Y
glycosylphosphatidylinositol anchored protein|glycosylphosphatidyl inositol anchored protein|Y
surface-assisted laser desorption/ionisation|surface-assisted laser desorption ionisation|Y
surface-assisted laser desorption/ionisation|surface-assisted laser desorption-ionisation|Y
Fc-gamma-receptor-mediated|Fcgamma-receptor-mediated|Y
ω3-polyunsaturated fatty acid|ω-3-polyunsaturated fatty acid|Y
anti-human T cell lymphotropic virus type I antibody|anti-human T cell lymphotrophic virus type I antibody|Y
anti-human T cell lymphotropic virus type I antibody|anti-human T cell lymphotropic virus type-I antibody|Y
anti-human T cell lymphotropic virus type I antibody|anti-human T cell lymphotropic virus type 1 antibody|Y
human transforming growth factor-β|human transforming growth factor-β1|Y
human transforming growth factor-β|human transforming growth factor-β3|Y
human transforming growth factor-β|human transforming growth factor-β2|Y
hyper-cholesterolemia|hypercholesterolemia|Y
thrombo-embolic event|thromboembolic event|Y
percutaneous transhepatic cholangiography|percutaneous trans-hepatic cholangiography|Y
prostaglandin G/H synthase-II|prostaglandin G/H synthase-I|Y
gut-enriched krueppel-like factor|gut-enriched kruppel-like factor|Y
distortion-product oto-acoustic emission|distortion product oto-acoustic emission|Y
cheno-deoxycholic acid|chenodeoxycholic acid|Y
alpha-methyl acyl-coenzyme A racemase|alpha-methylacyl-coenzyme A racemase|Y
pre-proparathyroid hormone|preproparathyroid hormone|Y
interleukine-3 receptor α chain|interleukin-3 receptor α chain|Y
non-aqueous reversed-phase high performance liquid chromatography|nonaqueous reversed phase high performance liquid chromatography|Y
ubiquitin-conjugating enzyme 10|ubiquitin-conjugating enzyme 1|Y
CC chemokine ligand 2|CC chemokine ligand 22|Y
CC chemokine ligand 2|CC chemokine ligand 21|Y
mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1|mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2|Y
spinocerebellar ataxia type 12|spinocerebellar ataxia type 1|Y
local cerebral metabolic rate for glucose|local cerebral metabolic rates for glucose|Y
nonsyncytium-inducing|non-syncytium-inducing|Y
benzo(a)pyrene diol-epoxide-DNA adduct level|benzo(a)pyrene-diol-epoxide-DNA adduct level|Y
hemagglutination-inhibiting|haemagglutination-inhibiting|Y
peroxisome proliferator-activated receptor γ 2|peroxisome proliferator-activated receptor γ 1|Y
anti-human T cell lymphotrophic virus type I antibody|anti-human T-cell lymphotrophic virus type I antibody|Y
anti-human T cell lymphotrophic virus type I antibody|anti-human T cell lymphotrophic virus type-I antibody|Y
lectin-like oxidised low-density lipoprotein receptor 1|lectin-like oxidised low density lipoprotein receptor 1|Y
peroxisome proliferator-activated receptor γ-1|peroxisome proliferator-activated receptor γ 1|Y
interferon-inducible T cell α chemoattractant|interferon-inducible T cell α-chemoattractant|Y
CTP:phosphoethanolamine cytidylyltransferase|CTP: phosphoethanolamine cytidylyltransferase|Y
Insulin-like growth factor binding protein|insulin-like growth factor binding protein|Y
traumatic reticuloperitonitis|traumatic reticulo-peritonitis|Y
postmeiotic segregation increased 2|post-meiotic segregation increased 2|Y
steroid 5-α-reductase type II|steroid 5α-reductase type II|Y
steroid 5-α-reductase type II|steroid 5-α-reductase type I|Y
oxidized nicotinamide adenine dinucleotide phosphate|oxidized nicotinamide-adenine dinucleotide phosphate|Y
oxidized nicotinamide adenine dinucleotide phosphate|oxidised nicotinamide adenine dinucleotide phosphate|Y
human T-cell lymphoma/leukaemia virus type II|human T-cell lymphoma/leukemia virus type I|Y
human T-cell lymphoma/leukaemia virus type II|human T-cell lymphoma/leukaemia virus type I|Y
Musca domestica glutathione S-transferase-2|Musca domestica glutathione S-transferase|Y
oculodentodigital dysplasia|oculodento-digital dysplasia|Y
spermatocyte/spermatid-specific thioredoxin-1|spermatocyte/spermatid-specific thioredoxin-2|Y
calcium-dependent signalling pathway|calcium-dependent signaling pathway|Y
anti-extractable nuclear antigen|antiextractable nuclear antigen|Y
type II InsP(3) receptor|type I InsP(3) receptor|Y
post-adrenocorticotrophic hormone|post-adrenocorticotropic hormone|Y
micro-invasive carcinoma|microinvasive carcinoma|Y
planned extra-capsular cataract extraction|planned extracapsular cataract extraction|Y
periodic lateralized epileptiform discharge|periodic lateralized epileptiform discharges|Y
nickel-nitrilotriacetic acid|nickel-nitrilo-triacetic acid|Y
colony-forming unit granulocyte macrophage|colony forming unit granulocyte macrophage|Y
colony-forming unit granulocyte macrophage|colony-forming unit granulocyte-macrophage|Y
bovine immunodeficiency-like virus|bovine immuno-deficiency-like virus|Y
pathological tumor-4, node-1, metastasis-0|pathological tumor-3, node-1, metastasis-0|Y
quantitative computerized tomography scan|quantitative computerised tomography scan|Y
bacteria-associated hemophagocytic syndrome|bacteria-associated hæmophagocytic syndrome|Y
technetium 99m labeled red blood cell|technetium 99m labelled red blood cell|Y
transforming growth factor-β receptor-II|transforming growth factor-β receptor II|Y
neural-precursor-cell-expressed, developmentally down-regulated 5|neural-precursor-cell-expressed developmentally down-regulated 9|Y
neural-precursor-cell-expressed, developmentally down-regulated 5|neural-precursor-cell-expressed, developmentally down-regulated 4|Y
neural-precursor-cell-expressed, developmentally down-regulated 5|neural-precursor-cell-expressed, developmentally downregulated 5|Y
neural-precursor-cell-expressed, developmentally down-regulated 5|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor-cell-expressed, developmentally down-regulated 5|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor-cell-expressed, developmentally down-regulated 5|neural-precursor-cell-expressed developmentally downregulated 5|Y
neural-precursor-cell-expressed, developmentally down-regulated 5|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural-precursor-cell-expressed, developmentally down-regulated 5|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor-cell-expressed, developmentally down-regulated 5|neural-precursor-cell-expressed developmentally down-regulated 1|Y
neural-precursor-cell-expressed, developmentally down-regulated 5|neural-precursor-cell-expressed, developmentally downregulated 2|Y
human chorionic gonadotropin-β|human chorionic gonadotrophin-β|Y
combined spinal epidural anaesthesia|combined spinal epidural anesthesia|Y
nausea, vomiting, diarrhea|nause, vomiting, diarrhea|Y
athero-sclerotic vascular disease|atherosclerotic vascular disease|Y
sub-foveal choroidal neovascularization|sub-foveal choroidal neo-vascularization|Y
upflow anaerobic sludge blanket reactor|up-flow anaerobic sludge blanket reactor|Y
non-contrast computed tomography|noncontrast computed tomography|Y
forkhead box class O4|forkhead box class O|Y
randomly amplified polymorphic DNA profile|random amplified polymorphic DNA profile|Y
N-(phosphonoacetyl)-L-aspartate|N-(phosphonacetyl)-L-aspartate|Y
microtubule associated protein light chain-3|microtubule associated protein-1 light chain-3|Y
microtubule associated protein light chain-3|microtubule associated protein light chain 3|Y
microtubule associated protein light chain-3|microtubule associated protein 1 light chain-3|Y
upper aero-digestive tract cancer|upper aerodigestive tract cancer|Y
alpha2-macroglobulin receptor associated protein|alpha2 macroglobulin receptor associated protein|Y
alpha2-macroglobulin receptor associated protein|alpha2-macroglobulin receptor-associated protein|Y
vascular endothelial growth factor receptor 1|vascular endothelial growth factor receptor 3|Y
vascular endothelial growth factor receptor 1|vascular endothelial growth factor receptor 2|Y
pituitary adenylate cyclase activating polypeptide receptor|pituitary adenylate cyclase-activating polypeptide receptor|Y
antithyroid microsomal antibody|anti-thyroid microsomal antibody|Y
tumour necrosis factor receptor-associated protein-1|tumor necrosis factor receptor-associated protein-1|Y
spontaneous intra-cerebral haematoma|spontaneous intra-cerebral hematoma|Y
cerebrovascular reactivity|cerebro-vascular reactivity|Y
cluster of differentiation 28|cluster of differentiation 8|Y
cluster of differentiation 28|cluster of differentiation 2|Y
Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-2|Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico|Y
trimethylamino-diphenylhexatriene|trimethylaminodiphenylhexatriene|Y
regulatory subunit I α|regulatory subunit Iα|Y
Tricophyton mentagrophytes|Trichophyton mentagrophytes|Y
veratryl-glycerol-beta-guaiacyl ether|veratrylglycerol-beta-guaiacyl ether|Y
infectious salmon anaemia|infectious salmon anemia|Y
other neurological diseases|other neurological disease|Y
beta amyloid precursor protein cleaving enzyme 1|beta amyloid precursor protein cleaving enzyme 2|Y
beta amyloid precursor protein cleaving enzyme 1|beta-amyloid precursor protein cleaving enzyme 1|Y
beta amyloid precursor protein cleaving enzyme 1|beta amyloid precursor protein cleaving enzyme-1|Y
pathogenesis-related protein 1|pathogenesis-related protein 10|Y
amine oxidase, copper containing 3|amine oxidase copper containing 3|Y
antiasialo GM-1 antibody|anti-asialo GM-1 antibody|Y
human insulin-like growth factor II|human insulin-like growth factor I|Y
broncho-alveolar lavage fluid|bronchoalveolar lavage fluid|Y
time-resolved fluorescence resonance energy transfer|time resolved fluorescence resonance energy transfer|Y
alpha-methyl-acyl-coenzyme A racemase|alpha-methylacyl-coenzyme A racemase|Y
Janus kinase/signal transducers and activators of transcription|Janus kinase/signal transducer and activator of transcription|Y
ultra-conserved region|ultraconserved region|Y
molt inhibiting hormone|moult inhibiting hormone|Y
8-cyclopentyl-1,3-dipropylxanthine|8-cyclopentyl-1, 3-dipropylxanthine|Y
platelet-derived growth factor beta receptor|platelet-derived growth factor beta-receptor|Y
nursing development units|nursing development unit|Y
tert-butyldimethylsilyl ether|tert-butyl-dimethylsilyl ether|Y
oxidised nicotinamide adenine dinucleotide|oxidized nicotinamide adenine dinucleotide|Y
intra-operative auto-transfusion|intraoperative auto-transfusion|Y
intra-operative auto-transfusion|intra-operative autotransfusion|Y
transcatheter chemoembolisation|trans-catheter chemoembolisation|Y
TBP-associated factor 15|TBP-associated factor 1|Y
N-methyl-D- aspartate|N-methyl-D aspartate|Y
N-methyl-D- aspartate|N-methyl-D-aspartate|Y
nonconvulsive generalized status epilepticus|nonconvulsive generalised status epilepticus|Y
nonsupperative otitis media|non-supperative otitis media|Y
4,4'-methylene dianiline|4,4'-methylenedianiline|Y
American Spinal Injury Association Impairment Scale grade C|American Spinal Injury Association Impairment Scale grade A|Y
anti-human T-cell lymphotrophic virus type I antibody|anti-human T-cell lymphotrophic virus type 1 antibody|Y
intra-vital microscopy|intravital microscopy|Y
recombinant human bone morphogenetic protein 2|recombinant human bone morphogenetic protein|Y
recombinant human bone morphogenetic protein 2|recombinant human bone morphogenetic protein 4|Y
recombinant human bone morphogenetic protein 2|recombinant human bone morphogenetic protein 12|Y
uteroplacental insufficiency|utero-placental insufficiency|Y
human granulocyte macrophage colony stimulating factor|human granulocyte-macrophage colony stimulating factor|Y
human granulocyte macrophage colony stimulating factor|human granulocyte macrophage-colony stimulating factor|Y
prostate intra-epithelial neoplasia|prostate intraepithelial neoplasia|Y
soluble receptor for interleukin-2|soluble receptors for interleukin-2|Y
peptidyl-glycine-alpha-amidating mono-oxygenase|peptidylglycine-alpha-amidating mono-oxygenase|Y
peptidyl-glycine-alpha-amidating mono-oxygenase|peptidyl-glycine-alpha-amidating monooxygenase|Y
peptidyl-glycine-alpha-amidating mono-oxygenase|peptidylglycine-alpha-amidating monooxygenase|Y
soluble cluster of differentiation antigen 86|soluble cluster of differentiation antigen 83|Y
soluble cluster of differentiation antigen 86|soluble cluster of differentiation antigen 80|Y
soluble cluster of differentiation antigen 86|soluble cluster of differentiation antigen 36|Y
soluble cluster of differentiation antigen 86|soluble cluster of differentiation antigen 26|Y
sry-related high mobility group-box gene 9|Sry-related high mobility group-box gene 9|Y
endothelial monocyte activating polypeptide-2|endothelial monocyte activating polypeptide|Y
α 2c-adrenergic receptor|α2c-adrenergic receptor|Y
serum β 2 microglobulin value|serum β2 microglobulin value|Y
3' untranslated regions|3' untranslated region|Y
B cell-specific Moloney murine leukaemia virus integration site 1|B-cell-specific Moloney murine leukemia virus integration site 1|Y
prepro-cholecystokinin|preprocholecystokinin|Y
inositol triphosphate receptor|inositol trisphosphate receptor|Y
interleukin 12 receptor β2 chain|interleukin 12 receptor β 2 chain|Y
ras-related GTP-binding protein 34|ras-related GTP-binding protein 3|Y
cisplatin, etoposide, and bleomycin|cisplatin, etoposide and bleomycin|Y
mitogen-activated protein kinase-activated protein kinase 1|mitogen-activated protein kinase-activated protein kinase 5|Y
subthreshold depression|sub-threshold depression|Y
gamma-amino-butyric acidB receptor|gamma-amino-butyric acid B receptor|Y
prenatal nicotine exposure|pre-natal nicotine exposure|Y
tumor necrosis factor receptor superfamily member 11a|tumor necrosis factor receptor superfamily member 11b|Y
immobilized metal ion affinity chromatography|immobilised metal ion affinity chromatography|Y
Standard Pseudoisochromatic Plates Part 2|Standard Pseudoisochromatic Plates-Part 2|Y
extracellular signal-regulated protein kinases|extracellular signal-regulated protein kinase|Y
extracellular signal-regulated protein kinases|Extracellular signal-regulated protein kinases|Y
anti-hepatitis B surface antibody|antihepatitis B surface antibody|Y
juxta-membrane region|juxtamembrane region|Y
tumour necrosis factor receptor-associated factor 2|tumour necrosis factor receptor associated factor 2|Y
tumour necrosis factor receptor-associated factor 2|tumour necrosis factor receptor-associated factor 1|Y
a disintegrin and metalloprotease with thrombospondin motifs-10|a disintegrin and metalloprotease with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motifs-10|a disintegrin and metalloprotease with thrombospondin motifs-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-10|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-10|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-10|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motifs-10|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloprotease with thrombospondin motifs-10|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motifs-10|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motifs-10|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motifs-10|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motifs-10|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
non-epileptic seizure|non-epileptic seizures|Y
non-epileptic seizure|nonepileptic seizure|Y
dendro-dendritic synaptosome|dendrodendritic synaptosome|Y
American Society of Anesthesiologists class 2|American Society of Anesthesiologists class I|Y
American Society of Anesthesiologists class 2|American Society of Anesthesiologists Class 2|Y
American Society of Anesthesiologists class 2|American Society of Anesthesiologists class 1|Y
attenuated total reflectance-Fourier transform infra red spectroscopy|attenuated total reflectance Fourier transform infrared spectroscopy|Y
matrix assisted laser desorption/ionisation mass spectrometry|matrix assisted laser desorption/ionization mass spectrometry|Y
matrix assisted laser desorption/ionisation mass spectrometry|matrix assisted laser desorption/ionisation-mass spectrometry|Y
synaptosomal-associated protein of 25 kDa|synaptosomal associated protein of 25 kDa|Y
intraoperative ultrasound|intra-operative ultrasound|Y
pro-gonadotropin-releasing hormone|pro-gonadotrophin-releasing hormone|Y
extra-corporeal shockwave treatment|extra-corporeal shock wave treatment|Y
extra-corporeal shockwave treatment|extra-corporeal shock-wave treatment|Y
folyl-polyglutamate synthetase|folylpolyglutamate synthetase|Y
antidouble-stranded deoxyribonucleic acid antibody|anti-double-stranded deoxyribonucleic acid antibody|Y
methyl cytosine-phosphate-guanosine binding domain protein 1|methyl cytosine-phosphate-guanosine binding domain protein|Y
cytotoxic T-lymphocyte-associated antigen 8|cytotoxic T-lymphocyte-associated antigen 4|Y
histopathological examination|histo-pathological examination|Y
insulin/insulin-like growth factor 1 signalling|insulin/insulin-like growth factor 1 signaling|Y
insulin/insulin-like growth factor 1 signalling|insulin/insulin-like growth factor signalling|Y
erythroid kruppel-like factor|erythroid krueppel-like factor|Y
NON-EXPRESSOR OF PATHOGENESIS-RELATED GENES1|NONEXPRESSOR OF PATHOGENESIS-RELATED GENES-1|Y
standardized mortality ratios|standardized mortality ratio|Y
mitogen activated protein kinase-activated protein kinase-3|mitogen activated protein kinase-activated protein kinase|Y
mitogen activated protein kinase-activated protein kinase-3|mitogen activated protein kinase-activated protein kinase 3|Y
anti-interleukin 15 monoclonal antibody|antiinterleukin 15 monoclonal antibody|Y
visible/near-infrared reflectance spectroscopy|visible/near infrared reflectance spectroscopy|Y
store-operated Ca2+ channel|store-operated Ca2+ channels|Y
macrophage-inflammatory protein 1 α|macrophage-inflammatory protein 1α|Y
extended X-ray absorption fine structure spectroscopy|extended x-ray absorption fine structure spectroscopy|Y
enzyme-linked immuno-absorbant assay|enzyme-linked immunoabsorbant assay|Y
chronic acalculous cholecystitis|chronic calculous cholecystitis|Y
toll-interleukin-1 receptor domain-containing adapter-inducing interferon β|toll/interleukin-1 receptor domain-containing adapter-inducing interferon β|Y
toll-interleukin-1 receptor domain-containing adapter-inducing interferon β|toll-interleukin1 receptor domain-containing adapter inducing interferon β|Y
Danish Verapamil Infarction Trial II|Danish Verapamil Infarction Trial III|Y
cerebro-cranial trauma|cerebrocranial trauma|Y
fluorescent amplified fragment-length polymorphism|fluorescent amplified-fragment-length polymorphism|Y
transaxial tomography|trans-axial tomography|Y
clinical global impression of change|clinical global impressions of change|Y
cytokine-induced neutrophil chemoattractant 2|cytokine-induced neutrophil chemoattractant 1|Y
cytokine-induced neutrophil chemoattractant 2|cytokine-induced neutrophil chemoattractant-2|Y
University of California Los Angeles Medical Center|University of California-Los Angeles Medical Center|Y
cardio-facio-cutaneous|cardio-faciocutaneous|Y
a disintegrin and metalloprotease-9|a disintegrin and metalloprotease-19|Y
major histocompatibility complex class II trans-activator|major histocompatibility complex class II transactivator|Y
galactorrhœa amenorrhea hyperprolactinemia syndrome|galactorrhœa-amenorrhea hyperprolactinemia syndrome|Y
galactorrhœa amenorrhea hyperprolactinemia syndrome|galactorrhœa amenorrhoea hyperprolactinaemia syndrome|Y
enterochromaffinlike cell|enterochromaffin-like cell|Y
extrapleural pneumonectomy|extra-pleural pneumonectomy|Y
transurethral microwave thermotherapy|transurethral microwave thermo-therapy|Y
aminoterminal proB-type natriuretic peptide|amino-terminal pro-B-type natriuretic peptide|Y
aminoterminal proB-type natriuretic peptide|amino-terminal proB-type natriuretic peptide|Y
aminoterminal proB-type natriuretic peptide|aminoterminal pro-B-type natriuretic peptide|Y
peptide nucleic acid/DNA chimaera|peptide nucleic acid/DNA chimera|Y
matrix-assisted laser desorption ionisation-mass spectrometry imaging|matrix-assisted laser desorption ionisation mass spectrometry imaging|Y
MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3|MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4|Y
activity-regulated cytoskeletal associated protein|activity regulated cytoskeletal associated protein|Y
sino-atrial conduction time|sinoatrial conduction time|Y
7,12-dimethylbenz(a) anthracene|7,12-dimethylbenz(a)anthracene|Y
tetra-hydro-beta-carboline|tetrahydro-beta-carboline|Y
major-histocompatibility-complex class I-related chain A|major histocompatibility-complex class I-related chain A|Y
anti-TCR alphabeta monoclonal antibody|anti-TCR alpha/beta monoclonal antibody|Y
radioimmunoprecipitation assay|radio-immunoprecipitation assay|Y
receptors for interleukin-2|receptor for interleukin-2|Y
triangular fibrocartilage|triangular fibro-cartilage|Y
severe fever with thrombocytopenia syndrome virus|severe fever with thrombocytopaenia syndrome virus|Y
augmented correlation consistent polarised valence double zeta basis set|augmented correlation-consistent polarised valence double zeta basis set|Y
post-partum depression|postpartum depression|Y
rates of glucose appearance|rate of glucose appearance|Y
retro-pharyngeal abscess|retropharyngeal abscess|Y
heart-rate-corrected Q-T interval|heart-rate-corrected QT interval|Y
interdigestive migrating contraction|interdigestive migrating contractions|Y
pre-pro-corticotrophin-releasing factor|pre-pro-corticotropin-releasing factor|Y
deoxyguanosine triphosphate|deoxy-guanosine triphosphate|Y
chicken luteinising hormone-releasing hormone I|chicken luteinising hormone-releasing hormone II|Y
human transforming growth factor-β 2|human transforming growth factor-β2|Y
Michael E. DeBakey Veteran's Affairs Medical Center|Michael E DeBakey Veteran's Affairs Medical Center|Y
Michael E. DeBakey Veteran's Affairs Medical Center|Michael E. DeBakey Veterans Affairs Medical Center|Y
G protein-coupled estrogen receptor|G protein-coupled oestrogen receptor|Y
University of California, Berkeley|University of California Berkeley|Y
magneto-encephalogram|magnetoencephalogram|Y
gel-filtered platelet|gel-filtered platelets|Y
evoked excitatory post-synaptic current|evoked excitatory postsynaptic current|Y
perioperative intraperitoneal chemotherapy|peri-operative intraperitoneal chemotherapy|Y
wheat germ agglutinin conjugated to horseradish peroxidase|Wheat germ agglutinin conjugated to horseradish peroxidase|Y
matrix assisted laser desorption/ionization time of flight mass spectrometry|matrix-assisted laser desorption/ionization time of flight mass spectrometry|Y
Organisation for Economic Co-operation and Development|Organisation for Economic Cooperation and Development|Y
neural precursor cell expressed, developmentally downregulated 9|neural precursor cell expressed developmentally downregulated 4|Y
neural precursor cell expressed, developmentally downregulated 9|neural precursor cell expressed developmentally downregulated 5|Y
neural precursor cell expressed, developmentally downregulated 9|neural precursor cell expressed developmentally downregulated 2|Y
neural precursor cell expressed, developmentally downregulated 9|neural precursor cell-expressed, developmentally downregulated 9|Y
neural precursor cell expressed, developmentally downregulated 9|neural precursor cell expressed, developmentally downregulated 2|Y
neural precursor cell expressed, developmentally downregulated 9|neural precursor cell expressed, developmentally down-regulated 4|Y
neural precursor cell expressed, developmentally downregulated 9|neural precursor cell expressed, developmentally down-regulated 1|Y
neural precursor cell expressed, developmentally downregulated 9|neural precursor cell expressed developmentally down-regulated 9|Y
neural precursor cell expressed, developmentally downregulated 9|neural precursor cell-expressed developmentally downregulated 9|Y
neural precursor cell expressed, developmentally downregulated 9|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell expressed, developmentally downregulated 9|neural precursor cell expressed, developmentally down-regulated 5|Y
wet distiller's grain|wet distillers grain|Y
proteasome subunit β type 10|proteasome subunit β type 1|Y
interdigestive myoelectric complex|interdigestive myo-electric complex|Y
TBP-associated factor 10|TBP-associated factor 1|Y
sodium taurocholate co-transporting polypeptide|sodium taurocholate cotransporting polypeptide|Y
sodium taurodihydrofusidate|sodium tauro-dihydrofusidate|Y
transporter associated with antigen processing 1|transporter associated with antigen processing 2|Y
head-down-tilt bedrest|head-down-tilt bed-rest|Y
head-down-tilt bedrest|head-down-tilt bed rest|Y
American Orthopedic Foot and Ankle Society ankle-hind foot score|American Orthopaedic Foot and Ankle Society ankle-hindfoot score|Y
3-isobutyl-1-methyl xanthine|3-isobutyl-1-methylxanthine|Y
peptide-major histocompatibility complex class II complex|peptide/major histocompatibility complex class II complex|Y
American Society of Anesthesiologists grade V|American Society of Anesthesiologists grade 2|Y
American Society of Anesthesiologists grade V|American Society of Anesthesiologists grade I|Y
American Society of Anesthesiologists grade V|American Society of Anesthesiologists grade 1|Y
American Society of Anesthesiologists grade V|American Society of Anesthesiologists grade 5|Y
sympatho-adrenal system|sympathoadrenal system|Y
ras-related GTP-binding protein 22B|ras-related GTP-binding protein 2B|Y
ras-related GTP-binding protein 22B|ras-related GTP-binding protein 22|Y
voiding cystourethrography|voiding cysto-urethrography|Y
University of California Davis Medical Center|University of California-Davis Medical Center|Y
University of California Davis Medical Center|University of California, Davis, Medical Center|Y
gas chromatography/negative ion chemical ionisation mass spectrometry|gas chromatography/negative ion chemical ionisation/mass spectrometry|Y
gas chromatography/negative ion chemical ionisation mass spectrometry|gas chromatography/negative ion chemical ionization mass spectrometry|Y
American Society of Anesthesiology Grade 5|American Society of Anaesthesiology Grade 5|Y
American Society of Anesthesiology Grade 5|American Society of Anesthesiology Grade 2|Y
American Society of Anesthesiology Grade 5|American Society of Anesthesiology Grade 3|Y
American Society of Anesthesiology Grade 5|American Society of Anesthesiology Grade 1|Y
intra-periaquaductal gray|intraperiaquaductal gray|Y
human leukocyte antigen-D-related antigen|human leucocyte antigen-D-related antigen|Y
bioelectrical activity|bio-electrical activity|Y
ATP-binding cassette subfamily B member 1|ATP-binding cassette subfamily B member-1|Y
generalized tonic-clonic seizure|generalized tonic-clonic seizures|Y
anti-IL 5 monoclonal antibody|anti-IL 15 monoclonal antibody|Y
soluble cluster of differentiation antigen 83|soluble cluster of differentiation antigen 80|Y
soluble cluster of differentiation antigen 83|soluble cluster of differentiation antigen 36|Y
soluble cluster of differentiation antigen 83|soluble cluster of differentiation antigen 30|Y
anti-epidermal growth factor receptor agent|antiepidermal growth factor receptor agent|Y
peptidylglycine-alpha-amidating mono-oxygenase|peptidyl-glycine-alpha-amidating monooxygenase|Y
peptidylglycine-alpha-amidating mono-oxygenase|peptidylglycine-alpha-amidating monooxygenase|Y
cyclin-dependent kinase-interacting protein 1|cyclin-dependent kinase interacting protein 1|Y
technetium-99m-labeled human serum albumin|technetium-99m-labelled human serum albumin|Y
attenuated total reflection infrared spectroscopy|attenuated total-reflection infrared spectroscopy|Y
beta-hexachloro-cyclohexane|beta-hexachlorocyclohexane|Y
anti-TCR-alpha beta monoclonal antibody|anti-TCR-alphabeta monoclonal antibody|Y
TATA-binding protein associated factor-10|TATA-binding protein-associated factor-10|Y
TATA-binding protein associated factor-10|TATA-binding protein associated factor-11|Y
TATA-binding protein associated factor-10|TATA-binding protein associated factor-12|Y
transcription factor B|transcription factor σB|Y
β-site amyloid precursor protein-cleaving enzyme 1|β-site amyloid precursor protein-cleaving enzyme|Y
maternal serum alpha fetoprotein|maternal serum alpha feto protein|Y
augmented correlation-consistent polarized valence triple-zeta basis set|augmented correlation-consistent polarized-valence triple-zeta basis set|Y
nonnucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitors|Y
laevonorgestrel releasing intrauterine system|levonorgestrel releasing intra uterine system|Y
laevonorgestrel releasing intrauterine system|laevonorgestrel releasing intra uterine system|Y
anti-interleukin 1alpha monoclonal antibody|anti-interleukin-1alpha monoclonal antibody|Y
anti-interleukin 1alpha monoclonal antibody|anti-interleukin 1 alpha monoclonal antibody|Y
anti-interleukin 1alpha monoclonal antibody|antiinterleukin 1alpha monoclonal antibody|Y
uridine diphosphate glucuronyltransferase|uridine diphosphate glucuronosyltransferase|Y
muco-ciliary clearance|mucociliary clearance|Y
branchpoint sequence|branch point sequence|Y
serum insulin-like growth factor II level|serum insulin-like growth factor-II level|Y
mitogen activated protein kinase activated protein kinase|mitogen activated protein kinase-activated protein kinase|Y
mitogen activated protein kinase activated protein kinase|mitogen activated protein kinase activated protein kinase 2|Y
mitogen activated protein kinase activated protein kinase|mitogen activated protein kinase activated protein kinase-2|Y
mitogen activated protein kinase activated protein kinase|mitogen-activated protein kinase activated protein kinase|Y
mitogen activated protein kinase activated protein kinase|mitogen activated protein kinase activated protein kinase 1|Y
spermidine-spermine-N(1)-acetyltransferase|spermidine-spermine N(1)-acetyltransferase|Y
cytotoxic T lymphocyte associated antigen-4|cytotoxic T-lymphocyte associated antigen-4|Y
corticotropin releasing hormone receptor 2|corticotropin-releasing hormone receptor 2|Y
corticotropin releasing hormone receptor 2|corticotropin releasing hormone receptor-2|Y
corticotropin releasing hormone receptor 2|corticotrophin releasing hormone receptor 2|Y
corticotropin releasing hormone receptor 2|corticotropin releasing hormone receptor 1|Y
Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico|Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico|Y
multi-slice computed tomography coronary angiography|multislice computed tomography coronary angiography|Y
antimacrophage globulin|anti-macrophage globulin|Y
Kiddie Schedule for Affective Disorders and Schizophrenia, Present and Lifetime|Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime|Y
Kiddie Schedule for Affective Disorders and Schizophrenia, Present and Lifetime|Kiddie-Schedule for Affective Disorders and Schizophrenia, Present and Lifetime|Y
ethyldeshydroxysparsomycin|ethyldeshydroxy-sparsomycin|Y
somatosensory evoked response|somatosensory evoked responses|Y
cob(I)alamin adenosyl-transferase|cob(I)alamin adenosyltransferase|Y
phosphatidylethanolamine binding protein 1|phosphatidylethanolamine binding protein|Y
CC chemokine receptor 7|C-C chemokine receptor 7|Y
hemoglobin Bologna-St. Orsola|haemoglobin Bologna-St. Orsola|Y
steady-state plasma concentration|steady-state plasma concentrations|Y
src homology 2 domain-containing protein tyrosine phosphatase-2|Src homology 2 domain-containing protein tyrosine phosphatase-2|Y
methyl cytidine-phosphate-guanosine binding domain 1|methyl cytidine-phosphate-guanosine binding domain 2|Y
methyl cytidine-phosphate-guanosine binding domain 1|methyl cytidine-phosphate-guanosine binding domain 5|Y
thyrotropin-releasing hormone receptor-1|thyrotropin releasing hormone receptor-1|Y
thyrotropin-releasing hormone receptor-1|thyrotropin-releasing hormone receptor 1|Y
antiglycoprotein Ib antibody|anti-glycoprotein Ib antibody|Y
acetylated low density lipoprotein|acetylated low density lipoproteins|Y
galactorrhœa-amenorrhœa hyperprolactinaemia syndrome|galactorrhœa-amenorrhea hyperprolactinaemia syndrome|Y
retinoic acid receptor-related orphan receptor gamma-T|retinoic acid receptor-related orphan receptor gamma T|Y
adult T-cell leukemia-virus-associated antigen|adult T-cell leukemia virus-associated antigen|Y
99mTc-labelled red blood cell|99mTc-labeled red blood cell|Y
Kruppel-like factor 6|Krueppel-like factor 6|Y
formin homology domain containing protein 1|formin homology domain containing protein-1|Y
melanoma differentiation associated gene-5|melanoma differentiation-associated gene-5|Y
melanoma differentiation associated gene-5|melanoma differentiation associated gene-7|Y
sodium potassium chloride cotransporter 2|sodium potassium 2 chloride cotransporter 2|Y
sodium potassium chloride cotransporter 2|sodium potassium chloride cotransporter 1|Y
a disintegrin and metalloprotease-33|a disintegrin and metalloprotease-3|Y
thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome|thrombotic thrombocytopenic purpura/hemolytic uremic syndrome|Y
thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome|thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome|Y
mesoporous bio-active glass|meso-porous bio-active glass|Y
anti-interleukin-3 antibody|anti-interleukin-13 antibody|Y
antisingle stranded DNA|anti-single stranded DNA|Y
corticotropin-releasing hormone receptor 2|corticotropin-releasing hormone receptor 1|Y
corticotropin-releasing hormone receptor 2|corticotropin-releasing-hormone receptor 2|Y
testicular intraepithelial neoplasia|testicular intra-epithelial neoplasia|Y
enterohemorrhagic E coli|entero-hemorrhagic E coli|Y
intravascular erythrocyte aggregation|intra-vascular erythrocyte aggregation|Y
granulocyte-macrophage colony stimulating factor receptor|granulocyte-macrophage colony-stimulating factor receptor|Y
crosspolarisation magic angle spinning nuclear magnetic resonance spectroscopy|cross-polarization magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic angle spinning nuclear magnetic resonance spectroscopy|cross polarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation magic angle spinning nuclear magnetic resonance spectroscopy|cross polarisation/magic angle spinning nuclear magnetic resonance spectroscopy|Y
benzo[a]pyrene diolepoxide|benzo[a]pyrene diol-epoxide|Y
standardised incidence ratio|standardised incidence ratios|Y
tetrahydroxycholestanoic acid|tetra-hydroxycholestanoic acid|Y
kruppel-like factor 15|kruppel-like factor 5|Y
cytokine induced neutrophil chemoattractant 1|cytokine-induced neutrophil chemoattractant 1|Y
cytokine induced neutrophil chemoattractant 1|cytokine induced neutrophil chemoattractant 3|Y
cytokine induced neutrophil chemoattractant 1|cytokine induced neutrophil chemoattractant|Y
alpha 2-HS-glycoprotein|alpha 2HS-glycoprotein|Y
S100 calcium binding protein A1|S100 calcium binding protein A12|Y
Hypophthalmichthys molitrix|Hypophthalamichthys molitrix|Y
Reis-Buckler's corneal dystrophy|Reis-Bucklers corneal dystrophy|Y
non-aqueous reversed phase|nonaqueous reversed phase|Y
multi-linear regression analysis|multilinear regression analysis|Y
Biopharmaceutics Classification System Class 4|Biopharmaceutics Classification System Class 1|Y
microimmunofluorescence|micro-immunofluorescence|Y
aromatase knockout mouse|aromatase knock-out mouse|Y
eukaryotic translation elongation factor-1α1|eukaryotic translation elongation factor-1-α-1|Y
oesophagogastro-duodenoscopy|oesophago-gastro-duodenoscopy|Y
ras-related GTP-binding protein 33B|ras-related GTP-binding protein 33|Y
ras-related GTP-binding protein 33B|ras-related GTP-binding protein 3B|Y
low-molecular-weight chromium-binding substance|low-molecular-weight chromium binding substance|Y
thrombolysis in myocardial infarction grade 0|thrombolysis in myocardial infarction grade 2|Y
5 alpha-androstan-17 beta-ol-3-one|5 alpha-androstane-17 beta-ol-3-one|Y
cyclic adenosine monophosphate receptor|cyclic adenosine monophosphate receptor 1|Y
TATA-binding protein-associated factor 11|TATA-binding protein-associated factor 1|Y
TATA-binding protein-associated factor 11|TATA-binding protein associated factor 11|Y
receptor-like protein-tyrosine phosphatase-psi|receptor-like protein-tyrosine phosphatase psi|Y
enzyme linked immunofiltration assay|enzyme linked immuno-filtration assay|Y
peroxisome proliferator-activated receptor-gamma1|peroxisome proliferator-activated receptor-gamma 1|Y
peroxisome proliferator-activated receptor-gamma1|peroxisome proliferator-activated receptor-gamma|Y
combretastatin A1 phosphate|combretastatin A-1 phosphate|Y
evoked otoacoustic emissions|evoked otoacoustic emission|Y
indocyanine green angiography-guided photodynamic therapy|indocyanine green angiography guided photodynamic therapy|Y
transforming growth factor α-Pseudomonas exotoxin 40|transforming growth factor-α-Pseudomonas exotoxin 40|Y
post-synaptic current|postsynaptic current|Y
nanoelectrospray mass spectrometry|nano-electrospray mass spectrometry|Y
TNM pathologic stage N1bi|TNM pathologic stage N1bii|Y
TNM pathologic stage N1bi|TNM pathologic stage N1biv|Y
hairy and enhancer of split 1|hairy and enhancer of split1|Y
mitogen/extracellular signal-regulated kinase kinase 6|mitogen/extracellular signal-regulated kinase kinase 5|Y
anti-beta 2 glycoprotein I antibody|anti-beta2 glycoprotein I antibody|Y
Paecilomyces fumoso-roseus|Paecilomyces fumosoroseus|Y
sex-determining region Y-box 10|sex-determining region Y-box 1|Y
Fas-associated death domain-like interleukin-1 β-converting enzyme-inhibitory protein|Fas-associated death domain-like interleukin-1β converting enzyme-inhibitory protein|Y
Fas-associated death domain-like interleukin-1 β-converting enzyme-inhibitory protein|Fas-associated death domain-like interleukin-1β-converting enzyme-inhibitory protein|Y
TBP-associated factor-12|TBP-associated factor-2|Y
Stanford Hypnotic Susceptibility Scale, Form C|Stanford Hypnotic Susceptibility Scale: Form C|Y
American Society of Anaesthesiology status IV|American Society of Anaesthesiology status I|Y
American Society of Anaesthesiology status IV|American Society of Anaesthesiology status V|Y
smooth lipopolysaccharide|smooth lipo-polysaccharide|Y
excision repair cross complementing-group 4|excision repair cross complementing group 4|Y
excision repair cross complementing-group 4|excision repair cross-complementing-group 4|Y
cluster of differentiation 33|cluster of differentiation 133|Y
multidrug resistance associated protein 1|multidrug-resistance associated protein 1|Y
intranasal midazolam|intra-nasal midazolam|Y
Autographa californica M nucleopolyhedrovirus|Autographa californica nucleopolyhedrovirus|Y
gut-enriched Kruppel-like factor|gut-enriched Krueppel-like factor|Y
cyclophosphamide, vincristine, and prednisolone|cyclophosphamide, vincristine, and prednisone|Y
inductively coupled plasma-atomic emission spectrometry|inductively coupled plasma/atomic emission spectrometry|Y
inductively coupled plasma-atomic emission spectrometry|inductively coupled plasma atomic emission spectrometry|Y
α7-nicotinic acetylcholine receptor|α 7-nicotinic acetylcholine receptor|Y
a disintegrin and metalloproteinase-8|a disintegrin and metalloproteinase-28|Y
anti-galactose antibody|antigalactose antibody|Y
polymerase chain reaction-sequence specific primer|polymerase chain reaction/sequence specific primer|Y
N-formyl-methionyl-leucylphenylalanine|N-formylmethionyl-leucylphenylalanine|Y
two-dimensional time-of-flight magnetic resonance angiography|two dimensional time-of-flight magnetic resonance angiography|Y
mitogen-activated protein kinase phosphatase|mitogen activated protein kinase phosphatase|Y
mitogen-activated protein kinase phosphatase|mitogen-activated protein kinase phosphatase-1|Y
mitogen-activated protein kinase phosphatase|mitogen-activated protein kinase phosphatase 1|Y
polymerized bovine haemoglobin|polymerized bovine hemoglobin|Y
Pituitary adenylate cyclase activating polypeptide|pituitary adenylate cyclase activating polypeptide|Y
v-rel reticuloendotheliosis viral oncogene homolog B|v-rel reticuloendotheliosis viral oncogene homologue B|Y
American Society of Anaesthesiology physical status 1|American Society of Anaesthesiology physical status|Y
insulin/insulin-like growth factor-1 signaling|insulin/insulin-like growth factor 1 signaling|Y
peroxisome proliferator activated receptor gamma coactivator 1alpha protein|peroxisome proliferator-activated receptor gamma coactivator 1alpha protein|Y
extrahepatic bile duct|extra-hepatic bile duct|Y
positron emission tomography-computed tomography|positron emission tomography/computed tomography|Y
procollagen type III peptide|pro-collagen type III peptide|Y
ALG2-interacting protein X|ALG-2-interacting protein X|Y
cross-polarization magic-angle spinning NMR|cross-polarization magic angle spinning NMR|Y
cross-polarization magic-angle spinning NMR|cross-polarization/magic-angle spinning NMR|Y
cellular inhibitor of apoptosis protein 2|cellular inhibitor of apoptosis protein|Y
cellular inhibitor of apoptosis protein 2|cellular inhibitor of apoptosis protein 1|Y
cellular inhibitor of apoptosis protein 2|cellular inhibitor of apoptosis protein-2|Y
transforming growth factor-beta receptor II|transforming growth factor-beta receptor-II|Y
transforming growth factor-beta receptor II|transforming growth factor-beta receptor I|Y
hyper-phenylalaninaemia|hyper-phenylalaninemia|Y
ubiquitin-like modifier activating enzyme 2|ubiquitin-like modifier activating enzyme 4|Y
ubiquitin-like modifier activating enzyme 2|ubiquitin-like modifier activating enzyme 5|Y
ubiquitin-like modifier activating enzyme 2|ubiquitin-like modifier activating enzyme 6|Y
transforming growth factor-beta|transforming growth factor-beta1|Y
transforming growth factor-beta|transforming growth factor-beta3|Y
transforming growth factor-beta|transforming growth factor-beta2|Y
antikappa light chain monoclonal antibody|anti-kappa light chain monoclonal antibody|Y
human adenovirus serotype 1|human adenovirus serotype 21|Y
human adenovirus serotype 1|human adenovirus serotype 31|Y
human adenovirus serotype 1|human adenovirus serotype 14|Y
galactorrhœa-amenorrhea hyperprolactinaemia syndrome|galactorrhœa-amenorrhea hyperprolactinemia syndrome|Y
galactorrhœa-amenorrhea hyperprolactinaemia syndrome|galactorrhœa-amenorrhoea hyperprolactinaemia syndrome|Y
galactorrhœa-amenorrhea hyperprolactinaemia syndrome|galactorrhœa-amenorrhoea hyperprolactinemia syndrome|Y
thrombotic thrombocytopenic purpura/hemolytic uremic syndrome|thrombotic thrombocytopenic purpura-hemolytic uremic syndrome|Y
a disintegrin and metalloprotease 23|a disintegrin and metalloprotease 3|Y
nonadrenergic noncholinergic inhibitory nerve|non-adrenergic non-cholinergic inhibitory nerve|Y
antiinterleukin 12 antibody|antiinterleukin 2 antibody|Y
HIV/sexually transmitted infection prevention programme|HIV/sexually-transmitted infection prevention programme|Y
chondroectodermal dysplasia|chondro-ectodermal dysplasia|Y
anti-IL6R monoclonal antibody|anti-IL 6R monoclonal antibody|Y
anti-β2 glycoprotein I antibody|anti-β-2 glycoprotein I antibody|Y
pustulosis palmo-plantaris|pustulosis palmoplantaris|Y
poly(lactic-coglycolic acid)|poly(lactic-co-glycolic acid)|Y
a disintegrin and metalloprotease with thrombospondin motif-17|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motif-17|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motif-17|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motif-17|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloprotease with thrombospondin motif-17|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motif-17|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motif-17|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motif-17|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motif-17|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motif-17|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motif-17|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-17|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motif-17|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
3β-hydroxy steroid-dehydrogenase deficiency|3β-hydroxysteroid-dehydrogenase deficiency|Y
laevonorgestrel-releasing intra uterine system|laevonorgestrel releasing intra uterine system|Y
axillo-femoral bypass|axillo-femoral by-pass|Y
a disintegrin and metalloproteinase with thrombospondin motif-4|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloproteinase with thrombospondin motif-4|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motif-4|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motif-4|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motif-4|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-4|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motif-4|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motif-4|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motif-4|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-4|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motif-4|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motif-4|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-4|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motif-4|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
ras-related GTP-binding protein 7b|ras-related GTP-binding protein 7|Y
neural precursor cell expressed developmentally downregulated 4|neural precursor cell expressed developmentally downregulated 5|Y
neural precursor cell expressed developmentally downregulated 4|neural precursor cell expressed developmentally downregulated 2|Y
neural precursor cell expressed developmentally downregulated 4|neural precursor cell expressed, developmentally downregulated 2|Y
neural precursor cell expressed developmentally downregulated 4|neural precursor cell expressed, developmentally down-regulated 4|Y
neural precursor cell expressed developmentally downregulated 4|neural precursor cell expressed developmentally down-regulated 9|Y
neural precursor cell expressed developmentally downregulated 4|neural precursor cell-expressed developmentally down-regulated 4|Y
organic anion transporting polypeptide 1A2|organic anion-transporting polypeptide 1A2|Y
organic anion transporting polypeptide 1A2|organic anion transporting polypeptide 2|Y
organic anion transporting polypeptide 1A2|organic anion transporting polypeptide 1|Y
anorectal malignant melanoma|ano-rectal malignant melanoma|Y
oedema, proteinuria and hypertension of pregnancy|edema, proteinuria and hypertension of pregnancy|Y
N-terminal pro-brain natriuretic peptide level|N-terminal probrain natriuretic peptide level|Y
mitogen-activated protein kinase kinase 2|mitogen-activated protein kinase kinase 7|Y
mitogen-activated protein kinase kinase 2|mitogen-activated protein kinase kinase 6|Y
mitogen-activated protein kinase kinase 2|mitogen-activated protein kinase kinase-2|Y
mitogen-activated protein kinase kinase 2|mitogen-activated protein kinase kinase 1|Y
American Society of Anaesthesiologists Grade II|American Society of Anesthesiologists Grade I|Y
trans-cutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation|Y
Lens Opacity Classification System II|Lens Opacity Classification System III|Y
antipolyribosylribitolphosphate antibody|anti-polyribosylribitol phosphate antibody|Y
Veterans' Affairs Medical Center|Veterans Affairs Medical Center|Y
aorticopulmonary septal defect|aortico-pulmonary septal defect|Y
type-2 insulin-like growth factor receptor|type 2 insulin-like growth factor receptor|Y
central primitive neuro-ectodermal tumour|central primitive neuroectodermal tumor|Y
herpesvirus of turkeys|herpesvirus of turkey|Y
anti-human herpes virus 6 immunoglobulin G|anti-human herpes virus-6 immunoglobulin G|Y
NADPH:cytochrome P-450 reductase|NADPH:cytochrome P450 reductase|Y
retro-grade pyelography|retrograde pyelography|Y
nontypeable Haemophilus influenzae|nontypeable Hemophilus influenzae|Y
recombinant human transforming growth factor-beta3|recombinant human transforming growth factor-beta1|Y
recombinant human transforming growth factor-beta3|recombinant human transforming growth factor beta3|Y
recombinant human transforming growth factor-beta3|recombinant human transforming growth factor-beta|Y
oesophago-gastroduodenoscopy|oesophago-gastro-duodenoscopy|Y
post-transplant lymphoproliferative disease|posttransplant lympho-proliferative disease|Y
2-amino-3-methylimidazo[4,5-f]quinoline|2-amino-3-methylimidazo-[4,5-f]quinoline|Y
subfoveal choroidal neo-vascularisation|subfoveal choroidal neovascularisation|Y
thyroid auto-immunity|thyroid autoimmunity|Y
anti-haemophilic factor|anti-hemophilic factor|Y
peroxisome-proliferator-activated receptor-gamma coactivator-1 alpha|peroxisome-proliferator-activated receptor-gamma co-activator 1 alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator-1 alpha|peroxisome-proliferator-activated receptor-gamma co-activator-1 alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator-1 alpha|peroxisome proliferator-activated receptor-gamma coactivator-1alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator-1 alpha|peroxisome-proliferator-activated receptor-gamma co-activator-1alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator-1 alpha|peroxisome-proliferator-activated receptor-gamma coactivator-1alpha|Y
peroxisome-proliferator-activated receptor-gamma coactivator-1 alpha|peroxisome-proliferator-activated receptor gamma coactivator-1 alpha|Y
intra-hepatic metastasis|intrahepatic metastasis|Y
γ-aminobutyric acid-B receptor|γ-amino-butyric acid-B receptor|Y
electro-immunotransfer blot assay|electroimmunotransfer blot assay|Y
nonessential amino acid|non essential amino acid|Y
organophosphorus-ester induced delayed neurotoxicity|organophosphorus-ester-induced delayed neurotoxicity|Y
thermo-mechanical loading|thermomechanical loading|Y
inductively coupled plasma/atomic emission spectrometry|inductively coupled plasma atomic emission spectrometry|Y
fan beam dual-energy X-ray absorptiometry|fanbeam dual-energy X-ray absorptiometry|Y
fan beam dual-energy X-ray absorptiometry|fan beam dual-energy x-ray absorptiometry|Y
serine-rich Entamoeba histolytica protein|serine rich Entamoeba histolytica protein|Y
B-cell acute lymphoblastic leucemia|B-cell acute lymphoblastic leucaemia|Y
lectin-like oxidised low density lipoprotein receptor-1|lectin-like oxidised low density lipoprotein receptor 1|Y
immuno-reactive corticotropin-releasing factor|immunoreactive corticotropin-releasing factor|Y
previously treated patient|previously treated patients|Y
surfactantlike material|surfactant-like material|Y
ras-related GTP-binding protein 23|ras-related GTP-binding protein 3|Y
para-amino-hippuric acid clearance|para-aminohippuric acid clearance|Y
methylglutaconyl coenzyme A hydratase|methyl-glutaconyl coenzyme A hydratase|Y
GTP-binding protein βγ-subunit|GTP-binding protein β-γ-subunit|Y
GTP-binding protein βγ-subunit|GTP-binding protein β-subunit|Y
interleukin 1 α protein|interleukin 1α protein|Y
American Society of Anaesthesiologists status 4|American Society of Anaesthesiologists status I|Y
American Society of Anaesthesiologists status 4|American Society of Anaesthesiologists status 1|Y
American Society of Anaesthesiologists status 4|American Society of Anaesthesiologists status 5|Y
a disintegrin and metalloprotease with thrombospondin motifs-5|a disintegrin and metalloprotease with thrombospondin motif-1|Y
a disintegrin and metalloprotease with thrombospondin motifs-5|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motifs-15|Y
a disintegrin and metalloprotease with thrombospondin motifs-5|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-5|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motifs-5|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-5|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motifs-5|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
cross-polarization magic angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross-polarization magic angle spinning nuclear magnetic resonance spectroscopy|crosspolarization magic-angle spinning nuclear magnetic resonance spectroscopy|Y
anti-toll-like receptor-2 monoclonal antibody|anti-toll like receptor-2 monoclonal antibody|Y
X-linked thrombo-cytopenia|X-linked thrombo-cytopaenia|Y
diisopropylfluorophosphate|di-isopropylfluorophosphate|Y
insulinlike growth factor 1 protein|insulin-like growth factor 1 protein|Y
human gonadotropin releasing hormone associated peptid|human gonadotrophin releasing hormone associated peptide|Y
Fcγ receptor-dependent|Fc-γ receptor-dependent|Y
two-electron reduced-density matrix method|two-electron reduced-density-matrix method|Y
TATA-binding protein-associated factor-12|TATA-binding protein-associated factor-10|Y
TATA-binding protein-associated factor-12|TATA-binding protein associated factor-12|Y
TATA-binding protein-associated factor-12|TATA-binding protein-associated factor-2|Y
TATA-binding protein-associated factor-12|TATA-binding protein-associated factor-1|Y
corticomuscular coherence|cortico-muscular coherence|Y
bone marrow-derived mast cell|bone marrow-derived mast cells|Y
macrophage-inflammatory protein-3β|macrophage-inflammatory protein-3 β|Y
anti-interleukin 5 antibody|anti-interleukin 15 antibody|Y
American Society of Anesthesiologists physical status 2|American Society of Anesthesiologists physical status 4|Y
American Society of Anesthesiologists physical status 2|American Society of Anesthesiologists physical status 5|Y
benzo[a]pyrene-diol-epoxide DNA adduct level|benzo[a]pyrene diol-epoxide DNA adduct level|Y
intraventricular septal thickness|intra-ventricular septal thickness|Y
semi-micro column high-performance liquid chromatography|semimicro column high-performance liquid chromatography|Y
lectin-like oxidised low density lipoprotein receptor 1|lectin-like oxidized low density lipoprotein receptor 1|Y
purinergic 2X receptor|purinergic 2X4 receptor|Y
cavo-tricuspid isthmus-dependent atrial flutter|cavo-tricuspid isthmus dependent atrial flutter|Y
death effector domain-containing DNA binding protein|death effector domain-containing DNA binding protein 2|Y
peri-operative major cardiovascular event|perioperative major cardiovascular event|Y
sequence tagged sites|sequence tagged site|Y
left mid-clavicular line|left midclavicular line|Y
TGFbeta-induced factor|TGF-beta-induced factor|Y
transient receptor potential melastatin 3|transient receptor potential melastatin 6|Y
transient receptor potential melastatin 3|transient receptor potential melastatin 7|Y
transient receptor potential melastatin 3|transient receptor potential melastatin 8|Y
transient receptor potential melastatin 3|transient receptor potential melastatin 1|Y
spinocerebellar ataxia 1|spinocerebellar ataxia 10|Y
light harvesting chlorophyll a/b binding protein-I|light harvesting chlorophyll a/b-binding protein-I|Y
light harvesting chlorophyll a/b binding protein-I|light harvesting chlorophyll a/b binding protein I|Y
soluble receptor activator of nuclear factor kappaB ligand|soluble receptor activator of nuclear factor-kappaB ligand|Y
cross-polarization/magic-angle-spinning nuclear magnetic resonance|cross polarization/magic-angle-spinning nuclear magnetic resonance|Y
Toll-interleukin-1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
Toll-interleukin-1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
TATA-binding protein associated factor-9|TATA-binding protein associated factor-2|Y
TATA-binding protein associated factor-9|TATA-binding protein associated factor-4|Y
TATA-binding protein associated factor-9|TATA-binding protein-associated factor-9|Y
TATA-binding protein associated factor-9|TATA-binding protein associated factor-7|Y
isovolumetric regulation|iso-volumetric regulation|Y
posttransplantation erythrocytosis|post-transplantation erythrocytosis|Y
mucosal addressin cell adhesion molecule|mucosal addressin cell adhesion molecule 1|Y
tumour-draining lymph node lymphocyte|tumor-draining lymph node lymphocyte|Y
technetium-99m labelled human serum albumin|technetium-99m-labelled human serum albumin|Y
International Neuroblastoma Staging System Stage I|International Neuroblastoma Staging System Stage 1|Y
International Neuroblastoma Staging System Stage I|International Neuroblastoma Staging System Stage III|Y
TBP-associated factor 7|TBP-associated factor 17|Y
complex chromosome rearrangements|complex chromosome rearrangement|Y
multidetector-row computed tomography scan|multi-detector-row computed tomography scan|Y
orthodromic reentrant tachycardia|orthodromic re-entrant tachycardia|Y
American Society of Anaesthesiologists class 1|American Society of Anaesthesiologists Class 1|Y
American Society of Anaesthesiologists class 1|American Society of Anaesthesiologists class 4|Y
American Society of Anaesthesiologists class 1|American Society of Anesthesiologists class 1|Y
pre-optic anterior hypothalamus|preoptic anterior hypothalamus|Y
polyelectrolyte complex|poly-electrolyte complex|Y
sex-determining region Y, box 10|sex-determining region Y, box 1|Y
sex-determining region Y, box 10|sex-determining region Y box 10|Y
insulin-like growth factor II mRNA-binding protein-3|insulin-like growth factor-II mRNA-binding protein-3|Y
insulin-like growth factor II mRNA-binding protein-3|insulin-like growth factor II mRNA-binding protein-1|Y
insulin-like growth factor II mRNA-binding protein-3|insulin-like growth factor II mRNA-binding protein-2|Y
dehydroxy-methylepoxyquinomicin|dehydroxymethylepoxyquinomicin|Y
tumor necrosis factor-related apoptosis-inducing ligand receptor-1|tumour necrosis factor-related apoptosis-inducing ligand receptor-1|Y
tumor necrosis factor-related apoptosis-inducing ligand receptor-1|tumour necrosis factor-related apoptosis-inducing ligand receptor 1|Y
excision repair cross-complementing group 6|excision repair cross-complementing group 3|Y
excision repair cross-complementing group 6|excision repair cross-complementing group 5|Y
excision repair cross-complementing group 6|excision repair cross complementing group 6|Y
4G5G plasminogen activator inhibitor-1 polymorphism|4G/5G plasminogen activator inhibitor-1 polymorphism|Y
hypo-gammaglobulinemia|hypo-gammaglobulinaemia|Y
hypo-gammaglobulinemia|hypo-gamma-globulinemia|Y
neural precursor cell expressed developmentally downregulated 5|neural precursor cell expressed developmentally downregulated 2|Y
neural precursor cell expressed developmentally downregulated 5|neural precursor cell expressed, developmentally downregulated 2|Y
neural precursor cell expressed developmentally downregulated 5|neural precursor cell expressed developmentally down-regulated 9|Y
neural precursor cell expressed developmentally downregulated 5|neural precursor cell expressed, developmentally down-regulated 5|Y
American Society of Anesthesiologists Status I|American Society of Anaesthesiologists Status IV|Y
American Society of Anesthesiologists Status I|American Society of Anesthesiologists Status 1|Y
American Society of Anesthesiologists Status I|American Society of Anaesthesiologists Status II|Y
American Society of Anesthesiologists Status I|American Society of Anesthesiologists Status 4|Y
promyelocytic leukaemia/retinoic acid receptor alpha|promyelocytic leukaemia-retinoic acid receptor alpha|Y
promyelocytic leukaemia/retinoic acid receptor alpha|promyelocytic leukemia/retinoic acid receptor alpha|Y
tumor necrosis factor receptor-associated protein-1|tumor necrosis factor receptor-associated protein 1|Y
whey acidic protein four disulfide core domain 9|whey acidic protein four disulfide core domain 2|Y
wet distillers grain|wet distillers' grain|Y
total iron binding capacit|total iron binding capacity|Y
phosphorylated p38MAPK|phosphorylated p38 MAPK|Y
extratemporal epilepsy|extra-temporal epilepsy|Y
nonequilibrium pH gradient electrophoresis|non-equilibrium pH gradient electrophoresis|Y
anti-T-cell receptor-alpha/beta antibody|anti-T-cell receptor alpha/beta antibody|Y
electroactive polymer|electro-active polymer|Y
feline pan-leucopaenia|feline pan-leucopenia|Y
hematopoietic cell transplantation-specific comorbidity index|haematopoietic cell transplantation-specific comorbidity index|Y
American Society of Anesthesiology Class V|American Society of Anesthesiology Class 2|Y
American Society of Anesthesiology Class V|American Society of Anesthesiology Class 4|Y
endotoxinlike activity|endotoxin-like activity|Y
humero-radial synostosis|humeroradial synostosis|Y
programmed temperature vaporiser|programmed temperature vapouriser|Y
human chorionic gonadotropin stimulated|human chorionic gonadotrophin stimulated|Y
carbohydrate deficient glycoprotein syndrome type 2|carbohydrate deficient glycoprotein syndrome type 1|Y
Escherichia coli hemolysin|Escherichia coli haemolysin|Y
NIMA-related kinase 2B|NIMA-related kinase 2|Y
norepinephrine pre-contracted|norepinephrine precontracted|Y
thermoluminescent dosimeter|thermo-luminescent dosimeter|Y
capillary isoelectric focusing-electrospray ionization mass spectrometry|capillary isoelectric focusing-electrospray ionisation mass spectrometry|Y
interphotoreceptor matrix proteoglycan 1|interphotoreceptor matrix proteoglycan 2|Y
L-NG-monomethylarginine|L-NG-monomethyl arginine|Y
L-NG-monomethylarginine|L-NG-monomethyl-arginine|Y
mitogen-activated protein kinase activated protein kinase-1|mitogen-activated protein kinase activated protein kinase|Y
protein tyrosine phosphatase nonreceptor 22|protein tyrosine phosphatase non-receptor 22|Y
Globo H-keyhole limpet hemocyanin QS-21 vaccine|globo H-keyhole limpet hemocyanin QS-21 vaccine|Y
5'-p-fluorosulfonylbenzoyladenosine|5'-p-fluorosulfonylbenzoyl adenosine|Y
xenotropic murine leukaemia-related virus|xenotropic murine leukemia-related virus|Y
cervico-thoracic orthosis|cervicothoracic orthosis|Y
sub-clinical hypothyroidism|subclinical hypothyroidism|Y
oto-spondylo-megaepiphyseal dysplasia|otospondylo-megaepiphyseal dysplasia|Y
mitogen extracellular signal regulated kinase 1|mitogen extracellular signal-regulated kinase 1|Y
anti-IL-5 monoclonal antibody|anti-IL-15 monoclonal antibody|Y
ras-related GTP-binding protein 35|ras-related GTP-binding protein 5|Y
ras-related GTP-binding protein 35|ras-related GTP-binding protein 3|Y
thyro-mental distance|thyromental distance|Y
normo-triglyceridaemic|normo-triglyceridemic|Y
periarteriolar lymphoid sheaths|periarteriolar lymphoid sheath|Y
quinolone resistance-determining regions|quinolone resistance-determining region|Y
gonadotrophin surge-inhibiting factor|gonadotropin surge-inhibiting factor|Y
ethylene diamine tetra-acetic acid|ethylenediamine tetra-acetic acid|Y
ribosomal protein S18|ribosomal protein S8|Y
para-ventricular nucleus|paraventricular nucleus|Y
Strongylocentrotus purpuratus epidermal growth factor II|Strongylocentrotus purpuratus epidermal growth factor I|Y
American Society of Anesthesiologists Class II|American Society of Anesthesiologists Class IV|Y
frontometaphyseal dysplasia|fronto-metaphyseal dysplasia|Y
sector-field inductively coupled plasma-mass spectrometry|sector field inductively coupled plasma-mass spectrometry|Y
mesangiocapillary glomerulonephritis type ii|mesangiocapillary glomerulonephritis type iii|Y
calcium- and diacylglycerol-regulated guanine nucleotide exchange factor|calcium- and diacylglycerol-regulated guanine nucleotide exchange factor II|Y
calcium- and diacylglycerol-regulated guanine nucleotide exchange factor|calcium- and diacylglycerol-regulated guanine nucleotide exchange factor Ia|Y
translation elongation factor 1δ|translation elongation factor 1 δ|Y
Michael E DeBakey Veteran's Affairs Medical Center|Michael E. DeBakey Veterans Affairs Medical Center|Y
enzyme-linked immuno-electrotransfer blot assay|enzyme-linked immunoelectro-transfer blot assay|Y
multi-mode interference|multimode interference|Y
Salmonella enteritidis fimbrial antigen 21|Salmonella enteritidis fimbrial antigen 17|Y
Salmonella enteritidis fimbrial antigen 21|Salmonella enteritidis fimbrial antigen 18|Y
Salmonella enteritidis fimbrial antigen 21|Salmonella enteritidis fimbrial antigen 14|Y
17-item Hamilton Rating Scale for Depression|21-item Hamilton Rating Scale for Depression|Y
size-exclusion chromatography/multiangle laser light scattering|size exclusion chromatography/multiangle laser light scattering|Y
size-exclusion chromatography/multiangle laser light scattering|size-exclusion chromatography/multi-angle laser light scattering|Y
size-exclusion chromatography/multiangle laser light scattering|size-exclusion chromatography-multi-angle laser light scattering|Y
capillary electrophoresis electrospray ionisation time of flight mass spectrometry|capillary electrophoresis-electrospray ionisation time of flight mass spectrometry|Y
capillary electrophoresis electrospray ionisation time of flight mass spectrometry|capillary electrophoresis-electrospray ionization time of flight mass spectrometry|Y
capillary electrophoresis electrospray ionisation time of flight mass spectrometry|capillary electrophoresis-electrospray ionisation-time of flight mass spectrometry|Y
glycerophosphate acyltransferase|glycerolphosphate acyltransferase|Y
corticotrophin-releasing-hormone receptor|corticotropin-releasing-hormone receptor|Y
singlet oxygen-sensitized delayed fluorescence|singlet-oxygen-sensitized delayed fluorescence|Y
Krüppel-like factor-13|Krüppel-like factor-3|Y
insulin-like growth factor-II mRNA-binding protein 3|insulin-like growth factor-II mRNA-binding protein|Y
insulin-like growth factor-II mRNA-binding protein 3|insulin-like growth factor-II mRNA-binding protein-3|Y
insulin-like growth factor-II mRNA-binding protein 3|insulin-like growth factor-II mRNA-binding protein 2|Y
thyrotropin-releasing hormone receptor|thyrotrophin-releasing hormone receptor|Y
[3H]inositol phosphates|[3H]inositol phosphate|Y
flame atomic absorption spectrophotometry|flame atomic absorption spectrophotometer|Y
cluster of differentiation antigen 33|cluster of differentiation antigen 133|Y
tumor infiltrating lymphocyte|tumour infiltrating lymphocyte|Y
ultrasound guided fine-needle aspiration biopsy|ultrasound-guided fine-needle aspiration biopsy|Y
γglutamyl transpeptidase|γ-glutamyl transpeptidase|Y
tumour necrosis factor-alpha protease inhibitor-1|tumor necrosis factor-alpha protease inhibitor-1|Y
intraoperative auto-transfusion|intraoperative autotransfusion|Y
2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine|2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine|Y
2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine|2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine|Y
2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine|2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine|Y
receptor-like protein tyrosine phosphatase-κ|receptor-like protein tyrosine phosphatase-ψ|Y
receptor-like protein tyrosine phosphatase-κ|receptor-like protein tyrosine phosphatase-μ|Y
ribosomal protein S21|ribosomal protein S2|Y
neural-precursor cell-expressed, developmentally down-regulated 4|neural-precursor-cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally down-regulated 4|neural-precursor cell-expressed developmentally down-regulated 5|Y
neural-precursor cell-expressed, developmentally down-regulated 4|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally down-regulated 4|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural-precursor cell-expressed, developmentally down-regulated 4|neural precursor cell-expressed developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally down-regulated 4|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural-precursor cell-expressed, developmentally down-regulated 4|neural-precursor cell-expressed, developmentally downregulated 1|Y
ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry|ultra-performance liquid chromatography-electrospray ionisation tandem mass spectrometry|Y
ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry|ultraperformance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry|ultra performance liquid chromatography/electrospray ionisation tandem mass spectrometry|Y
ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry|ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome|thrombotic thrombocytopenic purpura-hemolytic uremic syndrome|Y
cross-correlated relaxation-induced polarisation transfer|cross-correlated relaxation-induced polarization transfer|Y
retinoblastoma protein-interacting zinc finger protein|retinoblastoma protein-interacting zinc-finger protein|Y
N-nitrosodimethylamine|N-nitrosodiethylamine|Y
poly(epsilon-caprolactone)|poly-(epsilon-caprolactone)|Y
laser desorption ionisation time of flight mass spectrometry|laser-desorption ionisation time of flight mass spectrometry|Y
Ralph H Johnson Veteran's Affairs Medical Center|Ralph H. Johnson Veteran's Affairs Medical Center|Y
Ralph H Johnson Veteran's Affairs Medical Center|Ralph H Johnson Veterans' Affairs Medical Center|Y
tumor-resistant antigen|tumour-resistant antigen|Y
trans-catheter chemo-embolisation|trans-catheter chemoembolisation|Y
ras-related GTP-binding protein 33|ras-related GTP-binding protein 3|Y
phosphorylated cyclic AMP response element binding protein|phosphorylated cyclic AMP responsive element binding protein|Y
tetracycline resistant neisseria gonorrhoeae|tetracycline resistant neisseria gonorrheae|Y
chronic intestinal pseudo-obstruction syndrome|chronic intestinal pseudoobstruction syndrome|Y
neoadjuvant chemotherapy|neo-adjuvant chemotherapy|Y
cell-free supernatant|cell-free supernatants|Y
p-nitrophenylsulfate|p-nitrophenyl sulfate|Y
ilio-hypogastric nerve|iliohypogastric nerve|Y
tetramethylrhodamine ethyl ester|tetramethylrhodamine methyl ester|Y
[3H]-5-hydroxytryptamine|[3H]5-hydroxytryptamine|Y
ras-related GTP-binding protein 11b|ras-related GTP-binding protein 1b|Y
post-dialysis fatigue|postdialysis fatigue|Y
Paediatric Risk of Mortality|Pediatric Risk of Mortality|Y
distal arterio-venous fistula|distal arteriovenous fistula|Y
receptor-like protein-tyrosine phosphatase alpha|receptor-like protein-tyrosine phosphatase-alpha|Y
American Society of Anesthesiology grade 3|American Society of Anesthesiology grade|Y
American Society of Anesthesiology grade 3|American Society of Anesthesiology grade I|Y
American Society of Anesthesiology grade 3|American Society of Anesthesiology Grade 3|Y
matrix-assisted laser desorption/ionization time of flight mass spectrometric|matrix-assisted laser desorption/ionization time of flight mass spectrometry|Y
matrix-assisted laser desorption/ionization time of flight mass spectrometric|matrix-assisted laser desorption ionization time of flight mass spectrometric|Y
Walter and Eliza Hall Institute 3B|Walter and Eliza Hall Institute 3|Y
multisystem organ failure|multi-system organ failure|Y
succino-dehydrogenase|succinodehydrogenase|Y
non-milk extrinsic sugars|non-milk extrinsic sugar|Y
gonadotrophin releasing hormone antagonist|gonadotrophin-releasing hormone antagonist|Y
gonadotrophin releasing hormone antagonist|gonadotropin releasing hormone antagonist|Y
disease modifying antirheumatic drug|disease modifying anti-rheumatic drug|Y
ethyldeshydroxy-sparsomycin|ethyldehydroxy-sparsomycin|Y
anti-human T cell lymphotrophic virus type-I antibody|anti-human T cell lymphotropic virus type-I antibody|Y
photoplethysmography|photo-plethysmography|Y
crosspolarisation/magic angle spinning nuclear magnetic resonance spectroscopy|cross-polarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation/magic angle spinning nuclear magnetic resonance spectroscopy|cross polarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation/magic angle spinning nuclear magnetic resonance spectroscopy|cross polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
crosspolarisation/magic angle spinning nuclear magnetic resonance spectroscopy|cross polarisation/magic angle spinning nuclear magnetic resonance spectroscopy|Y
nicotinamide adenine di-nucleotide phosphate-diaphorase|nicotinamide adenine di-nucleotide phosphate diaphorase|Y
oxidized low-density lipoprotein receptor-1|oxidized low-density lipoprotein receptor 1|Y
oxidized low-density lipoprotein receptor-1|oxidized low density lipoprotein receptor-1|Y
up-conversion luminescence|upconversion luminescence|Y
para-chlorophenylalanine|para-chlorophenyl alanine|Y
para-chlorophenylalanine|parachlorophenylalanine|Y
HIV/hepatitis B virus coinfection|HIV/hepatitis B virus co-infection|Y
follicular fluid meiosis-activating sterol|follicular fluid meiosis activating sterol|Y
œsophago-respiratory fistula|œsophagorespiratory fistula|Y
Triticum aestivum endoxylanase inhibitor II|Triticum aestivum endoxylanase inhibitor I|Y
stromal-derived factor 1α|stromal-derived factor 1|Y
endothelial leukocyte adhesion molecule-1|endothelial-leukocyte adhesion molecule-1|Y
Yersinia enterocolitica serotype O3|Yersinia enterocolitica serotype O:3|Y
maximum inspiratory flow rate at 75% of vital capacity|maximum inspiratory flow rate at 25% of vital capacity|Y
sulfonylurea receptor 2B|sulfonylurea receptor 2|Y
platelet-derived growth factor type beta receptor|platelet-derived growth factor type-beta receptor|Y
demineralised freeze dried bone allograft|demineralized freeze dried bone allograft|Y
progressive familial intrahepatic cholestasis|progressive familial intra-hepatic cholestasis|Y
intravenous γglobulin|intravenous γ-globulin|Y
tumour necrosis factor receptor associated factor 5|tumour necrosis factor receptor associated factor 2|Y
visual vestibulo-ocular reflex|visual vestibuloocular reflex|Y
transurethral microwave thermo-therapy|trans-urethral microwave thermo-therapy|Y
temporo-mandibular opening index|temporomandibular opening index|Y
nuclear factor erythroid 2 p45-related factor-2|nuclear factor-erythroid 2 p45-related factor-2|Y
aminoacyl-tRNA synthetase-interacting multifunctional protein-3|aminoacyl-tRNA synthetase-interacting multifunctional protein 3|Y
human adenovirus type 7|human adenovirus type 47|Y
principal coordinate analysis|principal co-ordinate analysis|Y
neonatal alloimmune thrombocytopenia|neonatal allo-immune thrombocytopenia|Y
American Society of Anaesthesiologists Class 5|American Society of Anaesthesiologists Class 1|Y
N-methyl-DL-aspartate|N-methyl-D-aspartate|Y
N-methyl-DL-aspartate|N-methyl-D,L-aspartate|Y
iso-electric electroencephalogram|isoelectric electroencephalogram|Y
sterol response element-binding protein 1-c|sterol response element-binding protein 1-a|Y
sterol response element-binding protein 1-c|sterol response element binding protein 1-c|Y
National Institute of Health Stroke Scale|National Institutes of Health Stroke Scale|Y
in-situ end labeling|in-situ end labelling|Y
antinuclear cytoplasmic antibody|anti-nuclear cytoplasmic antibody|Y
deproteinized polysaccharide protein complex|deproteinized polysaccharide-protein complex|Y
transient receptor potential vanilloid type 2|transient receptor potential vanilloid type 3|Y
G-protein-coupled oestrogen receptor|G-protein-coupled estrogen receptor|Y
enterochromaffin like|enterochromaffinlike|Y
liver and activation-regulated chemokine|liver- and activation-regulated chemokine|Y
mitogen-activated protein kinase kinase 7|mitogen-activated protein kinase kinase 6|Y
mitogen-activated protein kinase kinase 7|mitogen-activated protein kinase kinase-7|Y
mitogen-activated protein kinase kinase 7|mitogen-activated protein kinase kinase 1|Y
bone multicellular unit|bone multi-cellular unit|Y
A disintegrin and metalloproteinase-15|A disintegrin and metalloproteinase-5|Y
Cellular Nonlinear Network Universal Machine|Cellular Non-linear Network Universal Machine|Y
endothelial monocyte activating polypeptide|endothelial-monocyte activating polypeptide|Y
antihemophilic factor|anti-hemophilic factor|Y
cross-polarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|cross polarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross-polarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross-polarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
soluble cluster of differentiation 4|soluble cluster of differentiation 14|Y
multiplex fluorescence in-situ hybridization|multiplex fluorescence in-situ hybridisation|Y
glycogen storage disease type 1|glycogen storage disease type 1b|Y
tick-borne encephalitis|tickborne encephalitis|Y
prepulse facilitation|pre-pulse facilitation|Y
triple quadrupole tandem mass spectrometry|triple quadrupole tandem mass spectrometer|Y
beta-amyloid precursor protein cleaving enzyme|beta-amyloid precursor protein cleaving enzyme 1|Y
beta-amyloid precursor protein cleaving enzyme|beta-amyloid precursor protein cleaving enzyme-2|Y
National Health and Nutrition Examination Survey|National Health and Nutrition Examination Surveys|Y
antiIL-10 receptor antibody|antiIL-1 receptor antibody|Y
antiIL-10 receptor antibody|anti-IL-10 receptor antibody|Y
anti-myelin-associated glycoprotein neuropathy|anti-myelin associated glycoprotein neuropathy|Y
renovascular hypertension|reno-vascular hypertension|Y
recombinant canine granulocyte colony-stimulating factor|Recombinant canine granulocyte colony-stimulating factor|Y
recombinant canine granulocyte colony-stimulating factor|recombinant canine granulocyte-colony-stimulating factor|Y
peroxisome proliferator-activated receptor gamma coactivator 1 alpha|peroxisome proliferator-activated receptor-gamma coactivator 1 alpha|Y
peroxisome proliferator-activated receptor gamma coactivator 1 alpha|peroxisome proliferator-activated receptor gamma co-activator 1 alpha|Y
peroxisome proliferator-activated receptor gamma coactivator 1 alpha|peroxisome proliferator-activated receptor-gamma co-activator 1 alpha|Y
peroxisome proliferator-activated receptor gamma coactivator 1 alpha|peroxisome-proliferator-activated receptor gamma coactivator 1 alpha|Y
signal transducer and activator of transcription 2|signal transducer and activator of transcription|Y
signal transducer and activator of transcription 2|signal transducer and activator of transcription 6|Y
signal transducer and activator of transcription 2|signal transducer and activator of transcription 3|Y
glycosylphosphatidylinositol-anchored|glycosyl-phosphatidylinositol-anchored|Y
glycosylphosphatidylinositol-anchored|glycosylphosphatidyl-inositol-anchored|Y
sterol response element-binding protein-1-a|sterol response element-binding protein 1-a|Y
γ-glutamyltranspeptidase|γ-glutamyl transpeptidase|Y
upper gastro-intestinal bleeding|upper gastrointestinal bleeding|Y
mitogen activated protein kinase-activated protein kinase|mitogen activated protein kinase-activated protein kinase 3|Y
in situ end labelling|in situ end labeling|Y
colonization factor antigen II|colonization factor antigen I|Y
insulin-like growth factor II messenger RNA binding protein 2|insulin-like growth factor II messenger RNA binding protein 1|Y
1(-2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea|1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea|Y
neuro-developmental therapy|neurodevelopmental therapy|Y
vibro-acoustic stimulation test|vibroacoustic stimulation test|Y
extracellular signal-regulated protein kinase 5|extracellular signal-regulated protein kinase|Y
extracellular signal-regulated protein kinase 5|extracellular signal-regulated protein kinase 2|Y
spondylo-epiphyseal dysplasia|spondyloepiphyseal dysplasia|Y
galactorrhœa-amenorrhea hyperprolactinemia syndrome|galactorrhœa-amenorrhoea hyperprolactinaemia syndrome|Y
galactorrhœa-amenorrhea hyperprolactinemia syndrome|galactorrhœa-amenorrhoea hyperprolactinemia syndrome|Y
nicotinamide adenine dinucleotide independent|nicotinamide adenine dinucleotide dependent|Y
American Society of Anesthesiology physical status III|American Society of Anesthesiology physical status II|Y
American Society of Anesthesiology physical status III|American Society of Anaesthesiology physical status III|Y
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling assay|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling assay|Y
transforming growth factor-beta-1|transforming growth factor-beta1|Y
F-18 fluoro deoxyglucose|F-18 fluorodeoxyglucose|Y
Salmonella enteritidis fimbrial antigen 17|Salmonella enteritidis fimbrial antigen 18|Y
Salmonella enteritidis fimbrial antigen 17|Salmonella enteritidis fimbrial antigen 14|Y
nicotinamide adenine dinucleotide phosphate oxidase 1|nicotinamide adenine dinucleotide phosphate oxidase|Y
Phleum pratense protein 5|Phleum pratense protein 5a|Y
Phleum pratense protein 5|Phleum pratense protein 5b|Y
cardiothoracic ratio|cardio-thoracic ratio|Y
recombinant human transforming growth factor-beta1|recombinant human transforming growth factor-beta|Y
peroxisome proliferator-activated receptor gamma coactivator-1alpha protein|peroxisome proliferator-activated receptor gamma coactivator 1alpha protein|Y
multiminicore disease|multi-minicore disease|Y
serotonin reuptake transporter|serotonin re-uptake transporter|Y
mitogen activated protein kinase activated protein kinase 2|mitogen activated protein kinase activated protein kinase-2|Y
mitogen activated protein kinase activated protein kinase 2|mitogen activated protein kinase activated protein kinase 1|Y
antituberculous treatment|anti-tuberculous treatment|Y
chicken luteinizing hormone releasing hormone I|chicken luteinizing hormone releasing hormone II|Y
galactorrhoea amenorrhœa hyperprolactinaemia syndrome|galactorrhoea-amenorrhœa hyperprolactinaemia syndrome|Y
galactorrhoea amenorrhœa hyperprolactinaemia syndrome|galactorrhea amenorrhœa hyperprolactinemia syndrome|Y
human corticotrophin-releasing hormone|human corticotropin-releasing hormone|Y
mid-sagittal diameter|midsagittal diameter|Y
Standard Pseudoisochromatic Plates-part 2|Standard Pseudoisochromatic Plates-Part 2|Y
peroxisome proliferator-activated receptor γ co-activator-1|peroxisome proliferator-activated receptor γ co-activator 1|Y
peroxisome proliferator-activated receptor γ co-activator-1|peroxisome proliferator-activated receptor γ co-activator-1α|Y
post-menopausal estrogen progestin intervention|postmenopausal estrogen progestin intervention|Y
recombinant human transforming growth factor beta2|recombinant human transforming growth factor beta3|Y
recombinant human transforming growth factor beta2|recombinant human transforming growth factor beta 2|Y
receptor-type protein tyrosine phosphatase-beta|receptor-type protein tyrosine phosphatase beta|Y
parahydroxy-mercuribenzoate|parahydroxymercuribenzoate|Y
solid phase extraction-high-performance liquid chromatography-tandem mass spectrometry|solid-phase extraction-high-performance liquid chromatography/tandem mass spectrometry|Y
solid-phase extraction-liquid chromatography-electrospray-tandem mass spectrometry|solid phase extraction-liquid chromatography-electrospray tandem mass spectrometry|Y
subperiosteal abscess|sub-periosteal abscess|Y
radioimmuno-detection|radioimmunodetection|Y
sub-orbicularis oculi fat|suborbicularis oculi fat|Y
Bjork-Shiley convexo-concave heart valve|Björk-Shiley convexo-concave heart valve|Y
visual evoked response|visual evoked responses|Y
interleukine-5 receptor-α|interleukin-5 receptor-α|Y
auditory evoked potential|auditory evoked potentials|Y
Vibrio cholerae O1 biotype ElTor|Vibrio cholerae O1 biotype El-Tor|Y
American Society of Anaesthesiologists status IV|American Society of Anaesthesiologists Status IV|Y
American Society of Anaesthesiologists status IV|American Society of Anaesthesiologists status I|Y
American Society of Anaesthesiologists status IV|American Society of Anaesthesiologists status II|Y
multi-fluor fluorescence in situ hybridisation|multifluor fluorescence in situ hybridisation|Y
multi-fluor fluorescence in situ hybridisation|multi-fluor fluorescence in-situ hybridisation|Y
5-(N-ethyl-N-isopropyl) amiloride|5-(N-ethyl-N-isopropyl)amiloride|Y
human T-cell lymphoma/leukemia virus type I|human T-cell lymphoma/leukaemia virus type I|Y
6-methoxy-N-(3-sulfopropyl) quinolinium|6-methoxy-N-(3-sulfopropyl)quinolinium|Y
Transfusion-associated graft-versus-host disease|transfusion-associated graft-versus-host disease|Y
high resolution gas chromatography/mass spectrometry|high resolution gas chromatography-mass spectrometry|Y
ouabainlike substance|ouabain-like substance|Y
estrogen receptor-β knock-out mouse|oestrogen receptor-β knock-out mouse|Y
bispecific monoclonal antibody|bi-specific monoclonal antibody|Y
macro-molecular creatine kinase 1|macromolecular creatine kinase 1|Y
gas chromatography/negative ion chemical ionization-mass spectrometry|gas chromatography/negative ion chemical ionization mass spectrometry|Y
α-1-anti-chymotrypsin|α-1-antichymotrypsin|Y
micro-chip electrophoresis|microchip electrophoresis|Y
Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime|Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime|Y
Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime|Kiddie-Schedule for Affective Disorders and Schizophrenia, Present and Lifetime|Y
N-formylmethionyl-leucyl-phenylalanine|N-formylmethionyl-leucylphenylalanine|Y
mitogen-activated protein kinase-dependent signaling pathway|mitogen activated protein kinase-dependent signalling pathway|Y
interleukin-4 receptor α subunit|interleukine-4 receptor α subunit|Y
American Society of Anaesthesiology grade I|American Society of Anaesthesiology grade II|Y
American Society of Anaesthesiology grade I|American Society of Anaesthesiology grade III|Y
American Society of Anaesthesiology grade I|American Society of Anaesthesiology grade 4|Y
American Society of Anaesthesiology grade I|American Society of Anaesthesiology grade V|Y
American Society of Anaesthesiology grade I|American Society of Anesthesiology grade I|Y
American Society of Anaesthesiology grade I|American Society of Anesthesiology grade II|Y
noninfectious hemagglutinin|non-infectious hemagglutinin|Y
interleukin-15 receptor alpha|interleukine-15 receptor alpha|Y
immunoglobulin superfamily 13|immunoglobulin superfamily 1|Y
immunoglobulin superfamily 13|immunoglobulin superfamily 3|Y
idiopathic fecal incontinence|idiopathic faecal incontinence|Y
over-training syndrome|overtraining syndrome|Y
adeno associated virus|adenoassociated virus|Y
ras-related GTP-binding protein 6A|ras-related GTP-binding protein 6|Y
uncoordinated protein 64|uncoordinated protein 6|Y
advance practice nurse|advanced practice nurse|Y
succinyl-aminoimidazole carboxamide ribotide synthetase|succinylaminoimidazole carboxamide ribotide synthetase|Y
intra-epithelial neoplasia|intraepithelial neoplasia|Y
anti-toll like receptor-2 monoclonal antibody|anti-toll like receptor-4 monoclonal antibody|Y
Charcot-Marie-Tooth type 2A disease|Charcot-Marie-Tooth type 2 disease|Y
liquid chromatography/atmospheric pressure chemical ionisation ion trap mass spectrometry|liquid chromatography-atmospheric pressure chemical ionisation-ion trap mass spectrometry|Y
pituitary adenylate cyclase-activating peptide type 1 receptor|pituitary adenylate cyclase activating peptide type 1 receptor|Y
IL13 receptor alpha2|IL-13 receptor alpha2|Y
galactorrhœa amenorrhoea hyperprolactinaemia syndrome|galactorrhœa-amenorrhoea hyperprolactinaemia syndrome|Y
capillary electrophoresis laser-induced fluorescence|capillary electrophoresis-laser-induced fluorescence|Y
regional cerebral bloodflow|regional cerebral blood flow|Y
inter-hemispheric inhibition|interhemispheric inhibition|Y
American Society of Anesthesiology physical status II|American Society of Anaesthesiology physical status III|Y
superficial musculo-aponeurotic system|superficial musculoaponeurotic system|Y
gas chromatography/high-resolution mass spectrometry|gas chromatography/high resolution mass spectrometry|Y
δ aminolevulinic acid|δ aminolaevulinic acid|Y
NF-kappaB essential modulator|NFkappaB essential modulator|Y
catechol-O-methyltransferase|catechol-O-methyl-transferase|Y
peroxisome proliferator-activated receptor-γ coactivator 1 α|peroxisome proliferator-activated receptor γ co-activator 1 α|Y
peroxisome proliferator-activated receptor-γ coactivator 1 α|peroxisome proliferator-activated receptor-γ co-activator 1α|Y
peroxisome proliferator-activated receptor-γ coactivator 1 α|peroxisome-proliferator-activated receptor-γ co-activator 1 α|Y
peroxisome proliferator-activated receptor-γ coactivator 1 α|peroxisome proliferator-activated receptor-γ co-activator-1 α|Y
FK506 binding protein 12.6|FK-506 binding protein 12.6|Y
a disintegrin and metalloproteinase-15|a disintegrin and metalloproteinase-5|Y
delayed microembolism syndrome|delayed micro-embolism syndrome|Y
DNA-protein crosslink|DNA-protein crosslinks|Y
enteroaggregative E coli|enteroaggregative E. coli|Y
extracellular signal-regulated protein kinase|extracellular signal-regulated protein kinase 2|Y
isotope dilution-gas chromatography-mass spectrometry|isotope dilution-gas chromatography/mass spectrometry|Y
mitogen-activated protein kinases|mitogen-activated protein kinase|Y
dorsolateral subluxation|dorso-lateral subluxation|Y
di-(2-ethylhexyl)phthalate|di(2-ethylhexyl)phthalate|Y
di-(2-ethylhexyl)phthalate|di-(2-ethylhexyl) phthalate|Y
di-(2-ethylhexyl)phthalate|di-(2-ethylhexyl)-phthalate|Y
Bardet-Biedl syndrome gene 1|Bardet-Biedl syndrome gene 10|Y
insulin-like growth factor-II mRNA binding protein|insulin-like growth factor-II mRNA-binding protein|Y
insulin-like growth factor-II mRNA binding protein|insulin-like growth factor-II mRNA binding protein-3|Y
insulin-like growth factor-II mRNA binding protein|insulin-like growth factor-II mRNA binding protein-2|Y
anti-polyribosylribitol phosphate antibody|anti-polyribosyl ribitol phosphate antibody|Y
thyrotropin-releasing hormone receptor type 2|thyrotropin-releasing hormone receptor type 1|Y
Na(+)/Ca(2+)-exchanger|Na(+)/Ca(2+)-exchange|Y
laevonorgestrel intra-uterine device|levonorgestrel intra-uterine device|Y
phosphorylated extracellular signal regulated kinase|phosphorylated extracellular signal regulated kinase 2|Y
ultra-performance liquid chromatography-electrospray ionisation tandem mass spectrometry|ultraperformance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
ultra-performance liquid chromatography-electrospray ionisation tandem mass spectrometry|ultra performance liquid chromatography/electrospray ionisation tandem mass spectrometry|Y
ultra-performance liquid chromatography-electrospray ionisation tandem mass spectrometry|ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
Src homology region 2 domain-containing phosphatase-2|Src homology region 2 domain-containing phosphatase 2|Y
Src homology region 2 domain-containing phosphatase-2|Src homology region 2 domain-containing phosphatase|Y
a disintegrin and metalloprotease with thrombospondin motif-1|a disintegrin and metalloprotease with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motif-1|a disintegrin and metalloprotease with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloprotease with thrombospondin motif-1|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-1|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motif-1|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motif-1|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motif-1|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motif-1|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-1|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motif-1|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motif-1|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
transcatheter arterial chemo-embolisation|transcatheter arterial chemoembolisation|Y
cytoplasmic polyadenylation element binding protein 4|cytoplasmic polyadenylation element binding protein 3|Y
cytoplasmic polyadenylation element binding protein 4|cytoplasmic polyadenylation element binding protein 2|Y
three colour fluorescence in-situ hybridisation|three color fluorescence in-situ hybridisation|Y
orthogonal partial least squares discriminant analysis|orthogonal partial least-squares discriminant analysis|Y
nonthymomatous myasthenia gravis|non-thymomatous myasthenia gravis|Y
matrix-assisted laser desorption ionisation time of flight mass spectrometric|matrix-assisted laser desorption ionization time of flight mass spectrometric|Y
matrix-assisted laser desorption ionisation time of flight mass spectrometric|matrix-assisted laser desorption ionisation time of flight mass spectrometry|Y
coraco-acromial ligament|coracoacromial ligament|Y
corticotropin releasing hormone receptor-1|corticotrophin releasing hormone receptor-1|Y
corticotropin releasing hormone receptor-1|corticotropin releasing hormone receptor-2|Y
corticotropin releasing hormone receptor-1|corticotropin releasing hormone receptor 1|Y
alpha,beta-methylene adenosine 5'-triphosphate|alpha,beta-methyleneadenosine 5'-triphosphate|Y
interleukin 22 receptor|interleukin 2 receptor|Y
light-harvesting chlorophyll a/b-binding protein II|light-harvesting chlorophyll a/b-binding protein-II|Y
cardio-thoracic surgery|cardiothoracic surgery|Y
endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangio pancreatography|Y
ras-related GTP-binding protein 32|ras-related GTP-binding protein 3|Y
heat and moisture exchanger|heat and moisture exchangers|Y
locoregional failure|loco-regional failure|Y
myocardial perfusion single-photon emission computerised tomography|myocardial perfusion single-photon emission computerized tomography|Y
a disintegrin and metalloprotease with thrombospondin motifs-7|a disintegrin and metalloproteinase with thrombospondin motif-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-7|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motifs-7|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloprotease with thrombospondin motifs-7|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motifs-7|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motifs-7|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
palmo-plantar pustular psoriasis|palmoplantar pustular psoriasis|Y
α1-acid glycoprotein|α 1-acid glycoprotein|Y
transforming growth factor-β receptor I|transforming growth factor-β receptor II|Y
tetrahydro-aminoacridine|tetrahydroaminoacridine|Y
transforming growth factor β receptor II|transforming growth factor-β receptor II|Y
ras-related GTP-binding protein 3A|ras-related GTP-binding protein 3|Y
ras-related GTP-binding protein 3A|ras-related GTP-binding protein 39A|Y
transient receptor potential vanilloid receptor 6|transient receptor potential vanilloid receptor 1|Y
transient receptor potential vanilloid receptor 6|transient receptor potential vanilloid receptor 5|Y
interleukin-12 receptor β1|interleukin-12 receptor β 1|Y
platelet-derived microparticles|platelet-derived microparticle|Y
IFN-alpha producing cell|IFN-alpha producing cells|Y
soluble cluster of differentiation antigen 80|soluble cluster of differentiation antigen 30|Y
calcium- and diacylglycerol-regulated guanine nucleotide exchange factor II|calcium- and diacylglycerol-regulated guanine nucleotide exchange factor III|Y
calcium- and diacylglycerol-regulated guanine nucleotide exchange factor II|calcium- and diacylglycerol-regulated guanine nucleotide exchange factor Ia|Y
stromal derived factor 1-alpha|stromal derived factor 1alpha|Y
POU domain, class 3, transcription factor 1|POU domain, class 3, transcription factor 3|Y
soluble interleukine-6 receptor α|soluble interleukin-6 receptor α|Y
nanoflow liquid chromatography tandem mass spectrometry|nano-flow liquid chromatography tandem mass spectrometry|Y
TATA-binding protein-associated factor 1|TATA-binding protein-associated factor 4|Y
TATA-binding protein-associated factor 1|TATA-binding protein-associated factor-1|Y
peroxisome-proliferator-activated receptor-gamma co-activator 1 alpha|peroxisome-proliferator-activated receptor-gamma co-activator-1 alpha|Y
peroxisome-proliferator-activated receptor-gamma co-activator 1 alpha|peroxisome-proliferator-activated receptor-gamma co-activator-1alpha|Y
peroxisome-proliferator-activated receptor-gamma co-activator 1 alpha|peroxisome-proliferator-activated receptor-gamma co-activator 1alpha|Y
peroxisome-proliferator-activated receptor-gamma co-activator 1 alpha|peroxisome proliferator-activated receptor-gamma coactivator 1 alpha|Y
peroxisome-proliferator-activated receptor-gamma co-activator 1 alpha|peroxisome proliferator-activated receptor-gamma co-activator 1 alpha|Y
peroxisome-proliferator-activated receptor-gamma co-activator 1 alpha|peroxisome-proliferator-activated receptor gamma coactivator 1 alpha|Y
cytosolic phospholipase A2α|cytosolic phospholipase A2|Y
a disintegrin and metalloprotease with thrombospondin motif-18|a disintegrin and metalloprotease with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motif-18|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motif-18|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloprotease with thrombospondin motif-18|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motif-18|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motif-18|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motif-18|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-18|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motif-18|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
a disintegrin and metalloprotease with thrombospondin motif-18|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
death-inducing signaling complex|death-inducing signalling complex|Y
self administered alcoholism screening test|self-administered alcoholism screening test|Y
activated Cdc42-associated tyrosine kinase 1|activated Cdc42 associated tyrosine kinase 1|Y
procollagen type III aminoterminal peptide|procollagen type III amino-terminal peptide|Y
transcutaneous electrical nerve stimulation|transcutaneous electric nerve stimulation|Y
β amyloid precursor protein-cleaving enzyme|β amyloid precursor protein-cleaving enzyme-2|Y
pentatrico-peptide repeat|pentatricopeptide repeat|Y
thoraco-lumbosacral orthosis|thoracolumbosacral orthosis|Y
hyperosmolar nonketotic diabetic coma|hyperosmolar non-ketotic diabetic coma|Y
American Society of Anaesthesiology physical status|American Society of Anesthesiology physical status|Y
tetramethylrhodamine isothio-cyanate|tetramethylrhodamine isothiocyanate|Y
anti-glomerular basement membrane|antiglomerular basement membrane|Y
diaspirin-cross-linked haemoglobin|diaspirin-cross-linked hemoglobin|Y
signal transducer and activator of transcription|signal transducer and activator of transcription-6|Y
signal transducer and activator of transcription|signal transducer and activator of transcription-1|Y
signal transducer and activator of transcription|signal transducer and activator of transcription 6|Y
signal transducer and activator of transcription|signal transducer and activator of transcription 3|Y
gonadotrophin releasing hormone analog|gonadotropin releasing hormone analog|Y
field excitatory post-synaptic potential|field excitatory postsynaptic potential|Y
voltage dependent anion selective channel 3|voltage dependent anion selective channel|Y
epi-gallo-catechin gallate|epi-gallocatechin gallate|Y
epi-gallo-catechin gallate|epigallo-catechin gallate|Y
src homology 2 domain-containing transforming protein C1|Src homology 2 domain-containing transforming protein C1|Y
non-gonococcal urethritis|nongonococcal urethritis|Y
dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin|dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin|Y
peroxisome proliferator-activated receptor alpha agonist|peroxisome proliferator-activated receptor-alpha agonist|Y
peroxisome proliferator-activated receptor alpha agonist|peroxisome-proliferator-activated receptor alpha agonist|Y
corticotropin-releasing hormone receptor 1|corticotropin releasing hormone receptor 1|Y
non-governmental organisations|non-governmental organisation|Y
American Society of Anaesthesiologists Status IV|American Society of Anaesthesiologists Status II|Y
trauma-focused cognitive-behavioural therapy|trauma-focused cognitive behavioural therapy|Y
transforming growth factor-beta 1|transforming growth factor-beta1|Y
insulin-like growth factor-II messenger RNA-binding protein-1|insulin-like growth factor-II messenger RNA-binding protein-3|Y
insulin-like growth factor-II messenger RNA-binding protein-1|insulin-like growth factor-II messenger RNA binding protein-1|Y
osteoclast-like giant cell|osteoclastlike giant cell|Y
transforming growth factor-β type I receptor kinase|transforming growth factor β type I receptor kinase|Y
matrix assisted laser desorption/ionisation time-of-flight mass spectrometry|matrix assisted laser desorption/ionization time-of-flight mass spectrometry|Y
anti-human immunodeficiency virus type 1|anti-human immunodeficiency virus type-1|Y
generalized linear modeling|generalized linear modelling|Y
Rush Presbyterian-Saint Luke's Medical Center|Rush Presbyterian Saint Luke's Medical Center|Y
Rush Presbyterian-Saint Luke's Medical Center|Rush Presbyterian-Saint Luke's Medical Centre|Y
alpha-thalassaemia/mental retardation syndrome X-linked|alpha-thalassemia/mental retardation syndrome X-linked|Y
fluorescent amplified fragment length polymorphism analysis|fluorescent amplified-fragment length polymorphism analysis|Y
peroxisome proliferator-activated receptor gamma coactivator-1|peroxisome proliferator-activated receptor-gamma co-activator-1|Y
peroxisome proliferator-activated receptor gamma coactivator-1|peroxisome proliferator-activated receptor gamma co-activator 1|Y
peroxisome proliferator-activated receptor gamma coactivator-1|Peroxisome proliferator-activated receptor gamma coactivator-1|Y
promyelocytic leukemia-retinoic acid receptor-α|promyelocytic leukemia/retinoic acid receptor-α|Y
promyelocytic leukemia-retinoic acid receptor-α|promyelocytic leukemia-retinoic acid receptor α|Y
mammalian gonadotropin releasing hormone|mammalian gonadotropin-releasing hormone|Y
acidic proline-rich protein|acidic proline-rich proteins|Y
anti-ovulatory activity|antiovulatory activity|Y
intra-peritoneal haemorrhage|intra-peritoneal hemorrhage|Y
type 2 sodium phosphate co-transporter|type 2 sodium phosphate cotransporter|Y
intra-vascular large B cell lymphoma|intravascular large B cell lymphoma|Y
corticotrophin releasing hormone receptor-1|corticotrophin releasing hormone receptor-2|Y
anti-dinitrophenyl immunoglobulin E|antidinitrophenyl immunoglobulin E|Y
receptor-like protein tyrosine phosphatase kappa|receptor-like protein tyrosine phosphatase-kappa|Y
inter-stimulus distance|interstimulus distance|Y
total i.v. anesthesia|total i.v. anaesthesia|Y
neural precursor cell expressed developmentally downregulated 2|neural precursor cell expressed, developmentally downregulated 2|Y
neural precursor cell expressed developmentally downregulated 2|neural precursor cell-expressed developmentally down-regulated 2|Y
neural precursor cell expressed developmentally downregulated 2|neural precursor cell expressed developmentally down-regulated 9|Y
work-place health promotion|workplace health promotion|Y
semimicro high-performance liquid chromatography|semi-micro high-performance liquid chromatography|Y
nonribosomal peptide synthetase|non-ribosomal peptide synthetase|Y
reaction centre-light harvesting complex I|reaction centre-light-harvesting complex I|Y
reaction centre-light harvesting complex I|reaction center-light harvesting complex I|Y
a disintegrin and metalloproteinase with thrombospondin motifs-15|a disintegrin and metalloproteinase with thrombospondin motifs-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-15|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motifs-15|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motifs-15|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motifs-15|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motifs-15|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-15|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-15|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-15|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motifs-15|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motifs-15|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motifs-15|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motifs-15|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
a disintegrin and metalloproteinase with thrombospondin motifs-15|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-15|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-15|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
monomethylarsonic acid|mono-methylarsonic acid|Y
microtubule associated protein-1 light chain-3|microtubule associated protein 1 light chain-3|Y
human leucocyte antigen-D-related antigen|human leucocyte antigen D-related antigen|Y
anti-human immunodeficiency virus activity|anti-human immunodeficiency virus 1 activity|Y
anti-human immunodeficiency virus activity|antihuman immunodeficiency virus activity|Y
surface enhanced laser desorption/ionisation time-of-flight mass spectrometry|surface enhanced laser desorption ionisation time-of-flight mass spectrometry|Y
forkhead box class O|forkhead box class O2|Y
Rouxen-Y gastric bypass|Roux-en-Y gastric bypass|Y
peroxisome proliferator-activated receptor-gamma 1|peroxisome proliferator-activated receptor-gamma|Y
sector field inductively-coupled plasma mass spectrometry|sector field inductively coupled plasma mass spectrometry|Y
judgments of learning|judgment of learning|Y
tissue bound angiotensin-converting enzyme|tissue bound angiotensin converting enzyme|Y
oestrogen receptor α knockout mouse|estrogen receptor α knockout mouse|Y
recombinant human interleukin 18|recombinant human interleukin 8|Y
granule bound starch synthase I|granule bound starch synthase II|Y
prebeta1-high density lipoprotein|pre-beta1-high density lipoprotein|Y
tubulo-reticular inclusion|tubuloreticular inclusion|Y
transient receptor potential melastatin 6|transient receptor potential melastatin 7|Y
transient receptor potential melastatin 6|transient receptor potential melastatin 8|Y
transient receptor potential melastatin 6|transient receptor potential melastatin 1|Y
cysteine-cysteine chemokine ligand 5|cysteine-cysteine chemokine ligand 25|Y
pylorus-preserving pancreatico-duodenectomy|pylorus-preserving pancreato-duodenectomy|Y
peptidyl-glycine-alpha-amidating monooxygenase|peptidyl-glycine alpha-amidating monooxygenase|Y
peptidyl-glycine-alpha-amidating monooxygenase|peptidylglycine-alpha-amidating monooxygenase|Y
immunoglobulin-containing cell|immunoglobulin-containing cells|Y
erythroblastic leukemia viral oncogene homolog 3|erythroblastic leukemia viral oncogene homolog 2|Y
erythroblastic leukemia viral oncogene homolog 3|erythroblastic leukemia viral oncogene homolog A|Y
erythroblastic leukemia viral oncogene homolog 3|erythroblastic leukemia viral oncogene homolog 4|Y
homo-gamma-linolenoyl ethanolamide|homo-gamma-linolenoylethanolamide|Y
non-melanoma skin cancers|non-melanoma skin cancer|Y
transforming growth factor-beta receptor type I|transforming growth factor-beta receptor type 1|Y
transforming growth factor-beta receptor type I|transforming growth factor-beta receptor type 2|Y
surface generalised Born continuum solvation model|surface-generalised Born continuum solvation model|Y
surface generalised Born continuum solvation model|surface generalized Born continuum solvation model|Y
Escherichia coli BL21|Escherichia coli BL-21|Y
dendritic cell-tumor cell hybrid|dendritic cell-tumour cell hybrid|Y
flow cytometry crossmatch|flow cytometry cross-match|Y
pancreaticogastrostomy|pancreatico-gastrostomy|Y
N-terminal pro-B-type natriuretic peptide|N-terminal-pro-B-type natriuretic peptide|Y
N-terminal pro-B-type natriuretic peptide|N-terminal proB-type natriuretic peptide|Y
N-terminal pro-B-type natriuretic peptide|N-terminal pro B-type natriuretic peptide|Y
tumor necrosis factor-related apoptosis-inducing ligand|tumor necrosis factor-related apoptosis inducing ligand|Y
preprocorticotropin releasing factor|preprocorticotrophin releasing factor|Y
SAP90/PSD95-associated protein|SAP90/PSD-95-associated protein|Y
American Society of Anaesthesiologists status I|American Society of Anaesthesiologists status 1|Y
American Society of Anaesthesiologists status I|American Society of Anaesthesiologists status III|Y
American Society of Anaesthesiologists status I|American Society of Anaesthesiologists status II|Y
American Society of Anaesthesiologists status I|American Society of Anaesthesiologists status 5|Y
retinoic-acid-receptor-related orphan receptor γT|retinoic-acid-receptor-related orphan receptor γ|Y
G-protein β-γ subunit|G-protein βγ subunit|Y
gamma-aminobutyric acidA-benzodiazepine receptor complex|gamma-aminobutyric acidA/benzodiazepine receptor complex|Y
arginine metabolism regulator III|arginine metabolism regulator II|Y
latent transforming growth factor-beta binding protein 1|latent transforming growth factor beta binding protein 1|Y
poly-levolactic acid|poly-laevolactic acid|Y
liquid chromatographic/mass spectrometric|liquid chromatographic-mass spectrometric|Y
extracellular regulated kinases|extracellular regulated kinase|Y
vascular endothelial growth factor receptor 3|vascular endothelial growth factor receptor 2|Y
structural maintenance of chromosome protein 1|structural maintenance of chromosome protein 3|Y
serotonin selective re-uptake inhibitor|serotonin selective reuptake inhibitor|Y
gastrointestinal complication|gastro-intestinal complication|Y
G protein alphaq subunit|G protein alpha subunit|Y
anti-ribonucleoprotein|antiribonucleoprotein|Y
university-affiliated Veterans Administration Medical Center|university affiliated Veteran's Administration Medical Center|Y
electro-mechanical dissociation|electromechanical dissociation|Y
anti-toll like receptor-4 monoclonal antibody|anti-toll like receptor 4 monoclonal antibody|Y
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide|1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide|Y
Fanconi anaemia-associated nuclease 1|Fanconi anemia-associated nuclease 1|Y
promyelocytic leukaemia-retinoic acid receptor α|promyelocytic leukemia-retinoic acid receptor α|Y
dehydrodihydroxylysinonorleucine|dehydro-dihydroxylysinonorleucine|Y
extended Hückel tight binding band calculation|extended Hückel tight-binding band calculation|Y
triglyceride lowering diet|triglycerid lowering diet|Y
acro-kerato-elastoidosis|acro-keratoelastoidosis|Y
acro-kerato-elastoidosis|acrokerato-elastoidosis|Y
C-EBP homologous protein|CEBP homologous protein|Y
prepro-parathyroid hormone|preproparathyroid hormone|Y
delta9-tetrahydrocannabinol|delta 9-tetrahydrocannabinol|Y
transient receptor potential vanilloid receptor 1|transient receptor potential vanilloid receptor 5|Y
type 2 corticotrophin-releasing-hormone receptor|type-2 corticotrophin-releasing-hormone receptor|Y
type 2 corticotrophin-releasing-hormone receptor|type 2 corticotrophin-releasing hormone receptor|Y
oxidized low-density lipoprotein receptor 1|oxidized low density lipoprotein receptor 1|Y
excision repair cross complementing group 4|excision repair cross complementing group 5|Y
excision repair cross complementing group 4|excision repair cross complementing group 2|Y
excision repair cross complementing group 4|excision repair cross complementing group 6|Y
tumor necrosis factor receptor superfamily member 8|tumor necrosis factor receptor superfamily member 9|Y
tumor necrosis factor-related apoptosis inducing ligand receptor|tumour necrosis factor related apoptosis inducing ligand receptor|Y
soluble N-ethyl-maleimide-sensitive factor attachment protein receptor|soluble N-ethylmaleimide-sensitive factor attachment protein receptor|Y
soluble N-ethyl-maleimide-sensitive factor attachment protein receptor|soluble N-ethylmaleimide-sensitive factor attachment protein receptors|Y
carotid blow-out syndrome|carotid blowout syndrome|Y
Minneapolis Veterans Administration Medical Center|Minneapolis Veterans' Administration Medical Center|Y
Minneapolis Veterans Administration Medical Center|Minneapolis Veteran's Administration Medical Center|Y
latent transforming growth factor beta binding protein-2|latent transforming growth factor beta binding protein 2|Y
non-structural protein 4|non-structural protein 4B|Y
similar to mothers against decapentaplegic homolog 2|similar to mothers against decapentaplegic homolog 8|Y
recombinant human transforming growth factor beta3|recombinant human transforming growth factor beta 3|Y
tracheo-bronchomalacia|tracheobronchomalacia|Y
immuno-enzymatic assay|immunoenzymatic assay|Y
left salpingoophorectomy|left salpingooophorectomy|Y
short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing|shortlasting, unilateral, neuralgiform headache attacks with conjunctival injection and tearing|Y
matrix-assisted laser desorption/ionization time of flight mass spectrometry|matrix-assisted laser desorption ionization time of flight mass spectrometry|Y
anti-β 2-glycoprotein I antibody|anti-β2-glycoprotein I antibody|Y
N-Nitroso(2-hydroxypropyl)(2-oxopropyl)amine|N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine|Y
platelet-derived growth factor-AB|platelet-derived growth factor-B|Y
poly-hydroxyethylmethacrylate|poly-hydroxyethyl-methacrylate|Y
antithyroid antibody|anti-thyroid antibody|Y
recombinant human interferon α 2b|recombinant human interferon α2b|Y
13,14-dihydro-15-keto-prostaglandin F2 alpha|13,14-dihydro-15-keto prostaglandin F2 alpha|Y
serotonin norepinephrine re-uptake inhibitor|serotonin norepinephrine reuptake inhibitor|Y
latent transforming growth factor beta binding protein 1|latent transforming growth factor beta binding protein 2|Y
latent transforming growth factor beta binding protein 1|latent transforming growth factor beta binding protein 4|Y
latent transforming growth factor beta binding protein 1|latent transforming growth factor beta binding protein 3|Y
cellular inhibitor of apoptosis protein|cellular inhibitor of apoptosis protein 1|Y
cellular inhibitor of apoptosis protein|cellular inhibitor of apoptosis protein-2|Y
levonorgestrel releasing intra uterine system|laevonorgestrel releasing intra uterine system|Y
homozygous α 1-protease inhibitor deficiency|homozygous α 1-proteinase inhibitor deficiency|Y
toll-interleukin1 receptor domain-containing adapter inducing interferon beta|toll-interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
agar-gel immuno-diffusion|agargel immuno-diffusion|Y
intraoperative ultrasonography|intra-operative ultrasonography|Y
percutaneous trans-hepatic portography|percutaneous transhepatic portography|Y
nontypeable Hemophilus influenzae|non-typeable Hemophilus influenzae|Y
combined antiretroviral therapy|combined anti-retroviral therapy|Y
American Society of Anesthesiologists status 5|American Society of Anaesthesiologists status 5|Y
never in mitosis, gene A-related kinase 3|never in mitosis, gene A-related kinase 6|Y
never in mitosis, gene A-related kinase 3|never in mitosis, gene A-related kinase 4|Y
World Health Organisation Quality of Life-Brief version|World Health Organisation Quality of Life-brief version|Y
3-hydroxy-3-methylglutaryl-CoA reductase|3-hydroxy-3-methyl-glutaryl-CoA reductase|Y
DXP reducto-isomerase|DXP reductoisomerase|Y
platelet-derived growth factor-BB|platelet-derived growth factor-B|Y
TATA-binding protein-associated factor 4|TATA-binding protein-associated factor-4|Y
side-stream darkfield imaging|side-stream dark field imaging|Y
TBP associated factor-1|TBP associated factor-12|Y
TBP associated factor-1|TBP associated factor-11|Y
src homology-2 domain-containing protein tyrosine phosphatase 2|Src homology-2 domain-containing protein tyrosine phosphatase 2|Y
src homology-2 domain-containing protein tyrosine phosphatase 2|src homology-2 domain-containing protein tyrosine phosphatase|Y
porcine pregnancy-associated glycoprotein 2|porcine pregnancy-associated glycoprotein-2|Y
B-cell leukaemia/lymphoma-2|B-cell leukemia/lymphoma-2|Y
anti-IL4 monoclonal antibody|anti-IL 4 monoclonal antibody|Y
NMDA receptor antagonist D-2-amino-5-phosphonovalerate|NMDA receptor antagonist 2-amino-5-phosphonovalerate|Y
killer immunoglobulin-like receptor 2DS1|killer immunoglobulin-like receptor 2DS3|Y
killer immunoglobulin-like receptor 2DS1|killer immunoglobulin-like receptor 2DS2|Y
linearised multi-stage model|linearised multistage model|Y
immunoreceptor tyrosine-based activation motif|immuno-receptor tyrosine-based activation motif|Y
a disintegrin and metalloprotease-3|a disintegrin and metalloprotease-23|Y
electro-encephalographic study|electroencephalographic study|Y
prostaglandin F-(2) α|prostaglandin F-(2)α|Y
latent transforming growth factor beta binding protein 2|latent transforming growth factor beta binding protein 4|Y
latent transforming growth factor beta binding protein 2|latent transforming growth factor beta binding protein 3|Y
hydroxy-propyl-β-cyclodextrin|hydroxypropyl-β-cyclodextrin|Y
radio-immunoguided surgery|radioimmunoguided surgery|Y
trans-jugular intrahepatic porto-caval shunt|trans-jugular intrahepatic portocaval shunt|Y
long-segment Barrett's esophagus|long-segment Barrett's oesophagus|Y
uncoordinated protein 119|uncoordinated protein 11|Y
Drosophila glutamate receptor I|Drosophila glutamate receptor IB|Y
tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone|tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone|Y
krueppel-like factor-6|kruppel-like factor-6|Y
American Society of Anaesthesiologists Grade 4|American Society of Anaesthesiologists Grade 5|Y
American Society of Anaesthesiologists Grade 4|American Society of Anaesthesiologists grade 4|Y
non-parenchymal cells|non-parenchymal cell|Y
alpha-fluoromethyl histidine|alpha-fluoromethylhistidine|Y
arachidoyl-coenzyme A|arachidonyl-coenzyme A|Y
recombinant human interleukin-1α|recombinant human interleukin-1 α|Y
tumor associated antigen|tumour associated antigen|Y
Reis-Bucklers' corneal dystrophy|Reis-Bucklers corneal dystrophy|Y
single-photon-emission computed tomography|single-photon emission computed tomography|Y
gas chromatography/negative-ion chemical ionization mass spectrometry|gas chromatography/negative ion chemical ionization mass spectrometry|Y
tumour necrosis factor related apoptosis inducing ligand|tumour necrosis factor-related apoptosis inducing ligand|Y
tumour necrosis factor related apoptosis inducing ligand|tumor necrosis factor related apoptosis inducing ligand|Y
hereditary angioneurotic œdema|hereditary angio-neurotic œdema|Y
Wingless-type MMTV integration site family member 7B|wingless-type MMTV integration site family member 7B|Y
electoconvulsive shock therapy|electroconvulsive shock therapy|Y
toll/interleukin-1 receptor domain-containing adapter-inducing interferon beta|toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
Na-K-Cl co-transporter|Na-K-2Cl co-transporter|Y
stromal-derived factor 1alpha|stromal-derived factor 1-alpha|Y
zwitterionic detergent 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate|zwitterionic detergent 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate|Y
human germinal center-associated lymphoma|human germinal centre-associated lymphoma|Y
human germinal center-associated lymphoma|human germinal center associated lymphoma|Y
human germinal center-associated lymphoma|human germinal-center-associated lymphoma|Y
high density lipoproteins2|high density lipoprotein2|Y
enteric septicemia of catfish|enteric septicaemia of catfish|Y
metabotropic glutamate receptor subtype 5|metabotropic glutamate receptor subtype 6|Y
metabotropic glutamate receptor subtype 5|metabotropic glutamate receptor subtype 4|Y
flavin-containing monooxygenase 5|flavin-containing mono-oxygenase 5|Y
delayed nonmatch to sample|delayed non-match to sample|Y
ovine growth hormone|bovine growth hormone|Y
nonmatching-to-sample|non-matching-to-sample|Y
anti-interleukin 2 receptor monoclonal antibody|antiinterleukin 2 receptor monoclonal antibody|Y
anti-interleukin 2 receptor monoclonal antibody|anti-interleukin 4 receptor monoclonal antibody|Y
self-mutilative behavior|self-mutilative behaviour|Y
American Society of Anaesthesiologists grade 3|American Society of Anaesthesiologists grade 5|Y
American Society of Anaesthesiologists grade 3|American Society of Anaesthesiologists grade 4|Y
mitogen-activated protein kinase activated protein kinase 5|mitogen-activated protein kinase-activated protein kinase 5|Y
mitogen-activated protein kinase activated protein kinase 5|mitogen-activated protein kinase activated protein kinase|Y
containing only apoA-I|containing only apo A-I|Y
total cavopulmonary connection|total cavo-pulmonary connection|Y
phenylalanyl-methionyl-arginyl-phenylalaninamide-like|phenylalanyl-methionyl-arginyl-phenylalaninamidelike|Y
feline fibrosarcoma virus|feline fibro-sarcoma virus|Y
a disintegrin and metalloproteinase with thrombospondin motif-7|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motif-7|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motif-7|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motif-7|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-7|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motif-7|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motif-7|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motif-7|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-7|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motif-7|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motif-7|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-7|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motif-7|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
immunoglobulin-secreting cells|immunoglobulin-secreting cell|Y
American Society of Anesthesiologists physical status 4|American Society of Anesthesiologists physical status 5|Y
American Society of Anesthesiologists physical status 4|American Society of Anaesthesiologists physical status 4|Y
ste-20-related proline alanine rich kinase|Ste-20-related proline alanine rich kinase|Y
American Society of Anesthesiologists Status 1|American Society of Anesthesiologists Status 4|Y
autoimmune thyroid disease|auto-immune thyroid disease|Y
TNM pathologic stage N1bii|TNM pathologic stage N1biii|Y
N,N'-dicyclohexylcarbodiimide|N,N'-dicyclohexyl carbodiimide|Y
technetium-99m-methoxy isobutyl isonitrile|technetium-99m-methoxyisobutylisonitrile|Y
self-consistent charge density functional tight-binding method|self-consistent charge density functional tight binding method|Y
temperature-programed desorption mass spectrometry|temperature programed desorption mass spectrometry|Y
ribosomal protein S2|ribosomal protein S27|Y
ribosomal protein S2|ribosomal protein S26|Y
ribosomal protein S2|ribosomal protein S29|Y
immunocytochemical staining|immuno-cytochemical staining|Y
technetium 99m-labelled|technetium 99m-labeled|Y
giant cell tumor of bone|giant cell tumour of bone|Y
thiazide sensitive NaCl cotransporter|thiazide sensitive NaCl co-transporter|Y
thiazide sensitive NaCl cotransporter|thiazide sensitive Na-Cl cotransporter|Y
multi-fluor fluorescence in-situ hybridization|multi-fluor fluorescence in-situ hybridisation|Y
gastro-enteropancreatic|gastro-entero-pancreatic|Y
inter-spike interval histogram|interspike interval histogram|Y
three-color fluorescence in-situ hybridization|three-colour fluorescence in-situ hybridization|Y
three-color fluorescence in-situ hybridization|three-color fluorescence in-situ hybridisation|Y
photocatalytic degradation|photo-catalytic degradation|Y
biventricular hypertrophy|bi-ventricular hypertrophy|Y
midlatency auditory evoked response|mid-latency auditory evoked response|Y
American Society of Anaesthesiology grade II|American Society of Anaesthesiology grade III|Y
American Society of Anaesthesiology grade II|American Society of Anaesthesiology Grade II|Y
American Society of Anaesthesiology grade II|American Society of Anesthesiology grade I|Y
American Society of Anaesthesiology grade II|American Society of Anesthesiology grade II|Y
ras-related GTP-binding protein 3B|ras-related GTP-binding protein 3|Y
pattern-reversal visual evoked potential|pattern reversal visual evoked potential|Y
tumor necrosis factor receptor superfamily member 10b|tumor necrosis factor receptor superfamily member 11b|Y
tumor necrosis factor receptor superfamily member 10b|tumor necrosis factor receptor superfamily member 10d|Y
antinuclear antibody|anti nuclear antibody|Y
non-sense-mediated decay|nonsense-mediated decay|Y
functional magnetic resonance images|functional magnetic resonance image|Y
antiinterleukin 5 monoclonal antibody|antiinterleukin 15 monoclonal antibody|Y
immunoglobulin superfamily 1|immunoglobulin superfamily 11|Y
excision repair cross-complementing-group 2|excision repair cross-complementing-group 1|Y
excision repair cross-complementing-group 2|excision repair cross-complementing-group 4|Y
neural precursor cell-expressed, developmentally downregulated 9|neural precursor cell-expressed developmentally down-regulated 9|Y
neural precursor cell-expressed, developmentally downregulated 9|neural precursor cell-expressed developmentally downregulated 1|Y
neural precursor cell-expressed, developmentally downregulated 9|neural precursor cell-expressed developmentally downregulated 9|Y
neural precursor cell-expressed, developmentally downregulated 9|neural precursor cell-expressed, developmentally downregulated 8|Y
neural precursor cell-expressed, developmentally downregulated 9|neural precursor cell-expressed, developmentally downregulated 1|Y
neural precursor cell-expressed, developmentally downregulated 9|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell-expressed, developmentally downregulated 9|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell-expressed, developmentally downregulated 9|neural precursor cell-expressed, developmentally down-regulated 2|Y
intra-ligand charge transfer|intraligand charge transfer|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|toll/interleukin-1 receptor domain-containing adapter-inducing interferon β|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|toll/interleukin 1 receptor domain-containing adapter-inducing interferon β|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
multi-targeted antifolate|multitargeted antifolate|Y
X-linked hypophosphataemia|X-linked hypophosphatemia|Y
sham-operated controls|sham-operated control|Y
peroxisome proliferator activated receptor gamma co-activator 1|peroxisome proliferator activated receptor gamma coactivator 1|Y
peroxisome proliferator activated receptor gamma co-activator 1|peroxisome proliferator-activated receptor gamma co-activator 1|Y
benzo[a]pyrene diol-epoxide DNA adduct level|benzo[a]pyrene diol epoxide DNA adduct level|Y
Transforming growth factor-beta|Transforming growth factor-betas|Y
electrocochleography|electro-cochleography|Y
propylbenzilyl-choline mustard|propylbenzilylcholine mustard|Y
oscillatory after-potential|oscillatory afterpotential|Y
American Society of Anesthesiology physical status 2|American Society of Anesthesiology physical status|Y
American Society of Anesthesiology physical status 2|American Society of Anesthesiology physical status 3|Y
neural-precursor-cell-expressed developmentally down-regulated 9|neural-precursor-cell-expressed, developmentally down-regulated 4|Y
neural-precursor-cell-expressed developmentally down-regulated 9|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor-cell-expressed developmentally down-regulated 9|neural-precursor-cell-expressed developmentally downregulated 5|Y
neural-precursor-cell-expressed developmentally down-regulated 9|neural-precursor-cell-expressed developmentally down-regulated 1|Y
reno-medullary interstitial cell|renomedullary interstitial cell|Y
contour clamped homogeneous electric field|contour-clamped homogeneous electric field|Y
organophosphorus ester-induced delayed neurotoxicity|organophosphorus-ester-induced delayed neurotoxicity|Y
chloromethylfluorescein di-acetate|chloromethylfluorescein diacetate|Y
Bos taurus autosome 11|Bos taurus autosome 1|Y
melanoma differentiation-associated gene-5|melanoma differentiation-associated gene 5|Y
melanoma differentiation-associated gene-5|melanoma-differentiation-associated gene-5|Y
recombinant human granulocyte-macrophage colony stimulating factor|recombinant human granulocyte macrophage colony stimulating factor|Y
beta-amyloid precursor protein-cleaving enzyme 1|beta-amyloid precursor protein cleaving enzyme 1|Y
sterol regulatory element-binding protein-1-c|sterol regulatory element binding protein-1-c|Y
sterol regulatory element-binding protein-1-c|sterol regulatory element-binding protein-1-a|Y
rat placental lactogen II|rat placental lactogen I|Y
anti-protamine immunoglobulin E|antiprotamine immunoglobulin E|Y
ubiquitin-conjugating enzyme 11|ubiquitin-conjugating enzyme 1|Y
bulbocavernosus reflex|bulbo-cavernosus reflex|Y
attenuated total reflectance Fourier transform infrared spectroscopy|attenuated total reflectance Fourier transform infra-red spectroscopy|Y
size exclusion chromatography-multi-angle laser light scattering|size exclusion chromatography/multiangle laser light scattering|Y
size exclusion chromatography-multi-angle laser light scattering|size-exclusion chromatography-multi-angle laser light scattering|Y
technetium-99m methoxyisobutylisonitrile|technetium-99m-methoxyisobutylisonitrile|Y
ribosomal protein S7|ribosomal protein S27|Y
olivopontocerebellar atrophy|olivo-pontocerebellar atrophy|Y
circulating platelet aggregate|circulating platelet aggregates|Y
colo-rectal carcinoma|colorectal carcinoma|Y
peroxisome proliferator-activated receptor γ coactivator 1|peroxisome proliferator-activated receptor γ co-activator 1|Y
peroxisome proliferator-activated receptor γ coactivator 1|peroxisome proliferator-activated receptor γ co-activator 1α|Y
single-photon emission computed tomography|single-photon emission-computed tomography|Y
spinocerebellar ataxia type 10|spinocerebellar ataxia type 1|Y
Src homology-2 domain-containing protein tyrosine phosphatase 2|Src homology-2 domain-containing protein tyrosine phosphatase-2|Y
Src homology-2 domain-containing protein tyrosine phosphatase 2|Src-homology-2 domain-containing protein tyrosine phosphatase 2|Y
pharmaco-mechanical thrombectomy|pharmacomechanical thrombectomy|Y
retinoic acid-inducible gene I-like receptor|retinoic-acid-inducible gene I-like receptor|Y
Manual Ability Classification System level III|Manual Ability Classification System level II|Y
N`-nitrosonornicotine|N-nitrosonornicotine|Y
United States Department of Health, Education and Welfare|United States Department of Health, Education, and Welfare|Y
kruppel-like factor-13|kruppel-like factor-3|Y
anti-β-2-glycoprotein 1 antibody|anti-β2-glycoprotein 1 antibody|Y
extra-cellular resistance|extracellular resistance|Y
bone gamma-carboxyglutamic acid-containing protein|bone gamma-carboxyglutamic acid containing protein|Y
phosphorylated p38 mitogen-activated protein kinase|phosphorylated p38 mitogen activated protein kinase|Y
Veterans' Health Administration medical center|Veterans Health Administration medical center|Y
root phototropism protein 5|root phototropism protein 5a|Y
root phototropism protein 5|root phototropism protein 5b|Y
expressed breastmilk|expressed breast milk|Y
Von Hippel-Lindau tumour suppressor protein|von Hippel-Lindau tumour suppressor protein|Y
microtubule-associated protein 1 light chain-3|microtubule-associated protein 1 light chain-3B|Y
microtubule-associated protein 1 light chain-3|microtubule-associated protein 1 light chain 3|Y
microtubule-associated protein 1 light chain-3|microtubule associated protein 1 light chain-3|Y
Bio-Breeding/Worcester|BioBreeding/Worcester|Y
Neuro-Psychiatric Inventory-Nursing Home version|Neuro-Psychiatric Inventory-Nursing Home Version|Y
follicular fluid meiosis activating sterol|follicular-fluid meiosis activating sterol|Y
evoked otoacoustic emission|evoked oto-acoustic emission|Y
interphase fluorescence in situ hybridisation|interphase fluorescence in-situ hybridisation|Y
neural-precursor-cell-expressed, developmentally down-regulated 4|neural-precursor-cell-expressed, developmentally downregulated 5|Y
neural-precursor-cell-expressed, developmentally down-regulated 4|neural-precursor-cell-expressed developmentally down-regulated 4|Y
neural-precursor-cell-expressed, developmentally down-regulated 4|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor-cell-expressed, developmentally down-regulated 4|neural-precursor-cell-expressed developmentally down-regulated 1|Y
neural-precursor-cell-expressed, developmentally down-regulated 4|neural-precursor-cell-expressed, developmentally downregulated 2|Y
multi-programmable pacemaker|multiprogrammable pacemaker|Y
American Society of Anaesthesiology status I|American Society of Anaesthesiology status|Y
American Society of Anaesthesiology status I|American Society of Anaesthesiology status V|Y
Src homology-2 domain-containing protein tyrosine phosphatase-2|Src homology 2 domain-containing protein tyrosine phosphatase-2|Y
non-governmental organisation|nongovernmental organisation|Y
thiazide sensitive Na-Cl co-transporter|thiazide sensitive NaCl co-transporter|Y
thiazide sensitive Na-Cl co-transporter|thiazide sensitive Na-Cl cotransporter|Y
University of California, San Diego|University of California San Diego|Y
human granulocyte-macrophage colony-stimulating factor|human granulocyte-macrophage colony stimulating factor|Y
human granulocyte-macrophage colony-stimulating factor|human granulocyte-macrophage-colony-stimulating factor|Y
tumour necrosis factor-related apoptosis-inducing ligand-receptor 1|tumour necrosis factor-related apoptosis-inducing ligand receptor 1|Y
2-amino-6-methyl-dipyrido[1,2-a|2-amino-6-methyldipyrido[1,2-a|Y
catalysed reporter deposition-fluorescence in situ hybridization|catalyzed reporter deposition-fluorescence in situ hybridization|Y
beta-methylamino-alanine|beta-methylaminoalanine|Y
TBP-associated factor 1|TBP-associated factor 17|Y
Zygowilliopsis californica|Zygowillopsis californica|Y
transient receptor potential vanilloid 4|transient receptor potential vanilloid 3|Y
gamma-aminobutyric acid B receptor|gamma-amino-butyric acid B receptor|Y
gamma-aminobutyric acid B receptor|gamma-amino butyric acid B receptor|Y
tail-less complex polypeptide 1|tailless complex polypeptide 1|Y
countercurrent distribution|counter-current distribution|Y
anti-sheep red blood cell antibody|antisheep red blood cell antibody|Y
intra-cellular binding protein|intracellular binding protein|Y
peptidoglycan recognition protein I α|peptidoglycan recognition protein Iα|Y
nucleotide-binding domain and leucine-rich-repeat-containing family|nucleotide-binding domain and leucine-rich-repeat containing family|Y
restriction endonuclease analysis-pulsed-field gel electrophoresis|restriction endonuclease analysis-pulsed field gel electrophoresis|Y
TATA-binding protein-associated factor-6|TATA-binding protein-associated factor-3|Y
TATA-binding protein-associated factor-6|TATA-binding protein-associated factor-4|Y
TATA-binding protein-associated factor-6|TATA-binding protein-associated factor-9|Y
TATA-binding protein-associated factor-6|TATA-binding protein-associated factor-7|Y
TATA-binding protein-associated factor-6|TATA-binding protein-associated factor-2|Y
TATA-binding protein-associated factor-6|TATA-binding protein-associated factor-1|Y
secreted frizzled-related protein|secreted frizzled-related proteins|Y
lipoprotein-associated phospholipase A2|lipoprotein-associated phospholipase A(2)|Y
autoimmune polyendocrine syndrome type 2|autoimmune polyendocrine syndrome type 1|Y
peroxisome proliferator-activated receptor-gamma|peroxisome proliferator-activated receptor-gamma-2|Y
European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30|European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30|Y
European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30|European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30|Y
European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30|European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire Core-30|Y
multifacility healthcare organisation|multi-facility healthcare organisation|Y
x-ray absorption near edge structure spectrum|X-ray absorption near edge structure spectrum|Y
Triticum aestivum endoxylanase inhibitor I|Triticum aestivum endoxylanase inhibitor|Y
DL-alpha-difluoromethylornithine|D,L-alpha-difluoromethylornithine|Y
colony forming unit granulocyte macrophage|colony forming unit-granulocyte macrophage|Y
transcription factor σB|transcription factor σ B|Y
Salmonella enteritidis fimbrial antigen 18|Salmonella enteritidis fimbrial antigen 14|Y
colony forming unit-granulocyte macrophage|colony forming unit-granulocyte/macrophage|Y
heterogeneous nuclear ribonucleoprotein|heterogeneous nuclear ribonucleoprotein K|Y
heterogeneous nuclear ribonucleoprotein|heterogeneous nuclear ribonucleoprotein I|Y
oro-facio-digital syndrome type IV|oro-facio-digital syndrome type I|Y
TATA-binding protein-associated factor-3|TATA-binding protein-associated factor-4|Y
TATA-binding protein-associated factor-3|TATA-binding protein-associated factor-9|Y
TATA-binding protein-associated factor-3|TATA-binding protein-associated factor-7|Y
TATA-binding protein-associated factor-3|TATA-binding protein-associated factor-2|Y
TATA-binding protein-associated factor-3|TATA-binding protein-associated factor-1|Y
anti-bothropic complex|antibothropic complex|Y
a disintegrin and metalloproteinase with thrombospondin motifs-12|a disintegrin and metalloproteinase with thrombospondin motif-17|Y
a disintegrin and metalloproteinase with thrombospondin motifs-12|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motifs-12|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motifs-12|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motifs-12|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-12|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-12|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-12|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motifs-12|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-12|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-12|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motifs-12|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motifs-12|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-12|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-12|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
voiding cystourethrogram|voiding cysto-urethrogram|Y
voiding cystourethrogram|voiding cystourethogram|Y
benzo(a)pyrene diolepoxide-DNA adduct|benzo(a)pyrene diol epoxide-DNA adduct|Y
benzo(a)pyrene diolepoxide-DNA adduct|benzo(a)pyrene diol-epoxide-DNA adduct|Y
anti-histocompatibility leukocyte antigen class II antibody|anti-histocompatibility leukocyte antigen class I antibody|Y
tumour necrosis factor receptor 1-associated periodic syndrome|tumour necrosis factor receptor-associated periodic syndrome|Y
tumour necrosis factor receptor 1-associated periodic syndrome|tumor necrosis factor receptor-associated periodic syndrome|Y
neural precursor cell expressed, developmentally downregulated 2|neural precursor cell expressed, developmentally down-regulated 4|Y
neural precursor cell expressed, developmentally downregulated 2|neural precursor cell expressed, developmentally down-regulated 1|Y
neural precursor cell expressed, developmentally downregulated 2|neural precursor cell-expressed, developmentally down-regulated 2|Y
neural precursor cell expressed, developmentally downregulated 2|neural precursor cell expressed, developmentally down-regulated 5|Y
neuro-circulatory dystonia|neurocirculatory dystonia|Y
hepatic nuclear factor 4 α|hepatic nuclear factor 4α|Y
colony-forming unit granulocyte-macrophage|colony-forming unit/granulocyte-macrophage|Y
signal transducer and activator of transcription-6|signal transducer and activator of transcription-1|Y
signal transducer and activator of transcription-6|signal transducer and activator of transcription 6|Y
palmitoyl-myristoyl-phosphatidylcholine|palmitoylmyristoyl-phosphatidylcholine|Y
Clinical Global Impression-Improvement of Illness scale|Clinical Global Impression-Improvement of Illness Scale|Y
university affiliated Veterans Administration medical center|university-affiliated Veterans Administration medical center|Y
Yo-Yo intermittent recovery test level 2|Yo-Yo intermittent recovery test level 1|Y
voltage-gated calcium channel alpha 1-subunit|voltage-gated calcium channel alpha1-subunit|Y
hyperpolarizing after-potential|hyperpolarizing afterpotential|Y
high-pressure freezing-freeze substitution|high-pressure freezing/freeze substitution|Y
right gastroepiploic artery|right gastro-epiploic artery|Y
alpha-amino-3-hydroxy-5-methyl-4-isoxazole proprionate|alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate|Y
polymerase chain reaction-sequence specific priming|polymerase chain reaction-sequence-specific priming|Y
cross-polarisation/magic-angle spinning nuclear magnetic resonance|cross-polarisation/magic angle spinning nuclear magnetic resonance|Y
polymerase chain reaction-sequence based typing|polymerase chain reaction-sequence-based typing|Y
multifluor fluorescence in situ hybridisation|multifluor fluorescence in situ hybridization|Y
non-coincidence effect|noncoincidence effect|Y
Palo Alto Veteran's Administration Medical Center|Palo Alto Veterans Administration Medical Center|Y
X-linked agammaglobulinemia|X-linked agammaglobulinaemia|Y
microtubule-associated protein 1 light chain-3B|microtubule-associated protein 1 light chain 3B|Y
extracellular signal-regulated kinase-2|extracellular signal-regulated kinase-1/2|Y
bone marrow-derived mesenchymal stem cell|bone marrow derived mesenchymal stem cell|Y
ubiquitin-protein ligase|ubiquitin-protein ligases|Y
American Society of Anesthesiologists Grade 3|American Society of Anesthesiologists Grade I|Y
American Society of Anesthesiologists Grade 3|American Society of Anesthesiologists Grade 1|Y
neural precursor cell-expressed developmentally down-regulated 9|neural precursor cell-expressed developmentally downregulated 1|Y
neural precursor cell-expressed developmentally down-regulated 9|neural precursor cell-expressed developmentally down-regulated 2|Y
neural precursor cell-expressed developmentally down-regulated 9|neural precursor cell expressed developmentally down-regulated 9|Y
neural precursor cell-expressed developmentally down-regulated 9|neural precursor cell-expressed developmentally down-regulated 4|Y
neural precursor cell-expressed developmentally down-regulated 9|neural precursor cell-expressed developmentally downregulated 9|Y
neural precursor cell-expressed developmentally down-regulated 9|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell-expressed developmentally down-regulated 9|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell-expressed developmentally down-regulated 9|neural precursor cell-expressed, developmentally down-regulated 2|Y
A disintegrin and metalloprotease-23|A disintegrin and metalloprotease-3|Y
Møller-Plesset second-order perturbation theory|Møller-Plesset second order perturbation theory|Y
hyper-phenylalaninemia|hyperphenylalaninemia|Y
Na+/glucose cotransporter|Na+/glucose co-transporter|Y
Kiddie-Schedule for Affective Disorders and Schizophrenia|Kiddie Schedule for Affective Disorders and Schizophrenia|Y
3,4-methylenedioxymethamphetamine|3,4-methylenedioxyethamphetamine|Y
enzyme-linked immuno-sorbent assay|enzyme-linked immunosorbent assay|Y
immunoreactive corticotropin-releasing factor|immunoreactive corticotropin releasing factor|Y
antirabbit immunoglobulin G|anti-rabbit immunoglobulin G|Y
enzyme-linked immuno sorbent assay|enzyme-linked immunosorbent assay|Y
Minneapolis Veterans' Administration Medical Center|Minneapolis Veteran's Administration Medical Center|Y
chronic nonspecific lung disease|chronic non-specific lung disease|Y
electro-magnetic flowmeter|electromagnetic flowmeter|Y
proteinase-activated receptor|proteinase-activated receptors|Y
Nod-like receptor family pyrin domain containing 3|Nod-like receptor family pyrin domain containing-3|Y
video cassette recorder|videocassette recorder|Y
microtubule-associated protein 1 light-chain 3|microtubule-associated protein 1 light chain 3|Y
x-ray absorption near edge structure analysis|X-ray absorption near edge structure analysis|Y
pyelonephritis-associated pilus protein D|pyelonephritis-associated pilus protein B|Y
inhibitory κB kinase|inhibitory κ B kinase|Y
nuclear factor-erythroid 2 p45-related factor 2|nuclear factor-erythroid 2 p45-related factor-2|Y
amino-terminal pro-B-type natriuretic peptide|amino-terminal proB-type natriuretic peptide|Y
amino-terminal pro-B-type natriuretic peptide|aminoterminal pro-B-type natriuretic peptide|Y
insulinlike growth factor binding protein 4|insulinlike growth factor binding protein 3|Y
microtubule associated protein 1 light chain 3|microtubule associated protein light chain 3|Y
microtubule associated protein 1 light chain 3|microtubule-associated protein 1 light chain 3|Y
microtubule associated protein 1 light chain 3|microtubule associated protein 1 light chain-3|Y
atrio-ventricular canal|atrioventricular canal|Y
gadolinium tetra-azacyclododecane tetra-acetic acid|gadolinium tetra-azacyclododecane tetraacetic acid|Y
manual materials handling|manual material handling|Y
peroxisome-proliferator-activated receptor-gamma co-activator-1 alpha|peroxisome-proliferator-activated receptor-gamma co-activator-1alpha|Y
peroxisome-proliferator-activated receptor-gamma co-activator-1 alpha|peroxisome-proliferator-activated receptor-gamma co-activator 1alpha|Y
peroxisome-proliferator-activated receptor-gamma co-activator-1 alpha|peroxisome-proliferator-activated receptor-gamma coactivator-1alpha|Y
peroxisome-proliferator-activated receptor-gamma co-activator-1 alpha|peroxisome-proliferator-activated receptor gamma coactivator-1 alpha|Y
cytotoxic T-lymphocyte-associated antigen 4|cytotoxic T lymphocyte-associated antigen 4|Y
re-expansion pulmonary oedema|re-expansion pulmonary edema|Y
Oral Impacts on Daily Performances|Oral Impacts on Daily Performance|Y
circumscribed choroidal haemangioma|circumscribed choroidal hemangioma|Y
least-significant difference post hoc test|least-significant difference post-hoc test|Y
American Society of Anesthesiologists Grade I|American Society of Anesthesiologists grade I|Y
American Society of Anesthesiologists Grade I|American Society of Anesthesiologists Grade 1|Y
microtubule-associated protein light chain 3|microtubule associated protein light chain 3|Y
microtubule-associated protein light chain 3|microtubule-associated protein 1 light chain 3|Y
capillary electrophoresis-electrospray ionisation time of flight mass spectrometry|capillary electrophoresis-electrospray ionization time of flight mass spectrometry|Y
capillary electrophoresis-electrospray ionisation time of flight mass spectrometry|capillary electrophoresis-electrospray ionisation-time of flight mass spectrometry|Y
extracellular calcium concentrations|extracellular calcium concentration|Y
platelet-derived growth factor|platelet-derived growth factors|Y
cross-polarisation magic angle spinning nuclear magnetic resonance spectroscopy|cross polarisation magic angle spinning nuclear magnetic resonance spectroscopy|Y
steroid 5-alpha reductase type II|steroid 5-alpha reductase type I|Y
endocrine disrupting compounds|endocrine disrupting compound|Y
ubiquitin-conjugating enzyme|ubiquitin-conjugating enzymes|Y
(123)I-beta-methyl-iodophenyl pentadecanoic acid|(123)I-beta-methyl-iodophenylpentadecanoic acid|Y
type II heparin induced thrombocytopaenia|type II heparin induced thrombocytopenia|Y
corticotropin-releasing factor type-2 receptor|corticotropin-releasing factor type 2 receptor|Y
corticotropin-releasing factor type-2 receptor|corticotropin releasing factor type-2 receptor|Y
microtubule associated protein light chain 3|microtubule associated protein light-chain 3|Y
time-of-flight secondary-ion mass spectroscopy|time-of-flight secondary ion mass spectroscopy|Y
preadipocyte factor 1|pre-adipocyte factor 1|Y
intraocular foreign body|intra-ocular foreign body|Y
electron microscopic in-situ hybridization|electron microscopic in-situ hybridisation|Y
src homology 2 domain containing protein tyrosine phosphatase substrate 1|Src homology 2 domain containing protein tyrosine phosphatase substrate 1|Y
src homology 2 domain containing protein tyrosine phosphatase substrate 1|src homology 2 domain-containing protein tyrosine phosphatase substrate 1|Y
interleukin 8 receptor|interleukin 18 receptor|Y
peroxisome proliferator-activated receptor-gamma coactivator-1alpha|peroxisome-proliferator-activated receptor-gamma co-activator-1alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator-1alpha|peroxisome proliferator-activated receptor gamma co-activator-1alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator-1alpha|peroxisome proliferator-activated receptor-gamma coactivator 1 alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator-1alpha|peroxisome-proliferator-activated receptor-gamma coactivator-1alpha|Y
American Society of Anesthesiologists grade III|American Society of Anesthesiologists grade I|Y
American Society of Anesthesiologists grade III|American Society of Anesthesiologists grade II|Y
pre-ornithine carbamoyl transferase|pre-ornithine carbamoyltransferase|Y
a disintegrin and metalloproteinase with thrombospondin motif-17|a disintegrin and metalloproteinase with thrombospondin motifs-10|Y
a disintegrin and metalloproteinase with thrombospondin motif-17|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motif-17|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-17|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motif-17|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motif-17|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motif-17|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-17|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motif-17|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motif-17|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
poly(propylene oxide)|poly(propyleneoxide)|Y
size exclusion chromatography/multiangle laser light scattering|size-exclusion chromatography/multi-angle laser light scattering|Y
high performance liquid chromatography/thermospray mass spectrometry|high-performance liquid chromatography/thermospray mass spectrometry|Y
latent transforming growth factor beta binding protein 4|latent transforming growth factor beta binding protein 3|Y
neural precursor cell-expressed developmentally downregulated 1|neural precursor cell-expressed developmentally down-regulated 2|Y
neural precursor cell-expressed developmentally downregulated 1|neural precursor cell-expressed developmentally down-regulated 4|Y
neural precursor cell-expressed developmentally downregulated 1|neural precursor cell-expressed developmentally downregulated 9|Y
neural precursor cell-expressed developmentally downregulated 1|neural precursor cell-expressed, developmentally downregulated 8|Y
neural precursor cell-expressed developmentally downregulated 1|neural precursor cell-expressed, developmentally downregulated 1|Y
neural precursor cell-expressed developmentally downregulated 1|neural-precursor cell-expressed, developmentally downregulated 1|Y
pregnancy specific β-1 glycoprotein|pregnancy specific β1 glycoprotein|Y
liquid chromatography-atmospheric pressure photoionisation mass spectrometry|liquid chromatography-atmospheric pressure photoionization mass spectrometry|Y
a disintegrin and metalloproteinase with thrombospondin motifs-10|a disintegrin and metalloproteinase with thrombospondin motifs-16|Y
a disintegrin and metalloproteinase with thrombospondin motifs-10|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motifs-10|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-10|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-10|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-10|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motifs-10|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motifs-10|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motifs-10|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-10|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-10|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
angioimmunoblastic lymphadenopathy|angio-immunoblastic lymphadenopathy|Y
alpha-fluoromethylhistidine|alpha-fluoromethyl-histidine|Y
poly(propylene imine)|poly(propyleneimine)|Y
intra-coronary radiation therapy|intracoronary radiation therapy|Y
alkaline phosphatase ant-ialkaline phosphatase technique|alkaline phosphatase antialkaline phosphatase technique|Y
Toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-β|Y
Toll/interleukin1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon β|Y
radioimmuno-precipitation|radioimmunoprecipitation|Y
p65 nuclear factor-kappaB subunit|p65 nuclear factor-kappa B subunit|Y
intra-atrial communication|intraatrial communication|Y
peroxisome proliferator-activated receptor γ coactivator-1 α|peroxisome proliferator-activated receptor γ co-activator 1 α|Y
peroxisome proliferator-activated receptor γ coactivator-1 α|peroxisome proliferator-activated receptor γ co-activator-1α|Y
peroxisome proliferator-activated receptor γ coactivator-1 α|peroxisome proliferator-activated receptor-γ co-activator-1 α|Y
pre-ejection period index|preejection period index|Y
intravascular bronchio-alveolar tumour|intravascular bronchio-alveolar tumor|Y
metallo-phthalocyanine|metallophthalocyanine|Y
a disintegrin and metalloproteinase with thrombospondin motifs-16|a disintegrin and metalloproteinase with thrombospondin motifs|Y
a disintegrin and metalloproteinase with thrombospondin motifs-16|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs-16|a disintegrin and metalloproteinase with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motifs-16|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-16|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motifs-16|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloproteinase with thrombospondin motifs-16|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motifs-16|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motifs-16|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-16|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-16|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
serum insulin-like growth factor-II level|serum insulin-like growth factor-I level|Y
granulocyte macrophage colony-stimulating factor|granulocyte-macrophage colony-stimulating factor|Y
granulocyte macrophage colony-stimulating factor|granulocyte macrophage-colony-stimulating factor|Y
heterogeneous nuclear ribonucleoprotein K|heterogeneous nuclear ribonucleoprotein I|Y
fluorodeoxyglucose positron emission tomography|fluoro-deoxy-glucose positron emission tomography|Y
anti-IL18 monoclonal antibody|anti-IL8 monoclonal antibody|Y
grade III acute graft-versus-host disease|grade II acute graft-versus-host disease|Y
B-lymphocyte induced maturation protein 1|B lymphocyte induced maturation protein 1|Y
extra-articular feature|extraarticular feature|Y
retinoic-acid-receptor-related orphan receptor gammaT|retinoic-acid-receptor-related orphan receptor gammat|Y
retinoic-acid-receptor-related orphan receptor gammaT|retinoic-acid-receptor-related orphan receptor gamma-T|Y
immobilised metal-ion affinity chromatography|immobilised metal ion affinity chromatography|Y
Osteoporosis Self-assessment Tool for Asians|Osteoporosis Self-Assessment Tool for Asians|Y
intra-cellular fluid volume|intracellular fluid volume|Y
electro-encephalographic wave|electroencephalographic wave|Y
receptor protein tyrosine phosphatase delta|receptor protein tyrosine phosphatase eta|Y
American Society of Anaesthesiologists physical status 3|American Society of Anaesthesiologists physical status 1|Y
American Society of Anaesthesiologists physical status 3|American Society of Anaesthesiologists physical status 4|Y
American Society of Anaesthesiologists physical status 3|American Society of Anaesthesiologists physical status 5|Y
American Society of Anaesthesiology class 3|American Society of Anaesthesiology class 2|Y
American Society of Anaesthesiology class 3|American Society of Anaesthesiology class 1|Y
8-(p-sulfophenyl)theophylline|8-(p-sulfophenyl) theophylline|Y
peptidylglycine α-amidating monooxygenase|peptidyl-glycine α-amidating mono-oxygenase|Y
lamprey gonadotropin-releasing hormone-I|lamprey gonadotropin releasing hormone-I|Y
audio-computer-assisted self-interviewing|audio-computer assisted self-interviewing|Y
audio-computer-assisted self-interviewing|audio computer-assisted self-interviewing|Y
vitamin D3 up-regulated protein-1|vitamin D3 upregulated protein-1|Y
oral vesiculo-erosive disease|oral vesiculoerosive disease|Y
antibody secreting cell|antibody secreting cells|Y
RPM1 interacting protein4|RPM1 interacting protein 4|Y
autoimmune lympho-proliferative syndrome|auto-immune lymphoproliferative syndrome|Y
capillary electrophoresis-inductively coupled plasma mass spectrometry|capillary electrophoresis inductively coupled plasma mass spectrometry|Y
atlantoaxial impaction|atlanto-axial impaction|Y
randomized controlled clinical trial|randomized controlled clinical trials|Y
anti-interleukin 6 neutralizing antibody|antiinterleukin 6 neutralizing antibody|Y
immunofixation electrophoresis|immuno-fixation electrophoresis|Y
augmented correlation consistent polarized valence quadruple zeta basis set|augmented correlation consistent polarised valence quadruple zeta basis set|Y
sector field inductively coupled plasma mass spectrometry|sector field inductively coupled plasma-mass spectrometry|Y
fibro-cartilaginous embolism|fibrocartilaginous embolism|Y
high-energy shockwave therapy|high-energy shock-wave therapy|Y
ethylenediaminetetraacetic acid disodium salt|ethylenediaminetetra-acetic acid disodium salt|Y
a disintegrin and metalloprotease with thrombospondin motif-13|a disintegrin and metalloprotease with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motif-13|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motif-13|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motif-13|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motif-13|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-13|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motif-13|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloprotease with thrombospondin motif-13|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
a disintegrin and metalloprotease with thrombospondin motif-13|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
randomly amplified polymorphic DNA polymerase chain reaction|randomly amplified polymorphic DNA-polymerase chain reaction|Y
clinical global impressions-improvement of illness scale|clinical global impressions improvement of illness scale|Y
gamma-aminobutyric acidB|gamma-aminobutyric acid B|Y
cholangio-cellular carcinoma|cholangiocellular carcinoma|Y
localised surface plasmon resonance spectroscopy|localized surface plasmon resonance spectroscopy|Y
tanned red cell hemagglutination inhibition immunoassay|tanned red cell haemagglutination inhibition immunoassay|Y
tumour-associated macrophage|tumor-associated macrophage|Y
fibroblast growth factor receptor 2|fibroblast growth factor receptor 2c|Y
3'untranslated region|3' untranslated region|Y
non-migrating fraction|nonmigrating fraction|Y
Wechsler Preschool and Primary Scale of Intelligence, Revised|Wechsler Preschool and Primary Scale of Intelligence Revised|Y
Wechsler Preschool and Primary Scale of Intelligence, Revised|Wechsler Preschool and Primary Scale of Intelligence-Revised|Y
post-menopausal bleeding|postmenopausal bleeding|Y
colony-forming units-granulocyte-macrophage|colony-forming units-granulocyte/macrophage|Y
Nashville Veteran's Affairs Medical Center|Nashville Veterans Affairs Medical Center|Y
TGF-β-activated kinase 1-binding protein-1|TGF-β-activated kinase 1 binding protein-1|Y
insulinlike growth factor receptor 1|insulin-like growth factor receptor 1|Y
deepidermised dermis|de-epidermised dermis|Y
macrophage inflammatory protein-1α protein|macrophage inflammatory protein 1α protein|Y
postconcussion syndrome|post-concussion syndrome|Y
G protein alpha subunit|G protein alphai subunit|Y
sodium-taurocholate cotransporting polypeptide|sodium taurocholate cotransporting polypeptide|Y
interleukine-15 receptor α|interleukine-5 receptor α|Y
mitogen-activated protein kinase kinase 6|mitogen-activated protein kinase kinase 1|Y
peroxisome proliferator-activated receptor γ co-activator 1 α|peroxisome proliferator-activated receptor-γ co-activator 1α|Y
peroxisome proliferator-activated receptor γ co-activator 1 α|peroxisome proliferator-activated receptor γ co-activator 1|Y
peroxisome proliferator-activated receptor γ co-activator 1 α|peroxisome proliferator-activated receptor γ co-activator-1α|Y
peroxisome proliferator-activated receptor γ co-activator 1 α|peroxisome proliferator-activated receptor γ co-activator 1α|Y
insulin-like growth factor II messenger RNA-binding protein-3|insulin-like growth factor II messenger RNA-binding protein|Y
insulin-like growth factor II messenger RNA-binding protein-3|insulin-like growth factor-II messenger RNA-binding protein-3|Y
delayed ischemic neurological deficit|delayed ischemic neurological deficits|Y
Na-K-Cl co-transporter 1|Na-K-Cl cotransporter 1|Y
galactosylhydroxylysyl glucosyl-transferase|galactosylhydroxylysyl glucosyltransferase|Y
intra-operative floppy iris syndrome|intraoperative floppy iris syndrome|Y
anti-myelin associated glycoprotein neuropathy|antimyelin associated glycoprotein neuropathy|Y
beta site amyloid precursor protein-cleaving enzyme 2|beta site amyloid precursor protein-cleaving enzyme|Y
beta site amyloid precursor protein-cleaving enzyme 2|beta-site amyloid precursor protein-cleaving enzyme 2|Y
American Society of Anesthesiology Grade 2|American Society of Anesthesiology Grade 3|Y
American Society of Anesthesiology Grade 2|American Society of Anesthesiology Grade 1|Y
senescence-accelerated mouse resistant 1|senescence-accelerated mouse-resistant 1|Y
1-palmitoyl-2-oleoylphosphatidylcholine|1-palmitoyl-2-oleoyl-phosphatidylcholine|Y
immunoglobulin heavy chain gene|immuno-globulin heavy chain gene|Y
spinocerebellar ataxia type 1|spinocerebellar ataxia type 19|Y
spinocerebellar ataxia type 1|spinocerebellar ataxia type 14|Y
spinocerebellar ataxia type 1|spinocerebellar ataxia type 13|Y
spinocerebellar ataxia type 1|spinocerebellar ataxia type 17|Y
spinocerebellar ataxia type 1|spinocerebellar ataxia type 16|Y
spinocerebellar ataxia type 1|spinocerebellar ataxia type 21|Y
capillary electrophoresis-electrospray ionization time of flight mass spectrometry|capillary electrophoresis-electrospray ionisation-time of flight mass spectrometry|Y
isovolumetric contraction time|iso-volumetric contraction time|Y
p110gamma PI 3-kinase|p110gamma PI3-kinase|Y
Epstein-Barr virus cell surface antigen 5|Epstein-Barr virus cell surface antigen 4|Y
World Health Organization Quality of Life-brief version|World Health Organisation Quality of Life-brief version|Y
tumor necrosis factor receptor-associated factor-6|tumor necrosis factor receptor-associated factor 6|Y
American Society of Anesthesiologists Class|American Society of Anesthesiologists Class 3|Y
American Society of Anesthesiologists Class|American Society of Anesthesiologists Class 2|Y
American Society of Anesthesiologists Class|American Society of Anesthesiologists Class 4|Y
multi-variate discriminant analysis|multivariate discriminant analysis|Y
American Society of Anaesthesiologists status 1|American Society of Anaesthesiologists status 5|Y
glucocorticoid receptor-interacting protein-1|glucocorticoid receptor interacting protein-1|Y
Children's Yale Brown Obsessive Compulsive Scale|Children's Yale Brown Obsessive-Compulsive Scale|Y
American Society of Anaesthesiology class 2|American Society of Anaesthesiology class 1|Y
gastro-intestinal stromal tumor|gastro-intestinal stromal tumour|Y
American Society of Anaesthesiology grade III|American Society of Anesthesiology grade II|Y
American Society of Anesthesiologists Class 3|American Society of Anesthesiologists Class 2|Y
American Society of Anesthesiologists Class 3|American Society of Anesthesiologists Class 4|Y
endoscopic pancreato-cholangiography|endoscopic pancreatocholangiography|Y
xeroderma pigmentosum complementation group G|xeroderma pigmentosum complementation group E|Y
hyperglycaemic hyperosmolar non-ketotic syndrome|hyperglycemic hyperosmolar non-ketotic syndrome|Y
hyperglycaemic hyperosmolar non-ketotic syndrome|hyperglycemic hyperosmolar nonketotic syndrome|Y
medullary collecting tubule|medullary collecting tubules|Y
non-accidental injury|nonaccidental injury|Y
porto-pulmonary hypertension|portopulmonary hypertension|Y
recombinant human interferon α2b|recombinant human interferon α-2b|Y
G-protein coupled oestrogen receptor|G-protein coupled estrogen receptor|Y
trans-jugular intra-hepatic porto-systemic shunt|trans-jugular intra-hepatic portosystemic shunt|Y
trans-jugular intra-hepatic porto-systemic shunt|trans-jugular intrahepatic portosystemic shunt|Y
caudomedial nidopallium|caudo-medial nidopallium|Y
ras-related GTP-binding protein 3|ras-related GTP-binding protein 39|Y
ras-related GTP-binding protein 3|ras-related GTP-binding protein 38|Y
American Society of Anaesthesiology Class 4|American Society of Anesthesiology Class 4|Y
thyrotropin releasing hormone receptor-1|thyrotropin releasing hormone receptor 1|Y
insulin-like growth factor-II mRNA-binding protein|insulin-like growth factor-II mRNA-binding protein-3|Y
insulin-like growth factor-II mRNA-binding protein|insulin-like growth factor-II mRNA-binding protein 2|Y
recombinant human transforming growth factor beta 2|recombinant human transforming growth factor-beta 2|Y
recombinant human transforming growth factor beta 2|recombinant human transforming growth factor beta 3|Y
recombinant human transforming growth factor beta 2|recombinant human transforming growth factor beta 1|Y
alpha-foeto-protein level|alpha-feto-protein level|Y
sub-macular hemorrhage|sub-macular haemorrhage|Y
tumour necrosis factor β production|tumor necrosis factor β production|Y
anti-lymphocyte serum|antilymphocyte serum|Y
thyrotropin-releasing hormone receptor 1|thyrotropin-releasing hormone receptor 2|Y
thyrotropin-releasing hormone receptor 1|thyrotropin releasing hormone receptor 1|Y
thyrotropin-releasing hormone receptor 1|thyrotrophin-releasing hormone receptor 1|Y
peroxisome-proliferator-activated receptor-gamma co-activator-1alpha|peroxisome-proliferator-activated receptor-gamma co-activator 1alpha|Y
peroxisome-proliferator-activated receptor-gamma co-activator-1alpha|peroxisome-proliferator-activated receptor-gamma coactivator-1alpha|Y
neural precursor cell expressed, developmentally down-regulated 4|neural precursor cell expressed, developmentally down-regulated 1|Y
neural precursor cell expressed, developmentally down-regulated 4|neural precursor cell expressed developmentally down-regulated 9|Y
neural precursor cell expressed, developmentally down-regulated 4|neural precursor cell-expressed developmentally down-regulated 4|Y
neural precursor cell expressed, developmentally down-regulated 4|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell expressed, developmentally down-regulated 4|neural precursor cell expressed, developmentally down-regulated 5|Y
doubly labeled water|doubly labelled water|Y
aminoacyl-tRNA synthetase-interacting multifunctional protein 1|aminoacyl-tRNA synthetase-interacting multifunctional protein 2|Y
aminoacyl-tRNA synthetase-interacting multifunctional protein 1|aminoacyl-tRNA synthetase-interacting multifunctional protein 3|Y
aminoacyl-tRNA synthetase-interacting multifunctional protein 1|aminoacyl tRNA synthetase-interacting multi-functional protein 1|Y
nickel-nitrilo-tri-acetic acid|nickel-nitrilo-triacetic acid|Y
a disintegrin and metalloprotease 9|a disintegrin and metalloprotease 29|Y
sex determining region Y box 6|sex determining region Y, box 6|Y
American Society of Anesthesiologists grade 2|American Society of Anesthesiologists grade I|Y
American Society of Anesthesiologists grade 2|American Society of Anesthesiologists grade 1|Y
American Society of Anesthesiologists grade 2|American Society of Anesthesiologists grade 5|Y
oral antidiabetic drug|oral anti-diabetic drug|Y
poly(dimethylsiloxane)|poly(dimethyl-siloxane)|Y
poly(dimethylsiloxane)|poly-(dimethylsiloxane)|Y
infra-patellar fat pad|infrapatellar fat pad|Y
computed tomographic scan|computed tomographic scans|Y
anti-ethinyloestradiol antibody|anti-ethinylestradiol antibody|Y
corticotropin-releasing factor 2 receptor|corticotropin-releasing factor 1 receptor|Y
American Society of Anaesthesiology Grade II|American Society of Anesthesiology Grade II|Y
focused ion beam scanning electron microscopy|focused ion beam-scanning electron microscopy|Y
TATA-binding protein-associated factor-10|TATA-binding protein-associated factor-1|Y
World Health Organisation Quality of Life-Bref|World Health Organization Quality of Life-Bref|Y
[3H]-N-methyl scopolamine|[3H]N-methyl scopolamine|Y
Na+-taurocholate cotransporting polypeptide|Na+/taurocholate cotransporting polypeptide|Y
mixed leucocyte-tumour cell culture|mixed leucocyte-tumor cell culture|Y
methylglyoxal bis(guanylhydrazone)|ethylglyoxal bis(guanylhydrazone)|Y
Src homology 2 domain-containing protein tyrosine phosphatase 1|src homology 2 domain-containing protein tyrosine phosphatase 1|Y
trans-jugular intra-hepatic portosystemic shunt|trans-jugular intrahepatic portosystemic shunt|Y
toll/interleukin-1 receptor domain-containing adapter-inducing interferon β|toll/interleukin 1 receptor domain-containing adapter-inducing interferon β|Y
toll/interleukin-1 receptor domain-containing adapter-inducing interferon β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon β|Y
cortico-basal degeneration|corticobasal degeneration|Y
Ralph H. Johnson Veterans' Administration Medical Center|Ralph H Johnson Veterans Administration Medical Center|Y
Ralph H. Johnson Veterans' Administration Medical Center|Ralph H Johnson Veterans' Administration Medical Center|Y
estimated fetal weight|estimated faetal weight|Y
rosette forming cell|rosette forming cells|Y
lamprey gonadotropin releasing hormone-I|lamprey gonadotropin releasing hormone-III|Y
receptor-like protein tyrosine phosphatase ζ|receptor-like protein tyrosine phosphatase η|Y
brainstem auditory evoked potential|brain-stem auditory evoked potential|Y
brainstem auditory evoked potential|brain stem auditory evoked potential|Y
photoactivated localisation microscopy|photo-activated localisation microscopy|Y
mitogen/extracellular-signal-regulated kinase kinase 5|mitogen/extracellular signal-regulated kinase kinase 5|Y
sub-mitochondrial particle|submitochondrial particle|Y
socio-economic position|socioeconomic position|Y
type-2 corticotrophin-releasing-hormone receptor|type-2 corticotropin-releasing-hormone receptor|Y
anti-interleukin 1 alpha monoclonal antibody|antiinterleukin 1alpha monoclonal antibody|Y
T cell receptor γ δ-positive|T cell receptor γδ-positive|Y
peroxidase-antiperoxidase|peroxidase-anti-peroxidase|Y
oligomycin sensitivity-conferring protein|oligomycin-sensitivity-conferring protein|Y
recombinant human transforming growth factor alpha|recombinant human transforming growth factor-alpha|Y
a disintegrin and metalloproteinase with thrombospondin motifs|a disintegrin and metalloproteinase with thrombospondin motifs-4|Y
a disintegrin and metalloproteinase with thrombospondin motifs|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motifs|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloproteinase with thrombospondin motifs|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motifs|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motifs|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
thyrotropin releasing hormone test|thyrotrophin releasing hormone test|Y
reexpansion pulmonary edema|re-expansion pulmonary edema|Y
multiplex fluorescence in-situ hybridisation|multiplex fluorescence in situ hybridisation|Y
soluble N-ethylmaleimide-sensitive factor attachment protein receptor|soluble N-ethylmaleimide-sensitive factor attachment protein receptors|Y
tumour necrosis factor-related apoptosis inducing ligand|tumor necrosis factor-related apoptosis inducing ligand|Y
micro-vascular endothelial cell|microvascular endothelial cell|Y
2-arachidonoylglycerol|2-arachidonoyl-glycerol|Y
orofaciodigital syndrome|oro-faciodigital syndrome|Y
anti-interleukin-12 neutralizing antibody|anti-interleukin 12 neutralizing antibody|Y
cyclin-dependent kinase-activating kinase|cyclin dependent kinase-activating kinase|Y
Ralph H Johnson Veterans Administration Medical Center|Ralph H Johnson Veterans' Administration Medical Center|Y
adult T-cell leukemia-associated antigen|adult T-cell leukaemia-associated antigen|Y
luteinizing hormone-follicle stimulating hormone releasing hormone|luteinizing hormone follicle stimulating hormone releasing hormone|Y
luteinizing hormone-follicle stimulating hormone releasing hormone|luteinising hormone-follicle stimulating hormone releasing hormone|Y
TATA-binding protein-associated factor-4|TATA-binding protein associated factor-4|Y
TATA-binding protein-associated factor-4|TATA-binding protein-associated factor-9|Y
TATA-binding protein-associated factor-4|TATA-binding protein-associated factor-7|Y
TATA-binding protein-associated factor-4|TATA-binding protein-associated factor-2|Y
TATA-binding protein-associated factor-4|TATA-binding protein-associated factor-1|Y
GTP-binding protein βγ subunit|GTP-binding protein γ subunit|Y
equine chorionic gonadotropin|equine chorionic gonadotrophin|Y
transforming growth factor beta-activated kinase 1-binding protein 1|transforming growth factor beta-activated kinase 1-binding protein-1|Y
α1-protease inhibitor|α 1-protease inhibitor|Y
gamma-aminobutyric acid type B receptor|gamma-amino-butyric acid type B receptor|Y
American Society of Anesthesiology Grade II|American Society of Anesthesiology grade II|Y
Toll-interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Toll/interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Y
Toll-interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
Toll-interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
Toll-interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
doublesex and mab-3-related transcription factor 1|doublesex and mab-3 related transcription factor 1|Y
cyclin-dependent kinase interacting protein 1|cyclin dependent kinase interacting protein 1|Y
neuronal precursor cell-expressed developmentally down-regulated 4|neural precursor cell-expressed developmentally down-regulated 4|Y
neuronal precursor cell-expressed developmentally down-regulated 4|neural precursor cell-expressed, developmentally down-regulated 4|Y
matrix assisted laser desorption/ionization-mass spectrometry|matrix assisted laser desorption/ionization mass spectrometry|Y
matrix assisted laser desorption/ionization-mass spectrometry|matrix assisted laser desorption/ionisation-mass spectrometry|Y
a disintegrin and metalloproteinase with thrombospondin motifs-4|a disintegrin and metalloproteinase with thrombospondin motifs-7|Y
a disintegrin and metalloproteinase with thrombospondin motifs-4|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motifs-4|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-4|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motifs-4|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-4|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-4|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motifs-4|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
anti-T cell receptor-alpha beta monoclonal antibody|anti-T cell receptor-alpha/beta monoclonal antibody|Y
anti-T cell receptor-alpha beta monoclonal antibody|anti-T-cell receptor-alpha beta monoclonal antibody|Y
total intrauterine volume|total intra-uterine volume|Y
Dissociative Experiences Scale|Dissociative Experience Scale|Y
nipple areolar complex|nipple areola complex|Y
peroxisome proliferator-activated receptor gamma co-activator-1alpha|peroxisome proliferator-activated receptor gamma co-activator 1 alpha|Y
programmed-temperature vapourizer|programmed-temperature vaporizer|Y
peripherally inserted central catheter|peripherally inserted central catheters|Y
cross-polarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross-polarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross-polarization/magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
erythroblastic leukemia viral oncogene homolog 2|erythroblastic leukemia viral oncogene homolog A|Y
erythroblastic leukemia viral oncogene homolog 2|erythroblastic leukemia viral oncogene homolog 4|Y
reaction center-light-harvesting complex 1|reaction center-light-harvesting complex I|Y
Seattle Veterans' Administration Medical Center|Seattle Veteran's Administration Medical Center|Y
laevodopa induced dyskinesia|laevo-dopa induced dyskinesia|Y
non-metastatic protein 23|nonmetastatic protein 23|Y
Schedule for Affective Disorders and Schizophrenia-Lifetime Version|Schedule for Affective Disorders and Schizophrenia Lifetime Version|Y
matrix assisted laser desorption ionization-mass spectrometry imaging|matrix assisted laser desorption ionization mass spectrometry imaging|Y
alphamethylparatyrosine|alpha-methylparatyrosine|Y
bone morphogenetic protein receptor type 2|bone morphogenetic protein receptor type 1|Y
receptor-like protein tyrosine phosphatase-ψ|receptor-like protein tyrosine phosphatase-μ|Y
sequence-characterized amplified region marker|sequence characterized amplified region marker|Y
upstream activating sequence|upstream activating sequences|Y
insulin-induced hypoglycemia|insulin-induced hypoglycaemia|Y
reaction center-light-harvesting complex I|reaction centre-light-harvesting complex I|Y
reaction center-light-harvesting complex I|reaction center-light harvesting complex I|Y
G protein coupled oestrogen receptor|G protein coupled estrogen receptor|Y
post-marketing surveillance|postmarketing surveillance|Y
excision repair cross complementing group 5|excision repair cross complementing group 2|Y
excision repair cross complementing group 5|excision repair cross-complementing group 5|Y
excision repair cross complementing group 5|excision repair cross complementing group 6|Y
corticotropin releasing hormone receptor-2|corticotrophin releasing hormone receptor-2|Y
Paediatric Evaluation of Disability Inventory|Pediatric Evaluation of Disability Inventory|Y
neuropsychiatric systemic lupus erythematosus|neuro-psychiatric systemic lupus erythematosus|Y
fluorine-18-labeled fluoro-deoxy-glucose|fluorine 18-labeled fluoro-deoxy-glucose|Y
near infrared reflectance spectroscopy|near infra-red reflectance spectroscopy|Y
multivariate curve resolution-alternating least squares|multivariate curve resolution alternating least squares|Y
src homology 2 domain-containing protein-tyrosine phosphatase 1|src homology 2 domain-containing protein tyrosine phosphatase 1|Y
human adenovirus serotype 36|human adenovirus serotype 6|Y
interleukin-13 receptor α-1 chain|interleukine-13 receptor α-1 chain|Y
interleukin-13 receptor α-1 chain|interleukin-13 receptor α1 chain|Y
post-prandial glucose|postprandial glucose|Y
cytokine induced neutrophil chemoattractant-2|cytokine induced neutrophil chemoattractant|Y
cytokine induced neutrophil chemoattractant-2|cytokine-induced neutrophil chemoattractant-2|Y
melanocyte-stimulating hormones|melanocyte-stimulating hormone|Y
bone morphogenetic protein receptor type 1|bone morphogenetic protein receptor type 1A|Y
total circulating hemoglobin|total circulating haemoglobin|Y
anti-T cell receptor alpha/beta antibody|anti-T-cell receptor alpha/beta antibody|Y
sub-zonal sperm insertion|subzonal sperm insertion|Y
dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin|dendritic cell-specific intercellular adhesion molecule 3 grabbing nonintegrin|Y
killer immunoglobulin-like receptor 2DS3|killer immunoglobulin-like receptor 2DS2|Y
American Society of Anaesthesiologists grade 5|American Society of Anaesthesiologists Grade 5|Y
American Society of Anaesthesiologists grade 5|American Society of Anaesthesiologists grade 4|Y
American Society of Anaesthesiologists grade 5|American Society of Anesthesiologists grade 5|Y
heteroduplex analysis|hetero-duplex analysis|Y
surface-assisted laser desorption ionisation|surface-assisted laser desorption-ionisation|Y
circulating recombinant form|circulating recombinant forms|Y
oxidised low density lipoprotein receptor 1|oxidized low density lipoprotein receptor 1|Y
immunoreactive proinsulin|immunoreactive pro-insulin|Y
intraabdominal hypertension|intra-abdominal hypertension|Y
mucosa associated lymphoid tissue-type lymphoma|mucosa-associated lymphoid tissue-type lymphoma|Y
anti-interleukin 13 antibody|anti-interleukin 1 antibody|Y
recombinant human bone morphogenetic protein|recombinant human bone morphogenetic protein 4|Y
insulin-like growth factor-II mRNA-binding protein-3|insulin-like growth factor-II mRNA binding protein-3|Y
eukaryotic translation elongation factor 1B|eukaryotic translation elongation factor 1A|Y
Women, Infants, and Children Program|Women, Infants and Children Program|Y
recombinant interleukin 12|recombinant interleukin 1|Y
nicotinamide-adenine dinucleotide linked|nicotinamide adenine dinucleotide linked|Y
para-nitrosodimethylaniline|para-nitrosodimethyl-aniline|Y
activity regulated cytoskeletal associated protein|activity regulated cytoskeletal-associated protein|Y
staphylococcal cassette chromosome methicillin resistance type III|staphylococcal cassette chromosome methicillin resistance type I|Y
pre-messenger ribonucleoprotein|premessenger ribonucleoprotein|Y
nonnucleoside RT inhibitors|non-nucleoside RT inhibitors|Y
a disintegrin and metalloproteinase with thrombospondin motif-12|a disintegrin and metalloproteinase with thrombospondin motif-18|Y
a disintegrin and metalloproteinase with thrombospondin motif-12|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motif-12|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloproteinase with thrombospondin motif-12|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-12|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motif-12|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-12|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motif-12|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
endo-anal ultrasonography|endoanal ultrasonography|Y
American Spinal Injury Association grade B|American Spinal Injury Association grade A|Y
transient tachypnoea of the newborn|transient tachypnea of the newborn|Y
γ-aminobutyric acid/benzodiazepine receptor complex|γ-aminobutyric acid A/benzodiazepine receptor complex|Y
T cell receptor gammadelta-positive|T cell receptor gamma delta-positive|Y
sterol regulatory element-binding protein 1-a|sterol regulatory element-binding protein-1-a|Y
ras-related GTP-binding protein 27|ras-related GTP-binding protein 7|Y
pulsed electric fields|pulsed electric field|Y
American Society of Anesthesiology physical status|American Society of Anesthesiology physical status 3|Y
a disintegrin and metalloprotease with thrombospondin motif-5|a disintegrin and metalloprotease with thrombospondin motif-6|Y
a disintegrin and metalloprotease with thrombospondin motif-5|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloprotease with thrombospondin motif-5|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motif-5|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motif-5|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-5|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motif-5|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
tetra-acetyl phytosphingosine|tetraacetyl phytosphingosine|Y
myocardial perfusion single-photon-emission computerized tomography|myocardial perfusion single-photon emission computerized tomography|Y
oestrogen receptor-β knock-out mouse|oestrogen receptor-β knockout mouse|Y
Response Evaluation Criteria in Solid Tumours|Response Evaluation Criteria in Solid Tumors|Y
multislice computed tomography scan|multi-slice computed tomography scan|Y
a disintegrin and metalloproteinase with thrombospondin motifs-7|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motifs-7|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-7|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motifs-7|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-7|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-7|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motifs-7|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
calcium- and diacylglycerol-regulated guanine nucleotide exchange factor III|calcium- and diacylglycerol-regulated guanine nucleotide exchange factor Ia|Y
paramethoxyamphetamine|para-methoxyamphetamine|Y
intra-ocular lens power calculation|intraocular lens power calculation|Y
hyperglycemic hyperosmolar non-ketotic syndrome|hyperglycemic hyperosmolar nonketotic syndrome|Y
disseminated tumor cells|disseminated tumor cell|Y
myocardial perfusion single photon emission computed tomography|myocardial perfusion single-photon emission computed tomography|Y
TATA-binding protein associated factor-2|TATA-binding protein associated factor-4|Y
TATA-binding protein associated factor-2|TATA-binding protein associated factor-12|Y
TATA-binding protein associated factor-2|TATA-binding protein-associated factor-2|Y
TATA-binding protein associated factor-2|TATA-binding protein associated factor-7|Y
non-obese diabetic mouse|nonobese diabetic mouse|Y
mitogen activated protein kinase phosphatase|mitogen activated protein kinase phosphatase-1|Y
IL-13 receptor alpha 2|IL-13 receptor alpha2|Y
activated Cdc42 associated tyrosine kinase 1|activated Cdc42 associated tyrosine kinase 2|Y
transforming growth factor-β1|transforming growth factor-β 1|Y
haemoglobin Bart's disease|hemoglobin Bart's disease|Y
preproapolipoprotein C-2|preproapolipoprotein C2|Y
interferon stimulated gene factor-3 alpha|interferon stimulated gene factor-3alpha|Y
fanbeam dual-energy x-ray absorptiometry|fanbeam dual-energy X-ray absorptiometry|Y
fanbeam dual-energy x-ray absorptiometry|fan beam dual-energy x-ray absorptiometry|Y
cellular Fas-associated death domain-like interleukin-1beta converting enzyme-inhibitory protein|cellular Fas-associated death domain-like interleukin-1-beta converting enzyme-inhibitory protein|Y
Src homology 2 domain containing protein tyrosine phosphatase substrate-1|Src homology 2 domain containing protein tyrosine phosphatase substrate 1|Y
erythroblastic leukemia viral oncogene homolog A|erythroblastic leukemia viral oncogene homolog 4|Y
cytokine induced neutrophil chemoattractant 3|cytokine induced neutrophil chemoattractant|Y
promyelocytic leukaemia-retinoic acid receptor alpha|promyelocytic leukaemia-retinoic acid receptor-alpha|Y
promyelocytic leukaemia-retinoic acid receptor alpha|promyelocytic leukemia-retinoic acid receptor alpha|Y
stromal derived factor 1alpha|stromal derived factor 1 alpha|Y
intra-vascular malignant lymphomatosis|intravascular malignant lymphomatosis|Y
ras-related GTP-binding protein 39|ras-related GTP-binding protein 39A|Y
β-ketoacyl-acyl carrier protein synthase|β-ketoacyl-acyl carrier protein synthase I|Y
gastric myoelectrical activity|gastric myo-electrical activity|Y
oxidized nicotinamide-adenine dinucleotide|oxidized nicotinamide adenine dinucleotide|Y
disseminated intravascular coagulation-like|disseminated intravascular coagulation like|Y
light harvesting chlorophyll a/b protein I|light harvesting chlorophyll a/b-protein I|Y
myeloid DAP 12-associating lectin-1|myeloid DAP12-associating lectin-1|Y
light-harvesting chlorophyll a/b-binding protein|light-harvesting chlorophyll-a/b-binding protein|Y
anti-TCR-alphabeta monoclonal antibody|anti-TCR-alpha/beta monoclonal antibody|Y
ubiquitin-like modifier activating enzyme 4|ubiquitin-like modifier activating enzyme 5|Y
ubiquitin-like modifier activating enzyme 4|ubiquitin-like modifier activating enzyme 6|Y
glucagon-like peptide-1 receptor agonist|glucagon-like peptide 1 receptor agonist|Y
insulin-like growth factor II mRNA-binding protein-1|insulin-like growth factor II mRNA-binding protein-2|Y
oro-faciodigital syndrome|oro-facio-digital syndrome|Y
N-methyl-N'-nitro-N-nitrosoguanidine|N-methyl-N-nitro-N-nitrosoguanidine|Y
polypyrimidine-tract-binding protein-associated splicing factor|polypyrimidine tract-binding protein-associated splicing factor|Y
multiplex-fluorescence in situ hybridisation|multiplex-fluorescence in situ hybridization|Y
multiplex-fluorescence in situ hybridisation|multiplex fluorescence in situ hybridisation|Y
beta-amyloid precursor protein-cleaving enzyme-2|beta-amyloid precursor protein cleaving enzyme-2|Y
nuclear factor κB p50|nuclear factor κ B p50|Y
anti-interleukin-4 receptor monoclonal antibody|anti-interleukin 4 receptor monoclonal antibody|Y
a disintegrin and metalloproteinase with thrombospondin motif-18|a disintegrin and metalloproteinase with thrombospondin motif-5|Y
a disintegrin and metalloproteinase with thrombospondin motif-18|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-18|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motif-18|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motif-18|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
Escherichia coli strain DH5alpha|Escherichia coli strain DH5-alpha|Y
Src homology 2 domain containing protein tyrosine phosphatase 2|Src homology 2 domain containing protein tyrosine phosphatase|Y
Src homology 2 domain containing protein tyrosine phosphatase 2|Src homology 2 domain containing protein tyrosine phosphatase-2|Y
United Network for Organ Sharing status I|United Network for Organ Sharing status 1|Y
United Network for Organ Sharing status I|United Network for Organ Sharing status 2|Y
13carbon urea breath test|13-carbon urea breath test|Y
2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine|2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine|Y
2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine|2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine|Y
immunoglobulin G4 associated cholangitis|immunoglobulin G4-associated cholangitis|Y
peroxisome proliferator-activated receptor-γ co-activator 1α|peroxisome-proliferator-activated receptor-γ co-activator 1 α|Y
peroxisome proliferator-activated receptor-γ co-activator 1α|peroxisome proliferator-activated receptor-γ co-activator-1α|Y
peroxisome proliferator-activated receptor-γ co-activator 1α|peroxisome proliferator-activated receptor-γ co-activator-1 α|Y
peroxisome proliferator-activated receptor-γ co-activator 1α|peroxisome proliferator-activated receptor γ co-activator 1α|Y
permeability coefficients|permeability coefficient|Y
American Society of Anesthesiologists grade I|American Society of Anesthesiologists grade II|Y
American Society of Anesthesiologists grade I|American Society of Anesthesiologists grade 1|Y
American Society of Anesthesiologists grade I|American Society of Anesthesiologists grade 5|Y
thoraco-abdominal asynchrony|thoracoabdominal asynchrony|Y
cross polarisation magic angle spinning nuclear magnetic resonance spectroscopy|cross polarisation/magic angle spinning nuclear magnetic resonance spectroscopy|Y
ethane dimethanesulfonate|ethane dimethane sulfonate|Y
minimal erythemal dose|minimal erythema dose|Y
tumor necrosis factor related apoptosis inducing ligand|tumor necrosis factor-related apoptosis inducing ligand|Y
para-hydroxy-triamterene|para-hydroxytriamterene|Y
antiacetylcholinesterase|anti-acetylcholinesterase|Y
posttransplant erythrocytosis|post-transplant erythrocytosis|Y
human T-lymphotropic virus type I-associated|human T lymphotropic virus type I-associated|Y
human T-lymphotropic virus type I-associated|human T-lymphotropic virus type 1-associated|Y
Snf2-related CREB-binding protein activator protein|Snf-2-related CREB-binding protein activator protein|Y
4'6-diamidino-2-phenylindole|4'-6-diamidino-2-phenylindole|Y
cluster of differentiation 163|cluster of differentiation 63|Y
anti-cyclooxygenase 2 antibody|anticyclooxygenase 2 antibody|Y
anti-interleukin 1 antibody|anti-interleukin 18 antibody|Y
anti-interleukin 1 antibody|anti-interleukin 15 antibody|Y
methyl cytidine-phosphate-guanosine binding domain 2|methyl cytidine-phosphate-guanosine binding domain 5|Y
delayed after depolarization|delayed afterdepolarization|Y
beta-site amyloid precursor protein cleaving enzyme 1|beta-site amyloid precursor protein cleaving enzyme|Y
beta-site amyloid precursor protein cleaving enzyme 1|beta-site amyloid precursor protein cleaving enzyme 2|Y
beta-site amyloid precursor protein cleaving enzyme 1|beta site amyloid precursor protein cleaving enzyme 1|Y
beta-site amyloid precursor protein cleaving enzyme 1|beta-site amyloid precursor protein cleaving enzyme-1|Y
intra-operative autotransfusion|intraoperative autotransfusion|Y
anti-retinal antibody|antiretinal antibody|Y
placental anemia-inducing factor|placental anaemia-inducing factor|Y
sodium-coupled neutral amino acid transporter 1|sodium-coupled neutral amino acid transporter 2|Y
sodium-coupled neutral amino acid transporter 1|sodium-coupled neutral amino acid transporter-1|Y
sodium-coupled neutral amino acid transporter 1|sodium-coupled neutral amino acid transporter 3|Y
atlanto-axial kyphosis|atlantoaxial kyphosis|Y
excision repair cross-complementing-group 1|excision repair cross-complementing-group 4|Y
peptidoglycan recognition protein L|peptidoglycan recognition protein LC|Y
Moller-Plesset second order perturbation theory|Moeller-Plesset second order perturbation theory|Y
Moller-Plesset second order perturbation theory|Møller-Plesset second order perturbation theory|Y
health-care-associated methicillin-resistant Staphylococcus aureus|health care-associated methicillin-resistant Staphylococcus aureus|Y
size-exclusion chromatography/multi-angle laser light scattering|size-exclusion chromatography-multi-angle laser light scattering|Y
American Society of Anaesthesiology grade 4|American Society of Anaesthesiology grade V|Y
1,25-dihydroxyvitamin D3|1,25-dihydroxyvitamin D|Y
intracarotid sodium amytal|intra-carotid sodium amytal|Y
γ-aminobutyric acid A/benzodiazepine receptor complex|γ-aminobutyric acid A-benzodiazepine receptor complex|Y
non-convulsive status epilepticus|nonconvulsive status epilepticus|Y
corticotrophin releasing hormone receptor 2|corticotrophin releasing hormone receptor-2|Y
anti-IL-4 receptor alpha antibody|anti-IL4 receptor alpha antibody|Y
university-affiliated Veterans' Affairs medical center|university-affiliated Veterans Affairs medical center|Y
mitogen activated protein kinase kinase 1|mitogen-activated protein kinase kinase 1|Y
soluble interleukin 2 receptor-α|soluble interleukin 2 receptorα|Y
extra-renal Wilms tumour|extra-renal Wilms tumor|Y
human immunodeficiency virus associated dementia|human immunodeficiency virus-associated dementia|Y
A disintegrin and metalloprotease-33|A disintegrin and metalloprotease-3|Y
color-coded duplex sonography|colour-coded duplex sonography|Y
interleukin-1 β-converting enzyme inhibitor|interleukin-1β-converting enzyme inhibitor|Y
heat shock protein 90 β|heat shock protein 90β|Y
interferon stimulated gene factor 3|interferon stimulated gene factor 3γ|Y
interferon stimulated gene factor 3|interferon stimulated gene factor 3α|Y
neural precursor cell expressed, developmentally down-regulated 1|neural precursor cell expressed developmentally down-regulated 9|Y
neural precursor cell expressed, developmentally down-regulated 1|neural precursor cell-expressed, developmentally downregulated 1|Y
neural precursor cell expressed, developmentally down-regulated 1|neural precursor cell expressed, developmentally down-regulated 5|Y
a disintegrin and metalloprotease with thrombospondin motif-6|a disintegrin and metalloprotease with thrombospondin motif-19|Y
a disintegrin and metalloprotease with thrombospondin motif-6|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motif-6|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-6|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motif-6|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
specificity protein transcription factor|specificity protein 1 transcription factor|Y
human immunodeficiency virus-associated dementia|human immunodeficiency virus-1-associated dementia|Y
microtubule associated protein-1 light-chain 3|microtubule associated protein light-chain 3|Y
cis-platinum diammine dichloride|cis-platinum diamminedichloride|Y
nicotinamide adenine dinucleotide-linked|nicotinamide adenine dinucleotide linked|Y
AIDS Drug Assistance Programs|AIDS Drug Assistance Program|Y
corticotropin-releasing-hormone receptor|corticotropin-releasing-hormone receptor 2|Y
anti-IL 4 receptor antibody|anti-IL4 receptor antibody|Y
cytoplasmic polyadenylation element binding protein 3|cytoplasmic polyadenylation element binding protein 2|Y
parafluorohexahydrosiladifenidol|parafluoro-hexahydrosiladifenidol|Y
sodium-coupled neutral amino acid transporter 2|sodium-coupled neutral amino acid transporter 3|Y
extrastriate body area|extra-striate body area|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon beta|Toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Y
toll-interleukin 1 receptor domain-containing adapter-inducing interferon beta|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
transforming growth factor β-activated kinase-1|transforming growth factor-β-activated kinase-1|Y
scanning electron microscopy-energy dispersive X-ray spectrometry|scanning electron microscopy-energy-dispersive X-ray spectrometry|Y
tumor necrosis factor receptor associated factor 1|tumor necrosis factor receptor associated factor-1|Y
recombinant interleukine-1 α|recombinant interleukin-1 α|Y
TATA-binding protein associated factor-11|TATA-binding protein associated factor 11|Y
TATA-binding protein associated factor-11|TATA-binding protein associated factor-12|Y
Björk-Shiley convexoconcave heart valve|Björk-Shiley convexo-concave heart valve|Y
amino-terminal proB-type natriuretic peptide|aminoterminal pro-B-type natriuretic peptide|Y
hypercholesterolemic|hyper-cholesterolemic|Y
tumor necrosis factor-β|tumour necrosis factor-β|Y
interleukine-15 receptor alpha-chain|interleukin-15 receptor alpha-chain|Y
galactorrhœa-amenorrhoea hyperprolactinaemia syndrome|galactorrhœa-amenorrhoea hyperprolactinemia syndrome|Y
endoscopic transanal resection|endoscopic trans-anal resection|Y
3-β-hydroxysteroid dehydrogenase deficiency|3β-hydroxysteroid dehydrogenase deficiency|Y
coronary artery bypass surgery|coronary artery by-pass surgery|Y
Bos taurus autosome 21|Bos taurus autosome 1|Y
vinylcyclohexene di-epoxide|vinyl cyclohexene di-epoxide|Y
steroid 5-α-reductase type 2|steroid 5α-reductase type 2|Y
antischizont monoclonal antibody|anti-schizont monoclonal antibody|Y
transient receptor potential melastatin 7|transient receptor potential melastatin 8|Y
transient receptor potential melastatin 7|transient receptor potential melastatin 1|Y
a disintegrin and metalloproteinase with thrombospondin motif-5|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-5|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motif-5|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motif-5|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-5|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motif-5|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
antiIL-4 receptor monoclonal antibody|anti-IL-4 receptor monoclonal antibody|Y
anti-T-cell receptor alpha/beta antibody|anti-T-cell receptor alpha beta antibody|Y
antiherpes simplex virus type 2 antibody|anti-herpes simplex virus type 2 antibody|Y
cluster designation 68|cluster designation 8|Y
average bioequivalence|average bio-equivalence|Y
para-hydroxymercuribenzoate|parahydroxymercuribenzoate|Y
aminoacyl-tRNA synthetase-interacting multifunctional protein 2|aminoacyl tRNA synthetase-interacting multifunctional protein 2|Y
aminoacyl-tRNA synthetase-interacting multifunctional protein 2|aminoacyl-tRNA synthetase-interacting multifunctional protein 3|Y
recombinant interleukin 21|recombinant interleukin 1|Y
cluster of differentiation 68|cluster of differentiation 8|Y
in-bred alcohol-preferring rat|inbred alcohol-preferring rat|Y
peroxisome-proliferator-activated receptor-γ co-activator 1 α|peroxisome-proliferator-activated receptor-γ coactivator 1α|Y
intranasal corticosteroid|intra-nasal corticosteroid|Y
retinoic-acid-receptor-related orphan receptor γ|retinoic-acid-receptor-related orphan receptor|Y
retinoic-acid-receptor-related orphan receptor γ|retinoic-acid-receptor-related orphan receptor-γ|Y
cortical collecting ducts|cortical collecting duct|Y
peristimulus time histogram|peri-stimulus time histogram|Y
methicillin-resistant S. epidermidis|meticillin-resistant S. epidermidis|Y
anti-hepatitis E virus|antihepatitis E virus|Y
TATA-binding protein associated factor-4|TATA-binding protein associated factor-7|Y
tumor-cell migratory inhibition factor|tumour-cell migratory inhibition factor|Y
antivaricella zoster virus|anti-varicella zoster virus|Y
matrix-assisted laser desorption ionization time of flight mass spectrometric|matrix-assisted laser desorption ionization time of flight mass spectrometry|Y
excision repair cross-complementing group 3|excision repair cross-complementing group 5|Y
interleukine-18 receptor alpha chain|interleukin-18 receptor alpha chain|Y
Medical Outcomes Study 36 Item Short-Form Health Survey Version 2|Medical Outcomes Study 36-Item Short-Form Health Survey Version 2|Y
pneumococcal purpura-producing principle|pneumococcal purpura producing principle|Y
persistent hyperinsulinaemic hypoglycaemia of infancy|persistent hyperinsulinemic hypoglycemia of infancy|Y
circulating intercellular adhesion molecule-1|circulating intercellular adhesion molecule-2|Y
circulating intercellular adhesion molecule-1|circulating intercellular adhesion molecule-3|Y
maxillomandibular fixation|maxillo-mandibular fixation|Y
interleukin-6 receptor-alpha|interleukine-6 receptor-alpha|Y
corticotropin-releasing hormone receptor type-2|corticotropin releasing hormone receptor type-2|Y
retinoic-acid-receptor-related orphan receptor gammat|retinoic-acid-receptor-related orphan receptor gamma-t|Y
Depression Adjective Check List|Depression Adjective Check Lists|Y
microtubule-associated protein 1 light chain 3|microtubule-associated protein 1 light chain 3B|Y
a disintegrin and metalloprotease with thrombospondin motif-19|a disintegrin and metalloprotease with thrombospondin motif-16|Y
a disintegrin and metalloprotease with thrombospondin motif-19|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-19|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motif-19|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
interleukin 12 receptor β1|interleukin 12 receptor β 1|Y
levo-dopa induced dyskinesia|laevo-dopa induced dyskinesia|Y
vasopressin 1A receptor|vasopressin 1 receptor|Y
American Society of Anesthesiologists physical status 5|American Society of Anaesthesiologists physical status 5|Y
human embryonic kidney 293T cell line|human embryonic kidney 293 cell line|Y
benzo[a]pyrene diol epoxide DNA adduct level|benzo[a]pyrene diol epoxide-DNA adduct level|Y
terminal-deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling|terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling|Y
excision repair cross complementing group 2|excision repair cross complementing group 6|Y
a disintegrin and metalloprotease with thrombospondin motif-16|a disintegrin and metalloprotease with thrombospondin motif-12|Y
a disintegrin and metalloprotease with thrombospondin motif-16|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motif-16|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
neural-precursor-cell-expressed, developmentally downregulated 5|neural-precursor-cell-expressed developmentally downregulated 5|Y
neural-precursor-cell-expressed, developmentally downregulated 5|neural-precursor cell-expressed, developmentally down-regulated 5|Y
neural-precursor-cell-expressed, developmentally downregulated 5|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor-cell-expressed, developmentally downregulated 5|neural-precursor-cell-expressed, developmentally downregulated 2|Y
cAMP dependent protein kinase|c-AMP dependent protein kinase|Y
ribosomal protein L9|ribosomal protein L19|Y
p-hydroxymercuriphenyl sulfonate|p-hydroxymercuriphenylsulfonate|Y
cytotoxic T-lymphocyte antigen 2 α|cytotoxic T-lymphocyte antigen 2α|Y
prepro-brain natriuretic peptide|pre-pro-brain natriuretic peptide|Y
pseudo-hypoparathyroidism|pseudohypoparathyroidism|Y
three color fluorescence in-situ hybridisation|three-color fluorescence in-situ hybridisation|Y
intracranial electroencephalography|intracranial electro-encephalography|Y
phosphorylated cAMP responsive element binding protein|phosphorylated cAMP response element binding protein|Y
IFN-gamma activation site|IFNgamma activation site|Y
insulin/IGF1 signalling|insulin/IGF-1 signalling|Y
glycophosphatidylinositol-linked protein|glycophosphatidyl inositol-linked protein|Y
alpha-naphthyl isothiocyanate|alpha-naphthylisothiocyanate|Y
extra-renal Wilm's tumor|extra-renal Wilms tumor|Y
American Society of Anaesthesiologists physical status 1|American Society of Anaesthesiologists physical status 4|Y
American Society of Anaesthesiologists physical status 1|American Society of Anaesthesiologists physical status 5|Y
light harvesting chlorophyll-a/b-binding protein|light-harvesting chlorophyll-a/b-binding protein|Y
peroxisome-proliferator-activated receptor-gamma co-activator 1alpha|peroxisome proliferator-activated receptor-gamma co-activator 1 alpha|Y
peroxisome-proliferator-activated receptor-gamma co-activator 1alpha|peroxisome-proliferator-activated receptor-gamma coactivator-1alpha|Y
aminoacyl tRNA synthetase-interacting multifunctional protein 2|aminoacyl tRNA synthetase-interacting multi-functional protein 1|Y
disseminated tumour cell|disseminated tumor cell|Y
Wechsler Intelligence Scale for Children-Third Edition|Wechsler Intelligence Scale for Children Third Edition|Y
multidimensional pain scale|multi-dimensional pain scale|Y
endothelial-leukocyte adhesion molecule 1|endothelial-leukocyte adhesion molecule-1|Y
subfoveal choroidal neo-vascularization|sub-foveal choroidal neo-vascularization|Y
accelerated-phase chronic myeloid leukemia|accelerated phase chronic myeloid leukemia|Y
a disintegrin and metalloprotease with thrombospondin motif-12|a disintegrin and metalloprotease with thrombospondin motif|Y
a disintegrin and metalloprotease with thrombospondin motif-12|a disintegrin and metalloproteinase with thrombospondin motif-2|Y
a disintegrin and metalloprotease with thrombospondin motif-12|a disintegrin and metalloprotease with thrombospondin motifs-15|Y
metabotropic glutamate receptor subtype 6|metabotropic glutamate receptor subtype 4|Y
transforming growth factor-β signalling pathway|transforming growth factor-β signaling pathway|Y
actin related protein2|actin related protein|Y
familial atypical multiple mole melanoma|familial atypical multiple-mole melanoma|Y
alpha2 macroglobulin receptor-associated protein|alpha2 macroglobulin receptor associated protein|Y
alpha2 macroglobulin receptor-associated protein|alpha2-macroglobulin receptor-associated protein|Y
peroxisome proliferator activated receptor-gamma-2|peroxisome proliferator-activated receptor-gamma-2|Y
3β-hydroxysteroid-dehydrogenase deficiency|3β-hydroxysteroid dehydrogenase deficiency|Y
matrix assisted laser desorption-ionization mass spectrometry|matrix assisted laser desorption/ionization mass spectrometry|Y
B-prolymphocytic leukaemia|B-prolymphocytic leukemia|Y
oxidized low density lipoprotein receptor-1|oxidized low density lipoprotein receptor 1|Y
glycosyl-phosphatidylinositol-anchored protein|glycosylphosphatidyl-inositol-anchored protein|Y
kruppel-associated box-associated protein 1|Kruppel-associated box-associated protein 1|Y
kruppel-associated box-associated protein 1|krüppel-associated box-associated protein 1|Y
kruppel-associated box-associated protein 1|krueppel-associated box-associated protein 1|Y
cyclo-pentyl-adenosine|cyclo-pentyladenosine|Y
American Society of Anesthesiologists class I|American Society of Anesthesiologists class 1|Y
Salt Lake City Veterans' Administration Medical Center|Salt Lake City Veterans Administration Medical Center|Y
beta-site amyloid precursor protein-cleaving enzyme 2|beta-site amyloid precursor protein cleaving enzyme 2|Y
autoimmunity associated behavioral syndrome|autoimmunity-associated behavioral syndrome|Y
oligoasthenoteratozoospermia|oligoastheno-teratozoospermia|Y
sterol response element binding protein 1c|sterol response element binding protein 1-c|Y
human adenovirus serotype 45|human adenovirus serotype 5|Y
postprandial lipemia|post-prandial lipemia|Y
crosspolarization magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
peroxisome proliferator activated receptor gamma coactivator 1|peroxisome proliferator-activated receptor gamma co-activator 1|Y
activating signal co-integrator 1|activating signal cointegrator 1|Y
receptor-like protein-tyrosine phosphatase δ|receptor-like protein-tyrosine phosphatase μ|Y
insulin-like growth factor-II messenger RNA-binding protein-3|insulin-like growth factor-II messenger RNA binding protein-3|Y
trichorhinophalangeal syndrome type II|trichorhinophalangeal syndrome type I|Y
signal transducer and activator of transcription 5b|signal transducer and activator of transcription-5b|Y
fluorine-18 labelled fluorodeoxyglucose|fluorine-18 labeled fluorodeoxyglucose|Y
cerebral hypo-perfusion|cerebral hypoperfusion|Y
circulating intercellular adhesion molecule-2|circulating intercellular adhesion molecule-3|Y
monosegmental pedicle instrumentation|mono-segmental pedicle instrumentation|Y
continuous veno-venous hemodialysis|continuous venovenous hemodialysis|Y
Tumor necrosis factor receptor-associated periodic syndrome|tumor necrosis factor receptor-associated periodic syndrome|Y
American Society of Anesthesiologists Class 2|American Society of Anesthesiologists Class 4|Y
O-desmethyl venlafaxine|O-desmethylvenlafaxine|Y
amygdalohippocampectomy|amygdalo-hippocampectomy|Y
parafluoro-hexahydrosiladifenidol|para-fluoro-hexahydrosiladifenidol|Y
transient receptor potential melastatin 8|transient receptor potential melastatin 1|Y
beta-site amyloid precursor protein cleaving enzyme|beta-site amyloid precursor protein cleaving enzyme 2|Y
beta-site amyloid precursor protein cleaving enzyme|beta-site amyloid precursor protein cleaving enzyme-1|Y
phospho-p38-mitogen-activated protein kinase|phospho-p38 mitogen-activated protein kinase|Y
peroxisome proliferator-activated receptor-gamma coactivator 1 alpha|peroxisome proliferator-activated receptor gamma co-activator 1 alpha|Y
peroxisome proliferator-activated receptor-gamma coactivator 1 alpha|peroxisome proliferator-activated receptor-gamma co-activator 1 alpha|Y
guanosine triphosphatase-activating protein|guanosine triphosphatase-activating protein 1|Y
intra-operative radiotherapy|intraoperative radiotherapy|Y
spermidine/spermine N(1)-acetyltransferase|spermidine-spermine N(1)-acetyltransferase|Y
never in mitosis, gene A-related kinase 6|never in mitosis, gene A-related kinase 4|Y
enterobacterial common antigen|entero-bacterial common antigen|Y
amyotrophic lateral sclerosis|amyotropic lateral sclerosis|Y
severe combined immunodeficiency repopulating cell|severe combined immunodeficiency-repopulating cell|Y
picture archiving and communication system|picture archiving and communications system|Y
membrane-type matrix metalloproteinase 1|membrane-type matrix metalloproteinase-1|Y
a disintegrin and metalloproteinase with thrombospondin motif-2|a disintegrin and metalloproteinase with thrombospondin motifs-6|Y
a disintegrin and metalloproteinase with thrombospondin motif-2|a disintegrin and metalloproteinase with thrombospondin motif-13|Y
a disintegrin and metalloproteinase with thrombospondin motif-2|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motif-2|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motif-2|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
bacillus-Calmette-Guerin-activated killer cell|bacillus-Calmette-Guerin activated killer cell|Y
nonaqueous phase liquid|non-aqueous phase liquid|Y
free insulinlike growth factor|free insulin-like growth factor|Y
pre-beta 1-high density lipoprotein|pre-beta1-high density lipoprotein|Y
dual-color chromogenic in-situ hybridization|dual-colour chromogenic in-situ hybridization|Y
membrane-associated guanylate kinases|membrane-associated guanylate kinase|Y
thermogravimetry/derivative thermogravimetry|thermogravimetry-derivative thermogravimetry|Y
ubiquitin-like modifier activating enzyme 5|ubiquitin-like modifier activating enzyme 6|Y
sex-determining region Y, box 8|sex-determining region Y box 8|Y
left salpingo-oophorectomy|left salpingooophorectomy|Y
augmented correlation consistent polarised valence quadruple zeta basis set|augmented correlation-consistent polarised valence quadruple zeta basis set|Y
extracellular K+ concentration|extracellular K+ concentrations|Y
peroxisome proliferator-activated receptor|peroxisome proliferator-activated receptor β|Y
electro-magnetic radiation|electromagnetic radiation|Y
enhanced chemi-luminescence|enhanced chemiluminescence|Y
transforming growth factor-alpha-Pseudomonas exotoxin 40|transforming growth factor-alpha-Pseudomonas exotoxin-40|Y
pre-interleukin 1beta|pre-interleukin 1 beta|Y
glycosylphosphatidylinositol anchored|glycosylphosphatidyl-inositol anchored|Y
mitogen-activated protein kinase kinase-2|mitogen-activated protein kinase kinase-7|Y
homozygous alpha 1-PI deficiency|homozygous alpha1-PI deficiency|Y
interleukine-4 receptor α|interleukin-4 receptor α|Y
promyelocytic leukemia/retinoic acid receptor-alpha|promyelocytic leukemia/retinoic acid receptor alpha|Y
gonadotropin-releasing factor|gonadotrophin-releasing factor|Y
never-in-mitosis Aspergillus-related kinase 7|never-in-mitosis Aspergillus-related kinase|Y
extrarenal Wilms tumor|extra-renal Wilms tumor|Y
thyrotrophin-releasing hormone receptor 1|thyrotrophin-releasing hormone receptor|Y
neural-precursor cell-expressed developmentally down-regulated 5|neural-precursor-cell-expressed developmentally downregulated 5|Y
neural-precursor cell-expressed developmentally down-regulated 5|neural-precursor cell-expressed, developmentally down-regulated 5|Y
diisopropyliminodiacetic acid|di-isopropyliminodiacetic acid|Y
tumour necrosis factor receptor-associated periodic syndrome|tumor necrosis factor receptor-associated periodic syndrome|Y
corticotrophin releasing hormone receptor type-2|corticotrophin releasing hormone receptor type 2|Y
corticotrophin releasing hormone receptor type-2|corticotropin releasing hormone receptor type-2|Y
Src homology 2 domain containing protein tyrosine phosphatase|Src homology 2 domain containing protein tyrosine phosphatase-2|Y
pre-B-cell leukemia transcription factor-1|pre-B-cell leukaemia transcription factor-1|Y
mucosa-associated lymphoid tissue|mucosa-associated lymphoid tissues|Y
parahydroxymethamphetamine|para-hydroxymethamphetamine|Y
tumor necrosis factor receptor superfamily member 9|tumor necrosis factor receptor superfamily member 19|Y
toll/interleukin 1 receptor domain-containing adapter-inducing interferon β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon β|Y
Fas-associated death domain-like interleukin-1β converting enzyme-inhibitory protein|Fas-associated death domain-like interleukin-1β-converting enzyme-inhibitory protein|Y
polymerase chain reaction sequence-based typing|polymerase chain reaction-sequence-based typing|Y
neural-precursor-cell-expressed developmentally down-regulated 4|neural-precursor-cell-expressed developmentally downregulated 5|Y
neural-precursor-cell-expressed developmentally down-regulated 4|neural-precursor-cell-expressed developmentally down-regulated 1|Y
interleukin 13 receptor α 2-chain|interleukin 13 receptor α2-chain|Y
temporoparietal junction|temporo-parietal junction|Y
methane mono-oxygenase|methane monooxygenase|Y
solute carrier family 7 member 11|solute carrier family 7 member 1|Y
grazing-incidence small angle X-ray scattering|grazing-incidence small-angle X-ray scattering|Y
soluble cluster of differentiation antigen 36|soluble cluster of differentiation antigen 26|Y
soluble cluster of differentiation antigen 36|soluble cluster of differentiation antigen 30|Y
organosulfur compound|organo-sulfur compound|Y
cross polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|cross polarisation/magic angle spinning nuclear magnetic resonance spectroscopy|Y
cross polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
cross polarisation/magic-angle spinning nuclear magnetic resonance spectroscopy|crosspolarization/magic-angle spinning nuclear magnetic resonance spectroscopy|Y
University of California SanFrancisco|University of California San Francisco|Y
continuous venovenous haemo-diafiltration|continuous veno-venous hemo-diafiltration|Y
continuous venovenous haemo-diafiltration|continuous venovenous hemo-diafiltration|Y
transient-evoked oto-acoustic emission|transient-evoked otoacoustic emission|Y
peroxidase antiperoxidase technique|peroxidase anti-peroxidase technique|Y
synthase inhibitor N(omega)-nitro-L-arginine|synthase inhibitor Nomega-nitro-L-arginine|Y
ethylenediamine tetra-acetic acid|ethylenediaminetetra-acetic acid|Y
neural precursor cell-expressed developmentally down-regulated 2|neural precursor cell-expressed developmentally down-regulated 4|Y
neural precursor cell-expressed developmentally down-regulated 2|neural precursor cell-expressed developmentally downregulated 9|Y
neural precursor cell-expressed developmentally down-regulated 2|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell-expressed developmentally down-regulated 2|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell-expressed developmentally down-regulated 2|neural precursor cell-expressed, developmentally down-regulated 2|Y
insulin-like growth factor-II messenger RNA binding protein-1|insulin-like growth factor-II messenger RNA binding protein-3|Y
insulin-like growth factor-II messenger RNA binding protein-1|insulin-like growth factor-II messenger RNA binding protein-2|Y
European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30|European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire Core-30|Y
ileorectal anastomosis|ileo-rectal anastomosis|Y
macrophage inflammatory protein 3α|macrophage inflammatory protein 3 α|Y
dithiobis(succinimidyl propionate|dithiobis(succinimidyl propionate)|Y
dendritic cell/tumor fusion|dendritic cell/tumour fusion|Y
a disintegrin and metalloproteinase with thrombospondin motifs-6|a disintegrin and metalloproteinase with thrombospondin motifs-2|Y
a disintegrin and metalloproteinase with thrombospondin motifs-6|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-6|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motifs-6|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon-beta|toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Toll/interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon-beta|toll/interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
surface-enhanced laser desorption ionization|surface-enhanced laser desorption ionisation|Y
excimer laser photorefractive keratectomy|excimer laser photo-refractive keratectomy|Y
TBP associated factor 7|TBP associated factor 17|Y
Wechsler Preschool and Primary Scale of Intelligence Revised|Wechsler Preschool and Primary Scale of Intelligence-Revised|Y
microorifice uniform deposit impactor|micro-orifice uniform deposit impactor|Y
knowledge, attitude and practice|knowledge attitude and practice|Y
T-cell-receptor γδ cell|T-cell-receptor γ δ cell|Y
insulin-like growth factor-II messenger RNA binding protein-3|insulin-like growth factor-II messenger RNA binding protein-2|Y
insulin-like growth factor-II messenger RNA binding protein-3|insulin-like growth factor-II messenger RNA binding protein 3|Y
anti-IL10 receptor antibody|anti-IL-10 receptor antibody|Y
magno-cellular dorsal nucleus|magnocellular dorsal nucleus|Y
uridine diphosphoglucuronosyltransferase|uridine diphospho-glucuronosyltransferase|Y
homozygous α 1-PI deficiency|homozygous α1-PI deficiency|Y
N-methyl-N`-nitro-N-nitrosoguanidine|N-methyl-N-nitro-N-nitrosoguanidine|Y
micturating cystourethrography|micturating cysto-urethrography|Y
galactorrhea amenorrhœa hyperprolactinæmia syndrome|galactorrhea amenorrhœa hyperprolactinemia syndrome|Y
intravascular volume|intra-vascular volume|Y
intra-cerebral pathogenicity index|intracerebral pathogenicity index|Y
columnar-lined esophagus|columnar-lined oesophagus|Y
quantitative gated single photon emission computed tomography|quantitative gated single-photon emission computed tomography|Y
tumor necrosis factor receptor-associated factor 5|tumor necrosis factor receptor-associated factor 6|Y
insulin-like growth factor-II mRNA binding protein-3|insulin-like growth factor-II mRNA binding protein-2|Y
International Society of Paediatric Oncology|International Society of Pediatric Oncology|Y
pediatric Crohn's disease activity index|paediatric Crohn's disease activity index|Y
medio-basal hypothalamus|mediobasal hypothalamus|Y
tumor necrosis factor receptor superfamily member 1B|tumor necrosis factor receptor superfamily member 12|Y
tumor necrosis factor receptor superfamily member 1B|tumor necrosis factor receptor superfamily member 19|Y
neural-precursor-cell-expressed developmentally downregulated 5|neural-precursor-cell-expressed, developmentally downregulated 8|Y
neural-precursor-cell-expressed developmentally downregulated 5|neural-precursor-cell-expressed developmentally down-regulated 1|Y
neural-precursor-cell-expressed developmentally downregulated 5|neural-precursor-cell-expressed, developmentally downregulated 2|Y
TGF-β receptor type II|TGFβ receptor type II|Y
didodecyl-dimethyl ammonium bromide|didodecyl-dimethylammonium bromide|Y
activated Cdc42-associated tyrosine kinase-2|activated Cdc42 associated tyrosine kinase-2|Y
Bos taurus autosome 17|Bos taurus autosome 1|Y
acrokeratoelastoidosis|acro-keratoelastoidosis|Y
acrokeratoelastoidosis|acrokerato-elastoidosis|Y
mitogen-activated protein kinase phosphatase-1|mitogen activated protein kinase phosphatase-1|Y
mitogen-activated protein kinase phosphatase-1|mitogen-activated protein kinase phosphatase 1|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Toll-interleukin-1 receptor domain-containing adapter-inducing interferon beta|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Toll/interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
Toll-interleukin1 receptor domain-containing adapter-inducing interferon beta|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
galactorrhoea-amenorrhoea hyperprolactinæmia syndrome|galactorrhea-amenorrhoea hyperprolactinæmia syndrome|Y
galactorrhoea-amenorrhoea hyperprolactinæmia syndrome|galactorrhoea-amenorrhea hyperprolactinæmia syndrome|Y
activated Cdc42 associated tyrosine kinase-2|activated Cdc42 associated tyrosine kinase 2|Y
hyper-cholesterolaemic|hyper-cholesterolemic|Y
anti-asialo GM1 antibody|anti-asialo GM-1 antibody|Y
post-operative radiotherapy|postoperative radiotherapy|Y
surface-enhanced laser desorption ionisation|surface-enhanced laser desorption-ionisation|Y
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy|cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy|Y
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy|Y
cyclopentyladenosine|cyclo-pentyladenosine|Y
ribosomal protein L7A|ribosomal protein L7|Y
pancreatoduodenal resection|pancreato-duodenal resection|Y
neural-precursor cell-expressed, developmentally down-regulated 5|neural-precursor cell-expressed, developmentally downregulated 1|Y
American Society of Anesthesiology grade|American Society of Anesthesiology grade I|Y
homozygous α-1-proteinase inhibitor deficiency|homozygous α 1-proteinase inhibitor deficiency|Y
organic anion transporting polypeptide 2|organic anion transporting polypeptide 1|Y
retinoic acid receptor-related orphan receptor alpha|retinoic acid receptor-related orphan receptor-alpha|Y
high-speed counter-current chromatography|high speed counter-current chromatography|Y
galactorrhea-amenorrhoea hyperprolactinæmia syndrome|galactorrhoea-amenorrhea hyperprolactinæmia syndrome|Y
neural-precursor-cell-expressed, developmentally downregulated 8|neural-precursor-cell-expressed, developmentally downregulated 2|Y
Mycoplasma-like organisms|Mycoplasma-like organism|Y
a disintegrin and metalloproteinase with thrombospondin motif-13|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motif-13|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
autonomously replicating sequence|autonomously replicating sequences|Y
cytochrome P-450 2b10|cytochrome P-450 2b-10|Y
T-cell-restricted intracellular antigen-related protein|T-cell restricted intracellular antigen-related protein|Y
intraventricular hemorrhage|intra-ventricular hemorrhage|Y
anti-T-cell receptor αβ antibody|anti-T-cell receptor α β antibody|Y
estrogen receptor β knockout mouse|estrogen receptor β knock out mouse|Y
World Health Organization Quality of Life-BREF|World Health Organisation Quality of Life-BREF|Y
delayed after-depolarization|delayed afterdepolarization|Y
encephalomyosynangiosis|encephalo-myosynangiosis|Y
2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine|2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine|Y
interleukin-18 receptor alpha subunit|interleukine-18 receptor alpha subunit|Y
signal transducer and activator of transcription 6|signal transducer and activator of transcription 3|Y
American Society of Anesthesiology status|American Society of Anesthesiology status 4|Y
American Society of Anesthesiology status|American Society of Anaesthesiology status|Y
American Society of Anesthesiology status|American Society of Anesthesiology status 5|Y
Clostridium difficile–associated diarrhea|Clostridium difficile-associated diarrhea|Y
grazing-incidence small-angle X-ray scattering|grazing incidence small-angle X-ray scattering|Y
sodium coupled neutral amino acid transporter|sodium coupled neutral amino acid transporter-1|Y
otitis media with effusions|otitis media with effusion|Y
glutamate ionotropic receptor AMPA type subunit 3|glutamate ionotropic receptor AMPA type subunit 2|Y
pituitary adenylate cyclase activating polypeptide type 1 receptor|pituitary adenylate cyclase-activating polypeptide type 1 receptor|Y
cross polarisation magic-angle-spinning nuclear magnetic resonance spectroscopy|crosspolarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
superconducting quantum interference device|super-conducting quantum interference device|Y
a disintegrin and metalloproteinase with thrombospondin motifs-2|a disintegrin and metalloproteinase with thrombospondin motifs-9|Y
a disintegrin and metalloproteinase with thrombospondin motifs-2|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motifs-2|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
sodium coupled neutral amino acid transporter-1|sodium-coupled neutral amino acid transporter-1|Y
distortion product otoacoustic emission|distortion product oto-acoustic emission|Y
12-tetradecanoylphorbol-13-acetate|12-tetradecanoyl-phorbol-13-acetate|Y
sixteen-slice spiral computed tomography|sixteen slice spiral computed tomography|Y
ultraperformance liquid chromatography-electrospray ionization tandem mass spectrometry|ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry|Y
human immunodeficiency virus-hepatitis B virus coinfection|human immunodeficiency virus-hepatitis C virus coinfection|Y
Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-β|Toll/interleukin1 receptor domain-containing adapter-inducing interferon β|Y
peroxisome proliferator-activated receptor-γ co-activator-1α|peroxisome proliferator-activated receptor γ co-activator-1α|Y
peroxisome proliferator-activated receptor-γ co-activator-1α|peroxisome proliferator-activated receptor-γ co-activator-1 α|Y
hepatorenal syndrome|hepato-renal syndrome|Y
Src homology region 2 domain-containing phosphatase 2|Src homology region 2 domain-containing phosphatase|Y
Kruppel-associated box-associated protein 1|Krüppel-associated box-associated protein 1|Y
phenazine methosulfate|phenazine ethosulfate|Y
plasma insulin-like growth factor II level|plasma insulin-like growth factor I level|Y
recombinant human transforming growth factor-beta 2|recombinant human transforming growth factor-beta|Y
tumor necrosis factor receptor superfamily member 12|tumor necrosis factor receptor superfamily member 19|Y
sodium-coupled neutral amino acid transporter-3|sodium-coupled neutral amino acid transporter-1|Y
sodium-coupled neutral amino acid transporter-3|sodium-coupled neutral amino acid transporter 3|Y
melatonin receptor 1B|melatonin receptor 1|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|toll/interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Y
toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
velo-pharyngeal dysfunction|velopharyngeal dysfunction|Y
Fcγ-receptor-dependent|Fc γ-receptor-dependent|Y
non-specific cytotoxic cell receptor protein|non-specific cytotoxic cell receptor protein-1|Y
immobilized artificial membrane chromatography|immobilised artificial membrane chromatography|Y
human immunodeficiency virus type 1 subtype D|human immunodeficiency virus type 1 subtype F|Y
cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy|Y
staphylococcal cassette chromosome methicillin resistance type V|staphylococcal cassette chromosome methicillin resistance type I|Y
Fcγ receptor-mediated|Fc γ receptor-mediated|Y
ion-pair reversed-phase high-performance liquid chromatography|ion-pair reversed-phase high performance liquid chromatography|Y
5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin|5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)-tetralin|Y
conserved non-coding sequence-2|conserved noncoding sequence-2|Y
TATA-binding protein-associated factor-9|TATA-binding protein-associated factor-7|Y
TATA-binding protein-associated factor-9|TATA-binding protein-associated factor-2|Y
TATA-binding protein-associated factor-9|TATA-binding protein-associated factor-1|Y
promyelocytic leukemia/retinoic acid receptor alpha|promyelocytic leukemia-retinoic acid receptor alpha|Y
transforming growth factor-beta receptor type 1|transforming growth factor-beta receptor type 2|Y
transforming growth factor-beta receptor type 1|transforming growth factor beta receptor type 1|Y
recombinant human tumor necrosis factor-α|recombinant human tumour necrosis factor-α|Y
capillary isoelectric focusing electrospray ionisation mass spectrometry|capillary isoelectric focusing-electrospray ionisation mass spectrometry|Y
spermidine-spermine N(1)-acetyltransferase|spermidine-spermine N1-acetyltransferase|Y
electron probe x-ray microanalyser|electron probe x-ray micro-analyser|Y
American Society of Anesthesiology status 4|American Society of Anesthesiology status 5|Y
first dorsal interosseous muscle|first dorsal interosseus muscle|Y
neural precursor cell expressed developmentally down-regulated 9|neural precursor cell-expressed developmentally downregulated 9|Y
neural precursor cell expressed developmentally down-regulated 9|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell expressed developmentally down-regulated 9|neural precursor cell expressed, developmentally down-regulated 5|Y
type II heparin-induced thrombocytopenia|type II heparin induced thrombocytopenia|Y
neutrophil gelatinase associated lipocalin|neutrophil gelatinase-associated lipocalin|Y
killer immunoglobulin-like receptor 2DL2|killer immunoglobulin-like receptor 2DS2|Y
Vitamin D-dependent calcium-binding protein|vitamin D-dependent calcium-binding protein|Y
neuronal intranuclear inclusion|neuronal intra-nuclear inclusion|Y
a disintegrin and metalloproteinase with thrombospondin motifs-9|a disintegrin and metalloproteinase with thrombospondin motif-3|Y
a disintegrin and metalloproteinase with thrombospondin motifs-9|a disintegrin and metalloproteinase with thrombospondin motifs-18|Y
peroxisome proliferator-activated receptor γ co-activator 1|peroxisome proliferator-activated receptor γ co-activator 1α|Y
retinoic-acid-receptor-related orphan receptor|retinoic-acid-receptor-related orphan receptor-γ|Y
neural precursor cell-expressed developmentally down-regulated 4|neural precursor cell-expressed developmentally downregulated 9|Y
neural precursor cell-expressed developmentally down-regulated 4|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell-expressed developmentally down-regulated 4|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell-expressed developmentally down-regulated 4|neural precursor cell-expressed, developmentally down-regulated 2|Y
apolipoprotein AI-mediated|apolipoprotein A-I-mediated|Y
supraventricular arrhythmia|supra-ventricular arrhythmia|Y
peroxisome proliferator activated receptor gamma 1|peroxisome proliferator activated receptor gamma1|Y
basic-helix-loop-helix leucine zipper protein|basic-helix-loop-helix-leucine zipper protein|Y
directly observed treatment-short course|directly observed treatment short course|Y
peroxisome proliferator-activated receptor gamma co-activator 1 alpha|peroxisome proliferator-activated receptor-gamma co-activator 1 alpha|Y
peroxisome proliferator-activated receptor gamma co-activator 1 alpha|peroxisome-proliferator-activated receptor gamma coactivator 1 alpha|Y
uretero-vesical junction|ureterovesical junction|Y
Krüppel-associated box-associated protein 1|krüppel-associated box-associated protein 1|Y
human T-cell lymphotropic virus type I-associated|human T cell lymphotropic virus type I-associated|Y
American Society of Anesthesiology grade I|American Society of Anesthesiology grade II|Y
light-harvesting chlorophyll a/b binding protein I|light harvesting chlorophyll a/b binding protein I|Y
non-Hodgkin lymphoma|non-Hodgkin lymphomas|Y
anti-capsular antibody|anticapsular antibody|Y
activating signal cointegrator-2|activating signal co-integrator-2|Y
peroxisome proliferator-activated receptor γ co-activator-1α|peroxisome proliferator-activated receptor-γ co-activator-1 α|Y
peroxisome proliferator-activated receptor γ co-activator-1α|peroxisome proliferator-activated receptor γ co-activator 1α|Y
matrix-assisted laser desorption/ionization time-of-flight mass spectrometry|matrix assisted laser desorption/ionization time-of-flight mass spectrometry|Y
retinoic-acid-receptor-related orphan receptor gamma-T|retinoic-acid-receptor-related orphan receptor gamma-t|Y
polymorphonuclear granulocyte|polymorphonuclear granulocytes|Y
topoisomerase IIβ-binding protein 1|topoisomerase II β-binding protein 1|Y
neural precursor cell-expressed developmentally downregulated 9|neural precursor cell-expressed, developmentally downregulated 8|Y
neural precursor cell-expressed developmentally downregulated 9|neural precursor cell-expressed, developmentally downregulated 1|Y
neural precursor cell-expressed developmentally downregulated 9|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell-expressed, developmentally downregulated 8|neural precursor cell-expressed, developmentally downregulated 1|Y
neural precursor cell-expressed, developmentally downregulated 8|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell-expressed, developmentally downregulated 8|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell-expressed, developmentally downregulated 8|neural precursor cell-expressed, developmentally down-regulated 2|Y
matrix assisted laser desorption/ionization time-of-flight mass spectrometry|matrix assisted laser desorption/ionization time-of-flight mass spectrometric|Y
thermo-luminescence detector|thermoluminescence detector|Y
American Society of Anesthesiologists status III|American Society of Anaesthesiologists status III|Y
American Society of Anesthesiologists status III|American Society of Anaesthesiologists status II|Y
geniculo-hypothalamic tract|geniculohypothalamic tract|Y
arginine metabolism regulator II|arginine metabolism regulator I|Y
maximum tolerated dose|maximum tolerated doses|Y
N-terminal proB-type natriuretic peptide|N-terminal pro B-type natriuretic peptide|Y
pharyngoepiglottic fold|pharyngo-epiglottic fold|Y
poly(3-hydroxybutyrate-co-3-hydroxyvalerate)|poly-(3-hydroxybutyrate-co-3-hydroxyvalerate)|Y
transforming growth factor-beta 2|transforming growth factor-beta2|Y
cross-polarization/magic-angle-spinning NMR|cross-polarization/magic-angle spinning NMR|Y
orofaciodigital syndrome type VII|orofaciodigital syndrome type II|Y
tumor necrosis factor receptor associated factor-1|tumour necrosis factor receptor associated factor-1|Y
tumor necrosis factor receptor associated factor-1|tumor necrosis factor receptor associated factor-2|Y
anti-matrix metallopeptidase-3 antibody|anti-matrix metallopeptidase-13 antibody|Y
di-isopropyl-iminodiacetic acid|di-isopropyliminodiacetic acid|Y
severe combined immunodeficient repopulating cell|severe combined immunodeficient-repopulating cell|Y
peroxisome-proliferator-activated receptor gamma coactivator 1 alpha|peroxisome-proliferator-activated receptor gamma coactivator-1 alpha|Y
anti-cluster of differentiation 3 antibody|anti-cluster of differentiation 4 antibody|Y
post-spike facilitation|postspike facilitation|Y
neural precursor cell-expressed, developmentally downregulated 1|neural precursor cell-expressed, developmentally down-regulated 9|Y
neural precursor cell-expressed, developmentally downregulated 1|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell-expressed, developmentally downregulated 1|neural precursor cell-expressed, developmentally down-regulated 2|Y
neural precursor cell-expressed, developmentally downregulated 1|neural-precursor cell-expressed, developmentally downregulated 1|Y
γ-amino-butyric acid type A|γ-aminobutyric acid type A|Y
anti-β2-glycoprotein I antibody|anti-β-2-glycoprotein I antibody|Y
surface-enhanced laser desorption/ionization time of flight mass spectrometry|surface-enhanced laser desorption ionization time of flight mass spectrometry|Y
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30|European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30|Y
carcino-embryonic antigen|carcinoembryonic antigen|Y
primer extension preamplification|primer extension pre-amplification|Y
guanosine triphosphatase activating protein 1|guanosine triphosphatase-activating protein 1|Y
posttraumatic headache|post-traumatic headache|Y
American Society of Anesthesiology Class 2|American Society of Anesthesiology Class 4|Y
American Society of Anaesthesiologists status III|American Society of Anaesthesiologists status II|Y
pulsed magnetic field|pulsed magnetic fields|Y
von Hippel-Lindau tumor-suppressor protein|Von Hippel-Lindau tumor-suppressor protein|Y
recombinant human interleukin 5|recombinant human interleukin 15|Y
American Society of Anaesthesiology status|American Society of Anaesthesiology status V|Y
TATA-binding protein-associated factor-7|TATA-binding protein-associated factor-2|Y
TATA-binding protein-associated factor-7|TATA-binding protein-associated factor-1|Y
TATA-binding protein-associated factor-7|TATA-binding protein associated factor-7|Y
dithiobis(succinimidylpropionate)|dithiobis(succinimidyl propionate)|Y
type 2 corticotrophin releasing hormone receptor|type 2 corticotrophin-releasing hormone receptor|Y
amyotrophic choreo-acanthocytosis|amyotrophic choreoacanthocytosis|Y
X-ray absorption near edge structure spectrum|X-ray absorption near-edge structure spectrum|Y
vein of Galen aneurysmal malformations|vein of Galen aneurysmal malformation|Y
Society of Pediatric Urology|Society of Paediatric Urology|Y
ultrapurified polymerized bovine hemoglobin|ultrapurified polymerised bovine hemoglobin|Y
Toll-interleukin-1 receptor domain-containing adapter-inducing interferon beta|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
lithium/pilocarpine induced status epilepticus|lithium/pilocarpine-induced status epilepticus|Y
antiglomerular basement membrane antibody disease|anti-glomerular basement membrane antibody disease|Y
extracellular signal-regulated kinase-1/2|extracellular signal-regulated kinase-1|Y
matrix-assisted laser desorption ionization time of flight mass spectrometry|matrix-assisted laser desorption ionisation time of flight mass spectrometry|Y
United Network for Organ Sharing status 1|United Network for Organ Sharing status 2|Y
liquid chromatography-ion-trap mass spectrometry|liquid chromatography/ion-trap mass spectrometry|Y
glucose transporter 12|glucose transporter 2|Y
hæmatoencephalic barrier|hæmato encephalic barrier|Y
α-feto-protein level|α-foeto-protein level|Y
American Society of Anesthesiologists Grade 1|American Society of Anesthesiologists grade 1|Y
liquid chromatography/ion trap mass spectrometry|liquid chromatography/ion-trap mass spectrometry|Y
Src homology 2 domain-containing protein tyrosine phosphatase-2|Src homology 2 domain containing protein tyrosine phosphatase-2|Y
TATA-binding protein-associated factor-2|TATA-binding protein-associated factor-1|Y
American Society of Anaesthesiologists status II|American Society of Anaesthesiologists Status II|Y
trans-activation response region|transactivation response region|Y
neural precursor cell-expressed, developmentally down-regulated 9|neural precursor cell-expressed, developmentally down-regulated 4|Y
neural precursor cell-expressed, developmentally down-regulated 9|neural precursor cell-expressed, developmentally down-regulated 2|Y
anti-neutrophil cytoplasmic antibody negative|anti-neutrophil cytoplasmic antibody-negative|Y
digoxin-like substance|digoxinlike substance|Y
Ehlers Danlos syndrome type VIII|Ehlers Danlos syndrome type III|Y
peroxisome-proliferator-activated receptor-gamma coactivator-1alpha|peroxisome-proliferator-activated receptor gamma coactivator-1 alpha|Y
acid-sensing ion channel 1|acid-sensing ion channel 1b|Y
neural precursor cell-expressed, developmentally down-regulated 4|neural precursor cell-expressed, developmentally down-regulated 2|Y
Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-beta|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
recombinant human transforming growth factor beta 3|recombinant human transforming growth factor beta 1|Y
TBP associated factor-12|TBP associated factor-2|Y
anti-histocompatibility leukocyte antigen class I antibody|anti-histocompatibility leucocyte antigen class I antibody|Y
loco-regional relapse|locoregional relapse|Y
dictyosome-like structures|dictyosome-like structure|Y
light-harvesting chlorophyll a/b binding protein-II|light-harvesting chlorophyll a/b-binding protein-II|Y
(123)I-β-methyl-iodophenyl pentadecanoic acid|(123)I-β-methyl-iodophenylpentadecanoic acid|Y
American Society of Anesthesiology Grade 3|American Society of Anesthesiology Grade 1|Y
non-expressor of pathenogenesis-related genes 1|nonexpressor of pathenogenesis-related genes1|Y
non-expressor of pathenogenesis-related genes 1|nonexpressor of pathenogenesis-related genes 1|Y
surface enhanced laser desorption/ionisation time of flight mass spectrometry|surface enhanced laser desorption ionisation time of flight mass spectrometry|Y
Portland Veterans' Affairs Medical Center|Portland Veteran's Affairs Medical Center|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon beta|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
Toll/interleukin 1 receptor domain-containing adapter-inducing interferon beta|Toll-interleukin 1 receptor domain-containing adapter-inducing interferon beta|Y
glycophosphatidylinositol anchored protein|glycophosphatidylinositol-anchored protein|Y
nonmetric multi-dimensional scaling|non-metric multi-dimensional scaling|Y
toll/interleukin 1 receptor domain-containing adapter-inducing interferon-beta|Toll/interleukin1 receptor domain-containing adapter-inducing interferon-beta|Y
Ehlers Danlos syndrome type II|Ehlers Danlos syndrome type III|Y
phospho-p38 mitogen activated protein kinase|phospho-p38 mitogen-activated protein kinase|Y
phenolchloroform-petroleum ether|phenol-chloroform-petroleum ether|Y
receptor-like protein-tyrosine phosphatase-η|receptor-like protein-tyrosine phosphatase-ζ|Y
pituitary-tumor transforming gene|pituitary-tumour transforming gene|Y
a disintegrin and metalloprotease 3|a disintegrin and metalloprotease 33|Y
beta-site amyloid precursor protein-cleaving enzyme-1|beta-site amyloid precursor protein cleaving enzyme-1|Y
human T cell leukemia virus type I-infected|human T cell leukemia virus type 1-infected|Y
nonexpressor of pathenogenesis-related genes1|nonexpressor of pathenogenesis-related genes 1|Y
type 2 corticotropin-releasing hormone receptor|type 2 corticotrophin-releasing hormone receptor|Y
American Society of Anaesthesiologists physical status 4|American Society of Anaesthesiologists physical status 5|Y
solute carrier family 7 member 1|solute carrier family 7 member 14|Y
crosspolarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|cross-polarisation/magic-angle-spinning nuclear magnetic resonance spectroscopy|Y
crossed immunoelectrophoresis|crossed immuno-electrophoresis|Y
continuous veno-venous hemo-diafiltration|continuous venovenous hemo-diafiltration|Y
nonspecific urethritis|non-specific urethritis|Y
antihepatitis C virus antibody|anti-hepatitis C virus antibody|Y
tumour necrosis factor-related apoptosis-inducing ligand receptor-1|tumour necrosis factor-related apoptosis-inducing ligand receptor 1|Y
American Society of Anesthesiologists grade 1|American Society of Anesthesiologists grade 5|Y
orofaciodigital syndrome type III|orofaciodigital syndrome type II|Y
trans-esophageal Doppler|trans-oesophageal Doppler|Y
